The pellet was suspended in 1% sodium dodecyl sulfate in Tris-EDTA (TE), proteinase K was added, and the samples were incubated overnight.	[('PMC1233920', 'M01009', 73, 85, 'proteinase K')]	['The', 'pellet', 'was', 'suspended', 'in', '1', '%', 'sodium', 'dodecyl', 'sulfate', 'in', 'Tris', '-', 'EDTA', '(', 'TE', ')', ',', 'protein', '##ase', 'K', 'was', 'added', ',', 'and', 'the', 'samples', 'were', 'incubated', 'overnight', '.']	[0, 4, 11, 15, 25, 28, 29, 31, 38, 46, 54, 57, 61, 62, 67, 68, 70, 71, 73, 80, 84, 86, 90, 95, 97, 101, 105, 113, 118, 128, 137]	[3, 10, 14, 24, 27, 29, 30, 37, 45, 53, 56, 61, 62, 66, 68, 70, 71, 72, 80, 83, 85, 89, 95, 96, 100, 104, 112, 117, 127, 137, 138]	['The', 'pellet', 'was', 'suspended', 'in', '1%', 'sodium', 'dodecyl', 'sulfate', 'in', 'Tris-EDTA', '(', 'TE', ')', ',', 'proteinase', 'K', 'was', 'added', ',', 'and', 'the', 'samples', 'were', 'incubated', 'overnight', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR was performed by adding 1 μl of community DNA to a reaction mixture (50-μl final volume) containing 20 nmol of each primer, 40 nmol of deoxynucleotide triphosphates, and 1 U of Taq polymerase.	[('PMC1233920', 'M02001', 181, 195, 'Taq polymerase')]	['PCR', 'was', 'performed', 'by', 'adding', '1', 'μ', '##l', 'of', 'community', 'DNA', 'to', 'a', 'reaction', 'mixture', '(', '50', '-', 'μ', '##l', 'final', 'volume', ')', 'containing', '20', 'nmol', 'of', 'each', 'primer', ',', '40', 'nmol', 'of', 'deoxy', '##nucle', '##otide', 'trip', '##ho', '##sp', '##hat', '##es', ',', 'and', '1', 'U', 'of', 'Taq', 'polymerase', '.']	[0, 4, 8, 18, 21, 28, 30, 31, 33, 36, 46, 50, 53, 55, 64, 72, 73, 75, 76, 77, 79, 85, 91, 93, 104, 107, 112, 115, 120, 126, 128, 131, 136, 139, 144, 149, 155, 159, 161, 163, 166, 168, 170, 174, 176, 178, 181, 185, 195]	[3, 7, 17, 20, 27, 29, 31, 32, 35, 45, 49, 52, 54, 63, 71, 73, 75, 76, 77, 78, 84, 91, 92, 103, 106, 111, 114, 119, 126, 127, 130, 135, 138, 144, 149, 154, 159, 161, 163, 166, 168, 169, 173, 175, 177, 180, 184, 195, 196]	['PCR', 'was', 'performed', 'by', 'adding', '1', 'μl', 'of', 'community', 'DNA', 'to', 'a', 'reaction', 'mixture', '(', '50-μl', 'final', 'volume', ')', 'containing', '20', 'nmol', 'of', 'each', 'primer', ',', '40', 'nmol', 'of', 'deoxynucleotide', 'triphosphates', ',', 'and', '1', 'U', 'of', 'Taq', 'polymerase', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 5, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
Strains of Ruminococcus, as well as some bifidobacteria, have been defined as the major producers of extracellular glycosidases that degrade ABH and Lewis blood group active oligosaccharide chains of mucin (16, 17).	[('PMC126580', 'D06004', 101, 127, 'extracellular glycosidases')]	['Strain', '##s', 'of', 'Ru', '##min', '##ococcus', ',', 'as', 'well', 'as', 'some', 'bif', '##ido', '##ba', '##ct', '##eri', '##a', ',', 'have', 'been', 'defined', 'as', 'the', 'major', 'producers', 'of', 'extracellular', 'glycos', '##idase', '##s', 'that', 'degrade', 'AB', '##H', 'and', 'Lewis', 'blood', 'group', 'active', 'olig', '##osacchar', '##ide', 'chains', 'of', 'muc', '##in', '(', '16', ',', '17', ')', '.']	[0, 6, 8, 11, 13, 16, 23, 25, 28, 33, 36, 41, 44, 47, 49, 51, 54, 55, 57, 62, 67, 75, 78, 82, 88, 98, 101, 115, 121, 126, 128, 133, 141, 143, 145, 149, 155, 161, 167, 174, 178, 186, 190, 197, 200, 203, 206, 207, 209, 211, 213, 214]	[6, 7, 10, 13, 16, 23, 24, 27, 32, 35, 40, 44, 47, 49, 51, 54, 55, 56, 61, 66, 74, 77, 81, 87, 97, 100, 114, 121, 126, 127, 132, 140, 143, 144, 148, 154, 160, 166, 173, 178, 186, 189, 196, 199, 203, 205, 207, 209, 210, 213, 214, 215]	['Strains', 'of', 'Ruminococcus', ',', 'as', 'well', 'as', 'some', 'bifidobacteria', ',', 'have', 'been', 'defined', 'as', 'the', 'major', 'producers', 'of', 'extracellular', 'glycosidases', 'that', 'degrade', 'ABH', 'and', 'Lewis', 'blood', 'group', 'active', 'oligosaccharide', 'chains', 'of', 'mucin', '(', '16', ',', '17', ')', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA.	[('PMC126580', 'F23003', 98, 108, 'polymerase')]	['Prof', '##iling', 'of', 'complex', 'microbial', 'populations', 'by', 'den', '##aturing', 'gradient', 'gel', 'electrophoresis', 'analysis', 'of', 'polymerase', 'chain', 'reaction', '-', 'amplified', 'genes', 'coding', 'for', '16', '##S', 'rRNA', '.']	[0, 4, 10, 13, 21, 31, 43, 46, 49, 57, 66, 70, 86, 95, 98, 109, 115, 123, 124, 134, 140, 147, 151, 153, 155, 159]	[4, 9, 12, 20, 30, 42, 45, 49, 56, 65, 69, 85, 94, 97, 108, 114, 123, 124, 133, 139, 146, 150, 153, 154, 159, 160]	['Profiling', 'of', 'complex', 'microbial', 'populations', 'by', 'denaturing', 'gradient', 'gel', 'electrophoresis', 'analysis', 'of', 'polymerase', 'chain', 'reaction', '-', 'amplified', 'genes', 'coding', 'for', '16S', 'rRNA', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes.	[('PMC126580', 'F29002', 90, 100, 'polymerase')]	['Att', '##achment', 'of', 'a', '40', '-', 'base', '-', 'pair', 'G', '+', 'C', '-', 'rich', 'sequence', '(', 'GC', '-', 'clamp', ')', 'to', 'genomic', 'DNA', 'fragments', 'by', 'the', 'polymerase', 'chain', 'reaction', 'results', 'in', 'improved', 'detection', 'of', 'single', '-', 'base', 'changes', '.']	[0, 3, 11, 14, 16, 18, 19, 23, 24, 29, 30, 31, 32, 33, 38, 47, 48, 50, 51, 56, 58, 61, 69, 73, 83, 86, 90, 101, 107, 116, 124, 127, 136, 146, 149, 155, 156, 161, 168]	[3, 10, 13, 15, 18, 19, 23, 24, 28, 30, 31, 32, 33, 37, 46, 48, 50, 51, 56, 57, 60, 68, 72, 82, 85, 89, 100, 106, 115, 123, 126, 135, 145, 148, 155, 156, 160, 168, 169]	['Attachment', 'of', 'a', '40-base-', 'pair', 'G', '+', 'C-rich', 'sequence', '(', 'GC-clamp', ')', 'to', 'genomic', 'DNA', 'fragments', 'by', 'the', 'polymerase', 'chain', 'reaction', 'results', 'in', 'improved', 'detection', 'of', 'single', '-', 'base', 'changes', '.']	[2, 1, 1, 4, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCRs were performed with a Taq DNA polymerase kit from Life Technologies (Gaithersburg, Md.).	[('PMC126580', 'M02001', 27, 45, 'Taq DNA polymerase')]	['PCR', '##s', 'were', 'performed', 'with', 'a', 'Taq', 'DNA', 'polymerase', 'kit', 'from', 'Life', 'Technologies', '(', 'Ga', '##ither', '##s', '##burg', ',', 'M', '##d', '.', ')', '.']	[0, 3, 5, 10, 20, 25, 27, 31, 35, 46, 50, 55, 60, 73, 74, 76, 81, 82, 86, 88, 89, 90, 91, 92]	[3, 4, 9, 19, 24, 26, 30, 34, 45, 49, 54, 59, 72, 74, 76, 81, 82, 86, 87, 89, 90, 91, 92, 93]	['PCRs', 'were', 'performed', 'with', 'a', 'Taq', 'DNA', 'polymerase', 'kit', 'from', 'Life', 'Technologies', '(', 'Gaithersburg', ',', 'Md', '.', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Each 50-μl PCR mixture contained each deoxynucleoside triphosphate at a concentration of 10 mM, 1.25 U of Taq polymerase, 10 μmol of each primer, and 1 μl of a DNA solution.	[('PMC126580', 'M02002', 106, 120, 'Taq polymerase')]	['Each', '50', '-', 'μ', '##l', 'PCR', 'mixture', 'contained', 'each', 'deoxy', '##nucle', '##oside', 'trip', '##ho', '##sp', '##hat', '##e', 'at', 'a', 'concentration', 'of', '10', 'mM', ',', '1', '.', '25', 'U', 'of', 'Taq', 'polymerase', ',', '10', 'μ', '##mol', 'of', 'each', 'primer', ',', 'and', '1', 'μ', '##l', 'of', 'a', 'DNA', 'solution', '.']	[0, 5, 7, 8, 9, 11, 15, 23, 33, 38, 43, 48, 54, 58, 60, 62, 65, 67, 70, 72, 86, 89, 92, 94, 96, 97, 98, 101, 103, 106, 110, 120, 122, 125, 126, 130, 133, 138, 144, 146, 150, 152, 153, 155, 158, 160, 164, 172]	[4, 7, 8, 9, 10, 14, 22, 32, 37, 43, 48, 53, 58, 60, 62, 65, 66, 69, 71, 85, 88, 91, 94, 95, 97, 98, 100, 102, 105, 109, 120, 121, 124, 126, 129, 132, 137, 144, 145, 149, 151, 153, 154, 157, 159, 163, 172, 173]	['Each', '50-μl', 'PCR', 'mixture', 'contained', 'each', 'deoxynucleoside', 'triphosphate', 'at', 'a', 'concentration', 'of', '10', 'mM', ',', '1.25', 'U', 'of', 'Taq', 'polymerase', ',', '10', 'μmol', 'of', 'each', 'primer', ',', 'and', '1', 'μl', 'of', 'a', 'DNA', 'solution', '.']	[1, 4, 1, 1, 1, 1, 3, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteinase K (200 μg/ml; Roche Applied Science, Indianapolis, IN) was added to the mixture.	[('PMC1287824', 'M02001', 0, 12, 'Proteinase K')]	['Protein', '##ase', 'K', '(', '200', 'μ', '##g', '/', 'ml', ';', 'Roche', 'Applied', 'Science', ',', 'Indian', '##apolis', ',', 'IN', ')', 'was', 'added', 'to', 'the', 'mixture', '.']	[0, 7, 11, 13, 14, 18, 19, 20, 21, 23, 25, 31, 39, 46, 48, 54, 60, 62, 64, 66, 70, 76, 79, 83, 90]	[7, 10, 12, 14, 17, 19, 20, 21, 23, 24, 30, 38, 46, 47, 54, 60, 61, 64, 65, 69, 75, 78, 82, 90, 91]	['Proteinase', 'K', '(', '200', 'μg', '/', 'ml', ';', 'Roche', 'Applied', 'Science', ',', 'Indianapolis', ',', 'IN', ')', 'was', 'added', 'to', 'the', 'mixture', '.']	[2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The samples were then heated at 55°C for 2 h. Proteinase K was inactivated by heating at 95°C for 5 min.	[('PMC1287824', 'M02002', 46, 58, 'Proteinase K')]	['The', 'samples', 'were', 'then', 'heated', 'at', '55', '##°', '##C', 'for', '2', 'h', '.', 'Protein', '##ase', 'K', 'was', 'inactivated', 'by', 'heating', 'at', '95', '##°', '##C', 'for', '5', 'min', '.']	[0, 4, 12, 17, 22, 29, 32, 34, 35, 37, 41, 43, 44, 46, 53, 57, 59, 63, 75, 78, 86, 89, 91, 92, 94, 98, 100, 103]	[3, 11, 16, 21, 28, 31, 34, 35, 36, 40, 42, 44, 45, 53, 56, 58, 62, 74, 77, 85, 88, 91, 92, 93, 97, 99, 103, 104]	['The', 'samples', 'were', 'then', 'heated', 'at', '55°C', 'for', '2', 'h', '.', 'Proteinase', 'K', 'was', 'inactivated', 'by', 'heating', 'at', '95°C', 'for', '5', 'min', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One microliter of the lysed sample was added to a reaction mixture (final volume, 50 μl) containing 20 pmol of each primer, 40 nmol of deoxynucleoside triphosphates, and 1 U of Platinum Taq polymerase (Invitrogen, San Diego, CA).	[('PMC1287824', 'M03005', 186, 200, 'Taq polymerase')]	['One', 'microl', '##iter', 'of', 'the', 'lysed', 'sample', 'was', 'added', 'to', 'a', 'reaction', 'mixture', '(', 'final', 'volume', ',', '50', 'μ', '##l', ')', 'containing', '20', 'pmol', 'of', 'each', 'primer', ',', '40', 'nmol', 'of', 'deoxy', '##nucle', '##oside', 'trip', '##ho', '##sp', '##hat', '##es', ',', 'and', '1', 'U', 'of', 'Pl', '##atinum', 'Taq', 'polymerase', '(', 'Invitrogen', ',', 'San', 'Diego', ',', 'CA', ')', '.']	[0, 4, 10, 15, 18, 22, 28, 35, 39, 45, 48, 50, 59, 67, 68, 74, 80, 82, 85, 86, 87, 89, 100, 103, 108, 111, 116, 122, 124, 127, 132, 135, 140, 145, 151, 155, 157, 159, 162, 164, 166, 170, 172, 174, 177, 179, 186, 190, 201, 202, 212, 214, 218, 223, 225, 227, 228]	[3, 10, 14, 17, 21, 27, 34, 38, 44, 47, 49, 58, 66, 68, 73, 80, 81, 84, 86, 87, 88, 99, 102, 107, 110, 115, 122, 123, 126, 131, 134, 140, 145, 150, 155, 157, 159, 162, 164, 165, 169, 171, 173, 176, 179, 185, 189, 200, 202, 212, 213, 217, 223, 224, 227, 228, 229]	['One', 'microliter', 'of', 'the', 'lysed', 'sample', 'was', 'added', 'to', 'a', 'reaction', 'mixture', '(', 'final', 'volume', ',', '50', 'μl', ')', 'containing', '20', 'pmol', 'of', 'each', 'primer', ',', '40', 'nmol', 'of', 'deoxynucleoside', 'triphosphates', ',', 'and', '1', 'U', 'of', 'Platinum', 'Taq', 'polymerase', '(', 'Invitrogen', ',', 'San', 'Diego', ',', 'CA', ')', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Purified PCR-amplified 16S rRNA inserts were sequenced using an ABI Prism cycle sequencing kit (BigDye terminator cycle sequencing kit with AmpliTaq DNA polymerase FS, GeneAmp PCR system 9700; ABI).	[('PMC1287824', 'M05000', 149, 163, 'DNA polymerase')]	['Pur', '##ified', 'PCR', '-', 'amplified', '16', '##S', 'rRNA', 'inserts', 'were', 'sequenced', 'using', 'an', 'ABI', 'Prism', 'cycle', 'sequencing', 'kit', '(', 'Big', '##D', '##ye', 'termin', '##ator', 'cycle', 'sequencing', 'kit', 'with', 'Ampl', '##i', '##Ta', '##q', 'DNA', 'polymerase', 'FS', ',', 'Gene', '##Am', '##p', 'PCR', 'system', '97', '##00', ';', 'ABI', ')', '.']	[0, 3, 9, 12, 13, 23, 25, 27, 32, 40, 45, 55, 61, 64, 68, 74, 80, 91, 95, 96, 99, 100, 103, 109, 114, 120, 131, 135, 140, 144, 145, 147, 149, 153, 164, 166, 168, 172, 174, 176, 180, 187, 189, 191, 193, 196, 197]	[3, 8, 12, 13, 22, 25, 26, 31, 39, 44, 54, 60, 63, 67, 73, 79, 90, 94, 96, 99, 100, 102, 109, 113, 119, 130, 134, 139, 144, 145, 147, 148, 152, 163, 166, 167, 172, 174, 175, 179, 186, 189, 191, 192, 196, 197, 198]	['Purified', 'PCR-amplified', '16S', 'rRNA', 'inserts', 'were', 'sequenced', 'using', 'an', 'ABI', 'Prism', 'cycle', 'sequencing', 'kit', '(', 'BigDye', 'terminator', 'cycle', 'sequencing', 'kit', 'with', 'AmpliTaq', 'DNA', 'polymerase', 'FS', ',', 'GeneAmp', 'PCR', 'system', '9700', ';', 'ABI', ')', '.']	[2, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A novel class of CoA-transferase involved in short-chain fatty acid metabolism in butyrate-producing human colonic bacteria.	[('PMC1698357', 'F07002', 17, 32, 'CoA-transferase')]	['A', 'novel', 'class', 'of', 'Co', '##A', '-', 'transfer', '##ase', 'involved', 'in', 'short', '-', 'chain', 'fatty', 'acid', 'metabolism', 'in', 'but', '##yrate', '-', 'producing', 'human', 'colonic', 'bacteria', '.']	[0, 2, 8, 14, 17, 19, 20, 21, 29, 33, 42, 45, 50, 51, 57, 63, 68, 79, 82, 85, 90, 91, 101, 107, 115, 123]	[1, 7, 13, 16, 19, 20, 21, 29, 32, 41, 44, 50, 51, 56, 62, 67, 78, 81, 85, 90, 91, 100, 106, 114, 123, 124]	['A', 'novel', 'class', 'of', 'CoA-transferase', 'involved', 'in', 'short', '-', 'chain', 'fatty', 'acid', 'metabolism', 'in', 'butyrate', '-', 'producing', 'human', 'colonic', 'bacteria', '.']	[1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.	[('PMC1698357', 'F12003', 6, 26, 'beta-D-galactosidase')]	"['Fe', '##cal', 'beta', '-', 'D', '-', 'galact', '##osidase', 'production', 'and', 'Bi', '##fi', '##do', '##ba', '##ct', '##eri', '##a', 'are', 'decreased', 'in', 'Crohn', ""'"", 's', 'disease', '.']"	[0, 2, 6, 10, 11, 12, 13, 19, 27, 38, 42, 44, 46, 48, 50, 52, 55, 57, 61, 71, 74, 79, 80, 82, 89]	[2, 5, 10, 11, 12, 13, 19, 26, 37, 41, 44, 46, 48, 50, 52, 55, 56, 60, 70, 73, 79, 80, 81, 89, 90]	"['Fecal', 'beta-D-galactosidase', 'production', 'and', 'Bifidobacteria', 'are', 'decreased', 'in', ""Crohn's"", 'disease', '.']"	[2, 6, 1, 1, 7, 1, 1, 1, 3, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA.	[('PMC1698357', 'F35002', 98, 108, 'polymerase')]	['Prof', '##iling', 'of', 'complex', 'microbial', 'populations', 'by', 'den', '##aturing', 'gradient', 'gel', 'electrophoresis', 'analysis', 'of', 'polymerase', 'chain', 'reaction', '-', 'amplified', 'genes', 'coding', 'for', '16', '##S', 'rRNA', '.']	[0, 4, 10, 13, 21, 31, 43, 46, 49, 57, 66, 70, 86, 95, 98, 109, 115, 123, 124, 134, 140, 147, 151, 153, 155, 159]	[4, 9, 12, 20, 30, 42, 45, 49, 56, 65, 69, 85, 94, 97, 108, 114, 123, 124, 133, 139, 146, 150, 153, 154, 159, 160]	['Profiling', 'of', 'complex', 'microbial', 'populations', 'by', 'denaturing', 'gradient', 'gel', 'electrophoresis', 'analysis', 'of', 'polymerase', 'chain', 'reaction', '-', 'amplified', 'genes', 'coding', 'for', '16S', 'rRNA', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Extracts were treated with DNase-free RNase (100 μg/ml), and the DNA concentration was determined using a Nanodrop spectrophotometer.	[('PMC1698357', 'M01001', 27, 32, 'DNase'), ('PMC1698357', 'M01001', 38, 43, 'RNase')]	['Extr', '##acts', 'were', 'treated', 'with', 'DNase', '-', 'free', 'RNase', '(', '100', 'μ', '##g', '/', 'ml', ')', ',', 'and', 'the', 'DNA', 'concentration', 'was', 'determined', 'using', 'a', 'Nano', '##drop', 'spectrophot', '##ometer', '.']	[0, 4, 9, 14, 22, 27, 32, 33, 38, 44, 45, 49, 50, 51, 52, 54, 55, 57, 61, 65, 69, 83, 87, 98, 104, 106, 110, 115, 126, 132]	[4, 8, 13, 21, 26, 32, 33, 37, 43, 45, 48, 50, 51, 52, 54, 55, 56, 60, 64, 68, 82, 86, 97, 103, 105, 110, 114, 126, 132, 133]	['Extracts', 'were', 'treated', 'with', 'DNase', '-', 'free', 'RNase', '(', '100', 'μg', '/', 'ml', ')', ',', 'and', 'the', 'DNA', 'concentration', 'was', 'determined', 'using', 'a', 'Nanodrop', 'spectrophotometer', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR mixtures of 50 μl contained 1× buffer (20 mM Tris, pH 8.4, 50 mM KCl), 3 mM MgCl2, 200 μM of each deoxynucleoside triphosphate, 1.25 U of Taq polymerase (Invitrogen, United Kingdom), and 10 pmol of each primer.	[('PMC1698357', 'M02002', 142, 156, 'Taq polymerase')]	['PCR', 'mixtures', 'of', '50', 'μ', '##l', 'contained', '1', '##×', 'buffer', '(', '20', 'mM', 'Tris', ',', 'pH', '8', '.', '4', ',', '50', 'mM', 'KCl', ')', ',', '3', 'mM', 'MgCl', '##2', ',', '200', 'μ', '##M', 'of', 'each', 'deoxy', '##nucle', '##oside', 'trip', '##ho', '##sp', '##hat', '##e', ',', '1', '.', '25', 'U', 'of', 'Taq', 'polymerase', '(', 'Invitrogen', ',', 'United', 'Kingdom', ')', ',', 'and', '10', 'pmol', 'of', 'each', 'primer', '.']	[0, 4, 13, 16, 19, 20, 22, 32, 33, 35, 42, 43, 46, 49, 53, 55, 58, 59, 60, 61, 63, 66, 69, 72, 73, 75, 77, 80, 84, 85, 87, 91, 92, 94, 97, 102, 107, 112, 118, 122, 124, 126, 129, 130, 132, 133, 134, 137, 139, 142, 146, 157, 158, 168, 170, 177, 184, 185, 187, 191, 194, 199, 202, 207, 213]	[3, 12, 15, 18, 20, 21, 31, 33, 34, 41, 43, 45, 48, 53, 54, 57, 59, 60, 61, 62, 65, 68, 72, 73, 74, 76, 79, 84, 85, 86, 90, 92, 93, 96, 101, 107, 112, 117, 122, 124, 126, 129, 130, 131, 133, 134, 136, 138, 141, 145, 156, 158, 168, 169, 176, 184, 185, 186, 190, 193, 198, 201, 206, 213, 214]	['PCR', 'mixtures', 'of', '50', 'μl', 'contained', '1×', 'buffer', '(', '20', 'mM', 'Tris', ',', 'pH', '8.4', ',', '50', 'mM', 'KCl', ')', ',', '3', 'mM', 'MgCl2', ',', '200', 'μM', 'of', 'each', 'deoxynucleoside', 'triphosphate', ',', '1.25', 'U', 'of', 'Taq', 'polymerase', '(', 'Invitrogen', ',', 'United', 'Kingdom', ')', ',', 'and', '10', 'pmol', 'of', 'each', 'primer', '.']	[1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 3, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In all cases, reactions were carried out with Red Taq DNA polymerase ready mix (25 μl; Sigma, Poole, Dorset, United Kingdom), HDA primers (2 μl of each, 5 μM), nanopure water (16 μl), and extracted community DNA (5 μl, corresponding to ca.10 ng).	[('PMC1796972', 'M03003', 50, 68, 'Taq DNA polymerase')]	['In', 'all', 'cases', ',', 'reactions', 'were', 'carried', 'out', 'with', 'Red', 'Taq', 'DNA', 'polymerase', 'ready', 'mix', '(', '25', 'μ', '##l', ';', 'Sigma', ',', 'Po', '##ole', ',', 'Dor', '##set', ',', 'United', 'Kingdom', ')', ',', 'HD', '##A', 'primers', '(', '2', 'μ', '##l', 'of', 'each', ',', '5', 'μ', '##M', ')', ',', 'nanop', '##ure', 'water', '(', '16', 'μ', '##l', ')', ',', 'and', 'extracted', 'community', 'DNA', '(', '5', 'μ', '##l', ',', 'corresponding', 'to', 'ca', '.', '10', 'ng', ')', '.']	[0, 3, 7, 12, 14, 24, 29, 37, 41, 46, 50, 54, 58, 69, 75, 79, 80, 83, 84, 85, 87, 92, 94, 96, 99, 101, 104, 107, 109, 116, 123, 124, 126, 128, 130, 138, 139, 141, 142, 144, 147, 151, 153, 155, 156, 157, 158, 160, 165, 169, 175, 176, 179, 180, 181, 182, 184, 188, 198, 208, 212, 213, 215, 216, 217, 219, 233, 236, 238, 239, 242, 244, 245]	[2, 6, 12, 13, 23, 28, 36, 40, 45, 49, 53, 57, 68, 74, 78, 80, 82, 84, 85, 86, 92, 93, 96, 99, 100, 104, 107, 108, 115, 123, 124, 125, 128, 129, 137, 139, 140, 142, 143, 146, 151, 152, 154, 156, 157, 158, 159, 165, 168, 174, 176, 178, 180, 181, 182, 183, 187, 197, 207, 211, 213, 214, 216, 217, 218, 232, 235, 238, 239, 241, 244, 245, 246]	['In', 'all', 'cases', ',', 'reactions', 'were', 'carried', 'out', 'with', 'Red', 'Taq', 'DNA', 'polymerase', 'ready', 'mix', '(', '25', 'μl', ';', 'Sigma', ',', 'Poole', ',', 'Dorset', ',', 'United', 'Kingdom', ')', ',', 'HDA', 'primers', '(', '2', 'μl', 'of', 'each', ',', '5', 'μM', ')', ',', 'nanopure', 'water', '(', '16', 'μl', ')', ',', 'and', 'extracted', 'community', 'DNA', '(', '5', 'μl', ',', 'corresponding', 'to', 'ca.10', 'ng', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among the abundant proteins secreted by cercariae was the cercarial protease that has been implicated in degradation of host proteins, secreted proteins proposed to mediate immune invasion by larvae, and proteins implicated in protection of parasites against oxidative stress.	[('PMC2467291', 'A01004', 68, 76, 'protease')]	['Among', 'the', 'abundant', 'proteins', 'secreted', 'by', 'cer', '##car', '##iae', 'was', 'the', 'cer', '##car', '##ial', 'protease', 'that', 'has', 'been', 'implicated', 'in', 'degradation', 'of', 'host', 'proteins', ',', 'secreted', 'proteins', 'proposed', 'to', 'mediate', 'immune', 'invasion', 'by', 'larvae', ',', 'and', 'proteins', 'implicated', 'in', 'protection', 'of', 'parasites', 'against', 'oxidative', 'stress', '.']	[0, 6, 10, 19, 28, 37, 40, 43, 46, 50, 54, 58, 61, 64, 68, 77, 82, 86, 91, 102, 105, 117, 120, 125, 133, 135, 144, 153, 162, 165, 173, 180, 189, 192, 198, 200, 204, 213, 224, 227, 238, 241, 251, 259, 269, 275]	[5, 9, 18, 27, 36, 39, 43, 46, 49, 53, 57, 61, 64, 67, 76, 81, 85, 90, 101, 104, 116, 119, 124, 133, 134, 143, 152, 161, 164, 172, 179, 188, 191, 198, 199, 203, 212, 223, 226, 237, 240, 250, 258, 268, 275, 276]	['Among', 'the', 'abundant', 'proteins', 'secreted', 'by', 'cercariae', 'was', 'the', 'cercarial', 'protease', 'that', 'has', 'been', 'implicated', 'in', 'degradation', 'of', 'host', 'proteins', ',', 'secreted', 'proteins', 'proposed', 'to', 'mediate', 'immune', 'invasion', 'by', 'larvae', ',', 'and', 'proteins', 'implicated', 'in', 'protection', 'of', 'parasites', 'against', 'oxidative', 'stress', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There were, however, abundant immunoglobulins, complement factors, and serine protease inhibitors in skin.	[('PMC2467291', 'A01009', 71, 86, 'serine protease')]	['There', 'were', ',', 'however', ',', 'abundant', 'immunoglobulin', '##s', ',', 'complement', 'factors', ',', 'and', 'serine', 'protease', 'inhibitors', 'in', 'skin', '.']	[0, 6, 10, 12, 19, 21, 30, 44, 45, 47, 58, 65, 67, 71, 78, 87, 98, 101, 105]	[5, 10, 11, 19, 20, 29, 44, 45, 46, 57, 65, 66, 70, 77, 86, 97, 100, 105, 106]	['There', 'were', ',', 'however', ',', 'abundant', 'immunoglobulins', ',', 'complement', 'factors', ',', 'and', 'serine', 'protease', 'inhibitors', 'in', 'skin', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O']
Abundant immunoglobulins, complement factors, and serine protease inhibitors in skin form a biochemical barrier that complements the structural barrier of the epidermis, basement membrane, and dermis.	[('PMC2467291', 'A02003', 50, 65, 'serine protease')]	['Ab', '##undant', 'immunoglobulin', '##s', ',', 'complement', 'factors', ',', 'and', 'serine', 'protease', 'inhibitors', 'in', 'skin', 'form', 'a', 'biochemical', 'barrier', 'that', 'complement', '##s', 'the', 'structural', 'barrier', 'of', 'the', 'epidermis', ',', 'basement', 'membrane', ',', 'and', 'derm', '##is', '.']	[0, 2, 9, 23, 24, 26, 37, 44, 46, 50, 57, 66, 77, 80, 85, 90, 92, 104, 112, 117, 127, 129, 133, 144, 152, 155, 159, 168, 170, 179, 187, 189, 193, 197, 199]	[2, 8, 23, 24, 25, 36, 44, 45, 49, 56, 65, 76, 79, 84, 89, 91, 103, 111, 116, 127, 128, 132, 143, 151, 154, 158, 168, 169, 178, 187, 188, 192, 197, 199, 200]	['Abundant', 'immunoglobulins', ',', 'complement', 'factors', ',', 'and', 'serine', 'protease', 'inhibitors', 'in', 'skin', 'form', 'a', 'biochemical', 'barrier', 'that', 'complements', 'the', 'structural', 'barrier', 'of', 'the', 'epidermis', ',', 'basement', 'membrane', ',', 'and', 'dermis', '.']	[2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The fragmentation of some of these host proteins suggests that breaching of host defenses by cercariae includes specific degradation of immunoglobulins and complement, and either degradation of, or overwhelming the host protease inhibitor repertoire.	[('PMC2467291', 'A02004', 220, 228, 'protease')]	['The', 'fragmentation', 'of', 'some', 'of', 'these', 'host', 'proteins', 'suggests', 'that', 'bre', '##aching', 'of', 'host', 'defense', '##s', 'by', 'cer', '##car', '##iae', 'includes', 'specific', 'degradation', 'of', 'immunoglobulin', '##s', 'and', 'complement', ',', 'and', 'either', 'degradation', 'of', ',', 'or', 'overwhel', '##ming', 'the', 'host', 'protease', 'inhibitor', 'repertoire', '.']	[0, 4, 18, 21, 26, 29, 35, 40, 49, 58, 63, 66, 73, 76, 81, 88, 90, 93, 96, 99, 103, 112, 121, 133, 136, 150, 152, 156, 166, 168, 172, 179, 191, 193, 195, 198, 206, 211, 215, 220, 229, 239, 249]	[3, 17, 20, 25, 28, 34, 39, 48, 57, 62, 66, 72, 75, 80, 88, 89, 92, 96, 99, 102, 111, 120, 132, 135, 150, 151, 155, 166, 167, 171, 178, 190, 193, 194, 197, 206, 210, 214, 219, 228, 238, 249, 250]	['The', 'fragmentation', 'of', 'some', 'of', 'these', 'host', 'proteins', 'suggests', 'that', 'breaching', 'of', 'host', 'defenses', 'by', 'cercariae', 'includes', 'specific', 'degradation', 'of', 'immunoglobulins', 'and', 'complement', ',', 'and', 'either', 'degradation', 'of', ',', 'or', 'overwhelming', 'the', 'host', 'protease', 'inhibitor', 'repertoire', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O']
The fragmentation of some of these host proteins suggests that breaching of host defenses by cercariae includes specific degradation of immune response proteins and overwhelming the host protease inhibitor repertoire.	[('PMC2467291', 'A03007', 187, 195, 'protease')]	['The', 'fragmentation', 'of', 'some', 'of', 'these', 'host', 'proteins', 'suggests', 'that', 'bre', '##aching', 'of', 'host', 'defense', '##s', 'by', 'cer', '##car', '##iae', 'includes', 'specific', 'degradation', 'of', 'immune', 'response', 'proteins', 'and', 'overwhel', '##ming', 'the', 'host', 'protease', 'inhibitor', 'repertoire', '.']	[0, 4, 18, 21, 26, 29, 35, 40, 49, 58, 63, 66, 73, 76, 81, 88, 90, 93, 96, 99, 103, 112, 121, 133, 136, 143, 152, 161, 165, 173, 178, 182, 187, 196, 206, 216]	[3, 17, 20, 25, 28, 34, 39, 48, 57, 62, 66, 72, 75, 80, 88, 89, 92, 96, 99, 102, 111, 120, 132, 135, 142, 151, 160, 164, 173, 177, 181, 186, 195, 205, 216, 217]	['The', 'fragmentation', 'of', 'some', 'of', 'these', 'host', 'proteins', 'suggests', 'that', 'breaching', 'of', 'host', 'defenses', 'by', 'cercariae', 'includes', 'specific', 'degradation', 'of', 'immune', 'response', 'proteins', 'and', 'overwhelming', 'the', 'host', 'protease', 'inhibitor', 'repertoire', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O']
The resolution of mass spectrometry following tryptic digest may also not identify peptide fragments generated from host proteins that are targets for cercarial protease, or other protease activity.	[('PMC2467291', 'D00005', 161, 169, 'protease'), ('PMC2467291', 'D00005', 180, 188, 'protease')]	['The', 'resolution', 'of', 'mass', 'spectrometry', 'following', 'tryp', '##tic', 'diges', '##t', 'may', 'also', 'not', 'identify', 'peptide', 'fragments', 'generated', 'from', 'host', 'proteins', 'that', 'are', 'targets', 'for', 'cer', '##car', '##ial', 'protease', ',', 'or', 'other', 'protease', 'activity', '.']	[0, 4, 15, 18, 23, 36, 46, 50, 54, 59, 61, 65, 70, 74, 83, 91, 101, 111, 116, 121, 130, 135, 139, 147, 151, 154, 157, 161, 169, 171, 174, 180, 189, 197]	[3, 14, 17, 22, 35, 45, 50, 53, 59, 60, 64, 69, 73, 82, 90, 100, 110, 115, 120, 129, 134, 138, 146, 150, 154, 157, 160, 169, 170, 173, 179, 188, 197, 198]	['The', 'resolution', 'of', 'mass', 'spectrometry', 'following', 'tryptic', 'digest', 'may', 'also', 'not', 'identify', 'peptide', 'fragments', 'generated', 'from', 'host', 'proteins', 'that', 'are', 'targets', 'for', 'cercarial', 'protease', ',', 'or', 'other', 'protease', 'activity', '.']	[1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'S', 'O', 'O']
Previous studies have implicated a small gene family of closely related serine proteases, called cercarial elastase, in facilitating this invasion in one species of schistosome, S. mansoni[13],[14].	[('PMC2467291', 'D01002', 72, 88, 'serine proteases'), ('PMC2467291', 'D01002', 107, 115, 'elastase')]	['Previous', 'studies', 'have', 'implicated', 'a', 'small', 'gene', 'family', 'of', 'closely', 'related', 'serine', 'proteases', ',', 'called', 'cer', '##car', '##ial', 'elast', '##ase', ',', 'in', 'facilitating', 'this', 'invasion', 'in', 'one', 'species', 'of', 'sch', '##ist', '##osome', ',', 'S', '.', 'man', '##son', '##i', '[', '13', ']', ',', '[', '14', ']', '.']	[0, 9, 17, 22, 33, 35, 41, 46, 53, 56, 64, 72, 79, 88, 90, 97, 100, 103, 107, 112, 115, 117, 120, 133, 138, 147, 150, 154, 162, 165, 168, 171, 176, 178, 179, 181, 184, 187, 188, 189, 191, 192, 193, 194, 196, 197]	[8, 16, 21, 32, 34, 40, 45, 52, 55, 63, 71, 78, 88, 89, 96, 100, 103, 106, 112, 115, 116, 119, 132, 137, 146, 149, 153, 161, 164, 168, 171, 176, 177, 179, 180, 184, 187, 188, 189, 191, 192, 193, 194, 196, 197, 198]	['Previous', 'studies', 'have', 'implicated', 'a', 'small', 'gene', 'family', 'of', 'closely', 'related', 'serine', 'proteases', ',', 'called', 'cercarial', 'elastase', ',', 'in', 'facilitating', 'this', 'invasion', 'in', 'one', 'species', 'of', 'schistosome', ',', 'S', '.', 'mansoni[13],[14]', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 10, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cercarial elastase was identified as a major component of acetabular gland secretions by proteomic analyses of artificially activated cercariae [11],[12].	[('PMC2467291', 'D01004', 10, 18, 'elastase')]	['Cer', '##car', '##ial', 'elast', '##ase', 'was', 'identified', 'as', 'a', 'major', 'component', 'of', 'acet', '##abular', 'gland', 'secretion', '##s', 'by', 'proteomic', 'analyses', 'of', 'artificially', 'activated', 'cer', '##car', '##iae', '[', '11', ']', ',', '[', '12', ']', '.']	[0, 3, 6, 10, 15, 19, 23, 34, 37, 39, 45, 55, 58, 62, 69, 75, 84, 86, 89, 99, 108, 111, 124, 134, 137, 140, 144, 145, 147, 148, 149, 150, 152, 153]	[3, 6, 9, 15, 18, 22, 33, 36, 38, 44, 54, 57, 62, 68, 74, 84, 85, 88, 98, 107, 110, 123, 133, 137, 140, 143, 145, 147, 148, 149, 150, 152, 153, 154]	['Cercarial', 'elastase', 'was', 'identified', 'as', 'a', 'major', 'component', 'of', 'acetabular', 'gland', 'secretions', 'by', 'proteomic', 'analyses', 'of', 'artificially', 'activated', 'cercariae', '[11],[12]', '.']	[3, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 3, 7, 1]	['O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This present analysis of proteins detected during cercarial invasion of recently harvested human skin confirms that this protease is a major secretory product released during skin invasion.	[('PMC2467291', 'D01005', 121, 129, 'protease')]	['This', 'present', 'analysis', 'of', 'proteins', 'detected', 'during', 'cer', '##car', '##ial', 'invasion', 'of', 'recently', 'harvested', 'human', 'skin', 'confirms', 'that', 'this', 'protease', 'is', 'a', 'major', 'secretory', 'product', 'released', 'during', 'skin', 'invasion', '.']	[0, 5, 13, 22, 25, 34, 43, 50, 53, 56, 60, 69, 72, 81, 91, 97, 102, 111, 116, 121, 130, 133, 135, 141, 151, 159, 168, 175, 180, 188]	[4, 12, 21, 24, 33, 42, 49, 53, 56, 59, 68, 71, 80, 90, 96, 101, 110, 115, 120, 129, 132, 134, 140, 150, 158, 167, 174, 179, 188, 189]	['This', 'present', 'analysis', 'of', 'proteins', 'detected', 'during', 'cercarial', 'invasion', 'of', 'recently', 'harvested', 'human', 'skin', 'confirms', 'that', 'this', 'protease', 'is', 'a', 'major', 'secretory', 'product', 'released', 'during', 'skin', 'invasion', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Most of the peptides detected as cercarial elastase were in the range of 26 to 37 kDa on a one-dimensional SDS-PAGE.	[('PMC2467291', 'D01006', 43, 51, 'elastase')]	['Most', 'of', 'the', 'peptides', 'detected', 'as', 'cer', '##car', '##ial', 'elast', '##ase', 'were', 'in', 'the', 'range', 'of', '26', 'to', '37', 'kDa', 'on', 'a', 'one', '-', 'dimensional', 'SDS', '-', 'PA', '##GE', '.']	[0, 5, 8, 12, 21, 30, 33, 36, 39, 43, 48, 52, 57, 60, 64, 70, 73, 76, 79, 82, 86, 89, 91, 94, 95, 107, 110, 111, 113, 115]	[4, 7, 11, 20, 29, 32, 36, 39, 42, 48, 51, 56, 59, 63, 69, 72, 75, 78, 81, 85, 88, 90, 94, 95, 106, 110, 111, 113, 115, 116]	['Most', 'of', 'the', 'peptides', 'detected', 'as', 'cercarial', 'elastase', 'were', 'in', 'the', 'range', 'of', '26', 'to', '37', 'kDa', 'on', 'a', 'one', '-', 'dimensional', 'SDS-PAGE', '.']	[1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, peptides were also detected in the 15 to 19-kDa range, consistent with a known autocatalytic product of cercarial elastase turnover identified in biochemical studies as 17 kDa [31].	[('PMC2467291', 'D01008', 123, 131, 'elastase')]	['However', ',', 'peptides', 'were', 'also', 'detected', 'in', 'the', '15', 'to', '19', '-', 'kDa', 'range', ',', 'consistent', 'with', 'a', 'known', 'auto', '##catal', '##ytic', 'product', 'of', 'cer', '##car', '##ial', 'elast', '##ase', 'turnover', 'identified', 'in', 'biochemical', 'studies', 'as', '17', 'kDa', '[', '31', ']', '.']	[0, 7, 9, 18, 23, 28, 37, 40, 44, 47, 50, 52, 53, 57, 62, 64, 75, 80, 82, 88, 92, 97, 102, 110, 113, 116, 119, 123, 128, 132, 141, 152, 155, 167, 175, 178, 181, 185, 186, 188, 189]	[7, 8, 17, 22, 27, 36, 39, 43, 46, 49, 52, 53, 56, 62, 63, 74, 79, 81, 87, 92, 97, 101, 109, 112, 116, 119, 122, 128, 131, 140, 151, 154, 166, 174, 177, 180, 184, 186, 188, 189, 190]	['However', ',', 'peptides', 'were', 'also', 'detected', 'in', 'the', '15', 'to', '19-kDa', 'range', ',', 'consistent', 'with', 'a', 'known', 'autocatalytic', 'product', 'of', 'cercarial', 'elastase', 'turnover', 'identified', 'in', 'biochemical', 'studies', 'as', '17', 'kDa', '[', '31', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cercarial elastase peptides were also found at 64 kDa in early invasion, along with alpha-1-antitrypsin peptides, suggesting the formation of a complex.	[('PMC2467291', 'D01009', 10, 18, 'elastase')]	['Cer', '##car', '##ial', 'elast', '##ase', 'peptides', 'were', 'also', 'found', 'at', '64', 'kDa', 'in', 'early', 'invasion', ',', 'along', 'with', 'alpha', '-', '1', '-', 'antit', '##ryp', '##sin', 'peptides', ',', 'suggesting', 'the', 'formation', 'of', 'a', 'complex', '.']	[0, 3, 6, 10, 15, 19, 28, 33, 38, 44, 47, 50, 54, 57, 63, 71, 73, 79, 84, 89, 90, 91, 92, 97, 100, 104, 112, 114, 125, 129, 139, 142, 144, 151]	[3, 6, 9, 15, 18, 27, 32, 37, 43, 46, 49, 53, 56, 62, 71, 72, 78, 83, 89, 90, 91, 92, 97, 100, 103, 112, 113, 124, 128, 138, 141, 143, 151, 152]	['Cercarial', 'elastase', 'peptides', 'were', 'also', 'found', 'at', '64', 'kDa', 'in', 'early', 'invasion', ',', 'along', 'with', 'alpha-1-antitrypsin', 'peptides', ',', 'suggesting', 'the', 'formation', 'of', 'a', 'complex', '.']	[3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among these latter proteins are the cercarial elastase itself, which may degrade host immunoglobulins [35], as well as SPO-1, T-cell stimulating antigen (11 kD) and paramyosin.	[('PMC2467291', 'D02005', 46, 54, 'elastase')]	['Among', 'these', 'latter', 'proteins', 'are', 'the', 'cer', '##car', '##ial', 'elast', '##ase', 'itself', ',', 'which', 'may', 'degrade', 'host', 'immunoglobulin', '##s', '[', '35', ']', ',', 'as', 'well', 'as', 'SP', '##O', '-', '1', ',', 'T', '-', 'cell', 'stimulating', 'antigen', '(', '11', 'k', '##D', ')', 'and', 'param', '##yo', '##sin', '.']	[0, 6, 12, 19, 28, 32, 36, 39, 42, 46, 51, 55, 61, 63, 69, 73, 81, 86, 100, 102, 103, 105, 106, 108, 111, 116, 119, 121, 122, 123, 124, 126, 127, 128, 133, 145, 153, 154, 157, 158, 159, 161, 165, 170, 172, 175]	[5, 11, 18, 27, 31, 35, 39, 42, 45, 51, 54, 61, 62, 68, 72, 80, 85, 100, 101, 103, 105, 106, 107, 110, 115, 118, 121, 122, 123, 124, 125, 127, 128, 132, 144, 152, 154, 156, 158, 159, 160, 164, 170, 172, 175, 176]	['Among', 'these', 'latter', 'proteins', 'are', 'the', 'cercarial', 'elastase', 'itself', ',', 'which', 'may', 'degrade', 'host', 'immunoglobulins', '[', '35', ']', ',', 'as', 'well', 'as', 'SPO-1', ',', 'T-cell', 'stimulating', 'antigen', '(', '11', 'kD', ')', 'and', 'paramyosin', '.']	[1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 2, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The so-called “pre-acetabular glands” are known to contain high concentrations of calcium, the exact function of which unknown, although it was proposed that a high calcium concentrations might serve as post-translational regulation of protease activity [36].	[('PMC2467291', 'D03001', 236, 244, 'protease')]	['The', 'so', '-', 'called', '“', 'pre', '-', 'acet', '##abular', 'glands', '”', 'are', 'known', 'to', 'contain', 'high', 'concentrations', 'of', 'calcium', ',', 'the', 'exact', 'function', 'of', 'which', 'unknown', ',', 'although', 'it', 'was', 'proposed', 'that', 'a', 'high', 'calcium', 'concentrations', 'might', 'serve', 'as', 'post', '-', 'translational', 'regulation', 'of', 'protease', 'activity', '[', '36', ']', '.']	[0, 4, 6, 7, 14, 15, 18, 19, 23, 30, 36, 38, 42, 48, 51, 59, 64, 79, 82, 89, 91, 95, 101, 110, 113, 119, 126, 128, 137, 140, 144, 153, 158, 160, 165, 173, 188, 194, 200, 203, 207, 208, 222, 233, 236, 245, 254, 255, 257, 258]	[3, 6, 7, 13, 15, 18, 19, 23, 29, 36, 37, 41, 47, 50, 58, 63, 78, 81, 89, 90, 94, 100, 109, 112, 118, 126, 127, 136, 139, 143, 152, 157, 159, 164, 172, 187, 193, 199, 202, 207, 208, 221, 232, 235, 244, 253, 255, 257, 258, 259]	['The', 'so', '-', 'called', '“', 'pre', '-', 'acetabular', 'glands', '”', 'are', 'known', 'to', 'contain', 'high', 'concentrations', 'of', 'calcium', ',', 'the', 'exact', 'function', 'of', 'which', 'unknown', ',', 'although', 'it', 'was', 'proposed', 'that', 'a', 'high', 'calcium', 'concentrations', 'might', 'serve', 'as', 'post', '-', 'translational', 'regulation', 'of', 'protease', 'activity', '[', '36', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O']
At the later (120 min) stage of invasion, cercariae released enzymes implicated in protection against oxidative stress, including GST-26, thioredoxin peroxidase and superoxide dismutase [21],[37],[38].	[('PMC2467291', 'D04000', 138, 160, 'thioredoxin peroxidase'), ('PMC2467291', 'D04000', 165, 185, 'superoxide dismutase')]	['At', 'the', 'later', '(', '120', 'min', ')', 'stage', 'of', 'invasion', ',', 'cer', '##car', '##iae', 'released', 'enzymes', 'implicated', 'in', 'protection', 'against', 'oxidative', 'stress', ',', 'including', 'GST', '-', '26', ',', 'thi', '##ored', '##oxin', 'peroxidase', 'and', 'superoxide', 'dismutase', '[', '21', ']', ',', '[', '37', ']', ',', '[', '38', ']', '.']	[0, 3, 7, 13, 14, 18, 21, 23, 29, 32, 40, 42, 45, 48, 52, 61, 69, 80, 83, 94, 102, 112, 118, 120, 130, 133, 134, 136, 138, 141, 145, 150, 161, 165, 176, 186, 187, 189, 190, 191, 192, 194, 195, 196, 197, 199, 200]	[2, 6, 12, 14, 17, 21, 22, 28, 31, 40, 41, 45, 48, 51, 60, 68, 79, 82, 93, 101, 111, 118, 119, 129, 133, 134, 136, 137, 141, 145, 149, 160, 164, 175, 185, 187, 189, 190, 191, 192, 194, 195, 196, 197, 199, 200, 201]	['At', 'the', 'later', '(', '120', 'min', ')', 'stage', 'of', 'invasion', ',', 'cercariae', 'released', 'enzymes', 'implicated', 'in', 'protection', 'against', 'oxidative', 'stress', ',', 'including', 'GST-26', ',', 'thioredoxin', 'peroxidase', 'and', 'superoxide', 'dismutase', '[21],[37],[38]', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 11, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Caspase 14 was detected in skin invaded by cercariae, suggesting that not only was there epidermal cell lysis, but also that apoptotic pathways were induced during cercarial invasion.	[('PMC2467291', 'D07002', 0, 10, 'Caspase 14')]	['Cas', '##pa', '##se', '14', 'was', 'detected', 'in', 'skin', 'inv', '##aded', 'by', 'cer', '##car', '##iae', ',', 'suggesting', 'that', 'not', 'only', 'was', 'there', 'epidermal', 'cell', 'lysis', ',', 'but', 'also', 'that', 'apoptotic', 'pathways', 'were', 'induced', 'during', 'cer', '##car', '##ial', 'invasion', '.']	[0, 3, 5, 8, 11, 15, 24, 27, 32, 35, 40, 43, 46, 49, 52, 54, 65, 70, 74, 79, 83, 89, 99, 104, 109, 111, 115, 120, 125, 135, 144, 149, 157, 164, 167, 170, 174, 182]	[3, 5, 7, 10, 14, 23, 26, 31, 35, 39, 42, 46, 49, 52, 53, 64, 69, 73, 78, 82, 88, 98, 103, 109, 110, 114, 119, 124, 134, 143, 148, 156, 163, 167, 170, 173, 182, 183]	['Caspase', '14', 'was', 'detected', 'in', 'skin', 'invaded', 'by', 'cercariae', ',', 'suggesting', 'that', 'not', 'only', 'was', 'there', 'epidermal', 'cell', 'lysis', ',', 'but', 'also', 'that', 'apoptotic', 'pathways', 'were', 'induced', 'during', 'cercarial', 'invasion', '.']	[3, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gelsolin, an 81 kDa native protein, has a 41 kDa fragment associated with caspase 3 degradation during apoptosis [41].	[('PMC2467291', 'D07006', 74, 83, 'caspase 3')]	['Gel', '##sol', '##in', ',', 'an', '81', 'kDa', 'native', 'protein', ',', 'has', 'a', '41', 'kDa', 'fragment', 'associated', 'with', 'caspase', '3', 'degradation', 'during', 'apoptosis', '[', '41', ']', '.']	[0, 3, 6, 8, 10, 13, 16, 20, 27, 34, 36, 40, 42, 45, 49, 58, 69, 74, 82, 84, 96, 103, 113, 114, 116, 117]	[3, 6, 8, 9, 12, 15, 19, 26, 34, 35, 39, 41, 44, 48, 57, 68, 73, 81, 83, 95, 102, 112, 114, 116, 117, 118]	['Gelsolin', ',', 'an', '81', 'kDa', 'native', 'protein', ',', 'has', 'a', '41', 'kDa', 'fragment', 'associated', 'with', 'caspase', '3', 'degradation', 'during', 'apoptosis', '[', '41', ']', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Previous work had identified apoptotic cells in naïve mouse skin exposed to cercariae, as well as increases in caspase-3, but the earliest time point sampled in that study was 8 hours post-exposure [42].	[('PMC2467291', 'D07009', 111, 120, 'caspase-3')]	['Previous', 'work', 'had', 'identified', 'apoptotic', 'cells', 'in', 'naïve', 'mouse', 'skin', 'exposed', 'to', 'cer', '##car', '##iae', ',', 'as', 'well', 'as', 'increases', 'in', 'caspase', '-', '3', ',', 'but', 'the', 'earliest', 'time', 'point', 'sampled', 'in', 'that', 'study', 'was', '8', 'hours', 'post', '-', 'exposure', '[', '42', ']', '.']	[0, 9, 14, 18, 29, 39, 45, 48, 54, 60, 65, 73, 76, 79, 82, 85, 87, 90, 95, 98, 108, 111, 118, 119, 120, 122, 126, 130, 139, 144, 150, 158, 161, 166, 172, 176, 178, 184, 188, 189, 198, 199, 201, 202]	[8, 13, 17, 28, 38, 44, 47, 53, 59, 64, 72, 75, 79, 82, 85, 86, 89, 94, 97, 107, 110, 118, 119, 120, 121, 125, 129, 138, 143, 149, 157, 160, 165, 171, 175, 177, 183, 188, 189, 197, 199, 201, 202, 203]	['Previous', 'work', 'had', 'identified', 'apoptotic', 'cells', 'in', 'naïve', 'mouse', 'skin', 'exposed', 'to', 'cercariae', ',', 'as', 'well', 'as', 'increases', 'in', 'caspase-3', ',', 'but', 'the', 'earliest', 'time', 'point', 'sampled', 'in', 'that', 'study', 'was', '8', 'hours', 'post', '-', 'exposure', '[', '42', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Numerous peptides were identified for the protease inhibitors α-1 antitrypsin, α-1 anti-chymotrypsin, and antithrombin, as well as other major serum proteins (Table 2).	[('PMC2467291', 'D08001', 42, 50, 'protease')]	['Numerous', 'peptides', 'were', 'identified', 'for', 'the', 'protease', 'inhibitors', 'α', '-', '1', 'antit', '##ryp', '##sin', ',', 'α', '-', '1', 'anti', '-', 'ch', '##ym', '##otr', '##yp', '##sin', ',', 'and', 'antit', '##hr', '##omb', '##in', ',', 'as', 'well', 'as', 'other', 'major', 'serum', 'proteins', '(', 'Table', '2', ')', '.']	[0, 9, 18, 23, 34, 38, 42, 51, 62, 63, 64, 66, 71, 74, 77, 79, 80, 81, 83, 87, 88, 90, 92, 95, 97, 100, 102, 106, 111, 113, 116, 118, 120, 123, 128, 131, 137, 143, 149, 158, 159, 165, 166, 167]	[8, 17, 22, 33, 37, 41, 50, 61, 63, 64, 65, 71, 74, 77, 78, 80, 81, 82, 87, 88, 90, 92, 95, 97, 100, 101, 105, 111, 113, 116, 118, 119, 122, 127, 130, 136, 142, 148, 157, 159, 164, 166, 167, 168]	['Numerous', 'peptides', 'were', 'identified', 'for', 'the', 'protease', 'inhibitors', 'α-1', 'antitrypsin', ',', 'α-1', 'anti-', 'chymotrypsin', ',', 'and', 'antithrombin', ',', 'as', 'well', 'as', 'other', 'major', 'serum', 'proteins', '(', 'Table', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 3, 2, 5, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This may either indicate an activation of the C3 pathway in response to invading cercariae, or degradation of C3 components by cercarial proteases as a mechanism of immune evasion.	[('PMC2467291', 'D08011', 137, 146, 'proteases')]	['This', 'may', 'either', 'indicate', 'an', 'activation', 'of', 'the', 'C', '##3', 'pathway', 'in', 'response', 'to', 'inv', '##ading', 'cer', '##car', '##iae', ',', 'or', 'degradation', 'of', 'C', '##3', 'components', 'by', 'cer', '##car', '##ial', 'proteases', 'as', 'a', 'mechanism', 'of', 'immune', 'ev', '##asion', '.']	[0, 5, 9, 16, 25, 28, 39, 42, 46, 47, 49, 57, 60, 69, 72, 75, 81, 84, 87, 90, 92, 95, 107, 110, 111, 113, 124, 127, 130, 133, 137, 147, 150, 152, 162, 165, 172, 174, 179]	[4, 8, 15, 24, 27, 38, 41, 45, 47, 48, 56, 59, 68, 71, 75, 80, 84, 87, 90, 91, 94, 106, 109, 111, 112, 123, 126, 130, 133, 136, 146, 149, 151, 161, 164, 171, 174, 179, 180]	['This', 'may', 'either', 'indicate', 'an', 'activation', 'of', 'the', 'C3', 'pathway', 'in', 'response', 'to', 'invading', 'cercariae', ',', 'or', 'degradation', 'of', 'C3', 'components', 'by', 'cercarial', 'proteases', 'as', 'a', 'mechanism', 'of', 'immune', 'evasion', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
C1 inhibitor may therefore represent a major target for cercarial proteases.	[('PMC2467291', 'D09001', 66, 75, 'proteases')]	['C', '##1', 'inhibitor', 'may', 'therefore', 'represent', 'a', 'major', 'target', 'for', 'cer', '##car', '##ial', 'proteases', '.']	[0, 1, 3, 13, 17, 27, 37, 39, 45, 52, 56, 59, 62, 66, 75]	[1, 2, 12, 16, 26, 36, 38, 44, 51, 55, 59, 62, 65, 75, 76]	['C1', 'inhibitor', 'may', 'therefore', 'represent', 'a', 'major', 'target', 'for', 'cercarial', 'proteases', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O']
Finally, it was noteworthy that α-1-antitrypsin and elastase were present in higher molecular weight forms in the same gel slice, consistent with a complex between this inhibitor and the cercarial elastase.	[('PMC2467291', 'D10000', 52, 60, 'elastase'), ('PMC2467291', 'D10000', 197, 205, 'elastase')]	['Finally', ',', 'it', 'was', 'noteworthy', 'that', 'α', '-', '1', '-', 'antit', '##ryp', '##sin', 'and', 'elast', '##ase', 'were', 'present', 'in', 'higher', 'molecular', 'weight', 'forms', 'in', 'the', 'same', 'gel', 'slice', ',', 'consistent', 'with', 'a', 'complex', 'between', 'this', 'inhibitor', 'and', 'the', 'cer', '##car', '##ial', 'elast', '##ase', '.']	[0, 7, 9, 12, 16, 27, 32, 33, 34, 35, 36, 41, 44, 48, 52, 57, 61, 66, 74, 77, 84, 94, 101, 107, 110, 114, 119, 123, 128, 130, 141, 146, 148, 156, 164, 169, 179, 183, 187, 190, 193, 197, 202, 205]	[7, 8, 11, 15, 26, 31, 33, 34, 35, 36, 41, 44, 47, 51, 57, 60, 65, 73, 76, 83, 93, 100, 106, 109, 113, 118, 122, 128, 129, 140, 145, 147, 155, 163, 168, 178, 182, 186, 190, 193, 196, 202, 205, 206]	['Finally', ',', 'it', 'was', 'noteworthy', 'that', 'α-1-antitrypsin', 'and', 'elastase', 'were', 'present', 'in', 'higher', 'molecular', 'weight', 'forms', 'in', 'the', 'same', 'gel', 'slice', ',', 'consistent', 'with', 'a', 'complex', 'between', 'this', 'inhibitor', 'and', 'the', 'cercarial', 'elastase', '.']	[1, 1, 1, 1, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
In vitro studies had shown that α-1-antitrypsin was indeed a potent cercarial elastase inhibitor [31].	[('PMC2467291', 'D10001', 78, 86, 'elastase')]	['In', 'vitro', 'studies', 'had', 'shown', 'that', 'α', '-', '1', '-', 'antit', '##ryp', '##sin', 'was', 'indeed', 'a', 'potent', 'cer', '##car', '##ial', 'elast', '##ase', 'inhibitor', '[', '31', ']', '.']	[0, 3, 9, 17, 21, 27, 32, 33, 34, 35, 36, 41, 44, 48, 52, 59, 61, 68, 71, 74, 78, 83, 87, 97, 98, 100, 101]	[2, 8, 16, 20, 26, 31, 33, 34, 35, 36, 41, 44, 47, 51, 58, 60, 67, 71, 74, 77, 83, 86, 96, 98, 100, 101, 102]	['In', 'vitro', 'studies', 'had', 'shown', 'that', 'α-1-antitrypsin', 'was', 'indeed', 'a', 'potent', 'cercarial', 'elastase', 'inhibitor', '[', '31', ']', '.']	[1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
McKerrow JH, Newport G, Fishelson Z. Recent insights into the structure and function of a larval proteinase involved in host infection by a multicellular parasite.	[('PMC2467291', 'F08001', 97, 107, 'proteinase')]	['McK', '##err', '##ow', 'JH', ',', 'New', '##port', 'G', ',', 'Fish', '##elson', 'Z', '.', 'Recent', 'insights', 'into', 'the', 'structure', 'and', 'function', 'of', 'a', 'larval', 'protein', '##ase', 'involved', 'in', 'host', 'infection', 'by', 'a', 'multic', '##ellular', 'parasite', '.']	[0, 3, 6, 9, 11, 13, 16, 21, 22, 24, 28, 34, 35, 37, 44, 53, 58, 62, 72, 76, 85, 88, 90, 97, 104, 108, 117, 120, 125, 135, 138, 140, 146, 154, 162]	[3, 6, 8, 11, 12, 16, 20, 22, 23, 28, 33, 35, 36, 43, 52, 57, 61, 71, 75, 84, 87, 89, 96, 104, 107, 116, 119, 124, 134, 137, 139, 146, 153, 162, 163]	['McKerrow', 'JH', ',', 'Newport', 'G', ',', 'Fishelson', 'Z', '.', 'Recent', 'insights', 'into', 'the', 'structure', 'and', 'function', 'of', 'a', 'larval', 'proteinase', 'involved', 'in', 'host', 'infection', 'by', 'a', 'multicellular', 'parasite', '.']	[3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry.	[('PMC2467291', 'F10002', 24, 33, 'proteases')]	['Identification', 'of', 'novel', 'proteases', 'and', 'immunomod', '##ulators', 'in', 'the', 'secretion', '##s', 'of', 'sch', '##ist', '##osome', 'cer', '##car', '##iae', 'that', 'facilitate', 'host', 'entry', '.']	[0, 15, 18, 24, 34, 38, 47, 55, 58, 62, 71, 73, 76, 79, 82, 88, 91, 94, 98, 103, 114, 119, 124]	[14, 17, 23, 33, 37, 47, 54, 57, 61, 71, 72, 75, 79, 82, 87, 91, 94, 97, 102, 113, 118, 124, 125]	['Identification', 'of', 'novel', 'proteases', 'and', 'immunomodulators', 'in', 'the', 'secretions', 'of', 'schistosome', 'cercariae', 'that', 'facilitate', 'host', 'entry', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 3, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes.	[('PMC2467291', 'F12002', 10, 18, 'elastase')]	['Cer', '##car', '##ial', 'elast', '##ase', 'is', 'encoded', 'by', 'a', 'functionally', 'conserved', 'gene', 'family', 'across', 'multiple', 'species', 'of', 'sch', '##ist', '##osomes', '.']	[0, 3, 6, 10, 15, 19, 22, 30, 33, 35, 48, 58, 63, 70, 77, 86, 94, 97, 100, 103, 109]	[3, 6, 9, 15, 18, 21, 29, 32, 34, 47, 57, 62, 69, 76, 85, 93, 96, 100, 103, 109, 110]	['Cercarial', 'elastase', 'is', 'encoded', 'by', 'a', 'functionally', 'conserved', 'gene', 'family', 'across', 'multiple', 'species', 'of', 'schistosomes', '.']	[3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Schistosome invasion of human skin and degradation of dermal elastin are mediated by a single serine protease.	[('PMC2467291', 'F13002', 94, 109, 'serine protease')]	['Sch', '##ist', '##osome', 'invasion', 'of', 'human', 'skin', 'and', 'degradation', 'of', 'dermal', 'elast', '##in', 'are', 'mediated', 'by', 'a', 'single', 'serine', 'protease', '.']	[0, 3, 6, 12, 21, 24, 30, 35, 39, 51, 54, 61, 66, 69, 73, 82, 85, 87, 94, 101, 109]	[3, 6, 11, 20, 23, 29, 34, 38, 50, 53, 60, 66, 68, 72, 81, 84, 86, 93, 100, 109, 110]	['Schistosome', 'invasion', 'of', 'human', 'skin', 'and', 'degradation', 'of', 'dermal', 'elastin', 'are', 'mediated', 'by', 'a', 'single', 'serine', 'protease', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
Schistosoma mansoni: cloning the gene encoding glutathione peroxidase.	[('PMC2467291', 'F20002', 47, 69, 'glutathione peroxidase')]	['Sch', '##ist', '##osom', '##a', 'man', '##son', '##i', ':', 'cloning', 'the', 'gene', 'encoding', 'glutathione', 'peroxidase', '.']	[0, 3, 6, 10, 12, 15, 18, 19, 21, 29, 33, 38, 47, 59, 69]	[3, 6, 10, 11, 15, 18, 19, 20, 28, 32, 37, 46, 58, 69, 70]	['Schistosoma', 'mansoni', ':', 'cloning', 'the', 'gene', 'encoding', 'glutathione', 'peroxidase', '.']	[4, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
McKerrow JH, Pino-Heiss S, Lindquist R, Werb Z. Purification and characterization of an elastinolytic proteinase secreted by cercariae of Schistosoma mansoni.	[('PMC2467291', 'F30001', 102, 112, 'proteinase')]	['McK', '##err', '##ow', 'JH', ',', 'Pin', '##o', '-', 'He', '##iss', 'S', ',', 'Lind', '##quist', 'R', ',', 'Wer', '##b', 'Z', '.', 'Purification', 'and', 'character', '##ization', 'of', 'an', 'elast', '##ino', '##ly', '##tic', 'protein', '##ase', 'secreted', 'by', 'cer', '##car', '##iae', 'of', 'Sch', '##ist', '##osom', '##a', 'man', '##son', '##i', '.']	[0, 3, 6, 9, 11, 13, 16, 17, 18, 20, 24, 25, 27, 31, 37, 38, 40, 43, 45, 46, 48, 61, 65, 74, 82, 85, 88, 93, 96, 98, 102, 109, 113, 122, 125, 128, 131, 135, 138, 141, 144, 148, 150, 153, 156, 157]	[3, 6, 8, 11, 12, 16, 17, 18, 20, 23, 25, 26, 31, 36, 38, 39, 43, 44, 46, 47, 60, 64, 74, 81, 84, 87, 93, 96, 98, 101, 109, 112, 121, 124, 128, 131, 134, 137, 141, 144, 148, 149, 153, 156, 157, 158]	['McKerrow', 'JH', ',', 'Pino-Heiss', 'S', ',', 'Lindquist', 'R', ',', 'Werb', 'Z', '.', 'Purification', 'and', 'characterization', 'of', 'an', 'elastinolytic', 'proteinase', 'secreted', 'by', 'cercariae', 'of', 'Schistosoma', 'mansoni', '.']	[3, 1, 1, 5, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 4, 2, 1, 1, 3, 1, 4, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteases from Schistosoma mansoni cercariae cleave IgE at solvent exposed interdomain regions.	[('PMC2467291', 'F34002', 0, 9, 'Proteases')]	['Prote', '##ases', 'from', 'Sch', '##ist', '##osom', '##a', 'man', '##son', '##i', 'cer', '##car', '##iae', 'cle', '##ave', 'IgE', 'at', 'solvent', 'exposed', 'inter', '##domain', 'regions', '.']	[0, 5, 10, 15, 18, 21, 25, 27, 30, 33, 35, 38, 41, 45, 48, 52, 56, 59, 67, 75, 80, 87, 94]	[5, 9, 14, 18, 21, 25, 26, 30, 33, 34, 38, 41, 44, 48, 51, 55, 58, 66, 74, 80, 86, 94, 95]	['Proteases', 'from', 'Schistosoma', 'mansoni', 'cercariae', 'cleave', 'IgE', 'at', 'solvent', 'exposed', 'interdomain', 'regions', '.']	[2, 1, 4, 3, 3, 2, 1, 1, 1, 1, 2, 1, 1]	['B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Calcium content of cercariae and its effects on protease activity in vitro.	[('PMC2467291', 'F35003', 48, 56, 'protease')]	['Calcium', 'content', 'of', 'cer', '##car', '##iae', 'and', 'its', 'effects', 'on', 'protease', 'activity', 'in', 'vitro', '.']	[0, 8, 16, 19, 22, 25, 29, 33, 37, 45, 48, 57, 66, 69, 74]	[7, 15, 18, 22, 25, 28, 32, 36, 44, 47, 56, 65, 68, 74, 75]	['Calcium', 'content', 'of', 'cercariae', 'and', 'its', 'effects', 'on', 'protease', 'activity', 'in', 'vitro', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O']
Molecular cloning and tissue distribution of a 26-kilodalton Schistosoma mansoni glutathione S-transferase.	[('PMC2467291', 'F36002', 81, 106, 'glutathione S-transferase')]	['Molecular', 'cloning', 'and', 'tissue', 'distribution', 'of', 'a', '26', '-', 'kil', '##odal', '##ton', 'Sch', '##ist', '##osom', '##a', 'man', '##son', '##i', 'glutathione', 'S', '-', 'transfer', '##ase', '.']	[0, 10, 18, 22, 29, 42, 45, 47, 49, 50, 53, 57, 61, 64, 67, 71, 73, 76, 79, 81, 93, 94, 95, 103, 106]	[9, 17, 21, 28, 41, 44, 46, 49, 50, 53, 57, 60, 64, 67, 71, 72, 76, 79, 80, 92, 94, 95, 103, 106, 107]	['Molecular', 'cloning', 'and', 'tissue', 'distribution', 'of', 'a', '26-kilodalton', 'Schistosoma', 'mansoni', 'glutathione', 'S-transferase', '.']	[1, 1, 1, 1, 1, 1, 1, 5, 4, 3, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
Molecular and enzymatic characterization of Schistosoma mansoni thioredoxin peroxidase.	[('PMC2467291', 'F37002', 64, 86, 'thioredoxin peroxidase')]	['Molecular', 'and', 'enzymatic', 'character', '##ization', 'of', 'Sch', '##ist', '##osom', '##a', 'man', '##son', '##i', 'thi', '##ored', '##oxin', 'peroxidase', '.']	[0, 10, 14, 24, 33, 41, 44, 47, 50, 54, 56, 59, 62, 64, 67, 71, 76, 86]	[9, 13, 23, 33, 40, 43, 47, 50, 54, 55, 59, 62, 63, 67, 71, 75, 86, 87]	['Molecular', 'and', 'enzymatic', 'characterization', 'of', 'Schistosoma', 'mansoni', 'thioredoxin', 'peroxidase', '.']	[1, 1, 1, 2, 1, 4, 3, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Andresen K, Tom TD, Strand M. Characterization of cDNA clones encoding a novel calcium-activated neutral proteinase from Schistosoma mansoni.	[('PMC2467291', 'F39001', 105, 115, 'proteinase')]	['Andre', '##sen', 'K', ',', 'Tom', 'TD', ',', 'Str', '##and', 'M', '.', 'Character', '##ization', 'of', 'cDNA', 'clones', 'encoding', 'a', 'novel', 'calcium', '-', 'activated', 'neutral', 'protein', '##ase', 'from', 'Sch', '##ist', '##osom', '##a', 'man', '##son', '##i', '.']	[0, 5, 9, 10, 12, 16, 18, 20, 23, 27, 28, 30, 39, 47, 50, 55, 62, 71, 73, 79, 86, 87, 97, 105, 112, 116, 121, 124, 127, 131, 133, 136, 139, 140]	[5, 8, 10, 11, 15, 18, 19, 23, 26, 28, 29, 39, 46, 49, 54, 61, 70, 72, 78, 86, 87, 96, 104, 112, 115, 120, 124, 127, 131, 132, 136, 139, 140, 141]	['Andresen', 'K', ',', 'Tom', 'TD', ',', 'Strand', 'M', '.', 'Characterization', 'of', 'cDNA', 'clones', 'encoding', 'a', 'novel', 'calcium', '-', 'activated', 'neutral', 'proteinase', 'from', 'Schistosoma', 'mansoni', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Boccellino M, Giuberti G, Quagliuolo L, Marra M, D'Alessandro AM, et al. Apoptosis induced by interferon-alpha and antagonized by EGF is regulated by caspase-3-mediated cleavage of gelsolin in human epidermoid cancer cells.	[('PMC2467291', 'F40001', 150, 159, 'caspase-3')]	"['Bo', '##cc', '##elli', '##no', 'M', ',', 'Gi', '##uber', '##ti', 'G', ',', 'Qu', '##agl', '##iu', '##olo', 'L', ',', 'Mar', '##ra', 'M', ',', 'D', ""'"", 'Al', '##ess', '##and', '##ro', 'AM', ',', 'et', 'al', '.', 'Apoptosis', 'induced', 'by', 'interferon', '-', 'alpha', 'and', 'antagon', '##ized', 'by', 'EGF', 'is', 'regulated', 'by', 'caspase', '-', '3', '-', 'mediated', 'cleavage', 'of', 'gels', '##olin', 'in', 'human', 'epid', '##erm', '##oid', 'cancer', 'cells', '.']"	[0, 2, 4, 8, 11, 12, 14, 16, 20, 23, 24, 26, 28, 31, 33, 37, 38, 40, 43, 46, 47, 49, 50, 51, 53, 56, 59, 62, 64, 66, 69, 71, 73, 83, 91, 94, 104, 105, 111, 115, 122, 127, 130, 134, 137, 147, 150, 157, 158, 159, 160, 169, 178, 181, 185, 190, 193, 199, 203, 206, 210, 217, 222]	[2, 4, 8, 10, 12, 13, 16, 20, 22, 24, 25, 28, 31, 33, 36, 38, 39, 43, 45, 47, 48, 50, 51, 53, 56, 59, 61, 64, 65, 68, 71, 72, 82, 90, 93, 104, 105, 110, 114, 122, 126, 129, 133, 136, 146, 149, 157, 158, 159, 160, 168, 177, 180, 185, 189, 192, 198, 203, 206, 209, 216, 222, 223]	"['Boccellino', 'M', ',', 'Giuberti', 'G', ',', 'Quagliuolo', 'L', ',', 'Marra', 'M', ',', ""D'Alessandro"", 'AM', ',', 'et', 'al', '.', 'Apoptosis', 'induced', 'by', 'interferon', '-', 'alpha', 'and', 'antagonized', 'by', 'EGF', 'is', 'regulated', 'by', 'caspase-3', '-', 'mediated', 'cleavage', 'of', 'gelsolin', 'in', 'human', 'epidermoid', 'cancer', 'cells', '.']"	[4, 1, 1, 3, 1, 1, 4, 1, 1, 2, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, uninduced free swimming cercaria release relatively small number of non-acetabular gland proteins including enolase, GST-28, and actin 2	[('PMC2467291', 'I03002', 121, 128, 'enolase')]	['In', 'contrast', ',', 'unin', '##duced', 'free', 'swimming', 'cer', '##car', '##ia', 'release', 'relatively', 'small', 'number', 'of', 'non', '-', 'acet', '##abular', 'gland', 'proteins', 'including', 'en', '##olas', '##e', ',', 'GST', '-', '28', ',', 'and', 'actin', '2']	[0, 3, 11, 13, 17, 23, 28, 37, 40, 43, 46, 54, 65, 71, 78, 81, 84, 85, 89, 96, 102, 111, 121, 123, 127, 128, 130, 133, 134, 136, 138, 142, 148]	[2, 11, 12, 17, 22, 27, 36, 40, 43, 45, 53, 64, 70, 77, 80, 84, 85, 89, 95, 101, 110, 120, 123, 127, 128, 129, 133, 134, 136, 137, 141, 147, 149]	['In', 'contrast', ',', 'uninduced', 'free', 'swimming', 'cercaria', 'release', 'relatively', 'small', 'number', 'of', 'non', '-', 'acetabular', 'gland', 'proteins', 'including', 'enolase', ',', 'GST-28', ',', 'and', 'actin', '2']	[1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The major secreted proteins include a gene family of histolytic serine proteases that likely facilitate degradation of host tissue barriers, and factors that may contribute to immune evasion	[('PMC2467291', 'I03004', 64, 80, 'serine proteases')]	['The', 'major', 'secreted', 'proteins', 'include', 'a', 'gene', 'family', 'of', 'hist', '##olytic', 'serine', 'proteases', 'that', 'likely', 'facilitate', 'degradation', 'of', 'host', 'tissue', 'barriers', ',', 'and', 'factors', 'that', 'may', 'contribute', 'to', 'immune', 'ev', '##asion']	[0, 4, 10, 19, 28, 36, 38, 43, 50, 53, 57, 64, 71, 81, 86, 93, 104, 116, 119, 124, 131, 139, 141, 145, 153, 158, 162, 173, 176, 183, 185]	[3, 9, 18, 27, 35, 37, 42, 49, 52, 57, 63, 70, 80, 85, 92, 103, 115, 118, 123, 130, 139, 140, 144, 152, 157, 161, 172, 175, 182, 185, 190]	['The', 'major', 'secreted', 'proteins', 'include', 'a', 'gene', 'family', 'of', 'histolytic', 'serine', 'proteases', 'that', 'likely', 'facilitate', 'degradation', 'of', 'host', 'tissue', 'barriers', ',', 'and', 'factors', 'that', 'may', 'contribute', 'to', 'immune', 'evasion']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The results also provide for the first time a glimpse at host-parasite interactions involving host-derived protease inhibitors and complement-mediated responses to invading larvae.	[('PMC2467291', 'I04003', 107, 115, 'protease')]	['The', 'results', 'also', 'provide', 'for', 'the', 'first', 'time', 'a', 'gli', '##mp', '##se', 'at', 'host', '-', 'parasite', 'interactions', 'involving', 'host', '-', 'derived', 'protease', 'inhibitors', 'and', 'complement', '-', 'mediated', 'responses', 'to', 'inv', '##ading', 'larvae', '.']	[0, 4, 12, 17, 25, 29, 33, 39, 44, 46, 49, 51, 54, 57, 61, 62, 71, 84, 94, 98, 99, 107, 116, 127, 131, 141, 142, 151, 161, 164, 167, 173, 179]	[3, 11, 16, 24, 28, 32, 38, 43, 45, 49, 51, 53, 56, 61, 62, 70, 83, 93, 98, 99, 106, 115, 126, 130, 141, 142, 150, 160, 163, 167, 172, 179, 180]	['The', 'results', 'also', 'provide', 'for', 'the', 'first', 'time', 'a', 'glimpse', 'at', 'host', '-', 'parasite', 'interactions', 'involving', 'host', '-', 'derived', 'protease', 'inhibitors', 'and', 'complement', '-', 'mediated', 'responses', 'to', 'invading', 'larvae', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five-micron sections of human skin invaded by cercariae were processed and stained using the Apop Tag Peroxidase	[('PMC2467291', 'M04001', 102, 112, 'Peroxidase')]	['Five', '-', 'micron', 'sections', 'of', 'human', 'skin', 'inv', '##aded', 'by', 'cer', '##car', '##iae', 'were', 'processed', 'and', 'stained', 'using', 'the', 'Apop', 'Tag', 'Per', '##oxidase']	[0, 4, 5, 12, 21, 24, 30, 35, 38, 43, 46, 49, 52, 56, 61, 71, 75, 83, 89, 93, 98, 102, 105]	[4, 5, 11, 20, 23, 29, 34, 38, 42, 45, 49, 52, 55, 60, 70, 74, 82, 88, 92, 97, 101, 105, 112]	['Five', '-', 'micron', 'sections', 'of', 'human', 'skin', 'invaded', 'by', 'cercariae', 'were', 'processed', 'and', 'stained', 'using', 'the', 'Apop', 'Tag', 'Peroxidase']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E']
These included the cercarial elastase (aka cercarial protease) isoforms 2a, 1a and 1b.	[('PMC2467291', 'R00003', 29, 37, 'elastase'), ('PMC2467291', 'R00003', 53, 61, 'protease')]	['These', 'included', 'the', 'cer', '##car', '##ial', 'elast', '##ase', '(', 'ak', '##a', 'cer', '##car', '##ial', 'protease', ')', 'isoforms', '2', '##a', ',', '1', '##a', 'and', '1', '##b', '.']	[0, 6, 15, 19, 22, 25, 29, 34, 38, 39, 41, 43, 46, 49, 53, 61, 63, 72, 73, 74, 76, 77, 79, 83, 84, 85]	[5, 14, 18, 22, 25, 28, 34, 37, 39, 41, 42, 46, 49, 52, 61, 62, 71, 73, 74, 75, 77, 78, 82, 84, 85, 86]	['These', 'included', 'the', 'cercarial', 'elastase', '(', 'aka', 'cercarial', 'protease', ')', 'isoforms', '2a', ',', '1a', 'and', '1b', '.']	[1, 1, 1, 3, 2, 1, 2, 3, 1, 1, 1, 2, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This is the serine protease implicated in degradation of host tissue barriers [14].	[('PMC2467291', 'R00004', 12, 27, 'serine protease')]	['This', 'is', 'the', 'serine', 'protease', 'implicated', 'in', 'degradation', 'of', 'host', 'tissue', 'barriers', '[', '14', ']', '.']	[0, 5, 8, 12, 19, 28, 39, 42, 54, 57, 62, 69, 78, 79, 81, 82]	[4, 7, 11, 18, 27, 38, 41, 53, 56, 61, 68, 77, 79, 81, 82, 83]	['This', 'is', 'the', 'serine', 'protease', 'implicated', 'in', 'degradation', 'of', 'host', 'tissue', 'barriers', '[', '14', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A schistosome serpin (serine protease inhibitor) was also identified and corresponds to that previously reported in cercarial secretions released into media in vitro [11].	[('PMC2467291', 'R00005', 22, 37, 'serine protease')]	['A', 'sch', '##ist', '##osome', 'ser', '##pin', '(', 'serine', 'protease', 'inhibitor', ')', 'was', 'also', 'identified', 'and', 'corresponds', 'to', 'that', 'previously', 'reported', 'in', 'cer', '##car', '##ial', 'secretion', '##s', 'released', 'into', 'media', 'in', 'vitro', '[', '11', ']', '.']	[0, 2, 5, 8, 14, 17, 21, 22, 29, 38, 47, 49, 53, 58, 69, 73, 85, 88, 93, 104, 113, 116, 119, 122, 126, 135, 137, 146, 151, 157, 160, 166, 167, 169, 170]	[1, 5, 8, 13, 17, 20, 22, 28, 37, 47, 48, 52, 57, 68, 72, 84, 87, 92, 103, 112, 115, 119, 122, 125, 135, 136, 145, 150, 156, 159, 165, 167, 169, 170, 171]	['A', 'schistosome', 'serpin', '(', 'serine', 'protease', 'inhibitor', ')', 'was', 'also', 'identified', 'and', 'corresponds', 'to', 'that', 'previously', 'reported', 'in', 'cercarial', 'secretions', 'released', 'into', 'media', 'in', 'vitro', '[', '11', ']', '.']	[1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Two schistosome-specific proteins, Sm20.8 and Sm21.7, previously reported to be components of the schistosome surface or subjacent tegument [19],[20], and two glutathione-S-transferases, GST 26 and GST 28, were released from the parasite.	[('PMC2467291', 'R01000', 159, 185, 'glutathione-S-transferases')]	['Two', 'sch', '##ist', '##osome', '-', 'specific', 'proteins', ',', 'Sm', '##20', '.', '8', 'and', 'Sm', '##21', '.', '7', ',', 'previously', 'reported', 'to', 'be', 'components', 'of', 'the', 'sch', '##ist', '##osome', 'surface', 'or', 'subj', '##acent', 'te', '##gu', '##ment', '[', '19', ']', ',', '[', '20', ']', ',', 'and', 'two', 'glutathione', '-', 'S', '-', 'transfer', '##ases', ',', 'GST', '26', 'and', 'GST', '28', ',', 'were', 'released', 'from', 'the', 'parasite', '.']	[0, 4, 7, 10, 15, 16, 25, 33, 35, 37, 39, 40, 42, 46, 48, 50, 51, 52, 54, 65, 74, 77, 80, 91, 94, 98, 101, 104, 110, 118, 121, 125, 131, 133, 135, 140, 141, 143, 144, 145, 146, 148, 149, 151, 155, 159, 170, 171, 172, 173, 181, 185, 187, 191, 194, 198, 202, 204, 206, 211, 220, 225, 229, 237]	[3, 7, 10, 15, 16, 24, 33, 34, 37, 39, 40, 41, 45, 48, 50, 51, 52, 53, 64, 73, 76, 79, 90, 93, 97, 101, 104, 109, 117, 120, 125, 130, 133, 135, 139, 141, 143, 144, 145, 146, 148, 149, 150, 154, 158, 170, 171, 172, 173, 181, 185, 186, 190, 193, 197, 201, 204, 205, 210, 219, 224, 228, 237, 238]	['Two', 'schistosome', '-', 'specific', 'proteins', ',', 'Sm20.8', 'and', 'Sm21.7', ',', 'previously', 'reported', 'to', 'be', 'components', 'of', 'the', 'schistosome', 'surface', 'or', 'subjacent', 'tegument', '[19],[20]', ',', 'and', 'two', 'glutathione-S-transferases', ',', 'GST', '26', 'and', 'GST', '28', ',', 'were', 'released', 'from', 'the', 'parasite', '.']	[1, 3, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 3, 7, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, a group of schistosome glycolytic enzymes and kinases, known to be abundant in the cytoplasm of larval gland cells were identified.	[('PMC2467291', 'R01001', 55, 62, 'kinases')]	['Finally', ',', 'a', 'group', 'of', 'sch', '##ist', '##osome', 'glycol', '##ytic', 'enzymes', 'and', 'kinases', ',', 'known', 'to', 'be', 'abundant', 'in', 'the', 'cytoplasm', 'of', 'larval', 'gland', 'cells', 'were', 'identified', '.']	[0, 7, 9, 11, 17, 20, 23, 26, 32, 38, 43, 51, 55, 62, 64, 70, 73, 76, 85, 88, 92, 102, 105, 112, 118, 124, 129, 139]	[7, 8, 10, 16, 19, 23, 26, 31, 38, 42, 50, 54, 62, 63, 69, 72, 75, 84, 87, 91, 101, 104, 111, 117, 123, 128, 139, 140]	['Finally', ',', 'a', 'group', 'of', 'schistosome', 'glycolytic', 'enzymes', 'and', 'kinases', ',', 'known', 'to', 'be', 'abundant', 'in', 'the', 'cytoplasm', 'of', 'larval', 'gland', 'cells', 'were', 'identified', '.']	[1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These are presumbably released as holosecretion from the acetabular cells [11],[12] and included glyceraldehyde-3-phosphate-dehydrogenase, glycerol phosphorylase, triose phosphate isomerase, fructose-1-6 adolase, cytosolic ATP-guanidine kinase, and enolase.	[('PMC2467291', 'R01002', 97, 137, 'glyceraldehyde-3-phosphate-dehydrogenase'), ('PMC2467291', 'R01002', 139, 161, 'glycerol phosphorylase'), ('PMC2467291', 'R01002', 163, 189, 'triose phosphate isomerase'), ('PMC2467291', 'R01002', 191, 211, 'fructose-1-6 adolase'), ('PMC2467291', 'R01002', 223, 243, 'ATP-guanidine kinase'), ('PMC2467291', 'R01002', 249, 256, 'enolase')]	['These', 'are', 'presum', '##ba', '##bl', '##y', 'released', 'as', 'hol', '##ose', '##cre', '##tion', 'from', 'the', 'acet', '##abular', 'cells', '[', '11', ']', ',', '[', '12', ']', 'and', 'included', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', '-', 'dehydrogenase', ',', 'glycerol', 'phosphoryl', '##ase', ',', 'tri', '##ose', 'phosphate', 'isomer', '##ase', ',', 'fructose', '-', '1', '-', '6', 'ad', '##olas', '##e', ',', 'cytosolic', 'ATP', '-', 'guan', '##idine', 'kinase', ',', 'and', 'en', '##olas', '##e', '.']	[0, 6, 10, 16, 18, 20, 22, 31, 34, 37, 40, 43, 48, 53, 57, 61, 68, 74, 75, 77, 78, 79, 80, 82, 84, 88, 97, 103, 111, 112, 113, 114, 123, 124, 137, 139, 148, 158, 161, 163, 166, 170, 180, 186, 189, 191, 199, 200, 201, 202, 204, 206, 210, 211, 213, 223, 226, 227, 231, 237, 243, 245, 249, 251, 255, 256]	[5, 9, 16, 18, 20, 21, 30, 33, 37, 40, 43, 47, 52, 56, 61, 67, 73, 75, 77, 78, 79, 80, 82, 83, 87, 96, 103, 111, 112, 113, 114, 123, 124, 137, 138, 147, 158, 161, 162, 166, 169, 179, 186, 189, 190, 199, 200, 201, 202, 203, 206, 210, 211, 212, 222, 226, 227, 231, 236, 243, 244, 248, 251, 255, 256, 257]	['These', 'are', 'presumbably', 'released', 'as', 'holosecretion', 'from', 'the', 'acetabular', 'cells', '[11],[12]', 'and', 'included', 'glyceraldehyde-3-phosphate', '-', 'dehydrogenase', ',', 'glycerol', 'phosphorylase', ',', 'triose', 'phosphate', 'isomerase', ',', 'fructose-1-6', 'adolase', ',', 'cytosolic', 'ATP-guanidine', 'kinase', ',', 'and', 'enolase', '.']	[1, 1, 4, 1, 1, 4, 1, 1, 2, 1, 7, 1, 1, 6, 1, 1, 1, 1, 2, 1, 2, 1, 2, 1, 5, 3, 1, 1, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O']
At two hours post invasion, many larval proteins increased in abundance including GST 28, GST 26, the elastase isoforms, and the glycolytic enzymes.	[('PMC2467291', 'R02000', 102, 110, 'elastase')]	['At', 'two', 'hours', 'post', 'invasion', ',', 'many', 'larval', 'proteins', 'increased', 'in', 'abundance', 'including', 'GST', '28', ',', 'GST', '26', ',', 'the', 'elast', '##ase', 'isoforms', ',', 'and', 'the', 'glycol', '##ytic', 'enzymes', '.']	[0, 3, 7, 13, 18, 26, 28, 33, 40, 49, 59, 62, 72, 82, 86, 88, 90, 94, 96, 98, 102, 107, 111, 119, 121, 125, 129, 135, 140, 147]	[2, 6, 12, 17, 26, 27, 32, 39, 48, 58, 61, 71, 81, 85, 88, 89, 93, 96, 97, 101, 107, 110, 119, 120, 124, 128, 135, 139, 147, 148]	['At', 'two', 'hours', 'post', 'invasion', ',', 'many', 'larval', 'proteins', 'increased', 'in', 'abundance', 'including', 'GST', '28', ',', 'GST', '26', ',', 'the', 'elastase', 'isoforms', ',', 'and', 'the', 'glycolytic', 'enzymes', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
New proteins were detected at 120 minutes, notably schistosome-derived thioredoxin, thioredoxin peroxidase and superoxide dismutase [21].	[('PMC2467291', 'R02001', 84, 106, 'thioredoxin peroxidase'), ('PMC2467291', 'R02001', 111, 131, 'superoxide dismutase')]	['New', 'proteins', 'were', 'detected', 'at', '120', 'minutes', ',', 'notably', 'sch', '##ist', '##osome', '-', 'derived', 'thi', '##ored', '##oxin', ',', 'thi', '##ored', '##oxin', 'peroxidase', 'and', 'superoxide', 'dismutase', '[', '21', ']', '.']	[0, 4, 13, 18, 27, 30, 34, 41, 43, 51, 54, 57, 62, 63, 71, 74, 78, 82, 84, 87, 91, 96, 107, 111, 122, 132, 133, 135, 136]	[3, 12, 17, 26, 29, 33, 41, 42, 50, 54, 57, 62, 63, 70, 74, 78, 82, 83, 87, 91, 95, 106, 110, 121, 131, 133, 135, 136, 137]	['New', 'proteins', 'were', 'detected', 'at', '120', 'minutes', ',', 'notably', 'schistosome', '-', 'derived', 'thioredoxin', ',', 'thioredoxin', 'peroxidase', 'and', 'superoxide', 'dismutase', '[', '21', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O']
Proteins such as host cystatin and aspartyl protease precursor, may also derive from sweat glands in the skin [25].	[('PMC2467291', 'R04005', 35, 52, 'aspartyl protease')]	['Proteins', 'such', 'as', 'host', 'cyst', '##atin', 'and', 'aspart', '##yl', 'protease', 'precursor', ',', 'may', 'also', 'derive', 'from', 'swe', '##at', 'glands', 'in', 'the', 'skin', '[', '25', ']', '.']	[0, 9, 14, 17, 22, 26, 31, 35, 41, 44, 53, 62, 64, 68, 73, 80, 85, 88, 91, 98, 101, 105, 110, 111, 113, 114]	[8, 13, 16, 21, 26, 30, 34, 41, 43, 52, 62, 63, 67, 72, 79, 84, 88, 90, 97, 100, 104, 109, 111, 113, 114, 115]	['Proteins', 'such', 'as', 'host', 'cystatin', 'and', 'aspartyl', 'protease', 'precursor', ',', 'may', 'also', 'derive', 'from', 'sweat', 'glands', 'in', 'the', 'skin', '[', '25', ']', '.']	[1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There were many serum proteins, including immunoglobulins, apolipoprotein, haptoglobin, alpha-2 macroglobulin, complement C4, C3, and C2b (the complement protease fragment), and fibrinogens (alpha, beta, and gamma).	[('PMC2467291', 'R04006', 154, 162, 'protease')]	['There', 'were', 'many', 'serum', 'proteins', ',', 'including', 'immunoglobulin', '##s', ',', 'apo', '##lip', '##oprotein', ',', 'ha', '##pt', '##oglobin', ',', 'alpha', '-', '2', 'macro', '##glob', '##ulin', ',', 'complement', 'C', '##4', ',', 'C', '##3', ',', 'and', 'C', '##2', '##b', '(', 'the', 'complement', 'protease', 'fragment', ')', ',', 'and', 'fibrinogen', '##s', '(', 'alpha', ',', 'beta', ',', 'and', 'gamma', ')', '.']	[0, 6, 11, 16, 22, 30, 32, 42, 56, 57, 59, 62, 65, 73, 75, 77, 79, 86, 88, 93, 94, 96, 101, 105, 109, 111, 122, 123, 124, 126, 127, 128, 130, 134, 135, 136, 138, 139, 143, 154, 163, 171, 172, 174, 178, 188, 190, 191, 196, 198, 202, 204, 208, 213, 214]	[5, 10, 15, 21, 30, 31, 41, 56, 57, 58, 62, 65, 73, 74, 77, 79, 86, 87, 93, 94, 95, 101, 105, 109, 110, 121, 123, 124, 125, 127, 128, 129, 133, 135, 136, 137, 139, 142, 153, 162, 171, 172, 173, 177, 188, 189, 191, 196, 197, 202, 203, 207, 213, 214, 215]	['There', 'were', 'many', 'serum', 'proteins', ',', 'including', 'immunoglobulins', ',', 'apolipoprotein', ',', 'haptoglobin', ',', 'alpha-2', 'macroglobulin', ',', 'complement', 'C4', ',', 'C3', ',', 'and', 'C2b', '(', 'the', 'complement', 'protease', 'fragment', ')', ',', 'and', 'fibrinogens', '(', 'alpha', ',', 'beta', ',', 'and', 'gamma', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 3, 3, 1, 1, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There was a striking accumulation of host serine protease inhibitors (serpins) in both control and experimental skin samples.	[('PMC2467291', 'R06000', 42, 57, 'serine protease')]	['There', 'was', 'a', 'striking', 'accumulation', 'of', 'host', 'serine', 'protease', 'inhibitors', '(', 'ser', '##pin', '##s', ')', 'in', 'both', 'control', 'and', 'experimental', 'skin', 'samples', '.']	[0, 6, 10, 12, 21, 34, 37, 42, 49, 58, 69, 70, 73, 76, 77, 79, 82, 87, 95, 99, 112, 117, 124]	[5, 9, 11, 20, 33, 36, 41, 48, 57, 68, 70, 73, 76, 77, 78, 81, 86, 94, 98, 111, 116, 124, 125]	['There', 'was', 'a', 'striking', 'accumulation', 'of', 'host', 'serine', 'protease', 'inhibitors', '(', 'serpins', ')', 'in', 'both', 'control', 'and', 'experimental', 'skin', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It readily interacts with the ATP-binding cassette transporter ABCA1, the SR-B1 scavenger receptor; activates the enzyme lecithin-cholesterol acyl transferase (lecithin-cholesterol acyl transferase), which is critical for HDL maturation.	[('PMC2614615', 'A00003', 121, 158, 'lecithin-cholesterol acyl transferase'), ('PMC2614615', 'A00003', 160, 197, 'lecithin-cholesterol acyl transferase')]	['It', 'readily', 'interacts', 'with', 'the', 'ATP', '-', 'binding', 'cassette', 'transporter', 'ABC', '##A', '##1', ',', 'the', 'SR', '-', 'B', '##1', 'scav', '##enger', 'receptor', ';', 'activates', 'the', 'enzyme', 'lec', '##ithi', '##n', '-', 'cholesterol', 'acyl', 'transfer', '##ase', '(', 'lec', '##ithi', '##n', '-', 'cholesterol', 'acyl', 'transfer', '##ase', ')', ',', 'which', 'is', 'critical', 'for', 'HDL', 'maturation', '.']	[0, 3, 11, 21, 26, 30, 33, 34, 42, 51, 63, 66, 67, 68, 70, 74, 76, 77, 78, 80, 84, 90, 98, 100, 110, 114, 121, 124, 128, 129, 130, 142, 147, 155, 159, 160, 163, 167, 168, 169, 181, 186, 194, 197, 198, 200, 206, 209, 218, 222, 226, 236]	[2, 10, 20, 25, 29, 33, 34, 41, 50, 62, 66, 67, 68, 69, 73, 76, 77, 78, 79, 84, 89, 98, 99, 109, 113, 120, 124, 128, 129, 130, 141, 146, 155, 158, 160, 163, 167, 168, 169, 180, 185, 194, 197, 198, 199, 205, 208, 217, 221, 225, 236, 237]	['It', 'readily', 'interacts', 'with', 'the', 'ATP', '-', 'binding', 'cassette', 'transporter', 'ABCA1', ',', 'the', 'SR-B1', 'scavenger', 'receptor', ';', 'activates', 'the', 'enzyme', 'lecithin', '-', 'cholesterol', 'acyl', 'transferase', '(', 'lecithin', '-', 'cholesterol', 'acyl', 'transferase', ')', ',', 'which', 'is', 'critical', 'for', 'HDL', 'maturation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It also has antioxidant and antiinflammatory properties, along with the HDL-associated enzymes paraoxonase, platelet activating factor acetylhydrolase (platelet activating factor acetylhydrolase), and glutathione peroxidase.	[('PMC2614615', 'A00004', 95, 106, 'paraoxonase'), ('PMC2614615', 'A00004', 108, 150, 'platelet activating factor acetylhydrolase'), ('PMC2614615', 'A00004', 152, 194, 'platelet activating factor acetylhydrolase'), ('PMC2614615', 'A00004', 201, 223, 'glutathione peroxidase')]	['It', 'also', 'has', 'antioxidant', 'and', 'anti', '##inflammatory', 'properties', ',', 'along', 'with', 'the', 'HDL', '-', 'associated', 'enzymes', 'para', '##oxo', '##nas', '##e', ',', 'platelet', 'activating', 'factor', 'acetyl', '##hydro', '##las', '##e', '(', 'platelet', 'activating', 'factor', 'acetyl', '##hydro', '##las', '##e', ')', ',', 'and', 'glutathione', 'peroxidase', '.']	[0, 3, 8, 12, 24, 28, 32, 45, 55, 57, 63, 68, 72, 75, 76, 87, 95, 99, 102, 105, 106, 108, 117, 128, 135, 141, 146, 149, 151, 152, 161, 172, 179, 185, 190, 193, 194, 195, 197, 201, 213, 223]	[2, 7, 11, 23, 27, 32, 44, 55, 56, 62, 67, 71, 75, 76, 86, 94, 99, 102, 105, 106, 107, 116, 127, 134, 141, 146, 149, 150, 152, 160, 171, 178, 185, 190, 193, 194, 195, 196, 200, 212, 223, 224]	['It', 'also', 'has', 'antioxidant', 'and', 'antiinflammatory', 'properties', ',', 'along', 'with', 'the', 'HDL-associated', 'enzymes', 'paraoxonase', ',', 'platelet', 'activating', 'factor', 'acetylhydrolase', '(', 'platelet', 'activating', 'factor', 'acetylhydrolase', ')', ',', 'and', 'glutathione', 'peroxidase', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'E', 'O']
A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.	[('PMC2614615', 'F48001', 107, 143, 'lecithin:cholesterol acyltransferase')]	['A', '-', 'I', 'and', 'A', '-', 'II', 'promote', 'remodeling', 'of', 'reconstituted', 'high', 'density', 'lipoprotein', '##s', 'and', 'alter', 'their', 'reactivity', 'with', 'lec', '##ithi', '##n', ':', 'cholesterol', 'acyl', '##transferase', '.']	[0, 1, 2, 4, 8, 9, 10, 13, 21, 32, 35, 49, 54, 62, 73, 75, 79, 85, 91, 102, 107, 110, 114, 115, 116, 128, 132, 143]	[1, 2, 3, 7, 9, 10, 12, 20, 31, 34, 48, 53, 61, 73, 74, 78, 84, 90, 101, 106, 110, 114, 115, 116, 127, 132, 143, 144]	['A-I', 'and', 'A-II', 'promote', 'remodeling', 'of', 'reconstituted', 'high', 'density', 'lipoproteins', 'and', 'alter', 'their', 'reactivity', 'with', 'lecithin', ':', 'cholesterol', 'acyltransferase', '.']	[3, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
Clay M A, Pyle D H, Rye K A, Barter P J. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.	[('PMC2614615', 'F49000', 165, 201, 'lecithin:cholesterol acyltransferase')]	['Cl', '##ay', 'M', 'A', ',', 'Py', '##le', 'D', 'H', ',', 'Ry', '##e', 'K', 'A', ',', 'Bart', '##er', 'P', 'J', '.', 'Formation', 'of', 'spherical', ',', 'reconstituted', 'high', 'density', 'lipoprotein', '##s', 'containing', 'both', 'apo', '##lip', '##oprotein', '##s', 'A', '-', 'I', 'and', 'A', '-', 'II', 'is', 'mediated', 'by', 'lec', '##ithi', '##n', ':', 'cholesterol', 'acyl', '##transferase', '.']	[0, 2, 5, 7, 8, 10, 12, 15, 17, 18, 20, 22, 24, 26, 27, 29, 33, 36, 38, 39, 41, 51, 54, 63, 65, 79, 84, 92, 103, 105, 116, 121, 124, 127, 135, 137, 138, 139, 141, 145, 146, 147, 150, 153, 162, 165, 168, 172, 173, 174, 186, 190, 201]	[2, 4, 6, 8, 9, 12, 14, 16, 18, 19, 22, 23, 25, 27, 28, 33, 35, 37, 39, 40, 50, 53, 63, 64, 78, 83, 91, 103, 104, 115, 120, 124, 127, 135, 136, 138, 139, 140, 144, 146, 147, 149, 152, 161, 164, 168, 172, 173, 174, 185, 190, 201, 202]	['Clay', 'M', 'A', ',', 'Pyle', 'D', 'H', ',', 'Rye', 'K', 'A', ',', 'Barter', 'P', 'J', '.', 'Formation', 'of', 'spherical', ',', 'reconstituted', 'high', 'density', 'lipoproteins', 'containing', 'both', 'apolipoproteins', 'A-I', 'and', 'A-II', 'is', 'mediated', 'by', 'lecithin', ':', 'cholesterol', 'acyltransferase', '.']	[2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 3, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
Yokoyama S, Fukushima D, Kupferberg J P, Kezdy F J, Kaiser E T. The mechanism of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I and an amphiphilic peptide.	[('PMC2614615', 'F58000', 95, 131, 'lecithin:cholesterol acyltransferase')]	['Y', '##ok', '##oya', '##ma', 'S', ',', 'Fuk', '##ush', '##ima', 'D', ',', 'Ku', '##pf', '##er', '##berg', 'J', 'P', ',', 'Ke', '##z', '##dy', 'F', 'J', ',', 'Ka', '##iser', 'E', 'T', '.', 'The', 'mechanism', 'of', 'activation', 'of', 'lec', '##ithi', '##n', ':', 'cholesterol', 'acyl', '##transferase', 'by', 'apo', '##lip', '##oprotein', 'A', '-', 'I', 'and', 'an', 'amph', '##iph', '##ilic', 'peptide', '.']	[0, 1, 3, 6, 9, 10, 12, 15, 18, 22, 23, 25, 27, 29, 31, 36, 38, 39, 41, 43, 44, 47, 49, 50, 52, 54, 59, 61, 62, 64, 68, 78, 81, 92, 95, 98, 102, 103, 104, 116, 120, 132, 135, 138, 141, 150, 151, 152, 154, 158, 161, 165, 168, 173, 180]	[1, 3, 6, 8, 10, 11, 15, 18, 21, 23, 24, 27, 29, 31, 35, 37, 39, 40, 43, 44, 46, 48, 50, 51, 54, 58, 60, 62, 63, 67, 77, 80, 91, 94, 98, 102, 103, 104, 115, 120, 131, 134, 138, 141, 149, 151, 152, 153, 157, 160, 165, 168, 172, 180, 181]	['Yokoyama', 'S', ',', 'Fukushima', 'D', ',', 'Kupferberg', 'J', 'P', ',', 'Kezdy', 'F', 'J', ',', 'Kaiser', 'E', 'T', '.', 'The', 'mechanism', 'of', 'activation', 'of', 'lecithin', ':', 'cholesterol', 'acyltransferase', 'by', 'apolipoprotein', 'A-I', 'and', 'an', 'amphiphilic', 'peptide', '.']	[4, 1, 1, 3, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 3, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Yuan Y, Jackson S P, Newnham H H, Mitchell C A, Salem H H. An essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2.	[('PMC2614615', 'F76000', 160, 176, 'phospholipase A2')]	['Yuan', 'Y', ',', 'Jackson', 'S', 'P', ',', 'New', '##n', '##ham', 'H', 'H', ',', 'Mitchell', 'C', 'A', ',', 'Sal', '##em', 'H', 'H', '.', 'An', 'essential', 'role', 'for', 'lys', '##ophosph', '##atidyl', '##choline', 'in', 'the', 'inhibition', 'of', 'platelet', 'aggregation', 'by', 'secretory', 'phospholip', '##ase', 'A', '##2', '.']	[0, 5, 6, 8, 16, 18, 19, 21, 24, 25, 29, 31, 32, 34, 43, 45, 46, 48, 51, 54, 56, 57, 59, 62, 72, 77, 81, 84, 91, 97, 105, 108, 112, 123, 126, 135, 147, 150, 160, 170, 174, 175, 176]	[4, 6, 7, 15, 17, 19, 20, 24, 25, 28, 30, 32, 33, 42, 44, 46, 47, 51, 53, 55, 57, 58, 61, 71, 76, 80, 84, 91, 97, 104, 107, 111, 122, 125, 134, 146, 149, 159, 170, 173, 175, 176, 177]	['Yuan', 'Y', ',', 'Jackson', 'S', 'P', ',', 'Newnham', 'H', 'H', ',', 'Mitchell', 'C', 'A', ',', 'Salem', 'H', 'H', '.', 'An', 'essential', 'role', 'for', 'lysophosphatidylcholine', 'in', 'the', 'inhibition', 'of', 'platelet', 'aggregation', 'by', 'secretory', 'phospholipase', 'A2', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Using tandem mass spectrometry to quantify site-specific chlorination and nitration of proteins: model system studies with high density lipoprotein oxidized by myeloperoxidase.	[('PMC2614615', 'F88001', 160, 175, 'myeloperoxidase')]	['Using', 'tandem', 'mass', 'spectrometry', 'to', 'quantify', 'site', '-', 'specific', 'chlor', '##ination', 'and', 'nitr', '##ation', 'of', 'proteins', ':', 'model', 'system', 'studies', 'with', 'high', 'density', 'lipoprotein', 'oxidized', 'by', 'myel', '##oper', '##oxidase', '.']	[0, 6, 13, 18, 31, 34, 43, 47, 48, 57, 62, 70, 74, 78, 84, 87, 95, 97, 103, 110, 118, 123, 128, 136, 148, 157, 160, 164, 168, 175]	[5, 12, 17, 30, 33, 42, 47, 48, 56, 62, 69, 73, 78, 83, 86, 95, 96, 102, 109, 117, 122, 127, 135, 147, 156, 159, 164, 168, 175, 176]	['Using', 'tandem', 'mass', 'spectrometry', 'to', 'quantify', 'site', '-', 'specific', 'chlorination', 'and', 'nitration', 'of', 'proteins', ':', 'model', 'system', 'studies', 'with', 'high', 'density', 'lipoprotein', 'oxidized', 'by', 'myeloperoxidase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Zheng L, Settle M, Brubaker G, Schmitt D, Hazen S L, Smith J D, Kinter M. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in abca1-dependent cholesterol efflux from macrophages.	[('PMC2614615', 'F89000', 158, 173, 'myeloperoxidase')]	['Zheng', 'L', ',', 'Set', '##tle', 'M', ',', 'Br', '##uba', '##ker', 'G', ',', 'Sch', '##mitt', 'D', ',', 'Ha', '##zen', 'S', 'L', ',', 'Smith', 'J', 'D', ',', 'Kin', '##ter', 'M', '.', 'Local', '##ization', 'of', 'nitr', '##ation', 'and', 'chlor', '##ination', 'sites', 'on', 'apo', '##lip', '##oprotein', 'A', '-', 'I', 'catalyzed', 'by', 'myel', '##oper', '##oxidase', 'in', 'human', 'athe', '##roma', 'and', 'associated', 'oxidative', 'impairment', 'in', 'ab', '##ca', '##1', '-', 'dependent', 'cholesterol', 'efflux', 'from', 'macrophages', '.']	[0, 6, 7, 9, 12, 16, 17, 19, 21, 24, 28, 29, 31, 34, 39, 40, 42, 44, 48, 50, 51, 53, 59, 61, 62, 64, 67, 71, 72, 74, 79, 87, 90, 94, 100, 104, 109, 117, 123, 126, 129, 132, 141, 142, 143, 145, 155, 158, 162, 166, 174, 177, 183, 187, 192, 196, 207, 217, 228, 231, 233, 235, 236, 237, 247, 259, 266, 271, 282]	[5, 7, 8, 12, 15, 17, 18, 21, 24, 27, 29, 30, 34, 38, 40, 41, 44, 47, 49, 51, 52, 58, 60, 62, 63, 67, 70, 72, 73, 79, 86, 89, 94, 99, 103, 109, 116, 122, 125, 129, 132, 140, 142, 143, 144, 154, 157, 162, 166, 173, 176, 182, 187, 191, 195, 206, 216, 227, 230, 233, 235, 236, 237, 246, 258, 265, 270, 282, 283]	['Zheng', 'L', ',', 'Settle', 'M', ',', 'Brubaker', 'G', ',', 'Schmitt', 'D', ',', 'Hazen', 'S', 'L', ',', 'Smith', 'J', 'D', ',', 'Kinter', 'M', '.', 'Localization', 'of', 'nitration', 'and', 'chlorination', 'sites', 'on', 'apolipoprotein', 'A-I', 'catalyzed', 'by', 'myeloperoxidase', 'in', 'human', 'atheroma', 'and', 'associated', 'oxidative', 'impairment', 'in', 'abca1-dependent', 'cholesterol', 'efflux', 'from', 'macrophages', '.']	[1, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 2, 1, 1, 3, 3, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs abca1-dependent cholesterol transport.	[('PMC2614615', 'F91001', 4, 19, 'myeloperoxidase')]	['The', 'myel', '##oper', '##oxidase', 'product', 'hypo', '##chlor', '##ous', 'acid', 'oxid', '##izes', 'HDL', 'in', 'the', 'human', 'artery', 'wall', 'and', 'impairs', 'ab', '##ca', '##1', '-', 'dependent', 'cholesterol', 'transport', '.']	[0, 4, 8, 12, 20, 28, 32, 37, 41, 46, 50, 55, 59, 62, 66, 72, 79, 84, 88, 96, 98, 100, 101, 102, 112, 124, 133]	[3, 8, 12, 19, 27, 32, 37, 40, 45, 50, 54, 58, 61, 65, 71, 78, 83, 87, 95, 98, 100, 101, 102, 111, 123, 133, 134]	['The', 'myeloperoxidase', 'product', 'hypochlorous', 'acid', 'oxidizes', 'HDL', 'in', 'the', 'human', 'artery', 'wall', 'and', 'impairs', 'abca1-dependent', 'cholesterol', 'transport', '.']	[1, 3, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Zheng L, Nukuna B, Brennan M-L, Mingjiang S, Goormastic M, Settle M, Schmitt D, Xiaoming F, Thomson L, Fox P L, Ischiropoulos H, Smith J D, Kinter M, Hazen S L. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.	[('PMC2614615', 'F92000', 206, 221, 'myeloperoxidase')]	['Zheng', 'L', ',', 'Nu', '##ku', '##na', 'B', ',', 'Bren', '##nan', 'M', '-', 'L', ',', 'Min', '##g', '##jiang', 'S', ',', 'Go', '##orm', '##astic', 'M', ',', 'Set', '##tle', 'M', ',', 'Sch', '##mitt', 'D', ',', 'Xiao', '##ming', 'F', ',', 'Thom', '##son', 'L', ',', 'Fox', 'P', 'L', ',', 'Is', '##chi', '##rop', '##oul', '##os', 'H', ',', 'Smith', 'J', 'D', ',', 'Kin', '##ter', 'M', ',', 'Ha', '##zen', 'S', 'L', '.', 'Ap', '##olip', '##oprotein', 'A', '-', 'I', 'is', 'a', 'selective', 'target', 'for', 'myel', '##oper', '##oxidase', '-', 'catalyzed', 'oxidation', 'and', 'functional', 'impairment', 'in', 'subjects', 'with', 'cardiovascular', 'disease', '.']	[0, 6, 7, 9, 11, 13, 16, 17, 19, 23, 27, 28, 29, 30, 32, 35, 36, 42, 43, 45, 47, 50, 56, 57, 59, 62, 66, 67, 69, 72, 77, 78, 80, 84, 89, 90, 92, 96, 100, 101, 103, 107, 109, 110, 112, 114, 117, 120, 123, 126, 127, 129, 135, 137, 138, 140, 143, 147, 148, 150, 152, 156, 158, 159, 161, 163, 167, 176, 177, 178, 180, 183, 185, 195, 202, 206, 210, 214, 221, 222, 232, 242, 246, 257, 268, 271, 280, 285, 300, 307]	[5, 7, 8, 11, 13, 15, 17, 18, 23, 26, 28, 29, 30, 31, 35, 36, 41, 43, 44, 47, 50, 55, 57, 58, 62, 65, 67, 68, 72, 76, 78, 79, 84, 88, 90, 91, 96, 99, 101, 102, 106, 108, 110, 111, 114, 117, 120, 123, 125, 127, 128, 134, 136, 138, 139, 143, 146, 148, 149, 152, 155, 157, 159, 160, 163, 167, 175, 177, 178, 179, 182, 184, 194, 201, 205, 210, 214, 221, 222, 231, 241, 245, 256, 267, 270, 279, 284, 299, 307, 308]	['Zheng', 'L', ',', 'Nukuna', 'B', ',', 'Brennan', 'M-L', ',', 'Mingjiang', 'S', ',', 'Goormastic', 'M', ',', 'Settle', 'M', ',', 'Schmitt', 'D', ',', 'Xiaoming', 'F', ',', 'Thomson', 'L', ',', 'Fox', 'P', 'L', ',', 'Ischiropoulos', 'H', ',', 'Smith', 'J', 'D', ',', 'Kinter', 'M', ',', 'Hazen', 'S', 'L', '.', 'Apolipoprotein', 'A-I', 'is', 'a', 'selective', 'target', 'for', 'myeloperoxidase', '-', 'catalyzed', 'oxidation', 'and', 'functional', 'impairment', 'in', 'subjects', 'with', 'cardiovascular', 'disease', '.']	[1, 1, 1, 3, 1, 1, 2, 3, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, reconstitution could be accomplished when discoidal ApoA-I was incubated in the presence of lecithin-cholesterol acyl transferase and LDL.	[('PMC2614615', 'I05002', 102, 139, 'lecithin-cholesterol acyl transferase')]	['Moreover', ',', 'reconstit', '##ution', 'could', 'be', 'accomplished', 'when', 'disc', '##oidal', 'Ap', '##oA', '-', 'I', 'was', 'incubated', 'in', 'the', 'presence', 'of', 'lec', '##ithi', '##n', '-', 'cholesterol', 'acyl', 'transfer', '##ase', 'and', 'LDL', '.']	[0, 8, 10, 19, 25, 31, 34, 47, 52, 56, 62, 64, 66, 67, 69, 73, 83, 86, 90, 99, 102, 105, 109, 110, 111, 123, 128, 136, 140, 144, 147]	[8, 9, 19, 24, 30, 33, 46, 51, 56, 61, 64, 66, 67, 68, 72, 82, 85, 89, 98, 101, 105, 109, 110, 111, 122, 127, 136, 139, 143, 147, 148]	['Moreover', ',', 'reconstitution', 'could', 'be', 'accomplished', 'when', 'discoidal', 'ApoA-I', 'was', 'incubated', 'in', 'the', 'presence', 'of', 'lecithin', '-', 'cholesterol', 'acyl', 'transferase', 'and', 'LDL', '.']	[1, 1, 2, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
(34) using fluorescence resonance energy transfer (FRET) found that apoA-I in spherical particles, prepared with the lecithin-cholesterol acyl transferase method, had reduced intermolecular interactions and a more variable conformation.	[('PMC2614615', 'I05010', 117, 154, 'lecithin-cholesterol acyl transferase')]	['(', '34', ')', 'using', 'fluorescence', 'resonance', 'energy', 'transfer', '(', 'FRET', ')', 'found', 'that', 'apo', '##A', '-', 'I', 'in', 'spherical', 'particles', ',', 'prepared', 'with', 'the', 'lec', '##ithi', '##n', '-', 'cholesterol', 'acyl', 'transfer', '##ase', 'method', ',', 'had', 'reduced', 'intermolecular', 'interactions', 'and', 'a', 'more', 'variable', 'conformation', '.']	[0, 1, 3, 5, 11, 24, 34, 41, 50, 51, 55, 57, 63, 68, 71, 72, 73, 75, 78, 88, 97, 99, 108, 113, 117, 120, 124, 125, 126, 138, 143, 151, 155, 161, 163, 167, 175, 190, 203, 207, 209, 214, 223, 235]	[1, 3, 4, 10, 23, 33, 40, 49, 51, 55, 56, 62, 67, 71, 72, 73, 74, 77, 87, 97, 98, 107, 112, 116, 120, 124, 125, 126, 137, 142, 151, 154, 161, 162, 166, 174, 189, 202, 206, 208, 213, 222, 235, 236]	['(', '34', ')', 'using', 'fluorescence', 'resonance', 'energy', 'transfer', '(', 'FRET', ')', 'found', 'that', 'apoA-I', 'in', 'spherical', 'particles', ',', 'prepared', 'with', 'the', 'lecithin', '-', 'cholesterol', 'acyl', 'transferase', 'method', ',', 'had', 'reduced', 'intermolecular', 'interactions', 'and', 'a', 'more', 'variable', 'conformation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In reconstitution studies, the mixing in vitro of two discoidal complexes, one containing apoA-I and the other apoA-II, in the presence of lecithin-cholesterol acyl transferase generated, via a fusion process, a spherical HDL in which the apoA-I/apoA-II molar ratio was 0.7:1, a range consistent with that seen in native HDL (50).	[('PMC2614615', 'I09003', 139, 176, 'lecithin-cholesterol acyl transferase')]	['In', 'reconstit', '##ution', 'studies', ',', 'the', 'mixing', 'in', 'vitro', 'of', 'two', 'disc', '##oidal', 'complexes', ',', 'one', 'containing', 'apo', '##A', '-', 'I', 'and', 'the', 'other', 'apo', '##A', '-', 'II', ',', 'in', 'the', 'presence', 'of', 'lec', '##ithi', '##n', '-', 'cholesterol', 'acyl', 'transfer', '##ase', 'generated', ',', 'via', 'a', 'fusion', 'process', ',', 'a', 'spherical', 'HDL', 'in', 'which', 'the', 'apo', '##A', '-', 'I', '/', 'apo', '##A', '-', 'II', 'molar', 'ratio', 'was', '0', '.', '7', ':', '1', ',', 'a', 'range', 'consistent', 'with', 'that', 'seen', 'in', 'native', 'HDL', '(', '50', ')', '.']	[0, 3, 12, 18, 25, 27, 31, 38, 41, 47, 50, 54, 58, 64, 73, 75, 79, 90, 93, 94, 95, 97, 101, 105, 111, 114, 115, 116, 118, 120, 123, 127, 136, 139, 142, 146, 147, 148, 160, 165, 173, 177, 186, 188, 192, 194, 201, 208, 210, 212, 222, 226, 229, 235, 239, 242, 243, 244, 245, 246, 249, 250, 251, 254, 260, 266, 270, 271, 272, 273, 274, 275, 277, 279, 285, 296, 301, 306, 311, 314, 321, 325, 326, 328, 329]	[2, 12, 17, 25, 26, 30, 37, 40, 46, 49, 53, 58, 63, 73, 74, 78, 89, 93, 94, 95, 96, 100, 104, 110, 114, 115, 116, 118, 119, 122, 126, 135, 138, 142, 146, 147, 148, 159, 164, 173, 176, 186, 187, 191, 193, 200, 208, 209, 211, 221, 225, 228, 234, 238, 242, 243, 244, 245, 246, 249, 250, 251, 253, 259, 265, 269, 271, 272, 273, 274, 275, 276, 278, 284, 295, 300, 305, 310, 313, 320, 324, 326, 328, 329, 330]	['In', 'reconstitution', 'studies', ',', 'the', 'mixing', 'in', 'vitro', 'of', 'two', 'discoidal', 'complexes', ',', 'one', 'containing', 'apoA-I', 'and', 'the', 'other', 'apoA-II', ',', 'in', 'the', 'presence', 'of', 'lecithin', '-', 'cholesterol', 'acyl', 'transferase', 'generated', ',', 'via', 'a', 'fusion', 'process', ',', 'a', 'spherical', 'HDL', 'in', 'which', 'the', 'apoA-I', '/', 'apoA-II', 'molar', 'ratio', 'was', '0.7', ':', '1', ',', 'a', 'range', 'consistent', 'with', 'that', 'seen', 'in', 'native', 'HDL', '(', '50', ')', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In 1979 a synthetic amphipathic helical docosapeptide was shown to have similar surface properties to that of apoA-I (58) and to activate lecithin-cholesterol acyl transferase (59).	[('PMC2614615', 'I10005', 138, 175, 'lecithin-cholesterol acyl transferase')]	['In', '197', '##9', 'a', 'synthetic', 'amph', '##ip', '##ath', '##ic', 'helical', 'doc', '##osa', '##peptide', 'was', 'shown', 'to', 'have', 'similar', 'surface', 'properties', 'to', 'that', 'of', 'apo', '##A', '-', 'I', '(', '58', ')', 'and', 'to', 'activate', 'lec', '##ithi', '##n', '-', 'cholesterol', 'acyl', 'transfer', '##ase', '(', '59', ')', '.']	[0, 3, 6, 8, 10, 20, 24, 26, 29, 32, 40, 43, 46, 54, 58, 64, 67, 72, 80, 88, 99, 102, 107, 110, 113, 114, 115, 117, 118, 120, 122, 126, 129, 138, 141, 145, 146, 147, 159, 164, 172, 176, 177, 179, 180]	[2, 6, 7, 9, 19, 24, 26, 29, 31, 39, 43, 46, 53, 57, 63, 66, 71, 79, 87, 98, 101, 106, 109, 113, 114, 115, 116, 118, 120, 121, 125, 128, 137, 141, 145, 146, 147, 158, 163, 172, 175, 177, 179, 180, 181]	['In', '1979', 'a', 'synthetic', 'amphipathic', 'helical', 'docosapeptide', 'was', 'shown', 'to', 'have', 'similar', 'surface', 'properties', 'to', 'that', 'of', 'apoA-I', '(', '58', ')', 'and', 'to', 'activate', 'lecithin', '-', 'cholesterol', 'acyl', 'transferase', '(', '59', ')', '.']	[1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Currently, the most extensively studied among the apoA-I mimetics has been peptide D-4F composed of 18 d-amino acids designed to resist degradation by the intestinal peptidases and also permitting administration by the oral route (60).	[('PMC2614615', 'I10006', 166, 176, 'peptidases')]	['Currently', ',', 'the', 'most', 'extensively', 'studied', 'among', 'the', 'apo', '##A', '-', 'I', 'mim', '##et', '##ics', 'has', 'been', 'peptide', 'D', '-', '4', '##F', 'composed', 'of', '18', 'd', '-', 'amino', 'acids', 'designed', 'to', 'resist', 'degradation', 'by', 'the', 'intestinal', 'pepti', '##dase', '##s', 'and', 'also', 'permit', '##ting', 'administration', 'by', 'the', 'oral', 'route', '(', '60', ')', '.']	[0, 9, 11, 15, 20, 32, 40, 46, 50, 53, 54, 55, 57, 60, 62, 66, 70, 75, 83, 84, 85, 86, 88, 97, 100, 103, 104, 105, 111, 117, 126, 129, 136, 148, 151, 155, 166, 171, 175, 177, 181, 186, 192, 197, 212, 215, 219, 224, 230, 231, 233, 234]	[9, 10, 14, 19, 31, 39, 45, 49, 53, 54, 55, 56, 60, 62, 65, 69, 74, 82, 84, 85, 86, 87, 96, 99, 102, 104, 105, 110, 116, 125, 128, 135, 147, 150, 154, 165, 171, 175, 176, 180, 185, 192, 196, 211, 214, 218, 223, 229, 231, 233, 234, 235]	['Currently', ',', 'the', 'most', 'extensively', 'studied', 'among', 'the', 'apoA-I', 'mimetics', 'has', 'been', 'peptide', 'D-4F', 'composed', 'of', '18', 'd-amino', 'acids', 'designed', 'to', 'resist', 'degradation', 'by', 'the', 'intestinal', 'peptidases', 'and', 'also', 'permitting', 'administration', 'by', 'the', 'oral', 'route', '(', '60', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
From the mechanistic viewpoint, in the apo E-null mouse model, D-4F was found to cause a redistribution of apoA-I from α migrating to small size (7 to 8 nm) pre-β migrating HDL enriched in active paraoxonase (62), probably via combined displacement and remodeling processes.	[('PMC2614615', 'I10009', 196, 207, 'paraoxonase')]	['From', 'the', 'mechanistic', 'viewpoint', ',', 'in', 'the', 'apo', 'E', '-', 'null', 'mouse', 'model', ',', 'D', '-', '4', '##F', 'was', 'found', 'to', 'cause', 'a', 'redistribution', 'of', 'apo', '##A', '-', 'I', 'from', 'α', 'migrating', 'to', 'small', 'size', '(', '7', 'to', '8', 'nm', ')', 'pre', '-', 'β', 'migrating', 'HDL', 'enriched', 'in', 'active', 'para', '##oxo', '##nas', '##e', '(', '62', ')', ',', 'probably', 'via', 'combined', 'displacement', 'and', 'remodeling', 'processes', '.']	[0, 5, 9, 21, 30, 32, 35, 39, 43, 44, 45, 50, 56, 61, 63, 64, 65, 66, 68, 72, 78, 81, 87, 89, 104, 107, 110, 111, 112, 114, 119, 121, 131, 134, 140, 145, 146, 148, 151, 153, 155, 157, 160, 161, 163, 173, 177, 186, 189, 196, 200, 203, 206, 208, 209, 211, 212, 214, 223, 227, 236, 249, 253, 264, 273]	[4, 8, 20, 30, 31, 34, 38, 42, 44, 45, 49, 55, 61, 62, 64, 65, 66, 67, 71, 77, 80, 86, 88, 103, 106, 110, 111, 112, 113, 118, 120, 130, 133, 139, 144, 146, 147, 150, 152, 155, 156, 160, 161, 162, 172, 176, 185, 188, 195, 200, 203, 206, 207, 209, 211, 212, 213, 222, 226, 235, 248, 252, 263, 273, 274]	['From', 'the', 'mechanistic', 'viewpoint', ',', 'in', 'the', 'apo', 'E-null', 'mouse', 'model', ',', 'D-4F', 'was', 'found', 'to', 'cause', 'a', 'redistribution', 'of', 'apoA-I', 'from', 'α', 'migrating', 'to', 'small', 'size', '(', '7', 'to', '8', 'nm', ')', 'pre-β', 'migrating', 'HDL', 'enriched', 'in', 'active', 'paraoxonase', '(', '62', ')', ',', 'probably', 'via', 'combined', 'displacement', 'and', 'remodeling', 'processes', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Second, this association causes HDL remodeling and the formation of small pre-β migrating particles containing apoA-I, but not apoA-II, enriched in paraoxonase, thus having antiinflammatory and antiatherogenic properties.	[('PMC2614615', 'I11002', 148, 159, 'paraoxonase')]	['Second', ',', 'this', 'association', 'causes', 'HDL', 'remodeling', 'and', 'the', 'formation', 'of', 'small', 'pre', '-', 'β', 'migrating', 'particles', 'containing', 'apo', '##A', '-', 'I', ',', 'but', 'not', 'apo', '##A', '-', 'II', ',', 'enriched', 'in', 'para', '##oxo', '##nas', '##e', ',', 'thus', 'having', 'anti', '##inflammatory', 'and', 'anti', '##ather', '##ogenic', 'properties', '.']	[0, 6, 8, 13, 25, 32, 36, 47, 51, 55, 65, 68, 74, 77, 78, 80, 90, 100, 111, 114, 115, 116, 117, 119, 123, 127, 130, 131, 132, 134, 136, 145, 148, 152, 155, 158, 159, 161, 166, 173, 177, 190, 194, 198, 203, 210, 220]	[6, 7, 12, 24, 31, 35, 46, 50, 54, 64, 67, 73, 77, 78, 79, 89, 99, 110, 114, 115, 116, 117, 118, 122, 126, 130, 131, 132, 134, 135, 144, 147, 152, 155, 158, 159, 160, 165, 172, 177, 189, 193, 198, 203, 209, 220, 221]	['Second', ',', 'this', 'association', 'causes', 'HDL', 'remodeling', 'and', 'the', 'formation', 'of', 'small', 'pre-β', 'migrating', 'particles', 'containing', 'apoA-I', ',', 'but', 'not', 'apoA-II', ',', 'enriched', 'in', 'paraoxonase', ',', 'thus', 'having', 'antiinflammatory', 'and', 'antiatherogenic', 'properties', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 2, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Also, as a consequence of remodeling, the mature HDL, by losing some of its apoA-I component becomes enriched in apoA-II and impoverished in paraoxonase given the antagonistic action of apoA-II for this enzyme.	[('PMC2614615', 'I11004', 141, 152, 'paraoxonase')]	['Also', ',', 'as', 'a', 'consequence', 'of', 'remodeling', ',', 'the', 'mature', 'HDL', ',', 'by', 'losing', 'some', 'of', 'its', 'apo', '##A', '-', 'I', 'component', 'becomes', 'enriched', 'in', 'apo', '##A', '-', 'II', 'and', 'imp', '##over', '##ished', 'in', 'para', '##oxo', '##nas', '##e', 'given', 'the', 'antagonist', '##ic', 'action', 'of', 'apo', '##A', '-', 'II', 'for', 'this', 'enzyme', '.']	[0, 4, 6, 9, 11, 23, 26, 36, 38, 42, 49, 52, 54, 57, 64, 69, 72, 76, 79, 80, 81, 83, 93, 101, 110, 113, 116, 117, 118, 121, 125, 128, 132, 138, 141, 145, 148, 151, 153, 159, 163, 173, 176, 183, 186, 189, 190, 191, 194, 198, 203, 209]	[4, 5, 8, 10, 22, 25, 36, 37, 41, 48, 52, 53, 56, 63, 68, 71, 75, 79, 80, 81, 82, 92, 100, 109, 112, 116, 117, 118, 120, 124, 128, 132, 137, 140, 145, 148, 151, 152, 158, 162, 173, 175, 182, 185, 189, 190, 191, 193, 197, 202, 209, 210]	['Also', ',', 'as', 'a', 'consequence', 'of', 'remodeling', ',', 'the', 'mature', 'HDL', ',', 'by', 'losing', 'some', 'of', 'its', 'apoA-I', 'component', 'becomes', 'enriched', 'in', 'apoA-II', 'and', 'impoverished', 'in', 'paraoxonase', 'given', 'the', 'antagonistic', 'action', 'of', 'apoA-II', 'for', 'this', 'enzyme', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 3, 1, 4, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This view is further corroborated by recent observations in mice in which an increased expression of apoA-II caused an acute inhibitory effect on the hydrolysis of VLDL and chylomicron triglycerides, which suggests that in acquiring apoA-II from circulating HDL that acts as a reservoir, triglyceride-rich particles become a poor substrate for lipoprotein lipase (66).	[('PMC2614615', 'I12003', 344, 362, 'lipoprotein lipase')]	['This', 'view', 'is', 'further', 'corrobor', '##ated', 'by', 'recent', 'observations', 'in', 'mice', 'in', 'which', 'an', 'increased', 'expression', 'of', 'apo', '##A', '-', 'II', 'caused', 'an', 'acute', 'inhibitory', 'effect', 'on', 'the', 'hydrolysis', 'of', 'VL', '##DL', 'and', 'ch', '##yl', '##omic', '##ron', 'triglycerides', ',', 'which', 'suggests', 'that', 'in', 'acquiring', 'apo', '##A', '-', 'II', 'from', 'circulating', 'HDL', 'that', 'acts', 'as', 'a', 'reservoir', ',', 'triglyceride', '-', 'rich', 'particles', 'become', 'a', 'poor', 'substrate', 'for', 'lipoprotein', 'lipase', '(', '66', ')', '.']	[0, 5, 10, 13, 21, 29, 34, 37, 44, 57, 60, 65, 68, 74, 77, 87, 98, 101, 104, 105, 106, 109, 116, 119, 125, 136, 143, 146, 150, 161, 164, 166, 169, 173, 175, 177, 181, 185, 198, 200, 206, 215, 220, 223, 233, 236, 237, 238, 241, 246, 258, 262, 267, 272, 275, 277, 286, 288, 300, 301, 306, 316, 323, 325, 330, 340, 344, 356, 363, 364, 366, 367]	[4, 9, 12, 20, 29, 33, 36, 43, 56, 59, 64, 67, 73, 76, 86, 97, 100, 104, 105, 106, 108, 115, 118, 124, 135, 142, 145, 149, 160, 163, 166, 168, 172, 175, 177, 181, 184, 198, 199, 205, 214, 219, 222, 232, 236, 237, 238, 240, 245, 257, 261, 266, 271, 274, 276, 286, 287, 300, 301, 305, 315, 322, 324, 329, 339, 343, 355, 362, 364, 366, 367, 368]	['This', 'view', 'is', 'further', 'corroborated', 'by', 'recent', 'observations', 'in', 'mice', 'in', 'which', 'an', 'increased', 'expression', 'of', 'apoA-II', 'caused', 'an', 'acute', 'inhibitory', 'effect', 'on', 'the', 'hydrolysis', 'of', 'VLDL', 'and', 'chylomicron', 'triglycerides', ',', 'which', 'suggests', 'that', 'in', 'acquiring', 'apoA-II', 'from', 'circulating', 'HDL', 'that', 'acts', 'as', 'a', 'reservoir', ',', 'triglyceride', '-', 'rich', 'particles', 'become', 'a', 'poor', 'substrate', 'for', 'lipoprotein', 'lipase', '(', '66', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O']
What is emerging is that the HDL proteome contains, in addition to the previously recognized quantitatively “minor” apolipoproteins, enzymes, and transport proteins relevant to lipid metabolism and many others that are not in the lipid area but are involved in the processes of acute-phase response, proteinase inhibition, and complement regulation.	[('PMC2614615', 'I13001', 300, 310, 'proteinase')]	['What', 'is', 'emerging', 'is', 'that', 'the', 'HDL', 'proteome', 'contains', ',', 'in', 'addition', 'to', 'the', 'previously', 'recognized', 'quantitatively', '“', 'minor', '”', 'apo', '##lip', '##oprotein', '##s', ',', 'enzymes', ',', 'and', 'transport', 'proteins', 'relevant', 'to', 'lipid', 'metabolism', 'and', 'many', 'others', 'that', 'are', 'not', 'in', 'the', 'lipid', 'area', 'but', 'are', 'involved', 'in', 'the', 'processes', 'of', 'acute', '-', 'phase', 'response', ',', 'protein', '##ase', 'inhibition', ',', 'and', 'complement', 'regulation', '.']	[0, 5, 8, 17, 20, 25, 29, 33, 42, 50, 52, 55, 64, 67, 71, 82, 93, 108, 109, 114, 116, 119, 122, 130, 131, 133, 140, 142, 146, 156, 165, 174, 177, 183, 194, 198, 203, 210, 215, 219, 223, 226, 230, 236, 241, 245, 249, 258, 261, 265, 275, 278, 283, 284, 290, 298, 300, 307, 311, 321, 323, 327, 338, 348]	[4, 7, 16, 19, 24, 28, 32, 41, 50, 51, 54, 63, 66, 70, 81, 92, 107, 109, 114, 115, 119, 122, 130, 131, 132, 140, 141, 145, 155, 164, 173, 176, 182, 193, 197, 202, 209, 214, 218, 222, 225, 229, 235, 240, 244, 248, 257, 260, 264, 274, 277, 283, 284, 289, 298, 299, 307, 310, 321, 322, 326, 337, 348, 349]	['What', 'is', 'emerging', 'is', 'that', 'the', 'HDL', 'proteome', 'contains', ',', 'in', 'addition', 'to', 'the', 'previously', 'recognized', 'quantitatively', '“', 'minor', '”', 'apolipoproteins', ',', 'enzymes', ',', 'and', 'transport', 'proteins', 'relevant', 'to', 'lipid', 'metabolism', 'and', 'many', 'others', 'that', 'are', 'not', 'in', 'the', 'lipid', 'area', 'but', 'are', 'involved', 'in', 'the', 'processes', 'of', 'acute', '-', 'phase', 'response', ',', 'proteinase', 'inhibition', ',', 'and', 'complement', 'regulation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
The discovery in HDL of a soluble phospholipase A2 was followed by the identification of phospholipid lysoderivatives (75,76,77).	[('PMC2614615', 'I14002', 34, 50, 'phospholipase A2')]	['The', 'discovery', 'in', 'HDL', 'of', 'a', 'soluble', 'phospholip', '##ase', 'A', '##2', 'was', 'followed', 'by', 'the', 'identification', 'of', 'phospholipid', 'lys', '##oder', '##iva', '##tives', '(', '75', ',', '76', ',', '77', ')', '.']	[0, 4, 14, 17, 21, 24, 26, 34, 44, 48, 49, 51, 55, 64, 67, 71, 86, 89, 102, 105, 109, 112, 118, 119, 121, 122, 124, 125, 127, 128]	[3, 13, 16, 20, 23, 25, 33, 44, 47, 49, 50, 54, 63, 66, 70, 85, 88, 101, 105, 109, 112, 117, 119, 121, 122, 124, 125, 127, 128, 129]	['The', 'discovery', 'in', 'HDL', 'of', 'a', 'soluble', 'phospholipase', 'A2', 'was', 'followed', 'by', 'the', 'identification', 'of', 'phospholipid', 'lysoderivatives', '(', '75', ',', '76', ',', '77', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sphingosine kinase, the enzyme that phosphorylates sphingosine to produce S1P, is expressed in platelets (79) as well as in a variety of peripheral blood cells, including erythrocytes, neutrophils, and mononuclear cells (80).	[('PMC2614615', 'I15001', 0, 18, 'Sphingosine kinase')]	['Sp', '##hing', '##osine', 'kinase', ',', 'the', 'enzyme', 'that', 'phosphoryl', '##ates', 'sphing', '##osine', 'to', 'produce', 'S', '##1', '##P', ',', 'is', 'expressed', 'in', 'platelets', '(', '79', ')', 'as', 'well', 'as', 'in', 'a', 'variety', 'of', 'peripheral', 'blood', 'cells', ',', 'including', 'erythrocytes', ',', 'neutrophils', ',', 'and', 'mononuclear', 'cells', '(', '80', ')', '.']	[0, 2, 6, 12, 18, 20, 24, 31, 36, 46, 51, 57, 63, 66, 74, 75, 76, 77, 79, 82, 92, 95, 105, 106, 108, 110, 113, 118, 121, 124, 126, 134, 137, 148, 154, 159, 161, 171, 183, 185, 196, 198, 202, 214, 220, 221, 223, 224]	[2, 6, 11, 18, 19, 23, 30, 35, 46, 50, 57, 62, 65, 73, 75, 76, 77, 78, 81, 91, 94, 104, 106, 108, 109, 112, 117, 120, 123, 125, 133, 136, 147, 153, 159, 160, 170, 183, 184, 196, 197, 201, 213, 219, 221, 223, 224, 225]	['Sphingosine', 'kinase', ',', 'the', 'enzyme', 'that', 'phosphorylates', 'sphingosine', 'to', 'produce', 'S1P', ',', 'is', 'expressed', 'in', 'platelets', '(', '79', ')', 'as', 'well', 'as', 'in', 'a', 'variety', 'of', 'peripheral', 'blood', 'cells', ',', 'including', 'erythrocytes', ',', 'neutrophils', ',', 'and', 'mononuclear', 'cells', '(', '80', ')', '.']	[3, 1, 1, 1, 1, 1, 2, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of note, erythrocytes cannot produce sphingosine and also display relatively low levels of sphingosine kinase activity (84).	[('PMC2614615', 'I15003', 91, 109, 'sphingosine kinase')]	['Of', 'note', ',', 'erythrocytes', 'cannot', 'produce', 'sphing', '##osine', 'and', 'also', 'display', 'relatively', 'low', 'levels', 'of', 'sphing', '##osine', 'kinase', 'activity', '(', '84', ')', '.']	[0, 3, 7, 9, 22, 29, 37, 43, 49, 53, 58, 66, 77, 81, 88, 91, 97, 103, 110, 119, 120, 122, 123]	[2, 7, 8, 21, 28, 36, 43, 48, 52, 57, 65, 76, 80, 87, 90, 97, 102, 109, 118, 120, 122, 123, 124]	['Of', 'note', ',', 'erythrocytes', 'cannot', 'produce', 'sphingosine', 'and', 'also', 'display', 'relatively', 'low', 'levels', 'of', 'sphingosine', 'kinase', 'activity', '(', '84', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
In addition, they efficiently convert exogenous sphingosine to S1P. The fact that erythrocytes lack S1P-degrading enzymes (e.g., sphingosine lyase and S1P phosphatase) permits them to accumulate large amounts of S1P (84, 85).	[('PMC2614615', 'I15004', 129, 146, 'sphingosine lyase'), ('PMC2614615', 'I15004', 151, 166, 'S1P phosphatase')]	['In', 'addition', ',', 'they', 'efficiently', 'convert', 'exogenous', 'sphing', '##osine', 'to', 'S', '##1', '##P', '.', 'The', 'fact', 'that', 'erythrocytes', 'lack', 'S', '##1', '##P', '-', 'degrad', '##ing', 'enzymes', '(', 'e', '.', 'g', '.', ',', 'sphing', '##osine', 'ly', '##ase', 'and', 'S', '##1', '##P', 'phosphatase', ')', 'permits', 'them', 'to', 'accumulate', 'large', 'amounts', 'of', 'S', '##1', '##P', '(', '84', ',', '85', ')', '.']	[0, 3, 11, 13, 18, 30, 38, 48, 54, 60, 63, 64, 65, 66, 68, 72, 77, 82, 95, 100, 101, 102, 103, 104, 110, 114, 122, 123, 124, 125, 126, 127, 129, 135, 141, 143, 147, 151, 152, 153, 155, 166, 168, 176, 181, 184, 195, 201, 209, 212, 213, 214, 216, 217, 219, 221, 223, 224]	[2, 11, 12, 17, 29, 37, 47, 54, 59, 62, 64, 65, 66, 67, 71, 76, 81, 94, 99, 101, 102, 103, 104, 110, 113, 121, 123, 124, 125, 126, 127, 128, 135, 140, 143, 146, 150, 152, 153, 154, 166, 167, 175, 180, 183, 194, 200, 208, 211, 213, 214, 215, 217, 219, 220, 223, 224, 225]	['In', 'addition', ',', 'they', 'efficiently', 'convert', 'exogenous', 'sphingosine', 'to', 'S1P', '.', 'The', 'fact', 'that', 'erythrocytes', 'lack', 'S1P-degrading', 'enzymes', '(', 'e.g', '.', ',', 'sphingosine', 'lyase', 'and', 'S1P', 'phosphatase', ')', 'permits', 'them', 'to', 'accumulate', 'large', 'amounts', 'of', 'S1P', '(', '84', ',', '85', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 6, 1, 1, 3, 1, 1, 2, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five proteins (α-fetoprotein, fetuin A, macrophage migration inhibitory factor, pyruvate dehydrogenase E1 component, and lactoferrin) were upregulated and one protein (decorin) was downregulated.	[('PMC2679092', 'A02002', 80, 105, 'pyruvate dehydrogenase E1')]	['Five', 'proteins', '(', 'α', '-', 'fet', '##oprotein', ',', 'fet', '##uin', 'A', ',', 'macrophage', 'migration', 'inhibitory', 'factor', ',', 'pyruvate', 'dehydrogenase', 'E', '##1', 'component', ',', 'and', 'lact', '##of', '##err', '##in', ')', 'were', 'upregulated', 'and', 'one', 'protein', '(', 'decor', '##in', ')', 'was', 'downregulated', '.']	[0, 5, 14, 15, 16, 17, 20, 28, 30, 33, 37, 38, 40, 51, 61, 72, 78, 80, 89, 103, 104, 106, 115, 117, 121, 125, 127, 130, 132, 134, 139, 151, 155, 159, 167, 168, 173, 175, 177, 181, 194]	[4, 13, 15, 16, 17, 20, 28, 29, 33, 36, 38, 39, 50, 60, 71, 78, 79, 88, 102, 104, 105, 115, 116, 120, 125, 127, 130, 132, 133, 138, 150, 154, 158, 166, 168, 173, 175, 176, 180, 194, 195]	['Five', 'proteins', '(', 'α-fetoprotein', ',', 'fetuin', 'A', ',', 'macrophage', 'migration', 'inhibitory', 'factor', ',', 'pyruvate', 'dehydrogenase', 'E1', 'component', ',', 'and', 'lactoferrin', ')', 'were', 'upregulated', 'and', 'one', 'protein', '(', 'decorin', ')', 'was', 'downregulated', '.']	[1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five proteins (α-fetoprotein, fetuin-A, macrophage migration inhibitory factor, pyruvate dehydrogenase E1 component, and lactoferrin) were upregulated and one (decorin) was downregulated.	[('PMC2679092', 'D00004', 80, 105, 'pyruvate dehydrogenase E1')]	['Five', 'proteins', '(', 'α', '-', 'fet', '##oprotein', ',', 'fet', '##uin', '-', 'A', ',', 'macrophage', 'migration', 'inhibitory', 'factor', ',', 'pyruvate', 'dehydrogenase', 'E', '##1', 'component', ',', 'and', 'lact', '##of', '##err', '##in', ')', 'were', 'upregulated', 'and', 'one', '(', 'decor', '##in', ')', 'was', 'downregulated', '.']	[0, 5, 14, 15, 16, 17, 20, 28, 30, 33, 36, 37, 38, 40, 51, 61, 72, 78, 80, 89, 103, 104, 106, 115, 117, 121, 125, 127, 130, 132, 134, 139, 151, 155, 159, 160, 165, 167, 169, 173, 186]	[4, 13, 15, 16, 17, 20, 28, 29, 33, 36, 37, 38, 39, 50, 60, 71, 78, 79, 88, 102, 104, 105, 115, 116, 120, 125, 127, 130, 132, 133, 138, 150, 154, 158, 160, 165, 167, 168, 172, 186, 187]	['Five', 'proteins', '(', 'α-fetoprotein', ',', 'fetuin-A', ',', 'macrophage', 'migration', 'inhibitory', 'factor', ',', 'pyruvate', 'dehydrogenase', 'E1', 'component', ',', 'and', 'lactoferrin', ')', 'were', 'upregulated', 'and', 'one', '(', 'decorin', ')', 'was', 'downregulated', '.']	[1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fetuin-A is a member of the cystatin superfamily of cysteine protease inhibitors.	[('PMC2679092', 'D01002', 52, 69, 'cysteine protease')]	['Fe', '##tu', '##in', '-', 'A', 'is', 'a', 'member', 'of', 'the', 'cyst', '##atin', 'superfamily', 'of', 'cysteine', 'protease', 'inhibitors', '.']	[0, 2, 4, 6, 7, 9, 12, 14, 21, 24, 28, 32, 37, 49, 52, 61, 70, 80]	[2, 4, 6, 7, 8, 11, 13, 20, 23, 27, 32, 36, 48, 51, 60, 69, 80, 81]	['Fetuin-A', 'is', 'a', 'member', 'of', 'the', 'cystatin', 'superfamily', 'of', 'cysteine', 'protease', 'inhibitors', '.']	[5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
On a cellular level, fetuin-A is a multifunctional molecule and acts as an antagonist of TGF-β, regulating cytokine-dependent osteogenesis and inhibiting insulin receptor tyrosine kinase and some protease activities (Fig 4) (21).	[('PMC2679092', 'D01005', 171, 186, 'tyrosine kinase'), ('PMC2679092', 'D01005', 196, 204, 'protease')]	['On', 'a', 'cellular', 'level', ',', 'fet', '##uin', '-', 'A', 'is', 'a', 'multif', '##unctional', 'molecule', 'and', 'acts', 'as', 'an', 'antagonist', 'of', 'TGF', '-', 'β', ',', 'regulating', 'cytokine', '-', 'dependent', 'oste', '##ogenesis', 'and', 'inhibiting', 'insulin', 'receptor', 'tyrosine', 'kinase', 'and', 'some', 'protease', 'activities', '(', 'Fig', '4', ')', '(', '21', ')', '.']	[0, 3, 5, 14, 19, 21, 24, 27, 28, 30, 33, 35, 41, 51, 60, 64, 69, 72, 75, 86, 89, 92, 93, 94, 96, 107, 115, 116, 126, 130, 139, 143, 154, 162, 171, 180, 187, 191, 196, 205, 216, 217, 221, 222, 224, 225, 227, 228]	[2, 4, 13, 19, 20, 24, 27, 28, 29, 32, 34, 41, 50, 59, 63, 68, 71, 74, 85, 88, 92, 93, 94, 95, 106, 115, 116, 125, 130, 138, 142, 153, 161, 170, 179, 186, 190, 195, 204, 215, 217, 220, 222, 223, 225, 227, 228, 229]	['On', 'a', 'cellular', 'level', ',', 'fetuin-A', 'is', 'a', 'multifunctional', 'molecule', 'and', 'acts', 'as', 'an', 'antagonist', 'of', 'TGF-β', ',', 'regulating', 'cytokine', '-', 'dependent', 'osteogenesis', 'and', 'inhibiting', 'insulin', 'receptor', 'tyrosine', 'kinase', 'and', 'some', 'protease', 'activities', '(', 'Fig', '4', ')', '(', '21', ')', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Macrophage migration inhibitory factor has been shown to be involved in angiogenesis mediated through the mitogen-activated protein kinase pathway and associated with increased production of angiogenic proteins such as VEGF-A and MMPs (Fig 4) (28).	[('PMC2679092', 'D04004', 106, 138, 'mitogen-activated protein kinase')]	['Mac', '##roph', '##age', 'migration', 'inhibitory', 'factor', 'has', 'been', 'shown', 'to', 'be', 'involved', 'in', 'angiogenesis', 'mediated', 'through', 'the', 'mitogen', '-', 'activated', 'protein', 'kinase', 'pathway', 'and', 'associated', 'with', 'increased', 'production', 'of', 'angiogenic', 'proteins', 'such', 'as', 'VEGF', '-', 'A', 'and', 'MMP', '##s', '(', 'Fig', '4', ')', '(', '28', ')', '.']	[0, 3, 7, 11, 21, 32, 39, 43, 48, 54, 57, 60, 69, 72, 85, 94, 102, 106, 113, 114, 124, 132, 139, 147, 151, 162, 167, 177, 188, 191, 202, 211, 216, 219, 223, 224, 226, 230, 233, 235, 236, 240, 241, 243, 244, 246, 247]	[3, 7, 10, 20, 31, 38, 42, 47, 53, 56, 59, 68, 71, 84, 93, 101, 105, 113, 114, 123, 131, 138, 146, 150, 161, 166, 176, 187, 190, 201, 210, 215, 218, 223, 224, 225, 229, 233, 234, 236, 239, 241, 242, 244, 246, 247, 248]	['Macrophage', 'migration', 'inhibitory', 'factor', 'has', 'been', 'shown', 'to', 'be', 'involved', 'in', 'angiogenesis', 'mediated', 'through', 'the', 'mitogen', '-', 'activated', 'protein', 'kinase', 'pathway', 'and', 'associated', 'with', 'increased', 'production', 'of', 'angiogenic', 'proteins', 'such', 'as', 'VEGF-A', 'and', 'MMPs', '(', 'Fig', '4', ')', '(', '28', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We hypothesize that the decreased levels of decorin may be responsible for the increased cellular proliferation with increased matrix metalloproteinase activity that has been observed in animal models of hemodialysis graft failure (Fig 4) (6).	[('PMC2679092', 'D06006', 127, 151, 'matrix metalloproteinase')]	['We', 'hypothesize', 'that', 'the', 'decreased', 'levels', 'of', 'decor', '##in', 'may', 'be', 'responsible', 'for', 'the', 'increased', 'cellular', 'proliferation', 'with', 'increased', 'matrix', 'metalloprotein', '##ase', 'activity', 'that', 'has', 'been', 'observed', 'in', 'animal', 'models', 'of', 'hemodialysis', 'graft', 'failure', '(', 'Fig', '4', ')', '(', '6', ')', '.']	[0, 3, 15, 20, 24, 34, 41, 44, 49, 52, 56, 59, 71, 75, 79, 89, 98, 112, 117, 127, 134, 148, 152, 161, 166, 170, 175, 184, 187, 194, 201, 204, 217, 223, 231, 232, 236, 237, 239, 240, 241, 242]	[2, 14, 19, 23, 33, 40, 43, 49, 51, 55, 58, 70, 74, 78, 88, 97, 111, 116, 126, 133, 148, 151, 160, 165, 169, 174, 183, 186, 193, 200, 203, 216, 222, 230, 232, 235, 237, 238, 240, 241, 242, 243]	['We', 'hypothesize', 'that', 'the', 'decreased', 'levels', 'of', 'decorin', 'may', 'be', 'responsible', 'for', 'the', 'increased', 'cellular', 'proliferation', 'with', 'increased', 'matrix', 'metalloproteinase', 'activity', 'that', 'has', 'been', 'observed', 'in', 'animal', 'models', 'of', 'hemodialysis', 'graft', 'failure', '(', 'Fig', '4', ')', '(', '6', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pyruvate dehydrogenase E1 is an enzyme involved in the pyruvate dehydrogenase complex (43).	[('PMC2679092', 'D08000', 0, 25, 'Pyruvate dehydrogenase E1'), ('PMC2679092', 'D08000', 55, 85, 'pyruvate dehydrogenase complex')]	['Pyr', '##uvate', 'dehydrogenase', 'E', '##1', 'is', 'an', 'enzyme', 'involved', 'in', 'the', 'pyruvate', 'dehydrogenase', 'complex', '(', '43', ')', '.']	[0, 3, 9, 23, 24, 26, 29, 32, 39, 48, 51, 55, 64, 78, 86, 87, 89, 90]	[3, 8, 22, 24, 25, 28, 31, 38, 47, 50, 54, 63, 77, 85, 87, 89, 90, 91]	['Pyruvate', 'dehydrogenase', 'E1', 'is', 'an', 'enzyme', 'involved', 'in', 'the', 'pyruvate', 'dehydrogenase', 'complex', '(', '43', ')', '.']	[2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
The role of pyruvate dehydrogenase E1 in vascular disease has not been reported to date, and its role in hemodialysis graft failure needs to be determined.	[('PMC2679092', 'D08003', 12, 37, 'pyruvate dehydrogenase E1')]	['The', 'role', 'of', 'pyruvate', 'dehydrogenase', 'E', '##1', 'in', 'vascular', 'disease', 'has', 'not', 'been', 'reported', 'to', 'date', ',', 'and', 'its', 'role', 'in', 'hemodialysis', 'graft', 'failure', 'needs', 'to', 'be', 'determined', '.']	[0, 4, 9, 12, 21, 35, 36, 38, 41, 50, 58, 62, 66, 71, 80, 83, 87, 89, 93, 97, 102, 105, 118, 124, 132, 138, 141, 144, 154]	[3, 8, 11, 20, 34, 36, 37, 40, 49, 57, 61, 65, 70, 79, 82, 87, 88, 92, 96, 101, 104, 117, 123, 131, 137, 140, 143, 154, 155]	['The', 'role', 'of', 'pyruvate', 'dehydrogenase', 'E1', 'in', 'vascular', 'disease', 'has', 'not', 'been', 'reported', 'to', 'date', ',', 'and', 'its', 'role', 'in', 'hemodialysis', 'graft', 'failure', 'needs', 'to', 'be', 'determined', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts.	[('PMC2679092', 'F05002', 38, 64, 'matrix metalloproteinase-2')]	['Adv', '##enti', '##tial', 'remodeling', 'with', 'increased', 'matrix', 'metalloprotein', '##ase', '-', '2', 'activity', 'in', 'a', 'porcine', 'arteri', '##ove', '##no', '##us', 'polyt', '##etra', '##fluor', '##oe', '##thy', '##len', '##e', 'grafts', '.']	[0, 3, 7, 12, 23, 28, 38, 45, 59, 62, 63, 65, 74, 77, 79, 87, 93, 96, 98, 101, 106, 110, 115, 117, 120, 123, 125, 131]	[3, 7, 11, 22, 27, 37, 44, 59, 62, 63, 64, 73, 76, 78, 86, 93, 96, 98, 100, 106, 110, 115, 117, 120, 123, 124, 131, 132]	['Adventitial', 'remodeling', 'with', 'increased', 'matrix', 'metalloproteinase-2', 'activity', 'in', 'a', 'porcine', 'arteriovenous', 'polytetrafluoroethylene', 'grafts', '.']	[3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model.	[('PMC2679092', 'F08002', 0, 24, 'Matrix metalloproteinase')]	['Matrix', 'metalloprotein', '##ase', 'inhibition', 'reduces', 'int', '##imal', 'hyperplasia', 'in', 'a', 'porcine', 'arteri', '##ove', '##no', '##us', '-', 'graft', 'model', '.']	[0, 7, 21, 25, 36, 44, 47, 52, 64, 67, 69, 77, 83, 86, 88, 90, 91, 97, 102]	[6, 21, 24, 35, 43, 47, 51, 63, 66, 68, 76, 83, 86, 88, 90, 91, 96, 102, 103]	['Matrix', 'metalloproteinase', 'inhibition', 'reduces', 'intimal', 'hyperplasia', 'in', 'a', 'porcine', 'arteriovenous', '-', 'graft', 'model', '.']	[1, 2, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Increased expression of a disintegrin and metalloproteinase thrombospondin-1 (AD-AMTS-1) in thrombosed hemodialysis grafts.	[('PMC2679092', 'F10002', 42, 59, 'metalloproteinase')]	['Increased', 'expression', 'of', 'a', 'dis', '##integr', '##in', 'and', 'metalloprotein', '##ase', 'thrombo', '##sp', '##ond', '##in', '-', '1', '(', 'AD', '-', 'AM', '##TS', '-', '1', ')', 'in', 'thrombo', '##sed', 'hemodialysis', 'grafts', '.']	[0, 10, 21, 24, 26, 29, 35, 38, 42, 56, 60, 67, 69, 72, 74, 75, 77, 78, 80, 81, 83, 85, 86, 87, 89, 92, 99, 103, 116, 122]	[9, 20, 23, 25, 29, 35, 37, 41, 56, 59, 67, 69, 72, 74, 75, 76, 78, 80, 81, 83, 85, 86, 87, 88, 91, 99, 102, 115, 122, 123]	['Increased', 'expression', 'of', 'a', 'disintegrin', 'and', 'metalloproteinase', 'thrombospondin-1', '(', 'AD-AMTS-1', ')', 'in', 'thrombosed', 'hemodialysis', 'grafts', '.']	[1, 1, 1, 1, 3, 1, 2, 6, 1, 6, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pyruvate dehydrogenase-1 alpha deficiency: males and females differ yet again.	[('PMC2679092', 'F42002', 0, 30, 'Pyruvate dehydrogenase-1 alpha')]	['Pyr', '##uvate', 'dehydrogenase', '-', '1', 'alpha', 'deficiency', ':', 'males', 'and', 'females', 'differ', 'yet', 'again', '.']	[0, 3, 9, 22, 23, 25, 31, 41, 43, 49, 53, 61, 68, 72, 77]	[3, 8, 22, 23, 24, 30, 41, 42, 48, 52, 60, 67, 71, 77, 78]	['Pyruvate', 'dehydrogenase-1', 'alpha', 'deficiency', ':', 'males', 'and', 'females', 'differ', 'yet', 'again', '.']	[2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
At a cellular level, many proteins have been identified to be associated with failed hemodialysis access, including vascular endothelial growth factor-A (VEGF-A), platelet-derived growth factor, transforming growth factor-β (TGF-β), basic fibroblast growth factor, and matrix metalloproteinases (MMPs) (4–9).	[('PMC2679092', 'I01002', 269, 294, 'matrix metalloproteinases')]	['At', 'a', 'cellular', 'level', ',', 'many', 'proteins', 'have', 'been', 'identified', 'to', 'be', 'associated', 'with', 'failed', 'hemodialysis', 'access', ',', 'including', 'vascular', 'endothelial', 'growth', 'factor', '-', 'A', '(', 'VEGF', '-', 'A', ')', ',', 'platelet', '-', 'derived', 'growth', 'factor', ',', 'transforming', 'growth', 'factor', '-', 'β', '(', 'TGF', '-', 'β', ')', ',', 'basic', 'fibroblast', 'growth', 'factor', ',', 'and', 'matrix', 'metalloprotein', '##ases', '(', 'MMP', '##s', ')', '(', '4', '–', '9', ')', '.']	[0, 3, 5, 14, 19, 21, 26, 35, 40, 45, 56, 59, 62, 73, 78, 85, 98, 104, 106, 116, 125, 137, 144, 150, 151, 153, 154, 158, 159, 160, 161, 163, 171, 172, 180, 187, 193, 195, 208, 215, 221, 222, 224, 225, 228, 229, 230, 231, 233, 239, 250, 257, 263, 265, 269, 276, 290, 295, 296, 299, 300, 302, 303, 304, 305, 306, 307]	[2, 4, 13, 19, 20, 25, 34, 39, 44, 55, 58, 61, 72, 77, 84, 97, 104, 105, 115, 124, 136, 143, 150, 151, 152, 154, 158, 159, 160, 161, 162, 171, 172, 179, 186, 193, 194, 207, 214, 221, 222, 223, 225, 228, 229, 230, 231, 232, 238, 249, 256, 263, 264, 268, 275, 290, 294, 296, 299, 300, 301, 303, 304, 305, 306, 307, 308]	['At', 'a', 'cellular', 'level', ',', 'many', 'proteins', 'have', 'been', 'identified', 'to', 'be', 'associated', 'with', 'failed', 'hemodialysis', 'access', ',', 'including', 'vascular', 'endothelial', 'growth', 'factor-A', '(', 'VEGF-A', ')', ',', 'platelet', '-', 'derived', 'growth', 'factor', ',', 'transforming', 'growth', 'factor-β', '(', 'TGF-β', ')', ',', 'basic', 'fibroblast', 'growth', 'factor', ',', 'and', 'matrix', 'metalloproteinases', '(', 'MMPs', ')', '(', '4–', '9', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The upregulated group included α-fetoprotein, fetuin-A, macrophage migration inhibitory factor, lactoferrin, and pyruvate dehydrogenase E1 component (Table 1), and the downregulated group included decorin (Table 2).	[('PMC2679092', 'R01003', 113, 138, 'pyruvate dehydrogenase E1')]	['The', 'upregulated', 'group', 'included', 'α', '-', 'fet', '##oprotein', ',', 'fet', '##uin', '-', 'A', ',', 'macrophage', 'migration', 'inhibitory', 'factor', ',', 'lact', '##of', '##err', '##in', ',', 'and', 'pyruvate', 'dehydrogenase', 'E', '##1', 'component', '(', 'Table', '1', ')', ',', 'and', 'the', 'downregulated', 'group', 'included', 'decor', '##in', '(', 'Table', '2', ')', '.']	[0, 4, 16, 22, 31, 32, 33, 36, 44, 46, 49, 52, 53, 54, 56, 67, 77, 88, 94, 96, 100, 102, 105, 107, 109, 113, 122, 136, 137, 139, 149, 150, 156, 157, 158, 160, 164, 168, 182, 188, 197, 202, 205, 206, 212, 213, 214]	[3, 15, 21, 30, 32, 33, 36, 44, 45, 49, 52, 53, 54, 55, 66, 76, 87, 94, 95, 100, 102, 105, 107, 108, 112, 121, 135, 137, 138, 148, 150, 155, 157, 158, 159, 163, 167, 181, 187, 196, 202, 204, 206, 211, 213, 214, 215]	['The', 'upregulated', 'group', 'included', 'α-fetoprotein', ',', 'fetuin-A', ',', 'macrophage', 'migration', 'inhibitory', 'factor', ',', 'lactoferrin', ',', 'and', 'pyruvate', 'dehydrogenase', 'E1', 'component', '(', 'Table', '1', ')', ',', 'and', 'the', 'downregulated', 'group', 'included', 'decorin', '(', 'Table', '2', ')', '.']	[1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a.	[('PMC2682433', 'F08002', 33, 56, 'cyclin-dependent kinase')]	['Stem', '-', 'cell', 'ageing', 'modified', 'by', 'the', 'cyclin', '-', 'dependent', 'kinase', 'inhibitor', 'p', '##16', '##INK', '##4', '##a', '.']	[0, 4, 5, 10, 17, 26, 29, 33, 39, 40, 50, 57, 67, 68, 70, 73, 74, 75]	[4, 5, 9, 16, 25, 28, 32, 39, 40, 49, 56, 66, 68, 70, 73, 74, 75, 76]	['Stem', '-', 'cell', 'ageing', 'modified', 'by', 'the', 'cyclin', '-', 'dependent', 'kinase', 'inhibitor', 'p16INK4a', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PLCL1 is of interest because it has significant homology to phospholipase C, which lies downstream of VEGFR2 signaling19.	[('PMC2682433', 'I06004', 60, 75, 'phospholipase C')]	['PLC', '##L', '##1', 'is', 'of', 'interest', 'because', 'it', 'has', 'significant', 'homology', 'to', 'phospholip', '##ase', 'C', ',', 'which', 'lies', 'downstream', 'of', 'VEGF', '##R', '##2', 'signaling', '##19', '.']	[0, 3, 4, 6, 9, 12, 21, 29, 32, 36, 48, 57, 60, 70, 74, 75, 77, 83, 88, 99, 102, 106, 107, 109, 118, 120]	[3, 4, 5, 8, 11, 20, 28, 31, 35, 47, 56, 59, 70, 73, 75, 76, 82, 87, 98, 101, 106, 107, 108, 118, 120, 121]	['PLCL1', 'is', 'of', 'interest', 'because', 'it', 'has', 'significant', 'homology', 'to', 'phospholipase', 'C', ',', 'which', 'lies', 'downstream', 'of', 'VEGFR2', 'signaling19', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These genes encode the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a, as well as ARF, a regulator of p53 activity.	[('PMC2682433', 'I08003', 23, 46, 'cyclin-dependent kinase')]	['These', 'genes', 'encode', 'the', 'cyclin', '-', 'dependent', 'kinase', 'inhibitors', 'p', '##15', '##INK', '##4', '##b', 'and', 'p', '##16', '##INK', '##4', '##a', ',', 'as', 'well', 'as', 'AR', '##F', ',', 'a', 'regulator', 'of', 'p', '##53', 'activity', '.']	[0, 6, 12, 19, 23, 29, 30, 40, 47, 58, 59, 61, 64, 65, 67, 71, 72, 74, 77, 78, 79, 81, 84, 89, 92, 94, 95, 97, 99, 109, 112, 113, 116, 124]	[5, 11, 18, 22, 29, 30, 39, 46, 57, 59, 61, 64, 65, 66, 70, 72, 74, 77, 78, 79, 80, 83, 88, 91, 94, 95, 96, 98, 108, 111, 113, 115, 124, 125]	['These', 'genes', 'encode', 'the', 'cyclin', '-', 'dependent', 'kinase', 'inhibitors', 'p15INK4b', 'and', 'p16INK4a', ',', 'as', 'well', 'as', 'ARF', ',', 'a', 'regulator', 'of', 'p53', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition to HMGA2, which encodes a chromatin-binding protein, we found associations with a SNP (rs10946808) in a histone cluster on chromosome 6, a SNP (rs12986413) in the histone methyltransferase DOT1L gene and a SNP (rs724016) in an intron of the methyl-DNA-binding transcriptional repressor gene ZBTB38.	[('PMC2687076', 'D02001', 175, 200, 'histone methyltransferase')]	['In', 'addition', 'to', 'HM', '##GA', '##2', ',', 'which', 'encodes', 'a', 'chromatin', '-', 'binding', 'protein', ',', 'we', 'found', 'associations', 'with', 'a', 'SNP', '(', 'rs', '##109', '##46', '##80', '##8', ')', 'in', 'a', 'histone', 'cluster', 'on', 'chromosome', '6', ',', 'a', 'SNP', '(', 'rs', '##129', '##86', '##41', '##3', ')', 'in', 'the', 'histone', 'methyl', '##transferase', 'DO', '##T', '##1', '##L', 'gene', 'and', 'a', 'SNP', '(', 'rs', '##72', '##40', '##16', ')', 'in', 'an', 'intron', 'of', 'the', 'methyl', '-', 'DNA', '-', 'binding', 'transcriptional', 'repressor', 'gene', 'Z', '##BT', '##B', '##38', '.']	[0, 3, 12, 15, 17, 19, 20, 22, 28, 36, 38, 47, 48, 56, 63, 65, 68, 74, 87, 92, 94, 98, 99, 101, 104, 106, 108, 109, 111, 114, 116, 124, 132, 135, 146, 147, 149, 151, 155, 156, 158, 161, 163, 165, 166, 168, 171, 175, 183, 189, 201, 203, 204, 205, 207, 212, 216, 218, 222, 223, 225, 227, 229, 231, 233, 236, 239, 246, 249, 253, 259, 260, 263, 264, 272, 288, 298, 303, 304, 306, 307, 309]	[2, 11, 14, 17, 19, 20, 21, 27, 35, 37, 47, 48, 55, 63, 64, 67, 73, 86, 91, 93, 97, 99, 101, 104, 106, 108, 109, 110, 113, 115, 123, 131, 134, 145, 147, 148, 150, 154, 156, 158, 161, 163, 165, 166, 167, 170, 174, 182, 189, 200, 203, 204, 205, 206, 211, 215, 217, 221, 223, 225, 227, 229, 231, 232, 235, 238, 245, 248, 252, 259, 260, 263, 264, 271, 287, 297, 302, 304, 306, 307, 309, 310]	['In', 'addition', 'to', 'HMGA2', ',', 'which', 'encodes', 'a', 'chromatin', '-', 'binding', 'protein', ',', 'we', 'found', 'associations', 'with', 'a', 'SNP', '(', 'rs10946808', ')', 'in', 'a', 'histone', 'cluster', 'on', 'chromosome', '6', ',', 'a', 'SNP', '(', 'rs12986413', ')', 'in', 'the', 'histone', 'methyltransferase', 'DOT1L', 'gene', 'and', 'a', 'SNP', '(', 'rs724016', ')', 'in', 'an', 'intron', 'of', 'the', 'methyl-DNA', '-', 'binding', 'transcriptional', 'repressor', 'gene', 'ZBTB38', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It is currently unclear how genetic variation at these loci modulate height, but there is a precedent for a connection between regulation of chromatin structure and stature: Sotos syndrome (MIM117550), characterized by extreme tall stature, is caused by mutations and deletions in the histone methyltransferase gene NSD1.	[('PMC2687076', 'D02002', 285, 310, 'histone methyltransferase')]	['It', 'is', 'currently', 'unclear', 'how', 'genetic', 'variation', 'at', 'these', 'loci', 'modulate', 'height', ',', 'but', 'there', 'is', 'a', 'preced', '##ent', 'for', 'a', 'connection', 'between', 'regulation', 'of', 'chromatin', 'structure', 'and', 'stat', '##ure', ':', 'So', '##to', '##s', 'syndrome', '(', 'MIM', '##117', '##55', '##0', ')', ',', 'characterized', 'by', 'extreme', 'tall', 'stat', '##ure', ',', 'is', 'caused', 'by', 'mutations', 'and', 'deletions', 'in', 'the', 'histone', 'methyl', '##transferase', 'gene', 'NS', '##D', '##1', '.']	[0, 3, 6, 16, 24, 28, 36, 46, 49, 55, 60, 69, 75, 77, 81, 87, 90, 92, 98, 102, 106, 108, 119, 127, 138, 141, 151, 161, 165, 169, 172, 174, 176, 178, 180, 189, 190, 193, 196, 198, 199, 200, 202, 216, 219, 227, 232, 236, 239, 241, 244, 251, 254, 264, 268, 278, 281, 285, 293, 299, 311, 316, 318, 319, 320]	[2, 5, 15, 23, 27, 35, 45, 48, 54, 59, 68, 75, 76, 80, 86, 89, 91, 98, 101, 105, 107, 118, 126, 137, 140, 150, 160, 164, 169, 172, 173, 176, 178, 179, 188, 190, 193, 196, 198, 199, 200, 201, 215, 218, 226, 231, 236, 239, 240, 243, 250, 253, 263, 267, 277, 280, 284, 292, 299, 310, 315, 318, 319, 320, 321]	['It', 'is', 'currently', 'unclear', 'how', 'genetic', 'variation', 'at', 'these', 'loci', 'modulate', 'height', ',', 'but', 'there', 'is', 'a', 'precedent', 'for', 'a', 'connection', 'between', 'regulation', 'of', 'chromatin', 'structure', 'and', 'stature', ':', 'Sotos', 'syndrome', '(', 'MIM117550', ')', ',', 'characterized', 'by', 'extreme', 'tall', 'stature', ',', 'is', 'caused', 'by', 'mutations', 'and', 'deletions', 'in', 'the', 'histone', 'methyltransferase', 'gene', 'NSD1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
When we examined our list of 12 height loci, we were somewhat surprised to find three additional previously described targets of let-7: the cell cycle regulator CDK6 (ref. 26), the histone methyltransferase DOT1L​27 and the gene LIN28B​28.	[('PMC2687076', 'D03002', 181, 206, 'histone methyltransferase')]	['When', 'we', 'examined', 'our', 'list', 'of', '12', 'height', 'loci', ',', 'we', 'were', 'somewhat', 'surprise', '##d', 'to', 'find', 'three', 'additional', 'previously', 'described', 'targets', 'of', 'let', '-', '7', ':', 'the', 'cell', 'cycle', 'regulator', 'CDK', '##6', '(', 'ref', '.', '26', ')', ',', 'the', 'histone', 'methyl', '##transferase', 'DO', '##T', '##1', '##L', '##27', 'and', 'the', 'gene', 'LI', '##N', '##28', '##B', '##28', '.']	[0, 5, 8, 17, 21, 26, 29, 32, 39, 43, 45, 48, 53, 62, 70, 72, 75, 80, 86, 97, 108, 118, 126, 129, 132, 133, 134, 136, 140, 145, 151, 161, 164, 166, 167, 170, 172, 174, 175, 177, 181, 189, 195, 207, 209, 210, 211, 213, 216, 220, 224, 229, 231, 232, 234, 236, 238]	[4, 7, 16, 20, 25, 28, 31, 38, 43, 44, 47, 52, 61, 70, 71, 74, 79, 85, 96, 107, 117, 125, 128, 132, 133, 134, 135, 139, 144, 150, 160, 164, 165, 167, 170, 171, 174, 175, 176, 180, 188, 195, 206, 209, 210, 211, 212, 215, 219, 223, 228, 231, 232, 234, 235, 238, 239]	['When', 'we', 'examined', 'our', 'list', 'of', '12', 'height', 'loci', ',', 'we', 'were', 'somewhat', 'surprised', 'to', 'find', 'three', 'additional', 'previously', 'described', 'targets', 'of', 'let-7', ':', 'the', 'cell', 'cycle', 'regulator', 'CDK6', '(', 'ref', '.', '26', ')', ',', 'the', 'histone', 'methyltransferase', 'DOT1L\u200b27', 'and', 'the', 'gene', 'LIN28B\u200b28', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 5, 1, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A SNP 28 kb upstream of PRKG2 (rs1662845), which encodes the cGMP-dependent protein kinase II (cGKII), showed strong association with height in our meta-analysis of GWA scans (P = 5.7 × 10-5), and in the same direction in the European American height panel (P = 8.5 × 10-6) and the FUSION stage 2 sample (P = 0.001), but not in the FINRISK97 (P = 0.93, opposite direction) and PPP (P = 0.16, opposite direction) panels.	[('PMC2687076', 'D04001', 61, 93, 'cGMP-dependent protein kinase II')]	['A', 'SNP', '28', 'kb', 'upstream', 'of', 'PR', '##K', '##G', '##2', '(', 'rs', '##166', '##28', '##45', ')', ',', 'which', 'encodes', 'the', 'c', '##GMP', '-', 'dependent', 'protein', 'kinase', 'II', '(', 'c', '##G', '##KI', '##I', ')', ',', 'showed', 'strong', 'association', 'with', 'height', 'in', 'our', 'meta', '-', 'analysis', 'of', 'GW', '##A', 'scans', '(', 'P', '=', '5', '.', '7', '×', '10', '-', '5', ')', ',', 'and', 'in', 'the', 'same', 'direction', 'in', 'the', 'European', 'American', 'height', 'panel', '(', 'P', '=', '8', '.', '5', '×', '10', '-', '6', ')', 'and', 'the', 'FU', '##SION', 'stage', '2', 'sample', '(', 'P', '=', '0', '.', '00', '##1', ')', ',', 'but', 'not', 'in', 'the', 'FI', '##NR', '##IS', '##K', '##97', '(', 'P', '=', '0', '.', '93', ',', 'opposite', 'direction', ')', 'and', 'PP', '##P', '(', 'P', '=', '0', '.', '16', ',', 'opposite', 'direction', ')', 'panels', '.']	[0, 2, 6, 9, 12, 21, 24, 26, 27, 28, 30, 31, 33, 36, 38, 40, 41, 43, 49, 57, 61, 62, 65, 66, 76, 84, 91, 94, 95, 96, 97, 99, 100, 101, 103, 110, 117, 129, 134, 141, 144, 148, 152, 153, 162, 165, 167, 169, 175, 176, 178, 180, 181, 182, 184, 186, 188, 189, 190, 191, 193, 197, 200, 204, 209, 219, 222, 226, 235, 244, 251, 257, 258, 260, 262, 263, 264, 266, 268, 270, 271, 272, 274, 278, 282, 284, 289, 295, 297, 304, 305, 307, 309, 310, 311, 313, 314, 315, 317, 321, 325, 328, 332, 334, 336, 338, 339, 342, 343, 345, 347, 348, 349, 351, 353, 362, 371, 373, 377, 379, 381, 382, 384, 386, 387, 388, 390, 392, 401, 410, 412, 418]	[1, 5, 8, 11, 20, 23, 26, 27, 28, 29, 31, 33, 36, 38, 40, 41, 42, 48, 56, 60, 62, 65, 66, 75, 83, 90, 93, 95, 96, 97, 99, 100, 101, 102, 109, 116, 128, 133, 140, 143, 147, 152, 153, 161, 164, 167, 168, 174, 176, 177, 179, 181, 182, 183, 185, 188, 189, 190, 191, 192, 196, 199, 203, 208, 218, 221, 225, 234, 243, 250, 256, 258, 259, 261, 263, 264, 265, 267, 270, 271, 272, 273, 277, 281, 284, 288, 294, 296, 303, 305, 306, 308, 310, 311, 313, 314, 315, 316, 320, 324, 327, 331, 334, 336, 338, 339, 341, 343, 344, 346, 348, 349, 351, 352, 361, 371, 372, 376, 379, 380, 382, 383, 385, 387, 388, 390, 391, 400, 410, 411, 418, 419]	['A', 'SNP', '28', 'kb', 'upstream', 'of', 'PRKG2', '(', 'rs1662845', ')', ',', 'which', 'encodes', 'the', 'cGMP-dependent', 'protein', 'kinase', 'II', '(', 'cGKII', ')', ',', 'showed', 'strong', 'association', 'with', 'height', 'in', 'our', 'meta-', 'analysis', 'of', 'GWA', 'scans', '(', 'P', '=', '5.7', '×', '10-5', ')', ',', 'and', 'in', 'the', 'same', 'direction', 'in', 'the', 'European', 'American', 'height', 'panel', '(', 'P', '=', '8.5', '×', '10-6', ')', 'and', 'the', 'FUSION', 'stage', '2', 'sample', '(', 'P', '=', '0.001', ')', ',', 'but', 'not', 'in', 'the', 'FINRISK97', '(', 'P', '=', '0.93', ',', 'opposite', 'direction', ')', 'and', 'PPP', '(', 'P', '=', '0.16', ',', 'opposite', 'direction', ')', 'panels', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several newly identified loci associated with height are located near genes with less immediately apparent connections to stature, including the G protein-coupled receptor gene GPR126, a locus that encompasses the thyroid hormone receptor interactor TRIP11 and the ataxin ATXN3 genes, a locus with the Huntingtin-interacting gene SH3GL3 and the glycoprotein metalloprotease gene ADAMTSL3 (the later often mutated in colon cancer31), a locus with gene CHCHD7, frequently fused to the PLAG1 oncogene in salivary gland adenomas32, and the epidermal retinal dehydrogenase 2 gene RDHE2.	[('PMC2687076', 'D05000', 345, 373, 'glycoprotein metalloprotease'), ('PMC2687076', 'D05000', 546, 569, 'retinal dehydrogenase 2')]	['Several', 'newly', 'identified', 'loci', 'associated', 'with', 'height', 'are', 'located', 'near', 'genes', 'with', 'less', 'immediately', 'apparent', 'connections', 'to', 'stat', '##ure', ',', 'including', 'the', 'G', 'protein', '-', 'coupled', 'receptor', 'gene', 'GP', '##R', '##126', ',', 'a', 'locus', 'that', 'encompasses', 'the', 'thyroid', 'hormone', 'receptor', 'interact', '##or', 'TRI', '##P', '##11', 'and', 'the', 'at', '##ax', '##in', 'AT', '##X', '##N', '##3', 'genes', ',', 'a', 'locus', 'with', 'the', 'Hu', '##nt', '##ing', '##tin', '-', 'interacting', 'gene', 'SH', '##3', '##GL', '##3', 'and', 'the', 'glycoprotein', 'metall', '##oprot', '##ea', '##se', 'gene', 'ADAM', '##TS', '##L', '##3', '(', 'the', 'later', 'often', 'mutated', 'in', 'colon', 'cancer', '##31', ')', ',', 'a', 'locus', 'with', 'gene', 'CH', '##CH', '##D', '##7', ',', 'frequently', 'fused', 'to', 'the', 'PLA', '##G', '##1', 'onc', '##ogene', 'in', 'salivary', 'gland', 'adenomas', '##32', ',', 'and', 'the', 'epidermal', 'retinal', 'dehydrogenase', '2', 'gene', 'RD', '##HE', '##2', '.']	[0, 8, 14, 25, 30, 41, 46, 53, 57, 65, 70, 76, 81, 86, 98, 107, 119, 122, 126, 129, 131, 141, 145, 147, 154, 155, 163, 172, 177, 179, 180, 183, 185, 187, 193, 198, 210, 214, 222, 230, 239, 247, 250, 253, 254, 257, 261, 265, 267, 269, 272, 274, 275, 276, 278, 283, 285, 287, 293, 298, 302, 304, 306, 309, 312, 313, 325, 330, 332, 333, 335, 337, 341, 345, 358, 364, 369, 371, 374, 379, 383, 385, 386, 388, 389, 393, 399, 405, 413, 416, 422, 428, 430, 431, 433, 435, 441, 446, 451, 453, 455, 456, 457, 459, 470, 476, 479, 483, 486, 487, 489, 492, 498, 501, 510, 516, 524, 526, 528, 532, 536, 546, 554, 568, 570, 575, 577, 579, 580]	[7, 13, 24, 29, 40, 45, 52, 56, 64, 69, 75, 80, 85, 97, 106, 118, 121, 126, 129, 130, 140, 144, 146, 154, 155, 162, 171, 176, 179, 180, 183, 184, 186, 192, 197, 209, 213, 221, 229, 238, 247, 249, 253, 254, 256, 260, 264, 267, 269, 271, 274, 275, 276, 277, 283, 284, 286, 292, 297, 301, 304, 306, 309, 312, 313, 324, 329, 332, 333, 335, 336, 340, 344, 357, 364, 369, 371, 373, 378, 383, 385, 386, 387, 389, 392, 398, 404, 412, 415, 421, 428, 430, 431, 432, 434, 440, 445, 450, 453, 455, 456, 457, 458, 469, 475, 478, 482, 486, 487, 488, 492, 497, 500, 509, 515, 524, 526, 527, 531, 535, 545, 553, 567, 569, 574, 577, 579, 580, 581]	['Several', 'newly', 'identified', 'loci', 'associated', 'with', 'height', 'are', 'located', 'near', 'genes', 'with', 'less', 'immediately', 'apparent', 'connections', 'to', 'stature', ',', 'including', 'the', 'G', 'protein', '-', 'coupled', 'receptor', 'gene', 'GPR126', ',', 'a', 'locus', 'that', 'encompasses', 'the', 'thyroid', 'hormone', 'receptor', 'interactor', 'TRIP11', 'and', 'the', 'ataxin', 'ATXN3', 'genes', ',', 'a', 'locus', 'with', 'the', 'Huntingtin', '-', 'interacting', 'gene', 'SH3GL3', 'and', 'the', 'glycoprotein', 'metalloprotease', 'gene', 'ADAMTSL3', '(', 'the', 'later', 'often', 'mutated', 'in', 'colon', 'cancer31', ')', ',', 'a', 'locus', 'with', 'gene', 'CHCHD7', ',', 'frequently', 'fused', 'to', 'the', 'PLAG1', 'oncogene', 'in', 'salivary', 'gland', 'adenomas32', ',', 'and', 'the', 'epidermal', 'retinal', 'dehydrogenase', '2', 'gene', 'RDHE2', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 3, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II.	[('PMC2687076', 'F28002', 58, 90, 'cGMP-dependent protein kinase II')]	['Int', '##estinal', 'secretory', 'defects', 'and', 'dwarf', '##ism', 'in', 'mice', 'lacking', 'c', '##GMP', '-', 'dependent', 'protein', 'kinase', 'II', '.']	[0, 3, 11, 21, 29, 33, 38, 42, 45, 50, 58, 59, 62, 63, 73, 81, 88, 90]	[3, 10, 20, 28, 32, 38, 41, 44, 49, 57, 59, 62, 63, 72, 80, 87, 90, 91]	['Intestinal', 'secretory', 'defects', 'and', 'dwarfism', 'in', 'mice', 'lacking', 'cGMP-dependent', 'protein', 'kinase', 'II', '.']	[2, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes.	[('PMC2687076', 'F29002', 0, 38, 'Cyclic GMP-dependent protein kinase II')]	['Cycl', '##ic', 'GM', '##P', '-', 'dependent', 'protein', 'kinase', 'II', 'is', 'a', 'molecular', 'switch', 'from', 'proliferation', 'to', 'hypertroph', '##ic', 'differentiation', 'of', 'chondrocytes', '.']	[0, 4, 7, 9, 10, 11, 21, 29, 36, 39, 42, 44, 54, 61, 66, 80, 83, 93, 96, 112, 115, 127]	[4, 6, 9, 10, 11, 20, 28, 35, 38, 41, 43, 53, 60, 65, 79, 82, 93, 95, 111, 114, 127, 128]	['Cyclic', 'GMP-dependent', 'protein', 'kinase', 'II', 'is', 'a', 'molecular', 'switch', 'from', 'proliferation', 'to', 'hypertrophic', 'differentiation', 'of', 'chondrocytes', '.']	[2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter.	[('PMC2687147', 'F08002', 34, 54, 'human hepatic lipase')]	['Transcription', '##al', 'regulation', 'of', 'the', 'human', 'hepatic', 'lipase', '(', 'LI', '##PC', ')', 'gene', 'promoter', '.']	[0, 13, 16, 27, 30, 34, 40, 48, 55, 56, 58, 60, 62, 67, 75]	[13, 15, 26, 29, 33, 39, 47, 54, 56, 58, 60, 61, 66, 75, 76]	['Transcriptional', 'regulation', 'of', 'the', 'human', 'hepatic', 'lipase', '(', 'LIPC', ')', 'gene', 'promoter', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.	[('PMC2701337', 'F01002', 47, 86, 'bilirubin UDP-glucuronosyltransferase 1')]	"['The', 'genetic', 'basis', 'of', 'the', 'reduced', 'expression', 'of', 'bilirubin', 'UDP', '-', 'gluc', '##uron', '##osyl', '##transferase', '1', 'in', 'Gilbert', ""'"", 's', 'syndrome', '.']"	[0, 4, 12, 18, 21, 25, 33, 44, 47, 57, 60, 61, 65, 69, 73, 85, 87, 90, 97, 98, 100, 108]	[3, 11, 17, 20, 24, 32, 43, 46, 56, 60, 61, 65, 69, 73, 84, 86, 89, 97, 98, 99, 108, 109]	"['The', 'genetic', 'basis', 'of', 'the', 'reduced', 'expression', 'of', 'bilirubin', 'UDP-glucuronosyltransferase', '1', 'in', ""Gilbert's"", 'syndrome', '.']"	[1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Van Es H.H., Bout A., Liu J., Anderson L., Duncan A.M., Bosma P., Oude Elferink R., Jansen P.L., Chowdhury J.R., Schurr E. Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.	[('PMC2701337', 'F05001', 147, 174, 'UDP glucuronosyltransferase')]	['Van', 'Es', 'H', '.', 'H', '.', ',', 'Bou', '##t', 'A', '.', ',', 'Liu', 'J', '.', ',', 'Anderson', 'L', '.', ',', 'Dun', '##can', 'A', '.', 'M', '.', ',', 'Bos', '##ma', 'P', '.', ',', 'O', '##ude', 'El', '##fer', '##ink', 'R', '.', ',', 'Jan', '##sen', 'P', '.', 'L', '.', ',', 'Cho', '##w', '##dh', '##ury', 'J', '.', 'R', '.', ',', 'Sch', '##ur', '##r', 'E', '.', 'Ass', '##ignment', 'of', 'the', 'human', 'UDP', 'gluc', '##uron', '##osyl', '##transferase', 'gene', '(', 'U', '##GT', '##1', '##A', '##1', ')', 'to', 'chromosome', 'region', '2', '##q', '##37', '.']	[0, 4, 7, 8, 9, 10, 11, 13, 16, 18, 19, 20, 22, 26, 27, 28, 30, 39, 40, 41, 43, 46, 50, 51, 52, 53, 54, 56, 59, 62, 63, 64, 66, 67, 71, 73, 76, 80, 81, 82, 84, 87, 91, 92, 93, 94, 95, 97, 100, 101, 103, 107, 108, 109, 110, 111, 113, 116, 118, 120, 121, 123, 126, 134, 137, 141, 147, 151, 155, 159, 163, 175, 180, 181, 182, 184, 185, 186, 187, 189, 192, 203, 210, 211, 212, 214]	[3, 6, 8, 9, 10, 11, 12, 16, 17, 19, 20, 21, 25, 27, 28, 29, 38, 40, 41, 42, 46, 49, 51, 52, 53, 54, 55, 59, 61, 63, 64, 65, 67, 70, 73, 76, 79, 81, 82, 83, 87, 90, 92, 93, 94, 95, 96, 100, 101, 103, 106, 108, 109, 110, 111, 112, 116, 118, 119, 121, 122, 126, 133, 136, 140, 146, 150, 155, 159, 163, 174, 179, 181, 182, 184, 185, 186, 187, 188, 191, 202, 209, 211, 212, 214, 215]	['Van', 'Es', 'H.H', '.', ',', 'Bout', 'A', '.', ',', 'Liu', 'J', '.', ',', 'Anderson', 'L', '.', ',', 'Duncan', 'A.M', '.', ',', 'Bosma', 'P', '.', ',', 'Oude', 'Elferink', 'R', '.', ',', 'Jansen', 'P.L', '.', ',', 'Chowdhury', 'J.R', '.', ',', 'Schurr', 'E', '.', 'Assignment', 'of', 'the', 'human', 'UDP', 'glucuronosyltransferase', 'gene', '(', 'UGT1A1', ')', 'to', 'chromosome', 'region', '2q37', '.']	[1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 1, 2, 3, 1, 1, 4, 3, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 5, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Iolascon A., Faienza M.F., Perrotta S., Meloni G.F., Ruggiu G., del Giudice E.M. Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates.	[('PMC2701337', 'F08001', 116, 149, 'glucose-6-phosphate dehydrogenase')]	"['I', '##olas', '##con', 'A', '.', ',', 'Fa', '##ien', '##za', 'M', '.', 'F', '.', ',', 'Per', '##rot', '##ta', 'S', '.', ',', 'Mel', '##oni', 'G', '.', 'F', '.', ',', 'Ru', '##gg', '##iu', 'G', '.', ',', 'del', 'Gi', '##udi', '##ce', 'E', '.', 'M', '.', 'Gilbert', ""'"", 's', 'syndrome', 'and', 'ja', '##und', '##ice', 'in', 'glucose', '-', '6', '-', 'phosphate', 'dehydrogenase', 'deficient', 'neonates', '.']"	[0, 1, 5, 9, 10, 11, 13, 15, 18, 21, 22, 23, 24, 25, 27, 30, 33, 36, 37, 38, 40, 43, 47, 48, 49, 50, 51, 53, 55, 57, 60, 61, 62, 64, 68, 70, 73, 76, 77, 78, 79, 81, 88, 89, 91, 100, 104, 106, 109, 113, 116, 123, 124, 125, 126, 136, 150, 160, 168]	[1, 5, 8, 10, 11, 12, 15, 18, 20, 22, 23, 24, 25, 26, 30, 33, 35, 37, 38, 39, 43, 46, 48, 49, 50, 51, 52, 55, 57, 59, 61, 62, 63, 67, 70, 73, 75, 77, 78, 79, 80, 88, 89, 90, 99, 103, 106, 109, 112, 115, 123, 124, 125, 126, 135, 149, 159, 168, 169]	"['Iolascon', 'A', '.', ',', 'Faienza', 'M.F', '.', ',', 'Perrotta', 'S', '.', ',', 'Meloni', 'G.F', '.', ',', 'Ruggiu', 'G', '.', ',', 'del', 'Giudice', 'E.M', '.', ""Gilbert's"", 'syndrome', 'and', 'jaundice', 'in', 'glucose-6-phosphate', 'dehydrogenase', 'deficient', 'neonates', '.']"	[3, 1, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 3, 1, 1, 1, 1, 3, 3, 1, 3, 1, 1, 3, 1, 5, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function.	[('PMC2701337', 'F09002', 0, 20, 'Phosphodiesterase 8B')]	['Phosph', '##odies', '##terase', '8', '##B', 'gene', 'variants', 'are', 'associated', 'with', 'serum', 'TSH', 'levels', 'and', 'thyroid', 'function', '.']	[0, 6, 11, 18, 19, 21, 26, 35, 39, 50, 55, 61, 65, 72, 76, 84, 92]	[6, 11, 17, 19, 20, 25, 34, 38, 49, 54, 60, 64, 71, 75, 83, 92, 93]	['Phosphodiesterase', '8B', 'gene', 'variants', 'are', 'associated', 'with', 'serum', 'TSH', 'levels', 'and', 'thyroid', 'function', '.']	[3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In hepatocytes, bilirubin is glucuronidated by (UDP)-glucuronosyltransferase and thereby transformed into a water soluble conjugated molecule (2).	[('PMC2701337', 'I00002', 47, 76, '(UDP)-glucuronosyltransferase')]	['In', 'hepatocytes', ',', 'bilirubin', 'is', 'gluc', '##uron', '##idated', 'by', '(', 'UDP', ')', '-', 'gluc', '##uron', '##osyl', '##transferase', 'and', 'thereby', 'transformed', 'into', 'a', 'water', 'soluble', 'conjugated', 'molecule', '(', '2', ')', '.']	[0, 3, 14, 16, 26, 29, 33, 37, 44, 47, 48, 51, 52, 53, 57, 61, 65, 77, 81, 89, 101, 106, 108, 114, 122, 133, 142, 143, 144, 145]	[2, 14, 15, 25, 28, 33, 37, 43, 46, 48, 51, 52, 53, 57, 61, 65, 76, 80, 88, 100, 105, 107, 113, 121, 132, 141, 143, 144, 145, 146]	['In', 'hepatocytes', ',', 'bilirubin', 'is', 'glucuronidated', 'by', '(UDP)-glucuronosyltransferase', 'and', 'thereby', 'transformed', 'into', 'a', 'water', 'soluble', 'conjugated', 'molecule', '(', '2', ')', '.']	[1, 1, 1, 1, 1, 3, 1, 8, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Baum et al.6, using DNA pooling, identified a SNP located in DGKH (diacylglycerol kinase eta) that was associated with bipolar disorder in 1,233 cases and 1,439 controls with a P value of 1.5 × 10-8.	[('PMC2703780', 'I01001', 67, 88, 'diacylglycerol kinase')]	['Ba', '##um', 'et', 'al', '.', '6', ',', 'using', 'DNA', 'pooling', ',', 'identified', 'a', 'SNP', 'located', 'in', 'DG', '##KH', '(', 'di', '##acyl', '##glycerol', 'kinase', 'et', '##a', ')', 'that', 'was', 'associated', 'with', 'bipolar', 'disorder', 'in', '1', ',', '233', 'cases', 'and', '1', ',', '43', '##9', 'controls', 'with', 'a', 'P', 'value', 'of', '1', '.', '5', '×', '10', '-', '8', '.']	[0, 2, 5, 8, 10, 11, 12, 14, 20, 24, 31, 33, 44, 46, 50, 58, 61, 63, 66, 67, 69, 73, 82, 89, 91, 92, 94, 99, 103, 114, 119, 127, 136, 139, 140, 141, 145, 151, 155, 156, 157, 159, 161, 170, 175, 177, 179, 185, 188, 189, 190, 192, 194, 196, 197, 198]	[2, 4, 7, 10, 11, 12, 13, 19, 23, 31, 32, 43, 45, 49, 57, 60, 63, 65, 67, 69, 73, 81, 88, 91, 92, 93, 98, 102, 113, 118, 126, 135, 138, 140, 141, 144, 150, 154, 156, 157, 159, 160, 169, 174, 176, 178, 184, 187, 189, 190, 191, 193, 196, 197, 198, 199]	['Baum', 'et', 'al.6', ',', 'using', 'DNA', 'pooling', ',', 'identified', 'a', 'SNP', 'located', 'in', 'DGKH', '(', 'diacylglycerol', 'kinase', 'eta', ')', 'that', 'was', 'associated', 'with', 'bipolar', 'disorder', 'in', '1', ',', '233', 'cases', 'and', '1', ',', '439', 'controls', 'with', 'a', 'P', 'value', 'of', '1.5', '×', '10-8', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genetic signatures of strong recent positive selection at the lactase gene.	[('PMC2719288', 'F06002', 62, 69, 'lactase')]	['Genetic', 'signatures', 'of', 'strong', 'recent', 'positive', 'selection', 'at', 'the', 'lact', '##ase', 'gene', '.']	[0, 8, 19, 22, 29, 36, 45, 55, 58, 62, 66, 70, 74]	[7, 18, 21, 28, 35, 44, 54, 57, 61, 66, 69, 74, 75]	['Genetic', 'signatures', 'of', 'strong', 'recent', 'positive', 'selection', 'at', 'the', 'lactase', 'gene', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
Microsatellite variation and evolution of human lactase persistence.	[('PMC2719288', 'F07002', 48, 55, 'lactase')]	['Micros', '##atellite', 'variation', 'and', 'evolution', 'of', 'human', 'lact', '##ase', 'persistence', '.']	[0, 6, 15, 25, 29, 39, 42, 48, 52, 56, 67]	[6, 14, 24, 28, 38, 41, 47, 52, 55, 67, 68]	['Microsatellite', 'variation', 'and', 'evolution', 'of', 'human', 'lactase', 'persistence', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
Inhibition of cyclin-dependent kinase 5 activity protects pancreatic β cells from glucotoxicity.	[('PMC2719288', 'F107002', 14, 39, 'cyclin-dependent kinase 5')]	['Inhibition', 'of', 'cyclin', '-', 'dependent', 'kinase', '5', 'activity', 'protects', 'pancreatic', 'β', 'cells', 'from', 'gluc', '##otoxicity', '.']	[0, 11, 14, 20, 21, 31, 38, 40, 49, 58, 69, 71, 77, 82, 86, 95]	[10, 13, 20, 21, 30, 37, 39, 48, 57, 68, 70, 76, 81, 86, 95, 96]	['Inhibition', 'of', 'cyclin', '-', 'dependent', 'kinase', '5', 'activity', 'protects', 'pancreatic', 'β', 'cells', 'from', 'glucotoxicity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.	[('PMC2719288', 'F40002', 18, 32, '5-lipoxygenase')]	['The', 'gene', 'encoding', '5', '-', 'lip', '##oxygenase', 'activating', 'protein', 'confers', 'risk', 'of', 'myocardial', 'infarction', 'and', 'stroke', '.']	[0, 4, 9, 18, 19, 20, 23, 33, 44, 52, 60, 65, 68, 79, 90, 94, 100]	[3, 8, 17, 19, 20, 23, 32, 43, 51, 59, 64, 67, 78, 89, 93, 100, 101]	['The', 'gene', 'encoding', '5-lipoxygenase', 'activating', 'protein', 'confers', 'risk', 'of', 'myocardial', 'infarction', 'and', 'stroke', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction.	[('PMC2719288', 'F41002', 31, 55, 'leukotriene A4 hydrolase')]	['A', 'variant', 'of', 'the', 'gene', 'encoding', 'leuk', '##otri', '##ene', 'A', '##4', 'hydro', '##las', '##e', 'confers', 'ethnicity', '-', 'specific', 'risk', 'of', 'myocardial', 'infarction', '.']	[0, 2, 10, 13, 17, 22, 31, 35, 39, 43, 44, 46, 51, 54, 56, 64, 73, 74, 83, 88, 91, 102, 112]	[1, 9, 12, 16, 21, 30, 35, 39, 42, 44, 45, 51, 54, 55, 63, 73, 74, 82, 87, 90, 101, 112, 113]	['A', 'variant', 'of', 'the', 'gene', 'encoding', 'leukotriene', 'A4', 'hydrolase', 'confers', 'ethnicity', '-', 'specific', 'risk', 'of', 'myocardial', 'infarction', '.']	[1, 1, 1, 1, 1, 1, 3, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.	[('PMC2719288', 'F46002', 2, 35, 'methylthioadenosine phosphorylase')]	['A', 'methyl', '##thi', '##oa', '##den', '##osine', 'phosphoryl', '##ase', '(', 'MT', '##AP', ')', 'fusion', 'transcript', 'identifies', 'a', 'new', 'gene', 'on', 'chromosome', '9', '##p', '##21', 'that', 'is', 'frequently', 'deleted', 'in', 'cancer', '.']	[0, 2, 8, 11, 13, 16, 22, 32, 36, 37, 39, 41, 43, 50, 61, 72, 74, 78, 83, 86, 97, 98, 99, 102, 107, 110, 121, 129, 132, 138]	[1, 8, 11, 13, 16, 21, 32, 35, 37, 39, 41, 42, 49, 60, 71, 73, 77, 82, 85, 96, 98, 99, 101, 106, 109, 120, 128, 131, 138, 139]	['A', 'methylthioadenosine', 'phosphorylase', '(', 'MTAP', ')', 'fusion', 'transcript', 'identifies', 'a', 'new', 'gene', 'on', 'chromosome', '9p21', 'that', 'is', 'frequently', 'deleted', 'in', 'cancer', '.']	[1, 5, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary calls.	[('PMC2719288', 'F47002', 20, 48, 'C1-tetrahydrofolate synthase')]	['Human', 'mitochondrial', 'C', '##1', '-', 'tetra', '##hydro', '##fol', '##ate', 'synthase', ':', 'gene', 'structure', ',', 'tissue', 'distribution', 'of', 'the', 'mRNA', ',', 'and', 'immuno', '##local', '##ization', 'in', 'Chinese', 'hams', '##ter', 'ovary', 'calls', '.']	[0, 6, 20, 21, 22, 23, 28, 33, 36, 40, 48, 50, 55, 64, 66, 73, 86, 89, 93, 97, 99, 103, 109, 114, 122, 125, 133, 137, 141, 147, 152]	[5, 19, 21, 22, 23, 28, 33, 36, 39, 48, 49, 54, 64, 65, 72, 85, 88, 92, 97, 98, 102, 109, 114, 121, 124, 132, 137, 140, 146, 152, 153]	['Human', 'mitochondrial', 'C1-tetrahydrofolate', 'synthase', ':', 'gene', 'structure', ',', 'tissue', 'distribution', 'of', 'the', 'mRNA', ',', 'and', 'immunolocalization', 'in', 'Chinese', 'hamster', 'ovary', 'calls', '.']	[1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Enzymatic characterization of human mitochondrial C1-tetrahydrofolate synthase.	[('PMC2719288', 'F48002', 50, 78, 'C1-tetrahydrofolate synthase')]	['En', '##zym', '##atic', 'character', '##ization', 'of', 'human', 'mitochondrial', 'C', '##1', '-', 'tetra', '##hydro', '##fol', '##ate', 'synthase', '.']	[0, 2, 5, 10, 19, 27, 30, 36, 50, 51, 52, 53, 58, 63, 66, 70, 78]	[2, 5, 9, 19, 26, 29, 35, 49, 51, 52, 53, 58, 63, 66, 69, 78, 79]	['Enzymatic', 'characterization', 'of', 'human', 'mitochondrial', 'C1-tetrahydrofolate', 'synthase', '.']	[3, 2, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.	[('PMC2719288', 'F49002', 75, 110, 'methylenetetrahydrofolate reductase')]	['A', 'candidate', 'genetic', 'risk', 'factor', 'for', 'vascular', 'disease', ':', 'a', 'common', 'mutation', 'in', 'methyl', '##ene', '##tetra', '##hydro', '##fol', '##ate', 'reductase', '.']	[0, 2, 12, 20, 25, 32, 36, 45, 52, 54, 56, 63, 72, 75, 81, 84, 89, 94, 97, 101, 110]	[1, 11, 19, 24, 31, 35, 44, 52, 53, 55, 62, 71, 74, 81, 84, 89, 94, 97, 100, 110, 111]	['A', 'candidate', 'genetic', 'risk', 'factor', 'for', 'vascular', 'disease', ':', 'a', 'common', 'mutation', 'in', 'methylenetetrahydrofolate', 'reductase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
The ADAMTS proteases, extracellular matrix, and vascular disease—Waking the sleeping giant(s)!	[('PMC2719288', 'F53002', 4, 20, 'ADAMTS proteases')]	['The', 'ADAM', '##TS', 'proteases', ',', 'extracellular', 'matrix', ',', 'and', 'vascular', 'disease', '—', 'Wa', '##king', 'the', 'sleep', '##ing', 'giant', '(', 's', ')', '!']	[0, 4, 8, 11, 20, 22, 36, 42, 44, 48, 57, 64, 65, 67, 72, 76, 81, 85, 90, 91, 92, 93]	[3, 8, 10, 20, 21, 35, 42, 43, 47, 56, 64, 65, 67, 71, 75, 81, 84, 90, 91, 92, 93, 94]	['The', 'ADAMTS', 'proteases', ',', 'extracellular', 'matrix', ',', 'and', 'vascular', 'disease', '—', 'Waking', 'the', 'sleeping', 'giant(s)', '!']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 4, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.	[('PMC2719288', 'F87002', 63, 91, 'protein tyrosine phosphatase')]	['A', 'miss', '##ense', 'single', '-', 'nucleotide', 'polymorphism', 'in', 'a', 'gene', 'encoding', 'a', 'protein', 'tyrosine', 'phosphatase', '(', 'PTP', '##N', '##22', ')', 'is', 'associated', 'with', 'rheumatoid', 'arthritis', '.']	[0, 2, 6, 11, 17, 18, 29, 42, 45, 47, 52, 61, 63, 71, 80, 92, 93, 96, 97, 99, 101, 104, 115, 120, 131, 140]	[1, 6, 10, 17, 18, 28, 41, 44, 46, 51, 60, 62, 70, 79, 91, 93, 96, 97, 99, 100, 103, 114, 119, 130, 140, 141]	['A', 'missense', 'single', '-', 'nucleotide', 'polymorphism', 'in', 'a', 'gene', 'encoding', 'a', 'protein', 'tyrosine', 'phosphatase', '(', 'PTPN22', ')', 'is', 'associated', 'with', 'rheumatoid', 'arthritis', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region.	[('PMC2719288', 'F93002', 115, 123, 'helicase')]	['A', 'genome', '-', 'wide', 'association', 'study', 'of', 'nons', '##yn', '##onymous', 'SNPs', 'identifies', 'a', 'type', '1', 'diabetes', 'locus', 'in', 'the', 'interferon', '-', 'induced', 'helic', '##ase', '(', 'IF', '##IH', '##1', ')', 'region', '.']	[0, 2, 8, 9, 14, 26, 32, 35, 39, 41, 49, 54, 65, 67, 72, 74, 83, 89, 92, 96, 106, 107, 115, 120, 124, 125, 127, 129, 130, 132, 138]	[1, 8, 9, 13, 25, 31, 34, 39, 41, 48, 53, 64, 66, 71, 73, 82, 88, 91, 95, 106, 107, 114, 120, 123, 125, 127, 129, 130, 131, 138, 139]	['A', 'genome', '-', 'wide', 'association', 'study', 'of', 'nonsynonymous', 'SNPs', 'identifies', 'a', 'type', '1', 'diabetes', 'locus', 'in', 'the', 'interferon', '-', 'induced', 'helicase', '(', 'IFIH1', ')', 'region', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response.	[('PMC2719288', 'F95001', 31, 60, 'Protein tyrosine phosphatases')]	['Mus', '##tel', '##in', 'T', ',', 'Van', '##g', 'T', ',', 'Bot', '##tin', '##i', 'N', '.', 'Protein', 'tyrosine', 'phosphatase', '##s', 'and', 'the', 'immune', 'response', '.']	[0, 3, 6, 9, 10, 12, 15, 17, 18, 20, 23, 26, 28, 29, 31, 39, 48, 59, 61, 65, 69, 76, 84]	[3, 6, 8, 10, 11, 15, 16, 18, 19, 23, 26, 27, 29, 30, 38, 47, 59, 60, 64, 68, 75, 84, 85]	['Mustelin', 'T', ',', 'Vang', 'T', ',', 'Bottini', 'N', '.', 'Protein', 'tyrosine', 'phosphatases', 'and', 'the', 'immune', 'response', '.']	[3, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.	[('PMC2719288', 'F96002', 33, 53, 'tyrosine phosphatase')]	['A', 'functional', 'variant', 'of', 'lymphoid', 'tyrosine', 'phosphatase', 'is', 'associated', 'with', 'type', 'I', 'diabetes', '.']	[0, 2, 13, 21, 24, 33, 42, 54, 57, 68, 73, 78, 80, 88]	[1, 12, 20, 23, 32, 41, 53, 56, 67, 72, 77, 79, 88, 89]	['A', 'functional', 'variant', 'of', 'lymphoid', 'tyrosine', 'phosphatase', 'is', 'associated', 'with', 'type', 'I', 'diabetes', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aside from evolutionary interest, genes showing evidence of natural selection are particularly interesting for the biology of traits such as infectious diseases; possible targets for selection include NADSYN1 (NAD synthetase 1) at 11q13, which could have a role in prevention of pellagra, as well as TLR1 (toll-like receptor 1) at 4p14, for which a role in the biology of tuberculosis and leprosy has been suggested10.	[('PMC2719288', 'I13006', 210, 226, 'NAD synthetase 1')]	['As', '##ide', 'from', 'evolutionary', 'interest', ',', 'genes', 'showing', 'evidence', 'of', 'natural', 'selection', 'are', 'particularly', 'interesting', 'for', 'the', 'biology', 'of', 'traits', 'such', 'as', 'infectious', 'diseases', ';', 'possible', 'targets', 'for', 'selection', 'include', 'NAD', '##SY', '##N', '##1', '(', 'NAD', 'synthe', '##tase', '1', ')', 'at', '11', '##q', '##13', ',', 'which', 'could', 'have', 'a', 'role', 'in', 'prevention', 'of', 'pel', '##lag', '##ra', ',', 'as', 'well', 'as', 'TLR', '##1', '(', 'to', '##ll', '-', 'like', 'receptor', '1', ')', 'at', '4', '##p', '##14', ',', 'for', 'which', 'a', 'role', 'in', 'the', 'biology', 'of', 'tuberculosis', 'and', 'lep', '##ros', '##y', 'has', 'been', 'suggested', '##10', '.']	[0, 2, 6, 11, 24, 32, 34, 40, 48, 57, 60, 68, 78, 82, 95, 107, 111, 115, 123, 126, 133, 138, 141, 152, 160, 162, 171, 179, 183, 193, 201, 204, 206, 207, 209, 210, 214, 220, 225, 226, 228, 231, 233, 234, 236, 238, 244, 250, 255, 257, 262, 265, 276, 279, 282, 285, 287, 289, 292, 297, 300, 303, 305, 306, 308, 310, 311, 316, 325, 326, 328, 331, 332, 333, 335, 337, 341, 347, 349, 354, 357, 361, 369, 372, 385, 389, 392, 395, 397, 401, 406, 415, 417]	[2, 5, 10, 23, 32, 33, 39, 47, 56, 59, 67, 77, 81, 94, 106, 110, 114, 122, 125, 132, 137, 140, 151, 160, 161, 170, 178, 182, 192, 200, 204, 206, 207, 208, 210, 213, 220, 224, 226, 227, 230, 233, 234, 236, 237, 243, 249, 254, 256, 261, 264, 275, 278, 282, 285, 287, 288, 291, 296, 299, 303, 304, 306, 308, 310, 311, 315, 324, 326, 327, 330, 332, 333, 335, 336, 340, 346, 348, 353, 356, 360, 368, 371, 384, 388, 392, 395, 396, 400, 405, 415, 417, 418]	['Aside', 'from', 'evolutionary', 'interest', ',', 'genes', 'showing', 'evidence', 'of', 'natural', 'selection', 'are', 'particularly', 'interesting', 'for', 'the', 'biology', 'of', 'traits', 'such', 'as', 'infectious', 'diseases', ';', 'possible', 'targets', 'for', 'selection', 'include', 'NADSYN1', '(', 'NAD', 'synthetase', '1', ')', 'at', '11q13', ',', 'which', 'could', 'have', 'a', 'role', 'in', 'prevention', 'of', 'pellagra', ',', 'as', 'well', 'as', 'TLR1', '(', 'toll', '-', 'like', 'receptor', '1', ')', 'at', '4p14', ',', 'for', 'which', 'a', 'role', 'in', 'the', 'biology', 'of', 'tuberculosis', 'and', 'leprosy', 'has', 'been', 'suggested10', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In particular association findings have been reported with both disorders at DAOA (d-amino acid oxidase activator), DISC1 (disrupted in schizophrenia 1), NRG1 (neuregulin1) and DTNBP1 (dystrobrevin binding protein 1)31.	[('PMC2719288', 'I32002', 83, 103, 'd-amino acid oxidase')]	['In', 'particular', 'association', 'findings', 'have', 'been', 'reported', 'with', 'both', 'disorders', 'at', 'DA', '##OA', '(', 'd', '-', 'amino', 'acid', 'oxidase', 'activator', ')', ',', 'DISC', '##1', '(', 'disrupted', 'in', 'schizophrenia', '1', ')', ',', 'NR', '##G', '##1', '(', 'neur', '##eg', '##ulin', '##1', ')', 'and', 'DT', '##NB', '##P', '##1', '(', 'dyst', '##rob', '##rev', '##in', 'binding', 'protein', '1', ')', '31', '.']	[0, 3, 14, 26, 35, 40, 45, 54, 59, 64, 74, 77, 79, 82, 83, 84, 85, 91, 96, 104, 113, 114, 116, 120, 122, 123, 133, 136, 150, 151, 152, 154, 156, 157, 159, 160, 164, 166, 170, 171, 173, 177, 179, 181, 182, 184, 185, 189, 192, 195, 198, 206, 214, 215, 216, 218]	[2, 13, 25, 34, 39, 44, 53, 58, 63, 73, 76, 79, 81, 83, 84, 85, 90, 95, 103, 113, 114, 115, 120, 121, 123, 132, 135, 149, 151, 152, 153, 156, 157, 158, 160, 164, 166, 170, 171, 172, 176, 179, 181, 182, 183, 185, 189, 192, 195, 197, 205, 213, 215, 216, 218, 219]	['In', 'particular', 'association', 'findings', 'have', 'been', 'reported', 'with', 'both', 'disorders', 'at', 'DAOA', '(', 'd-amino', 'acid', 'oxidase', 'activator', ')', ',', 'DISC1', '(', 'disrupted', 'in', 'schizophrenia', '1', ')', ',', 'NRG1', '(', 'neuregulin1', ')', 'and', 'DTNBP1', '(', 'dystrobrevin', 'binding', 'protein', '1)31', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 4, 1, 4, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These include PALB2 (partner and localizer of BRCA2), which is involved in stability of key nuclear structures including chromatin and the nuclear matrix; NDUFAB1 (NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1), which encodes a subunit of complex I of the mitochondrial respiratory chain; and DCTN5 (dynactin 5), which encodes a protein involved in intracellular transport that is known to interact with the gene ‘disrupted in schizophrenia 1’ (DISCI)32, the latter having been implicated in susceptibility to bipolar disorder as well as schizophrenia33.	[('PMC2719288', 'I33002', 164, 182, 'NADH dehydrogenase')]	['These', 'include', 'PA', '##LB', '##2', '(', 'partner', 'and', 'localize', '##r', 'of', 'BRCA', '##2', ')', ',', 'which', 'is', 'involved', 'in', 'stability', 'of', 'key', 'nuclear', 'structures', 'including', 'chromatin', 'and', 'the', 'nuclear', 'matrix', ';', 'ND', '##U', '##FA', '##B', '##1', '(', 'NADH', 'dehydrogenase', '(', 'ub', '##iqu', '##ino', '##ne', ')', '1', ',', 'alpha', '/', 'beta', 'subc', '##omplex', ',', '1', ')', ',', 'which', 'encodes', 'a', 'subunit', 'of', 'complex', 'I', 'of', 'the', 'mitochondrial', 'respiratory', 'chain', ';', 'and', 'DCT', '##N', '##5', '(', 'dy', '##na', '##ct', '##in', '5', ')', ',', 'which', 'encodes', 'a', 'protein', 'involved', 'in', 'intracellular', 'transport', 'that', 'is', 'known', 'to', 'interact', 'with', 'the', 'gene', '‘', 'disrupted', 'in', 'schizophrenia', '1', '’', '(', 'DISC', '##I', ')', '32', ',', 'the', 'latter', 'having', 'been', 'implicated', 'in', 'susceptibility', 'to', 'bipolar', 'disorder', 'as', 'well', 'as', 'schizophrenia', '##33', '.']	[0, 6, 14, 16, 18, 20, 21, 29, 33, 41, 43, 46, 50, 51, 52, 54, 60, 63, 72, 75, 85, 88, 92, 100, 111, 121, 131, 135, 139, 147, 153, 155, 157, 158, 160, 161, 163, 164, 169, 183, 184, 186, 189, 192, 194, 196, 197, 199, 204, 205, 210, 214, 220, 222, 223, 224, 226, 232, 240, 242, 250, 253, 261, 263, 266, 270, 284, 296, 301, 303, 307, 310, 311, 313, 314, 316, 318, 320, 323, 324, 325, 327, 333, 341, 343, 351, 360, 363, 377, 387, 392, 395, 401, 404, 413, 418, 422, 427, 428, 438, 441, 455, 456, 458, 459, 463, 464, 465, 467, 469, 473, 480, 487, 492, 503, 506, 521, 524, 532, 541, 544, 549, 552, 565, 567]	[5, 13, 16, 18, 19, 21, 28, 32, 41, 42, 45, 50, 51, 52, 53, 59, 62, 71, 74, 84, 87, 91, 99, 110, 120, 130, 134, 138, 146, 153, 154, 157, 158, 160, 161, 162, 164, 168, 182, 184, 186, 189, 192, 194, 195, 197, 198, 204, 205, 209, 214, 220, 221, 223, 224, 225, 231, 239, 241, 249, 252, 260, 262, 265, 269, 283, 295, 301, 302, 306, 310, 311, 312, 314, 316, 318, 320, 322, 324, 325, 326, 332, 340, 342, 350, 359, 362, 376, 386, 391, 394, 400, 403, 412, 417, 421, 426, 428, 437, 440, 454, 456, 457, 459, 463, 464, 465, 467, 468, 472, 479, 486, 491, 502, 505, 520, 523, 531, 540, 543, 548, 551, 565, 567, 568]	['These', 'include', 'PALB2', '(', 'partner', 'and', 'localizer', 'of', 'BRCA2', ')', ',', 'which', 'is', 'involved', 'in', 'stability', 'of', 'key', 'nuclear', 'structures', 'including', 'chromatin', 'and', 'the', 'nuclear', 'matrix', ';', 'NDUFAB1', '(', 'NADH', 'dehydrogenase', '(', 'ubiquinone', ')', '1', ',', 'alpha', '/', 'beta', 'subcomplex', ',', '1', ')', ',', 'which', 'encodes', 'a', 'subunit', 'of', 'complex', 'I', 'of', 'the', 'mitochondrial', 'respiratory', 'chain', ';', 'and', 'DCTN5', '(', 'dynactin', '5', ')', ',', 'which', 'encodes', 'a', 'protein', 'involved', 'in', 'intracellular', 'transport', 'that', 'is', 'known', 'to', 'interact', 'with', 'the', 'gene', '‘', 'disrupted', 'in', 'schizophrenia', '1', '’', '(DISCI)32', ',', 'the', 'latter', 'having', 'been', 'implicated', 'in', 'susceptibility', 'to', 'bipolar', 'disorder', 'as', 'well', 'as', 'schizophrenia33', '.']	[1, 1, 3, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genome-wide linkage studies have mapped several loci that may affect susceptibility to CAD/myocardial infarction40 although for only two of these has the likely gene been identified (ALOX5AP (arachidonate 5-lipoxygenase-activating protein) and LTA4H (leukotriene A4 hydrolase))41,42.	[('PMC2719288', 'I38003', 192, 219, 'arachidonate 5-lipoxygenase'), ('PMC2719288', 'I38003', 251, 275, 'leukotriene A4 hydrolase')]	['Genome', '-', 'wide', 'linkage', 'studies', 'have', 'mapped', 'several', 'loci', 'that', 'may', 'affect', 'susceptibility', 'to', 'CAD', '/', 'myocardial', 'infarction', '##40', 'although', 'for', 'only', 'two', 'of', 'these', 'has', 'the', 'likely', 'gene', 'been', 'identified', '(', 'AL', '##OX', '##5', '##AP', '(', 'ar', '##achid', '##onate', '5', '-', 'lip', '##oxygenase', '-', 'activating', 'protein', ')', 'and', 'LT', '##A', '##4', '##H', '(', 'leuk', '##otri', '##ene', 'A', '##4', 'hydro', '##las', '##e', ')', ')', '41', ',', '42', '.']	[0, 6, 7, 12, 20, 28, 33, 40, 48, 53, 58, 62, 69, 84, 87, 90, 91, 102, 112, 115, 124, 128, 133, 137, 140, 146, 150, 154, 161, 166, 171, 182, 183, 185, 187, 188, 191, 192, 194, 199, 205, 206, 207, 210, 219, 220, 231, 238, 240, 244, 246, 247, 248, 250, 251, 255, 259, 263, 264, 266, 271, 274, 275, 276, 277, 279, 280, 282]	[6, 7, 11, 19, 27, 32, 39, 47, 52, 57, 61, 68, 83, 86, 90, 91, 101, 112, 114, 123, 127, 132, 136, 139, 145, 149, 153, 160, 165, 170, 181, 183, 185, 187, 188, 190, 192, 194, 199, 204, 206, 207, 210, 219, 220, 230, 238, 239, 243, 246, 247, 248, 249, 251, 255, 259, 262, 264, 265, 271, 274, 275, 276, 277, 279, 280, 282, 283]	['Genome', '-', 'wide', 'linkage', 'studies', 'have', 'mapped', 'several', 'loci', 'that', 'may', 'affect', 'susceptibility', 'to', 'CAD', '/', 'myocardial', 'infarction40', 'although', 'for', 'only', 'two', 'of', 'these', 'has', 'the', 'likely', 'gene', 'been', 'identified', '(', 'ALOX5AP', '(', 'arachidonate', '5-lipoxygenase-', 'activating', 'protein', ')', 'and', 'LTA4H', '(', 'leukotriene', 'A4', 'hydrolase))41', ',', '42', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 5, 1, 1, 1, 1, 4, 1, 3, 2, 6, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
The region of interest contains the coding sequences of genes for two cyclin dependent kinase inhibitors, CDKN2A (encoding p16INK4a) and CDKN2B (p15INK4b), although the most closely associated SNP is some distance removed.	[('PMC2719288', 'I39004', 70, 93, 'cyclin dependent kinase')]	['The', 'region', 'of', 'interest', 'contains', 'the', 'coding', 'sequences', 'of', 'genes', 'for', 'two', 'cyclin', 'dependent', 'kinase', 'inhibitors', ',', 'CDK', '##N', '##2', '##A', '(', 'encoding', 'p', '##16', '##INK', '##4', '##a', ')', 'and', 'CDK', '##N', '##2', '##B', '(', 'p', '##15', '##INK', '##4', '##b', ')', ',', 'although', 'the', 'most', 'closely', 'associated', 'SNP', 'is', 'some', 'distance', 'removed', '.']	[0, 4, 11, 14, 23, 32, 36, 43, 53, 56, 62, 66, 70, 77, 87, 94, 104, 106, 109, 110, 111, 113, 114, 123, 124, 126, 129, 130, 131, 133, 137, 140, 141, 142, 144, 145, 146, 148, 151, 152, 153, 154, 156, 165, 169, 174, 182, 193, 197, 200, 205, 214, 221]	[3, 10, 13, 22, 31, 35, 42, 52, 55, 61, 65, 69, 76, 86, 93, 104, 105, 109, 110, 111, 112, 114, 122, 124, 126, 129, 130, 131, 132, 136, 140, 141, 142, 143, 145, 146, 148, 151, 152, 153, 154, 155, 164, 168, 173, 181, 192, 196, 199, 204, 213, 221, 222]	['The', 'region', 'of', 'interest', 'contains', 'the', 'coding', 'sequences', 'of', 'genes', 'for', 'two', 'cyclin', 'dependent', 'kinase', 'inhibitors', ',', 'CDKN2A', '(', 'encoding', 'p16INK4a', ')', 'and', 'CDKN2B', '(', 'p15INK4b', ')', ',', 'although', 'the', 'most', 'closely', 'associated', 'SNP', 'is', 'some', 'distance', 'removed', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 1, 4, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Besides CDKN2A and CDKN2B, the only other known gene nearby is MTAP which encodes methylthioadenosine phosphorylase, an enzyme that contributes to polyamine metabolism and is important for the salvage of both adenine and methionine.	[('PMC2719288', 'I39007', 82, 115, 'methylthioadenosine phosphorylase')]	['Besides', 'CDK', '##N', '##2', '##A', 'and', 'CDK', '##N', '##2', '##B', ',', 'the', 'only', 'other', 'known', 'gene', 'nearby', 'is', 'MT', '##AP', 'which', 'encodes', 'methyl', '##thi', '##oa', '##den', '##osine', 'phosphoryl', '##ase', ',', 'an', 'enzyme', 'that', 'contributes', 'to', 'poly', '##amine', 'metabolism', 'and', 'is', 'important', 'for', 'the', 'sal', '##vage', 'of', 'both', 'adenine', 'and', 'methionine', '.']	[0, 8, 11, 12, 13, 15, 19, 22, 23, 24, 25, 27, 31, 36, 42, 48, 53, 60, 63, 65, 68, 74, 82, 88, 91, 93, 96, 102, 112, 115, 117, 120, 127, 132, 144, 147, 151, 157, 168, 172, 175, 185, 189, 193, 196, 201, 204, 209, 217, 221, 231]	[7, 11, 12, 13, 14, 18, 22, 23, 24, 25, 26, 30, 35, 41, 47, 52, 59, 62, 65, 67, 73, 81, 88, 91, 93, 96, 101, 112, 115, 116, 119, 126, 131, 143, 146, 151, 156, 167, 171, 174, 184, 188, 192, 196, 200, 203, 208, 216, 220, 231, 232]	['Besides', 'CDKN2A', 'and', 'CDKN2B', ',', 'the', 'only', 'other', 'known', 'gene', 'nearby', 'is', 'MTAP', 'which', 'encodes', 'methylthioadenosine', 'phosphorylase', ',', 'an', 'enzyme', 'that', 'contributes', 'to', 'polyamine', 'metabolism', 'and', 'is', 'important', 'for', 'the', 'salvage', 'of', 'both', 'adenine', 'and', 'methionine', '.']	[1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 5, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A potentially interesting association is at rs6922269 (P=6.3×10-6), an intronic SNP in MTHFD1L, which encodes methylenetetrahydrofolate dehydrogenase (NADP+-dependent) 1-like, the mitochondrial isozyme of C1-tetrahydrofolate (THF) synthase48,49.	[('PMC2719288', 'I40001', 110, 149, 'methylenetetrahydrofolate dehydrogenase'), ('PMC2719288', 'I40001', 205, 239, 'C1-tetrahydrofolate (THF) synthase')]	['A', 'potentially', 'interesting', 'association', 'is', 'at', 'rs', '##69', '##22', '##26', '##9', '(', 'P', '=', '6', '.', '3', '##×10', '-', '6', ')', ',', 'an', 'intron', '##ic', 'SNP', 'in', 'MT', '##HF', '##D', '##1', '##L', ',', 'which', 'encodes', 'methyl', '##ene', '##tetra', '##hydro', '##fol', '##ate', 'dehydrogenase', '(', 'NAD', '##P', '+', '-', 'dependent', ')', '1', '-', 'like', ',', 'the', 'mitochondrial', 'iso', '##zyme', 'of', 'C', '##1', '-', 'tetra', '##hydro', '##fol', '##ate', '(', 'THF', ')', 'synthase', '##48', ',', '49', '.']	[0, 2, 14, 26, 38, 41, 44, 46, 48, 50, 52, 54, 55, 56, 57, 58, 59, 60, 63, 64, 65, 66, 68, 71, 77, 80, 84, 87, 89, 91, 92, 93, 94, 96, 102, 110, 116, 119, 124, 129, 132, 136, 150, 151, 154, 155, 156, 157, 166, 168, 169, 170, 174, 176, 180, 194, 197, 202, 205, 206, 207, 208, 213, 218, 221, 225, 226, 229, 231, 239, 241, 242, 244]	[1, 13, 25, 37, 40, 43, 46, 48, 50, 52, 53, 55, 56, 57, 58, 59, 60, 63, 64, 65, 66, 67, 70, 77, 79, 83, 86, 89, 91, 92, 93, 94, 95, 101, 109, 116, 119, 124, 129, 132, 135, 149, 151, 154, 155, 156, 157, 166, 167, 169, 170, 174, 175, 179, 193, 197, 201, 204, 206, 207, 208, 213, 218, 221, 224, 226, 229, 230, 239, 241, 242, 244, 245]	['A', 'potentially', 'interesting', 'association', 'is', 'at', 'rs6922269', '(', 'P=6.3×10-6', ')', ',', 'an', 'intronic', 'SNP', 'in', 'MTHFD1L', ',', 'which', 'encodes', 'methylenetetrahydrofolate', 'dehydrogenase', '(', 'NADP', '+', '-', 'dependent', ')', '1-', 'like', ',', 'the', 'mitochondrial', 'isozyme', 'of', 'C1-tetrahydrofolate', '(', 'THF', ')', 'synthase48', ',', '49', '.']	[1, 1, 1, 1, 1, 1, 5, 1, 8, 1, 1, 1, 2, 1, 1, 5, 1, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 7, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
C1-THF synthases interconvert the one carbon units carried by the biologically active form of folic acid, C1-tetrahydrofolate.	[('PMC2719288', 'I40002', 0, 16, 'C1-THF synthases')]	['C', '##1', '-', 'THF', 'synthase', '##s', 'inter', '##conver', '##t', 'the', 'one', 'carbon', 'units', 'carried', 'by', 'the', 'biologically', 'active', 'form', 'of', 'foli', '##c', 'acid', ',', 'C', '##1', '-', 'tetra', '##hydro', '##fol', '##ate', '.']	[0, 1, 2, 3, 7, 15, 17, 22, 28, 30, 34, 38, 45, 51, 59, 62, 66, 79, 86, 91, 94, 98, 100, 104, 106, 107, 108, 109, 114, 119, 122, 125]	[1, 2, 3, 6, 15, 16, 22, 28, 29, 33, 37, 44, 50, 58, 61, 65, 78, 85, 90, 93, 98, 99, 104, 105, 107, 108, 109, 114, 119, 122, 125, 126]	['C1-THF', 'synthases', 'interconvert', 'the', 'one', 'carbon', 'units', 'carried', 'by', 'the', 'biologically', 'active', 'form', 'of', 'folic', 'acid', ',', 'C1-tetrahydrofolate', '.']	[4, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 7, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Another enzyme in the same pathway, methylene THF reductase (encoded by MTHFR) is subject to a common mutation which influences plasma homocysteine level50 and has been associated with increased risk of coronary and other atherosclerotic disease51.	[('PMC2719288', 'I40004', 36, 59, 'methylene THF reductase')]	['Another', 'enzyme', 'in', 'the', 'same', 'pathway', ',', 'methyl', '##ene', 'THF', 'reductase', '(', 'encoded', 'by', 'MT', '##HF', '##R', ')', 'is', 'subject', 'to', 'a', 'common', 'mutation', 'which', 'influences', 'plasma', 'hom', '##ocysteine', 'level', '##50', 'and', 'has', 'been', 'associated', 'with', 'increased', 'risk', 'of', 'coronary', 'and', 'other', 'atherosclerotic', 'disease', '##51', '.']	[0, 8, 15, 18, 22, 27, 34, 36, 42, 46, 50, 60, 61, 69, 72, 74, 76, 77, 79, 82, 90, 93, 95, 102, 111, 117, 128, 135, 138, 148, 153, 156, 160, 164, 169, 180, 185, 195, 200, 203, 212, 216, 222, 238, 245, 247]	[7, 14, 17, 21, 26, 34, 35, 42, 45, 49, 59, 61, 68, 71, 74, 76, 77, 78, 81, 89, 92, 94, 101, 110, 116, 127, 134, 138, 147, 153, 155, 159, 163, 168, 179, 184, 194, 199, 202, 211, 215, 221, 237, 245, 247, 248]	['Another', 'enzyme', 'in', 'the', 'same', 'pathway', ',', 'methylene', 'THF', 'reductase', '(', 'encoded', 'by', 'MTHFR', ')', 'is', 'subject', 'to', 'a', 'common', 'mutation', 'which', 'influences', 'plasma', 'homocysteine', 'level50', 'and', 'has', 'been', 'associated', 'with', 'increased', 'risk', 'of', 'coronary', 'and', 'other', 'atherosclerotic', 'disease51', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An intronic SNP in ADAMTS17 (a disintegrin and metalloproteinase with thrombospondin motifs 17), which showed modest association (rs1994016; P=1.1×10-4) in our primary analysis, showed a much stronger association in the expanded reference group analysis (see below and Supplementary Table 9).	[('PMC2719288', 'I41000', 47, 64, 'metalloproteinase')]	['An', 'intron', '##ic', 'SNP', 'in', 'ADAM', '##TS', '##17', '(', 'a', 'dis', '##integr', '##in', 'and', 'metalloprotein', '##ase', 'with', 'thrombo', '##sp', '##ond', '##in', 'motifs', '17', ')', ',', 'which', 'showed', 'modest', 'association', '(', 'rs', '##199', '##40', '##16', ';', 'P', '=', '1', '.', '1', '##×10', '-', '4', ')', 'in', 'our', 'primary', 'analysis', ',', 'showed', 'a', 'much', 'stronger', 'association', 'in', 'the', 'expanded', 'reference', 'group', 'analysis', '(', 'see', 'below', 'and', 'Supplementary', 'Table', '9', ')', '.']	[0, 3, 9, 12, 16, 19, 23, 25, 28, 29, 31, 34, 40, 43, 47, 61, 65, 70, 77, 79, 82, 85, 92, 94, 95, 97, 103, 110, 117, 129, 130, 132, 135, 137, 139, 141, 142, 143, 144, 145, 146, 149, 150, 151, 153, 156, 160, 168, 176, 178, 185, 187, 192, 201, 213, 216, 220, 229, 239, 245, 254, 255, 259, 265, 269, 283, 289, 290, 291]	[2, 9, 11, 15, 18, 23, 25, 27, 29, 30, 34, 40, 42, 46, 61, 64, 69, 77, 79, 82, 84, 91, 94, 95, 96, 102, 109, 116, 128, 130, 132, 135, 137, 139, 140, 142, 143, 144, 145, 146, 149, 150, 151, 152, 155, 159, 167, 176, 177, 184, 186, 191, 200, 212, 215, 219, 228, 238, 244, 253, 255, 258, 264, 268, 282, 288, 290, 291, 292]	['An', 'intronic', 'SNP', 'in', 'ADAMTS17', '(', 'a', 'disintegrin', 'and', 'metalloproteinase', 'with', 'thrombospondin', 'motifs', '17', ')', ',', 'which', 'showed', 'modest', 'association', '(', 'rs1994016', ';', 'P=1.1×10-4', ')', 'in', 'our', 'primary', 'analysis', ',', 'showed', 'a', 'much', 'stronger', 'association', 'in', 'the', 'expanded', 'reference', 'group', 'analysis', '(', 'see', 'below', 'and', 'Supplementary', 'Table', '9', ')', '.']	[1, 2, 1, 1, 3, 1, 1, 3, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 8, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In 2001, positional cloning identified CARD15 (caspase recruitment domain family, member 15; NOD2) as the first confirmed CD-susceptibility gene60,61.	[('PMC2719288', 'I43001', 47, 54, 'caspase')]	['In', '2001', ',', 'positional', 'cloning', 'identified', 'CAR', '##D', '##15', '(', 'caspase', 'recruitment', 'domain', 'family', ',', 'member', '15', ';', 'NOD', '##2', ')', 'as', 'the', 'first', 'confirmed', 'CD', '-', 'susceptibility', 'gene', '##60', ',', '61', '.']	[0, 3, 7, 9, 20, 28, 39, 42, 43, 46, 47, 55, 67, 74, 80, 82, 89, 91, 93, 96, 97, 99, 102, 106, 112, 122, 124, 125, 140, 144, 146, 147, 149]	[2, 7, 8, 19, 27, 38, 42, 43, 45, 47, 54, 66, 73, 80, 81, 88, 91, 92, 96, 97, 98, 101, 105, 111, 121, 124, 125, 139, 144, 146, 147, 149, 150]	['In', '2001', ',', 'positional', 'cloning', 'identified', 'CARD15', '(', 'caspase', 'recruitment', 'domain', 'family', ',', 'member', '15', ';', 'NOD2', ')', 'as', 'the', 'first', 'confirmed', 'CD-susceptibility', 'gene60', ',', '61', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The first of these includes several SNPs around IRGM (immunity-related guanosine triphosphatase; the human homologue of the mouse Irgm/Lrg47), the strongest singal being at rs1000113 (P=5.1×10-8).	[('PMC2719288', 'I46000', 71, 95, 'guanosine triphosphatase')]	['The', 'first', 'of', 'these', 'includes', 'several', 'SNPs', 'around', 'IR', '##GM', '(', 'immunity', '-', 'related', 'guan', '##osine', 'trip', '##ho', '##sp', '##hat', '##ase', ';', 'the', 'human', 'homolog', '##ue', 'of', 'the', 'mouse', 'Ir', '##gm', '/', 'L', '##r', '##g', '##47', ')', ',', 'the', 'strongest', 'sing', '##al', 'being', 'at', 'rs', '##1000', '##113', '(', 'P', '=', '5', '.', '1', '##×10', '-', '8', ')', '.']	[0, 4, 10, 13, 19, 28, 36, 41, 48, 50, 53, 54, 62, 63, 71, 75, 81, 85, 87, 89, 92, 95, 97, 101, 107, 114, 117, 120, 124, 130, 132, 134, 135, 136, 137, 138, 140, 141, 143, 147, 157, 161, 164, 170, 173, 175, 179, 183, 184, 185, 186, 187, 188, 189, 192, 193, 194, 195]	[3, 9, 12, 18, 27, 35, 40, 47, 50, 52, 54, 62, 63, 70, 75, 80, 85, 87, 89, 92, 95, 96, 100, 106, 114, 116, 119, 123, 129, 132, 134, 135, 136, 137, 138, 140, 141, 142, 146, 156, 161, 163, 169, 172, 175, 179, 182, 184, 185, 186, 187, 188, 189, 192, 193, 194, 195, 196]	['The', 'first', 'of', 'these', 'includes', 'several', 'SNPs', 'around', 'IRGM', '(', 'immunity', '-', 'related', 'guanosine', 'triphosphatase', ';', 'the', 'human', 'homologue', 'of', 'the', 'mouse', 'Irgm', '/', 'Lrg47', ')', ',', 'the', 'strongest', 'singal', 'being', 'at', 'rs1000113', '(', 'P=5.1×10-8', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 5, 1, 1, 1, 2, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 2, 1, 1, 3, 1, 8, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The final novel association, at rs2542151 (P=4.6×10-8) maps 5.5-kb upstream of PTPN2 (protein tyrosine phosphatase, non-receptor type 2) on chromosome 18p11.	[('PMC2719288', 'I49000', 86, 114, 'protein tyrosine phosphatase')]	['The', 'final', 'novel', 'association', ',', 'at', 'rs', '##25', '##42', '##15', '##1', '(', 'P', '=', '4', '.', '6', '##×10', '-', '8', ')', 'maps', '5', '.', '5', '-', 'kb', 'upstream', 'of', 'PTP', '##N', '##2', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '2', ')', 'on', 'chromosome', '18', '##p', '##11', '.']	[0, 4, 10, 16, 27, 29, 32, 34, 36, 38, 40, 42, 43, 44, 45, 46, 47, 48, 51, 52, 53, 55, 60, 61, 62, 63, 64, 67, 76, 79, 82, 83, 85, 86, 94, 103, 114, 116, 119, 120, 129, 134, 135, 137, 140, 151, 153, 154, 156]	[3, 9, 15, 27, 28, 31, 34, 36, 38, 40, 41, 43, 44, 45, 46, 47, 48, 51, 52, 53, 54, 59, 61, 62, 63, 64, 66, 75, 78, 82, 83, 84, 86, 93, 102, 114, 115, 119, 120, 128, 133, 135, 136, 139, 150, 153, 154, 156, 157]	['The', 'final', 'novel', 'association', ',', 'at', 'rs2542151', '(', 'P=4.6×10-8', ')', 'maps', '5.5-kb', 'upstream', 'of', 'PTPN2', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '2', ')', 'on', 'chromosome', '18p11', '.']	[1, 1, 1, 1, 1, 1, 5, 1, 8, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PTPN2 encodes the T cell protein tyrosine phosphatase TCPTP, a key negative regulator of inflammatory responses.	[('PMC2719288', 'I49001', 25, 53, 'protein tyrosine phosphatase')]	['PTP', '##N', '##2', 'encodes', 'the', 'T', 'cell', 'protein', 'tyrosine', 'phosphatase', 'TCP', '##TP', ',', 'a', 'key', 'negative', 'regulator', 'of', 'inflammatory', 'responses', '.']	[0, 3, 4, 6, 14, 18, 20, 25, 33, 42, 54, 57, 59, 61, 63, 67, 76, 86, 89, 102, 111]	[3, 4, 5, 13, 17, 19, 24, 32, 41, 53, 57, 59, 60, 62, 66, 75, 85, 88, 101, 111, 112]	['PTPN2', 'encodes', 'the', 'T', 'cell', 'protein', 'tyrosine', 'phosphatase', 'TCPTP', ',', 'a', 'key', 'negative', 'regulator', 'of', 'inflammatory', 'responses', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
None of the variants previously associated with HT showed evidence for association in our study although we note that some, such as promoter of the WNK1 (WNK lysine deficient protein kinase 1) gene78,79, are not well tagged by the Affymetrix chip.	[('PMC2719288', 'I54000', 158, 191, 'lysine deficient protein kinase 1')]	['None', 'of', 'the', 'variants', 'previously', 'associated', 'with', 'HT', 'showed', 'evidence', 'for', 'association', 'in', 'our', 'study', 'although', 'we', 'note', 'that', 'some', ',', 'such', 'as', 'promoter', 'of', 'the', 'W', '##NK', '##1', '(', 'W', '##NK', 'lysine', 'deficient', 'protein', 'kinase', '1', ')', 'gene', '##78', ',', '79', ',', 'are', 'not', 'well', 'tagged', 'by', 'the', 'Aff', '##yme', '##tri', '##x', 'chip', '.']	[0, 5, 8, 12, 21, 32, 43, 48, 51, 58, 67, 71, 83, 86, 90, 96, 105, 108, 113, 118, 122, 124, 129, 132, 141, 144, 148, 149, 151, 153, 154, 155, 158, 165, 175, 183, 190, 191, 193, 197, 199, 200, 202, 204, 208, 212, 217, 224, 227, 231, 234, 237, 240, 242, 246]	[4, 7, 11, 20, 31, 42, 47, 50, 57, 66, 70, 82, 85, 89, 95, 104, 107, 112, 117, 122, 123, 128, 131, 140, 143, 147, 149, 151, 152, 154, 155, 157, 164, 174, 182, 189, 191, 192, 197, 199, 200, 202, 203, 207, 211, 216, 223, 226, 230, 234, 237, 240, 241, 246, 247]	['None', 'of', 'the', 'variants', 'previously', 'associated', 'with', 'HT', 'showed', 'evidence', 'for', 'association', 'in', 'our', 'study', 'although', 'we', 'note', 'that', 'some', ',', 'such', 'as', 'promoter', 'of', 'the', 'WNK1', '(', 'WNK', 'lysine', 'deficient', 'protein', 'kinase', '1', ')', 'gene78', ',', '79', ',', 'are', 'not', 'well', 'tagged', 'by', 'the', 'Affymetrix', 'chip', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In common with several autoimmune diseases including T1D, carriage of the T allele of the rs2476601 SNP in the PTPN22 (protein tyrosine phosphatase, non-receptor type 22) gene has been reproducibly associated with RA, conferring a genetic relative risk of approximately 1.8 (refs 88​,​ ​89).	[('PMC2719288', 'I58002', 119, 147, 'protein tyrosine phosphatase')]	['In', 'common', 'with', 'several', 'autoimmune', 'diseases', 'including', 'T', '##1', '##D', ',', 'carri', '##age', 'of', 'the', 'T', 'allele', 'of', 'the', 'rs', '##24', '##76', '##60', '##1', 'SNP', 'in', 'the', 'PTP', '##N', '##22', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '22', ')', 'gene', 'has', 'been', 'reproduc', '##ibly', 'associated', 'with', 'RA', ',', 'confer', '##ring', 'a', 'genetic', 'relative', 'risk', 'of', 'approximately', '1', '.', '8', '(', 'ref', '##s', '88', ',', '89', ')', '.']	[0, 3, 10, 15, 23, 34, 43, 53, 54, 55, 56, 58, 63, 67, 70, 74, 76, 83, 86, 90, 92, 94, 96, 98, 100, 104, 107, 111, 114, 115, 118, 119, 127, 136, 147, 149, 152, 153, 162, 167, 169, 171, 176, 180, 185, 193, 198, 209, 214, 216, 218, 224, 229, 231, 239, 248, 253, 256, 270, 271, 272, 274, 275, 278, 280, 283, 287, 289, 290]	[2, 9, 14, 22, 33, 42, 52, 54, 55, 56, 57, 63, 66, 69, 73, 75, 82, 85, 89, 92, 94, 96, 98, 99, 103, 106, 110, 114, 115, 117, 119, 126, 135, 147, 148, 152, 153, 161, 166, 169, 170, 175, 179, 184, 193, 197, 208, 213, 216, 217, 224, 228, 230, 238, 247, 252, 255, 269, 271, 272, 273, 275, 278, 279, 282, 284, 289, 290, 291]	['In', 'common', 'with', 'several', 'autoimmune', 'diseases', 'including', 'T1D', ',', 'carriage', 'of', 'the', 'T', 'allele', 'of', 'the', 'rs2476601', 'SNP', 'in', 'the', 'PTPN22', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '22', ')', 'gene', 'has', 'been', 'reproducibly', 'associated', 'with', 'RA', ',', 'conferring', 'a', 'genetic', 'relative', 'risk', 'of', 'approximately', '1.8', '(', 'refs', '88\u200b', ',', '\u200b', '\u200b89', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 0, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Examples include SNPs within genes implicated in the TNF pathway (for example, rs2771369 in TNFAIP2 (tumour necrosis factor, alpha-induced protein 2)) or in the regulation of T-cell function (rs854350 in GZMB (granzyme B) and rs4750316 in PRKCQ (protein kinase C, theta)).	[('PMC2719288', 'I62001', 246, 262, 'protein kinase C')]	['Examples', 'include', 'SNPs', 'within', 'genes', 'implicated', 'in', 'the', 'TNF', 'pathway', '(', 'for', 'example', ',', 'rs', '##27', '##71', '##36', '##9', 'in', 'TNF', '##AI', '##P', '##2', '(', 'tumour', 'necrosis', 'factor', ',', 'alpha', '-', 'induced', 'protein', '2', ')', ')', 'or', 'in', 'the', 'regulation', 'of', 'T', '-', 'cell', 'function', '(', 'rs', '##85', '##43', '##50', 'in', 'G', '##Z', '##MB', '(', 'gran', '##zyme', 'B', ')', 'and', 'rs', '##47', '##50', '##31', '##6', 'in', 'PR', '##K', '##C', '##Q', '(', 'protein', 'kinase', 'C', ',', 'theta', ')', ')', '.']	[0, 9, 17, 22, 29, 35, 46, 49, 53, 57, 65, 66, 70, 77, 79, 81, 83, 85, 87, 89, 92, 95, 97, 98, 100, 101, 108, 117, 123, 125, 130, 131, 139, 147, 148, 149, 151, 154, 157, 161, 172, 175, 176, 177, 182, 191, 192, 194, 196, 198, 201, 204, 205, 206, 209, 210, 214, 219, 220, 222, 226, 228, 230, 232, 234, 236, 239, 241, 242, 243, 245, 246, 254, 261, 262, 264, 269, 270, 271]	[8, 16, 21, 28, 34, 45, 48, 52, 56, 64, 66, 69, 77, 78, 81, 83, 85, 87, 88, 91, 95, 97, 98, 99, 101, 107, 116, 123, 124, 130, 131, 138, 146, 148, 149, 150, 153, 156, 160, 171, 174, 176, 177, 181, 190, 192, 194, 196, 198, 200, 203, 205, 206, 208, 210, 214, 218, 220, 221, 225, 228, 230, 232, 234, 235, 238, 241, 242, 243, 244, 246, 253, 260, 262, 263, 269, 270, 271, 272]	['Examples', 'include', 'SNPs', 'within', 'genes', 'implicated', 'in', 'the', 'TNF', 'pathway', '(', 'for', 'example', ',', 'rs2771369', 'in', 'TNFAIP2', '(', 'tumour', 'necrosis', 'factor', ',', 'alpha', '-', 'induced', 'protein', '2', ')', ')', 'or', 'in', 'the', 'regulation', 'of', 'T-cell', 'function', '(', 'rs854350', 'in', 'GZMB', '(', 'granzyme', 'B', ')', 'and', 'rs4750316', 'in', 'PRKCQ', '(', 'protein', 'kinase', 'C', ',', 'theta', ')', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 3, 1, 2, 1, 1, 1, 5, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
There are six genes/regions for which there is strong pre-existing statistical support for a role in T1D-susceptibility: these are the major histocompatibility complex (MHC), the genes encoding insulin, CTLA-4 (cytotoxic T-lymphocyte associated 4) and PTPN22 (protein tyrosine phosphatase, non-receptor type 22), and the regions around the interleukin 2 receptor alpha (IL2RA/CD25) and interferon-induced helicase 1 genes (IFIH1/MDA5)94.	[('PMC2719288', 'I64002', 260, 288, 'protein tyrosine phosphatase'), ('PMC2719288', 'I64002', 405, 415, 'helicase 1')]	['There', 'are', 'six', 'genes', '/', 'regions', 'for', 'which', 'there', 'is', 'strong', 'pre', '-', 'existing', 'statistical', 'support', 'for', 'a', 'role', 'in', 'T', '##1', '##D', '-', 'susceptibility', ':', 'these', 'are', 'the', 'major', 'hist', '##ocomp', '##ati', '##bility', 'complex', '(', 'MHC', ')', ',', 'the', 'genes', 'encoding', 'insulin', ',', 'CTL', '##A', '-', '4', '(', 'cytotoxic', 'T', '-', 'lymphocyte', 'associated', '4', ')', 'and', 'PTP', '##N', '##22', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '22', ')', ',', 'and', 'the', 'regions', 'around', 'the', 'interleukin', '2', 'receptor', 'alpha', '(', 'IL', '##2', '##RA', '/', 'CD', '##25', ')', 'and', 'interferon', '-', 'induced', 'helic', '##ase', '1', 'genes', '(', 'IF', '##IH', '##1', '/', 'MDA', '##5', ')', '94', '.']	[0, 6, 10, 14, 19, 20, 28, 32, 38, 44, 47, 54, 57, 58, 67, 79, 87, 91, 93, 98, 101, 102, 103, 104, 105, 119, 121, 127, 131, 135, 141, 145, 150, 153, 160, 168, 169, 172, 173, 175, 179, 185, 194, 201, 203, 206, 207, 208, 210, 211, 221, 222, 223, 234, 245, 246, 248, 252, 255, 256, 259, 260, 268, 277, 288, 290, 293, 294, 303, 308, 310, 311, 313, 317, 321, 329, 336, 340, 352, 354, 363, 369, 370, 372, 373, 375, 376, 378, 380, 382, 386, 396, 397, 405, 410, 414, 416, 422, 423, 425, 427, 428, 429, 432, 433, 434, 436]	[5, 9, 13, 19, 20, 27, 31, 37, 43, 46, 53, 57, 58, 66, 78, 86, 90, 92, 97, 100, 102, 103, 104, 105, 119, 120, 126, 130, 134, 140, 145, 150, 153, 159, 167, 169, 172, 173, 174, 178, 184, 193, 201, 202, 206, 207, 208, 209, 211, 220, 222, 223, 233, 244, 246, 247, 251, 255, 256, 258, 260, 267, 276, 288, 289, 293, 294, 302, 307, 310, 311, 312, 316, 320, 328, 335, 339, 351, 353, 362, 368, 370, 372, 373, 375, 376, 378, 380, 381, 385, 396, 397, 404, 410, 413, 415, 421, 423, 425, 427, 428, 429, 432, 433, 434, 436, 437]	['There', 'are', 'six', 'genes', '/', 'regions', 'for', 'which', 'there', 'is', 'strong', 'pre', '-', 'existing', 'statistical', 'support', 'for', 'a', 'role', 'in', 'T1D-susceptibility', ':', 'these', 'are', 'the', 'major', 'histocompatibility', 'complex', '(', 'MHC', ')', ',', 'the', 'genes', 'encoding', 'insulin', ',', 'CTLA-4', '(', 'cytotoxic', 'T-lymphocyte', 'associated', '4', ')', 'and', 'PTPN22', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '22', ')', ',', 'and', 'the', 'regions', 'around', 'the', 'interleukin', '2', 'receptor', 'alpha', '(', 'IL2RA', '/', 'CD25', ')', 'and', 'interferon', '-', 'induced', 'helicase', '1', 'genes', '(', 'IFIH1', '/', 'MDA5)94', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These include ERBB3 (receptor tyrosine-protein kinase erbB-3 precursor) at 12q13 and SH2B3/LNK (SH2B adaptor protein 3), TRAFD1 (TRAF-type zinc finger domain containing 1) and PTPN11 (protein tyrosine phosphatase, non-receptor type 11) at 12q24.	[('PMC2719288', 'I66002', 30, 53, 'tyrosine-protein kinase'), ('PMC2719288', 'I66002', 184, 212, 'protein tyrosine phosphatase')]	['These', 'include', 'ER', '##BB', '##3', '(', 'receptor', 'tyrosine', '-', 'protein', 'kinase', 'er', '##bB', '-', '3', 'precursor', ')', 'at', '12', '##q', '##13', 'and', 'SH', '##2', '##B', '##3', '/', 'LN', '##K', '(', 'SH', '##2', '##B', 'adapt', '##or', 'protein', '3', ')', ',', 'TRA', '##FD', '##1', '(', 'TRA', '##F', '-', 'type', 'zinc', 'finger', 'domain', 'containing', '1', ')', 'and', 'PTP', '##N', '##11', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '11', ')', 'at', '12', '##q', '##24', '.']	[0, 6, 14, 16, 18, 20, 21, 30, 38, 39, 47, 54, 56, 58, 59, 61, 70, 72, 75, 77, 78, 81, 85, 87, 88, 89, 90, 91, 93, 95, 96, 98, 99, 101, 106, 109, 117, 118, 119, 121, 124, 126, 128, 129, 132, 133, 134, 139, 144, 151, 158, 169, 170, 172, 176, 179, 180, 183, 184, 192, 201, 212, 214, 217, 218, 227, 232, 234, 236, 239, 241, 242, 244]	[5, 13, 16, 18, 19, 21, 29, 38, 39, 46, 53, 56, 58, 59, 60, 70, 71, 74, 77, 78, 80, 84, 87, 88, 89, 90, 91, 93, 94, 96, 98, 99, 100, 106, 108, 116, 118, 119, 120, 124, 126, 127, 129, 132, 133, 134, 138, 143, 150, 157, 168, 170, 171, 175, 179, 180, 182, 184, 191, 200, 212, 213, 217, 218, 226, 231, 234, 235, 238, 241, 242, 244, 245]	['These', 'include', 'ERBB3', '(', 'receptor', 'tyrosine', '-', 'protein', 'kinase', 'erbB-3', 'precursor', ')', 'at', '12q13', 'and', 'SH2B3', '/', 'LNK', '(', 'SH2B', 'adaptor', 'protein', '3', ')', ',', 'TRAFD1', '(', 'TRAF', '-', 'type', 'zinc', 'finger', 'domain', 'containing', '1', ')', 'and', 'PTPN11', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '11', ')', 'at', '12q24', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 4, 1, 2, 1, 3, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It is also a member of the same family of regulatory phosphatases as PTPN22, already established as an important susceptibility gene for T1D and other autoimmune diseases94,97.	[('PMC2719288', 'I66005', 42, 65, 'regulatory phosphatases')]	['It', 'is', 'also', 'a', 'member', 'of', 'the', 'same', 'family', 'of', 'regulatory', 'phosphatase', '##s', 'as', 'PTP', '##N', '##22', ',', 'already', 'established', 'as', 'an', 'important', 'susceptibility', 'gene', 'for', 'T', '##1', '##D', 'and', 'other', 'autoimmune', 'diseases', '##94', ',', '97', '.']	[0, 3, 6, 11, 13, 20, 23, 27, 32, 39, 42, 53, 64, 66, 69, 72, 73, 75, 77, 85, 97, 100, 103, 113, 128, 133, 137, 138, 139, 141, 145, 151, 162, 170, 172, 173, 175]	[2, 5, 10, 12, 19, 22, 26, 31, 38, 41, 52, 64, 65, 68, 72, 73, 75, 76, 84, 96, 99, 102, 112, 127, 132, 136, 138, 139, 140, 144, 150, 161, 170, 172, 173, 175, 176]	['It', 'is', 'also', 'a', 'member', 'of', 'the', 'same', 'family', 'of', 'regulatory', 'phosphatases', 'as', 'PTPN22', ',', 'already', 'established', 'as', 'an', 'important', 'susceptibility', 'gene', 'for', 'T1D', 'and', 'other', 'autoimmune', 'diseases94', ',', '97', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Also, the region of association identified on 18p11 (Supplementary Fig. 14), which seems to confer susceptibility to all three autoimmune conditions studied (combined trend test P=9×10-8, P=4.6×10-8 for CD, 1.9×10-2 for RA, and 1.9×10-6 for T1D: Supplementary Table 11), maps to a single gene, PTPN2 (protein tyrosine phosphatase, non-receptor type 2), a member of the same family as PTPN22 and PTPN11 and involved in immune regulation96.	[('PMC2719288', 'I67001', 301, 329, 'protein tyrosine phosphatase')]	['Also', ',', 'the', 'region', 'of', 'association', 'identified', 'on', '18', '##p', '##11', '(', 'Supplementary', 'Fig', '.', '14', ')', ',', 'which', 'seems', 'to', 'confer', 'susceptibility', 'to', 'all', 'three', 'autoimmune', 'conditions', 'studied', '(', 'combined', 'trend', 'test', 'P', '=', '9', '##×10', '-', '8', ',', 'P', '=', '4', '.', '6', '##×10', '-', '8', 'for', 'CD', ',', '1', '.', '9', '##×10', '-', '2', 'for', 'RA', ',', 'and', '1', '.', '9', '##×10', '-', '6', 'for', 'T', '##1', '##D', ':', 'Supplementary', 'Table', '11', ')', ',', 'maps', 'to', 'a', 'single', 'gene', ',', 'PTP', '##N', '##2', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '2', ')', ',', 'a', 'member', 'of', 'the', 'same', 'family', 'as', 'PTP', '##N', '##22', 'and', 'PTP', '##N', '##11', 'and', 'involved', 'in', 'immune', 'regulation', '##96', '.']	[0, 4, 6, 10, 17, 20, 32, 43, 46, 48, 49, 52, 53, 67, 70, 72, 74, 75, 77, 83, 89, 92, 99, 114, 117, 121, 127, 138, 149, 157, 158, 167, 173, 178, 179, 180, 181, 184, 185, 186, 188, 189, 190, 191, 192, 193, 196, 197, 199, 203, 205, 207, 208, 209, 210, 213, 214, 216, 220, 222, 224, 228, 229, 230, 231, 234, 235, 237, 241, 242, 243, 244, 246, 260, 266, 268, 269, 271, 276, 279, 281, 288, 292, 294, 297, 298, 300, 301, 309, 318, 329, 331, 334, 335, 344, 349, 350, 351, 353, 355, 362, 365, 369, 374, 381, 384, 387, 388, 391, 395, 398, 399, 402, 406, 415, 418, 425, 435, 437]	[4, 5, 9, 16, 19, 31, 42, 45, 48, 49, 51, 53, 66, 70, 71, 74, 75, 76, 82, 88, 91, 98, 113, 116, 120, 126, 137, 148, 156, 158, 166, 172, 177, 179, 180, 181, 184, 185, 186, 187, 189, 190, 191, 192, 193, 196, 197, 198, 202, 205, 206, 208, 209, 210, 213, 214, 215, 219, 222, 223, 227, 229, 230, 231, 234, 235, 236, 240, 242, 243, 244, 245, 259, 265, 268, 269, 270, 275, 278, 280, 287, 292, 293, 297, 298, 299, 301, 308, 317, 329, 330, 334, 335, 343, 348, 350, 351, 352, 354, 361, 364, 368, 373, 380, 383, 387, 388, 390, 394, 398, 399, 401, 405, 414, 417, 424, 435, 437, 438]	['Also', ',', 'the', 'region', 'of', 'association', 'identified', 'on', '18p11', '(', 'Supplementary', 'Fig', '.', '14', ')', ',', 'which', 'seems', 'to', 'confer', 'susceptibility', 'to', 'all', 'three', 'autoimmune', 'conditions', 'studied', '(', 'combined', 'trend', 'test', 'P=9×10-8', ',', 'P=4.6×10-8', 'for', 'CD', ',', '1.9×10-2', 'for', 'RA', ',', 'and', '1.9×10-6', 'for', 'T1D', ':', 'Supplementary', 'Table', '11', ')', ',', 'maps', 'to', 'a', 'single', 'gene', ',', 'PTPN2', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '2', ')', ',', 'a', 'member', 'of', 'the', 'same', 'family', 'as', 'PTPN22', 'and', 'PTPN11', 'and', 'involved', 'in', 'immune', 'regulation96', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 8, 1, 1, 1, 6, 1, 1, 1, 1, 6, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CDK5RAP1 is known to inhibit the activation of CDK5, a cyclin-dependent kinase which has been implicated in the maintenance of normal beta-cell function108.	[('PMC2719288', 'I75002', 55, 78, 'cyclin-dependent kinase')]	['CDK', '##5', '##RAP', '##1', 'is', 'known', 'to', 'inhibit', 'the', 'activation', 'of', 'CDK', '##5', ',', 'a', 'cyclin', '-', 'dependent', 'kinase', 'which', 'has', 'been', 'implicated', 'in', 'the', 'maintenance', 'of', 'normal', 'beta', '-', 'cell', 'function', '##108', '.']	[0, 3, 4, 7, 9, 12, 18, 21, 29, 33, 44, 47, 50, 51, 53, 55, 61, 62, 72, 79, 85, 89, 94, 105, 108, 112, 124, 127, 134, 138, 139, 144, 152, 155]	[3, 4, 7, 8, 11, 17, 20, 28, 32, 43, 46, 50, 51, 52, 54, 61, 62, 71, 78, 84, 88, 93, 104, 107, 111, 123, 126, 133, 138, 139, 143, 152, 155, 156]	['CDK5RAP1', 'is', 'known', 'to', 'inhibit', 'the', 'activation', 'of', 'CDK5', ',', 'a', 'cyclin', '-', 'dependent', 'kinase', 'which', 'has', 'been', 'implicated', 'in', 'the', 'maintenance', 'of', 'normal', 'beta', '-', 'cell', 'function108', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis.	[('PMC2748125', 'F06002', 4, 27, 'serine/threonine kinase')]	['The', 'serine', '/', 'thre', '##onine', 'kinase', 'Ne', '##k', '##6', 'is', 'required', 'for', 'cell', 'cycle', 'progression', 'through', 'mitosis', '.']	[0, 4, 10, 11, 15, 21, 28, 30, 31, 33, 36, 45, 49, 54, 60, 72, 80, 87]	[3, 10, 11, 15, 20, 27, 30, 31, 32, 35, 44, 48, 53, 59, 71, 79, 87, 88]	['The', 'serine', '/', 'threonine', 'kinase', 'Nek6', 'is', 'required', 'for', 'cell', 'cycle', 'progression', 'through', 'mitosis', '.']	[1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Differential expression of novel tyrosine kinase substrates during breast cancer development.	[('PMC2748125', 'F08002', 33, 48, 'tyrosine kinase')]	['Differential', 'expression', 'of', 'novel', 'tyrosine', 'kinase', 'substrates', 'during', 'breast', 'cancer', 'development', '.']	[0, 13, 24, 27, 33, 42, 49, 60, 67, 74, 81, 92]	[12, 23, 26, 32, 41, 48, 59, 66, 73, 80, 92, 93]	['Differential', 'expression', 'of', 'novel', 'tyrosine', 'kinase', 'substrates', 'during', 'breast', 'cancer', 'development', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
NEK10 (Never-in mitosis related kinase 10) is one of a family of 11 NIMA (never in mitosis a) related kinases that are involved in cell cycle control7.	[('PMC2748125', 'I06001', 32, 38, 'kinase'), ('PMC2748125', 'I06001', 102, 109, 'kinases')]	['NE', '##K', '##10', '(', 'Never', '-', 'in', 'mitosis', 'related', 'kinase', '10', ')', 'is', 'one', 'of', 'a', 'family', 'of', '11', 'NI', '##MA', '(', 'never', 'in', 'mitosis', 'a', ')', 'related', 'kinases', 'that', 'are', 'involved', 'in', 'cell', 'cycle', 'control', '##7', '.']	[0, 2, 3, 6, 7, 12, 13, 16, 24, 32, 39, 41, 43, 46, 50, 53, 55, 62, 65, 68, 70, 73, 74, 80, 83, 91, 92, 94, 102, 110, 115, 119, 128, 131, 136, 142, 149, 150]	[2, 3, 5, 7, 12, 13, 15, 23, 31, 38, 41, 42, 45, 49, 52, 54, 61, 64, 67, 70, 72, 74, 79, 82, 90, 92, 93, 101, 109, 114, 118, 127, 130, 135, 141, 149, 150, 151]	['NEK10', '(', 'Never', '-', 'in', 'mitosis', 'related', 'kinase', '10', ')', 'is', 'one', 'of', 'a', 'family', 'of', '11', 'NIMA', '(', 'never', 'in', 'mitosis', 'a', ')', 'related', 'kinases', 'that', 'are', 'involved', 'in', 'cell', 'cycle', 'control7', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SLC4A7 (solute carrier family 4, sodium bicarbonate cotransporter, member 7) is a potential tyrosine kinase substrate that has been shown to have reduced expression in breast tumor sections and cell lines9.	[('PMC2748125', 'I06003', 92, 107, 'tyrosine kinase')]	['SLC', '##4', '##A', '##7', '(', 'solute', 'carrier', 'family', '4', ',', 'sodium', 'bicarbonate', 'cotrans', '##porter', ',', 'member', '7', ')', 'is', 'a', 'potential', 'tyrosine', 'kinase', 'substrate', 'that', 'has', 'been', 'shown', 'to', 'have', 'reduced', 'expression', 'in', 'breast', 'tumor', 'sections', 'and', 'cell', 'lines', '##9', '.']	[0, 3, 4, 5, 7, 8, 15, 23, 30, 31, 33, 40, 52, 59, 65, 67, 74, 75, 77, 80, 82, 92, 101, 108, 118, 123, 127, 132, 138, 141, 146, 154, 165, 168, 175, 181, 190, 194, 199, 204, 205]	[3, 4, 5, 6, 8, 14, 22, 29, 31, 32, 39, 51, 59, 65, 66, 73, 75, 76, 79, 81, 91, 100, 107, 117, 122, 126, 131, 137, 140, 145, 153, 164, 167, 174, 180, 189, 193, 198, 204, 205, 206]	['SLC4A7', '(', 'solute', 'carrier', 'family', '4', ',', 'sodium', 'bicarbonate', 'cotransporter', ',', 'member', '7', ')', 'is', 'a', 'potential', 'tyrosine', 'kinase', 'substrate', 'that', 'has', 'been', 'shown', 'to', 'have', 'reduced', 'expression', 'in', 'breast', 'tumor', 'sections', 'and', 'cell', 'lines9', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Twenty-seven studies genotyped the SNPs using a 5′ endonuclease assay (Taqman), using reagents supplied by Applied Biosystems and tested centrally.	[('PMC2748125', 'M01002', 51, 63, 'endonuclease')]	['Twenty', '-', 'seven', 'studies', 'genotype', '##d', 'the', 'SNPs', 'using', 'a', '5', '′', 'end', '##onuclease', 'assay', '(', 'Taq', '##man', ')', ',', 'using', 'reagents', 'supplied', 'by', 'Applied', 'Biosystems', 'and', 'tested', 'centrally', '.']	[0, 6, 7, 13, 21, 29, 31, 35, 40, 46, 48, 49, 51, 54, 64, 70, 71, 74, 77, 78, 80, 86, 95, 104, 107, 115, 126, 130, 137, 146]	[6, 7, 12, 20, 29, 30, 34, 39, 45, 47, 49, 50, 54, 63, 69, 71, 74, 77, 78, 79, 85, 94, 103, 106, 114, 125, 129, 136, 146, 147]	['Twenty', '-', 'seven', 'studies', 'genotyped', 'the', 'SNPs', 'using', 'a', '5′', 'endonuclease', 'assay', '(', 'Taqman', ')', ',', 'using', 'reagents', 'supplied', 'by', 'Applied', 'Biosystems', 'and', 'tested', 'centrally', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The proposed mechanism relies upon a NOD-LRR family member (Naip5) to detect invading L. pneumophila and subsequently activate autophagy, or if Naip5 signalling is sustained, proinflammatory cell death via caspase 1.	[('PMC2757939', 'D02007', 206, 215, 'caspase 1')]	['The', 'proposed', 'mechanism', 'relies', 'upon', 'a', 'NOD', '-', 'LR', '##R', 'family', 'member', '(', 'Na', '##ip', '##5', ')', 'to', 'detect', 'inv', '##ading', 'L', '.', 'pneum', '##ophila', 'and', 'subsequently', 'activate', 'autophagy', ',', 'or', 'if', 'Na', '##ip', '##5', 'signalling', 'is', 'sustained', ',', 'proinflammatory', 'cell', 'death', 'via', 'caspase', '1', '.']	[0, 4, 13, 23, 30, 35, 37, 40, 41, 43, 45, 52, 59, 60, 62, 64, 65, 67, 70, 77, 80, 86, 87, 89, 94, 101, 105, 118, 127, 136, 138, 141, 144, 146, 148, 150, 161, 164, 173, 175, 191, 196, 202, 206, 214, 215]	[3, 12, 22, 29, 34, 36, 40, 41, 43, 44, 51, 58, 60, 62, 64, 65, 66, 69, 76, 80, 85, 87, 88, 94, 100, 104, 117, 126, 136, 137, 140, 143, 146, 148, 149, 160, 163, 173, 174, 190, 195, 201, 205, 213, 215, 216]	['The', 'proposed', 'mechanism', 'relies', 'upon', 'a', 'NOD-LRR', 'family', 'member', '(', 'Naip5', ')', 'to', 'detect', 'invading', 'L', '.', 'pneumophila', 'and', 'subsequently', 'activate', 'autophagy', ',', 'or', 'if', 'Naip5', 'signalling', 'is', 'sustained', ',', 'proinflammatory', 'cell', 'death', 'via', 'caspase', '1', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
In particular, previous studies of the p40phox protein encoded by the NCF4 gene have demonstrated that it plays an important role in NADPH oxidase activity and the generation of reactive oxygen species (ROS) production upon phagocytosis17,18; both important for mounting an effective anti-microbial response.	[('PMC2757939', 'D04001', 133, 146, 'NADPH oxidase')]	['In', 'particular', ',', 'previous', 'studies', 'of', 'the', 'p', '##40', '##ph', '##ox', 'protein', 'encoded', 'by', 'the', 'NC', '##F', '##4', 'gene', 'have', 'demonstrated', 'that', 'it', 'plays', 'an', 'important', 'role', 'in', 'NADPH', 'oxidase', 'activity', 'and', 'the', 'generation', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', 'production', 'upon', 'phagocytosis', '##17', ',', '18', ';', 'both', 'important', 'for', 'mounting', 'an', 'effective', 'anti', '-', 'microbial', 'response', '.']	[0, 3, 13, 15, 24, 32, 35, 39, 40, 42, 44, 47, 55, 63, 66, 70, 72, 73, 75, 80, 85, 98, 103, 106, 112, 115, 125, 130, 133, 139, 147, 156, 160, 164, 175, 178, 187, 194, 202, 203, 206, 208, 219, 224, 236, 238, 239, 241, 243, 248, 258, 262, 271, 274, 284, 288, 289, 299, 307]	[2, 13, 14, 23, 31, 34, 38, 40, 42, 44, 46, 54, 62, 65, 69, 72, 73, 74, 79, 84, 97, 102, 105, 111, 114, 124, 129, 132, 138, 146, 155, 159, 163, 174, 177, 186, 193, 201, 203, 206, 207, 218, 223, 236, 238, 239, 241, 242, 247, 257, 261, 270, 273, 283, 288, 289, 298, 307, 308]	['In', 'particular', ',', 'previous', 'studies', 'of', 'the', 'p40phox', 'protein', 'encoded', 'by', 'the', 'NCF4', 'gene', 'have', 'demonstrated', 'that', 'it', 'plays', 'an', 'important', 'role', 'in', 'NADPH', 'oxidase', 'activity', 'and', 'the', 'generation', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', 'production', 'upon', 'phagocytosis17', ',', '18', ';', 'both', 'important', 'for', 'mounting', 'an', 'effective', 'anti-', 'microbial', 'response', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Neutrophils from p40phox−/− mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing.	[('PMC2757939', 'F16002', 59, 72, 'NADPH oxidase')]	['Neu', '##troph', '##ils', 'from', 'p', '##40', '##ph', '##ox', '##−', '/', '−', 'mice', 'exhibit', 'severe', 'defects', 'in', 'NADPH', 'oxidase', 'regulation', 'and', 'oxid', '##ant', '-', 'dependent', 'bacterial', 'killing', '.']	[0, 3, 8, 12, 17, 18, 20, 22, 24, 25, 26, 28, 33, 41, 48, 56, 59, 65, 73, 84, 88, 92, 95, 96, 106, 116, 123]	[3, 8, 11, 16, 18, 20, 22, 24, 25, 26, 27, 32, 40, 47, 55, 58, 64, 72, 83, 87, 92, 95, 96, 105, 115, 123, 124]	['Neutrophils', 'from', 'p40phox−', '/', '−', 'mice', 'exhibit', 'severe', 'defects', 'in', 'NADPH', 'oxidase', 'regulation', 'and', 'oxidant', '-', 'dependent', 'bacterial', 'killing', '.']	[3, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcgammaIIA receptor-induced phagocytosis.	[('PMC2757939', 'F17002', 59, 72, 'NADPH oxidase')]	['The', 'phospho', '##inos', '##iti', '##de', '-', 'binding', 'protein', 'p', '##40', '##ph', '##ox', 'activates', 'the', 'NADPH', 'oxidase', 'during', 'Fc', '##gamma', '##II', '##A', 'receptor', '-', 'induced', 'phagocytosis', '.']	[0, 4, 11, 15, 18, 20, 21, 29, 37, 38, 40, 42, 45, 55, 59, 65, 73, 80, 82, 87, 89, 91, 99, 100, 108, 120]	[3, 11, 15, 18, 20, 21, 28, 36, 38, 40, 42, 44, 54, 58, 64, 72, 79, 82, 87, 89, 90, 99, 100, 107, 120, 121]	['The', 'phosphoinositide', '-', 'binding', 'protein', 'p40phox', 'activates', 'the', 'NADPH', 'oxidase', 'during', 'FcgammaIIA', 'receptor', '-', 'induced', 'phagocytosis', '.']	[1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genomic structure, chromosomal localization, start of transcription, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleotide phosphate-oxidase complex.	[('PMC2757939', 'F18002', 137, 188, 'nicotinamide adenine dinucleotide phosphate-oxidase')]	['Genomic', 'structure', ',', 'chromosomal', 'localization', ',', 'start', 'of', 'transcription', ',', 'and', 'tissue', 'expression', 'of', 'the', 'human', 'p', '##40', '-', 'ph', '##ox', ',', 'a', 'new', 'component', 'of', 'the', 'nicotin', '##amide', 'adenine', 'din', '##ucleotide', 'phosphate', '-', 'oxidase', 'complex', '.']	[0, 8, 17, 19, 31, 43, 45, 51, 54, 67, 69, 73, 80, 91, 94, 98, 104, 105, 107, 108, 110, 112, 114, 116, 120, 130, 133, 137, 144, 150, 158, 161, 171, 180, 181, 189, 196]	[7, 17, 18, 30, 43, 44, 50, 53, 67, 68, 72, 79, 90, 93, 97, 103, 105, 107, 108, 110, 112, 113, 115, 119, 129, 132, 136, 144, 149, 157, 161, 170, 180, 181, 188, 196, 197]	['Genomic', 'structure', ',', 'chromosomal', 'localization', ',', 'start', 'of', 'transcription', ',', 'and', 'tissue', 'expression', 'of', 'the', 'human', 'p40-phox', ',', 'a', 'new', 'component', 'of', 'the', 'nicotinamide', 'adenine', 'dinucleotide', 'phosphate', '-', 'oxidase', 'complex', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
In all cases cDNA was made from RNA templates using a standard reverse transcriptase protocol (iScript, BioRad), with 500 ng of RNA per reaction.	[('PMC2757939', 'M06002', 63, 84, 'reverse transcriptase')]	['In', 'all', 'cases', 'cDNA', 'was', 'made', 'from', 'RNA', 'templates', 'using', 'a', 'standard', 'reverse', 'transcriptase', 'protocol', '(', 'i', '##Script', ',', 'Bio', '##Rad', ')', ',', 'with', '500', 'ng', 'of', 'RNA', 'per', 'reaction', '.']	[0, 3, 7, 13, 18, 22, 27, 32, 36, 46, 52, 54, 63, 71, 85, 94, 95, 96, 102, 104, 107, 110, 111, 113, 118, 122, 125, 128, 132, 136, 144]	[2, 6, 12, 17, 21, 26, 31, 35, 45, 51, 53, 62, 70, 84, 93, 95, 96, 102, 103, 107, 110, 111, 112, 117, 121, 124, 127, 131, 135, 144, 145]	['In', 'all', 'cases', 'cDNA', 'was', 'made', 'from', 'RNA', 'templates', 'using', 'a', 'standard', 'reverse', 'transcriptase', 'protocol', '(', 'iScript', ',', 'BioRad', ')', ',', 'with', '500', 'ng', 'of', 'RNA', 'per', 'reaction', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The resulting template cDNAs were diluted 1:10 in nuclease-free water and 10 ul of this template used for each 40 ul qPCR reaction.	[('PMC2757939', 'M06003', 50, 58, 'nuclease')]	['The', 'resulting', 'template', 'cDNA', '##s', 'were', 'diluted', '1', ':', '10', 'in', 'nucle', '##ase', '-', 'free', 'water', 'and', '10', 'ul', 'of', 'this', 'template', 'used', 'for', 'each', '40', 'ul', 'qPCR', 'reaction', '.']	[0, 4, 14, 23, 27, 29, 34, 42, 43, 44, 47, 50, 55, 58, 59, 64, 70, 74, 77, 80, 83, 88, 97, 102, 106, 111, 114, 117, 122, 130]	[3, 13, 22, 27, 28, 33, 41, 43, 44, 46, 49, 55, 58, 59, 63, 69, 73, 76, 79, 82, 87, 96, 101, 105, 110, 113, 116, 121, 130, 131]	['The', 'resulting', 'template', 'cDNAs', 'were', 'diluted', '1', ':', '10', 'in', 'nuclease', '-', 'free', 'water', 'and', '10', 'ul', 'of', 'this', 'template', 'used', 'for', 'each', '40', 'ul', 'qPCR', 'reaction', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NCF4 encodes the 7 p40phox protein that has previously been demonstrated to play an important role in NADPH oxidase activity and the generation of reactive oxygen species (ROS) production upon phagocytosis17,18; both important for mounting an effective anti-microbial response.	[('PMC2757939', 'R07001', 102, 115, 'NADPH oxidase')]	['NC', '##F', '##4', 'encodes', 'the', '7', 'p', '##40', '##ph', '##ox', 'protein', 'that', 'has', 'previously', 'been', 'demonstrated', 'to', 'play', 'an', 'important', 'role', 'in', 'NADPH', 'oxidase', 'activity', 'and', 'the', 'generation', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', 'production', 'upon', 'phagocytosis', '##17', ',', '18', ';', 'both', 'important', 'for', 'mounting', 'an', 'effective', 'anti', '-', 'microbial', 'response', '.']	[0, 2, 3, 5, 13, 17, 19, 20, 22, 24, 27, 35, 40, 44, 55, 60, 73, 76, 81, 84, 94, 99, 102, 108, 116, 125, 129, 133, 144, 147, 156, 163, 171, 172, 175, 177, 188, 193, 205, 207, 208, 210, 212, 217, 227, 231, 240, 243, 253, 257, 258, 268, 276]	[2, 3, 4, 12, 16, 18, 20, 22, 24, 26, 34, 39, 43, 54, 59, 72, 75, 80, 83, 93, 98, 101, 107, 115, 124, 128, 132, 143, 146, 155, 162, 170, 172, 175, 176, 187, 192, 205, 207, 208, 210, 211, 216, 226, 230, 239, 242, 252, 257, 258, 267, 276, 277]	['NCF4', 'encodes', 'the', '7', 'p40phox', 'protein', 'that', 'has', 'previously', 'been', 'demonstrated', 'to', 'play', 'an', 'important', 'role', 'in', 'NADPH', 'oxidase', 'activity', 'and', 'the', 'generation', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', 'production', 'upon', 'phagocytosis17', ',', '18', ';', 'both', 'important', 'for', 'mounting', 'an', 'effective', 'anti-', 'microbial', 'response', '.']	[3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NCF4 encodes p40phox, a component of the NADPH oxidase complex required for optimal ROS generation in immune cells.	[('PMC2757939', 'R12000', 41, 54, 'NADPH oxidase')]	['NC', '##F', '##4', 'encodes', 'p', '##40', '##ph', '##ox', ',', 'a', 'component', 'of', 'the', 'NADPH', 'oxidase', 'complex', 'required', 'for', 'optimal', 'ROS', 'generation', 'in', 'immune', 'cells', '.']	[0, 2, 3, 5, 13, 14, 16, 18, 20, 22, 24, 34, 37, 41, 47, 55, 63, 72, 76, 84, 88, 99, 102, 109, 114]	[2, 3, 4, 12, 14, 16, 18, 20, 21, 23, 33, 36, 40, 46, 54, 62, 71, 75, 83, 87, 98, 101, 108, 114, 115]	['NCF4', 'encodes', 'p40phox', ',', 'a', 'component', 'of', 'the', 'NADPH', 'oxidase', 'complex', 'required', 'for', 'optimal', 'ROS', 'generation', 'in', 'immune', 'cells', '.']	[3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Human 8-oxoguanine DNA glycosylase 1 (hOGG1) is a BER enzyme responsible for identifying and assisting in the removal of oxidized guanine.	[('PMC2771025', 'D03003', 6, 36, '8-oxoguanine DNA glycosylase 1')]	['Human', '8', '-', 'ox', '##og', '##uan', '##ine', 'DNA', 'glycos', '##yl', '##ase', '1', '(', 'h', '##OG', '##G', '##1', ')', 'is', 'a', 'BER', 'enzyme', 'responsible', 'for', 'identifying', 'and', 'assist', '##ing', 'in', 'the', 'removal', 'of', 'oxidized', 'guan', '##ine', '.']	[0, 6, 7, 8, 10, 12, 15, 19, 23, 29, 31, 35, 37, 38, 39, 41, 42, 43, 45, 48, 50, 54, 61, 73, 77, 89, 93, 99, 103, 106, 110, 118, 121, 130, 134, 137]	[5, 7, 8, 10, 12, 15, 18, 22, 29, 31, 34, 36, 38, 39, 41, 42, 43, 44, 47, 49, 53, 60, 72, 76, 88, 92, 99, 102, 105, 109, 117, 120, 129, 134, 137, 138]	['Human', '8-oxoguanine', 'DNA', 'glycosylase', '1', '(', 'hOGG1', ')', 'is', 'a', 'BER', 'enzyme', 'responsible', 'for', 'identifying', 'and', 'assisting', 'in', 'the', 'removal', 'of', 'oxidized', 'guanine', '.']	[1, 6, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion.	[('PMC2771025', 'F13001', 89, 114, 'glutathione-S-transferase')]	['Oxid', '##ative', 'DNA', 'damage', 'in', 'vivo', ':', 'relationship', 'to', 'age', ',', 'plasma', 'antioxidants', ',', 'drug', 'metabolism', ',', 'glutathione', '-', 'S', '-', 'transfer', '##ase', 'activity', 'and', 'urinary', 'creatinine', 'excretion', '.']	[0, 4, 10, 14, 21, 24, 28, 30, 43, 46, 49, 51, 58, 70, 72, 77, 87, 89, 100, 101, 102, 103, 111, 115, 124, 128, 136, 147, 156]	[4, 9, 13, 20, 23, 28, 29, 42, 45, 49, 50, 57, 70, 71, 76, 87, 88, 100, 101, 102, 103, 111, 114, 123, 127, 135, 146, 156, 157]	['Oxidative', 'DNA', 'damage', 'in', 'vivo', ':', 'relationship', 'to', 'age', ',', 'plasma', 'antioxidants', ',', 'drug', 'metabolism', ',', 'glutathione-S-transferase', 'activity', 'and', 'urinary', 'creatinine', 'excretion', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
19. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction.	[('PMC2803020', 'F18000', 114, 127, 'streptokinase')]	['19', '.', 'ISI', '##S', '-', '3', '(', 'Third', 'International', 'Study', 'of', 'Inf', '##arc', '##t', 'Survival', ')', 'Collaborative', 'Group', 'ISI', '##S', '-', '3', ':', 'a', 'randomised', 'comparison', 'of', 'strept', '##ok', '##inase', 'vs', 'tissue', 'plasmin', '##ogen', 'activator', 'vs', 'anis', '##tre', '##plas', '##e', 'and', 'of', 'aspirin', 'plus', 'heparin', 'vs', 'aspirin', 'alone', 'among', '41', '299', 'cases', 'of', 'suspected', 'acute', 'myocardial', 'infarction', '.']	[0, 2, 4, 7, 8, 9, 11, 12, 18, 32, 38, 41, 44, 47, 49, 57, 59, 73, 79, 82, 83, 84, 85, 87, 89, 100, 111, 114, 120, 122, 128, 131, 138, 145, 150, 160, 163, 167, 170, 174, 176, 180, 183, 191, 196, 204, 207, 215, 221, 227, 230, 234, 240, 243, 253, 259, 270, 280]	[2, 3, 7, 8, 9, 10, 12, 17, 31, 37, 40, 44, 47, 48, 57, 58, 72, 78, 82, 83, 84, 85, 86, 88, 99, 110, 113, 120, 122, 127, 130, 137, 145, 149, 159, 162, 167, 170, 174, 175, 179, 182, 190, 195, 203, 206, 214, 220, 226, 229, 233, 239, 242, 252, 258, 269, 280, 281]	['19', '.', 'ISIS-3', '(', 'Third', 'International', 'Study', 'of', 'Infarct', 'Survival', ')', 'Collaborative', 'Group', 'ISIS-3', ':', 'a', 'randomised', 'comparison', 'of', 'streptokinase', 'vs', 'tissue', 'plasminogen', 'activator', 'vs', 'anistreplase', 'and', 'of', 'aspirin', 'plus', 'heparin', 'vs', 'aspirin', 'alone', 'among', '41', '299', 'cases', 'of', 'suspected', 'acute', 'myocardial', 'infarction', '.']	[1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease.	[('PMC2803020', 'F67002', 0, 39, 'Lipoprotein-associated phospholipase A2')]	['Lip', '##oprotein', '-', 'associated', 'phospholip', '##ase', 'A', '##2', 'as', 'an', 'independent', 'predictor', 'of', 'coronary', 'heart', 'disease', '.']	[0, 3, 11, 12, 23, 33, 37, 38, 40, 43, 46, 58, 68, 71, 80, 86, 93]	[3, 11, 12, 22, 33, 36, 38, 39, 42, 45, 57, 67, 70, 79, 85, 93, 94]	['Lipoprotein', '-', 'associated', 'phospholipase', 'A2', 'as', 'an', 'independent', 'predictor', 'of', 'coronary', 'heart', 'disease', '.']	[2, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The single-nucleotide polymorphism most strongly associated with lower serum iron concentration was rs4820268 (P = 5.12 × 10−9), located in exon 13 of the transmembrane protease serine 6 (TMPRSS6) gene, an enzyme that promotes iron absorption and recycling by inhibiting hepcidin antimicrobial peptide transcription.	[('PMC2803694', 'A00002', 155, 186, 'transmembrane protease serine 6')]	['The', 'single', '-', 'nucleotide', 'polymorphism', 'most', 'strongly', 'associated', 'with', 'lower', 'serum', 'iron', 'concentration', 'was', 'rs', '##48', '##202', '##68', '(', 'P', '=', '5', '.', '12', '×', '10−', '##9', ')', ',', 'located', 'in', 'exon', '13', 'of', 'the', 'transmembrane', 'protease', 'serine', '6', '(', 'TM', '##PR', '##SS', '##6', ')', 'gene', ',', 'an', 'enzyme', 'that', 'promotes', 'iron', 'absorption', 'and', 'recycling', 'by', 'inhibiting', 'hep', '##ci', '##din', 'antimicrobial', 'peptide', 'transcription', '.']	[0, 4, 10, 11, 22, 35, 40, 49, 60, 65, 71, 77, 82, 96, 100, 102, 104, 107, 110, 111, 113, 115, 116, 117, 120, 122, 125, 126, 127, 129, 137, 140, 145, 148, 151, 155, 169, 178, 185, 187, 188, 190, 192, 194, 195, 197, 201, 203, 206, 213, 218, 227, 232, 243, 247, 257, 260, 271, 274, 276, 280, 294, 302, 315]	[3, 10, 11, 21, 34, 39, 48, 59, 64, 70, 76, 81, 95, 99, 102, 104, 107, 109, 111, 112, 114, 116, 117, 119, 121, 125, 126, 127, 128, 136, 139, 144, 147, 150, 154, 168, 177, 184, 186, 188, 190, 192, 194, 195, 196, 201, 202, 205, 212, 217, 226, 231, 242, 246, 256, 259, 270, 274, 276, 279, 293, 301, 315, 316]	['The', 'single', '-', 'nucleotide', 'polymorphism', 'most', 'strongly', 'associated', 'with', 'lower', 'serum', 'iron', 'concentration', 'was', 'rs4820268', '(', 'P', '=', '5.12', '×', '10−9', ')', ',', 'located', 'in', 'exon', '13', 'of', 'the', 'transmembrane', 'protease', 'serine', '6', '(', 'TMPRSS6', ')', 'gene', ',', 'an', 'enzyme', 'that', 'promotes', 'iron', 'absorption', 'and', 'recycling', 'by', 'inhibiting', 'hepcidin', 'antimicrobial', 'peptide', 'transcription', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The serine protease TMPRSS6 is required to sense iron deficiency.	[('PMC2803694', 'F19002', 4, 19, 'serine protease')]	['The', 'serine', 'protease', 'TM', '##PR', '##SS', '##6', 'is', 'required', 'to', 'sense', 'iron', 'deficiency', '.']	[0, 4, 11, 20, 22, 24, 26, 28, 31, 40, 43, 49, 54, 64]	[3, 10, 19, 22, 24, 26, 27, 30, 39, 42, 48, 53, 64, 65]	['The', 'serine', 'protease', 'TMPRSS6', 'is', 'required', 'to', 'sense', 'iron', 'deficiency', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.	[('PMC2803694', 'F20002', 4, 32, 'serine protease matriptase-2')]	['The', 'serine', 'protease', 'mat', '##rip', '##tase', '-', '2', '(', 'TM', '##PR', '##SS', '##6', ')', 'inhibits', 'hep', '##ci', '##din', 'activation', 'by', 'cle', '##aving', 'membrane', 'hem', '##oj', '##uv', '##elin', '.']	[0, 4, 11, 20, 23, 26, 30, 31, 33, 34, 36, 38, 40, 41, 43, 52, 55, 57, 61, 72, 75, 78, 84, 93, 96, 98, 100, 104]	[3, 10, 19, 23, 26, 30, 31, 32, 34, 36, 38, 40, 41, 42, 51, 55, 57, 60, 71, 74, 78, 83, 92, 96, 98, 100, 104, 105]	['The', 'serine', 'protease', 'matriptase-2', '(', 'TMPRSS6', ')', 'inhibits', 'hepcidin', 'activation', 'by', 'cleaving', 'membrane', 'hemojuvelin', '.']	[1, 1, 1, 5, 1, 4, 1, 1, 3, 1, 1, 2, 1, 4, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A common polymorphism on chromosome 22 in the transmembrane serine protease 6 (TMPRSS6) or matriptase-2 gene reached genome-wide significance (supplemental Table 1; supplemental Figure 1).	[('PMC2803694', 'R00003', 46, 77, 'transmembrane serine protease 6'), ('PMC2803694', 'R00003', 91, 103, 'matriptase-2')]	['A', 'common', 'polymorphism', 'on', 'chromosome', '22', 'in', 'the', 'transmembrane', 'serine', 'protease', '6', '(', 'TM', '##PR', '##SS', '##6', ')', 'or', 'mat', '##rip', '##tase', '-', '2', 'gene', 'reached', 'genome', '-', 'wide', 'significance', '(', 'supplemental', 'Table', '1', ';', 'supplemental', 'Figure', '1', ')', '.']	[0, 2, 9, 22, 25, 36, 39, 42, 46, 60, 67, 76, 78, 79, 81, 83, 85, 86, 88, 91, 94, 97, 101, 102, 104, 109, 117, 123, 124, 129, 142, 143, 156, 162, 163, 165, 178, 185, 186, 187]	[1, 8, 21, 24, 35, 38, 41, 45, 59, 66, 75, 77, 79, 81, 83, 85, 86, 87, 90, 94, 97, 101, 102, 103, 108, 116, 123, 124, 128, 141, 143, 155, 161, 163, 164, 177, 184, 186, 187, 188]	['A', 'common', 'polymorphism', 'on', 'chromosome', '22', 'in', 'the', 'transmembrane', 'serine', 'protease', '6', '(', 'TMPRSS6', ')', 'or', 'matriptase-2', 'gene', 'reached', 'genome', '-', 'wide', 'significance', '(', 'supplemental', 'Table', '1', ';', 'supplemental', 'Figure', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several genes are required for appropriate HAMP expression, including the hemochromatosis gene, HFE24 and hemojuvelin (HFE2).25 The 2 leading TMPRSS6 SNPs are synonymous SNPs in the LDL-receptor class A-like (LDLRA) domain (rs4820268) and a missense SNP within the trypsin-like serine protease domain (rs855791).	[('PMC2803694', 'R02001', 278, 293, 'serine protease')]	['Several', 'genes', 'are', 'required', 'for', 'appropriate', 'HA', '##MP', 'expression', ',', 'including', 'the', 'hem', '##ochrom', '##atosis', 'gene', ',', 'HF', '##E', '##24', 'and', 'hem', '##oj', '##uv', '##elin', '(', 'HF', '##E', '##2', ')', '.', '25', 'The', '2', 'leading', 'TM', '##PR', '##SS', '##6', 'SNPs', 'are', 'syn', '##onymous', 'SNPs', 'in', 'the', 'LDL', '-', 'receptor', 'class', 'A', '-', 'like', '(', 'LDL', '##RA', ')', 'domain', '(', 'rs', '##48', '##202', '##68', ')', 'and', 'a', 'miss', '##ense', 'SNP', 'within', 'the', 'trypsin', '-', 'like', 'serine', 'protease', 'domain', '(', 'rs', '##85', '##57', '##91', ')', '.']	[0, 8, 14, 18, 27, 31, 43, 45, 48, 58, 60, 70, 74, 77, 83, 90, 94, 96, 98, 99, 102, 106, 109, 111, 113, 118, 119, 121, 122, 123, 124, 125, 128, 132, 134, 142, 144, 146, 148, 150, 155, 159, 162, 170, 175, 178, 182, 185, 186, 195, 201, 202, 203, 208, 209, 212, 214, 216, 223, 224, 226, 228, 231, 233, 235, 239, 241, 245, 250, 254, 261, 265, 272, 273, 278, 285, 294, 301, 302, 304, 306, 308, 310, 311]	[7, 13, 17, 26, 30, 42, 45, 47, 58, 59, 69, 73, 77, 83, 89, 94, 95, 98, 99, 101, 105, 109, 111, 113, 117, 119, 121, 122, 123, 124, 125, 127, 131, 133, 141, 144, 146, 148, 149, 154, 158, 162, 169, 174, 177, 181, 185, 186, 194, 200, 202, 203, 207, 209, 212, 214, 215, 222, 224, 226, 228, 231, 233, 234, 238, 240, 245, 249, 253, 260, 264, 272, 273, 277, 284, 293, 300, 302, 304, 306, 308, 310, 311, 312]	['Several', 'genes', 'are', 'required', 'for', 'appropriate', 'HAMP', 'expression', ',', 'including', 'the', 'hemochromatosis', 'gene', ',', 'HFE24', 'and', 'hemojuvelin', '(HFE2).25', 'The', '2', 'leading', 'TMPRSS6', 'SNPs', 'are', 'synonymous', 'SNPs', 'in', 'the', 'LDL-receptor', 'class', 'A', '-', 'like', '(', 'LDLRA', ')', 'domain', '(', 'rs4820268', ')', 'and', 'a', 'missense', 'SNP', 'within', 'the', 'trypsin', '-', 'like', 'serine', 'protease', 'domain', '(', 'rs855791', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 3, 1, 4, 7, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
GSTP1, a glutathione-S-transferase isoenzyme involved in HNE conjugation [34, 35], was induced in lung tissue of smokers whereas other GSTs, GSTA2 and GSTM1, showed no difference in expression levels between smokers and nonsmokers [36].	[('PMC2818256', 'D03003', 9, 34, 'glutathione-S-transferase')]	['GST', '##P', '##1', ',', 'a', 'glutathione', '-', 'S', '-', 'transfer', '##ase', 'iso', '##enzyme', 'involved', 'in', 'HN', '##E', 'conjugation', '[', '34', ',', '35', ']', ',', 'was', 'induced', 'in', 'lung', 'tissue', 'of', 'smokers', 'whereas', 'other', 'GST', '##s', ',', 'GST', '##A', '##2', 'and', 'GST', '##M', '##1', ',', 'showed', 'no', 'difference', 'in', 'expression', 'levels', 'between', 'smokers', 'and', 'nons', '##mo', '##kers', '[', '36', ']', '.']	[0, 3, 4, 5, 7, 9, 20, 21, 22, 23, 31, 35, 38, 45, 54, 57, 59, 61, 73, 74, 76, 78, 80, 81, 83, 87, 95, 98, 103, 110, 113, 121, 129, 135, 138, 139, 141, 144, 145, 147, 151, 154, 155, 156, 158, 165, 168, 179, 182, 193, 200, 208, 216, 220, 224, 226, 231, 232, 234, 235]	[3, 4, 5, 6, 8, 20, 21, 22, 23, 31, 34, 38, 44, 53, 56, 59, 60, 72, 74, 76, 77, 80, 81, 82, 86, 94, 97, 102, 109, 112, 120, 128, 134, 138, 139, 140, 144, 145, 146, 150, 154, 155, 156, 157, 164, 167, 178, 181, 192, 199, 207, 215, 219, 224, 226, 230, 232, 234, 235, 236]	['GSTP1', ',', 'a', 'glutathione-S-transferase', 'isoenzyme', 'involved', 'in', 'HNE', 'conjugation', '[', '34', ',', '35', ']', ',', 'was', 'induced', 'in', 'lung', 'tissue', 'of', 'smokers', 'whereas', 'other', 'GSTs', ',', 'GSTA2', 'and', 'GSTM1', ',', 'showed', 'no', 'difference', 'in', 'expression', 'levels', 'between', 'smokers', 'and', 'nonsmokers', '[', '36', ']', '.']	[3, 1, 1, 6, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
On the other hand, genetic polymorphism of glutathione-S-transferase may affect gene expression if the mutation is located in the promoter region.	[('PMC2818256', 'D03004', 43, 68, 'glutathione-S-transferase')]	['On', 'the', 'other', 'hand', ',', 'genetic', 'polymorphism', 'of', 'glutathione', '-', 'S', '-', 'transfer', '##ase', 'may', 'affect', 'gene', 'expression', 'if', 'the', 'mutation', 'is', 'located', 'in', 'the', 'promoter', 'region', '.']	[0, 3, 7, 13, 17, 19, 27, 40, 43, 54, 55, 56, 57, 65, 69, 73, 80, 85, 96, 99, 103, 112, 115, 123, 126, 130, 139, 145]	[2, 6, 12, 17, 18, 26, 39, 42, 54, 55, 56, 57, 65, 68, 72, 79, 84, 95, 98, 102, 111, 114, 122, 125, 129, 138, 145, 146]	['On', 'the', 'other', 'hand', ',', 'genetic', 'polymorphism', 'of', 'glutathione-S-transferase', 'may', 'affect', 'gene', 'expression', 'if', 'the', 'mutation', 'is', 'located', 'in', 'the', 'promoter', 'region', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[37] studied single nucleotide polymorphisms (SNPs) of GSTA4, another glutathione-S-transferase that accepts HNE as a substrate [38].	[('PMC2818256', 'D03006', 70, 95, 'glutathione-S-transferase')]	['[', '37', ']', 'studied', 'single', 'nucleotide', 'polymorphisms', '(', 'SNPs', ')', 'of', 'GST', '##A', '##4', ',', 'another', 'glutathione', '-', 'S', '-', 'transfer', '##ase', 'that', 'accepts', 'HN', '##E', 'as', 'a', 'substrate', '[', '38', ']', '.']	[0, 1, 3, 5, 13, 20, 31, 45, 46, 50, 52, 55, 58, 59, 60, 62, 70, 81, 82, 83, 84, 92, 96, 101, 109, 111, 113, 116, 118, 128, 129, 131, 132]	[1, 3, 4, 12, 19, 30, 44, 46, 50, 51, 54, 58, 59, 60, 61, 69, 81, 82, 83, 84, 92, 95, 100, 108, 111, 112, 115, 117, 127, 129, 131, 132, 133]	['[', '37', ']', 'studied', 'single', 'nucleotide', 'polymorphisms', '(', 'SNPs', ')', 'of', 'GSTA4', ',', 'another', 'glutathione-S-transferase', 'that', 'accepts', 'HNE', 'as', 'a', 'substrate', '[', '38', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The low LPO-MA excretion in nine smokers may also be due to smoking-induced phase I metabolism, resulting in enhanced conversion of HNE and ONE into DHN which is not a glutathione-S-transferase substrate.	[('PMC2818256', 'D04000', 168, 193, 'glutathione-S-transferase')]	['The', 'low', 'LP', '##O', '-', 'MA', 'excretion', 'in', 'nine', 'smokers', 'may', 'also', 'be', 'due', 'to', 'smoking', '-', 'induced', 'phase', 'I', 'metabolism', ',', 'resulting', 'in', 'enhanced', 'conversion', 'of', 'HN', '##E', 'and', 'ONE', 'into', 'DH', '##N', 'which', 'is', 'not', 'a', 'glutathione', '-', 'S', '-', 'transfer', '##ase', 'substrate', '.']	[0, 4, 8, 10, 11, 12, 15, 25, 28, 33, 41, 45, 50, 53, 57, 60, 67, 68, 76, 82, 84, 94, 96, 106, 109, 118, 129, 132, 134, 136, 140, 144, 149, 151, 153, 159, 162, 166, 168, 179, 180, 181, 182, 190, 194, 203]	[3, 7, 10, 11, 12, 14, 24, 27, 32, 40, 44, 49, 52, 56, 59, 67, 68, 75, 81, 83, 94, 95, 105, 108, 117, 128, 131, 134, 135, 139, 143, 148, 151, 152, 158, 161, 165, 167, 179, 180, 181, 182, 190, 193, 203, 204]	['The', 'low', 'LPO-MA', 'excretion', 'in', 'nine', 'smokers', 'may', 'also', 'be', 'due', 'to', 'smoking', '-', 'induced', 'phase', 'I', 'metabolism', ',', 'resulting', 'in', 'enhanced', 'conversion', 'of', 'HNE', 'and', 'ONE', 'into', 'DHN', 'which', 'is', 'not', 'a', 'glutathione-S-transferase', 'substrate', '.']	[1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Aldo-keto reductase 1B10 (AKR1B10) is known to reduce HNE to DHN and to reduce ONE to ONO [41].	[('PMC2818256', 'D04001', 0, 24, 'Aldo-keto reductase 1B10')]	['Al', '##do', '-', 'ket', '##o', 'reductase', '1', '##B', '##10', '(', 'AK', '##R', '##1', '##B', '##10', ')', 'is', 'known', 'to', 'reduce', 'HN', '##E', 'to', 'DH', '##N', 'and', 'to', 'reduce', 'ONE', 'to', 'ON', '##O', '[', '41', ']', '.']	[0, 2, 4, 5, 8, 10, 20, 21, 22, 25, 26, 28, 29, 30, 31, 33, 35, 38, 44, 47, 54, 56, 58, 61, 63, 65, 69, 72, 79, 83, 86, 88, 90, 91, 93, 94]	[2, 4, 5, 8, 9, 19, 21, 22, 24, 26, 28, 29, 30, 31, 33, 34, 37, 43, 46, 53, 56, 57, 60, 63, 64, 68, 71, 78, 82, 85, 88, 89, 91, 93, 94, 95]	['Aldo', '-', 'keto', 'reductase', '1B10', '(', 'AKR1B10', ')', 'is', 'known', 'to', 'reduce', 'HNE', 'to', 'DHN', 'and', 'to', 'reduce', 'ONE', 'to', 'ONO', '[', '41', ']', '.']	[2, 1, 2, 1, 3, 1, 5, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[43], would direct the metabolism of HNE to DHN, resulting in decreased formation of glutathione-S-transferase-mediated metabolites and MA conjugates (Scheme 1).	[('PMC2818256', 'D04004', 85, 110, 'glutathione-S-transferase')]	['[', '43', ']', ',', 'would', 'direct', 'the', 'metabolism', 'of', 'HN', '##E', 'to', 'DH', '##N', ',', 'resulting', 'in', 'decreased', 'formation', 'of', 'glutathione', '-', 'S', '-', 'transfer', '##ase', '-', 'mediated', 'metabolites', 'and', 'MA', 'conjugates', '(', 'Scheme', '1', ')', '.']	[0, 1, 3, 4, 6, 12, 19, 23, 34, 37, 39, 41, 44, 46, 47, 49, 59, 62, 72, 82, 85, 96, 97, 98, 99, 107, 110, 111, 120, 132, 136, 139, 150, 151, 158, 159, 160]	[1, 3, 4, 5, 11, 18, 22, 33, 36, 39, 40, 43, 46, 47, 48, 58, 61, 71, 81, 84, 96, 97, 98, 99, 107, 110, 111, 119, 131, 135, 138, 149, 151, 157, 159, 160, 161]	['[', '43', ']', ',', 'would', 'direct', 'the', 'metabolism', 'of', 'HNE', 'to', 'DHN', ',', 'resulting', 'in', 'decreased', 'formation', 'of', 'glutathione-S-transferase', '-', 'mediated', 'metabolites', 'and', 'MA', 'conjugates', '(', 'Scheme', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The oxidation of alpha-beta unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases.	[('PMC2818256', 'F09001', 94, 117, 'aldehyde dehydrogenases')]	['The', 'oxidation', 'of', 'alpha', '-', 'beta', 'unsaturated', 'ald', '##eh', '##yd', '##ic', 'products', 'of', 'lipid', 'peroxidation', 'by', 'rat', 'liver', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', '##s', '.']	[0, 4, 14, 17, 22, 23, 28, 40, 43, 45, 47, 50, 59, 62, 68, 81, 84, 88, 94, 97, 99, 101, 103, 116, 117]	[3, 13, 16, 22, 23, 27, 39, 43, 45, 47, 49, 58, 61, 67, 80, 83, 87, 93, 97, 99, 101, 102, 116, 117, 118]	['The', 'oxidation', 'of', 'alpha', '-', 'beta', 'unsaturated', 'aldehydic', 'products', 'of', 'lipid', 'peroxidation', 'by', 'rat', 'liver', 'aldehyde', 'dehydrogenases', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O']
Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal.	[('PMC2818256', 'F10001', 34, 56, 'aldehyde dehydrogenase')]	['Inhibition', 'of', 'human', 'mitochondrial', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', 'by', '4', '-', 'hydroxy', '##non', '-', '2', '-', 'en', '##al', 'and', '4', '-', 'ox', '##ono', '##n', '-', '2', '-', 'en', '##al', '.']	[0, 11, 14, 20, 34, 37, 39, 41, 43, 57, 60, 61, 62, 69, 72, 73, 74, 75, 77, 80, 84, 85, 86, 88, 91, 92, 93, 94, 95, 97, 99]	[10, 13, 19, 33, 37, 39, 41, 42, 56, 59, 61, 62, 69, 72, 73, 74, 75, 77, 79, 83, 85, 86, 88, 91, 92, 93, 94, 95, 97, 99, 100]	['Inhibition', 'of', 'human', 'mitochondrial', 'aldehyde', 'dehydrogenase', 'by', '4-hydroxynon-2-enal', 'and', '4-oxonon-2-enal', '.']	[1, 1, 1, 1, 4, 1, 1, 9, 1, 10, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase.	[('PMC2818256', 'F11001', 94, 110, 'aldose reductase')]	['Metabolism', 'of', 'lipid', 'peroxidation', 'product', ',', '4', '-', 'hydroxy', '##non', '##ena', '##l', '(', 'HN', '##E', ')', 'in', 'rat', 'erythrocytes', ':', 'role', 'of', 'ald', '##ose', 'reductase', '.']	[0, 11, 14, 20, 33, 40, 42, 43, 44, 51, 54, 57, 59, 60, 62, 63, 65, 68, 72, 84, 86, 91, 94, 97, 101, 110]	[10, 13, 19, 32, 40, 41, 43, 44, 51, 54, 57, 58, 60, 62, 63, 64, 67, 71, 84, 85, 90, 93, 97, 100, 110, 111]	['Metabolism', 'of', 'lipid', 'peroxidation', 'product', ',', '4-hydroxynonenal', '(', 'HNE', ')', 'in', 'rat', 'erythrocytes', ':', 'role', 'of', 'aldose', 'reductase', '.']	[1, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Aldose reductase catalyzes reduction of the lipid peroxidation product 4-oxonon-2-enal.	[('PMC2818256', 'F13001', 0, 16, 'Aldose reductase')]	['Al', '##dose', 'reductase', 'cataly', '##zes', 'reduction', 'of', 'the', 'lipid', 'peroxidation', 'product', '4', '-', 'ox', '##ono', '##n', '-', '2', '-', 'en', '##al', '.']	[0, 2, 7, 17, 23, 27, 37, 40, 44, 50, 63, 71, 72, 73, 75, 78, 79, 80, 81, 82, 84, 86]	[2, 6, 16, 23, 26, 36, 39, 43, 49, 62, 70, 72, 73, 75, 78, 79, 80, 81, 82, 84, 86, 87]	['Aldose', 'reductase', 'catalyzes', 'reduction', 'of', 'the', 'lipid', 'peroxidation', 'product', '4-oxonon-2-enal', '.']	[2, 1, 2, 1, 1, 1, 1, 1, 1, 10, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[16] Agianian B, Tucker PA, Schouten A, Leonard K, Bullard B, Gros P. Structure of a Drosophila sigma class glutathione S-transferase reveals a novel active site topography suited for lipid peroxidation products.	[('PMC2818256', 'F15000', 108, 133, 'glutathione S-transferase')]	['[', '16', ']', 'Ag', '##iani', '##an', 'B', ',', 'Tu', '##ck', '##er', 'PA', ',', 'Sch', '##out', '##en', 'A', ',', 'Leon', '##ard', 'K', ',', 'Bull', '##ard', 'B', ',', 'Gro', '##s', 'P', '.', 'Structure', 'of', 'a', 'Drosophila', 'sigma', 'class', 'glutathione', 'S', '-', 'transfer', '##ase', 'reveals', 'a', 'novel', 'active', 'site', 'topography', 'suited', 'for', 'lipid', 'peroxidation', 'products', '.']	[0, 1, 3, 5, 7, 11, 14, 15, 17, 19, 21, 24, 26, 28, 31, 34, 37, 38, 40, 44, 48, 49, 51, 55, 59, 60, 62, 65, 67, 68, 70, 80, 83, 85, 96, 102, 108, 120, 121, 122, 130, 134, 142, 144, 150, 157, 162, 173, 180, 184, 190, 203, 211]	[1, 3, 4, 7, 11, 13, 15, 16, 19, 21, 23, 26, 27, 31, 34, 36, 38, 39, 44, 47, 49, 50, 55, 58, 60, 61, 65, 66, 68, 69, 79, 82, 84, 95, 101, 107, 119, 121, 122, 130, 133, 141, 143, 149, 156, 161, 172, 179, 183, 189, 202, 211, 212]	['[', '16', ']', 'Agianian', 'B', ',', 'Tucker', 'PA', ',', 'Schouten', 'A', ',', 'Leonard', 'K', ',', 'Bullard', 'B', ',', 'Gros', 'P', '.', 'Structure', 'of', 'a', 'Drosophila', 'sigma', 'class', 'glutathione', 'S-transferase', 'reveals', 'a', 'novel', 'active', 'site', 'topography', 'suited', 'for', 'lipid', 'peroxidation', 'products', '.']	[1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate.	[('PMC2818256', 'F16001', 135, 163, 'glutathione S-transferase A4')]	['Gen', '##otoxicity', 'of', '4', '-', 'hydroxy', '-', '2', '-', 'none', '##nal', 'in', 'human', 'colon', 'tumor', 'cells', 'is', 'associated', 'with', 'cellular', 'levels', 'of', 'glutathione', 'and', 'the', 'modulation', 'of', 'glutathione', 'S', '-', 'transfer', '##ase', 'A', '##4', 'expression', 'by', 'but', '##yrate', '.']	[0, 3, 13, 16, 17, 18, 25, 26, 27, 28, 32, 36, 39, 45, 51, 57, 63, 66, 77, 82, 91, 98, 101, 113, 117, 121, 132, 135, 147, 148, 149, 157, 161, 162, 164, 175, 178, 181, 186]	[3, 12, 15, 17, 18, 25, 26, 27, 28, 32, 35, 38, 44, 50, 56, 62, 65, 76, 81, 90, 97, 100, 112, 116, 120, 131, 134, 146, 148, 149, 157, 160, 162, 163, 174, 177, 181, 186, 187]	['Genotoxicity', 'of', '4-hydroxy-2-nonenal', 'in', 'human', 'colon', 'tumor', 'cells', 'is', 'associated', 'with', 'cellular', 'levels', 'of', 'glutathione', 'and', 'the', 'modulation', 'of', 'glutathione', 'S-transferase', 'A4', 'expression', 'by', 'butyrate', '.']	[2, 1, 8, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Several glutathione S-transferase isozymes that protect against oxidative injury are expressed in human liver mitochondria.	[('PMC2818256', 'F33001', 8, 33, 'glutathione S-transferase')]	['Several', 'glutathione', 'S', '-', 'transfer', '##ase', 'iso', '##zymes', 'that', 'protect', 'against', 'oxidative', 'injury', 'are', 'expressed', 'in', 'human', 'liver', 'mitochondria', '.']	[0, 8, 20, 21, 22, 30, 34, 37, 43, 48, 56, 64, 74, 81, 85, 95, 98, 104, 110, 122]	[7, 19, 21, 22, 30, 33, 37, 42, 47, 55, 63, 73, 80, 84, 94, 97, 103, 109, 122, 123]	['Several', 'glutathione', 'S-transferase', 'isozymes', 'that', 'protect', 'against', 'oxidative', 'injury', 'are', 'expressed', 'in', 'human', 'liver', 'mitochondria', '.']	[1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glutathione transferases.	[('PMC2818256', 'F34001', 0, 24, 'Glutathione transferases')]	['Glut', '##athione', 'transfer', '##ases', '.']	[0, 4, 12, 20, 24]	[4, 11, 20, 24, 25]	['Glutathione', 'transferases', '.']	[2, 2, 1]	['B', 'I', 'I', 'E', 'O']
[38] Hubatsch I, Ridderstrom M, Mannervik B. Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation.	[('PMC2818256', 'F37000', 51, 79, 'glutathione transferase A4-4')]	['[', '38', ']', 'Hub', '##ats', '##ch', 'I', ',', 'Ri', '##dd', '##ers', '##trom', 'M', ',', 'Mann', '##erv', '##ik', 'B', '.', 'Human', 'glutathione', 'transfer', '##ase', 'A', '##4', '-', '4', ':', 'an', 'alpha', 'class', 'enzyme', 'with', 'high', 'catalytic', 'efficiency', 'in', 'the', 'conjugation', 'of', '4', '-', 'hydroxy', '##non', '##ena', '##l', 'and', 'other', 'gen', '##otoxic', 'products', 'of', 'lipid', 'peroxidation', '.']	[0, 1, 3, 5, 8, 11, 14, 15, 17, 19, 21, 24, 29, 30, 32, 36, 39, 42, 43, 45, 51, 63, 71, 75, 76, 77, 78, 79, 81, 84, 90, 96, 103, 108, 113, 123, 134, 137, 141, 153, 156, 157, 158, 165, 168, 171, 173, 177, 183, 186, 193, 202, 205, 211, 223]	[1, 3, 4, 8, 11, 13, 15, 16, 19, 21, 24, 28, 30, 31, 36, 39, 41, 43, 44, 50, 62, 71, 74, 76, 77, 78, 79, 80, 83, 89, 95, 102, 107, 112, 122, 133, 136, 140, 152, 155, 157, 158, 165, 168, 171, 172, 176, 182, 186, 192, 201, 204, 210, 223, 224]	['[', '38', ']', 'Hubatsch', 'I', ',', 'Ridderstrom', 'M', ',', 'Mannervik', 'B', '.', 'Human', 'glutathione', 'transferase', 'A4-4', ':', 'an', 'alpha', 'class', 'enzyme', 'with', 'high', 'catalytic', 'efficiency', 'in', 'the', 'conjugation', 'of', '4-hydroxynonenal', 'and', 'other', 'genotoxic', 'products', 'of', 'lipid', 'peroxidation', '.']	[1, 1, 1, 3, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[41] Martin HJ, Maser E. Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes.	[('PMC2818256', 'F40000', 39, 58, 'aldo-keto-reductase')]	['[', '41', ']', 'Martin', 'HJ', ',', 'Mas', '##er', 'E', '.', 'Role', 'of', 'human', 'ald', '##o', '-', 'ket', '##o', '-', 'reductase', 'AK', '##R', '##1', '##B', '##10', 'in', 'the', 'protection', 'against', 'toxic', 'ald', '##eh', '##yd', '##es', '.']	[0, 1, 3, 5, 12, 14, 16, 19, 22, 23, 25, 30, 33, 39, 42, 43, 44, 47, 48, 49, 59, 61, 62, 63, 64, 67, 70, 74, 85, 93, 99, 102, 104, 106, 108]	[1, 3, 4, 11, 14, 15, 19, 21, 23, 24, 29, 32, 38, 42, 43, 44, 47, 48, 49, 58, 61, 62, 63, 64, 66, 69, 73, 84, 92, 98, 102, 104, 106, 108, 109]	['[', '41', ']', 'Martin', 'HJ', ',', 'Maser', 'E', '.', 'Role', 'of', 'human', 'aldo', '-', 'keto', '-', 'reductase', 'AKR1B10', 'in', 'the', 'protection', 'against', 'toxic', 'aldehydes', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[42] Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, Shibahara J, Taniguchi H, Ishikawa S, Ito H, Yamamoto S, Iwanari H, Hironaka M, Ishikawa Y, Niki T, Sohara Y, Kodama T, Nishimura M, Fukayama M, Dosaka-Akita H, Aburatani H. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers’ non-small cell lung carcinomas.	[('PMC2818256', 'F41000', 259, 278, 'aldo-keto reductase')]	['[', '42', ']', 'Fuk', '##um', '##oto', 'S', ',', 'Yam', '##auc', '##hi', 'N', ',', 'Mor', '##igu', '##chi', 'H', ',', 'Hi', '##pp', '##o', 'Y', ',', 'Wat', '##anabe', 'A', ',', 'Shi', '##ba', '##har', '##a', 'J', ',', 'Tan', '##igu', '##chi', 'H', ',', 'Ish', '##ikawa', 'S', ',', 'Ito', 'H', ',', 'Yam', '##amoto', 'S', ',', 'Iw', '##ana', '##ri', 'H', ',', 'Hir', '##ona', '##ka', 'M', ',', 'Ish', '##ikawa', 'Y', ',', 'Nik', '##i', 'T', ',', 'So', '##har', '##a', 'Y', ',', 'Ko', '##dam', '##a', 'T', ',', 'Nish', '##imura', 'M', ',', 'Fuk', '##ayama', 'M', ',', 'Do', '##sa', '##ka', '-', 'Ak', '##ita', 'H', ',', 'Ab', '##ura', '##tan', '##i', 'H', '.', 'Overexpression', 'of', 'the', 'ald', '##o', '-', 'ket', '##o', 'reductase', 'family', 'protein', 'AK', '##R', '##1', '##B', '##10', 'is', 'highly', 'correlated', 'with', 'smokers', '’', 'non', '-', 'small', 'cell', 'lung', 'carcinomas', '.']	[0, 1, 3, 5, 8, 10, 14, 15, 17, 20, 23, 26, 27, 29, 32, 35, 39, 40, 42, 44, 46, 48, 49, 51, 54, 60, 61, 63, 66, 68, 71, 73, 74, 76, 79, 82, 86, 87, 89, 92, 98, 99, 101, 105, 106, 108, 111, 117, 118, 120, 122, 125, 128, 129, 131, 134, 137, 140, 141, 143, 146, 152, 153, 155, 158, 160, 161, 163, 165, 168, 170, 171, 173, 175, 178, 180, 181, 183, 187, 193, 194, 196, 199, 205, 206, 208, 210, 212, 214, 215, 217, 221, 222, 224, 226, 229, 232, 234, 235, 237, 252, 255, 259, 262, 263, 264, 267, 269, 279, 286, 294, 296, 297, 298, 299, 302, 305, 312, 323, 328, 335, 337, 340, 341, 347, 352, 357, 367]	[1, 3, 4, 8, 10, 13, 15, 16, 20, 23, 25, 27, 28, 32, 35, 38, 40, 41, 44, 46, 47, 49, 50, 54, 59, 61, 62, 66, 68, 71, 72, 74, 75, 79, 82, 85, 87, 88, 92, 97, 99, 100, 104, 106, 107, 111, 116, 118, 119, 122, 125, 127, 129, 130, 134, 137, 139, 141, 142, 146, 151, 153, 154, 158, 159, 161, 162, 165, 168, 169, 171, 172, 175, 178, 179, 181, 182, 187, 192, 194, 195, 199, 204, 206, 207, 210, 212, 214, 215, 217, 220, 222, 223, 226, 229, 232, 233, 235, 236, 251, 254, 258, 262, 263, 264, 267, 268, 278, 285, 293, 296, 297, 298, 299, 301, 304, 311, 322, 327, 335, 336, 340, 341, 346, 351, 356, 367, 368]	['[', '42', ']', 'Fukumoto', 'S', ',', 'Yamauchi', 'N', ',', 'Moriguchi', 'H', ',', 'Hippo', 'Y', ',', 'Watanabe', 'A', ',', 'Shibahara', 'J', ',', 'Taniguchi', 'H', ',', 'Ishikawa', 'S', ',', 'Ito', 'H', ',', 'Yamamoto', 'S', ',', 'Iwanari', 'H', ',', 'Hironaka', 'M', ',', 'Ishikawa', 'Y', ',', 'Niki', 'T', ',', 'Sohara', 'Y', ',', 'Kodama', 'T', ',', 'Nishimura', 'M', ',', 'Fukayama', 'M', ',', 'Dosaka-Akita', 'H', ',', 'Aburatani', 'H', '.', 'Overexpression', 'of', 'the', 'aldo', '-', 'keto', 'reductase', 'family', 'protein', 'AKR1B10', 'is', 'highly', 'correlated', 'with', 'smokers', '’', 'non', '-', 'small', 'cell', 'lung', 'carcinomas', '.']	[1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 4, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 6, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[43] Nagaraj NS, Beckers S, Mensah JK, Waigel S, Vigneswaran N, Zacharias W. Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells.	[('PMC2818256', 'F42000', 133, 153, 'aldo-keto reductases')]	['[', '43', ']', 'Nag', '##araj', 'NS', ',', 'Becker', '##s', 'S', ',', 'Men', '##sa', '##h', 'JK', ',', 'Wa', '##ige', '##l', 'S', ',', 'Vi', '##gn', '##es', '##war', '##an', 'N', ',', 'Z', '##ach', '##aria', '##s', 'W', '.', 'Ci', '##gar', '##ette', 'smoke', 'condens', '##ate', 'induces', 'cytochrome', '##s', 'P', '##450', 'and', 'ald', '##o', '-', 'ket', '##o', 'reductase', '##s', 'in', 'oral', 'cancer', 'cells', '.']	[0, 1, 3, 5, 8, 13, 15, 17, 23, 25, 26, 28, 31, 33, 35, 37, 39, 41, 44, 46, 47, 49, 51, 53, 55, 58, 61, 62, 64, 65, 68, 72, 74, 75, 77, 79, 82, 87, 93, 100, 104, 112, 122, 124, 125, 129, 133, 136, 137, 138, 141, 143, 152, 154, 157, 162, 169, 174]	[1, 3, 4, 8, 12, 15, 16, 23, 24, 26, 27, 31, 33, 34, 37, 38, 41, 44, 45, 47, 48, 51, 53, 55, 58, 60, 62, 63, 65, 68, 72, 73, 75, 76, 79, 82, 86, 92, 100, 103, 111, 122, 123, 125, 128, 132, 136, 137, 138, 141, 142, 152, 153, 156, 161, 168, 174, 175]	['[', '43', ']', 'Nagaraj', 'NS', ',', 'Beckers', 'S', ',', 'Mensah', 'JK', ',', 'Waigel', 'S', ',', 'Vigneswaran', 'N', ',', 'Zacharias', 'W', '.', 'Cigarette', 'smoke', 'condensate', 'induces', 'cytochromes', 'P450', 'and', 'aldo', '-', 'keto', 'reductases', 'in', 'oral', 'cancer', 'cells', '.']	[1, 1, 1, 2, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 5, 1, 1, 4, 1, 1, 3, 1, 2, 1, 2, 2, 1, 2, 1, 2, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
HNE, ONE, and their phase I metabolites have also been shown to undergo phase II metabolism, forming Michael-type conjugates with glutathione (GSH) [2], a reaction mediated by glutathione S-transferase (glutathione-S-transferase)	[('PMC2818256', 'I00010', 176, 201, 'glutathione S-transferase'), ('PMC2818256', 'I00010', 203, 228, 'glutathione-S-transferase')]	['HN', '##E', ',', 'ONE', ',', 'and', 'their', 'phase', 'I', 'metabolites', 'have', 'also', 'been', 'shown', 'to', 'undergo', 'phase', 'II', 'metabolism', ',', 'forming', 'Michael', '-', 'type', 'conjugates', 'with', 'glutathione', '(', 'GSH', ')', '[', '2', ']', ',', 'a', 'reaction', 'mediated', 'by', 'glutathione', 'S', '-', 'transfer', '##ase', '(', 'glutathione', '-', 'S', '-', 'transfer', '##ase', ')']	[0, 2, 3, 5, 8, 10, 14, 20, 26, 28, 40, 45, 50, 55, 61, 64, 72, 78, 81, 91, 93, 101, 108, 109, 114, 125, 130, 142, 143, 146, 148, 149, 150, 151, 153, 155, 164, 173, 176, 188, 189, 190, 198, 202, 203, 214, 215, 216, 217, 225, 228]	[2, 3, 4, 8, 9, 13, 19, 25, 27, 39, 44, 49, 54, 60, 63, 71, 77, 80, 91, 92, 100, 108, 109, 113, 124, 129, 141, 143, 146, 147, 149, 150, 151, 152, 154, 163, 172, 175, 187, 189, 190, 198, 201, 203, 214, 215, 216, 217, 225, 228, 229]	['HNE', ',', 'ONE', ',', 'and', 'their', 'phase', 'I', 'metabolites', 'have', 'also', 'been', 'shown', 'to', 'undergo', 'phase', 'II', 'metabolism', ',', 'forming', 'Michael', '-', 'type', 'conjugates', 'with', 'glutathione', '(', 'GSH', ')', '[', '2', ']', ',', 'a', 'reaction', 'mediated', 'by', 'glutathione', 'S-transferase', '(', 'glutathione-S-transferase', ')']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 6, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O']
A conspicuous finding of this comparative analysis was the presence of host cell-specific (LIM1215 exosome) proteins such as A33, cadherin-17, carcinoembryonic antigen, epithelial cell surface antigen (EpCAM), proliferating cell nuclear antigen, epidermal growth factor receptor, mucin 13, misshapen-like kinase 1, keratin 18, mitogen-activated protein kinase 4, claudins (1, 3, and 7), centrosomal protein 55 kDa, and ephrin-B1 and -B2.	[('PMC2830834', 'A00005', 290, 313, 'misshapen-like kinase 1'), ('PMC2830834', 'A00005', 327, 361, 'mitogen-activated protein kinase 4')]	['A', 'cons', '##pic', '##uous', 'finding', 'of', 'this', 'comparative', 'analysis', 'was', 'the', 'presence', 'of', 'host', 'cell', '-', 'specific', '(', 'LI', '##M', '##121', '##5', 'ex', '##osome', ')', 'proteins', 'such', 'as', 'A', '##33', ',', 'cad', '##her', '##in', '-', '17', ',', 'carcin', '##oe', '##mb', '##ry', '##onic', 'antigen', ',', 'epithelial', 'cell', 'surface', 'antigen', '(', 'Ep', '##CAM', ')', ',', 'proliferating', 'cell', 'nuclear', 'antigen', ',', 'epidermal', 'growth', 'factor', 'receptor', ',', 'muc', '##in', '13', ',', 'miss', '##ha', '##pen', '-', 'like', 'kinase', '1', ',', 'keratin', '18', ',', 'mitogen', '-', 'activated', 'protein', 'kinase', '4', ',', 'cl', '##aud', '##ins', '(', '1', ',', '3', ',', 'and', '7', ')', ',', 'centr', '##osomal', 'protein', '55', 'kDa', ',', 'and', 'ep', '##hr', '##in', '-', 'B', '##1', 'and', '-', 'B', '##2', '.']	[0, 2, 6, 9, 14, 22, 25, 30, 42, 51, 55, 59, 68, 71, 76, 80, 81, 90, 91, 93, 94, 97, 99, 101, 106, 108, 117, 122, 125, 126, 128, 130, 133, 136, 138, 139, 141, 143, 149, 151, 153, 155, 160, 167, 169, 180, 185, 193, 201, 202, 204, 207, 208, 210, 224, 229, 237, 244, 246, 256, 263, 270, 278, 280, 283, 286, 288, 290, 294, 296, 299, 300, 305, 312, 313, 315, 323, 325, 327, 334, 335, 345, 353, 360, 361, 363, 365, 368, 372, 373, 374, 376, 377, 379, 383, 384, 385, 387, 392, 399, 407, 410, 413, 415, 419, 421, 423, 425, 426, 427, 429, 433, 434, 435, 436]	[1, 6, 9, 13, 21, 24, 29, 41, 50, 54, 58, 67, 70, 75, 80, 81, 89, 91, 93, 94, 97, 98, 101, 106, 107, 116, 121, 124, 126, 128, 129, 133, 136, 138, 139, 141, 142, 149, 151, 153, 155, 159, 167, 168, 179, 184, 192, 200, 202, 204, 207, 208, 209, 223, 228, 236, 244, 245, 255, 262, 269, 278, 279, 283, 285, 288, 289, 294, 296, 299, 300, 304, 311, 313, 314, 322, 325, 326, 334, 335, 344, 352, 359, 361, 362, 365, 368, 371, 373, 374, 375, 377, 378, 382, 384, 385, 386, 392, 398, 406, 409, 413, 414, 418, 421, 423, 425, 426, 427, 428, 432, 434, 435, 436, 437]	['A', 'conspicuous', 'finding', 'of', 'this', 'comparative', 'analysis', 'was', 'the', 'presence', 'of', 'host', 'cell', '-', 'specific', '(', 'LIM1215', 'exosome', ')', 'proteins', 'such', 'as', 'A33', ',', 'cadherin-17', ',', 'carcinoembryonic', 'antigen', ',', 'epithelial', 'cell', 'surface', 'antigen', '(', 'EpCAM', ')', ',', 'proliferating', 'cell', 'nuclear', 'antigen', ',', 'epidermal', 'growth', 'factor', 'receptor', ',', 'mucin', '13', ',', 'misshapen', '-', 'like', 'kinase', '1', ',', 'keratin', '18', ',', 'mitogen', '-', 'activated', 'protein', 'kinase', '4', ',', 'claudins', '(', '1', ',', '3', ',', 'and', '7', ')', ',', 'centrosomal', 'protein', '55', 'kDa', ',', 'and', 'ephrin-B1', 'and', '-', 'B2', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 2, 1, 5, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 6, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, we report the presence of the enzyme phospholipid scramblase implicated in transbilayer lipid distribution membrane remodeling.	[('PMC2830834', 'A00006', 50, 73, 'phospholipid scramblase')]	['Furthermore', ',', 'we', 'report', 'the', 'presence', 'of', 'the', 'enzyme', 'phospholipid', 'scr', '##amb', '##las', '##e', 'implicated', 'in', 'trans', '##bil', '##ayer', 'lipid', 'distribution', 'membrane', 'remodeling', '.']	[0, 11, 13, 16, 23, 27, 36, 39, 43, 50, 63, 66, 69, 72, 74, 85, 88, 93, 96, 101, 107, 120, 129, 139]	[11, 12, 15, 22, 26, 35, 38, 42, 49, 62, 66, 69, 72, 73, 84, 87, 93, 96, 100, 106, 119, 128, 139, 140]	['Furthermore', ',', 'we', 'report', 'the', 'presence', 'of', 'the', 'enzyme', 'phospholipid', 'scramblase', 'implicated', 'in', 'transbilayer', 'lipid', 'distribution', 'membrane', 'remodeling', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The Rab GTPase family.	[('PMC2830834', 'F69002', 4, 14, 'Rab GTPase')]	['The', 'Rab', 'GTP', '##ase', 'family', '.']	[0, 4, 8, 11, 15, 21]	[3, 7, 11, 14, 21, 22]	['The', 'Rab', 'GTPase', 'family', '.']	[1, 1, 2, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O']
The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking.	[('PMC2830834', 'F70002', 13, 24, 'Rho GTPases')]	['The', 'atypical', 'Rho', 'GTP', '##ases', 'Mir', '##o', '-', '1', 'and', 'Mir', '##o', '-', '2', 'have', 'essential', 'roles', 'in', 'mitochondrial', 'trafficking', '.']	[0, 4, 13, 17, 20, 25, 28, 29, 30, 32, 36, 39, 40, 41, 43, 48, 58, 64, 67, 81, 92]	[3, 12, 16, 20, 24, 28, 29, 30, 31, 35, 39, 40, 41, 42, 47, 57, 63, 66, 80, 92, 93]	['The', 'atypical', 'Rho', 'GTPases', 'Miro-1', 'and', 'Miro-2', 'have', 'essential', 'roles', 'in', 'mitochondrial', 'trafficking', '.']	[1, 1, 1, 2, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Atypical Rho GTPases have roles in mitochondrial homeostasis and apoptosis.	[('PMC2830834', 'F71002', 9, 20, 'Rho GTPases')]	['At', '##yp', '##ical', 'Rho', 'GTP', '##ases', 'have', 'roles', 'in', 'mitochondrial', 'homeostasis', 'and', 'apoptosis', '.']	[0, 2, 4, 9, 13, 16, 21, 26, 32, 35, 49, 61, 65, 74]	[2, 4, 8, 12, 16, 20, 25, 31, 34, 48, 60, 64, 74, 75]	['Atypical', 'Rho', 'GTPases', 'have', 'roles', 'in', 'mitochondrial', 'homeostasis', 'and', 'apoptosis', '.']	[3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Membranes were probed with mouse anti-CD9 (Santa Cruz Biotechnology; 1:1,000), mouse anti-TSG101 (BD Biosciences, 1:500), mouse anti-HSP70 (BD Biosciences; 1:1,000), mouse anti-Alix (Cell Signaling Technology; 1:1,000), and mouse anti-human A33 antibodies (1 μg/ml) for 1 h in TBST followed by incubation in horseradish peroxidase-conjugated goat anti-mouse IgG (Bio-Rad; 1:5,000) or IRDye 800CW goat anti-mouse IgG (LI-COR Biosciences; 1:15,000) for 1 h. All antibody incubations were carried out at RT with shaking, and blots were washed (three times) with TBST for 10 min after each incubation step.	[('PMC2830834', 'M04002', 308, 330, 'horseradish peroxidase')]	['Membrane', '##s', 'were', 'probed', 'with', 'mouse', 'anti', '-', 'CD', '##9', '(', 'Santa', 'Cruz', 'Biotechnology', ';', '1', ':', '1', ',', '000', ')', ',', 'mouse', 'anti', '-', 'TS', '##G', '##101', '(', 'BD', 'Biosciences', ',', '1', ':', '500', ')', ',', 'mouse', 'anti', '-', 'HSP', '##70', '(', 'BD', 'Biosciences', ';', '1', ':', '1', ',', '000', ')', ',', 'mouse', 'anti', '-', 'Ali', '##x', '(', 'Cell', 'Signaling', 'Technology', ';', '1', ':', '1', ',', '000', ')', ',', 'and', 'mouse', 'anti', '-', 'human', 'A', '##33', 'antibodies', '(', '1', 'μ', '##g', '/', 'ml', ')', 'for', '1', 'h', 'in', 'TB', '##ST', 'followed', 'by', 'incubation', 'in', 'horse', '##radi', '##sh', 'peroxidase', '-', 'conjugated', 'goat', 'anti', '-', 'mouse', 'IgG', '(', 'Bio', '-', 'Rad', ';', '1', ':', '5', ',', '000', ')', 'or', 'IR', '##D', '##ye', '800', '##C', '##W', 'goat', 'anti', '-', 'mouse', 'IgG', '(', 'LI', '-', 'COR', 'Biosciences', ';', '1', ':', '15', ',', '000', ')', 'for', '1', 'h', '.', 'All', 'antibody', 'incubation', '##s', 'were', 'carried', 'out', 'at', 'RT', 'with', 'shaking', ',', 'and', 'blots', 'were', 'washed', '(', 'three', 'times', ')', 'with', 'TB', '##ST', 'for', '10', 'min', 'after', 'each', 'incubation', 'step', '.']	[0, 8, 10, 15, 22, 27, 33, 37, 38, 40, 42, 43, 49, 54, 67, 69, 70, 71, 72, 73, 76, 77, 79, 85, 89, 90, 92, 93, 97, 98, 101, 112, 114, 115, 116, 119, 120, 122, 128, 132, 133, 136, 139, 140, 143, 154, 156, 157, 158, 159, 160, 163, 164, 166, 172, 176, 177, 180, 182, 183, 188, 198, 208, 210, 211, 212, 213, 214, 217, 218, 220, 224, 230, 234, 235, 241, 242, 245, 256, 257, 259, 260, 261, 262, 264, 266, 270, 272, 274, 277, 279, 282, 291, 294, 305, 308, 313, 317, 320, 330, 331, 342, 347, 351, 352, 358, 362, 363, 366, 367, 370, 372, 373, 374, 375, 376, 379, 381, 384, 386, 387, 390, 393, 394, 396, 401, 405, 406, 412, 416, 417, 419, 420, 424, 435, 437, 438, 439, 441, 442, 445, 447, 451, 453, 454, 456, 460, 469, 479, 481, 486, 494, 498, 501, 504, 509, 516, 518, 522, 528, 533, 540, 541, 547, 552, 554, 559, 561, 564, 568, 571, 575, 581, 586, 597, 601]	[8, 9, 14, 21, 26, 32, 37, 38, 40, 41, 43, 48, 53, 67, 68, 70, 71, 72, 73, 76, 77, 78, 84, 89, 90, 92, 93, 96, 98, 100, 112, 113, 115, 116, 119, 120, 121, 127, 132, 133, 136, 138, 140, 142, 154, 155, 157, 158, 159, 160, 163, 164, 165, 171, 176, 177, 180, 181, 183, 187, 197, 208, 209, 211, 212, 213, 214, 217, 218, 219, 223, 229, 234, 235, 240, 242, 244, 255, 257, 258, 260, 261, 262, 264, 265, 269, 271, 273, 276, 279, 281, 290, 293, 304, 307, 313, 317, 319, 330, 331, 341, 346, 351, 352, 357, 361, 363, 366, 367, 370, 371, 373, 374, 375, 376, 379, 380, 383, 386, 387, 389, 393, 394, 395, 400, 405, 406, 411, 415, 417, 419, 420, 423, 435, 436, 438, 439, 441, 442, 445, 446, 450, 452, 454, 455, 459, 468, 479, 480, 485, 493, 497, 500, 503, 508, 516, 517, 521, 527, 532, 539, 541, 546, 552, 553, 558, 561, 563, 567, 570, 574, 580, 585, 596, 601, 602]	['Membranes', 'were', 'probed', 'with', 'mouse', 'anti-CD9', '(', 'Santa', 'Cruz', 'Biotechnology', ';', '1', ':', '1', ',', '000', ')', ',', 'mouse', 'anti-TSG101', '(', 'BD', 'Biosciences', ',', '1', ':', '500', ')', ',', 'mouse', 'anti-HSP70', '(', 'BD', 'Biosciences', ';', '1', ':', '1', ',', '000', ')', ',', 'mouse', 'anti-Alix', '(', 'Cell', 'Signaling', 'Technology', ';', '1', ':', '1', ',', '000', ')', ',', 'and', 'mouse', 'anti-', 'human', 'A33', 'antibodies', '(', '1', 'μg', '/', 'ml', ')', 'for', '1', 'h', 'in', 'TBST', 'followed', 'by', 'incubation', 'in', 'horseradish', 'peroxidase', '-', 'conjugated', 'goat', 'anti-', 'mouse', 'IgG', '(', 'Bio-Rad', ';', '1', ':', '5', ',', '000', ')', 'or', 'IRDye', '800CW', 'goat', 'anti-', 'mouse', 'IgG', '(', 'LI-COR', 'Biosciences', ';', '1', ':', '15', ',', '000', ')', 'for', '1', 'h', '.', 'All', 'antibody', 'incubations', 'were', 'carried', 'out', 'at', 'RT', 'with', 'shaking', ',', 'and', 'blots', 'were', 'washed', '(', 'three', 'times', ')', 'with', 'TBST', 'for', '10', 'min', 'after', 'each', 'incubation', 'step', '.']	[2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, several kinases (LYN, MINK1, and MAP4K4), proteases (ADAM10, DPEP1, and ST14), transporters (SLC1A4, SLC16A1, and CLIC1), and receptors (CD46, CD55, and NOTCH1) were also present.	[('PMC2830834', 'R03003', 23, 30, 'kinases'), ('PMC2830834', 'R03003', 57, 66, 'proteases')]	['Interestingly', ',', 'several', 'kinases', '(', 'LY', '##N', ',', 'MIN', '##K', '##1', ',', 'and', 'MAP', '##4', '##K', '##4', ')', ',', 'proteases', '(', 'ADAM', '##10', ',', 'DP', '##EP', '##1', ',', 'and', 'ST', '##14', ')', ',', 'transporters', '(', 'SLC', '##1', '##A', '##4', ',', 'SLC', '##16', '##A', '##1', ',', 'and', 'CL', '##IC', '##1', ')', ',', 'and', 'receptors', '(', 'CD', '##46', ',', 'CD', '##55', ',', 'and', 'NOT', '##CH', '##1', ')', 'were', 'also', 'present', '.']	[0, 13, 15, 23, 31, 32, 34, 35, 37, 40, 41, 42, 44, 48, 51, 52, 53, 54, 55, 57, 67, 68, 72, 74, 76, 78, 80, 81, 83, 87, 89, 91, 92, 94, 107, 108, 111, 112, 113, 114, 116, 119, 121, 122, 123, 125, 129, 131, 133, 134, 135, 137, 141, 151, 152, 154, 156, 158, 160, 162, 164, 168, 171, 173, 174, 176, 181, 186, 193]	[13, 14, 22, 30, 32, 34, 35, 36, 40, 41, 42, 43, 47, 51, 52, 53, 54, 55, 56, 66, 68, 72, 74, 75, 78, 80, 81, 82, 86, 89, 91, 92, 93, 106, 108, 111, 112, 113, 114, 115, 119, 121, 122, 123, 124, 128, 131, 133, 134, 135, 136, 140, 150, 152, 154, 156, 157, 160, 162, 163, 167, 171, 173, 174, 175, 180, 185, 193, 194]	['Interestingly', ',', 'several', 'kinases', '(', 'LYN', ',', 'MINK1', ',', 'and', 'MAP4K4', ')', ',', 'proteases', '(', 'ADAM10', ',', 'DPEP1', ',', 'and', 'ST14', ')', ',', 'transporters', '(', 'SLC1A4', ',', 'SLC16A1', ',', 'and', 'CLIC1', ')', ',', 'and', 'receptors', '(', 'CD46', ',', 'CD55', ',', 'and', 'NOTCH1', ')', 'were', 'also', 'present', '.']	[1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 4, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 4, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Phosphatidylserine externalization is thought to be due to the action of floppase, flippase, and scramblase activities (52); this is justified by the identification of phospholipid scramblase in our study.	[('PMC2830834', 'R03006', 73, 81, 'floppase'), ('PMC2830834', 'R03006', 83, 91, 'flippase'), ('PMC2830834', 'R03006', 97, 107, 'scramblase')]	['Phosph', '##atidyl', '##ser', '##ine', 'external', '##ization', 'is', 'thought', 'to', 'be', 'due', 'to', 'the', 'action', 'of', 'flo', '##pp', '##ase', ',', 'flip', '##pa', '##se', ',', 'and', 'scr', '##amb', '##las', '##e', 'activities', '(', '52', ')', ';', 'this', 'is', 'justified', 'by', 'the', 'identification', 'of', 'phospholipid', 'scr', '##amb', '##las', '##e', 'in', 'our', 'study', '.']	[0, 6, 12, 15, 19, 27, 35, 38, 46, 49, 52, 56, 59, 63, 70, 73, 76, 78, 81, 83, 87, 89, 91, 93, 97, 100, 103, 106, 108, 119, 120, 122, 123, 125, 130, 133, 143, 146, 150, 165, 168, 181, 184, 187, 190, 192, 195, 199, 204]	[6, 12, 15, 18, 27, 34, 37, 45, 48, 51, 55, 58, 62, 69, 72, 76, 78, 81, 82, 87, 89, 91, 92, 96, 100, 103, 106, 107, 118, 120, 122, 123, 124, 129, 132, 142, 145, 149, 164, 167, 180, 184, 187, 190, 191, 194, 198, 204, 205]	['Phosphatidylserine', 'externalization', 'is', 'thought', 'to', 'be', 'due', 'to', 'the', 'action', 'of', 'floppase', ',', 'flippase', ',', 'and', 'scramblase', 'activities', '(', '52', ')', ';', 'this', 'is', 'justified', 'by', 'the', 'identification', 'of', 'phospholipid', 'scramblase', 'in', 'our', 'study', '.']	[4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Each individual tetraspanin protein performs differently via actions through their respective interactors; for example, CD9 and CD82 mediate metastasis inhibition by several mechanisms, whereas CD151 supports tumor progression by activating matrix metalloproteinases (54, 62).	[('PMC2830834', 'R04011', 241, 266, 'matrix metalloproteinases')]	['Each', 'individual', 'tetra', '##sp', '##ani', '##n', 'protein', 'performs', 'differently', 'via', 'actions', 'through', 'their', 'respective', 'interact', '##ors', ';', 'for', 'example', ',', 'CD', '##9', 'and', 'CD', '##82', 'mediate', 'metastasis', 'inhibition', 'by', 'several', 'mechanisms', ',', 'whereas', 'CD', '##15', '##1', 'supports', 'tumor', 'progression', 'by', 'activating', 'matrix', 'metalloprotein', '##ases', '(', '54', ',', '62', ')', '.']	[0, 5, 16, 21, 23, 26, 28, 36, 45, 57, 61, 69, 77, 83, 94, 102, 105, 107, 111, 118, 120, 122, 124, 128, 130, 133, 141, 152, 163, 166, 174, 184, 186, 194, 196, 198, 200, 209, 215, 227, 230, 241, 248, 262, 267, 268, 270, 272, 274, 275]	[4, 15, 21, 23, 26, 27, 35, 44, 56, 60, 68, 76, 82, 93, 102, 105, 106, 110, 118, 119, 122, 123, 127, 130, 132, 140, 151, 162, 165, 173, 184, 185, 193, 196, 198, 199, 208, 214, 226, 229, 240, 247, 262, 266, 268, 270, 271, 274, 275, 276]	['Each', 'individual', 'tetraspanin', 'protein', 'performs', 'differently', 'via', 'actions', 'through', 'their', 'respective', 'interactors', ';', 'for', 'example', ',', 'CD9', 'and', 'CD82', 'mediate', 'metastasis', 'inhibition', 'by', 'several', 'mechanisms', ',', 'whereas', 'CD151', 'supports', 'tumor', 'progression', 'by', 'activating', 'matrix', 'metalloproteinases', '(', '54', ',', '62', ')', '.']	[1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Likewise, RAS domains (68) are found in Ras proteins (69, 70), which are small GTPases that perform GTP binding.	[('PMC2830834', 'R06003', 79, 86, 'GTPases')]	['Likewise', ',', 'RAS', 'domains', '(', '68', ')', 'are', 'found', 'in', 'Ras', 'proteins', '(', '69', ',', '70', ')', ',', 'which', 'are', 'small', 'GTP', '##ases', 'that', 'perform', 'GTP', 'binding', '.']	[0, 8, 10, 14, 22, 23, 25, 27, 31, 37, 40, 44, 53, 54, 56, 58, 60, 61, 63, 69, 73, 79, 82, 87, 92, 100, 104, 111]	[8, 9, 13, 21, 23, 25, 26, 30, 36, 39, 43, 52, 54, 56, 57, 60, 61, 62, 68, 72, 78, 82, 86, 91, 99, 103, 111, 112]	['Likewise', ',', 'RAS', 'domains', '(', '68', ')', 'are', 'found', 'in', 'Ras', 'proteins', '(', '69', ',', '70', ')', ',', 'which', 'are', 'small', 'GTPases', 'that', 'perform', 'GTP', 'binding', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
These small GTPases are predominantly found in the exosomes and perform functions with respect to cell growth, proliferation, and differentiation.	[('PMC2830834', 'R06004', 12, 19, 'GTPases')]	['These', 'small', 'GTP', '##ases', 'are', 'predominantly', 'found', 'in', 'the', 'ex', '##osomes', 'and', 'perform', 'functions', 'with', 'respect', 'to', 'cell', 'growth', ',', 'proliferation', ',', 'and', 'differentiation', '.']	[0, 6, 12, 15, 20, 24, 38, 44, 47, 51, 53, 60, 64, 72, 82, 87, 95, 98, 103, 109, 111, 124, 126, 130, 145]	[5, 11, 15, 19, 23, 37, 43, 46, 50, 53, 59, 63, 71, 81, 86, 94, 97, 102, 109, 110, 124, 125, 129, 145, 146]	['These', 'small', 'GTPases', 'are', 'predominantly', 'found', 'in', 'the', 'exosomes', 'and', 'perform', 'functions', 'with', 'respect', 'to', 'cell', 'growth', ',', 'proliferation', ',', 'and', 'differentiation', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Preferential enrichment of RAS domains in exosomes suggests the dominance of GTPases in these vesicles.	[('PMC2830834', 'R06006', 77, 84, 'GTPases')]	['Pref', '##erential', 'enrichment', 'of', 'RAS', 'domains', 'in', 'ex', '##osomes', 'suggests', 'the', 'dominance', 'of', 'GTP', '##ases', 'in', 'these', 'vesicles', '.']	[0, 4, 13, 24, 27, 31, 39, 42, 44, 51, 60, 64, 74, 77, 80, 85, 88, 94, 102]	[4, 12, 23, 26, 30, 38, 41, 44, 50, 59, 63, 73, 76, 80, 84, 87, 93, 102, 103]	['Preferential', 'enrichment', 'of', 'RAS', 'domains', 'in', 'exosomes', 'suggests', 'the', 'dominance', 'of', 'GTPases', 'in', 'these', 'vesicles', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O']
MIRO domains are found in Rho GTPases (71) that are larger than the classical small GTPases.	[('PMC2830834', 'R06008', 26, 37, 'Rho GTPases'), ('PMC2830834', 'R06008', 84, 91, 'GTPases')]	['MI', '##RO', 'domains', 'are', 'found', 'in', 'Rho', 'GTP', '##ases', '(', '71', ')', 'that', 'are', 'larger', 'than', 'the', 'classical', 'small', 'GTP', '##ases', '.']	[0, 2, 5, 13, 17, 23, 26, 30, 33, 38, 39, 41, 43, 48, 52, 59, 64, 68, 78, 84, 87, 91]	[2, 4, 12, 16, 22, 25, 29, 33, 37, 39, 41, 42, 47, 51, 58, 63, 67, 77, 83, 87, 91, 92]	['MIRO', 'domains', 'are', 'found', 'in', 'Rho', 'GTPases', '(', '71', ')', 'that', 'are', 'larger', 'than', 'the', 'classical', 'small', 'GTPases', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
Rho GTPases perform roles in mitochondrial homeostasis, apoptosis, and trafficking (72).	[('PMC2830834', 'R06009', 0, 11, 'Rho GTPases')]	['Rho', 'GTP', '##ases', 'perform', 'roles', 'in', 'mitochondrial', 'homeostasis', ',', 'apoptosis', ',', 'and', 'trafficking', '(', '72', ')', '.']	[0, 4, 7, 12, 20, 26, 29, 43, 54, 56, 65, 67, 71, 83, 84, 86, 87]	[3, 7, 11, 19, 25, 28, 42, 54, 55, 65, 66, 70, 82, 84, 86, 87, 88]	['Rho', 'GTPases', 'perform', 'roles', 'in', 'mitochondrial', 'homeostasis', ',', 'apoptosis', ',', 'and', 'trafficking', '(', '72', ')', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Distribution of the molecular function for the 31 proteins revealed that 23% of them are reported to have GTPase activity (supplemental Fig.	[('PMC2830834', 'R08013', 106, 112, 'GTPase')]	['Distribution', 'of', 'the', 'molecular', 'function', 'for', 'the', '31', 'proteins', 'revealed', 'that', '23', '%', 'of', 'them', 'are', 'reported', 'to', 'have', 'GTP', '##ase', 'activity', '(', 'supplemental', 'Fig', '.']	[0, 13, 16, 20, 30, 39, 43, 47, 50, 59, 68, 73, 75, 77, 80, 85, 89, 98, 101, 106, 109, 113, 122, 123, 136, 139]	[12, 15, 19, 29, 38, 42, 46, 49, 58, 67, 72, 75, 76, 79, 84, 88, 97, 100, 105, 109, 112, 121, 123, 135, 139, 140]	['Distribution', 'of', 'the', 'molecular', 'function', 'for', 'the', '31', 'proteins', 'revealed', 'that', '23%', 'of', 'them', 'are', 'reported', 'to', 'have', 'GTPase', 'activity', '(', 'supplemental', 'Fig', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
These molecules include A33, cadherin-17, centrosomal protein 55 kDa (CEP55), claudin 1 (CLDN1), claudin 3 (CLDN3), claudin 7 (CLDN7), epidermal growth factor receptor, ephrin receptor A2 (EPHA2), keratin 18 (KRT18), mucin 13 (MUC13), proliferating cell nuclear antigen, POLD1, PPP2R1B, carcinoembryonic antigen, epithelial cell surface antigen (EpCAM), misshapen-like kinase 1, mitogen-activated protein kinase 4, ephrin-B1, ephrin-B2, and RUVBL1.	[('PMC2830834', 'R09007', 354, 377, 'misshapen-like kinase 1'), ('PMC2830834', 'R09007', 379, 413, 'mitogen-activated protein kinase 4')]	['These', 'molecules', 'include', 'A', '##33', ',', 'cad', '##her', '##in', '-', '17', ',', 'centr', '##osomal', 'protein', '55', 'kDa', '(', 'CE', '##P', '##55', ')', ',', 'cl', '##aud', '##in', '1', '(', 'CL', '##DN', '##1', ')', ',', 'cl', '##aud', '##in', '3', '(', 'CL', '##DN', '##3', ')', ',', 'cl', '##aud', '##in', '7', '(', 'CL', '##DN', '##7', ')', ',', 'epidermal', 'growth', 'factor', 'receptor', ',', 'ep', '##hr', '##in', 'receptor', 'A', '##2', '(', 'EP', '##HA', '##2', ')', ',', 'keratin', '18', '(', 'KR', '##T', '##18', ')', ',', 'muc', '##in', '13', '(', 'MU', '##C', '##13', ')', ',', 'proliferating', 'cell', 'nuclear', 'antigen', ',', 'POL', '##D', '##1', ',', 'PP', '##P', '##2', '##R', '##1', '##B', ',', 'carcin', '##oe', '##mb', '##ry', '##onic', 'antigen', ',', 'epithelial', 'cell', 'surface', 'antigen', '(', 'Ep', '##CAM', ')', ',', 'miss', '##ha', '##pen', '-', 'like', 'kinase', '1', ',', 'mitogen', '-', 'activated', 'protein', 'kinase', '4', ',', 'ep', '##hr', '##in', '-', 'B', '##1', ',', 'ep', '##hr', '##in', '-', 'B', '##2', ',', 'and', 'RU', '##V', '##BL', '##1', '.']	[0, 6, 16, 24, 25, 27, 29, 32, 35, 37, 38, 40, 42, 47, 54, 62, 65, 69, 70, 72, 73, 75, 76, 78, 80, 83, 86, 88, 89, 91, 93, 94, 95, 97, 99, 102, 105, 107, 108, 110, 112, 113, 114, 116, 118, 121, 124, 126, 127, 129, 131, 132, 133, 135, 145, 152, 159, 167, 169, 171, 173, 176, 185, 186, 188, 189, 191, 193, 194, 195, 197, 205, 208, 209, 211, 212, 214, 215, 217, 220, 223, 226, 227, 229, 230, 232, 233, 235, 249, 254, 262, 269, 271, 274, 275, 276, 278, 280, 281, 282, 283, 284, 285, 287, 293, 295, 297, 299, 304, 311, 313, 324, 329, 337, 345, 346, 348, 351, 352, 354, 358, 360, 363, 364, 369, 376, 377, 379, 386, 387, 397, 405, 412, 413, 415, 417, 419, 421, 422, 423, 424, 426, 428, 430, 432, 433, 434, 435, 437, 441, 443, 444, 446, 447]	[5, 15, 23, 25, 27, 28, 32, 35, 37, 38, 40, 41, 47, 53, 61, 64, 68, 70, 72, 73, 75, 76, 77, 80, 83, 85, 87, 89, 91, 93, 94, 95, 96, 99, 102, 104, 106, 108, 110, 112, 113, 114, 115, 118, 121, 123, 125, 127, 129, 131, 132, 133, 134, 144, 151, 158, 167, 168, 171, 173, 175, 184, 186, 187, 189, 191, 193, 194, 195, 196, 204, 207, 209, 211, 212, 214, 215, 216, 220, 222, 225, 227, 229, 230, 232, 233, 234, 248, 253, 261, 269, 270, 274, 275, 276, 277, 280, 281, 282, 283, 284, 285, 286, 293, 295, 297, 299, 303, 311, 312, 323, 328, 336, 344, 346, 348, 351, 352, 353, 358, 360, 363, 364, 368, 375, 377, 378, 386, 387, 396, 404, 411, 413, 414, 417, 419, 421, 422, 423, 424, 425, 428, 430, 432, 433, 434, 435, 436, 440, 443, 444, 446, 447, 448]	['These', 'molecules', 'include', 'A33', ',', 'cadherin-17', ',', 'centrosomal', 'protein', '55', 'kDa', '(', 'CEP55', ')', ',', 'claudin', '1', '(', 'CLDN1', ')', ',', 'claudin', '3', '(', 'CLDN3', ')', ',', 'claudin', '7', '(', 'CLDN7', ')', ',', 'epidermal', 'growth', 'factor', 'receptor', ',', 'ephrin', 'receptor', 'A2', '(', 'EPHA2', ')', ',', 'keratin', '18', '(', 'KRT18', ')', ',', 'mucin', '13', '(', 'MUC13', ')', ',', 'proliferating', 'cell', 'nuclear', 'antigen', ',', 'POLD1', ',', 'PPP2R1B', ',', 'carcinoembryonic', 'antigen', ',', 'epithelial', 'cell', 'surface', 'antigen', '(', 'EpCAM', ')', ',', 'misshapen', '-', 'like', 'kinase', '1', ',', 'mitogen', '-', 'activated', 'protein', 'kinase', '4', ',', 'ephrin-B1', ',', 'ephrin-B2', ',', 'and', 'RUVBL1', '.']	[1, 1, 1, 2, 1, 5, 1, 2, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 6, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Orho-Melander M., Melander O., Guiducci C., Perez-Martinez P., Corella D., Roos C., Tewhey R., Rieder M.J., Hall J., Abecasis G. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.	[('PMC2833364', 'F38001', 160, 171, 'glucokinase')]	['Or', '##ho', '-', 'Mel', '##ander', 'M', '.', ',', 'Mel', '##ander', 'O', '.', ',', 'Guid', '##ucci', 'C', '.', ',', 'Pere', '##z', '-', 'Martinez', 'P', '.', ',', 'Core', '##lla', 'D', '.', ',', 'Ro', '##os', 'C', '.', ',', 'Te', '##whe', '##y', 'R', '.', ',', 'Ri', '##eder', 'M', '.', 'J', '.', ',', 'Hall', 'J', '.', ',', 'Ab', '##eca', '##sis', 'G', '.', 'Common', 'miss', '##ense', 'variant', 'in', 'the', 'gluc', '##ok', '##inase', 'regulatory', 'protein', 'gene', 'is', 'associated', 'with', 'increased', 'plasma', 'triglyceride', 'and', 'C', '-', 'reactive', 'protein', 'but', 'lower', 'fasting', 'glucose', 'concentrations', '.']	[0, 2, 4, 5, 8, 14, 15, 16, 18, 21, 27, 28, 29, 31, 35, 40, 41, 42, 44, 48, 49, 50, 59, 60, 61, 63, 67, 71, 72, 73, 75, 77, 80, 81, 82, 84, 86, 89, 91, 92, 93, 95, 97, 102, 103, 104, 105, 106, 108, 113, 114, 115, 117, 119, 122, 126, 127, 129, 136, 140, 145, 153, 156, 160, 164, 166, 172, 183, 191, 196, 199, 210, 215, 225, 232, 245, 249, 250, 251, 260, 268, 272, 278, 286, 294, 308]	[2, 4, 5, 8, 13, 15, 16, 17, 21, 26, 28, 29, 30, 35, 39, 41, 42, 43, 48, 49, 50, 58, 60, 61, 62, 67, 70, 72, 73, 74, 77, 79, 81, 82, 83, 86, 89, 90, 92, 93, 94, 97, 101, 103, 104, 105, 106, 107, 112, 114, 115, 116, 119, 122, 125, 127, 128, 135, 140, 144, 152, 155, 159, 164, 166, 171, 182, 190, 195, 198, 209, 214, 224, 231, 244, 248, 250, 251, 259, 267, 271, 277, 285, 293, 308, 309]	['Orho-Melander', 'M', '.', ',', 'Melander', 'O', '.', ',', 'Guiducci', 'C', '.', ',', 'Perez-Martinez', 'P', '.', ',', 'Corella', 'D', '.', ',', 'Roos', 'C', '.', ',', 'Tewhey', 'R', '.', ',', 'Rieder', 'M.J', '.', ',', 'Hall', 'J', '.', ',', 'Abecasis', 'G', '.', 'Common', 'missense', 'variant', 'in', 'the', 'glucokinase', 'regulatory', 'protein', 'gene', 'is', 'associated', 'with', 'increased', 'plasma', 'triglyceride', 'and', 'C-reactive', 'protein', 'but', 'lower', 'fasting', 'glucose', 'concentrations', '.']	[5, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, gene array studies showed that insulin deprivation also decreased the transcript levels of genes involved in oxidative phosphorylation, which was validated by RT-PCR-based measurements of cytochrome c oxidase and ATP synthase, and mitochondrial transcription factor	[('PMC2866659', 'D05006', 201, 221, 'cytochrome c oxidase'), ('PMC2866659', 'D05006', 226, 238, 'ATP synthase')]	['Furthermore', ',', 'gene', 'array', 'studies', 'showed', 'that', 'insulin', 'deprivation', 'also', 'decreased', 'the', 'transcript', 'levels', 'of', 'genes', 'involved', 'in', 'oxidative', 'phosphorylation', ',', 'which', 'was', 'validated', 'by', 'RT', '-', 'PCR', '-', 'based', 'measurements', 'of', 'cytochrome', 'c', 'oxidase', 'and', 'ATP', 'synthase', ',', 'and', 'mitochondrial', 'transcription', 'factor']	[0, 11, 13, 18, 24, 32, 39, 44, 52, 64, 69, 79, 83, 94, 101, 104, 110, 119, 122, 132, 147, 149, 155, 159, 169, 172, 174, 175, 178, 179, 185, 198, 201, 212, 214, 222, 226, 230, 238, 240, 244, 258, 272]	[11, 12, 17, 23, 31, 38, 43, 51, 63, 68, 78, 82, 93, 100, 103, 109, 118, 121, 131, 147, 148, 154, 158, 168, 171, 174, 175, 178, 179, 184, 197, 200, 211, 213, 221, 225, 229, 238, 239, 243, 257, 271, 278]	['Furthermore', ',', 'gene', 'array', 'studies', 'showed', 'that', 'insulin', 'deprivation', 'also', 'decreased', 'the', 'transcript', 'levels', 'of', 'genes', 'involved', 'in', 'oxidative', 'phosphorylation', ',', 'which', 'was', 'validated', 'by', 'RT-PCR', '-', 'based', 'measurements', 'of', 'cytochrome', 'c', 'oxidase', 'and', 'ATP', 'synthase', ',', 'and', 'mitochondrial', 'transcription', 'factor']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
This effect is compounded by the conversion of citrate to acetyl CoA by the enzyme ATP citrate lyase [30]; an effect that is likely to contribute to the NMR-observable increases in plasma acetate.	[('PMC2866659', 'D05009', 83, 100, 'ATP citrate lyase')]	['This', 'effect', 'is', 'compound', '##ed', 'by', 'the', 'conversion', 'of', 'citrate', 'to', 'acetyl', 'Co', '##A', 'by', 'the', 'enzyme', 'ATP', 'citrate', 'ly', '##ase', '[', '30', ']', ';', 'an', 'effect', 'that', 'is', 'likely', 'to', 'contribute', 'to', 'the', 'NMR', '-', 'observable', 'increases', 'in', 'plasma', 'acetate', '.']	[0, 5, 12, 15, 23, 26, 29, 33, 44, 47, 55, 58, 65, 67, 69, 72, 76, 83, 87, 95, 97, 101, 102, 104, 105, 107, 110, 117, 122, 125, 132, 135, 146, 149, 153, 156, 157, 168, 178, 181, 188, 195]	[4, 11, 14, 23, 25, 28, 32, 43, 46, 54, 57, 64, 67, 68, 71, 75, 82, 86, 94, 97, 100, 102, 104, 105, 106, 109, 116, 121, 124, 131, 134, 145, 148, 152, 156, 157, 167, 177, 180, 187, 195, 196]	['This', 'effect', 'is', 'compounded', 'by', 'the', 'conversion', 'of', 'citrate', 'to', 'acetyl', 'CoA', 'by', 'the', 'enzyme', 'ATP', 'citrate', 'lyase', '[', '30', ']', ';', 'an', 'effect', 'that', 'is', 'likely', 'to', 'contribute', 'to', 'the', 'NMR-observable', 'increases', 'in', 'plasma', 'acetate', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Second, the conversion of pyruvate to acetyl CoA is likely decreased under these conditions due to the absence of insulin's effect on activating pyruvate dehydrogenase.	[('PMC2866659', 'D05014', 145, 167, 'pyruvate dehydrogenase')]	"['Second', ',', 'the', 'conversion', 'of', 'pyruvate', 'to', 'acetyl', 'Co', '##A', 'is', 'likely', 'decreased', 'under', 'these', 'conditions', 'due', 'to', 'the', 'absence', 'of', 'insulin', ""'"", 's', 'effect', 'on', 'activating', 'pyruvate', 'dehydrogenase', '.']"	[0, 6, 8, 12, 23, 26, 35, 38, 45, 47, 49, 52, 59, 69, 75, 81, 92, 96, 99, 103, 111, 114, 121, 122, 124, 131, 134, 145, 154, 167]	[6, 7, 11, 22, 25, 34, 37, 44, 47, 48, 51, 58, 68, 74, 80, 91, 95, 98, 102, 110, 113, 121, 122, 123, 130, 133, 144, 153, 167, 168]	"['Second', ',', 'the', 'conversion', 'of', 'pyruvate', 'to', 'acetyl', 'CoA', 'is', 'likely', 'decreased', 'under', 'these', 'conditions', 'due', 'to', 'the', 'absence', 'of', ""insulin's"", 'effect', 'on', 'activating', 'pyruvate', 'dehydrogenase', '.']"	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
Several factors may contribute to rising acetate levels with insulin deprivation, including 1) impaired mitochondrial substrate oxidation, 2) induction of acetyl-CoA synthetase 2 under ketogenic conditions [32], 3) increased acetate release from the liver [32], and 4) a defective acetate switch and exogenous acetate production by gut microbes [6].	[('PMC2866659', 'D06001', 155, 178, 'acetyl-CoA synthetase 2')]	['Several', 'factors', 'may', 'contribute', 'to', 'rising', 'acetate', 'levels', 'with', 'insulin', 'deprivation', ',', 'including', '1', ')', 'impaired', 'mitochondrial', 'substrate', 'oxidation', ',', '2', ')', 'induction', 'of', 'acetyl', '-', 'Co', '##A', 'synthe', '##tase', '2', 'under', 'ket', '##ogenic', 'conditions', '[', '32', ']', ',', '3', ')', 'increased', 'acetate', 'release', 'from', 'the', 'liver', '[', '32', ']', ',', 'and', '4', ')', 'a', 'defective', 'acetate', 'switch', 'and', 'exogenous', 'acetate', 'production', 'by', 'gut', 'microbes', '[', '6', ']', '.']	[0, 8, 16, 20, 31, 34, 41, 49, 56, 61, 69, 80, 82, 92, 93, 95, 104, 118, 128, 137, 139, 140, 142, 152, 155, 161, 162, 164, 166, 172, 177, 179, 185, 188, 195, 206, 207, 209, 210, 212, 213, 215, 225, 233, 241, 246, 250, 256, 257, 259, 260, 262, 266, 267, 269, 271, 281, 289, 296, 300, 310, 318, 329, 332, 336, 345, 346, 347, 348]	[7, 15, 19, 30, 33, 40, 48, 55, 60, 68, 80, 81, 91, 93, 94, 103, 117, 127, 137, 138, 140, 141, 151, 154, 161, 162, 164, 165, 172, 176, 178, 184, 188, 194, 205, 207, 209, 210, 211, 213, 214, 224, 232, 240, 245, 249, 255, 257, 259, 260, 261, 265, 267, 268, 270, 280, 288, 295, 299, 309, 317, 328, 331, 335, 344, 346, 347, 348, 349]	['Several', 'factors', 'may', 'contribute', 'to', 'rising', 'acetate', 'levels', 'with', 'insulin', 'deprivation', ',', 'including', '1', ')', 'impaired', 'mitochondrial', 'substrate', 'oxidation', ',', '2', ')', 'induction', 'of', 'acetyl-CoA', 'synthetase', '2', 'under', 'ketogenic', 'conditions', '[', '32', ']', ',', '3', ')', 'increased', 'acetate', 'release', 'from', 'the', 'liver', '[', '32', ']', ',', 'and', '4', ')', 'a', 'defective', 'acetate', 'switch', 'and', 'exogenous', 'acetate', 'production', 'by', 'gut', 'microbes', '[', '6', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Oxidative stress during insulin deprivation appears to be due, in part, to activation of NADPH oxidase and uncoupling of endothelium nitric oxide synthase [36].	[('PMC2866659', 'D07002', 89, 102, 'NADPH oxidase'), ('PMC2866659', 'D07002', 133, 154, 'nitric oxide synthase')]	['Oxid', '##ative', 'stress', 'during', 'insulin', 'deprivation', 'appears', 'to', 'be', 'due', ',', 'in', 'part', ',', 'to', 'activation', 'of', 'NADPH', 'oxidase', 'and', 'unc', '##oupling', 'of', 'endothelium', 'nitric', 'oxide', 'synthase', '[', '36', ']', '.']	[0, 4, 10, 17, 24, 32, 44, 52, 55, 58, 61, 63, 66, 70, 72, 75, 86, 89, 95, 103, 107, 110, 118, 121, 133, 140, 146, 155, 156, 158, 159]	[4, 9, 16, 23, 31, 43, 51, 54, 57, 61, 62, 65, 70, 71, 74, 85, 88, 94, 102, 106, 110, 117, 120, 132, 139, 145, 154, 156, 158, 159, 160]	['Oxidative', 'stress', 'during', 'insulin', 'deprivation', 'appears', 'to', 'be', 'due', ',', 'in', 'part', ',', 'to', 'activation', 'of', 'NADPH', 'oxidase', 'and', 'uncoupling', 'of', 'endothelium', 'nitric', 'oxide', 'synthase', '[', '36', ']', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
Molecular characterization of a heteromeric ATP-citrate lyase that generates cytosolic acetyl-coenzyme A in Arabidopsis.	[('PMC2866659', 'F29002', 44, 61, 'ATP-citrate lyase')]	['Molecular', 'character', '##ization', 'of', 'a', 'heter', '##omeric', 'ATP', '-', 'citrate', 'ly', '##ase', 'that', 'generates', 'cytosolic', 'acetyl', '-', 'coe', '##n', '##zyme', 'A', 'in', 'Arabidopsis', '.']	[0, 10, 19, 27, 30, 32, 37, 44, 47, 48, 56, 58, 62, 67, 77, 87, 93, 94, 97, 98, 103, 105, 108, 119]	[9, 19, 26, 29, 31, 37, 43, 47, 48, 55, 58, 61, 66, 76, 86, 93, 94, 97, 98, 102, 104, 107, 119, 120]	['Molecular', 'characterization', 'of', 'a', 'heteromeric', 'ATP-citrate', 'lyase', 'that', 'generates', 'cytosolic', 'acetyl', '-', 'coenzyme', 'A', 'in', 'Arabidopsis', '.']	[1, 2, 1, 1, 2, 3, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.	[('PMC2866659', 'F35002', 91, 106, 'NAD(P)H oxidase'), ('PMC2866659', 'F35002', 123, 144, 'nitric oxide synthase')]	['Mechanisms', 'of', 'increased', 'vascular', 'superoxide', 'production', 'in', 'human', 'diabetes', 'mellitus', ':', 'role', 'of', 'NAD', '(', 'P', ')', 'H', 'oxidase', 'and', 'endothelial', 'nitric', 'oxide', 'synthase', '.']	[0, 11, 14, 24, 33, 44, 55, 58, 64, 73, 81, 83, 88, 91, 94, 95, 96, 97, 99, 107, 111, 123, 130, 136, 144]	[10, 13, 23, 32, 43, 54, 57, 63, 72, 81, 82, 87, 90, 94, 95, 96, 97, 98, 106, 110, 122, 129, 135, 144, 145]	['Mechanisms', 'of', 'increased', 'vascular', 'superoxide', 'production', 'in', 'human', 'diabetes', 'mellitus', ':', 'role', 'of', 'NAD(P)H', 'oxidase', 'and', 'endothelial', 'nitric', 'oxide', 'synthase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O']
Urate oxidase: primary structure and evolutionary implications.	[('PMC2883001', 'F07002', 0, 13, 'Urate oxidase')]	['Ur', '##ate', 'oxidase', ':', 'primary', 'structure', 'and', 'evolutionary', 'implications', '.']	[0, 2, 6, 13, 15, 23, 33, 37, 50, 62]	[2, 5, 13, 14, 22, 32, 36, 49, 62, 63]	['Urate', 'oxidase', ':', 'primary', 'structure', 'and', 'evolutionary', 'implications', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Carducci C, Birarelli M, Leuzzi V, et al. Guanidinoacetate and creatine plus creatinine assessment in physiologic fluids: an effective diagnostic tool for the biochemical diagnosis of arginine:glycine amidinotransferase and guanidinoacetate methyltransferase deficiencies.	[('PMC2883001', 'F10001', 184, 219, 'arginine:glycine amidinotransferase'), ('PMC2883001', 'F10001', 224, 258, 'guanidinoacetate methyltransferase')]	['Card', '##ucci', 'C', ',', 'Bir', '##arel', '##li', 'M', ',', 'Leu', '##zz', '##i', 'V', ',', 'et', 'al', '.', 'Gu', '##ani', '##din', '##oa', '##ce', '##ta', '##te', 'and', 'cre', '##atine', 'plus', 'creatinine', 'assessment', 'in', 'physiologic', 'fluids', ':', 'an', 'effective', 'diagnostic', 'tool', 'for', 'the', 'biochemical', 'diagnosis', 'of', 'arginine', ':', 'glycine', 'am', '##idin', '##otransferase', 'and', 'guan', '##idin', '##oa', '##ce', '##ta', '##te', 'methyl', '##transferase', 'deficiencies', '.']	[0, 4, 9, 10, 12, 15, 19, 22, 23, 25, 28, 30, 32, 33, 35, 38, 40, 42, 44, 47, 50, 52, 54, 56, 59, 63, 66, 72, 77, 88, 99, 102, 114, 120, 122, 125, 135, 146, 151, 155, 159, 171, 181, 184, 192, 193, 201, 203, 207, 220, 224, 228, 232, 234, 236, 238, 241, 247, 259, 271]	[4, 8, 10, 11, 15, 19, 21, 23, 24, 28, 30, 31, 33, 34, 37, 40, 41, 44, 47, 50, 52, 54, 56, 58, 62, 66, 71, 76, 87, 98, 101, 113, 120, 121, 124, 134, 145, 150, 154, 158, 170, 180, 183, 192, 193, 200, 203, 207, 219, 223, 228, 232, 234, 236, 238, 240, 247, 258, 271, 272]	['Carducci', 'C', ',', 'Birarelli', 'M', ',', 'Leuzzi', 'V', ',', 'et', 'al', '.', 'Guanidinoacetate', 'and', 'creatine', 'plus', 'creatinine', 'assessment', 'in', 'physiologic', 'fluids', ':', 'an', 'effective', 'diagnostic', 'tool', 'for', 'the', 'biochemical', 'diagnosis', 'of', 'arginine', ':', 'glycine', 'amidinotransferase', 'and', 'guanidinoacetate', 'methyltransferase', 'deficiencies', '.']	[2, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Humans (as well as other hominoid primates and birds), lack urate oxidase, a peroxisomal enzyme that catalyzes the oxidation of uric acid to allantoin in most mammals (8).	[('PMC2883001', 'I02005', 60, 73, 'urate oxidase')]	['Human', '##s', '(', 'as', 'well', 'as', 'other', 'hom', '##ino', '##id', 'primates', 'and', 'birds', ')', ',', 'lack', 'ur', '##ate', 'oxidase', ',', 'a', 'peroxis', '##omal', 'enzyme', 'that', 'cataly', '##zes', 'the', 'oxidation', 'of', 'ur', '##ic', 'acid', 'to', 'all', '##anto', '##in', 'in', 'most', 'mammals', '(', '8', ')', '.']	[0, 5, 7, 8, 11, 16, 19, 25, 28, 31, 34, 43, 47, 52, 53, 55, 60, 62, 66, 73, 75, 77, 84, 89, 96, 101, 107, 111, 115, 125, 128, 130, 133, 138, 141, 144, 148, 151, 154, 159, 167, 168, 169, 170]	[5, 6, 8, 10, 15, 18, 24, 28, 31, 33, 42, 46, 52, 53, 54, 59, 62, 65, 73, 74, 76, 84, 88, 95, 100, 107, 110, 114, 124, 127, 130, 132, 137, 140, 144, 148, 150, 153, 158, 166, 168, 169, 170, 171]	['Humans', '(', 'as', 'well', 'as', 'other', 'hominoid', 'primates', 'and', 'birds', ')', ',', 'lack', 'urate', 'oxidase', ',', 'a', 'peroxisomal', 'enzyme', 'that', 'catalyzes', 'the', 'oxidation', 'of', 'uric', 'acid', 'to', 'allantoin', 'in', 'most', 'mammals', '(', '8', ')', '.']	[2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Expression of the beta 6 isoform may affect secretion of matrix metalloproteinases and tumor progression (14,15).	[('PMC2883345', 'D02006', 57, 82, 'matrix metalloproteinases')]	['Expression', 'of', 'the', 'beta', '6', 'isoform', 'may', 'affect', 'secretion', 'of', 'matrix', 'metalloprotein', '##ases', 'and', 'tumor', 'progression', '(', '14', ',', '15', ')', '.']	[0, 11, 14, 18, 23, 25, 33, 37, 44, 54, 57, 64, 78, 83, 87, 93, 105, 106, 108, 109, 111, 112]	[10, 13, 17, 22, 24, 32, 36, 43, 53, 56, 63, 78, 82, 86, 92, 104, 106, 108, 109, 111, 112, 113]	['Expression', 'of', 'the', 'beta', '6', 'isoform', 'may', 'affect', 'secretion', 'of', 'matrix', 'metalloproteinases', 'and', 'tumor', 'progression', '(', '14', ',', '15', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Also implicated in severe UC is phospholipase C-β1 (PLCB1; rs6039206, p= 1.5×10−5), an intracellular transductor of extracellular signals, including IL-1β and TNF-α in rheumatoid arthritis 68.	[('PMC2959149', 'D05000', 32, 50, 'phospholipase C-β1')]	['Also', 'implicated', 'in', 'severe', 'UC', 'is', 'phospholip', '##ase', 'C', '-', 'β', '##1', '(', 'PLC', '##B', '##1', ';', 'rs', '##60', '##39', '##206', ',', 'p', '=', '1', '.', '5', '##×10', '##−', '##5', ')', ',', 'an', 'intracellular', 'transduc', '##tor', 'of', 'extracellular', 'signals', ',', 'including', 'IL', '-', '1', '##β', 'and', 'TNF', '-', 'α', 'in', 'rheumatoid', 'arthritis', '68', '.']	[0, 5, 16, 19, 26, 29, 32, 42, 46, 47, 48, 49, 51, 52, 55, 56, 57, 59, 61, 63, 65, 68, 70, 71, 73, 74, 75, 76, 79, 80, 81, 82, 84, 87, 101, 109, 113, 116, 130, 137, 139, 149, 151, 152, 153, 155, 159, 162, 163, 165, 168, 179, 189, 191]	[4, 15, 18, 25, 28, 31, 42, 45, 47, 48, 49, 50, 52, 55, 56, 57, 58, 61, 63, 65, 68, 69, 71, 72, 74, 75, 76, 79, 80, 81, 82, 83, 86, 100, 109, 112, 115, 129, 137, 138, 148, 151, 152, 153, 154, 158, 162, 163, 164, 167, 178, 188, 191, 192]	['Also', 'implicated', 'in', 'severe', 'UC', 'is', 'phospholipase', 'C-β1', '(', 'PLCB1', ';', 'rs6039206', ',', 'p=', '1.5×10−5', ')', ',', 'an', 'intracellular', 'transductor', 'of', 'extracellular', 'signals', ',', 'including', 'IL-1β', 'and', 'TNF-α', 'in', 'rheumatoid', 'arthritis', '68', '.']	[1, 1, 1, 1, 1, 1, 2, 4, 1, 3, 1, 4, 1, 2, 6, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Localization of membrane-associated guanylate kinase (MAGI)-1/BAI-associated protein (BAP) 1 at tight junctions of epithelial cells.	[('PMC2959149', 'F51002', 16, 52, 'membrane-associated guanylate kinase')]	['Local', '##ization', 'of', 'membrane', '-', 'associated', 'guan', '##ylate', 'kinase', '(', 'MAG', '##I', ')', '-', '1', '/', 'BA', '##I', '-', 'associated', 'protein', '(', 'BA', '##P', ')', '1', 'at', 'tight', 'junctions', 'of', 'epithelial', 'cells', '.']	[0, 5, 13, 16, 24, 25, 36, 40, 46, 53, 54, 57, 58, 59, 60, 61, 62, 64, 65, 66, 77, 85, 86, 88, 89, 91, 93, 96, 102, 112, 115, 126, 131]	[5, 12, 15, 24, 25, 35, 40, 45, 52, 54, 57, 58, 59, 60, 61, 62, 64, 65, 66, 76, 84, 86, 88, 89, 90, 92, 95, 101, 111, 114, 125, 131, 132]	['Localization', 'of', 'membrane', '-', 'associated', 'guanylate', 'kinase', '(MAGI)-1', '/', 'BAI-associated', 'protein', '(', 'BAP', ')', '1', 'at', 'tight', 'junctions', 'of', 'epithelial', 'cells', '.']	[2, 1, 1, 1, 1, 2, 1, 6, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox.	[('PMC2959149', 'F68002', 80, 95, 'phospholipase C')]	['Anti', '##thetic', 'regulation', 'by', 'beta', '-', 'adren', '##ergic', 'receptors', 'of', 'G', '##q', 'receptor', 'signaling', 'via', 'phospholip', '##ase', 'C', 'underlie', '##s', 'the', 'airway', 'beta', '-', 'agonist', 'paradox', '.']	[0, 4, 11, 22, 25, 29, 30, 35, 41, 51, 54, 55, 57, 66, 76, 80, 90, 94, 96, 104, 106, 110, 117, 121, 122, 130, 137]	[4, 10, 21, 24, 29, 30, 35, 40, 50, 53, 55, 56, 65, 75, 79, 90, 93, 95, 104, 105, 109, 116, 121, 122, 129, 137, 138]	['Antithetic', 'regulation', 'by', 'beta', '-', 'adrenergic', 'receptors', 'of', 'Gq', 'receptor', 'signaling', 'via', 'phospholipase', 'C', 'underlies', 'the', 'airway', 'beta', '-', 'agonist', 'paradox', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This gene encodes PMCA1, a plasma membrane calcium/calmodulin dependent ATPase that is expressed in vascular endothelium and is involved in calcium pumping from the cytosol to the extracellular compartment.24 An investigation of cultured rat aortic smooth muscle cells found elevated PMCA1 mRNA levels in spontaneously hypertensive rats compared to nonhypertensive controls, consistent with a role of ATP2B1 in blood pressure regulation.25	[('PMC2998712', 'D01001', 43, 78, 'calcium/calmodulin dependent ATPase')]	['This', 'gene', 'encodes', 'PMC', '##A', '##1', ',', 'a', 'plasma', 'membrane', 'calcium', '/', 'cal', '##mod', '##ulin', 'dependent', 'ATPase', 'that', 'is', 'expressed', 'in', 'vascular', 'endothelium', 'and', 'is', 'involved', 'in', 'calcium', 'pumping', 'from', 'the', 'cytosol', 'to', 'the', 'extracellular', 'compartment', '.', '24', 'An', 'investigation', 'of', 'cultured', 'rat', 'aortic', 'smooth', 'muscle', 'cells', 'found', 'elevated', 'PMC', '##A', '##1', 'mRNA', 'levels', 'in', 'spontaneously', 'hypertensive', 'rats', 'compared', 'to', 'non', '##hypertensive', 'controls', ',', 'consistent', 'with', 'a', 'role', 'of', 'ATP', '##2', '##B', '##1', 'in', 'blood', 'pressure', 'regulation', '.', '25']	[0, 5, 10, 18, 21, 22, 23, 25, 27, 34, 43, 50, 51, 54, 57, 62, 72, 79, 84, 87, 97, 100, 109, 121, 125, 128, 137, 140, 148, 156, 161, 165, 173, 176, 180, 194, 205, 206, 209, 212, 226, 229, 238, 242, 249, 256, 263, 269, 275, 284, 287, 288, 290, 295, 302, 305, 319, 332, 337, 346, 349, 352, 365, 373, 375, 386, 391, 393, 398, 401, 404, 405, 406, 408, 411, 417, 426, 436, 437]	[4, 9, 17, 21, 22, 23, 24, 26, 33, 42, 50, 51, 54, 57, 61, 71, 78, 83, 86, 96, 99, 108, 120, 124, 127, 136, 139, 147, 155, 160, 164, 172, 175, 179, 193, 205, 206, 208, 211, 225, 228, 237, 241, 248, 255, 262, 268, 274, 283, 287, 288, 289, 294, 301, 304, 318, 331, 336, 345, 348, 352, 364, 373, 374, 385, 390, 392, 397, 400, 404, 405, 406, 407, 410, 416, 425, 436, 437, 439]	['This', 'gene', 'encodes', 'PMCA1', ',', 'a', 'plasma', 'membrane', 'calcium', '/', 'calmodulin', 'dependent', 'ATPase', 'that', 'is', 'expressed', 'in', 'vascular', 'endothelium', 'and', 'is', 'involved', 'in', 'calcium', 'pumping', 'from', 'the', 'cytosol', 'to', 'the', 'extracellular', 'compartment.24', 'An', 'investigation', 'of', 'cultured', 'rat', 'aortic', 'smooth', 'muscle', 'cells', 'found', 'elevated', 'PMCA1', 'mRNA', 'levels', 'in', 'spontaneously', 'hypertensive', 'rats', 'compared', 'to', 'nonhypertensive', 'controls', ',', 'consistent', 'with', 'a', 'role', 'of', 'ATP2B1', 'in', 'blood', 'pressure', 'regulation.25']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Located near the midpoint between SH2B3 and C12orf51 is ALDH2, encoding acetaldehyde dehydrogenase 2, a critical enzyme in alcohol metabolism.	[('PMC2998712', 'D02009', 72, 100, 'acetaldehyde dehydrogenase 2')]	['Loc', '##ated', 'near', 'the', 'mid', '##point', 'between', 'SH', '##2', '##B', '##3', 'and', 'C', '##12', '##orf', '##51', 'is', 'AL', '##DH', '##2', ',', 'encoding', 'acet', '##aldehyde', 'dehydrogenase', '2', ',', 'a', 'critical', 'enzyme', 'in', 'alcohol', 'metabolism', '.']	[0, 3, 8, 13, 17, 20, 26, 34, 36, 37, 38, 40, 44, 45, 47, 50, 53, 56, 58, 60, 61, 63, 72, 76, 85, 99, 100, 102, 104, 113, 120, 123, 131, 141]	[3, 7, 12, 16, 20, 25, 33, 36, 37, 38, 39, 43, 45, 47, 50, 52, 55, 58, 60, 61, 62, 71, 76, 84, 98, 100, 101, 103, 112, 119, 122, 130, 141, 142]	['Located', 'near', 'the', 'midpoint', 'between', 'SH2B3', 'and', 'C12orf51', 'is', 'ALDH2', ',', 'encoding', 'acetaldehyde', 'dehydrogenase', '2', ',', 'a', 'critical', 'enzyme', 'in', 'alcohol', 'metabolism', '.']	[2, 1, 1, 2, 1, 4, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A SNP (rs1004467) attaining genome-wide significance is in CYP17A1, encoding steroid 17-alpha-hydroxylase, an enzyme necessary for steroidogenesis.	[('PMC2998712', 'D03000', 85, 105, '17-alpha-hydroxylase')]	['A', 'SNP', '(', 'rs', '##100', '##44', '##67', ')', 'attain', '##ing', 'genome', '-', 'wide', 'significance', 'is', 'in', 'CYP', '##17', '##A', '##1', ',', 'encoding', 'steroid', '17', '-', 'alpha', '-', 'hydroxyl', '##ase', ',', 'an', 'enzyme', 'necessary', 'for', 'steroid', '##ogenesis', '.']	[0, 2, 6, 7, 9, 12, 14, 16, 18, 24, 28, 34, 35, 40, 53, 56, 59, 62, 64, 65, 66, 68, 77, 85, 87, 88, 93, 94, 102, 105, 107, 110, 117, 127, 131, 138, 146]	[1, 5, 7, 9, 12, 14, 16, 17, 24, 27, 34, 35, 39, 52, 55, 58, 62, 64, 65, 66, 67, 76, 84, 87, 88, 93, 94, 102, 105, 106, 109, 116, 126, 130, 138, 146, 147]	['A', 'SNP', '(', 'rs1004467', ')', 'attaining', 'genome', '-', 'wide', 'significance', 'is', 'in', 'CYP17A1', ',', 'encoding', 'steroid', '17-alpha-', 'hydroxylase', ',', 'an', 'enzyme', 'necessary', 'for', 'steroidogenesis', '.']	[1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mutations in CYP17A1 are found in patients with 17α-hydroxylase deficiency, which is characterized by congenital adrenal hyperplasia with apparent mineralocorticoid excess, salt retention, hypokalemia, and hypertension.31 Numerous mutations in CYP17A1 have been identified in patients with 17α-hydroxylase deficiency leading to a spectrum of phenotypic severity.32 Although mutations in CYP17A1 causing phenotypic 17α-hydroxylase deficiency are rare, our data suggest that common variants in CYP17A1 may also be associated with blood pressure by promoting mild forms of enzyme deficiency or dysfunction.	[('PMC2998712', 'D03001', 48, 63, '17α-hydroxylase'), ('PMC2998712', 'D03001', 290, 305, '17α-hydroxylase'), ('PMC2998712', 'D03001', 414, 429, '17α-hydroxylase')]	['Mutations', 'in', 'CYP', '##17', '##A', '##1', 'are', 'found', 'in', 'patients', 'with', '17', '##α', '-', 'hydroxyl', '##ase', 'deficiency', ',', 'which', 'is', 'characterized', 'by', 'congenital', 'adrenal', 'hyperplasia', 'with', 'apparent', 'mineral', '##ocortic', '##oid', 'excess', ',', 'salt', 'retention', ',', 'hypo', '##ka', '##lem', '##ia', ',', 'and', 'hypertension', '.', '31', 'Numerous', 'mutations', 'in', 'CYP', '##17', '##A', '##1', 'have', 'been', 'identified', 'in', 'patients', 'with', '17', '##α', '-', 'hydroxyl', '##ase', 'deficiency', 'leading', 'to', 'a', 'spectrum', 'of', 'phenotypic', 'severity', '.', '32', 'Although', 'mutations', 'in', 'CYP', '##17', '##A', '##1', 'causing', 'phenotypic', '17', '##α', '-', 'hydroxyl', '##ase', 'deficiency', 'are', 'rare', ',', 'our', 'data', 'suggest', 'that', 'common', 'variants', 'in', 'CYP', '##17', '##A', '##1', 'may', 'also', 'be', 'associated', 'with', 'blood', 'pressure', 'by', 'promoting', 'mild', 'forms', 'of', 'enzyme', 'deficiency', 'or', 'dysfunction', '.']	[0, 10, 13, 16, 18, 19, 21, 25, 31, 34, 43, 48, 50, 51, 52, 60, 64, 74, 76, 82, 85, 99, 102, 113, 121, 133, 138, 147, 154, 161, 165, 171, 173, 178, 187, 189, 193, 195, 198, 200, 202, 206, 218, 219, 222, 231, 241, 244, 247, 249, 250, 252, 257, 262, 273, 276, 285, 290, 292, 293, 294, 302, 306, 317, 325, 328, 330, 339, 342, 353, 361, 362, 365, 374, 384, 387, 390, 392, 393, 395, 403, 414, 416, 417, 418, 426, 430, 441, 445, 449, 451, 455, 460, 468, 473, 480, 489, 492, 495, 497, 498, 500, 504, 509, 512, 523, 528, 534, 543, 546, 556, 561, 567, 570, 577, 588, 591, 602]	[9, 12, 16, 18, 19, 20, 24, 30, 33, 42, 47, 50, 51, 52, 60, 63, 74, 75, 81, 84, 98, 101, 112, 120, 132, 137, 146, 154, 161, 164, 171, 172, 177, 187, 188, 193, 195, 198, 200, 201, 205, 218, 219, 221, 230, 240, 243, 247, 249, 250, 251, 256, 261, 272, 275, 284, 289, 292, 293, 294, 302, 305, 316, 324, 327, 329, 338, 341, 352, 361, 362, 364, 373, 383, 386, 390, 392, 393, 394, 402, 413, 416, 417, 418, 426, 429, 440, 444, 449, 450, 454, 459, 467, 472, 479, 488, 491, 495, 497, 498, 499, 503, 508, 511, 522, 527, 533, 542, 545, 555, 560, 566, 569, 576, 587, 590, 602, 603]	['Mutations', 'in', 'CYP17A1', 'are', 'found', 'in', 'patients', 'with', '17α-hydroxylase', 'deficiency', ',', 'which', 'is', 'characterized', 'by', 'congenital', 'adrenal', 'hyperplasia', 'with', 'apparent', 'mineralocorticoid', 'excess', ',', 'salt', 'retention', ',', 'hypokalemia', ',', 'and', 'hypertension.31', 'Numerous', 'mutations', 'in', 'CYP17A1', 'have', 'been', 'identified', 'in', 'patients', 'with', '17α-hydroxylase', 'deficiency', 'leading', 'to', 'a', 'spectrum', 'of', 'phenotypic', 'severity.32', 'Although', 'mutations', 'in', 'CYP17A1', 'causing', 'phenotypic', '17α-hydroxylase', 'deficiency', 'are', 'rare', ',', 'our', 'data', 'suggest', 'that', 'common', 'variants', 'in', 'CYP17A1', 'may', 'also', 'be', 'associated', 'with', 'blood', 'pressure', 'by', 'promoting', 'mild', 'forms', 'of', 'enzyme', 'deficiency', 'or', 'dysfunction', '.']	[1, 1, 4, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CSK encodes cytoplasmic tyrosine kinase, which is involved in angiotensin II dependent vascular smoot muscle cell proliferation.36	[('PMC2998712', 'D05002', 24, 39, 'tyrosine kinase')]	['CS', '##K', 'encodes', 'cytoplasmic', 'tyrosine', 'kinase', ',', 'which', 'is', 'involved', 'in', 'angiotensin', 'II', 'dependent', 'vascular', 'smoot', 'muscle', 'cell', 'proliferation', '.', '36']	[0, 2, 4, 12, 24, 33, 39, 41, 47, 50, 59, 62, 74, 77, 87, 96, 102, 109, 114, 127, 128]	[2, 3, 11, 23, 32, 39, 40, 46, 49, 58, 61, 73, 76, 86, 95, 101, 108, 113, 127, 128, 130]	['CSK', 'encodes', 'cytoplasmic', 'tyrosine', 'kinase', ',', 'which', 'is', 'involved', 'in', 'angiotensin', 'II', 'dependent', 'vascular', 'smoot', 'muscle', 'cell', 'proliferation.36']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The Brazilian CAH Multicenter Study Group Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency.	[('PMC2998712', 'F30002', 138, 152, '17-hydroxylase')]	['The', 'Brazilian', 'CA', '##H', 'Multic', '##enter', 'Study', 'Group', 'Two', 'prevalent', 'CYP', '##17', 'mutations', 'and', 'genotype', '-', 'phenotype', 'correlations', 'in', '24', 'Brazilian', 'patients', 'with', '17', '-', 'hydroxyl', '##ase', 'deficiency', '.']	[0, 4, 14, 16, 18, 24, 30, 36, 42, 46, 56, 59, 62, 72, 76, 84, 85, 95, 108, 111, 114, 124, 133, 138, 140, 141, 149, 153, 163]	[3, 13, 16, 17, 24, 29, 35, 41, 45, 55, 59, 61, 71, 75, 84, 85, 94, 107, 110, 113, 123, 132, 137, 140, 141, 149, 152, 163, 164]	['The', 'Brazilian', 'CAH', 'Multicenter', 'Study', 'Group', 'Two', 'prevalent', 'CYP17', 'mutations', 'and', 'genotype', '-', 'phenotype', 'correlations', 'in', '24', 'Brazilian', 'patients', 'with', '17-hydroxylase', 'deficiency', '.']	[1, 1, 2, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
Yang J, Cui B, Sun S, Shi T, Zheng S, Bi Y, Liu J, Zhao Y, Chen J, Ning G, Li X. Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene.	[('PMC2998712', 'F31001', 129, 148, '17alpha-hydroxylase'), ('PMC2998712', 'F31001', 149, 160, '17,20 lyase')]	['Yang', 'J', ',', 'Cu', '##i', 'B', ',', 'Sun', 'S', ',', 'Shi', 'T', ',', 'Zheng', 'S', ',', 'Bi', 'Y', ',', 'Liu', 'J', ',', 'Zhao', 'Y', ',', 'Chen', 'J', ',', 'Nin', '##g', 'G', ',', 'Li', 'X', '.', 'Phen', '##otype', '-', 'genotype', 'correlation', 'in', 'eight', 'Chinese', '17', '##alpha', '-', 'hydroxyl', '##ase', '/', '17', ',', '20', 'ly', '##ase', '-', 'deficiency', 'patients', 'with', 'five', 'novel', 'mutations', 'of', 'CYP', '##17', '##A', '##1', 'gene', '.']	[0, 5, 6, 8, 10, 12, 13, 15, 19, 20, 22, 26, 27, 29, 35, 36, 38, 41, 42, 44, 48, 49, 51, 56, 57, 59, 64, 65, 67, 70, 72, 73, 75, 78, 79, 81, 85, 90, 91, 100, 112, 115, 121, 129, 131, 136, 137, 145, 148, 149, 151, 152, 155, 157, 160, 161, 172, 181, 186, 191, 197, 207, 210, 213, 215, 216, 218, 222]	[4, 6, 7, 10, 11, 13, 14, 18, 20, 21, 25, 27, 28, 34, 36, 37, 40, 42, 43, 47, 49, 50, 55, 57, 58, 63, 65, 66, 70, 71, 73, 74, 77, 79, 80, 85, 90, 91, 99, 111, 114, 120, 128, 131, 136, 137, 145, 148, 149, 151, 152, 154, 157, 160, 161, 171, 180, 185, 190, 196, 206, 209, 213, 215, 216, 217, 222, 223]	['Yang', 'J', ',', 'Cui', 'B', ',', 'Sun', 'S', ',', 'Shi', 'T', ',', 'Zheng', 'S', ',', 'Bi', 'Y', ',', 'Liu', 'J', ',', 'Zhao', 'Y', ',', 'Chen', 'J', ',', 'Ning', 'G', ',', 'Li', 'X', '.', 'Phenotype', '-', 'genotype', 'correlation', 'in', 'eight', 'Chinese', '17alpha', '-', 'hydroxylase', '/', '17', ',', '20', 'lyase', '-', 'deficiency', 'patients', 'with', 'five', 'novel', 'mutations', 'of', 'CYP17A1', 'gene', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The smallest p-value among individuals of African ancestry was for an intronic SNP in the ADAM metallopeptidase with thrombospondin type 1 motif, 12 (ADAMTS12) gene.	[('PMC3033765', 'R03005', 90, 111, 'ADAM metallopeptidase')]	['The', 'smallest', 'p', '-', 'value', 'among', 'individuals', 'of', 'African', 'ancest', '##ry', 'was', 'for', 'an', 'intron', '##ic', 'SNP', 'in', 'the', 'ADAM', 'metall', '##ope', '##pt', '##idase', 'with', 'thrombo', '##sp', '##ond', '##in', 'type', '1', 'motif', ',', '12', '(', 'ADAM', '##TS', '##12', ')', 'gene', '.']	[0, 4, 13, 14, 15, 21, 27, 39, 42, 50, 56, 59, 63, 67, 70, 76, 79, 83, 86, 90, 95, 101, 104, 106, 112, 117, 124, 126, 129, 132, 137, 139, 144, 146, 149, 150, 154, 156, 158, 160, 164]	[3, 12, 14, 15, 20, 26, 38, 41, 49, 56, 58, 62, 66, 69, 76, 78, 82, 85, 89, 94, 101, 104, 106, 111, 116, 124, 126, 129, 131, 136, 138, 144, 145, 148, 150, 154, 156, 158, 159, 164, 165]	['The', 'smallest', 'p-value', 'among', 'individuals', 'of', 'African', 'ancestry', 'was', 'for', 'an', 'intronic', 'SNP', 'in', 'the', 'ADAM', 'metallopeptidase', 'with', 'thrombospondin', 'type', '1', 'motif', ',', '12', '(', 'ADAMTS12', ')', 'gene', '.']	[1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Forkhead box O (FOXO) transcription factors induce cell growth arrest and apoptosis, which can be prevented by FOXO phosphorylation by the survival kinase AKT in response to growth factors such as IGF-I (39).	[('PMC3043664', 'D03004', 148, 154, 'kinase')]	['For', '##kh', '##ead', 'box', 'O', '(', 'FOX', '##O', ')', 'transcription', 'factors', 'induce', 'cell', 'growth', 'arrest', 'and', 'apoptosis', ',', 'which', 'can', 'be', 'prevented', 'by', 'FOX', '##O', 'phosphorylation', 'by', 'the', 'survival', 'kinase', 'AKT', 'in', 'response', 'to', 'growth', 'factors', 'such', 'as', 'IGF', '-', 'I', '(', '39', ')', '.']	[0, 3, 5, 9, 13, 15, 16, 19, 20, 22, 36, 44, 51, 56, 63, 70, 74, 83, 85, 91, 95, 98, 108, 111, 114, 116, 132, 135, 139, 148, 155, 159, 162, 171, 174, 181, 189, 194, 197, 200, 201, 203, 204, 206, 207]	[3, 5, 8, 12, 14, 16, 19, 20, 21, 35, 43, 50, 55, 62, 69, 73, 83, 84, 90, 94, 97, 107, 110, 114, 115, 131, 134, 138, 147, 154, 158, 161, 170, 173, 180, 188, 193, 196, 200, 201, 202, 204, 206, 207, 208]	['Forkhead', 'box', 'O', '(', 'FOXO', ')', 'transcription', 'factors', 'induce', 'cell', 'growth', 'arrest', 'and', 'apoptosis', ',', 'which', 'can', 'be', 'prevented', 'by', 'FOXO', 'phosphorylation', 'by', 'the', 'survival', 'kinase', 'AKT', 'in', 'response', 'to', 'growth', 'factors', 'such', 'as', 'IGF-I', '(', '39', ')', '.']	[3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes.	[('PMC3076530', 'F18002', 74, 92, '6alpha-hydroxylase')]	['CYP', '##2', '##C', '##8', 'polymorphisms', 'in', 'Caucasian', '##s', 'and', 'their', 'relationship', 'with', 'paclitaxel', '6', '##alpha', '-', 'hydroxyl', '##ase', 'activity', 'in', 'human', 'liver', 'micros', '##omes', '.']	[0, 3, 4, 5, 7, 21, 24, 33, 35, 39, 45, 58, 63, 74, 75, 80, 81, 89, 93, 102, 105, 111, 117, 123, 127]	[3, 4, 5, 6, 20, 23, 33, 34, 38, 44, 57, 62, 73, 75, 80, 81, 89, 92, 101, 104, 110, 116, 123, 127, 128]	['CYP2C8', 'polymorphisms', 'in', 'Caucasians', 'and', 'their', 'relationship', 'with', 'paclitaxel', '6alpha', '-', 'hydroxylase', 'activity', 'in', 'human', 'liver', 'microsomes', '.']	[4, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cerivastatin, an HMG-CoA reductase inhibitor (statin), was withdrawn from the market in 2001 because of a pronounced increase in the risk of rhabdomyolysis, which causes muscle pain and weakness and sometimes renal failure and death [5].	[('PMC3076530', 'I01000', 17, 34, 'HMG-CoA reductase')]	['Cer', '##ivas', '##ta', '##tin', ',', 'an', 'HM', '##G', '-', 'Co', '##A', 'reductase', 'inhibitor', '(', 'statin', ')', ',', 'was', 'withdrawn', 'from', 'the', 'market', 'in', '2001', 'because', 'of', 'a', 'pronounced', 'increase', 'in', 'the', 'risk', 'of', 'rh', '##abd', '##omy', '##olysis', ',', 'which', 'causes', 'muscle', 'pain', 'and', 'weakness', 'and', 'sometimes', 'renal', 'failure', 'and', 'death', '[', '5', ']', '.']	[0, 3, 7, 9, 12, 14, 17, 19, 20, 21, 23, 25, 35, 45, 46, 52, 53, 55, 59, 69, 74, 78, 85, 88, 93, 101, 104, 106, 117, 126, 129, 133, 138, 141, 143, 146, 149, 155, 157, 163, 170, 177, 182, 186, 195, 199, 209, 215, 223, 227, 233, 234, 235, 236]	[3, 7, 9, 12, 13, 16, 19, 20, 21, 23, 24, 34, 44, 46, 52, 53, 54, 58, 68, 73, 77, 84, 87, 92, 100, 103, 105, 116, 125, 128, 132, 137, 140, 143, 146, 149, 155, 156, 162, 169, 176, 181, 185, 194, 198, 208, 214, 222, 226, 232, 234, 235, 236, 237]	['Cerivastatin', ',', 'an', 'HMG-CoA', 'reductase', 'inhibitor', '(', 'statin', ')', ',', 'was', 'withdrawn', 'from', 'the', 'market', 'in', '2001', 'because', 'of', 'a', 'pronounced', 'increase', 'in', 'the', 'risk', 'of', 'rhabdomyolysis', ',', 'which', 'causes', 'muscle', 'pain', 'and', 'weakness', 'and', 'sometimes', 'renal', 'failure', 'and', 'death', '[', '5', ']', '.']	[4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Definite rhabdomyolysis was defined as muscle pain or weakness associated with creatine kinase levels greater than 10 times the upper limit of laboratory normal.	[('PMC3076530', 'M01004', 79, 94, 'creatine kinase')]	['Def', '##inite', 'rh', '##abd', '##omy', '##olysis', 'was', 'defined', 'as', 'muscle', 'pain', 'or', 'weakness', 'associated', 'with', 'cre', '##atine', 'kinase', 'levels', 'greater', 'than', '10', 'times', 'the', 'upper', 'limit', 'of', 'laboratory', 'normal', '.']	[0, 3, 9, 11, 14, 17, 24, 28, 36, 39, 46, 51, 54, 63, 74, 79, 82, 88, 95, 102, 110, 115, 118, 124, 128, 134, 140, 143, 154, 160]	[3, 8, 11, 14, 17, 23, 27, 35, 38, 45, 50, 53, 62, 73, 78, 82, 87, 94, 101, 109, 114, 117, 123, 127, 133, 139, 142, 153, 160, 161]	['Definite', 'rhabdomyolysis', 'was', 'defined', 'as', 'muscle', 'pain', 'or', 'weakness', 'associated', 'with', 'creatine', 'kinase', 'levels', 'greater', 'than', '10', 'times', 'the', 'upper', 'limit', 'of', 'laboratory', 'normal', '.']	[2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
HVH controls with a creatine kinase value >10 times the upper limit of laboratory normal in the year before their qualifying statin-use date were excluded (n=2).	[('PMC3076530', 'M02006', 20, 35, 'creatine kinase')]	['HV', '##H', 'controls', 'with', 'a', 'cre', '##atine', 'kinase', 'value', '>', '10', 'times', 'the', 'upper', 'limit', 'of', 'laboratory', 'normal', 'in', 'the', 'year', 'before', 'their', 'qual', '##ifying', 'statin', '-', 'use', 'date', 'were', 'excluded', '(', 'n', '=', '2', ')', '.']	[0, 2, 4, 13, 18, 20, 23, 29, 36, 42, 43, 46, 52, 56, 62, 68, 71, 82, 89, 92, 96, 101, 108, 114, 118, 125, 131, 132, 136, 141, 146, 155, 156, 157, 158, 159, 160]	[2, 3, 12, 17, 19, 23, 28, 35, 41, 43, 45, 51, 55, 61, 67, 70, 81, 88, 91, 95, 100, 107, 113, 118, 124, 131, 132, 135, 140, 145, 154, 156, 157, 158, 159, 160, 161]	['HVH', 'controls', 'with', 'a', 'creatine', 'kinase', 'value', '>', '10', 'times', 'the', 'upper', 'limit', 'of', 'laboratory', 'normal', 'in', 'the', 'year', 'before', 'their', 'qualifying', 'statin', '-', 'use', 'date', 'were', 'excluded', '(', 'n=2', ')', '.']	[2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genotyping methods included an Illumina Goldengate custom panel and, for failed or undesignable SNPs, the Taqman 5' nuclease discrimination assay.	[('PMC3076530', 'M06002', 116, 124, 'nuclease')]	"['Gen', '##otyping', 'methods', 'included', 'an', 'Illumina', 'Gold', '##eng', '##ate', 'custom', 'panel', 'and', ',', 'for', 'failed', 'or', 'undes', '##ign', '##able', 'SNPs', ',', 'the', 'Taq', '##man', '5', ""'"", 'nucle', '##ase', 'discrimination', 'assay', '.']"	[0, 3, 11, 19, 28, 31, 40, 44, 47, 51, 58, 64, 67, 69, 73, 80, 83, 88, 91, 96, 100, 102, 106, 109, 113, 114, 116, 121, 125, 140, 145]	[3, 10, 18, 27, 30, 39, 44, 47, 50, 57, 63, 67, 68, 72, 79, 82, 88, 91, 95, 100, 101, 105, 109, 112, 114, 115, 121, 124, 139, 145, 146]	"['Genotyping', 'methods', 'included', 'an', 'Illumina', 'Goldengate', 'custom', 'panel', 'and', ',', 'for', 'failed', 'or', 'undesignable', 'SNPs', ',', 'the', 'Taqman', '5', ""'"", 'nuclease', 'discrimination', 'assay', '.']"	[2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O']
Most cases experienced both muscle pain and weakness; creatine kinase values indicated significant muscle damage; 81.6% were hospitalized; and 21.6% had renal failure (top part of Table 1).	[('PMC3076530', 'R00001', 54, 69, 'creatine kinase')]	['Most', 'cases', 'experienced', 'both', 'muscle', 'pain', 'and', 'weakness', ';', 'cre', '##atine', 'kinase', 'values', 'indicated', 'significant', 'muscle', 'damage', ';', '81', '.', '6', '%', 'were', 'hospitalized', ';', 'and', '21', '.', '6', '%', 'had', 'renal', 'failure', '(', 'top', 'part', 'of', 'Table', '1', ')', '.']	[0, 5, 11, 23, 28, 35, 40, 44, 52, 54, 57, 63, 70, 77, 87, 99, 106, 112, 114, 116, 117, 118, 120, 125, 137, 139, 143, 145, 146, 147, 149, 153, 159, 167, 168, 172, 177, 180, 186, 187, 188]	[4, 10, 22, 27, 34, 39, 43, 52, 53, 57, 62, 69, 76, 86, 98, 105, 112, 113, 116, 117, 118, 119, 124, 137, 138, 142, 145, 146, 147, 148, 152, 158, 166, 168, 171, 176, 179, 185, 187, 188, 189]	['Most', 'cases', 'experienced', 'both', 'muscle', 'pain', 'and', 'weakness', ';', 'creatine', 'kinase', 'values', 'indicated', 'significant', 'muscle', 'damage', ';', '81.6%', 'were', 'hospitalized', ';', 'and', '21.6%', 'had', 'renal', 'failure', '(', 'top', 'part', 'of', 'Table', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A novel endonuclease IV post-PCR genotyping system.	[('PMC3080600', 'F31002', 8, 23, 'endonuclease IV')]	['A', 'novel', 'end', '##onuclease', 'IV', 'post', '-', 'PCR', 'genotyping', 'system', '.']	[0, 2, 8, 11, 21, 24, 28, 29, 33, 44, 50]	[1, 7, 11, 20, 23, 28, 29, 32, 43, 50, 51]	['A', 'novel', 'endonuclease', 'IV', 'post-PCR', 'genotyping', 'system', '.']	[1, 1, 2, 1, 3, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, in addition to being possibly associated with DILI in the Spanish, B*1801 was further associated with peak alanine transaminase values in these cases, suggesting a possible role for this allele in phenotypic expression.	[('PMC3129430', 'D04001', 122, 142, 'alanine transaminase')]	['Interestingly', ',', 'in', 'addition', 'to', 'being', 'possibly', 'associated', 'with', 'DI', '##LI', 'in', 'the', 'Spanish', ',', 'B', '*', '180', '##1', 'was', 'further', 'associated', 'with', 'peak', 'alanine', 'trans', '##aminase', 'values', 'in', 'these', 'cases', ',', 'suggesting', 'a', 'possible', 'role', 'for', 'this', 'allele', 'in', 'phenotypic', 'expression', '.']	[0, 13, 15, 18, 27, 30, 36, 45, 56, 61, 63, 66, 69, 73, 80, 82, 83, 84, 87, 89, 93, 101, 112, 117, 122, 130, 135, 143, 150, 153, 159, 164, 166, 177, 179, 188, 193, 197, 202, 209, 212, 223, 233]	[13, 14, 17, 26, 29, 35, 44, 55, 60, 63, 65, 68, 72, 80, 81, 83, 84, 87, 88, 92, 100, 111, 116, 121, 129, 135, 142, 149, 152, 158, 164, 165, 176, 178, 187, 192, 196, 201, 208, 211, 222, 233, 234]	['Interestingly', ',', 'in', 'addition', 'to', 'being', 'possibly', 'associated', 'with', 'DILI', 'in', 'the', 'Spanish', ',', 'B*1801', 'was', 'further', 'associated', 'with', 'peak', 'alanine', 'transaminase', 'values', 'in', 'these', 'cases', ',', 'suggesting', 'a', 'possible', 'role', 'for', 'this', 'allele', 'in', 'phenotypic', 'expression', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Though comparatively rare, DILI is a serious clinical problem with up to 10% of cases with simultaneous severe elevations in alanine transaminase (alanine transaminase) and bilirubin developing liver failure.1	[('PMC3129430', 'I00002', 125, 145, 'alanine transaminase'), ('PMC3129430', 'I00002', 147, 167, 'alanine transaminase')]	['Though', 'comparatively', 'rare', ',', 'DI', '##LI', 'is', 'a', 'serious', 'clinical', 'problem', 'with', 'up', 'to', '10', '%', 'of', 'cases', 'with', 'simultaneous', 'severe', 'elevations', 'in', 'alanine', 'trans', '##aminase', '(', 'alanine', 'trans', '##aminase', ')', 'and', 'bilirubin', 'developing', 'liver', 'failure', '.', '1']	[0, 7, 21, 25, 27, 29, 32, 35, 37, 45, 54, 62, 67, 70, 73, 75, 77, 80, 86, 91, 104, 111, 122, 125, 133, 138, 146, 147, 155, 160, 167, 169, 173, 183, 194, 200, 207, 208]	[6, 20, 25, 26, 29, 31, 34, 36, 44, 53, 61, 66, 69, 72, 75, 76, 79, 85, 90, 103, 110, 121, 124, 132, 138, 145, 147, 154, 160, 167, 168, 172, 182, 193, 199, 207, 208, 209]	['Though', 'comparatively', 'rare', ',', 'DILI', 'is', 'a', 'serious', 'clinical', 'problem', 'with', 'up', 'to', '10%', 'of', 'cases', 'with', 'simultaneous', 'severe', 'elevations', 'in', 'alanine', 'transaminase', '(', 'alanine', 'transaminase', ')', 'and', 'bilirubin', 'developing', 'liver', 'failure.1']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inclusion criteria were suspected liver injury due to AC with either: (a) clinically apparent jaundice or bilirubin > 2.4 mg/dL (after exclusion of cases due to hemolysis), or (b) alanine transaminase >	[('PMC3129430', 'M01001', 180, 200, 'alanine transaminase')]	['Inclusion', 'criteria', 'were', 'suspected', 'liver', 'injury', 'due', 'to', 'AC', 'with', 'either', ':', '(', 'a', ')', 'clinically', 'apparent', 'ja', '##und', '##ice', 'or', 'bilirubin', '>', '2', '.', '4', 'mg', '/', 'd', '##L', '(', 'after', 'exclusion', 'of', 'cases', 'due', 'to', 'hem', '##olysis', ')', ',', 'or', '(', 'b', ')', 'alanine', 'trans', '##aminase', '>']	[0, 10, 19, 24, 34, 40, 47, 51, 54, 57, 62, 68, 70, 71, 72, 74, 85, 94, 96, 99, 103, 106, 116, 118, 119, 120, 122, 124, 125, 126, 128, 129, 135, 145, 148, 154, 158, 161, 164, 170, 171, 173, 176, 177, 178, 180, 188, 193, 201]	[9, 18, 23, 33, 39, 46, 50, 53, 56, 61, 68, 69, 71, 72, 73, 84, 93, 96, 99, 102, 105, 115, 117, 119, 120, 121, 124, 125, 126, 127, 129, 134, 144, 147, 153, 157, 160, 164, 170, 171, 172, 175, 177, 178, 179, 187, 193, 200, 202]	['Inclusion', 'criteria', 'were', 'suspected', 'liver', 'injury', 'due', 'to', 'AC', 'with', 'either', ':', '(', 'a', ')', 'clinically', 'apparent', 'jaundice', 'or', 'bilirubin', '>', '2.4', 'mg', '/', 'dL', '(', 'after', 'exclusion', 'of', 'cases', 'due', 'to', 'hemolysis', ')', ',', 'or', '(', 'b', ')', 'alanine', 'transaminase', '>']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Case definitions included (i) acute liver injury defined as presenting symptoms suggestive of liver disorder (nausea, vomiting, abdominal pain and/or jaundice) referred to a specialist or admitted to hospital, and (ii) alanine transaminase >2× ULN or (iii) aspartate aminotransferase (AST), alkaline phosphatase and total bilirubin >2× ULN.	[('PMC3129430', 'M03000', 219, 239, 'alanine transaminase'), ('PMC3129430', 'M03000', 257, 283, 'aspartate aminotransferase'), ('PMC3129430', 'M03000', 291, 311, 'alkaline phosphatase')]	['Case', 'definitions', 'included', '(', 'i', ')', 'acute', 'liver', 'injury', 'defined', 'as', 'presenting', 'symptoms', 'suggestive', 'of', 'liver', 'disorder', '(', 'nausea', ',', 'vomiting', ',', 'abdominal', 'pain', 'and', '/', 'or', 'ja', '##und', '##ice', ')', 'referred', 'to', 'a', 'specialist', 'or', 'admitted', 'to', 'hospital', ',', 'and', '(', 'ii', ')', 'alanine', 'trans', '##aminase', '>', '2', '##×', 'UL', '##N', 'or', '(', 'iii', ')', 'aspart', '##ate', 'amino', '##transferase', '(', 'AST', ')', ',', 'alkaline', 'phosphatase', 'and', 'total', 'bilirubin', '>', '2', '##×', 'UL', '##N', '.']	[0, 5, 17, 26, 27, 28, 30, 36, 42, 49, 57, 60, 71, 80, 91, 94, 100, 109, 110, 116, 118, 126, 128, 138, 143, 146, 147, 150, 152, 155, 158, 160, 169, 172, 174, 185, 188, 197, 200, 208, 210, 214, 215, 217, 219, 227, 232, 240, 241, 242, 244, 246, 248, 251, 252, 255, 257, 263, 267, 272, 284, 285, 288, 289, 291, 300, 312, 316, 322, 332, 333, 334, 336, 338, 339]	[4, 16, 25, 27, 28, 29, 35, 41, 48, 56, 59, 70, 79, 90, 93, 99, 108, 110, 116, 117, 126, 127, 137, 142, 146, 147, 149, 152, 155, 158, 159, 168, 171, 173, 184, 187, 196, 199, 208, 209, 213, 215, 217, 218, 226, 232, 239, 241, 242, 243, 246, 247, 250, 252, 255, 256, 263, 266, 272, 283, 285, 288, 289, 290, 299, 311, 315, 321, 331, 333, 334, 335, 338, 339, 340]	['Case', 'definitions', 'included', '(i)', 'acute', 'liver', 'injury', 'defined', 'as', 'presenting', 'symptoms', 'suggestive', 'of', 'liver', 'disorder', '(', 'nausea', ',', 'vomiting', ',', 'abdominal', 'pain', 'and', '/', 'or', 'jaundice', ')', 'referred', 'to', 'a', 'specialist', 'or', 'admitted', 'to', 'hospital', ',', 'and', '(ii)', 'alanine', 'transaminase', '>', '2×', 'ULN', 'or', '(iii)', 'aspartate', 'aminotransferase', '(', 'AST', ')', ',', 'alkaline', 'phosphatase', 'and', 'total', 'bilirubin', '>', '2×', 'ULN', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 2, 1, 3, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inclusion laboratory criteria for AC-DILI cases in this study were (i) clinically apparent jaundice or bilirubin > 2.4 mg/dL (after exclusion of cases due to hemolysis), or (b) alanine transaminase ≥5× ULN or (c) alkaline phosphatase ≥2× ULN.	[('PMC3129430', 'M04001', 177, 197, 'alanine transaminase'), ('PMC3129430', 'M04001', 213, 233, 'alkaline phosphatase')]	['Inclusion', 'laboratory', 'criteria', 'for', 'AC', '-', 'DI', '##LI', 'cases', 'in', 'this', 'study', 'were', '(', 'i', ')', 'clinically', 'apparent', 'ja', '##und', '##ice', 'or', 'bilirubin', '>', '2', '.', '4', 'mg', '/', 'd', '##L', '(', 'after', 'exclusion', 'of', 'cases', 'due', 'to', 'hem', '##olysis', ')', ',', 'or', '(', 'b', ')', 'alanine', 'trans', '##aminase', '≥', '5', '##×', 'UL', '##N', 'or', '(', 'c', ')', 'alkaline', 'phosphatase', '≥', '2', '##×', 'UL', '##N', '.']	[0, 10, 21, 30, 34, 36, 37, 39, 42, 48, 51, 56, 62, 67, 68, 69, 71, 82, 91, 93, 96, 100, 103, 113, 115, 116, 117, 119, 121, 122, 123, 125, 126, 132, 142, 145, 151, 155, 158, 161, 167, 168, 170, 173, 174, 175, 177, 185, 190, 198, 199, 200, 202, 204, 206, 209, 210, 211, 213, 222, 234, 235, 236, 238, 240, 241]	[9, 20, 29, 33, 36, 37, 39, 41, 47, 50, 55, 61, 66, 68, 69, 70, 81, 90, 93, 96, 99, 102, 112, 114, 116, 117, 118, 121, 122, 123, 124, 126, 131, 141, 144, 150, 154, 157, 161, 167, 168, 169, 172, 174, 175, 176, 184, 190, 197, 199, 200, 201, 204, 205, 208, 210, 211, 212, 221, 233, 235, 236, 237, 240, 241, 242]	['Inclusion', 'laboratory', 'criteria', 'for', 'AC-DILI', 'cases', 'in', 'this', 'study', 'were', '(i)', 'clinically', 'apparent', 'jaundice', 'or', 'bilirubin', '>', '2.4', 'mg', '/', 'dL', '(', 'after', 'exclusion', 'of', 'cases', 'due', 'to', 'hemolysis', ')', ',', 'or', '(', 'b', ')', 'alanine', 'transaminase', '≥', '5×', 'ULN', 'or', '(', 'c', ')', 'alkaline', 'phosphatase', '≥', '2×', 'ULN', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Inclusion laboratory criteria were a) serum AST or alanine transaminase >5× ULN on two separate occasions, b) serum alkaline phosphatase >2× ULN on two consecutive occasions, or c) serum total bilirubin > 2.4 mg/dL in the absence of a competing cause of hyperbilirubinemia.	[('PMC3129430', 'M05003', 51, 71, 'alanine transaminase'), ('PMC3129430', 'M05003', 116, 136, 'alkaline phosphatase')]	['Inclusion', 'laboratory', 'criteria', 'were', 'a', ')', 'serum', 'AST', 'or', 'alanine', 'trans', '##aminase', '>', '5', '##×', 'UL', '##N', 'on', 'two', 'separate', 'occasions', ',', 'b', ')', 'serum', 'alkaline', 'phosphatase', '>', '2', '##×', 'UL', '##N', 'on', 'two', 'consecutive', 'occasions', ',', 'or', 'c', ')', 'serum', 'total', 'bilirubin', '>', '2', '.', '4', 'mg', '/', 'd', '##L', 'in', 'the', 'absence', 'of', 'a', 'competing', 'cause', 'of', 'hyper', '##bil', '##irubin', '##emia', '.']	[0, 10, 21, 30, 35, 36, 38, 44, 48, 51, 59, 64, 72, 73, 74, 76, 78, 80, 83, 87, 96, 105, 107, 108, 110, 116, 125, 137, 138, 139, 141, 143, 145, 148, 152, 164, 173, 175, 178, 179, 181, 187, 193, 203, 205, 206, 207, 209, 211, 212, 213, 215, 218, 222, 230, 233, 235, 245, 251, 254, 259, 262, 268, 272]	[9, 20, 29, 34, 36, 37, 43, 47, 50, 58, 64, 71, 73, 74, 75, 78, 79, 82, 86, 95, 105, 106, 108, 109, 115, 124, 136, 138, 139, 140, 143, 144, 147, 151, 163, 173, 174, 177, 179, 180, 186, 192, 202, 204, 206, 207, 208, 211, 212, 213, 214, 217, 221, 229, 232, 234, 244, 250, 253, 259, 262, 268, 272, 273]	['Inclusion', 'laboratory', 'criteria', 'were', 'a', ')', 'serum', 'AST', 'or', 'alanine', 'transaminase', '>', '5×', 'ULN', 'on', 'two', 'separate', 'occasions', ',', 'b', ')', 'serum', 'alkaline', 'phosphatase', '>', '2×', 'ULN', 'on', 'two', 'consecutive', 'occasions', ',', 'or', 'c', ')', 'serum', 'total', 'bilirubin', '>', '2.4', 'mg', '/', 'dL', 'in', 'the', 'absence', 'of', 'a', 'competing', 'cause', 'of', 'hyperbilirubinemia', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Rs2476601 is a non-synonymous SNP in PTPN22, the gene encoding the lymphoid-specific protein tyrosine phosphatase, nonreceptor type 22 involved in T-cell-receptor signaling, and has been reported to be associated with multiple autoimmune diseases.28 Although the association was not genome-wide significant, it had a p-value of 0.023 after Bonferroni correction for all the published GWA associations with autoimmune diseases that were genotyped in our study.27 The association of the PTPN22 SNPs with DILI appeared stronger in the UK and US cases than in those from Spain (Table S2).	[('PMC3129430', 'R06006', 85, 113, 'protein tyrosine phosphatase')]	['Rs', '##24', '##76', '##60', '##1', 'is', 'a', 'non', '-', 'syn', '##onymous', 'SNP', 'in', 'PTP', '##N', '##22', ',', 'the', 'gene', 'encoding', 'the', 'lymphoid', '-', 'specific', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '##receptor', 'type', '22', 'involved', 'in', 'T', '-', 'cell', '-', 'receptor', 'signaling', ',', 'and', 'has', 'been', 'reported', 'to', 'be', 'associated', 'with', 'multiple', 'autoimmune', 'diseases', '.', '28', 'Although', 'the', 'association', 'was', 'not', 'genome', '-', 'wide', 'significant', ',', 'it', 'had', 'a', 'p', '-', 'value', 'of', '0', '.', '02', '##3', 'after', 'Bonferroni', 'correction', 'for', 'all', 'the', 'published', 'GW', '##A', 'associations', 'with', 'autoimmune', 'diseases', 'that', 'were', 'genotype', '##d', 'in', 'our', 'study', '.', '27', 'The', 'association', 'of', 'the', 'PTP', '##N', '##22', 'SNPs', 'with', 'DI', '##LI', 'appeared', 'stronger', 'in', 'the', 'UK', 'and', 'US', 'cases', 'than', 'in', 'those', 'from', 'Spain', '(', 'Table', 'S', '##2', ')', '.']	[0, 2, 4, 6, 8, 10, 13, 15, 18, 19, 22, 30, 34, 37, 40, 41, 43, 45, 49, 54, 63, 67, 75, 76, 85, 93, 102, 113, 115, 118, 127, 132, 135, 144, 147, 148, 149, 153, 154, 163, 172, 174, 178, 182, 187, 196, 199, 202, 213, 218, 227, 238, 246, 247, 250, 259, 263, 275, 279, 283, 289, 290, 295, 306, 308, 311, 315, 317, 318, 319, 325, 328, 329, 330, 332, 334, 340, 351, 362, 366, 370, 374, 384, 386, 388, 401, 406, 417, 426, 431, 436, 444, 446, 449, 453, 458, 459, 462, 466, 478, 481, 485, 488, 489, 492, 497, 502, 504, 507, 516, 525, 528, 532, 535, 539, 542, 548, 553, 556, 562, 567, 573, 574, 580, 581, 582, 583]	[2, 4, 6, 8, 9, 12, 14, 18, 19, 22, 29, 33, 36, 40, 41, 43, 44, 48, 53, 62, 66, 75, 76, 84, 92, 101, 113, 114, 118, 126, 131, 134, 143, 146, 148, 149, 153, 154, 162, 172, 173, 177, 181, 186, 195, 198, 201, 212, 217, 226, 237, 246, 247, 249, 258, 262, 274, 278, 282, 289, 290, 294, 306, 307, 310, 314, 316, 318, 319, 324, 327, 329, 330, 332, 333, 339, 350, 361, 365, 369, 373, 383, 386, 387, 400, 405, 416, 425, 430, 435, 444, 445, 448, 452, 458, 459, 461, 465, 477, 480, 484, 488, 489, 491, 496, 501, 504, 506, 515, 524, 527, 531, 534, 538, 541, 547, 552, 555, 561, 566, 572, 574, 579, 581, 582, 583, 584]	['Rs2476601', 'is', 'a', 'non', '-', 'synonymous', 'SNP', 'in', 'PTPN22', ',', 'the', 'gene', 'encoding', 'the', 'lymphoid', '-', 'specific', 'protein', 'tyrosine', 'phosphatase', ',', 'nonreceptor', 'type', '22', 'involved', 'in', 'T-cell', '-', 'receptor', 'signaling', ',', 'and', 'has', 'been', 'reported', 'to', 'be', 'associated', 'with', 'multiple', 'autoimmune', 'diseases.28', 'Although', 'the', 'association', 'was', 'not', 'genome', '-', 'wide', 'significant', ',', 'it', 'had', 'a', 'p-value', 'of', '0.023', 'after', 'Bonferroni', 'correction', 'for', 'all', 'the', 'published', 'GWA', 'associations', 'with', 'autoimmune', 'diseases', 'that', 'were', 'genotyped', 'in', 'our', 'study.27', 'The', 'association', 'of', 'the', 'PTPN22', 'SNPs', 'with', 'DILI', 'appeared', 'stronger', 'in', 'the', 'UK', 'and', 'US', 'cases', 'than', 'in', 'those', 'from', 'Spain', '(', 'Table', 'S2', ')', '.']	[5, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We investigated the relationship between the top-associated HLA alleles and clinical features of AC-DILI, including age-at-onset, pattern of liver damage and disease severity as assessed by magnitude of transaminase or bilirubin elevation (Table S5).	[('PMC3129430', 'R10000', 203, 215, 'transaminase')]	['We', 'investigated', 'the', 'relationship', 'between', 'the', 'top', '-', 'associated', 'HLA', 'alleles', 'and', 'clinical', 'features', 'of', 'AC', '-', 'DI', '##LI', ',', 'including', 'age', '-', 'at', '-', 'onset', ',', 'pattern', 'of', 'liver', 'damage', 'and', 'disease', 'severity', 'as', 'assessed', 'by', 'magnitude', 'of', 'trans', '##aminase', 'or', 'bilirubin', 'elevation', '(', 'Table', 'S', '##5', ')', '.']	[0, 3, 16, 20, 33, 41, 45, 48, 49, 60, 64, 72, 76, 85, 94, 97, 99, 100, 102, 104, 106, 116, 119, 120, 122, 123, 128, 130, 138, 141, 147, 154, 158, 166, 175, 178, 187, 190, 200, 203, 208, 216, 219, 229, 239, 240, 246, 247, 248, 249]	[2, 15, 19, 32, 40, 44, 48, 49, 59, 63, 71, 75, 84, 93, 96, 99, 100, 102, 104, 105, 115, 119, 120, 122, 123, 128, 129, 137, 140, 146, 153, 157, 165, 174, 177, 186, 189, 199, 202, 208, 215, 218, 228, 238, 240, 245, 247, 248, 249, 250]	['We', 'investigated', 'the', 'relationship', 'between', 'the', 'top', '-', 'associated', 'HLA', 'alleles', 'and', 'clinical', 'features', 'of', 'AC-DILI', ',', 'including', 'age', '-', 'at', '-', 'onset', ',', 'pattern', 'of', 'liver', 'damage', 'and', 'disease', 'severity', 'as', 'assessed', 'by', 'magnitude', 'of', 'transaminase', 'or', 'bilirubin', 'elevation', '(', 'Table', 'S5', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
B*1801 carriage was significantly correlated with peak alanine transaminase values in Spanish (p=0.0056, Figure 3A), but not in Northwestern Europeans (p=0.90).	[('PMC3129430', 'R10001', 55, 75, 'alanine transaminase')]	['B', '*', '180', '##1', 'carri', '##age', 'was', 'significantly', 'correlated', 'with', 'peak', 'alanine', 'trans', '##aminase', 'values', 'in', 'Spanish', '(', 'p', '=', '0', '.', '00', '##56', ',', 'Figure', '3', '##A', ')', ',', 'but', 'not', 'in', 'North', '##western', 'European', '##s', '(', 'p', '=', '0', '.', '90', ')', '.']	[0, 1, 2, 5, 7, 12, 16, 20, 34, 45, 50, 55, 63, 68, 76, 83, 86, 94, 95, 96, 97, 98, 99, 101, 103, 105, 112, 113, 114, 115, 117, 121, 125, 128, 133, 141, 149, 151, 152, 153, 154, 155, 156, 158, 159]	[1, 2, 5, 6, 12, 15, 19, 33, 44, 49, 54, 62, 68, 75, 82, 85, 93, 95, 96, 97, 98, 99, 101, 103, 104, 111, 113, 114, 115, 116, 120, 124, 127, 133, 140, 149, 150, 152, 153, 154, 155, 156, 158, 159, 160]	['B*1801', 'carriage', 'was', 'significantly', 'correlated', 'with', 'peak', 'alanine', 'transaminase', 'values', 'in', 'Spanish', '(', 'p=0.0056', ',', 'Figure', '3A', ')', ',', 'but', 'not', 'in', 'Northwestern', 'Europeans', '(', 'p=0.90', ')', '.']	[4, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1, 2, 2, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR was performed using 50 ng of genomic DNA, Taq DNA polymerase (EF Taq, SolGent, Daejeon, Korea), and 0.5 pM of each primer under the following conditions: 30 cycles of PCR consisting of denaturation for 10 s at 98℃, annealing for 30 s at 65℃, extension for 2 min at 72℃, and a final extension for 10 min at 72℃ in a thermocycler (Gene Amp PCR system 9700, Applied Biosystems, Foster, CA).	[('PMC3249587', 'M02001', 46, 64, 'Taq DNA polymerase')]	['PCR', 'was', 'performed', 'using', '50', 'ng', 'of', 'genomic', 'DNA', ',', 'Taq', 'DNA', 'polymerase', '(', 'EF', 'Taq', ',', 'Sol', '##Gen', '##t', ',', 'Da', '##ej', '##eon', ',', 'Korea', ')', ',', 'and', '0', '.', '5', 'pM', 'of', 'each', 'primer', 'under', 'the', 'following', 'conditions', ':', '30', 'cycles', 'of', 'PCR', 'consisting', 'of', 'denaturation', 'for', '10', 's', 'at', '[UNK]', ',', 'annealing', 'for', '30', 's', 'at', '[UNK]', ',', 'extension', 'for', '2', 'min', 'at', '[UNK]', ',', 'and', 'a', 'final', 'extension', 'for', '10', 'min', 'at', '[UNK]', 'in', 'a', 'therm', '##ocy', '##cle', '##r', '(', 'Gene', 'Am', '##p', 'PCR', 'system', '97', '##00', ',', 'Applied', 'Biosystems', ',', 'Foster', ',', 'CA', ')', '.']	[0, 4, 8, 18, 24, 27, 30, 33, 41, 44, 46, 50, 54, 65, 66, 69, 72, 74, 77, 80, 81, 83, 85, 87, 90, 92, 97, 98, 100, 104, 105, 106, 108, 111, 114, 119, 126, 132, 136, 146, 156, 158, 161, 168, 171, 175, 186, 189, 202, 206, 209, 211, -1, 217, 219, 229, 233, 236, 238, -1, 244, 246, 256, 260, 262, 266, -1, 272, 274, 278, 280, 286, 296, 300, 303, 307, -1, 314, 317, 319, 324, 327, 330, 332, 333, 338, 340, 342, 346, 353, 355, 357, 359, 367, 377, 379, 385, 387, 389, 390]	[3, 7, 17, 23, 26, 29, 32, 40, 44, 45, 49, 53, 64, 66, 68, 72, 73, 77, 80, 81, 82, 85, 87, 90, 91, 97, 98, 99, 103, 105, 106, 107, 110, 113, 118, 125, 131, 135, 145, 156, 157, 160, 167, 170, 174, 185, 188, 201, 205, 208, 210, 213, 4, 218, 228, 232, 235, 237, 240, 4, 245, 255, 259, 261, 265, 268, 4, 273, 277, 279, 285, 295, 299, 302, 306, 309, 4, 316, 318, 324, 327, 330, 331, 333, 337, 340, 341, 345, 352, 355, 357, 358, 366, 377, 378, 385, 386, 389, 390, 391]	['PCR', 'was', 'performed', 'using', '50', 'ng', 'of', 'genomic', 'DNA', ',', 'Taq', 'DNA', 'polymerase', '(', 'EF', 'Taq', ',', 'SolGent', ',', 'Daejeon', ',', 'Korea', ')', ',', 'and', '0.5', 'pM', 'of', 'each', 'primer', 'under', 'the', 'following', 'conditions', ':', '30', 'cycles', 'of', 'PCR', 'consisting', 'of', 'denaturation', 'for', '10', 's', 'at', '98℃', ',', 'annealing', 'for', '30', 's', 'at', '65℃', ',', 'extension', 'for', '2', 'min', 'at', '72℃', ',', 'and', 'a', 'final', 'extension', 'for', '10', 'min', 'at', '72℃', 'in', 'a', 'thermocycler', '(', 'Gene', 'Amp', 'PCR', 'system', '9700', ',', 'Applied', 'Biosystems', ',', 'Foster', ',', 'CA', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A total of 20 µl reaction mixture was used for PCR containing 50 ng of genomic DNA, Taq DNA polymerase, and 0.5 M of each primer under the following conditions: 30 cycles of PCR consisting of denaturation for 10 s at 98℃, annealing for 20 s at 65℃, extension for 40 s at 72℃, and a final extension for 10 min at 72℃ in a thermocycler (Gene Amp PCR system 9700, Applied Biosystems).	[('PMC3249587', 'M03007', 84, 102, 'Taq DNA polymerase')]	['A', 'total', 'of', '20', '[UNK]', 'reaction', 'mixture', 'was', 'used', 'for', 'PCR', 'containing', '50', 'ng', 'of', 'genomic', 'DNA', ',', 'Taq', 'DNA', 'polymerase', ',', 'and', '0', '.', '5', 'M', 'of', 'each', 'primer', 'under', 'the', 'following', 'conditions', ':', '30', 'cycles', 'of', 'PCR', 'consisting', 'of', 'denaturation', 'for', '10', 's', 'at', '[UNK]', ',', 'annealing', 'for', '20', 's', 'at', '[UNK]', ',', 'extension', 'for', '40', 's', 'at', '[UNK]', ',', 'and', 'a', 'final', 'extension', 'for', '10', 'min', 'at', '[UNK]', 'in', 'a', 'therm', '##ocy', '##cle', '##r', '(', 'Gene', 'Am', '##p', 'PCR', 'system', '97', '##00', ',', 'Applied', 'Biosystems', ')', '.']	[0, 2, 8, 11, -1, 17, 26, 34, 38, 43, 47, 51, 62, 65, 68, 71, 79, 82, 84, 88, 92, 102, 104, 108, 109, 110, 112, 114, 117, 122, 129, 135, 139, 149, 159, 161, 164, 171, 174, 178, 189, 192, 205, 209, 212, 214, -1, 220, 222, 232, 236, 239, 241, -1, 247, 249, 259, 263, 266, 268, -1, 274, 276, 280, 282, 288, 298, 302, 305, 309, -1, 316, 319, 321, 326, 329, 332, 334, 335, 340, 342, 344, 348, 355, 357, 359, 361, 369, 379, 380]	[1, 7, 10, 13, 4, 25, 33, 37, 42, 46, 50, 61, 64, 67, 70, 78, 82, 83, 87, 91, 102, 103, 107, 109, 110, 111, 113, 116, 121, 128, 134, 138, 148, 159, 160, 163, 170, 173, 177, 188, 191, 204, 208, 211, 213, 216, 4, 221, 231, 235, 238, 240, 243, 4, 248, 258, 262, 265, 267, 270, 4, 275, 279, 281, 287, 297, 301, 304, 308, 311, 4, 318, 320, 326, 329, 332, 333, 335, 339, 342, 343, 347, 354, 357, 359, 360, 368, 379, 380, 381]	['A', 'total', 'of', '20', 'µl', 'reaction', 'mixture', 'was', 'used', 'for', 'PCR', 'containing', '50', 'ng', 'of', 'genomic', 'DNA', ',', 'Taq', 'DNA', 'polymerase', ',', 'and', '0.5', 'M', 'of', 'each', 'primer', 'under', 'the', 'following', 'conditions', ':', '30', 'cycles', 'of', 'PCR', 'consisting', 'of', 'denaturation', 'for', '10', 's', 'at', '98℃', ',', 'annealing', 'for', '20', 's', 'at', '65℃', ',', 'extension', 'for', '40', 's', 'at', '72℃', ',', 'and', 'a', 'final', 'extension', 'for', '10', 'min', 'at', '72℃', 'in', 'a', 'thermocycler', '(', 'Gene', 'Amp', 'PCR', 'system', '9700', ',', 'Applied', 'Biosystems', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
First-strand complementary DNA (cDNA) was synthesized using oligo-dT primer and superscript II reverse transcriptase (Invitrogen).	[('PMC3249587', 'M04001', 95, 116, 'reverse transcriptase')]	['First', '-', 'strand', 'complementary', 'DNA', '(', 'cDNA', ')', 'was', 'synthesized', 'using', 'olig', '##o', '-', 'dT', 'primer', 'and', 'supers', '##cript', 'II', 'reverse', 'transcriptase', '(', 'Invitrogen', ')', '.']	[0, 5, 6, 13, 27, 31, 32, 36, 38, 42, 54, 60, 64, 65, 66, 69, 76, 80, 86, 92, 95, 103, 117, 118, 128, 129]	[5, 6, 12, 26, 30, 32, 36, 37, 41, 53, 59, 64, 65, 66, 68, 75, 79, 86, 91, 94, 102, 116, 118, 128, 129, 130]	['First', '-', 'strand', 'complementary', 'DNA', '(', 'cDNA', ')', 'was', 'synthesized', 'using', 'oligo-dT', 'primer', 'and', 'superscript', 'II', 'reverse', 'transcriptase', '(', 'Invitrogen', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O']
Reaction mixtures were composed of 1 × SYBR Green Tbr polymerase Master Mix (FINNZYMES, Vantaa, Finland), 0.5 × ROX, 20 pmol of each primer, and 10 ng of cDNA.	[('PMC3249587', 'M04003', 54, 64, 'polymerase')]	['Reaction', 'mixtures', 'were', 'composed', 'of', '1', '×', 'SYBR', 'Green', 'Tb', '##r', 'polymerase', 'Master', 'Mix', '(', 'FI', '##NN', '##Z', '##Y', '##ME', '##S', ',', 'Van', '##ta', '##a', ',', 'Finland', ')', ',', '0', '.', '5', '×', 'RO', '##X', ',', '20', 'pmol', 'of', 'each', 'primer', ',', 'and', '10', 'ng', 'of', 'cDNA', '.']	[0, 9, 18, 23, 32, 35, 37, 39, 44, 50, 52, 54, 65, 72, 76, 77, 79, 81, 82, 83, 85, 86, 88, 91, 93, 94, 96, 103, 104, 106, 107, 108, 110, 112, 114, 115, 117, 120, 125, 128, 133, 139, 141, 145, 148, 151, 154, 158]	[8, 17, 22, 31, 34, 36, 38, 43, 49, 52, 53, 64, 71, 75, 77, 79, 81, 82, 83, 85, 86, 87, 91, 93, 94, 95, 103, 104, 105, 107, 108, 109, 111, 114, 115, 116, 119, 124, 127, 132, 139, 140, 144, 147, 150, 153, 158, 159]	['Reaction', 'mixtures', 'were', 'composed', 'of', '1', '×', 'SYBR', 'Green', 'Tbr', 'polymerase', 'Master', 'Mix', '(', 'FINNZYMES', ',', 'Vantaa', ',', 'Finland', ')', ',', '0.5', '×', 'ROX', ',', '20', 'pmol', 'of', 'each', 'primer', ',', 'and', '10', 'ng', 'of', 'cDNA', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 6, 1, 3, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The fragment encompassing the promoter region of APOM, -1747 to +55, was amplified with primers containing restriction endonuclease sites.	[('PMC3249587', 'M05000', 119, 131, 'endonuclease')]	['The', 'fragment', 'encompassing', 'the', 'promoter', 'region', 'of', 'AP', '##OM', ',', '-', '174', '##7', 'to', '+', '55', ',', 'was', 'amplified', 'with', 'primers', 'containing', 'restriction', 'end', '##onuclease', 'sites', '.']	[0, 4, 13, 26, 30, 39, 46, 49, 51, 53, 55, 56, 59, 61, 64, 65, 67, 69, 73, 83, 88, 96, 107, 119, 122, 132, 137]	[3, 12, 25, 29, 38, 45, 48, 51, 53, 54, 56, 59, 60, 63, 65, 67, 68, 72, 82, 87, 95, 106, 118, 122, 131, 137, 138]	['The', 'fragment', 'encompassing', 'the', 'promoter', 'region', 'of', 'APOM', ',', '-', '1747', 'to', '+55', ',', 'was', 'amplified', 'with', 'primers', 'containing', 'restriction', 'endonuclease', 'sites', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
Easy vector (Promega) and then sub-cloned into the luciferase expression vector pGL3 (Promega) between KpnI and HindIII sites.	[('PMC3249587', 'M05006', 51, 61, 'luciferase')]	['E', '##asy', 'vector', '(', 'Prom', '##eg', '##a', ')', 'and', 'then', 'sub', '-', 'cloned', 'into', 'the', 'luciferase', 'expression', 'vector', 'p', '##GL', '##3', '(', 'Prom', '##eg', '##a', ')', 'between', 'K', '##pn', '##I', 'and', 'Hind', '##III', 'sites', '.']	[0, 1, 5, 12, 13, 17, 19, 20, 22, 26, 31, 34, 35, 42, 47, 51, 62, 73, 80, 81, 83, 85, 86, 90, 92, 93, 95, 103, 104, 106, 108, 112, 116, 120, 125]	[1, 4, 11, 13, 17, 19, 20, 21, 25, 30, 34, 35, 41, 46, 50, 61, 72, 79, 81, 83, 84, 86, 90, 92, 93, 94, 102, 104, 106, 107, 111, 116, 119, 125, 126]	['Easy', 'vector', '(', 'Promega', ')', 'and', 'then', 'sub', '-', 'cloned', 'into', 'the', 'luciferase', 'expression', 'vector', 'pGL3', '(', 'Promega', ')', 'between', 'KpnI', 'and', 'HindIII', 'sites', '.']	[2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The preparation of cell lysate and assessment of luciferase activity were performed using the Dual-Glo Luciferase Assay System (Promega) according to manufacturer's protocol.	[('PMC3249587', 'M07003', 49, 59, 'luciferase'), ('PMC3249587', 'M07003', 103, 113, 'Luciferase')]	"['The', 'preparation', 'of', 'cell', 'lysate', 'and', 'assessment', 'of', 'luciferase', 'activity', 'were', 'performed', 'using', 'the', 'Dual', '-', 'Gl', '##o', 'Luc', '##ifera', '##se', 'Assay', 'System', '(', 'Prom', '##eg', '##a', ')', 'according', 'to', 'manufacturer', ""'"", 's', 'protocol', '.']"	[0, 4, 16, 19, 24, 31, 35, 46, 49, 60, 69, 74, 84, 90, 94, 98, 99, 101, 103, 106, 111, 114, 120, 127, 128, 132, 134, 135, 137, 147, 150, 162, 163, 165, 173]	[3, 15, 18, 23, 30, 34, 45, 48, 59, 68, 73, 83, 89, 93, 98, 99, 101, 102, 106, 111, 113, 119, 126, 128, 132, 134, 135, 136, 146, 149, 162, 163, 164, 173, 174]	"['The', 'preparation', 'of', 'cell', 'lysate', 'and', 'assessment', 'of', 'luciferase', 'activity', 'were', 'performed', 'using', 'the', 'Dual-Glo', 'Luciferase', 'Assay', 'System', '(', 'Promega', ')', 'according', 'to', ""manufacturer's"", 'protocol', '.']"	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Luciferase activity was measured using a Lumat LB 9507 luminometer (EG & G Berthhold, Bad Wildbad, Germany).	[('PMC3249587', 'M07004', 0, 10, 'Luciferase')]	['Luc', '##ifera', '##se', 'activity', 'was', 'measured', 'using', 'a', 'Lu', '##mat', 'LB', '95', '##07', 'lumin', '##ometer', '(', 'EG', '&', 'G', 'Bert', '##hh', '##old', ',', 'Bad', 'Wild', '##bad', ',', 'Germany', ')', '.']	[0, 3, 8, 11, 20, 24, 33, 39, 41, 43, 47, 50, 52, 55, 60, 67, 68, 71, 73, 75, 79, 81, 84, 86, 90, 94, 97, 99, 106, 107]	[3, 8, 10, 19, 23, 32, 38, 40, 43, 46, 49, 52, 54, 60, 66, 68, 70, 72, 74, 79, 81, 84, 85, 89, 94, 97, 98, 106, 107, 108]	['Luciferase', 'activity', 'was', 'measured', 'using', 'a', 'Lumat', 'LB', '9507', 'luminometer', '(', 'EG', '&', 'G', 'Berthhold', ',', 'Bad', 'Wildbad', ',', 'Germany', ')', '.']	[3, 1, 1, 1, 1, 1, 2, 1, 2, 2, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Firefly luciferase activity, as AVPR1A promoter activity, was normalized using the activity of Renilla luciferase.	[('PMC3249587', 'M07005', 0, 18, 'Firefly luciferase'), ('PMC3249587', 'M07005', 103, 113, 'luciferase')]	['Fire', '##fly', 'luciferase', 'activity', ',', 'as', 'AV', '##PR', '##1', '##A', 'promoter', 'activity', ',', 'was', 'normalized', 'using', 'the', 'activity', 'of', 'Ren', '##illa', 'luciferase', '.']	[0, 4, 8, 19, 27, 29, 32, 34, 36, 37, 39, 48, 56, 58, 62, 73, 79, 83, 92, 95, 98, 103, 113]	[4, 7, 18, 27, 28, 31, 34, 36, 37, 38, 47, 56, 57, 61, 72, 78, 82, 91, 94, 98, 102, 113, 114]	['Firefly', 'luciferase', 'activity', ',', 'as', 'AVPR1A', 'promoter', 'activity', ',', 'was', 'normalized', 'using', 'the', 'activity', 'of', 'Renilla', 'luciferase', '.']	[2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O']
Luciferase activity was expressed as relative light units (RLUs).	[('PMC3249587', 'M07006', 0, 10, 'Luciferase')]	['Luc', '##ifera', '##se', 'activity', 'was', 'expressed', 'as', 'relative', 'light', 'units', '(', 'RL', '##Us', ')', '.']	[0, 3, 8, 11, 20, 24, 34, 37, 46, 52, 58, 59, 61, 63, 64]	[3, 8, 10, 19, 23, 33, 36, 45, 51, 57, 59, 61, 63, 64, 65]	['Luciferase', 'activity', 'was', 'expressed', 'as', 'relative', 'light', 'units', '(', 'RLUs', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Luciferase reporter assay was performed to further explore whether the C to A substitution at the promoter region of APOM affects the transcription activity.	[('PMC3249587', 'R05003', 0, 10, 'Luciferase')]	['Luc', '##ifera', '##se', 'reporter', 'assay', 'was', 'performed', 'to', 'further', 'explore', 'whether', 'the', 'C', 'to', 'A', 'substitution', 'at', 'the', 'promoter', 'region', 'of', 'AP', '##OM', 'affects', 'the', 'transcription', 'activity', '.']	[0, 3, 8, 11, 20, 26, 30, 40, 43, 51, 59, 67, 71, 73, 76, 78, 91, 94, 98, 107, 114, 117, 119, 122, 130, 134, 148, 156]	[3, 8, 10, 19, 25, 29, 39, 42, 50, 58, 66, 70, 72, 75, 77, 90, 93, 97, 106, 113, 116, 119, 121, 129, 133, 147, 156, 157]	['Luciferase', 'reporter', 'assay', 'was', 'performed', 'to', 'further', 'explore', 'whether', 'the', 'C', 'to', 'A', 'substitution', 'at', 'the', 'promoter', 'region', 'of', 'APOM', 'affects', 'the', 'transcription', 'activity', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The luciferase activity of the rs805297-A construct was slightly decreased compared with that of the rs805297-C construct in the HEK293 cells (P = 0.016) (Figure 2B).	[('PMC3249587', 'R05004', 4, 14, 'luciferase')]	['The', 'luciferase', 'activity', 'of', 'the', 'rs', '##80', '##52', '##97', '-', 'A', 'construct', 'was', 'slightly', 'decreased', 'compared', 'with', 'that', 'of', 'the', 'rs', '##80', '##52', '##97', '-', 'C', 'construct', 'in', 'the', 'HEK', '##293', 'cells', '(', 'P', '=', '0', '.', '01', '##6', ')', '(', 'Figure', '2', '##B', ')', '.']	[0, 4, 15, 24, 27, 31, 33, 35, 37, 39, 40, 42, 52, 56, 65, 75, 84, 89, 94, 97, 101, 103, 105, 107, 109, 110, 112, 122, 125, 129, 132, 136, 142, 143, 145, 147, 148, 149, 151, 152, 154, 155, 162, 163, 164, 165]	[3, 14, 23, 26, 30, 33, 35, 37, 39, 40, 41, 51, 55, 64, 74, 83, 88, 93, 96, 100, 103, 105, 107, 109, 110, 111, 121, 124, 128, 132, 135, 141, 143, 144, 146, 148, 149, 151, 152, 153, 155, 161, 163, 164, 165, 166]	['The', 'luciferase', 'activity', 'of', 'the', 'rs805297-A', 'construct', 'was', 'slightly', 'decreased', 'compared', 'with', 'that', 'of', 'the', 'rs805297-C', 'construct', 'in', 'the', 'HEK293', 'cells', '(', 'P', '=', '0.016', ')', '(', 'Figure', '2B', ')', '.']	[1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1]	['O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, we found one SNP within guanine deaminase, which was associated in the GENDEP GWAS approach, significantly associated with TESI.	[('PMC3260972', 'D01006', 33, 50, 'guanine deaminase')]	['However', ',', 'we', 'found', 'one', 'SNP', 'within', 'guan', '##ine', 'de', '##aminase', ',', 'which', 'was', 'associated', 'in', 'the', 'GEN', '##DE', '##P', 'GW', '##AS', 'approach', ',', 'significantly', 'associated', 'with', 'TE', '##SI', '.']	[0, 7, 9, 12, 18, 22, 26, 33, 37, 41, 43, 50, 52, 58, 62, 73, 76, 80, 83, 85, 87, 89, 92, 100, 102, 116, 127, 132, 134, 136]	[7, 8, 11, 17, 21, 25, 32, 37, 40, 43, 50, 51, 57, 61, 72, 75, 79, 83, 85, 86, 89, 91, 100, 101, 115, 126, 131, 134, 136, 137]	['However', ',', 'we', 'found', 'one', 'SNP', 'within', 'guanine', 'deaminase', ',', 'which', 'was', 'associated', 'in', 'the', 'GENDEP', 'GWAS', 'approach', ',', 'significantly', 'associated', 'with', 'TESI', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the Genome-Based Therapeutic Drugs for Depression (GENDEP) study, a genetic marker in the vicinity of the guanine deaminase (guanine deaminase) gene was associated with emergent or worsening of suicidal ideation (Perroud et al, 2010).	[('PMC3260972', 'I01005', 109, 126, 'guanine deaminase'), ('PMC3260972', 'I01005', 128, 145, 'guanine deaminase')]	['In', 'the', 'Genome', '-', 'Based', 'Therapeutic', 'Drugs', 'for', 'Depression', '(', 'GEN', '##DE', '##P', ')', 'study', ',', 'a', 'genetic', 'marker', 'in', 'the', 'vicinity', 'of', 'the', 'guan', '##ine', 'de', '##aminase', '(', 'guan', '##ine', 'de', '##aminase', ')', 'gene', 'was', 'associated', 'with', 'emergent', 'or', 'worsening', 'of', 'suicidal', 'idea', '##tion', '(', 'Per', '##ro', '##ud', 'et', 'al', ',', '2010', ')', '.']	[0, 3, 7, 13, 14, 20, 32, 38, 42, 53, 54, 57, 59, 60, 62, 67, 69, 71, 79, 86, 89, 93, 102, 105, 109, 113, 117, 119, 127, 128, 132, 136, 138, 145, 147, 152, 156, 167, 172, 181, 184, 194, 197, 206, 210, 215, 216, 219, 221, 224, 227, 229, 231, 235, 236]	[2, 6, 13, 14, 19, 31, 37, 41, 52, 54, 57, 59, 60, 61, 67, 68, 70, 78, 85, 88, 92, 101, 104, 108, 113, 116, 119, 126, 128, 132, 135, 138, 145, 146, 151, 155, 166, 171, 180, 183, 193, 196, 205, 210, 214, 216, 219, 221, 223, 226, 229, 230, 235, 236, 237]	['In', 'the', 'Genome', '-', 'Based', 'Therapeutic', 'Drugs', 'for', 'Depression', '(', 'GENDEP', ')', 'study', ',', 'a', 'genetic', 'marker', 'in', 'the', 'vicinity', 'of', 'the', 'guanine', 'deaminase', '(', 'guanine', 'deaminase', ')', 'gene', 'was', 'associated', 'with', 'emergent', 'or', 'worsening', 'of', 'suicidal', 'ideation', '(', 'Perroud', 'et', 'al', ',', '2010', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In candidate gene studies, associations with suicidal ideation were found with genetic markers within the genes encoding the glutamate receptors GRIK2 and GRIA3 (Laje et al, 2007), and the cyclic adenosine response-element binding protein (CREB1) (Perlis et al, 2007b) in the STAR*D cohort and the genes encoding brain-derived neurotrophic factor (BDNF), the neurotrophic tyrosine kinase receptor type 2 (NTRK2), and α-2 adrenergic receptor (ADRA2A) (Perroud et al, 2009) in GENDEP.	[('PMC3260972', 'I01006', 372, 387, 'tyrosine kinase')]	['In', 'candidate', 'gene', 'studies', ',', 'associations', 'with', 'suicidal', 'idea', '##tion', 'were', 'found', 'with', 'genetic', 'markers', 'within', 'the', 'genes', 'encoding', 'the', 'glutamate', 'receptors', 'GR', '##IK', '##2', 'and', 'GR', '##IA', '##3', '(', 'La', '##je', 'et', 'al', ',', '2007', ')', ',', 'and', 'the', 'cyclic', 'adenosine', 'response', '-', 'element', 'binding', 'protein', '(', 'CREB', '##1', ')', '(', 'Per', '##lis', 'et', 'al', ',', '2007', '##b', ')', 'in', 'the', 'ST', '##AR', '*', 'D', 'cohort', 'and', 'the', 'genes', 'encoding', 'brain', '-', 'derived', 'neurot', '##rophic', 'factor', '(', 'BDNF', ')', ',', 'the', 'neurot', '##rophic', 'tyrosine', 'kinase', 'receptor', 'type', '2', '(', 'NT', '##RK', '##2', ')', ',', 'and', 'α', '-', '2', 'adren', '##ergic', 'receptor', '(', 'AD', '##RA', '##2', '##A', ')', '(', 'Per', '##ro', '##ud', 'et', 'al', ',', '2009', ')', 'in', 'GEN', '##DE', '##P', '.']	[0, 3, 13, 18, 25, 27, 40, 45, 54, 58, 63, 68, 74, 79, 87, 95, 102, 106, 112, 121, 125, 135, 145, 147, 149, 151, 155, 157, 159, 161, 162, 164, 167, 170, 172, 174, 178, 179, 181, 185, 189, 196, 206, 214, 215, 223, 231, 239, 240, 244, 245, 247, 248, 251, 255, 258, 260, 262, 266, 267, 269, 272, 276, 278, 280, 281, 283, 290, 294, 298, 304, 313, 318, 319, 327, 333, 340, 347, 348, 352, 353, 355, 359, 365, 372, 381, 388, 397, 402, 404, 405, 407, 409, 410, 411, 413, 417, 418, 419, 421, 426, 432, 441, 442, 444, 446, 447, 448, 450, 451, 454, 456, 459, 462, 464, 466, 470, 472, 475, 478, 480, 481]	[2, 12, 17, 25, 26, 39, 44, 53, 58, 62, 67, 73, 78, 86, 94, 101, 105, 111, 120, 124, 134, 144, 147, 149, 150, 154, 157, 159, 160, 162, 164, 166, 169, 172, 173, 178, 179, 180, 184, 188, 195, 205, 214, 215, 222, 230, 238, 240, 244, 245, 246, 248, 251, 254, 257, 260, 261, 266, 267, 268, 271, 275, 278, 280, 281, 282, 289, 293, 297, 303, 312, 318, 319, 326, 333, 339, 346, 348, 352, 353, 354, 358, 365, 371, 380, 387, 396, 401, 403, 405, 407, 409, 410, 411, 412, 416, 418, 419, 420, 426, 431, 440, 442, 444, 446, 447, 448, 449, 451, 454, 456, 458, 461, 464, 465, 470, 471, 474, 478, 480, 481, 482]	['In', 'candidate', 'gene', 'studies', ',', 'associations', 'with', 'suicidal', 'ideation', 'were', 'found', 'with', 'genetic', 'markers', 'within', 'the', 'genes', 'encoding', 'the', 'glutamate', 'receptors', 'GRIK2', 'and', 'GRIA3', '(', 'Laje', 'et', 'al', ',', '2007', ')', ',', 'and', 'the', 'cyclic', 'adenosine', 'response', '-', 'element', 'binding', 'protein', '(', 'CREB1', ')', '(', 'Perlis', 'et', 'al', ',', '2007b', ')', 'in', 'the', 'STAR*D', 'cohort', 'and', 'the', 'genes', 'encoding', 'brain', '-', 'derived', 'neurotrophic', 'factor', '(', 'BDNF', ')', ',', 'the', 'neurotrophic', 'tyrosine', 'kinase', 'receptor', 'type', '2', '(', 'NTRK2', ')', ',', 'and', 'α-2', 'adrenergic', 'receptor', '(', 'ADRA2A', ')', '(', 'Perroud', 'et', 'al', ',', '2009', ')', 'in', 'GENDEP', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 2, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the GWAS approach, the best associated SNP rs11143230 was located in the vicinity of guanine deaminase.	[('PMC3260972', 'R06000', 88, 105, 'guanine deaminase')]	['In', 'the', 'GW', '##AS', 'approach', ',', 'the', 'best', 'associated', 'SNP', 'rs', '##111', '##43', '##23', '##0', 'was', 'located', 'in', 'the', 'vicinity', 'of', 'guan', '##ine', 'de', '##aminase', '.']	[0, 3, 7, 9, 12, 20, 22, 26, 31, 42, 46, 48, 51, 53, 55, 57, 61, 69, 72, 76, 85, 88, 92, 96, 98, 105]	[2, 6, 9, 11, 20, 21, 25, 30, 41, 45, 48, 51, 53, 55, 56, 60, 68, 71, 75, 84, 87, 92, 95, 98, 105, 106]	['In', 'the', 'GWAS', 'approach', ',', 'the', 'best', 'associated', 'SNP', 'rs11143230', 'was', 'located', 'in', 'the', 'vicinity', 'of', 'guanine', 'deaminase', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
We analyzed 68 SNPs (rs11143230 was not genotyped) within guanine deaminase in our discovery sample.	[('PMC3260972', 'R06001', 58, 75, 'guanine deaminase')]	['We', 'analyzed', '68', 'SNPs', '(', 'rs', '##111', '##43', '##23', '##0', 'was', 'not', 'genotype', '##d', ')', 'within', 'guan', '##ine', 'de', '##aminase', 'in', 'our', 'discovery', 'sample', '.']	[0, 3, 12, 15, 20, 21, 23, 26, 28, 30, 32, 36, 40, 48, 49, 51, 58, 62, 66, 68, 76, 79, 83, 93, 99]	[2, 11, 14, 19, 21, 23, 26, 28, 30, 31, 35, 39, 48, 49, 50, 57, 62, 65, 68, 75, 78, 82, 92, 99, 100]	['We', 'analyzed', '68', 'SNPs', '(', 'rs11143230', 'was', 'not', 'genotyped', ')', 'within', 'guanine', 'deaminase', 'in', 'our', 'discovery', 'sample', '.']	[1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 2, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Previous genome-wide association studies (GWAS) have identified numerous single nucleotide polymorphisms (SNPs) associated with the number of cigarettes smoked per day (CPD) and a Dopamine Beta-Hydroxylase (Dopamine Beta-Hydroxylase) locus associated with smoking cessation in multiple populations.	[('PMC3302576', 'A00001', 180, 205, 'Dopamine Beta-Hydroxylase'), ('PMC3302576', 'A00001', 207, 232, 'Dopamine Beta-Hydroxylase')]	['Previous', 'genome', '-', 'wide', 'association', 'studies', '(', 'GW', '##AS', ')', 'have', 'identified', 'numerous', 'single', 'nucleotide', 'polymorphisms', '(', 'SNPs', ')', 'associated', 'with', 'the', 'number', 'of', 'cigarettes', 'smoke', '##d', 'per', 'day', '(', 'CP', '##D', ')', 'and', 'a', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', '(', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', ')', 'locus', 'associated', 'with', 'smoking', 'cessation', 'in', 'multiple', 'populations', '.']	[0, 9, 15, 16, 21, 33, 41, 42, 44, 46, 48, 53, 64, 73, 80, 91, 105, 106, 110, 112, 123, 128, 132, 139, 142, 153, 158, 160, 164, 168, 169, 171, 172, 174, 178, 180, 182, 184, 187, 189, 193, 194, 199, 201, 204, 206, 207, 209, 211, 214, 216, 220, 221, 226, 228, 231, 232, 234, 240, 251, 256, 264, 274, 277, 286, 297]	[8, 15, 16, 20, 32, 40, 42, 44, 46, 47, 52, 63, 72, 79, 90, 104, 106, 110, 111, 122, 127, 131, 138, 141, 152, 158, 159, 163, 167, 169, 171, 172, 173, 177, 179, 182, 184, 187, 188, 193, 194, 199, 201, 204, 205, 207, 209, 211, 214, 215, 220, 221, 226, 228, 231, 232, 233, 239, 250, 255, 263, 273, 276, 285, 297, 298]	['Previous', 'genome', '-', 'wide', 'association', 'studies', '(', 'GWAS', ')', 'have', 'identified', 'numerous', 'single', 'nucleotide', 'polymorphisms', '(', 'SNPs', ')', 'associated', 'with', 'the', 'number', 'of', 'cigarettes', 'smoked', 'per', 'day', '(', 'CPD', ')', 'and', 'a', 'Dopamine', 'Beta-Hydroxylase', '(', 'Dopamine', 'Beta-Hydroxylase', ')', 'locus', 'associated', 'with', 'smoking', 'cessation', 'in', 'multiple', 'populations', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 4, 6, 1, 4, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A candidate SNP (rs3025343) in the Dopamine Beta-Hydroxylase was significantly (p=0.015) associated with smoking cessation.	[('PMC3302576', 'A03003', 35, 60, 'Dopamine Beta-Hydroxylase')]	['A', 'candidate', 'SNP', '(', 'rs', '##30', '##25', '##34', '##3', ')', 'in', 'the', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', 'was', 'significantly', '(', 'p', '=', '0', '.', '01', '##5', ')', 'associated', 'with', 'smoking', 'cessation', '.']	[0, 2, 12, 16, 17, 19, 21, 23, 25, 26, 28, 31, 35, 37, 39, 42, 44, 48, 49, 54, 56, 59, 61, 65, 79, 80, 81, 82, 83, 84, 86, 87, 89, 100, 105, 113, 122]	[1, 11, 15, 17, 19, 21, 23, 25, 26, 27, 30, 34, 37, 39, 42, 43, 48, 49, 54, 56, 59, 60, 64, 78, 80, 81, 82, 83, 84, 86, 87, 88, 99, 104, 112, 122, 123]	['A', 'candidate', 'SNP', '(', 'rs3025343', ')', 'in', 'the', 'Dopamine', 'Beta-Hydroxylase', 'was', 'significantly', '(', 'p=0.015', ')', 'associated', 'with', 'smoking', 'cessation', '.']	[1, 1, 1, 1, 5, 1, 1, 1, 4, 6, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Associations of CHRNA3/CHRNA5 and CYP2A6 loci with CPD and Dopamine Beta-Hydroxylase with smoking cessation are also likely of importance in the smoking behaviors of COPD patients.	[('PMC3302576', 'A04001', 59, 84, 'Dopamine Beta-Hydroxylase')]	['Association', '##s', 'of', 'CH', '##RNA', '##3', '/', 'CH', '##RNA', '##5', 'and', 'CYP', '##2', '##A', '##6', 'loci', 'with', 'CP', '##D', 'and', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', 'with', 'smoking', 'cessation', 'are', 'also', 'likely', 'of', 'importance', 'in', 'the', 'smoking', 'behaviors', 'of', 'COPD', 'patients', '.']	[0, 11, 13, 16, 18, 21, 22, 23, 25, 28, 30, 34, 37, 38, 39, 41, 46, 51, 53, 55, 59, 61, 63, 66, 68, 72, 73, 78, 80, 83, 85, 90, 98, 108, 112, 117, 124, 127, 138, 141, 145, 153, 163, 166, 171, 179]	[11, 12, 15, 18, 21, 22, 23, 25, 28, 29, 33, 37, 38, 39, 40, 45, 50, 53, 54, 58, 61, 63, 66, 67, 72, 73, 78, 80, 83, 84, 89, 97, 107, 111, 116, 123, 126, 137, 140, 144, 152, 162, 165, 170, 179, 180]	['Associations', 'of', 'CHRNA3', '/', 'CHRNA5', 'and', 'CYP2A6', 'loci', 'with', 'CPD', 'and', 'Dopamine', 'Beta-Hydroxylase', 'with', 'smoking', 'cessation', 'are', 'also', 'likely', 'of', 'importance', 'in', 'the', 'smoking', 'behaviors', 'of', 'COPD', 'patients', '.']	[2, 1, 3, 1, 3, 1, 4, 1, 1, 2, 1, 4, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of importance, we additionally confirmed in COPD subjects the previously reported association of a marker (rs3025343) in the Dopamine Beta-Hydroxylase locus with smoking cessation.	[('PMC3302576', 'D00003', 125, 150, 'Dopamine Beta-Hydroxylase')]	['Of', 'importance', ',', 'we', 'additionally', 'confirmed', 'in', 'COPD', 'subjects', 'the', 'previously', 'reported', 'association', 'of', 'a', 'marker', '(', 'rs', '##30', '##25', '##34', '##3', ')', 'in', 'the', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', 'locus', 'with', 'smoking', 'cessation', '.']	[0, 3, 13, 15, 18, 31, 41, 44, 49, 58, 62, 73, 82, 94, 97, 99, 106, 107, 109, 111, 113, 115, 116, 118, 121, 125, 127, 129, 132, 134, 138, 139, 144, 146, 149, 151, 157, 162, 170, 179]	[2, 13, 14, 17, 30, 40, 43, 48, 57, 61, 72, 81, 93, 96, 98, 105, 107, 109, 111, 113, 115, 116, 117, 120, 124, 127, 129, 132, 133, 138, 139, 144, 146, 149, 150, 156, 161, 169, 179, 180]	['Of', 'importance', ',', 'we', 'additionally', 'confirmed', 'in', 'COPD', 'subjects', 'the', 'previously', 'reported', 'association', 'of', 'a', 'marker', '(', 'rs3025343', ')', 'in', 'the', 'Dopamine', 'Beta-Hydroxylase', 'locus', 'with', 'smoking', 'cessation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 4, 6, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Analysis of smoking cessation did not reveal any loci associated below the suggestive significance level, and it showed that the previously reported 10 association between rs3025343 in the Dopamine Beta-Hydroxylase locus can be replicated in COPD subjects with a nominal significance threshold.	[('PMC3302576', 'D06000', 189, 214, 'Dopamine Beta-Hydroxylase')]	['Analysis', 'of', 'smoking', 'cessation', 'did', 'not', 'reveal', 'any', 'loci', 'associated', 'below', 'the', 'suggestive', 'significance', 'level', ',', 'and', 'it', 'showed', 'that', 'the', 'previously', 'reported', '10', 'association', 'between', 'rs', '##30', '##25', '##34', '##3', 'in', 'the', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', 'locus', 'can', 'be', 'replicated', 'in', 'COPD', 'subjects', 'with', 'a', 'nominal', 'significance', 'threshold', '.']	[0, 9, 12, 20, 30, 34, 38, 45, 49, 54, 65, 71, 75, 86, 99, 104, 106, 110, 113, 120, 125, 129, 140, 149, 152, 164, 172, 174, 176, 178, 180, 182, 185, 189, 191, 193, 196, 198, 202, 203, 208, 210, 213, 215, 221, 225, 228, 239, 242, 247, 256, 261, 263, 271, 284, 293]	[8, 11, 19, 29, 33, 37, 44, 48, 53, 64, 70, 74, 85, 98, 104, 105, 109, 112, 119, 124, 128, 139, 148, 151, 163, 171, 174, 176, 178, 180, 181, 184, 188, 191, 193, 196, 197, 202, 203, 208, 210, 213, 214, 220, 224, 227, 238, 241, 246, 255, 260, 262, 270, 283, 293, 294]	['Analysis', 'of', 'smoking', 'cessation', 'did', 'not', 'reveal', 'any', 'loci', 'associated', 'below', 'the', 'suggestive', 'significance', 'level', ',', 'and', 'it', 'showed', 'that', 'the', 'previously', 'reported', '10', 'association', 'between', 'rs3025343', 'in', 'the', 'Dopamine', 'Beta-Hydroxylase', 'locus', 'can', 'be', 'replicated', 'in', 'COPD', 'subjects', 'with', 'a', 'nominal', 'significance', 'threshold', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 4, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dopamine Beta-Hydroxylase is a plausible candidate gene for smoking cessation since it participates in the metabolism of dopamine.	[('PMC3302576', 'D06001', 0, 25, 'Dopamine Beta-Hydroxylase')]	['Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', 'is', 'a', 'plausible', 'candidate', 'gene', 'for', 'smoking', 'cessation', 'since', 'it', 'participates', 'in', 'the', 'metabolism', 'of', 'dopamine', '.']	[0, 2, 4, 7, 9, 13, 14, 19, 21, 24, 26, 29, 31, 41, 51, 56, 60, 68, 78, 84, 87, 100, 103, 107, 118, 121, 129]	[2, 4, 7, 8, 13, 14, 19, 21, 24, 25, 28, 30, 40, 50, 55, 59, 67, 77, 83, 86, 99, 102, 106, 117, 120, 129, 130]	['Dopamine', 'Beta-Hydroxylase', 'is', 'a', 'plausible', 'candidate', 'gene', 'for', 'smoking', 'cessation', 'since', 'it', 'participates', 'in', 'the', 'metabolism', 'of', 'dopamine', '.']	[4, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recent Genome Wide Association Studies (GWAS) have identified loci associated with smoking cessation (Dopamine Beta-Hydroxylase on chromosome 9q34) and CPD (e.g. nicotinic acetylcholine receptor locus on chromosome 15q25 and Cytochrome P2A6 (CYP2A6) locus on chromosome 19q13) in multiple populations,8–11 although GWAS of smoking behaviors specifically within COPD subjects have not been reported.	[('PMC3302576', 'I01001', 102, 127, 'Dopamine Beta-Hydroxylase')]	['Recent', 'Genome', 'Wide', 'Association', 'Studies', '(', 'GW', '##AS', ')', 'have', 'identified', 'loci', 'associated', 'with', 'smoking', 'cessation', '(', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', 'on', 'chromosome', '9', '##q', '##34', ')', 'and', 'CP', '##D', '(', 'e', '.', 'g', '.', 'nicotin', '##ic', 'acetylcholine', 'receptor', 'locus', 'on', 'chromosome', '15', '##q', '##25', 'and', 'Cyt', '##ochrome', 'P', '##2', '##A', '##6', '(', 'CYP', '##2', '##A', '##6', ')', 'locus', 'on', 'chromosome', '19', '##q', '##13', ')', 'in', 'multiple', 'populations', ',', '8', '–', '11', 'although', 'GW', '##AS', 'of', 'smoking', 'behaviors', 'specifically', 'within', 'COPD', 'subjects', 'have', 'not', 'been', 'reported', '.']	[0, 7, 14, 19, 31, 39, 40, 42, 44, 46, 51, 62, 67, 78, 83, 91, 101, 102, 104, 106, 109, 111, 115, 116, 121, 123, 126, 128, 131, 142, 143, 144, 146, 148, 152, 154, 156, 157, 158, 159, 160, 162, 169, 172, 186, 195, 201, 204, 215, 217, 218, 221, 225, 228, 236, 237, 238, 239, 241, 242, 245, 246, 247, 248, 250, 256, 259, 270, 272, 273, 275, 277, 280, 289, 300, 301, 302, 303, 306, 315, 317, 320, 323, 331, 341, 354, 361, 366, 375, 380, 384, 389, 397]	[6, 13, 18, 30, 38, 40, 42, 44, 45, 50, 61, 66, 77, 82, 90, 100, 102, 104, 106, 109, 110, 115, 116, 121, 123, 126, 127, 130, 141, 143, 144, 146, 147, 151, 154, 155, 157, 158, 159, 160, 161, 169, 171, 185, 194, 200, 203, 214, 217, 218, 220, 224, 228, 235, 237, 238, 239, 240, 242, 245, 246, 247, 248, 249, 255, 258, 269, 272, 273, 275, 276, 279, 288, 300, 301, 302, 303, 305, 314, 317, 319, 322, 330, 340, 353, 360, 365, 374, 379, 383, 388, 397, 398]	['Recent', 'Genome', 'Wide', 'Association', 'Studies', '(', 'GWAS', ')', 'have', 'identified', 'loci', 'associated', 'with', 'smoking', 'cessation', '(', 'Dopamine', 'Beta-Hydroxylase', 'on', 'chromosome', '9q34', ')', 'and', 'CPD', '(', 'e.g', '.', 'nicotinic', 'acetylcholine', 'receptor', 'locus', 'on', 'chromosome', '15q25', 'and', 'Cytochrome', 'P2A6', '(', 'CYP2A6', ')', 'locus', 'on', 'chromosome', '19q13', ')', 'in', 'multiple', 'populations', ',', '8–', '11', 'although', 'GWAS', 'of', 'smoking', 'behaviors', 'specifically', 'within', 'COPD', 'subjects', 'have', 'not', 'been', 'reported', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 6, 1, 1, 3, 1, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 3, 1, 2, 4, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Since a candidate SNP from the Dopamine Beta-Hydroxylase locus and most of the candidate SNPs from the CYP2A6 locus were imputed in all cohorts, we searched for the best proxy SNP genotyped in at least 3 of the cohorts.	[('PMC3302576', 'M02002', 31, 56, 'Dopamine Beta-Hydroxylase')]	['Since', 'a', 'candidate', 'SNP', 'from', 'the', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', 'locus', 'and', 'most', 'of', 'the', 'candidate', 'SNPs', 'from', 'the', 'CYP', '##2', '##A', '##6', 'locus', 'were', 'imp', '##uted', 'in', 'all', 'cohorts', ',', 'we', 'searched', 'for', 'the', 'best', 'proxy', 'SNP', 'genotype', '##d', 'in', 'at', 'least', '3', 'of', 'the', 'cohorts', '.']	[0, 6, 8, 18, 22, 27, 31, 33, 35, 38, 40, 44, 45, 50, 52, 55, 57, 63, 67, 72, 75, 79, 89, 94, 99, 103, 106, 107, 108, 110, 116, 121, 124, 129, 132, 136, 143, 145, 148, 157, 161, 165, 170, 176, 180, 188, 190, 193, 196, 202, 204, 207, 211, 218]	[5, 7, 17, 21, 26, 30, 33, 35, 38, 39, 44, 45, 50, 52, 55, 56, 62, 66, 71, 74, 78, 88, 93, 98, 102, 106, 107, 108, 109, 115, 120, 124, 128, 131, 135, 143, 144, 147, 156, 160, 164, 169, 175, 179, 188, 189, 192, 195, 201, 203, 206, 210, 218, 219]	['Since', 'a', 'candidate', 'SNP', 'from', 'the', 'Dopamine', 'Beta-Hydroxylase', 'locus', 'and', 'most', 'of', 'the', 'candidate', 'SNPs', 'from', 'the', 'CYP2A6', 'locus', 'were', 'imputed', 'in', 'all', 'cohorts', ',', 'we', 'searched', 'for', 'the', 'best', 'proxy', 'SNP', 'genotyped', 'in', 'at', 'least', '3', 'of', 'the', 'cohorts', '.']	[1, 1, 1, 1, 1, 1, 4, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Candidate SNP rs3025343 in the Dopamine Beta-Hydroxylase locus showed nominally significant association with smoking cessation with the same direction of effect as seen in recent GWAS, yet with substantial heterogeneity between studies (table 3).	[('PMC3302576', 'R04004', 31, 56, 'Dopamine Beta-Hydroxylase')]	['Candida', '##te', 'SNP', 'rs', '##30', '##25', '##34', '##3', 'in', 'the', 'Do', '##pa', '##min', '##e', 'Beta', '-', 'Hydro', '##xy', '##las', '##e', 'locus', 'showed', 'nominal', '##ly', 'significant', 'association', 'with', 'smoking', 'cessation', 'with', 'the', 'same', 'direction', 'of', 'effect', 'as', 'seen', 'in', 'recent', 'GW', '##AS', ',', 'yet', 'with', 'substantial', 'heterogeneity', 'between', 'studies', '(', 'table', '3', ')', '.']	[0, 7, 10, 14, 16, 18, 20, 22, 24, 27, 31, 33, 35, 38, 40, 44, 45, 50, 52, 55, 57, 63, 70, 77, 80, 92, 104, 109, 117, 127, 132, 136, 141, 151, 154, 161, 164, 169, 172, 179, 181, 183, 185, 189, 194, 206, 220, 228, 236, 237, 243, 244, 245]	[7, 9, 13, 16, 18, 20, 22, 23, 26, 30, 33, 35, 38, 39, 44, 45, 50, 52, 55, 56, 62, 69, 77, 79, 91, 103, 108, 116, 126, 131, 135, 140, 150, 153, 160, 163, 168, 171, 178, 181, 183, 184, 188, 193, 205, 219, 227, 235, 237, 242, 244, 245, 246]	['Candidate', 'SNP', 'rs3025343', 'in', 'the', 'Dopamine', 'Beta-Hydroxylase', 'locus', 'showed', 'nominally', 'significant', 'association', 'with', 'smoking', 'cessation', 'with', 'the', 'same', 'direction', 'of', 'effect', 'as', 'seen', 'in', 'recent', 'GWAS', ',', 'yet', 'with', 'substantial', 'heterogeneity', 'between', 'studies', '(', 'table', '3', ')', '.']	[2, 1, 5, 1, 1, 4, 6, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Smrt RD, et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1.	[('PMC3303194', 'F16001', 76, 92, 'ubiquitin ligase')]	['Sm', '##rt', 'RD', ',', 'et', 'al', '.', 'Micro', '##RNA', 'miR', '-', '137', 'regulates', 'neuronal', 'maturation', 'by', 'targeting', 'ubiquitin', 'ligase', 'mind', 'bomb', '-', '1', '.']	[0, 2, 5, 7, 9, 12, 14, 16, 21, 25, 28, 29, 33, 43, 52, 63, 66, 76, 86, 93, 98, 102, 103, 104]	[2, 4, 7, 8, 11, 14, 15, 21, 24, 28, 29, 32, 42, 51, 62, 65, 75, 85, 92, 97, 102, 103, 104, 105]	['Smrt', 'RD', ',', 'et', 'al', '.', 'MicroRNA', 'miR-137', 'regulates', 'neuronal', 'maturation', 'by', 'targeting', 'ubiquitin', 'ligase', 'mind', 'bomb-1', '.']	[2, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
The third best locus, rs7004633 (P = 2.8 × 10−8) on 8q21.3, is 400 kb from the nearest gene (MMP16, encoding matrix metallopeptidase 16).	[('PMC3303194', 'I05004', 109, 135, 'matrix metallopeptidase 16')]	['The', 'third', 'best', 'locus', ',', 'rs', '##700', '##46', '##33', '(', 'P', '=', '2', '.', '8', '×', '10−', '##8', ')', 'on', '8', '##q', '##21', '.', '3', ',', 'is', '400', 'kb', 'from', 'the', 'nearest', 'gene', '(', 'MMP', '##16', ',', 'encoding', 'matrix', 'metall', '##ope', '##pt', '##idase', '16', ')', '.']	[0, 4, 10, 15, 20, 22, 24, 27, 29, 32, 33, 35, 37, 38, 39, 41, 43, 46, 47, 49, 52, 53, 54, 56, 57, 58, 60, 63, 67, 70, 75, 79, 87, 92, 93, 96, 98, 100, 109, 116, 122, 125, 127, 133, 135, 136]	[3, 9, 14, 20, 21, 24, 27, 29, 31, 33, 34, 36, 38, 39, 40, 42, 46, 47, 48, 51, 53, 54, 56, 57, 58, 59, 62, 66, 69, 74, 78, 86, 91, 93, 96, 98, 99, 108, 115, 122, 125, 127, 132, 135, 136, 137]	['The', 'third', 'best', 'locus', ',', 'rs7004633', '(', 'P', '=', '2.8', '×', '10−8', ')', 'on', '8q21.3', ',', 'is', '400', 'kb', 'from', 'the', 'nearest', 'gene', '(', 'MMP16', ',', 'encoding', 'matrix', 'metallopeptidase', '16', ')', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 2, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Of the genes implicated here in wheezing and influenza acquisition, it is interesting to note that two are myosin-related genes: myosin light chain kinase (associated here with acquisition of natural influenza) and MYH14 (associated here with wheezing post-vaccination).	[('PMC3334304', 'D02000', 129, 154, 'myosin light chain kinase')]	['Of', 'the', 'genes', 'implicated', 'here', 'in', 'whe', '##ez', '##ing', 'and', 'influenza', 'acquisition', ',', 'it', 'is', 'interesting', 'to', 'note', 'that', 'two', 'are', 'myosin', '-', 'related', 'genes', ':', 'myosin', 'light', 'chain', 'kinase', '(', 'associated', 'here', 'with', 'acquisition', 'of', 'natural', 'influenza', ')', 'and', 'MY', '##H', '##14', '(', 'associated', 'here', 'with', 'whe', '##ez', '##ing', 'post', '-', 'vaccination', ')', '.']	[0, 3, 7, 13, 24, 29, 32, 35, 37, 41, 45, 55, 66, 68, 71, 74, 86, 89, 94, 99, 103, 107, 113, 114, 122, 127, 129, 136, 142, 148, 155, 156, 167, 172, 177, 189, 192, 200, 209, 211, 215, 217, 218, 221, 222, 233, 238, 243, 246, 248, 252, 256, 257, 268, 269]	[2, 6, 12, 23, 28, 31, 35, 37, 40, 44, 54, 66, 67, 70, 73, 85, 88, 93, 98, 102, 106, 113, 114, 121, 127, 128, 135, 141, 147, 154, 156, 166, 171, 176, 188, 191, 199, 209, 210, 214, 217, 218, 220, 222, 232, 237, 242, 246, 248, 251, 256, 257, 268, 269, 270]	['Of', 'the', 'genes', 'implicated', 'here', 'in', 'wheezing', 'and', 'influenza', 'acquisition', ',', 'it', 'is', 'interesting', 'to', 'note', 'that', 'two', 'are', 'myosin', '-', 'related', 'genes', ':', 'myosin', 'light', 'chain', 'kinase', '(', 'associated', 'here', 'with', 'acquisition', 'of', 'natural', 'influenza', ')', 'and', 'MYH14', '(', 'associated', 'here', 'with', 'wheezing', 'post', '-', 'vaccination', ')', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
myosin light chain kinase is a nonmuscle myosin light chain kinase isoform involved in inflammatory response and myosin light chain kinase genetic variants have been implicated in susceptibility to sepsis-induced acute lung injury and asthma38–40.	[('PMC3334304', 'D02001', 0, 25, 'myosin light chain kinase'), ('PMC3334304', 'D02001', 41, 66, 'myosin light chain kinase'), ('PMC3334304', 'D02001', 113, 138, 'myosin light chain kinase')]	['myosin', 'light', 'chain', 'kinase', 'is', 'a', 'non', '##mus', '##cle', 'myosin', 'light', 'chain', 'kinase', 'isoform', 'involved', 'in', 'inflammatory', 'response', 'and', 'myosin', 'light', 'chain', 'kinase', 'genetic', 'variants', 'have', 'been', 'implicated', 'in', 'susceptibility', 'to', 'sepsis', '-', 'induced', 'acute', 'lung', 'injury', 'and', 'asthma', '##38', '–', '40', '.']	[0, 7, 13, 19, 26, 29, 31, 34, 37, 41, 48, 54, 60, 67, 75, 84, 87, 100, 109, 113, 120, 126, 132, 139, 147, 156, 161, 166, 177, 180, 195, 198, 204, 205, 213, 219, 224, 231, 235, 241, 243, 244, 246]	[6, 12, 18, 25, 28, 30, 34, 37, 40, 47, 53, 59, 66, 74, 83, 86, 99, 108, 112, 119, 125, 131, 138, 146, 155, 160, 165, 176, 179, 194, 197, 204, 205, 212, 218, 223, 230, 234, 241, 243, 244, 246, 247]	['myosin', 'light', 'chain', 'kinase', 'is', 'a', 'nonmuscle', 'myosin', 'light', 'chain', 'kinase', 'isoform', 'involved', 'in', 'inflammatory', 'response', 'and', 'myosin', 'light', 'chain', 'kinase', 'genetic', 'variants', 'have', 'been', 'implicated', 'in', 'susceptibility', 'to', 'sepsis', '-', 'induced', 'acute', 'lung', 'injury', 'and', 'asthma38', '–', '40', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gao L, Grant AV, Rafaels N, et al. Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma.	[('PMC3334304', 'F37001', 56, 81, 'myosin light chain kinase')]	['Gao', 'L', ',', 'Grant', 'AV', ',', 'Raf', '##ael', '##s', 'N', ',', 'et', 'al', '.', 'Polym', '##orphism', '##s', 'in', 'the', 'myosin', 'light', 'chain', 'kinase', 'gene', 'that', 'confer', 'risk', 'of', 'severe', 'sepsis', 'are', 'associated', 'with', 'a', 'lower', 'risk', 'of', 'asthma', '.']	[0, 4, 5, 7, 13, 15, 17, 20, 23, 25, 26, 28, 31, 33, 35, 40, 47, 49, 52, 56, 63, 69, 75, 82, 87, 92, 99, 104, 107, 114, 121, 125, 136, 141, 143, 149, 154, 157, 163]	[3, 5, 6, 12, 15, 16, 20, 23, 24, 26, 27, 30, 33, 34, 40, 47, 48, 51, 55, 62, 68, 74, 81, 86, 91, 98, 103, 106, 113, 120, 124, 135, 140, 142, 148, 153, 156, 163, 164]	['Gao', 'L', ',', 'Grant', 'AV', ',', 'Rafaels', 'N', ',', 'et', 'al', '.', 'Polymorphisms', 'in', 'the', 'myosin', 'light', 'chain', 'kinase', 'gene', 'that', 'confer', 'risk', 'of', 'severe', 'sepsis', 'are', 'associated', 'with', 'a', 'lower', 'risk', 'of', 'asthma', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans.	[('PMC3334304', 'F38002', 17, 42, 'myosin light chain kinase')]	['A', 'variant', 'of', 'the', 'myosin', 'light', 'chain', 'kinase', 'gene', 'is', 'associated', 'with', 'severe', 'asthma', 'in', 'African', 'Americans', '.']	[0, 2, 10, 13, 17, 24, 30, 36, 43, 48, 51, 62, 67, 74, 81, 84, 92, 101]	[1, 9, 12, 16, 23, 29, 35, 42, 47, 50, 61, 66, 73, 80, 83, 91, 101, 102]	['A', 'variant', 'of', 'the', 'myosin', 'light', 'chain', 'kinase', 'gene', 'is', 'associated', 'with', 'severe', 'asthma', 'in', 'African', 'Americans', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Christie JD, Ma SF, Aplenc R, et al. Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma.	[('PMC3334304', 'F39001', 54, 79, 'myosin light chain kinase')]	['Christi', '##e', 'JD', ',', 'Ma', 'SF', ',', 'Ap', '##len', '##c', 'R', ',', 'et', 'al', '.', 'Variation', 'in', 'the', 'myosin', 'light', 'chain', 'kinase', 'gene', 'is', 'associated', 'with', 'development', 'of', 'acute', 'lung', 'injury', 'after', 'major', 'trauma', '.']	[0, 7, 9, 11, 13, 16, 18, 20, 22, 25, 27, 28, 30, 33, 35, 37, 47, 50, 54, 61, 67, 73, 80, 85, 88, 99, 104, 116, 119, 125, 130, 137, 143, 149, 155]	[7, 8, 11, 12, 15, 18, 19, 22, 25, 26, 28, 29, 32, 35, 36, 46, 49, 53, 60, 66, 72, 79, 84, 87, 98, 103, 115, 118, 124, 129, 136, 142, 148, 155, 156]	['Christie', 'JD', ',', 'Ma', 'SF', ',', 'Aplenc', 'R', ',', 'et', 'al', '.', 'Variation', 'in', 'the', 'myosin', 'light', 'chain', 'kinase', 'gene', 'is', 'associated', 'with', 'development', 'of', 'acute', 'lung', 'injury', 'after', 'major', 'trauma', '.']	[2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Seven of the associations at p<9.0×10−5 were within or near genes, including myosin, heavy chain 14 (MYH14), chromosome 8 open reading frame 34 (C8orf 34), fibroblast growth factor 1 (FGF1), transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2), glutamate receptor interacting protein 2 (GRIP2), and xylosyltransferase I (XYLT1).	[('PMC3334304', 'R03002', 312, 332, 'xylosyltransferase I')]	['Seven', 'of', 'the', 'associations', 'at', 'p', '<', '9', '.', '0', '##×10', '##−', '##5', 'were', 'within', 'or', 'near', 'genes', ',', 'including', 'myosin', ',', 'heavy', 'chain', '14', '(', 'MY', '##H', '##14', ')', ',', 'chromosome', '8', 'open', 'reading', 'frame', '34', '(', 'C', '##8', '##orf', '34', ')', ',', 'fibroblast', 'growth', 'factor', '1', '(', 'FGF', '##1', ')', ',', 'transcription', 'factor', '7', '-', 'like', '2', '(', 'T', '-', 'cell', 'specific', ',', 'HM', '##G', '-', 'box', ')', '(', 'TC', '##F', '##7', '##L', '##2', ')', ',', 'glutamate', 'receptor', 'interacting', 'protein', '2', '(', 'GR', '##IP', '##2', ')', ',', 'and', 'xyl', '##osyl', '##transferase', 'I', '(', 'XY', '##LT', '##1', ')', '.']	[0, 6, 9, 13, 26, 29, 30, 31, 32, 33, 34, 37, 38, 40, 45, 52, 55, 60, 65, 67, 77, 83, 85, 91, 97, 100, 101, 103, 104, 106, 107, 109, 120, 122, 127, 135, 141, 144, 145, 146, 147, 151, 153, 154, 156, 167, 174, 181, 183, 184, 187, 188, 189, 191, 205, 212, 213, 214, 219, 221, 222, 223, 224, 229, 237, 239, 241, 242, 243, 246, 248, 249, 251, 252, 253, 254, 255, 256, 258, 268, 277, 289, 297, 299, 300, 302, 304, 305, 306, 308, 312, 315, 319, 331, 333, 334, 336, 338, 339, 340]	[5, 8, 12, 25, 28, 30, 31, 32, 33, 34, 37, 38, 39, 44, 51, 54, 59, 65, 66, 76, 83, 84, 90, 96, 99, 101, 103, 104, 106, 107, 108, 119, 121, 126, 134, 140, 143, 145, 146, 147, 150, 153, 154, 155, 166, 173, 180, 182, 184, 187, 188, 189, 190, 204, 211, 213, 214, 218, 220, 222, 223, 224, 228, 237, 238, 241, 242, 243, 246, 247, 249, 251, 252, 253, 254, 255, 256, 257, 267, 276, 288, 296, 298, 300, 302, 304, 305, 306, 307, 311, 315, 319, 330, 332, 334, 336, 338, 339, 340, 341]	['Seven', 'of', 'the', 'associations', 'at', 'p', '<', '9.0×10−5', 'were', 'within', 'or', 'near', 'genes', ',', 'including', 'myosin', ',', 'heavy', 'chain', '14', '(', 'MYH14', ')', ',', 'chromosome', '8', 'open', 'reading', 'frame', '34', '(', 'C8orf', '34', ')', ',', 'fibroblast', 'growth', 'factor', '1', '(', 'FGF1', ')', ',', 'transcription', 'factor', '7-', 'like', '2', '(', 'T-cell', 'specific', ',', 'HMG-box', ')', '(', 'TCF7L2', ')', ',', 'glutamate', 'receptor', 'interacting', 'protein', '2', '(', 'GRIP2', ')', ',', 'and', 'xylosyltransferase', 'I', '(', 'XYLT1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
These candidate genes include amiloride-sensitive cation channel 1, neuronal (ACCN1), N-acetyltransferase 5 (GCN5-related, putative) (NAT5), chromosome 20 open reading frame 26 (C20orf26), PR domain containing 2, with ZNF domain (PRDM2), KIAA0232, and myosin light chain kinase (myosin light chain kinase).	[('PMC3334304', 'R05003', 86, 107, 'N-acetyltransferase 5'), ('PMC3334304', 'R05003', 252, 277, 'myosin light chain kinase'), ('PMC3334304', 'R05003', 279, 304, 'myosin light chain kinase')]	['These', 'candidate', 'genes', 'include', 'am', '##il', '##ori', '##de', '-', 'sensitive', 'cation', 'channel', '1', ',', 'neuronal', '(', 'ACC', '##N', '##1', ')', ',', 'N', '-', 'acetyl', '##transferase', '5', '(', 'GC', '##N', '##5', '-', 'related', ',', 'putative', ')', '(', 'NAT', '##5', ')', ',', 'chromosome', '20', 'open', 'reading', 'frame', '26', '(', 'C', '##20', '##orf', '##26', ')', ',', 'PR', 'domain', 'containing', '2', ',', 'with', 'Z', '##NF', 'domain', '(', 'PR', '##DM', '##2', ')', ',', 'KI', '##AA', '##02', '##32', ',', 'and', 'myosin', 'light', 'chain', 'kinase', '(', 'myosin', 'light', 'chain', 'kinase', ')', '.']	[0, 6, 16, 22, 30, 32, 34, 37, 39, 40, 50, 57, 65, 66, 68, 77, 78, 81, 82, 83, 84, 86, 87, 88, 94, 106, 108, 109, 111, 112, 113, 114, 121, 123, 131, 133, 134, 137, 138, 139, 141, 152, 155, 160, 168, 174, 177, 178, 179, 181, 184, 186, 187, 189, 192, 199, 210, 211, 213, 218, 219, 222, 229, 230, 232, 234, 235, 236, 238, 240, 242, 244, 246, 248, 252, 259, 265, 271, 278, 279, 286, 292, 298, 304, 305]	[5, 15, 21, 29, 32, 34, 37, 39, 40, 49, 56, 64, 66, 67, 76, 78, 81, 82, 83, 84, 85, 87, 88, 94, 105, 107, 109, 111, 112, 113, 114, 121, 122, 131, 132, 134, 137, 138, 139, 140, 151, 154, 159, 167, 173, 176, 178, 179, 181, 184, 186, 187, 188, 191, 198, 209, 211, 212, 217, 219, 221, 228, 230, 232, 234, 235, 236, 237, 240, 242, 244, 246, 247, 251, 258, 264, 270, 277, 279, 285, 291, 297, 304, 305, 306]	['These', 'candidate', 'genes', 'include', 'amiloride', '-', 'sensitive', 'cation', 'channel', '1', ',', 'neuronal', '(', 'ACCN1', ')', ',', 'N-acetyltransferase', '5', '(', 'GCN5', '-', 'related', ',', 'putative', ')', '(', 'NAT5', ')', ',', 'chromosome', '20', 'open', 'reading', 'frame', '26', '(', 'C20orf26', ')', ',', 'PR', 'domain', 'containing', '2', ',', 'with', 'ZNF', 'domain', '(', 'PRDM2', ')', ',', 'KIAA0232', ',', 'and', 'myosin', 'light', 'chain', 'kinase', '(', 'myosin', 'light', 'chain', 'kinase', ')', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O']
ABO encodes for glycosyltransferases responsible for post translational glycosylation of procoagulant FVIII and von Willebrand Factor (VWF).[23] ABO O blood group phenotype and genotype (i.e., ABO rs8176719) is associated with a decreased risk for VTE,[7, 8, 24] presumably due to decreased plasma levels of FVIII and VWF.[25, 26] ABO-mediated glycosylation protects VWF from proteolysis by ADAMTS13[27] such that individuals with type O blood group (homozygous exon 6 ABO rs8176719 deletion) and hypoglycosylated VWF have ~25% lower plasma FVIII and VWF levels.[24, 28]	[('PMC3419811', 'D00001', 16, 36, 'glycosyltransferases')]	['AB', '##O', 'encodes', 'for', 'glycos', '##yl', '##transferase', '##s', 'responsible', 'for', 'post', 'translational', 'glycosylation', 'of', 'proc', '##oa', '##gu', '##lan', '##t', 'FV', '##III', 'and', 'von', 'Will', '##eb', '##ran', '##d', 'Factor', '(', 'V', '##WF', ')', '.', '[', '23', ']', 'AB', '##O', 'O', 'blood', 'group', 'phenotype', 'and', 'genotype', '(', 'i', '.', 'e', '.', ',', 'AB', '##O', 'rs', '##81', '##76', '##71', '##9', ')', 'is', 'associated', 'with', 'a', 'decreased', 'risk', 'for', 'VT', '##E', ',', '[', '7', ',', '8', ',', '24', ']', 'presumably', 'due', 'to', 'decreased', 'plasma', 'levels', 'of', 'FV', '##III', 'and', 'V', '##WF', '.', '[', '25', ',', '26', ']', 'AB', '##O', '-', 'mediated', 'glycosylation', 'protects', 'V', '##WF', 'from', 'proteolysis', 'by', 'ADAM', '##TS', '##13', '[', '27', ']', 'such', 'that', 'individuals', 'with', 'type', 'O', 'blood', 'group', '(', 'homozygous', 'exon', '6', 'AB', '##O', 'rs', '##81', '##76', '##71', '##9', 'deletion', ')', 'and', 'hypogly', '##cos', '##ylated', 'V', '##WF', 'have', '~', '25', '%', 'lower', 'plasma', 'FV', '##III', 'and', 'V', '##WF', 'levels', '.', '[', '24', ',', '28', ']']	[0, 2, 4, 12, 16, 22, 24, 35, 37, 49, 53, 58, 72, 86, 89, 93, 95, 97, 100, 102, 104, 108, 112, 116, 120, 122, 125, 127, 134, 135, 136, 138, 139, 140, 141, 143, 145, 147, 149, 151, 157, 163, 173, 177, 186, 187, 188, 189, 190, 191, 193, 195, 197, 199, 201, 203, 205, 206, 208, 211, 222, 227, 229, 239, 244, 248, 250, 251, 252, 253, 254, 256, 257, 259, 261, 263, 274, 278, 281, 291, 298, 305, 308, 310, 314, 318, 319, 321, 322, 323, 325, 327, 329, 331, 333, 334, 335, 344, 358, 367, 368, 371, 376, 388, 391, 395, 397, 399, 400, 402, 404, 409, 414, 426, 431, 436, 438, 444, 450, 451, 462, 467, 469, 471, 473, 475, 477, 479, 481, 483, 491, 493, 497, 504, 507, 514, 515, 518, 523, 524, 526, 528, 534, 541, 543, 547, 551, 552, 555, 561, 562, 563, 565, 567, 569]	[2, 3, 11, 15, 22, 24, 35, 36, 48, 52, 57, 71, 85, 88, 93, 95, 97, 100, 101, 104, 107, 111, 115, 120, 122, 125, 126, 133, 135, 136, 138, 139, 140, 141, 143, 144, 147, 148, 150, 156, 162, 172, 176, 185, 187, 188, 189, 190, 191, 192, 195, 196, 199, 201, 203, 205, 206, 207, 210, 221, 226, 228, 238, 243, 247, 250, 251, 252, 253, 254, 255, 257, 258, 261, 262, 273, 277, 280, 290, 297, 304, 307, 310, 313, 317, 319, 321, 322, 323, 325, 326, 329, 330, 333, 334, 335, 343, 357, 366, 368, 370, 375, 387, 390, 395, 397, 399, 400, 402, 403, 408, 413, 425, 430, 435, 437, 443, 449, 451, 461, 466, 468, 471, 472, 475, 477, 479, 481, 482, 491, 492, 496, 504, 507, 513, 515, 517, 522, 524, 526, 527, 533, 540, 543, 546, 550, 552, 554, 561, 562, 563, 565, 566, 569, 570]	['ABO', 'encodes', 'for', 'glycosyltransferases', 'responsible', 'for', 'post', 'translational', 'glycosylation', 'of', 'procoagulant', 'FVIII', 'and', 'von', 'Willebrand', 'Factor', '(VWF).[23]', 'ABO', 'O', 'blood', 'group', 'phenotype', 'and', 'genotype', '(', 'i.e', '.', ',', 'ABO', 'rs8176719', ')', 'is', 'associated', 'with', 'a', 'decreased', 'risk', 'for', 'VTE', ',', '[', '7', ',', '8', ',', '24', ']', 'presumably', 'due', 'to', 'decreased', 'plasma', 'levels', 'of', 'FVIII', 'and', 'VWF.[25', ',', '26', ']', 'ABO', '-', 'mediated', 'glycosylation', 'protects', 'VWF', 'from', 'proteolysis', 'by', 'ADAMTS13[27]', 'such', 'that', 'individuals', 'with', 'type', 'O', 'blood', 'group', '(', 'homozygous', 'exon', '6', 'ABO', 'rs8176719', 'deletion', ')', 'and', 'hypoglycosylated', 'VWF', 'have', '~25%', 'lower', 'plasma', 'FVIII', 'and', 'VWF', 'levels.[24', ',', '28', ']']	[2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 2, 1, 1, 4, 1, 8, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 5, 1, 1, 1, 3, 2, 1, 3, 1, 1, 2, 1, 2, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
F5 encodes for plasma procoagulant Factor(F) V; FV accelerates activation of prothrombin to thrombin by catalyzing assembly of the prothrombinase complex.	[('PMC3419811', 'D04001', 131, 145, 'prothrombinase')]	['F', '##5', 'encodes', 'for', 'plasma', 'proc', '##oa', '##gu', '##lan', '##t', 'Factor', '(', 'F', ')', 'V', ';', 'FV', 'accelerate', '##s', 'activation', 'of', 'prot', '##hr', '##omb', '##in', 'to', 'thrombin', 'by', 'cataly', '##zing', 'assembly', 'of', 'the', 'prot', '##hr', '##omb', '##inase', 'complex', '.']	[0, 1, 3, 11, 15, 22, 26, 28, 30, 33, 35, 41, 42, 43, 45, 46, 48, 51, 61, 63, 74, 77, 81, 83, 86, 89, 92, 101, 104, 110, 115, 124, 127, 131, 135, 137, 140, 146, 153]	[1, 2, 10, 14, 21, 26, 28, 30, 33, 34, 41, 42, 43, 44, 46, 47, 50, 61, 62, 73, 76, 81, 83, 86, 88, 91, 100, 103, 110, 114, 123, 126, 130, 135, 137, 140, 145, 153, 154]	['F5', 'encodes', 'for', 'plasma', 'procoagulant', 'Factor(F)', 'V', ';', 'FV', 'accelerates', 'activation', 'of', 'prothrombin', 'to', 'thrombin', 'by', 'catalyzing', 'assembly', 'of', 'the', 'prothrombinase', 'complex', '.']	[2, 1, 1, 1, 5, 4, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
Activated Protein C (APC), a serine protease, inactivates FV via cleavage at arginine[R]306, R506 and R679; initial APC cleavage at R506 is required for rapid FV inactivation by APC cleavage at R306 and R679.[37]	[('PMC3419811', 'D04003', 0, 19, 'Activated Protein C'), ('PMC3419811', 'D04003', 29, 44, 'serine protease')]	['Activ', '##ated', 'Protein', 'C', '(', 'APC', ')', ',', 'a', 'serine', 'protease', ',', 'in', '##activ', '##ates', 'FV', 'via', 'cleavage', 'at', 'arginine', '[', 'R', ']', '30', '##6', ',', 'R', '##506', 'and', 'R', '##67', '##9', ';', 'initial', 'APC', 'cleavage', 'at', 'R', '##506', 'is', 'required', 'for', 'rapid', 'FV', 'inactivation', 'by', 'APC', 'cleavage', 'at', 'R', '##30', '##6', 'and', 'R', '##67', '##9', '.', '[', '37', ']']	[0, 5, 10, 18, 20, 21, 24, 25, 27, 29, 36, 44, 46, 48, 53, 58, 61, 65, 74, 77, 85, 86, 87, 88, 90, 91, 93, 94, 98, 102, 103, 105, 106, 108, 116, 120, 129, 132, 133, 137, 140, 149, 153, 159, 162, 175, 178, 182, 191, 194, 195, 197, 199, 203, 204, 206, 207, 208, 209, 211]	[5, 9, 17, 19, 21, 24, 25, 26, 28, 35, 44, 45, 48, 53, 57, 60, 64, 73, 76, 85, 86, 87, 88, 90, 91, 92, 94, 97, 101, 103, 105, 106, 107, 115, 119, 128, 131, 133, 136, 139, 148, 152, 158, 161, 174, 177, 181, 190, 193, 195, 197, 198, 202, 204, 206, 207, 208, 209, 211, 212]	['Activated', 'Protein', 'C', '(', 'APC', ')', ',', 'a', 'serine', 'protease', ',', 'inactivates', 'FV', 'via', 'cleavage', 'at', 'arginine[R]306', ',', 'R506', 'and', 'R679', ';', 'initial', 'APC', 'cleavage', 'at', 'R506', 'is', 'required', 'for', 'rapid', 'FV', 'inactivation', 'by', 'APC', 'cleavage', 'at', 'R306', 'and', 'R679.[37]']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 6, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 7]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
ATP1B1 encodes for a Na+/K+ ATPase important in endothelial cell and platelet function, NME7 encodes for a nucleoside-diphosphate kinase important in erythropoiesis and CD4 T-cell activation, BLZF1 (JEM-1) encodes for basic leucine zipper nuclear factor 1 which is important for the response of acute promyelocytic leukemia to retinoic acid, and SLC19A2 encodes for a thiamine transporter protein (THTR-1) implicated in thiamine-responsive megaloblastic anemia.	[('PMC3419811', 'D06001', 28, 34, 'ATPase'), ('PMC3419811', 'D06001', 107, 136, 'nucleoside-diphosphate kinase')]	['ATP', '##1', '##B', '##1', 'encodes', 'for', 'a', 'Na', '+', '/', 'K', '+', 'ATPase', 'important', 'in', 'endothelial', 'cell', 'and', 'platelet', 'function', ',', 'NM', '##E', '##7', 'encodes', 'for', 'a', 'nucle', '##oside', '-', 'diph', '##osphate', 'kinase', 'important', 'in', 'eryth', '##rop', '##oi', '##esis', 'and', 'CD', '##4', 'T', '-', 'cell', 'activation', ',', 'BL', '##Z', '##F', '##1', '(', 'JE', '##M', '-', '1', ')', 'encodes', 'for', 'basic', 'leucine', 'zi', '##pper', 'nuclear', 'factor', '1', 'which', 'is', 'important', 'for', 'the', 'response', 'of', 'acute', 'prom', '##yel', '##ocytic', 'leukemia', 'to', 'retin', '##oic', 'acid', ',', 'and', 'SLC', '##19', '##A', '##2', 'encodes', 'for', 'a', 'thi', '##amine', 'transporter', 'protein', '(', 'TH', '##TR', '-', '1', ')', 'implicated', 'in', 'thi', '##amine', '-', 'responsive', 'meg', '##alo', '##bl', '##astic', 'anemia', '.']	[0, 3, 4, 5, 7, 15, 19, 21, 23, 24, 25, 26, 28, 35, 45, 48, 60, 65, 69, 78, 86, 88, 90, 91, 93, 101, 105, 107, 112, 117, 118, 122, 130, 137, 147, 150, 155, 158, 160, 165, 169, 171, 173, 174, 175, 180, 190, 192, 194, 195, 196, 198, 199, 201, 202, 203, 204, 206, 214, 218, 224, 232, 234, 239, 247, 254, 256, 262, 265, 275, 279, 283, 292, 295, 301, 305, 308, 315, 324, 327, 332, 336, 340, 342, 346, 349, 351, 352, 354, 362, 366, 368, 371, 377, 389, 397, 398, 400, 402, 403, 404, 406, 417, 420, 423, 428, 429, 440, 443, 446, 448, 454, 460]	[3, 4, 5, 6, 14, 18, 20, 23, 24, 25, 26, 27, 34, 44, 47, 59, 64, 68, 77, 86, 87, 90, 91, 92, 100, 104, 106, 112, 117, 118, 122, 129, 136, 146, 149, 155, 158, 160, 164, 168, 171, 172, 174, 175, 179, 190, 191, 194, 195, 196, 197, 199, 201, 202, 203, 204, 205, 213, 217, 223, 231, 234, 238, 246, 253, 255, 261, 264, 274, 278, 282, 291, 294, 300, 305, 308, 314, 323, 326, 332, 335, 340, 341, 345, 349, 351, 352, 353, 361, 365, 367, 371, 376, 388, 396, 398, 400, 402, 403, 404, 405, 416, 419, 423, 428, 429, 439, 443, 446, 448, 453, 460, 461]	['ATP1B1', 'encodes', 'for', 'a', 'Na+', '/', 'K+', 'ATPase', 'important', 'in', 'endothelial', 'cell', 'and', 'platelet', 'function', ',', 'NME7', 'encodes', 'for', 'a', 'nucleoside', '-', 'diphosphate', 'kinase', 'important', 'in', 'erythropoiesis', 'and', 'CD4', 'T-cell', 'activation', ',', 'BLZF1', '(', 'JEM-1', ')', 'encodes', 'for', 'basic', 'leucine', 'zipper', 'nuclear', 'factor', '1', 'which', 'is', 'important', 'for', 'the', 'response', 'of', 'acute', 'promyelocytic', 'leukemia', 'to', 'retinoic', 'acid', ',', 'and', 'SLC19A2', 'encodes', 'for', 'a', 'thiamine', 'transporter', 'protein', '(', 'THTR-1', ')', 'implicated', 'in', 'thiamine', '-', 'responsive', 'megaloblastic', 'anemia', '.']	[4, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 2, 1, 1, 1, 4, 1, 2, 3, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature.	[('PMC3419811', 'F38002', 69, 88, 'activated protein C')]	['Mutation', 'in', 'blood', 'coagulation', 'factor', 'V', 'associated', 'with', 'resistance', 'to', 'activated', 'protein', 'C', '.', 'Nature', '.']	[0, 9, 12, 18, 30, 37, 39, 50, 55, 66, 69, 79, 87, 88, 90, 96]	[8, 11, 17, 29, 36, 38, 49, 54, 65, 68, 78, 86, 88, 89, 96, 97]	['Mutation', 'in', 'blood', 'coagulation', 'factor', 'V', 'associated', 'with', 'resistance', 'to', 'activated', 'protein', 'C', '.', 'Nature', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O']
Heightened thrombin generation in individuals with resistance to activated protein C. Thromb Haemost.	[('PMC3419811', 'F40002', 65, 84, 'activated protein C')]	['He', '##ight', '##ened', 'thrombin', 'generation', 'in', 'individuals', 'with', 'resistance', 'to', 'activated', 'protein', 'C', '.', 'Thromb', 'Haem', '##ost', '.']	[0, 2, 6, 11, 20, 31, 34, 46, 51, 62, 65, 75, 83, 84, 86, 93, 97, 100]	[2, 6, 10, 19, 30, 33, 45, 50, 61, 64, 74, 82, 84, 85, 92, 97, 100, 101]	['Heightened', 'thrombin', 'generation', 'in', 'individuals', 'with', 'resistance', 'to', 'activated', 'protein', 'C', '.', 'Thromb', 'Haemost', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
First, the sterol-C4-Methyl oxidase-like (SC4MOL) gene has been shown to be under-expressed in an animal model of T2D and to play a key role in cholesterol biosynthesis with implications for the regulation of energy metabolism, obesity and dyslipidemia (11–15).	[('PMC3459464', 'D01000', 11, 35, 'sterol-C4-Methyl oxidase')]	['First', ',', 'the', 'ster', '##ol', '-', 'C', '##4', '-', 'Methyl', 'oxidase', '-', 'like', '(', 'SC', '##4', '##MO', '##L', ')', 'gene', 'has', 'been', 'shown', 'to', 'be', 'under', '-', 'expressed', 'in', 'an', 'animal', 'model', 'of', 'T', '##2', '##D', 'and', 'to', 'play', 'a', 'key', 'role', 'in', 'cholesterol', 'biosynthesis', 'with', 'implications', 'for', 'the', 'regulation', 'of', 'energy', 'metabolism', ',', 'obesity', 'and', 'dys', '##lipidemia', '(', '11', '–', '15', ')', '.']	[0, 5, 7, 11, 15, 17, 18, 19, 20, 21, 28, 35, 36, 41, 42, 44, 45, 47, 48, 50, 55, 59, 64, 70, 73, 76, 81, 82, 92, 95, 98, 105, 111, 114, 115, 116, 118, 122, 125, 130, 132, 136, 141, 144, 156, 169, 174, 187, 191, 195, 206, 209, 216, 226, 228, 236, 240, 243, 253, 254, 256, 257, 259, 260]	[5, 6, 10, 15, 17, 18, 19, 20, 21, 27, 35, 36, 40, 42, 44, 45, 47, 48, 49, 54, 58, 63, 69, 72, 75, 81, 82, 91, 94, 97, 104, 110, 113, 115, 116, 117, 121, 124, 129, 131, 135, 140, 143, 155, 168, 173, 186, 190, 194, 205, 208, 215, 226, 227, 235, 239, 243, 252, 254, 256, 257, 259, 260, 261]	['First', ',', 'the', 'sterol-C4-Methyl', 'oxidase', '-', 'like', '(', 'SC4MOL', ')', 'gene', 'has', 'been', 'shown', 'to', 'be', 'under', '-', 'expressed', 'in', 'an', 'animal', 'model', 'of', 'T2D', 'and', 'to', 'play', 'a', 'key', 'role', 'in', 'cholesterol', 'biosynthesis', 'with', 'implications', 'for', 'the', 'regulation', 'of', 'energy', 'metabolism', ',', 'obesity', 'and', 'dyslipidemia', '(', '11–', '15', ')', '.']	[1, 1, 1, 7, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sato Y., Koshioka S., Kirino Y., Kamimoto T., Kawazoe K., Abe S., Minakuchi K., Nakahori Y. Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway.	[('PMC3459464', 'F12001', 100, 123, 'dipeptidyl peptidase IV')]	['Sato', 'Y', '.', ',', 'Kos', '##hi', '##oka', 'S', '.', ',', 'Kir', '##ino', 'Y', '.', ',', 'Kam', '##imoto', 'T', '.', ',', 'Kaw', '##azo', '##e', 'K', '.', ',', 'Ab', '##e', 'S', '.', ',', 'Min', '##aku', '##chi', 'K', '.', ',', 'Nak', '##ah', '##ori', 'Y', '.', 'Role', 'of', 'dip', '##epti', '##dy', '##l', 'pepti', '##dase', 'IV', '(', 'DPP', '##4', ')', 'in', 'the', 'development', 'of', 'dys', '##lipidemia', ':', 'DPP', '##4', 'contributes', 'to', 'the', 'steroid', 'metabolism', 'pathway', '.']	[0, 5, 6, 7, 9, 12, 14, 18, 19, 20, 22, 25, 29, 30, 31, 33, 36, 42, 43, 44, 46, 49, 52, 54, 55, 56, 58, 60, 62, 63, 64, 66, 69, 72, 76, 77, 78, 80, 83, 85, 89, 90, 92, 97, 100, 103, 107, 109, 111, 116, 121, 124, 125, 128, 129, 131, 134, 138, 150, 153, 156, 165, 167, 170, 172, 184, 187, 191, 199, 210, 217]	[4, 6, 7, 8, 12, 14, 17, 19, 20, 21, 25, 28, 30, 31, 32, 36, 41, 43, 44, 45, 49, 52, 53, 55, 56, 57, 60, 61, 63, 64, 65, 69, 72, 75, 77, 78, 79, 83, 85, 88, 90, 91, 96, 99, 103, 107, 109, 110, 116, 120, 123, 125, 128, 129, 130, 133, 137, 149, 152, 156, 165, 166, 170, 171, 183, 186, 190, 198, 209, 217, 218]	['Sato', 'Y', '.', ',', 'Koshioka', 'S', '.', ',', 'Kirino', 'Y', '.', ',', 'Kamimoto', 'T', '.', ',', 'Kawazoe', 'K', '.', ',', 'Abe', 'S', '.', ',', 'Minakuchi', 'K', '.', ',', 'Nakahori', 'Y', '.', 'Role', 'of', 'dipeptidyl', 'peptidase', 'IV', '(', 'DPP4', ')', 'in', 'the', 'development', 'of', 'dyslipidemia', ':', 'DPP4', 'contributes', 'to', 'the', 'steroid', 'metabolism', 'pathway', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 4, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Yoshizaki T., Imamura T., Babendure J.L., Lu J.C., Sonoda N., Olefsky J.M. Myosin 5a is an insulin-stimulated Akt2 (protein kinase Bbeta) substrate modulating GLUT4 vesicle translocation.	[('PMC3459464', 'F19001', 116, 130, 'protein kinase')]	['Yosh', '##iza', '##ki', 'T', '.', ',', 'Im', '##amura', 'T', '.', ',', 'Bab', '##end', '##ure', 'J', '.', 'L', '.', ',', 'Lu', 'J', '.', 'C', '.', ',', 'Son', '##oda', 'N', '.', ',', 'Ol', '##ef', '##sky', 'J', '.', 'M', '.', 'My', '##osin', '5', '##a', 'is', 'an', 'insulin', '-', 'stimulated', 'Akt', '##2', '(', 'protein', 'kinase', 'B', '##beta', ')', 'substrate', 'modulating', 'GLUT', '##4', 'vesicle', 'translocation', '.']	[0, 4, 7, 10, 11, 12, 14, 16, 22, 23, 24, 26, 29, 32, 36, 37, 38, 39, 40, 42, 45, 46, 47, 48, 49, 51, 54, 58, 59, 60, 62, 64, 66, 70, 71, 72, 73, 75, 77, 82, 83, 85, 88, 91, 98, 99, 110, 113, 115, 116, 124, 131, 132, 136, 138, 148, 159, 163, 165, 173, 186]	[4, 7, 9, 11, 12, 13, 16, 21, 23, 24, 25, 29, 32, 35, 37, 38, 39, 40, 41, 44, 46, 47, 48, 49, 50, 54, 57, 59, 60, 61, 64, 66, 69, 71, 72, 73, 74, 77, 81, 83, 84, 87, 90, 98, 99, 109, 113, 114, 116, 123, 130, 132, 136, 137, 147, 158, 163, 164, 172, 186, 187]	['Yoshizaki', 'T', '.', ',', 'Imamura', 'T', '.', ',', 'Babendure', 'J.L', '.', ',', 'Lu', 'J.C', '.', ',', 'Sonoda', 'N', '.', ',', 'Olefsky', 'J.M', '.', 'Myosin', '5a', 'is', 'an', 'insulin', '-', 'stimulated', 'Akt2', '(', 'protein', 'kinase', 'Bbeta', ')', 'substrate', 'modulating', 'GLUT4', 'vesicle', 'translocation', '.']	[3, 1, 1, 1, 2, 1, 1, 1, 3, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 3, 1, 2, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fasting plasma glucose was measured on integra 400 plus (Roche Diagnostics) using an enzymatic method with hexokinase, and the unit was mg/dl.	[('PMC3459464', 'M02002', 107, 117, 'hexokinase')]	['Fast', '##ing', 'plasma', 'glucose', 'was', 'measured', 'on', 'integr', '##a', '400', 'plus', '(', 'Roche', 'Diagnostics', ')', 'using', 'an', 'enzymatic', 'method', 'with', 'hex', '##ok', '##inase', ',', 'and', 'the', 'unit', 'was', 'mg', '/', 'dl', '.']	[0, 4, 8, 15, 23, 27, 36, 39, 45, 47, 51, 56, 57, 63, 74, 76, 82, 85, 95, 102, 107, 110, 112, 117, 119, 123, 127, 132, 136, 138, 139, 141]	[4, 7, 14, 22, 26, 35, 38, 45, 46, 50, 55, 57, 62, 74, 75, 81, 84, 94, 101, 106, 110, 112, 117, 118, 122, 126, 131, 135, 138, 139, 141, 142]	['Fasting', 'plasma', 'glucose', 'was', 'measured', 'on', 'integra', '400', 'plus', '(', 'Roche', 'Diagnostics', ')', 'using', 'an', 'enzymatic', 'method', 'with', 'hexokinase', ',', 'and', 'the', 'unit', 'was', 'mg', '/', 'dl', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Forty-one SNPs within an ∼76 kb (∼100 to ∼170 kb) region near neurotrophic tyrosine kinase, receptor, type 2 (NTRK2) reached P < 5.0 × 10−6.	[('PMC3459464', 'R02002', 75, 90, 'tyrosine kinase')]	['Forty', '-', 'one', 'SNPs', 'within', 'an', '∼', '##76', 'kb', '(', '∼', '##100', 'to', '∼', '##170', 'kb', ')', 'region', 'near', 'neurot', '##rophic', 'tyrosine', 'kinase', ',', 'receptor', ',', 'type', '2', '(', 'NT', '##RK', '##2', ')', 'reached', 'P', '<', '5', '.', '0', '×', '10−', '##6', '.']	[0, 5, 6, 10, 15, 22, 25, 26, 29, 32, 33, 34, 38, 41, 42, 46, 48, 50, 57, 62, 68, 75, 84, 90, 92, 100, 102, 107, 109, 110, 112, 114, 115, 117, 125, 127, 129, 130, 131, 133, 135, 138, 139]	[5, 6, 9, 14, 21, 24, 26, 28, 31, 33, 34, 37, 40, 42, 45, 48, 49, 56, 61, 68, 74, 83, 90, 91, 100, 101, 106, 108, 110, 112, 114, 115, 116, 124, 126, 128, 130, 131, 132, 134, 138, 139, 140]	['Forty', '-', 'one', 'SNPs', 'within', 'an', '∼76', 'kb', '(', '∼100', 'to', '∼170', 'kb', ')', 'region', 'near', 'neurotrophic', 'tyrosine', 'kinase', ',', 'receptor', ',', 'type', '2', '(', 'NTRK2', ')', 'reached', 'P', '<', '5.0', '×', '10−6', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SNP rs17046216 in sterol-C4-methyl oxidase-like (SC4MOL) was associated with FI and IR (P = 4.6 × 10−7 and 9.9 × 10−7, respectively; Supplementary Material, Fig. S3).	[('PMC3459464', 'R02006', 18, 42, 'sterol-C4-methyl oxidase')]	['SNP', 'rs', '##170', '##46', '##21', '##6', 'in', 'ster', '##ol', '-', 'C', '##4', '-', 'methyl', 'oxidase', '-', 'like', '(', 'SC', '##4', '##MO', '##L', ')', 'was', 'associated', 'with', 'FI', 'and', 'IR', '(', 'P', '=', '4', '.', '6', '×', '10−', '##7', 'and', '9', '.', '9', '×', '10−', '##7', ',', 'respectively', ';', 'Supplementary', 'Material', ',', 'Fig', '.', 'S', '##3', ')', '.']	[0, 4, 6, 9, 11, 13, 15, 18, 22, 24, 25, 26, 27, 28, 35, 42, 43, 48, 49, 51, 52, 54, 55, 57, 61, 72, 77, 80, 84, 87, 88, 90, 92, 93, 94, 96, 98, 101, 103, 107, 108, 109, 111, 113, 116, 117, 119, 131, 133, 147, 155, 157, 160, 162, 163, 164, 165]	[3, 6, 9, 11, 13, 14, 17, 22, 24, 25, 26, 27, 28, 34, 42, 43, 47, 49, 51, 52, 54, 55, 56, 60, 71, 76, 79, 83, 86, 88, 89, 91, 93, 94, 95, 97, 101, 102, 106, 108, 109, 110, 112, 116, 117, 118, 131, 132, 146, 155, 156, 160, 161, 163, 164, 165, 166]	['SNP', 'rs17046216', 'in', 'sterol-C4-methyl', 'oxidase', '-', 'like', '(', 'SC4MOL', ')', 'was', 'associated', 'with', 'FI', 'and', 'IR', '(', 'P', '=', '4.6', '×', '10−7', 'and', '9.9', '×', '10−7', ',', 'respectively', ';', 'Supplementary', 'Material', ',', 'Fig', '.', 'S3', ')', '.']	[1, 5, 1, 7, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The protein product of AJAP1, SHREW1, interacts with basigin, a mediator of matrix metalloprotease (MMP) activity (Schreiner et al., 2007) involved in tooth development in rat (Schwab et al., 2007) and mouse models (Kumamoto and Ooya, 2006).	[('PMC3521449', 'R01005', 76, 98, 'matrix metalloprotease')]	['The', 'protein', 'product', 'of', 'AJ', '##AP', '##1', ',', 'SHR', '##EW', '##1', ',', 'interacts', 'with', 'bas', '##ig', '##in', ',', 'a', 'mediator', 'of', 'matrix', 'metall', '##oprot', '##ea', '##se', '(', 'MMP', ')', 'activity', '(', 'Schr', '##ei', '##ner', 'et', 'al', '.', ',', '2007', ')', 'involved', 'in', 'tooth', 'development', 'in', 'rat', '(', 'Schw', '##ab', 'et', 'al', '.', ',', '2007', ')', 'and', 'mouse', 'models', '(', 'Ku', '##ma', '##mo', '##to', 'and', 'O', '##oya', ',', '2006', ')', '.']	[0, 4, 12, 20, 23, 25, 27, 28, 30, 33, 35, 36, 38, 48, 53, 56, 58, 60, 62, 64, 73, 76, 83, 89, 94, 96, 99, 100, 103, 105, 114, 115, 119, 121, 125, 128, 130, 131, 133, 137, 139, 148, 151, 157, 169, 172, 176, 177, 181, 184, 187, 189, 190, 192, 196, 198, 202, 208, 215, 216, 218, 220, 222, 225, 229, 230, 233, 235, 239, 240]	[3, 11, 19, 22, 25, 27, 28, 29, 33, 35, 36, 37, 47, 52, 56, 58, 60, 61, 63, 72, 75, 82, 89, 94, 96, 98, 100, 103, 104, 113, 115, 119, 121, 124, 127, 130, 131, 132, 137, 138, 147, 150, 156, 168, 171, 175, 177, 181, 183, 186, 189, 190, 191, 196, 197, 201, 207, 214, 216, 218, 220, 222, 224, 228, 230, 233, 234, 239, 240, 241]	['The', 'protein', 'product', 'of', 'AJAP1', ',', 'SHREW1', ',', 'interacts', 'with', 'basigin', ',', 'a', 'mediator', 'of', 'matrix', 'metalloprotease', '(', 'MMP', ')', 'activity', '(', 'Schreiner', 'et', 'al', '.', ',', '2007', ')', 'involved', 'in', 'tooth', 'development', 'in', 'rat', '(', 'Schwab', 'et', 'al', '.', ',', '2007', ')', 'and', 'mouse', 'models', '(', 'Kumamoto', 'and', 'Ooya', ',', '2006', ')', '.']	[1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Candidate gene association studies for cannabis use have mainly focussed on genes known to be involved in the endogenous cannabinoid system: the cannabinoid receptor 1 gene (CNR1) and the fatty acid amide hydrolase gene (FAAH).	[('PMC3548058', 'I00004', 188, 214, 'fatty acid amide hydrolase')]	['Candida', '##te', 'gene', 'association', 'studies', 'for', 'cannabis', 'use', 'have', 'mainly', 'focus', '##sed', 'on', 'genes', 'known', 'to', 'be', 'involved', 'in', 'the', 'endogenous', 'cann', '##abin', '##oid', 'system', ':', 'the', 'cann', '##abin', '##oid', 'receptor', '1', 'gene', '(', 'CN', '##R', '##1', ')', 'and', 'the', 'fatty', 'acid', 'amide', 'hydro', '##las', '##e', 'gene', '(', 'FA', '##AH', ')', '.']	[0, 7, 10, 15, 27, 35, 39, 48, 52, 57, 64, 69, 73, 76, 82, 88, 91, 94, 103, 106, 110, 121, 125, 129, 133, 139, 141, 145, 149, 153, 157, 166, 168, 173, 174, 176, 177, 178, 180, 184, 188, 194, 199, 205, 210, 213, 215, 220, 221, 223, 225, 226]	[7, 9, 14, 26, 34, 38, 47, 51, 56, 63, 69, 72, 75, 81, 87, 90, 93, 102, 105, 109, 120, 125, 129, 132, 139, 140, 144, 149, 153, 156, 165, 167, 172, 174, 176, 177, 178, 179, 183, 187, 193, 198, 204, 210, 213, 214, 219, 221, 223, 225, 226, 227]	['Candidate', 'gene', 'association', 'studies', 'for', 'cannabis', 'use', 'have', 'mainly', 'focussed', 'on', 'genes', 'known', 'to', 'be', 'involved', 'in', 'the', 'endogenous', 'cannabinoid', 'system', ':', 'the', 'cannabinoid', 'receptor', '1', 'gene', '(', 'CNR1', ')', 'and', 'the', 'fatty', 'acid', 'amide', 'hydrolase', 'gene', '(', 'FAAH', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Increased levels of small peptides in the plasma could be the result of excessive proteosomal activity, abnormalities in removal of peptides by peptidases or altered function of peptide transporters.	[('PMC3754980', 'D02001', 144, 154, 'peptidases')]	['Increased', 'levels', 'of', 'small', 'peptides', 'in', 'the', 'plasma', 'could', 'be', 'the', 'result', 'of', 'excessive', 'prote', '##osomal', 'activity', ',', 'abnormalities', 'in', 'removal', 'of', 'peptides', 'by', 'pepti', '##dase', '##s', 'or', 'altered', 'function', 'of', 'peptide', 'transporters', '.']	[0, 10, 17, 20, 26, 35, 38, 42, 49, 55, 58, 62, 69, 72, 82, 87, 94, 102, 104, 118, 121, 129, 132, 141, 144, 149, 153, 155, 158, 166, 175, 178, 186, 198]	[9, 16, 19, 25, 34, 37, 41, 48, 54, 57, 61, 68, 71, 81, 87, 93, 102, 103, 117, 120, 128, 131, 140, 143, 149, 153, 154, 157, 165, 174, 177, 185, 198, 199]	['Increased', 'levels', 'of', 'small', 'peptides', 'in', 'the', 'plasma', 'could', 'be', 'the', 'result', 'of', 'excessive', 'proteosomal', 'activity', ',', 'abnormalities', 'in', 'removal', 'of', 'peptides', 'by', 'peptidases', 'or', 'altered', 'function', 'of', 'peptide', 'transporters', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acetylphenylalanine is a hazardous metabolite of phenylalanine and is elevated in phenylketonuria due to lack of phenylalanine hydroxylase, the enzyme that converts phenylalanine to tyrosine [28].	[('PMC3754980', 'D03001', 113, 138, 'phenylalanine hydroxylase')]	['Acet', '##yl', '##phenyl', '##alanine', 'is', 'a', 'hazardous', 'metabolite', 'of', 'phenyl', '##alanine', 'and', 'is', 'elevated', 'in', 'phenyl', '##ket', '##on', '##uria', 'due', 'to', 'lack', 'of', 'phenyl', '##alanine', 'hydroxyl', '##ase', ',', 'the', 'enzyme', 'that', 'converts', 'phenyl', '##alanine', 'to', 'tyrosine', '[', '28', ']', '.']	[0, 4, 6, 12, 20, 23, 25, 35, 46, 49, 55, 63, 67, 70, 79, 82, 88, 91, 93, 98, 102, 105, 110, 113, 119, 127, 135, 138, 140, 144, 151, 156, 165, 171, 179, 182, 191, 192, 194, 195]	[4, 6, 12, 19, 22, 24, 34, 45, 48, 55, 62, 66, 69, 78, 81, 88, 91, 93, 97, 101, 104, 109, 112, 119, 126, 135, 138, 139, 143, 150, 155, 164, 171, 178, 181, 190, 192, 194, 195, 196]	['Acetylphenylalanine', 'is', 'a', 'hazardous', 'metabolite', 'of', 'phenylalanine', 'and', 'is', 'elevated', 'in', 'phenylketonuria', 'due', 'to', 'lack', 'of', 'phenylalanine', 'hydroxylase', ',', 'the', 'enzyme', 'that', 'converts', 'phenylalanine', 'to', 'tyrosine', '[', '28', ']', '.']	[4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice.	[('PMC3754980', 'F07002', 82, 105, 'xanthine oxidoreductase')]	['Un', '##targeted', 'plasma', 'metabolite', 'profiling', 'reveals', 'the', 'broad', 'systemic', 'consequences', 'of', 'x', '##anth', '##ine', 'oxid', '##ored', '##uct', '##ase', 'inactivation', 'in', 'mice', '.']	[0, 2, 11, 18, 29, 39, 47, 51, 57, 66, 79, 82, 83, 87, 91, 95, 99, 102, 106, 119, 122, 126]	[2, 10, 17, 28, 38, 46, 50, 56, 65, 78, 81, 83, 87, 90, 95, 99, 102, 105, 118, 121, 126, 127]	['Untargeted', 'plasma', 'metabolite', 'profiling', 'reveals', 'the', 'broad', 'systemic', 'consequences', 'of', 'xanthine', 'oxidoreductase', 'inactivation', 'in', 'mice', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Genetic variants in the complement factor H gene (CFH) and the age-related maculopathy susceptibility 2/HtrA serine peptidase 1 (ARMS2/HTRA1) locus have been strongly and consistently associated with AMD.	[('PMC3754980', 'I01001', 109, 127, 'serine peptidase 1')]	['Genetic', 'variants', 'in', 'the', 'complement', 'factor', 'H', 'gene', '(', 'CF', '##H', ')', 'and', 'the', 'age', '-', 'related', 'mac', '##ulo', '##pathy', 'susceptibility', '2', '/', 'H', '##tr', '##A', 'serine', 'pepti', '##dase', '1', '(', 'AR', '##MS', '##2', '/', 'HT', '##RA', '##1', ')', 'locus', 'have', 'been', 'strongly', 'and', 'consistently', 'associated', 'with', 'AMD', '.']	[0, 8, 17, 20, 24, 35, 42, 44, 49, 50, 52, 53, 55, 59, 63, 66, 67, 75, 78, 81, 87, 102, 103, 104, 105, 107, 109, 116, 121, 126, 128, 129, 131, 133, 134, 135, 137, 139, 140, 142, 148, 153, 158, 167, 171, 184, 195, 200, 203]	[7, 16, 19, 23, 34, 41, 43, 48, 50, 52, 53, 54, 58, 62, 66, 67, 74, 78, 81, 86, 101, 103, 104, 105, 107, 108, 115, 121, 125, 127, 129, 131, 133, 134, 135, 137, 139, 140, 141, 147, 152, 157, 166, 170, 183, 194, 199, 203, 204]	['Genetic', 'variants', 'in', 'the', 'complement', 'factor', 'H', 'gene', '(', 'CFH', ')', 'and', 'the', 'age', '-', 'related', 'maculopathy', 'susceptibility', '2', '/', 'HtrA', 'serine', 'peptidase', '1', '(', 'ARMS2', '/', 'HTRA1', ')', 'locus', 'have', 'been', 'strongly', 'and', 'consistently', 'associated', 'with', 'AMD', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A number of proteins have not been previously associated to AMD including alpha-1-antitrypsin, fibrinogen alpha chain and prostaglandin H2-D isomerase.	[('PMC4020801', 'A01003', 122, 150, 'prostaglandin H2-D isomerase')]	['A', 'number', 'of', 'proteins', 'have', 'not', 'been', 'previously', 'associated', 'to', 'AMD', 'including', 'alpha', '-', '1', '-', 'antit', '##ryp', '##sin', ',', 'fibrinogen', 'alpha', 'chain', 'and', 'prostaglandin', 'H', '##2', '-', 'D', 'isomer', '##ase', '.']	[0, 2, 9, 12, 21, 26, 30, 35, 46, 57, 60, 64, 74, 79, 80, 81, 82, 87, 90, 93, 95, 106, 112, 118, 122, 136, 137, 138, 139, 141, 147, 150]	[1, 8, 11, 20, 25, 29, 34, 45, 56, 59, 63, 73, 79, 80, 81, 82, 87, 90, 93, 94, 105, 111, 117, 121, 135, 137, 138, 139, 140, 147, 150, 151]	['A', 'number', 'of', 'proteins', 'have', 'not', 'been', 'previously', 'associated', 'to', 'AMD', 'including', 'alpha-1-antitrypsin', ',', 'fibrinogen', 'alpha', 'chain', 'and', 'prostaglandin', 'H2-D', 'isomerase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 4, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
Alpha-1-antitrypsin is an acute phase protein member of the serpin family that inhibits a wide variety of proteases and thereby protects tissues from enzymes of inflammatory cells, especially neutrophil elastase.	[('PMC4020801', 'D06001', 106, 115, 'proteases'), ('PMC4020801', 'D06001', 192, 211, 'neutrophil elastase')]	['Alpha', '-', '1', '-', 'antit', '##ryp', '##sin', 'is', 'an', 'acute', 'phase', 'protein', 'member', 'of', 'the', 'ser', '##pin', 'family', 'that', 'inhibits', 'a', 'wide', 'variety', 'of', 'proteases', 'and', 'thereby', 'protects', 'tissues', 'from', 'enzymes', 'of', 'inflammatory', 'cells', ',', 'especially', 'neutrophil', 'elast', '##ase', '.']	[0, 5, 6, 7, 8, 13, 16, 20, 23, 26, 32, 38, 46, 53, 56, 60, 63, 67, 74, 79, 88, 90, 95, 103, 106, 116, 120, 128, 137, 145, 150, 158, 161, 174, 179, 181, 192, 203, 208, 211]	[5, 6, 7, 8, 13, 16, 19, 22, 25, 31, 37, 45, 52, 55, 59, 63, 66, 73, 78, 87, 89, 94, 102, 105, 115, 119, 127, 136, 144, 149, 157, 160, 173, 179, 180, 191, 202, 208, 211, 212]	['Alpha-1-antitrypsin', 'is', 'an', 'acute', 'phase', 'protein', 'member', 'of', 'the', 'serpin', 'family', 'that', 'inhibits', 'a', 'wide', 'variety', 'of', 'proteases', 'and', 'thereby', 'protects', 'tissues', 'from', 'enzymes', 'of', 'inflammatory', 'cells', ',', 'especially', 'neutrophil', 'elastase', '.']	[7, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
In humans, prostaglandin H2-D isomerase catalyzes the conversion of prostaglandin H2 to prostaglandin D2, which functions as a neuromodulator and as a trophic factor in the central nervous system for fatty acid biosynthesis.	[('PMC4020801', 'D08000', 11, 39, 'prostaglandin H2-D isomerase')]	['In', 'humans', ',', 'prostaglandin', 'H', '##2', '-', 'D', 'isomer', '##ase', 'cataly', '##zes', 'the', 'conversion', 'of', 'prostaglandin', 'H', '##2', 'to', 'prostaglandin', 'D', '##2', ',', 'which', 'functions', 'as', 'a', 'neurom', '##od', '##ulator', 'and', 'as', 'a', 'trophic', 'factor', 'in', 'the', 'central', 'nervous', 'system', 'for', 'fatty', 'acid', 'biosynthesis', '.']	[0, 3, 9, 11, 25, 26, 27, 28, 30, 36, 40, 46, 50, 54, 65, 68, 82, 83, 85, 88, 102, 103, 104, 106, 112, 122, 125, 127, 133, 135, 142, 146, 149, 151, 159, 166, 169, 173, 181, 189, 196, 200, 206, 211, 223]	[2, 9, 10, 24, 26, 27, 28, 29, 36, 39, 46, 49, 53, 64, 67, 81, 83, 84, 87, 101, 103, 104, 105, 111, 121, 124, 126, 133, 135, 141, 145, 148, 150, 158, 165, 168, 172, 180, 188, 195, 199, 205, 210, 223, 224]	['In', 'humans', ',', 'prostaglandin', 'H2-D', 'isomerase', 'catalyzes', 'the', 'conversion', 'of', 'prostaglandin', 'H2', 'to', 'prostaglandin', 'D2', ',', 'which', 'functions', 'as', 'a', 'neuromodulator', 'and', 'as', 'a', 'trophic', 'factor', 'in', 'the', 'central', 'nervous', 'system', 'for', 'fatty', 'acid', 'biosynthesis', '.']	[1, 1, 1, 1, 4, 2, 2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The interactome analysis surprisingly showed a highly interconnected network of 18 of the 19 relevant proteins, where only 36 additional molecules were needed to generate a specific molecular network, suggesting that the up-regulated proteins form a potential dysregulated functional cluster encompassing immune responses and complement cascade proteins, protease cascades maybe linked to the membrane attack complex or possibly to counteract the enzymatic effect of up-regulated molecules such as GPX3, RBP3 and PTGDS, or as modulators of gene activation cascades.	[('PMC4020801', 'D10000', 355, 363, 'protease')]	['The', 'interact', '##ome', 'analysis', 'surprisingly', 'showed', 'a', 'highly', 'interconnected', 'network', 'of', '18', 'of', 'the', '19', 'relevant', 'proteins', ',', 'where', 'only', '36', 'additional', 'molecules', 'were', 'needed', 'to', 'generate', 'a', 'specific', 'molecular', 'network', ',', 'suggesting', 'that', 'the', 'up', '-', 'regulated', 'proteins', 'form', 'a', 'potential', 'dys', '##regulated', 'functional', 'cluster', 'encompassing', 'immune', 'responses', 'and', 'complement', 'cascade', 'proteins', ',', 'protease', 'cascades', 'maybe', 'linked', 'to', 'the', 'membrane', 'attack', 'complex', 'or', 'possibly', 'to', 'counter', '##act', 'the', 'enzymatic', 'effect', 'of', 'up', '-', 'regulated', 'molecules', 'such', 'as', 'GP', '##X', '##3', ',', 'RB', '##P', '##3', 'and', 'PT', '##GD', '##S', ',', 'or', 'as', 'modulators', 'of', 'gene', 'activation', 'cascades', '.']	[0, 4, 12, 16, 25, 38, 45, 47, 54, 69, 77, 80, 83, 86, 90, 93, 102, 110, 112, 118, 123, 126, 137, 147, 152, 159, 162, 171, 173, 182, 192, 199, 201, 212, 217, 221, 223, 224, 234, 243, 248, 250, 260, 263, 273, 284, 292, 305, 312, 322, 326, 337, 345, 353, 355, 364, 373, 379, 386, 389, 393, 402, 409, 417, 420, 429, 432, 439, 443, 447, 457, 464, 467, 469, 470, 480, 490, 495, 498, 500, 501, 502, 504, 506, 507, 509, 513, 515, 517, 518, 520, 523, 526, 537, 540, 545, 556, 564]	[3, 12, 15, 24, 37, 44, 46, 53, 68, 76, 79, 82, 85, 89, 92, 101, 110, 111, 117, 122, 125, 136, 146, 151, 158, 161, 170, 172, 181, 191, 199, 200, 211, 216, 220, 223, 224, 233, 242, 247, 249, 259, 263, 272, 283, 291, 304, 311, 321, 325, 336, 344, 353, 354, 363, 372, 378, 385, 388, 392, 401, 408, 416, 419, 428, 431, 439, 442, 446, 456, 463, 466, 469, 470, 479, 489, 494, 497, 500, 501, 502, 503, 506, 507, 508, 512, 515, 517, 518, 519, 522, 525, 536, 539, 544, 555, 564, 565]	['The', 'interactome', 'analysis', 'surprisingly', 'showed', 'a', 'highly', 'interconnected', 'network', 'of', '18', 'of', 'the', '19', 'relevant', 'proteins', ',', 'where', 'only', '36', 'additional', 'molecules', 'were', 'needed', 'to', 'generate', 'a', 'specific', 'molecular', 'network', ',', 'suggesting', 'that', 'the', 'up', '-', 'regulated', 'proteins', 'form', 'a', 'potential', 'dysregulated', 'functional', 'cluster', 'encompassing', 'immune', 'responses', 'and', 'complement', 'cascade', 'proteins', ',', 'protease', 'cascades', 'maybe', 'linked', 'to', 'the', 'membrane', 'attack', 'complex', 'or', 'possibly', 'to', 'counteract', 'the', 'enzymatic', 'effect', 'of', 'up', '-', 'regulated', 'molecules', 'such', 'as', 'GPX3', ',', 'RBP3', 'and', 'PTGDS', ',', 'or', 'as', 'modulators', 'of', 'gene', 'activation', 'cascades', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The up-regulation of GPX3 is of particular interest, since it was shown previously that cataracts contain elevated levels of oxidants such as dehydroascorbic acid (DHA), indicative of oxidative stress, linked to a potentially elevated level of extracellular glutathione peroxidase GPX3 [42].	[('PMC4020801', 'D11000', 258, 280, 'glutathione peroxidase')]	['The', 'up', '-', 'regulation', 'of', 'GP', '##X', '##3', 'is', 'of', 'particular', 'interest', ',', 'since', 'it', 'was', 'shown', 'previously', 'that', 'cataract', '##s', 'contain', 'elevated', 'levels', 'of', 'oxid', '##ants', 'such', 'as', 'dehydr', '##oa', '##sc', '##orb', '##ic', 'acid', '(', 'DHA', ')', ',', 'indicative', 'of', 'oxidative', 'stress', ',', 'linked', 'to', 'a', 'potentially', 'elevated', 'level', 'of', 'extracellular', 'glutathione', 'peroxidase', 'GP', '##X', '##3', '[', '42', ']', '.']	[0, 4, 6, 7, 18, 21, 23, 24, 26, 29, 32, 43, 51, 53, 59, 62, 66, 72, 83, 88, 96, 98, 106, 115, 122, 125, 129, 134, 139, 142, 148, 150, 152, 155, 158, 163, 164, 167, 168, 170, 181, 184, 194, 200, 202, 209, 212, 214, 226, 235, 241, 244, 258, 270, 281, 283, 284, 286, 287, 289, 290]	[3, 6, 7, 17, 20, 23, 24, 25, 28, 31, 42, 51, 52, 58, 61, 65, 71, 82, 87, 96, 97, 105, 114, 121, 124, 129, 133, 138, 141, 148, 150, 152, 155, 157, 162, 164, 167, 168, 169, 180, 183, 193, 200, 201, 208, 211, 213, 225, 234, 240, 243, 257, 269, 280, 283, 284, 285, 287, 289, 290, 291]	['The', 'up', '-', 'regulation', 'of', 'GPX3', 'is', 'of', 'particular', 'interest', ',', 'since', 'it', 'was', 'shown', 'previously', 'that', 'cataracts', 'contain', 'elevated', 'levels', 'of', 'oxidants', 'such', 'as', 'dehydroascorbic', 'acid', '(', 'DHA', ')', ',', 'indicative', 'of', 'oxidative', 'stress', ',', 'linked', 'to', 'a', 'potentially', 'elevated', 'level', 'of', 'extracellular', 'glutathione', 'peroxidase', 'GPX3', '[', '42', ']', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Ecker SM, Pfahler SM, Hines JC, Lovelace AS, Glaser BM (2012) Sequential in-office vitreous aspirates demonstrate vitreous matrix metalloproteinase 9 levels correlate with the amount of subretinal fluid in eyes with wet age-related macular degeneration.	[('PMC4020801', 'F09001', 123, 149, 'matrix metalloproteinase 9')]	['Eck', '##er', 'SM', ',', 'Pf', '##ahl', '##er', 'SM', ',', 'Hin', '##es', 'JC', ',', 'Lo', '##vel', '##ace', 'AS', ',', 'Glas', '##er', 'BM', '(', '2012', ')', 'Sequ', '##ential', 'in', '-', 'office', 'vitre', '##ous', 'aspir', '##ates', 'demonstrate', 'vitre', '##ous', 'matrix', 'metalloprotein', '##ase', '9', 'levels', 'correlate', 'with', 'the', 'amount', 'of', 'sub', '##ret', '##inal', 'fluid', 'in', 'eyes', 'with', 'wet', 'age', '-', 'related', 'macular', 'degeneration', '.']	[0, 3, 6, 8, 10, 12, 15, 18, 20, 22, 25, 28, 30, 32, 34, 37, 41, 43, 45, 49, 52, 55, 56, 60, 62, 66, 73, 75, 76, 83, 88, 92, 97, 102, 114, 119, 123, 130, 144, 148, 150, 157, 167, 172, 176, 183, 186, 189, 192, 197, 203, 206, 211, 216, 220, 223, 224, 232, 240, 252]	[3, 5, 8, 9, 12, 15, 17, 20, 21, 25, 27, 30, 31, 34, 37, 40, 43, 44, 49, 51, 54, 56, 60, 61, 66, 72, 75, 76, 82, 88, 91, 97, 101, 113, 119, 122, 129, 144, 147, 149, 156, 166, 171, 175, 182, 185, 189, 192, 196, 202, 205, 210, 215, 219, 223, 224, 231, 239, 252, 253]	['Ecker', 'SM', ',', 'Pfahler', 'SM', ',', 'Hines', 'JC', ',', 'Lovelace', 'AS', ',', 'Glaser', 'BM', '(', '2012', ')', 'Sequential', 'in', '-', 'office', 'vitreous', 'aspirates', 'demonstrate', 'vitreous', 'matrix', 'metalloproteinase', '9', 'levels', 'correlate', 'with', 'the', 'amount', 'of', 'subretinal', 'fluid', 'in', 'eyes', 'with', 'wet', 'age', '-', 'related', 'macular', 'degeneration', '.']	[2, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 2, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Blots were incubated with primary antibodies (Santa Cruz Biotechnology) for 2 h at 4°C followed by incubation with secondary antibodies conjugated to horseradish peroxidase (Santa Cruz Biotechnology) for 2 h at 4°C.	[('PMC4020801', 'M13004', 150, 172, 'horseradish peroxidase')]	['Blo', '##ts', 'were', 'incubated', 'with', 'primary', 'antibodies', '(', 'Santa', 'Cruz', 'Biotechnology', ')', 'for', '2', 'h', 'at', '4°', '##C', 'followed', 'by', 'incubation', 'with', 'secondary', 'antibodies', 'conjugated', 'to', 'horse', '##radi', '##sh', 'peroxidase', '(', 'Santa', 'Cruz', 'Biotechnology', ')', 'for', '2', 'h', 'at', '4°', '##C', '.']	[0, 3, 6, 11, 21, 26, 34, 45, 46, 52, 57, 70, 72, 76, 78, 80, 83, 85, 87, 96, 99, 110, 115, 125, 136, 147, 150, 155, 159, 162, 173, 174, 180, 185, 198, 200, 204, 206, 208, 211, 213, 214]	[3, 5, 10, 20, 25, 33, 44, 46, 51, 56, 70, 71, 75, 77, 79, 82, 85, 86, 95, 98, 109, 114, 124, 135, 146, 149, 155, 159, 161, 172, 174, 179, 184, 198, 199, 203, 205, 207, 210, 213, 214, 215]	['Blots', 'were', 'incubated', 'with', 'primary', 'antibodies', '(', 'Santa', 'Cruz', 'Biotechnology', ')', 'for', '2', 'h', 'at', '4°C', 'followed', 'by', 'incubation', 'with', 'secondary', 'antibodies', 'conjugated', 'to', 'horseradish', 'peroxidase', '(', 'Santa', 'Cruz', 'Biotechnology', ')', 'for', '2', 'h', 'at', '4°C', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This expanded network of 54 proteins, including molecules known to be associated with the query molecules, consists of an immunoglobulin-cluster and complement activation (containing IGHA1, IGKC, IGHG1, IGLC2, AHSG, ITIH1, and FGA), suggesting inflammation and acute phase response processes being activated in the original source tissue, and processes including cell adhesion, lipid metabolism (RBP3, PTGDS), transport (APOA1, ALB, TTR, TF), anti-apoptosis (GPX3), and proteolysis (proteases (HP) and protease inhibitors (HRG, SERPINA1 and SERPINC1)).	[('PMC4020801', 'R04001', 483, 492, 'proteases')]	['This', 'expanded', 'network', 'of', '54', 'proteins', ',', 'including', 'molecules', 'known', 'to', 'be', 'associated', 'with', 'the', 'query', 'molecules', ',', 'consists', 'of', 'an', 'immunoglobulin', '-', 'cluster', 'and', 'complement', 'activation', '(', 'containing', 'IG', '##HA', '##1', ',', 'IG', '##K', '##C', ',', 'IG', '##HG', '##1', ',', 'IG', '##LC', '##2', ',', 'AH', '##SG', ',', 'IT', '##IH', '##1', ',', 'and', 'FG', '##A', ')', ',', 'suggesting', 'inflammation', 'and', 'acute', 'phase', 'response', 'processes', 'being', 'activated', 'in', 'the', 'original', 'source', 'tissue', ',', 'and', 'processes', 'including', 'cell', 'adhesion', ',', 'lipid', 'metabolism', '(', 'RB', '##P', '##3', ',', 'PT', '##GD', '##S', ')', ',', 'transport', '(', 'AP', '##OA', '##1', ',', 'AL', '##B', ',', 'TT', '##R', ',', 'TF', ')', ',', 'anti', '-', 'apoptosis', '(', 'GP', '##X', '##3', ')', ',', 'and', 'proteolysis', '(', 'proteases', '(', 'HP', ')', 'and', 'protease', 'inhibitors', '(', 'HR', '##G', ',', 'SER', '##PI', '##NA', '##1', 'and', 'SER', '##PI', '##NC', '##1', ')', ')', '.']	[0, 5, 14, 22, 25, 28, 36, 38, 48, 58, 64, 67, 70, 81, 86, 90, 96, 105, 107, 116, 119, 122, 136, 137, 145, 149, 160, 171, 172, 183, 185, 187, 188, 190, 192, 193, 194, 196, 198, 200, 201, 203, 205, 207, 208, 210, 212, 214, 216, 218, 220, 221, 223, 227, 229, 230, 231, 233, 244, 257, 261, 267, 273, 282, 292, 298, 308, 311, 315, 324, 331, 337, 339, 343, 353, 363, 368, 376, 378, 384, 395, 396, 398, 399, 400, 402, 404, 406, 407, 408, 410, 420, 421, 423, 425, 426, 428, 430, 431, 433, 435, 436, 438, 440, 441, 443, 447, 448, 458, 459, 461, 462, 463, 464, 466, 470, 482, 483, 493, 494, 496, 498, 502, 511, 522, 523, 525, 526, 528, 531, 533, 535, 537, 541, 544, 546, 548, 549, 550, 551]	[4, 13, 21, 24, 27, 36, 37, 47, 57, 63, 66, 69, 80, 85, 89, 95, 105, 106, 115, 118, 121, 136, 137, 144, 148, 159, 170, 172, 182, 185, 187, 188, 189, 192, 193, 194, 195, 198, 200, 201, 202, 205, 207, 208, 209, 212, 214, 215, 218, 220, 221, 222, 226, 229, 230, 231, 232, 243, 256, 260, 266, 272, 281, 291, 297, 307, 310, 314, 323, 330, 337, 338, 342, 352, 362, 367, 376, 377, 383, 394, 396, 398, 399, 400, 401, 404, 406, 407, 408, 409, 419, 421, 423, 425, 426, 427, 430, 431, 432, 435, 436, 437, 440, 441, 442, 447, 448, 457, 459, 461, 462, 463, 464, 465, 469, 481, 483, 492, 494, 496, 497, 501, 510, 521, 523, 525, 526, 527, 531, 533, 535, 536, 540, 544, 546, 548, 549, 550, 551, 552]	['This', 'expanded', 'network', 'of', '54', 'proteins', ',', 'including', 'molecules', 'known', 'to', 'be', 'associated', 'with', 'the', 'query', 'molecules', ',', 'consists', 'of', 'an', 'immunoglobulin', '-', 'cluster', 'and', 'complement', 'activation', '(', 'containing', 'IGHA1', ',', 'IGKC', ',', 'IGHG1', ',', 'IGLC2', ',', 'AHSG', ',', 'ITIH1', ',', 'and', 'FGA', ')', ',', 'suggesting', 'inflammation', 'and', 'acute', 'phase', 'response', 'processes', 'being', 'activated', 'in', 'the', 'original', 'source', 'tissue', ',', 'and', 'processes', 'including', 'cell', 'adhesion', ',', 'lipid', 'metabolism', '(', 'RBP3', ',', 'PTGDS', ')', ',', 'transport', '(', 'APOA1', ',', 'ALB', ',', 'TTR', ',', 'TF', ')', ',', 'anti-', 'apoptosis', '(', 'GPX3', ')', ',', 'and', 'proteolysis', '(', 'proteases', '(', 'HP', ')', 'and', 'protease', 'inhibitors', '(', 'HRG', ',', 'SERPINA1', 'and', 'SERPINC1', ')', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 3, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These results support a mediating effect of aldehyde dehydrogenase deficiency on alcohol consumption in males and a secondary, culturally-mediated limitation on alcohol consumption by females that should be appropriately modeled in future studies of alcohol consumption in populations where this may be a factor.	[('PMC4149216', 'A00008', 44, 66, 'aldehyde dehydrogenase')]	['These', 'results', 'support', 'a', 'mediating', 'effect', 'of', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', 'deficiency', 'on', 'alcohol', 'consumption', 'in', 'males', 'and', 'a', 'secondary', ',', 'culturally', '-', 'mediated', 'limitation', 'on', 'alcohol', 'consumption', 'by', 'females', 'that', 'should', 'be', 'appropriately', 'modeled', 'in', 'future', 'studies', 'of', 'alcohol', 'consumption', 'in', 'populations', 'where', 'this', 'may', 'be', 'a', 'factor', '.']	[0, 6, 14, 22, 24, 34, 41, 44, 47, 49, 51, 53, 67, 78, 81, 89, 101, 104, 110, 114, 116, 125, 127, 137, 138, 147, 158, 161, 169, 181, 184, 192, 197, 204, 207, 221, 229, 232, 239, 247, 250, 258, 270, 273, 285, 291, 296, 300, 303, 305, 311]	[5, 13, 21, 23, 33, 40, 43, 47, 49, 51, 52, 66, 77, 80, 88, 100, 103, 109, 113, 115, 125, 126, 137, 138, 146, 157, 160, 168, 180, 183, 191, 196, 203, 206, 220, 228, 231, 238, 246, 249, 257, 269, 272, 284, 290, 295, 299, 302, 304, 311, 312]	['These', 'results', 'support', 'a', 'mediating', 'effect', 'of', 'aldehyde', 'dehydrogenase', 'deficiency', 'on', 'alcohol', 'consumption', 'in', 'males', 'and', 'a', 'secondary', ',', 'culturally', '-', 'mediated', 'limitation', 'on', 'alcohol', 'consumption', 'by', 'females', 'that', 'should', 'be', 'appropriately', 'modeled', 'in', 'future', 'studies', 'of', 'alcohol', 'consumption', 'in', 'populations', 'where', 'this', 'may', 'be', 'a', 'factor', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Studies by Yokoyama and colleagues demonstrate an elevated risk of esophageal cancer among alcohol dehydrogenase deficient individuals (rs671 GG) who frequently consume alcohol (Yokoyama et al.	[('PMC4149216', 'D02001', 91, 112, 'alcohol dehydrogenase')]	['Studies', 'by', 'Y', '##ok', '##oya', '##ma', 'and', 'colleagues', 'demonstrate', 'an', 'elevated', 'risk', 'of', 'esophageal', 'cancer', 'among', 'alcohol', 'dehydrogenase', 'deficient', 'individuals', '(', 'rs', '##67', '##1', 'GG', ')', 'who', 'frequently', 'consume', 'alcohol', '(', 'Y', '##ok', '##oya', '##ma', 'et', 'al', '.']	[0, 8, 11, 12, 14, 17, 20, 24, 35, 47, 50, 59, 64, 67, 78, 85, 91, 99, 113, 123, 135, 136, 138, 140, 142, 144, 146, 150, 161, 169, 177, 178, 179, 181, 184, 187, 190, 192]	[7, 10, 12, 14, 17, 19, 23, 34, 46, 49, 58, 63, 66, 77, 84, 90, 98, 112, 122, 134, 136, 138, 140, 141, 144, 145, 149, 160, 168, 176, 178, 179, 181, 184, 186, 189, 192, 193]	['Studies', 'by', 'Yokoyama', 'and', 'colleagues', 'demonstrate', 'an', 'elevated', 'risk', 'of', 'esophageal', 'cancer', 'among', 'alcohol', 'dehydrogenase', 'deficient', 'individuals', '(', 'rs671', 'GG', ')', 'who', 'frequently', 'consume', 'alcohol', '(', 'Yokoyama', 'et', 'al', '.']	[1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants.	[('PMC4149216', 'F10001', 44, 65, 'alcohol dehydrogenase'), ('PMC4149216', 'F10001', 70, 92, 'aldehyde dehydrogenase')]	['The', 'genetics', 'of', 'alcohol', 'metabolism', ':', 'role', 'of', 'alcohol', 'dehydrogenase', 'and', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', 'variants', '.']	[0, 4, 13, 16, 24, 34, 36, 41, 44, 52, 66, 70, 73, 75, 77, 79, 93, 101]	[3, 12, 15, 23, 34, 35, 40, 43, 51, 65, 69, 73, 75, 77, 78, 92, 101, 102]	['The', 'genetics', 'of', 'alcohol', 'metabolism', ':', 'role', 'of', 'alcohol', 'dehydrogenase', 'and', 'aldehyde', 'dehydrogenase', 'variants', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O']
Li D, Zhao H, Gelernter J. Strong association of the alcohol dehydrogenase 1B gene ADH1B with alcohol dependence and alcohol-induced medical diseases.	[('PMC4149216', 'F21000', 53, 74, 'alcohol dehydrogenase')]	['Li', 'D', ',', 'Zhao', 'H', ',', 'Gel', '##ern', '##ter', 'J', '.', 'Strong', 'association', 'of', 'the', 'alcohol', 'dehydrogenase', '1', '##B', 'gene', 'AD', '##H', '##1', '##B', 'with', 'alcohol', 'dependence', 'and', 'alcohol', '-', 'induced', 'medical', 'diseases', '.']	[0, 3, 4, 6, 11, 12, 14, 17, 20, 24, 25, 27, 34, 46, 49, 53, 61, 75, 76, 78, 83, 85, 86, 87, 89, 94, 102, 113, 117, 124, 125, 133, 141, 149]	[2, 4, 5, 10, 12, 13, 17, 20, 23, 25, 26, 33, 45, 48, 52, 60, 74, 76, 77, 82, 85, 86, 87, 88, 93, 101, 112, 116, 124, 125, 132, 140, 149, 150]	['Li', 'D', ',', 'Zhao', 'H', ',', 'Gelernter', 'J', '.', 'Strong', 'association', 'of', 'the', 'alcohol', 'dehydrogenase', '1B', 'gene', 'ADH1B', 'with', 'alcohol', 'dependence', 'and', 'alcohol', '-', 'induced', 'medical', 'diseases', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Li D, Zhao H, Gelernter J. Strong protective effect of the aldehyde dehydrogenase gene ALDH2 504lys	[('PMC4149216', 'F23000', 59, 81, 'aldehyde dehydrogenase')]	['Li', 'D', ',', 'Zhao', 'H', ',', 'Gel', '##ern', '##ter', 'J', '.', 'Strong', 'protective', 'effect', 'of', 'the', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', 'gene', 'AL', '##DH', '##2', '50', '##4', '##lys']	[0, 3, 4, 6, 11, 12, 14, 17, 20, 24, 25, 27, 34, 45, 52, 55, 59, 62, 64, 66, 68, 82, 87, 89, 91, 93, 95, 96]	[2, 4, 5, 10, 12, 13, 17, 20, 23, 25, 26, 33, 44, 51, 54, 58, 62, 64, 66, 67, 81, 86, 89, 91, 92, 95, 96, 99]	['Li', 'D', ',', 'Zhao', 'H', ',', 'Gelernter', 'J', '.', 'Strong', 'protective', 'effect', 'of', 'the', 'aldehyde', 'dehydrogenase', 'gene', 'ALDH2', '504lys']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thomasson HR, Crabb DW, Edenberg HJ, Li T-K. Alcohol and aldehyde dehydrogenase polymorphisms and alcoholism.	[('PMC4149216', 'F36000', 57, 79, 'aldehyde dehydrogenase')]	['Thomas', '##son', 'HR', ',', 'Cra', '##bb', 'DW', ',', 'Ed', '##enberg', 'HJ', ',', 'Li', 'T', '-', 'K', '.', 'Alcohol', 'and', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', 'polymorphisms', 'and', 'alcohol', '##ism', '.']	[0, 6, 10, 12, 14, 17, 20, 22, 24, 26, 33, 35, 37, 40, 41, 42, 43, 45, 53, 57, 60, 62, 64, 66, 80, 94, 98, 105, 108]	[6, 9, 12, 13, 17, 19, 22, 23, 26, 32, 35, 36, 39, 41, 42, 43, 44, 52, 56, 60, 62, 64, 65, 79, 93, 97, 105, 108, 109]	['Thomasson', 'HR', ',', 'Crabb', 'DW', ',', 'Edenberg', 'HJ', ',', 'Li', 'T-K', '.', 'Alcohol', 'and', 'aldehyde', 'dehydrogenase', 'polymorphisms', 'and', 'alcoholism', '.']	[2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Alcohol dependence (AD) is a moderately heritable disorder for which two major families of risk genes have been mapped via linkage and candidate gene association studies: the alcohol dehydrogenase (ADH) family, which contributes to variation in speed of ethanol metabolism and yields a variable concentration of acetaldehyde following alcohol consumption; and the aldehyde dehydrogenase (ALDH) gene family, which mediates acetaldehyde clearance (Edenberg 2007; Li et al. 2011, 2012a, 2012b).	[('PMC4149216', 'I00000', 175, 196, 'alcohol dehydrogenase'), ('PMC4149216', 'I00000', 364, 386, 'aldehyde dehydrogenase')]	['Alcohol', 'dependence', '(', 'AD', ')', 'is', 'a', 'moderately', 'herit', '##able', 'disorder', 'for', 'which', 'two', 'major', 'families', 'of', 'risk', 'genes', 'have', 'been', 'mapped', 'via', 'linkage', 'and', 'candidate', 'gene', 'association', 'studies', ':', 'the', 'alcohol', 'dehydrogenase', '(', 'AD', '##H', ')', 'family', ',', 'which', 'contributes', 'to', 'variation', 'in', 'speed', 'of', 'ethanol', 'metabolism', 'and', 'yields', 'a', 'variable', 'concentration', 'of', 'acet', '##aldehyde', 'following', 'alcohol', 'consumption', ';', 'and', 'the', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', '(', 'AL', '##DH', ')', 'gene', 'family', ',', 'which', 'mediates', 'acet', '##aldehyde', 'clearance', '(', 'Ed', '##enberg', '2007', ';', 'Li', 'et', 'al', '.', '2011', ',', '2012', '##a', ',', '2012', '##b', ')', '.']	[0, 8, 19, 20, 22, 24, 27, 29, 40, 45, 50, 59, 63, 69, 73, 79, 88, 91, 96, 102, 107, 112, 119, 123, 131, 135, 145, 150, 162, 169, 171, 175, 183, 197, 198, 200, 201, 203, 209, 211, 217, 229, 232, 242, 245, 251, 254, 262, 273, 277, 284, 286, 295, 309, 312, 316, 325, 335, 343, 354, 356, 360, 364, 367, 369, 371, 373, 387, 388, 390, 392, 394, 399, 405, 407, 413, 422, 426, 435, 445, 446, 448, 455, 459, 461, 464, 467, 469, 471, 475, 477, 481, 482, 484, 488, 489, 490]	[7, 18, 20, 22, 23, 26, 28, 39, 45, 49, 58, 62, 68, 72, 78, 87, 90, 95, 101, 106, 111, 118, 122, 130, 134, 144, 149, 161, 169, 170, 174, 182, 196, 198, 200, 201, 202, 209, 210, 216, 228, 231, 241, 244, 250, 253, 261, 272, 276, 283, 285, 294, 308, 311, 316, 324, 334, 342, 354, 355, 359, 363, 367, 369, 371, 372, 386, 388, 390, 392, 393, 398, 405, 406, 412, 421, 426, 434, 444, 446, 448, 454, 459, 460, 463, 466, 469, 470, 475, 476, 481, 482, 483, 488, 489, 490, 491]	['Alcohol', 'dependence', '(', 'AD', ')', 'is', 'a', 'moderately', 'heritable', 'disorder', 'for', 'which', 'two', 'major', 'families', 'of', 'risk', 'genes', 'have', 'been', 'mapped', 'via', 'linkage', 'and', 'candidate', 'gene', 'association', 'studies', ':', 'the', 'alcohol', 'dehydrogenase', '(', 'ADH', ')', 'family', ',', 'which', 'contributes', 'to', 'variation', 'in', 'speed', 'of', 'ethanol', 'metabolism', 'and', 'yields', 'a', 'variable', 'concentration', 'of', 'acetaldehyde', 'following', 'alcohol', 'consumption', ';', 'and', 'the', 'aldehyde', 'dehydrogenase', '(', 'ALDH', ')', 'gene', 'family', ',', 'which', 'mediates', 'acetaldehyde', 'clearance', '(', 'Edenberg', '2007', ';', 'Li', 'et', 'al', '.', '2011', ',', '2012a', ',', '2012b', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
AD, flushing response, and maximum drinks all show multiple significant associations in males in the region of chromosome 12 containing aldehyde dehydrogenase gene, ALDH2.	[('PMC4149216', 'R02000', 136, 158, 'aldehyde dehydrogenase')]	['AD', ',', 'flu', '##sh', '##ing', 'response', ',', 'and', 'maximum', 'drinks', 'all', 'show', 'multiple', 'significant', 'associations', 'in', 'males', 'in', 'the', 'region', 'of', 'chromosome', '12', 'containing', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', 'gene', ',', 'AL', '##DH', '##2', '.']	[0, 2, 4, 7, 9, 13, 21, 23, 27, 35, 42, 46, 51, 60, 72, 85, 88, 94, 97, 101, 108, 111, 122, 125, 136, 139, 141, 143, 145, 159, 163, 165, 167, 169, 170]	[2, 3, 7, 9, 12, 21, 22, 26, 34, 41, 45, 50, 59, 71, 84, 87, 93, 96, 100, 107, 110, 121, 124, 135, 139, 141, 143, 144, 158, 163, 164, 167, 169, 170, 171]	['AD', ',', 'flushing', 'response', ',', 'and', 'maximum', 'drinks', 'all', 'show', 'multiple', 'significant', 'associations', 'in', 'males', 'in', 'the', 'region', 'of', 'chromosome', '12', 'containing', 'aldehyde', 'dehydrogenase', 'gene', ',', 'ALDH2', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Results: Among European-ancestry participants, 31 SNPs in or near the fatty acid desaturase (fatty acid desaturase) 1 and 2 cluster were associated with cis/trans-18:2; a top hit was rs174548 (β = 0.0035, P = 4.90 × 10−15), an SNP previously associated with circulating n–3 and n–6 polyunsaturated fatty acid concentrations.	[('PMC4307209', 'A03000', 70, 91, 'fatty acid desaturase'), ('PMC4307209', 'A03000', 93, 114, 'fatty acid desaturase')]	['Results', ':', 'Among', 'European', '-', 'ancest', '##ry', 'participants', ',', '31', 'SNPs', 'in', 'or', 'near', 'the', 'fatty', 'acid', 'des', '##atur', '##ase', '(', 'fatty', 'acid', 'des', '##atur', '##ase', ')', '1', 'and', '2', 'cluster', 'were', 'associated', 'with', 'cis', '/', 'trans', '-', '18', ':', '2', ';', 'a', 'top', 'hit', 'was', 'rs', '##174', '##54', '##8', '(', 'β', '=', '0', '.', '00', '##35', ',', 'P', '=', '4', '.', '90', '×', '10−', '##15', ')', ',', 'an', 'SNP', 'previously', 'associated', 'with', 'circulating', 'n', '–', '3', 'and', 'n', '–', '6', 'poly', '##uns', '##aturated', 'fatty', 'acid', 'concentrations', '.']	[0, 7, 9, 15, 23, 24, 30, 33, 45, 47, 50, 55, 58, 61, 66, 70, 76, 81, 84, 88, 92, 93, 99, 104, 107, 111, 114, 116, 118, 122, 124, 132, 137, 148, 153, 156, 157, 162, 163, 165, 166, 167, 169, 171, 175, 179, 183, 185, 188, 190, 192, 193, 195, 197, 198, 199, 201, 203, 205, 207, 209, 210, 211, 214, 216, 219, 221, 222, 224, 227, 231, 242, 253, 258, 270, 271, 272, 274, 278, 279, 280, 282, 286, 289, 298, 304, 309, 323]	[7, 8, 14, 23, 24, 30, 32, 45, 46, 49, 54, 57, 60, 65, 69, 75, 80, 84, 88, 91, 93, 98, 103, 107, 111, 114, 115, 117, 121, 123, 131, 136, 147, 152, 156, 157, 162, 163, 165, 166, 167, 168, 170, 174, 178, 182, 185, 188, 190, 191, 193, 194, 196, 198, 199, 201, 203, 204, 206, 208, 210, 211, 213, 215, 219, 221, 222, 223, 226, 230, 241, 252, 257, 269, 271, 272, 273, 277, 279, 280, 281, 286, 289, 297, 303, 308, 323, 324]	['Results', ':', 'Among', 'European', '-', 'ancestry', 'participants', ',', '31', 'SNPs', 'in', 'or', 'near', 'the', 'fatty', 'acid', 'desaturase', '(', 'fatty', 'acid', 'desaturase', ')', '1', 'and', '2', 'cluster', 'were', 'associated', 'with', 'cis', '/', 'trans-18', ':', '2', ';', 'a', 'top', 'hit', 'was', 'rs174548', '(', 'β', '=', '0.0035', ',', 'P', '=', '4.90', '×', '10−15', ')', ',', 'an', 'SNP', 'previously', 'associated', 'with', 'circulating', 'n', '–', '3', 'and', 'n', '–', '6', 'polyunsaturated', 'fatty', 'acid', 'concentrations', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The FADS1/2 cluster encodes fatty acid desaturase enzymes that regulate endogenous metabolism of cis n–3 and n–6 PUFA (20, 22).	[('PMC4307209', 'D01000', 28, 49, 'fatty acid desaturase')]	['The', 'FA', '##DS', '##1', '/', '2', 'cluster', 'encodes', 'fatty', 'acid', 'des', '##atur', '##ase', 'enzymes', 'that', 'regulate', 'endogenous', 'metabolism', 'of', 'cis', 'n', '–', '3', 'and', 'n', '–', '6', 'PU', '##FA', '(', '20', ',', '22', ')', '.']	[0, 4, 6, 8, 9, 10, 12, 20, 28, 34, 39, 42, 46, 50, 58, 63, 72, 83, 94, 97, 101, 102, 103, 105, 109, 110, 111, 113, 115, 118, 119, 121, 123, 125, 126]	[3, 6, 8, 9, 10, 11, 19, 27, 33, 38, 42, 46, 49, 57, 62, 71, 82, 93, 96, 100, 102, 103, 104, 108, 110, 111, 112, 115, 117, 119, 121, 122, 125, 126, 127]	['The', 'FADS1', '/', '2', 'cluster', 'encodes', 'fatty', 'acid', 'desaturase', 'enzymes', 'that', 'regulate', 'endogenous', 'metabolism', 'of', 'cis', 'n', '–', '3', 'and', 'n', '–', '6', 'PUFA', '(', '20', ',', '22', ')', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Subsequent differences in arachidonic acid concentrations could then alter activities of FADS2 and stearoyl-CoA desaturase, enzymes that could be involved in metabolism (or, less likely, synthesis) of cis/trans-18:2.	[('PMC4307209', 'D01007', 99, 122, 'stearoyl-CoA desaturase')]	['Subsequent', 'differences', 'in', 'ar', '##achid', '##onic', 'acid', 'concentrations', 'could', 'then', 'alter', 'activities', 'of', 'FA', '##DS', '##2', 'and', 'ste', '##aro', '##yl', '-', 'Co', '##A', 'des', '##atur', '##ase', ',', 'enzymes', 'that', 'could', 'be', 'involved', 'in', 'metabolism', '(', 'or', ',', 'less', 'likely', ',', 'synthesis', ')', 'of', 'cis', '/', 'trans', '-', '18', ':', '2', '.']	[0, 11, 23, 26, 28, 33, 38, 43, 58, 64, 69, 75, 86, 89, 91, 93, 95, 99, 102, 105, 107, 108, 110, 112, 115, 119, 122, 124, 132, 137, 143, 146, 155, 158, 169, 170, 172, 174, 179, 185, 187, 196, 198, 201, 204, 205, 210, 211, 213, 214, 215]	[10, 22, 25, 28, 33, 37, 42, 57, 63, 68, 74, 85, 88, 91, 93, 94, 98, 102, 105, 107, 108, 110, 111, 115, 119, 122, 123, 131, 136, 142, 145, 154, 157, 168, 170, 172, 173, 178, 185, 186, 196, 197, 200, 204, 205, 210, 211, 213, 214, 215, 216]	['Subsequent', 'differences', 'in', 'arachidonic', 'acid', 'concentrations', 'could', 'then', 'alter', 'activities', 'of', 'FADS2', 'and', 'stearoyl-CoA', 'desaturase', ',', 'enzymes', 'that', 'could', 'be', 'involved', 'in', 'metabolism', '(', 'or', ',', 'less', 'likely', ',', 'synthesis', ')', 'of', 'cis', '/', 'trans-18', ':', '2', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Arachidonic acid could also alter the rate of incorporation or removal of cis/trans-18:2 from phospholipids, for instance, by influencing concentrations or activities of lysophosphatidyl acyltransferase or phospholipase A2, respectively.	[('PMC4307209', 'D01008', 170, 202, 'lysophosphatidyl acyltransferase'), ('PMC4307209', 'D01008', 206, 222, 'phospholipase A2')]	['Ara', '##chi', '##don', '##ic', 'acid', 'could', 'also', 'alter', 'the', 'rate', 'of', 'incorporation', 'or', 'removal', 'of', 'cis', '/', 'trans', '-', '18', ':', '2', 'from', 'phospholipids', ',', 'for', 'instance', ',', 'by', 'influencing', 'concentrations', 'or', 'activities', 'of', 'lys', '##ophosph', '##atidyl', 'acyl', '##transferase', 'or', 'phospholip', '##ase', 'A', '##2', ',', 'respectively', '.']	[0, 3, 6, 9, 12, 17, 23, 28, 34, 38, 43, 46, 60, 63, 71, 74, 77, 78, 83, 84, 86, 87, 89, 94, 107, 109, 113, 121, 123, 126, 138, 153, 156, 167, 170, 173, 180, 187, 191, 203, 206, 216, 220, 221, 222, 224, 236]	[3, 6, 9, 11, 16, 22, 27, 33, 37, 42, 45, 59, 62, 70, 73, 77, 78, 83, 84, 86, 87, 88, 93, 107, 108, 112, 121, 122, 125, 137, 152, 155, 166, 169, 173, 180, 186, 191, 202, 205, 216, 219, 221, 222, 223, 236, 237]	['Arachidonic', 'acid', 'could', 'also', 'alter', 'the', 'rate', 'of', 'incorporation', 'or', 'removal', 'of', 'cis', '/', 'trans-18', ':', '2', 'from', 'phospholipids', ',', 'for', 'instance', ',', 'by', 'influencing', 'concentrations', 'or', 'activities', 'of', 'lysophosphatidyl', 'acyltransferase', 'or', 'phospholipase', 'A2', ',', 'respectively', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 2, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O']
Hellstrand S, Sonestedt E, Ericson U, Gullberg B, Wirfalt E, Hedblad B, Orho-Melander M.Intake levels of dietary long-chain PUFAs modify the association between genetic variation in fatty acid desaturase and LDL-C. J Lipid Res2012;53:1183–9.	[('PMC4307209', 'F29001', 182, 203, 'fatty acid desaturase')]	['Hel', '##ls', '##tran', '##d', 'S', ',', 'Son', '##ested', '##t', 'E', ',', 'Eric', '##son', 'U', ',', 'Gu', '##ll', '##berg', 'B', ',', 'Wir', '##fal', '##t', 'E', ',', 'Hed', '##bl', '##ad', 'B', ',', 'Or', '##ho', '-', 'Mel', '##ander', 'M', '.', 'Int', '##ake', 'levels', 'of', 'dietary', 'long', '-', 'chain', 'PU', '##FAs', 'modify', 'the', 'association', 'between', 'genetic', 'variation', 'in', 'fatty', 'acid', 'des', '##atur', '##ase', 'and', 'LDL', '-', 'C', '.', 'J', 'Lipid', 'Res', '##201', '##2', ';', '53', ':', '118', '##3', '–', '9', '.']	[0, 3, 5, 9, 11, 12, 14, 17, 22, 24, 25, 27, 31, 35, 36, 38, 40, 42, 47, 48, 50, 53, 56, 58, 59, 61, 64, 66, 69, 70, 72, 74, 76, 77, 80, 86, 87, 88, 91, 95, 102, 105, 113, 117, 118, 124, 126, 130, 137, 141, 153, 161, 169, 179, 182, 188, 193, 196, 200, 204, 208, 211, 212, 213, 215, 217, 223, 226, 229, 230, 231, 233, 234, 237, 238, 239, 240]	[3, 5, 9, 10, 12, 13, 17, 22, 23, 25, 26, 31, 34, 36, 37, 40, 42, 46, 48, 49, 53, 56, 57, 59, 60, 64, 66, 68, 70, 71, 74, 76, 77, 80, 85, 87, 88, 91, 94, 101, 104, 112, 117, 118, 123, 126, 129, 136, 140, 152, 160, 168, 178, 181, 187, 192, 196, 200, 203, 207, 211, 212, 213, 214, 216, 222, 226, 229, 230, 231, 233, 234, 237, 238, 239, 240, 241]	['Hellstrand', 'S', ',', 'Sonestedt', 'E', ',', 'Ericson', 'U', ',', 'Gullberg', 'B', ',', 'Wirfalt', 'E', ',', 'Hedblad', 'B', ',', 'Orho-Melander', 'M.Intake', 'levels', 'of', 'dietary', 'long', '-', 'chain', 'PUFAs', 'modify', 'the', 'association', 'between', 'genetic', 'variation', 'in', 'fatty', 'acid', 'desaturase', 'and', 'LDL-C', '.', 'J', 'Lipid', 'Res2012', ';', '53', ':', '1183–', '9', '.']	[4, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 5, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E, Sandri M, Friso S, Pizzolo F, Schaeffer L, et al. fatty acid desaturase genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease.	[('PMC4307209', 'F31001', 118, 139, 'fatty acid desaturase'), ('PMC4307209', 'F31001', 154, 164, 'desaturase')]	['Martin', '##elli', 'N', ',', 'Gir', '##elli', 'D', ',', 'Male', '##rb', '##a', 'G', ',', 'Gu', '##arin', '##i', 'P', ',', 'Ill', '##ig', 'T', ',', 'Tra', '##bet', '##ti', 'E', ',', 'Sand', '##ri', 'M', ',', 'Fri', '##so', 'S', ',', 'Pi', '##zz', '##olo', 'F', ',', 'Sch', '##ae', '##ffer', 'L', ',', 'et', 'al', '.', 'fatty', 'acid', 'des', '##atur', '##ase', 'genotypes', 'and', 'des', '##atur', '##ase', 'activity', 'estimated', 'by', 'the', 'ratio', 'of', 'ar', '##achid', '##onic', 'acid', 'to', 'lin', '##ole', '##ic', 'acid', 'are', 'associated', 'with', 'inflammation', 'and', 'coronary', 'artery', 'disease', '.']	[0, 6, 11, 12, 14, 17, 22, 23, 25, 29, 31, 33, 34, 36, 38, 42, 44, 45, 47, 50, 53, 54, 56, 59, 62, 65, 66, 68, 72, 75, 76, 78, 81, 84, 85, 87, 89, 91, 95, 96, 98, 101, 103, 108, 109, 111, 114, 116, 118, 124, 129, 132, 136, 140, 150, 154, 157, 161, 165, 174, 184, 187, 191, 197, 200, 202, 207, 212, 217, 220, 223, 226, 229, 234, 238, 249, 254, 267, 271, 280, 287, 294]	[6, 10, 12, 13, 17, 21, 23, 24, 29, 31, 32, 34, 35, 38, 42, 43, 45, 46, 50, 52, 54, 55, 59, 62, 64, 66, 67, 72, 74, 76, 77, 81, 83, 85, 86, 89, 91, 94, 96, 97, 101, 103, 107, 109, 110, 113, 116, 117, 123, 128, 132, 136, 139, 149, 153, 157, 161, 164, 173, 183, 186, 190, 196, 199, 202, 207, 211, 216, 219, 223, 226, 228, 233, 237, 248, 253, 266, 270, 279, 286, 294, 295]	['Martinelli', 'N', ',', 'Girelli', 'D', ',', 'Malerba', 'G', ',', 'Guarini', 'P', ',', 'Illig', 'T', ',', 'Trabetti', 'E', ',', 'Sandri', 'M', ',', 'Friso', 'S', ',', 'Pizzolo', 'F', ',', 'Schaeffer', 'L', ',', 'et', 'al', '.', 'fatty', 'acid', 'desaturase', 'genotypes', 'and', 'desaturase', 'activity', 'estimated', 'by', 'the', 'ratio', 'of', 'arachidonic', 'acid', 'to', 'linoleic', 'acid', 'are', 'associated', 'with', 'inflammation', 'and', 'coronary', 'artery', 'disease', '.']	[2, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aslibekyan S, Jensen MK, Campos H, Linkletter CD, Loucks EB, Ordovas JM, Deka R, Rimm EB, Baylin A.Fatty acid desaturase gene variants, cardiovascular risk factors, and myocardial infarction in the Costa Rica study.	[('PMC4307209', 'F35001', 99, 120, 'Fatty acid desaturase')]	['As', '##li', '##be', '##ky', '##an', 'S', ',', 'Jensen', 'MK', ',', 'Camp', '##os', 'H', ',', 'Link', '##lett', '##er', 'CD', ',', 'Lou', '##cks', 'EB', ',', 'Ord', '##ova', '##s', 'JM', ',', 'De', '##ka', 'R', ',', 'Ri', '##mm', 'EB', ',', 'Bay', '##lin', 'A', '.', 'Fat', '##ty', 'acid', 'des', '##atur', '##ase', 'gene', 'variants', ',', 'cardiovascular', 'risk', 'factors', ',', 'and', 'myocardial', 'infarction', 'in', 'the', 'Costa', 'Ric', '##a', 'study', '.']	[0, 2, 4, 6, 8, 11, 12, 14, 21, 23, 25, 29, 32, 33, 35, 39, 43, 46, 48, 50, 53, 57, 59, 61, 64, 67, 69, 71, 73, 75, 78, 79, 81, 83, 86, 88, 90, 93, 97, 98, 99, 102, 105, 110, 113, 117, 121, 126, 134, 136, 151, 156, 163, 165, 169, 180, 191, 194, 198, 204, 207, 209, 214]	[2, 4, 6, 8, 10, 12, 13, 20, 23, 24, 29, 31, 33, 34, 39, 43, 45, 48, 49, 53, 56, 59, 60, 64, 67, 68, 71, 72, 75, 77, 79, 80, 83, 85, 88, 89, 93, 96, 98, 99, 102, 104, 109, 113, 117, 120, 125, 134, 135, 150, 155, 163, 164, 168, 179, 190, 193, 197, 203, 207, 208, 214, 215]	['Aslibekyan', 'S', ',', 'Jensen', 'MK', ',', 'Campos', 'H', ',', 'Linkletter', 'CD', ',', 'Loucks', 'EB', ',', 'Ordovas', 'JM', ',', 'Deka', 'R', ',', 'Rimm', 'EB', ',', 'Baylin', 'A.Fatty', 'acid', 'desaturase', 'gene', 'variants', ',', 'cardiovascular', 'risk', 'factors', ',', 'and', 'myocardial', 'infarction', 'in', 'the', 'Costa', 'Rica', 'study', '.']	[5, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 2, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study.	[('PMC4307209', 'F36002', 22, 32, 'desaturase')]	['Mark', '##ers', 'of', 'endogenous', 'des', '##atur', '##ase', 'activity', 'and', 'risk', 'of', 'coronary', 'heart', 'disease', 'in', 'the', 'CAR', '##EM', '##A', 'cohort', 'study', '.']	[0, 4, 8, 11, 22, 25, 29, 33, 42, 46, 51, 54, 63, 69, 77, 80, 84, 87, 89, 91, 98, 103]	[4, 7, 10, 21, 25, 29, 32, 41, 45, 50, 53, 62, 68, 76, 79, 83, 87, 89, 90, 97, 103, 104]	['Markers', 'of', 'endogenous', 'desaturase', 'activity', 'and', 'risk', 'of', 'coronary', 'heart', 'disease', 'in', 'the', 'CAREMA', 'cohort', 'study', '.']	[2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Li SW, Lin K, Ma P, Zhang ZL, Zhou YD, Lu SY, Zhou X, Liu SM.FADS gene polymorphisms confer the risk of coronary artery disease in a Chinese Han population through the altered desaturase activities: based on high-resolution melting analysis.	[('PMC4307209', 'F37001', 176, 186, 'desaturase')]	['Li', 'SW', ',', 'Lin', 'K', ',', 'Ma', 'P', ',', 'Zhang', 'Z', '##L', ',', 'Zhou', 'Y', '##D', ',', 'Lu', 'SY', ',', 'Zhou', 'X', ',', 'Liu', 'SM', '.', 'FA', '##DS', 'gene', 'polymorphisms', 'confer', 'the', 'risk', 'of', 'coronary', 'artery', 'disease', 'in', 'a', 'Chinese', 'Han', 'population', 'through', 'the', 'altered', 'des', '##atur', '##ase', 'activities', ':', 'based', 'on', 'high', '-', 'resolution', 'melting', 'analysis', '.']	[0, 3, 5, 7, 11, 12, 14, 17, 18, 20, 26, 27, 28, 30, 35, 36, 37, 39, 42, 44, 46, 51, 52, 54, 58, 60, 61, 63, 66, 71, 85, 92, 96, 101, 104, 113, 120, 128, 131, 133, 141, 145, 156, 164, 168, 176, 179, 183, 187, 197, 199, 205, 208, 212, 213, 224, 232, 240]	[2, 5, 6, 10, 12, 13, 16, 18, 19, 25, 27, 28, 29, 34, 36, 37, 38, 41, 44, 45, 50, 52, 53, 57, 60, 61, 63, 65, 70, 84, 91, 95, 100, 103, 112, 119, 127, 130, 132, 140, 144, 155, 163, 167, 175, 179, 183, 186, 197, 198, 204, 207, 212, 213, 223, 231, 240, 241]	['Li', 'SW', ',', 'Lin', 'K', ',', 'Ma', 'P', ',', 'Zhang', 'ZL', ',', 'Zhou', 'YD', ',', 'Lu', 'SY', ',', 'Zhou', 'X', ',', 'Liu', 'SM.FADS', 'gene', 'polymorphisms', 'confer', 'the', 'risk', 'of', 'coronary', 'artery', 'disease', 'in', 'a', 'Chinese', 'Han', 'population', 'through', 'the', 'altered', 'desaturase', 'activities', ':', 'based', 'on', 'high', '-', 'resolution', 'melting', 'analysis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mathias RA, Fu W, Akey JM, Ainsworth HC, Torgerson DG, Ruczinski I, Sergeant S, Barnes KC, Chilton FH.Adaptive evolution of the fatty acid desaturase gene cluster within Africa.	[('PMC4307209', 'F38001', 128, 149, 'fatty acid desaturase')]	['Math', '##ias', 'RA', ',', 'Fu', 'W', ',', 'Ak', '##ey', 'JM', ',', 'Ai', '##ns', '##worth', 'HC', ',', 'Tor', '##gers', '##on', 'DG', ',', 'Ru', '##cz', '##inski', 'I', ',', 'Ser', '##ge', '##ant', 'S', ',', 'Bar', '##nes', 'KC', ',', 'Chi', '##lt', '##on', 'FH', '.', 'Adaptive', 'evolution', 'of', 'the', 'fatty', 'acid', 'des', '##atur', '##ase', 'gene', 'cluster', 'within', 'Africa', '.']	[0, 4, 8, 10, 12, 15, 16, 18, 20, 23, 25, 27, 29, 31, 37, 39, 41, 44, 48, 51, 53, 55, 57, 59, 65, 66, 68, 71, 73, 77, 78, 80, 83, 87, 89, 91, 94, 96, 99, 101, 102, 111, 121, 124, 128, 134, 139, 142, 146, 150, 155, 163, 170, 176]	[4, 7, 10, 11, 14, 16, 17, 20, 22, 25, 26, 29, 31, 36, 39, 40, 44, 48, 50, 53, 54, 57, 59, 64, 66, 67, 71, 73, 76, 78, 79, 83, 86, 89, 90, 94, 96, 98, 101, 102, 110, 120, 123, 127, 133, 138, 142, 146, 149, 154, 162, 169, 176, 177]	['Mathias', 'RA', ',', 'Fu', 'W', ',', 'Akey', 'JM', ',', 'Ainsworth', 'HC', ',', 'Torgerson', 'DG', ',', 'Ruczinski', 'I', ',', 'Sergeant', 'S', ',', 'Barnes', 'KC', ',', 'Chilton', 'FH.Adaptive', 'evolution', 'of', 'the', 'fatty', 'acid', 'desaturase', 'gene', 'cluster', 'within', 'Africa', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 3, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Differences in arachidonic acid levels and fatty acid desaturase (fatty acid desaturase) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome.	[('PMC4307209', 'F39002', 43, 64, 'fatty acid desaturase'), ('PMC4307209', 'F39002', 66, 87, 'fatty acid desaturase')]	['Differences', 'in', 'ar', '##achid', '##onic', 'acid', 'levels', 'and', 'fatty', 'acid', 'des', '##atur', '##ase', '(', 'fatty', 'acid', 'des', '##atur', '##ase', ')', 'gene', 'variants', 'in', 'African', 'Americans', 'and', 'European', 'Americans', 'with', 'diabetes', 'or', 'the', 'metabolic', 'syndrome', '.']	[0, 12, 15, 17, 22, 27, 32, 39, 43, 49, 54, 57, 61, 65, 66, 72, 77, 80, 84, 87, 89, 94, 103, 106, 114, 124, 128, 137, 147, 152, 161, 164, 168, 178, 186]	[11, 14, 17, 22, 26, 31, 38, 42, 48, 53, 57, 61, 64, 66, 71, 76, 80, 84, 87, 88, 93, 102, 105, 113, 123, 127, 136, 146, 151, 160, 163, 167, 177, 186, 187]	['Differences', 'in', 'arachidonic', 'acid', 'levels', 'and', 'fatty', 'acid', 'desaturase', '(', 'fatty', 'acid', 'desaturase', ')', 'gene', 'variants', 'in', 'African', 'Americans', 'and', 'European', 'Americans', 'with', 'diabetes', 'or', 'the', 'metabolic', 'syndrome', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The impact of fatty acid desaturase genetic variants on omega6 polyunsaturated fatty acid metabolism in African Americans.	[('PMC4307209', 'F40002', 14, 35, 'fatty acid desaturase')]	['The', 'impact', 'of', 'fatty', 'acid', 'des', '##atur', '##ase', 'genetic', 'variants', 'on', 'om', '##eg', '##a', '##6', 'poly', '##uns', '##aturated', 'fatty', 'acid', 'metabolism', 'in', 'African', 'Americans', '.']	[0, 4, 11, 14, 20, 25, 28, 32, 36, 44, 53, 56, 58, 60, 61, 63, 67, 70, 79, 85, 90, 101, 104, 112, 121]	[3, 10, 13, 19, 24, 28, 32, 35, 43, 52, 55, 58, 60, 61, 62, 67, 70, 78, 84, 89, 100, 103, 111, 121, 122]	['The', 'impact', 'of', 'fatty', 'acid', 'desaturase', 'genetic', 'variants', 'on', 'omega6', 'polyunsaturated', 'fatty', 'acid', 'metabolism', 'in', 'African', 'Americans', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, because our top hit with 18:2ct replicated in Chinese and Hispanics but not in African Americans, we explored the full loci of 2 genes in this region [fatty acid desaturase (fatty acid desaturase) 1/2 region: 61566604–61635303, ∼70 kb, in Human Genome build 37; 61323180–61391879 in build 36] in African Americans by using fine mapping (1000 Genomes imputation data) to assess whether absence of top hit association might be due to differences in genetic architecture between races.	[('PMC4307209', 'M05004', 164, 185, 'fatty acid desaturase'), ('PMC4307209', 'M05004', 187, 208, 'fatty acid desaturase')]	['In', 'addition', ',', 'because', 'our', 'top', 'hit', 'with', '18', ':', '2', '##ct', 'replicated', 'in', 'Chinese', 'and', 'Hispanic', '##s', 'but', 'not', 'in', 'African', 'Americans', ',', 'we', 'explored', 'the', 'full', 'loci', 'of', '2', 'genes', 'in', 'this', 'region', '[', 'fatty', 'acid', 'des', '##atur', '##ase', '(', 'fatty', 'acid', 'des', '##atur', '##ase', ')', '1', '/', '2', 'region', ':', '61', '##56', '##66', '##04', '–', '61', '##63', '##53', '##03', ',', '∼', '##70', 'kb', ',', 'in', 'Human', 'Genome', 'build', '37', ';', '61', '##32', '##31', '##80', '–', '61', '##39', '##18', '##79', 'in', 'build', '36', ']', 'in', 'African', 'Americans', 'by', 'using', 'fine', 'mapping', '(', '1000', 'Genome', '##s', 'imp', '##utation', 'data', ')', 'to', 'assess', 'whether', 'absence', 'of', 'top', 'hit', 'association', 'might', 'be', 'due', 'to', 'differences', 'in', 'genetic', 'architecture', 'between', 'race', '##s', '.']	[0, 3, 11, 13, 21, 25, 29, 33, 38, 40, 41, 42, 45, 56, 59, 67, 71, 79, 81, 85, 89, 92, 100, 109, 111, 114, 123, 127, 132, 137, 140, 142, 148, 151, 156, 163, 164, 170, 175, 178, 182, 186, 187, 193, 198, 201, 205, 208, 210, 211, 212, 214, 220, 222, 224, 226, 228, 230, 231, 233, 235, 237, 239, 241, 242, 245, 247, 249, 252, 258, 265, 271, 273, 275, 277, 279, 281, 283, 284, 286, 288, 290, 293, 296, 302, 304, 306, 309, 317, 327, 330, 336, 341, 349, 350, 355, 361, 363, 366, 374, 378, 380, 383, 390, 398, 406, 409, 413, 417, 429, 435, 438, 442, 445, 457, 460, 468, 481, 489, 493, 494]	[2, 11, 12, 20, 24, 28, 32, 37, 40, 41, 42, 44, 55, 58, 66, 70, 79, 80, 84, 88, 91, 99, 109, 110, 113, 122, 126, 131, 136, 139, 141, 147, 150, 155, 162, 164, 169, 174, 178, 182, 185, 187, 192, 197, 201, 205, 208, 209, 211, 212, 213, 220, 221, 224, 226, 228, 230, 231, 233, 235, 237, 239, 240, 242, 244, 247, 248, 251, 257, 264, 270, 273, 274, 277, 279, 281, 283, 284, 286, 288, 290, 292, 295, 301, 304, 305, 308, 316, 326, 329, 335, 340, 348, 350, 354, 361, 362, 366, 373, 378, 379, 382, 389, 397, 405, 408, 412, 416, 428, 434, 437, 441, 444, 456, 459, 467, 480, 488, 493, 494, 495]	['In', 'addition', ',', 'because', 'our', 'top', 'hit', 'with', '18', ':', '2ct', 'replicated', 'in', 'Chinese', 'and', 'Hispanics', 'but', 'not', 'in', 'African', 'Americans', ',', 'we', 'explored', 'the', 'full', 'loci', 'of', '2', 'genes', 'in', 'this', 'region', '[', 'fatty', 'acid', 'desaturase', '(', 'fatty', 'acid', 'desaturase', ')', '1', '/', '2', 'region', ':', '61566604–', '61635303', ',', '∼70', 'kb', ',', 'in', 'Human', 'Genome', 'build', '37', ';', '61323180–', '61391879', 'in', 'build', '36', ']', 'in', 'African', 'Americans', 'by', 'using', 'fine', 'mapping', '(', '1000', 'Genomes', 'imputation', 'data', ')', 'to', 'assess', 'whether', 'absence', 'of', 'top', 'hit', 'association', 'might', 'be', 'due', 'to', 'differences', 'in', 'genetic', 'architecture', 'between', 'races', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 5, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Neutrophil elastase, IL-1β, IL-1ra, IL-6, Il-8, TNF-α, and vascular endothelial growth factor were measured in ES and IS.	[('PMC4342834', 'A03002', 0, 19, 'Neutrophil elastase')]	['Neu', '##troph', '##il', 'elast', '##ase', ',', 'IL', '-', '1', '##β', ',', 'IL', '-', '1', '##ra', ',', 'IL', '-', '6', ',', 'Il', '-', '8', ',', 'TNF', '-', 'α', ',', 'and', 'vascular', 'endothelial', 'growth', 'factor', 'were', 'measured', 'in', 'ES', 'and', 'IS', '.']	[0, 3, 8, 11, 16, 19, 21, 23, 24, 25, 26, 28, 30, 31, 32, 34, 36, 38, 39, 40, 42, 44, 45, 46, 48, 51, 52, 53, 55, 59, 68, 80, 87, 94, 99, 108, 111, 114, 118, 120]	[3, 8, 10, 16, 19, 20, 23, 24, 25, 26, 27, 30, 31, 32, 34, 35, 38, 39, 40, 41, 44, 45, 46, 47, 51, 52, 53, 54, 58, 67, 79, 86, 93, 98, 107, 110, 113, 117, 120, 121]	['Neutrophil', 'elastase', ',', 'IL-1β', ',', 'IL-1ra', ',', 'IL-6', ',', 'Il-8', ',', 'TNF-α', ',', 'and', 'vascular', 'endothelial', 'growth', 'factor', 'were', 'measured', 'in', 'ES', 'and', 'IS', '.']	[3, 2, 1, 4, 1, 4, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Divergence between microbiota in upper airway compared with lower airway samples, indicating greater differences between communities, was associated with increased sputum neutrophil elastase.	[('PMC4342834', 'A03006', 171, 190, 'neutrophil elastase')]	['Div', '##erge', '##nce', 'between', 'microbiota', 'in', 'upper', 'airway', 'compared', 'with', 'lower', 'airway', 'samples', ',', 'indicating', 'greater', 'differences', 'between', 'communities', ',', 'was', 'associated', 'with', 'increased', 'sputum', 'neutrophil', 'elast', '##ase', '.']	[0, 3, 7, 11, 19, 30, 33, 39, 46, 55, 60, 66, 73, 80, 82, 93, 101, 113, 121, 132, 134, 138, 149, 154, 164, 171, 182, 187, 190]	[3, 7, 10, 18, 29, 32, 38, 45, 54, 59, 65, 72, 80, 81, 92, 100, 112, 120, 132, 133, 137, 148, 153, 163, 170, 181, 187, 190, 191]	['Divergence', 'between', 'microbiota', 'in', 'upper', 'airway', 'compared', 'with', 'lower', 'airway', 'samples', ',', 'indicating', 'greater', 'differences', 'between', 'communities', ',', 'was', 'associated', 'with', 'increased', 'sputum', 'neutrophil', 'elastase', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Furthermore, Pseudomonas, Enterobacteriaceae, and, to a more moderate degree, Staphylococcus were positively associated with sputum neutrophil elastase, a known mediator of CF airways damage.	[('PMC4342834', 'D00006', 132, 151, 'neutrophil elastase')]	['Furthermore', ',', 'Pseudomonas', ',', 'Enter', '##obacteria', '##ce', '##ae', ',', 'and', ',', 'to', 'a', 'more', 'moderate', 'degree', ',', 'Staphylococcus', 'were', 'positively', 'associated', 'with', 'sputum', 'neutrophil', 'elast', '##ase', ',', 'a', 'known', 'mediator', 'of', 'CF', 'airways', 'damage', '.']	[0, 11, 13, 24, 26, 31, 40, 42, 44, 46, 49, 51, 54, 56, 61, 70, 76, 78, 93, 98, 109, 120, 125, 132, 143, 148, 151, 153, 155, 161, 170, 173, 176, 184, 190]	[11, 12, 24, 25, 31, 40, 42, 44, 45, 49, 50, 53, 55, 60, 69, 76, 77, 92, 97, 108, 119, 124, 131, 142, 148, 151, 152, 154, 160, 169, 172, 175, 183, 190, 191]	['Furthermore', ',', 'Pseudomonas', ',', 'Enterobacteriaceae', ',', 'and', ',', 'to', 'a', 'more', 'moderate', 'degree', ',', 'Staphylococcus', 'were', 'positively', 'associated', 'with', 'sputum', 'neutrophil', 'elastase', ',', 'a', 'known', 'mediator', 'of', 'CF', 'airways', 'damage', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, decreased Shannon diversity, evenness, and increased divergence between upper and lower airway samples (measured as Hill numbers for β-diversity) were associated with increased sputum neutrophil elastase.	[('PMC4342834', 'D01001', 193, 212, 'neutrophil elastase')]	['However', ',', 'decreased', 'Shannon', 'diversity', ',', 'even', '##ness', ',', 'and', 'increased', 'divergence', 'between', 'upper', 'and', 'lower', 'airway', 'samples', '(', 'measured', 'as', 'Hill', 'numbers', 'for', 'β', '-', 'diversity', ')', 'were', 'associated', 'with', 'increased', 'sputum', 'neutrophil', 'elast', '##ase', '.']	[0, 7, 9, 19, 27, 36, 38, 42, 46, 48, 52, 62, 73, 81, 87, 91, 97, 104, 112, 113, 122, 125, 130, 138, 142, 143, 144, 153, 155, 160, 171, 176, 186, 193, 204, 209, 212]	[7, 8, 18, 26, 36, 37, 42, 46, 47, 51, 61, 72, 80, 86, 90, 96, 103, 111, 113, 121, 124, 129, 137, 141, 143, 144, 153, 154, 159, 170, 175, 185, 192, 203, 209, 212, 213]	['However', ',', 'decreased', 'Shannon', 'diversity', ',', 'evenness', ',', 'and', 'increased', 'divergence', 'between', 'upper', 'and', 'lower', 'airway', 'samples', '(', 'measured', 'as', 'Hill', 'numbers', 'for', 'β-diversity', ')', 'were', 'associated', 'with', 'increased', 'sputum', 'neutrophil', 'elastase', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Divergence of bacterial communities between upper and lower airway samples, likely due to expansion of bacterial pathogens, was associated with increased neutrophil elastase, possibly representing a mechanism of disease activity.	[('PMC4342834', 'D05005', 154, 173, 'neutrophil elastase')]	['Div', '##erge', '##nce', 'of', 'bacterial', 'communities', 'between', 'upper', 'and', 'lower', 'airway', 'samples', ',', 'likely', 'due', 'to', 'expansion', 'of', 'bacterial', 'pathogens', ',', 'was', 'associated', 'with', 'increased', 'neutrophil', 'elast', '##ase', ',', 'possibly', 'representing', 'a', 'mechanism', 'of', 'disease', 'activity', '.']	[0, 3, 7, 11, 14, 24, 36, 44, 50, 54, 60, 67, 74, 76, 83, 87, 90, 100, 103, 113, 122, 124, 128, 139, 144, 154, 165, 170, 173, 175, 184, 197, 199, 209, 212, 220, 228]	[3, 7, 10, 13, 23, 35, 43, 49, 53, 59, 66, 74, 75, 82, 86, 89, 99, 102, 112, 122, 123, 127, 138, 143, 153, 164, 170, 173, 174, 183, 196, 198, 208, 211, 219, 228, 229]	['Divergence', 'of', 'bacterial', 'communities', 'between', 'upper', 'and', 'lower', 'airway', 'samples', ',', 'likely', 'due', 'to', 'expansion', 'of', 'bacterial', 'pathogens', ',', 'was', 'associated', 'with', 'increased', 'neutrophil', 'elastase', ',', 'possibly', 'representing', 'a', 'mechanism', 'of', 'disease', 'activity', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Expectorated and induced sputum samples were processed as previously described (26) and analyzed for total cell counts and differentials, free neutrophil elastase activity (Sigma Diagnostics) (lower limit of detection [LLD], 0.5 μg/ml), and the following cytokines (R&D Systems, Minneapolis, MN): IL-1β (LLD, 2.5 pg/ml), IL-1ra (LLD, 40 pg/ml), IL-6 (LLD, 2.0 pg/ml), IL-8 (LLD, 1.0 pg/ml), TNF-α (LLD, 4.0 pg/ml), and vascular endothelial growth factor (VEGF) (LLD, 12 pg/ml).	[('PMC4342834', 'M04000', 143, 162, 'neutrophil elastase')]	['Exp', '##ector', '##ated', 'and', 'induced', 'sputum', 'samples', 'were', 'processed', 'as', 'previously', 'described', '(', '26', ')', 'and', 'analyzed', 'for', 'total', 'cell', 'counts', 'and', 'differential', '##s', ',', 'free', 'neutrophil', 'elast', '##ase', 'activity', '(', 'Sigma', 'Diagnostics', ')', '(', 'lower', 'limit', 'of', 'detection', '[', 'LL', '##D', ']', ',', '0', '.', '5', 'μ', '##g', '/', 'ml', ')', ',', 'and', 'the', 'following', 'cytokines', '(', 'R', '&', 'D', 'Systems', ',', 'Min', '##nea', '##pol', '##is', ',', 'MN', ')', ':', 'IL', '-', '1', '##β', '(', 'LL', '##D', ',', '2', '.', '5', 'pg', '/', 'ml', ')', ',', 'IL', '-', '1', '##ra', '(', 'LL', '##D', ',', '40', 'pg', '/', 'ml', ')', ',', 'IL', '-', '6', '(', 'LL', '##D', ',', '2', '.', '0', 'pg', '/', 'ml', ')', ',', 'IL', '-', '8', '(', 'LL', '##D', ',', '1', '.', '0', 'pg', '/', 'ml', ')', ',', 'TNF', '-', 'α', '(', 'LL', '##D', ',', '4', '.', '0', 'pg', '/', 'ml', ')', ',', 'and', 'vascular', 'endothelial', 'growth', 'factor', '(', 'VEGF', ')', '(', 'LL', '##D', ',', '12', 'pg', '/', 'ml', ')', '.']	[0, 3, 8, 13, 17, 25, 32, 40, 45, 55, 58, 69, 79, 80, 82, 84, 88, 97, 101, 107, 112, 119, 123, 135, 136, 138, 143, 154, 159, 163, 172, 173, 179, 190, 192, 193, 199, 205, 208, 218, 219, 221, 222, 223, 225, 226, 227, 229, 230, 231, 232, 234, 235, 237, 241, 245, 255, 265, 266, 267, 268, 270, 277, 279, 282, 285, 288, 290, 292, 294, 295, 297, 299, 300, 301, 303, 304, 306, 307, 309, 310, 311, 313, 315, 316, 318, 319, 321, 323, 324, 325, 328, 329, 331, 332, 334, 337, 339, 340, 342, 343, 345, 347, 348, 350, 351, 353, 354, 356, 357, 358, 360, 362, 363, 365, 366, 368, 370, 371, 373, 374, 376, 377, 379, 380, 381, 383, 385, 386, 388, 389, 391, 394, 395, 397, 398, 400, 401, 403, 404, 405, 407, 409, 410, 412, 413, 415, 419, 428, 440, 447, 454, 455, 459, 461, 462, 464, 465, 467, 470, 472, 473, 475, 476]	[3, 8, 12, 16, 24, 31, 39, 44, 54, 57, 68, 78, 80, 82, 83, 87, 96, 100, 106, 111, 118, 122, 135, 136, 137, 142, 153, 159, 162, 171, 173, 178, 190, 191, 193, 198, 204, 207, 217, 219, 221, 222, 223, 224, 226, 227, 228, 230, 231, 232, 234, 235, 236, 240, 244, 254, 264, 266, 267, 268, 269, 277, 278, 282, 285, 288, 290, 291, 294, 295, 296, 299, 300, 301, 302, 304, 306, 307, 308, 310, 311, 312, 315, 316, 318, 319, 320, 323, 324, 325, 327, 329, 331, 332, 333, 336, 339, 340, 342, 343, 344, 347, 348, 349, 351, 353, 354, 355, 357, 358, 359, 362, 363, 365, 366, 367, 370, 371, 372, 374, 376, 377, 378, 380, 381, 382, 385, 386, 388, 389, 390, 394, 395, 396, 398, 400, 401, 402, 404, 405, 406, 409, 410, 412, 413, 414, 418, 427, 439, 446, 453, 455, 459, 460, 462, 464, 465, 466, 469, 472, 473, 475, 476, 477]	['Expectorated', 'and', 'induced', 'sputum', 'samples', 'were', 'processed', 'as', 'previously', 'described', '(', '26', ')', 'and', 'analyzed', 'for', 'total', 'cell', 'counts', 'and', 'differentials', ',', 'free', 'neutrophil', 'elastase', 'activity', '(', 'Sigma', 'Diagnostics', ')', '(', 'lower', 'limit', 'of', 'detection', '[', 'LLD', ']', ',', '0.5', 'μg', '/', 'ml', ')', ',', 'and', 'the', 'following', 'cytokines', '(', 'R&D', 'Systems', ',', 'Minneapolis', ',', 'MN', ')', ':', 'IL-1β', '(', 'LLD', ',', '2.5', 'pg', '/', 'ml', ')', ',', 'IL-1ra', '(', 'LLD', ',', '40', 'pg', '/', 'ml', ')', ',', 'IL-6', '(', 'LLD', ',', '2.0', 'pg', '/', 'ml', ')', ',', 'IL-8', '(', 'LLD', ',', '1.0', 'pg', '/', 'ml', ')', ',', 'TNF-α', '(', 'LLD', ',', '4.0', 'pg', '/', 'ml', ')', ',', 'and', 'vascular', 'endothelial', 'growth', 'factor', '(', 'VEGF', ')', '(', 'LLD', ',', '12', 'pg', '/', 'ml', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 4, 1, 2, 1, 3, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inflammatory markers measured from 14 ES and IS pairs were highly correlated, with the exception of IL-1ra: neutrophil elastase (r = 0.64; P = 0.01), IL-6 (r = 0.61; P = 0.02), IL-8 (r = 0.58; P = 0.03), IL-1β (r = 0.69; P = 0.005), TNF-α (r = 0.71; P = 0.003), VEGF (r = 0.65; P = 0.01), and IL-1ra (r = −0.1; P = 0.8) (Figure E6).	[('PMC4342834', 'R07000', 108, 127, 'neutrophil elastase')]	['Inf', '##lammatory', 'markers', 'measured', 'from', '14', 'ES', 'and', 'IS', 'pairs', 'were', 'highly', 'correlated', ',', 'with', 'the', 'exception', 'of', 'IL', '-', '1', '##ra', ':', 'neutrophil', 'elast', '##ase', '(', 'r', '=', '0', '.', '64', ';', 'P', '=', '0', '.', '01', ')', ',', 'IL', '-', '6', '(', 'r', '=', '0', '.', '61', ';', 'P', '=', '0', '.', '02', ')', ',', 'IL', '-', '8', '(', 'r', '=', '0', '.', '58', ';', 'P', '=', '0', '.', '03', ')', ',', 'IL', '-', '1', '##β', '(', 'r', '=', '0', '.', '69', ';', 'P', '=', '0', '.', '00', '##5', ')', ',', 'TNF', '-', 'α', '(', 'r', '=', '0', '.', '71', ';', 'P', '=', '0', '.', '00', '##3', ')', ',', 'VEGF', '(', 'r', '=', '0', '.', '65', ';', 'P', '=', '0', '.', '01', ')', ',', 'and', 'IL', '-', '1', '##ra', '(', 'r', '=', '−0', '.', '1', ';', 'P', '=', '0', '.', '8', ')', '(', 'Figure', 'E', '##6', ')', '.']	[0, 3, 13, 21, 30, 35, 38, 41, 45, 48, 54, 59, 66, 76, 78, 83, 87, 97, 100, 102, 103, 104, 106, 108, 119, 124, 128, 129, 131, 133, 134, 135, 137, 139, 141, 143, 144, 145, 147, 148, 150, 152, 153, 155, 156, 158, 160, 161, 162, 164, 166, 168, 170, 171, 172, 174, 175, 177, 179, 180, 182, 183, 185, 187, 188, 189, 191, 193, 195, 197, 198, 199, 201, 202, 204, 206, 207, 208, 210, 211, 213, 215, 216, 217, 219, 221, 223, 225, 226, 227, 229, 230, 231, 233, 236, 237, 239, 240, 242, 244, 245, 246, 248, 250, 252, 254, 255, 256, 258, 259, 260, 262, 267, 268, 270, 272, 273, 274, 276, 278, 280, 282, 283, 284, 286, 287, 289, 293, 295, 296, 297, 300, 301, 303, 305, 307, 308, 309, 311, 313, 315, 316, 317, 318, 320, 321, 328, 329, 330, 331]	[3, 12, 20, 29, 34, 37, 40, 44, 47, 53, 58, 65, 76, 77, 82, 86, 96, 99, 102, 103, 104, 106, 107, 118, 124, 127, 129, 130, 132, 134, 135, 137, 138, 140, 142, 144, 145, 147, 148, 149, 152, 153, 154, 156, 157, 159, 161, 162, 164, 165, 167, 169, 171, 172, 174, 175, 176, 179, 180, 181, 183, 184, 186, 188, 189, 191, 192, 194, 196, 198, 199, 201, 202, 203, 206, 207, 208, 209, 211, 212, 214, 216, 217, 219, 220, 222, 224, 226, 227, 229, 230, 231, 232, 236, 237, 238, 240, 241, 243, 245, 246, 248, 249, 251, 253, 255, 256, 258, 259, 260, 261, 266, 268, 269, 271, 273, 274, 276, 277, 279, 281, 283, 284, 286, 287, 288, 292, 295, 296, 297, 299, 301, 302, 304, 307, 308, 309, 310, 312, 314, 316, 317, 318, 319, 321, 327, 329, 330, 331, 332]	['Inflammatory', 'markers', 'measured', 'from', '14', 'ES', 'and', 'IS', 'pairs', 'were', 'highly', 'correlated', ',', 'with', 'the', 'exception', 'of', 'IL-1ra', ':', 'neutrophil', 'elastase', '(', 'r', '=', '0.64', ';', 'P', '=', '0.01', ')', ',', 'IL-6', '(', 'r', '=', '0.61', ';', 'P', '=', '0.02', ')', ',', 'IL-8', '(', 'r', '=', '0.58', ';', 'P', '=', '0.03', ')', ',', 'IL-1β', '(', 'r', '=', '0.69', ';', 'P', '=', '0.005', ')', ',', 'TNF-α', '(', 'r', '=', '0.71', ';', 'P', '=', '0.003', ')', ',', 'VEGF', '(', 'r', '=', '0.65', ';', 'P', '=', '0.01', ')', ',', 'and', 'IL-1ra', '(', 'r', '=', '−0.1', ';', 'P', '=', '0.8', ')', '(', 'Figure', 'E6', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although not statistically significant, there was a trend toward lower neutrophil elastase in ES compared with IS samples (P = 0.08), with a median difference of −0.15 log10 μg/ml.	[('PMC4342834', 'R07001', 71, 90, 'neutrophil elastase')]	['Although', 'not', 'statistically', 'significant', ',', 'there', 'was', 'a', 'trend', 'toward', 'lower', 'neutrophil', 'elast', '##ase', 'in', 'ES', 'compared', 'with', 'IS', 'samples', '(', 'P', '=', '0', '.', '08', ')', ',', 'with', 'a', 'median', 'difference', 'of', '−0', '.', '15', 'log', '##10', 'μ', '##g', '/', 'ml', '.']	[0, 9, 13, 27, 38, 40, 46, 50, 52, 58, 65, 71, 82, 87, 91, 94, 97, 106, 111, 114, 122, 123, 125, 127, 128, 129, 131, 132, 134, 139, 141, 148, 159, 162, 164, 165, 168, 171, 174, 175, 176, 177, 179]	[8, 12, 26, 38, 39, 45, 49, 51, 57, 64, 70, 81, 87, 90, 93, 96, 105, 110, 113, 121, 123, 124, 126, 128, 129, 131, 132, 133, 138, 140, 147, 158, 161, 164, 165, 167, 171, 173, 175, 176, 177, 179, 180]	['Although', 'not', 'statistically', 'significant', ',', 'there', 'was', 'a', 'trend', 'toward', 'lower', 'neutrophil', 'elastase', 'in', 'ES', 'compared', 'with', 'IS', 'samples', '(', 'P', '=', '0.08', ')', ',', 'with', 'a', 'median', 'difference', 'of', '−0.15', 'log10', 'μg', '/', 'ml', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 2, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
By qPCR, P. aeruginosa load was associated with increased sputum neutrophil elastase (r = 0.53; P = 0.04), whereas S. aureus was associated with increased IL-1β (r = 0.61;	[('PMC4342834', 'R08000', 65, 84, 'neutrophil elastase')]	['By', 'qPCR', ',', 'P', '.', 'aeruginosa', 'load', 'was', 'associated', 'with', 'increased', 'sputum', 'neutrophil', 'elast', '##ase', '(', 'r', '=', '0', '.', '53', ';', 'P', '=', '0', '.', '04', ')', ',', 'whereas', 'S', '.', 'aureus', 'was', 'associated', 'with', 'increased', 'IL', '-', '1', '##β', '(', 'r', '=', '0', '.', '61', ';']	[0, 3, 7, 9, 10, 12, 23, 28, 32, 43, 48, 58, 65, 76, 81, 85, 86, 88, 90, 91, 92, 94, 96, 98, 100, 101, 102, 104, 105, 107, 115, 116, 118, 125, 129, 140, 145, 155, 157, 158, 159, 161, 162, 164, 166, 167, 168, 170]	[2, 7, 8, 10, 11, 22, 27, 31, 42, 47, 57, 64, 75, 81, 84, 86, 87, 89, 91, 92, 94, 95, 97, 99, 101, 102, 104, 105, 106, 114, 116, 117, 124, 128, 139, 144, 154, 157, 158, 159, 160, 162, 163, 165, 167, 168, 170, 171]	['By', 'qPCR', ',', 'P', '.', 'aeruginosa', 'load', 'was', 'associated', 'with', 'increased', 'sputum', 'neutrophil', 'elastase', '(', 'r', '=', '0.53', ';', 'P', '=', '0.04', ')', ',', 'whereas', 'S', '.', 'aureus', 'was', 'associated', 'with', 'increased', 'IL-1β', '(', 'r', '=', '0.61', ';']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
P = 0.02) and VEGF (r = 0.59; P = 0.02) and was marginally associated with neutrophil elastase (r = 0.47;	[('PMC4342834', 'R08001', 75, 94, 'neutrophil elastase')]	['P', '=', '0', '.', '02', ')', 'and', 'VEGF', '(', 'r', '=', '0', '.', '59', ';', 'P', '=', '0', '.', '02', ')', 'and', 'was', 'marginally', 'associated', 'with', 'neutrophil', 'elast', '##ase', '(', 'r', '=', '0', '.', '47', ';']	[0, 2, 4, 5, 6, 8, 10, 14, 19, 20, 22, 24, 25, 26, 28, 30, 32, 34, 35, 36, 38, 40, 44, 48, 59, 70, 75, 86, 91, 95, 96, 98, 100, 101, 102, 104]	[1, 3, 5, 6, 8, 9, 13, 18, 20, 21, 23, 25, 26, 28, 29, 31, 33, 35, 36, 38, 39, 43, 47, 58, 69, 74, 85, 91, 94, 96, 97, 99, 101, 102, 104, 105]	['P', '=', '0.02', ')', 'and', 'VEGF', '(', 'r', '=', '0.59', ';', 'P', '=', '0.02', ')', 'and', 'was', 'marginally', 'associated', 'with', 'neutrophil', 'elastase', '(', 'r', '=', '0.47', ';']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Shannon diversity index and evenness were inversely associated with neutrophil elastase (r = −0.5; P = 0.06 for both comparisons).	[('PMC4342834', 'R09001', 68, 87, 'neutrophil elastase')]	['Shannon', 'diversity', 'index', 'and', 'even', '##ness', 'were', 'inversely', 'associated', 'with', 'neutrophil', 'elast', '##ase', '(', 'r', '=', '−0', '.', '5', ';', 'P', '=', '0', '.', '06', 'for', 'both', 'comparisons', ')', '.']	[0, 8, 18, 24, 28, 32, 37, 42, 52, 63, 68, 79, 84, 88, 89, 91, 93, 95, 96, 97, 99, 101, 103, 104, 105, 108, 112, 117, 128, 129]	[7, 17, 23, 27, 32, 36, 41, 51, 62, 67, 78, 84, 87, 89, 90, 92, 95, 96, 97, 98, 100, 102, 104, 105, 107, 111, 116, 128, 129, 130]	['Shannon', 'diversity', 'index', 'and', 'evenness', 'were', 'inversely', 'associated', 'with', 'neutrophil', 'elastase', '(', 'r', '=', '−0.5', ';', 'P', '=', '0.06', 'for', 'both', 'comparisons', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Increased β-diversity, suggesting divergence in airway bacterial communities in different niches within the same subject, was associated with increased neutrophil elastase (r = 0.65;	[('PMC4342834', 'R09003', 152, 171, 'neutrophil elastase')]	['Increased', 'β', '-', 'diversity', ',', 'suggesting', 'divergence', 'in', 'airway', 'bacterial', 'communities', 'in', 'different', 'niche', '##s', 'within', 'the', 'same', 'subject', ',', 'was', 'associated', 'with', 'increased', 'neutrophil', 'elast', '##ase', '(', 'r', '=', '0', '.', '65', ';']	[0, 10, 11, 12, 21, 23, 34, 45, 48, 55, 65, 77, 80, 90, 95, 97, 104, 108, 113, 120, 122, 126, 137, 142, 152, 163, 168, 172, 173, 175, 177, 178, 179, 181]	[9, 11, 12, 21, 22, 33, 44, 47, 54, 64, 76, 79, 89, 95, 96, 103, 107, 112, 120, 121, 125, 136, 141, 151, 162, 168, 171, 173, 174, 176, 178, 179, 181, 182]	['Increased', 'β-diversity', ',', 'suggesting', 'divergence', 'in', 'airway', 'bacterial', 'communities', 'in', 'different', 'niches', 'within', 'the', 'same', 'subject', ',', 'was', 'associated', 'with', 'increased', 'neutrophil', 'elastase', '(', 'r', '=', '0.65', ';']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Consistent with qPCR results, Pseudomonas RA determined by sequencing was associated with increased neutrophil elastase (r = 0.52; P = 0.06).	[('PMC4342834', 'R10000', 100, 119, 'neutrophil elastase')]	['Consistent', 'with', 'qPCR', 'results', ',', 'Pseudomonas', 'RA', 'determined', 'by', 'sequencing', 'was', 'associated', 'with', 'increased', 'neutrophil', 'elast', '##ase', '(', 'r', '=', '0', '.', '52', ';', 'P', '=', '0', '.', '06', ')', '.']	[0, 11, 16, 21, 28, 30, 42, 45, 56, 59, 70, 74, 85, 90, 100, 111, 116, 120, 121, 123, 125, 126, 127, 129, 131, 133, 135, 136, 137, 139, 140]	[10, 15, 20, 28, 29, 41, 44, 55, 58, 69, 73, 84, 89, 99, 110, 116, 119, 121, 122, 124, 126, 127, 129, 130, 132, 134, 136, 137, 139, 140, 141]	['Consistent', 'with', 'qPCR', 'results', ',', 'Pseudomonas', 'RA', 'determined', 'by', 'sequencing', 'was', 'associated', 'with', 'increased', 'neutrophil', 'elastase', '(', 'r', '=', '0.52', ';', 'P', '=', '0.06', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In summary, the mean levels of AFP, alkaline phosphatase (alkaline phosphatase), and gamma-glutamyl transpeptidase (gamma-glutamyl transpeptidase) were significantly higher in the HCC group, while prothrombin time (PT) was lower.	[('PMC4683945', 'R01001', 36, 56, 'alkaline phosphatase'), ('PMC4683945', 'R01001', 58, 78, 'alkaline phosphatase'), ('PMC4683945', 'R01001', 85, 114, 'gamma-glutamyl transpeptidase'), ('PMC4683945', 'R01001', 116, 145, 'gamma-glutamyl transpeptidase')]	['In', 'summary', ',', 'the', 'mean', 'levels', 'of', 'AF', '##P', ',', 'alkaline', 'phosphatase', '(', 'alkaline', 'phosphatase', ')', ',', 'and', 'gamma', '-', 'glut', '##amyl', 'trans', '##pe', '##pt', '##idase', '(', 'gamma', '-', 'glut', '##amyl', 'trans', '##pe', '##pt', '##idase', ')', 'were', 'significantly', 'higher', 'in', 'the', 'HCC', 'group', ',', 'while', 'prot', '##hr', '##omb', '##in', 'time', '(', 'PT', ')', 'was', 'lower', '.']	[0, 3, 10, 12, 16, 21, 28, 31, 33, 34, 36, 45, 57, 58, 67, 78, 79, 81, 85, 90, 91, 95, 100, 105, 107, 109, 115, 116, 121, 122, 126, 131, 136, 138, 140, 145, 147, 152, 166, 173, 176, 180, 184, 189, 191, 197, 201, 203, 206, 209, 214, 215, 217, 219, 223, 228]	[2, 10, 11, 15, 20, 27, 30, 33, 34, 35, 44, 56, 58, 66, 78, 79, 80, 84, 90, 91, 95, 99, 105, 107, 109, 114, 116, 121, 122, 126, 130, 136, 138, 140, 145, 146, 151, 165, 172, 175, 179, 183, 189, 190, 196, 201, 203, 206, 208, 213, 215, 217, 218, 222, 228, 229]	['In', 'summary', ',', 'the', 'mean', 'levels', 'of', 'AFP', ',', 'alkaline', 'phosphatase', '(', 'alkaline', 'phosphatase', ')', ',', 'and', 'gamma', '-', 'glutamyl', 'transpeptidase', '(', 'gamma', '-', 'glutamyl', 'transpeptidase', ')', 'were', 'significantly', 'higher', 'in', 'the', 'HCC', 'group', ',', 'while', 'prothrombin', 'time', '(', 'PT', ')', 'was', 'lower', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'B', 'B', 'E', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
At GCKR, the index SNP (rs1260326; C>T) encodes an amino acid change from proline to leucine (P446L) in the glucokinase regulator protein (GKRP).	[('PMC4819009', 'D01000', 108, 119, 'glucokinase')]	['At', 'GC', '##K', '##R', ',', 'the', 'index', 'SNP', '(', 'rs', '##126', '##03', '##26', ';', 'C', '>', 'T', ')', 'encodes', 'an', 'amino', 'acid', 'change', 'from', 'proline', 'to', 'leucine', '(', 'P', '##44', '##6', '##L', ')', 'in', 'the', 'gluc', '##ok', '##inase', 'regulator', 'protein', '(', 'GK', '##RP', ')', '.']	[0, 3, 5, 6, 7, 9, 13, 19, 23, 24, 26, 29, 31, 33, 35, 36, 37, 38, 40, 48, 51, 57, 62, 69, 74, 82, 85, 93, 94, 95, 97, 98, 99, 101, 104, 108, 112, 114, 120, 130, 138, 139, 141, 143, 144]	[2, 5, 6, 7, 8, 12, 18, 22, 24, 26, 29, 31, 33, 34, 36, 37, 38, 39, 47, 50, 56, 61, 68, 73, 81, 84, 92, 94, 95, 97, 98, 99, 100, 103, 107, 112, 114, 119, 129, 137, 139, 141, 143, 144, 145]	['At', 'GCKR', ',', 'the', 'index', 'SNP', '(', 'rs1260326', ';', 'C', '>', 'T', ')', 'encodes', 'an', 'amino', 'acid', 'change', 'from', 'proline', 'to', 'leucine', '(', 'P446L', ')', 'in', 'the', 'glucokinase', 'regulator', 'protein', '(', 'GKRP', ')', '.']	[1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
GKRP binds to glucokinase (glucokinase) and inhibits its activities.	[('PMC4819009', 'D01003', 14, 25, 'glucokinase'), ('PMC4819009', 'D01003', 27, 38, 'glucokinase')]	['GK', '##RP', 'binds', 'to', 'gluc', '##ok', '##inase', '(', 'gluc', '##ok', '##inase', ')', 'and', 'inhibits', 'its', 'activities', '.']	[0, 2, 5, 11, 14, 18, 20, 26, 27, 31, 33, 38, 40, 44, 53, 57, 67]	[2, 4, 10, 13, 18, 20, 25, 27, 31, 33, 38, 39, 43, 52, 56, 67, 68]	['GKRP', 'binds', 'to', 'glucokinase', '(', 'glucokinase', ')', 'and', 'inhibits', 'its', 'activities', '.']	[2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
glucokinase is a rate-limiting enzyme in hepatic glucose uptake and glycogen storage, and is a negative modifier of hepatic gluconeogenesis.	[('PMC4819009', 'D01004', 0, 11, 'glucokinase')]	['gluc', '##ok', '##inase', 'is', 'a', 'rate', '-', 'limiting', 'enzyme', 'in', 'hepatic', 'glucose', 'uptake', 'and', 'glycogen', 'storage', ',', 'and', 'is', 'a', 'negative', 'modi', '##fi', '##er', 'of', 'hepatic', 'gluc', '##one', '##ogenesis', '.']	[0, 4, 6, 12, 15, 17, 21, 22, 31, 38, 41, 49, 57, 64, 68, 77, 84, 86, 90, 93, 95, 104, 108, 110, 113, 116, 124, 128, 131, 139]	[4, 6, 11, 14, 16, 21, 22, 30, 37, 40, 48, 56, 63, 67, 76, 84, 85, 89, 92, 94, 103, 108, 110, 112, 115, 123, 128, 131, 139, 140]	['glucokinase', 'is', 'a', 'rate', '-', 'limiting', 'enzyme', 'in', 'hepatic', 'glucose', 'uptake', 'and', 'glycogen', 'storage', ',', 'and', 'is', 'a', 'negative', 'modifier', 'of', 'hepatic', 'gluconeogenesis', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
GKRP with the T allele at rs1260326 shows reduced binding to glucokinase, thereby increasing glucokinase activity in the liver, promoting hepatic glucose uptake and lowering blood glucose [21,28].	[('PMC4819009', 'D01005', 61, 72, 'glucokinase'), ('PMC4819009', 'D01005', 93, 104, 'glucokinase')]	['GK', '##RP', 'with', 'the', 'T', 'allele', 'at', 'rs', '##126', '##03', '##26', 'shows', 'reduced', 'binding', 'to', 'gluc', '##ok', '##inase', ',', 'thereby', 'increasing', 'gluc', '##ok', '##inase', 'activity', 'in', 'the', 'liver', ',', 'promoting', 'hepatic', 'glucose', 'uptake', 'and', 'lowering', 'blood', 'glucose', '[', '21', ',', '28', ']', '.']	[0, 2, 5, 10, 14, 16, 23, 26, 28, 31, 33, 36, 42, 50, 58, 61, 65, 67, 72, 74, 82, 93, 97, 99, 105, 114, 117, 121, 126, 128, 138, 146, 154, 161, 165, 174, 180, 188, 189, 191, 192, 194, 195]	[2, 4, 9, 13, 15, 22, 25, 28, 31, 33, 35, 41, 49, 57, 60, 65, 67, 72, 73, 81, 92, 97, 99, 104, 113, 116, 120, 126, 127, 137, 145, 153, 160, 164, 173, 179, 187, 189, 191, 192, 194, 195, 196]	['GKRP', 'with', 'the', 'T', 'allele', 'at', 'rs1260326', 'shows', 'reduced', 'binding', 'to', 'glucokinase', ',', 'thereby', 'increasing', 'glucokinase', 'activity', 'in', 'the', 'liver', ',', 'promoting', 'hepatic', 'glucose', 'uptake', 'and', 'lowering', 'blood', 'glucose', '[', '21', ',', '28', ']', '.']	[2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PPP1R3B encodes the regulatory subunit 3b of protein phosphatase 1 (PP1) and is highly expressed in both skeletal muscle and the liver [31].	[('PMC4819009', 'D02004', 45, 66, 'protein phosphatase 1')]	['PP', '##P', '##1', '##R', '##3', '##B', 'encodes', 'the', 'regulatory', 'subunit', '3', '##b', 'of', 'protein', 'phosphatase', '1', '(', 'PP', '##1', ')', 'and', 'is', 'highly', 'expressed', 'in', 'both', 'skeletal', 'muscle', 'and', 'the', 'liver', '[', '31', ']', '.']	[0, 2, 3, 4, 5, 6, 8, 16, 20, 31, 39, 40, 42, 45, 53, 65, 67, 68, 70, 71, 73, 77, 80, 87, 97, 100, 105, 114, 121, 125, 129, 135, 136, 138, 139]	[2, 3, 4, 5, 6, 7, 15, 19, 30, 38, 40, 41, 44, 52, 64, 66, 68, 70, 71, 72, 76, 79, 86, 96, 99, 104, 113, 120, 124, 128, 134, 136, 138, 139, 140]	['PPP1R3B', 'encodes', 'the', 'regulatory', 'subunit', '3b', 'of', 'protein', 'phosphatase', '1', '(', 'PP1', ')', 'and', 'is', 'highly', 'expressed', 'in', 'both', 'skeletal', 'muscle', 'and', 'the', 'liver', '[', '31', ']', '.']	[6, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PPP1R3B suppresses deactivation of glycogen phosphorylase and enhances activation of glycogen synthase in the liver [33].	[('PMC4819009', 'D02006', 35, 57, 'glycogen phosphorylase'), ('PMC4819009', 'D02006', 85, 102, 'glycogen synthase')]	['PP', '##P', '##1', '##R', '##3', '##B', 'suppresses', 'de', '##activation', 'of', 'glycogen', 'phosphoryl', '##ase', 'and', 'enhances', 'activation', 'of', 'glycogen', 'synthase', 'in', 'the', 'liver', '[', '33', ']', '.']	[0, 2, 3, 4, 5, 6, 8, 19, 21, 32, 35, 44, 54, 58, 62, 71, 82, 85, 94, 103, 106, 110, 116, 117, 119, 120]	[2, 3, 4, 5, 6, 7, 18, 21, 31, 34, 43, 54, 57, 61, 70, 81, 84, 93, 102, 105, 109, 115, 117, 119, 120, 121]	['PPP1R3B', 'suppresses', 'deactivation', 'of', 'glycogen', 'phosphorylase', 'and', 'enhances', 'activation', 'of', 'glycogen', 'synthase', 'in', 'the', 'liver', '[', '33', ']', '.']	[6, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For example, glucokinase is important in glucose metabolism in both β-cells and hepatocytes, and the index variant of glucokinase (rs4607517) in the GWASs of glycaemic traits is in high linkage disequilibrium with a variant in the β-cell-specific promoter of GCK and not variants in the hepatocyte-specific promoter [34].	[('PMC4819009', 'D03002', 13, 24, 'glucokinase'), ('PMC4819009', 'D03002', 118, 129, 'glucokinase')]	['For', 'example', ',', 'gluc', '##ok', '##inase', 'is', 'important', 'in', 'glucose', 'metabolism', 'in', 'both', 'β', '-', 'cells', 'and', 'hepatocytes', ',', 'and', 'the', 'index', 'variant', 'of', 'gluc', '##ok', '##inase', '(', 'rs', '##46', '##07', '##51', '##7', ')', 'in', 'the', 'GW', '##AS', '##s', 'of', 'glyc', '##ae', '##mic', 'traits', 'is', 'in', 'high', 'linkage', 'dise', '##quilibrium', 'with', 'a', 'variant', 'in', 'the', 'β', '-', 'cell', '-', 'specific', 'promoter', 'of', 'GC', '##K', 'and', 'not', 'variants', 'in', 'the', 'hepat', '##ocyte', '-', 'specific', 'promoter', '[', '34', ']', '.']	[0, 4, 11, 13, 17, 19, 25, 28, 38, 41, 49, 60, 63, 68, 69, 70, 76, 80, 91, 93, 97, 101, 107, 115, 118, 122, 124, 130, 131, 133, 135, 137, 139, 140, 142, 145, 149, 151, 153, 155, 158, 162, 164, 168, 175, 178, 181, 186, 194, 198, 209, 214, 216, 224, 227, 231, 232, 233, 237, 238, 247, 256, 259, 261, 263, 267, 271, 280, 283, 287, 292, 297, 298, 307, 316, 317, 319, 320]	[3, 11, 12, 17, 19, 24, 27, 37, 40, 48, 59, 62, 67, 69, 70, 75, 79, 91, 92, 96, 100, 106, 114, 117, 122, 124, 129, 131, 133, 135, 137, 139, 140, 141, 144, 148, 151, 153, 154, 157, 162, 164, 167, 174, 177, 180, 185, 193, 198, 208, 213, 215, 223, 226, 230, 232, 233, 237, 238, 246, 255, 258, 261, 262, 266, 270, 279, 282, 286, 292, 297, 298, 306, 315, 317, 319, 320, 321]	['For', 'example', ',', 'glucokinase', 'is', 'important', 'in', 'glucose', 'metabolism', 'in', 'both', 'β-cells', 'and', 'hepatocytes', ',', 'and', 'the', 'index', 'variant', 'of', 'glucokinase', '(', 'rs4607517', ')', 'in', 'the', 'GWASs', 'of', 'glycaemic', 'traits', 'is', 'in', 'high', 'linkage', 'disequilibrium', 'with', 'a', 'variant', 'in', 'the', 'β-cell-', 'specific', 'promoter', 'of', 'GCK', 'and', 'not', 'variants', 'in', 'the', 'hepatocyte', '-', 'specific', 'promoter', '[', '34', ']', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 5, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.	[('PMC4819009', 'F20002', 125, 136, 'glucokinase')]	['The', 'P', '##44', '##6', '##L', 'variant', 'in', 'GC', '##K', '##R', 'associated', 'with', 'fasting', 'plasma', 'glucose', 'and', 'triglyceride', 'levels', 'exerts', 'its', 'effect', 'through', 'increased', 'gluc', '##ok', '##inase', 'activity', 'in', 'liver', '.']	[0, 4, 5, 7, 8, 10, 18, 21, 23, 24, 26, 37, 42, 50, 57, 65, 69, 82, 89, 96, 100, 107, 115, 125, 129, 131, 137, 146, 149, 154]	[3, 5, 7, 8, 9, 17, 20, 23, 24, 25, 36, 41, 49, 56, 64, 68, 81, 88, 95, 99, 106, 114, 124, 129, 131, 136, 145, 148, 154, 155]	['The', 'P446L', 'variant', 'in', 'GCKR', 'associated', 'with', 'fasting', 'plasma', 'glucose', 'and', 'triglyceride', 'levels', 'exerts', 'its', 'effect', 'through', 'increased', 'glucokinase', 'activity', 'in', 'liver', '.']	[1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis.	[('PMC4819009', 'F21002', 16, 37, 'protein phosphatase 1')]	['Fast', '##ing', '-', 'induced', 'protein', 'phosphatase', '1', 'regulatory', 'subunit', 'contributes', 'to', 'post', '##pr', '##andial', 'blood', 'glucose', 'homeostasis', 'via', 'regulation', 'of', 'hepatic', 'glycogen', '##esis', '.']	[0, 4, 7, 8, 16, 24, 36, 38, 49, 57, 69, 72, 76, 78, 85, 91, 99, 111, 115, 126, 129, 137, 145, 149]	[4, 7, 8, 15, 23, 35, 37, 48, 56, 68, 71, 76, 78, 84, 90, 98, 110, 114, 125, 128, 136, 145, 149, 150]	['Fasting', '-', 'induced', 'protein', 'phosphatase', '1', 'regulatory', 'subunit', 'contributes', 'to', 'postprandial', 'blood', 'glucose', 'homeostasis', 'via', 'regulation', 'of', 'hepatic', 'glycogenesis', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1.	[('PMC4819009', 'F30002', 82, 103, 'protein phosphatase-1')]	['Organ', '##izing', 'glucose', 'disposal', ':', 'emerging', 'roles', 'of', 'the', 'glycogen', 'targeting', 'subunits', 'of', 'protein', 'phosphatase', '-', '1', '.']	[0, 5, 11, 19, 27, 29, 38, 44, 47, 51, 60, 70, 79, 82, 90, 101, 102, 103]	[5, 10, 18, 27, 28, 37, 43, 46, 50, 59, 69, 78, 81, 89, 101, 102, 103, 104]	['Organizing', 'glucose', 'disposal', ':', 'emerging', 'roles', 'of', 'the', 'glycogen', 'targeting', 'subunits', 'of', 'protein', 'phosphatase-1', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Amino acid sequence and expression of the hepatic glycogen-binding (GL)-subunit of protein phosphatase-1.	[('PMC4819009', 'F32002', 83, 104, 'protein phosphatase-1')]	['Amin', '##o', 'acid', 'sequence', 'and', 'expression', 'of', 'the', 'hepatic', 'glycogen', '-', 'binding', '(', 'GL', ')', '-', 'subunit', 'of', 'protein', 'phosphatase', '-', '1', '.']	[0, 4, 6, 11, 20, 24, 35, 38, 42, 50, 58, 59, 67, 68, 70, 71, 72, 80, 83, 91, 102, 103, 104]	[4, 5, 10, 19, 23, 34, 37, 41, 49, 58, 59, 66, 68, 70, 71, 72, 79, 82, 90, 102, 103, 104, 105]	['Amino', 'acid', 'sequence', 'and', 'expression', 'of', 'the', 'hepatic', 'glycogen', '-', 'binding', '(GL)-subunit', 'of', 'protein', 'phosphatase-1', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Our results suggest that, since kynurenine monoxygenase diverts the kynurenine pathway toward the synthesis of xanthurenic acid, its inhibition may also contribute to glucose homeostasis.	[('PMC4915629', 'A04001', 32, 55, 'kynurenine monoxygenase')]	['Our', 'results', 'suggest', 'that', ',', 'since', 'k', '##yn', '##uren', '##ine', 'mono', '##xy', '##gen', '##ase', 'diver', '##ts', 'the', 'k', '##yn', '##uren', '##ine', 'pathway', 'toward', 'the', 'synthesis', 'of', 'x', '##anth', '##uren', '##ic', 'acid', ',', 'its', 'inhibition', 'may', 'also', 'contribute', 'to', 'glucose', 'homeostasis', '.']	[0, 4, 12, 20, 24, 26, 32, 33, 35, 39, 43, 47, 49, 52, 56, 61, 64, 68, 69, 71, 75, 79, 87, 94, 98, 108, 111, 112, 116, 120, 123, 127, 129, 133, 144, 148, 153, 164, 167, 175, 186]	[3, 11, 19, 24, 25, 31, 33, 35, 39, 42, 47, 49, 52, 55, 61, 63, 67, 69, 71, 75, 78, 86, 93, 97, 107, 110, 112, 116, 120, 122, 127, 128, 132, 143, 147, 152, 163, 166, 174, 186, 187]	['Our', 'results', 'suggest', 'that', ',', 'since', 'kynurenine', 'monoxygenase', 'diverts', 'the', 'kynurenine', 'pathway', 'toward', 'the', 'synthesis', 'of', 'xanthurenic', 'acid', ',', 'its', 'inhibition', 'may', 'also', 'contribute', 'to', 'glucose', 'homeostasis', '.']	[1, 1, 1, 1, 1, 1, 4, 4, 2, 1, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The enzyme kynurenine 3-monooxygenase (kynurenine 3-monooxygenase) is located at a critical branching point in the kynurenine pathway such that the inhibition of this enzyme by either pharmacological or genetic means may shift the flux towards the formation of kynurenic acid rather than to the synthesis of xanthurenic acid.	[('PMC4915629', 'D03000', 11, 37, 'kynurenine 3-monooxygenase'), ('PMC4915629', 'D03000', 39, 65, 'kynurenine 3-monooxygenase')]	['The', 'enzyme', 'k', '##yn', '##uren', '##ine', '3', '-', 'mono', '##oxygenase', '(', 'k', '##yn', '##uren', '##ine', '3', '-', 'mono', '##oxygenase', ')', 'is', 'located', 'at', 'a', 'critical', 'branching', 'point', 'in', 'the', 'k', '##yn', '##uren', '##ine', 'pathway', 'such', 'that', 'the', 'inhibition', 'of', 'this', 'enzyme', 'by', 'either', 'pharmacological', 'or', 'genetic', 'means', 'may', 'shift', 'the', 'flux', 'towards', 'the', 'formation', 'of', 'k', '##yn', '##uren', '##ic', 'acid', 'rather', 'than', 'to', 'the', 'synthesis', 'of', 'x', '##anth', '##uren', '##ic', 'acid', '.']	[0, 4, 11, 12, 14, 18, 22, 23, 24, 28, 38, 39, 40, 42, 46, 50, 51, 52, 56, 65, 67, 70, 78, 81, 83, 92, 102, 108, 111, 115, 116, 118, 122, 126, 134, 139, 144, 148, 159, 162, 167, 174, 177, 184, 200, 203, 211, 217, 221, 227, 231, 236, 244, 248, 258, 261, 262, 264, 268, 271, 276, 283, 288, 291, 295, 305, 308, 309, 313, 317, 320, 324]	[3, 10, 12, 14, 18, 21, 23, 24, 28, 37, 39, 40, 42, 46, 49, 51, 52, 56, 65, 66, 69, 77, 80, 82, 91, 101, 107, 110, 114, 116, 118, 122, 125, 133, 138, 143, 147, 158, 161, 166, 173, 176, 183, 199, 202, 210, 216, 220, 226, 230, 235, 243, 247, 257, 260, 262, 264, 268, 270, 275, 282, 287, 290, 294, 304, 307, 309, 313, 317, 319, 324, 325]	['The', 'enzyme', 'kynurenine', '3-monooxygenase', '(', 'kynurenine', '3-monooxygenase', ')', 'is', 'located', 'at', 'a', 'critical', 'branching', 'point', 'in', 'the', 'kynurenine', 'pathway', 'such', 'that', 'the', 'inhibition', 'of', 'this', 'enzyme', 'by', 'either', 'pharmacological', 'or', 'genetic', 'means', 'may', 'shift', 'the', 'flux', 'towards', 'the', 'formation', 'of', 'kynurenic', 'acid', 'rather', 'than', 'to', 'the', 'synthesis', 'of', 'xanthurenic', 'acid', '.']	[1, 1, 4, 4, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The inhibition of kynurenine 3-monooxygenase has suggested that kynurenine 3-monooxygenase regulates the production of downstream KP metabolites.	[('PMC4915629', 'D03001', 18, 44, 'kynurenine 3-monooxygenase'), ('PMC4915629', 'D03001', 64, 90, 'kynurenine 3-monooxygenase')]	['The', 'inhibition', 'of', 'k', '##yn', '##uren', '##ine', '3', '-', 'mono', '##oxygenase', 'has', 'suggested', 'that', 'k', '##yn', '##uren', '##ine', '3', '-', 'mono', '##oxygenase', 'regulates', 'the', 'production', 'of', 'downstream', 'KP', 'metabolites', '.']	[0, 4, 15, 18, 19, 21, 25, 29, 30, 31, 35, 45, 49, 59, 64, 65, 67, 71, 75, 76, 77, 81, 91, 101, 105, 116, 119, 130, 133, 144]	[3, 14, 17, 19, 21, 25, 28, 30, 31, 35, 44, 48, 58, 63, 65, 67, 71, 74, 76, 77, 81, 90, 100, 104, 115, 118, 129, 132, 144, 145]	['The', 'inhibition', 'of', 'kynurenine', '3-monooxygenase', 'has', 'suggested', 'that', 'kynurenine', '3-monooxygenase', 'regulates', 'the', 'production', 'of', 'downstream', 'KP', 'metabolites', '.']	[1, 1, 1, 4, 4, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We have previously shown that the adipose tissue expression of kynurenine 3-monooxygenase was associated with higher HbA1c in women with obesity and was expressed preferentially in pro-inflammatory M1 macrophages [7].	[('PMC4915629', 'D03002', 63, 89, 'kynurenine 3-monooxygenase')]	['We', 'have', 'previously', 'shown', 'that', 'the', 'adipose', 'tissue', 'expression', 'of', 'k', '##yn', '##uren', '##ine', '3', '-', 'mono', '##oxygenase', 'was', 'associated', 'with', 'higher', 'HbA', '##1', '##c', 'in', 'women', 'with', 'obesity', 'and', 'was', 'expressed', 'preferentially', 'in', 'pro', '-', 'inflammatory', 'M', '##1', 'macrophages', '[', '7', ']', '.']	[0, 3, 8, 19, 25, 30, 34, 42, 49, 60, 63, 64, 66, 70, 74, 75, 76, 80, 90, 94, 105, 110, 117, 120, 121, 123, 126, 132, 137, 145, 149, 153, 163, 178, 181, 184, 185, 198, 199, 201, 213, 214, 215, 216]	[2, 7, 18, 24, 29, 33, 41, 48, 59, 62, 64, 66, 70, 73, 75, 76, 80, 89, 93, 104, 109, 116, 120, 121, 122, 125, 131, 136, 144, 148, 152, 162, 177, 180, 184, 185, 197, 199, 200, 212, 214, 215, 216, 217]	['We', 'have', 'previously', 'shown', 'that', 'the', 'adipose', 'tissue', 'expression', 'of', 'kynurenine', '3-monooxygenase', 'was', 'associated', 'with', 'higher', 'HbA1c', 'in', 'women', 'with', 'obesity', 'and', 'was', 'expressed', 'preferentially', 'in', 'pro', '-', 'inflammatory', 'M1', 'macrophages', '[', '7', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Both the activation of kynurenine 3-monooxygenase and, consequently, the potential synthesis of xanthurenic acid may be deleterious to glucose homeostasis.	[('PMC4915629', 'D03003', 23, 49, 'kynurenine 3-monooxygenase')]	['Both', 'the', 'activation', 'of', 'k', '##yn', '##uren', '##ine', '3', '-', 'mono', '##oxygenase', 'and', ',', 'consequently', ',', 'the', 'potential', 'synthesis', 'of', 'x', '##anth', '##uren', '##ic', 'acid', 'may', 'be', 'deleterious', 'to', 'glucose', 'homeostasis', '.']	[0, 5, 9, 20, 23, 24, 26, 30, 34, 35, 36, 40, 50, 53, 55, 67, 69, 73, 83, 93, 96, 97, 101, 105, 108, 113, 117, 120, 132, 135, 143, 154]	[4, 8, 19, 22, 24, 26, 30, 33, 35, 36, 40, 49, 53, 54, 67, 68, 72, 82, 92, 95, 97, 101, 105, 107, 112, 116, 119, 131, 134, 142, 154, 155]	['Both', 'the', 'activation', 'of', 'kynurenine', '3-monooxygenase', 'and', ',', 'consequently', ',', 'the', 'potential', 'synthesis', 'of', 'xanthurenic', 'acid', 'may', 'be', 'deleterious', 'to', 'glucose', 'homeostasis', '.']	[1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NF-κB activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-γ and tumor necrosis factor-α.	[('PMC4915629', 'F01002', 32, 55, 'indoleamine dioxygenase')]	['NF', '-', 'κ', '##B', 'activation', 'contributes', 'to', 'ind', '##ole', '##amine', 'di', '##oxygenase', 'transcriptional', 'synerg', '##y', 'induced', 'by', 'IFN', '-', 'γ', 'and', 'tumor', 'necrosis', 'factor', '-', 'α', '.']	[0, 2, 3, 4, 6, 17, 29, 32, 35, 38, 44, 46, 56, 72, 78, 80, 88, 91, 94, 95, 97, 101, 107, 116, 122, 123, 124]	[2, 3, 4, 5, 16, 28, 31, 35, 38, 43, 46, 55, 71, 78, 79, 87, 90, 94, 95, 96, 100, 106, 115, 122, 123, 124, 125]	['NF-κB', 'activation', 'contributes', 'to', 'indoleamine', 'dioxygenase', 'transcriptional', 'synergy', 'induced', 'by', 'IFN-γ', 'and', 'tumor', 'necrosis', 'factor-α', '.']	[4, 1, 1, 1, 3, 2, 1, 2, 1, 1, 3, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The inflammation state increases the activity of indoleamine 2,3-dioxygenase (IDO1)	[('PMC4915629', 'I00001', 49, 76, 'indoleamine 2,3-dioxygenase')]	['The', 'inflammation', 'state', 'increases', 'the', 'activity', 'of', 'ind', '##ole', '##amine', '2', ',', '3', '-', 'di', '##oxygenase', '(', 'ID', '##O', '##1', ')']	[0, 4, 17, 23, 33, 37, 46, 49, 52, 55, 61, 62, 63, 64, 65, 67, 77, 78, 80, 81, 82]	[3, 16, 22, 32, 36, 45, 48, 52, 55, 60, 62, 63, 64, 65, 67, 76, 78, 80, 81, 82, 83]	['The', 'inflammation', 'state', 'increases', 'the', 'activity', 'of', 'indoleamine', '2', ',', '3-dioxygenase', '(', 'IDO1', ')']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
LPCs are plasma lipids that are created from phospatidylcholines by action of phospholipase A2 or by oxidation.	[('PMC5323494', 'D01005', 78, 94, 'phospholipase A2')]	['LP', '##Cs', 'are', 'plasma', 'lipids', 'that', 'are', 'created', 'from', 'ph', '##osp', '##atidyl', '##choline', '##s', 'by', 'action', 'of', 'phospholip', '##ase', 'A', '##2', 'or', 'by', 'oxidation', '.']	[0, 2, 5, 9, 16, 23, 28, 32, 40, 45, 47, 50, 56, 63, 65, 68, 75, 78, 88, 92, 93, 95, 98, 101, 110]	[2, 4, 8, 15, 22, 27, 31, 39, 44, 47, 50, 56, 63, 64, 67, 74, 77, 88, 91, 93, 94, 97, 100, 110, 111]	['LPCs', 'are', 'plasma', 'lipids', 'that', 'are', 'created', 'from', 'phospatidylcholines', 'by', 'action', 'of', 'phospholipase', 'A2', 'or', 'by', 'oxidation', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Unsaturated FAs including C18:1, C18:2, and C20:4 have been shown to activate protein kinase C (PKC) dependently on or independently of Ca2+ and phospholipids (Murakami et al. 1986), and might be involved in sustaining parasite growth.	[('PMC5323494', 'D04013', 78, 94, 'protein kinase C')]	['Un', '##sa', '##tur', '##ated', 'FA', '##s', 'including', 'C', '##18', ':', '1', ',', 'C', '##18', ':', '2', ',', 'and', 'C', '##20', ':', '4', 'have', 'been', 'shown', 'to', 'activate', 'protein', 'kinase', 'C', '(', 'PKC', ')', 'dependent', '##ly', 'on', 'or', 'independently', 'of', 'Ca', '##2', '+', 'and', 'phospholipids', '(', 'Mur', '##aka', '##mi', 'et', 'al', '.', '1986', ')', ',', 'and', 'might', 'be', 'involved', 'in', 'sustain', '##ing', 'parasite', 'growth', '.']	[0, 2, 4, 7, 12, 14, 16, 26, 27, 29, 30, 31, 33, 34, 36, 37, 38, 40, 44, 45, 47, 48, 50, 55, 60, 66, 69, 78, 86, 93, 95, 96, 99, 101, 110, 113, 116, 119, 133, 136, 138, 139, 141, 145, 159, 160, 163, 166, 169, 172, 174, 176, 180, 181, 183, 187, 193, 196, 205, 208, 215, 219, 228, 234]	[2, 4, 7, 11, 14, 15, 25, 27, 29, 30, 31, 32, 34, 36, 37, 38, 39, 43, 45, 47, 48, 49, 54, 59, 65, 68, 77, 85, 92, 94, 96, 99, 100, 110, 112, 115, 118, 132, 135, 138, 139, 140, 144, 158, 160, 163, 166, 168, 171, 174, 175, 180, 181, 182, 186, 192, 195, 204, 207, 215, 218, 227, 234, 235]	['Unsaturated', 'FAs', 'including', 'C18', ':', '1', ',', 'C18', ':', '2', ',', 'and', 'C20', ':', '4', 'have', 'been', 'shown', 'to', 'activate', 'protein', 'kinase', 'C', '(', 'PKC', ')', 'dependently', 'on', 'or', 'independently', 'of', 'Ca2+', 'and', 'phospholipids', '(', 'Murakami', 'et', 'al', '.', '1986', ')', ',', 'and', 'might', 'be', 'involved', 'in', 'sustaining', 'parasite', 'growth', '.']	[4, 2, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Jackson SK, Abate W, Tonks A. Lysophospholipid acyltransferases: Novel potential regulators of the inflammatory response and target for new drug discovery.	[('PMC5323494', 'F31000', 30, 63, 'Lysophospholipid acyltransferases')]	['Jackson', 'SK', ',', 'Ab', '##ate', 'W', ',', 'Ton', '##ks', 'A', '.', 'Lys', '##ophosph', '##olipid', 'acyl', '##transferase', '##s', ':', 'Novel', 'potential', 'regulators', 'of', 'the', 'inflammatory', 'response', 'and', 'target', 'for', 'new', 'drug', 'discovery', '.']	[0, 8, 10, 12, 14, 18, 19, 21, 24, 27, 28, 30, 33, 40, 47, 51, 62, 63, 65, 71, 81, 92, 95, 99, 112, 121, 125, 132, 136, 140, 145, 154]	[7, 10, 11, 14, 17, 19, 20, 24, 26, 28, 29, 33, 40, 46, 51, 62, 63, 64, 70, 80, 91, 94, 98, 111, 120, 124, 131, 135, 139, 144, 154, 155]	['Jackson', 'SK', ',', 'Abate', 'W', ',', 'Tonks', 'A', '.', 'Lysophospholipid', 'acyltransferases', ':', 'Novel', 'potential', 'regulators', 'of', 'the', 'inflammatory', 'response', 'and', 'target', 'for', 'new', 'drug', 'discovery', '.']	[1, 1, 1, 2, 1, 1, 2, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Murakami K, Chan SY, Routtenberg A. Protein-kinase-C activation by Cis-fatty acid in the absence of Ca2+ and phospholipids.	[('PMC5323494', 'F43000', 36, 52, 'Protein-kinase-C')]	['Mur', '##aka', '##mi', 'K', ',', 'Chan', 'SY', ',', 'Rout', '##ten', '##berg', 'A', '.', 'Protein', '-', 'kinase', '-', 'C', 'activation', 'by', 'Ci', '##s', '-', 'fatty', 'acid', 'in', 'the', 'absence', 'of', 'Ca', '##2', '+', 'and', 'phospholipids', '.']	[0, 3, 6, 9, 10, 12, 17, 19, 21, 25, 28, 33, 34, 36, 43, 44, 50, 51, 53, 64, 67, 69, 70, 71, 77, 82, 85, 89, 97, 100, 102, 103, 105, 109, 122]	[3, 6, 8, 10, 11, 16, 19, 20, 25, 28, 32, 34, 35, 43, 44, 50, 51, 52, 63, 66, 69, 70, 71, 76, 81, 84, 88, 96, 99, 102, 103, 104, 108, 122, 123]	['Murakami', 'K', ',', 'Chan', 'SY', ',', 'Routtenberg', 'A', '.', 'Protein-kinase-C', 'activation', 'by', 'Cis', '-', 'fatty', 'acid', 'in', 'the', 'absence', 'of', 'Ca2+', 'and', 'phospholipids', '.']	[3, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Characterization of the Plasmodium falciparum and P. berghei glycerol 3-phosphate acyltransferase involved in FASII fatty acid utilization in the malaria parasite apicoplast.	[('PMC5323494', 'F54001', 61, 97, 'glycerol 3-phosphate acyltransferase')]	['Character', '##ization', 'of', 'the', 'Plasmodium', 'falciparum', 'and', 'P', '.', 'ber', '##gh', '##ei', 'glycerol', '3', '-', 'phosphate', 'acyl', '##transferase', 'involved', 'in', 'FA', '##SI', '##I', 'fatty', 'acid', 'utilization', 'in', 'the', 'malaria', 'parasite', 'ap', '##ico', '##plas', '##t', '.']	[0, 9, 17, 20, 24, 35, 46, 50, 51, 53, 56, 58, 61, 70, 71, 72, 82, 86, 98, 107, 110, 112, 114, 116, 122, 127, 139, 142, 146, 154, 163, 165, 168, 172, 173]	[9, 16, 19, 23, 34, 45, 49, 51, 52, 56, 58, 60, 69, 71, 72, 81, 86, 97, 106, 109, 112, 114, 115, 121, 126, 138, 141, 145, 153, 162, 165, 168, 172, 173, 174]	['Characterization', 'of', 'the', 'Plasmodium', 'falciparum', 'and', 'P', '.', 'berghei', 'glycerol', '3-phosphate', 'acyltransferase', 'involved', 'in', 'FASII', 'fatty', 'acid', 'utilization', 'in', 'the', 'malaria', 'parasite', 'apicoplast', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This results in increased hepatic production of VLDL, suppression of VLDL lipolysis by inhibition of lipoprotein lipase and increased adipose tissue lipolysis.	[('PMC5323494', 'I01007', 101, 119, 'lipoprotein lipase')]	['This', 'results', 'in', 'increased', 'hepatic', 'production', 'of', 'VL', '##DL', ',', 'suppression', 'of', 'VL', '##DL', 'lip', '##olysis', 'by', 'inhibition', 'of', 'lipoprotein', 'lipase', 'and', 'increased', 'adipose', 'tissue', 'lip', '##olysis', '.']	[0, 5, 13, 16, 26, 34, 45, 48, 50, 52, 54, 66, 69, 71, 74, 77, 84, 87, 98, 101, 113, 120, 124, 134, 142, 149, 152, 158]	[4, 12, 15, 25, 33, 44, 47, 50, 52, 53, 65, 68, 71, 73, 77, 83, 86, 97, 100, 112, 119, 123, 133, 141, 148, 152, 158, 159]	['This', 'results', 'in', 'increased', 'hepatic', 'production', 'of', 'VLDL', ',', 'suppression', 'of', 'VLDL', 'lipolysis', 'by', 'inhibition', 'of', 'lipoprotein', 'lipase', 'and', 'increased', 'adipose', 'tissue', 'lipolysis', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
LysoPG stimulated intracellular calcium signaling via phospholipase C activation in OVCAR-3 human ovarian cancer cells [26].	[('PMC5564526', 'D01009', 54, 69, 'phospholipase C')]	['Lys', '##o', '##PG', 'stimulated', 'intracellular', 'calcium', 'signaling', 'via', 'phospholip', '##ase', 'C', 'activation', 'in', 'OV', '##CAR', '-', '3', 'human', 'ovarian', 'cancer', 'cells', '[', '26', ']', '.']	[0, 3, 4, 7, 18, 32, 40, 50, 54, 64, 68, 70, 81, 84, 86, 89, 90, 92, 98, 106, 113, 119, 120, 122, 123]	[3, 4, 6, 17, 31, 39, 49, 53, 64, 67, 69, 80, 83, 86, 89, 90, 91, 97, 105, 112, 118, 120, 122, 123, 124]	['LysoPG', 'stimulated', 'intracellular', 'calcium', 'signaling', 'via', 'phospholipase', 'C', 'activation', 'in', 'OVCAR-3', 'human', 'ovarian', 'cancer', 'cells', '[', '26', ']', '.']	[3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It is also the substrate of lysophospholipase D, an enzyme converting LysoPC to LPA during cancer progression [27].	[('PMC5564526', 'D02002', 28, 47, 'lysophospholipase D')]	['It', 'is', 'also', 'the', 'substrate', 'of', 'lys', '##ophosph', '##olip', '##ase', 'D', ',', 'an', 'enzyme', 'converting', 'Lys', '##o', '##PC', 'to', 'LP', '##A', 'during', 'cancer', 'progression', '[', '27', ']', '.']	[0, 3, 6, 11, 15, 25, 28, 31, 38, 42, 46, 47, 49, 52, 59, 70, 73, 74, 77, 80, 82, 84, 91, 98, 110, 111, 113, 114]	[2, 5, 10, 14, 24, 27, 31, 38, 42, 45, 47, 48, 51, 58, 69, 73, 74, 76, 79, 82, 83, 90, 97, 109, 111, 113, 114, 115]	['It', 'is', 'also', 'the', 'substrate', 'of', 'lysophospholipase', 'D', ',', 'an', 'enzyme', 'converting', 'LysoPC', 'to', 'LPA', 'during', 'cancer', 'progression', '[', '27', ']', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lysophospholipase D over-expression has been determined in several cancers, such as breast cancer, glioblastoma, and hepatocellular carcinoma [28, 29].	[('PMC5564526', 'D02003', 0, 19, 'Lysophospholipase D')]	['Lys', '##ophosph', '##olip', '##ase', 'D', 'over', '-', 'expression', 'has', 'been', 'determined', 'in', 'several', 'cancers', ',', 'such', 'as', 'breast', 'cancer', ',', 'gli', '##oblastoma', ',', 'and', 'hepatocellular', 'carcinoma', '[', '28', ',', '29', ']', '.']	[0, 3, 10, 14, 18, 20, 24, 25, 36, 40, 45, 56, 59, 67, 74, 76, 81, 84, 91, 97, 99, 102, 111, 113, 117, 132, 142, 143, 145, 147, 149, 150]	[3, 10, 14, 17, 19, 24, 25, 35, 39, 44, 55, 58, 66, 74, 75, 80, 83, 90, 97, 98, 102, 111, 112, 116, 131, 141, 143, 145, 146, 149, 150, 151]	['Lysophospholipase', 'D', 'over', '-', 'expression', 'has', 'been', 'determined', 'in', 'several', 'cancers', ',', 'such', 'as', 'breast', 'cancer', ',', 'glioblastoma', ',', 'and', 'hepatocellular', 'carcinoma', '[', '28', ',', '29', ']', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Ceramide is metabolized by ceramide kinase to generate ceramide-1-phosphate (C1P) and by ceramidase to generate sphingosine, which is further phosphorylated to sphingosine-1-phosphate (S1P) by sphingosine kinase.	[('PMC5564526', 'D04002', 27, 42, 'ceramide kinase'), ('PMC5564526', 'D04002', 89, 99, 'ceramidase'), ('PMC5564526', 'D04002', 193, 211, 'sphingosine kinase')]	['Cer', '##amide', 'is', 'metabol', '##ized', 'by', 'cer', '##amide', 'kinase', 'to', 'generate', 'cer', '##amide', '-', '1', '-', 'phosphate', '(', 'C', '##1', '##P', ')', 'and', 'by', 'cer', '##amid', '##ase', 'to', 'generate', 'sphing', '##osine', ',', 'which', 'is', 'further', 'phosphorylated', 'to', 'sphing', '##osine', '-', '1', '-', 'phosphate', '(', 'S', '##1', '##P', ')', 'by', 'sphing', '##osine', 'kinase', '.']	[0, 3, 9, 12, 19, 24, 27, 30, 36, 43, 46, 55, 58, 63, 64, 65, 66, 76, 77, 78, 79, 80, 82, 86, 89, 92, 96, 100, 103, 112, 118, 123, 125, 131, 134, 142, 157, 160, 166, 171, 172, 173, 174, 184, 185, 186, 187, 188, 190, 193, 199, 205, 211]	[3, 8, 11, 19, 23, 26, 30, 35, 42, 45, 54, 58, 63, 64, 65, 66, 75, 77, 78, 79, 80, 81, 85, 88, 92, 96, 99, 102, 111, 118, 123, 124, 130, 133, 141, 156, 159, 166, 171, 172, 173, 174, 183, 185, 186, 187, 188, 189, 192, 199, 204, 211, 212]	['Ceramide', 'is', 'metabolized', 'by', 'ceramide', 'kinase', 'to', 'generate', 'ceramide-1-phosphate', '(', 'C1P', ')', 'and', 'by', 'ceramidase', 'to', 'generate', 'sphingosine', ',', 'which', 'is', 'further', 'phosphorylated', 'to', 'sphingosine-1-phosphate', '(', 'S1P', ')', 'by', 'sphingosine', 'kinase', '.']	[2, 1, 2, 1, 2, 1, 1, 1, 6, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 6, 1, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
High ceramide kinase expression has been reported to be associated with poor recurrence-free survival in women with ER-negative breast cancer [32].	[('PMC5564526', 'D04003', 5, 20, 'ceramide kinase')]	['High', 'cer', '##amide', 'kinase', 'expression', 'has', 'been', 'reported', 'to', 'be', 'associated', 'with', 'poor', 'recurrence', '-', 'free', 'survival', 'in', 'women', 'with', 'ER', '-', 'negative', 'breast', 'cancer', '[', '32', ']', '.']	[0, 5, 8, 14, 21, 32, 36, 41, 50, 53, 56, 67, 72, 77, 87, 88, 93, 102, 105, 111, 116, 118, 119, 128, 135, 142, 143, 145, 146]	[4, 8, 13, 20, 31, 35, 40, 49, 52, 55, 66, 71, 76, 87, 88, 92, 101, 104, 110, 115, 118, 119, 127, 134, 141, 143, 145, 146, 147]	['High', 'ceramide', 'kinase', 'expression', 'has', 'been', 'reported', 'to', 'be', 'associated', 'with', 'poor', 'recurrence', '-', 'free', 'survival', 'in', 'women', 'with', 'ER-negative', 'breast', 'cancer', '[', '32', ']', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
S1P and sphingosine kinase, have been implicated in many cellular processes including cell growth, proliferation, survival, and migration.	[('PMC5564526', 'D04004', 8, 26, 'sphingosine kinase')]	['S', '##1', '##P', 'and', 'sphing', '##osine', 'kinase', ',', 'have', 'been', 'implicated', 'in', 'many', 'cellular', 'processes', 'including', 'cell', 'growth', ',', 'proliferation', ',', 'survival', ',', 'and', 'migration', '.']	[0, 1, 2, 4, 8, 14, 20, 26, 28, 33, 38, 49, 52, 57, 66, 76, 86, 91, 97, 99, 112, 114, 122, 124, 128, 137]	[1, 2, 3, 7, 14, 19, 26, 27, 32, 37, 48, 51, 56, 65, 75, 85, 90, 97, 98, 112, 113, 122, 123, 127, 137, 138]	['S1P', 'and', 'sphingosine', 'kinase', ',', 'have', 'been', 'implicated', 'in', 'many', 'cellular', 'processes', 'including', 'cell', 'growth', ',', 'proliferation', ',', 'survival', ',', 'and', 'migration', '.']	[3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PIs were metabolized by 1-phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) to generate phosphatidylinositol 5-phosphate, which was further metabolized by 1-phosphatidylinositol-5-phosphate 4-kinase (PIP4K2) to generate phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2)	[('PMC5564526', 'D05001', 24, 67, '1-phosphatidylinositol-3-phosphate 5-kinase'), ('PMC5564526', 'D05001', 157, 200, '1-phosphatidylinositol-5-phosphate 4-kinase')]	['PI', '##s', 'were', 'metabol', '##ized', 'by', '1', '-', 'phosphatidyl', '##inositol', '-', '3', '-', 'phosphate', '5', '-', 'kinase', '(', 'PI', '##K', '##f', '##y', '##ve', ')', 'to', 'generate', 'phosphatidyl', '##inositol', '5', '-', 'phosphate', ',', 'which', 'was', 'further', 'metabol', '##ized', 'by', '1', '-', 'phosphatidyl', '##inositol', '-', '5', '-', 'phosphate', '4', '-', 'kinase', '(', 'PIP', '##4', '##K', '##2', ')', 'to', 'generate', 'phosphatidyl', '##inositol', '-', '4', ',', '5', '-', 'bis', '##phosphate', '(', 'PI', '(', '4', ',', '5', ')', 'P', '##2', ')']	[0, 2, 4, 9, 16, 21, 24, 25, 26, 38, 46, 47, 48, 49, 59, 60, 61, 68, 69, 71, 72, 73, 74, 76, 78, 81, 90, 102, 111, 112, 113, 122, 124, 130, 134, 142, 149, 154, 157, 158, 159, 171, 179, 180, 181, 182, 192, 193, 194, 201, 202, 205, 206, 207, 208, 210, 213, 222, 234, 242, 243, 244, 245, 246, 247, 250, 260, 261, 263, 264, 265, 266, 267, 268, 269, 270]	[2, 3, 8, 16, 20, 23, 25, 26, 38, 46, 47, 48, 49, 58, 60, 61, 67, 69, 71, 72, 73, 74, 76, 77, 80, 89, 102, 110, 112, 113, 122, 123, 129, 133, 141, 149, 153, 156, 158, 159, 171, 179, 180, 181, 182, 191, 193, 194, 200, 202, 205, 206, 207, 208, 209, 212, 221, 234, 242, 243, 244, 245, 246, 247, 250, 259, 261, 263, 264, 265, 266, 267, 268, 269, 270, 271]	['PIs', 'were', 'metabolized', 'by', '1-phosphatidylinositol-3-phosphate', '5-kinase', '(', 'PIKfyve', ')', 'to', 'generate', 'phosphatidylinositol', '5-phosphate', ',', 'which', 'was', 'further', 'metabolized', 'by', '1-phosphatidylinositol-5-phosphate', '4-kinase', '(', 'PIP4K2', ')', 'to', 'generate', 'phosphatidylinositol-4,5-bisphosphate', '(', 'PI(4,5)P2', ')']	[2, 1, 2, 1, 8, 3, 1, 5, 1, 1, 1, 2, 3, 1, 1, 1, 1, 2, 1, 8, 3, 1, 4, 1, 1, 1, 9, 1, 8, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PI(4,5)P2 was the direct substrate of phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway conducted by PIK3C to generate PI(3,4,5)P3.	[('PMC5564526', 'D05003', 38, 67, 'phosphatidylinositol 3-kinase')]	['PI', '(', '4', ',', '5', ')', 'P', '##2', 'was', 'the', 'direct', 'substrate', 'of', 'phosphatidyl', '##inositol', '3', '-', 'kinase', '(', 'PI', '##3', '##K', ')', '/', 'AKT', 'signaling', 'pathway', 'conducted', 'by', 'PI', '##K', '##3', '##C', 'to', 'generate', 'PI', '(', '3', ',', '4', ',', '5', ')', 'P', '##3', '.']	[0, 2, 3, 4, 5, 6, 7, 8, 10, 14, 18, 25, 35, 38, 50, 59, 60, 61, 68, 69, 71, 72, 73, 74, 75, 79, 89, 97, 107, 110, 112, 113, 114, 116, 119, 128, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139]	[2, 3, 4, 5, 6, 7, 8, 9, 13, 17, 24, 34, 37, 50, 58, 60, 61, 67, 69, 71, 72, 73, 74, 75, 78, 88, 96, 106, 109, 112, 113, 114, 115, 118, 127, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140]	['PI(4,5)P2', 'was', 'the', 'direct', 'substrate', 'of', 'phosphatidylinositol', '3-kinase', '(', 'PI3K', ')', '/', 'AKT', 'signaling', 'pathway', 'conducted', 'by', 'PIK3C', 'to', 'generate', 'PI(3,4,5)P3', '.']	[8, 1, 1, 1, 1, 1, 2, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 10, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Ceramide kinase promotes tumor cell survival and mammary tumor recurrence.	[('PMC5564526', 'F31002', 0, 15, 'Ceramide kinase')]	['Cer', '##amide', 'kinase', 'promotes', 'tumor', 'cell', 'survival', 'and', 'mammary', 'tumor', 'recurrence', '.']	[0, 3, 9, 16, 25, 31, 36, 45, 49, 57, 63, 73]	[3, 8, 15, 24, 30, 35, 44, 48, 56, 62, 73, 74]	['Ceramide', 'kinase', 'promotes', 'tumor', 'cell', 'survival', 'and', 'mammary', 'tumor', 'recurrence', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Liu Y, Lai YC, Hill EV, Tyteca D, Carpentier S, Ingvaldsen A, Vertommen D, Lantier L, Foretz M, Dequiedt F. Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is an AMPK target participating in contraction-stimulated glucose uptake in skeletal muscle.	[('PMC5564526', 'F32001', 108, 149, 'Phosphatidylinositol 3-phosphate 5-kinase')]	['Liu', 'Y', ',', 'Lai', 'Y', '##C', ',', 'Hill', 'EV', ',', 'Ty', '##te', '##ca', 'D', ',', 'Car', '##pent', '##ier', 'S', ',', 'In', '##g', '##val', '##ds', '##en', 'A', ',', 'Ver', '##to', '##mm', '##en', 'D', ',', 'La', '##nt', '##ier', 'L', ',', 'Fore', '##tz', 'M', ',', 'De', '##qu', '##ied', '##t', 'F', '.', 'Phosph', '##atidyl', '##inositol', '3', '-', 'phosphate', '5', '-', 'kinase', '(', 'PI', '##K', '##f', '##y', '##ve', ')', 'is', 'an', 'AMPK', 'target', 'participating', 'in', 'contraction', '-', 'stimulated', 'glucose', 'uptake', 'in', 'skeletal', 'muscle', '.']	[0, 4, 5, 7, 11, 12, 13, 15, 20, 22, 24, 26, 28, 31, 32, 34, 37, 41, 45, 46, 48, 50, 51, 54, 56, 59, 60, 62, 65, 67, 69, 72, 73, 75, 77, 79, 83, 84, 86, 90, 93, 94, 96, 98, 100, 103, 105, 106, 108, 114, 120, 129, 130, 131, 141, 142, 143, 150, 151, 153, 154, 155, 156, 158, 160, 163, 166, 171, 178, 192, 195, 206, 207, 218, 226, 233, 236, 245, 251]	[3, 5, 6, 10, 12, 13, 14, 19, 22, 23, 26, 28, 30, 32, 33, 37, 41, 44, 46, 47, 50, 51, 54, 56, 58, 60, 61, 65, 67, 69, 71, 73, 74, 77, 79, 82, 84, 85, 90, 92, 94, 95, 98, 100, 103, 104, 106, 107, 114, 120, 128, 130, 131, 140, 142, 143, 149, 151, 153, 154, 155, 156, 158, 159, 162, 165, 170, 177, 191, 194, 206, 207, 217, 225, 232, 235, 244, 251, 252]	['Liu', 'Y', ',', 'Lai', 'YC', ',', 'Hill', 'EV', ',', 'Tyteca', 'D', ',', 'Carpentier', 'S', ',', 'Ingvaldsen', 'A', ',', 'Vertommen', 'D', ',', 'Lantier', 'L', ',', 'Foretz', 'M', ',', 'Dequiedt', 'F', '.', 'Phosphatidylinositol', '3-phosphate', '5-kinase', '(', 'PIKfyve', ')', 'is', 'an', 'AMPK', 'target', 'participating', 'in', 'contraction', '-', 'stimulated', 'glucose', 'uptake', 'in', 'skeletal', 'muscle', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 5, 1, 1, 4, 1, 1, 3, 1, 1, 2, 1, 1, 4, 1, 1, 3, 3, 3, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Survey of urine from transplant recipients for polyomaviruses JC and BK using the polymerase chain reaction.	[('PMC5847550', 'F31002', 82, 92, 'polymerase')]	['Survey', 'of', 'urine', 'from', 'transplant', 'recipients', 'for', 'poly', '##oma', '##virus', '##es', 'JC', 'and', 'BK', 'using', 'the', 'polymerase', 'chain', 'reaction', '.']	[0, 7, 10, 16, 21, 32, 43, 47, 51, 54, 59, 62, 65, 69, 72, 78, 82, 93, 99, 107]	[6, 9, 15, 20, 31, 42, 46, 51, 54, 59, 61, 64, 68, 71, 77, 81, 92, 98, 107, 108]	['Survey', 'of', 'urine', 'from', 'transplant', 'recipients', 'for', 'polyomaviruses', 'JC', 'and', 'BK', 'using', 'the', 'polymerase', 'chain', 'reaction', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O']
Clinical laboratory records included gender and the results of urinalysis tests, such as presence of bacterial cells, red blood cells, leukocytes, epithelial cells and casts (assessed by phase contrast microscopy), nitrite concentration (associated with bacterial nitrate reduction) and leukocyte esterase activities (derived from the activity of white blood cell proteases and esterases released into urine).	[('PMC5847550', 'M00006', 287, 305, 'leukocyte esterase'), ('PMC5847550', 'M00006', 364, 373, 'proteases'), ('PMC5847550', 'M00006', 378, 387, 'esterases')]	['Clinical', 'laboratory', 'records', 'included', 'gender', 'and', 'the', 'results', 'of', 'ur', '##inal', '##ysis', 'tests', ',', 'such', 'as', 'presence', 'of', 'bacterial', 'cells', ',', 'red', 'blood', 'cells', ',', 'leukocytes', ',', 'epithelial', 'cells', 'and', 'cast', '##s', '(', 'assessed', 'by', 'phase', 'contrast', 'microscopy', ')', ',', 'nitrite', 'concentration', '(', 'associated', 'with', 'bacterial', 'nitrate', 'reduction', ')', 'and', 'leukocyte', 'ester', '##ase', 'activities', '(', 'derived', 'from', 'the', 'activity', 'of', 'white', 'blood', 'cell', 'proteases', 'and', 'ester', '##ases', 'released', 'into', 'urine', ')', '.']	[0, 9, 20, 28, 37, 44, 48, 52, 60, 63, 65, 69, 74, 79, 81, 86, 89, 98, 101, 111, 116, 118, 122, 128, 133, 135, 145, 147, 158, 164, 168, 172, 174, 175, 184, 187, 193, 202, 212, 213, 215, 223, 237, 238, 249, 254, 264, 272, 281, 283, 287, 297, 302, 306, 317, 318, 326, 331, 335, 344, 347, 353, 359, 364, 374, 378, 383, 388, 397, 402, 407, 408]	[8, 19, 27, 36, 43, 47, 51, 59, 62, 65, 69, 73, 79, 80, 85, 88, 97, 100, 110, 116, 117, 121, 127, 133, 134, 145, 146, 157, 163, 167, 172, 173, 175, 183, 186, 192, 201, 212, 213, 214, 222, 236, 238, 248, 253, 263, 271, 281, 282, 286, 296, 302, 305, 316, 318, 325, 330, 334, 343, 346, 352, 358, 363, 373, 377, 383, 387, 396, 401, 407, 408, 409]	['Clinical', 'laboratory', 'records', 'included', 'gender', 'and', 'the', 'results', 'of', 'urinalysis', 'tests', ',', 'such', 'as', 'presence', 'of', 'bacterial', 'cells', ',', 'red', 'blood', 'cells', ',', 'leukocytes', ',', 'epithelial', 'cells', 'and', 'casts', '(', 'assessed', 'by', 'phase', 'contrast', 'microscopy', ')', ',', 'nitrite', 'concentration', '(', 'associated', 'with', 'bacterial', 'nitrate', 'reduction', ')', 'and', 'leukocyte', 'esterase', 'activities', '(', 'derived', 'from', 'the', 'activity', 'of', 'white', 'blood', 'cell', 'proteases', 'and', 'esterases', 'released', 'into', 'urine', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
The suspension was supplemented with 60 µl chicken egg lysozyme (200 µg/ml), and 5 µl Linker RNase A, gently mixed and incubated for 60 min at 37 °C.	[('PMC5847550', 'M01005', 93, 98, 'RNase')]	['The', 'suspension', 'was', 'supplemented', 'with', '60', '[UNK]', 'chicken', 'egg', 'lys', '##ozyme', '(', '200', '[UNK]', '/', 'ml', ')', ',', 'and', '5', '[UNK]', 'Link', '##er', 'RNase', 'A', ',', 'gently', 'mixed', 'and', 'incubated', 'for', '60', 'min', 'at', '37', '°', '##C', '.']	[0, 4, 15, 19, 32, 37, -1, 43, 51, 55, 58, 64, 65, -1, 71, 72, 74, 75, 77, 81, -1, 86, 90, 93, 99, 100, 102, 109, 115, 119, 129, 133, 136, 140, 143, 146, 147, 148]	[3, 14, 18, 31, 36, 39, 4, 50, 54, 58, 63, 65, 68, 4, 72, 74, 75, 76, 80, 82, 4, 90, 92, 98, 100, 101, 108, 114, 118, 128, 132, 135, 139, 142, 145, 147, 148, 149]	['The', 'suspension', 'was', 'supplemented', 'with', '60', 'µl', 'chicken', 'egg', 'lysozyme', '(', '200', 'µg', '/', 'ml', ')', ',', 'and', '5', 'µl', 'Linker', 'RNase', 'A', ',', 'gently', 'mixed', 'and', 'incubated', 'for', '60', 'min', 'at', '37', '°C', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After addition of 100 µl 10% SDS and 42 µl Proteinase K (20 mg/ml), bacterial lysis was allowed to proceed overnight at 55 °C.	[('PMC5847550', 'M01006', 43, 55, 'Proteinase K')]	['After', 'addition', 'of', '100', '[UNK]', '10', '%', 'SDS', 'and', '42', '[UNK]', 'Protein', '##ase', 'K', '(', '20', 'mg', '/', 'ml', ')', ',', 'bacterial', 'lysis', 'was', 'allowed', 'to', 'proceed', 'overnight', 'at', '55', '°', '##C', '.']	[0, 6, 15, 18, -1, 25, 27, 29, 33, 37, -1, 43, 50, 54, 56, 57, 60, 62, 63, 65, 66, 68, 78, 84, 88, 96, 99, 107, 117, 120, 123, 124, 125]	[5, 14, 17, 21, 4, 27, 28, 32, 36, 39, 4, 50, 53, 55, 57, 59, 62, 63, 65, 66, 67, 77, 83, 87, 95, 98, 106, 116, 119, 122, 124, 125, 126]	['After', 'addition', 'of', '100', 'µl', '10%', 'SDS', 'and', '42', 'µl', 'Proteinase', 'K', '(', '20', 'mg', '/', 'ml', ')', ',', 'bacterial', 'lysis', 'was', 'allowed', 'to', 'proceed', 'overnight', 'at', '55', '°C', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using approximately 100 ng of extracted DNA, amplicons were generated with Platinum Taq polymerase (Life Technologies, CA) using the following cycling conditions: 95 °C for 5 min for an initial denaturing step followed by 95 °C for 30 sec, 55 °C for 30 sec, 72 °C for 30 sec for a total of 35 cycles followed by a final extension step of 72 °C for 7 min then stored at 4 °C.	[('PMC5847550', 'M03004', 84, 98, 'Taq polymerase')]	['Using', 'approximately', '100', 'ng', 'of', 'extracted', 'DNA', ',', 'amplic', '##ons', 'were', 'generated', 'with', 'Pl', '##atinum', 'Taq', 'polymerase', '(', 'Life', 'Technologies', ',', 'CA', ')', 'using', 'the', 'following', 'cycling', 'conditions', ':', '95', '°', '##C', 'for', '5', 'min', 'for', 'an', 'initial', 'den', '##aturing', 'step', 'followed', 'by', '95', '°', '##C', 'for', '30', 'sec', ',', '55', '°', '##C', 'for', '30', 'sec', ',', '72', '°', '##C', 'for', '30', 'sec', 'for', 'a', 'total', 'of', '35', 'cycles', 'followed', 'by', 'a', 'final', 'extension', 'step', 'of', '72', '°', '##C', 'for', '7', 'min', 'then', 'stored', 'at', '4', '°', '##C', '.']	[0, 6, 20, 24, 27, 30, 40, 43, 45, 51, 55, 60, 70, 75, 77, 84, 88, 99, 100, 105, 117, 119, 121, 123, 129, 133, 143, 151, 161, 163, 166, 167, 169, 173, 175, 179, 183, 186, 194, 197, 205, 210, 219, 222, 225, 226, 228, 232, 235, 238, 240, 243, 244, 246, 250, 253, 256, 258, 261, 262, 264, 268, 271, 275, 279, 281, 287, 290, 293, 300, 309, 312, 314, 320, 330, 335, 338, 341, 342, 344, 348, 350, 354, 359, 366, 369, 371, 372, 373]	[5, 19, 23, 26, 29, 39, 43, 44, 51, 54, 59, 69, 74, 77, 83, 87, 98, 100, 104, 117, 118, 121, 122, 128, 132, 142, 150, 161, 162, 165, 167, 168, 172, 174, 178, 182, 185, 193, 197, 204, 209, 218, 221, 224, 226, 227, 231, 234, 238, 239, 242, 244, 245, 249, 252, 256, 257, 260, 262, 263, 267, 270, 274, 278, 280, 286, 289, 292, 299, 308, 311, 313, 319, 329, 334, 337, 340, 342, 343, 347, 349, 353, 358, 365, 368, 370, 372, 373, 374]	['Using', 'approximately', '100', 'ng', 'of', 'extracted', 'DNA', ',', 'amplicons', 'were', 'generated', 'with', 'Platinum', 'Taq', 'polymerase', '(', 'Life', 'Technologies', ',', 'CA', ')', 'using', 'the', 'following', 'cycling', 'conditions', ':', '95', '°C', 'for', '5', 'min', 'for', 'an', 'initial', 'denaturing', 'step', 'followed', 'by', '95', '°C', 'for', '30', 'sec', ',', '55', '°C', 'for', '30', 'sec', ',', '72', '°C', 'for', '30', 'sec', 'for', 'a', 'total', 'of', '35', 'cycles', 'followed', 'by', 'a', 'final', 'extension', 'step', 'of', '72', '°C', 'for', '7', 'min', 'then', 'stored', 'at', '4', '°C', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Studies have shown that CYP epoxygenases influence vascular inflammation and atherosclerosis, which make an important contribution to the progression of the disease [16,17].	[('PMC6047792', 'D01002', 24, 40, 'CYP epoxygenases')]	['Studies', 'have', 'shown', 'that', 'CYP', 'epoxy', '##gen', '##ases', 'influence', 'vascular', 'inflammation', 'and', 'atherosclerosis', ',', 'which', 'make', 'an', 'important', 'contribution', 'to', 'the', 'progression', 'of', 'the', 'disease', '[', '16', ',', '17', ']', '.']	[0, 8, 13, 19, 24, 28, 33, 36, 41, 51, 60, 73, 77, 92, 94, 100, 105, 108, 118, 131, 134, 138, 150, 153, 157, 165, 166, 168, 169, 171, 172]	[7, 12, 18, 23, 27, 33, 36, 40, 50, 59, 72, 76, 92, 93, 99, 104, 107, 117, 130, 133, 137, 149, 152, 156, 164, 166, 168, 169, 171, 172, 173]	['Studies', 'have', 'shown', 'that', 'CYP', 'epoxygenases', 'influence', 'vascular', 'inflammation', 'and', 'atherosclerosis', ',', 'which', 'make', 'an', 'important', 'contribution', 'to', 'the', 'progression', 'of', 'the', 'disease', '[', '16', ',', '17', ']', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology.	[('PMC6047792', 'F17002', 21, 38, 'Epoxide Hydrolase')]	['Ep', '##oxide', '##s', 'and', 'Sol', '##uble', 'Ep', '##oxide', 'Hydro', '##las', '##e', 'in', 'Cardiovascular', 'Physiology', '.']	[0, 2, 7, 9, 13, 16, 21, 23, 29, 34, 37, 39, 42, 57, 67]	[2, 7, 8, 12, 16, 20, 23, 28, 34, 37, 38, 41, 56, 67, 68]	['Epoxides', 'and', 'Soluble', 'Epoxide', 'Hydrolase', 'in', 'Cardiovascular', 'Physiology', '.']	[3, 1, 2, 2, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
ADP also causes a number of intracellular events including inhibition of adenylyl cyclase, mobilization of calcium from intracellular stores, and rapid calcium influx in platelets [8,9].	[('PMC6047792', 'I02004', 73, 89, 'adenylyl cyclase')]	['ADP', 'also', 'causes', 'a', 'number', 'of', 'intracellular', 'events', 'including', 'inhibition', 'of', 'aden', '##yl', '##yl', 'cyclase', ',', 'mobilization', 'of', 'calcium', 'from', 'intracellular', 'stores', ',', 'and', 'rapid', 'calcium', 'influx', 'in', 'platelets', '[', '8', ',', '9', ']', '.']	[0, 4, 9, 16, 18, 25, 28, 42, 49, 59, 70, 73, 77, 79, 82, 89, 91, 104, 107, 115, 120, 134, 140, 142, 146, 152, 160, 167, 170, 180, 181, 182, 183, 184, 185]	[3, 8, 15, 17, 24, 27, 41, 48, 58, 69, 72, 77, 79, 81, 89, 90, 103, 106, 114, 119, 133, 140, 141, 145, 151, 159, 166, 169, 179, 181, 182, 183, 184, 185, 186]	['ADP', 'also', 'causes', 'a', 'number', 'of', 'intracellular', 'events', 'including', 'inhibition', 'of', 'adenylyl', 'cyclase', ',', 'mobilization', 'of', 'calcium', 'from', 'intracellular', 'stores', ',', 'and', 'rapid', 'calcium', 'influx', 'in', 'platelets', '[', '8', ',', '9', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Platelet cyclooxygenase (cyclooxygenase)-1 generated thromboxane (TX) A2 is the primary prostanoid that stimulates platelet aggregation; its action is counter-balanced by prostaglandin (PG)I2 (prostacyclin), a product of vascular cyclooxygenase.	[('PMC6047792', 'I02006', 9, 23, 'cyclooxygenase'), ('PMC6047792', 'I02006', 25, 39, 'cyclooxygenase'), ('PMC6047792', 'I02006', 230, 244, 'cyclooxygenase')]	['Plate', '##let', 'cyclo', '##oxygenase', '(', 'cyclo', '##oxygenase', ')', '-', '1', 'generated', 'thrombo', '##x', '##ane', '(', 'TX', ')', 'A', '##2', 'is', 'the', 'primary', 'prost', '##ano', '##id', 'that', 'stimulates', 'platelet', 'aggregation', ';', 'its', 'action', 'is', 'counter', '-', 'balanced', 'by', 'prostaglandin', '(', 'PG', ')', 'I', '##2', '(', 'prost', '##acy', '##clin', ')', ',', 'a', 'product', 'of', 'vascular', 'cyclo', '##oxygenase', '.']	[0, 5, 9, 14, 24, 25, 30, 39, 40, 41, 43, 53, 60, 61, 65, 66, 68, 70, 71, 73, 76, 80, 88, 93, 96, 99, 104, 115, 124, 135, 137, 141, 148, 151, 158, 159, 168, 171, 185, 186, 188, 189, 190, 192, 193, 198, 201, 205, 206, 208, 210, 218, 221, 230, 235, 244]	[5, 8, 14, 23, 25, 30, 39, 40, 41, 42, 52, 60, 61, 64, 66, 68, 69, 71, 72, 75, 79, 87, 93, 96, 98, 103, 114, 123, 135, 136, 140, 147, 150, 158, 159, 167, 170, 184, 186, 188, 189, 190, 191, 193, 198, 201, 205, 206, 207, 209, 217, 220, 229, 235, 244, 245]	['Platelet', 'cyclooxygenase', '(cyclooxygenase)-1', 'generated', 'thromboxane', '(', 'TX', ')', 'A2', 'is', 'the', 'primary', 'prostanoid', 'that', 'stimulates', 'platelet', 'aggregation', ';', 'its', 'action', 'is', 'counter', '-', 'balanced', 'by', 'prostaglandin', '(PG)I2', '(', 'prostacyclin', ')', ',', 'a', 'product', 'of', 'vascular', 'cyclooxygenase', '.']	[2, 2, 6, 1, 3, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'B', 'E', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
Prior to GC-MS analysis, the following steps were completed: 1) mixed and vortexed 15μl urine and 10°C L-leucine-13C6 (0.02 mg/ml, internal standard solution); 2) added 15μl urease into the mixed solution to degrade the urea at 37 °C for 60 minutes; 3) extracted the mixture successively using 240I1/4l and 80I1/4l of ice-cold methanol; 4) vortexed the obtained mixture for 30 seconds and then conducted centrifugation (at 4 °C, 14000 rpm x5 minutes); 5) at room temperature, transferred 224ul supernatant into a glass vial for vacuum drying; 6) derivatized the obtained dried metabolic extract using 30μl methoxyamine (20 mg/ml) at 37 °C for 90 minutes; 7) added 30μl of N,O-bis(trimethylsilyl) trifluoroacetamide with 1% trimethylchlorosilane into the obtained dried metabolic extract; 8) heated the mixture at 70 °C for 60 minutes to obtain trimethylsilyl derivatives; 9) after derivatization and cooling to room temperature, added 1.0μl derivative into the GC-MS system.	[('PMC6188484', 'M01003', 174, 180, 'urease')]	['Prior', 'to', 'GC', '-', 'MS', 'analysis', ',', 'the', 'following', 'steps', 'were', 'completed', ':', '1', ')', 'mixed', 'and', 'vortex', '##ed', '15', '##μ', '##l', 'urine', 'and', '10', '##°', '##C', 'L', '-', 'leucine', '-', '13', '##C', '##6', '(', '0', '.', '02', 'mg', '/', 'ml', ',', 'internal', 'standard', 'solution', ')', ';', '2', ')', 'added', '15', '##μ', '##l', 'urea', '##se', 'into', 'the', 'mixed', 'solution', 'to', 'degrade', 'the', 'urea', 'at', '37', '°', '##C', 'for', '60', 'minutes', ';', '3', ')', 'extracted', 'the', 'mixture', 'successively', 'using', '240', '##I', '##1', '/', '4', '##l', 'and', '80', '##I', '##1', '/', '4', '##l', 'of', 'ice', '-', 'cold', 'methanol', ';', '4', ')', 'vortex', '##ed', 'the', 'obtained', 'mixture', 'for', '30', 'seconds', 'and', 'then', 'conducted', 'centrifugation', '(', 'at', '4', '°', '##C', ',', '140', '##00', 'rpm', 'x', '##5', 'minutes', ')', ';', '5', ')', 'at', 'room', 'temperature', ',', 'transferred', '224', '##ul', 'supernatant', 'into', 'a', 'glass', 'via', '##l', 'for', 'vacuum', 'drying', ';', '6', ')', 'deriv', '##atized', 'the', 'obtained', 'dried', 'metabolic', 'extract', 'using', '30', '##μ', '##l', 'meth', '##oxy', '##amine', '(', '20', 'mg', '/', 'ml', ')', 'at', '37', '°', '##C', 'for', '90', 'minutes', ';', '7', ')', 'added', '30', '##μ', '##l', 'of', 'N', ',', 'O', '-', 'bis', '(', 'trim', '##ethyl', '##sil', '##yl', ')', 'tri', '##fluor', '##oa', '##ce', '##ta', '##mid', '##e', 'with', '1', '%', 'trim', '##ethyl', '##chlor', '##osi', '##lane', 'into', 'the', 'obtained', 'dried', 'metabolic', 'extract', ';', '8', ')', 'heated', 'the', 'mixture', 'at', '70', '°', '##C', 'for', '60', 'minutes', 'to', 'obtain', 'trim', '##ethyl', '##sil', '##yl', 'derivatives', ';', '9', ')', 'after', 'deriv', '##atization', 'and', 'cooling', 'to', 'room', 'temperature', ',', 'added', '1', '.', '0', '##μ', '##l', 'derivative', 'into', 'the']	[0, 6, 9, 11, 12, 15, 23, 25, 29, 39, 45, 50, 59, 61, 62, 64, 70, 74, 80, 83, 85, 86, 88, 94, 98, 100, 101, 103, 104, 105, 112, 113, 115, 116, 118, 119, 120, 121, 124, 126, 127, 129, 131, 140, 149, 157, 158, 160, 161, 163, 169, 171, 172, 174, 178, 181, 186, 190, 196, 205, 208, 216, 220, 225, 228, 231, 232, 234, 238, 241, 248, 250, 251, 253, 263, 267, 275, 288, 294, 297, 298, 299, 300, 301, 303, 307, 309, 310, 311, 312, 313, 315, 318, 321, 322, 327, 335, 337, 338, 340, 346, 349, 353, 362, 370, 374, 377, 385, 389, 394, 404, 419, 420, 423, 425, 426, 427, 429, 432, 435, 439, 440, 442, 449, 450, 452, 453, 455, 458, 463, 474, 476, 488, 491, 494, 506, 511, 513, 519, 522, 524, 528, 535, 541, 543, 544, 546, 551, 558, 562, 571, 577, 587, 595, 601, 603, 604, 606, 610, 613, 619, 620, 623, 625, 626, 628, 630, 633, 636, 637, 639, 643, 646, 653, 655, 656, 658, 664, 666, 667, 669, 672, 673, 674, 675, 676, 679, 680, 684, 689, 692, 694, 696, 699, 704, 706, 708, 710, 713, 715, 720, 721, 723, 727, 732, 737, 740, 745, 750, 754, 763, 769, 779, 786, 788, 789, 791, 798, 802, 810, 813, 816, 817, 819, 823, 826, 834, 837, 844, 848, 853, 856, 859, 870, 872, 873, 875, 881, 886, 896, 900, 908, 911, 916, 927, 929, 935, 936, 937, 938, 939, 941, 952, 957]	[5, 8, 11, 12, 14, 23, 24, 28, 38, 44, 49, 59, 60, 62, 63, 69, 73, 80, 82, 85, 86, 87, 93, 97, 100, 101, 102, 104, 105, 112, 113, 115, 116, 117, 119, 120, 121, 123, 126, 127, 129, 130, 139, 148, 157, 158, 159, 161, 162, 168, 171, 172, 173, 178, 180, 185, 189, 195, 204, 207, 215, 219, 224, 227, 230, 232, 233, 237, 240, 248, 249, 251, 252, 262, 266, 274, 287, 293, 297, 298, 299, 300, 301, 302, 306, 309, 310, 311, 312, 313, 314, 317, 321, 322, 326, 335, 336, 338, 339, 346, 348, 352, 361, 369, 373, 376, 384, 388, 393, 403, 418, 420, 422, 424, 426, 427, 428, 432, 434, 438, 440, 441, 449, 450, 451, 453, 454, 457, 462, 474, 475, 487, 491, 493, 505, 510, 512, 518, 522, 523, 527, 534, 541, 542, 544, 545, 551, 557, 561, 570, 576, 586, 594, 600, 603, 604, 605, 610, 613, 618, 620, 622, 625, 626, 628, 629, 632, 635, 637, 638, 642, 645, 653, 654, 656, 657, 663, 666, 667, 668, 671, 673, 674, 675, 676, 679, 680, 684, 689, 692, 694, 695, 699, 704, 706, 708, 710, 713, 714, 719, 721, 722, 727, 732, 737, 740, 744, 749, 753, 762, 768, 778, 786, 787, 789, 790, 797, 801, 809, 812, 815, 817, 818, 822, 825, 833, 836, 843, 848, 853, 856, 858, 870, 871, 873, 874, 880, 886, 895, 899, 907, 910, 915, 927, 928, 934, 936, 937, 938, 939, 940, 951, 956, 960]	['Prior', 'to', 'GC-MS', 'analysis', ',', 'the', 'following', 'steps', 'were', 'completed', ':', '1', ')', 'mixed', 'and', 'vortexed', '15μl', 'urine', 'and', '10°C', 'L-leucine-13C6', '(', '0.02', 'mg', '/', 'ml', ',', 'internal', 'standard', 'solution', ')', ';', '2', ')', 'added', '15μl', 'urease', 'into', 'the', 'mixed', 'solution', 'to', 'degrade', 'the', 'urea', 'at', '37', '°C', 'for', '60', 'minutes', ';', '3', ')', 'extracted', 'the', 'mixture', 'successively', 'using', '240I1', '/', '4l', 'and', '80I1', '/', '4l', 'of', 'ice', '-', 'cold', 'methanol', ';', '4', ')', 'vortexed', 'the', 'obtained', 'mixture', 'for', '30', 'seconds', 'and', 'then', 'conducted', 'centrifugation', '(', 'at', '4', '°C', ',', '14000', 'rpm', 'x5', 'minutes', ')', ';', '5', ')', 'at', 'room', 'temperature', ',', 'transferred', '224ul', 'supernatant', 'into', 'a', 'glass', 'vial', 'for', 'vacuum', 'drying', ';', '6', ')', 'derivatized', 'the', 'obtained', 'dried', 'metabolic', 'extract', 'using', '30μl', 'methoxyamine', '(', '20', 'mg', '/', 'ml', ')', 'at', '37', '°C', 'for', '90', 'minutes', ';', '7', ')', 'added', '30μl', 'of', 'N', ',', 'O-bis(trimethylsilyl)', 'trifluoroacetamide', 'with', '1%', 'trimethylchlorosilane', 'into', 'the', 'obtained', 'dried', 'metabolic', 'extract', ';', '8', ')', 'heated', 'the', 'mixture', 'at', '70', '°C', 'for', '60', 'minutes', 'to', 'obtain', 'trimethylsilyl', 'derivatives', ';', '9', ')', 'after', 'derivatization', 'and', 'cooling', 'to', 'room', 'temperature', ',', 'added', '1.0μl', 'derivative', 'into', 'the']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 3, 7, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 9, 7, 1, 2, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Saiki T.Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease.	[('PMC6403054', 'F11001', 8, 23, 'Myeloperoxidase')]	['Sa', '##iki', 'T', '.', 'My', '##elo', '##per', '##oxidase', 'concentrations', 'in', 'the', 'stool', 'as', 'a', 'new', 'parameter', 'of', 'inflammatory', 'bowel', 'disease', '.']	[0, 2, 6, 7, 8, 10, 13, 16, 24, 39, 42, 46, 52, 55, 57, 61, 71, 74, 87, 93, 100]	[2, 5, 7, 8, 10, 13, 16, 23, 38, 41, 45, 51, 54, 56, 60, 70, 73, 86, 92, 100, 101]	['Saiki', 'T.Myeloperoxidase', 'concentrations', 'in', 'the', 'stool', 'as', 'a', 'new', 'parameter', 'of', 'inflammatory', 'bowel', 'disease', '.']	[2, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The most useful biomarker to date, faecal calprotectin, has been shown to correlate with endoscopic and histopathologic remission with a sensitivity of 85% and specificity of 89%.9 It has been reported to predict relapse for those patients in remission, with both a sensitivity and a specificity of 69%.10 A number of other potential biomarkers have been proposed for UC including C-reactive protein11 levels in serum, along with myeloperoxidase12 and lactoferrin13 levels in faeces.	[('PMC6403054', 'I01000', 430, 445, 'myeloperoxidase')]	['The', 'most', 'useful', 'biomarker', 'to', 'date', ',', 'faecal', 'cal', '##prot', '##ectin', ',', 'has', 'been', 'shown', 'to', 'correlate', 'with', 'endoscopic', 'and', 'histopath', '##ologic', 'remission', 'with', 'a', 'sensitivity', 'of', '85', '%', 'and', 'specificity', 'of', '89', '%', '.', '9', 'It', 'has', 'been', 'reported', 'to', 'predict', 'relapse', 'for', 'those', 'patients', 'in', 'remission', ',', 'with', 'both', 'a', 'sensitivity', 'and', 'a', 'specificity', 'of', '69', '%', '.', '10', 'A', 'number', 'of', 'other', 'potential', 'biomarkers', 'have', 'been', 'proposed', 'for', 'UC', 'including', 'C', '-', 'reactive', 'protein', '##11', 'levels', 'in', 'serum', ',', 'along', 'with', 'myel', '##oper', '##oxidase', '##12', 'and', 'lact', '##of', '##err', '##in', '##13', 'levels', 'in', 'fa', '##eces', '.']	[0, 4, 9, 16, 26, 29, 33, 35, 42, 45, 49, 54, 56, 60, 65, 71, 74, 84, 89, 100, 104, 113, 120, 130, 135, 137, 149, 152, 154, 156, 160, 172, 175, 177, 178, 179, 181, 184, 188, 193, 202, 205, 213, 221, 225, 231, 240, 243, 252, 254, 259, 264, 266, 278, 282, 284, 296, 299, 301, 302, 303, 306, 308, 315, 318, 324, 334, 345, 350, 355, 364, 368, 371, 381, 382, 383, 392, 399, 402, 409, 412, 417, 419, 425, 430, 434, 438, 445, 448, 452, 456, 458, 461, 463, 466, 473, 476, 478, 482]	[3, 8, 15, 25, 28, 33, 34, 41, 45, 49, 54, 55, 59, 64, 70, 73, 83, 88, 99, 103, 113, 119, 129, 134, 136, 148, 151, 154, 155, 159, 171, 174, 177, 178, 179, 180, 183, 187, 192, 201, 204, 212, 220, 224, 230, 239, 242, 252, 253, 258, 263, 265, 277, 281, 283, 295, 298, 301, 302, 303, 305, 307, 314, 317, 323, 333, 344, 349, 354, 363, 367, 370, 380, 382, 383, 391, 399, 401, 408, 411, 417, 418, 424, 429, 434, 438, 445, 447, 451, 456, 458, 461, 463, 465, 472, 475, 478, 482, 483]	['The', 'most', 'useful', 'biomarker', 'to', 'date', ',', 'faecal', 'calprotectin', ',', 'has', 'been', 'shown', 'to', 'correlate', 'with', 'endoscopic', 'and', 'histopathologic', 'remission', 'with', 'a', 'sensitivity', 'of', '85%', 'and', 'specificity', 'of', '89%.9', 'It', 'has', 'been', 'reported', 'to', 'predict', 'relapse', 'for', 'those', 'patients', 'in', 'remission', ',', 'with', 'both', 'a', 'sensitivity', 'and', 'a', 'specificity', 'of', '69%.10', 'A', 'number', 'of', 'other', 'potential', 'biomarkers', 'have', 'been', 'proposed', 'for', 'UC', 'including', 'C-reactive', 'protein11', 'levels', 'in', 'serum', ',', 'along', 'with', 'myeloperoxidase12', 'and', 'lactoferrin13', 'levels', 'in', 'faeces', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PC is synthesized by the Kennedy or CDP-choline pathway, whereas PE is synthesized via the CDP-ethanolamine and phosphatidylserine decarboxylase pathways.	[('PMC6432873', 'D01004', 112, 144, 'phosphatidylserine decarboxylase')]	['PC', 'is', 'synthesized', 'by', 'the', 'Kennedy', 'or', 'CD', '##P', '-', 'choline', 'pathway', ',', 'whereas', 'PE', 'is', 'synthesized', 'via', 'the', 'CD', '##P', '-', 'ethanol', '##amine', 'and', 'phosphatidyl', '##ser', '##ine', 'dec', '##arboxyl', '##ase', 'pathways', '.']	[0, 3, 6, 18, 21, 25, 33, 36, 38, 39, 40, 48, 55, 57, 65, 68, 71, 83, 87, 91, 93, 94, 95, 102, 108, 112, 124, 127, 131, 134, 141, 145, 153]	[2, 5, 17, 20, 24, 32, 35, 38, 39, 40, 47, 55, 56, 64, 67, 70, 82, 86, 90, 93, 94, 95, 102, 107, 111, 124, 127, 130, 134, 141, 144, 153, 154]	['PC', 'is', 'synthesized', 'by', 'the', 'Kennedy', 'or', 'CDP-choline', 'pathway', ',', 'whereas', 'PE', 'is', 'synthesized', 'via', 'the', 'CDP-ethanolamine', 'and', 'phosphatidylserine', 'decarboxylase', 'pathways', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 3, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Additionally, approximately 30% of PC is biosynthesized by PE under phosphatidylethanolamine N-methyltransferase (phosphatidylethanolamine N-methyltransferase) catalysis in the liver (19).	[('PMC6432873', 'D01005', 68, 112, 'phosphatidylethanolamine N-methyltransferase'), ('PMC6432873', 'D01005', 114, 158, 'phosphatidylethanolamine N-methyltransferase')]	['Additionally', ',', 'approximately', '30', '%', 'of', 'PC', 'is', 'bios', '##yn', '##the', '##sized', 'by', 'PE', 'under', 'phosphatidyl', '##ethanol', '##amine', 'N', '-', 'methyl', '##transferase', '(', 'phosphatidyl', '##ethanol', '##amine', 'N', '-', 'methyl', '##transferase', ')', 'catalysis', 'in', 'the', 'liver', '(', '19', ')', '.']	[0, 12, 14, 28, 30, 32, 35, 38, 41, 45, 47, 50, 56, 59, 62, 68, 80, 87, 93, 94, 95, 101, 113, 114, 126, 133, 139, 140, 141, 147, 158, 160, 170, 173, 177, 183, 184, 186, 187]	[12, 13, 27, 30, 31, 34, 37, 40, 45, 47, 50, 55, 58, 61, 67, 80, 87, 92, 94, 95, 101, 112, 114, 126, 133, 138, 140, 141, 147, 158, 159, 169, 172, 176, 182, 184, 186, 187, 188]	['Additionally', ',', 'approximately', '30%', 'of', 'PC', 'is', 'biosynthesized', 'by', 'PE', 'under', 'phosphatidylethanolamine', 'N-methyltransferase', '(', 'phosphatidylethanolamine', 'N-methyltransferase', ')', 'catalysis', 'in', 'the', 'liver', '(', '19', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 3, 4, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Skeletal muscle undergoes remodeling in response to exercise (22), and in particular, unbalanced PC and PE synthesis can regulate muscle insulin sensitivity by choline/ethanolamine phosphotransferase 1 as the terminal enzyme in the Kennedy pathway of phospholipid synthesis (23, 24).	[('PMC6432873', 'D01008', 160, 201, 'choline/ethanolamine phosphotransferase 1')]	['Sk', '##ele', '##tal', 'muscle', 'undergoes', 'remodeling', 'in', 'response', 'to', 'exercise', '(', '22', ')', ',', 'and', 'in', 'particular', ',', 'unbalanced', 'PC', 'and', 'PE', 'synthesis', 'can', 'regulate', 'muscle', 'insulin', 'sensitivity', 'by', 'choline', '/', 'ethanol', '##amine', 'phospho', '##transferase', '1', 'as', 'the', 'terminal', 'enzyme', 'in', 'the', 'Kennedy', 'pathway', 'of', 'phospholipid', 'synthesis', '(', '23', ',', '24', ')', '.']	[0, 2, 5, 9, 16, 26, 37, 40, 49, 52, 61, 62, 64, 65, 67, 71, 74, 84, 86, 97, 100, 104, 107, 117, 121, 130, 137, 145, 157, 160, 167, 168, 175, 181, 188, 200, 202, 205, 209, 218, 225, 228, 232, 240, 248, 251, 264, 274, 275, 277, 279, 281, 282]	[2, 5, 8, 15, 25, 36, 39, 48, 51, 60, 62, 64, 65, 66, 70, 73, 84, 85, 96, 99, 103, 106, 116, 120, 129, 136, 144, 156, 159, 167, 168, 175, 180, 188, 199, 201, 204, 208, 217, 224, 227, 231, 239, 247, 250, 263, 273, 275, 277, 278, 281, 282, 283]	['Skeletal', 'muscle', 'undergoes', 'remodeling', 'in', 'response', 'to', 'exercise', '(', '22', ')', ',', 'and', 'in', 'particular', ',', 'unbalanced', 'PC', 'and', 'PE', 'synthesis', 'can', 'regulate', 'muscle', 'insulin', 'sensitivity', 'by', 'choline', '/', 'ethanolamine', 'phosphotransferase', '1', 'as', 'the', 'terminal', 'enzyme', 'in', 'the', 'Kennedy', 'pathway', 'of', 'phospholipid', 'synthesis', '(', '23', ',', '24', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, lifestyle-induced weight loss resulted in a lower serum ceramide concentration (32), which led to significant alterations in the regulation of ceramide biosynthesis genes in the liver, especially CER (ceramide synthase) and SPTLC (serine palmitoyltransferase) expression (33).	[('PMC6432873', 'D02005', 211, 228, 'ceramide synthase'), ('PMC6432873', 'D02005', 241, 268, 'serine palmitoyltransferase')]	['Moreover', ',', 'lifestyle', '-', 'induced', 'weight', 'loss', 'resulted', 'in', 'a', 'lower', 'serum', 'cer', '##amide', 'concentration', '(', '32', ')', ',', 'which', 'led', 'to', 'significant', 'alterations', 'in', 'the', 'regulation', 'of', 'cer', '##amide', 'biosynthesis', 'genes', 'in', 'the', 'liver', ',', 'especially', 'CER', '(', 'cer', '##amide', 'synthase', ')', 'and', 'SP', '##TL', '##C', '(', 'serine', 'palm', '##ito', '##yl', '##transferase', ')', 'expression', '(', '33', ')', '.']	[0, 8, 10, 19, 20, 28, 35, 40, 49, 52, 54, 60, 66, 69, 75, 89, 90, 92, 93, 95, 101, 105, 108, 120, 132, 135, 139, 150, 153, 156, 162, 175, 181, 184, 188, 193, 195, 206, 210, 211, 214, 220, 228, 230, 234, 236, 238, 240, 241, 248, 252, 255, 257, 268, 270, 281, 282, 284, 285]	[8, 9, 19, 20, 27, 34, 39, 48, 51, 53, 59, 65, 69, 74, 88, 90, 92, 93, 94, 100, 104, 107, 119, 131, 134, 138, 149, 152, 156, 161, 174, 180, 183, 187, 193, 194, 205, 209, 211, 214, 219, 228, 229, 233, 236, 238, 239, 241, 247, 252, 255, 257, 268, 269, 280, 282, 284, 285, 286]	['Moreover', ',', 'lifestyle', '-', 'induced', 'weight', 'loss', 'resulted', 'in', 'a', 'lower', 'serum', 'ceramide', 'concentration', '(', '32', ')', ',', 'which', 'led', 'to', 'significant', 'alterations', 'in', 'the', 'regulation', 'of', 'ceramide', 'biosynthesis', 'genes', 'in', 'the', 'liver', ',', 'especially', 'CER', '(', 'ceramide', 'synthase', ')', 'and', 'SPTLC', '(', 'serine', 'palmitoyltransferase', ')', 'expression', '(', '33', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Polymerase matters: Non‐proofreading enzymes inflate fungal community richness estimates by up to 15%.	[('PMC6436432', 'F42001', 0, 10, 'Polymerase')]	['Polymer', '##ase', 'matters', ':', 'Non', '‐', 'proof', '##reading', 'enzymes', 'infl', '##ate', 'fungal', 'community', 'richness', 'estimates', 'by', 'up', 'to', '15', '%', '.']	[0, 7, 11, 18, 20, 23, 24, 29, 37, 45, 49, 53, 60, 70, 79, 89, 92, 95, 98, 100, 101]	[7, 10, 18, 19, 23, 24, 29, 36, 44, 49, 52, 59, 69, 78, 88, 91, 94, 97, 100, 101, 102]	['Polymerase', 'matters', ':', 'Non', '‐', 'proofreading', 'enzymes', 'inflate', 'fungal', 'community', 'richness', 'estimates', 'by', 'up', 'to', '15%', '.']	[2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Primary PCR was carried out in a reaction mixture (reaction volume 50 μl) consisting of 1 μl each of 10 mmol/L deoxynucleotide triphosphates (dNTPs; Thermo scientific, MA, USA), 5 μl forward primer pA_Illum_FP (10 μmol/L; ATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAGAGTTTGATCMTGGCTCAG) and 5 μl reverse primer pD′_Illum_RP (10 μmol/L; GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGTATTACCGCGGCTGCTG), 0.5 μl 2 U/μl Phusion Green Hot Start II High‐Fidelity DNA polymerase (Thermo scientific, MA, USA), 10 μl 5× Green HF PCR buffer (F‐537), 5 μl template DNA, and 23.5 μl sterile water.	[('PMC6436432', 'M07002', 440, 454, 'DNA polymerase')]	['Primary', 'PCR', 'was', 'carried', 'out', 'in', 'a', 'reaction', 'mixture', '(', 'reaction', 'volume', '50', 'μ', '##l', ')', 'consisting', 'of', '1', 'μ', '##l', 'each', 'of', '10', 'mmol', '/', 'L', 'deoxy', '##nucle', '##otide', 'trip', '##ho', '##sp', '##hat', '##es', '(', 'd', '##NT', '##Ps', ';', 'Thermo', 'scientific', ',', 'MA', ',', 'USA', ')', ',', '5', 'μ', '##l', 'forward', 'primer', 'pA', '_', 'Ill', '##um', '_', 'FP', '(', '10', 'μ', '##mol', '/', 'L', ';', 'AT', '##CTA', '##CAC', '##TC', '##TT', '##TC', '##CC', '##TA', '##CAC', '##GA', '##CG', '##CTC', '##TT', '##CCG', '##ATC', '##TA', '##GA', '##GTT', '##TG', '##ATC', '##MT', '##GG', '##CTC', '##AG', ')', 'and', '5', 'μ', '##l', 'reverse', 'primer', 'p', '##D', '′', '_', 'Ill', '##um', '_', 'RP', '(', '10', 'μ', '##mol', '/', 'L', ';', 'GT', '##GA', '##CTG', '##GA', '##GTT', '##CAG', '##ACG', '##TG', '##TG', '##CTC', '##TT', '##CCG', '##ATC', '##TG', '##TA', '##TT', '##ACC', '##GC', '##GG', '##CTG', '##CTG', ')', ',', '0', '.', '5', 'μ', '##l', '2', 'U', '/', 'μ', '##l', 'Ph', '##usion', 'Green', 'Hot', 'Start', 'II', 'High', '‐', 'Fi', '##del', '##ity', 'DNA', 'polymerase', '(', 'Thermo', 'scientific', ',', 'MA', ',', 'USA', ')', ',', '10', 'μ', '##l', '5', '##×', 'Green', 'HF', 'PCR', 'buffer', '(', 'F', '‐', '53', '##7', ')', ',', '5', 'μ', '##l', 'template', 'DNA', ',', 'and', '23', '.', '5', 'μ', '##l', 'sterile', 'water', '.']	[0, 8, 12, 16, 24, 28, 31, 33, 42, 50, 51, 60, 67, 70, 71, 72, 74, 85, 88, 90, 91, 93, 98, 101, 104, 108, 109, 111, 116, 121, 127, 131, 133, 135, 138, 141, 142, 143, 145, 147, 149, 156, 166, 168, 170, 172, 175, 176, 178, 180, 181, 183, 191, 198, 200, 201, 204, 206, 207, 210, 211, 214, 215, 218, 219, 220, 222, 224, 227, 230, 232, 234, 236, 238, 240, 243, 245, 247, 250, 252, 255, 258, 260, 262, 265, 267, 270, 272, 274, 277, 279, 281, 285, 287, 288, 290, 298, 305, 306, 307, 308, 309, 312, 314, 315, 318, 319, 322, 323, 326, 327, 328, 330, 332, 334, 337, 339, 342, 345, 348, 350, 352, 355, 357, 360, 363, 365, 367, 369, 372, 374, 376, 379, 382, 383, 385, 386, 387, 389, 390, 392, 394, 395, 396, 397, 399, 401, 407, 413, 417, 423, 426, 430, 431, 433, 436, 440, 444, 455, 456, 463, 473, 475, 477, 479, 482, 483, 485, 488, 489, 491, 492, 494, 500, 503, 507, 514, 515, 516, 517, 519, 520, 521, 523, 525, 526, 528, 537, 540, 542, 546, 548, 549, 551, 552, 554, 562, 567]	[7, 11, 15, 23, 27, 30, 32, 41, 49, 51, 59, 66, 69, 71, 72, 73, 84, 87, 89, 91, 92, 97, 100, 103, 108, 109, 110, 116, 121, 126, 131, 133, 135, 138, 140, 142, 143, 145, 147, 148, 155, 166, 167, 170, 171, 175, 176, 177, 179, 181, 182, 190, 197, 200, 201, 204, 206, 207, 209, 211, 213, 215, 218, 219, 220, 221, 224, 227, 230, 232, 234, 236, 238, 240, 243, 245, 247, 250, 252, 255, 258, 260, 262, 265, 267, 270, 272, 274, 277, 279, 280, 284, 286, 288, 289, 297, 304, 306, 307, 308, 309, 312, 314, 315, 317, 319, 321, 323, 326, 327, 328, 329, 332, 334, 337, 339, 342, 345, 348, 350, 352, 355, 357, 360, 363, 365, 367, 369, 372, 374, 376, 379, 382, 383, 384, 386, 387, 388, 390, 391, 393, 395, 396, 397, 398, 401, 406, 412, 416, 422, 425, 430, 431, 433, 436, 439, 443, 454, 456, 462, 473, 474, 477, 478, 482, 483, 484, 487, 489, 490, 492, 493, 499, 502, 506, 513, 515, 516, 517, 519, 520, 521, 522, 524, 526, 527, 536, 540, 541, 545, 548, 549, 550, 552, 553, 561, 567, 568]	['Primary', 'PCR', 'was', 'carried', 'out', 'in', 'a', 'reaction', 'mixture', '(', 'reaction', 'volume', '50', 'μl', ')', 'consisting', 'of', '1', 'μl', 'each', 'of', '10', 'mmol', '/', 'L', 'deoxynucleotide', 'triphosphates', '(', 'dNTPs', ';', 'Thermo', 'scientific', ',', 'MA', ',', 'USA', ')', ',', '5', 'μl', 'forward', 'primer', 'pA_Illum_FP', '(', '10', 'μmol', '/', 'L', ';', 'ATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAGAGTTTGATCMTGGCTCAG', ')', 'and', '5', 'μl', 'reverse', 'primer', 'pD′_Illum_RP', '(', '10', 'μmol', '/', 'L', ';', 'GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGTATTACCGCGGCTGCTG', ')', ',', '0.5', 'μl', '2', 'U', '/', 'μl', 'Phusion', 'Green', 'Hot', 'Start', 'II', 'High‐Fidelity', 'DNA', 'polymerase', '(', 'Thermo', 'scientific', ',', 'MA', ',', 'USA', ')', ',', '10', 'μl', '5×', 'Green', 'HF', 'PCR', 'buffer', '(', 'F‐537', ')', ',', '5', 'μl', 'template', 'DNA', ',', 'and', '23.5', 'μl', 'sterile', 'water', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 6, 1, 1, 2, 1, 1, 1, 24, 1, 1, 1, 2, 1, 1, 8, 1, 1, 2, 1, 1, 1, 21, 1, 1, 3, 2, 1, 1, 1, 2, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 3, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Primary PCR was carried out in a reaction mixture (reaction volume 50 μl) consisting of 1 μl each of 10 mmol/L dNTPs (Thermo scientific, MA, USA) 5 μl forward primer 505F (10 μmol/L; 5′–GTGCCAGCMGCCGCGGTAA‐3′) and 5 μl reverse primer 806R (10 μmol/L; 5′–GGACTACHVGGGTWTCTAAT‐3′), 0.5 μl 2 U/μl Phusion Green Hot Start II High‐Fidelity DNA polymerase (Thermo scientific, MA, USA), 10 μl 5× Green HF PCR buffer (F‐537), 5 μl template DNA and 23.5 μl sterile water.	[('PMC6436432', 'M08001', 335, 349, 'DNA polymerase')]	['Primary', 'PCR', 'was', 'carried', 'out', 'in', 'a', 'reaction', 'mixture', '(', 'reaction', 'volume', '50', 'μ', '##l', ')', 'consisting', 'of', '1', 'μ', '##l', 'each', 'of', '10', 'mmol', '/', 'L', 'd', '##NT', '##Ps', '(', 'Thermo', 'scientific', ',', 'MA', ',', 'USA', ')', '5', 'μ', '##l', 'forward', 'primer', '50', '##5', '##F', '(', '10', 'μ', '##mol', '/', 'L', ';', '5', '′', '–', 'GT', '##GC', '##CAG', '##CM', '##GC', '##CG', '##CGG', '##TA', '##A', '‐', '3', '′', ')', 'and', '5', 'μ', '##l', 'reverse', 'primer', '80', '##6', '##R', '(', '10', 'μ', '##mol', '/', 'L', ';', '5', '′', '–', 'GG', '##ACT', '##ACH', '##V', '##GGG', '##T', '##WT', '##CTA', '##AT', '‐', '3', '′', ')', ',', '0', '.', '5', 'μ', '##l', '2', 'U', '/', 'μ', '##l', 'Ph', '##usion', 'Green', 'Hot', 'Start', 'II', 'High', '‐', 'Fi', '##del', '##ity', 'DNA', 'polymerase', '(', 'Thermo', 'scientific', ',', 'MA', ',', 'USA', ')', ',', '10', 'μ', '##l', '5', '##×', 'Green', 'HF', 'PCR', 'buffer', '(', 'F', '‐', '53', '##7', ')', ',', '5', 'μ', '##l', 'template', 'DNA', 'and', '23', '.', '5', 'μ', '##l', 'sterile', 'water', '.']	[0, 8, 12, 16, 24, 28, 31, 33, 42, 50, 51, 60, 67, 70, 71, 72, 74, 85, 88, 90, 91, 93, 98, 101, 104, 108, 109, 111, 112, 114, 117, 118, 125, 135, 137, 139, 141, 144, 146, 148, 149, 151, 159, 166, 168, 169, 171, 172, 175, 176, 179, 180, 181, 183, 184, 185, 186, 188, 190, 193, 195, 197, 199, 202, 204, 205, 206, 207, 208, 210, 214, 216, 217, 219, 227, 234, 236, 237, 239, 240, 243, 244, 247, 248, 249, 251, 252, 253, 254, 256, 259, 262, 263, 266, 267, 269, 272, 274, 275, 276, 277, 278, 280, 281, 282, 284, 285, 287, 289, 290, 291, 292, 294, 296, 302, 308, 312, 318, 321, 325, 326, 328, 331, 335, 339, 350, 351, 358, 368, 370, 372, 374, 377, 378, 380, 383, 384, 386, 387, 389, 395, 398, 402, 409, 410, 411, 412, 414, 415, 416, 418, 420, 421, 423, 432, 436, 440, 442, 443, 445, 446, 448, 456, 461]	[7, 11, 15, 23, 27, 30, 32, 41, 49, 51, 59, 66, 69, 71, 72, 73, 84, 87, 89, 91, 92, 97, 100, 103, 108, 109, 110, 112, 114, 116, 118, 124, 135, 136, 139, 140, 144, 145, 147, 149, 150, 158, 165, 168, 169, 170, 172, 174, 176, 179, 180, 181, 182, 184, 185, 186, 188, 190, 193, 195, 197, 199, 202, 204, 205, 206, 207, 208, 209, 213, 215, 217, 218, 226, 233, 236, 237, 238, 240, 242, 244, 247, 248, 249, 250, 252, 253, 254, 256, 259, 262, 263, 266, 267, 269, 272, 274, 275, 276, 277, 278, 279, 281, 282, 283, 285, 286, 288, 290, 291, 292, 293, 296, 301, 307, 311, 317, 320, 325, 326, 328, 331, 334, 338, 349, 351, 357, 368, 369, 372, 373, 377, 378, 379, 382, 384, 385, 387, 388, 394, 397, 401, 408, 410, 411, 412, 414, 415, 416, 417, 419, 421, 422, 431, 435, 439, 442, 443, 444, 446, 447, 455, 461, 462]	['Primary', 'PCR', 'was', 'carried', 'out', 'in', 'a', 'reaction', 'mixture', '(', 'reaction', 'volume', '50', 'μl', ')', 'consisting', 'of', '1', 'μl', 'each', 'of', '10', 'mmol', '/', 'L', 'dNTPs', '(', 'Thermo', 'scientific', ',', 'MA', ',', 'USA', ')', '5', 'μl', 'forward', 'primer', '505F', '(', '10', 'μmol', '/', 'L', ';', '5′–', 'GTGCCAGCMGCCGCGGTAA‐3′', ')', 'and', '5', 'μl', 'reverse', 'primer', '806R', '(', '10', 'μmol', '/', 'L', ';', '5′–', 'GGACTACHVGGGTWTCTAAT‐3′', ')', ',', '0.5', 'μl', '2', 'U', '/', 'μl', 'Phusion', 'Green', 'Hot', 'Start', 'II', 'High‐Fidelity', 'DNA', 'polymerase', '(', 'Thermo', 'scientific', ',', 'MA', ',', 'USA', ')', ',', '10', 'μl', '5×', 'Green', 'HF', 'PCR', 'buffer', '(', 'F‐537', ')', ',', '5', 'μl', 'template', 'DNA', 'and', '23.5', 'μl', 'sterile', 'water', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 12, 1, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 12, 1, 1, 3, 2, 1, 1, 1, 2, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 3, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, they were harbored within more genes associated with carbohydrate metabolism: eight SNPs were located in seven carbohydrate metabolism genes including those encoding β-galactosidase, α-N-arabinofuranosidase, α-1, 2-mannosidase, rhamnulokinase, Rhamnogalacturonides degradation protein, β-galactosidase and D-lactate dehydrogenase (Table S9).	[('PMC6456665', 'R07001', 181, 196, 'β-galactosidase'), ('PMC6456665', 'R07001', 198, 221, 'α-N-arabinofuranosidase'), ('PMC6456665', 'R07001', 223, 241, 'α-1, 2-mannosidase'), ('PMC6456665', 'R07001', 243, 257, 'rhamnulokinase'), ('PMC6456665', 'R07001', 301, 316, 'β-galactosidase'), ('PMC6456665', 'R07001', 321, 344, 'D-lactate dehydrogenase')]	['Interestingly', ',', 'they', 'were', 'harbor', '##ed', 'within', 'more', 'genes', 'associated', 'with', 'carbohydrate', 'metabolism', ':', 'eight', 'SNPs', 'were', 'located', 'in', 'seven', 'carbohydrate', 'metabolism', 'genes', 'including', 'those', 'encoding', 'β', '-', 'galact', '##osidase', ',', 'α', '-', 'N', '-', 'ar', '##abin', '##of', '##uran', '##osidase', ',', 'α', '-', '1', ',', '2', '-', 'mann', '##osidase', ',', 'rh', '##am', '##nu', '##lo', '##kinase', ',', 'Rh', '##am', '##no', '##galact', '##uron', '##ides', 'degradation', 'protein', ',', 'β', '-', 'galact', '##osidase', 'and', 'D', '-', 'lactate', 'dehydrogenase', '(', 'Table', 'S', '##9', ')', '.']	[0, 13, 15, 20, 25, 31, 34, 41, 46, 52, 63, 68, 81, 91, 93, 99, 104, 109, 117, 120, 126, 139, 150, 156, 166, 172, 181, 182, 183, 189, 196, 198, 199, 200, 201, 202, 204, 208, 210, 214, 221, 223, 224, 225, 226, 228, 229, 230, 234, 241, 243, 245, 247, 249, 251, 257, 259, 261, 263, 265, 271, 275, 280, 292, 299, 301, 302, 303, 309, 317, 321, 322, 323, 331, 345, 346, 352, 353, 354, 355]	[13, 14, 19, 24, 31, 33, 40, 45, 51, 62, 67, 80, 91, 92, 98, 103, 108, 116, 119, 125, 138, 149, 155, 165, 171, 180, 182, 183, 189, 196, 197, 199, 200, 201, 202, 204, 208, 210, 214, 221, 222, 224, 225, 226, 227, 229, 230, 234, 241, 242, 245, 247, 249, 251, 257, 258, 261, 263, 265, 271, 275, 279, 291, 299, 300, 302, 303, 309, 316, 320, 322, 323, 330, 344, 346, 351, 353, 354, 355, 356]	['Interestingly', ',', 'they', 'were', 'harbored', 'within', 'more', 'genes', 'associated', 'with', 'carbohydrate', 'metabolism', ':', 'eight', 'SNPs', 'were', 'located', 'in', 'seven', 'carbohydrate', 'metabolism', 'genes', 'including', 'those', 'encoding', 'β-galactosidase', ',', 'α-N-arabinofuranosidase', ',', 'α-1', ',', '2-mannosidase', ',', 'rhamnulokinase', ',', 'Rhamnogalacturonides', 'degradation', 'protein', ',', 'β-galactosidase', 'and', 'D-lactate', 'dehydrogenase', '(', 'Table', 'S9', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 9, 1, 3, 1, 4, 1, 5, 1, 6, 1, 1, 1, 4, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
For participants with GPA, a detailed disease history was obtained including antineutrophil cytoplasmic antibody (ANCA) type by ELISA (proteinase-3 [PR3], myeloperoxidase [MPO], or negative), disease status determined by the Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis20 (BVAS/WG; BVAS/WG > 0 indicates active disease and BVAS/WG = 0 indicates disease remission), and sinonasal damage according to the ear, nose, and throat items on the Vasculitis Damage Index (VDI)21.	[('PMC6463278', 'M02001', 135, 147, 'proteinase-3'), ('PMC6463278', 'M02001', 155, 170, 'myeloperoxidase')]	['For', 'participants', 'with', 'GP', '##A', ',', 'a', 'detailed', 'disease', 'history', 'was', 'obtained', 'including', 'anti', '##neu', '##troph', '##il', 'cytoplasmic', 'antibody', '(', 'AN', '##CA', ')', 'type', 'by', 'ELISA', '(', 'protein', '##ase', '-', '3', '[', 'PR', '##3', ']', ',', 'myel', '##oper', '##oxidase', '[', 'MP', '##O', ']', ',', 'or', 'negative', ')', ',', 'disease', 'status', 'determined', 'by', 'the', 'Bir', '##ming', '##ham', 'Vas', '##cul', '##itis', 'Activity', 'Score', 'for', 'We', '##gener', '’', 's', 'Gran', '##ulo', '##mat', '##osis', '##20', '(', 'BV', '##AS', '/', 'WG', ';', 'BV', '##AS', '/', 'WG', '>', '0', 'indicates', 'active', 'disease', 'and', 'BV', '##AS', '/', 'WG', '=', '0', 'indicates', 'disease', 'remission', ')', ',', 'and', 'sin', '##ona', '##sal', 'damage', 'according', 'to', 'the', 'ear', ',', 'nose', ',', 'and', 'thro', '##at', 'items', 'on', 'the', 'Vas', '##cul', '##itis', 'Dam', '##age', 'Index', '(', 'VD', '##I', ')', '21', '.']	[0, 4, 17, 22, 24, 25, 27, 29, 38, 46, 54, 58, 67, 77, 81, 84, 89, 92, 104, 113, 114, 116, 118, 120, 125, 128, 134, 135, 142, 145, 146, 148, 149, 151, 152, 153, 155, 159, 163, 171, 172, 174, 175, 176, 178, 181, 189, 190, 192, 200, 207, 218, 221, 225, 228, 232, 236, 239, 242, 247, 256, 262, 266, 268, 273, 274, 276, 280, 283, 286, 290, 293, 294, 296, 298, 299, 301, 303, 305, 307, 308, 311, 313, 315, 325, 332, 340, 344, 346, 348, 349, 352, 354, 356, 366, 374, 383, 384, 386, 390, 393, 396, 400, 407, 417, 420, 424, 427, 429, 433, 435, 439, 443, 446, 452, 455, 459, 462, 465, 470, 473, 477, 483, 484, 486, 487, 488, 490]	[3, 16, 21, 24, 25, 26, 28, 37, 45, 53, 57, 66, 76, 81, 84, 89, 91, 103, 112, 114, 116, 118, 119, 124, 127, 133, 135, 142, 145, 146, 147, 149, 151, 152, 153, 154, 159, 163, 170, 172, 174, 175, 176, 177, 180, 189, 190, 191, 199, 206, 217, 220, 224, 228, 232, 235, 239, 242, 246, 255, 261, 265, 268, 273, 274, 275, 280, 283, 286, 290, 292, 294, 296, 298, 299, 301, 302, 305, 307, 308, 310, 312, 314, 324, 331, 339, 343, 346, 348, 349, 351, 353, 355, 365, 373, 383, 384, 385, 389, 393, 396, 399, 406, 416, 419, 423, 427, 428, 433, 434, 438, 443, 445, 451, 454, 458, 462, 465, 469, 473, 476, 482, 484, 486, 487, 488, 490, 491]	['For', 'participants', 'with', 'GPA', ',', 'a', 'detailed', 'disease', 'history', 'was', 'obtained', 'including', 'antineutrophil', 'cytoplasmic', 'antibody', '(', 'ANCA', ')', 'type', 'by', 'ELISA', '(', 'proteinase-3', '[', 'PR3', ']', ',', 'myeloperoxidase', '[', 'MPO', ']', ',', 'or', 'negative', ')', ',', 'disease', 'status', 'determined', 'by', 'the', 'Birmingham', 'Vasculitis', 'Activity', 'Score', 'for', 'Wegener’s', 'Granulomatosis20', '(', 'BVAS', '/', 'WG', ';', 'BVAS', '/', 'WG', '>', '0', 'indicates', 'active', 'disease', 'and', 'BVAS', '/', 'WG', '=', '0', 'indicates', 'disease', 'remission', ')', ',', 'and', 'sinonasal', 'damage', 'according', 'to', 'the', 'ear', ',', 'nose', ',', 'and', 'throat', 'items', 'on', 'the', 'Vasculitis', 'Damage', 'Index', '(VDI)21', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 4, 5, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 2, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For laboratory studies, differences were mainly generated from classical tumor markers between healthy controls and lung cancer patients, such as carbohydrate antigens, cytokeratin, carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen.	[('PMC6482867', 'R00002', 224, 231, 'enolase')]	['For', 'laboratory', 'studies', ',', 'differences', 'were', 'mainly', 'generated', 'from', 'classical', 'tumor', 'markers', 'between', 'healthy', 'controls', 'and', 'lung', 'cancer', 'patients', ',', 'such', 'as', 'carbohydrate', 'antigens', ',', 'cytok', '##era', '##tin', ',', 'carcin', '##oe', '##mb', '##ry', '##onic', 'antigen', ',', 'neuron', '-', 'specific', 'en', '##olas', '##e', 'and', 'squamous', 'cell', 'carcinoma', 'antigen', '.']	[0, 4, 15, 22, 24, 36, 41, 48, 58, 63, 73, 79, 87, 95, 103, 112, 116, 121, 128, 136, 138, 143, 146, 159, 167, 169, 174, 177, 180, 182, 188, 190, 192, 194, 199, 206, 208, 214, 215, 224, 226, 230, 232, 236, 245, 250, 260, 267]	[3, 14, 22, 23, 35, 40, 47, 57, 62, 72, 78, 86, 94, 102, 111, 115, 120, 127, 136, 137, 142, 145, 158, 167, 168, 174, 177, 180, 181, 188, 190, 192, 194, 198, 206, 207, 214, 215, 223, 226, 230, 231, 235, 244, 249, 259, 267, 268]	['For', 'laboratory', 'studies', ',', 'differences', 'were', 'mainly', 'generated', 'from', 'classical', 'tumor', 'markers', 'between', 'healthy', 'controls', 'and', 'lung', 'cancer', 'patients', ',', 'such', 'as', 'carbohydrate', 'antigens', ',', 'cytokeratin', ',', 'carcinoembryonic', 'antigen', ',', 'neuron', '-', 'specific', 'enolase', 'and', 'squamous', 'cell', 'carcinoma', 'antigen', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 5, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Results: A panel of differentially expressed serum proteins was identified, including proteins involved in the regulation of the cell cycle [e.g. cell division cycle 7-related protein kinase (CDC7)], in mitochondrial function [e.g. mitochondrial aldehyde dehydrogenase (ALDH2) and dimethyladenosine transferase 1 (TFB1M)], in lipid metabolism and transport [	[('PMC6489687', 'A00002', 176, 190, 'protein kinase'), ('PMC6489687', 'A00002', 246, 268, 'aldehyde dehydrogenase'), ('PMC6489687', 'A00002', 281, 312, 'dimethyladenosine transferase 1')]	['Results', ':', 'A', 'panel', 'of', 'differentially', 'expressed', 'serum', 'proteins', 'was', 'identified', ',', 'including', 'proteins', 'involved', 'in', 'the', 'regulation', 'of', 'the', 'cell', 'cycle', '[', 'e', '.', 'g', '.', 'cell', 'division', 'cycle', '7', '-', 'related', 'protein', 'kinase', '(', 'CDC', '##7', ')', ']', ',', 'in', 'mitochondrial', 'function', '[', 'e', '.', 'g', '.', 'mitochondrial', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', '(', 'AL', '##DH', '##2', ')', 'and', 'dimethyl', '##aden', '##osine', 'transfer', '##ase', '1', '(', 'TF', '##B', '##1', '##M', ')', ']', ',', 'in', 'lipid', 'metabolism', 'and', 'transport', '[']	[0, 7, 9, 11, 17, 20, 35, 45, 51, 60, 64, 74, 76, 86, 95, 104, 107, 111, 122, 125, 129, 134, 140, 141, 142, 143, 144, 146, 151, 160, 166, 167, 168, 176, 184, 191, 192, 195, 196, 197, 198, 200, 203, 217, 226, 227, 228, 229, 230, 232, 246, 249, 251, 253, 255, 269, 270, 272, 274, 275, 277, 281, 289, 293, 299, 307, 311, 313, 314, 316, 317, 318, 319, 320, 321, 323, 326, 332, 343, 347, 357]	[7, 8, 10, 16, 19, 34, 44, 50, 59, 63, 74, 75, 85, 94, 103, 106, 110, 121, 124, 128, 133, 139, 141, 142, 143, 144, 145, 150, 159, 165, 167, 168, 175, 183, 190, 192, 195, 196, 197, 198, 199, 202, 216, 225, 227, 228, 229, 230, 231, 245, 249, 251, 253, 254, 268, 270, 272, 274, 275, 276, 280, 289, 293, 298, 307, 310, 312, 314, 316, 317, 318, 319, 320, 321, 322, 325, 331, 342, 346, 356, 358]	['Results', ':', 'A', 'panel', 'of', 'differentially', 'expressed', 'serum', 'proteins', 'was', 'identified', ',', 'including', 'proteins', 'involved', 'in', 'the', 'regulation', 'of', 'the', 'cell', 'cycle', '[', 'e.g', '.', 'cell', 'division', 'cycle', '7-', 'related', 'protein', 'kinase', '(', 'CDC7', ')', ']', ',', 'in', 'mitochondrial', 'function', '[', 'e.g', '.', 'mitochondrial', 'aldehyde', 'dehydrogenase', '(', 'ALDH2', ')', 'and', 'dimethyladenosine', 'transferase', '1', '(', 'TFB1M', ')', ']', ',', 'in', 'lipid', 'metabolism', 'and', 'transport', '[']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 3, 1, 1, 3, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Concerning proteins involved in the regulation of the cell cycle, cell division cycle 7-related protein kinase (cell division cycle 7-related protein kinase) is implicated in cell division, cell-cycle checkpoint mechanisms, and cancer progression.	[('PMC6489687', 'D02002', 96, 110, 'protein kinase'), ('PMC6489687', 'D02002', 112, 156, 'cell division cycle 7-related protein kinase')]	['Concerning', 'proteins', 'involved', 'in', 'the', 'regulation', 'of', 'the', 'cell', 'cycle', ',', 'cell', 'division', 'cycle', '7', '-', 'related', 'protein', 'kinase', '(', 'cell', 'division', 'cycle', '7', '-', 'related', 'protein', 'kinase', ')', 'is', 'implicated', 'in', 'cell', 'division', ',', 'cell', '-', 'cycle', 'checkpoint', 'mechanisms', ',', 'and', 'cancer', 'progression', '.']	[0, 11, 20, 29, 32, 36, 47, 50, 54, 59, 64, 66, 71, 80, 86, 87, 88, 96, 104, 111, 112, 117, 126, 132, 133, 134, 142, 150, 156, 158, 161, 172, 175, 180, 188, 190, 194, 195, 201, 212, 222, 224, 228, 235, 246]	[10, 19, 28, 31, 35, 46, 49, 53, 58, 64, 65, 70, 79, 85, 87, 88, 95, 103, 110, 112, 116, 125, 131, 133, 134, 141, 149, 156, 157, 160, 171, 174, 179, 188, 189, 194, 195, 200, 211, 222, 223, 227, 234, 246, 247]	['Concerning', 'proteins', 'involved', 'in', 'the', 'regulation', 'of', 'the', 'cell', 'cycle', ',', 'cell', 'division', 'cycle', '7-', 'related', 'protein', 'kinase', '(', 'cell', 'division', 'cycle', '7-', 'related', 'protein', 'kinase', ')', 'is', 'implicated', 'in', 'cell', 'division', ',', 'cell', '-', 'cycle', 'checkpoint', 'mechanisms', ',', 'and', 'cancer', 'progression', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It has also been reported that high level expression of cell division cycle 7-related protein kinase is linked to unfavorable prognosis (16).	[('PMC6489687', 'D02004', 56, 100, 'cell division cycle 7-related protein kinase')]	['It', 'has', 'also', 'been', 'reported', 'that', 'high', 'level', 'expression', 'of', 'cell', 'division', 'cycle', '7', '-', 'related', 'protein', 'kinase', 'is', 'linked', 'to', 'unfavorable', 'prognosis', '(', '16', ')', '.']	[0, 3, 7, 12, 17, 26, 31, 36, 42, 53, 56, 61, 70, 76, 77, 78, 86, 94, 101, 104, 111, 114, 126, 136, 137, 139, 140]	[2, 6, 11, 16, 25, 30, 35, 41, 52, 55, 60, 69, 75, 77, 78, 85, 93, 100, 103, 110, 113, 125, 135, 137, 139, 140, 141]	['It', 'has', 'also', 'been', 'reported', 'that', 'high', 'level', 'expression', 'of', 'cell', 'division', 'cycle', '7-', 'related', 'protein', 'kinase', 'is', 'linked', 'to', 'unfavorable', 'prognosis', '(', '16', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, a phase 1 study investigating a cell division cycle 7-related protein kinase inhibitor (TAK-931) in patients with advanced non-hematological malignancies is currently ongoing (17).	[('PMC6489687', 'D02005', 47, 91, 'cell division cycle 7-related protein kinase')]	['Interestingly', ',', 'a', 'phase', '1', 'study', 'investigating', 'a', 'cell', 'division', 'cycle', '7', '-', 'related', 'protein', 'kinase', 'inhibitor', '(', 'TA', '##K', '-', '93', '##1', ')', 'in', 'patients', 'with', 'advanced', 'non', '-', 'hemat', '##ological', 'malignancies', 'is', 'currently', 'ongoing', '(', '17', ')', '.']	[0, 13, 15, 17, 23, 25, 31, 45, 47, 52, 61, 67, 68, 69, 77, 85, 92, 102, 103, 105, 106, 107, 109, 110, 112, 115, 124, 129, 138, 141, 142, 147, 156, 169, 172, 182, 190, 191, 193, 194]	[13, 14, 16, 22, 24, 30, 44, 46, 51, 60, 66, 68, 69, 76, 84, 91, 101, 103, 105, 106, 107, 109, 110, 111, 114, 123, 128, 137, 141, 142, 147, 155, 168, 171, 181, 189, 191, 193, 194, 195]	['Interestingly', ',', 'a', 'phase', '1', 'study', 'investigating', 'a', 'cell', 'division', 'cycle', '7-', 'related', 'protein', 'kinase', 'inhibitor', '(', 'TAK-931', ')', 'in', 'patients', 'with', 'advanced', 'non', '-', 'hematological', 'malignancies', 'is', 'currently', 'ongoing', '(', '17', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mitochondrial aldehyde dehydrogenase (ALDH2) belongs to the ALDH family of enzymes.	[('PMC6489687', 'D03001', 14, 36, 'aldehyde dehydrogenase')]	['Mitochondrial', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', '(', 'AL', '##DH', '##2', ')', 'belongs', 'to', 'the', 'AL', '##DH', 'family', 'of', 'enzymes', '.']	[0, 14, 17, 19, 21, 23, 37, 38, 40, 42, 43, 45, 53, 56, 60, 62, 65, 72, 75, 82]	[13, 17, 19, 21, 22, 36, 38, 40, 42, 43, 44, 52, 55, 59, 62, 64, 71, 74, 82, 83]	['Mitochondrial', 'aldehyde', 'dehydrogenase', '(', 'ALDH2', ')', 'belongs', 'to', 'the', 'ALDH', 'family', 'of', 'enzymes', '.']	[1, 4, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Additionally, our results showed overexpression of mitochondrial dimethyladenosine transferase 1 (TFB1M), which is consistent with previous findings revealing elevated expression of transcription factors associated with mitochondrial biogenesis in FBC, including TFB1M (20).	[('PMC6489687', 'D03004', 65, 96, 'dimethyladenosine transferase 1')]	['Additionally', ',', 'our', 'results', 'showed', 'overexpression', 'of', 'mitochondrial', 'dimethyl', '##aden', '##osine', 'transfer', '##ase', '1', '(', 'TF', '##B', '##1', '##M', ')', ',', 'which', 'is', 'consistent', 'with', 'previous', 'findings', 'revealing', 'elevated', 'expression', 'of', 'transcription', 'factors', 'associated', 'with', 'mitochondrial', 'biogenesis', 'in', 'FB', '##C', ',', 'including', 'TF', '##B', '##1', '##M', '(', '20', ')', '.']	[0, 12, 14, 18, 26, 33, 48, 51, 65, 73, 77, 83, 91, 95, 97, 98, 100, 101, 102, 103, 104, 106, 112, 115, 126, 131, 140, 149, 159, 168, 179, 182, 196, 204, 215, 220, 234, 245, 248, 250, 251, 253, 263, 265, 266, 267, 269, 270, 272, 273]	[12, 13, 17, 25, 32, 47, 50, 64, 73, 77, 82, 91, 94, 96, 98, 100, 101, 102, 103, 104, 105, 111, 114, 125, 130, 139, 148, 158, 167, 178, 181, 195, 203, 214, 219, 233, 244, 247, 250, 251, 252, 262, 265, 266, 267, 268, 270, 272, 273, 274]	['Additionally', ',', 'our', 'results', 'showed', 'overexpression', 'of', 'mitochondrial', 'dimethyladenosine', 'transferase', '1', '(', 'TFB1M', ')', ',', 'which', 'is', 'consistent', 'with', 'previous', 'findings', 'revealing', 'elevated', 'expression', 'of', 'transcription', 'factors', 'associated', 'with', 'mitochondrial', 'biogenesis', 'in', 'FBC', ',', 'including', 'TFB1M', '(', '20', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aromatase (CYP19A1) is responsible for the transformation of androgen precursors into estrogens.	[('PMC6489687', 'D06000', 0, 9, 'Aromatase')]	['Ar', '##omat', '##ase', '(', 'CYP', '##19', '##A', '##1', ')', 'is', 'responsible', 'for', 'the', 'transformation', 'of', 'androgen', 'precursors', 'into', 'estrogen', '##s', '.']	[0, 2, 6, 10, 11, 14, 16, 17, 18, 20, 23, 35, 39, 43, 58, 61, 70, 81, 86, 94, 95]	[2, 6, 9, 11, 14, 16, 17, 18, 19, 22, 34, 38, 42, 57, 60, 69, 80, 85, 94, 95, 96]	['Aromatase', '(', 'CYP19A1', ')', 'is', 'responsible', 'for', 'the', 'transformation', 'of', 'androgen', 'precursors', 'into', 'estrogens', '.']	[3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aromatase inhibitors (AIs) are extensively used for treating hormone receptor-positive, postmenopausal women with breast cancer as well as patients with metastatic MBC.	[('PMC6489687', 'D06002', 0, 9, 'Aromatase')]	['Ar', '##omat', '##ase', 'inhibitors', '(', 'AI', '##s', ')', 'are', 'extensively', 'used', 'for', 'treating', 'hormone', 'receptor', '-', 'positive', ',', 'postmenopausal', 'women', 'with', 'breast', 'cancer', 'as', 'well', 'as', 'patients', 'with', 'metastatic', 'MB', '##C', '.']	[0, 2, 6, 10, 21, 22, 24, 25, 27, 31, 43, 48, 52, 61, 69, 77, 78, 86, 88, 103, 109, 114, 121, 128, 131, 136, 139, 148, 153, 164, 166, 167]	[2, 6, 9, 20, 22, 24, 25, 26, 30, 42, 47, 51, 60, 68, 77, 78, 86, 87, 102, 108, 113, 120, 127, 130, 135, 138, 147, 152, 163, 166, 167, 168]	['Aromatase', 'inhibitors', '(', 'AIs', ')', 'are', 'extensively', 'used', 'for', 'treating', 'hormone', 'receptor', '-', 'positive', ',', 'postmenopausal', 'women', 'with', 'breast', 'cancer', 'as', 'well', 'as', 'patients', 'with', 'metastatic', 'MBC', '.']	[3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, four proteins were detected only in the MBC group and not in the control samples: actin-related protein 2/3 complex subunit 4 (ARPC4), dual specificity mitogen-activated protein kinase kinase 4 (MP2K4), ectoderm-neural cortex protein 1 (ENC1), and matrix metalloproteinase-27 (MMP27).	[('PMC6489687', 'D07000', 161, 202, 'mitogen-activated protein kinase kinase 4'), ('PMC6489687', 'D07000', 257, 284, 'matrix metalloproteinase-27')]	['Finally', ',', 'four', 'proteins', 'were', 'detected', 'only', 'in', 'the', 'MB', '##C', 'group', 'and', 'not', 'in', 'the', 'control', 'samples', ':', 'actin', '-', 'related', 'protein', '2', '/', '3', 'complex', 'subunit', '4', '(', 'AR', '##PC', '##4', ')', ',', 'dual', 'specificity', 'mitogen', '-', 'activated', 'protein', 'kinase', 'kinase', '4', '(', 'MP', '##2', '##K', '##4', ')', ',', 'ect', '##oderm', '-', 'neural', 'cortex', 'protein', '1', '(', 'EN', '##C', '##1', ')', ',', 'and', 'matrix', 'metalloprotein', '##ase', '-', '27', '(', 'MMP', '##27', ')', '.']	[0, 7, 9, 14, 23, 28, 37, 42, 45, 49, 51, 53, 59, 63, 67, 70, 74, 82, 89, 91, 96, 97, 105, 113, 114, 115, 117, 125, 133, 135, 136, 138, 140, 141, 142, 144, 149, 161, 168, 169, 179, 187, 194, 201, 203, 204, 206, 207, 208, 209, 210, 212, 215, 220, 221, 228, 235, 243, 245, 246, 248, 249, 250, 251, 253, 257, 264, 278, 281, 282, 285, 286, 289, 291, 292]	[7, 8, 13, 22, 27, 36, 41, 44, 48, 51, 52, 58, 62, 66, 69, 73, 81, 89, 90, 96, 97, 104, 112, 114, 115, 116, 124, 132, 134, 136, 138, 140, 141, 142, 143, 148, 160, 168, 169, 178, 186, 193, 200, 202, 204, 206, 207, 208, 209, 210, 211, 215, 220, 221, 227, 234, 242, 244, 246, 248, 249, 250, 251, 252, 256, 263, 278, 281, 282, 284, 286, 289, 291, 292, 293]	['Finally', ',', 'four', 'proteins', 'were', 'detected', 'only', 'in', 'the', 'MBC', 'group', 'and', 'not', 'in', 'the', 'control', 'samples', ':', 'actin', '-', 'related', 'protein', '2', '/', '3', 'complex', 'subunit', '4', '(', 'ARPC4', ')', ',', 'dual', 'specificity', 'mitogen', '-', 'activated', 'protein', 'kinase', 'kinase', '4', '(', 'MP2K4', ')', ',', 'ectoderm', '-', 'neural', 'cortex', 'protein', '1', '(', 'ENC1', ')', ',', 'and', 'matrix', 'metalloproteinase-27', '(', 'MMP27', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Bonte D, Lindvall C, Liu H, Dykema K, Furge K, Weinreich M. CDC7-DBF4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation.	[('PMC6489687', 'F14001', 70, 76, 'kinase')]	['Bon', '##te', 'D', ',', 'Lind', '##val', '##l', 'C', ',', 'Liu', 'H', ',', 'Dy', '##ke', '##ma', 'K', ',', 'Fur', '##ge', 'K', ',', 'Wein', '##reich', 'M', '.', 'CDC', '##7', '-', 'DB', '##F', '##4', 'kinase', 'overexpression', 'in', 'multiple', 'cancers', 'and', 'tumor', 'cell', 'lines', 'is', 'correlated', 'with', 'p', '##53', 'inactivation', '.']	[0, 3, 6, 7, 9, 13, 16, 18, 19, 21, 25, 26, 28, 30, 32, 35, 36, 38, 41, 44, 45, 47, 51, 57, 58, 60, 63, 64, 65, 67, 68, 70, 77, 92, 95, 104, 112, 116, 122, 127, 133, 136, 147, 152, 153, 156, 168]	[3, 5, 7, 8, 13, 16, 17, 19, 20, 24, 26, 27, 30, 32, 34, 36, 37, 41, 43, 45, 46, 51, 56, 58, 59, 63, 64, 65, 67, 68, 69, 76, 91, 94, 103, 111, 115, 121, 126, 132, 135, 146, 151, 153, 155, 168, 169]	['Bonte', 'D', ',', 'Lindvall', 'C', ',', 'Liu', 'H', ',', 'Dykema', 'K', ',', 'Furge', 'K', ',', 'Weinreich', 'M', '.', 'CDC7-DBF4', 'kinase', 'overexpression', 'in', 'multiple', 'cancers', 'and', 'tumor', 'cell', 'lines', 'is', 'correlated', 'with', 'p53', 'inactivation', '.']	[2, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Zagouri F, Sergentanis TN, Azim HA Jr., Chrysikos D, Dimopoulos MA, Psaltopoulou T. Aromatase inhibitors in male breast cancer: a pooled analysis.	[('PMC6489687', 'F31001', 84, 93, 'Aromatase')]	['Z', '##ago', '##uri', 'F', ',', 'Ser', '##gent', '##ani', '##s', 'TN', ',', 'Az', '##im', 'HA', 'Jr', '.', ',', 'Chr', '##ysi', '##ko', '##s', 'D', ',', 'Dim', '##opoulos', 'MA', ',', 'Ps', '##alt', '##opo', '##ulo', '##u', 'T', '.', 'Ar', '##omat', '##ase', 'inhibitors', 'in', 'male', 'breast', 'cancer', ':', 'a', 'pooled', 'analysis', '.']	[0, 1, 4, 8, 9, 11, 14, 18, 21, 23, 25, 27, 29, 32, 35, 37, 38, 40, 43, 46, 48, 50, 51, 53, 56, 64, 66, 68, 70, 73, 76, 79, 81, 82, 84, 86, 90, 94, 105, 108, 113, 120, 126, 128, 130, 137, 145]	[1, 4, 7, 9, 10, 14, 18, 21, 22, 25, 26, 29, 31, 34, 37, 38, 39, 43, 46, 48, 49, 51, 52, 56, 63, 66, 67, 70, 73, 76, 79, 80, 82, 83, 86, 90, 93, 104, 107, 112, 119, 126, 127, 129, 136, 145, 146]	['Zagouri', 'F', ',', 'Sergentanis', 'TN', ',', 'Azim', 'HA', 'Jr', '.', ',', 'Chrysikos', 'D', ',', 'Dimopoulos', 'MA', ',', 'Psaltopoulou', 'T', '.', 'Aromatase', 'inhibitors', 'in', 'male', 'breast', 'cancer', ':', 'a', 'pooled', 'analysis', '.']	[3, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.	[('PMC6489687', 'F32001', 161, 170, 'sulfatase'), ('PMC6489687', 'F32001', 175, 184, 'aromatase')]	['Pas', '##qual', '##ini', 'JR', ',', 'Che', '##tri', '##te', 'G', ',', 'Black', '##er', 'C', ',', 'Fe', '##inst', '##ei', '##n', 'MC', ',', 'Del', '##alo', '##nde', 'L', ',', 'Tal', '##bi', 'M', ',', 'Mal', '##oche', 'C', '.', 'Concentration', '##s', 'of', 'estr', '##one', ',', 'estradiol', ',', 'and', 'estr', '##one', 'sulfate', 'and', 'evaluation', 'of', 'sulf', '##atase', 'and', 'arom', '##atase', 'activities', 'in', 'pre', '-', 'and', 'postmenopausal', 'breast', 'cancer', 'patients', '.']	[0, 3, 7, 11, 13, 15, 18, 21, 24, 25, 27, 32, 35, 36, 38, 40, 44, 46, 48, 50, 52, 55, 58, 62, 63, 65, 68, 71, 72, 74, 77, 82, 83, 85, 98, 100, 103, 107, 110, 112, 121, 123, 127, 131, 135, 143, 147, 158, 161, 165, 171, 175, 179, 185, 196, 199, 202, 204, 208, 223, 230, 237, 245]	[3, 7, 10, 13, 14, 18, 21, 23, 25, 26, 32, 34, 36, 37, 40, 44, 46, 47, 50, 51, 55, 58, 61, 63, 64, 68, 70, 72, 73, 77, 81, 83, 84, 98, 99, 102, 107, 110, 111, 121, 122, 126, 131, 134, 142, 146, 157, 160, 165, 170, 174, 179, 184, 195, 198, 202, 203, 207, 222, 229, 236, 245, 246]	['Pasqualini', 'JR', ',', 'Chetrite', 'G', ',', 'Blacker', 'C', ',', 'Feinstein', 'MC', ',', 'Delalonde', 'L', ',', 'Talbi', 'M', ',', 'Maloche', 'C', '.', 'Concentrations', 'of', 'estrone', ',', 'estradiol', ',', 'and', 'estrone', 'sulfate', 'and', 'evaluation', 'of', 'sulfatase', 'and', 'aromatase', 'activities', 'in', 'pre-', 'and', 'postmenopausal', 'breast', 'cancer', 'patients', '.']	[3, 1, 1, 3, 1, 1, 2, 1, 1, 4, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Matrix metalloproteinases as breast cancer drivers and therapeutic targets.	[('PMC6489687', 'F37002', 0, 25, 'Matrix metalloproteinases')]	['Matrix', 'metalloprotein', '##ases', 'as', 'breast', 'cancer', 'drivers', 'and', 'therapeutic', 'targets', '.']	[0, 7, 21, 26, 29, 36, 43, 51, 55, 67, 74]	[6, 21, 25, 28, 35, 42, 50, 54, 66, 74, 75]	['Matrix', 'metalloproteinases', 'as', 'breast', 'cancer', 'drivers', 'and', 'therapeutic', 'targets', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aromatase ELISA kit was purchased from Fine Biotech (EH2665; Fine Test, Wuhan, Hubei, P. R. China).	[('PMC6489687', 'M05001', 0, 9, 'Aromatase')]	['Ar', '##omat', '##ase', 'ELISA', 'kit', 'was', 'purchased', 'from', 'Fine', 'Biotech', '(', 'EH', '##26', '##65', ';', 'Fine', 'Test', ',', 'Wu', '##han', ',', 'Hub', '##ei', ',', 'P', '.', 'R', '.', 'China', ')', '.']	[0, 2, 6, 10, 16, 20, 24, 34, 39, 44, 52, 53, 55, 57, 59, 61, 66, 70, 72, 74, 77, 79, 82, 84, 86, 87, 89, 90, 92, 97, 98]	[2, 6, 9, 15, 19, 23, 33, 38, 43, 51, 53, 55, 57, 59, 60, 65, 70, 71, 74, 77, 78, 82, 84, 85, 87, 88, 90, 91, 97, 98, 99]	['Aromatase', 'ELISA', 'kit', 'was', 'purchased', 'from', 'Fine', 'Biotech', '(', 'EH2665', ';', 'Fine', 'Test', ',', 'Wuhan', ',', 'Hubei', ',', 'P', '.', 'R', '.', 'China', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Serum aromatase (CYP19A1) concentrations in patients with MBC and healthy controls were measured using ELISA since CYP19A1 is an endoplasmic reticulum enzyme also detected in the serum.	[('PMC6489687', 'R02001', 6, 15, 'aromatase')]	['Serum', 'arom', '##atase', '(', 'CYP', '##19', '##A', '##1', ')', 'concentrations', 'in', 'patients', 'with', 'MB', '##C', 'and', 'healthy', 'controls', 'were', 'measured', 'using', 'ELISA', 'since', 'CYP', '##19', '##A', '##1', 'is', 'an', 'endoplasmic', 'reticulum', 'enzyme', 'also', 'detected', 'in', 'the', 'serum', '.']	[0, 6, 10, 16, 17, 20, 22, 23, 24, 26, 41, 44, 53, 58, 60, 62, 66, 74, 83, 88, 97, 103, 109, 115, 118, 120, 121, 123, 126, 129, 141, 151, 158, 163, 172, 175, 179, 184]	[5, 10, 15, 17, 20, 22, 23, 24, 25, 40, 43, 52, 57, 60, 61, 65, 73, 82, 87, 96, 102, 108, 114, 118, 120, 121, 122, 125, 128, 140, 150, 157, 162, 171, 174, 178, 184, 185]	['Serum', 'aromatase', '(', 'CYP19A1', ')', 'concentrations', 'in', 'patients', 'with', 'MBC', 'and', 'healthy', 'controls', 'were', 'measured', 'using', 'ELISA', 'since', 'CYP19A1', 'is', 'an', 'endoplasmic', 'reticulum', 'enzyme', 'also', 'detected', 'in', 'the', 'serum', '.']	[1, 2, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Amur S. G., Shanker G., Cochran J. M., Ved H. S., Pieringer R. A. Correlation between inhibition of myelin basic protein (arginine) methyltransferase by sinefungin and lack of compact myelin formation in cultures of cerebral cells from embryonic mice.	[('PMC6507152', 'F26001', 100, 149, 'myelin basic protein (arginine) methyltransferase')]	['Am', '##ur', 'S', '.', 'G', '.', ',', 'Sha', '##nk', '##er', 'G', '.', ',', 'Coch', '##ran', 'J', '.', 'M', '.', ',', 'Ve', '##d', 'H', '.', 'S', '.', ',', 'Pier', '##inger', 'R', '.', 'A', '.', 'Correlation', 'between', 'inhibition', 'of', 'myelin', 'basic', 'protein', '(', 'arginine', ')', 'methyl', '##transferase', 'by', 'sine', '##fung', '##in', 'and', 'lack', 'of', 'compact', 'myelin', 'formation', 'in', 'cultures', 'of', 'cerebral', 'cells', 'from', 'embryonic', 'mice', '.']	[0, 2, 5, 6, 8, 9, 10, 12, 15, 17, 20, 21, 22, 24, 28, 32, 33, 35, 36, 37, 39, 41, 43, 44, 46, 47, 48, 50, 54, 60, 61, 63, 64, 66, 78, 86, 97, 100, 107, 113, 121, 122, 130, 132, 138, 150, 153, 157, 161, 164, 168, 173, 176, 184, 191, 201, 204, 213, 216, 225, 231, 236, 246, 250]	[2, 4, 6, 7, 9, 10, 11, 15, 17, 19, 21, 22, 23, 28, 31, 33, 34, 36, 37, 38, 41, 42, 44, 45, 47, 48, 49, 54, 59, 61, 62, 64, 65, 77, 85, 96, 99, 106, 112, 120, 122, 130, 131, 138, 149, 152, 157, 161, 163, 167, 172, 175, 183, 190, 200, 203, 212, 215, 224, 230, 235, 245, 250, 251]	['Amur', 'S', '.', 'G', '.', ',', 'Shanker', 'G', '.', ',', 'Cochran', 'J', '.', 'M', '.', ',', 'Ved', 'H', '.', 'S', '.', ',', 'Pieringer', 'R', '.', 'A', '.', 'Correlation', 'between', 'inhibition', 'of', 'myelin', 'basic', 'protein', '(', 'arginine', ')', 'methyltransferase', 'by', 'sinefungin', 'and', 'lack', 'of', 'compact', 'myelin', 'formation', 'in', 'cultures', 'of', 'cerebral', 'cells', 'from', 'embryonic', 'mice', '.']	[2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It is oxidized to xanthine by xanthine oxidase (a form of xanthine oxidoreductase), whereas uric acid is the end product of their degradation [43].	[('PMC6521312', 'D04003', 30, 46, 'xanthine oxidase'), ('PMC6521312', 'D04003', 58, 81, 'xanthine oxidoreductase')]	['It', 'is', 'oxidized', 'to', 'x', '##anth', '##ine', 'by', 'x', '##anth', '##ine', 'oxidase', '(', 'a', 'form', 'of', 'x', '##anth', '##ine', 'oxid', '##ored', '##uct', '##ase', ')', ',', 'whereas', 'ur', '##ic', 'acid', 'is', 'the', 'end', 'product', 'of', 'their', 'degradation', '[', '43', ']', '.']	[0, 3, 6, 15, 18, 19, 23, 27, 30, 31, 35, 39, 47, 48, 50, 55, 58, 59, 63, 67, 71, 75, 78, 81, 82, 84, 92, 94, 97, 102, 105, 109, 113, 121, 124, 130, 142, 143, 145, 146]	[2, 5, 14, 17, 19, 23, 26, 29, 31, 35, 38, 46, 48, 49, 54, 57, 59, 63, 66, 71, 75, 78, 81, 82, 83, 91, 94, 96, 101, 104, 108, 112, 120, 123, 129, 141, 143, 145, 146, 147]	['It', 'is', 'oxidized', 'to', 'xanthine', 'by', 'xanthine', 'oxidase', '(', 'a', 'form', 'of', 'xanthine', 'oxidoreductase', ')', ',', 'whereas', 'uric', 'acid', 'is', 'the', 'end', 'product', 'of', 'their', 'degradation', '[', '43', ']', '.']	[1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Elevated levels of AMP can be attributed to increased conversion of adenosine to AMP by adenosine kinase enzymes during cell proliferation [45].	[('PMC6521312', 'D04006', 88, 104, 'adenosine kinase')]	['Ele', '##vated', 'levels', 'of', 'AMP', 'can', 'be', 'attributed', 'to', 'increased', 'conversion', 'of', 'adenosine', 'to', 'AMP', 'by', 'adenosine', 'kinase', 'enzymes', 'during', 'cell', 'proliferation', '[', '45', ']', '.']	[0, 3, 9, 16, 19, 23, 27, 30, 41, 44, 54, 65, 68, 78, 81, 85, 88, 98, 105, 113, 120, 125, 139, 140, 142, 143]	[3, 8, 15, 18, 22, 26, 29, 40, 43, 53, 64, 67, 77, 80, 84, 87, 97, 104, 112, 119, 124, 138, 140, 142, 143, 144]	['Elevated', 'levels', 'of', 'AMP', 'can', 'be', 'attributed', 'to', 'increased', 'conversion', 'of', 'adenosine', 'to', 'AMP', 'by', 'adenosine', 'kinase', 'enzymes', 'during', 'cell', 'proliferation', '[', '45', ']', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.	[('PMC6521312', 'F23002', 99, 132, 'glucose-6-phosphate dehydrogenase')]	['Metab', '##olo', '##mic', 'profile', 'of', 'glycolysis', 'and', 'the', 'pent', '##ose', 'phosphate', 'pathway', 'identifies', 'the', 'central', 'role', 'of', 'glucose', '-', '6', '-', 'phosphate', 'dehydrogenase', 'in', 'clear', 'cell', '-', 'renal', 'cell', 'carcinoma', '.']	[0, 5, 8, 12, 20, 23, 34, 38, 42, 46, 50, 60, 68, 79, 83, 91, 96, 99, 106, 107, 108, 109, 119, 133, 136, 142, 146, 147, 153, 158, 167]	[5, 8, 11, 19, 22, 33, 37, 41, 46, 49, 59, 67, 78, 82, 90, 95, 98, 106, 107, 108, 109, 118, 132, 135, 141, 146, 147, 152, 157, 167, 168]	['Metabolomic', 'profile', 'of', 'glycolysis', 'and', 'the', 'pentose', 'phosphate', 'pathway', 'identifies', 'the', 'central', 'role', 'of', 'glucose-6-phosphate', 'dehydrogenase', 'in', 'clear', 'cell', '-', 'renal', 'cell', 'carcinoma', '.']	[3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Hille R. Molybdenum-containing hydroxylases.	[('PMC6521312', 'F42001', 9, 43, 'Molybdenum-containing hydroxylases')]	['Hill', '##e', 'R', '.', 'Mol', '##yb', '##den', '##um', '-', 'containing', 'hydroxyl', '##ases', '.']	[0, 4, 6, 7, 9, 12, 14, 17, 19, 20, 31, 39, 43]	[4, 5, 7, 8, 12, 14, 17, 19, 20, 30, 39, 43, 44]	['Hille', 'R', '.', 'Molybdenum', '-', 'containing', 'hydroxylases', '.']	[2, 1, 1, 4, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
In addition, there were increases in non-gluten proteins such as triticins, purinins, globulins, serpins, and alpha-amylase/protease inhibitors.	[('PMC6521778', 'A00007', 110, 123, 'alpha-amylase'), ('PMC6521778', 'A00007', 124, 132, 'protease')]	['In', 'addition', ',', 'there', 'were', 'increases', 'in', 'non', '-', 'glut', '##en', 'proteins', 'such', 'as', 'tri', '##tic', '##ins', ',', 'pur', '##inin', '##s', ',', 'glob', '##ulin', '##s', ',', 'ser', '##pin', '##s', ',', 'and', 'alpha', '-', 'amyl', '##ase', '/', 'protease', 'inhibitors', '.']	[0, 3, 11, 13, 19, 24, 34, 37, 40, 41, 45, 48, 57, 62, 65, 68, 71, 74, 76, 79, 83, 84, 86, 90, 94, 95, 97, 100, 103, 104, 106, 110, 115, 116, 120, 123, 124, 133, 143]	[2, 11, 12, 18, 23, 33, 36, 40, 41, 45, 47, 56, 61, 64, 68, 71, 74, 75, 79, 83, 84, 85, 90, 94, 95, 96, 100, 103, 104, 105, 109, 115, 116, 120, 123, 124, 132, 143, 144]	['In', 'addition', ',', 'there', 'were', 'increases', 'in', 'non', '-', 'gluten', 'proteins', 'such', 'as', 'triticins', ',', 'purinins', ',', 'globulins', ',', 'serpins', ',', 'and', 'alpha', '-', 'amylase', '/', 'protease', 'inhibitors', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'S', 'O', 'O']
Recently, Nunes-Miranda et al. (2017) presented evidence that y-type HMW-GS encoded by the B genome are subject to proteolytic processing at the C-terminus by an asparaginyl endopeptidase.	[('PMC6521778', 'D01007', 162, 187, 'asparaginyl endopeptidase')]	['Recently', ',', 'Nu', '##nes', '-', 'Mir', '##anda', 'et', 'al', '.', '(', '2017', ')', 'presented', 'evidence', 'that', 'y', '-', 'type', 'HM', '##W', '-', 'GS', 'encoded', 'by', 'the', 'B', 'genome', 'are', 'subject', 'to', 'proteolytic', 'processing', 'at', 'the', 'C', '-', 'terminus', 'by', 'an', 'as', '##par', '##agi', '##ny', '##l', 'end', '##ope', '##pt', '##idase', '.']	[0, 8, 10, 12, 15, 16, 19, 24, 27, 29, 31, 32, 36, 38, 48, 57, 62, 63, 64, 69, 71, 72, 73, 76, 84, 87, 91, 93, 100, 104, 112, 115, 127, 138, 141, 145, 146, 147, 156, 159, 162, 164, 167, 170, 172, 174, 177, 180, 182, 187]	[8, 9, 12, 15, 16, 19, 23, 26, 29, 30, 32, 36, 37, 47, 56, 61, 63, 64, 68, 71, 72, 73, 75, 83, 86, 90, 92, 99, 103, 111, 114, 126, 137, 140, 144, 146, 147, 155, 158, 161, 164, 167, 170, 172, 173, 177, 180, 182, 187, 188]	['Recently', ',', 'Nunes-Miranda', 'et', 'al', '.', '(', '2017', ')', 'presented', 'evidence', 'that', 'y', '-', 'type', 'HMW-GS', 'encoded', 'by', 'the', 'B', 'genome', 'are', 'subject', 'to', 'proteolytic', 'processing', 'at', 'the', 'C-terminus', 'by', 'an', 'asparaginyl', 'endopeptidase', '.']	[1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
Certain omega-1,2 gliadins and some LMW-GS have also been shown to undergo post-translational cleavage at the N-terminus by an asparaginyl endopeptidase (Dupont et al., 2004; Egidi et al., 2014).	[('PMC6521778', 'D01010', 127, 152, 'asparaginyl endopeptidase')]	['Certain', 'om', '##eg', '##a', '-', '1', ',', '2', 'gli', '##adi', '##ns', 'and', 'some', 'LM', '##W', '-', 'GS', 'have', 'also', 'been', 'shown', 'to', 'undergo', 'post', '-', 'translational', 'cleavage', 'at', 'the', 'N', '-', 'terminus', 'by', 'an', 'as', '##par', '##agi', '##ny', '##l', 'end', '##ope', '##pt', '##idase', '(', 'Du', '##pon', '##t', 'et', 'al', '.', ',', '2004', ';', 'Eg', '##idi', 'et', 'al', '.', ',', '2014', ')', '.']	[0, 8, 10, 12, 13, 14, 15, 16, 18, 21, 24, 27, 31, 36, 38, 39, 40, 43, 48, 53, 58, 64, 67, 75, 79, 80, 94, 103, 106, 110, 111, 112, 121, 124, 127, 129, 132, 135, 137, 139, 142, 145, 147, 153, 154, 156, 159, 161, 164, 166, 167, 169, 173, 175, 177, 181, 184, 186, 187, 189, 193, 194]	[7, 10, 12, 13, 14, 15, 16, 17, 21, 24, 26, 30, 35, 38, 39, 40, 42, 47, 52, 57, 63, 66, 74, 79, 80, 93, 102, 105, 109, 111, 112, 120, 123, 126, 129, 132, 135, 137, 138, 142, 145, 147, 152, 154, 156, 159, 160, 163, 166, 167, 168, 173, 174, 177, 180, 183, 186, 187, 188, 193, 194, 195]	['Certain', 'omega-1,2', 'gliadins', 'and', 'some', 'LMW-GS', 'have', 'also', 'been', 'shown', 'to', 'undergo', 'post', '-', 'translational', 'cleavage', 'at', 'the', 'N-terminus', 'by', 'an', 'asparaginyl', 'endopeptidase', '(', 'Dupont', 'et', 'al', '.', ',', '2004', ';', 'Egidi', 'et', 'al', '.', ',', '2014', ')', '.']	[1, 7, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 4, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, asparaginyl endopeptidases are reported to cleave at aspartate residues with a lower efficiency and these residues are found in both proteins (Müntz et al., 2002).	[('PMC6521778', 'D01014', 9, 35, 'asparaginyl endopeptidases')]	['However', ',', 'as', '##par', '##agi', '##ny', '##l', 'end', '##ope', '##pt', '##idase', '##s', 'are', 'reported', 'to', 'cle', '##ave', 'at', 'aspart', '##ate', 'residues', 'with', 'a', 'lower', 'efficiency', 'and', 'these', 'residues', 'are', 'found', 'in', 'both', 'proteins', '(', 'Mü', '##nt', '##z', 'et', 'al', '.', ',', '2002', ')', '.']	[0, 7, 9, 11, 14, 17, 19, 21, 24, 27, 29, 34, 36, 40, 49, 52, 55, 59, 62, 68, 72, 81, 86, 88, 94, 105, 109, 115, 124, 128, 134, 137, 142, 151, 152, 154, 156, 158, 161, 163, 164, 166, 170, 171]	[7, 8, 11, 14, 17, 19, 20, 24, 27, 29, 34, 35, 39, 48, 51, 55, 58, 61, 68, 71, 80, 85, 87, 93, 104, 108, 114, 123, 127, 133, 136, 141, 150, 152, 154, 156, 157, 160, 163, 164, 165, 170, 171, 172]	['However', ',', 'asparaginyl', 'endopeptidases', 'are', 'reported', 'to', 'cleave', 'at', 'aspartate', 'residues', 'with', 'a', 'lower', 'efficiency', 'and', 'these', 'residues', 'are', 'found', 'in', 'both', 'proteins', '(', 'Müntz', 'et', 'al', '.', ',', '2002', ')', '.']	[1, 1, 5, 5, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The spectrum of low molecular weight alpha-amylase/protease inhibitor genes expressed in the US bread wheat cultivar Butte 86.BMC Res.	[('PMC6521778', 'F13001', 37, 50, 'alpha-amylase'), ('PMC6521778', 'F13001', 51, 59, 'protease')]	['The', 'spectrum', 'of', 'low', 'molecular', 'weight', 'alpha', '-', 'amyl', '##ase', '/', 'protease', 'inhibitor', 'genes', 'expressed', 'in', 'the', 'US', 'bread', 'wheat', 'cultiv', '##ar', 'But', '##te', '86', '.', 'BMC', 'Res', '.']	[0, 4, 13, 16, 20, 30, 37, 42, 43, 47, 50, 51, 60, 70, 76, 86, 89, 93, 96, 102, 108, 114, 117, 120, 123, 125, 126, 130, 133]	[3, 12, 15, 19, 29, 36, 42, 43, 47, 50, 51, 59, 69, 75, 85, 88, 92, 95, 101, 107, 114, 116, 120, 122, 125, 126, 129, 133, 134]	['The', 'spectrum', 'of', 'low', 'molecular', 'weight', 'alpha', '-', 'amylase', '/', 'protease', 'inhibitor', 'genes', 'expressed', 'in', 'the', 'US', 'bread', 'wheat', 'cultivar', 'Butte', '86.BMC', 'Res', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Deciphering the complexities of the wheat flour proteome using quantitative two-dimensional electrophoresis, three proteases and tandem mass spectrometry.	[('PMC6521778', 'F20001', 115, 124, 'proteases')]	['Dec', '##ipher', '##ing', 'the', 'complexities', 'of', 'the', 'wheat', 'flour', 'proteome', 'using', 'quantitative', 'two', '-', 'dimensional', 'electrophoresis', ',', 'three', 'proteases', 'and', 'tandem', 'mass', 'spectrometry', '.']	[0, 3, 8, 12, 16, 29, 32, 36, 42, 48, 57, 63, 76, 79, 80, 92, 107, 109, 115, 125, 129, 136, 141, 153]	[3, 8, 11, 15, 28, 31, 35, 41, 47, 56, 62, 75, 79, 80, 91, 107, 108, 114, 124, 128, 135, 140, 153, 154]	['Deciphering', 'the', 'complexities', 'of', 'the', 'wheat', 'flour', 'proteome', 'using', 'quantitative', 'two', '-', 'dimensional', 'electrophoresis', ',', 'three', 'proteases', 'and', 'tandem', 'mass', 'spectrometry', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O']
Legumains – a family of asparagine-specific cysteine endopeptidases involved in propolypeptide processing and protein breakdown in plants.	[('PMC6521778', 'F32001', 24, 67, 'asparagine-specific cysteine endopeptidases')]	['Leg', '##uma', '##ins', '–', 'a', 'family', 'of', 'as', '##par', '##agi', '##ne', '-', 'specific', 'cysteine', 'end', '##ope', '##pt', '##idase', '##s', 'involved', 'in', 'prop', '##oly', '##peptide', 'processing', 'and', 'protein', 'breakdown', 'in', 'plants', '.']	[0, 3, 6, 10, 12, 14, 21, 24, 26, 29, 32, 34, 35, 44, 53, 56, 59, 61, 66, 68, 77, 80, 84, 87, 95, 106, 110, 118, 128, 131, 137]	[3, 6, 9, 11, 13, 20, 23, 26, 29, 32, 34, 35, 43, 52, 56, 59, 61, 66, 67, 76, 79, 84, 87, 94, 105, 109, 117, 127, 130, 137, 138]	['Legumains', '–', 'a', 'family', 'of', 'asparagine', '-', 'specific', 'cysteine', 'endopeptidases', 'involved', 'in', 'propolypeptide', 'processing', 'and', 'protein', 'breakdown', 'in', 'plants', '.']	[3, 1, 1, 1, 1, 4, 1, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This fragment was amplified from 20 DPA endosperm RNA using primers QF18 and QR18 described in Altenbach and Kothari (2007), inserted in opposite orientations on either side of a 146 bp intron from a wheat starch synthase gene, then placed under the regulatory control of the HMW-GS Dy10 promoter and the HMW-GS Dx5 terminator as described in Altenbach and Allen (2011).	[('PMC6521778', 'M01001', 206, 221, 'starch synthase')]	['This', 'fragment', 'was', 'amplified', 'from', '20', 'DP', '##A', 'endos', '##perm', 'RNA', 'using', 'primers', 'Q', '##F', '##18', 'and', 'QR', '##18', 'described', 'in', 'Alt', '##en', '##bach', 'and', 'Ko', '##th', '##ari', '(', '2007', ')', ',', 'inserted', 'in', 'opposite', 'orientations', 'on', 'either', 'side', 'of', 'a', '146', 'bp', 'intron', 'from', 'a', 'wheat', 'starch', 'synthase', 'gene', ',', 'then', 'placed', 'under', 'the', 'regulatory', 'control', 'of', 'the', 'HM', '##W', '-', 'GS', 'Dy', '##10', 'promoter', 'and', 'the', 'HM', '##W', '-', 'GS', 'D', '##x', '##5', 'termin', '##ator', 'as', 'described', 'in', 'Alt', '##en', '##bach', 'and', 'Allen', '(', '2011', ')', '.']	[0, 5, 14, 18, 28, 33, 36, 38, 40, 45, 50, 54, 60, 68, 69, 70, 73, 77, 79, 82, 92, 95, 98, 100, 105, 109, 111, 113, 117, 118, 122, 123, 125, 134, 137, 146, 159, 162, 169, 174, 177, 179, 183, 186, 193, 198, 200, 206, 213, 222, 226, 228, 233, 240, 246, 250, 261, 269, 272, 276, 278, 279, 280, 283, 285, 288, 297, 301, 305, 307, 308, 309, 312, 313, 314, 316, 322, 327, 330, 340, 343, 346, 348, 353, 357, 363, 364, 368, 369]	[4, 13, 17, 27, 32, 35, 38, 39, 45, 49, 53, 59, 67, 69, 70, 72, 76, 79, 81, 91, 94, 98, 100, 104, 108, 111, 113, 116, 118, 122, 123, 124, 133, 136, 145, 158, 161, 168, 173, 176, 178, 182, 185, 192, 197, 199, 205, 212, 221, 226, 227, 232, 239, 245, 249, 260, 268, 271, 275, 278, 279, 280, 282, 285, 287, 296, 300, 304, 307, 308, 309, 311, 313, 314, 315, 322, 326, 329, 339, 342, 346, 348, 352, 356, 362, 364, 368, 369, 370]	['This', 'fragment', 'was', 'amplified', 'from', '20', 'DPA', 'endosperm', 'RNA', 'using', 'primers', 'QF18', 'and', 'QR18', 'described', 'in', 'Altenbach', 'and', 'Kothari', '(', '2007', ')', ',', 'inserted', 'in', 'opposite', 'orientations', 'on', 'either', 'side', 'of', 'a', '146', 'bp', 'intron', 'from', 'a', 'wheat', 'starch', 'synthase', 'gene', ',', 'then', 'placed', 'under', 'the', 'regulatory', 'control', 'of', 'the', 'HMW-GS', 'Dy10', 'promoter', 'and', 'the', 'HMW-GS', 'Dx5', 'terminator', 'as', 'described', 'in', 'Altenbach', 'and', 'Allen', '(', '2011', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 3, 1, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 4, 3, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All cases of CD were positive for antibody reactivity to transglutaminase 2 (the most sensitive and specific serologic marker of CD), determined as previously described (Lau et al., 2013).	[('PMC6521778', 'M04002', 57, 75, 'transglutaminase 2')]	['All', 'cases', 'of', 'CD', 'were', 'positive', 'for', 'antibody', 'reactivity', 'to', 'trans', '##glut', '##aminase', '2', '(', 'the', 'most', 'sensitive', 'and', 'specific', 'ser', '##ologic', 'marker', 'of', 'CD', ')', ',', 'determined', 'as', 'previously', 'described', '(', 'Lau', 'et', 'al', '.', ',', '2013', ')', '.']	[0, 4, 10, 13, 16, 21, 30, 34, 43, 54, 57, 62, 66, 74, 76, 77, 81, 86, 96, 100, 109, 112, 119, 126, 129, 131, 132, 134, 145, 148, 159, 169, 170, 174, 177, 179, 180, 182, 186, 187]	[3, 9, 12, 15, 20, 29, 33, 42, 53, 56, 62, 66, 73, 75, 77, 80, 85, 95, 99, 108, 112, 118, 125, 128, 131, 132, 133, 144, 147, 158, 168, 170, 173, 176, 179, 180, 181, 186, 187, 188]	['All', 'cases', 'of', 'CD', 'were', 'positive', 'for', 'antibody', 'reactivity', 'to', 'transglutaminase', '2', '(', 'the', 'most', 'sensitive', 'and', 'specific', 'serologic', 'marker', 'of', 'CD', ')', ',', 'determined', 'as', 'previously', 'described', '(', 'Lau', 'et', 'al', '.', ',', '2013', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Spots 1 and 2 contained omega-1,2 gliadin BAN29067 as well as protein disulfide isomerase and beta-amylase.	[('PMC6521778', 'R02002', 62, 89, 'protein disulfide isomerase'), ('PMC6521778', 'R02002', 94, 106, 'beta-amylase')]	['Sp', '##ots', '1', 'and', '2', 'contained', 'om', '##eg', '##a', '-', '1', ',', '2', 'gli', '##adi', '##n', 'BA', '##N', '##29', '##06', '##7', 'as', 'well', 'as', 'protein', 'disulfide', 'isomer', '##ase', 'and', 'beta', '-', 'amyl', '##ase', '.']	[0, 2, 6, 8, 12, 14, 24, 26, 28, 29, 30, 31, 32, 34, 37, 40, 42, 44, 45, 47, 49, 51, 54, 59, 62, 70, 80, 86, 90, 94, 98, 99, 103, 106]	[2, 5, 7, 11, 13, 23, 26, 28, 29, 30, 31, 32, 33, 37, 40, 41, 44, 45, 47, 49, 50, 53, 58, 61, 69, 79, 86, 89, 93, 98, 99, 103, 106, 107]	['Spots', '1', 'and', '2', 'contained', 'omega-1,2', 'gliadin', 'BAN29067', 'as', 'well', 'as', 'protein', 'disulfide', 'isomerase', 'and', 'beta', '-', 'amylase', '.']	[2, 1, 1, 1, 1, 7, 3, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O']
Spot 1 in Figure 3D contained protein disulfide isomerase and beta-amylase while spots 2 and 3 were identified as beta-amylases.	[('PMC6521778', 'R02011', 30, 57, 'protein disulfide isomerase'), ('PMC6521778', 'R02011', 62, 74, 'beta-amylase'), ('PMC6521778', 'R02011', 114, 127, 'beta-amylases')]	['Sp', '##ot', '1', 'in', 'Figure', '3', '##D', 'contained', 'protein', 'disulfide', 'isomer', '##ase', 'and', 'beta', '-', 'amyl', '##ase', 'while', 'spots', '2', 'and', '3', 'were', 'identified', 'as', 'beta', '-', 'amyl', '##ases', '.']	[0, 2, 5, 7, 10, 17, 18, 20, 30, 38, 48, 54, 58, 62, 66, 67, 71, 75, 81, 87, 89, 93, 95, 100, 111, 114, 118, 119, 123, 127]	[2, 4, 6, 9, 16, 18, 19, 29, 37, 47, 54, 57, 61, 66, 67, 71, 74, 80, 86, 88, 92, 94, 99, 110, 113, 118, 119, 123, 127, 128]	['Spot', '1', 'in', 'Figure', '3D', 'contained', 'protein', 'disulfide', 'isomerase', 'and', 'beta', '-', 'amylase', 'while', 'spots', '2', 'and', '3', 'were', 'identified', 'as', 'beta', '-', 'amylases', '.']	[2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
We compared the performance of high fidelity polymerases and various numbers of rounds of amplification when amplifying a mock community and human stool samples.	[('PMC6531881', 'A00002', 45, 56, 'polymerases')]	['We', 'compared', 'the', 'performance', 'of', 'high', 'fidelity', 'polymerase', '##s', 'and', 'various', 'numbers', 'of', 'rounds', 'of', 'amplification', 'when', 'amplify', '##ing', 'a', 'mock', 'community', 'and', 'human', 'stool', 'samples', '.']	[0, 3, 12, 16, 28, 31, 36, 45, 55, 57, 61, 69, 77, 80, 87, 90, 104, 109, 116, 120, 122, 127, 137, 141, 147, 153, 160]	[2, 11, 15, 27, 30, 35, 44, 55, 56, 60, 68, 76, 79, 86, 89, 103, 108, 116, 119, 121, 126, 136, 140, 146, 152, 160, 161]	['We', 'compared', 'the', 'performance', 'of', 'high', 'fidelity', 'polymerases', 'and', 'various', 'numbers', 'of', 'rounds', 'of', 'amplification', 'when', 'amplifying', 'a', 'mock', 'community', 'and', 'human', 'stool', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Namely, using a polymerase with the highest possible fidelity and minimizing the number of rounds of PCR reduced the sequencing error rate, fraction of chimeric sequences, and bias.	[('PMC6531881', 'A00004', 16, 26, 'polymerase')]	['Namely', ',', 'using', 'a', 'polymerase', 'with', 'the', 'highest', 'possible', 'fidelity', 'and', 'minimizing', 'the', 'number', 'of', 'rounds', 'of', 'PCR', 'reduced', 'the', 'sequencing', 'error', 'rate', ',', 'fraction', 'of', 'chimeric', 'sequences', ',', 'and', 'bias', '.']	[0, 6, 8, 14, 16, 27, 32, 36, 44, 53, 62, 66, 77, 81, 88, 91, 98, 101, 105, 113, 117, 128, 134, 138, 140, 149, 152, 161, 170, 172, 176, 180]	[6, 7, 13, 15, 26, 31, 35, 43, 52, 61, 65, 76, 80, 87, 90, 97, 100, 104, 112, 116, 127, 133, 138, 139, 148, 151, 160, 170, 171, 175, 180, 181]	['Namely', ',', 'using', 'a', 'polymerase', 'with', 'the', 'highest', 'possible', 'fidelity', 'and', 'minimizing', 'the', 'number', 'of', 'rounds', 'of', 'PCR', 'reduced', 'the', 'sequencing', 'error', 'rate', ',', 'fraction', 'of', 'chimeric', 'sequences', ',', 'and', 'bias', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the results indicate that the variation in human stool samples is generally larger than that introduced by the choice of polymerase or number of rounds of PCR.	[('PMC6531881', 'A00009', 130, 140, 'polymerase')]	['However', ',', 'the', 'results', 'indicate', 'that', 'the', 'variation', 'in', 'human', 'stool', 'samples', 'is', 'generally', 'larger', 'than', 'that', 'introduced', 'by', 'the', 'choice', 'of', 'polymerase', 'or', 'number', 'of', 'rounds', 'of', 'PCR', '.']	[0, 7, 9, 13, 21, 30, 35, 39, 49, 52, 58, 64, 72, 75, 85, 92, 97, 102, 113, 116, 120, 127, 130, 141, 144, 151, 154, 161, 164, 167]	[7, 8, 12, 20, 29, 34, 38, 48, 51, 57, 63, 71, 74, 84, 91, 96, 101, 112, 115, 119, 126, 129, 140, 143, 150, 153, 160, 163, 167, 168]	['However', ',', 'the', 'results', 'indicate', 'that', 'the', 'variation', 'in', 'human', 'stool', 'samples', 'is', 'generally', 'larger', 'than', 'that', 'introduced', 'by', 'the', 'choice', 'of', 'polymerase', 'or', 'number', 'of', 'rounds', 'of', 'PCR', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We quantified the effects of the choice of polymerase and number of PCR cycles on the quality of downstream data.	[('PMC6531881', 'A01003', 43, 53, 'polymerase')]	['We', 'quantified', 'the', 'effects', 'of', 'the', 'choice', 'of', 'polymerase', 'and', 'number', 'of', 'PCR', 'cycles', 'on', 'the', 'quality', 'of', 'downstream', 'data', '.']	[0, 3, 14, 18, 26, 29, 33, 40, 43, 54, 58, 65, 68, 72, 79, 82, 86, 94, 97, 108, 112]	[2, 13, 17, 25, 28, 32, 39, 42, 53, 57, 64, 67, 71, 78, 81, 85, 93, 96, 107, 112, 113]	['We', 'quantified', 'the', 'effects', 'of', 'the', 'choice', 'of', 'polymerase', 'and', 'number', 'of', 'PCR', 'cycles', 'on', 'the', 'quality', 'of', 'downstream', 'data', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The effects are relatively small compared to the variation in human stool samples; however, care should be taken to use polymerases with the highest possible fidelity and to minimize the number of rounds of PCR.	[('PMC6531881', 'A01005', 120, 131, 'polymerases')]	['The', 'effects', 'are', 'relatively', 'small', 'compared', 'to', 'the', 'variation', 'in', 'human', 'stool', 'samples', ';', 'however', ',', 'care', 'should', 'be', 'taken', 'to', 'use', 'polymerase', '##s', 'with', 'the', 'highest', 'possible', 'fidelity', 'and', 'to', 'minimize', 'the', 'number', 'of', 'rounds', 'of', 'PCR', '.']	[0, 4, 12, 16, 27, 33, 42, 45, 49, 59, 62, 68, 74, 81, 83, 90, 92, 97, 104, 107, 113, 116, 120, 130, 132, 137, 141, 149, 158, 167, 171, 174, 183, 187, 194, 197, 204, 207, 210]	[3, 11, 15, 26, 32, 41, 44, 48, 58, 61, 67, 73, 81, 82, 90, 91, 96, 103, 106, 112, 115, 119, 130, 131, 136, 140, 148, 157, 166, 170, 173, 182, 186, 193, 196, 203, 206, 210, 211]	['The', 'effects', 'are', 'relatively', 'small', 'compared', 'to', 'the', 'variation', 'in', 'human', 'stool', 'samples', ';', 'however', ',', 'care', 'should', 'be', 'taken', 'to', 'use', 'polymerases', 'with', 'the', 'highest', 'possible', 'fidelity', 'and', 'to', 'minimize', 'the', 'number', 'of', 'rounds', 'of', 'PCR', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our results suggest that the number of rounds of PCR and to a lesser degree the choice of DNA polymerase impact the analysis of 16S rRNA gene sequence data from bacterial communities.	[('PMC6531881', 'D00000', 94, 104, 'polymerase')]	['Our', 'results', 'suggest', 'that', 'the', 'number', 'of', 'rounds', 'of', 'PCR', 'and', 'to', 'a', 'lesser', 'degree', 'the', 'choice', 'of', 'DNA', 'polymerase', 'impact', 'the', 'analysis', 'of', '16', '##S', 'rRNA', 'gene', 'sequence', 'data', 'from', 'bacterial', 'communities', '.']	[0, 4, 12, 20, 25, 29, 36, 39, 46, 49, 53, 57, 60, 62, 69, 76, 80, 87, 90, 94, 105, 112, 116, 125, 128, 130, 132, 137, 142, 151, 156, 161, 171, 182]	[3, 11, 19, 24, 28, 35, 38, 45, 48, 52, 56, 59, 61, 68, 75, 79, 86, 89, 93, 104, 111, 115, 124, 127, 130, 131, 136, 141, 150, 155, 160, 170, 182, 183]	['Our', 'results', 'suggest', 'that', 'the', 'number', 'of', 'rounds', 'of', 'PCR', 'and', 'to', 'a', 'lesser', 'degree', 'the', 'choice', 'of', 'DNA', 'polymerase', 'impact', 'the', 'analysis', 'of', '16S', 'rRNA', 'gene', 'sequence', 'data', 'from', 'bacterial', 'communities', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The observed sequencing error rates and alpha diversity metrics followed the manufacturers’ measurements of their polymerases’ fidelity (Fig. 1).	[('PMC6531881', 'D01000', 114, 125, 'polymerases')]	['The', 'observed', 'sequencing', 'error', 'rates', 'and', 'alpha', 'diversity', 'metrics', 'followed', 'the', 'manufacturers', '’', 'measurements', 'of', 'their', 'polymerase', '##s', '’', 'fidelity', '(', 'Fig', '.', '1', ')', '.']	[0, 4, 13, 24, 30, 36, 40, 46, 56, 64, 73, 77, 90, 92, 105, 108, 114, 124, 125, 127, 136, 137, 140, 142, 143, 144]	[3, 12, 23, 29, 35, 39, 45, 55, 63, 72, 76, 90, 91, 104, 107, 113, 124, 125, 126, 135, 137, 140, 141, 143, 144, 145]	['The', 'observed', 'sequencing', 'error', 'rates', 'and', 'alpha', 'diversity', 'metrics', 'followed', 'the', 'manufacturers', '’', 'measurements', 'of', 'their', 'polymerases', '’', 'fidelity', '(', 'Fig', '.', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among these polymerases, the KAPA polymerase consistently resulted in a lower error rate, lower chimera rate, and lower bias across rounds of PCR for the mock community samples.	[('PMC6531881', 'D01002', 12, 22, 'polymerase'), ('PMC6531881', 'D01002', 34, 44, 'polymerase')]	['Among', 'these', 'polymerase', '##s', ',', 'the', 'KA', '##PA', 'polymerase', 'consistently', 'resulted', 'in', 'a', 'lower', 'error', 'rate', ',', 'lower', 'chim', '##era', 'rate', ',', 'and', 'lower', 'bias', 'across', 'rounds', 'of', 'PCR', 'for', 'the', 'mock', 'community', 'samples', '.']	[0, 6, 12, 22, 23, 25, 29, 31, 34, 45, 58, 67, 70, 72, 78, 84, 88, 90, 96, 100, 104, 108, 110, 114, 120, 125, 132, 139, 142, 146, 150, 154, 159, 169, 176]	[5, 11, 22, 23, 24, 28, 31, 33, 44, 57, 66, 69, 71, 77, 83, 88, 89, 95, 100, 103, 108, 109, 113, 119, 124, 131, 138, 141, 145, 149, 153, 158, 168, 176, 177]	['Among', 'these', 'polymerases', ',', 'the', 'KAPA', 'polymerase', 'consistently', 'resulted', 'in', 'a', 'lower', 'error', 'rate', ',', 'lower', 'chimera', 'rate', ',', 'and', 'lower', 'bias', 'across', 'rounds', 'of', 'PCR', 'for', 'the', 'mock', 'community', 'samples', '.']	[1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, among the human samples, the KAPA polymerase consistently had the lowest detected chimera rate and intercycle bias.	[('PMC6531881', 'D01003', 47, 57, 'polymerase')]	['Furthermore', ',', 'among', 'the', 'human', 'samples', ',', 'the', 'KA', '##PA', 'polymerase', 'consistently', 'had', 'the', 'lowest', 'detected', 'chim', '##era', 'rate', 'and', 'inter', '##cycle', 'bias', '.']	[0, 11, 13, 19, 23, 29, 36, 38, 42, 44, 47, 58, 71, 75, 79, 86, 95, 99, 103, 108, 112, 117, 123, 127]	[11, 12, 18, 22, 28, 36, 37, 41, 44, 46, 57, 70, 74, 78, 85, 94, 99, 102, 107, 111, 117, 122, 127, 128]	['Furthermore', ',', 'among', 'the', 'human', 'samples', ',', 'the', 'KAPA', 'polymerase', 'consistently', 'had', 'the', 'lowest', 'detected', 'chimera', 'rate', 'and', 'intercycle', 'bias', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, in our experience and despite efforts to optimize the yield with the KAPA polymerase, the reactions typically had a high proportion of primer-dimer products and low yield of correctly sized products.	[('PMC6531881', 'D01005', 83, 93, 'polymerase')]	['However', ',', 'in', 'our', 'experience', 'and', 'despite', 'efforts', 'to', 'optimize', 'the', 'yield', 'with', 'the', 'KA', '##PA', 'polymerase', ',', 'the', 'reactions', 'typically', 'had', 'a', 'high', 'proportion', 'of', 'primer', '-', 'dimer', 'products', 'and', 'low', 'yield', 'of', 'correctly', 'sized', 'products', '.']	[0, 7, 9, 12, 16, 27, 31, 39, 47, 50, 59, 63, 69, 74, 78, 80, 83, 93, 95, 99, 109, 119, 123, 125, 130, 141, 144, 150, 151, 157, 166, 170, 174, 180, 183, 193, 199, 207]	[7, 8, 11, 15, 26, 30, 38, 46, 49, 58, 62, 68, 73, 77, 80, 82, 93, 94, 98, 108, 118, 122, 124, 129, 140, 143, 150, 151, 156, 165, 169, 173, 179, 182, 192, 198, 207, 208]	['However', ',', 'in', 'our', 'experience', 'and', 'despite', 'efforts', 'to', 'optimize', 'the', 'yield', 'with', 'the', 'KAPA', 'polymerase', ',', 'the', 'reactions', 'typically', 'had', 'a', 'high', 'proportion', 'of', 'primer', '-', 'dimer', 'products', 'and', 'low', 'yield', 'of', 'correctly', 'sized', 'products', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although the error rate with the Accuprime polymerase was not as low as that with KAPA, we consider it to be an acceptable alternative.	[('PMC6531881', 'D01006', 43, 53, 'polymerase')]	['Although', 'the', 'error', 'rate', 'with', 'the', 'Acc', '##up', '##rim', '##e', 'polymerase', 'was', 'not', 'as', 'low', 'as', 'that', 'with', 'KA', '##PA', ',', 'we', 'consider', 'it', 'to', 'be', 'an', 'acceptable', 'alternative', '.']	[0, 9, 13, 19, 24, 29, 33, 36, 38, 41, 43, 54, 58, 62, 65, 69, 72, 77, 82, 84, 86, 88, 91, 100, 103, 106, 109, 112, 123, 134]	[8, 12, 18, 23, 28, 32, 36, 38, 41, 42, 53, 57, 61, 64, 68, 71, 76, 81, 84, 86, 87, 90, 99, 102, 105, 108, 111, 122, 134, 135]	['Although', 'the', 'error', 'rate', 'with', 'the', 'Accuprime', 'polymerase', 'was', 'not', 'as', 'low', 'as', 'that', 'with', 'KAPA', ',', 'we', 'consider', 'it', 'to', 'be', 'an', 'acceptable', 'alternative', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Considering that polymerase development is an active area of commercial development with potential new polymerases becoming available, it is important for researchers to understand how changing the polymerase impacts downstream analyses for their type of samples.	[('PMC6531881', 'D01007', 103, 114, 'polymerases'), ('PMC6531881', 'D01007', 198, 208, 'polymerase')]	['Considering', 'that', 'polymerase', 'development', 'is', 'an', 'active', 'area', 'of', 'commercial', 'development', 'with', 'potential', 'new', 'polymerase', '##s', 'becoming', 'available', ',', 'it', 'is', 'important', 'for', 'researchers', 'to', 'understand', 'how', 'changing', 'the', 'polymerase', 'impacts', 'downstream', 'analyses', 'for', 'their', 'type', 'of', 'samples', '.']	[0, 12, 17, 28, 40, 43, 46, 53, 58, 61, 72, 84, 89, 99, 103, 113, 115, 124, 133, 135, 138, 141, 151, 155, 167, 170, 181, 185, 194, 198, 209, 217, 228, 237, 241, 247, 252, 255, 262]	[11, 16, 27, 39, 42, 45, 52, 57, 60, 71, 83, 88, 98, 102, 113, 114, 123, 133, 134, 137, 140, 150, 154, 166, 169, 180, 184, 193, 197, 208, 216, 227, 236, 240, 246, 251, 254, 262, 263]	['Considering', 'that', 'polymerase', 'development', 'is', 'an', 'active', 'area', 'of', 'commercial', 'development', 'with', 'potential', 'new', 'polymerases', 'becoming', 'available', ',', 'it', 'is', 'important', 'for', 'researchers', 'to', 'understand', 'how', 'changing', 'the', 'polymerase', 'impacts', 'downstream', 'analyses', 'for', 'their', 'type', 'of', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Minimizing the level of DNA shearing, controlling for template concentration across samples, and using the fewest number of rounds of PCR with a polymerase that has the highest possible fidelity are strategies that can be employed to minimize the formation of chimeras.	[('PMC6531881', 'D02008', 145, 155, 'polymerase')]	['Minim', '##izing', 'the', 'level', 'of', 'DNA', 'shear', '##ing', ',', 'controlling', 'for', 'template', 'concentration', 'across', 'samples', ',', 'and', 'using', 'the', 'few', '##est', 'number', 'of', 'rounds', 'of', 'PCR', 'with', 'a', 'polymerase', 'that', 'has', 'the', 'highest', 'possible', 'fidelity', 'are', 'strategies', 'that', 'can', 'be', 'employed', 'to', 'minimize', 'the', 'formation', 'of', 'chim', '##eras', '.']	[0, 5, 11, 15, 21, 24, 28, 33, 36, 38, 50, 54, 63, 77, 84, 91, 93, 97, 103, 107, 110, 114, 121, 124, 131, 134, 138, 143, 145, 156, 161, 165, 169, 177, 186, 195, 199, 210, 215, 219, 222, 231, 234, 243, 247, 257, 260, 264, 268]	[5, 10, 14, 20, 23, 27, 33, 36, 37, 49, 53, 62, 76, 83, 91, 92, 96, 102, 106, 110, 113, 120, 123, 130, 133, 137, 142, 144, 155, 160, 164, 168, 176, 185, 194, 198, 209, 214, 218, 221, 230, 233, 242, 246, 256, 259, 264, 268, 269]	['Minimizing', 'the', 'level', 'of', 'DNA', 'shearing', ',', 'controlling', 'for', 'template', 'concentration', 'across', 'samples', ',', 'and', 'using', 'the', 'fewest', 'number', 'of', 'rounds', 'of', 'PCR', 'with', 'a', 'polymerase', 'that', 'has', 'the', 'highest', 'possible', 'fidelity', 'are', 'strategies', 'that', 'can', 'be', 'employed', 'to', 'minimize', 'the', 'formation', 'of', 'chimeras', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although care should always be taken when choosing a polymerase for 16S rRNA gene sequencing, our observations show that variation among polymerases is smaller than the actual biological variation in fecal communities between individuals.	[('PMC6531881', 'D02009', 53, 63, 'polymerase'), ('PMC6531881', 'D02009', 137, 148, 'polymerases')]	['Although', 'care', 'should', 'always', 'be', 'taken', 'when', 'choosing', 'a', 'polymerase', 'for', '16', '##S', 'rRNA', 'gene', 'sequencing', ',', 'our', 'observations', 'show', 'that', 'variation', 'among', 'polymerase', '##s', 'is', 'smaller', 'than', 'the', 'actual', 'biological', 'variation', 'in', 'fecal', 'communities', 'between', 'individuals', '.']	[0, 9, 14, 21, 28, 31, 37, 42, 51, 53, 64, 68, 70, 72, 77, 82, 92, 94, 98, 111, 116, 121, 131, 137, 147, 149, 152, 160, 165, 169, 176, 187, 197, 200, 206, 218, 226, 237]	[8, 13, 20, 27, 30, 36, 41, 50, 52, 63, 67, 70, 71, 76, 81, 92, 93, 97, 110, 115, 120, 130, 136, 147, 148, 151, 159, 164, 168, 175, 186, 196, 199, 205, 217, 225, 237, 238]	['Although', 'care', 'should', 'always', 'be', 'taken', 'when', 'choosing', 'a', 'polymerase', 'for', '16S', 'rRNA', 'gene', 'sequencing', ',', 'our', 'observations', 'show', 'that', 'variation', 'among', 'polymerases', 'is', 'smaller', 'than', 'the', 'actual', 'biological', 'variation', 'in', 'fecal', 'communities', 'between', 'individuals', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Beyond the imperfections of the best polymerases, sometimes difficult to lyse organisms require stringent lysis steps and low biomass samples require additional rounds of PCR.	[('PMC6531881', 'D03001', 37, 48, 'polymerases')]	['Beyond', 'the', 'imperfect', '##ions', 'of', 'the', 'best', 'polymerase', '##s', ',', 'sometimes', 'difficult', 'to', 'lys', '##e', 'organisms', 'require', 'stringent', 'lysis', 'steps', 'and', 'low', 'biomass', 'samples', 'require', 'additional', 'rounds', 'of', 'PCR', '.']	[0, 7, 11, 20, 25, 28, 32, 37, 47, 48, 50, 60, 70, 73, 76, 78, 88, 96, 106, 112, 118, 122, 126, 134, 142, 150, 161, 168, 171, 174]	[6, 10, 20, 24, 27, 31, 36, 47, 48, 49, 59, 69, 72, 76, 77, 87, 95, 105, 111, 117, 121, 125, 133, 141, 149, 160, 167, 170, 174, 175]	['Beyond', 'the', 'imperfections', 'of', 'the', 'best', 'polymerases', ',', 'sometimes', 'difficult', 'to', 'lyse', 'organisms', 'require', 'stringent', 'lysis', 'steps', 'and', 'low', 'biomass', 'samples', 'require', 'additional', 'rounds', 'of', 'PCR', '.']	[1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Error rate comparison during polymerase chain reaction by DNA polymerase.	[('PMC6531881', 'F24002', 29, 39, 'polymerase'), ('PMC6531881', 'F24002', 58, 72, 'DNA polymerase')]	['Error', 'rate', 'comparison', 'during', 'polymerase', 'chain', 'reaction', 'by', 'DNA', 'polymerase', '.']	[0, 6, 11, 22, 29, 40, 46, 55, 58, 62, 72]	[5, 10, 21, 28, 39, 45, 54, 57, 61, 72, 73]	['Error', 'rate', 'comparison', 'during', 'polymerase', 'chain', 'reaction', 'by', 'DNA', 'polymerase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'B', 'E', 'O']
PCR fidelity of Pfu DNA polymerase and other thermostable DNA polymerases.	[('PMC6531881', 'F25002', 20, 34, 'DNA polymerase'), ('PMC6531881', 'F25002', 58, 73, 'DNA polymerases')]	['PCR', 'fidelity', 'of', 'Pf', '##u', 'DNA', 'polymerase', 'and', 'other', 'therm', '##ost', '##able', 'DNA', 'polymerase', '##s', '.']	[0, 4, 13, 16, 18, 20, 24, 35, 39, 45, 50, 53, 58, 62, 72, 73]	[3, 12, 15, 18, 19, 23, 34, 38, 44, 50, 53, 57, 61, 72, 73, 74]	['PCR', 'fidelity', 'of', 'Pfu', 'DNA', 'polymerase', 'and', 'other', 'thermostable', 'DNA', 'polymerases', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Surveys of gene families using polymerase chain reaction: PCR selection and PCR drift.	[('PMC6531881', 'F31002', 31, 41, 'polymerase')]	['Survey', '##s', 'of', 'gene', 'families', 'using', 'polymerase', 'chain', 'reaction', ':', 'PCR', 'selection', 'and', 'PCR', 'drift', '.']	[0, 6, 8, 11, 16, 25, 31, 42, 48, 56, 58, 62, 72, 76, 80, 85]	[6, 7, 10, 15, 24, 30, 41, 47, 56, 57, 61, 71, 75, 79, 85, 86]	['Surveys', 'of', 'gene', 'families', 'using', 'polymerase', 'chain', 'reaction', ':', 'PCR', 'selection', 'and', 'PCR', 'drift', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The influence that the choice of DNA polymerase has on the formation of PCR artifacts has not been well studied.	[('PMC6531881', 'I02000', 33, 47, 'DNA polymerase')]	['The', 'influence', 'that', 'the', 'choice', 'of', 'DNA', 'polymerase', 'has', 'on', 'the', 'formation', 'of', 'PCR', 'artifacts', 'has', 'not', 'been', 'well', 'studied', '.']	[0, 4, 14, 19, 23, 30, 33, 37, 48, 52, 55, 59, 69, 72, 76, 86, 90, 94, 99, 104, 111]	[3, 13, 18, 22, 29, 32, 36, 47, 51, 54, 58, 68, 71, 75, 85, 89, 93, 98, 103, 111, 112]	['The', 'influence', 'that', 'the', 'choice', 'of', 'DNA', 'polymerase', 'has', 'on', 'the', 'formation', 'of', 'PCR', 'artifacts', 'has', 'not', 'been', 'well', 'studied', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There has been recent interest in how the choice of the hypervariable region and data analysis pipeline impact the sequencing error rate (15, 18,–20); however, these studies use the same DNA polymerase in the PCR step and implicitly assume that the rate of nucleotide misincorporation from PCR are significantly smaller than those from the sequencing phase.	[('PMC6531881', 'I02001', 187, 201, 'DNA polymerase')]	['There', 'has', 'been', 'recent', 'interest', 'in', 'how', 'the', 'choice', 'of', 'the', 'hyper', '##variable', 'region', 'and', 'data', 'analysis', 'pipeline', 'impact', 'the', 'sequencing', 'error', 'rate', '(', '15', ',', '18', ',', '–', '20', ')', ';', 'however', ',', 'these', 'studies', 'use', 'the', 'same', 'DNA', 'polymerase', 'in', 'the', 'PCR', 'step', 'and', 'implicitly', 'assume', 'that', 'the', 'rate', 'of', 'nucleotide', 'mis', '##inc', '##orp', '##oration', 'from', 'PCR', 'are', 'significantly', 'smaller', 'than', 'those', 'from', 'the', 'sequencing', 'phase', '.']	[0, 6, 10, 15, 22, 31, 34, 38, 42, 49, 52, 56, 61, 70, 77, 81, 86, 95, 104, 111, 115, 126, 132, 137, 138, 140, 142, 144, 145, 146, 148, 149, 151, 158, 160, 166, 174, 178, 182, 187, 191, 202, 205, 209, 213, 218, 222, 233, 240, 245, 249, 254, 257, 268, 271, 274, 277, 285, 290, 294, 298, 312, 320, 325, 331, 336, 340, 351, 356]	[5, 9, 14, 21, 30, 33, 37, 41, 48, 51, 55, 61, 69, 76, 80, 85, 94, 103, 110, 114, 125, 131, 136, 138, 140, 141, 144, 145, 146, 148, 149, 150, 158, 159, 165, 173, 177, 181, 186, 190, 201, 204, 208, 212, 217, 221, 232, 239, 244, 248, 253, 256, 267, 271, 274, 277, 284, 289, 293, 297, 311, 319, 324, 330, 335, 339, 350, 356, 357]	['There', 'has', 'been', 'recent', 'interest', 'in', 'how', 'the', 'choice', 'of', 'the', 'hypervariable', 'region', 'and', 'data', 'analysis', 'pipeline', 'impact', 'the', 'sequencing', 'error', 'rate', '(', '15', ',', '18', ',', '–20', ')', ';', 'however', ',', 'these', 'studies', 'use', 'the', 'same', 'DNA', 'polymerase', 'in', 'the', 'PCR', 'step', 'and', 'implicitly', 'assume', 'that', 'the', 'rate', 'of', 'nucleotide', 'misincorporation', 'from', 'PCR', 'are', 'significantly', 'smaller', 'than', 'those', 'from', 'the', 'sequencing', 'phase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A recent study found differences in the number of operational taxonomic units (OTUs) and chimeras between normal and high fidelity DNA polymerases (38).	[('PMC6531881', 'I02003', 131, 146, 'DNA polymerases')]	['A', 'recent', 'study', 'found', 'differences', 'in', 'the', 'number', 'of', 'operational', 'taxonomic', 'units', '(', 'OT', '##Us', ')', 'and', 'chim', '##eras', 'between', 'normal', 'and', 'high', 'fidelity', 'DNA', 'polymerase', '##s', '(', '38', ')', '.']	[0, 2, 9, 15, 21, 33, 36, 40, 47, 50, 62, 72, 78, 79, 81, 83, 85, 89, 93, 98, 106, 113, 117, 122, 131, 135, 145, 147, 148, 150, 151]	[1, 8, 14, 20, 32, 35, 39, 46, 49, 61, 71, 77, 79, 81, 83, 84, 88, 93, 97, 105, 112, 116, 121, 130, 134, 145, 146, 148, 150, 151, 152]	['A', 'recent', 'study', 'found', 'differences', 'in', 'the', 'number', 'of', 'operational', 'taxonomic', 'units', '(', 'OTUs', ')', 'and', 'chimeras', 'between', 'normal', 'and', 'high', 'fidelity', 'DNA', 'polymerases', '(', '38', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
The authors of the study reduced the difference between two polymerases by optimizing the annealing and extension steps within the PCR protocol (38).	[('PMC6531881', 'I02004', 60, 71, 'polymerases')]	['The', 'authors', 'of', 'the', 'study', 'reduced', 'the', 'difference', 'between', 'two', 'polymerase', '##s', 'by', 'optimizing', 'the', 'annealing', 'and', 'extension', 'steps', 'within', 'the', 'PCR', 'protocol', '(', '38', ')', '.']	[0, 4, 12, 15, 19, 25, 33, 37, 48, 56, 60, 70, 72, 75, 86, 90, 100, 104, 114, 120, 127, 131, 135, 144, 145, 147, 148]	[3, 11, 14, 18, 24, 32, 36, 47, 55, 59, 70, 71, 74, 85, 89, 99, 103, 113, 119, 126, 130, 134, 143, 145, 147, 148, 149]	['The', 'authors', 'of', 'the', 'study', 'reduced', 'the', 'difference', 'between', 'two', 'polymerases', 'by', 'optimizing', 'the', 'annealing', 'and', 'extension', 'steps', 'within', 'the', 'PCR', 'protocol', '(', '38', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Yet this optimization was specific for the community they were analyzing (i.e., captive and semicaptive red-shanked doucs) and assumed that if the two polymerases generate the same community structure that the community structure was correct.	[('PMC6531881', 'I02005', 151, 162, 'polymerases')]	['Yet', 'this', 'optimization', 'was', 'specific', 'for', 'the', 'community', 'they', 'were', 'analyzing', '(', 'i', '.', 'e', '.', ',', 'cap', '##tive', 'and', 'semic', '##apt', '##ive', 'red', '-', 'sh', '##ank', '##ed', 'do', '##uc', '##s', ')', 'and', 'assumed', 'that', 'if', 'the', 'two', 'polymerase', '##s', 'generate', 'the', 'same', 'community', 'structure', 'that', 'the', 'community', 'structure', 'was', 'correct', '.']	[0, 4, 9, 22, 26, 35, 39, 43, 53, 58, 63, 73, 74, 75, 76, 77, 78, 80, 83, 88, 92, 97, 100, 104, 107, 108, 110, 113, 116, 118, 120, 121, 123, 127, 135, 140, 143, 147, 151, 161, 163, 172, 176, 181, 191, 201, 206, 210, 220, 230, 234, 241]	[3, 8, 21, 25, 34, 38, 42, 52, 57, 62, 72, 74, 75, 76, 77, 78, 79, 83, 87, 91, 97, 100, 103, 107, 108, 110, 113, 115, 118, 120, 121, 122, 126, 134, 139, 142, 146, 150, 161, 162, 171, 175, 180, 190, 200, 205, 209, 219, 229, 233, 241, 242]	['Yet', 'this', 'optimization', 'was', 'specific', 'for', 'the', 'community', 'they', 'were', 'analyzing', '(', 'i.e', '.', ',', 'captive', 'and', 'semicaptive', 'red', '-', 'shanked', 'doucs', ')', 'and', 'assumed', 'that', 'if', 'the', 'two', 'polymerases', 'generate', 'the', 'same', 'community', 'structure', 'that', 'the', 'community', 'structure', 'was', 'correct', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Given the large number of DNA polymerases available to researchers, it is unlikely that a specific recommendation is possible.	[('PMC6531881', 'I02011', 26, 41, 'DNA polymerases')]	['Given', 'the', 'large', 'number', 'of', 'DNA', 'polymerase', '##s', 'available', 'to', 'researchers', ',', 'it', 'is', 'unlikely', 'that', 'a', 'specific', 'recommendation', 'is', 'possible', '.']	[0, 6, 10, 16, 23, 26, 30, 40, 42, 52, 55, 66, 68, 71, 74, 83, 88, 90, 99, 114, 117, 125]	[5, 9, 15, 22, 25, 29, 40, 41, 51, 54, 66, 67, 70, 73, 82, 87, 89, 98, 113, 116, 125, 126]	['Given', 'the', 'large', 'number', 'of', 'DNA', 'polymerases', 'available', 'to', 'researchers', ',', 'it', 'is', 'unlikely', 'that', 'a', 'specific', 'recommendation', 'is', 'possible', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This study investigated the impact of choice of high fidelity DNA polymerase and the number of rounds of amplification on the formation of PCR artifacts using a mock community and human stool samples.	[('PMC6531881', 'I03000', 62, 76, 'DNA polymerase')]	['This', 'study', 'investigated', 'the', 'impact', 'of', 'choice', 'of', 'high', 'fidelity', 'DNA', 'polymerase', 'and', 'the', 'number', 'of', 'rounds', 'of', 'amplification', 'on', 'the', 'formation', 'of', 'PCR', 'artifacts', 'using', 'a', 'mock', 'community', 'and', 'human', 'stool', 'samples', '.']	[0, 5, 11, 24, 28, 35, 38, 45, 48, 53, 62, 66, 77, 81, 85, 92, 95, 102, 105, 119, 122, 126, 136, 139, 143, 153, 159, 161, 166, 176, 180, 186, 192, 199]	[4, 10, 23, 27, 34, 37, 44, 47, 52, 61, 65, 76, 80, 84, 91, 94, 101, 104, 118, 121, 125, 135, 138, 142, 152, 158, 160, 165, 175, 179, 185, 191, 199, 200]	['This', 'study', 'investigated', 'the', 'impact', 'of', 'choice', 'of', 'high', 'fidelity', 'DNA', 'polymerase', 'and', 'the', 'number', 'of', 'rounds', 'of', 'amplification', 'on', 'the', 'formation', 'of', 'PCR', 'artifacts', 'using', 'a', 'mock', 'community', 'and', 'human', 'stool', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We tested (i) the effect of the polymerase on the error rate of the bases represented in the final sequences, (ii) the fraction of sequences that appeared to be chimeras and the ability to detect those chimeras, (iii) the bias of preferentially amplifying one fragment over another in a mixed pool of templates, and (iv) intersample variation in community structure of samples amplified with the same polymerase across the amplification process.	[('PMC6531881', 'I03002', 32, 42, 'polymerase'), ('PMC6531881', 'I03002', 401, 411, 'polymerase')]	['We', 'tested', '(', 'i', ')', 'the', 'effect', 'of', 'the', 'polymerase', 'on', 'the', 'error', 'rate', 'of', 'the', 'bases', 'represented', 'in', 'the', 'final', 'sequences', ',', '(', 'ii', ')', 'the', 'fraction', 'of', 'sequences', 'that', 'appeared', 'to', 'be', 'chim', '##eras', 'and', 'the', 'ability', 'to', 'detect', 'those', 'chim', '##eras', ',', '(', 'iii', ')', 'the', 'bias', 'of', 'preferentially', 'amplify', '##ing', 'one', 'fragment', 'over', 'another', 'in', 'a', 'mixed', 'pool', 'of', 'templates', ',', 'and', '(', 'iv', ')', 'inters', '##ample', 'variation', 'in', 'community', 'structure', 'of', 'samples', 'amplified', 'with', 'the', 'same', 'polymerase', 'across', 'the', 'amplification', 'process', '.']	[0, 3, 10, 11, 12, 14, 18, 25, 28, 32, 43, 46, 50, 56, 61, 64, 68, 74, 86, 89, 93, 99, 108, 110, 111, 113, 115, 119, 128, 131, 141, 146, 155, 158, 161, 165, 170, 174, 178, 186, 189, 196, 202, 206, 210, 212, 213, 216, 218, 222, 227, 230, 245, 252, 256, 260, 269, 274, 282, 285, 287, 293, 298, 301, 310, 312, 316, 317, 319, 321, 327, 333, 343, 346, 356, 366, 369, 377, 387, 392, 396, 401, 412, 419, 423, 437, 444]	[2, 9, 11, 12, 13, 17, 24, 27, 31, 42, 45, 49, 55, 60, 63, 67, 73, 85, 88, 92, 98, 108, 109, 111, 113, 114, 118, 127, 130, 140, 145, 154, 157, 160, 165, 169, 173, 177, 185, 188, 195, 201, 206, 210, 211, 213, 216, 217, 221, 226, 229, 244, 252, 255, 259, 268, 273, 281, 284, 286, 292, 297, 300, 310, 311, 315, 317, 319, 320, 327, 332, 342, 345, 355, 365, 368, 376, 386, 391, 395, 400, 411, 418, 422, 436, 444, 445]	['We', 'tested', '(i)', 'the', 'effect', 'of', 'the', 'polymerase', 'on', 'the', 'error', 'rate', 'of', 'the', 'bases', 'represented', 'in', 'the', 'final', 'sequences', ',', '(ii)', 'the', 'fraction', 'of', 'sequences', 'that', 'appeared', 'to', 'be', 'chimeras', 'and', 'the', 'ability', 'to', 'detect', 'those', 'chimeras', ',', '(iii)', 'the', 'bias', 'of', 'preferentially', 'amplifying', 'one', 'fragment', 'over', 'another', 'in', 'a', 'mixed', 'pool', 'of', 'templates', ',', 'and', '(iv)', 'intersample', 'variation', 'in', 'community', 'structure', 'of', 'samples', 'amplified', 'with', 'the', 'same', 'polymerase', 'across', 'the', 'amplification', 'process', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O']
To better understand the impact of DNA polymerase choice on PCR artifacts, we selected five high fidelity DNA polymerases and amplified the communities using 20, 25, 30, and 35 rounds of amplification.	[('PMC6531881', 'I03006', 35, 49, 'DNA polymerase'), ('PMC6531881', 'I03006', 106, 121, 'DNA polymerases')]	['To', 'better', 'understand', 'the', 'impact', 'of', 'DNA', 'polymerase', 'choice', 'on', 'PCR', 'artifacts', ',', 'we', 'selected', 'five', 'high', 'fidelity', 'DNA', 'polymerase', '##s', 'and', 'amplified', 'the', 'communities', 'using', '20', ',', '25', ',', '30', ',', 'and', '35', 'rounds', 'of', 'amplification', '.']	[0, 3, 10, 21, 25, 32, 35, 39, 50, 57, 60, 64, 73, 75, 78, 87, 92, 97, 106, 110, 120, 122, 126, 136, 140, 152, 158, 160, 162, 164, 166, 168, 170, 174, 177, 184, 187, 200]	[2, 9, 20, 24, 31, 34, 38, 49, 56, 59, 63, 73, 74, 77, 86, 91, 96, 105, 109, 120, 121, 125, 135, 139, 151, 157, 160, 161, 164, 165, 168, 169, 173, 176, 183, 186, 200, 201]	['To', 'better', 'understand', 'the', 'impact', 'of', 'DNA', 'polymerase', 'choice', 'on', 'PCR', 'artifacts', ',', 'we', 'selected', 'five', 'high', 'fidelity', 'DNA', 'polymerases', 'and', 'amplified', 'the', 'communities', 'using', '20', ',', '25', ',', '30', ',', 'and', '35', 'rounds', 'of', 'amplification', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Collectively, our results suggest that the number of rounds and to a lesser extent the choice of DNA polymerase used in PCR impact the sequence data.	[('PMC6531881', 'I03007', 97, 111, 'DNA polymerase')]	['Collectively', ',', 'our', 'results', 'suggest', 'that', 'the', 'number', 'of', 'rounds', 'and', 'to', 'a', 'lesser', 'extent', 'the', 'choice', 'of', 'DNA', 'polymerase', 'used', 'in', 'PCR', 'impact', 'the', 'sequence', 'data', '.']	[0, 12, 14, 18, 26, 34, 39, 43, 50, 53, 60, 64, 67, 69, 76, 83, 87, 94, 97, 101, 112, 117, 120, 124, 131, 135, 144, 148]	[12, 13, 17, 25, 33, 38, 42, 49, 52, 59, 63, 66, 68, 75, 82, 86, 93, 96, 100, 111, 116, 119, 123, 130, 134, 143, 148, 149]	['Collectively', ',', 'our', 'results', 'suggest', 'that', 'the', 'number', 'of', 'rounds', 'and', 'to', 'a', 'lesser', 'extent', 'the', 'choice', 'of', 'DNA', 'polymerase', 'used', 'in', 'PCR', 'impact', 'the', 'sequence', 'data', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five high fidelity DNA polymerases were tested, including AccuPrime (ThermoFisher, MA, USA), KAPA HIFI (Roche, IN, USA), Phusion (New England Biolabs, MA, USA), Platinum (ThermoFisher, MA, USA), and Q5 (New England Biolabs, MA, USA).	[('PMC6531881', 'M02000', 19, 34, 'DNA polymerases')]	['Five', 'high', 'fidelity', 'DNA', 'polymerase', '##s', 'were', 'tested', ',', 'including', 'Acc', '##u', '##Pr', '##ime', '(', 'Thermo', '##Fisher', ',', 'MA', ',', 'USA', ')', ',', 'KA', '##PA', 'HIF', '##I', '(', 'Roche', ',', 'IN', ',', 'USA', ')', ',', 'Ph', '##usion', '(', 'New', 'England', 'Biol', '##abs', ',', 'MA', ',', 'USA', ')', ',', 'Pl', '##atinum', '(', 'Thermo', '##Fisher', ',', 'MA', ',', 'USA', ')', ',', 'and', 'Q', '##5', '(', 'New', 'England', 'Biol', '##abs', ',', 'MA', ',', 'USA', ')', '.']	[0, 5, 10, 19, 23, 33, 35, 40, 46, 48, 58, 61, 62, 64, 68, 69, 75, 81, 83, 85, 87, 90, 91, 93, 95, 98, 101, 103, 104, 109, 111, 113, 115, 118, 119, 121, 123, 129, 130, 134, 142, 146, 149, 151, 153, 155, 158, 159, 161, 163, 170, 171, 177, 183, 185, 187, 189, 192, 193, 195, 199, 200, 202, 203, 207, 215, 219, 222, 224, 226, 228, 231, 232]	[4, 9, 18, 22, 33, 34, 39, 46, 47, 57, 61, 62, 64, 67, 69, 75, 81, 82, 85, 86, 90, 91, 92, 95, 97, 101, 102, 104, 109, 110, 113, 114, 118, 119, 120, 123, 128, 130, 133, 141, 146, 149, 150, 153, 154, 158, 159, 160, 163, 169, 171, 177, 183, 184, 187, 188, 192, 193, 194, 198, 200, 201, 203, 206, 214, 219, 222, 223, 226, 227, 231, 232, 233]	['Five', 'high', 'fidelity', 'DNA', 'polymerases', 'were', 'tested', ',', 'including', 'AccuPrime', '(', 'ThermoFisher', ',', 'MA', ',', 'USA', ')', ',', 'KAPA', 'HIFI', '(', 'Roche', ',', 'IN', ',', 'USA', ')', ',', 'Phusion', '(', 'New', 'England', 'Biolabs', ',', 'MA', ',', 'USA', ')', ',', 'Platinum', '(', 'ThermoFisher', ',', 'MA', ',', 'USA', ')', ',', 'and', 'Q5', '(', 'New', 'England', 'Biolabs', ',', 'MA', ',', 'USA', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Each PCR condition (i.e., combination of polymerase and number of rounds of PCR) was replicated four times for the mock community and one time for each fecal sample.	[('PMC6531881', 'M03000', 41, 51, 'polymerase')]	['Each', 'PCR', 'condition', '(', 'i', '.', 'e', '.', ',', 'combination', 'of', 'polymerase', 'and', 'number', 'of', 'rounds', 'of', 'PCR', ')', 'was', 'replicated', 'four', 'times', 'for', 'the', 'mock', 'community', 'and', 'one', 'time', 'for', 'each', 'fecal', 'sample', '.']	[0, 5, 9, 19, 20, 21, 22, 23, 24, 26, 38, 41, 52, 56, 63, 66, 73, 76, 79, 81, 85, 96, 101, 107, 111, 115, 120, 130, 134, 138, 143, 147, 152, 158, 164]	[4, 8, 18, 20, 21, 22, 23, 24, 25, 37, 40, 51, 55, 62, 65, 72, 75, 79, 80, 84, 95, 100, 106, 110, 114, 119, 129, 133, 137, 142, 146, 151, 157, 164, 165]	['Each', 'PCR', 'condition', '(', 'i.e', '.', ',', 'combination', 'of', 'polymerase', 'and', 'number', 'of', 'rounds', 'of', 'PCR', ')', 'was', 'replicated', 'four', 'times', 'for', 'the', 'mock', 'community', 'and', 'one', 'time', 'for', 'each', 'fecal', 'sample', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Regardless of the polymerase, the error rate increased with the number of rounds of amplification (Fig. 1).	[('PMC6531881', 'R00005', 18, 28, 'polymerase')]	['Regardless', 'of', 'the', 'polymerase', ',', 'the', 'error', 'rate', 'increased', 'with', 'the', 'number', 'of', 'rounds', 'of', 'amplification', '(', 'Fig', '.', '1', ')', '.']	[0, 11, 14, 18, 28, 30, 34, 40, 45, 55, 60, 64, 71, 74, 81, 84, 98, 99, 102, 104, 105, 106]	[10, 13, 17, 28, 29, 33, 39, 44, 54, 59, 63, 70, 73, 80, 83, 97, 99, 102, 103, 105, 106, 107]	['Regardless', 'of', 'the', 'polymerase', ',', 'the', 'error', 'rate', 'increased', 'with', 'the', 'number', 'of', 'rounds', 'of', 'amplification', '(', 'Fig', '.', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among the data generated using 30 rounds of PCR, the Accuprime polymerase had the highest error rate (i.e., 0.124%), followed by the Platinum (i.e., 0.094%), Phusion (i.e., 0.064%), KAPA (i.e., 0.062%), and Q5 (i.e., 0.060%) polymerases (Fig. 1).	[('PMC6531881', 'R00007', 63, 73, 'polymerase'), ('PMC6531881', 'R00007', 225, 236, 'polymerases')]	['Among', 'the', 'data', 'generated', 'using', '30', 'rounds', 'of', 'PCR', ',', 'the', 'Acc', '##up', '##rim', '##e', 'polymerase', 'had', 'the', 'highest', 'error', 'rate', '(', 'i', '.', 'e', '.', ',', '0', '.', '124', '%', ')', ',', 'followed', 'by', 'the', 'Pl', '##atinum', '(', 'i', '.', 'e', '.', ',', '0', '.', '09', '##4', '%', ')', ',', 'Ph', '##usion', '(', 'i', '.', 'e', '.', ',', '0', '.', '06', '##4', '%', ')', ',', 'KA', '##PA', '(', 'i', '.', 'e', '.', ',', '0', '.', '06', '##2', '%', ')', ',', 'and', 'Q', '##5', '(', 'i', '.', 'e', '.', ',', '0', '.', '06', '##0', '%', ')', 'polymerase', '##s', '(', 'Fig', '.', '1', ')', '.']	[0, 6, 10, 15, 25, 31, 34, 41, 44, 47, 49, 53, 56, 58, 61, 63, 74, 78, 82, 90, 96, 101, 102, 103, 104, 105, 106, 108, 109, 110, 113, 114, 115, 117, 126, 129, 133, 135, 142, 143, 144, 145, 146, 147, 149, 150, 151, 153, 154, 155, 156, 158, 160, 166, 167, 168, 169, 170, 171, 173, 174, 175, 177, 178, 179, 180, 182, 184, 187, 188, 189, 190, 191, 192, 194, 195, 196, 198, 199, 200, 201, 203, 207, 208, 210, 211, 212, 213, 214, 215, 217, 218, 219, 221, 222, 223, 225, 235, 237, 238, 241, 243, 244, 245]	[5, 9, 14, 24, 30, 33, 40, 43, 47, 48, 52, 56, 58, 61, 62, 73, 77, 81, 89, 95, 100, 102, 103, 104, 105, 106, 107, 109, 110, 113, 114, 115, 116, 125, 128, 132, 135, 141, 143, 144, 145, 146, 147, 148, 150, 151, 153, 154, 155, 156, 157, 160, 165, 167, 168, 169, 170, 171, 172, 174, 175, 177, 178, 179, 180, 181, 184, 186, 188, 189, 190, 191, 192, 193, 195, 196, 198, 199, 200, 201, 202, 206, 208, 209, 211, 212, 213, 214, 215, 216, 218, 219, 221, 222, 223, 224, 235, 236, 238, 241, 242, 244, 245, 246]	['Among', 'the', 'data', 'generated', 'using', '30', 'rounds', 'of', 'PCR', ',', 'the', 'Accuprime', 'polymerase', 'had', 'the', 'highest', 'error', 'rate', '(', 'i.e', '.', ',', '0.124%', ')', ',', 'followed', 'by', 'the', 'Platinum', '(', 'i.e', '.', ',', '0.094%', ')', ',', 'Phusion', '(', 'i.e', '.', ',', '0.064%', ')', ',', 'KAPA', '(', 'i.e', '.', ',', '0.062%', ')', ',', 'and', 'Q5', '(', 'i.e', '.', ',', '0.060%', ')', 'polymerases', '(', 'Fig', '.', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 5, 1, 1, 2, 1, 3, 1, 1, 5, 1, 1, 2, 1, 3, 1, 1, 5, 1, 1, 1, 2, 1, 3, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
When we applied a preclustering denoising step, which merged the counts of reads within 2 nt of a more abundant sequence (19), the error rates dropped considerably such that the Platinum polymerase had the highest error rate (i.e., 0.014%), followed by the Accuprime (i.e., 0.012%), Q5 (i.e., 0.0053%), Phusion (i.e., 0.0049%), and KAPA (i.e., 0.0049%) polymerases (Fig. 1).	[('PMC6531881', 'R00008', 187, 197, 'polymerase'), ('PMC6531881', 'R00008', 353, 364, 'polymerases')]	['When', 'we', 'applied', 'a', 'prec', '##lu', '##ster', '##ing', 'deno', '##ising', 'step', ',', 'which', 'merged', 'the', 'counts', 'of', 'reads', 'within', '2', 'nt', 'of', 'a', 'more', 'abundant', 'sequence', '(', '19', ')', ',', 'the', 'error', 'rates', 'dropped', 'considerably', 'such', 'that', 'the', 'Pl', '##atinum', 'polymerase', 'had', 'the', 'highest', 'error', 'rate', '(', 'i', '.', 'e', '.', ',', '0', '.', '01', '##4', '%', ')', ',', 'followed', 'by', 'the', 'Acc', '##up', '##rim', '##e', '(', 'i', '.', 'e', '.', ',', '0', '.', '01', '##2', '%', ')', ',', 'Q', '##5', '(', 'i', '.', 'e', '.', ',', '0', '.', '00', '##53', '%', ')', ',', 'Ph', '##usion', '(', 'i', '.', 'e', '.', ',', '0', '.', '00', '##49', '%', ')', ',', 'and', 'KA', '##PA', '(', 'i', '.', 'e', '.', ',', '0', '.', '00', '##49', '%', ')', 'polymerase', '##s', '(', 'Fig', '.', '1', ')', '.']	[0, 5, 8, 16, 18, 22, 24, 28, 32, 36, 42, 46, 48, 54, 61, 65, 72, 75, 81, 88, 90, 93, 96, 98, 103, 112, 121, 122, 124, 125, 127, 131, 137, 143, 151, 164, 169, 174, 178, 180, 187, 198, 202, 206, 214, 220, 225, 226, 227, 228, 229, 230, 232, 233, 234, 236, 237, 238, 239, 241, 250, 253, 257, 260, 262, 265, 267, 268, 269, 270, 271, 272, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 289, 290, 291, 293, 294, 295, 297, 299, 300, 301, 303, 305, 311, 312, 313, 314, 315, 316, 318, 319, 320, 322, 324, 325, 326, 328, 332, 334, 337, 338, 339, 340, 341, 342, 344, 345, 346, 348, 350, 351, 353, 363, 365, 366, 369, 371, 372, 373]	[4, 7, 15, 17, 22, 24, 28, 31, 36, 41, 46, 47, 53, 60, 64, 71, 74, 80, 87, 89, 92, 95, 97, 102, 111, 120, 122, 124, 125, 126, 130, 136, 142, 150, 163, 168, 173, 177, 180, 186, 197, 201, 205, 213, 219, 224, 226, 227, 228, 229, 230, 231, 233, 234, 236, 237, 238, 239, 240, 249, 252, 256, 260, 262, 265, 266, 268, 269, 270, 271, 272, 273, 275, 276, 278, 279, 280, 281, 282, 284, 285, 287, 288, 289, 290, 291, 292, 294, 295, 297, 299, 300, 301, 302, 305, 310, 312, 313, 314, 315, 316, 317, 319, 320, 322, 324, 325, 326, 327, 331, 334, 336, 338, 339, 340, 341, 342, 343, 345, 346, 348, 350, 351, 352, 363, 364, 366, 369, 370, 372, 373, 374]	['When', 'we', 'applied', 'a', 'preclustering', 'denoising', 'step', ',', 'which', 'merged', 'the', 'counts', 'of', 'reads', 'within', '2', 'nt', 'of', 'a', 'more', 'abundant', 'sequence', '(', '19', ')', ',', 'the', 'error', 'rates', 'dropped', 'considerably', 'such', 'that', 'the', 'Platinum', 'polymerase', 'had', 'the', 'highest', 'error', 'rate', '(', 'i.e', '.', ',', '0.014%', ')', ',', 'followed', 'by', 'the', 'Accuprime', '(', 'i.e', '.', ',', '0.012%', ')', ',', 'Q5', '(', 'i.e', '.', ',', '0.0053%', ')', ',', 'Phusion', '(', 'i.e', '.', ',', '0.0049%', ')', ',', 'and', 'KAPA', '(', 'i.e', '.', ',', '0.0049%', ')', 'polymerases', '(', 'Fig', '.', '1', ')', '.']	[1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 5, 1, 1, 2, 1, 3, 1, 1, 5, 1, 1, 2, 1, 3, 1, 1, 5, 1, 1, 1, 2, 1, 3, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Although specific recommendations are difficult to make because the phylogenetic diversity of the initial DNA template is likely to have an impact on the results, it is clear that using as few PCR cycles as necessary and a polymerase with the lowest possible error rate is a good guide to minimizing the impact of polymerase on the error rate.	[('PMC6531881', 'R00009', 223, 233, 'polymerase'), ('PMC6531881', 'R00009', 314, 324, 'polymerase')]	['Although', 'specific', 'recommendations', 'are', 'difficult', 'to', 'make', 'because', 'the', 'phylogenetic', 'diversity', 'of', 'the', 'initial', 'DNA', 'template', 'is', 'likely', 'to', 'have', 'an', 'impact', 'on', 'the', 'results', ',', 'it', 'is', 'clear', 'that', 'using', 'as', 'few', 'PCR', 'cycles', 'as', 'necessary', 'and', 'a', 'polymerase', 'with', 'the', 'lowest', 'possible', 'error', 'rate', 'is', 'a', 'good', 'guide', 'to', 'minimizing', 'the', 'impact', 'of', 'polymerase', 'on', 'the', 'error', 'rate', '.']	[0, 9, 18, 34, 38, 48, 51, 56, 64, 68, 81, 91, 94, 98, 106, 110, 119, 122, 129, 132, 137, 140, 147, 150, 154, 161, 163, 166, 169, 175, 180, 186, 189, 193, 197, 204, 207, 217, 221, 223, 234, 239, 243, 250, 259, 265, 270, 273, 275, 280, 286, 289, 300, 304, 311, 314, 325, 328, 332, 338, 342]	[8, 17, 33, 37, 47, 50, 55, 63, 67, 80, 90, 93, 97, 105, 109, 118, 121, 128, 131, 136, 139, 146, 149, 153, 161, 162, 165, 168, 174, 179, 185, 188, 192, 196, 203, 206, 216, 220, 222, 233, 238, 242, 249, 258, 264, 269, 272, 274, 279, 285, 288, 299, 303, 310, 313, 324, 327, 331, 337, 342, 343]	['Although', 'specific', 'recommendations', 'are', 'difficult', 'to', 'make', 'because', 'the', 'phylogenetic', 'diversity', 'of', 'the', 'initial', 'DNA', 'template', 'is', 'likely', 'to', 'have', 'an', 'impact', 'on', 'the', 'results', ',', 'it', 'is', 'clear', 'that', 'using', 'as', 'few', 'PCR', 'cycles', 'as', 'necessary', 'and', 'a', 'polymerase', 'with', 'the', 'lowest', 'possible', 'error', 'rate', 'is', 'a', 'good', 'guide', 'to', 'minimizing', 'the', 'impact', 'of', 'polymerase', 'on', 'the', 'error', 'rate', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O']
We compared the vendor-reported relative abundance of the 16S rRNA genes from each bacterium in the mock community to the data we generated across rounds of amplification and polymerase (Fig. 3).	[('PMC6531881', 'R03004', 175, 185, 'polymerase')]	['We', 'compared', 'the', 'vendor', '-', 'reported', 'relative', 'abundance', 'of', 'the', '16', '##S', 'rRNA', 'genes', 'from', 'each', 'bacterium', 'in', 'the', 'mock', 'community', 'to', 'the', 'data', 'we', 'generated', 'across', 'rounds', 'of', 'amplification', 'and', 'polymerase', '(', 'Fig', '.', '3', ')', '.']	[0, 3, 12, 16, 22, 23, 32, 41, 51, 54, 58, 60, 62, 67, 73, 78, 83, 93, 96, 100, 105, 115, 118, 122, 127, 130, 140, 147, 154, 157, 171, 175, 186, 187, 190, 192, 193, 194]	[2, 11, 15, 22, 23, 31, 40, 50, 53, 57, 60, 61, 66, 72, 77, 82, 92, 95, 99, 104, 114, 117, 121, 126, 129, 139, 146, 153, 156, 170, 174, 185, 187, 190, 191, 193, 194, 195]	['We', 'compared', 'the', 'vendor', '-', 'reported', 'relative', 'abundance', 'of', 'the', '16S', 'rRNA', 'genes', 'from', 'each', 'bacterium', 'in', 'the', 'mock', 'community', 'to', 'the', 'data', 'we', 'generated', 'across', 'rounds', 'of', 'amplification', 'and', 'polymerase', '(', 'Fig', '.', '3', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O']
With the exception of the sequence data generated using the KAPA polymerase, the ratios of the two Salmonella enterica V4 sequences from the mock community were lower than the expected ratio of 6:1.	[('PMC6531881', 'R04000', 65, 75, 'polymerase')]	['With', 'the', 'exception', 'of', 'the', 'sequence', 'data', 'generated', 'using', 'the', 'KA', '##PA', 'polymerase', ',', 'the', 'ratios', 'of', 'the', 'two', 'Salmonella', 'enter', '##ica', 'V', '##4', 'sequences', 'from', 'the', 'mock', 'community', 'were', 'lower', 'than', 'the', 'expected', 'ratio', 'of', '6', ':', '1', '.']	[0, 5, 9, 19, 22, 26, 35, 40, 50, 56, 60, 62, 65, 75, 77, 81, 88, 91, 95, 99, 110, 115, 119, 120, 122, 132, 137, 141, 146, 156, 161, 167, 172, 176, 185, 191, 194, 195, 196, 197]	[4, 8, 18, 21, 25, 34, 39, 49, 55, 59, 62, 64, 75, 76, 80, 87, 90, 94, 98, 109, 115, 118, 120, 121, 131, 136, 140, 145, 155, 160, 166, 171, 175, 184, 190, 193, 195, 196, 197, 198]	['With', 'the', 'exception', 'of', 'the', 'sequence', 'data', 'generated', 'using', 'the', 'KAPA', 'polymerase', ',', 'the', 'ratios', 'of', 'the', 'two', 'Salmonella', 'enterica', 'V4', 'sequences', 'from', 'the', 'mock', 'community', 'were', 'lower', 'than', 'the', 'expected', 'ratio', 'of', '6', ':', '1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Because the variation in bias between polymerases and across rounds of PCR could be artificially inflated due to sequencing errors and chimeras, we analyzed the alpha and beta diversity of the mock community data at different phases of the sequence curation pipeline (Fig. 4).	[('PMC6531881', 'R05000', 38, 49, 'polymerases')]	['Because', 'the', 'variation', 'in', 'bias', 'between', 'polymerase', '##s', 'and', 'across', 'rounds', 'of', 'PCR', 'could', 'be', 'artificially', 'infl', '##ated', 'due', 'to', 'sequencing', 'errors', 'and', 'chim', '##eras', ',', 'we', 'analyzed', 'the', 'alpha', 'and', 'beta', 'diversity', 'of', 'the', 'mock', 'community', 'data', 'at', 'different', 'phases', 'of', 'the', 'sequence', 'cur', '##ation', 'pipeline', '(', 'Fig', '.', '4', ')', '.']	[0, 8, 12, 22, 25, 30, 38, 48, 50, 54, 61, 68, 71, 75, 81, 84, 97, 101, 106, 110, 113, 124, 131, 135, 139, 143, 145, 148, 157, 161, 167, 171, 176, 186, 189, 193, 198, 208, 213, 216, 226, 233, 236, 240, 249, 252, 258, 267, 268, 271, 273, 274, 275]	[7, 11, 21, 24, 29, 37, 48, 49, 53, 60, 67, 70, 74, 80, 83, 96, 101, 105, 109, 112, 123, 130, 134, 139, 143, 144, 147, 156, 160, 166, 170, 175, 185, 188, 192, 197, 207, 212, 215, 225, 232, 235, 239, 248, 252, 257, 266, 268, 271, 272, 274, 275, 276]	['Because', 'the', 'variation', 'in', 'bias', 'between', 'polymerases', 'and', 'across', 'rounds', 'of', 'PCR', 'could', 'be', 'artificially', 'inflated', 'due', 'to', 'sequencing', 'errors', 'and', 'chimeras', ',', 'we', 'analyzed', 'the', 'alpha', 'and', 'beta', 'diversity', 'of', 'the', 'mock', 'community', 'data', 'at', 'different', 'phases', 'of', 'the', 'sequence', 'curation', 'pipeline', '(', 'Fig', '.', '4', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To study this further, we calculated alpha and beta diversity metrics using the human stool samples for each of the polymerases and rounds of amplification.	[('PMC6531881', 'R06001', 116, 127, 'polymerases')]	['To', 'study', 'this', 'further', ',', 'we', 'calculated', 'alpha', 'and', 'beta', 'diversity', 'metrics', 'using', 'the', 'human', 'stool', 'samples', 'for', 'each', 'of', 'the', 'polymerase', '##s', 'and', 'rounds', 'of', 'amplification', '.']	[0, 3, 9, 14, 21, 23, 26, 37, 43, 47, 52, 62, 70, 76, 80, 86, 92, 100, 104, 109, 112, 116, 126, 128, 132, 139, 142, 155]	[2, 8, 13, 21, 22, 25, 36, 42, 46, 51, 61, 69, 75, 79, 85, 91, 99, 103, 108, 111, 115, 126, 127, 131, 138, 141, 155, 156]	['To', 'study', 'this', 'further', ',', 'we', 'calculated', 'alpha', 'and', 'beta', 'diversity', 'metrics', 'using', 'the', 'human', 'stool', 'samples', 'for', 'each', 'of', 'the', 'polymerases', 'and', 'rounds', 'of', 'amplification', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
When we characterized the variation between rounds of amplification using human stool samples, the distance between the 25 and 30 rounds and 25 and 35 rounds varied considerably between samples and polymerases (Fig.	[('PMC6531881', 'R06004', 198, 209, 'polymerases')]	['When', 'we', 'characterized', 'the', 'variation', 'between', 'rounds', 'of', 'amplification', 'using', 'human', 'stool', 'samples', ',', 'the', 'distance', 'between', 'the', '25', 'and', '30', 'rounds', 'and', '25', 'and', '35', 'rounds', 'varied', 'considerably', 'between', 'samples', 'and', 'polymerase', '##s', '(', 'Fig', '.']	[0, 5, 8, 22, 26, 36, 44, 51, 54, 68, 74, 80, 86, 93, 95, 99, 108, 116, 120, 123, 127, 130, 137, 141, 144, 148, 151, 158, 165, 178, 186, 194, 198, 208, 210, 211, 214]	[4, 7, 21, 25, 35, 43, 50, 53, 67, 73, 79, 85, 93, 94, 98, 107, 115, 119, 122, 126, 129, 136, 140, 143, 147, 150, 157, 164, 177, 185, 193, 197, 208, 209, 211, 214, 215]	['When', 'we', 'characterized', 'the', 'variation', 'between', 'rounds', 'of', 'amplification', 'using', 'human', 'stool', 'samples', ',', 'the', 'distance', 'between', 'the', '25', 'and', '30', 'rounds', 'and', '25', 'and', '35', 'rounds', 'varied', 'considerably', 'between', 'samples', 'and', 'polymerases', '(', 'Fig', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O']
To test this, we determined the average Bray-Curtis distance between replicate reactions using the same polymerase and number of rounds of amplification (Fig. 6).	[('PMC6531881', 'R07001', 104, 114, 'polymerase')]	['To', 'test', 'this', ',', 'we', 'determined', 'the', 'average', 'Bra', '##y', '-', 'Cur', '##tis', 'distance', 'between', 'replicate', 'reactions', 'using', 'the', 'same', 'polymerase', 'and', 'number', 'of', 'rounds', 'of', 'amplification', '(', 'Fig', '.', '6', ')', '.']	[0, 3, 8, 12, 14, 17, 28, 32, 40, 43, 44, 45, 48, 52, 61, 69, 79, 89, 95, 99, 104, 115, 119, 126, 129, 136, 139, 153, 154, 157, 159, 160, 161]	[2, 7, 12, 13, 16, 27, 31, 39, 43, 44, 45, 48, 51, 60, 68, 78, 88, 94, 98, 103, 114, 118, 125, 128, 135, 138, 152, 154, 157, 158, 160, 161, 162]	['To', 'test', 'this', ',', 'we', 'determined', 'the', 'average', 'Bray-Curtis', 'distance', 'between', 'replicate', 'reactions', 'using', 'the', 'same', 'polymerase', 'and', 'number', 'of', 'rounds', 'of', 'amplification', '(', 'Fig', '.', '6', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the alimentary canal, unabsorbed EGCG and ECG were hydrolyzed by the esterases in saliva, gastric and pancreatic juices, and microbiota to form EGC and EC, respectively, and release gallic acid [10,11,27,28].	[('PMC6571926', 'D02001', 72, 81, 'esterases')]	['In', 'the', 'ali', '##mentary', 'canal', ',', 'una', '##bs', '##orbed', 'EG', '##CG', 'and', 'ECG', 'were', 'hydroly', '##zed', 'by', 'the', 'ester', '##ases', 'in', 'saliva', ',', 'gastric', 'and', 'pancreatic', 'juice', '##s', ',', 'and', 'microbiota', 'to', 'form', 'EG', '##C', 'and', 'EC', ',', 'respectively', ',', 'and', 'release', 'gall', '##ic', 'acid', '[', '10', ',', '11', ',', '27', ',', '28', ']', '.']	[0, 3, 7, 10, 18, 23, 25, 28, 30, 36, 38, 41, 45, 49, 54, 61, 65, 68, 72, 77, 82, 85, 91, 93, 101, 105, 116, 121, 122, 124, 128, 139, 142, 147, 149, 151, 155, 157, 159, 171, 173, 177, 185, 189, 192, 197, 198, 200, 201, 203, 204, 206, 207, 209, 210]	[2, 6, 10, 17, 23, 24, 28, 30, 35, 38, 40, 44, 48, 53, 61, 64, 67, 71, 77, 81, 84, 91, 92, 100, 104, 115, 121, 122, 123, 127, 138, 141, 146, 149, 150, 154, 157, 158, 171, 172, 176, 184, 189, 191, 196, 198, 200, 201, 203, 204, 206, 207, 209, 210, 211]	['In', 'the', 'alimentary', 'canal', ',', 'unabsorbed', 'EGCG', 'and', 'ECG', 'were', 'hydrolyzed', 'by', 'the', 'esterases', 'in', 'saliva', ',', 'gastric', 'and', 'pancreatic', 'juices', ',', 'and', 'microbiota', 'to', 'form', 'EGC', 'and', 'EC', ',', 'respectively', ',', 'and', 'release', 'gallic', 'acid', '[', '10', ',', '11', ',', '27', ',', '28', ']', '.']	[1, 1, 2, 1, 1, 3, 2, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Formation of GTP-derived urinary metabolites: Absorbed EGC, either directly from the GTP supplement, or from the hydrolysis of EGCG, likely underwent catechol-O-methyltransferase-mediated methylation followed by uridine 5’-diphospho-glucuronosyltransferase (UGT)-mediated glucuronidation to form methyl epigallocatechin glucuronide (Vu).	[('PMC6571926', 'D03000', 150, 178, 'catechol-O-methyltransferase'), ('PMC6571926', 'D03000', 212, 256, 'uridine 5’-diphospho-glucuronosyltransferase')]	['Formation', 'of', 'GTP', '-', 'derived', 'urinary', 'metabolites', ':', 'Abs', '##orbed', 'EG', '##C', ',', 'either', 'directly', 'from', 'the', 'GTP', 'supplement', ',', 'or', 'from', 'the', 'hydrolysis', 'of', 'EG', '##CG', ',', 'likely', 'underwent', 'catechol', '-', 'O', '-', 'methyl', '##transferase', '-', 'mediated', 'methylation', 'followed', 'by', 'ur', '##idine', '5', '’', '-', 'diph', '##osph', '##o', '-', 'gluc', '##uron', '##osyl', '##transferase', '(', 'U', '##GT', ')', '-', 'mediated', 'gluc', '##uron', '##idation', 'to', 'form', 'methyl', 'ep', '##iga', '##ll', '##oca', '##tech', '##in', 'gluc', '##uron', '##ide', '(', 'V', '##u', ')', '.']	[0, 10, 13, 16, 17, 25, 33, 44, 46, 49, 55, 57, 58, 60, 67, 76, 81, 85, 89, 99, 101, 104, 109, 113, 124, 127, 129, 131, 133, 140, 150, 158, 159, 160, 161, 167, 178, 179, 188, 200, 209, 212, 214, 220, 221, 222, 223, 227, 231, 232, 233, 237, 241, 245, 257, 258, 259, 261, 262, 263, 272, 276, 280, 288, 291, 296, 303, 305, 308, 310, 313, 317, 320, 324, 328, 332, 333, 334, 335, 336]	[9, 12, 16, 17, 24, 32, 44, 45, 49, 54, 57, 58, 59, 66, 75, 80, 84, 88, 99, 100, 103, 108, 112, 123, 126, 129, 131, 132, 139, 149, 158, 159, 160, 161, 167, 178, 179, 187, 199, 208, 211, 214, 219, 221, 222, 223, 227, 231, 232, 233, 237, 241, 245, 256, 258, 259, 261, 262, 263, 271, 276, 280, 287, 290, 295, 302, 305, 308, 310, 313, 317, 319, 324, 328, 331, 333, 334, 335, 336, 337]	['Formation', 'of', 'GTP', '-', 'derived', 'urinary', 'metabolites', ':', 'Absorbed', 'EGC', ',', 'either', 'directly', 'from', 'the', 'GTP', 'supplement', ',', 'or', 'from', 'the', 'hydrolysis', 'of', 'EGCG', ',', 'likely', 'underwent', 'catechol-O-methyltransferase', '-', 'mediated', 'methylation', 'followed', 'by', 'uridine', '5’-diphospho', '-', 'glucuronosyltransferase', '(', 'UGT', ')', '-', 'mediated', 'glucuronidation', 'to', 'form', 'methyl', 'epigallocatechin', 'glucuronide', '(', 'Vu', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 2, 6, 1, 4, 1, 2, 1, 1, 1, 3, 1, 1, 1, 6, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Similarly, absorbed EC was metabolized by catechol-O-methyltransferase-mediated methylation and sulfotransferase (SULT)-mediated sulfation reactions to form methyl epicatechin sulfate (IVu).	[('PMC6571926', 'D03001', 42, 70, 'catechol-O-methyltransferase'), ('PMC6571926', 'D03001', 96, 112, 'sulfotransferase')]	['Similarly', ',', 'absorbed', 'EC', 'was', 'metabol', '##ized', 'by', 'catechol', '-', 'O', '-', 'methyl', '##transferase', '-', 'mediated', 'methylation', 'and', 'sulf', '##otransferase', '(', 'SU', '##LT', ')', '-', 'mediated', 'sulf', '##ation', 'reactions', 'to', 'form', 'methyl', 'ep', '##icate', '##chi', '##n', 'sulfate', '(', 'IV', '##u', ')', '.']	[0, 9, 11, 20, 23, 27, 34, 39, 42, 50, 51, 52, 53, 59, 70, 71, 80, 92, 96, 100, 113, 114, 116, 118, 119, 120, 129, 133, 139, 149, 152, 157, 164, 166, 171, 174, 176, 184, 185, 187, 188, 189]	[9, 10, 19, 22, 26, 34, 38, 41, 50, 51, 52, 53, 59, 70, 71, 79, 91, 95, 100, 112, 114, 116, 118, 119, 120, 128, 133, 138, 148, 151, 156, 163, 166, 171, 174, 175, 183, 185, 187, 188, 189, 190]	['Similarly', ',', 'absorbed', 'EC', 'was', 'metabolized', 'by', 'catechol-O-methyltransferase', '-', 'mediated', 'methylation', 'and', 'sulfotransferase', '(', 'SULT', ')', '-', 'mediated', 'sulfation', 'reactions', 'to', 'form', 'methyl', 'epicatechin', 'sulfate', '(', 'IVu', ')', '.']	[1, 1, 1, 1, 1, 2, 1, 6, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, it has been shown that GTP, especially EGCG, can function as the inhibitors of diverse dehydrogenases and decarboxylases [51,52,53].	[('PMC6571926', 'D06018', 97, 111, 'dehydrogenases'), ('PMC6571926', 'D06018', 116, 130, 'decarboxylases')]	['Moreover', ',', 'it', 'has', 'been', 'shown', 'that', 'GTP', ',', 'especially', 'EG', '##CG', ',', 'can', 'function', 'as', 'the', 'inhibitors', 'of', 'diverse', 'dehydrogenase', '##s', 'and', 'dec', '##arboxyl', '##ases', '[', '51', ',', '52', ',', '53', ']', '.']	[0, 8, 10, 13, 17, 22, 28, 33, 36, 38, 49, 51, 53, 55, 59, 68, 71, 75, 86, 89, 97, 110, 112, 116, 119, 126, 131, 132, 134, 135, 137, 138, 140, 141]	[8, 9, 12, 16, 21, 27, 32, 36, 37, 48, 51, 53, 54, 58, 67, 70, 74, 85, 88, 96, 110, 111, 115, 119, 126, 130, 132, 134, 135, 137, 138, 140, 141, 142]	['Moreover', ',', 'it', 'has', 'been', 'shown', 'that', 'GTP', ',', 'especially', 'EGCG', ',', 'can', 'function', 'as', 'the', 'inhibitors', 'of', 'diverse', 'dehydrogenases', 'and', 'decarboxylases', '[', '51', ',', '52', ',', '53', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dostal A.M., Samavat H., Espejo L., Arikawa A.Y., Stendell-Hollis N.R., Kurzer M.S. Green tea extract and catechol-o-methyltransferase genotype modify fasting serum insulin and plasma adiponectin concentrations in a randomized controlled trial of overweight and obese postmenopausal women.	[('PMC6571926', 'F21001', 106, 134, 'catechol-o-methyltransferase')]	['Do', '##st', '##al', 'A', '.', 'M', '.', ',', 'Sam', '##ava', '##t', 'H', '.', ',', 'Esp', '##ej', '##o', 'L', '.', ',', 'Ar', '##ikawa', 'A', '.', 'Y', '.', ',', 'Sten', '##del', '##l', '-', 'Hol', '##lis', 'N', '.', 'R', '.', ',', 'Kur', '##zer', 'M', '.', 'S', '.', 'Green', 'tea', 'extract', 'and', 'catechol', '-', 'o', '-', 'methyl', '##transferase', 'genotype', 'modify', 'fasting', 'serum', 'insulin', 'and', 'plasma', 'adiponectin', 'concentrations', 'in', 'a', 'randomized', 'controlled', 'trial', 'of', 'overweight', 'and', 'obese', 'postmenopausal', 'women', '.']	[0, 2, 4, 7, 8, 9, 10, 11, 13, 16, 19, 21, 22, 23, 25, 28, 30, 32, 33, 34, 36, 38, 44, 45, 46, 47, 48, 50, 54, 57, 58, 59, 62, 66, 67, 68, 69, 70, 72, 75, 79, 80, 81, 82, 84, 90, 94, 102, 106, 114, 115, 116, 117, 123, 135, 144, 151, 159, 165, 173, 177, 184, 196, 211, 214, 216, 227, 238, 244, 247, 258, 262, 268, 283, 288]	[2, 4, 6, 8, 9, 10, 11, 12, 16, 19, 20, 22, 23, 24, 28, 30, 31, 33, 34, 35, 38, 43, 45, 46, 47, 48, 49, 54, 57, 58, 59, 62, 65, 67, 68, 69, 70, 71, 75, 78, 80, 81, 82, 83, 89, 93, 101, 105, 114, 115, 116, 117, 123, 134, 143, 150, 158, 164, 172, 176, 183, 195, 210, 213, 215, 226, 237, 243, 246, 257, 261, 267, 282, 288, 289]	['Dostal', 'A.M', '.', ',', 'Samavat', 'H', '.', ',', 'Espejo', 'L', '.', ',', 'Arikawa', 'A.Y', '.', ',', 'Stendell-Hollis', 'N.R', '.', ',', 'Kurzer', 'M.S', '.', 'Green', 'tea', 'extract', 'and', 'catechol-o-methyltransferase', 'genotype', 'modify', 'fasting', 'serum', 'insulin', 'and', 'plasma', 'adiponectin', 'concentrations', 'in', 'a', 'randomized', 'controlled', 'trial', 'of', 'overweight', 'and', 'obese', 'postmenopausal', 'women', '.']	[3, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 6, 3, 1, 1, 2, 3, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dostal A.M., Arikawa A., Espejo L., Bedell S., Kurzer M.S., Stendell-Hollis N.R. Green tea extract and catechol-o-methyltransferase genotype modify the post-prandial serum insulin response in a randomised trial of overweight and obese post-menopausal women.	[('PMC6571926', 'F22001', 103, 131, 'catechol-o-methyltransferase')]	['Do', '##st', '##al', 'A', '.', 'M', '.', ',', 'Ar', '##ikawa', 'A', '.', ',', 'Esp', '##ej', '##o', 'L', '.', ',', 'Bede', '##ll', 'S', '.', ',', 'Kur', '##zer', 'M', '.', 'S', '.', ',', 'Sten', '##del', '##l', '-', 'Hol', '##lis', 'N', '.', 'R', '.', 'Green', 'tea', 'extract', 'and', 'catechol', '-', 'o', '-', 'methyl', '##transferase', 'genotype', 'modify', 'the', 'post', '-', 'pr', '##andial', 'serum', 'insulin', 'response', 'in', 'a', 'randomised', 'trial', 'of', 'overweight', 'and', 'obese', 'post', '-', 'men', '##opausal', 'women', '.']	[0, 2, 4, 7, 8, 9, 10, 11, 13, 15, 21, 22, 23, 25, 28, 30, 32, 33, 34, 36, 40, 43, 44, 45, 47, 50, 54, 55, 56, 57, 58, 60, 64, 67, 68, 69, 72, 76, 77, 78, 79, 81, 87, 91, 99, 103, 111, 112, 113, 114, 120, 132, 141, 148, 152, 156, 157, 159, 166, 172, 180, 189, 192, 194, 205, 211, 214, 225, 229, 235, 239, 240, 243, 251, 256]	[2, 4, 6, 8, 9, 10, 11, 12, 15, 20, 22, 23, 24, 28, 30, 31, 33, 34, 35, 40, 42, 44, 45, 46, 50, 53, 55, 56, 57, 58, 59, 64, 67, 68, 69, 72, 75, 77, 78, 79, 80, 86, 90, 98, 102, 111, 112, 113, 114, 120, 131, 140, 147, 151, 156, 157, 159, 165, 171, 179, 188, 191, 193, 204, 210, 213, 224, 228, 234, 239, 240, 243, 250, 256, 257]	['Dostal', 'A.M', '.', ',', 'Arikawa', 'A', '.', ',', 'Espejo', 'L', '.', ',', 'Bedell', 'S', '.', ',', 'Kurzer', 'M.S', '.', ',', 'Stendell-Hollis', 'N.R', '.', 'Green', 'tea', 'extract', 'and', 'catechol-o-methyltransferase', 'genotype', 'modify', 'the', 'post', '-', 'prandial', 'serum', 'insulin', 'response', 'in', 'a', 'randomised', 'trial', 'of', 'overweight', 'and', 'obese', 'post', '-', 'menopausal', 'women', '.']	[3, 3, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 6, 3, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Uhlenhut K., Högger P. Facilitated cellular uptake and suppression of inducible nitric oxide synthase by a metabolite of maritime pine bark extract (pycnogenol) Free Radic.	[('PMC6571926', 'F35001', 80, 101, 'nitric oxide synthase')]	['U', '##hlen', '##hu', '##t', 'K', '.', ',', 'H', '##ö', '##gg', '##er', 'P', '.', 'Fac', '##ili', '##ta', '##ted', 'cellular', 'uptake', 'and', 'suppression', 'of', 'inducible', 'nitric', 'oxide', 'synthase', 'by', 'a', 'metabolite', 'of', 'mari', '##time', 'pine', 'bark', 'extract', '(', 'py', '##cn', '##ogen', '##ol', ')', 'Free', 'Radi', '##c', '.']	[0, 1, 5, 7, 9, 10, 11, 13, 14, 15, 17, 20, 21, 23, 26, 29, 31, 35, 44, 51, 55, 67, 70, 80, 87, 93, 102, 105, 107, 118, 121, 125, 130, 135, 140, 148, 149, 151, 153, 157, 159, 161, 166, 170, 171]	[1, 5, 7, 8, 10, 11, 12, 14, 15, 17, 19, 21, 22, 26, 29, 31, 34, 43, 50, 54, 66, 69, 79, 86, 92, 101, 104, 106, 117, 120, 125, 129, 134, 139, 147, 149, 151, 153, 157, 159, 160, 165, 170, 171, 172]	['Uhlenhut', 'K', '.', ',', 'Högger', 'P', '.', 'Facilitated', 'cellular', 'uptake', 'and', 'suppression', 'of', 'inducible', 'nitric', 'oxide', 'synthase', 'by', 'a', 'metabolite', 'of', 'maritime', 'pine', 'bark', 'extract', '(', 'pycnogenol', ')', 'Free', 'Radic', '.']	[4, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sun Y.N., Li W., Song S.B., Yan X.T., Zhao Y., Jo A.R., Kang J.S., Young Ho K. A new phenolic derivative with soluble epoxide hydrolase and nuclear factor-kappab inhibitory activity from the aqueous extract of acacia catechu.	[('PMC6571926', 'F36001', 118, 135, 'epoxide hydrolase')]	['Sun', 'Y', '.', 'N', '.', ',', 'Li', 'W', '.', ',', 'Song', 'S', '.', 'B', '.', ',', 'Yan', 'X', '.', 'T', '.', ',', 'Zhao', 'Y', '.', ',', 'Jo', 'A', '.', 'R', '.', ',', 'Kang', 'J', '.', 'S', '.', ',', 'Young', 'Ho', 'K', '.', 'A', 'new', 'phenolic', 'derivative', 'with', 'soluble', 'ep', '##oxide', 'hydro', '##las', '##e', 'and', 'nuclear', 'factor', '-', 'kappa', '##b', 'inhibitory', 'activity', 'from', 'the', 'aqueous', 'extract', 'of', 'ac', '##acia', 'catech', '##u', '.']	[0, 4, 5, 6, 7, 8, 10, 13, 14, 15, 17, 22, 23, 24, 25, 26, 28, 32, 33, 34, 35, 36, 38, 43, 44, 45, 47, 50, 51, 52, 53, 54, 56, 61, 62, 63, 64, 65, 67, 73, 76, 77, 79, 81, 85, 94, 105, 110, 118, 120, 126, 131, 134, 136, 140, 148, 154, 155, 160, 162, 173, 182, 187, 191, 199, 207, 210, 212, 217, 223, 224]	[3, 5, 6, 7, 8, 9, 12, 14, 15, 16, 21, 23, 24, 25, 26, 27, 31, 33, 34, 35, 36, 37, 42, 44, 45, 46, 49, 51, 52, 53, 54, 55, 60, 62, 63, 64, 65, 66, 72, 75, 77, 78, 80, 84, 93, 104, 109, 117, 120, 125, 131, 134, 135, 139, 147, 154, 155, 160, 161, 172, 181, 186, 190, 198, 206, 209, 212, 216, 223, 224, 225]	['Sun', 'Y.N', '.', ',', 'Li', 'W', '.', ',', 'Song', 'S.B', '.', ',', 'Yan', 'X.T', '.', ',', 'Zhao', 'Y', '.', ',', 'Jo', 'A.R', '.', ',', 'Kang', 'J.S', '.', ',', 'Young', 'Ho', 'K', '.', 'A', 'new', 'phenolic', 'derivative', 'with', 'soluble', 'epoxide', 'hydrolase', 'and', 'nuclear', 'factor', '-', 'kappab', 'inhibitory', 'activity', 'from', 'the', 'aqueous', 'extract', 'of', 'acacia', 'catechu', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Takagaki A., Nanjo F. Effects of metabolites produced from (−)-epigallocatechin gallate by rat intestinal bacteria on angiotensin i-converting enzyme activity and blood pressure in spontaneously hypertensive rats.	[('PMC6571926', 'F37001', 118, 149, 'angiotensin i-converting enzyme')]	['Tak', '##aga', '##ki', 'A', '.', ',', 'Nan', '##jo', 'F', '.', 'Effects', 'of', 'metabolites', 'produced', 'from', '(', '−', ')', '-', 'ep', '##iga', '##ll', '##oca', '##tech', '##in', 'gall', '##ate', 'by', 'rat', 'intestinal', 'bacteria', 'on', 'angiotensin', 'i', '-', 'converting', 'enzyme', 'activity', 'and', 'blood', 'pressure', 'in', 'spontaneously', 'hypertensive', 'rats', '.']	[0, 3, 6, 9, 10, 11, 13, 16, 19, 20, 22, 30, 33, 45, 54, 59, 60, 61, 62, 63, 65, 68, 70, 73, 77, 80, 84, 88, 91, 95, 106, 115, 118, 130, 131, 132, 143, 150, 159, 163, 169, 178, 181, 195, 208, 212]	[3, 6, 8, 10, 11, 12, 16, 18, 20, 21, 29, 32, 44, 53, 58, 60, 61, 62, 63, 65, 68, 70, 73, 77, 79, 84, 87, 90, 94, 105, 114, 117, 129, 131, 132, 142, 149, 158, 162, 168, 177, 180, 194, 207, 212, 213]	['Takagaki', 'A', '.', ',', 'Nanjo', 'F', '.', 'Effects', 'of', 'metabolites', 'produced', 'from', '(−)-epigallocatechin', 'gallate', 'by', 'rat', 'intestinal', 'bacteria', 'on', 'angiotensin', 'i-converting', 'enzyme', 'activity', 'and', 'blood', 'pressure', 'in', 'spontaneously', 'hypertensive', 'rats', '.']	[3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 10, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pournourmohammadi S., Grimaldi M., Stridh M.H., Lavallard V., Waagepetersen H.S., Wollheim C.B., Maechler P. Epigallocatechin-3-gallate (egcg) activates ampk through the inhibition of glutamate dehydrogenase in muscle and pancreatic ss-cells: A potential beneficial effect in the pre-diabetic state?	[('PMC6571926', 'F50001', 184, 207, 'glutamate dehydrogenase')]	['Po', '##urn', '##our', '##mo', '##ham', '##ma', '##di', 'S', '.', ',', 'Gr', '##imal', '##di', 'M', '.', ',', 'Str', '##id', '##h', 'M', '.', 'H', '.', ',', 'La', '##val', '##lar', '##d', 'V', '.', ',', 'Wa', '##age', '##pet', '##ersen', 'H', '.', 'S', '.', ',', 'Wol', '##l', '##heim', 'C', '.', 'B', '.', ',', 'Ma', '##ech', '##ler', 'P', '.', 'Ep', '##iga', '##ll', '##oca', '##tech', '##in', '-', '3', '-', 'gall', '##ate', '(', 'eg', '##cg', ')', 'activates', 'amp', '##k', 'through', 'the', 'inhibition', 'of', 'glutamate', 'dehydrogenase', 'in', 'muscle', 'and', 'pancreatic', 'ss', '-', 'cells', ':', 'A', 'potential', 'beneficial', 'effect', 'in', 'the', 'pre', '-', 'diabetic', 'state', '?']	[0, 2, 5, 8, 10, 13, 15, 18, 19, 20, 22, 24, 28, 31, 32, 33, 35, 38, 40, 42, 43, 44, 45, 46, 48, 50, 53, 56, 58, 59, 60, 62, 64, 67, 70, 76, 77, 78, 79, 80, 82, 85, 86, 91, 92, 93, 94, 95, 97, 99, 102, 106, 107, 109, 111, 114, 116, 119, 123, 125, 126, 127, 128, 132, 136, 137, 139, 141, 143, 153, 156, 158, 166, 170, 181, 184, 194, 208, 211, 218, 222, 233, 235, 236, 241, 243, 245, 255, 266, 273, 276, 280, 283, 284, 293, 298]	[2, 5, 8, 10, 13, 15, 17, 19, 20, 21, 24, 28, 30, 32, 33, 34, 38, 40, 41, 43, 44, 45, 46, 47, 50, 53, 56, 57, 59, 60, 61, 64, 67, 70, 75, 77, 78, 79, 80, 81, 85, 86, 90, 92, 93, 94, 95, 96, 99, 102, 105, 107, 108, 111, 114, 116, 119, 123, 125, 126, 127, 128, 132, 135, 137, 139, 141, 142, 152, 156, 157, 165, 169, 180, 183, 193, 207, 210, 217, 221, 232, 235, 236, 241, 242, 244, 254, 265, 272, 275, 279, 283, 284, 292, 298, 299]	['Pournourmohammadi', 'S', '.', ',', 'Grimaldi', 'M', '.', ',', 'Stridh', 'M.H', '.', ',', 'Lavallard', 'V', '.', ',', 'Waagepetersen', 'H.S', '.', ',', 'Wollheim', 'C.B', '.', ',', 'Maechler', 'P', '.', 'Epigallocatechin-3-gallate', '(', 'egcg', ')', 'activates', 'ampk', 'through', 'the', 'inhibition', 'of', 'glutamate', 'dehydrogenase', 'in', 'muscle', 'and', 'pancreatic', 'ss', '-', 'cells', ':', 'A', 'potential', 'beneficial', 'effect', 'in', 'the', 'pre', '-', 'diabetic', 'state', '?']	[7, 1, 1, 1, 3, 1, 1, 1, 3, 3, 1, 1, 4, 1, 1, 1, 4, 3, 1, 1, 3, 3, 1, 1, 3, 1, 1, 11, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Rodriguez-Caso C., Rodriguez-Agudo D., Sanchez-Jimenez F., Medina M.A. Green tea epigallocatechin-3-gallate is an inhibitor of mammalian histidine decarboxylase.	[('PMC6571926', 'F51001', 137, 160, 'histidine decarboxylase')]	['Rodriguez', '-', 'Cas', '##o', 'C', '.', ',', 'Rodriguez', '-', 'Ag', '##ud', '##o', 'D', '.', ',', 'San', '##che', '##z', '-', 'Jim', '##enez', 'F', '.', ',', 'Medi', '##na', 'M', '.', 'A', '.', 'Green', 'tea', 'ep', '##iga', '##ll', '##oca', '##tech', '##in', '-', '3', '-', 'gall', '##ate', 'is', 'an', 'inhibitor', 'of', 'mammalian', 'histidine', 'dec', '##arboxyl', '##ase', '.']	[0, 9, 10, 13, 15, 16, 17, 19, 28, 29, 31, 33, 35, 36, 37, 39, 42, 45, 46, 47, 50, 55, 56, 57, 59, 63, 66, 67, 68, 69, 71, 77, 81, 83, 86, 88, 91, 95, 97, 98, 99, 100, 104, 108, 111, 114, 124, 127, 137, 147, 150, 157, 160]	[9, 10, 13, 14, 16, 17, 18, 28, 29, 31, 33, 34, 36, 37, 38, 42, 45, 46, 47, 50, 54, 56, 57, 58, 63, 65, 67, 68, 69, 70, 76, 80, 83, 86, 88, 91, 95, 97, 98, 99, 100, 104, 107, 110, 113, 123, 126, 136, 146, 150, 157, 160, 161]	['Rodriguez-Caso', 'C', '.', ',', 'Rodriguez-Agudo', 'D', '.', ',', 'Sanchez-Jimenez', 'F', '.', ',', 'Medina', 'M.A', '.', 'Green', 'tea', 'epigallocatechin-3-gallate', 'is', 'an', 'inhibitor', 'of', 'mammalian', 'histidine', 'decarboxylase', '.']	[4, 1, 1, 1, 5, 1, 1, 1, 6, 1, 1, 1, 2, 3, 1, 1, 1, 11, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Li C., Li M., Chen P., Narayan S., Matschinsky F.M., Bennett M.J., Stanley C.A., Smith T.J. Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the adp activation site.	[('PMC6571926', 'F52001', 135, 158, 'glutamate dehydrogenase')]	['Li', 'C', '.', ',', 'Li', 'M', '.', ',', 'Chen', 'P', '.', ',', 'Nar', '##ayan', 'S', '.', ',', 'Mats', '##chi', '##ns', '##ky', 'F', '.', 'M', '.', ',', 'Bennett', 'M', '.', 'J', '.', ',', 'Stan', '##ley', 'C', '.', 'A', '.', ',', 'Smith', 'T', '.', 'J', '.', 'Green', 'tea', 'polyphen', '##ols', 'control', 'dys', '##regulated', 'glutamate', 'dehydrogenase', 'in', 'transgenic', 'mice', 'by', 'hi', '##ja', '##ck', '##ing', 'the', 'ad', '##p', 'activation', 'site', '.']	[0, 3, 4, 5, 7, 10, 11, 12, 14, 19, 20, 21, 23, 26, 31, 32, 33, 35, 39, 42, 44, 47, 48, 49, 50, 51, 53, 61, 62, 63, 64, 65, 67, 71, 75, 76, 77, 78, 79, 81, 87, 88, 89, 90, 92, 98, 102, 110, 114, 122, 125, 135, 145, 159, 162, 173, 178, 181, 183, 185, 187, 191, 195, 197, 199, 210, 214]	[2, 4, 5, 6, 9, 11, 12, 13, 18, 20, 21, 22, 26, 30, 32, 33, 34, 39, 42, 44, 46, 48, 49, 50, 51, 52, 60, 62, 63, 64, 65, 66, 71, 74, 76, 77, 78, 79, 80, 86, 88, 89, 90, 91, 97, 101, 110, 113, 121, 125, 134, 144, 158, 161, 172, 177, 180, 183, 185, 187, 190, 194, 197, 198, 209, 214, 215]	['Li', 'C', '.', ',', 'Li', 'M', '.', ',', 'Chen', 'P', '.', ',', 'Narayan', 'S', '.', ',', 'Matschinsky', 'F.M', '.', ',', 'Bennett', 'M.J', '.', ',', 'Stanley', 'C.A', '.', ',', 'Smith', 'T.J', '.', 'Green', 'tea', 'polyphenols', 'control', 'dysregulated', 'glutamate', 'dehydrogenase', 'in', 'transgenic', 'mice', 'by', 'hijacking', 'the', 'adp', 'activation', 'site', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 3, 1, 1, 1, 3, 1, 1, 2, 3, 1, 1, 1, 3, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, the high-activity genotype of catechol-O-methyltransferase (catechol-O-methyltransferase) was positively correlated with the post-prandial serum insulin response in the overweight and obese subjects taking the GTP supplement [23].	[('PMC6571926', 'I02002', 43, 71, 'catechol-O-methyltransferase'), ('PMC6571926', 'I02002', 73, 101, 'catechol-O-methyltransferase')]	['In', 'addition', ',', 'the', 'high', '-', 'activity', 'genotype', 'of', 'catechol', '-', 'O', '-', 'methyl', '##transferase', '(', 'catechol', '-', 'O', '-', 'methyl', '##transferase', ')', 'was', 'positively', 'correlated', 'with', 'the', 'post', '-', 'pr', '##andial', 'serum', 'insulin', 'response', 'in', 'the', 'overweight', 'and', 'obese', 'subjects', 'taking', 'the', 'GTP', 'supplement', '[', '23', ']', '.']	[0, 3, 11, 13, 17, 21, 22, 31, 40, 43, 51, 52, 53, 54, 60, 72, 73, 81, 82, 83, 84, 90, 101, 103, 107, 118, 129, 134, 138, 142, 143, 145, 152, 158, 166, 175, 178, 182, 193, 197, 203, 212, 219, 223, 227, 238, 239, 241, 242]	[2, 11, 12, 16, 21, 22, 30, 39, 42, 51, 52, 53, 54, 60, 71, 73, 81, 82, 83, 84, 90, 101, 102, 106, 117, 128, 133, 137, 142, 143, 145, 151, 157, 165, 174, 177, 181, 192, 196, 202, 211, 218, 222, 226, 237, 239, 241, 242, 243]	['In', 'addition', ',', 'the', 'high', '-', 'activity', 'genotype', 'of', 'catechol-O-methyltransferase', '(', 'catechol-O-methyltransferase', ')', 'was', 'positively', 'correlated', 'with', 'the', 'post', '-', 'prandial', 'serum', 'insulin', 'response', 'in', 'the', 'overweight', 'and', 'obese', 'subjects', 'taking', 'the', 'GTP', 'supplement', '[', '23', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PrimerProspector: de novo design and taxonomic analysis of barcoded polymerase chain reaction primers.	[('PMC6582744', 'F18002', 68, 78, 'polymerase')]	['Primer', '##Pro', '##spec', '##tor', ':', 'de', 'novo', 'design', 'and', 'taxonomic', 'analysis', 'of', 'bar', '##coded', 'polymerase', 'chain', 'reaction', 'primers', '.']	[0, 6, 9, 13, 16, 18, 21, 26, 33, 37, 47, 56, 59, 62, 68, 79, 85, 94, 101]	[6, 9, 13, 16, 17, 20, 25, 32, 36, 46, 55, 58, 62, 67, 78, 84, 93, 101, 102]	['PrimerProspector', ':', 'de', 'novo', 'design', 'and', 'taxonomic', 'analysis', 'of', 'barcoded', 'polymerase', 'chain', 'reaction', 'primers', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O']
Botta P, de Souza FM, Sangrey T, De Schutter E, Valenzuela CF (2010) Alcohol excites cerebellar Golgi cells by inhibiting the Na+/K+ ATPase.	[('PMC6584945', 'F13000', 133, 139, 'ATPase')]	['Bot', '##ta', 'P', ',', 'de', 'So', '##uz', '##a', 'FM', ',', 'San', '##gre', '##y', 'T', ',', 'De', 'Sch', '##utter', 'E', ',', 'Val', '##enz', '##uel', '##a', 'CF', '(', '2010', ')', 'Alcohol', 'excit', '##es', 'cerebellar', 'Golgi', 'cells', 'by', 'inhibiting', 'the', 'Na', '+', '/', 'K', '+', 'ATPase', '.']	[0, 3, 6, 7, 9, 12, 14, 16, 18, 20, 22, 25, 28, 30, 31, 33, 36, 39, 45, 46, 48, 51, 54, 57, 59, 62, 63, 67, 69, 77, 82, 85, 96, 102, 108, 111, 122, 126, 128, 129, 130, 131, 133, 139]	[3, 5, 7, 8, 11, 14, 16, 17, 20, 21, 25, 28, 29, 31, 32, 35, 39, 44, 46, 47, 51, 54, 57, 58, 61, 63, 67, 68, 76, 82, 84, 95, 101, 107, 110, 121, 125, 128, 129, 130, 131, 132, 139, 140]	['Botta', 'P', ',', 'de', 'Souza', 'FM', ',', 'Sangrey', 'T', ',', 'De', 'Schutter', 'E', ',', 'Valenzuela', 'CF', '(', '2010', ')', 'Alcohol', 'excites', 'cerebellar', 'Golgi', 'cells', 'by', 'inhibiting', 'the', 'Na+', '/', 'K+', 'ATPase', '.']	[2, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O']
Chronic ethanol consumption induces accumulation of proteins in the liver Golgi apparatus and decreases galactosyltransferase activity.	[('PMC6584945', 'F37001', 104, 125, 'galactosyltransferase')]	['Chronic', 'ethanol', 'consumption', 'induces', 'accumulation', 'of', 'proteins', 'in', 'the', 'liver', 'Golgi', 'apparatus', 'and', 'decreases', 'galact', '##osyl', '##transferase', 'activity', '.']	[0, 8, 16, 28, 36, 49, 52, 61, 64, 68, 74, 80, 90, 94, 104, 110, 114, 126, 134]	[7, 15, 27, 35, 48, 51, 60, 63, 67, 73, 79, 89, 93, 103, 110, 114, 125, 134, 135]	['Chronic', 'ethanol', 'consumption', 'induces', 'accumulation', 'of', 'proteins', 'in', 'the', 'liver', 'Golgi', 'apparatus', 'and', 'decreases', 'galactosyltransferase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
The catecholamine biosynthetic enzyme dopamine beta-hydroxylase (dopamine beta-hydroxylase): first genome-wide search positions trait-determining variants acting additively in the proximal promoter.	[('PMC6584945', 'F67001', 38, 63, 'dopamine beta-hydroxylase'), ('PMC6584945', 'F67001', 65, 90, 'dopamine beta-hydroxylase')]	['The', 'catechol', '##amine', 'biosynthetic', 'enzyme', 'dopamine', 'beta', '-', 'hydroxyl', '##ase', '(', 'dopamine', 'beta', '-', 'hydroxyl', '##ase', ')', ':', 'first', 'genome', '-', 'wide', 'search', 'positions', 'trait', '-', 'determining', 'variants', 'acting', 'additive', '##ly', 'in', 'the', 'proximal', 'promoter', '.']	[0, 4, 12, 18, 31, 38, 47, 51, 52, 60, 64, 65, 74, 78, 79, 87, 90, 91, 93, 99, 105, 106, 111, 118, 128, 133, 134, 146, 155, 162, 170, 173, 176, 180, 189, 197]	[3, 12, 17, 30, 37, 46, 51, 52, 60, 63, 65, 73, 78, 79, 87, 90, 91, 92, 98, 105, 106, 110, 117, 127, 133, 134, 145, 154, 161, 170, 172, 175, 179, 188, 197, 198]	['The', 'catecholamine', 'biosynthetic', 'enzyme', 'dopamine', 'beta', '-', 'hydroxylase', '(', 'dopamine', 'beta', '-', 'hydroxylase', ')', ':', 'first', 'genome', '-', 'wide', 'search', 'positions', 'trait', '-', 'determining', 'variants', 'acting', 'additively', 'in', 'the', 'proximal', 'promoter', '.']	[1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alcohol consumption during pregnancy alters glycoconjugates, galactosyltransferase activity and beta-COP proteins in the Golgi apparatus of hepatocytes in developing liver.	[('PMC6584945', 'F88001', 61, 82, 'galactosyltransferase')]	['Alcohol', 'consumption', 'during', 'pregnancy', 'alters', 'glyc', '##ocon', '##jug', '##ates', ',', 'galact', '##osyl', '##transferase', 'activity', 'and', 'beta', '-', 'COP', 'proteins', 'in', 'the', 'Golgi', 'apparatus', 'of', 'hepatocytes', 'in', 'developing', 'liver', '.']	[0, 8, 20, 27, 37, 44, 48, 52, 55, 59, 61, 67, 71, 83, 92, 96, 100, 101, 105, 114, 117, 121, 127, 137, 140, 152, 155, 166, 171]	[7, 19, 26, 36, 43, 48, 52, 55, 59, 60, 67, 71, 82, 91, 95, 100, 101, 104, 113, 116, 120, 126, 136, 139, 151, 154, 165, 171, 172]	['Alcohol', 'consumption', 'during', 'pregnancy', 'alters', 'glycoconjugates', ',', 'galactosyltransferase', 'activity', 'and', 'beta-COP', 'proteins', 'in', 'the', 'Golgi', 'apparatus', 'of', 'hepatocytes', 'in', 'developing', 'liver', '.']	[1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Notable exceptions include findings from the Study of Addiction: Genetics and Environment and the Collaborative Study on the Genetics of Alcoholism, which report risk variants for AD in novel loci including KIAA0040 (Zuo et al. 2012), the PHF3-PTP4A1 gene complex (Zuo et al. 2011, 2014), rs1437396 at chromosomal location 2p16.1 and other variants in the alcohol dehydrogenase (ADH) gene cluster (Gelernter et al. 2014).	[('PMC6584945', 'I01001', 356, 377, 'alcohol dehydrogenase')]	['Not', '##able', 'exceptions', 'include', 'findings', 'from', 'the', 'Study', 'of', 'Add', '##iction', ':', 'Genetics', 'and', 'Environment', 'and', 'the', 'Collaborative', 'Study', 'on', 'the', 'Genetics', 'of', 'Alcohol', '##ism', ',', 'which', 'report', 'risk', 'variants', 'for', 'AD', 'in', 'novel', 'loci', 'including', 'KI', '##AA', '##004', '##0', '(', 'Zu', '##o', 'et', 'al', '.', '2012', ')', ',', 'the', 'PH', '##F', '##3', '-', 'PTP', '##4', '##A', '##1', 'gene', 'complex', '(', 'Zu', '##o', 'et', 'al', '.', '2011', ',', '2014', ')', ',', 'rs', '##14', '##37', '##39', '##6', 'at', 'chromosomal', 'location', '2', '##p', '##16', '.', '1', 'and', 'other', 'variants', 'in', 'the', 'alcohol', 'dehydrogenase', '(', 'AD', '##H', ')', 'gene', 'cluster', '(', 'Gel', '##ern', '##ter', 'et', 'al', '.', '2014', ')', '.']	[0, 3, 8, 19, 27, 36, 41, 45, 51, 54, 57, 63, 65, 74, 78, 90, 94, 98, 112, 118, 121, 125, 134, 137, 144, 147, 149, 155, 162, 167, 176, 180, 183, 186, 192, 197, 207, 209, 211, 214, 216, 217, 219, 221, 224, 226, 228, 232, 233, 235, 239, 241, 242, 243, 244, 247, 248, 249, 251, 256, 264, 265, 267, 269, 272, 274, 276, 280, 282, 286, 287, 289, 291, 293, 295, 297, 299, 302, 314, 323, 324, 325, 327, 328, 330, 334, 340, 349, 352, 356, 364, 378, 379, 381, 382, 384, 389, 397, 398, 401, 404, 408, 411, 413, 415, 419, 420]	[3, 7, 18, 26, 35, 40, 44, 50, 53, 57, 63, 64, 73, 77, 89, 93, 97, 111, 117, 120, 124, 133, 136, 144, 147, 148, 154, 161, 166, 175, 179, 182, 185, 191, 196, 206, 209, 211, 214, 215, 217, 219, 220, 223, 226, 227, 232, 233, 234, 238, 241, 242, 243, 244, 247, 248, 249, 250, 255, 263, 265, 267, 268, 271, 274, 275, 280, 281, 286, 287, 288, 291, 293, 295, 297, 298, 301, 313, 322, 324, 325, 327, 328, 329, 333, 339, 348, 351, 355, 363, 377, 379, 381, 382, 383, 388, 396, 398, 401, 404, 407, 410, 413, 414, 419, 420, 421]	['Notable', 'exceptions', 'include', 'findings', 'from', 'the', 'Study', 'of', 'Addiction', ':', 'Genetics', 'and', 'Environment', 'and', 'the', 'Collaborative', 'Study', 'on', 'the', 'Genetics', 'of', 'Alcoholism', ',', 'which', 'report', 'risk', 'variants', 'for', 'AD', 'in', 'novel', 'loci', 'including', 'KIAA0040', '(', 'Zuo', 'et', 'al', '.', '2012', ')', ',', 'the', 'PHF3-PTP4A1', 'gene', 'complex', '(', 'Zuo', 'et', 'al', '.', '2011', ',', '2014', ')', ',', 'rs1437396', 'at', 'chromosomal', 'location', '2p16.1', 'and', 'other', 'variants', 'in', 'the', 'alcohol', 'dehydrogenase', '(', 'ADH', ')', 'gene', 'cluster', '(', 'Gelernter', 'et', 'al', '.', '2014', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of note are two sub-threshold SNPs in UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 (B4GALT6) (Table 1).	[('PMC6584945', 'R01007', 57, 87, 'beta 1,4-galactosyltransferase')]	['Of', 'note', 'are', 'two', 'sub', '-', 'threshold', 'SNPs', 'in', 'UDP', '-', 'Gal', ':', 'beta', '##Glc', '##NAc', 'beta', '1', ',', '4', '-', 'galact', '##osyl', '##transferase', ',', 'polypeptide', '6', '(', 'B', '##4', '##GA', '##LT', '##6', ')', '(', 'Table', '1', ')', '.']	[0, 3, 8, 12, 16, 19, 20, 30, 35, 38, 41, 42, 45, 46, 50, 53, 57, 62, 63, 64, 65, 66, 72, 76, 87, 89, 101, 103, 104, 105, 106, 108, 110, 111, 113, 114, 120, 121, 122]	[2, 7, 11, 15, 19, 20, 29, 34, 37, 41, 42, 45, 46, 50, 53, 56, 61, 63, 64, 65, 66, 72, 76, 87, 88, 100, 102, 104, 105, 106, 108, 110, 111, 112, 114, 119, 121, 122, 123]	['Of', 'note', 'are', 'two', 'sub', '-', 'threshold', 'SNPs', 'in', 'UDP-Gal', ':', 'betaGlcNAc', 'beta', '1', ',', '4-galactosyltransferase', ',', 'polypeptide', '6', '(', 'B4GALT6', ')', '(', 'Table', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 5, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To investigate for a special immune relationship in patients with SLE with their candidate pathobionts, we electrophoretically separated the components in extracts of eight monocultured RG strains (online supplementary table 5) after treatment with lysozyme and endonuclease.	[('PMC6585303', 'R13000', 249, 257, 'lysozyme'), ('PMC6585303', 'R13000', 262, 274, 'endonuclease')]	['To', 'investigate', 'for', 'a', 'special', 'immune', 'relationship', 'in', 'patients', 'with', 'SLE', 'with', 'their', 'candidate', 'path', '##obi', '##ont', '##s', ',', 'we', 'electroph', '##oretic', '##ally', 'separated', 'the', 'components', 'in', 'extracts', 'of', 'eight', 'monoc', '##ulture', '##d', 'RG', 'strains', '(', 'online', 'supplementary', 'table', '5', ')', 'after', 'treatment', 'with', 'lys', '##ozyme', 'and', 'end', '##onuclease', '.']	[0, 3, 15, 19, 21, 29, 36, 49, 52, 61, 66, 70, 75, 81, 91, 95, 98, 101, 102, 104, 107, 116, 122, 127, 137, 141, 152, 155, 164, 167, 173, 178, 184, 186, 189, 197, 198, 205, 219, 225, 226, 228, 234, 244, 249, 252, 258, 262, 265, 274]	[2, 14, 18, 20, 28, 35, 48, 51, 60, 65, 69, 74, 80, 90, 95, 98, 101, 102, 103, 106, 116, 122, 126, 136, 140, 151, 154, 163, 166, 172, 178, 184, 185, 188, 196, 198, 204, 218, 224, 226, 227, 233, 243, 248, 252, 257, 261, 265, 274, 275]	['To', 'investigate', 'for', 'a', 'special', 'immune', 'relationship', 'in', 'patients', 'with', 'SLE', 'with', 'their', 'candidate', 'pathobionts', ',', 'we', 'electrophoretically', 'separated', 'the', 'components', 'in', 'extracts', 'of', 'eight', 'monocultured', 'RG', 'strains', '(', 'online', 'supplementary', 'table', '5', ')', 'after', 'treatment', 'with', 'lysozyme', 'and', 'endonuclease', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'B', 'E', 'O']
Immunoblots revealed that many patients with lupus and healthy adult controls had IgG reactivity with antigenic bands, common to a range of RG strains (figure 2A–D), and these were protease-sensitive (figure 2E).	[('PMC6585303', 'R13001', 181, 189, 'protease')]	['Immun', '##oblot', '##s', 'revealed', 'that', 'many', 'patients', 'with', 'lupus', 'and', 'healthy', 'adult', 'controls', 'had', 'IgG', 'reactivity', 'with', 'antigenic', 'bands', ',', 'common', 'to', 'a', 'range', 'of', 'RG', 'strains', '(', 'figure', '2', '##A', '–', 'D', ')', ',', 'and', 'these', 'were', 'protease', '-', 'sensitive', '(', 'figure', '2', '##E', ')', '.']	[0, 5, 10, 12, 21, 26, 31, 40, 45, 51, 55, 63, 69, 78, 82, 86, 97, 102, 112, 117, 119, 126, 129, 131, 137, 140, 143, 151, 152, 159, 160, 161, 162, 163, 164, 166, 170, 176, 181, 189, 190, 200, 201, 208, 209, 210, 211]	[5, 10, 11, 20, 25, 30, 39, 44, 50, 54, 62, 68, 77, 81, 85, 96, 101, 111, 117, 118, 125, 128, 130, 136, 139, 142, 150, 152, 158, 160, 161, 162, 163, 164, 165, 169, 175, 180, 189, 190, 199, 201, 207, 209, 210, 211, 212]	['Immunoblots', 'revealed', 'that', 'many', 'patients', 'with', 'lupus', 'and', 'healthy', 'adult', 'controls', 'had', 'IgG', 'reactivity', 'with', 'antigenic', 'bands', ',', 'common', 'to', 'a', 'range', 'of', 'RG', 'strains', '(', 'figure', '2A', '–', 'D', ')', ',', 'and', 'these', 'were', 'protease', '-', 'sensitive', '(', 'figure', '2E', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Notably, serum IgG antibodies of lupus patients with SLEDAI activity scores of ≥8 were often highly reactive with specific conserved protease-resistant bands in the extract of the R. gnavus strain CC55_001C, which is here termed RG2 (online supplementary table 5).	[('PMC6585303', 'R13003', 133, 141, 'protease')]	['Notably', ',', 'serum', 'IgG', 'antibodies', 'of', 'lupus', 'patients', 'with', 'SLE', '##DA', '##I', 'activity', 'scores', 'of', '≥', '8', 'were', 'often', 'highly', 'reactive', 'with', 'specific', 'conserved', 'protease', '-', 'resistant', 'bands', 'in', 'the', 'extract', 'of', 'the', 'R', '.', 'gn', '##av', '##us', 'strain', 'CC', '##55', '_', '00', '##1', '##C', ',', 'which', 'is', 'here', 'termed', 'RG', '##2', '(', 'online', 'supplementary', 'table', '5', ')', '.']	[0, 7, 9, 15, 19, 30, 33, 39, 48, 53, 56, 58, 60, 69, 76, 79, 80, 82, 87, 93, 100, 109, 114, 123, 133, 141, 142, 152, 158, 161, 165, 173, 176, 180, 181, 183, 185, 187, 190, 197, 199, 201, 202, 204, 205, 206, 208, 214, 217, 222, 229, 231, 233, 234, 241, 255, 261, 262, 263]	[7, 8, 14, 18, 29, 32, 38, 47, 52, 56, 58, 59, 68, 75, 78, 80, 81, 86, 92, 99, 108, 113, 122, 132, 141, 142, 151, 157, 160, 164, 172, 175, 179, 181, 182, 185, 187, 189, 196, 199, 201, 202, 204, 205, 206, 207, 213, 216, 221, 228, 231, 232, 234, 240, 254, 260, 262, 263, 264]	['Notably', ',', 'serum', 'IgG', 'antibodies', 'of', 'lupus', 'patients', 'with', 'SLEDAI', 'activity', 'scores', 'of', '≥', '8', 'were', 'often', 'highly', 'reactive', 'with', 'specific', 'conserved', 'protease', '-', 'resistant', 'bands', 'in', 'the', 'extract', 'of', 'the', 'R', '.', 'gnavus', 'strain', 'CC55_001C', ',', 'which', 'is', 'here', 'termed', 'RG2', '(', 'online', 'supplementary', 'table', '5', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For investigations of the potential immune epitope features of the RG2 strain, we performed immunoblots with lupus IgG that detected high levels of oligomeric bands in the LG3 pool in the range of ~20–30 kDa protein markers, which resembled the reactivity pattern of protease-resistant antigens in the RG2 extract that were absent in other RG strains (figure 4A–D).	[('PMC6585303', 'R24000', 267, 275, 'protease')]	['For', 'investigations', 'of', 'the', 'potential', 'immune', 'epitope', 'features', 'of', 'the', 'RG', '##2', 'strain', ',', 'we', 'performed', 'immunoblot', '##s', 'with', 'lupus', 'IgG', 'that', 'detected', 'high', 'levels', 'of', 'oligomer', '##ic', 'bands', 'in', 'the', 'LG', '##3', 'pool', 'in', 'the', 'range', 'of', '~', '20', '–', '30', 'kDa', 'protein', 'markers', ',', 'which', 'resemble', '##d', 'the', 'reactivity', 'pattern', 'of', 'protease', '-', 'resistant', 'antigens', 'in', 'the', 'RG', '##2', 'extract', 'that', 'were', 'absent', 'in', 'other', 'RG', 'strains', '(', 'figure', '4', '##A', '–', 'D', ')', '.']	[0, 4, 19, 22, 26, 36, 43, 51, 60, 63, 67, 69, 71, 77, 79, 82, 92, 102, 104, 109, 115, 119, 124, 133, 138, 145, 148, 156, 159, 165, 168, 172, 174, 176, 181, 184, 188, 194, 197, 198, 200, 201, 204, 208, 216, 223, 225, 231, 239, 241, 245, 256, 264, 267, 275, 276, 286, 295, 298, 302, 304, 306, 314, 319, 324, 331, 334, 340, 343, 351, 352, 359, 360, 361, 362, 363, 364]	[3, 18, 21, 25, 35, 42, 50, 59, 62, 66, 69, 70, 77, 78, 81, 91, 102, 103, 108, 114, 118, 123, 132, 137, 144, 147, 156, 158, 164, 167, 171, 174, 175, 180, 183, 187, 193, 196, 198, 200, 201, 203, 207, 215, 223, 224, 230, 239, 240, 244, 255, 263, 266, 275, 276, 285, 294, 297, 301, 304, 305, 313, 318, 323, 330, 333, 339, 342, 350, 352, 358, 360, 361, 362, 363, 364, 365]	['For', 'investigations', 'of', 'the', 'potential', 'immune', 'epitope', 'features', 'of', 'the', 'RG2', 'strain', ',', 'we', 'performed', 'immunoblots', 'with', 'lupus', 'IgG', 'that', 'detected', 'high', 'levels', 'of', 'oligomeric', 'bands', 'in', 'the', 'LG3', 'pool', 'in', 'the', 'range', 'of', '~20', '–', '30', 'kDa', 'protein', 'markers', ',', 'which', 'resembled', 'the', 'reactivity', 'pattern', 'of', 'protease', '-', 'resistant', 'antigens', 'in', 'the', 'RG2', 'extract', 'that', 'were', 'absent', 'in', 'other', 'RG', 'strains', '(', 'figure', '4A', '–', 'D', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In fact, preincubation of a lupus serum with LG3 at 2 µg/mL inhibited all immunoblot reactivity with the oligomeric antigenic bands in the LG2 and LG3 pools and with the nuclease-treated RG2 extract, but did not affect the IgG reactivity with the protease-sensitive bands (figure 4E, F).	[('PMC6585303', 'R24001', 247, 255, 'protease')]	['In', 'fact', ',', 'preinc', '##ubation', 'of', 'a', 'lupus', 'serum', 'with', 'LG', '##3', 'at', '2', '[UNK]', '/', 'mL', 'inhibited', 'all', 'immunoblot', 'reactivity', 'with', 'the', 'oligomer', '##ic', 'antigenic', 'bands', 'in', 'the', 'LG', '##2', 'and', 'LG', '##3', 'pools', 'and', 'with', 'the', 'nucle', '##ase', '-', 'treated', 'RG', '##2', 'extract', ',', 'but', 'did', 'not', 'affect', 'the', 'IgG', 'reactivity', 'with', 'the', 'protease', '-', 'sensitive', 'bands', '(', 'figure', '4', '##E', ',', 'F', ')', '.']	[0, 3, 7, 9, 15, 23, 26, 28, 34, 40, 45, 47, 49, 52, -1, 56, 57, 60, 70, 74, 85, 96, 101, 105, 113, 116, 126, 132, 135, 139, 141, 143, 147, 149, 151, 157, 161, 166, 170, 175, 178, 179, 187, 189, 191, 198, 200, 204, 208, 212, 219, 223, 227, 238, 243, 247, 255, 256, 266, 272, 273, 280, 281, 282, 284, 285, 286]	[2, 7, 8, 15, 22, 25, 27, 33, 39, 44, 47, 48, 51, 53, 4, 57, 59, 69, 73, 84, 95, 100, 104, 113, 115, 125, 131, 134, 138, 141, 142, 146, 149, 150, 156, 160, 165, 169, 175, 178, 179, 186, 189, 190, 198, 199, 203, 207, 211, 218, 222, 226, 237, 242, 246, 255, 256, 265, 271, 273, 279, 281, 282, 283, 285, 286, 287]	['In', 'fact', ',', 'preincubation', 'of', 'a', 'lupus', 'serum', 'with', 'LG3', 'at', '2', 'µg', '/', 'mL', 'inhibited', 'all', 'immunoblot', 'reactivity', 'with', 'the', 'oligomeric', 'antigenic', 'bands', 'in', 'the', 'LG2', 'and', 'LG3', 'pools', 'and', 'with', 'the', 'nuclease', '-', 'treated', 'RG2', 'extract', ',', 'but', 'did', 'not', 'affect', 'the', 'IgG', 'reactivity', 'with', 'the', 'protease', '-', 'sensitive', 'bands', '(', 'figure', '4E', ',', 'F', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A recent study of macaques found that Lactobacillus regulated the Th17 axis by inhibiting the activity of indoleamine 2,3-dioxygenase 1 (25).	[('PMC6590206', 'D02010', 106, 135, 'indoleamine 2,3-dioxygenase 1')]	['A', 'recent', 'study', 'of', 'mac', '##aques', 'found', 'that', 'Lact', '##obacillus', 'regulated', 'the', 'Th', '##17', 'axis', 'by', 'inhibiting', 'the', 'activity', 'of', 'ind', '##ole', '##amine', '2', ',', '3', '-', 'di', '##oxygenase', '1', '(', '25', ')', '.']	[0, 2, 9, 15, 18, 21, 27, 33, 38, 42, 52, 62, 66, 68, 71, 76, 79, 90, 94, 103, 106, 109, 112, 118, 119, 120, 121, 122, 124, 134, 136, 137, 139, 140]	[1, 8, 14, 17, 21, 26, 32, 37, 42, 51, 61, 65, 68, 70, 75, 78, 89, 93, 102, 105, 109, 112, 117, 119, 120, 121, 122, 124, 133, 135, 137, 139, 140, 141]	['A', 'recent', 'study', 'of', 'macaques', 'found', 'that', 'Lactobacillus', 'regulated', 'the', 'Th17', 'axis', 'by', 'inhibiting', 'the', 'activity', 'of', 'indoleamine', '2', ',', '3-dioxygenase', '1', '(', '25', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
The sequences of microbial rRNA that can reflect the flora composition and diversity were used as targets, and sample-specific barcode sequences were used for PCR amplification of the variable regions of the 16S rRNA gene (Q5 HiFi DNA polymerase; NEB, Ipswich, MA, USA).	[('PMC6590206', 'M04000', 231, 245, 'DNA polymerase')]	['The', 'sequences', 'of', 'microbial', 'rRNA', 'that', 'can', 'reflect', 'the', 'flo', '##ra', 'composition', 'and', 'diversity', 'were', 'used', 'as', 'targets', ',', 'and', 'sample', '-', 'specific', 'bar', '##code', 'sequences', 'were', 'used', 'for', 'PCR', 'amplification', 'of', 'the', 'variable', 'regions', 'of', 'the', '16', '##S', 'rRNA', 'gene', '(', 'Q', '##5', 'Hi', '##Fi', 'DNA', 'polymerase', ';', 'NE', '##B', ',', 'Ip', '##sw', '##ich', ',', 'MA', ',', 'USA', ')', '.']	[0, 4, 14, 17, 27, 32, 37, 41, 49, 53, 56, 59, 71, 75, 85, 90, 95, 98, 105, 107, 111, 117, 118, 127, 130, 135, 145, 150, 155, 159, 163, 177, 180, 184, 193, 201, 204, 208, 210, 212, 217, 222, 223, 224, 226, 228, 231, 235, 245, 247, 249, 250, 252, 254, 256, 259, 261, 263, 265, 268, 269]	[3, 13, 16, 26, 31, 36, 40, 48, 52, 56, 58, 70, 74, 84, 89, 94, 97, 105, 106, 110, 117, 118, 126, 130, 134, 144, 149, 154, 158, 162, 176, 179, 183, 192, 200, 203, 207, 210, 211, 216, 221, 223, 224, 225, 228, 230, 234, 245, 246, 249, 250, 251, 254, 256, 259, 260, 263, 264, 268, 269, 270]	['The', 'sequences', 'of', 'microbial', 'rRNA', 'that', 'can', 'reflect', 'the', 'flora', 'composition', 'and', 'diversity', 'were', 'used', 'as', 'targets', ',', 'and', 'sample', '-', 'specific', 'barcode', 'sequences', 'were', 'used', 'for', 'PCR', 'amplification', 'of', 'the', 'variable', 'regions', 'of', 'the', '16S', 'rRNA', 'gene', '(', 'Q5', 'HiFi', 'DNA', 'polymerase', ';', 'NEB', ',', 'Ipswich', ',', 'MA', ',', 'USA', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 2, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Prevotella copri express a superoxide reductase and phosphoadenosine phosphosulfate reductase that may promote the development of inflammation.	[('PMC6605625', 'D03002', 27, 47, 'superoxide reductase'), ('PMC6605625', 'D03002', 52, 93, 'phosphoadenosine phosphosulfate reductase')]	['Prev', '##ote', '##lla', 'cop', '##ri', 'express', 'a', 'superoxide', 'reductase', 'and', 'phospho', '##aden', '##osine', 'phospho', '##sulf', '##ate', 'reductase', 'that', 'may', 'promote', 'the', 'development', 'of', 'inflammation', '.']	[0, 4, 7, 11, 14, 17, 25, 27, 38, 48, 52, 59, 63, 69, 76, 80, 84, 94, 99, 103, 111, 115, 127, 130, 142]	[4, 7, 10, 14, 16, 24, 26, 37, 47, 51, 59, 63, 68, 76, 80, 83, 93, 98, 102, 110, 114, 126, 129, 142, 143]	['Prevotella', 'copri', 'express', 'a', 'superoxide', 'reductase', 'and', 'phosphoadenosine', 'phosphosulfate', 'reductase', 'that', 'may', 'promote', 'the', 'development', 'of', 'inflammation', '.']	[3, 2, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA.	[('PMC6605625', 'F22002', 98, 108, 'polymerase')]	['Prof', '##iling', 'of', 'complex', 'microbial', 'populations', 'by', 'den', '##aturing', 'gradient', 'gel', 'electrophoresis', 'analysis', 'of', 'polymerase', 'chain', 'reaction', '-', 'amplified', 'genes', 'coding', 'for', '16', '##S', 'rRNA', '.']	[0, 4, 10, 13, 21, 31, 43, 46, 49, 57, 66, 70, 86, 95, 98, 109, 115, 123, 124, 134, 140, 147, 151, 153, 155, 159]	[4, 9, 12, 20, 30, 42, 45, 49, 56, 65, 69, 85, 94, 97, 108, 114, 123, 124, 133, 139, 146, 150, 153, 154, 159, 160]	['Profiling', 'of', 'complex', 'microbial', 'populations', 'by', 'denaturing', 'gradient', 'gel', 'electrophoresis', 'analysis', 'of', 'polymerase', 'chain', 'reaction', '-', 'amplified', 'genes', 'coding', 'for', '16S', 'rRNA', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Each 50 µl PCR reaction mixture contained 1 µl of each primer, 1 µl dNTPs (10 mM), 5 µl MgCl2 (25 mM), 5 µl 1X buffer, 0.4 µl Taq DNA polymerase (Takara Bio, Inc.) and 2 µl fecal DNA.	[('PMC6605625', 'M03001', 126, 144, 'Taq DNA polymerase')]	['Each', '50', '[UNK]', 'PCR', 'reaction', 'mixture', 'contained', '1', '[UNK]', 'of', 'each', 'primer', ',', '1', '[UNK]', 'd', '##NT', '##Ps', '(', '10', 'mM', ')', ',', '5', '[UNK]', 'MgCl', '##2', '(', '25', 'mM', ')', ',', '5', '[UNK]', '1', '##X', 'buffer', ',', '0', '.', '4', '[UNK]', 'Taq', 'DNA', 'polymerase', '(', 'Tak', '##ara', 'Bio', ',', 'Inc', '.', ')', 'and', '2', '[UNK]', 'fecal', 'DNA', '.']	[0, 5, -1, 11, 15, 24, 32, 42, -1, 47, 50, 55, 61, 63, -1, 68, 69, 71, 74, 75, 78, 80, 81, 83, -1, 88, 92, 94, 95, 98, 100, 101, 103, -1, 108, 109, 111, 117, 119, 120, 121, -1, 126, 130, 134, 145, 146, 149, 153, 156, 158, 161, 162, 164, 168, -1, 173, 179, 182]	[4, 7, 4, 14, 23, 31, 41, 43, 4, 49, 54, 61, 62, 64, 4, 69, 71, 73, 75, 77, 80, 81, 82, 84, 4, 92, 93, 95, 97, 100, 101, 102, 104, 4, 109, 110, 117, 118, 120, 121, 122, 4, 129, 133, 144, 146, 149, 152, 156, 157, 161, 162, 163, 167, 169, 4, 178, 182, 183]	['Each', '50', 'µl', 'PCR', 'reaction', 'mixture', 'contained', '1', 'µl', 'of', 'each', 'primer', ',', '1', 'µl', 'dNTPs', '(', '10', 'mM', ')', ',', '5', 'µl', 'MgCl2', '(', '25', 'mM', ')', ',', '5', 'µl', '1X', 'buffer', ',', '0.4', 'µl', 'Taq', 'DNA', 'polymerase', '(', 'Takara', 'Bio', ',', 'Inc', '.', ')', 'and', '2', 'µl', 'fecal', 'DNA', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Then, the samples were treated for 15 min at 65 °C with proteinase K according to the instructions of MagNA Pure LC DNA isolation kit III.	[('PMC6627446', 'M03004', 56, 68, 'proteinase K')]	['Then', ',', 'the', 'samples', 'were', 'treated', 'for', '15', 'min', 'at', '65', '°', '##C', 'with', 'protein', '##ase', 'K', 'according', 'to', 'the', 'instructions', 'of', 'Mag', '##NA', 'Pure', 'LC', 'DNA', 'isolation', 'kit', 'III', '.']	[0, 4, 6, 10, 18, 23, 31, 35, 38, 42, 45, 48, 49, 51, 56, 63, 67, 69, 79, 82, 86, 99, 102, 105, 108, 113, 116, 120, 130, 134, 137]	[4, 5, 9, 17, 22, 30, 34, 37, 41, 44, 47, 49, 50, 55, 63, 66, 68, 78, 81, 85, 98, 101, 105, 107, 112, 115, 119, 129, 133, 137, 138]	['Then', ',', 'the', 'samples', 'were', 'treated', 'for', '15', 'min', 'at', '65', '°C', 'with', 'proteinase', 'K', 'according', 'to', 'the', 'instructions', 'of', 'MagNA', 'Pure', 'LC', 'DNA', 'isolation', 'kit', 'III', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To quantify the bacterial load in salivary samples, we performed real-time PCR using LightCycler 480 instrument (Roche) and SYBR Premix ExTaq (Tli RNaseH Plus) (Takara Bio Europe).	[('PMC6627446', 'M06000', 147, 153, 'RNaseH')]	['To', 'quantify', 'the', 'bacterial', 'load', 'in', 'salivary', 'samples', ',', 'we', 'performed', 'real', '-', 'time', 'PCR', 'using', 'Light', '##Cy', '##cle', '##r', '480', 'instrument', '(', 'Roche', ')', 'and', 'SYBR', 'Pre', '##mix', 'Ex', '##Ta', '##q', '(', 'T', '##li', 'RNase', '##H', 'Plus', ')', '(', 'Tak', '##ara', 'Bio', 'Europe', ')', '.']	[0, 3, 12, 16, 26, 31, 34, 43, 50, 52, 55, 65, 69, 70, 75, 79, 85, 90, 92, 95, 97, 101, 112, 113, 118, 120, 124, 129, 132, 136, 138, 140, 142, 143, 144, 147, 152, 154, 158, 160, 161, 164, 168, 172, 178, 179]	[2, 11, 15, 25, 30, 33, 42, 50, 51, 54, 64, 69, 70, 74, 78, 84, 90, 92, 95, 96, 100, 111, 113, 118, 119, 123, 128, 132, 135, 138, 140, 141, 143, 144, 146, 152, 153, 158, 159, 161, 164, 167, 171, 178, 179, 180]	['To', 'quantify', 'the', 'bacterial', 'load', 'in', 'salivary', 'samples', ',', 'we', 'performed', 'real', '-', 'time', 'PCR', 'using', 'LightCycler', '480', 'instrument', '(', 'Roche', ')', 'and', 'SYBR', 'Premix', 'ExTaq', '(', 'Tli', 'RNaseH', 'Plus', ')', '(', 'Takara', 'Bio', 'Europe', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 2, 2, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gomes BPFA, Pinheiro ET, Jacinto RC, Zaia AA, Ferraz CCR, Souza-Filho FJ.Microbial analysis of canals of root-filled teeth with periapical lesions using polymerase chain reaction.	[('PMC6635307', 'F06001', 153, 163, 'polymerase')]	['Go', '##mes', 'BP', '##FA', ',', 'Pin', '##he', '##iro', 'ET', ',', 'Jac', '##int', '##o', 'RC', ',', 'Z', '##ai', '##a', 'AA', ',', 'Ferr', '##az', 'CCR', ',', 'So', '##uz', '##a', '-', 'Fil', '##ho', 'FJ', '.', 'Microb', '##ial', 'analysis', 'of', 'canal', '##s', 'of', 'root', '-', 'filled', 'teeth', 'with', 'peri', '##ap', '##ical', 'lesions', 'using', 'polymerase', 'chain', 'reaction', '.']	[0, 2, 6, 8, 10, 12, 15, 17, 21, 23, 25, 28, 31, 33, 35, 37, 38, 40, 42, 44, 46, 50, 53, 56, 58, 60, 62, 63, 64, 67, 70, 72, 73, 79, 83, 92, 95, 100, 102, 105, 109, 110, 117, 123, 128, 132, 134, 139, 147, 153, 164, 170, 178]	[2, 5, 8, 10, 11, 15, 17, 20, 23, 24, 28, 31, 32, 35, 36, 38, 40, 41, 44, 45, 50, 52, 56, 57, 60, 62, 63, 64, 67, 69, 72, 73, 79, 82, 91, 94, 100, 101, 104, 109, 110, 116, 122, 127, 132, 134, 138, 146, 152, 163, 169, 178, 179]	['Gomes', 'BPFA', ',', 'Pinheiro', 'ET', ',', 'Jacinto', 'RC', ',', 'Zaia', 'AA', ',', 'Ferraz', 'CCR', ',', 'Souza-Filho', 'FJ.Microbial', 'analysis', 'of', 'canals', 'of', 'root', '-', 'filled', 'teeth', 'with', 'periapical', 'lesions', 'using', 'polymerase', 'chain', 'reaction', '.']	[2, 2, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 6, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O']
Siqueira JF, Jr, Rocas IN.Polymerase chain reaction-based analysis of microorganisms associated with failed endodontic treatment.	[('PMC6635307', 'F20001', 26, 36, 'Polymerase')]	['Si', '##que', '##ira', 'JF', ',', 'Jr', ',', 'Roc', '##as', 'IN', '.', 'Polymer', '##ase', 'chain', 'reaction', '-', 'based', 'analysis', 'of', 'microorganisms', 'associated', 'with', 'failed', 'end', '##odontic', 'treatment', '.']	[0, 2, 5, 9, 11, 13, 15, 17, 20, 23, 25, 26, 33, 37, 43, 51, 52, 58, 67, 70, 85, 96, 101, 108, 111, 119, 128]	[2, 5, 8, 11, 12, 15, 16, 20, 22, 25, 26, 33, 36, 42, 51, 52, 57, 66, 69, 84, 95, 100, 107, 111, 118, 128, 129]	['Siqueira', 'JF', ',', 'Jr', ',', 'Rocas', 'IN.Polymerase', 'chain', 'reaction', '-', 'based', 'analysis', 'of', 'microorganisms', 'associated', 'with', 'failed', 'endodontic', 'treatment', '.']	[3, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Baumgartner JC, Siqueira JF, Jr, Xia T, Rocas IN.Geographical differences in bacteria detected in endodontic infections using polymerase chain reaction.	[('PMC6635307', 'F32001', 126, 136, 'polymerase')]	['Ba', '##um', '##gart', '##ner', 'JC', ',', 'Si', '##que', '##ira', 'JF', ',', 'Jr', ',', 'Xia', 'T', ',', 'Roc', '##as', 'IN', '.', 'Ge', '##ographical', 'differences', 'in', 'bacteria', 'detected', 'in', 'end', '##odontic', 'infections', 'using', 'polymerase', 'chain', 'reaction', '.']	[0, 2, 4, 8, 12, 14, 16, 18, 21, 25, 27, 29, 31, 33, 37, 38, 40, 43, 46, 48, 49, 51, 62, 74, 77, 86, 95, 98, 101, 109, 120, 126, 137, 143, 151]	[2, 4, 8, 11, 14, 15, 18, 21, 24, 27, 28, 31, 32, 36, 38, 39, 43, 45, 48, 49, 51, 61, 73, 76, 85, 94, 97, 101, 108, 119, 125, 136, 142, 151, 152]	['Baumgartner', 'JC', ',', 'Siqueira', 'JF', ',', 'Jr', ',', 'Xia', 'T', ',', 'Rocas', 'IN.Geographical', 'differences', 'in', 'bacteria', 'detected', 'in', 'endodontic', 'infections', 'using', 'polymerase', 'chain', 'reaction', '.']	[4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O']
Uric acid is the end-product of the purine oxidative degradation, deriving from hypoxanthine through xanthine by a NAD-dependent oxidoreductase (https://www.genome.jp/dbget-bin/www_bget?rn:R01768; https://www.genome.jp/dbget-bin/www_bget?rn:R02103).	[('PMC6650891', 'D00008', 115, 143, 'NAD-dependent oxidoreductase')]	['Ur', '##ic', 'acid', 'is', 'the', 'end', '-', 'product', 'of', 'the', 'pur', '##ine', 'oxidative', 'degradation', ',', 'deriving', 'from', 'hypo', '##x', '##anth', '##ine', 'through', 'x', '##anth', '##ine', 'by', 'a', 'NAD', '-', 'dependent', 'oxid', '##ored', '##uct', '##ase', '(', 'https', ':', '/', '/', 'www', '.', 'genome', '.', 'j', '##p', '/', 'db', '##get', '-', 'bin', '/', 'www', '_', 'b', '##get', '?', 'rn', ':', 'R', '##017', '##68', ';', 'https', ':', '/', '/', 'www', '.', 'genome', '.', 'j', '##p', '/', 'db', '##get', '-', 'bin', '/', 'www', '_', 'b', '##get', '?', 'rn', ':', 'R', '##02', '##103', ')', '.']	[0, 2, 5, 10, 13, 17, 20, 21, 29, 32, 36, 39, 43, 53, 64, 66, 75, 80, 84, 85, 89, 93, 101, 102, 106, 110, 113, 115, 118, 119, 129, 133, 137, 140, 144, 145, 150, 151, 152, 153, 156, 157, 163, 164, 165, 166, 167, 169, 172, 173, 176, 177, 180, 181, 182, 185, 186, 188, 189, 190, 193, 195, 197, 202, 203, 204, 205, 208, 209, 215, 216, 217, 218, 219, 221, 224, 225, 228, 229, 232, 233, 234, 237, 238, 240, 241, 242, 244, 247, 248]	[2, 4, 9, 12, 16, 20, 21, 28, 31, 35, 39, 42, 52, 64, 65, 74, 79, 84, 85, 89, 92, 100, 102, 106, 109, 112, 114, 118, 119, 128, 133, 137, 140, 143, 145, 150, 151, 152, 153, 156, 157, 163, 164, 165, 166, 167, 169, 172, 173, 176, 177, 180, 181, 182, 185, 186, 188, 189, 190, 193, 195, 196, 202, 203, 204, 205, 208, 209, 215, 216, 217, 218, 219, 221, 224, 225, 228, 229, 232, 233, 234, 237, 238, 240, 241, 242, 244, 247, 248, 249]	['Uric', 'acid', 'is', 'the', 'end', '-', 'product', 'of', 'the', 'purine', 'oxidative', 'degradation', ',', 'deriving', 'from', 'hypoxanthine', 'through', 'xanthine', 'by', 'a', 'NAD-dependent', 'oxidoreductase', '(', 'https', ':', '/', '/', 'www.genome.jp', '/', 'dbget', '-', 'bin', '/', 'www_bget?rn', ':', 'R01768', ';', 'https', ':', '/', '/', 'www.genome.jp', '/', 'dbget', '-', 'bin', '/', 'www_bget?rn', ':', 'R02103', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 3, 4, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 1, 6, 1, 3, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 1, 6, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dysregulation of fatty acid metabolism in cancer cells is well known [22,23] as it is the potential of fatty acid synthase (fatty acid synthase) as a drug target; in fact, fatty acid synthase was expressed above normal in MM [24] and CLL	[('PMC6650891', 'D02001', 103, 122, 'fatty acid synthase'), ('PMC6650891', 'D02001', 124, 143, 'fatty acid synthase'), ('PMC6650891', 'D02001', 172, 191, 'fatty acid synthase')]	['Dys', '##regulation', 'of', 'fatty', 'acid', 'metabolism', 'in', 'cancer', 'cells', 'is', 'well', 'known', '[', '22', ',', '23', ']', 'as', 'it', 'is', 'the', 'potential', 'of', 'fatty', 'acid', 'synthase', '(', 'fatty', 'acid', 'synthase', ')', 'as', 'a', 'drug', 'target', ';', 'in', 'fact', ',', 'fatty', 'acid', 'synthase', 'was', 'expressed', 'above', 'normal', 'in', 'MM', '[', '24', ']', 'and', 'CLL']	[0, 3, 14, 17, 23, 28, 39, 42, 49, 55, 58, 63, 69, 70, 72, 73, 75, 77, 80, 83, 86, 90, 100, 103, 109, 114, 123, 124, 130, 135, 143, 145, 148, 150, 155, 161, 163, 166, 170, 172, 178, 183, 192, 196, 206, 212, 219, 222, 225, 226, 228, 230, 234]	[3, 13, 16, 22, 27, 38, 41, 48, 54, 57, 62, 68, 70, 72, 73, 75, 76, 79, 82, 85, 89, 99, 102, 108, 113, 122, 124, 129, 134, 143, 144, 147, 149, 154, 161, 162, 165, 170, 171, 177, 182, 191, 195, 205, 211, 218, 221, 224, 226, 228, 229, 233, 237]	['Dysregulation', 'of', 'fatty', 'acid', 'metabolism', 'in', 'cancer', 'cells', 'is', 'well', 'known', '[', '22', ',', '23', ']', 'as', 'it', 'is', 'the', 'potential', 'of', 'fatty', 'acid', 'synthase', '(', 'fatty', 'acid', 'synthase', ')', 'as', 'a', 'drug', 'target', ';', 'in', 'fact', ',', 'fatty', 'acid', 'synthase', 'was', 'expressed', 'above', 'normal', 'in', 'MM', '[', '24', ']', 'and', 'CLL']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A connection has been suggested between defective intracellular glycine import and increase in tetrahydrofolate-bound one-carbon unit production resulting from conversion from serine to glycine by serine hydroxymethyltransferase (serine hydroxymethyltransferase)	[('PMC6650891', 'D03002', 197, 228, 'serine hydroxymethyltransferase'), ('PMC6650891', 'D03002', 230, 261, 'serine hydroxymethyltransferase')]	['A', 'connection', 'has', 'been', 'suggested', 'between', 'defective', 'intracellular', 'glycine', 'import', 'and', 'increase', 'in', 'tetra', '##hydro', '##fol', '##ate', '-', 'bound', 'one', '-', 'carbon', 'unit', 'production', 'resulting', 'from', 'conversion', 'from', 'serine', 'to', 'glycine', 'by', 'serine', 'hydroxy', '##methyl', '##transferase', '(', 'serine', 'hydroxy', '##methyl', '##transferase', ')']	[0, 2, 13, 17, 22, 32, 40, 50, 64, 72, 79, 83, 92, 95, 100, 105, 108, 111, 112, 118, 121, 122, 129, 134, 145, 155, 160, 171, 176, 183, 186, 194, 197, 204, 211, 217, 229, 230, 237, 244, 250, 261]	[1, 12, 16, 21, 31, 39, 49, 63, 71, 78, 82, 91, 94, 100, 105, 108, 111, 112, 117, 121, 122, 128, 133, 144, 154, 159, 170, 175, 182, 185, 193, 196, 203, 211, 217, 228, 230, 236, 244, 250, 261, 262]	['A', 'connection', 'has', 'been', 'suggested', 'between', 'defective', 'intracellular', 'glycine', 'import', 'and', 'increase', 'in', 'tetrahydrofolate', '-', 'bound', 'one', '-', 'carbon', 'unit', 'production', 'resulting', 'from', 'conversion', 'from', 'serine', 'to', 'glycine', 'by', 'serine', 'hydroxymethyltransferase', '(', 'serine', 'hydroxymethyltransferase', ')']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O']
Human serine hydroxymethyltransferase inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma.	[('PMC6650891', 'F08002', 6, 37, 'serine hydroxymethyltransferase')]	['Human', 'serine', 'hydroxy', '##methyl', '##transferase', 'inhibitors', 'reveal', 'defective', 'glycine', 'import', 'as', 'a', 'target', '##able', 'metabolic', 'vulnerability', 'of', 'diffuse', 'large', 'B', '-', 'cell', 'lymphoma', '.']	[0, 6, 13, 20, 26, 38, 49, 56, 66, 74, 81, 84, 86, 92, 97, 107, 121, 124, 132, 138, 139, 140, 145, 153]	[5, 12, 20, 26, 37, 48, 55, 65, 73, 80, 83, 85, 92, 96, 106, 120, 123, 131, 137, 139, 140, 144, 153, 154]	['Human', 'serine', 'hydroxymethyltransferase', 'inhibitors', 'reveal', 'defective', 'glycine', 'import', 'as', 'a', 'targetable', 'metabolic', 'vulnerability', 'of', 'diffuse', 'large', 'B-cell', 'lymphoma', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pera B., Krumsiek J., Assouline S.E., Marullo R., Patel J., Phillip J.M., Romána L., Mannc K.K., Cerchiettia L. Metabolomic profiling reveals cellular reprogramming of B-Cell lymphoma by a lysine deacetylase inhibitor through the choline pathway.	[('PMC6650891', 'F11001', 189, 207, 'lysine deacetylase')]	['Per', '##a', 'B', '.', ',', 'Kr', '##ums', '##iek', 'J', '.', ',', 'Ass', '##oul', '##ine', 'S', '.', 'E', '.', ',', 'Mar', '##ull', '##o', 'R', '.', ',', 'Patel', 'J', '.', ',', 'Phil', '##lip', 'J', '.', 'M', '.', ',', 'Rom', '##án', '##a', 'L', '.', ',', 'Mann', '##c', 'K', '.', 'K', '.', ',', 'Cer', '##chi', '##etti', '##a', 'L', '.', 'Metab', '##olo', '##mic', 'profiling', 'reveals', 'cellular', 'repro', '##gramming', 'of', 'B', '-', 'Cell', 'lymphoma', 'by', 'a', 'lysine', 'de', '##acetyl', '##ase', 'inhibitor', 'through', 'the', 'choline', 'pathway', '.']	[0, 3, 5, 6, 7, 9, 11, 14, 18, 19, 20, 22, 25, 28, 32, 33, 34, 35, 36, 38, 41, 44, 46, 47, 48, 50, 56, 57, 58, 60, 64, 68, 69, 70, 71, 72, 74, 77, 79, 81, 82, 83, 85, 89, 91, 92, 93, 94, 95, 97, 100, 103, 107, 109, 110, 112, 117, 120, 124, 134, 142, 151, 156, 165, 168, 169, 170, 175, 184, 187, 189, 196, 198, 204, 208, 218, 226, 230, 238, 245]	[3, 4, 6, 7, 8, 11, 14, 17, 19, 20, 21, 25, 28, 31, 33, 34, 35, 36, 37, 41, 44, 45, 47, 48, 49, 55, 57, 58, 59, 64, 67, 69, 70, 71, 72, 73, 77, 79, 80, 82, 83, 84, 89, 90, 92, 93, 94, 95, 96, 100, 103, 107, 108, 110, 111, 117, 120, 123, 133, 141, 150, 156, 164, 167, 169, 170, 174, 183, 186, 188, 195, 198, 204, 207, 217, 225, 229, 237, 245, 246]	['Pera', 'B', '.', ',', 'Krumsiek', 'J', '.', ',', 'Assouline', 'S.E', '.', ',', 'Marullo', 'R', '.', ',', 'Patel', 'J', '.', ',', 'Phillip', 'J.M', '.', ',', 'Romána', 'L', '.', ',', 'Mannc', 'K.K', '.', ',', 'Cerchiettia', 'L', '.', 'Metabolomic', 'profiling', 'reveals', 'cellular', 'reprogramming', 'of', 'B-Cell', 'lymphoma', 'by', 'a', 'lysine', 'deacetylase', 'inhibitor', 'through', 'the', 'choline', 'pathway', '.']	[2, 1, 1, 1, 3, 1, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 4, 1, 1, 3, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Buckley D., Duke G., Heuer T.S., O’Farrell M., Wagman A.S., McCulloch W., Kemble G. Fatty acid synthase-Modern tumor cell biology insights into a classical oncology target.	[('PMC6650891', 'F21001', 84, 103, 'Fatty acid synthase')]	['Buck', '##ley', 'D', '.', ',', 'Duke', 'G', '.', ',', 'He', '##uer', 'T', '.', 'S', '.', ',', 'O', '’', 'Far', '##rell', 'M', '.', ',', 'Wa', '##gm', '##an', 'A', '.', 'S', '.', ',', 'McC', '##ull', '##och', 'W', '.', ',', 'Ke', '##mb', '##le', 'G', '.', 'Fat', '##ty', 'acid', 'synthase', '-', 'Modern', 'tumor', 'cell', 'biology', 'insights', 'into', 'a', 'classical', 'oncology', 'target', '.']	[0, 4, 8, 9, 10, 12, 17, 18, 19, 21, 23, 27, 28, 29, 30, 31, 33, 34, 35, 38, 43, 44, 45, 47, 49, 51, 54, 55, 56, 57, 58, 60, 63, 66, 70, 71, 72, 74, 76, 78, 81, 82, 84, 87, 90, 95, 103, 104, 111, 117, 122, 130, 139, 144, 146, 156, 165, 171]	[4, 7, 9, 10, 11, 16, 18, 19, 20, 23, 26, 28, 29, 30, 31, 32, 34, 35, 38, 42, 44, 45, 46, 49, 51, 53, 55, 56, 57, 58, 59, 63, 66, 69, 71, 72, 73, 76, 78, 80, 82, 83, 87, 89, 94, 103, 104, 110, 116, 121, 129, 138, 143, 145, 155, 164, 171, 172]	['Buckley', 'D', '.', ',', 'Duke', 'G', '.', ',', 'Heuer', 'T.S', '.', ',', 'O’Farrell', 'M', '.', ',', 'Wagman', 'A.S', '.', ',', 'McCulloch', 'W', '.', ',', 'Kemble', 'G', '.', 'Fatty', 'acid', 'synthase-Modern', 'tumor', 'cell', 'biology', 'insights', 'into', 'a', 'classical', 'oncology', 'target', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 4, 1, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Wang W., Zhao X., Wang H., Liang Y. Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.	[('PMC6650891', 'F23001', 46, 65, 'fatty acid synthase')]	['Wang', 'W', '.', ',', 'Zhao', 'X', '.', ',', 'Wang', 'H', '.', ',', 'Liang', 'Y', '.', 'Increased', 'fatty', 'acid', 'synthase', 'as', 'a', 'potential', 'therapeutic', 'target', 'in', 'multiple', 'myeloma', '.']	[0, 5, 6, 7, 9, 14, 15, 16, 18, 23, 24, 25, 27, 33, 34, 36, 46, 52, 57, 66, 69, 71, 81, 93, 100, 103, 112, 119]	[4, 6, 7, 8, 13, 15, 16, 17, 22, 24, 25, 26, 32, 34, 35, 45, 51, 56, 65, 68, 70, 80, 92, 99, 102, 111, 119, 120]	['Wang', 'W', '.', ',', 'Zhao', 'X', '.', ',', 'Wang', 'H', '.', ',', 'Liang', 'Y', '.', 'Increased', 'fatty', 'acid', 'synthase', 'as', 'a', 'potential', 'therapeutic', 'target', 'in', 'multiple', 'myeloma', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cocco P., Zucca M., Sanna S., Satta G., Angelucci E., Gabbas A., Monne M., Campagna M., Scarpa A., Ennas M.G. Interaction between dietary and lifestyle risk factors and N-acetyl transferase polymorphisms in B-cell lymphoma etiology.	[('PMC6650891', 'F27001', 169, 189, 'N-acetyl transferase')]	['Co', '##cc', '##o', 'P', '.', ',', 'Zu', '##cc', '##a', 'M', '.', ',', 'San', '##na', 'S', '.', ',', 'Sat', '##ta', 'G', '.', ',', 'Angel', '##ucci', 'E', '.', ',', 'Gab', '##bas', 'A', '.', ',', 'Mon', '##ne', 'M', '.', ',', 'Camp', '##agn', '##a', 'M', '.', ',', 'Sc', '##arp', '##a', 'A', '.', ',', 'En', '##nas', 'M', '.', 'G', '.', 'Interaction', 'between', 'dietary', 'and', 'lifestyle', 'risk', 'factors', 'and', 'N', '-', 'acetyl', 'transfer', '##ase', 'polymorphisms', 'in', 'B', '-', 'cell', 'lymphoma', 'etiology', '.']	[0, 2, 4, 6, 7, 8, 10, 12, 14, 16, 17, 18, 20, 23, 26, 27, 28, 30, 33, 36, 37, 38, 40, 45, 50, 51, 52, 54, 57, 61, 62, 63, 65, 68, 71, 72, 73, 75, 79, 82, 84, 85, 86, 88, 90, 93, 95, 96, 97, 99, 101, 105, 106, 107, 108, 110, 122, 130, 138, 142, 152, 157, 165, 169, 170, 171, 178, 186, 190, 204, 207, 208, 209, 214, 223, 231]	[2, 4, 5, 7, 8, 9, 12, 14, 15, 17, 18, 19, 23, 25, 27, 28, 29, 33, 35, 37, 38, 39, 45, 49, 51, 52, 53, 57, 60, 62, 63, 64, 68, 70, 72, 73, 74, 79, 82, 83, 85, 86, 87, 90, 93, 94, 96, 97, 98, 101, 104, 106, 107, 108, 109, 121, 129, 137, 141, 151, 156, 164, 168, 170, 171, 177, 186, 189, 203, 206, 208, 209, 213, 222, 231, 232]	['Cocco', 'P', '.', ',', 'Zucca', 'M', '.', ',', 'Sanna', 'S', '.', ',', 'Satta', 'G', '.', ',', 'Angelucci', 'E', '.', ',', 'Gabbas', 'A', '.', ',', 'Monne', 'M', '.', ',', 'Campagna', 'M', '.', ',', 'Scarpa', 'A', '.', ',', 'Ennas', 'M.G', '.', 'Interaction', 'between', 'dietary', 'and', 'lifestyle', 'risk', 'factors', 'and', 'N-acetyl', 'transferase', 'polymorphisms', 'in', 'B-cell', 'lymphoma', 'etiology', '.']	[3, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Organophosphate pesticides are inhibitors of acetylcholinesterase.	[('PMC6660083', 'D10005', 45, 65, 'acetylcholinesterase')]	['Organ', '##ophosphate', 'pesticides', 'are', 'inhibitors', 'of', 'acetylcholine', '##ster', '##ase', '.']	[0, 5, 16, 27, 31, 42, 45, 58, 62, 65]	[5, 15, 26, 30, 41, 44, 58, 62, 65, 66]	['Organophosphate', 'pesticides', 'are', 'inhibitors', 'of', 'acetylcholinesterase', '.']	[2, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Exposures to acetylcholinesterase inhibitors, including organophosphate pesticides themselves [87], occurred in the Gulf, and have been implicated in GWI	[('PMC6660083', 'D10006', 13, 33, 'acetylcholinesterase')]	['Exposure', '##s', 'to', 'acetylcholine', '##ster', '##ase', 'inhibitors', ',', 'including', 'organ', '##ophosphate', 'pesticides', 'themselves', '[', '87', ']', ',', 'occurred', 'in', 'the', 'Gulf', ',', 'and', 'have', 'been', 'implicated', 'in', 'GW', '##I']	[0, 8, 10, 13, 26, 30, 34, 44, 46, 56, 61, 72, 83, 94, 95, 97, 98, 100, 109, 112, 116, 120, 122, 126, 131, 136, 147, 150, 152]	[8, 9, 12, 26, 30, 33, 44, 45, 55, 61, 71, 82, 93, 95, 97, 98, 99, 108, 111, 115, 120, 121, 125, 130, 135, 146, 149, 152, 153]	['Exposures', 'to', 'acetylcholinesterase', 'inhibitors', ',', 'including', 'organophosphate', 'pesticides', 'themselves', '[', '87', ']', ',', 'occurred', 'in', 'the', 'Gulf', ',', 'and', 'have', 'been', 'implicated', 'in', 'GWI']	[2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acetylcholinesterase inhibitors and Gulf War illnesses.	[('PMC6660083', 'F04002', 0, 20, 'Acetylcholinesterase')]	['Acet', '##yl', '##choline', '##ster', '##ase', 'inhibitors', 'and', 'Gulf', 'War', 'illnesses', '.']	[0, 4, 6, 13, 17, 21, 32, 36, 41, 45, 54]	[4, 6, 13, 17, 20, 31, 35, 40, 44, 54, 55]	['Acetylcholinesterase', 'inhibitors', 'and', 'Gulf', 'War', 'illnesses', '.']	[5, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Substrate specificity of rabbit aldehyde oxidase for nitroguanidine and nitromethylene neonicotinoid insecticides.	[('PMC6691966', 'F16002', 32, 48, 'aldehyde oxidase')]	['Subst', '##rate', 'specificity', 'of', 'rabbit', 'ald', '##eh', '##yd', '##e', 'oxidase', 'for', 'nitro', '##gu', '##ani', '##din', '##e', 'and', 'nitro', '##methyl', '##ene', 'neon', '##ico', '##tin', '##oid', 'insectic', '##ides', '.']	[0, 5, 10, 22, 25, 32, 35, 37, 39, 41, 49, 53, 58, 60, 63, 66, 68, 72, 77, 83, 87, 91, 94, 97, 101, 109, 113]	[5, 9, 21, 24, 31, 35, 37, 39, 40, 48, 52, 58, 60, 63, 66, 67, 71, 77, 83, 86, 91, 94, 97, 100, 109, 113, 114]	['Substrate', 'specificity', 'of', 'rabbit', 'aldehyde', 'oxidase', 'for', 'nitroguanidine', 'and', 'nitromethylene', 'neonicotinoid', 'insecticides', '.']	[2, 1, 1, 1, 4, 1, 1, 5, 1, 3, 4, 2, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Commensal biofilm up-regulated the transcription of a large group of key genes, which are involved in TLR signaling, including TLR7, the MyD88-dependent pathway (CD14, MyD88, TIRAP, TRAF6, IRAKs), MyD88-independent pathway (TAB1, TBK1, IRF3), and their downstream signaling pathways (NF-κB and mitogen-activated protein kinase pathways).	[('PMC6692492', 'A00009', 294, 326, 'mitogen-activated protein kinase')]	['Comm', '##ens', '##al', 'biofilm', 'up', '-', 'regulated', 'the', 'transcription', 'of', 'a', 'large', 'group', 'of', 'key', 'genes', ',', 'which', 'are', 'involved', 'in', 'TLR', 'signaling', ',', 'including', 'TLR', '##7', ',', 'the', 'My', '##D', '##88', '-', 'dependent', 'pathway', '(', 'CD', '##14', ',', 'My', '##D', '##88', ',', 'TI', '##RAP', ',', 'TRA', '##F', '##6', ',', 'IR', '##AK', '##s', ')', ',', 'My', '##D', '##88', '-', 'independent', 'pathway', '(', 'TA', '##B', '##1', ',', 'TB', '##K', '##1', ',', 'IRF', '##3', ')', ',', 'and', 'their', 'downstream', 'signaling', 'pathways', '(', 'NF', '-', 'κ', '##B', 'and', 'mitogen', '-', 'activated', 'protein', 'kinase', 'pathways', ')', '.']	[0, 4, 7, 10, 18, 20, 21, 31, 35, 49, 52, 54, 60, 66, 69, 73, 78, 80, 86, 90, 99, 102, 106, 115, 117, 127, 130, 131, 133, 137, 139, 140, 142, 143, 153, 161, 162, 164, 166, 168, 170, 171, 173, 175, 177, 180, 182, 185, 186, 187, 189, 191, 193, 194, 195, 197, 199, 200, 202, 203, 215, 223, 224, 226, 227, 228, 230, 232, 233, 234, 236, 239, 240, 241, 243, 247, 253, 264, 274, 283, 284, 286, 287, 288, 290, 294, 301, 302, 312, 320, 327, 335, 336]	[4, 7, 9, 17, 20, 21, 30, 34, 48, 51, 53, 59, 65, 68, 72, 78, 79, 85, 89, 98, 101, 105, 115, 116, 126, 130, 131, 132, 136, 139, 140, 142, 143, 152, 160, 162, 164, 166, 167, 170, 171, 173, 174, 177, 180, 181, 185, 186, 187, 188, 191, 193, 194, 195, 196, 199, 200, 202, 203, 214, 222, 224, 226, 227, 228, 229, 232, 233, 234, 235, 239, 240, 241, 242, 246, 252, 263, 273, 282, 284, 286, 287, 288, 289, 293, 301, 302, 311, 319, 326, 335, 336, 337]	['Commensal', 'biofilm', 'up', '-', 'regulated', 'the', 'transcription', 'of', 'a', 'large', 'group', 'of', 'key', 'genes', ',', 'which', 'are', 'involved', 'in', 'TLR', 'signaling', ',', 'including', 'TLR7', ',', 'the', 'MyD88-dependent', 'pathway', '(', 'CD14', ',', 'MyD88', ',', 'TIRAP', ',', 'TRAF6', ',', 'IRAKs', ')', ',', 'MyD88', '-', 'independent', 'pathway', '(', 'TAB1', ',', 'TBK1', ',', 'IRF3', ')', ',', 'and', 'their', 'downstream', 'signaling', 'pathways', '(', 'NF-κB', 'and', 'mitogen', '-', 'activated', 'protein', 'kinase', 'pathways', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 5, 1, 1, 2, 1, 3, 1, 2, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
Notably, the activation of the MyD88-dependent pathway resulted in the activation of either mitogen-activated protein kinase or NF-κB pathways (Brown et al., 2011), both of which lead to the expression of functional products such as pro-inflammatory cytokines and chemokines (Akira and Takeda, 2004).	[('PMC6692492', 'D04005', 92, 124, 'mitogen-activated protein kinase')]	['Notably', ',', 'the', 'activation', 'of', 'the', 'My', '##D', '##88', '-', 'dependent', 'pathway', 'resulted', 'in', 'the', 'activation', 'of', 'either', 'mitogen', '-', 'activated', 'protein', 'kinase', 'or', 'NF', '-', 'κ', '##B', 'pathways', '(', 'Brown', 'et', 'al', '.', ',', '2011', ')', ',', 'both', 'of', 'which', 'lead', 'to', 'the', 'expression', 'of', 'functional', 'products', 'such', 'as', 'pro', '-', 'inflammatory', 'cytokines', 'and', 'chemokines', '(', 'Ak', '##ira', 'and', 'Take', '##da', ',', '2004', ')', '.']	[0, 7, 9, 13, 24, 27, 31, 33, 34, 36, 37, 47, 55, 64, 67, 71, 82, 85, 92, 99, 100, 110, 118, 125, 128, 130, 131, 132, 134, 143, 144, 150, 153, 155, 156, 158, 162, 163, 165, 170, 173, 179, 184, 187, 191, 202, 205, 216, 225, 230, 233, 236, 237, 250, 260, 264, 275, 276, 278, 282, 286, 290, 292, 294, 298, 299]	[7, 8, 12, 23, 26, 30, 33, 34, 36, 37, 46, 54, 63, 66, 70, 81, 84, 91, 99, 100, 109, 117, 124, 127, 130, 131, 132, 133, 142, 144, 149, 152, 155, 156, 157, 162, 163, 164, 169, 172, 178, 183, 186, 190, 201, 204, 215, 224, 229, 232, 236, 237, 249, 259, 263, 274, 276, 278, 281, 285, 290, 292, 293, 298, 299, 300]	['Notably', ',', 'the', 'activation', 'of', 'the', 'MyD88-dependent', 'pathway', 'resulted', 'in', 'the', 'activation', 'of', 'either', 'mitogen', '-', 'activated', 'protein', 'kinase', 'or', 'NF-κB', 'pathways', '(', 'Brown', 'et', 'al', '.', ',', '2011', ')', ',', 'both', 'of', 'which', 'lead', 'to', 'the', 'expression', 'of', 'functional', 'products', 'such', 'as', 'pro', '-', 'inflammatory', 'cytokines', 'and', 'chemokines', '(', 'Akira', 'and', 'Takeda', ',', '2004', ')', '.']	[1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An immune response is triggered which results in inflammation, activation of osteoclasts or matrix metalloproteinase and damage to the alveolar bone and periodontal ligaments (Kinane et al., 2017).	[('PMC6692492', 'D06009', 92, 116, 'matrix metalloproteinase')]	['An', 'immune', 'response', 'is', 'triggered', 'which', 'results', 'in', 'inflammation', ',', 'activation', 'of', 'osteoclast', '##s', 'or', 'matrix', 'metalloprotein', '##ase', 'and', 'damage', 'to', 'the', 'alveolar', 'bone', 'and', 'periodontal', 'ligament', '##s', '(', 'Kin', '##ane', 'et', 'al', '.', ',', '2017', ')', '.']	[0, 3, 10, 19, 22, 32, 38, 46, 49, 61, 63, 74, 77, 87, 89, 92, 99, 113, 117, 121, 128, 131, 135, 144, 149, 153, 165, 173, 175, 176, 179, 183, 186, 188, 189, 191, 195, 196]	[2, 9, 18, 21, 31, 37, 45, 48, 61, 62, 73, 76, 87, 88, 91, 98, 113, 116, 120, 127, 130, 134, 143, 148, 152, 164, 173, 174, 176, 179, 182, 185, 188, 189, 190, 195, 196, 197]	['An', 'immune', 'response', 'is', 'triggered', 'which', 'results', 'in', 'inflammation', ',', 'activation', 'of', 'osteoclasts', 'or', 'matrix', 'metalloproteinase', 'and', 'damage', 'to', 'the', 'alveolar', 'bone', 'and', 'periodontal', 'ligaments', '(', 'Kinane', 'et', 'al', '.', ',', '2017', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk.	[('PMC6692492', 'F04001', 61, 68, 'kinases')]	['TLR', '-', 'signaling', 'networks', ':', 'an', 'integration', 'of', 'adapt', '##or', 'molecules', ',', 'kinases', ',', 'and', 'cross', '-', 'talk', '.']	[0, 3, 4, 14, 22, 24, 27, 39, 42, 47, 50, 59, 61, 68, 70, 74, 79, 80, 84]	[3, 4, 13, 22, 23, 26, 38, 41, 47, 49, 59, 60, 68, 69, 73, 79, 80, 84, 85]	['TLR-signaling', 'networks', ':', 'an', 'integration', 'of', 'adaptor', 'molecules', ',', 'kinases', ',', 'and', 'cross', '-', 'talk', '.']	[3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O']
A bacterial pathogen targets a host rab-family GTPase defense pathway with a GAP.	[('PMC6692492', 'F52001', 47, 53, 'GTPase')]	['A', 'bacterial', 'pathogen', 'targets', 'a', 'host', 'rab', '-', 'family', 'GTP', '##ase', 'defense', 'pathway', 'with', 'a', 'GAP', '.']	[0, 2, 12, 21, 29, 31, 36, 39, 40, 47, 50, 54, 62, 70, 75, 77, 80]	[1, 11, 20, 28, 30, 35, 39, 40, 46, 50, 53, 61, 69, 74, 76, 80, 81]	['A', 'bacterial', 'pathogen', 'targets', 'a', 'host', 'rab', '-', 'family', 'GTPase', 'defense', 'pathway', 'with', 'a', 'GAP', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
After the activation of TLRs, a number of downstream pathways are regulated, including nuclear factor kappa B (NF-κB), interferon regulatory factor (IRF) and mitogen-activated protein kinase (mitogen-activated protein kinase) pathways which target chemokine, cytokine and type I interferon production (Dowling and Mansell, 2016).	[('PMC6692492', 'I01001', 158, 190, 'mitogen-activated protein kinase'), ('PMC6692492', 'I01001', 192, 224, 'mitogen-activated protein kinase')]	['After', 'the', 'activation', 'of', 'TLR', '##s', ',', 'a', 'number', 'of', 'downstream', 'pathways', 'are', 'regulated', ',', 'including', 'nuclear', 'factor', 'kappa', 'B', '(', 'NF', '-', 'κ', '##B', ')', ',', 'interferon', 'regulatory', 'factor', '(', 'IRF', ')', 'and', 'mitogen', '-', 'activated', 'protein', 'kinase', '(', 'mitogen', '-', 'activated', 'protein', 'kinase', ')', 'pathways', 'which', 'target', 'chemokine', ',', 'cytokine', 'and', 'type', 'I', 'interferon', 'production', '(', 'Dow', '##ling', 'and', 'Man', '##sel', '##l', ',', '2016', ')', '.']	[0, 6, 10, 21, 24, 27, 28, 30, 32, 39, 42, 53, 62, 66, 75, 77, 87, 95, 102, 108, 110, 111, 113, 114, 115, 116, 117, 119, 130, 141, 148, 149, 152, 154, 158, 165, 166, 176, 184, 191, 192, 199, 200, 210, 218, 224, 226, 235, 241, 248, 257, 259, 268, 272, 277, 279, 290, 301, 302, 305, 310, 314, 317, 320, 321, 323, 327, 328]	[5, 9, 20, 23, 27, 28, 29, 31, 38, 41, 52, 61, 65, 75, 76, 86, 94, 101, 107, 109, 111, 113, 114, 115, 116, 117, 118, 129, 140, 147, 149, 152, 153, 157, 165, 166, 175, 183, 190, 192, 199, 200, 209, 217, 224, 225, 234, 240, 247, 257, 258, 267, 271, 276, 278, 289, 300, 302, 305, 309, 313, 317, 320, 321, 322, 327, 328, 329]	['After', 'the', 'activation', 'of', 'TLRs', ',', 'a', 'number', 'of', 'downstream', 'pathways', 'are', 'regulated', ',', 'including', 'nuclear', 'factor', 'kappa', 'B', '(', 'NF-κB', ')', ',', 'interferon', 'regulatory', 'factor', '(', 'IRF', ')', 'and', 'mitogen', '-', 'activated', 'protein', 'kinase', '(', 'mitogen', '-', 'activated', 'protein', 'kinase', ')', 'pathways', 'which', 'target', 'chemokine', ',', 'cytokine', 'and', 'type', 'I', 'interferon', 'production', '(', 'Dowling', 'and', 'Mansell', ',', '2016', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These biofilms each contain physiological numbers and typical bacterial genera, and are metabolically active (lactic acid and protease production) in line with the phenotypical differences of the in vivo biofilms, and influenced RHG cytokine secretion (Janus et al., 2015;	[('PMC6692492', 'I02012', 126, 134, 'protease')]	['These', 'biofilms', 'each', 'contain', 'physiological', 'numbers', 'and', 'typical', 'bacterial', 'genera', ',', 'and', 'are', 'metabolic', '##ally', 'active', '(', 'lactic', 'acid', 'and', 'protease', 'production', ')', 'in', 'line', 'with', 'the', 'phenotypic', '##al', 'differences', 'of', 'the', 'in', 'vivo', 'biofilms', ',', 'and', 'influenced', 'RH', '##G', 'cytokine', 'secretion', '(', 'Jan', '##us', 'et', 'al', '.', ',', '2015', ';']	[0, 6, 15, 20, 28, 42, 50, 54, 62, 72, 78, 80, 84, 88, 97, 102, 109, 110, 117, 122, 126, 135, 145, 147, 150, 155, 160, 164, 174, 177, 189, 192, 196, 199, 204, 212, 214, 218, 229, 231, 233, 242, 252, 253, 256, 259, 262, 264, 265, 267, 271]	[5, 14, 19, 27, 41, 49, 53, 61, 71, 78, 79, 83, 87, 97, 101, 108, 110, 116, 121, 125, 134, 145, 146, 149, 154, 159, 163, 174, 176, 188, 191, 195, 198, 203, 212, 213, 217, 228, 231, 232, 241, 251, 253, 256, 258, 261, 264, 265, 266, 271, 272]	['These', 'biofilms', 'each', 'contain', 'physiological', 'numbers', 'and', 'typical', 'bacterial', 'genera', ',', 'and', 'are', 'metabolically', 'active', '(', 'lactic', 'acid', 'and', 'protease', 'production', ')', 'in', 'line', 'with', 'the', 'phenotypical', 'differences', 'of', 'the', 'in', 'vivo', 'biofilms', ',', 'and', 'influenced', 'RHG', 'cytokine', 'secretion', '(', 'Janus', 'et', 'al', '.', ',', '2015', ';']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For the metabolic products which are typically pathogenic for caries (lactic acid production) or for periodontitis (protease activity, shown as substrate cleaved speed), results of the three biofilms are cited from our previous study (Janus et al., 2015; Figure 1B).	[('PMC6692492', 'R00003', 116, 124, 'protease')]	['For', 'the', 'metabolic', 'products', 'which', 'are', 'typically', 'pathogenic', 'for', 'caries', '(', 'lactic', 'acid', 'production', ')', 'or', 'for', 'period', '##ont', '##itis', '(', 'protease', 'activity', ',', 'shown', 'as', 'substrate', 'cleaved', 'speed', ')', ',', 'results', 'of', 'the', 'three', 'biofilms', 'are', 'cited', 'from', 'our', 'previous', 'study', '(', 'Jan', '##us', 'et', 'al', '.', ',', '2015', ';', 'Figure', '1', '##B', ')', '.']	[0, 4, 8, 18, 27, 33, 37, 47, 58, 62, 69, 70, 77, 82, 92, 94, 97, 101, 107, 110, 115, 116, 125, 133, 135, 141, 144, 154, 162, 167, 168, 170, 178, 181, 185, 191, 200, 204, 210, 215, 219, 228, 234, 235, 238, 241, 244, 246, 247, 249, 253, 255, 262, 263, 264, 265]	[3, 7, 17, 26, 32, 36, 46, 57, 61, 68, 70, 76, 81, 92, 93, 96, 100, 107, 110, 114, 116, 124, 133, 134, 140, 143, 153, 161, 167, 168, 169, 177, 180, 184, 190, 199, 203, 209, 214, 218, 227, 233, 235, 238, 240, 243, 246, 247, 248, 253, 254, 261, 263, 264, 265, 266]	['For', 'the', 'metabolic', 'products', 'which', 'are', 'typically', 'pathogenic', 'for', 'caries', '(', 'lactic', 'acid', 'production', ')', 'or', 'for', 'periodontitis', '(', 'protease', 'activity', ',', 'shown', 'as', 'substrate', 'cleaved', 'speed', ')', ',', 'results', 'of', 'the', 'three', 'biofilms', 'are', 'cited', 'from', 'our', 'previous', 'study', '(', 'Janus', 'et', 'al', '.', ',', '2015', ';', 'Figure', '1B', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Notably, MAP2K4 from the mitogen-activated protein kinase pathway was down-regulated (>2-fold) specifically by the commensal biofilm, and the immune stimulatory molecule IL12A was down-regulated >10-fold by the cariogenic biofilm (compared to 2-fold down-regulation by commensal biofilm and no regulation by gingivitis biofilm).	[('PMC6692492', 'R02001', 25, 57, 'mitogen-activated protein kinase')]	['Notably', ',', 'MAP', '##2', '##K', '##4', 'from', 'the', 'mitogen', '-', 'activated', 'protein', 'kinase', 'pathway', 'was', 'down', '-', 'regulated', '(', '>', '2', '-', 'fold', ')', 'specifically', 'by', 'the', 'commens', '##al', 'biofilm', ',', 'and', 'the', 'immune', 'stimul', '##atory', 'molecule', 'IL', '##12', '##A', 'was', 'down', '-', 'regulated', '>', '10', '-', 'fold', 'by', 'the', 'car', '##io', '##genic', 'biofilm', '(', 'compared', 'to', '2', '-', 'fold', 'down', '-', 'regulation', 'by', 'commens', '##al', 'biofilm', 'and', 'no', 'regulation', 'by', 'ging', '##iv', '##itis', 'biofilm', ')', '.']	[0, 7, 9, 12, 13, 14, 16, 21, 25, 32, 33, 43, 51, 58, 66, 70, 74, 75, 85, 86, 87, 88, 89, 93, 95, 108, 111, 115, 122, 125, 132, 134, 138, 142, 149, 155, 161, 170, 172, 174, 176, 180, 184, 185, 195, 196, 198, 199, 204, 207, 211, 214, 216, 222, 230, 231, 240, 243, 244, 245, 250, 254, 255, 266, 269, 276, 279, 287, 291, 294, 305, 308, 312, 314, 319, 326, 327]	[7, 8, 12, 13, 14, 15, 20, 24, 32, 33, 42, 50, 57, 65, 69, 74, 75, 84, 86, 87, 88, 89, 93, 94, 107, 110, 114, 122, 124, 132, 133, 137, 141, 148, 155, 160, 169, 172, 174, 175, 179, 184, 185, 194, 196, 198, 199, 203, 206, 210, 214, 216, 221, 229, 231, 239, 242, 244, 245, 249, 254, 255, 265, 268, 276, 278, 286, 290, 293, 304, 307, 312, 314, 318, 326, 327, 328]	['Notably', ',', 'MAP2K4', 'from', 'the', 'mitogen', '-', 'activated', 'protein', 'kinase', 'pathway', 'was', 'down', '-', 'regulated', '(', '>', '2-fold', ')', 'specifically', 'by', 'the', 'commensal', 'biofilm', ',', 'and', 'the', 'immune', 'stimulatory', 'molecule', 'IL12A', 'was', 'down', '-', 'regulated', '>', '10-fold', 'by', 'the', 'cariogenic', 'biofilm', '(', 'compared', 'to', '2-fold', 'down', '-', 'regulation', 'by', 'commensal', 'biofilm', 'and', 'no', 'regulation', 'by', 'gingivitis', 'biofilm', ')', '.']	[1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.	[('PMC6701140', 'F20002', 0, 20, 'Acetylcholinesterase')]	"['Acet', '##yl', '##choline', '##ster', '##ase', 'inhibitors', 'and', 'sleep', 'architecture', 'in', 'patients', 'with', 'Alzheimer', ""'"", 's', 'disease', '.']"	[0, 4, 6, 13, 17, 21, 32, 36, 42, 55, 58, 67, 72, 81, 82, 84, 91]	[4, 6, 13, 17, 20, 31, 35, 41, 54, 57, 66, 71, 81, 82, 83, 91, 92]	"['Acetylcholinesterase', 'inhibitors', 'and', 'sleep', 'architecture', 'in', 'patients', 'with', ""Alzheimer's"", 'disease', '.']"	[5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several studies suggested that besides improving the cognitive performance and ability of daily living in individuals with AD, acetylcholinesterase inhibitors (ChEIs), like donepezil, galantamine, and rivastigmine, also improved the mental behavioral symptoms and sleep quality of these patients [19–21].	[('PMC6701140', 'I03000', 127, 147, 'acetylcholinesterase')]	['Several', 'studies', 'suggested', 'that', 'besides', 'improving', 'the', 'cognitive', 'performance', 'and', 'ability', 'of', 'daily', 'living', 'in', 'individuals', 'with', 'AD', ',', 'acetylcholine', '##ster', '##ase', 'inhibitors', '(', 'Ch', '##EI', '##s', ')', ',', 'like', 'done', '##pez', '##il', ',', 'gal', '##anta', '##min', '##e', ',', 'and', 'ri', '##vas', '##tig', '##min', '##e', ',', 'also', 'improved', 'the', 'mental', 'behavioral', 'symptoms', 'and', 'sleep', 'quality', 'of', 'these', 'patients', '[', '19', '–', '21', ']', '.']	[0, 8, 16, 26, 31, 39, 49, 53, 63, 75, 79, 87, 90, 96, 103, 106, 118, 123, 125, 127, 140, 144, 148, 159, 160, 162, 164, 165, 166, 168, 173, 177, 180, 182, 184, 187, 191, 194, 195, 197, 201, 203, 206, 209, 212, 213, 215, 220, 229, 233, 240, 251, 260, 264, 270, 278, 281, 287, 296, 297, 299, 300, 302, 303]	[7, 15, 25, 30, 38, 48, 52, 62, 74, 78, 86, 89, 95, 102, 105, 117, 122, 125, 126, 140, 144, 147, 158, 160, 162, 164, 165, 166, 167, 172, 177, 180, 182, 183, 187, 191, 194, 195, 196, 200, 203, 206, 209, 212, 213, 214, 219, 228, 232, 239, 250, 259, 263, 269, 277, 280, 286, 295, 297, 299, 300, 302, 303, 304]	['Several', 'studies', 'suggested', 'that', 'besides', 'improving', 'the', 'cognitive', 'performance', 'and', 'ability', 'of', 'daily', 'living', 'in', 'individuals', 'with', 'AD', ',', 'acetylcholinesterase', 'inhibitors', '(', 'ChEIs', ')', ',', 'like', 'donepezil', ',', 'galantamine', ',', 'and', 'rivastigmine', ',', 'also', 'improved', 'the', 'mental', 'behavioral', 'symptoms', 'and', 'sleep', 'quality', 'of', 'these', 'patients', '[', '19–', '21', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 3, 1, 4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After polymerase chain reaction (PCR) amplification, DNA fragments will be sequenced on an Illumina HiSeq 2500 instrument and an Illumina HiSeq X instrument for 16S ribosomal DNA (16S rDNA) and metagenomics analyses (which will be chosen from some representative samples in the results of the 16S rDNA analysis), respectively, at Biomarker Technologies Co, Ltd. (Beijing, China) to analyze the differences in gut microbiome between patients with aMCI and individuals with normal cognition.	[('PMC6701140', 'M42001', 6, 16, 'polymerase')]	['After', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', ',', 'DNA', 'fragments', 'will', 'be', 'sequenced', 'on', 'an', 'Illumina', 'Hi', '##Seq', '2500', 'instrument', 'and', 'an', 'Illumina', 'Hi', '##Seq', 'X', 'instrument', 'for', '16', '##S', 'ribosomal', 'DNA', '(', '16', '##S', 'rDNA', ')', 'and', 'meta', '##gen', '##omics', 'analyses', '(', 'which', 'will', 'be', 'chosen', 'from', 'some', 'representative', 'samples', 'in', 'the', 'results', 'of', 'the', '16', '##S', 'rDNA', 'analysis', ')', ',', 'respectively', ',', 'at', 'Biom', '##arker', 'Technologies', 'Co', ',', 'Ltd', '.', '(', 'Beijing', ',', 'China', ')', 'to', 'analyze', 'the', 'differences', 'in', 'gut', 'microbi', '##ome', 'between', 'patients', 'with', 'a', '##MC', '##I', 'and', 'individuals', 'with', 'normal', 'cognition', '.']	[0, 6, 17, 23, 32, 33, 36, 38, 51, 53, 57, 67, 72, 75, 85, 88, 91, 100, 102, 106, 111, 122, 126, 129, 138, 140, 144, 146, 157, 161, 163, 165, 175, 179, 180, 182, 184, 188, 190, 194, 198, 201, 207, 216, 217, 223, 228, 231, 238, 243, 248, 263, 271, 274, 278, 286, 289, 293, 295, 297, 302, 310, 311, 313, 325, 327, 330, 334, 340, 353, 355, 357, 360, 362, 363, 370, 372, 377, 379, 382, 390, 394, 406, 409, 413, 420, 424, 432, 441, 446, 447, 449, 451, 455, 467, 472, 479, 488]	[5, 16, 22, 31, 33, 36, 37, 51, 52, 56, 66, 71, 74, 84, 87, 90, 99, 102, 105, 110, 121, 125, 128, 137, 140, 143, 145, 156, 160, 163, 164, 174, 178, 180, 182, 183, 188, 189, 193, 198, 201, 206, 215, 217, 222, 227, 230, 237, 242, 247, 262, 270, 273, 277, 285, 288, 292, 295, 296, 301, 310, 311, 312, 325, 326, 329, 334, 339, 352, 355, 356, 360, 361, 363, 370, 371, 377, 378, 381, 389, 393, 405, 408, 412, 420, 423, 431, 440, 445, 447, 449, 450, 454, 466, 471, 478, 488, 489]	['After', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', ',', 'DNA', 'fragments', 'will', 'be', 'sequenced', 'on', 'an', 'Illumina', 'HiSeq', '2500', 'instrument', 'and', 'an', 'Illumina', 'HiSeq', 'X', 'instrument', 'for', '16S', 'ribosomal', 'DNA', '(', '16S', 'rDNA', ')', 'and', 'metagenomics', 'analyses', '(', 'which', 'will', 'be', 'chosen', 'from', 'some', 'representative', 'samples', 'in', 'the', 'results', 'of', 'the', '16S', 'rDNA', 'analysis', ')', ',', 'respectively', ',', 'at', 'Biomarker', 'Technologies', 'Co', ',', 'Ltd', '.', '(', 'Beijing', ',', 'China', ')', 'to', 'analyze', 'the', 'differences', 'in', 'gut', 'microbiome', 'between', 'patients', 'with', 'aMCI', 'and', 'individuals', 'with', 'normal', 'cognition', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Another report evaluated deoxycytidine kinase gene expression in peripheral leukocytes from CLL patients and found no association between deoxycytidine kinase gene expression and enzymatic activity, suggesting that dCK mRNA levels are not a good indicator for dCK protein expression [23].	[('PMC6708594', 'D04009', 25, 45, 'deoxycytidine kinase'), ('PMC6708594', 'D04009', 138, 158, 'deoxycytidine kinase')]	['Another', 'report', 'evaluated', 'deoxy', '##cyt', '##idine', 'kinase', 'gene', 'expression', 'in', 'peripheral', 'leukocytes', 'from', 'CLL', 'patients', 'and', 'found', 'no', 'association', 'between', 'deoxy', '##cyt', '##idine', 'kinase', 'gene', 'expression', 'and', 'enzymatic', 'activity', ',', 'suggesting', 'that', 'd', '##CK', 'mRNA', 'levels', 'are', 'not', 'a', 'good', 'indicator', 'for', 'd', '##CK', 'protein', 'expression', '[', '23', ']', '.']	[0, 8, 15, 25, 30, 33, 39, 46, 51, 62, 65, 76, 87, 92, 96, 105, 109, 115, 118, 130, 138, 143, 146, 152, 159, 164, 175, 179, 189, 197, 199, 210, 215, 216, 219, 224, 231, 235, 239, 241, 246, 256, 260, 261, 264, 272, 283, 284, 286, 287]	[7, 14, 24, 30, 33, 38, 45, 50, 61, 64, 75, 86, 91, 95, 104, 108, 114, 117, 129, 137, 143, 146, 151, 158, 163, 174, 178, 188, 197, 198, 209, 214, 216, 218, 223, 230, 234, 238, 240, 245, 255, 259, 261, 263, 271, 282, 284, 286, 287, 288]	['Another', 'report', 'evaluated', 'deoxycytidine', 'kinase', 'gene', 'expression', 'in', 'peripheral', 'leukocytes', 'from', 'CLL', 'patients', 'and', 'found', 'no', 'association', 'between', 'deoxycytidine', 'kinase', 'gene', 'expression', 'and', 'enzymatic', 'activity', ',', 'suggesting', 'that', 'dCK', 'mRNA', 'levels', 'are', 'not', 'a', 'good', 'indicator', 'for', 'dCK', 'protein', 'expression', '[', '23', ']', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.	[('PMC6708594', 'F22001', 15, 55, 'deoxycytidine- and deoxyguanosine kinase')]	['The', 'pattern', 'of', 'deoxy', '##cyt', '##idine', '-', 'and', 'deoxy', '##gu', '##anos', '##ine', 'kinase', 'activity', 'in', 'relation', 'to', 'messenger', 'RNA', 'expression', 'in', 'blood', 'cells', 'from', 'untreated', 'patients', 'with', 'B', '-', 'cell', 'chronic', 'lymph', '##ocytic', 'leukemia', '.']	[0, 4, 12, 15, 20, 23, 28, 30, 34, 39, 41, 45, 49, 56, 65, 68, 77, 80, 90, 94, 105, 108, 114, 120, 125, 135, 144, 149, 150, 151, 156, 164, 169, 176, 184]	[3, 11, 14, 20, 23, 28, 29, 33, 39, 41, 45, 48, 55, 64, 67, 76, 79, 89, 93, 104, 107, 113, 119, 124, 134, 143, 148, 150, 151, 155, 163, 169, 175, 184, 185]	['The', 'pattern', 'of', 'deoxycytidine-', 'and', 'deoxyguanosine', 'kinase', 'activity', 'in', 'relation', 'to', 'messenger', 'RNA', 'expression', 'in', 'blood', 'cells', 'from', 'untreated', 'patients', 'with', 'B-cell', 'chronic', 'lymphocytic', 'leukemia', '.']	[1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fludarabine must undergo active intracellular transport and metabolism to form fludarabine triphosphate (F-ara-ATP), which inhibits ribonucleotide reductase and DNA polymerase and ultimately leads to cellular apoptosis in both actively dividing and resting cells [15].	[('PMC6708594', 'I00003', 132, 156, 'ribonucleotide reductase'), ('PMC6708594', 'I00003', 161, 175, 'DNA polymerase')]	['Flu', '##da', '##rab', '##ine', 'must', 'undergo', 'active', 'intracellular', 'transport', 'and', 'metabolism', 'to', 'form', 'flu', '##da', '##rab', '##ine', 'trip', '##ho', '##sp', '##hat', '##e', '(', 'F', '-', 'ar', '##a', '-', 'ATP', ')', ',', 'which', 'inhibits', 'rib', '##onucle', '##otide', 'reductase', 'and', 'DNA', 'polymerase', 'and', 'ultimately', 'leads', 'to', 'cellular', 'apoptosis', 'in', 'both', 'actively', 'dividing', 'and', 'resting', 'cells', '[', '15', ']', '.']	[0, 3, 5, 8, 12, 17, 25, 32, 46, 56, 60, 71, 74, 79, 82, 84, 87, 91, 95, 97, 99, 102, 104, 105, 106, 107, 109, 110, 111, 114, 115, 117, 123, 132, 135, 141, 147, 157, 161, 165, 176, 180, 191, 197, 200, 209, 219, 222, 227, 236, 245, 249, 257, 263, 264, 266, 267]	[3, 5, 8, 11, 16, 24, 31, 45, 55, 59, 70, 73, 78, 82, 84, 87, 90, 95, 97, 99, 102, 103, 105, 106, 107, 109, 110, 111, 114, 115, 116, 122, 131, 135, 141, 146, 156, 160, 164, 175, 179, 190, 196, 199, 208, 218, 221, 226, 235, 244, 248, 256, 262, 264, 266, 267, 268]	['Fludarabine', 'must', 'undergo', 'active', 'intracellular', 'transport', 'and', 'metabolism', 'to', 'form', 'fludarabine', 'triphosphate', '(', 'F-ara-ATP', ')', ',', 'which', 'inhibits', 'ribonucleotide', 'reductase', 'and', 'DNA', 'polymerase', 'and', 'ultimately', 'leads', 'to', 'cellular', 'apoptosis', 'in', 'both', 'actively', 'dividing', 'and', 'resting', 'cells', '[', '15', ']', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 5, 1, 6, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As represented in Figure 1, fludarabine (9-β-D-arabinofuranosyl-2-fluoroadenine, or F-ara-A) is administered as the monophosphate prodrug and is rapidly dephosphorylated in plasma to fludarabine by serum phosphatase and ecto-5’-nucleotidase (CD73)	[('PMC6708594', 'I00004', 198, 215, 'serum phosphatase'), ('PMC6708594', 'I00004', 220, 240, 'ecto-5’-nucleotidase')]	['As', 'represented', 'in', 'Figure', '1', ',', 'flu', '##da', '##rab', '##ine', '(', '9', '-', 'β', '-', 'D', '-', 'ar', '##abin', '##of', '##uran', '##osyl', '-', '2', '-', 'fluor', '##oa', '##den', '##ine', ',', 'or', 'F', '-', 'ar', '##a', '-', 'A', ')', 'is', 'administered', 'as', 'the', 'monop', '##ho', '##sp', '##hat', '##e', 'prod', '##ru', '##g', 'and', 'is', 'rapidly', 'dep', '##ho', '##sp', '##hor', '##ylated', 'in', 'plasma', 'to', 'flu', '##da', '##rab', '##ine', 'by', 'serum', 'phosphatase', 'and', 'ect', '##o', '-', '5', '’', '-', 'nucle', '##oti', '##dase', '(', 'CD', '##73', ')']	[0, 3, 15, 18, 25, 26, 28, 31, 33, 36, 40, 41, 42, 43, 44, 45, 46, 47, 49, 53, 55, 59, 63, 64, 65, 66, 71, 73, 76, 79, 81, 84, 85, 86, 88, 89, 90, 91, 93, 96, 109, 112, 116, 121, 123, 125, 128, 130, 134, 136, 138, 142, 145, 153, 156, 158, 160, 163, 170, 173, 180, 183, 186, 188, 191, 195, 198, 204, 216, 220, 223, 224, 225, 226, 227, 228, 233, 236, 241, 242, 244, 246]	[2, 14, 17, 24, 26, 27, 31, 33, 36, 39, 41, 42, 43, 44, 45, 46, 47, 49, 53, 55, 59, 63, 64, 65, 66, 71, 73, 76, 79, 80, 83, 85, 86, 88, 89, 90, 91, 92, 95, 108, 111, 115, 121, 123, 125, 128, 129, 134, 136, 137, 141, 144, 152, 156, 158, 160, 163, 169, 172, 179, 182, 186, 188, 191, 194, 197, 203, 215, 219, 223, 224, 225, 226, 227, 228, 233, 236, 240, 242, 244, 246, 247]	['As', 'represented', 'in', 'Figure', '1', ',', 'fludarabine', '(', '9-β-D-arabinofuranosyl-2-fluoroadenine', ',', 'or', 'F-ara-A', ')', 'is', 'administered', 'as', 'the', 'monophosphate', 'prodrug', 'and', 'is', 'rapidly', 'dephosphorylated', 'in', 'plasma', 'to', 'fludarabine', 'by', 'serum', 'phosphatase', 'and', 'ecto-5’-nucleotidase', '(', 'CD73', ')']	[1, 1, 1, 1, 1, 1, 4, 1, 18, 1, 1, 6, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 5, 1, 1, 1, 4, 1, 1, 1, 1, 9, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Once inside the cell, fludarabine is sequentially phosphorylated to the monophosphate (F-ara-AMP), diphosphate (F-ara-ADP), and triphosphate (F-ara-ATP) forms by deoxycytidine kinase (deoxycytidine kinase), adenylate kinase (adenylate kinase), and nucleoside diphosphate kinase (NDK), respectively [32].	[('PMC6708594', 'I00008', 162, 182, 'deoxycytidine kinase'), ('PMC6708594', 'I00008', 184, 204, 'deoxycytidine kinase'), ('PMC6708594', 'I00008', 207, 223, 'adenylate kinase'), ('PMC6708594', 'I00008', 225, 241, 'adenylate kinase')]	['Once', 'inside', 'the', 'cell', ',', 'flu', '##da', '##rab', '##ine', 'is', 'sequentially', 'phosphorylated', 'to', 'the', 'monop', '##ho', '##sp', '##hat', '##e', '(', 'F', '-', 'ar', '##a', '-', 'AMP', ')', ',', 'diph', '##osphate', '(', 'F', '-', 'ar', '##a', '-', 'ADP', ')', ',', 'and', 'trip', '##ho', '##sp', '##hat', '##e', '(', 'F', '-', 'ar', '##a', '-', 'ATP', ')', 'forms', 'by', 'deoxy', '##cyt', '##idine', 'kinase', '(', 'deoxy', '##cyt', '##idine', 'kinase', ')', ',', 'aden', '##ylate', 'kinase', '(', 'aden', '##ylate', 'kinase', ')', ',', 'and', 'nucle', '##oside', 'diph', '##osphate', 'kinase', '(', 'ND', '##K', ')', ',', 'respectively', '[', '32', ']', '.']	[0, 5, 12, 16, 20, 22, 25, 27, 30, 34, 37, 50, 65, 68, 72, 77, 79, 81, 84, 86, 87, 88, 89, 91, 92, 93, 96, 97, 99, 103, 111, 112, 113, 114, 116, 117, 118, 121, 122, 124, 128, 132, 134, 136, 139, 141, 142, 143, 144, 146, 147, 148, 151, 153, 159, 162, 167, 170, 176, 183, 184, 189, 192, 198, 204, 205, 207, 211, 217, 224, 225, 229, 235, 241, 242, 244, 248, 253, 259, 263, 271, 278, 279, 281, 282, 283, 285, 298, 299, 301, 302]	[4, 11, 15, 20, 21, 25, 27, 30, 33, 36, 49, 64, 67, 71, 77, 79, 81, 84, 85, 87, 88, 89, 91, 92, 93, 96, 97, 98, 103, 110, 112, 113, 114, 116, 117, 118, 121, 122, 123, 127, 132, 134, 136, 139, 140, 142, 143, 144, 146, 147, 148, 151, 152, 158, 161, 167, 170, 175, 182, 184, 189, 192, 197, 204, 205, 206, 211, 216, 223, 225, 229, 234, 241, 242, 243, 247, 253, 258, 263, 270, 277, 279, 281, 282, 283, 284, 297, 299, 301, 302, 303]	['Once', 'inside', 'the', 'cell', ',', 'fludarabine', 'is', 'sequentially', 'phosphorylated', 'to', 'the', 'monophosphate', '(', 'F-ara-AMP', ')', ',', 'diphosphate', '(', 'F-ara-ADP', ')', ',', 'and', 'triphosphate', '(', 'F-ara-ATP', ')', 'forms', 'by', 'deoxycytidine', 'kinase', '(', 'deoxycytidine', 'kinase', ')', ',', 'adenylate', 'kinase', '(', 'adenylate', 'kinase', ')', ',', 'and', 'nucleoside', 'diphosphate', 'kinase', '(', 'NDK', ')', ',', 'respectively', '[', '32', ']', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 5, 1, 6, 1, 1, 2, 1, 6, 1, 1, 1, 5, 1, 6, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 2, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
F-ara-AMP can also be dephosphorylated to fludarabine by 5’-nucleotidase (5’-nucleotidase) and deoxynucleotidase-1 (deoxynucleotidase-1).	[('PMC6708594', 'I00009', 57, 72, '5’-nucleotidase'), ('PMC6708594', 'I00009', 74, 89, '5’-nucleotidase'), ('PMC6708594', 'I00009', 95, 114, 'deoxynucleotidase-1'), ('PMC6708594', 'I00009', 116, 135, 'deoxynucleotidase-1')]	['F', '-', 'ar', '##a', '-', 'AMP', 'can', 'also', 'be', 'dep', '##ho', '##sp', '##hor', '##ylated', 'to', 'flu', '##da', '##rab', '##ine', 'by', '5', '’', '-', 'nucle', '##oti', '##dase', '(', '5', '’', '-', 'nucle', '##oti', '##dase', ')', 'and', 'deoxy', '##nucle', '##oti', '##dase', '-', '1', '(', 'deoxy', '##nucle', '##oti', '##dase', '-', '1', ')', '.']	[0, 1, 2, 4, 5, 6, 10, 14, 19, 22, 25, 27, 29, 32, 39, 42, 45, 47, 50, 54, 57, 58, 59, 60, 65, 68, 73, 74, 75, 76, 77, 82, 85, 89, 91, 95, 100, 105, 108, 112, 113, 115, 116, 121, 126, 129, 133, 134, 135, 136]	[1, 2, 4, 5, 6, 9, 13, 18, 21, 25, 27, 29, 32, 38, 41, 45, 47, 50, 53, 56, 58, 59, 60, 65, 68, 72, 74, 75, 76, 77, 82, 85, 89, 90, 94, 100, 105, 108, 112, 113, 114, 116, 121, 126, 129, 133, 134, 135, 136, 137]	['F-ara-AMP', 'can', 'also', 'be', 'dephosphorylated', 'to', 'fludarabine', 'by', '5’-nucleotidase', '(', '5’-nucleotidase', ')', 'and', 'deoxynucleotidase-1', '(', 'deoxynucleotidase-1', ')', '.']	[6, 1, 1, 1, 5, 1, 4, 1, 6, 1, 6, 1, 1, 6, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
The goals of these studies were to evaluate the feasibility of quantitating F-ara-ATP accumulation rate after ex vivo fludarabine exposure of CD4+ or CD8+ T-lymphocytes; to quantitate F-ara-ATP accumulation and variability in CD4+ and CD8+ T-lymphocytes isolated from healthy volunteers and patients awaiting HCT; and to assess possible mechanisms underlying the interindividual variability by analyzing gene expression levels of transporters (hENT1, hENT2, and hCNT3) and enzymes (deoxycytidine kinase, 5’-nucleotidase, and dNT-1) involved in fludarabine uptake and activation.	[('PMC6708594', 'I03002', 482, 502, 'deoxycytidine kinase'), ('PMC6708594', 'I03002', 504, 519, '5’-nucleotidase')]	['The', 'goals', 'of', 'these', 'studies', 'were', 'to', 'evaluate', 'the', 'feasibility', 'of', 'quantit', '##ating', 'F', '-', 'ar', '##a', '-', 'ATP', 'accumulation', 'rate', 'after', 'ex', 'vivo', 'flu', '##da', '##rab', '##ine', 'exposure', 'of', 'CD', '##4', '+', 'or', 'CD', '##8', '+', 'T', '-', 'lymphocytes', ';', 'to', 'quantit', '##ate', 'F', '-', 'ar', '##a', '-', 'ATP', 'accumulation', 'and', 'variability', 'in', 'CD', '##4', '+', 'and', 'CD', '##8', '+', 'T', '-', 'lymphocytes', 'isolated', 'from', 'healthy', 'volunteers', 'and', 'patients', 'awa', '##iting', 'HCT', ';', 'and', 'to', 'assess', 'possible', 'mechanisms', 'underlying', 'the', 'inter', '##individual', 'variability', 'by', 'analyzing', 'gene', 'expression', 'levels', 'of', 'transporters', '(', 'h', '##ENT', '##1', ',', 'h', '##ENT', '##2', ',', 'and', 'h', '##CNT', '##3', ')', 'and', 'enzymes', '(', 'deoxy', '##cyt', '##idine', 'kinase', ',', '5', '’', '-', 'nucle', '##oti', '##dase', ',', 'and', 'd', '##NT', '-', '1', ')', 'involved', 'in', 'flu', '##da', '##rab', '##ine', 'uptake', 'and', 'activation', '.']	[0, 4, 10, 13, 19, 27, 32, 35, 44, 48, 60, 63, 70, 76, 77, 78, 80, 81, 82, 86, 99, 104, 110, 113, 118, 121, 123, 126, 130, 139, 142, 144, 145, 147, 150, 152, 153, 155, 156, 157, 168, 170, 173, 180, 184, 185, 186, 188, 189, 190, 194, 207, 211, 223, 226, 228, 229, 231, 235, 237, 238, 240, 241, 242, 254, 263, 268, 276, 287, 291, 300, 303, 309, 312, 314, 318, 321, 328, 337, 348, 359, 363, 368, 379, 391, 394, 404, 409, 420, 427, 430, 443, 444, 445, 448, 449, 451, 452, 455, 456, 458, 462, 463, 466, 467, 469, 473, 481, 482, 487, 490, 496, 502, 504, 505, 506, 507, 512, 515, 519, 521, 525, 526, 528, 529, 530, 532, 541, 544, 547, 549, 552, 556, 563, 567, 577]	[3, 9, 12, 18, 26, 31, 34, 43, 47, 59, 62, 70, 75, 77, 78, 80, 81, 82, 85, 98, 103, 109, 112, 117, 121, 123, 126, 129, 138, 141, 144, 145, 146, 149, 152, 153, 154, 156, 157, 168, 169, 172, 180, 183, 185, 186, 188, 189, 190, 193, 206, 210, 222, 225, 228, 229, 230, 234, 237, 238, 239, 241, 242, 253, 262, 267, 275, 286, 290, 299, 303, 308, 312, 313, 317, 320, 327, 336, 347, 358, 362, 368, 378, 390, 393, 403, 408, 419, 426, 429, 442, 444, 445, 448, 449, 450, 452, 455, 456, 457, 461, 463, 466, 467, 468, 472, 480, 482, 487, 490, 495, 502, 503, 505, 506, 507, 512, 515, 519, 520, 524, 526, 528, 529, 530, 531, 540, 543, 547, 549, 552, 555, 562, 566, 577, 578]	['The', 'goals', 'of', 'these', 'studies', 'were', 'to', 'evaluate', 'the', 'feasibility', 'of', 'quantitating', 'F-ara-ATP', 'accumulation', 'rate', 'after', 'ex', 'vivo', 'fludarabine', 'exposure', 'of', 'CD4+', 'or', 'CD8+', 'T-lymphocytes', ';', 'to', 'quantitate', 'F-ara-ATP', 'accumulation', 'and', 'variability', 'in', 'CD4+', 'and', 'CD8+', 'T-lymphocytes', 'isolated', 'from', 'healthy', 'volunteers', 'and', 'patients', 'awaiting', 'HCT', ';', 'and', 'to', 'assess', 'possible', 'mechanisms', 'underlying', 'the', 'interindividual', 'variability', 'by', 'analyzing', 'gene', 'expression', 'levels', 'of', 'transporters', '(', 'hENT1', ',', 'hENT2', ',', 'and', 'hCNT3', ')', 'and', 'enzymes', '(', 'deoxycytidine', 'kinase', ',', '5’-nucleotidase', ',', 'and', 'dNT-1', ')', 'involved', 'in', 'fludarabine', 'uptake', 'and', 'activation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 6, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 3, 3, 1, 1, 2, 6, 1, 1, 1, 1, 3, 1, 3, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 6, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gene-specific TaqMan® Gene Expression Assays (Applied Biosystems, Foster City, CA) were used to quantitate gene expression of key transporters and enzymes involved in F-ara-ATP accumulation (see Figure 1): hENT1 (Hs00191940_m1), hENT2 (Hs00155426_m1), hCNT3 (Hs00223220_m1), deoxycytidine kinase (Hs00176127_m1), 5’-nucleotidase (Hs00366992_m1), and dNT-1 (Hs00274359_m1) relative to an internal endogenous control β-glucuronidase (GUS) (4333767F) on a 7900HT Fast Real-Time PCR System (Applied Biosystems).	[('PMC6708594', 'M05004', 275, 295, 'deoxycytidine kinase'), ('PMC6708594', 'M05004', 313, 328, '5’-nucleotidase')]	['Gene', '-', 'specific', 'Taq', '##Man', '®', 'Gene', 'Expression', 'Assay', '##s', '(', 'Applied', 'Biosystems', ',', 'Foster', 'City', ',', 'CA', ')', 'were', 'used', 'to', 'quantit', '##ate', 'gene', 'expression', 'of', 'key', 'transporters', 'and', 'enzymes', 'involved', 'in', 'F', '-', 'ar', '##a', '-', 'ATP', 'accumulation', '(', 'see', 'Figure', '1', ')', ':', 'h', '##ENT', '##1', '(', 'Hs', '##001', '##91', '##94', '##0', '_', 'm', '##1', ')', ',', 'h', '##ENT', '##2', '(', 'Hs', '##001', '##55', '##42', '##6', '_', 'm', '##1', ')', ',', 'h', '##CNT', '##3', '(', 'Hs', '##002', '##23', '##220', '_', 'm', '##1', ')', ',', 'deoxy', '##cyt', '##idine', 'kinase', '(', 'Hs', '##001', '##76', '##127', '_', 'm', '##1', ')', ',', '5', '’', '-', 'nucle', '##oti', '##dase', '(', 'Hs', '##003', '##66', '##99', '##2', '_', 'm', '##1', ')', ',', 'and', 'd', '##NT', '-', '1', '(', 'Hs', '##002', '##74', '##35', '##9', '_', 'm', '##1', ')', 'relative', 'to', 'an', 'internal', 'endogenous', 'control', 'β', '-', 'gluc', '##uron', '##idase', '(', 'GU', '##S', ')', '(', '43', '##33', '##76', '##7', '##F', ')', 'on', 'a', '79', '##00', '##HT', 'Fast', 'Real', '-', 'Time', 'PCR', 'System', '(', 'Applied', 'Biosystems', ')', '.']	[0, 4, 5, 14, 17, 20, 22, 27, 38, 43, 45, 46, 54, 64, 66, 73, 77, 79, 81, 83, 88, 93, 96, 103, 107, 112, 123, 126, 130, 143, 147, 155, 164, 167, 168, 169, 171, 172, 173, 177, 190, 191, 195, 202, 203, 204, 206, 207, 210, 212, 213, 215, 218, 220, 222, 223, 224, 225, 226, 227, 229, 230, 233, 235, 236, 238, 241, 243, 245, 246, 247, 248, 249, 250, 252, 253, 256, 258, 259, 261, 264, 266, 269, 270, 271, 272, 273, 275, 280, 283, 289, 296, 297, 299, 302, 304, 307, 308, 309, 310, 311, 313, 314, 315, 316, 321, 324, 329, 330, 332, 335, 337, 339, 340, 341, 342, 343, 344, 346, 350, 351, 353, 354, 356, 357, 359, 362, 364, 366, 367, 368, 369, 370, 372, 381, 384, 387, 396, 407, 415, 416, 417, 421, 425, 431, 432, 434, 435, 437, 438, 440, 442, 444, 445, 446, 448, 451, 453, 455, 457, 460, 465, 469, 470, 475, 479, 486, 487, 495, 505, 506]	[4, 5, 13, 17, 20, 21, 26, 37, 43, 44, 46, 53, 64, 65, 72, 77, 78, 81, 82, 87, 92, 95, 103, 106, 111, 122, 125, 129, 142, 146, 154, 163, 166, 168, 169, 171, 172, 173, 176, 189, 191, 194, 201, 203, 204, 205, 207, 210, 211, 213, 215, 218, 220, 222, 223, 224, 225, 226, 227, 228, 230, 233, 234, 236, 238, 241, 243, 245, 246, 247, 248, 249, 250, 251, 253, 256, 257, 259, 261, 264, 266, 269, 270, 271, 272, 273, 274, 280, 283, 288, 295, 297, 299, 302, 304, 307, 308, 309, 310, 311, 312, 314, 315, 316, 321, 324, 328, 330, 332, 335, 337, 339, 340, 341, 342, 343, 344, 345, 349, 351, 353, 354, 355, 357, 359, 362, 364, 366, 367, 368, 369, 370, 371, 380, 383, 386, 395, 406, 414, 416, 417, 421, 425, 430, 432, 434, 435, 436, 438, 440, 442, 444, 445, 446, 447, 450, 452, 455, 457, 459, 464, 469, 470, 474, 478, 485, 487, 494, 505, 506, 507]	['Gene', '-', 'specific', 'TaqMan', '®', 'Gene', 'Expression', 'Assays', '(', 'Applied', 'Biosystems', ',', 'Foster', 'City', ',', 'CA', ')', 'were', 'used', 'to', 'quantitate', 'gene', 'expression', 'of', 'key', 'transporters', 'and', 'enzymes', 'involved', 'in', 'F-ara-ATP', 'accumulation', '(', 'see', 'Figure', '1', ')', ':', 'hENT1', '(', 'Hs00191940_m1', ')', ',', 'hENT2', '(', 'Hs00155426_m1', ')', ',', 'hCNT3', '(', 'Hs00223220_m1', ')', ',', 'deoxycytidine', 'kinase', '(', 'Hs00176127_m1', ')', ',', '5’-nucleotidase', '(', 'Hs00366992_m1', ')', ',', 'and', 'dNT-1', '(', 'Hs00274359_m1', ')', 'relative', 'to', 'an', 'internal', 'endogenous', 'control', 'β-glucuronidase', '(', 'GUS', ')', '(', '4333767F', ')', 'on', 'a', '7900HT', 'Fast', 'Real-Time', 'PCR', 'System', '(', 'Applied', 'Biosystems', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 3, 1, 8, 1, 1, 3, 1, 8, 1, 1, 3, 1, 7, 1, 1, 3, 1, 1, 7, 1, 1, 6, 1, 8, 1, 1, 1, 4, 1, 8, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 5, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Analysis was performed using the 3 predictors of the two main determinants of F-ara-ATP accumulation: the genes of the uptake transporters pathway (hENT1, hENT2, and hCNT3) and the genes involved in the intracellular formation of F-ara-AMP (deoxycytidine kinase, 5’-nucleotidase, and dNT-1).	[('PMC6708594', 'M05015', 241, 261, 'deoxycytidine kinase'), ('PMC6708594', 'M05015', 263, 278, '5’-nucleotidase')]	['Analysis', 'was', 'performed', 'using', 'the', '3', 'predictors', 'of', 'the', 'two', 'main', 'determinants', 'of', 'F', '-', 'ar', '##a', '-', 'ATP', 'accumulation', ':', 'the', 'genes', 'of', 'the', 'uptake', 'transporters', 'pathway', '(', 'h', '##ENT', '##1', ',', 'h', '##ENT', '##2', ',', 'and', 'h', '##CNT', '##3', ')', 'and', 'the', 'genes', 'involved', 'in', 'the', 'intracellular', 'formation', 'of', 'F', '-', 'ar', '##a', '-', 'AMP', '(', 'deoxy', '##cyt', '##idine', 'kinase', ',', '5', '’', '-', 'nucle', '##oti', '##dase', ',', 'and', 'd', '##NT', '-', '1', ')', '.']	[0, 9, 13, 23, 29, 33, 35, 46, 49, 53, 57, 62, 75, 78, 79, 80, 82, 83, 84, 88, 100, 102, 106, 112, 115, 119, 126, 139, 147, 148, 149, 152, 153, 155, 156, 159, 160, 162, 166, 167, 170, 171, 173, 177, 181, 187, 196, 199, 203, 217, 227, 230, 231, 232, 234, 235, 236, 240, 241, 246, 249, 255, 261, 263, 264, 265, 266, 271, 274, 278, 280, 284, 285, 287, 288, 289, 290]	[8, 12, 22, 28, 32, 34, 45, 48, 52, 56, 61, 74, 77, 79, 80, 82, 83, 84, 87, 100, 101, 105, 111, 114, 118, 125, 138, 146, 148, 149, 152, 153, 154, 156, 159, 160, 161, 165, 167, 170, 171, 172, 176, 180, 186, 195, 198, 202, 216, 226, 229, 231, 232, 234, 235, 236, 239, 241, 246, 249, 254, 261, 262, 264, 265, 266, 271, 274, 278, 279, 283, 285, 287, 288, 289, 290, 291]	['Analysis', 'was', 'performed', 'using', 'the', '3', 'predictors', 'of', 'the', 'two', 'main', 'determinants', 'of', 'F-ara-ATP', 'accumulation', ':', 'the', 'genes', 'of', 'the', 'uptake', 'transporters', 'pathway', '(', 'hENT1', ',', 'hENT2', ',', 'and', 'hCNT3', ')', 'and', 'the', 'genes', 'involved', 'in', 'the', 'intracellular', 'formation', 'of', 'F-ara-AMP', '(', 'deoxycytidine', 'kinase', ',', '5’-nucleotidase', ',', 'and', 'dNT-1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 3, 1, 1, 6, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We then evaluated the mRNA expression levels of the transporters (hENT1, hENT2, hCNT3) and enzymes (deoxycytidine kinase, 5’-nucleotidase, and dNT-1) important in the uptake of fludarabine and subsequent formation of F-ara-ATP (see Figure 1).	[('PMC6708594', 'R04000', 100, 120, 'deoxycytidine kinase'), ('PMC6708594', 'R04000', 122, 137, '5’-nucleotidase')]	['We', 'then', 'evaluated', 'the', 'mRNA', 'expression', 'levels', 'of', 'the', 'transporters', '(', 'h', '##ENT', '##1', ',', 'h', '##ENT', '##2', ',', 'h', '##CNT', '##3', ')', 'and', 'enzymes', '(', 'deoxy', '##cyt', '##idine', 'kinase', ',', '5', '’', '-', 'nucle', '##oti', '##dase', ',', 'and', 'd', '##NT', '-', '1', ')', 'important', 'in', 'the', 'uptake', 'of', 'flu', '##da', '##rab', '##ine', 'and', 'subsequent', 'formation', 'of', 'F', '-', 'ar', '##a', '-', 'ATP', '(', 'see', 'Figure', '1', ')', '.']	[0, 3, 8, 18, 22, 27, 38, 45, 48, 52, 65, 66, 67, 70, 71, 73, 74, 77, 78, 80, 81, 84, 85, 87, 91, 99, 100, 105, 108, 114, 120, 122, 123, 124, 125, 130, 133, 137, 139, 143, 144, 146, 147, 148, 150, 160, 163, 167, 174, 177, 180, 182, 185, 189, 193, 204, 214, 217, 218, 219, 221, 222, 223, 227, 228, 232, 239, 240, 241]	[2, 7, 17, 21, 26, 37, 44, 47, 51, 64, 66, 67, 70, 71, 72, 74, 77, 78, 79, 81, 84, 85, 86, 90, 98, 100, 105, 108, 113, 120, 121, 123, 124, 125, 130, 133, 137, 138, 142, 144, 146, 147, 148, 149, 159, 162, 166, 173, 176, 180, 182, 185, 188, 192, 203, 213, 216, 218, 219, 221, 222, 223, 226, 228, 231, 238, 240, 241, 242]	['We', 'then', 'evaluated', 'the', 'mRNA', 'expression', 'levels', 'of', 'the', 'transporters', '(', 'hENT1', ',', 'hENT2', ',', 'hCNT3', ')', 'and', 'enzymes', '(', 'deoxycytidine', 'kinase', ',', '5’-nucleotidase', ',', 'and', 'dNT-1', ')', 'important', 'in', 'the', 'uptake', 'of', 'fludarabine', 'and', 'subsequent', 'formation', 'of', 'F-ara-ATP', '(', 'see', 'Figure', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1, 3, 1, 1, 6, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We observed wide variability in the expression levels of several of the genes, with hCNT3 displaying the highest variability, followed by hENT1 and deoxynucleotidase-1.	[('PMC6708594', 'R04002', 148, 167, 'deoxynucleotidase-1')]	['We', 'observed', 'wide', 'variability', 'in', 'the', 'expression', 'levels', 'of', 'several', 'of', 'the', 'genes', ',', 'with', 'h', '##CNT', '##3', 'displaying', 'the', 'highest', 'variability', ',', 'followed', 'by', 'h', '##ENT', '##1', 'and', 'deoxy', '##nucle', '##oti', '##dase', '-', '1', '.']	[0, 3, 12, 17, 29, 32, 36, 47, 54, 57, 65, 68, 72, 77, 79, 84, 85, 88, 90, 101, 105, 113, 124, 126, 135, 138, 139, 142, 144, 148, 153, 158, 161, 165, 166, 167]	[2, 11, 16, 28, 31, 35, 46, 53, 56, 64, 67, 71, 77, 78, 83, 85, 88, 89, 100, 104, 112, 124, 125, 134, 137, 139, 142, 143, 147, 153, 158, 161, 165, 166, 167, 168]	['We', 'observed', 'wide', 'variability', 'in', 'the', 'expression', 'levels', 'of', 'several', 'of', 'the', 'genes', ',', 'with', 'hCNT3', 'displaying', 'the', 'highest', 'variability', ',', 'followed', 'by', 'hENT1', 'and', 'deoxynucleotidase-1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O']
Less variability was observed in the expression of hENT2, deoxycytidine kinase, and 5’-nucleotidase.	[('PMC6708594', 'R04003', 58, 78, 'deoxycytidine kinase'), ('PMC6708594', 'R04003', 84, 99, '5’-nucleotidase')]	['Less', 'variability', 'was', 'observed', 'in', 'the', 'expression', 'of', 'h', '##ENT', '##2', ',', 'deoxy', '##cyt', '##idine', 'kinase', ',', 'and', '5', '’', '-', 'nucle', '##oti', '##dase', '.']	[0, 5, 17, 21, 30, 33, 37, 48, 51, 52, 55, 56, 58, 63, 66, 72, 78, 80, 84, 85, 86, 87, 92, 95, 99]	[4, 16, 20, 29, 32, 36, 47, 50, 52, 55, 56, 57, 63, 66, 71, 78, 79, 83, 85, 86, 87, 92, 95, 99, 100]	['Less', 'variability', 'was', 'observed', 'in', 'the', 'expression', 'of', 'hENT2', ',', 'deoxycytidine', 'kinase', ',', 'and', '5’-nucleotidase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 6, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O']
The difference in variability between healthy volunteers and HCT was particularly evident in the hENT1, hCNT3, and deoxynucleotidase-1 genes.	[('PMC6708594', 'R04005', 115, 134, 'deoxynucleotidase-1')]	['The', 'difference', 'in', 'variability', 'between', 'healthy', 'volunteers', 'and', 'HCT', 'was', 'particularly', 'evident', 'in', 'the', 'h', '##ENT', '##1', ',', 'h', '##CNT', '##3', ',', 'and', 'deoxy', '##nucle', '##oti', '##dase', '-', '1', 'genes', '.']	[0, 4, 15, 18, 30, 38, 46, 57, 61, 65, 69, 82, 90, 93, 97, 98, 101, 102, 104, 105, 108, 109, 111, 115, 120, 125, 128, 132, 133, 135, 140]	[3, 14, 17, 29, 37, 45, 56, 60, 64, 68, 81, 89, 92, 96, 98, 101, 102, 103, 105, 108, 109, 110, 114, 120, 125, 128, 132, 133, 134, 140, 141]	['The', 'difference', 'in', 'variability', 'between', 'healthy', 'volunteers', 'and', 'HCT', 'was', 'particularly', 'evident', 'in', 'the', 'hENT1', ',', 'hCNT3', ',', 'and', 'deoxynucleotidase-1', 'genes', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
The mRNA expression of deoxynucleotidase-1 was associated with F-ara-ATP accumulation in CD8+ cells (p < 0.0005), but the slope of the association was very small; therefore, it is unlikely that deoxynucleotidase-1 mRNA expression is a good marker for T-lymphocyte F-ara-ATP accumulation.	[('PMC6708594', 'R04008', 23, 42, 'deoxynucleotidase-1'), ('PMC6708594', 'R04008', 194, 213, 'deoxynucleotidase-1')]	['The', 'mRNA', 'expression', 'of', 'deoxy', '##nucle', '##oti', '##dase', '-', '1', 'was', 'associated', 'with', 'F', '-', 'ar', '##a', '-', 'ATP', 'accumulation', 'in', 'CD', '##8', '+', 'cells', '(', 'p', '<', '0', '.', '000', '##5', ')', ',', 'but', 'the', 'slope', 'of', 'the', 'association', 'was', 'very', 'small', ';', 'therefore', ',', 'it', 'is', 'unlikely', 'that', 'deoxy', '##nucle', '##oti', '##dase', '-', '1', 'mRNA', 'expression', 'is', 'a', 'good', 'marker', 'for', 'T', '-', 'lymphocyte', 'F', '-', 'ar', '##a', '-', 'ATP', 'accumulation', '.']	[0, 4, 9, 20, 23, 28, 33, 36, 40, 41, 43, 47, 58, 63, 64, 65, 67, 68, 69, 73, 86, 89, 91, 92, 94, 100, 101, 103, 105, 106, 107, 110, 111, 112, 114, 118, 122, 128, 131, 135, 147, 151, 156, 161, 163, 172, 174, 177, 180, 189, 194, 199, 204, 207, 211, 212, 214, 219, 230, 233, 235, 240, 247, 251, 252, 253, 264, 265, 266, 268, 269, 270, 274, 286]	[3, 8, 19, 22, 28, 33, 36, 40, 41, 42, 46, 57, 62, 64, 65, 67, 68, 69, 72, 85, 88, 91, 92, 93, 99, 101, 102, 104, 106, 107, 110, 111, 112, 113, 117, 121, 127, 130, 134, 146, 150, 155, 161, 162, 172, 173, 176, 179, 188, 193, 199, 204, 207, 211, 212, 213, 218, 229, 232, 234, 239, 246, 250, 252, 253, 263, 265, 266, 268, 269, 270, 273, 286, 287]	['The', 'mRNA', 'expression', 'of', 'deoxynucleotidase-1', 'was', 'associated', 'with', 'F-ara-ATP', 'accumulation', 'in', 'CD8+', 'cells', '(', 'p', '<', '0.0005', ')', ',', 'but', 'the', 'slope', 'of', 'the', 'association', 'was', 'very', 'small', ';', 'therefore', ',', 'it', 'is', 'unlikely', 'that', 'deoxynucleotidase-1', 'mRNA', 'expression', 'is', 'a', 'good', 'marker', 'for', 'T-lymphocyte', 'F-ara-ATP', 'accumulation', '.']	[1, 1, 1, 1, 6, 1, 1, 1, 6, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 3, 6, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
By virtue of inhibition of ribonucleotide reductase and DNA polymerase, fludarabine induces apoptosis and cell death [15].	[('PMC6708594', 'R05000', 27, 51, 'ribonucleotide reductase'), ('PMC6708594', 'R05000', 56, 70, 'DNA polymerase')]	['By', 'virtue', 'of', 'inhibition', 'of', 'rib', '##onucle', '##otide', 'reductase', 'and', 'DNA', 'polymerase', ',', 'flu', '##da', '##rab', '##ine', 'induces', 'apoptosis', 'and', 'cell', 'death', '[', '15', ']', '.']	[0, 3, 10, 13, 24, 27, 30, 36, 42, 52, 56, 60, 70, 72, 75, 77, 80, 84, 92, 102, 106, 111, 117, 118, 120, 121]	[2, 9, 12, 23, 26, 30, 36, 41, 51, 55, 59, 70, 71, 75, 77, 80, 83, 91, 101, 105, 110, 116, 118, 120, 121, 122]	['By', 'virtue', 'of', 'inhibition', 'of', 'ribonucleotide', 'reductase', 'and', 'DNA', 'polymerase', ',', 'fludarabine', 'induces', 'apoptosis', 'and', 'cell', 'death', '[', '15', ']', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An interaction exists between folate and riboflavin (vitamin B2) because riboflavin is a co-factor of methylenetetrahydrofolate reductase [30].	[('PMC6716160', 'D04006', 102, 137, 'methylenetetrahydrofolate reductase')]	['An', 'interaction', 'exists', 'between', 'folate', 'and', 'rib', '##ofl', '##avin', '(', 'vitamin', 'B', '##2', ')', 'because', 'rib', '##ofl', '##avin', 'is', 'a', 'co', '-', 'factor', 'of', 'methyl', '##ene', '##tetra', '##hydro', '##fol', '##ate', 'reductase', '[', '30', ']', '.']	[0, 3, 15, 22, 30, 37, 41, 44, 47, 52, 53, 61, 62, 63, 65, 73, 76, 79, 84, 87, 89, 91, 92, 99, 102, 108, 111, 116, 121, 124, 128, 138, 139, 141, 142]	[2, 14, 21, 29, 36, 40, 44, 47, 51, 53, 60, 62, 63, 64, 72, 76, 79, 83, 86, 88, 91, 92, 98, 101, 108, 111, 116, 121, 124, 127, 137, 139, 141, 142, 143]	['An', 'interaction', 'exists', 'between', 'folate', 'and', 'riboflavin', '(', 'vitamin', 'B2', ')', 'because', 'riboflavin', 'is', 'a', 'co', '-', 'factor', 'of', 'methylenetetrahydrofolate', 'reductase', '[', '30', ']', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Prostate cancer cells deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase in pre-clinical models [32].	[('PMC6716160', 'D05003', 35, 63, 'argininosuccinate synthetase'), ('PMC6716160', 'D05003', 105, 123, 'arginine deiminase')]	['Pros', '##ta', '##te', 'cancer', 'cells', 'deficient', 'in', 'arg', '##inin', '##os', '##ucci', '##nat', '##e', 'synthe', '##tase', 'are', 'sensitive', 'to', 'arginine', 'deprivation', 'by', 'arginine', 'de', '##imin', '##ase', 'in', 'pre', '-', 'clinical', 'models', '[', '32', ']', '.']	[0, 4, 6, 9, 16, 22, 32, 35, 38, 42, 44, 48, 51, 53, 59, 64, 68, 78, 81, 90, 102, 105, 114, 116, 120, 124, 127, 130, 131, 140, 147, 148, 150, 151]	[4, 6, 8, 15, 21, 31, 34, 38, 42, 44, 48, 51, 52, 59, 63, 67, 77, 80, 89, 101, 104, 113, 116, 120, 123, 126, 130, 131, 139, 146, 148, 150, 151, 152]	['Prostate', 'cancer', 'cells', 'deficient', 'in', 'argininosuccinate', 'synthetase', 'are', 'sensitive', 'to', 'arginine', 'deprivation', 'by', 'arginine', 'deiminase', 'in', 'pre', '-', 'clinical', 'models', '[', '32', ']', '.']	[3, 1, 1, 1, 1, 6, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Deprivation of arginine by recombinant human arginase in prostate cancer cells.	[('PMC6716160', 'F31001', 45, 53, 'arginase')]	['Dep', '##ri', '##vation', 'of', 'arginine', 'by', 'recombinant', 'human', 'arg', '##inase', 'in', 'prostate', 'cancer', 'cells', '.']	[0, 3, 5, 12, 15, 24, 27, 39, 45, 48, 54, 57, 66, 73, 78]	[3, 5, 11, 14, 23, 26, 38, 44, 48, 53, 56, 65, 72, 78, 79]	['Deprivation', 'of', 'arginine', 'by', 'recombinant', 'human', 'arginase', 'in', 'prostate', 'cancer', 'cells', '.']	[3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
Dietary ω-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.	[('PMC6716427', 'F12001', 81, 96, 'CYP-epoxygenase')]	['Dietary', 'ω', '-', '3', 'fatty', 'acids', 'modulate', 'the', 'ei', '##cos', '##ano', '##id', 'profile', 'in', 'man', 'primarily', 'via', 'the', 'CYP', '-', 'epoxy', '##gen', '##ase', 'pathway', '.']	[0, 8, 9, 10, 12, 18, 24, 33, 37, 39, 42, 45, 48, 56, 59, 63, 73, 77, 81, 84, 85, 90, 93, 97, 104]	[7, 9, 10, 11, 17, 23, 32, 36, 39, 42, 45, 47, 55, 58, 62, 72, 76, 80, 84, 85, 90, 93, 96, 104, 105]	['Dietary', 'ω-3', 'fatty', 'acids', 'modulate', 'the', 'eicosanoid', 'profile', 'in', 'man', 'primarily', 'via', 'the', 'CYP-epoxygenase', 'pathway', '.']	[1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O']
15-Lipoxygenase promotes chronic hypoxia–induced pulmonary artery inflammation via positive interaction with nuclear factor-κB. Arterioscler.	[('PMC6716427', 'F22001', 0, 15, '15-Lipoxygenase')]	['15', '-', 'Lip', '##oxygenase', 'promotes', 'chronic', 'hypoxia', '–', 'induced', 'pulmonary', 'artery', 'inflammation', 'via', 'positive', 'interaction', 'with', 'nuclear', 'factor', '-', 'κ', '##B', '.', 'Arter', '##ios', '##cle', '##r', '.']	[0, 2, 3, 6, 16, 25, 33, 40, 41, 49, 59, 66, 79, 83, 92, 104, 109, 117, 123, 124, 125, 126, 128, 133, 136, 139, 140]	[2, 3, 6, 15, 24, 32, 40, 41, 48, 58, 65, 78, 82, 91, 103, 108, 116, 123, 124, 125, 126, 127, 133, 136, 139, 140, 141]	['15-Lipoxygenase', 'promotes', 'chronic', 'hypoxia', '–', 'induced', 'pulmonary', 'artery', 'inflammation', 'via', 'positive', 'interaction', 'with', 'nuclear', 'factor-κB', '.', 'Arterioscler', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This inflammatory response results in a marked neutrophil infiltration with release of reactive oxygen species (ROS), pro-inflammatory lipid mediators (LMs), and proteases, including neutrophil elastase, with the final result of cleaving structural proteins, leading to bronchiectasis (McCarthy et al., 2014).	[('PMC6716427', 'I00003', 162, 171, 'proteases'), ('PMC6716427', 'I00003', 183, 202, 'neutrophil elastase')]	['This', 'inflammatory', 'response', 'results', 'in', 'a', 'marked', 'neutrophil', 'infiltration', 'with', 'release', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', ',', 'pro', '-', 'inflammatory', 'lipid', 'mediators', '(', 'LM', '##s', ')', ',', 'and', 'proteases', ',', 'including', 'neutrophil', 'elast', '##ase', ',', 'with', 'the', 'final', 'result', 'of', 'cle', '##aving', 'structural', 'proteins', ',', 'leading', 'to', 'bronch', '##ie', '##ct', '##asis', '(', 'McC', '##arth', '##y', 'et', 'al', '.', ',', '2014', ')', '.']	[0, 5, 18, 27, 35, 38, 40, 47, 58, 71, 76, 84, 87, 96, 103, 111, 112, 115, 116, 118, 121, 122, 135, 141, 151, 152, 154, 155, 156, 158, 162, 171, 173, 183, 194, 199, 202, 204, 209, 213, 219, 226, 229, 232, 238, 249, 257, 259, 267, 270, 276, 278, 280, 285, 286, 289, 293, 295, 298, 300, 301, 303, 307, 308]	[4, 17, 26, 34, 37, 39, 46, 57, 70, 75, 83, 86, 95, 102, 110, 112, 115, 116, 117, 121, 122, 134, 140, 150, 152, 154, 155, 156, 157, 161, 171, 172, 182, 193, 199, 202, 203, 208, 212, 218, 225, 228, 232, 237, 248, 257, 258, 266, 269, 276, 278, 280, 284, 286, 289, 293, 294, 297, 300, 301, 302, 307, 308, 309]	['This', 'inflammatory', 'response', 'results', 'in', 'a', 'marked', 'neutrophil', 'infiltration', 'with', 'release', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', ',', 'pro', '-', 'inflammatory', 'lipid', 'mediators', '(', 'LMs', ')', ',', 'and', 'proteases', ',', 'including', 'neutrophil', 'elastase', ',', 'with', 'the', 'final', 'result', 'of', 'cleaving', 'structural', 'proteins', ',', 'leading', 'to', 'bronchiectasis', '(', 'McCarthy', 'et', 'al', '.', ',', '2014', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several classes of DHA-derived LMs, arising from different lipoxygenases as well as aspirin-inactivated cyclooxygenase-2 (COX-2), such as resolvins (Serhan et al., 2002), protectins (Marcheselli et al., 2003; Serhan et al., 2011), and maresins (Serhan et al., 2009), and their aspirin-triggered epimers, have been identified as potentially important factors in the resolution phase of the inflammatory reaction (Serhan, 2014).	[('PMC6716427', 'I02000', 59, 72, 'lipoxygenases'), ('PMC6716427', 'I02000', 104, 120, 'cyclooxygenase-2')]	['Several', 'classes', 'of', 'DHA', '-', 'derived', 'LM', '##s', ',', 'arising', 'from', 'different', 'lip', '##oxygenase', '##s', 'as', 'well', 'as', 'aspirin', '-', 'inactivated', 'cyclo', '##oxygenase', '-', '2', '(', 'COX', '-', '2', ')', ',', 'such', 'as', 'resol', '##vin', '##s', '(', 'Ser', '##han', 'et', 'al', '.', ',', '2002', ')', ',', 'protect', '##ins', '(', 'March', '##ese', '##ll', '##i', 'et', 'al', '.', ',', '2003', ';', 'Ser', '##han', 'et', 'al', '.', ',', '2011', ')', ',', 'and', 'mar', '##es', '##ins', '(', 'Ser', '##han', 'et', 'al', '.', ',', '2009', ')', ',', 'and', 'their', 'aspirin', '-', 'triggered', 'ep', '##imer', '##s', ',', 'have', 'been', 'identified', 'as', 'potentially', 'important', 'factors', 'in', 'the', 'resolution', 'phase', 'of', 'the', 'inflammatory', 'reaction', '(', 'Ser', '##han', ',', '2014', ')', '.']	[0, 8, 16, 19, 22, 23, 31, 33, 34, 36, 44, 49, 59, 62, 71, 73, 76, 81, 84, 91, 92, 104, 109, 118, 119, 121, 122, 125, 126, 127, 128, 130, 135, 138, 143, 146, 148, 149, 152, 156, 159, 161, 162, 164, 168, 169, 171, 178, 182, 183, 188, 191, 193, 195, 198, 200, 201, 203, 207, 209, 212, 216, 219, 221, 222, 224, 228, 229, 231, 235, 238, 240, 244, 245, 248, 252, 255, 257, 258, 260, 264, 265, 267, 271, 277, 284, 285, 295, 297, 301, 302, 304, 309, 314, 325, 328, 340, 350, 358, 361, 365, 376, 382, 385, 389, 402, 411, 412, 415, 418, 420, 424, 425]	[7, 15, 18, 22, 23, 30, 33, 34, 35, 43, 48, 58, 62, 71, 72, 75, 80, 83, 91, 92, 103, 109, 118, 119, 120, 122, 125, 126, 127, 128, 129, 134, 137, 143, 146, 147, 149, 152, 155, 158, 161, 162, 163, 168, 169, 170, 178, 181, 183, 188, 191, 193, 194, 197, 200, 201, 202, 207, 208, 212, 215, 218, 221, 222, 223, 228, 229, 230, 234, 238, 240, 243, 245, 248, 251, 254, 257, 258, 259, 264, 265, 266, 270, 276, 284, 285, 294, 297, 301, 302, 303, 308, 313, 324, 327, 339, 349, 357, 360, 364, 375, 381, 384, 388, 401, 410, 412, 415, 418, 419, 424, 425, 426]	['Several', 'classes', 'of', 'DHA', '-', 'derived', 'LMs', ',', 'arising', 'from', 'different', 'lipoxygenases', 'as', 'well', 'as', 'aspirin', '-', 'inactivated', 'cyclooxygenase-2', '(', 'COX-2', ')', ',', 'such', 'as', 'resolvins', '(', 'Serhan', 'et', 'al', '.', ',', '2002', ')', ',', 'protectins', '(', 'Marcheselli', 'et', 'al', '.', ',', '2003', ';', 'Serhan', 'et', 'al', '.', ',', '2011', ')', ',', 'and', 'maresins', '(', 'Serhan', 'et', 'al', '.', ',', '2009', ')', ',', 'and', 'their', 'aspirin', '-', 'triggered', 'epimers', ',', 'have', 'been', 'identified', 'as', 'potentially', 'important', 'factors', 'in', 'the', 'resolution', 'phase', 'of', 'the', 'inflammatory', 'reaction', '(', 'Serhan', ',', '2014', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It seems that the strains carrying ARGs, i.e., 23S rRNA methyltransferases, have gained an advantage under the strong selective pressure of therapy.	[('PMC6718723', 'D05001', 51, 74, 'rRNA methyltransferases')]	['It', 'seems', 'that', 'the', 'strains', 'carrying', 'AR', '##Gs', ',', 'i', '.', 'e', '.', ',', '23', '##S', 'rRNA', 'methyl', '##transferase', '##s', ',', 'have', 'gained', 'an', 'advantage', 'under', 'the', 'strong', 'selective', 'pressure', 'of', 'therapy', '.']	[0, 3, 9, 14, 18, 26, 35, 37, 39, 41, 42, 43, 44, 45, 47, 49, 51, 56, 62, 73, 74, 76, 81, 88, 91, 101, 107, 111, 118, 128, 137, 140, 147]	[2, 8, 13, 17, 25, 34, 37, 39, 40, 42, 43, 44, 45, 46, 49, 50, 55, 62, 73, 74, 75, 80, 87, 90, 100, 106, 110, 117, 127, 136, 139, 147, 148]	['It', 'seems', 'that', 'the', 'strains', 'carrying', 'ARGs', ',', 'i.e', '.', ',', '23S', 'rRNA', 'methyltransferases', ',', 'have', 'gained', 'an', 'advantage', 'under', 'the', 'strong', 'selective', 'pressure', 'of', 'therapy', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, not all cases of significant increase are associated with in vitro resistance to macrolides and/or 23S rRNA methyltransferases presence in the genome.	[('PMC6718723', 'D06004', 112, 135, 'rRNA methyltransferases')]	['However', ',', 'not', 'all', 'cases', 'of', 'significant', 'increase', 'are', 'associated', 'with', 'in', 'vitro', 'resistance', 'to', 'macro', '##li', '##des', 'and', '/', 'or', '23', '##S', 'rRNA', 'methyl', '##transferase', '##s', 'presence', 'in', 'the', 'genome', '.']	[0, 7, 9, 13, 17, 23, 26, 38, 47, 51, 62, 67, 70, 76, 87, 90, 95, 97, 101, 104, 105, 108, 110, 112, 117, 123, 134, 136, 145, 148, 152, 158]	[7, 8, 12, 16, 22, 25, 37, 46, 50, 61, 66, 69, 75, 86, 89, 95, 97, 100, 104, 105, 107, 110, 111, 116, 123, 134, 135, 144, 147, 151, 158, 159]	['However', ',', 'not', 'all', 'cases', 'of', 'significant', 'increase', 'are', 'associated', 'with', 'in', 'vitro', 'resistance', 'to', 'macrolides', 'and', '/', 'or', '23S', 'rRNA', 'methyltransferases', 'presence', 'in', 'the', 'genome', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
In all cases, the HP infection was confirmed by urease testing and cytological examination of mucosal biopsies collected from the antral part of the stomach during gastroscopy study.	[('PMC6718723', 'M00001', 48, 54, 'urease')]	['In', 'all', 'cases', ',', 'the', 'HP', 'infection', 'was', 'confirmed', 'by', 'urea', '##se', 'testing', 'and', 'cyt', '##ological', 'examination', 'of', 'mucosal', 'biopsies', 'collected', 'from', 'the', 'ant', '##ral', 'part', 'of', 'the', 'stomach', 'during', 'gastro', '##sc', '##opy', 'study', '.']	[0, 3, 7, 12, 14, 18, 21, 31, 35, 45, 48, 52, 55, 63, 67, 70, 79, 91, 94, 102, 111, 121, 126, 130, 133, 137, 142, 145, 149, 157, 164, 170, 172, 176, 181]	[2, 6, 12, 13, 17, 20, 30, 34, 44, 47, 52, 54, 62, 66, 70, 78, 90, 93, 101, 110, 120, 125, 129, 133, 136, 141, 144, 148, 156, 163, 170, 172, 175, 181, 182]	['In', 'all', 'cases', ',', 'the', 'HP', 'infection', 'was', 'confirmed', 'by', 'urease', 'testing', 'and', 'cytological', 'examination', 'of', 'mucosal', 'biopsies', 'collected', 'from', 'the', 'antral', 'part', 'of', 'the', 'stomach', 'during', 'gastroscopy', 'study', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The whole genome shotgun sequencing on ABI/SOLiD 5500W platform in the 50 base pairs in single-end mode was performed according to the manufacturer's recommendations (Life Technologies, Foster City, CA, USA) using the following kits: 5500W Conversion Primers Kit, 5500W FlowChip V2, 5500W FlowChip Prep Pack, 5500W Template Amplification Kit v2, 5500W FWD1 SP Kit; 5500W FWD2 SP Kit; 5500W FWD SR Kit; 5500W FWD Ligase Kit; 5500W Run Cycle Buffer Kit, and 5500W FWD Buffer; 5500W Buffer D.	[('PMC6718723', 'M01004', 412, 418, 'Ligase')]	"['The', 'whole', 'genome', 'shot', '##gu', '##n', 'sequencing', 'on', 'ABI', '/', 'SOL', '##i', '##D', '550', '##0', '##W', 'platform', 'in', 'the', '50', 'base', 'pairs', 'in', 'single', '-', 'end', 'mode', 'was', 'performed', 'according', 'to', 'the', 'manufacturer', ""'"", 's', 'recommendations', '(', 'Life', 'Technologies', ',', 'Foster', 'City', ',', 'CA', ',', 'USA', ')', 'using', 'the', 'following', 'kits', ':', '550', '##0', '##W', 'Conver', '##sion', 'Primer', '##s', 'Kit', ',', '550', '##0', '##W', 'Flow', '##Ch', '##ip', 'V', '##2', ',', '550', '##0', '##W', 'Flow', '##Ch', '##ip', 'Pre', '##p', 'Pack', ',', '550', '##0', '##W', 'Tem', '##plate', 'Ampl', '##ification', 'Kit', 'v', '##2', ',', '550', '##0', '##W', 'FW', '##D', '##1', 'SP', 'Kit', ';', '550', '##0', '##W', 'FW', '##D', '##2', 'SP', 'Kit', ';', '550', '##0', '##W', 'FW', '##D', 'SR', 'Kit', ';', '550', '##0', '##W', 'FW', '##D', 'Lig', '##ase', 'Kit', ';', '550', '##0', '##W', 'Run', 'Cycle', 'Bu', '##ffer', 'Kit', ',', 'and', '550', '##0', '##W', 'FW', '##D', 'Bu', '##ffer', ';', '550', '##0', '##W', 'Bu', '##ffer', 'D', '.']"	[0, 4, 10, 17, 21, 23, 25, 36, 39, 42, 43, 46, 47, 49, 52, 53, 55, 64, 67, 71, 74, 79, 85, 88, 94, 95, 99, 104, 108, 118, 128, 131, 135, 147, 148, 150, 166, 167, 172, 184, 186, 193, 197, 199, 201, 203, 206, 208, 214, 218, 228, 232, 234, 237, 238, 240, 246, 251, 257, 259, 262, 264, 267, 268, 270, 274, 276, 279, 280, 281, 283, 286, 287, 289, 293, 295, 298, 301, 303, 307, 309, 312, 313, 315, 318, 324, 328, 338, 342, 343, 344, 346, 349, 350, 352, 354, 355, 357, 360, 363, 365, 368, 369, 371, 373, 374, 376, 379, 382, 384, 387, 388, 390, 392, 394, 397, 400, 402, 405, 406, 408, 410, 412, 415, 419, 422, 424, 427, 428, 430, 434, 440, 442, 447, 450, 452, 456, 459, 460, 462, 464, 466, 468, 472, 474, 477, 478, 480, 482, 487, 488]	[3, 9, 16, 21, 23, 24, 35, 38, 42, 43, 46, 47, 48, 52, 53, 54, 63, 66, 70, 73, 78, 84, 87, 94, 95, 98, 103, 107, 117, 127, 130, 134, 147, 148, 149, 165, 167, 171, 184, 185, 192, 197, 198, 201, 202, 206, 207, 213, 217, 227, 232, 233, 237, 238, 239, 246, 250, 257, 258, 262, 263, 267, 268, 269, 274, 276, 278, 280, 281, 282, 286, 287, 288, 293, 295, 297, 301, 302, 307, 308, 312, 313, 314, 318, 323, 328, 337, 341, 343, 344, 345, 349, 350, 351, 354, 355, 356, 359, 363, 364, 368, 369, 370, 373, 374, 375, 378, 382, 383, 387, 388, 389, 392, 393, 396, 400, 401, 405, 406, 407, 410, 411, 415, 418, 422, 423, 427, 428, 429, 433, 439, 442, 446, 450, 451, 455, 459, 460, 461, 464, 465, 468, 472, 473, 477, 478, 479, 482, 486, 488, 489]	"['The', 'whole', 'genome', 'shotgun', 'sequencing', 'on', 'ABI', '/', 'SOLiD', '5500W', 'platform', 'in', 'the', '50', 'base', 'pairs', 'in', 'single', '-', 'end', 'mode', 'was', 'performed', 'according', 'to', 'the', ""manufacturer's"", 'recommendations', '(', 'Life', 'Technologies', ',', 'Foster', 'City', ',', 'CA', ',', 'USA', ')', 'using', 'the', 'following', 'kits', ':', '5500W', 'Conversion', 'Primers', 'Kit', ',', '5500W', 'FlowChip', 'V2', ',', '5500W', 'FlowChip', 'Prep', 'Pack', ',', '5500W', 'Template', 'Amplification', 'Kit', 'v2', ',', '5500W', 'FWD1', 'SP', 'Kit', ';', '5500W', 'FWD2', 'SP', 'Kit', ';', '5500W', 'FWD', 'SR', 'Kit', ';', '5500W', 'FWD', 'Ligase', 'Kit', ';', '5500W', 'Run', 'Cycle', 'Buffer', 'Kit', ',', 'and', '5500W', 'FWD', 'Buffer', ';', '5500W', 'Buffer', 'D', '.']"	[1, 1, 1, 3, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 2, 1, 1, 3, 3, 2, 1, 3, 3, 2, 1, 1, 3, 2, 2, 1, 2, 1, 3, 3, 1, 1, 1, 3, 3, 1, 1, 1, 3, 2, 1, 1, 1, 3, 2, 2, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 2, 2, 1, 3, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In general, the number of different ARGs observed increased following HP eradication therapy (Wilcoxon signed rank test p < 0.01), particularly, the relative abundance of 23S rRNA methyltransferases—which are associated with macrolide resistance—increased significantly (GSA, adj.	[('PMC6718723', 'R06002', 175, 198, 'rRNA methyltransferases')]	['In', 'general', ',', 'the', 'number', 'of', 'different', 'AR', '##Gs', 'observed', 'increased', 'following', 'HP', 'eradication', 'therapy', '(', 'Wilcoxon', 'signed', 'rank', 'test', 'p', '<', '0', '.', '01', ')', ',', 'particularly', ',', 'the', 'relative', 'abundance', 'of', '23', '##S', 'rRNA', 'methyl', '##transferase', '##s', '—', 'which', 'are', 'associated', 'with', 'macro', '##li', '##de', 'resistance', '—', 'increased', 'significantly', '(', 'GS', '##A', ',', 'adj', '.']	[0, 3, 10, 12, 16, 23, 26, 36, 38, 41, 50, 60, 70, 73, 85, 93, 94, 103, 110, 115, 120, 122, 124, 125, 126, 128, 129, 131, 143, 145, 149, 158, 168, 171, 173, 175, 180, 186, 197, 198, 199, 205, 209, 220, 225, 230, 232, 235, 245, 246, 256, 270, 271, 273, 274, 276, 279]	[2, 10, 11, 15, 22, 25, 35, 38, 40, 49, 59, 69, 72, 84, 92, 94, 102, 109, 114, 119, 121, 123, 125, 126, 128, 129, 130, 143, 144, 148, 157, 167, 170, 173, 174, 179, 186, 197, 198, 199, 204, 208, 219, 224, 230, 232, 234, 245, 246, 255, 269, 271, 273, 274, 275, 279, 280]	['In', 'general', ',', 'the', 'number', 'of', 'different', 'ARGs', 'observed', 'increased', 'following', 'HP', 'eradication', 'therapy', '(', 'Wilcoxon', 'signed', 'rank', 'test', 'p', '<', '0.01', ')', ',', 'particularly', ',', 'the', 'relative', 'abundance', 'of', '23S', 'rRNA', 'methyltransferases', '—', 'which', 'are', 'associated', 'with', 'macrolide', 'resistance', '—', 'increased', 'significantly', '(', 'GSA', ',', 'adj', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The only HP003 isolates carrying 23S rRNA methyltransferase genes showed the complete resistance to azithromycin and the dramatic increase of their detection values.	[('PMC6718723', 'R14012', 37, 59, 'rRNA methyltransferase')]	['The', 'only', 'HP', '##003', 'isolates', 'carrying', '23', '##S', 'rRNA', 'methyl', '##transferase', 'genes', 'showed', 'the', 'complete', 'resistance', 'to', 'az', '##ith', '##romycin', 'and', 'the', 'dramatic', 'increase', 'of', 'their', 'detection', 'values', '.']	[0, 4, 9, 11, 15, 24, 33, 35, 37, 42, 48, 60, 66, 73, 77, 86, 97, 100, 102, 105, 113, 117, 121, 130, 139, 142, 148, 158, 164]	[3, 8, 11, 14, 23, 32, 35, 36, 41, 48, 59, 65, 72, 76, 85, 96, 99, 102, 105, 112, 116, 120, 129, 138, 141, 147, 157, 164, 165]	['The', 'only', 'HP003', 'isolates', 'carrying', '23S', 'rRNA', 'methyltransferase', 'genes', 'showed', 'the', 'complete', 'resistance', 'to', 'azithromycin', 'and', 'the', 'dramatic', 'increase', 'of', 'their', 'detection', 'values', '.']	[1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The HP009 isolates were completely resistant to azithromycin and carried no 23S rRNA methyltransferases genes.	[('PMC6718723', 'R14013', 80, 103, 'rRNA methyltransferases')]	['The', 'HP', '##009', 'isolates', 'were', 'completely', 'resistant', 'to', 'az', '##ith', '##romycin', 'and', 'carried', 'no', '23', '##S', 'rRNA', 'methyl', '##transferase', '##s', 'genes', '.']	[0, 4, 6, 10, 19, 24, 35, 45, 48, 50, 53, 61, 65, 73, 76, 78, 80, 85, 91, 102, 104, 109]	[3, 6, 9, 18, 23, 34, 44, 47, 50, 53, 60, 64, 72, 75, 78, 79, 84, 91, 102, 103, 109, 110]	['The', 'HP009', 'isolates', 'were', 'completely', 'resistant', 'to', 'azithromycin', 'and', 'carried', 'no', '23S', 'rRNA', 'methyltransferases', 'genes', '.']	[1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
The HP028 isolates being completely resistant to azithromycin and carrying 23S rRNA methyltransferases genes did not dramatically increase their detection value.	[('PMC6718723', 'R14014', 79, 102, 'rRNA methyltransferases')]	['The', 'HP', '##02', '##8', 'isolates', 'being', 'completely', 'resistant', 'to', 'az', '##ith', '##romycin', 'and', 'carrying', '23', '##S', 'rRNA', 'methyl', '##transferase', '##s', 'genes', 'did', 'not', 'dramatically', 'increase', 'their', 'detection', 'value', '.']	[0, 4, 6, 8, 10, 19, 25, 36, 46, 49, 51, 54, 62, 66, 75, 77, 79, 84, 90, 101, 103, 109, 113, 117, 130, 139, 145, 155, 160]	[3, 6, 8, 9, 18, 24, 35, 45, 48, 51, 54, 61, 65, 74, 77, 78, 83, 90, 101, 102, 108, 112, 116, 129, 138, 144, 154, 160, 161]	['The', 'HP028', 'isolates', 'being', 'completely', 'resistant', 'to', 'azithromycin', 'and', 'carrying', '23S', 'rRNA', 'methyltransferases', 'genes', 'did', 'not', 'dramatically', 'increase', 'their', 'detection', 'value', '.']	[1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inactivity is associated with higher insulin resistance, increased occurrence of glucose intolerance and diabetes mellitus, and reduced activity of the lipoprotein lipase.	[('PMC6731442', 'D03006', 152, 170, 'lipoprotein lipase')]	['In', '##activity', 'is', 'associated', 'with', 'higher', 'insulin', 'resistance', ',', 'increased', 'occurrence', 'of', 'glucose', 'into', '##ler', '##ance', 'and', 'diabetes', 'mellitus', ',', 'and', 'reduced', 'activity', 'of', 'the', 'lipoprotein', 'lipase', '.']	[0, 2, 11, 14, 25, 30, 37, 45, 55, 57, 67, 78, 81, 89, 93, 96, 101, 105, 114, 122, 124, 128, 136, 145, 148, 152, 164, 170]	[2, 10, 13, 24, 29, 36, 44, 55, 56, 66, 77, 80, 88, 93, 96, 100, 104, 113, 122, 123, 127, 135, 144, 147, 151, 163, 170, 171]	['Inactivity', 'is', 'associated', 'with', 'higher', 'insulin', 'resistance', ',', 'increased', 'occurrence', 'of', 'glucose', 'intolerance', 'and', 'diabetes', 'mellitus', ',', 'and', 'reduced', 'activity', 'of', 'the', 'lipoprotein', 'lipase', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
Species in the genus can utilize acetate CoA-transferase to affect butyrate synthesis [52].	[('PMC6731442', 'D10001', 33, 56, 'acetate CoA-transferase')]	['Species', 'in', 'the', 'genus', 'can', 'utilize', 'acetate', 'Co', '##A', '-', 'transfer', '##ase', 'to', 'affect', 'but', '##yrate', 'synthesis', '[', '52', ']', '.']	[0, 8, 11, 15, 21, 25, 33, 41, 43, 44, 45, 53, 57, 60, 67, 70, 76, 86, 87, 89, 90]	[7, 10, 14, 20, 24, 32, 40, 43, 44, 45, 53, 56, 59, 66, 70, 75, 85, 87, 89, 90, 91]	['Species', 'in', 'the', 'genus', 'can', 'utilize', 'acetate', 'CoA-transferase', 'to', 'affect', 'butyrate', 'synthesis', '[', '52', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Butyrate has histone deacetylase activity and signals via GRP43 and GRP109a, thereby influencing brain function or structure [53].	[('PMC6731442', 'D10002', 13, 32, 'histone deacetylase')]	['But', '##yrate', 'has', 'histone', 'de', '##acetyl', '##ase', 'activity', 'and', 'signals', 'via', 'GR', '##P', '##43', 'and', 'GR', '##P', '##109', '##a', ',', 'thereby', 'influencing', 'brain', 'function', 'or', 'structure', '[', '53', ']', '.']	[0, 3, 9, 13, 21, 23, 29, 33, 42, 46, 54, 58, 60, 61, 64, 68, 70, 71, 74, 75, 77, 85, 97, 103, 112, 115, 125, 126, 128, 129]	[3, 8, 12, 20, 23, 29, 32, 41, 45, 53, 57, 60, 61, 63, 67, 70, 71, 74, 75, 76, 84, 96, 102, 111, 114, 124, 126, 128, 129, 130]	['Butyrate', 'has', 'histone', 'deacetylase', 'activity', 'and', 'signals', 'via', 'GRP43', 'and', 'GRP109a', ',', 'thereby', 'influencing', 'brain', 'function', 'or', 'structure', '[', '53', ']', '.']	[2, 1, 1, 3, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity.	[('PMC6731442', 'F39002', 24, 43, 'histone deacetylase')]	['Val', '##pro', '##ic', 'acid', 'and', 'other', 'histone', 'de', '##acetyl', '##ase', 'inhibitors', 'induce', 'microglia', '##l', 'apoptosis', 'and', 'attenuate', 'lip', '##opolysaccharide', '-', 'induced', 'dopaminergic', 'neurot', '##oxicity', '.']	[0, 3, 6, 9, 14, 18, 24, 32, 34, 40, 44, 55, 62, 71, 73, 83, 87, 97, 100, 115, 116, 124, 137, 143, 150]	[3, 6, 8, 13, 17, 23, 31, 34, 40, 43, 54, 61, 71, 72, 82, 86, 96, 100, 115, 116, 123, 136, 143, 150, 151]	['Valproic', 'acid', 'and', 'other', 'histone', 'deacetylase', 'inhibitors', 'induce', 'microglial', 'apoptosis', 'and', 'attenuate', 'lipopolysaccharide', '-', 'induced', 'dopaminergic', 'neurotoxicity', '.']	[3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Development of a semiquantitative degenerate real-time PCR-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples.	[('PMC6731442', 'F51002', 100, 140, 'butyryl-coenzyme A (CoA) CoA transferase')]	['Development', 'of', 'a', 'semi', '##qu', '##antitative', 'degenerate', 'real', '-', 'time', 'PCR', '-', 'based', 'assay', 'for', 'estimation', 'of', 'numbers', 'of', 'but', '##yr', '##yl', '-', 'coe', '##n', '##zyme', 'A', '(', 'Co', '##A', ')', 'Co', '##A', 'transfer', '##ase', 'genes', 'in', 'complex', 'bacterial', 'samples', '.']	[0, 12, 15, 17, 21, 23, 34, 45, 49, 50, 55, 58, 59, 65, 71, 75, 86, 89, 97, 100, 103, 105, 107, 108, 111, 112, 117, 119, 120, 122, 123, 125, 127, 129, 137, 141, 147, 150, 158, 168, 175]	[11, 14, 16, 21, 23, 33, 44, 49, 50, 54, 58, 59, 64, 70, 74, 85, 88, 96, 99, 103, 105, 107, 108, 111, 112, 116, 118, 120, 122, 123, 124, 127, 128, 137, 140, 146, 149, 157, 167, 175, 176]	['Development', 'of', 'a', 'semiquantitative', 'degenerate', 'real', '-', 'time', 'PCR', '-', 'based', 'assay', 'for', 'estimation', 'of', 'numbers', 'of', 'butyryl', '-', 'coenzyme', 'A', '(', 'CoA', ')', 'CoA', 'transferase', 'genes', 'in', 'complex', 'bacterial', 'samples', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 2, 1, 2, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
PCRs were performed in triplicate in a 20 μL mixture containing 4 μL 5 × FastPfu Buffer, 2 μL 2.5 mM dNTPs, 0.8 μL of each primer (5 μM), 0.4 μL FastPfu Polymerase, and 10 ng template DNA.	[('PMC6731442', 'M05002', 153, 163, 'Polymerase')]	['PCR', '##s', 'were', 'performed', 'in', 'triplicate', 'in', 'a', '20', 'μ', '##L', 'mixture', 'containing', '4', 'μ', '##L', '5', '×', 'Fast', '##P', '##f', '##u', 'Bu', '##ffer', ',', '2', 'μ', '##L', '2', '.', '5', 'mM', 'd', '##NT', '##Ps', ',', '0', '.', '8', 'μ', '##L', 'of', 'each', 'primer', '(', '5', 'μ', '##M', ')', ',', '0', '.', '4', 'μ', '##L', 'Fast', '##P', '##f', '##u', 'Polymer', '##ase', ',', 'and', '10', 'ng', 'template', 'DNA', '.']	[0, 3, 5, 10, 20, 23, 34, 37, 39, 42, 43, 45, 53, 64, 66, 67, 69, 71, 73, 77, 78, 79, 81, 83, 87, 89, 91, 92, 94, 95, 96, 98, 101, 102, 104, 106, 108, 109, 110, 112, 113, 115, 118, 123, 130, 131, 133, 134, 135, 136, 138, 139, 140, 142, 143, 145, 149, 150, 151, 153, 160, 163, 165, 169, 172, 175, 184, 187]	[3, 4, 9, 19, 22, 33, 36, 38, 41, 43, 44, 52, 63, 65, 67, 68, 70, 72, 77, 78, 79, 80, 83, 87, 88, 90, 92, 93, 95, 96, 97, 100, 102, 104, 106, 107, 109, 110, 111, 113, 114, 117, 122, 129, 131, 132, 134, 135, 136, 137, 139, 140, 141, 143, 144, 149, 150, 151, 152, 160, 163, 164, 168, 171, 174, 183, 187, 188]	['PCRs', 'were', 'performed', 'in', 'triplicate', 'in', 'a', '20', 'μL', 'mixture', 'containing', '4', 'μL', '5', '×', 'FastPfu', 'Buffer', ',', '2', 'μL', '2.5', 'mM', 'dNTPs', ',', '0.8', 'μL', 'of', 'each', 'primer', '(', '5', 'μM', ')', ',', '0.4', 'μL', 'FastPfu', 'Polymerase', ',', 'and', '10', 'ng', 'template', 'DNA', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 4, 2, 1, 1, 2, 3, 1, 3, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 2, 4, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We selected the following factors for redundancy analysis (RDA)/correspondence analysis (CCA): age, BMI, alanine aminotransferase (alanine transaminase), aspartate aminotransferase (aspartate transaminase), urea, UA, creatinine (CR), glucose (GLU), TG, TCHO, HDL, LDL, APOA1, APOB, LPA, and NEFA (Supplementary File 2).	[('PMC6731442', 'R06000', 105, 129, 'alanine aminotransferase'), ('PMC6731442', 'R06000', 131, 151, 'alanine transaminase'), ('PMC6731442', 'R06000', 154, 180, 'aspartate aminotransferase'), ('PMC6731442', 'R06000', 182, 204, 'aspartate transaminase')]	['We', 'selected', 'the', 'following', 'factors', 'for', 'redundancy', 'analysis', '(', 'RD', '##A', ')', '/', 'correspondence', 'analysis', '(', 'CCA', ')', ':', 'age', ',', 'BMI', ',', 'alanine', 'amino', '##transferase', '(', 'alanine', 'trans', '##aminase', ')', ',', 'aspart', '##ate', 'amino', '##transferase', '(', 'aspart', '##ate', 'trans', '##aminase', ')', ',', 'urea', ',', 'UA', ',', 'creatinine', '(', 'CR', ')', ',', 'glucose', '(', 'GL', '##U', ')', ',', 'TG', ',', 'TC', '##HO', ',', 'HDL', ',', 'LDL', ',', 'AP', '##OA', '##1', ',', 'AP', '##OB', ',', 'LP', '##A', ',', 'and', 'NE', '##FA', '(', 'Supplementary', 'File', '2', ')', '.']	[0, 3, 12, 16, 26, 34, 38, 49, 58, 59, 61, 62, 63, 64, 79, 88, 89, 92, 93, 95, 98, 100, 103, 105, 113, 118, 130, 131, 139, 144, 151, 152, 154, 160, 164, 169, 181, 182, 188, 192, 197, 204, 205, 207, 211, 213, 215, 217, 228, 229, 231, 232, 234, 242, 243, 245, 246, 247, 249, 251, 253, 255, 257, 259, 262, 264, 267, 269, 271, 273, 274, 276, 278, 280, 282, 284, 285, 287, 291, 293, 296, 297, 311, 316, 317, 318]	[2, 11, 15, 25, 33, 37, 48, 57, 59, 61, 62, 63, 64, 78, 87, 89, 92, 93, 94, 98, 99, 103, 104, 112, 118, 129, 131, 138, 144, 151, 152, 153, 160, 163, 169, 180, 182, 188, 191, 197, 204, 205, 206, 211, 212, 215, 216, 227, 229, 231, 232, 233, 241, 243, 245, 246, 247, 248, 251, 252, 255, 257, 258, 262, 263, 267, 268, 271, 273, 274, 275, 278, 280, 281, 284, 285, 286, 290, 293, 295, 297, 310, 315, 317, 318, 319]	['We', 'selected', 'the', 'following', 'factors', 'for', 'redundancy', 'analysis', '(', 'RDA', ')', '/', 'correspondence', 'analysis', '(', 'CCA', ')', ':', 'age', ',', 'BMI', ',', 'alanine', 'aminotransferase', '(', 'alanine', 'transaminase', ')', ',', 'aspartate', 'aminotransferase', '(', 'aspartate', 'transaminase', ')', ',', 'urea', ',', 'UA', ',', 'creatinine', '(', 'CR', ')', ',', 'glucose', '(', 'GLU', ')', ',', 'TG', ',', 'TCHO', ',', 'HDL', ',', 'LDL', ',', 'APOA1', ',', 'APOB', ',', 'LPA', ',', 'and', 'NEFA', '(', 'Supplementary', 'File', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 2, 2, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
-0.414, P = 0.006) and alanine transaminase	[('PMC6731442', 'R07007', 23, 43, 'alanine transaminase')]	['-', '0', '.', '41', '##4', ',', 'P', '=', '0', '.', '00', '##6', ')', 'and', 'alanine', 'trans', '##aminase']	[0, 1, 2, 3, 5, 6, 8, 10, 12, 13, 14, 16, 17, 19, 23, 31, 36]	[1, 2, 3, 5, 6, 7, 9, 11, 13, 14, 16, 17, 18, 22, 30, 36, 43]	['-', '0.414', ',', 'P', '=', '0.006', ')', 'and', 'alanine', 'transaminase']	[1, 4, 1, 1, 1, 4, 1, 1, 1, 2]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E']
To assess the functional capacity for sulfate reduction among individual participants, the relative abundances of sulfate adenylyltransferase (EC 2.7.7.4) and adenylylsulfate reductase (EC 1.8.99.2) were specifically investigated among individual participants.	[('PMC6748593', 'R05000', 114, 141, 'sulfate adenylyltransferase'), ('PMC6748593', 'R05000', 159, 184, 'adenylylsulfate reductase')]	['To', 'assess', 'the', 'functional', 'capacity', 'for', 'sulfate', 'reduction', 'among', 'individual', 'participants', ',', 'the', 'relative', 'abundances', 'of', 'sulfate', 'aden', '##yl', '##yl', '##transferase', '(', 'EC', '2', '.', '7', '.', '7', '.', '4', ')', 'and', 'aden', '##yl', '##yl', '##sulf', '##ate', 'reductase', '(', 'EC', '1', '.', '8', '.', '99', '.', '2', ')', 'were', 'specifically', 'investigated', 'among', 'individual', 'participants', '.']	[0, 3, 10, 14, 25, 34, 38, 46, 56, 62, 73, 85, 87, 91, 100, 111, 114, 122, 126, 128, 130, 142, 143, 146, 147, 148, 149, 150, 151, 152, 153, 155, 159, 163, 165, 167, 171, 175, 185, 186, 189, 190, 191, 192, 193, 195, 196, 197, 199, 204, 217, 230, 236, 247, 259]	[2, 9, 13, 24, 33, 37, 45, 55, 61, 72, 85, 86, 90, 99, 110, 113, 121, 126, 128, 130, 141, 143, 145, 147, 148, 149, 150, 151, 152, 153, 154, 158, 163, 165, 167, 171, 174, 184, 186, 188, 190, 191, 192, 193, 195, 196, 197, 198, 203, 216, 229, 235, 246, 259, 260]	['To', 'assess', 'the', 'functional', 'capacity', 'for', 'sulfate', 'reduction', 'among', 'individual', 'participants', ',', 'the', 'relative', 'abundances', 'of', 'sulfate', 'adenylyltransferase', '(', 'EC', '2.7.7.4', ')', 'and', 'adenylylsulfate', 'reductase', '(', 'EC', '1.8.99.2', ')', 'were', 'specifically', 'investigated', 'among', 'individual', 'participants', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 7, 1, 1, 5, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
While the relative abundance of sulfate adenylyltransferase was significantly greater in participant 02 (post-hoc P ≤ 0.020) than all other participants, no other significant differences among individuals or dietary arm were noted, and other genes known to be involved in dissimilatory sulfate reduction could not be identified.	[('PMC6748593', 'R05001', 32, 59, 'sulfate adenylyltransferase')]	['While', 'the', 'relative', 'abundance', 'of', 'sulfate', 'aden', '##yl', '##yl', '##transferase', 'was', 'significantly', 'greater', 'in', 'participant', '02', '(', 'post', '-', 'hoc', 'P', '≤', '0', '.', '02', '##0', ')', 'than', 'all', 'other', 'participants', ',', 'no', 'other', 'significant', 'differences', 'among', 'individuals', 'or', 'dietary', 'arm', 'were', 'noted', ',', 'and', 'other', 'genes', 'known', 'to', 'be', 'involved', 'in', 'diss', '##imi', '##lat', '##ory', 'sulfate', 'reduction', 'could', 'not', 'be', 'identified', '.']	[0, 6, 10, 19, 29, 32, 40, 44, 46, 48, 60, 64, 78, 86, 89, 101, 104, 105, 109, 110, 114, 116, 118, 119, 120, 122, 123, 125, 130, 134, 140, 152, 154, 157, 163, 175, 187, 193, 205, 208, 216, 220, 225, 230, 232, 236, 242, 248, 254, 257, 260, 269, 272, 276, 279, 282, 286, 294, 304, 310, 314, 317, 327]	[5, 9, 18, 28, 31, 39, 44, 46, 48, 59, 63, 77, 85, 88, 100, 103, 105, 109, 110, 113, 115, 117, 119, 120, 122, 123, 124, 129, 133, 139, 152, 153, 156, 162, 174, 186, 192, 204, 207, 215, 219, 224, 230, 231, 235, 241, 247, 253, 256, 259, 268, 271, 276, 279, 282, 285, 293, 303, 309, 313, 316, 327, 328]	['While', 'the', 'relative', 'abundance', 'of', 'sulfate', 'adenylyltransferase', 'was', 'significantly', 'greater', 'in', 'participant', '02', '(', 'post', '-', 'hoc', 'P', '≤', '0.020', ')', 'than', 'all', 'other', 'participants', ',', 'no', 'other', 'significant', 'differences', 'among', 'individuals', 'or', 'dietary', 'arm', 'were', 'noted', ',', 'and', 'other', 'genes', 'known', 'to', 'be', 'involved', 'in', 'dissimilatory', 'sulfate', 'reduction', 'could', 'not', 'be', 'identified', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This is consistent with the available scientific literature, which showed that PUFAs, including EPA and ALA, inhibit inosine 5′-monophosphate dehydrogenase activity, which is a critical purine biosynthetic enzyme [26], and then increase the subsequent catabolites (inosine and hypoxanthine)	[('PMC6756100', 'D01006', 117, 155, 'inosine 5′-monophosphate dehydrogenase')]	['This', 'is', 'consistent', 'with', 'the', 'available', 'scientific', 'literature', ',', 'which', 'showed', 'that', 'PU', '##FAs', ',', 'including', 'EPA', 'and', 'AL', '##A', ',', 'inhibit', 'in', '##osine', '5', '′', '-', 'monop', '##ho', '##sp', '##hat', '##e', 'dehydrogenase', 'activity', ',', 'which', 'is', 'a', 'critical', 'pur', '##ine', 'biosynthetic', 'enzyme', '[', '26', ']', ',', 'and', 'then', 'increase', 'the', 'subsequent', 'cat', '##abol', '##ites', '(', 'in', '##osine', 'and', 'hypo', '##x', '##anth', '##ine', ')']	[0, 5, 8, 19, 24, 28, 38, 49, 59, 61, 67, 74, 79, 81, 84, 86, 96, 100, 104, 106, 107, 109, 117, 119, 125, 126, 127, 128, 133, 135, 137, 140, 142, 156, 164, 166, 172, 175, 177, 186, 189, 193, 206, 213, 214, 216, 217, 219, 223, 228, 237, 241, 252, 255, 259, 264, 265, 267, 273, 277, 281, 282, 286, 289]	[4, 7, 18, 23, 27, 37, 48, 59, 60, 66, 73, 78, 81, 84, 85, 95, 99, 103, 106, 107, 108, 116, 119, 124, 126, 127, 128, 133, 135, 137, 140, 141, 155, 164, 165, 171, 174, 176, 185, 189, 192, 205, 212, 214, 216, 217, 218, 222, 227, 236, 240, 251, 255, 259, 263, 265, 267, 272, 276, 281, 282, 286, 289, 290]	['This', 'is', 'consistent', 'with', 'the', 'available', 'scientific', 'literature', ',', 'which', 'showed', 'that', 'PUFAs', ',', 'including', 'EPA', 'and', 'ALA', ',', 'inhibit', 'inosine', '5′-monophosphate', 'dehydrogenase', 'activity', ',', 'which', 'is', 'a', 'critical', 'purine', 'biosynthetic', 'enzyme', '[', '26', ']', ',', 'and', 'then', 'increase', 'the', 'subsequent', 'catabolites', '(', 'inosine', 'and', 'hypoxanthine', ')']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 2, 8, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This may be a consequence of increased activation of xanthine oxidase and adenosine deaminase [34].	[('PMC6756100', 'D02005', 53, 69, 'xanthine oxidase'), ('PMC6756100', 'D02005', 74, 93, 'adenosine deaminase')]	['This', 'may', 'be', 'a', 'consequence', 'of', 'increased', 'activation', 'of', 'x', '##anth', '##ine', 'oxidase', 'and', 'adenosine', 'de', '##aminase', '[', '34', ']', '.']	[0, 5, 9, 12, 14, 26, 29, 39, 50, 53, 54, 58, 62, 70, 74, 84, 86, 94, 95, 97, 98]	[4, 8, 11, 13, 25, 28, 38, 49, 52, 54, 58, 61, 69, 73, 83, 86, 93, 95, 97, 98, 99]	['This', 'may', 'be', 'a', 'consequence', 'of', 'increased', 'activation', 'of', 'xanthine', 'oxidase', 'and', 'adenosine', 'deaminase', '[', '34', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis.	[('PMC6756100', 'F21002', 58, 82, 'isocitrate dehydrogenase')]	['Cere', '##bro', '##spin', '##al', 'fluid', 'metabol', '##omics', 'identifies', 'a', 'key', 'role', 'of', 'iso', '##cit', '##rate', 'dehydrogenase', 'in', 'bipolar', 'disorder', ':', 'evidence', 'in', 'support', 'of', 'mitochondrial', 'dysfunction', 'hypothesis', '.']	[0, 4, 7, 11, 14, 20, 27, 33, 44, 46, 50, 55, 58, 61, 64, 69, 83, 86, 94, 102, 104, 113, 116, 124, 127, 141, 153, 163]	[4, 7, 11, 13, 19, 27, 32, 43, 45, 49, 54, 57, 61, 64, 68, 82, 85, 93, 102, 103, 112, 115, 123, 126, 140, 152, 163, 164]	['Cerebrospinal', 'fluid', 'metabolomics', 'identifies', 'a', 'key', 'role', 'of', 'isocitrate', 'dehydrogenase', 'in', 'bipolar', 'disorder', ':', 'evidence', 'in', 'support', 'of', 'mitochondrial', 'dysfunction', 'hypothesis', '.']	[4, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inhibitory action of polyunsaturated fatty acids on IMP dehydrogenase.	[('PMC6756100', 'F25002', 52, 69, 'IMP dehydrogenase')]	['Inhib', '##itory', 'action', 'of', 'poly', '##uns', '##aturated', 'fatty', 'acids', 'on', 'IMP', 'dehydrogenase', '.']	[0, 5, 11, 18, 21, 25, 28, 37, 43, 49, 52, 56, 69]	[5, 10, 17, 20, 25, 28, 36, 42, 48, 51, 55, 69, 70]	['Inhibitory', 'action', 'of', 'polyunsaturated', 'fatty', 'acids', 'on', 'IMP', 'dehydrogenase', '.']	[2, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment.	[('PMC6756100', 'F33002', 0, 19, 'Adenosine deaminase'), ('PMC6756100', 'F33002', 35, 55, 'superoxide dismutase'), ('PMC6756100', 'F33002', 61, 77, 'xanthine oxidase')]	['Aden', '##osine', 'de', '##aminase', ',', 'nitric', 'oxide', ',', 'superoxide', 'dismutase', ',', 'and', 'x', '##anth', '##ine', 'oxidase', 'in', 'patients', 'with', 'major', 'depression', ':', 'impact', 'of', 'antidepressant', 'treatment', '.']	[0, 4, 10, 12, 19, 21, 28, 33, 35, 46, 55, 57, 61, 62, 66, 70, 78, 81, 90, 95, 101, 111, 113, 120, 123, 138, 147]	[4, 9, 12, 19, 20, 27, 33, 34, 45, 55, 56, 60, 62, 66, 69, 77, 80, 89, 94, 100, 111, 112, 119, 122, 137, 147, 148]	['Adenosine', 'deaminase', ',', 'nitric', 'oxide', ',', 'superoxide', 'dismutase', ',', 'and', 'xanthine', 'oxidase', 'in', 'patients', 'with', 'major', 'depression', ':', 'impact', 'of', 'antidepressant', 'treatment', '.']	[2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Compared with HCs, DN-MDD exhibited a decrease in fatty acids, including; capric acid, cis-9-palmitoleic acid, dodecanoic acid, oleic acid and palmitic acid, and the polyunsaturated fatty acids (PUFAs), including; eicosapentaenoic acid (EPA,ω-3) and arachidonic acid (AA,ω-6) which is generated from phospholipids through phospholipase A2 with lysophospholipids as a by-product.	[('PMC6756100', 'R02005', 322, 338, 'phospholipase A2')]	['Compared', 'with', 'HC', '##s', ',', 'DN', '-', 'MDD', 'exhibited', 'a', 'decrease', 'in', 'fatty', 'acids', ',', 'including', ';', 'cap', '##ric', 'acid', ',', 'cis', '-', '9', '-', 'palm', '##itol', '##ei', '##c', 'acid', ',', 'dodec', '##ano', '##ic', 'acid', ',', 'ole', '##ic', 'acid', 'and', 'palm', '##itic', 'acid', ',', 'and', 'the', 'poly', '##uns', '##aturated', 'fatty', 'acids', '(', 'PU', '##FAs', ')', ',', 'including', ';', 'ei', '##cos', '##ape', '##nt', '##ae', '##no', '##ic', 'acid', '(', 'EPA', ',', 'ω', '-', '3', ')', 'and', 'ar', '##achid', '##onic', 'acid', '(', 'AA', ',', 'ω', '-', '6', ')', 'which', 'is', 'generated', 'from', 'phospholipids', 'through', 'phospholip', '##ase', 'A', '##2', 'with', 'lys', '##ophosph', '##olipid', '##s', 'as', 'a', 'by', '-', 'product', '.']	[0, 9, 14, 16, 17, 19, 21, 22, 26, 36, 38, 47, 50, 56, 61, 63, 72, 74, 77, 81, 85, 87, 90, 91, 92, 93, 97, 101, 103, 105, 109, 111, 116, 119, 122, 126, 128, 131, 134, 139, 143, 147, 152, 156, 158, 162, 166, 170, 173, 182, 188, 194, 195, 197, 200, 201, 203, 212, 214, 216, 219, 222, 224, 226, 228, 231, 236, 237, 240, 241, 242, 243, 244, 246, 250, 252, 257, 262, 267, 268, 270, 271, 272, 273, 274, 276, 282, 285, 295, 300, 314, 322, 332, 336, 337, 339, 344, 347, 354, 360, 362, 365, 367, 369, 370, 377]	[8, 13, 16, 17, 18, 21, 22, 25, 35, 37, 46, 49, 55, 61, 62, 72, 73, 77, 80, 85, 86, 90, 91, 92, 93, 97, 101, 103, 104, 109, 110, 116, 119, 121, 126, 127, 131, 133, 138, 142, 147, 151, 156, 157, 161, 165, 170, 173, 181, 187, 193, 195, 197, 200, 201, 202, 212, 213, 216, 219, 222, 224, 226, 228, 230, 235, 237, 240, 241, 242, 243, 244, 245, 249, 252, 257, 261, 266, 268, 270, 271, 272, 273, 274, 275, 281, 284, 294, 299, 313, 321, 332, 335, 337, 338, 343, 347, 354, 360, 361, 364, 366, 369, 370, 377, 378]	['Compared', 'with', 'HCs', ',', 'DN-MDD', 'exhibited', 'a', 'decrease', 'in', 'fatty', 'acids', ',', 'including', ';', 'capric', 'acid', ',', 'cis-9-palmitoleic', 'acid', ',', 'dodecanoic', 'acid', ',', 'oleic', 'acid', 'and', 'palmitic', 'acid', ',', 'and', 'the', 'polyunsaturated', 'fatty', 'acids', '(', 'PUFAs', ')', ',', 'including', ';', 'eicosapentaenoic', 'acid', '(', 'EPA', ',', 'ω-3', ')', 'and', 'arachidonic', 'acid', '(', 'AA', ',', 'ω-6', ')', 'which', 'is', 'generated', 'from', 'phospholipids', 'through', 'phospholipase', 'A2', 'with', 'lysophospholipids', 'as', 'a', 'by', '-', 'product', '.']	[1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 8, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 7, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Subsequently, the suspension was supplemented with 600 IU of Qiagen proteinase K and incubated at 60°C for 1 h. Finally, 0.3 mL of Qiagen AL buffer was added and a final incubation at 70°C for 10 minutes was carried out.	[('PMC6774526', 'M04003', 68, 80, 'proteinase K')]	['Subsequently', ',', 'the', 'suspension', 'was', 'supplemented', 'with', '600', 'IU', 'of', 'Qi', '##agen', 'protein', '##ase', 'K', 'and', 'incubated', 'at', '60', '##°', '##C', 'for', '1', 'h', '.', 'Finally', ',', '0', '.', '3', 'mL', 'of', 'Qi', '##agen', 'AL', 'buffer', 'was', 'added', 'and', 'a', 'final', 'incubation', 'at', '70', '##°', '##C', 'for', '10', 'minutes', 'was', 'carried', 'out', '.']	[0, 12, 14, 18, 29, 33, 46, 51, 55, 58, 61, 63, 68, 75, 79, 81, 85, 95, 98, 100, 101, 103, 107, 109, 110, 112, 119, 121, 122, 123, 125, 128, 131, 133, 138, 141, 148, 152, 158, 162, 164, 170, 181, 184, 186, 187, 189, 193, 196, 204, 208, 216, 219]	[12, 13, 17, 28, 32, 45, 50, 54, 57, 60, 63, 67, 75, 78, 80, 84, 94, 97, 100, 101, 102, 106, 108, 110, 111, 119, 120, 122, 123, 124, 127, 130, 133, 137, 140, 147, 151, 157, 161, 163, 169, 180, 183, 186, 187, 188, 192, 195, 203, 207, 215, 219, 220]	['Subsequently', ',', 'the', 'suspension', 'was', 'supplemented', 'with', '600', 'IU', 'of', 'Qiagen', 'proteinase', 'K', 'and', 'incubated', 'at', '60°C', 'for', '1', 'h', '.', 'Finally', ',', '0.3', 'mL', 'of', 'Qiagen', 'AL', 'buffer', 'was', 'added', 'and', 'a', 'final', 'incubation', 'at', '70°C', 'for', '10', 'minutes', 'was', 'carried', 'out', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Myo-inositol showed an inverse relationship with the initial estimated glomerular filtration rate (eGFR) and was associated with the plasma level of soluble urokinase-type plasminogen activator receptor in FSGS patients.	[('PMC6789025', 'A00005', 157, 193, 'urokinase-type plasminogen activator')]	['My', '##o', '-', 'in', '##osi', '##tol', 'showed', 'an', 'inverse', 'relationship', 'with', 'the', 'initial', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'e', '##GFR', ')', 'and', 'was', 'associated', 'with', 'the', 'plasma', 'level', 'of', 'soluble', 'uro', '##kinase', '-', 'type', 'plasmin', '##ogen', 'activator', 'receptor', 'in', 'FS', '##GS', 'patients', '.']	[0, 2, 3, 4, 6, 9, 13, 20, 23, 31, 44, 49, 53, 61, 71, 82, 93, 98, 99, 100, 103, 105, 109, 113, 124, 129, 133, 140, 146, 149, 157, 160, 166, 167, 172, 179, 184, 194, 203, 206, 208, 211, 219]	[2, 3, 4, 6, 9, 12, 19, 22, 30, 43, 48, 52, 60, 70, 81, 92, 97, 99, 100, 103, 104, 108, 112, 123, 128, 132, 139, 145, 148, 156, 160, 166, 167, 171, 179, 183, 193, 202, 205, 208, 210, 219, 220]	['Myo', '-', 'inositol', 'showed', 'an', 'inverse', 'relationship', 'with', 'the', 'initial', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'eGFR', ')', 'and', 'was', 'associated', 'with', 'the', 'plasma', 'level', 'of', 'soluble', 'urokinase', '-', 'type', 'plasminogen', 'activator', 'receptor', 'in', 'FSGS', 'patients', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Myo-inositol treatment ameliorated the decreased expression of ZO-1 and synaptopodin in an in vitro FSGS model, and as myo-inositol increased, myo-inositol oxygenase tissue expression decreased proportionally to eGFR.	[('PMC6789025', 'A00006', 143, 165, 'myo-inositol oxygenase')]	['My', '##o', '-', 'in', '##osi', '##tol', 'treatment', 'amelior', '##ated', 'the', 'decreased', 'expression', 'of', 'Z', '##O', '-', '1', 'and', 'syn', '##apt', '##opo', '##din', 'in', 'an', 'in', 'vitro', 'FS', '##GS', 'model', ',', 'and', 'as', 'my', '##o', '-', 'in', '##osi', '##tol', 'increased', ',', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', 'tissue', 'expression', 'decreased', 'proportional', '##ly', 'to', 'e', '##GFR', '.']	[0, 2, 3, 4, 6, 9, 13, 23, 30, 35, 39, 49, 60, 63, 64, 65, 66, 68, 72, 75, 78, 81, 85, 88, 91, 94, 100, 102, 105, 110, 112, 116, 119, 121, 122, 123, 125, 128, 132, 141, 143, 145, 146, 147, 149, 152, 156, 162, 166, 173, 184, 194, 206, 209, 212, 213, 216]	[2, 3, 4, 6, 9, 12, 22, 30, 34, 38, 48, 59, 62, 64, 65, 66, 67, 71, 75, 78, 81, 84, 87, 90, 93, 99, 102, 104, 110, 111, 115, 118, 121, 122, 123, 125, 128, 131, 141, 142, 145, 146, 147, 149, 152, 155, 162, 165, 172, 183, 193, 206, 208, 211, 213, 216, 217]	['Myo', '-', 'inositol', 'treatment', 'ameliorated', 'the', 'decreased', 'expression', 'of', 'ZO-1', 'and', 'synaptopodin', 'in', 'an', 'in', 'vitro', 'FSGS', 'model', ',', 'and', 'as', 'myo', '-', 'inositol', 'increased', ',', 'myo', '-', 'inositol', 'oxygenase', 'tissue', 'expression', 'decreased', 'proportionally', 'to', 'eGFR', '.']	[2, 1, 3, 1, 2, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 3, 2, 1, 1, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, we investigated the effects of myo-inositol treatment in an in vitro FSGS model, and we found that myo-inositol oxygenase increased in proportion to eGFR in FSGS human kidney tissue, while it was inversely related to urinary myo-inositol.	[('PMC6789025', 'D00003', 109, 131, 'myo-inositol oxygenase')]	['Moreover', ',', 'we', 'investigated', 'the', 'effects', 'of', 'my', '##o', '-', 'in', '##osi', '##tol', 'treatment', 'in', 'an', 'in', 'vitro', 'FS', '##GS', 'model', ',', 'and', 'we', 'found', 'that', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', 'increased', 'in', 'proportion', 'to', 'e', '##GFR', 'in', 'FS', '##GS', 'human', 'kidney', 'tissue', ',', 'while', 'it', 'was', 'inversely', 'related', 'to', 'urinary', 'my', '##o', '-', 'in', '##osi', '##tol', '.']	[0, 8, 10, 13, 26, 30, 38, 41, 43, 44, 45, 47, 50, 54, 64, 67, 70, 73, 79, 81, 84, 89, 91, 95, 98, 104, 109, 111, 112, 113, 115, 118, 122, 128, 132, 142, 145, 156, 159, 160, 164, 167, 169, 172, 178, 185, 191, 193, 199, 202, 206, 216, 224, 227, 235, 237, 238, 239, 241, 244, 247]	[8, 9, 12, 25, 29, 37, 40, 43, 44, 45, 47, 50, 53, 63, 66, 69, 72, 78, 81, 83, 89, 90, 94, 97, 103, 108, 111, 112, 113, 115, 118, 121, 128, 131, 141, 144, 155, 158, 160, 163, 166, 169, 171, 177, 184, 191, 192, 198, 201, 205, 215, 223, 226, 234, 237, 238, 239, 241, 244, 247, 248]	['Moreover', ',', 'we', 'investigated', 'the', 'effects', 'of', 'myo', '-', 'inositol', 'treatment', 'in', 'an', 'in', 'vitro', 'FSGS', 'model', ',', 'and', 'we', 'found', 'that', 'myo', '-', 'inositol', 'oxygenase', 'increased', 'in', 'proportion', 'to', 'eGFR', 'in', 'FSGS', 'human', 'kidney', 'tissue', ',', 'while', 'it', 'was', 'inversely', 'related', 'to', 'urinary', 'myo', '-', 'inositol', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, Dutta RK et al.22 demonstrated that overexpression of myo-inositol oxygenase promotes degradation of myo-inositol and decreases myo-inositol levels, worsening cisplatin-induced acute kidney injury.	[('PMC6789025', 'D02006', 64, 86, 'myo-inositol oxygenase')]	['Moreover', ',', 'Du', '##tt', '##a', 'RK', 'et', 'al', '.', '22', 'demonstrated', 'that', 'overexpression', 'of', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', 'promotes', 'degradation', 'of', 'my', '##o', '-', 'in', '##osi', '##tol', 'and', 'decreases', 'my', '##o', '-', 'in', '##osi', '##tol', 'levels', ',', 'worsening', 'cisplatin', '-', 'induced', 'acute', 'kidney', 'injury', '.']	[0, 8, 10, 12, 14, 16, 19, 22, 24, 25, 28, 41, 46, 61, 64, 66, 67, 68, 70, 73, 77, 83, 87, 96, 108, 111, 113, 114, 115, 117, 120, 124, 128, 138, 140, 141, 142, 144, 147, 151, 157, 159, 169, 178, 179, 187, 193, 200, 206]	[8, 9, 12, 14, 15, 18, 21, 24, 25, 27, 40, 45, 60, 63, 66, 67, 68, 70, 73, 76, 83, 86, 95, 107, 110, 113, 114, 115, 117, 120, 123, 127, 137, 140, 141, 142, 144, 147, 150, 157, 158, 168, 178, 179, 186, 192, 199, 206, 207]	['Moreover', ',', 'Dutta', 'RK', 'et', 'al.22', 'demonstrated', 'that', 'overexpression', 'of', 'myo', '-', 'inositol', 'oxygenase', 'promotes', 'degradation', 'of', 'myo', '-', 'inositol', 'and', 'decreases', 'myo', '-', 'inositol', 'levels', ',', 'worsening', 'cisplatin', '-', 'induced', 'acute', 'kidney', 'injury', '.']	[1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These results are consistent with our findings that urinary myo-inositol is increased in FSGS patients with reduced renal function (increased suPAR level) or reduced myo-inositol oxygenase expression and that treatment with myo-inositol in the in vitro FSGS model resulted in an increase in the expression of various markers, which was similar to the attenuation of the disease.	[('PMC6789025', 'D02007', 166, 188, 'myo-inositol oxygenase')]	['These', 'results', 'are', 'consistent', 'with', 'our', 'findings', 'that', 'urinary', 'my', '##o', '-', 'in', '##osi', '##tol', 'is', 'increased', 'in', 'FS', '##GS', 'patients', 'with', 'reduced', 'renal', 'function', '(', 'increased', 'su', '##PAR', 'level', ')', 'or', 'reduced', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', 'expression', 'and', 'that', 'treatment', 'with', 'my', '##o', '-', 'in', '##osi', '##tol', 'in', 'the', 'in', 'vitro', 'FS', '##GS', 'model', 'resulted', 'in', 'an', 'increase', 'in', 'the', 'expression', 'of', 'various', 'markers', ',', 'which', 'was', 'similar', 'to', 'the', 'attenuation', 'of', 'the', 'disease', '.']	[0, 6, 14, 18, 29, 34, 38, 47, 52, 60, 62, 63, 64, 66, 69, 73, 76, 86, 89, 91, 94, 103, 108, 116, 122, 131, 132, 142, 144, 148, 153, 155, 158, 166, 168, 169, 170, 172, 175, 179, 185, 189, 200, 204, 209, 219, 224, 226, 227, 228, 230, 233, 237, 240, 244, 247, 253, 255, 258, 264, 273, 276, 279, 288, 291, 295, 306, 309, 317, 324, 326, 332, 336, 344, 347, 351, 363, 366, 370, 377]	[5, 13, 17, 28, 33, 37, 46, 51, 59, 62, 63, 64, 66, 69, 72, 75, 85, 88, 91, 93, 102, 107, 115, 121, 130, 132, 141, 144, 147, 153, 154, 157, 165, 168, 169, 170, 172, 175, 178, 185, 188, 199, 203, 208, 218, 223, 226, 227, 228, 230, 233, 236, 239, 243, 246, 252, 255, 257, 263, 272, 275, 278, 287, 290, 294, 305, 308, 316, 324, 325, 331, 335, 343, 346, 350, 362, 365, 369, 377, 378]	['These', 'results', 'are', 'consistent', 'with', 'our', 'findings', 'that', 'urinary', 'myo', '-', 'inositol', 'is', 'increased', 'in', 'FSGS', 'patients', 'with', 'reduced', 'renal', 'function', '(', 'increased', 'suPAR', 'level', ')', 'or', 'reduced', 'myo', '-', 'inositol', 'oxygenase', 'expression', 'and', 'that', 'treatment', 'with', 'myo', '-', 'inositol', 'in', 'the', 'in', 'vitro', 'FSGS', 'model', 'resulted', 'in', 'an', 'increase', 'in', 'the', 'expression', 'of', 'various', 'markers', ',', 'which', 'was', 'similar', 'to', 'the', 'attenuation', 'of', 'the', 'disease', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The relationship between myo-inositol and decreased renal function or myo-inositol oxygenase expression suggests a link between myo-inositol and tubular dysfunction.	[('PMC6789025', 'D05002', 70, 92, 'myo-inositol oxygenase')]	['The', 'relationship', 'between', 'my', '##o', '-', 'in', '##osi', '##tol', 'and', 'decreased', 'renal', 'function', 'or', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', 'expression', 'suggests', 'a', 'link', 'between', 'my', '##o', '-', 'in', '##osi', '##tol', 'and', 'tubular', 'dysfunction', '.']	[0, 4, 17, 25, 27, 28, 29, 31, 34, 38, 42, 52, 58, 67, 70, 72, 73, 74, 76, 79, 83, 89, 93, 104, 113, 115, 120, 128, 130, 131, 132, 134, 137, 141, 145, 153, 164]	[3, 16, 24, 27, 28, 29, 31, 34, 37, 41, 51, 57, 66, 69, 72, 73, 74, 76, 79, 82, 89, 92, 103, 112, 114, 119, 127, 130, 131, 132, 134, 137, 140, 144, 152, 164, 165]	['The', 'relationship', 'between', 'myo', '-', 'inositol', 'and', 'decreased', 'renal', 'function', 'or', 'myo', '-', 'inositol', 'oxygenase', 'expression', 'suggests', 'a', 'link', 'between', 'myo', '-', 'inositol', 'and', 'tubular', 'dysfunction', '.']	[1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.	[('PMC6789025', 'F03002', 28, 37, 'urokinase')]	['Ur', '##ine', 'but', 'not', 'serum', 'soluble', 'uro', '##kinase', 'receptor', '(', 'su', '##PAR', ')', 'may', 'identify', 'cases', 'of', 'recurrent', 'FS', '##GS', 'in', 'kidney', 'transplant', 'candidates', '.']	[0, 2, 6, 10, 14, 20, 28, 31, 38, 47, 48, 50, 53, 55, 59, 68, 74, 77, 87, 89, 92, 95, 102, 113, 123]	[2, 5, 9, 13, 19, 27, 31, 37, 46, 48, 50, 53, 54, 58, 67, 73, 76, 86, 89, 91, 94, 101, 112, 123, 124]	['Urine', 'but', 'not', 'serum', 'soluble', 'urokinase', 'receptor', '(', 'suPAR', ')', 'may', 'identify', 'cases', 'of', 'recurrent', 'FSGS', 'in', 'kidney', 'transplant', 'candidates', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling.	[('PMC6789025', 'F19002', 35, 46, 'calcineurin')]	['Assess', '##ing', 'the', 'metabolic', 'effects', 'of', 'calc', '##ine', '##urin', 'inhibitors', 'in', 'renal', 'transplant', 'recipients', 'by', 'urine', 'metabolic', 'profiling', '.']	[0, 6, 10, 14, 24, 32, 35, 39, 42, 47, 58, 61, 67, 78, 89, 92, 98, 108, 117]	[6, 9, 13, 23, 31, 34, 39, 42, 46, 57, 60, 66, 77, 88, 91, 97, 107, 117, 118]	['Assessing', 'the', 'metabolic', 'effects', 'of', 'calcineurin', 'inhibitors', 'in', 'renal', 'transplant', 'recipients', 'by', 'urine', 'metabolic', 'profiling', '.']	[2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI.	[('PMC6789025', 'F21002', 22, 44, 'Myo-Inositol Oxygenase')]	['Bene', '##fi', '##cia', '##l', 'Effects', 'of', 'My', '##o', '-', 'In', '##osi', '##tol', 'Oxygen', '##ase', 'Def', '##iciency', 'in', 'Ci', '##spl', '##atin', '-', 'Ind', '##uced', 'AKI', '.']	[0, 4, 6, 9, 11, 19, 22, 24, 25, 26, 28, 31, 35, 41, 45, 48, 56, 59, 61, 64, 68, 69, 72, 77, 80]	[4, 6, 9, 10, 18, 21, 24, 25, 26, 28, 31, 34, 41, 44, 48, 55, 58, 61, 64, 68, 69, 72, 76, 80, 81]	['Beneficial', 'Effects', 'of', 'Myo-Inositol', 'Oxygenase', 'Deficiency', 'in', 'Cisplatin-Induced', 'AKI', '.']	[4, 1, 1, 6, 2, 2, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although several studies have shown that soluble urokinase plasminogen-type activator receptor (suPAR) levels increase in primary FSGS2, there are reports that it is associated with decreased renal function rather than FSGS itself.	[('PMC6789025', 'I00001', 49, 85, 'urokinase plasminogen-type activator')]	['Although', 'several', 'studies', 'have', 'shown', 'that', 'soluble', 'uro', '##kinase', 'plasmin', '##ogen', '-', 'type', 'activator', 'receptor', '(', 'su', '##PAR', ')', 'levels', 'increase', 'in', 'primary', 'FS', '##GS', '##2', ',', 'there', 'are', 'reports', 'that', 'it', 'is', 'associated', 'with', 'decreased', 'renal', 'function', 'rather', 'than', 'FS', '##GS', 'itself', '.']	[0, 9, 17, 25, 30, 36, 41, 49, 52, 59, 66, 70, 71, 76, 86, 95, 96, 98, 101, 103, 110, 119, 122, 130, 132, 134, 135, 137, 143, 147, 155, 160, 163, 166, 177, 182, 192, 198, 207, 214, 219, 221, 224, 230]	[8, 16, 24, 29, 35, 40, 48, 52, 58, 66, 70, 71, 75, 85, 94, 96, 98, 101, 102, 109, 118, 121, 129, 132, 134, 135, 136, 142, 146, 154, 159, 162, 165, 176, 181, 191, 197, 206, 213, 218, 221, 223, 230, 231]	['Although', 'several', 'studies', 'have', 'shown', 'that', 'soluble', 'urokinase', 'plasminogen', '-', 'type', 'activator', 'receptor', '(', 'suPAR', ')', 'levels', 'increase', 'in', 'primary', 'FSGS2', ',', 'there', 'are', 'reports', 'that', 'it', 'is', 'associated', 'with', 'decreased', 'renal', 'function', 'rather', 'than', 'FSGS', 'itself', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Primary antibodies targeting glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Cell Signaling, Danvers, MA, USA), synaptopodin (Progen, Heidelberg, Germany), and ZO-1 (Cell Signaling) were used.	[('PMC6789025', 'M08001', 29, 69, 'glyceraldehyde 3-phosphate dehydrogenase')]	['Primary', 'antibodies', 'targeting', 'glycer', '##aldehyde', '3', '-', 'phosphate', 'dehydrogenase', '(', 'GAPDH', ',', 'Cell', 'Signaling', ',', 'Dan', '##vers', ',', 'MA', ',', 'USA', ')', ',', 'syn', '##apt', '##opo', '##din', '(', 'Prog', '##en', ',', 'Heidelberg', ',', 'Germany', ')', ',', 'and', 'Z', '##O', '-', '1', '(', 'Cell', 'Signaling', ')', 'were', 'used', '.']	[0, 8, 19, 29, 35, 44, 45, 46, 56, 70, 71, 76, 78, 83, 92, 94, 97, 101, 103, 105, 107, 110, 111, 113, 116, 119, 122, 126, 127, 131, 133, 135, 145, 147, 154, 155, 157, 161, 162, 163, 164, 166, 167, 172, 181, 183, 188, 192]	[7, 18, 28, 35, 43, 45, 46, 55, 69, 71, 76, 77, 82, 92, 93, 97, 101, 102, 105, 106, 110, 111, 112, 116, 119, 122, 125, 127, 131, 133, 134, 145, 146, 154, 155, 156, 160, 162, 163, 164, 165, 167, 171, 181, 182, 187, 192, 193]	['Primary', 'antibodies', 'targeting', 'glyceraldehyde', '3-phosphate', 'dehydrogenase', '(', 'GAPDH', ',', 'Cell', 'Signaling', ',', 'Danvers', ',', 'MA', ',', 'USA', ')', ',', 'synaptopodin', '(', 'Progen', ',', 'Heidelberg', ',', 'Germany', ')', ',', 'and', 'ZO-1', '(', 'Cell', 'Signaling', ')', 'were', 'used', '.']	[1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Staining was performed using polyclonal myo-inositol oxygenase antibody (1:1000; Thermo Fisher Scientific, Waltham, MA, USA) at 4 °C overnight, followed by incubation with dextran polymer conjugated with horseradish peroxidase (GBI Labs, Bothell, WA, USA) for 5 minutes at room temperature.	[('PMC6789025', 'M09001', 40, 62, 'myo-inositol oxygenase'), ('PMC6789025', 'M09001', 204, 226, 'horseradish peroxidase')]	['Sta', '##ining', 'was', 'performed', 'using', 'polyclonal', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', 'antibody', '(', '1', ':', '1000', ';', 'Thermo', 'Fisher', 'Scientific', ',', 'Wal', '##th', '##am', ',', 'MA', ',', 'USA', ')', 'at', '4', '°', '##C', 'overnight', ',', 'followed', 'by', 'incubation', 'with', 'dex', '##tran', 'polymer', 'conjugated', 'with', 'horse', '##radi', '##sh', 'peroxidase', '(', 'GB', '##I', 'Lab', '##s', ',', 'Both', '##ell', ',', 'WA', ',', 'USA', ')', 'for', '5', 'minutes', 'at', 'room', 'temperature', '.']	[0, 3, 9, 13, 23, 29, 40, 42, 43, 44, 46, 49, 53, 59, 63, 72, 73, 74, 75, 79, 81, 88, 95, 105, 107, 110, 112, 114, 116, 118, 120, 123, 125, 128, 130, 131, 133, 142, 144, 153, 156, 167, 172, 175, 180, 188, 199, 204, 209, 213, 216, 227, 228, 230, 232, 235, 236, 238, 242, 245, 247, 249, 251, 254, 256, 260, 262, 270, 273, 278, 289]	[3, 8, 12, 22, 28, 39, 42, 43, 44, 46, 49, 52, 59, 62, 71, 73, 74, 75, 79, 80, 87, 94, 105, 106, 110, 112, 114, 115, 118, 119, 123, 124, 127, 129, 131, 132, 142, 143, 152, 155, 166, 171, 175, 179, 187, 198, 203, 209, 213, 215, 226, 228, 230, 231, 235, 236, 237, 242, 245, 246, 249, 250, 254, 255, 259, 261, 269, 272, 277, 289, 290]	['Staining', 'was', 'performed', 'using', 'polyclonal', 'myo', '-', 'inositol', 'oxygenase', 'antibody', '(', '1', ':', '1000', ';', 'Thermo', 'Fisher', 'Scientific', ',', 'Waltham', ',', 'MA', ',', 'USA', ')', 'at', '4', '°C', 'overnight', ',', 'followed', 'by', 'incubation', 'with', 'dextran', 'polymer', 'conjugated', 'with', 'horseradish', 'peroxidase', '(', 'GBI', 'Labs', ',', 'Bothell', ',', 'WA', ',', 'USA', ')', 'for', '5', 'minutes', 'at', 'room', 'temperature', '.']	[2, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 2, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The myo-inositol oxygenase score was graded in a blinded fashion by a kidney pathologist.	[('PMC6789025', 'M09003', 4, 26, 'myo-inositol oxygenase')]	['The', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', 'score', 'was', 'graded', 'in', 'a', 'blinded', 'fashion', 'by', 'a', 'kidney', 'path', '##ologist', '.']	[0, 4, 6, 7, 8, 10, 13, 17, 23, 27, 33, 37, 44, 47, 49, 57, 65, 68, 70, 77, 81, 88]	[3, 6, 7, 8, 10, 13, 16, 23, 26, 32, 36, 43, 46, 48, 56, 64, 67, 69, 76, 81, 88, 89]	['The', 'myo', '-', 'inositol', 'oxygenase', 'score', 'was', 'graded', 'in', 'a', 'blinded', 'fashion', 'by', 'a', 'kidney', 'pathologist', '.']	[1, 2, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Next, we examined the expression of myo-inositol oxygenase (myo-inositol oxygenase), which is primarily expressed in the kidneys and is known to be a part of the inositol catabolism pathway, in patients with FSGS and MCD.	[('PMC6789025', 'R10000', 36, 58, 'myo-inositol oxygenase'), ('PMC6789025', 'R10000', 60, 82, 'myo-inositol oxygenase')]	['Next', ',', 'we', 'examined', 'the', 'expression', 'of', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', '(', 'my', '##o', '-', 'in', '##osi', '##tol', 'oxygen', '##ase', ')', ',', 'which', 'is', 'primarily', 'expressed', 'in', 'the', 'kidneys', 'and', 'is', 'known', 'to', 'be', 'a', 'part', 'of', 'the', 'in', '##osi', '##tol', 'cat', '##abolism', 'pathway', ',', 'in', 'patients', 'with', 'FS', '##GS', 'and', 'MC', '##D', '.']	[0, 4, 6, 9, 18, 22, 33, 36, 38, 39, 40, 42, 45, 49, 55, 59, 60, 62, 63, 64, 66, 69, 73, 79, 82, 83, 85, 91, 94, 104, 114, 117, 121, 129, 133, 136, 142, 145, 148, 150, 155, 158, 162, 164, 167, 171, 174, 182, 189, 191, 194, 203, 208, 210, 213, 217, 219, 220]	[4, 5, 8, 17, 21, 32, 35, 38, 39, 40, 42, 45, 48, 55, 58, 60, 62, 63, 64, 66, 69, 72, 79, 82, 83, 84, 90, 93, 103, 113, 116, 120, 128, 132, 135, 141, 144, 147, 149, 154, 157, 161, 164, 167, 170, 174, 181, 189, 190, 193, 202, 207, 210, 212, 216, 219, 220, 221]	['Next', ',', 'we', 'examined', 'the', 'expression', 'of', 'myo', '-', 'inositol', 'oxygenase', '(', 'myo', '-', 'inositol', 'oxygenase', ')', ',', 'which', 'is', 'primarily', 'expressed', 'in', 'the', 'kidneys', 'and', 'is', 'known', 'to', 'be', 'a', 'part', 'of', 'the', 'inositol', 'catabolism', 'pathway', ',', 'in', 'patients', 'with', 'FSGS', 'and', 'MCD', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 2, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The in vitro evaluation of inhibitory potency of Tem-oxidized products on human red blood cell acetylcholinesterase (RBC AChE) showed that Tem-dox-SO2 was the most potent inhibitor of human RBC AChE, and its effect was more pronounced than that observed for ethyl-paraoxon, a potent typical inhibitor of AChE.	[('PMC6791832', 'A00004', 95, 115, 'acetylcholinesterase')]	['The', 'in', 'vitro', 'evaluation', 'of', 'inhibitory', 'potency', 'of', 'Tem', '-', 'oxidized', 'products', 'on', 'human', 'red', 'blood', 'cell', 'acetylcholine', '##ster', '##ase', '(', 'RBC', 'ACh', '##E', ')', 'showed', 'that', 'Tem', '-', 'dox', '-', 'SO', '##2', 'was', 'the', 'most', 'potent', 'inhibitor', 'of', 'human', 'RBC', 'ACh', '##E', ',', 'and', 'its', 'effect', 'was', 'more', 'pronounced', 'than', 'that', 'observed', 'for', 'ethyl', '-', 'para', '##oxo', '##n', ',', 'a', 'potent', 'typical', 'inhibitor', 'of', 'ACh', '##E', '.']	[0, 4, 7, 13, 24, 27, 38, 46, 49, 52, 53, 62, 71, 74, 80, 84, 90, 95, 108, 112, 116, 117, 121, 124, 125, 127, 134, 139, 142, 143, 146, 147, 149, 151, 155, 159, 164, 171, 181, 184, 190, 194, 197, 198, 200, 204, 208, 215, 219, 224, 235, 240, 245, 254, 258, 263, 264, 268, 271, 272, 274, 276, 283, 291, 301, 304, 307, 308]	[3, 6, 12, 23, 26, 37, 45, 48, 52, 53, 61, 70, 73, 79, 83, 89, 94, 108, 112, 115, 117, 120, 124, 125, 126, 133, 138, 142, 143, 146, 147, 149, 150, 154, 158, 163, 170, 180, 183, 189, 193, 197, 198, 199, 203, 207, 214, 218, 223, 234, 239, 244, 253, 257, 263, 264, 268, 271, 272, 273, 275, 282, 290, 300, 303, 307, 308, 309]	['The', 'in', 'vitro', 'evaluation', 'of', 'inhibitory', 'potency', 'of', 'Tem', '-', 'oxidized', 'products', 'on', 'human', 'red', 'blood', 'cell', 'acetylcholinesterase', '(', 'RBC', 'AChE', ')', 'showed', 'that', 'Tem-dox-SO2', 'was', 'the', 'most', 'potent', 'inhibitor', 'of', 'human', 'RBC', 'AChE', ',', 'and', 'its', 'effect', 'was', 'more', 'pronounced', 'than', 'that', 'observed', 'for', 'ethyl', '-', 'paraoxon', ',', 'a', 'potent', 'typical', 'inhibitor', 'of', 'AChE', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mechanistic insight into acetylcholinesterase inhibition and acute toxicity of organophosphorus compounds: A molecular modeling study.	[('PMC6791832', 'F10002', 25, 45, 'acetylcholinesterase')]	['Mechan', '##istic', 'insight', 'into', 'acetylcholine', '##ster', '##ase', 'inhibition', 'and', 'acute', 'toxicity', 'of', 'organ', '##ophosph', '##orus', 'compounds', ':', 'A', 'molecular', 'modeling', 'study', '.']	[0, 6, 12, 20, 25, 38, 42, 46, 57, 61, 67, 76, 79, 84, 91, 96, 105, 107, 109, 119, 128, 133]	[6, 11, 19, 24, 38, 42, 45, 56, 60, 66, 75, 78, 84, 91, 95, 105, 106, 108, 118, 127, 133, 134]	['Mechanistic', 'insight', 'into', 'acetylcholinesterase', 'inhibition', 'and', 'acute', 'toxicity', 'of', 'organophosphorus', 'compounds', ':', 'A', 'molecular', 'modeling', 'study', '.']	[2, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A new and rapid colorimetric determination of acetylcholinesterase activity.	[('PMC6791832', 'F11002', 46, 66, 'acetylcholinesterase')]	['A', 'new', 'and', 'rapid', 'color', '##imetric', 'determination', 'of', 'acetylcholine', '##ster', '##ase', 'activity', '.']	[0, 2, 6, 10, 16, 21, 29, 43, 46, 59, 63, 67, 75]	[1, 5, 9, 15, 21, 28, 42, 45, 59, 63, 66, 75, 76]	['A', 'new', 'and', 'rapid', 'colorimetric', 'determination', 'of', 'acetylcholinesterase', 'activity', '.']	[1, 1, 1, 1, 2, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
At present, there is, to our knowledge, no information to clarify any relationship between metabolites of Tem and human red blood cell acetylcholinesterase (RBC AChE) inhibition.	[('PMC6791832', 'I03002', 135, 155, 'acetylcholinesterase')]	['At', 'present', ',', 'there', 'is', ',', 'to', 'our', 'knowledge', ',', 'no', 'information', 'to', 'clarify', 'any', 'relationship', 'between', 'metabolites', 'of', 'Tem', 'and', 'human', 'red', 'blood', 'cell', 'acetylcholine', '##ster', '##ase', '(', 'RBC', 'ACh', '##E', ')', 'inhibition', '.']	[0, 3, 10, 12, 18, 20, 22, 25, 29, 38, 40, 43, 55, 58, 66, 70, 83, 91, 103, 106, 110, 114, 120, 124, 130, 135, 148, 152, 156, 157, 161, 164, 165, 167, 177]	[2, 10, 11, 17, 20, 21, 24, 28, 38, 39, 42, 54, 57, 65, 69, 82, 90, 102, 105, 109, 113, 119, 123, 129, 134, 148, 152, 155, 157, 160, 164, 165, 166, 177, 178]	['At', 'present', ',', 'there', 'is', ',', 'to', 'our', 'knowledge', ',', 'no', 'information', 'to', 'clarify', 'any', 'relationship', 'between', 'metabolites', 'of', 'Tem', 'and', 'human', 'red', 'blood', 'cell', 'acetylcholinesterase', '(', 'RBC', 'AChE', ')', 'inhibition', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It is important to evaluate the inhibition of cholinesterases (AChE and butyrylcholinesterase (BuChE)) activities by the products generated by the oxidation of Tem in biotic and abiotic systems, as an indicator of possible toxicological hazard.	[('PMC6791832', 'I03003', 72, 93, 'butyrylcholinesterase')]	['It', 'is', 'important', 'to', 'evaluate', 'the', 'inhibition', 'of', 'choline', '##ster', '##ases', '(', 'ACh', '##E', 'and', 'but', '##yr', '##yl', '##choline', '##ster', '##ase', '(', 'Bu', '##Ch', '##E', ')', ')', 'activities', 'by', 'the', 'products', 'generated', 'by', 'the', 'oxidation', 'of', 'Tem', 'in', 'bio', '##tic', 'and', 'abiotic', 'systems', ',', 'as', 'an', 'indicator', 'of', 'possible', 'toxic', '##ological', 'hazard', '.']	[0, 3, 6, 16, 19, 28, 32, 43, 46, 53, 57, 62, 63, 66, 68, 72, 75, 77, 79, 86, 90, 94, 95, 97, 99, 100, 101, 103, 114, 117, 121, 130, 140, 143, 147, 157, 160, 164, 167, 170, 174, 178, 186, 193, 195, 198, 201, 211, 214, 223, 228, 237, 243]	[2, 5, 15, 18, 27, 31, 42, 45, 53, 57, 61, 63, 66, 67, 71, 75, 77, 79, 86, 90, 93, 95, 97, 99, 100, 101, 102, 113, 116, 120, 129, 139, 142, 146, 156, 159, 163, 166, 170, 173, 177, 185, 193, 194, 197, 200, 210, 213, 222, 228, 236, 243, 244]	['It', 'is', 'important', 'to', 'evaluate', 'the', 'inhibition', 'of', 'cholinesterases', '(', 'AChE', 'and', 'butyrylcholinesterase', '(', 'BuChE', ')', ')', 'activities', 'by', 'the', 'products', 'generated', 'by', 'the', 'oxidation', 'of', 'Tem', 'in', 'biotic', 'and', 'abiotic', 'systems', ',', 'as', 'an', 'indicator', 'of', 'possible', 'toxicological', 'hazard', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 6, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Therefore, the acute toxicity of Tem on the nervous system may be mainly attributed to Tem-oxons as a product of the biotransformation after oxidative desulfuration likely catalyzed by cytochrome P450 (cytochrome P450)14, as well as to the exposure of Tem-oxidized metabolites generated under oxidative environmental conditions8 and enhanced by water chlorination9.	[('PMC6791832', 'R10001', 202, 217, 'cytochrome P450')]	['Therefore', ',', 'the', 'acute', 'toxicity', 'of', 'Tem', 'on', 'the', 'nervous', 'system', 'may', 'be', 'mainly', 'attributed', 'to', 'Tem', '-', 'ox', '##ons', 'as', 'a', 'product', 'of', 'the', 'bio', '##trans', '##formation', 'after', 'oxidative', 'des', '##ulf', '##uration', 'likely', 'catalyzed', 'by', 'cytochrome', 'P', '##450', '(', 'cytochrome', 'P', '##450', ')', '14', ',', 'as', 'well', 'as', 'to', 'the', 'exposure', 'of', 'Tem', '-', 'oxidized', 'metabolites', 'generated', 'under', 'oxidative', 'environmental', 'conditions', '##8', 'and', 'enhanced', 'by', 'water', 'chlor', '##ination', '##9', '.']	[0, 9, 11, 15, 21, 30, 33, 37, 40, 44, 52, 59, 63, 66, 73, 84, 87, 90, 91, 93, 97, 100, 102, 110, 113, 117, 120, 125, 135, 141, 151, 154, 157, 165, 172, 182, 185, 196, 197, 201, 202, 213, 214, 217, 218, 220, 222, 225, 230, 233, 236, 240, 249, 252, 255, 256, 265, 277, 287, 293, 303, 317, 327, 329, 333, 342, 345, 351, 356, 363, 364]	[9, 10, 14, 20, 29, 32, 36, 39, 43, 51, 58, 62, 65, 72, 83, 86, 90, 91, 93, 96, 99, 101, 109, 112, 116, 120, 125, 134, 140, 150, 154, 157, 164, 171, 181, 184, 195, 197, 200, 202, 212, 214, 217, 218, 220, 221, 224, 229, 232, 235, 239, 248, 251, 255, 256, 264, 276, 286, 292, 302, 316, 327, 328, 332, 341, 344, 350, 356, 363, 364, 365]	['Therefore', ',', 'the', 'acute', 'toxicity', 'of', 'Tem', 'on', 'the', 'nervous', 'system', 'may', 'be', 'mainly', 'attributed', 'to', 'Tem', '-', 'oxons', 'as', 'a', 'product', 'of', 'the', 'biotransformation', 'after', 'oxidative', 'desulfuration', 'likely', 'catalyzed', 'by', 'cytochrome', 'P450', '(', 'cytochrome', 'P450)14', ',', 'as', 'well', 'as', 'to', 'the', 'exposure', 'of', 'Tem', '-', 'oxidized', 'metabolites', 'generated', 'under', 'oxidative', 'environmental', 'conditions8', 'and', 'enhanced', 'by', 'water', 'chlorination9', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The in vitro results on the inhibition of human RBC AChE by Tem-oxidized metabolites could help clarify the mechanism of action of Tem in mammals, since all of the latter possess the ability to inhibit AChE. Further research is needed on the involvement of cytochrome P450 in Tem-oxon formation and to evaluate other toxicological properties of Tem-oxidized metabolites.	[('PMC6791832', 'R10002', 257, 272, 'cytochrome P450')]	['The', 'in', 'vitro', 'results', 'on', 'the', 'inhibition', 'of', 'human', 'RBC', 'ACh', '##E', 'by', 'Tem', '-', 'oxidized', 'metabolites', 'could', 'help', 'clarify', 'the', 'mechanism', 'of', 'action', 'of', 'Tem', 'in', 'mammals', ',', 'since', 'all', 'of', 'the', 'latter', 'possess', 'the', 'ability', 'to', 'inhibit', 'ACh', '##E', '.', 'Further', 'research', 'is', 'needed', 'on', 'the', 'involvement', 'of', 'cytochrome', 'P', '##450', 'in', 'Tem', '-', 'ox', '##on', 'formation', 'and', 'to', 'evaluate', 'other', 'toxic', '##ological', 'properties', 'of', 'Tem', '-', 'oxidized', 'metabolites', '.']	[0, 4, 7, 13, 21, 24, 28, 39, 42, 48, 52, 55, 57, 60, 63, 64, 73, 85, 91, 96, 104, 108, 118, 121, 128, 131, 135, 138, 145, 147, 153, 157, 160, 164, 171, 179, 183, 191, 194, 202, 205, 206, 208, 216, 225, 228, 235, 238, 242, 254, 257, 268, 269, 273, 276, 279, 280, 282, 285, 295, 299, 302, 311, 317, 322, 331, 342, 345, 348, 349, 358, 369]	[3, 6, 12, 20, 23, 27, 38, 41, 47, 51, 55, 56, 59, 63, 64, 72, 84, 90, 95, 103, 107, 117, 120, 127, 130, 134, 137, 145, 146, 152, 156, 159, 163, 170, 178, 182, 190, 193, 201, 205, 206, 207, 215, 224, 227, 234, 237, 241, 253, 256, 267, 269, 272, 275, 279, 280, 282, 284, 294, 298, 301, 310, 316, 322, 330, 341, 344, 348, 349, 357, 369, 370]	['The', 'in', 'vitro', 'results', 'on', 'the', 'inhibition', 'of', 'human', 'RBC', 'AChE', 'by', 'Tem', '-', 'oxidized', 'metabolites', 'could', 'help', 'clarify', 'the', 'mechanism', 'of', 'action', 'of', 'Tem', 'in', 'mammals', ',', 'since', 'all', 'of', 'the', 'latter', 'possess', 'the', 'ability', 'to', 'inhibit', 'AChE', '.', 'Further', 'research', 'is', 'needed', 'on', 'the', 'involvement', 'of', 'cytochrome', 'P450', 'in', 'Tem', '-', 'oxon', 'formation', 'and', 'to', 'evaluate', 'other', 'toxicological', 'properties', 'of', 'Tem', '-', 'oxidized', 'metabolites', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lactate, urea and ammonia are released from strained tissues and, at the same time, creatine kinase and myoglobin leak into bloodstream from exasperated skeletal muscles.	[('PMC6803684', 'D01002', 84, 99, 'creatine kinase')]	['Lact', '##ate', ',', 'urea', 'and', 'ammonia', 'are', 'released', 'from', 'strain', '##ed', 'tissues', 'and', ',', 'at', 'the', 'same', 'time', ',', 'cre', '##atine', 'kinase', 'and', 'my', '##oglobin', 'leak', 'into', 'blood', '##stream', 'from', 'ex', '##asp', '##erated', 'skeletal', 'muscles', '.']	[0, 4, 7, 9, 14, 18, 26, 30, 39, 44, 50, 53, 61, 64, 66, 69, 73, 78, 82, 84, 87, 93, 100, 104, 106, 114, 119, 124, 129, 136, 141, 143, 146, 153, 162, 169]	[4, 7, 8, 13, 17, 25, 29, 38, 43, 50, 52, 60, 64, 65, 68, 72, 77, 82, 83, 87, 92, 99, 103, 106, 113, 118, 123, 129, 135, 140, 143, 146, 152, 161, 169, 170]	['Lactate', ',', 'urea', 'and', 'ammonia', 'are', 'released', 'from', 'strained', 'tissues', 'and', ',', 'at', 'the', 'same', 'time', ',', 'creatine', 'kinase', 'and', 'myoglobin', 'leak', 'into', 'bloodstream', 'from', 'exasperated', 'skeletal', 'muscles', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, this increased level may be also associated – to some extent – with oxidative stress as all creatine kinase isoenzymes are extremely susceptible to oxidative damage65.	[('PMC6803684', 'D09005', 101, 116, 'creatine kinase')]	['However', ',', 'this', 'increased', 'level', 'may', 'be', 'also', 'associated', '–', 'to', 'some', 'extent', '–', 'with', 'oxidative', 'stress', 'as', 'all', 'cre', '##atine', 'kinase', 'iso', '##enzyme', '##s', 'are', 'extremely', 'susceptible', 'to', 'oxidative', 'damage', '##65', '.']	[0, 7, 9, 14, 24, 30, 34, 37, 42, 53, 55, 58, 63, 70, 72, 77, 87, 94, 97, 101, 104, 110, 117, 120, 126, 128, 132, 142, 154, 157, 167, 173, 175]	[7, 8, 13, 23, 29, 33, 36, 41, 52, 54, 57, 62, 69, 71, 76, 86, 93, 96, 100, 104, 109, 116, 120, 126, 127, 131, 141, 153, 156, 166, 173, 175, 176]	['However', ',', 'this', 'increased', 'level', 'may', 'be', 'also', 'associated', '–', 'to', 'some', 'extent', '–', 'with', 'oxidative', 'stress', 'as', 'all', 'creatine', 'kinase', 'isoenzymes', 'are', 'extremely', 'susceptible', 'to', 'oxidative', 'damage65', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A Probable Causative Factor for an Old Problem: Selenium and Glutathione Peroxidase Appear to Play Important Roles in Epilepsy Pathogenesis.	[('PMC6803684', 'F41002', 61, 83, 'Glutathione Peroxidase')]	['A', 'Prob', '##able', 'Ca', '##us', '##ative', 'Factor', 'for', 'an', 'Old', 'Problem', ':', 'Sel', '##eni', '##um', 'and', 'Glut', '##athione', 'Per', '##oxidase', 'App', '##ear', 'to', 'Pl', '##ay', 'Import', '##ant', 'Role', '##s', 'in', 'Ep', '##ilep', '##sy', 'Path', '##ogenesis', '.']	[0, 2, 6, 11, 13, 15, 21, 28, 32, 35, 39, 46, 48, 51, 54, 57, 61, 65, 73, 76, 84, 87, 91, 94, 96, 99, 105, 109, 113, 115, 118, 120, 124, 127, 131, 139]	[1, 6, 10, 13, 15, 20, 27, 31, 34, 38, 46, 47, 51, 54, 56, 60, 65, 72, 76, 83, 87, 90, 93, 96, 98, 105, 108, 113, 114, 117, 120, 124, 126, 131, 139, 140]	['A', 'Probable', 'Causative', 'Factor', 'for', 'an', 'Old', 'Problem', ':', 'Selenium', 'and', 'Glutathione', 'Peroxidase', 'Appear', 'to', 'Play', 'Important', 'Roles', 'in', 'Epilepsy', 'Pathogenesis', '.']	[1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 2, 2, 2, 1, 2, 2, 2, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Changes in serum creatinine, uric acid, creatine kinase, and glomerular filtration rate in street runners.	[('PMC6803684', 'F62002', 40, 55, 'creatine kinase')]	['Changes', 'in', 'serum', 'creatinine', ',', 'ur', '##ic', 'acid', ',', 'cre', '##atine', 'kinase', ',', 'and', 'glomerular', 'filtration', 'rate', 'in', 'street', 'run', '##ners', '.']	[0, 8, 11, 17, 27, 29, 31, 34, 38, 40, 43, 49, 55, 57, 61, 72, 83, 88, 91, 98, 101, 105]	[7, 10, 16, 27, 28, 31, 33, 38, 39, 43, 48, 55, 56, 60, 71, 82, 87, 90, 97, 101, 105, 106]	['Changes', 'in', 'serum', 'creatinine', ',', 'uric', 'acid', ',', 'creatine', 'kinase', ',', 'and', 'glomerular', 'filtration', 'rate', 'in', 'street', 'runners', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Venkataraman P, Krishnamoorthy G, Selvakumar K, Arunakaran J. Oxidative Stress Alters Creatine Kinase System in Serum and Brain Regions of Polychlorinated Biphenyl (Aroclor 1254)-Exposed Rats: Protective Role of Melatonin.	[('PMC6803684', 'F64001', 86, 101, 'Creatine Kinase')]	['Ven', '##ka', '##ta', '##ram', '##an', 'P', ',', 'Kr', '##ish', '##nam', '##oor', '##thy', 'G', ',', 'Sel', '##va', '##ku', '##mar', 'K', ',', 'Ar', '##una', '##kar', '##an', 'J', '.', 'Oxid', '##ative', 'Stress', 'Alter', '##s', 'Cre', '##atine', 'Kin', '##ase', 'System', 'in', 'Serum', 'and', 'Brain', 'Region', '##s', 'of', 'Poly', '##chlor', '##inated', 'Bi', '##phenyl', '(', 'Ar', '##ocl', '##or', '125', '##4', ')', '-', 'Exp', '##osed', 'Rats', ':', 'Prote', '##ct', '##ive', 'Role', 'of', 'Mel', '##atonin', '.']	[0, 3, 5, 7, 10, 13, 14, 16, 18, 21, 24, 27, 31, 32, 34, 37, 39, 41, 45, 46, 48, 50, 53, 56, 59, 60, 62, 66, 72, 79, 84, 86, 89, 95, 98, 102, 109, 112, 118, 122, 128, 134, 136, 139, 143, 148, 155, 157, 164, 165, 167, 170, 173, 176, 177, 178, 179, 182, 187, 191, 193, 198, 200, 204, 209, 212, 215, 221]	[3, 5, 7, 10, 12, 14, 15, 18, 21, 24, 27, 30, 32, 33, 37, 39, 41, 44, 46, 47, 50, 53, 56, 58, 60, 61, 66, 71, 78, 84, 85, 89, 94, 98, 101, 108, 111, 117, 121, 127, 134, 135, 138, 143, 148, 154, 157, 163, 165, 167, 170, 172, 176, 177, 178, 179, 182, 186, 191, 192, 198, 200, 203, 208, 211, 215, 221, 222]	['Venkataraman', 'P', ',', 'Krishnamoorthy', 'G', ',', 'Selvakumar', 'K', ',', 'Arunakaran', 'J', '.', 'Oxidative', 'Stress', 'Alters', 'Creatine', 'Kinase', 'System', 'in', 'Serum', 'and', 'Brain', 'Regions', 'of', 'Polychlorinated', 'Biphenyl', '(', 'Aroclor', '1254)-Exposed', 'Rats', ':', 'Protective', 'Role', 'of', 'Melatonin', '.']	[5, 1, 1, 5, 1, 1, 4, 1, 1, 4, 1, 1, 2, 1, 2, 2, 2, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 3, 6, 1, 1, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Tretter L, Adam-Vizi V. Inhibition of Krebs Cycle Enzymes by Hydrogen Peroxide: A Key Role of α-Ketoglutarate Dehydrogenase in Limiting NADH Production under Oxidative Stress.	[('PMC6803684', 'F67001', 94, 123, 'α-Ketoglutarate Dehydrogenase')]	['Tre', '##tte', '##r', 'L', ',', 'Adam', '-', 'Vi', '##zi', 'V', '.', 'Inhibition', 'of', 'Krebs', 'Cycle', 'Enzyme', '##s', 'by', 'Hydrogen', 'Per', '##oxide', ':', 'A', 'Key', 'Role', 'of', 'α', '-', 'Ke', '##to', '##glut', '##ara', '##te', 'De', '##hydrogen', '##ase', 'in', 'Lim', '##iting', 'NADH', 'Production', 'under', 'Oxid', '##ative', 'Stress', '.']	[0, 3, 6, 8, 9, 11, 15, 16, 18, 21, 22, 24, 35, 38, 44, 50, 56, 58, 61, 70, 73, 78, 80, 82, 86, 91, 94, 95, 96, 98, 100, 104, 107, 110, 112, 120, 124, 127, 130, 136, 141, 152, 158, 162, 168, 174]	[3, 6, 7, 9, 10, 15, 16, 18, 20, 22, 23, 34, 37, 43, 49, 56, 57, 60, 69, 73, 78, 79, 81, 85, 90, 93, 95, 96, 98, 100, 104, 107, 109, 112, 120, 123, 126, 130, 135, 140, 151, 157, 162, 167, 174, 175]	['Tretter', 'L', ',', 'Adam-Vizi', 'V', '.', 'Inhibition', 'of', 'Krebs', 'Cycle', 'Enzymes', 'by', 'Hydrogen', 'Peroxide', ':', 'A', 'Key', 'Role', 'of', 'α-Ketoglutarate', 'Dehydrogenase', 'in', 'Limiting', 'NADH', 'Production', 'under', 'Oxidative', 'Stress', '.']	[3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 7, 3, 1, 2, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In all EG patients the concentrations of valproic acid in serum were in the therapeutic range, the patients had normal liver and renal functions and the serum transaminases levels were normal.	[('PMC6803684', 'M04000', 153, 172, 'serum transaminases')]	['In', 'all', 'EG', 'patients', 'the', 'concentrations', 'of', 'val', '##pro', '##ic', 'acid', 'in', 'serum', 'were', 'in', 'the', 'therapeutic', 'range', ',', 'the', 'patients', 'had', 'normal', 'liver', 'and', 'renal', 'functions', 'and', 'the', 'serum', 'trans', '##aminase', '##s', 'levels', 'were', 'normal', '.']	[0, 3, 7, 10, 19, 23, 38, 41, 44, 47, 50, 55, 58, 64, 69, 72, 76, 88, 93, 95, 99, 108, 112, 119, 125, 129, 135, 145, 149, 153, 159, 164, 171, 173, 180, 185, 191]	[2, 6, 9, 18, 22, 37, 40, 44, 47, 49, 54, 57, 63, 68, 71, 75, 87, 93, 94, 98, 107, 111, 118, 124, 128, 134, 144, 148, 152, 158, 164, 171, 172, 179, 184, 191, 192]	['In', 'all', 'EG', 'patients', 'the', 'concentrations', 'of', 'valproic', 'acid', 'in', 'serum', 'were', 'in', 'the', 'therapeutic', 'range', ',', 'the', 'patients', 'had', 'normal', 'liver', 'and', 'renal', 'functions', 'and', 'the', 'serum', 'transaminases', 'levels', 'were', 'normal', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Rapid suppression of 7-dehydrocholesterol reductase activity in keratinocytes by vitamin, D.J. Steroid Biochem.	[('PMC6821880', 'F47001', 21, 51, '7-dehydrocholesterol reductase')]	['Rapid', 'suppression', 'of', '7', '-', 'dehydr', '##och', '##olesterol', 'reductase', 'activity', 'in', 'keratinocytes', 'by', 'vitamin', ',', 'D', '.', 'J', '.', 'Ster', '##oid', 'Biochem', '.']	[0, 6, 18, 21, 22, 23, 29, 32, 42, 52, 61, 64, 78, 81, 88, 90, 91, 92, 93, 95, 99, 103, 110]	[5, 17, 20, 22, 23, 29, 32, 41, 51, 60, 63, 77, 80, 88, 89, 91, 92, 93, 94, 99, 102, 110, 111]	['Rapid', 'suppression', 'of', '7-dehydrocholesterol', 'reductase', 'activity', 'in', 'keratinocytes', 'by', 'vitamin', ',', 'D.J', '.', 'Steroid', 'Biochem', '.']	[1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Amplicon fragments for the library were generated with the high-fidelity Phusion polymerase in a PCR reaction using 16S V6-V8 fusion primers (Comeau et al., 2011).	[('PMC6821880', 'M04001', 81, 91, 'polymerase')]	['Ampl', '##icon', 'fragments', 'for', 'the', 'library', 'were', 'generated', 'with', 'the', 'high', '-', 'fidelity', 'Ph', '##usion', 'polymerase', 'in', 'a', 'PCR', 'reaction', 'using', '16', '##S', 'V', '##6', '-', 'V', '##8', 'fusion', 'primers', '(', 'Com', '##ea', '##u', 'et', 'al', '.', ',', '2011', ')', '.']	[0, 4, 9, 19, 23, 27, 35, 40, 50, 55, 59, 63, 64, 73, 75, 81, 92, 95, 97, 101, 110, 116, 118, 120, 121, 122, 123, 124, 126, 133, 141, 142, 145, 147, 149, 152, 154, 155, 157, 161, 162]	[4, 8, 18, 22, 26, 34, 39, 49, 54, 58, 63, 64, 72, 75, 80, 91, 94, 96, 100, 109, 115, 118, 119, 121, 122, 123, 124, 125, 132, 140, 142, 145, 147, 148, 151, 154, 155, 156, 161, 162, 163]	['Amplicon', 'fragments', 'for', 'the', 'library', 'were', 'generated', 'with', 'the', 'high', '-', 'fidelity', 'Phusion', 'polymerase', 'in', 'a', 'PCR', 'reaction', 'using', '16S', 'V6-V8', 'fusion', 'primers', '(', 'Comeau', 'et', 'al', '.', ',', '2011', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 5, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The V3 and V4 variables of the 16S rRNA region were amplified and the sequence library was generated by Polymerase chain reaction (PCR) using the following primer pair:	[('PMC6827100', 'M02000', 104, 114, 'Polymerase')]	['The', 'V', '##3', 'and', 'V', '##4', 'variables', 'of', 'the', '16', '##S', 'rRNA', 'region', 'were', 'amplified', 'and', 'the', 'sequence', 'library', 'was', 'generated', 'by', 'Polymer', '##ase', 'chain', 'reaction', '(', 'PCR', ')', 'using', 'the', 'following', 'primer', 'pair', ':']	[0, 4, 5, 7, 11, 12, 14, 24, 27, 31, 33, 35, 40, 47, 52, 62, 66, 70, 79, 87, 91, 101, 104, 111, 115, 121, 130, 131, 134, 136, 142, 146, 156, 163, 167]	[3, 5, 6, 10, 12, 13, 23, 26, 30, 33, 34, 39, 46, 51, 61, 65, 69, 78, 86, 90, 100, 103, 111, 114, 120, 129, 131, 134, 135, 141, 145, 155, 162, 167, 168]	['The', 'V3', 'and', 'V4', 'variables', 'of', 'the', '16S', 'rRNA', 'region', 'were', 'amplified', 'and', 'the', 'sequence', 'library', 'was', 'generated', 'by', 'Polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'using', 'the', 'following', 'primer', 'pair', ':']	[1, 2, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The amplification, sequencing, and library preparation workflow were conducted using Herculase II fusion DNA polymerase Nextera XT Index Kit V2, following the 16S metagenomic sequencing library preparation Part # 15044223 Rev. B protocol in Illumina® MiSeq® platform at Macrogen (Seoul, South Korea) yielding paired-end reads.	[('PMC6827100', 'M05000', 105, 119, 'DNA polymerase')]	['The', 'amplification', ',', 'sequencing', ',', 'and', 'library', 'preparation', 'workflow', 'were', 'conducted', 'using', 'Her', '##cul', '##ase', 'II', 'fusion', 'DNA', 'polymerase', 'Next', '##era', 'X', '##T', 'Index', 'Kit', 'V', '##2', ',', 'following', 'the', '16', '##S', 'meta', '##gen', '##omic', 'sequencing', 'library', 'preparation', 'Part', '#', '150', '##44', '##22', '##3', 'Rev', '.', 'B', 'protocol', 'in', 'Illumina', '®', 'Mi', '##Seq', '®', 'platform', 'at', 'Mac', '##rogen', '(', 'Seoul', ',', 'South', 'Korea', ')', 'yielding', 'paired', '-', 'end', 'reads', '.']	[0, 4, 17, 19, 29, 31, 35, 43, 55, 64, 69, 79, 85, 88, 91, 95, 98, 105, 109, 120, 124, 128, 129, 131, 137, 141, 142, 143, 145, 155, 159, 161, 163, 167, 170, 175, 186, 194, 206, 211, 213, 216, 218, 220, 222, 225, 227, 229, 238, 241, 249, 251, 253, 256, 258, 267, 270, 273, 279, 280, 285, 287, 293, 298, 300, 309, 315, 316, 320, 325]	[3, 17, 18, 29, 30, 34, 42, 54, 63, 68, 78, 84, 88, 91, 94, 97, 104, 108, 119, 124, 127, 129, 130, 136, 140, 142, 143, 144, 154, 158, 161, 162, 167, 170, 174, 185, 193, 205, 210, 212, 216, 218, 220, 221, 225, 226, 228, 237, 240, 249, 250, 253, 256, 257, 266, 269, 273, 278, 280, 285, 286, 292, 298, 299, 308, 315, 316, 319, 325, 326]	['The', 'amplification', ',', 'sequencing', ',', 'and', 'library', 'preparation', 'workflow', 'were', 'conducted', 'using', 'Herculase', 'II', 'fusion', 'DNA', 'polymerase', 'Nextera', 'XT', 'Index', 'Kit', 'V2', ',', 'following', 'the', '16S', 'metagenomic', 'sequencing', 'library', 'preparation', 'Part', '#', '15044223', 'Rev', '.', 'B', 'protocol', 'in', 'Illumina', '®', 'MiSeq', '®', 'platform', 'at', 'Macrogen', '(', 'Seoul', ',', 'South', 'Korea', ')', 'yielding', 'paired', '-', 'end', 'reads', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 2, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The metabolism of proline as a stress substrate modulates the carcinogenic pathway, and is responsible for destroying intracellular reactive oxygen species, mediated via p53-induced proline oxidase (57-59).	[('PMC6831194', 'D04002', 170, 197, 'p53-induced proline oxidase')]	['The', 'metabolism', 'of', 'proline', 'as', 'a', 'stress', 'substrate', 'modulates', 'the', 'carcin', '##ogenic', 'pathway', ',', 'and', 'is', 'responsible', 'for', 'destroy', '##ing', 'intracellular', 'reactive', 'oxygen', 'species', ',', 'mediated', 'via', 'p', '##53', '-', 'induced', 'proline', 'oxidase', '(', '57', '-', '59', ')', '.']	[0, 4, 15, 18, 26, 29, 31, 38, 48, 58, 62, 68, 75, 82, 84, 88, 91, 103, 107, 114, 118, 132, 141, 148, 155, 157, 166, 170, 171, 173, 174, 182, 190, 198, 199, 201, 202, 204, 205]	[3, 14, 17, 25, 28, 30, 37, 47, 57, 61, 68, 74, 82, 83, 87, 90, 102, 106, 114, 117, 131, 140, 147, 155, 156, 165, 169, 171, 173, 174, 181, 189, 197, 199, 201, 202, 204, 205, 206]	['The', 'metabolism', 'of', 'proline', 'as', 'a', 'stress', 'substrate', 'modulates', 'the', 'carcinogenic', 'pathway', ',', 'and', 'is', 'responsible', 'for', 'destroying', 'intracellular', 'reactive', 'oxygen', 'species', ',', 'mediated', 'via', 'p53-induced', 'proline', 'oxidase', '(', '57-59', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Diagnosis of adenylosuccinate lyase deficiency by metabolomic profiling in plasma reveals a phenotypic spectrum.	[('PMC6835521', 'F01002', 13, 35, 'adenylosuccinate lyase')]	['Diagnosis', 'of', 'aden', '##yl', '##os', '##ucci', '##nat', '##e', 'ly', '##ase', 'deficiency', 'by', 'metabol', '##omic', 'profiling', 'in', 'plasma', 'reveals', 'a', 'phenotypic', 'spectrum', '.']	[0, 10, 13, 17, 19, 21, 25, 28, 30, 32, 36, 47, 50, 57, 62, 72, 75, 82, 90, 92, 103, 111]	[9, 12, 17, 19, 21, 25, 28, 29, 32, 35, 46, 49, 57, 61, 71, 74, 81, 89, 91, 102, 111, 112]	['Diagnosis', 'of', 'adenylosuccinate', 'lyase', 'deficiency', 'by', 'metabolomic', 'profiling', 'in', 'plasma', 'reveals', 'a', 'phenotypic', 'spectrum', '.']	[1, 1, 6, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Epithelial cell damage was assessed based on lactate dehydrogenase release and inflammatory gene expression by using quantitative PCR.	[('PMC6842413', 'M03001', 45, 66, 'lactate dehydrogenase')]	['Epit', '##helial', 'cell', 'damage', 'was', 'assessed', 'based', 'on', 'lactate', 'dehydrogenase', 'release', 'and', 'inflammatory', 'gene', 'expression', 'by', 'using', 'quantitative', 'PCR', '.']	[0, 4, 11, 16, 23, 27, 36, 42, 45, 53, 67, 75, 79, 92, 97, 108, 111, 117, 130, 133]	[4, 10, 15, 22, 26, 35, 41, 44, 52, 66, 74, 78, 91, 96, 107, 110, 116, 129, 133, 134]	['Epithelial', 'cell', 'damage', 'was', 'assessed', 'based', 'on', 'lactate', 'dehydrogenase', 'release', 'and', 'inflammatory', 'gene', 'expression', 'by', 'using', 'quantitative', 'PCR', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
infection)20 were used to stimulate airway epithelial cell-line cultures in vitro before assessment of epithelial damage (lactate dehydrogenase levels in supernatants) and inflammatory gene expression.	[('PMC6842413', 'R09003', 122, 143, 'lactate dehydrogenase')]	['infection', ')', '20', 'were', 'used', 'to', 'stimulate', 'airway', 'epithelial', 'cell', '-', 'line', 'cultures', 'in', 'vitro', 'before', 'assessment', 'of', 'epithelial', 'damage', '(', 'lactate', 'dehydrogenase', 'levels', 'in', 'supernatants', ')', 'and', 'inflammatory', 'gene', 'expression', '.']	[0, 9, 10, 13, 18, 23, 26, 36, 43, 54, 58, 59, 64, 73, 76, 82, 89, 100, 103, 114, 121, 122, 130, 144, 151, 154, 166, 168, 172, 185, 190, 200]	[9, 10, 12, 17, 22, 25, 35, 42, 53, 58, 59, 63, 72, 75, 81, 88, 99, 102, 113, 120, 122, 129, 143, 150, 153, 166, 167, 171, 184, 189, 200, 201]	['infection)20', 'were', 'used', 'to', 'stimulate', 'airway', 'epithelial', 'cell', '-', 'line', 'cultures', 'in', 'vitro', 'before', 'assessment', 'of', 'epithelial', 'damage', '(', 'lactate', 'dehydrogenase', 'levels', 'in', 'supernatants', ')', 'and', 'inflammatory', 'gene', 'expression', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Walters WA, Caporaso JG, Lauber CL, Berg-Lyons D, Fierer N, Knight R. PrimerProspector: de novo design and taxonomic analysis of barcoded polymerase chain reaction primers.	[('PMC6860998', 'F17001', 138, 148, 'polymerase')]	['Walter', '##s', 'WA', ',', 'Cap', '##ora', '##so', 'JG', ',', 'Lau', '##ber', 'CL', ',', 'Berg', '-', 'Ly', '##ons', 'D', ',', 'Fi', '##erer', 'N', ',', 'Kn', '##ight', 'R', '.', 'Primer', '##Pro', '##spec', '##tor', ':', 'de', 'novo', 'design', 'and', 'taxonomic', 'analysis', 'of', 'bar', '##coded', 'polymerase', 'chain', 'reaction', 'primers', '.']	[0, 6, 8, 10, 12, 15, 18, 21, 23, 25, 28, 32, 34, 36, 40, 41, 43, 47, 48, 50, 52, 57, 58, 60, 62, 67, 68, 70, 76, 79, 83, 86, 88, 91, 96, 103, 107, 117, 126, 129, 132, 138, 149, 155, 164, 171]	[6, 7, 10, 11, 15, 18, 20, 23, 24, 28, 31, 34, 35, 40, 41, 43, 46, 48, 49, 52, 56, 58, 59, 62, 66, 68, 69, 76, 79, 83, 86, 87, 90, 95, 102, 106, 116, 125, 128, 132, 137, 148, 154, 163, 171, 172]	['Walters', 'WA', ',', 'Caporaso', 'JG', ',', 'Lauber', 'CL', ',', 'Berg-Lyons', 'D', ',', 'Fierer', 'N', ',', 'Knight', 'R', '.', 'PrimerProspector', ':', 'de', 'novo', 'design', 'and', 'taxonomic', 'analysis', 'of', 'barcoded', 'polymerase', 'chain', 'reaction', 'primers', '.']	[2, 1, 1, 3, 1, 1, 2, 1, 1, 4, 1, 1, 2, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O']
Methods for DNA extraction, polymerase chain reaction (PCR) amplification, and sequencing were previously described in detail.[12, 14, 15, 17] Briefly, DNA extraction, PCR amplification of the V4 region of the 16S rRNA gene, and amplicon preparation were performed as described by Caporaso et al.[17], using the universal bacterial primer set 515F/806R,[17, 18] and can be found on the Earth Microbiome Project website (http://www.earthmicrobiome.org/emp-standard-protocols/dna-extraction-protocol/).	[('PMC6860998', 'M04000', 28, 38, 'polymerase')]	['Methods', 'for', 'DNA', 'extraction', ',', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', ',', 'and', 'sequencing', 'were', 'previously', 'described', 'in', 'detail', '.', '[', '12', ',', '14', ',', '15', ',', '17', ']', 'Briefly', ',', 'DNA', 'extraction', ',', 'PCR', 'amplification', 'of', 'the', 'V', '##4', 'region', 'of', 'the', '16', '##S', 'rRNA', 'gene', ',', 'and', 'amplic', '##on', 'preparation', 'were', 'performed', 'as', 'described', 'by', 'Cap', '##ora', '##so', 'et', 'al', '.', '[', '17', ']', ',', 'using', 'the', 'universal', 'bacterial', 'primer', 'set', '51', '##5', '##F', '/', '80', '##6', '##R', ',', '[', '17', ',', '18', ']', 'and', 'can', 'be', 'found', 'on', 'the', 'Earth', 'Microb', '##io', '##me', 'Project', 'website', '(', 'http', ':', '/', '/', 'www', '.', 'earth', '##micro', '##bio', '##me', '.', 'org', '/', 'em', '##p', '-', 'standard', '-', 'protocols', '/', 'dn', '##a', '-', 'extraction', '-', 'protocol', '/', ')', '.']	[0, 8, 12, 16, 26, 28, 39, 45, 54, 55, 58, 60, 73, 75, 79, 90, 95, 106, 116, 119, 125, 126, 127, 129, 131, 133, 135, 137, 139, 141, 143, 150, 152, 156, 166, 168, 172, 186, 189, 193, 194, 196, 203, 206, 210, 212, 214, 219, 223, 225, 229, 235, 238, 250, 255, 265, 268, 278, 281, 284, 287, 290, 293, 295, 296, 297, 299, 300, 302, 308, 312, 322, 332, 339, 343, 345, 346, 347, 348, 350, 351, 352, 353, 354, 356, 358, 360, 362, 366, 370, 373, 379, 382, 386, 392, 398, 400, 403, 411, 419, 420, 424, 425, 426, 427, 430, 431, 436, 441, 444, 446, 447, 450, 451, 453, 454, 455, 463, 464, 473, 474, 476, 477, 478, 488, 489, 497, 498, 499]	[7, 11, 15, 26, 27, 38, 44, 53, 55, 58, 59, 73, 74, 78, 89, 94, 105, 115, 118, 125, 126, 127, 129, 130, 133, 134, 137, 138, 141, 142, 150, 151, 155, 166, 167, 171, 185, 188, 192, 194, 195, 202, 205, 209, 212, 213, 218, 223, 224, 228, 235, 237, 249, 254, 264, 267, 277, 280, 284, 287, 289, 292, 295, 296, 297, 299, 300, 301, 307, 311, 321, 331, 338, 342, 345, 346, 347, 348, 350, 351, 352, 353, 354, 356, 357, 360, 361, 365, 369, 372, 378, 381, 385, 391, 398, 400, 402, 410, 418, 420, 424, 425, 426, 427, 430, 431, 436, 441, 444, 446, 447, 450, 451, 453, 454, 455, 463, 464, 473, 474, 476, 477, 478, 488, 489, 497, 498, 499, 500]	['Methods', 'for', 'DNA', 'extraction', ',', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', ',', 'and', 'sequencing', 'were', 'previously', 'described', 'in', 'detail.[12', ',', '14', ',', '15', ',', '17', ']', 'Briefly', ',', 'DNA', 'extraction', ',', 'PCR', 'amplification', 'of', 'the', 'V4', 'region', 'of', 'the', '16S', 'rRNA', 'gene', ',', 'and', 'amplicon', 'preparation', 'were', 'performed', 'as', 'described', 'by', 'Caporaso', 'et', 'al.[17]', ',', 'using', 'the', 'universal', 'bacterial', 'primer', 'set', '515F', '/', '806R', ',', '[', '17', ',', '18', ']', 'and', 'can', 'be', 'found', 'on', 'the', 'Earth', 'Microbiome', 'Project', 'website', '(', 'http', ':', '/', '/', 'www.earthmicrobiome.org', '/', 'emp', '-', 'standard', '-', 'protocols', '/', 'dna-extraction-protocol/', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 8, 1, 2, 1, 1, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All polymerase chain reaction (PCR) reactions were carried out with Phusion® High-Fidelity PCR Master Mix (New England Biolabs, Ipswich, MA, USA), and mixture PCR products were purified with Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany).	[('PMC6861740', 'M04001', 4, 14, 'polymerase')]	['All', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'reactions', 'were', 'carried', 'out', 'with', 'Ph', '##usion', '®', 'High', '-', 'Fi', '##del', '##ity', 'PCR', 'Master', 'Mix', '(', 'New', 'England', 'Biol', '##abs', ',', 'Ip', '##sw', '##ich', ',', 'MA', ',', 'USA', ')', ',', 'and', 'mixture', 'PCR', 'products', 'were', 'purified', 'with', 'Qi', '##agen', 'Gel', 'Extraction', 'Kit', '(', 'Qi', '##agen', ',', 'Hil', '##den', ',', 'Germany', ')', '.']	[0, 4, 15, 21, 30, 31, 34, 36, 46, 51, 59, 63, 68, 70, 75, 77, 81, 82, 84, 87, 91, 95, 102, 106, 107, 111, 119, 123, 126, 128, 130, 132, 135, 137, 139, 141, 144, 145, 147, 151, 159, 163, 172, 177, 186, 191, 193, 198, 202, 213, 217, 218, 220, 224, 226, 229, 232, 234, 241, 242]	[3, 14, 20, 29, 31, 34, 35, 45, 50, 58, 62, 67, 70, 75, 76, 81, 82, 84, 87, 90, 94, 101, 105, 107, 110, 118, 123, 126, 127, 130, 132, 135, 136, 139, 140, 144, 145, 146, 150, 158, 162, 171, 176, 185, 190, 193, 197, 201, 212, 216, 218, 220, 224, 225, 229, 232, 233, 241, 242, 243]	['All', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'reactions', 'were', 'carried', 'out', 'with', 'Phusion', '®', 'High-Fidelity', 'PCR', 'Master', 'Mix', '(', 'New', 'England', 'Biolabs', ',', 'Ipswich', ',', 'MA', ',', 'USA', ')', ',', 'and', 'mixture', 'PCR', 'products', 'were', 'purified', 'with', 'Qiagen', 'Gel', 'Extraction', 'Kit', '(', 'Qiagen', ',', 'Hilden', ',', 'Germany', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1]	['O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Formate causes mitochondrial damage by inhibiting cytochrome c oxidase resulting in disruption of the electron transport chain and production of reactive oxygen species.34 Formate-induced cytotoxicity has been demonstrated in rat hippocampal cultures and in retinal (human and rat) cell cultures.35,36 Of interest, methanol poisoning is mediated by formate, producing optic nerve demyelination and subsequent progressive retinal axonal loss in humans.37,38 As mitochondrial dysfunction has been implicated in MS pathogenesis, it is of interest to note the higher formate levels in patients with MS.39 How formate is involved in this process, if at all, as a primary mediator or as part of an injurious cascade will require further mechanistic studies.	[('PMC6865851', 'D01004', 50, 70, 'cytochrome c oxidase')]	['Form', '##ate', 'causes', 'mitochondrial', 'damage', 'by', 'inhibiting', 'cytochrome', 'c', 'oxidase', 'resulting', 'in', 'disruption', 'of', 'the', 'electron', 'transport', 'chain', 'and', 'production', 'of', 'reactive', 'oxygen', 'species', '.', '34', 'Form', '##ate', '-', 'induced', 'cytotoxicity', 'has', 'been', 'demonstrated', 'in', 'rat', 'hippocampal', 'cultures', 'and', 'in', 'retinal', '(', 'human', 'and', 'rat', ')', 'cell', 'cultures', '.', '35', ',', '36', 'Of', 'interest', ',', 'methanol', 'poisoning', 'is', 'mediated', 'by', 'format', '##e', ',', 'producing', 'optic', 'nerve', 'dem', '##yel', '##ination', 'and', 'subsequent', 'progressive', 'retinal', 'axonal', 'loss', 'in', 'humans', '.', '37', ',', '38', 'As', 'mitochondrial', 'dysfunction', 'has', 'been', 'implicated', 'in', 'MS', 'pathogenesis', ',', 'it', 'is', 'of', 'interest', 'to', 'note', 'the', 'higher', 'format', '##e', 'levels', 'in', 'patients', 'with', 'MS', '.', '39', 'How', 'format', '##e', 'is', 'involved', 'in', 'this', 'process', ',', 'if', 'at', 'all', ',', 'as', 'a', 'primary', 'mediator', 'or', 'as', 'part', 'of', 'an', 'inj', '##uri', '##ous', 'cascade', 'will', 'require', 'further', 'mechanistic', 'studies', '.']	[0, 4, 8, 15, 29, 36, 39, 50, 61, 63, 71, 81, 84, 95, 98, 102, 111, 121, 127, 131, 142, 145, 154, 161, 168, 169, 172, 176, 179, 180, 188, 201, 205, 210, 223, 226, 230, 242, 251, 255, 258, 266, 267, 273, 277, 280, 282, 287, 295, 296, 298, 299, 302, 305, 313, 315, 324, 334, 337, 346, 349, 355, 356, 358, 368, 374, 380, 383, 386, 394, 398, 409, 421, 429, 436, 441, 444, 450, 451, 453, 454, 457, 460, 474, 486, 490, 495, 506, 509, 512, 524, 526, 529, 532, 535, 544, 547, 552, 556, 563, 569, 571, 578, 581, 590, 595, 597, 598, 601, 605, 611, 613, 616, 625, 628, 633, 640, 642, 645, 648, 651, 653, 656, 658, 666, 675, 678, 681, 686, 689, 692, 695, 698, 702, 710, 715, 723, 731, 743, 750]	[4, 7, 14, 28, 35, 38, 49, 60, 62, 70, 80, 83, 94, 97, 101, 110, 120, 126, 130, 141, 144, 153, 160, 168, 169, 171, 176, 179, 180, 187, 200, 204, 209, 222, 225, 229, 241, 250, 254, 257, 265, 267, 272, 276, 280, 281, 286, 295, 296, 298, 299, 301, 304, 313, 314, 323, 333, 336, 345, 348, 355, 356, 357, 367, 373, 379, 383, 386, 393, 397, 408, 420, 428, 435, 440, 443, 450, 451, 453, 454, 456, 459, 473, 485, 489, 494, 505, 508, 511, 524, 525, 528, 531, 534, 543, 546, 551, 555, 562, 569, 570, 577, 580, 589, 594, 597, 598, 600, 604, 611, 612, 615, 624, 627, 632, 640, 641, 644, 647, 651, 652, 655, 657, 665, 674, 677, 680, 685, 688, 691, 695, 698, 701, 709, 714, 722, 730, 742, 750, 751]	['Formate', 'causes', 'mitochondrial', 'damage', 'by', 'inhibiting', 'cytochrome', 'c', 'oxidase', 'resulting', 'in', 'disruption', 'of', 'the', 'electron', 'transport', 'chain', 'and', 'production', 'of', 'reactive', 'oxygen', 'species.34', 'Formate', '-', 'induced', 'cytotoxicity', 'has', 'been', 'demonstrated', 'in', 'rat', 'hippocampal', 'cultures', 'and', 'in', 'retinal', '(', 'human', 'and', 'rat', ')', 'cell', 'cultures.35', ',', '36', 'Of', 'interest', ',', 'methanol', 'poisoning', 'is', 'mediated', 'by', 'formate', ',', 'producing', 'optic', 'nerve', 'demyelination', 'and', 'subsequent', 'progressive', 'retinal', 'axonal', 'loss', 'in', 'humans.37', ',', '38', 'As', 'mitochondrial', 'dysfunction', 'has', 'been', 'implicated', 'in', 'MS', 'pathogenesis', ',', 'it', 'is', 'of', 'interest', 'to', 'note', 'the', 'higher', 'formate', 'levels', 'in', 'patients', 'with', 'MS.39', 'How', 'formate', 'is', 'involved', 'in', 'this', 'process', ',', 'if', 'at', 'all', ',', 'as', 'a', 'primary', 'mediator', 'or', 'as', 'part', 'of', 'an', 'injurious', 'cascade', 'will', 'require', 'further', 'mechanistic', 'studies', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Nicholls P.The effect of formate on cytochrome aa3 and on electron transport in the intact respiratory chain.	[('PMC6865851', 'F33001', 36, 50, 'cytochrome aa3')]	['Nich', '##oll', '##s', 'P', '.', 'The', 'effect', 'of', 'format', '##e', 'on', 'cytochrome', 'aa', '##3', 'and', 'on', 'electron', 'transport', 'in', 'the', 'intact', 'respiratory', 'chain', '.']	[0, 4, 7, 9, 10, 11, 15, 22, 25, 31, 33, 36, 47, 49, 51, 55, 58, 67, 77, 80, 84, 91, 103, 108]	[4, 7, 8, 10, 11, 14, 21, 24, 31, 32, 35, 46, 49, 50, 54, 57, 66, 76, 79, 83, 90, 102, 108, 109]	['Nicholls', 'P.The', 'effect', 'of', 'formate', 'on', 'cytochrome', 'aa3', 'and', 'on', 'electron', 'transport', 'in', 'the', 'intact', 'respiratory', 'chain', '.']	[3, 3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the glucose-alanine cycle pathway, glutamate dehydrogenase in muscle catalyzes the binding of α-ketoglutaric acid to ammonia to form glutamate, followed by glutamate catalyzed by alanine aminotransferase; pyruvic acid forms alpha-ketoglutarate and alanine [30].	[('PMC6875299', 'D01014', 38, 61, 'glutamate dehydrogenase')]	['In', 'the', 'glucose', '-', 'alanine', 'cycle', 'pathway', ',', 'glutamate', 'dehydrogenase', 'in', 'muscle', 'cataly', '##zes', 'the', 'binding', 'of', 'α', '-', 'ket', '##oglu', '##ta', '##ric', 'acid', 'to', 'ammonia', 'to', 'form', 'glutamate', ',', 'followed', 'by', 'glutamate', 'catalyzed', 'by', 'alanine', 'amino', '##transferase', ';', 'pyr', '##uv', '##ic', 'acid', 'forms', 'alpha', '-', 'ket', '##oglu', '##ta', '##rate', 'and', 'alanine', '[', '30', ']', '.']	[0, 3, 7, 14, 15, 23, 29, 36, 38, 48, 62, 65, 72, 78, 82, 86, 94, 97, 98, 99, 102, 106, 108, 112, 117, 120, 128, 131, 136, 145, 147, 156, 159, 169, 179, 182, 190, 195, 206, 208, 211, 213, 216, 221, 227, 232, 233, 236, 240, 242, 247, 251, 259, 260, 262, 263]	[2, 6, 14, 15, 22, 28, 36, 37, 47, 61, 64, 71, 78, 81, 85, 93, 96, 98, 99, 102, 106, 108, 111, 116, 119, 127, 130, 135, 145, 146, 155, 158, 168, 178, 181, 189, 195, 206, 207, 211, 213, 215, 220, 226, 232, 233, 236, 240, 242, 246, 250, 258, 260, 262, 263, 264]	['In', 'the', 'glucose', '-', 'alanine', 'cycle', 'pathway', ',', 'glutamate', 'dehydrogenase', 'in', 'muscle', 'catalyzes', 'the', 'binding', 'of', 'α-ketoglutaric', 'acid', 'to', 'ammonia', 'to', 'form', 'glutamate', ',', 'followed', 'by', 'glutamate', 'catalyzed', 'by', 'alanine', 'aminotransferase', ';', 'pyruvic', 'acid', 'forms', 'alpha', '-', 'ketoglutarate', 'and', 'alanine', '[', '30', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The concentrations of H2O2, NO2−, and NO3− after plasma jet treatment in the medium without cells were measured using the hydrogen peroxide/peroxidase assay kit (Thermo Fisher Scientific) and nitrite/nitrate colorimetric assay kit (Cayman), respectively.	[('PMC6875299', 'M05000', 140, 150, 'peroxidase')]	['The', 'concentrations', 'of', 'H', '##2', '##O', '##2', ',', 'NO', '##2−', ',', 'and', 'NO', '##3−', 'after', 'plasma', 'jet', 'treatment', 'in', 'the', 'medium', 'without', 'cells', 'were', 'measured', 'using', 'the', 'hydrogen', 'peroxide', '/', 'peroxidase', 'assay', 'kit', '(', 'Thermo', 'Fisher', 'Scientific', ')', 'and', 'nitrite', '/', 'nitrate', 'color', '##imetric', 'assay', 'kit', '(', 'Ca', '##yman', ')', ',', 'respectively', '.']	[0, 4, 19, 22, 23, 24, 25, 26, 28, 30, 32, 34, 38, 40, 43, 49, 56, 60, 70, 73, 77, 84, 92, 98, 103, 112, 118, 122, 131, 139, 140, 151, 157, 161, 162, 169, 176, 186, 188, 192, 199, 200, 208, 213, 221, 227, 231, 232, 234, 238, 239, 241, 253]	[3, 18, 21, 23, 24, 25, 26, 27, 30, 32, 33, 37, 40, 42, 48, 55, 59, 69, 72, 76, 83, 91, 97, 102, 111, 117, 121, 130, 139, 140, 150, 156, 160, 162, 168, 175, 186, 187, 191, 199, 200, 207, 213, 220, 226, 230, 232, 234, 238, 239, 240, 253, 254]	['The', 'concentrations', 'of', 'H2O2', ',', 'NO2−', ',', 'and', 'NO3−', 'after', 'plasma', 'jet', 'treatment', 'in', 'the', 'medium', 'without', 'cells', 'were', 'measured', 'using', 'the', 'hydrogen', 'peroxide', '/', 'peroxidase', 'assay', 'kit', '(', 'Thermo', 'Fisher', 'Scientific', ')', 'and', 'nitrite', '/', 'nitrate', 'colorimetric', 'assay', 'kit', '(', 'Cayman', ')', ',', 'respectively', '.']	[1, 1, 1, 4, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR reactions were performed in triplicate 20 μL mixture containing 4 μL of 5×FastPfu buffer, 2 μL of 2.5 mM dNTPs, 0.8 μL of each primer (5 μM), 0.4 μL of FastPfu polymerase, and 10 ng of template DNA.	[('PMC6885810', 'M01004', 164, 174, 'polymerase')]	['PCR', 'reactions', 'were', 'performed', 'in', 'triplicate', '20', 'μ', '##L', 'mixture', 'containing', '4', 'μ', '##L', 'of', '5', '##×', '##F', '##ast', '##P', '##f', '##u', 'buffer', ',', '2', 'μ', '##L', 'of', '2', '.', '5', 'mM', 'd', '##NT', '##Ps', ',', '0', '.', '8', 'μ', '##L', 'of', 'each', 'primer', '(', '5', 'μ', '##M', ')', ',', '0', '.', '4', 'μ', '##L', 'of', 'Fast', '##P', '##f', '##u', 'polymerase', ',', 'and', '10', 'ng', 'of', 'template', 'DNA', '.']	[0, 4, 14, 19, 29, 32, 43, 46, 47, 49, 57, 68, 70, 71, 73, 76, 77, 78, 79, 82, 83, 84, 86, 92, 94, 96, 97, 99, 102, 103, 104, 106, 109, 110, 112, 114, 116, 117, 118, 120, 121, 123, 126, 131, 138, 139, 141, 142, 143, 144, 146, 147, 148, 150, 151, 153, 156, 160, 161, 162, 164, 174, 176, 180, 183, 186, 189, 198, 201]	[3, 13, 18, 28, 31, 42, 45, 47, 48, 56, 67, 69, 71, 72, 75, 77, 78, 79, 82, 83, 84, 85, 92, 93, 95, 97, 98, 101, 103, 104, 105, 108, 110, 112, 114, 115, 117, 118, 119, 121, 122, 125, 130, 137, 139, 140, 142, 143, 144, 145, 147, 148, 149, 151, 152, 155, 160, 161, 162, 163, 174, 175, 179, 182, 185, 188, 197, 201, 202]	['PCR', 'reactions', 'were', 'performed', 'in', 'triplicate', '20', 'μL', 'mixture', 'containing', '4', 'μL', 'of', '5×FastPfu', 'buffer', ',', '2', 'μL', 'of', '2.5', 'mM', 'dNTPs', ',', '0.8', 'μL', 'of', 'each', 'primer', '(', '5', 'μM', ')', ',', '0.4', 'μL', 'of', 'FastPfu', 'polymerase', ',', 'and', '10', 'ng', 'of', 'template', 'DNA', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 7, 1, 1, 1, 2, 1, 3, 1, 3, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Trimethylamine and trimethylamine N-oxide, a flavin-containing monooxygenase 3 (flavin-containing monooxygenase 3)-mediated host-microbiome metabolic axis implicated in health and disease.	[('PMC6901393', 'F10001', 45, 78, 'flavin-containing monooxygenase 3'), ('PMC6901393', 'F10001', 80, 113, 'flavin-containing monooxygenase 3')]	['Tri', '##methyl', '##amine', 'and', 'trim', '##ethyl', '##amine', 'N', '-', 'oxide', ',', 'a', 'flav', '##in', '-', 'containing', 'mono', '##oxygenase', '3', '(', 'flav', '##in', '-', 'containing', 'mono', '##oxygenase', '3', ')', '-', 'mediated', 'host', '-', 'microbi', '##ome', 'metabolic', 'axis', 'implicated', 'in', 'health', 'and', 'disease', '.']	[0, 3, 9, 15, 19, 23, 28, 34, 35, 36, 41, 43, 45, 49, 51, 52, 63, 67, 77, 79, 80, 84, 86, 87, 98, 102, 112, 113, 114, 115, 124, 128, 129, 136, 140, 150, 155, 166, 169, 176, 180, 187]	[3, 9, 14, 18, 23, 28, 33, 35, 36, 41, 42, 44, 49, 51, 52, 62, 67, 76, 78, 80, 84, 86, 87, 97, 102, 111, 113, 114, 115, 123, 128, 129, 136, 139, 149, 154, 165, 168, 175, 179, 187, 188]	['Trimethylamine', 'and', 'trimethylamine', 'N-oxide', ',', 'a', 'flavin', '-', 'containing', 'monooxygenase', '3', '(', 'flavin', '-', 'containing', 'monooxygenase', '3', ')', '-', 'mediated', 'host', '-', 'microbiome', 'metabolic', 'axis', 'implicated', 'in', 'health', 'and', 'disease', '.']	[3, 1, 3, 3, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Shin JH, Nolte FS, Holloway BP, Morrison CJ: Rapid identification of up to three Candida species in a single reaction tube by a 5′ exonuclease assay using fluorescent DNA probes.	[('PMC6909750', 'F33001', 128, 142, '5′ exonuclease')]	['Shin', 'JH', ',', 'No', '##lt', '##e', 'FS', ',', 'Hol', '##low', '##ay', 'BP', ',', 'Morris', '##on', 'CJ', ':', 'Rapid', 'identification', 'of', 'up', 'to', 'three', 'Candida', 'species', 'in', 'a', 'single', 'reaction', 'tube', 'by', 'a', '5', '′', 'exon', '##ucle', '##ase', 'assay', 'using', 'fluorescent', 'DNA', 'probes', '.']	[0, 5, 7, 9, 11, 13, 15, 17, 19, 22, 25, 28, 30, 32, 38, 41, 43, 45, 51, 66, 69, 72, 75, 81, 89, 97, 100, 102, 109, 118, 123, 126, 128, 129, 131, 135, 139, 143, 149, 155, 167, 171, 177]	[4, 7, 8, 11, 13, 14, 17, 18, 22, 25, 27, 30, 31, 38, 40, 43, 44, 50, 65, 68, 71, 74, 80, 88, 96, 99, 101, 108, 117, 122, 125, 127, 129, 130, 135, 139, 142, 148, 154, 166, 170, 177, 178]	['Shin', 'JH', ',', 'Nolte', 'FS', ',', 'Holloway', 'BP', ',', 'Morrison', 'CJ', ':', 'Rapid', 'identification', 'of', 'up', 'to', 'three', 'Candida', 'species', 'in', 'a', 'single', 'reaction', 'tube', 'by', 'a', '5′', 'exonuclease', 'assay', 'using', 'fluorescent', 'DNA', 'probes', '.']	[1, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
To perform 16S phylogenetic analysis and quantitative polymerase chain reaction (PCR) assays, DNA was extracted as needed from 250 μL aliquots of saliva.	[('PMC6909750', 'M02002', 54, 64, 'polymerase')]	['To', 'perform', '16', '##S', 'phylogenetic', 'analysis', 'and', 'quantitative', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'assays', ',', 'DNA', 'was', 'extracted', 'as', 'needed', 'from', '250', 'μ', '##L', 'aliquots', 'of', 'saliva', '.']	[0, 3, 11, 13, 15, 28, 37, 41, 54, 65, 71, 80, 81, 84, 86, 92, 94, 98, 102, 112, 115, 122, 127, 131, 132, 134, 143, 146, 152]	[2, 10, 13, 14, 27, 36, 40, 53, 64, 70, 79, 81, 84, 85, 92, 93, 97, 101, 111, 114, 121, 126, 130, 132, 133, 142, 145, 152, 153]	['To', 'perform', '16S', 'phylogenetic', 'analysis', 'and', 'quantitative', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'assays', ',', 'DNA', 'was', 'extracted', 'as', 'needed', 'from', '250', 'μL', 'aliquots', 'of', 'saliva', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Samples were incubated in an enzymatic cocktail containing lysozyme (0.2 mg/mL) and proteinase K (0.4 mg/mL) followed by bead beating using a Biospec Products Mini-BeadBeater-8™ (BioSpec Products, Inc.).	[('PMC6909750', 'M03001', 59, 67, 'lysozyme'), ('PMC6909750', 'M03001', 84, 96, 'proteinase K')]	['Samples', 'were', 'incubated', 'in', 'an', 'enzymatic', 'cock', '##tail', 'containing', 'lys', '##ozyme', '(', '0', '.', '2', 'mg', '/', 'mL', ')', 'and', 'protein', '##ase', 'K', '(', '0', '.', '4', 'mg', '/', 'mL', ')', 'followed', 'by', 'bead', 'beat', '##ing', 'using', 'a', 'Bios', '##pec', 'Products', 'Mini', '-', 'Be', '##ad', '##Be', '##ater', '-', '8', '[UNK]', '(', 'Bio', '##Spec', 'Products', ',', 'Inc', '.', ')', '.']	[0, 8, 13, 23, 26, 29, 39, 43, 48, 59, 62, 68, 69, 70, 71, 73, 75, 76, 78, 80, 84, 91, 95, 97, 98, 99, 100, 102, 104, 105, 107, 109, 118, 121, 126, 130, 134, 140, 142, 146, 150, 159, 163, 164, 166, 168, 170, 174, 175, -1, 178, 179, 182, 187, 195, 197, 200, 201, 202]	[7, 12, 22, 25, 28, 38, 43, 47, 58, 62, 67, 69, 70, 71, 72, 75, 76, 78, 79, 83, 91, 94, 96, 98, 99, 100, 101, 104, 105, 107, 108, 117, 120, 125, 130, 133, 139, 141, 146, 149, 158, 163, 164, 166, 168, 170, 174, 175, 176, 4, 179, 182, 186, 195, 196, 200, 201, 202, 203]	['Samples', 'were', 'incubated', 'in', 'an', 'enzymatic', 'cocktail', 'containing', 'lysozyme', '(', '0.2', 'mg', '/', 'mL', ')', 'and', 'proteinase', 'K', '(', '0.4', 'mg', '/', 'mL', ')', 'followed', 'by', 'bead', 'beating', 'using', 'a', 'Biospec', 'Products', 'Mini-BeadBeater-8', '™', '(', 'BioSpec', 'Products', ',', 'Inc', '.', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 8, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Polymerase chain reaction (PCR) amplification was performed using the V3 forward primer 5′CCTACGGGGNGGCWGCAG-3′ and V4 reverse primer 5′GACTACHVGGGTATCTAATCC-3′, producing a 300-bp amplicon spanning the highly variable V3–V4 region of the 16S rRNA gene.	[('PMC6912393', 'M04000', 0, 10, 'Polymerase')]	['Polymer', '##ase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', 'was', 'performed', 'using', 'the', 'V', '##3', 'forward', 'primer', '5', '′', 'CCT', '##ACG', '##GGG', '##NG', '##GC', '##W', '##GC', '##AG', '-', '3', '′', 'and', 'V', '##4', 'reverse', 'primer', '5', '′', 'GA', '##CTA', '##CH', '##V', '##GGG', '##TA', '##TC', '##TA', '##ATCC', '-', '3', '′', ',', 'producing', 'a', '300', '-', 'bp', 'amplic', '##on', 'spanning', 'the', 'highly', 'variable', 'V', '##3', '–', 'V', '##4', 'region', 'of', 'the', '16', '##S', 'rRNA', 'gene', '.']	[0, 7, 11, 17, 26, 27, 30, 32, 46, 50, 60, 66, 70, 71, 73, 81, 88, 89, 90, 93, 96, 99, 101, 103, 104, 106, 108, 109, 110, 112, 116, 117, 119, 127, 134, 135, 136, 138, 141, 143, 144, 147, 149, 151, 153, 157, 158, 159, 160, 162, 172, 174, 177, 178, 181, 187, 190, 199, 203, 210, 219, 220, 221, 222, 223, 225, 232, 235, 239, 241, 243, 248, 252]	[7, 10, 16, 25, 27, 30, 31, 45, 49, 59, 65, 69, 71, 72, 80, 87, 89, 90, 93, 96, 99, 101, 103, 104, 106, 108, 109, 110, 111, 115, 117, 118, 126, 133, 135, 136, 138, 141, 143, 144, 147, 149, 151, 153, 157, 158, 159, 160, 161, 171, 173, 177, 178, 180, 187, 189, 198, 202, 209, 218, 220, 221, 222, 223, 224, 231, 234, 238, 241, 242, 247, 252, 253]	['Polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', 'was', 'performed', 'using', 'the', 'V3', 'forward', 'primer', '5′CCTACGGGGNGGCWGCAG-3′', 'and', 'V4', 'reverse', 'primer', '5′GACTACHVGGGTATCTAATCC-3′', ',', 'producing', 'a', '300-bp', 'amplicon', 'spanning', 'the', 'highly', 'variable', 'V3–V4', 'region', 'of', 'the', '16S', 'rRNA', 'gene', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 13, 1, 2, 1, 1, 14, 1, 1, 1, 3, 2, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1]	['B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Hypotaurine is finally oxidized to the final product taurine by hypotaurine dehydrogenase, which is then excreted out of the body or used within.	[('PMC6918408', 'D03001', 64, 89, 'hypotaurine dehydrogenase')]	['Hypot', '##aur', '##ine', 'is', 'finally', 'oxidized', 'to', 'the', 'final', 'product', 'tau', '##rine', 'by', 'hypot', '##aur', '##ine', 'dehydrogenase', ',', 'which', 'is', 'then', 'exc', '##reted', 'out', 'of', 'the', 'body', 'or', 'used', 'within', '.']	[0, 5, 8, 12, 15, 23, 32, 35, 39, 45, 53, 56, 61, 64, 69, 72, 76, 89, 91, 97, 100, 105, 108, 114, 118, 121, 125, 130, 133, 138, 144]	[5, 8, 11, 14, 22, 31, 34, 38, 44, 52, 56, 60, 63, 69, 72, 75, 89, 90, 96, 99, 104, 108, 113, 117, 120, 124, 129, 132, 137, 144, 145]	['Hypotaurine', 'is', 'finally', 'oxidized', 'to', 'the', 'final', 'product', 'taurine', 'by', 'hypotaurine', 'dehydrogenase', ',', 'which', 'is', 'then', 'excreted', 'out', 'of', 'the', 'body', 'or', 'used', 'within', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR reactions were performed in triplicate using a 20 μL mixture containing 4 μL of 5 × FastPfu Buffer, 2 μL of 2.5 mM dNTPs, 0.8 μL of each primer (5 μM), 0.4 μL of FastPfu Polymerase and 10 ng of template DNA.	[('PMC6920906', 'M07004', 174, 184, 'Polymerase')]	['PCR', 'reactions', 'were', 'performed', 'in', 'triplicate', 'using', 'a', '20', 'μ', '##L', 'mixture', 'containing', '4', 'μ', '##L', 'of', '5', '×', 'Fast', '##P', '##f', '##u', 'Bu', '##ffer', ',', '2', 'μ', '##L', 'of', '2', '.', '5', 'mM', 'd', '##NT', '##Ps', ',', '0', '.', '8', 'μ', '##L', 'of', 'each', 'primer', '(', '5', 'μ', '##M', ')', ',', '0', '.', '4', 'μ', '##L', 'of', 'Fast', '##P', '##f', '##u', 'Polymer', '##ase', 'and', '10', 'ng', 'of', 'template', 'DNA', '.']	[0, 4, 14, 19, 29, 32, 43, 49, 51, 54, 55, 57, 65, 76, 78, 79, 81, 84, 86, 88, 92, 93, 94, 96, 98, 102, 104, 106, 107, 109, 112, 113, 114, 116, 119, 120, 122, 124, 126, 127, 128, 130, 131, 133, 136, 141, 148, 149, 151, 152, 153, 154, 156, 157, 158, 160, 161, 163, 166, 170, 171, 172, 174, 181, 185, 189, 192, 195, 198, 207, 210]	[3, 13, 18, 28, 31, 42, 48, 50, 53, 55, 56, 64, 75, 77, 79, 80, 83, 85, 87, 92, 93, 94, 95, 98, 102, 103, 105, 107, 108, 111, 113, 114, 115, 118, 120, 122, 124, 125, 127, 128, 129, 131, 132, 135, 140, 147, 149, 150, 152, 153, 154, 155, 157, 158, 159, 161, 162, 165, 170, 171, 172, 173, 181, 184, 188, 191, 194, 197, 206, 210, 211]	['PCR', 'reactions', 'were', 'performed', 'in', 'triplicate', 'using', 'a', '20', 'μL', 'mixture', 'containing', '4', 'μL', 'of', '5', '×', 'FastPfu', 'Buffer', ',', '2', 'μL', 'of', '2.5', 'mM', 'dNTPs', ',', '0.8', 'μL', 'of', 'each', 'primer', '(', '5', 'μM', ')', ',', '0.4', 'μL', 'of', 'FastPfu', 'Polymerase', 'and', '10', 'ng', 'of', 'template', 'DNA', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 4, 2, 1, 1, 2, 1, 3, 1, 3, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 2, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fite A, Macfarlane GT, Cummings JH, Hopkins MJ, Kong SC, Furrie E, et al. Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction.	[('PMC6966866', 'F15001', 159, 169, 'polymerase')]	['Fit', '##e', 'A', ',', 'Mac', '##far', '##lane', 'GT', ',', 'Cum', '##ming', '##s', 'JH', ',', 'Hopkins', 'MJ', ',', 'Kong', 'SC', ',', 'Fur', '##rie', 'E', ',', 'et', 'al', '.', 'Identification', 'and', 'quantit', '##ation', 'of', 'mucosal', 'and', 'faecal', 'des', '##ulf', '##ov', '##ibri', '##os', 'using', 'real', 'time', 'polymerase', 'chain', 'reaction', '.']	[0, 3, 5, 6, 8, 11, 14, 19, 21, 23, 26, 30, 32, 34, 36, 44, 46, 48, 53, 55, 57, 60, 64, 65, 67, 70, 72, 74, 89, 93, 100, 106, 109, 117, 121, 128, 131, 134, 136, 140, 143, 149, 154, 159, 170, 176, 184]	[3, 4, 6, 7, 11, 14, 18, 21, 22, 26, 30, 31, 34, 35, 43, 46, 47, 52, 55, 56, 60, 63, 65, 66, 69, 72, 73, 88, 92, 100, 105, 108, 116, 120, 127, 131, 134, 136, 140, 142, 148, 153, 158, 169, 175, 184, 185]	['Fite', 'A', ',', 'Macfarlane', 'GT', ',', 'Cummings', 'JH', ',', 'Hopkins', 'MJ', ',', 'Kong', 'SC', ',', 'Furrie', 'E', ',', 'et', 'al', '.', 'Identification', 'and', 'quantitation', 'of', 'mucosal', 'and', 'faecal', 'desulfovibrios', 'using', 'real', 'time', 'polymerase', 'chain', 'reaction', '.']	[2, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O']
Real-time polymerase chain reaction shows that density centrifugation does not always remove chlamydia trachomatis from human semen.	[('PMC6966866', 'F26002', 10, 20, 'polymerase')]	['Real', '-', 'time', 'polymerase', 'chain', 'reaction', 'shows', 'that', 'density', 'centrifugation', 'does', 'not', 'always', 'remove', 'ch', '##lamyd', '##ia', 'trac', '##hom', '##atis', 'from', 'human', 'semen', '.']	[0, 4, 5, 10, 21, 27, 36, 42, 47, 55, 70, 75, 79, 86, 93, 95, 100, 103, 107, 110, 115, 120, 126, 131]	[4, 5, 9, 20, 26, 35, 41, 46, 54, 69, 74, 78, 85, 92, 95, 100, 102, 107, 110, 114, 119, 125, 131, 132]	['Real', '-', 'time', 'polymerase', 'chain', 'reaction', 'shows', 'that', 'density', 'centrifugation', 'does', 'not', 'always', 'remove', 'chlamydia', 'trachomatis', 'from', 'human', 'semen', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It is reported that proteases can act as signaling molecules through activation of proteinase-activated receptors (PARs) (Van Spaendonk et al., 2017), which involves cell proliferation and apoptosis, autoimmunity (Lisi et al., 2014), cytokine production, microenvironment inflammation, pain and epithelial barrier function (Amadesi and Bunnett, 2004).	[('PMC6974454', 'D03003', 20, 29, 'proteases'), ('PMC6974454', 'D03003', 83, 93, 'proteinase')]	['It', 'is', 'reported', 'that', 'proteases', 'can', 'act', 'as', 'signaling', 'molecules', 'through', 'activation', 'of', 'protein', '##ase', '-', 'activated', 'receptors', '(', 'PAR', '##s', ')', '(', 'Van', 'Sp', '##ae', '##nd', '##on', '##k', 'et', 'al', '.', ',', '2017', ')', ',', 'which', 'involves', 'cell', 'proliferation', 'and', 'apoptosis', ',', 'auto', '##immun', '##ity', '(', 'Lis', '##i', 'et', 'al', '.', ',', '2014', ')', ',', 'cytokine', 'production', ',', 'micro', '##environment', 'inflammation', ',', 'pain', 'and', 'epithelial', 'barrier', 'function', '(', 'Ama', '##des', '##i', 'and', 'Bu', '##nn', '##ett', ',', '2004', ')', '.']	[0, 3, 6, 15, 20, 30, 34, 38, 41, 51, 61, 69, 80, 83, 90, 93, 94, 104, 114, 115, 118, 119, 121, 122, 126, 128, 130, 132, 134, 136, 139, 141, 142, 144, 148, 149, 151, 157, 166, 171, 185, 189, 198, 200, 204, 209, 213, 214, 217, 219, 222, 224, 225, 227, 231, 232, 234, 243, 253, 255, 260, 272, 284, 286, 291, 295, 306, 314, 323, 324, 327, 330, 332, 336, 338, 340, 343, 345, 349, 350]	[2, 5, 14, 19, 29, 33, 37, 40, 50, 60, 68, 79, 82, 90, 93, 94, 103, 113, 115, 118, 119, 120, 122, 125, 128, 130, 132, 134, 135, 138, 141, 142, 143, 148, 149, 150, 156, 165, 170, 184, 188, 198, 199, 204, 209, 212, 214, 217, 218, 221, 224, 225, 226, 231, 232, 233, 242, 253, 254, 260, 271, 284, 285, 290, 294, 305, 313, 322, 324, 327, 330, 331, 335, 338, 340, 343, 344, 349, 350, 351]	['It', 'is', 'reported', 'that', 'proteases', 'can', 'act', 'as', 'signaling', 'molecules', 'through', 'activation', 'of', 'proteinase', '-', 'activated', 'receptors', '(', 'PARs', ')', '(', 'Van', 'Spaendonk', 'et', 'al', '.', ',', '2017', ')', ',', 'which', 'involves', 'cell', 'proliferation', 'and', 'apoptosis', ',', 'autoimmunity', '(', 'Lisi', 'et', 'al', '.', ',', '2014', ')', ',', 'cytokine', 'production', ',', 'microenvironment', 'inflammation', ',', 'pain', 'and', 'epithelial', 'barrier', 'function', '(', 'Amadesi', 'and', 'Bunnett', ',', '2004', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There was an increase of peptidases in tumor sites by functional analysis.	[('PMC6974454', 'D03004', 25, 35, 'peptidases')]	['There', 'was', 'an', 'increase', 'of', 'pepti', '##dase', '##s', 'in', 'tumor', 'sites', 'by', 'functional', 'analysis', '.']	[0, 6, 10, 13, 22, 25, 30, 34, 36, 39, 45, 51, 54, 65, 73]	[5, 9, 12, 21, 24, 30, 34, 35, 38, 44, 50, 53, 64, 73, 74]	['There', 'was', 'an', 'increase', 'of', 'peptidases', 'in', 'tumor', 'sites', 'by', 'functional', 'analysis', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteases produced by bacteria can degrade host tissue like extracellular matrix (ECM), destruct host physical barriers, and modulate host immune response, finally contributing to the onset and progression of tumors (Alfano et al., 2016).	[('PMC6974454', 'D03005', 0, 9, 'Proteases')]	['Prote', '##ases', 'produced', 'by', 'bacteria', 'can', 'degrade', 'host', 'tissue', 'like', 'extracellular', 'matrix', '(', 'ECM', ')', ',', 'dest', '##ru', '##ct', 'host', 'physical', 'barriers', ',', 'and', 'modulate', 'host', 'immune', 'response', ',', 'finally', 'contributing', 'to', 'the', 'onset', 'and', 'progression', 'of', 'tumors', '(', 'Alf', '##ano', 'et', 'al', '.', ',', '2016', ')', '.']	[0, 5, 10, 19, 22, 31, 35, 43, 48, 55, 60, 74, 81, 82, 85, 86, 88, 92, 94, 97, 102, 111, 119, 121, 125, 134, 139, 146, 154, 156, 164, 177, 180, 184, 190, 194, 206, 209, 216, 217, 220, 224, 227, 229, 230, 232, 236, 237]	[5, 9, 18, 21, 30, 34, 42, 47, 54, 59, 73, 80, 82, 85, 86, 87, 92, 94, 96, 101, 110, 119, 120, 124, 133, 138, 145, 154, 155, 163, 176, 179, 183, 189, 193, 205, 208, 215, 217, 220, 223, 226, 229, 230, 231, 236, 237, 238]	['Proteases', 'produced', 'by', 'bacteria', 'can', 'degrade', 'host', 'tissue', 'like', 'extracellular', 'matrix', '(', 'ECM', ')', ',', 'destruct', 'host', 'physical', 'barriers', ',', 'and', 'modulate', 'host', 'immune', 'response', ',', 'finally', 'contributing', 'to', 'the', 'onset', 'and', 'progression', 'of', 'tumors', '(', 'Alfano', 'et', 'al', '.', ',', '2016', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The decrease in the phosphotransferase system (PTS), glycolysis and galactose metabolism might reflect the community response to reduced sugar source on the tumor surface, since increased glucose uptake is essential for OSCC cells to survive (Eckert et al., 2016).	[('PMC6974454', 'D06003', 20, 38, 'phosphotransferase')]	['The', 'decrease', 'in', 'the', 'phospho', '##transferase', 'system', '(', 'PTS', ')', ',', 'glycolysis', 'and', 'galact', '##ose', 'metabolism', 'might', 'reflect', 'the', 'community', 'response', 'to', 'reduced', 'sugar', 'source', 'on', 'the', 'tumor', 'surface', ',', 'since', 'increased', 'glucose', 'uptake', 'is', 'essential', 'for', 'OS', '##CC', 'cells', 'to', 'survive', '(', 'Eck', '##ert', 'et', 'al', '.', ',', '2016', ')', '.']	[0, 4, 13, 16, 20, 27, 39, 46, 47, 50, 51, 53, 64, 68, 74, 78, 89, 95, 103, 107, 117, 126, 129, 137, 143, 150, 153, 157, 163, 170, 172, 178, 188, 196, 203, 206, 216, 220, 222, 225, 231, 234, 242, 243, 246, 250, 253, 255, 256, 258, 262, 263]	[3, 12, 15, 19, 27, 38, 45, 47, 50, 51, 52, 63, 67, 74, 77, 88, 94, 102, 106, 116, 125, 128, 136, 142, 149, 152, 156, 162, 170, 171, 177, 187, 195, 202, 205, 215, 219, 222, 224, 230, 233, 241, 243, 246, 249, 252, 255, 256, 257, 262, 263, 264]	['The', 'decrease', 'in', 'the', 'phosphotransferase', 'system', '(', 'PTS', ')', ',', 'glycolysis', 'and', 'galactose', 'metabolism', 'might', 'reflect', 'the', 'community', 'response', 'to', 'reduced', 'sugar', 'source', 'on', 'the', 'tumor', 'surface', ',', 'since', 'increased', 'glucose', 'uptake', 'is', 'essential', 'for', 'OSCC', 'cells', 'to', 'survive', '(', 'Eckert', 'et', 'al', '.', ',', '2016', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protease-activated receptors: protease signaling in the gastrointestinal tract.	[('PMC6974454', 'F03001', 0, 8, 'Protease'), ('PMC6974454', 'F03001', 30, 38, 'protease')]	['Prote', '##ase', '-', 'activated', 'receptors', ':', 'protease', 'signaling', 'in', 'the', 'gastro', '##intestinal', 'tract', '.']	[0, 5, 8, 9, 19, 28, 30, 39, 49, 52, 56, 62, 73, 78]	[5, 8, 9, 18, 28, 29, 38, 48, 51, 55, 62, 72, 78, 79]	['Protease', '-', 'activated', 'receptors', ':', 'protease', 'signaling', 'in', 'the', 'gastrointestinal', 'tract', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['B', 'E', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation.	[('PMC6974454', 'F11002', 17, 28, 'proteinases'), ('PMC6974454', 'F11002', 30, 40, 'proteinase')]	['Micro', '##environment', 'protein', '##ases', ',', 'protein', '##ase', '-', 'activated', 'receptor', 'regulation', ',', 'cancer', 'and', 'inflammation', '.']	[0, 5, 17, 24, 28, 30, 37, 40, 41, 51, 60, 70, 72, 79, 83, 95]	[5, 16, 24, 28, 29, 37, 40, 41, 50, 59, 70, 71, 78, 82, 95, 96]	['Microenvironment', 'proteinases', ',', 'proteinase', '-', 'activated', 'receptor', 'regulation', ',', 'cancer', 'and', 'inflammation', '.']	[2, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Regulation of intestinal permeability: the role of proteases.	[('PMC6974454', 'F61002', 51, 60, 'proteases')]	['Regulation', 'of', 'intestinal', 'permeability', ':', 'the', 'role', 'of', 'proteases', '.']	[0, 11, 14, 25, 37, 39, 43, 48, 51, 60]	[10, 13, 24, 37, 38, 42, 47, 50, 60, 61]	['Regulation', 'of', 'intestinal', 'permeability', ':', 'the', 'role', 'of', 'proteases', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O']
The V3-4 hypervariable region of the 16S rRNA genes was amplified using the primers 338F (5′-CCTACGGGNGGCWGCAG-3′) and 806R (5′-GACTACHVGGGTATCTAATCC-3′) with a TransStart Fastpfu DNA Polymerase (TransGen, Beijing, China).	[('PMC6974454', 'M01001', 180, 194, 'DNA Polymerase')]	['The', 'V', '##3', '-', '4', 'hyper', '##variable', 'region', 'of', 'the', '16', '##S', 'rRNA', 'genes', 'was', 'amplified', 'using', 'the', 'primers', '338', '##F', '(', '5', '′', '-', 'CCT', '##ACG', '##GG', '##NG', '##GC', '##W', '##GC', '##AG', '-', '3', '′', ')', 'and', '80', '##6', '##R', '(', '5', '′', '-', 'GA', '##CTA', '##CH', '##V', '##GGG', '##TA', '##TC', '##TA', '##ATCC', '-', '3', '′', ')', 'with', 'a', 'Trans', '##St', '##art', 'Fast', '##pf', '##u', 'DNA', 'Polymer', '##ase', '(', 'Trans', '##Gen', ',', 'Beijing', ',', 'China', ')', '.']	[0, 4, 5, 6, 7, 9, 14, 23, 30, 33, 37, 39, 41, 46, 52, 56, 66, 72, 76, 84, 87, 89, 90, 91, 92, 93, 96, 99, 101, 103, 105, 106, 108, 110, 111, 112, 113, 115, 119, 121, 122, 124, 125, 126, 127, 128, 130, 133, 135, 136, 139, 141, 143, 145, 149, 150, 151, 152, 154, 159, 161, 166, 168, 172, 176, 178, 180, 184, 191, 195, 196, 201, 204, 206, 213, 215, 220, 221]	[3, 5, 6, 7, 8, 14, 22, 29, 32, 36, 39, 40, 45, 51, 55, 65, 71, 75, 83, 87, 88, 90, 91, 92, 93, 96, 99, 101, 103, 105, 106, 108, 110, 111, 112, 113, 114, 118, 121, 122, 123, 125, 126, 127, 128, 130, 133, 135, 136, 139, 141, 143, 145, 149, 150, 151, 152, 153, 158, 160, 166, 168, 171, 176, 178, 179, 183, 191, 194, 196, 201, 204, 205, 213, 214, 220, 221, 222]	['The', 'V3-4', 'hypervariable', 'region', 'of', 'the', '16S', 'rRNA', 'genes', 'was', 'amplified', 'using', 'the', 'primers', '338F', '(', '5′-CCTACGGGNGGCWGCAG-3′', ')', 'and', '806R', '(', '5′-GACTACHVGGGTATCTAATCC-3′', ')', 'with', 'a', 'TransStart', 'Fastpfu', 'DNA', 'Polymerase', '(', 'TransGen', ',', 'Beijing', ',', 'China', ')', '.']	[1, 4, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 14, 1, 1, 3, 1, 15, 1, 1, 1, 3, 3, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Argininosuccinate is synthesized from the condensation of citrulline and aspartate by the enzyme argininosuccinate synthase; then, it is cleaved into fumarate and arginine by the enzyme argininosuccinate lyase (Haines et al., 2011).	[('PMC6993102', 'D00003', 97, 123, 'argininosuccinate synthase'), ('PMC6993102', 'D00003', 186, 209, 'argininosuccinate lyase')]	['Arg', '##inin', '##os', '##ucci', '##nat', '##e', 'is', 'synthesized', 'from', 'the', 'condensation', 'of', 'citr', '##ulli', '##ne', 'and', 'aspart', '##ate', 'by', 'the', 'enzyme', 'arg', '##inin', '##os', '##ucci', '##nat', '##e', 'synthase', ';', 'then', ',', 'it', 'is', 'cleaved', 'into', 'fum', '##ara', '##te', 'and', 'arginine', 'by', 'the', 'enzyme', 'arg', '##inin', '##os', '##ucci', '##nat', '##e', 'ly', '##ase', '(', 'Ha', '##ines', 'et', 'al', '.', ',', '2011', ')', '.']	[0, 3, 7, 9, 13, 16, 18, 21, 33, 38, 42, 55, 58, 62, 66, 69, 73, 79, 83, 86, 90, 97, 100, 104, 106, 110, 113, 115, 123, 125, 129, 131, 134, 137, 145, 150, 153, 156, 159, 163, 172, 175, 179, 186, 189, 193, 195, 199, 202, 204, 206, 210, 211, 213, 218, 221, 223, 224, 226, 230, 231]	[3, 7, 9, 13, 16, 17, 20, 32, 37, 41, 54, 57, 62, 66, 68, 72, 79, 82, 85, 89, 96, 100, 104, 106, 110, 113, 114, 123, 124, 129, 130, 133, 136, 144, 149, 153, 156, 158, 162, 171, 174, 178, 185, 189, 193, 195, 199, 202, 203, 206, 209, 211, 213, 217, 220, 223, 224, 225, 230, 231, 232]	['Argininosuccinate', 'is', 'synthesized', 'from', 'the', 'condensation', 'of', 'citrulline', 'and', 'aspartate', 'by', 'the', 'enzyme', 'argininosuccinate', 'synthase', ';', 'then', ',', 'it', 'is', 'cleaved', 'into', 'fumarate', 'and', 'arginine', 'by', 'the', 'enzyme', 'argininosuccinate', 'lyase', '(', 'Haines', 'et', 'al', '.', ',', '2011', ')', '.']	[6, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 6, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dihydrobiopterin (BH2) [m/z 278.0650] is a product of the oxidation of Tetrahydrobiopterin (BH4), an important cofactor for NO synthase (NO synthase).	[('PMC6993102', 'D01000', 124, 135, 'NO synthase'), ('PMC6993102', 'D01000', 137, 148, 'NO synthase')]	['Di', '##hydro', '##bio', '##pt', '##eri', '##n', '(', 'BH', '##2', ')', '[', 'm', '/', 'z', '278', '.', '06', '##50', ']', 'is', 'a', 'product', 'of', 'the', 'oxidation', 'of', 'Tetra', '##hydro', '##bio', '##pt', '##eri', '##n', '(', 'BH', '##4', ')', ',', 'an', 'important', 'co', '##factor', 'for', 'NO', 'synthase', '(', 'NO', 'synthase', ')', '.']	[0, 2, 7, 10, 12, 15, 17, 18, 20, 21, 23, 24, 25, 26, 28, 31, 32, 34, 36, 38, 41, 43, 51, 54, 58, 68, 71, 76, 81, 84, 86, 89, 91, 92, 94, 95, 96, 98, 101, 111, 113, 120, 124, 127, 136, 137, 140, 148, 149]	[2, 7, 10, 12, 15, 16, 18, 20, 21, 22, 24, 25, 26, 27, 31, 32, 34, 36, 37, 40, 42, 50, 53, 57, 67, 70, 76, 81, 84, 86, 89, 90, 92, 94, 95, 96, 97, 100, 110, 113, 119, 123, 126, 135, 137, 139, 148, 149, 150]	['Dihydrobiopterin', '(', 'BH2', ')', '[', 'm', '/', 'z', '278.0650', ']', 'is', 'a', 'product', 'of', 'the', 'oxidation', 'of', 'Tetrahydrobiopterin', '(', 'BH4', ')', ',', 'an', 'important', 'cofactor', 'for', 'NO', 'synthase', '(', 'NO', 'synthase', ')', '.']	[6, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'B', 'B', 'E', 'O', 'O']
Whenever there is a balance between cofactors and substrates in relation to Nicotinamide adenine dinucleotide phosphate (NADPH), NO synthase catalyzes the reduction of O2 and incorporates it into the guanidine group of L-arginine, generating NO.	[('PMC6993102', 'D01001', 129, 140, 'NO synthase')]	['Whenever', 'there', 'is', 'a', 'balance', 'between', 'co', '##factors', 'and', 'substrates', 'in', 'relation', 'to', 'Nic', '##otin', '##amide', 'adenine', 'din', '##ucleotide', 'phosphate', '(', 'NADPH', ')', ',', 'NO', 'synthase', 'cataly', '##zes', 'the', 'reduction', 'of', 'O', '##2', 'and', 'incorporates', 'it', 'into', 'the', 'guan', '##idine', 'group', 'of', 'L', '-', 'arginine', ',', 'generating', 'NO', '.']	[0, 9, 15, 18, 20, 28, 36, 38, 46, 50, 61, 64, 73, 76, 79, 83, 89, 97, 100, 110, 120, 121, 126, 127, 129, 132, 141, 147, 151, 155, 165, 168, 169, 171, 175, 188, 191, 196, 200, 204, 210, 216, 219, 220, 221, 229, 231, 242, 244]	[8, 14, 17, 19, 27, 35, 38, 45, 49, 60, 63, 72, 75, 79, 83, 88, 96, 100, 109, 119, 121, 126, 127, 128, 131, 140, 147, 150, 154, 164, 167, 169, 170, 174, 187, 190, 195, 199, 204, 209, 215, 218, 220, 221, 229, 230, 241, 244, 245]	['Whenever', 'there', 'is', 'a', 'balance', 'between', 'cofactors', 'and', 'substrates', 'in', 'relation', 'to', 'Nicotinamide', 'adenine', 'dinucleotide', 'phosphate', '(', 'NADPH', ')', ',', 'NO', 'synthase', 'catalyzes', 'the', 'reduction', 'of', 'O2', 'and', 'incorporates', 'it', 'into', 'the', 'guanidine', 'group', 'of', 'L-arginine', ',', 'generating', 'NO', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Nonetheless, in specific situations, such as the oxidation of BH4 into BH2, a molecule that cannot work as a cofactor for NO synthase, a phenomenon called “uncoupling” occurs.	[('PMC6993102', 'D01002', 122, 133, 'NO synthase')]	['Nonetheless', ',', 'in', 'specific', 'situations', ',', 'such', 'as', 'the', 'oxidation', 'of', 'BH', '##4', 'into', 'BH', '##2', ',', 'a', 'molecule', 'that', 'cannot', 'work', 'as', 'a', 'co', '##factor', 'for', 'NO', 'synthase', ',', 'a', 'phenomenon', 'called', '“', 'unc', '##oupling', '”', 'occurs', '.']	[0, 11, 13, 16, 25, 35, 37, 42, 45, 49, 59, 62, 64, 66, 71, 73, 74, 76, 78, 87, 92, 99, 104, 107, 109, 111, 118, 122, 125, 133, 135, 137, 148, 155, 156, 159, 166, 168, 174]	[11, 12, 15, 24, 35, 36, 41, 44, 48, 58, 61, 64, 65, 70, 73, 74, 75, 77, 86, 91, 98, 103, 106, 108, 111, 117, 121, 124, 133, 134, 136, 147, 154, 156, 159, 166, 167, 174, 175]	['Nonetheless', ',', 'in', 'specific', 'situations', ',', 'such', 'as', 'the', 'oxidation', 'of', 'BH4', 'into', 'BH2', ',', 'a', 'molecule', 'that', 'cannot', 'work', 'as', 'a', 'cofactor', 'for', 'NO', 'synthase', ',', 'a', 'phenomenon', 'called', '“', 'uncoupling', '”', 'occurs', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Uncoupled NO synthase generates superoxide instead of nitric oxide, leading to an oxidative stress state.	[('PMC6993102', 'D01003', 10, 21, 'NO synthase')]	['Un', '##coupled', 'NO', 'synthase', 'generates', 'superoxide', 'instead', 'of', 'nitric', 'oxide', ',', 'leading', 'to', 'an', 'oxidative', 'stress', 'state', '.']	[0, 2, 10, 13, 22, 32, 43, 51, 54, 61, 66, 68, 76, 79, 82, 92, 99, 104]	[2, 9, 12, 21, 31, 42, 50, 53, 60, 66, 67, 75, 78, 81, 91, 98, 104, 105]	['Uncoupled', 'NO', 'synthase', 'generates', 'superoxide', 'instead', 'of', 'nitric', 'oxide', ',', 'leading', 'to', 'an', 'oxidative', 'stress', 'state', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In oxidative stress, the enzyme phospholipase A presents increased activity, producing active mediators such as arachidonic acid (AA) metabolites (Balboa and Balsinde, 2006).	[('PMC6993102', 'D01007', 32, 47, 'phospholipase A')]	['In', 'oxidative', 'stress', ',', 'the', 'enzyme', 'phospholip', '##ase', 'A', 'presents', 'increased', 'activity', ',', 'producing', 'active', 'mediators', 'such', 'as', 'ar', '##achid', '##onic', 'acid', '(', 'AA', ')', 'metabolites', '(', 'Bal', '##bo', '##a', 'and', 'Bal', '##sin', '##de', ',', '2006', ')', '.']	[0, 3, 13, 19, 21, 25, 32, 42, 46, 48, 57, 67, 75, 77, 87, 94, 104, 109, 112, 114, 119, 124, 129, 130, 132, 134, 146, 147, 150, 152, 154, 158, 161, 164, 166, 168, 172, 173]	[2, 12, 19, 20, 24, 31, 42, 45, 47, 56, 66, 75, 76, 86, 93, 103, 108, 111, 114, 119, 123, 128, 130, 132, 133, 145, 147, 150, 152, 153, 157, 161, 164, 166, 167, 172, 173, 174]	['In', 'oxidative', 'stress', ',', 'the', 'enzyme', 'phospholipase', 'A', 'presents', 'increased', 'activity', ',', 'producing', 'active', 'mediators', 'such', 'as', 'arachidonic', 'acid', '(', 'AA', ')', 'metabolites', '(', 'Balboa', 'and', 'Balsinde', ',', '2006', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In an inflammatory environment, the enzyme Phospholipase A2 catalyzes the esterified AA present in the phospholipid membrane into free AA, which may be then oxidized in four different pathways: lipoxygenase (lipoxygenase), cyclooxygenase (cyclooxygenase), epoxygenase (CYTP450) and isoprostane.	[('PMC6993102', 'D02001', 43, 59, 'Phospholipase A2'), ('PMC6993102', 'D02001', 194, 206, 'lipoxygenase'), ('PMC6993102', 'D02001', 208, 220, 'lipoxygenase'), ('PMC6993102', 'D02001', 223, 237, 'cyclooxygenase'), ('PMC6993102', 'D02001', 239, 253, 'cyclooxygenase')]	['In', 'an', 'inflammatory', 'environment', ',', 'the', 'enzyme', 'Phosph', '##olip', '##ase', 'A', '##2', 'cataly', '##zes', 'the', 'ester', '##ified', 'AA', 'present', 'in', 'the', 'phospholipid', 'membrane', 'into', 'free', 'AA', ',', 'which', 'may', 'be', 'then', 'oxidized', 'in', 'four', 'different', 'pathways', ':', 'lip', '##oxygenase', '(', 'lip', '##oxygenase', ')', ',', 'cyclo', '##oxygenase', '(', 'cyclo', '##oxygenase', ')', ',', 'epoxy', '##gen', '##ase', '(', 'CY', '##TP', '##450', ')', 'and', 'isop', '##rost', '##ane', '.']	[0, 3, 6, 19, 30, 32, 36, 43, 49, 53, 57, 58, 60, 66, 70, 74, 79, 85, 88, 96, 99, 103, 116, 125, 130, 135, 137, 139, 145, 149, 152, 157, 166, 169, 174, 184, 192, 194, 197, 207, 208, 211, 220, 221, 223, 228, 238, 239, 244, 253, 254, 256, 261, 264, 268, 269, 271, 273, 276, 278, 282, 286, 290, 293]	[2, 5, 18, 30, 31, 35, 42, 49, 53, 56, 58, 59, 66, 69, 73, 79, 84, 87, 95, 98, 102, 115, 124, 129, 134, 137, 138, 144, 148, 151, 156, 165, 168, 173, 183, 192, 193, 197, 206, 208, 211, 220, 221, 222, 228, 237, 239, 244, 253, 254, 255, 261, 264, 267, 269, 271, 273, 276, 277, 281, 286, 290, 293, 294]	['In', 'an', 'inflammatory', 'environment', ',', 'the', 'enzyme', 'Phospholipase', 'A2', 'catalyzes', 'the', 'esterified', 'AA', 'present', 'in', 'the', 'phospholipid', 'membrane', 'into', 'free', 'AA', ',', 'which', 'may', 'be', 'then', 'oxidized', 'in', 'four', 'different', 'pathways', ':', 'lipoxygenase', '(', 'lipoxygenase', ')', ',', 'cyclooxygenase', '(', 'cyclooxygenase', ')', ',', 'epoxygenase', '(', 'CYTP450', ')', 'and', 'isoprostane', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 2, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1, 2, 1, 1, 3, 1, 3, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'B', 'B', 'E', 'O', 'O', 'B', 'E', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Prostaglandins are produced through the cyclooxygenase pathway, and leukotrienes through the lipoxygenase pathway.	[('PMC6993102', 'D02002', 40, 54, 'cyclooxygenase'), ('PMC6993102', 'D02002', 93, 105, 'lipoxygenase')]	['Pros', '##tag', '##land', '##ins', 'are', 'produced', 'through', 'the', 'cyclo', '##oxygenase', 'pathway', ',', 'and', 'leuk', '##otri', '##enes', 'through', 'the', 'lip', '##oxygenase', 'pathway', '.']	[0, 4, 7, 11, 15, 19, 28, 36, 40, 45, 55, 62, 64, 68, 72, 76, 81, 89, 93, 96, 106, 113]	[4, 7, 11, 14, 18, 27, 35, 39, 45, 54, 62, 63, 67, 72, 76, 80, 88, 92, 96, 105, 113, 114]	['Prostaglandins', 'are', 'produced', 'through', 'the', 'cyclooxygenase', 'pathway', ',', 'and', 'leukotrienes', 'through', 'the', 'lipoxygenase', 'pathway', '.']	[4, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
The main finding was that PGB2 induced Interleukin 2 (IL-2), activation of tyrosine kinase activities, and Nuclear factor kappa B (NF-κB).	[('PMC6993102', 'D03003', 75, 90, 'tyrosine kinase')]	['The', 'main', 'finding', 'was', 'that', 'PG', '##B', '##2', 'induced', 'Inter', '##le', '##ukin', '2', '(', 'IL', '-', '2', ')', ',', 'activation', 'of', 'tyrosine', 'kinase', 'activities', ',', 'and', 'Nuclear', 'factor', 'kappa', 'B', '(', 'NF', '-', 'κ', '##B', ')', '.']	[0, 4, 9, 17, 21, 26, 28, 29, 31, 39, 44, 46, 51, 53, 54, 56, 57, 58, 59, 61, 72, 75, 84, 91, 101, 103, 107, 115, 122, 128, 130, 131, 133, 134, 135, 136, 137]	[3, 8, 16, 20, 25, 28, 29, 30, 38, 44, 46, 50, 52, 54, 56, 57, 58, 59, 60, 71, 74, 83, 90, 101, 102, 106, 114, 121, 127, 129, 131, 133, 134, 135, 136, 137, 138]	['The', 'main', 'finding', 'was', 'that', 'PGB2', 'induced', 'Interleukin', '2', '(', 'IL-2', ')', ',', 'activation', 'of', 'tyrosine', 'kinase', 'activities', ',', 'and', 'Nuclear', 'factor', 'kappa', 'B', '(', 'NF-κB', ')', '.']	[1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
From neutrophil action, and with the participation of ω-hydroxylase, LTB4 is oxidized to 20-carboxy LTB4.	[('PMC6993102', 'D04003', 54, 67, 'ω-hydroxylase')]	['From', 'neutrophil', 'action', ',', 'and', 'with', 'the', 'participation', 'of', 'ω', '-', 'hydroxyl', '##ase', ',', 'LT', '##B', '##4', 'is', 'oxidized', 'to', '20', '-', 'carb', '##oxy', 'LT', '##B', '##4', '.']	[0, 5, 16, 22, 24, 28, 33, 37, 51, 54, 55, 56, 64, 67, 69, 71, 72, 74, 77, 86, 89, 91, 92, 96, 100, 102, 103, 104]	[4, 15, 22, 23, 27, 32, 36, 50, 53, 55, 56, 64, 67, 68, 71, 72, 73, 76, 85, 88, 91, 92, 96, 99, 102, 103, 104, 105]	['From', 'neutrophil', 'action', ',', 'and', 'with', 'the', 'participation', 'of', 'ω-hydroxylase', ',', 'LTB4', 'is', 'oxidized', 'to', '20-carboxy', 'LTB4', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 4, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Argininosuccinate synthase: at the center of arginine metabolism.	[('PMC6993102', 'F18001', 0, 26, 'Argininosuccinate synthase')]	['Arg', '##inin', '##os', '##ucci', '##nat', '##e', 'synthase', ':', 'at', 'the', 'center', 'of', 'arginine', 'metabolism', '.']	[0, 3, 7, 9, 13, 16, 18, 26, 28, 31, 35, 42, 45, 54, 64]	[3, 7, 9, 13, 16, 17, 26, 27, 30, 34, 41, 44, 53, 64, 65]	['Argininosuccinate', 'synthase', ':', 'at', 'the', 'center', 'of', 'arginine', 'metabolism', '.']	[6, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Chen J, Liu J. Characterization of the structure of anti-thrombin-binding heparan sulfate generated by heparan sulfate 3-O-sulfotransferase 5.	[('PMC6996235', 'F23001', 103, 141, 'heparan sulfate 3-O-sulfotransferase 5')]	['Chen', 'J', ',', 'Liu', 'J', '.', 'Character', '##ization', 'of', 'the', 'structure', 'of', 'anti', '-', 'thrombin', '-', 'binding', 'hepar', '##an', 'sulfate', 'generated', 'by', 'hepar', '##an', 'sulfate', '3', '-', 'O', '-', 'sulf', '##otransferase', '5', '.']	[0, 5, 6, 8, 12, 13, 15, 24, 32, 35, 39, 49, 52, 56, 57, 65, 66, 74, 79, 82, 90, 100, 103, 108, 111, 119, 120, 121, 122, 123, 127, 140, 141]	[4, 6, 7, 11, 13, 14, 24, 31, 34, 38, 48, 51, 56, 57, 65, 66, 73, 79, 81, 89, 99, 102, 108, 110, 118, 120, 121, 122, 123, 127, 139, 141, 142]	['Chen', 'J', ',', 'Liu', 'J', '.', 'Characterization', 'of', 'the', 'structure', 'of', 'anti-thrombin-', 'binding', 'heparan', 'sulfate', 'generated', 'by', 'heparan', 'sulfate', '3-O-sulfotransferase', '5', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 2, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
Reconstitution and characterization of the Vibrio cholerae vibriobactin synthetase from VibB, VibE, VibF, and VibH.Biochemistry3915522–15530.	[('PMC7005843', 'F100001', 72, 82, 'synthetase')]	['Recons', '##titution', 'and', 'character', '##ization', 'of', 'the', 'Vi', '##br', '##io', 'chol', '##era', '##e', 'vibr', '##io', '##ba', '##ct', '##in', 'synthe', '##tase', 'from', 'Vi', '##bB', ',', 'Vi', '##b', '##E', ',', 'Vi', '##b', '##F', ',', 'and', 'Vi', '##b', '##H', '.', 'Biochemistry', '##39', '##155', '##22', '–', '155', '##30', '.']	[0, 6, 15, 19, 28, 36, 39, 43, 45, 47, 50, 54, 57, 59, 63, 65, 67, 69, 72, 78, 83, 88, 90, 92, 94, 96, 97, 98, 100, 102, 103, 104, 106, 110, 112, 113, 114, 115, 127, 129, 132, 134, 135, 138, 140]	[6, 14, 18, 28, 35, 38, 42, 45, 47, 49, 54, 57, 58, 63, 65, 67, 69, 71, 78, 82, 87, 90, 92, 93, 96, 97, 98, 99, 102, 103, 104, 105, 109, 112, 113, 114, 115, 127, 129, 132, 134, 135, 138, 140, 141]	['Reconstitution', 'and', 'characterization', 'of', 'the', 'Vibrio', 'cholerae', 'vibriobactin', 'synthetase', 'from', 'VibB', ',', 'VibE', ',', 'VibF', ',', 'and', 'VibH.Biochemistry3915522', '–', '15530', '.']	[2, 1, 2, 1, 1, 3, 3, 5, 2, 1, 2, 1, 3, 1, 3, 1, 1, 8, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Differential expression of two siderophore-dependent iron-acquisition pathways in Erwinia chrysanthemi 3937: characterization of a novel ferrisiderophore permease of the ABC transporter family.	[('PMC7005843', 'F118001', 154, 162, 'permease')]	['Differential', 'expression', 'of', 'two', 'side', '##roph', '##ore', '-', 'dependent', 'iron', '-', 'acquisition', 'pathways', 'in', 'Er', '##win', '##ia', 'chr', '##ys', '##anth', '##emi', '39', '##37', ':', 'character', '##ization', 'of', 'a', 'novel', 'fer', '##ris', '##ider', '##ophore', 'perme', '##ase', 'of', 'the', 'ABC', 'transporter', 'family', '.']	[0, 13, 24, 27, 31, 35, 39, 42, 43, 53, 57, 58, 70, 79, 82, 84, 87, 90, 93, 95, 99, 103, 105, 107, 109, 118, 126, 129, 131, 137, 140, 143, 147, 154, 159, 163, 166, 170, 174, 186, 192]	[12, 23, 26, 30, 35, 39, 42, 43, 52, 57, 58, 69, 78, 81, 84, 87, 89, 93, 95, 99, 102, 105, 107, 108, 118, 125, 128, 130, 136, 140, 143, 147, 153, 159, 162, 165, 169, 173, 185, 192, 193]	['Differential', 'expression', 'of', 'two', 'siderophore', '-', 'dependent', 'iron', '-', 'acquisition', 'pathways', 'in', 'Erwinia', 'chrysanthemi', '3937', ':', 'characterization', 'of', 'a', 'novel', 'ferrisiderophore', 'permease', 'of', 'the', 'ABC', 'transporter', 'family', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 4, 2, 1, 2, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Roles of distal Asp in heme oxygenase from Corynebacterium diptheriae, HmuO: a water-driven oxygen activation mechanism.	[('PMC7005843', 'F120001', 23, 37, 'heme oxygenase')]	['Role', '##s', 'of', 'distal', 'Asp', 'in', 'heme', 'oxygen', '##ase', 'from', 'Cor', '##yn', '##eb', '##acterium', 'dip', '##ther', '##iae', ',', 'H', '##mu', '##O', ':', 'a', 'water', '-', 'driven', 'oxygen', 'activation', 'mechanism', '.']	[0, 4, 6, 9, 16, 20, 23, 28, 34, 38, 43, 46, 48, 50, 59, 62, 66, 69, 71, 72, 74, 75, 77, 79, 84, 85, 92, 99, 110, 119]	[4, 5, 8, 15, 19, 22, 27, 34, 37, 42, 46, 48, 50, 58, 62, 66, 69, 70, 72, 74, 75, 76, 78, 84, 85, 91, 98, 109, 119, 120]	['Roles', 'of', 'distal', 'Asp', 'in', 'heme', 'oxygenase', 'from', 'Corynebacterium', 'diptheriae', ',', 'HmuO', ':', 'a', 'water', '-', 'driven', 'oxygen', 'activation', 'mechanism', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 4, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacillus subtilis HmoB is a heme oxygenase with a novel structure.	[('PMC7005843', 'F139001', 28, 42, 'heme oxygenase')]	['Bacillus', 'subtilis', 'H', '##mo', '##B', 'is', 'a', 'heme', 'oxygen', '##ase', 'with', 'a', 'novel', 'structure', '.']	[0, 9, 18, 19, 21, 23, 26, 28, 33, 39, 43, 48, 50, 56, 65]	[8, 17, 19, 21, 22, 25, 27, 32, 39, 42, 47, 49, 55, 65, 66]	['Bacillus', 'subtilis', 'HmoB', 'is', 'a', 'heme', 'oxygenase', 'with', 'a', 'novel', 'structure', '.']	[1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Structure of the Escherichia coli O157:H7 heme oxygenase ChuS in complex with heme and enzymatic inactivation by mutation of the heme coordinating residue His-193.J. Biol.	[('PMC7005843', 'F167001', 42, 56, 'heme oxygenase')]	['Structure', 'of', 'the', 'Escherichia', 'coli', 'O', '##157', ':', 'H', '##7', 'heme', 'oxygen', '##ase', 'Chu', '##S', 'in', 'complex', 'with', 'heme', 'and', 'enzymatic', 'inactivation', 'by', 'mutation', 'of', 'the', 'heme', 'coordinating', 'residue', 'His', '-', '193', '.', 'J', '.', 'Biol', '.']	[0, 10, 13, 17, 29, 34, 35, 38, 39, 40, 42, 47, 53, 57, 60, 62, 65, 73, 78, 83, 87, 97, 110, 113, 122, 125, 129, 134, 147, 155, 158, 159, 162, 163, 164, 166, 170]	[9, 12, 16, 28, 33, 35, 38, 39, 40, 41, 46, 53, 56, 60, 61, 64, 72, 77, 82, 86, 96, 109, 112, 121, 124, 128, 133, 146, 154, 158, 159, 162, 163, 164, 165, 170, 171]	['Structure', 'of', 'the', 'Escherichia', 'coli', 'O157', ':', 'H7', 'heme', 'oxygenase', 'ChuS', 'in', 'complex', 'with', 'heme', 'and', 'enzymatic', 'inactivation', 'by', 'mutation', 'of', 'the', 'heme', 'coordinating', 'residue', 'His-193.J', '.', 'Biol', '.']	[1, 1, 1, 1, 1, 2, 1, 2, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fur and the novel regulator YqjI control transcription of the ferric reductase gene yqjH in Escherichia coli.	[('PMC7005843', 'F186001', 62, 78, 'ferric reductase')]	['Fur', 'and', 'the', 'novel', 'regulator', 'Y', '##q', '##j', '##I', 'control', 'transcription', 'of', 'the', 'fer', '##ric', 'reductase', 'gene', 'y', '##q', '##j', '##H', 'in', 'Escherichia', 'coli', '.']	[0, 4, 8, 12, 18, 28, 29, 30, 31, 33, 41, 55, 58, 62, 65, 69, 79, 84, 85, 86, 87, 89, 92, 104, 108]	[3, 7, 11, 17, 27, 29, 30, 31, 32, 40, 54, 57, 61, 65, 68, 78, 83, 85, 86, 87, 88, 91, 103, 108, 109]	['Fur', 'and', 'the', 'novel', 'regulator', 'YqjI', 'control', 'transcription', 'of', 'the', 'ferric', 'reductase', 'gene', 'yqjH', 'in', 'Escherichia', 'coli', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Crystal structure of Campylobacter jejuni ChuZ: a split-barrel family heme oxygenase with a novel heme-binding mode.	[('PMC7005843', 'F206001', 70, 84, 'heme oxygenase')]	['Crystal', 'structure', 'of', 'Camp', '##yl', '##obacter', 'je', '##jun', '##i', 'Chu', '##Z', ':', 'a', 'split', '-', 'bar', '##rel', 'family', 'heme', 'oxygen', '##ase', 'with', 'a', 'novel', 'heme', '-', 'binding', 'mode', '.']	[0, 8, 18, 21, 25, 27, 35, 37, 40, 42, 45, 46, 48, 50, 55, 56, 59, 63, 70, 75, 81, 85, 90, 92, 98, 102, 103, 111, 115]	[7, 17, 20, 25, 27, 34, 37, 40, 41, 45, 46, 47, 49, 55, 56, 59, 62, 69, 74, 81, 84, 89, 91, 97, 102, 103, 110, 115, 116]	['Crystal', 'structure', 'of', 'Campylobacter', 'jejuni', 'ChuZ', ':', 'a', 'split', '-', 'barrel', 'family', 'heme', 'oxygenase', 'with', 'a', 'novel', 'heme', '-', 'binding', 'mode', '.']	[1, 1, 1, 3, 3, 2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Overexpression and purification of ferric enterobactin esterase from Escherichia coli.	[('PMC7005843', 'F21001', 35, 63, 'ferric enterobactin esterase')]	['Overexpression', 'and', 'purification', 'of', 'fer', '##ric', 'enter', '##obac', '##tin', 'ester', '##ase', 'from', 'Escherichia', 'coli', '.']	[0, 15, 19, 32, 35, 38, 42, 47, 51, 55, 60, 64, 69, 81, 85]	[14, 18, 31, 34, 38, 41, 47, 51, 54, 60, 63, 68, 80, 85, 86]	['Overexpression', 'and', 'purification', 'of', 'ferric', 'enterobactin', 'esterase', 'from', 'Escherichia', 'coli', '.']	[1, 1, 1, 1, 2, 3, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Ironing out siderophore biosynthesis: a review of non-ribosomal peptide synthetase (non-ribosomal peptide synthetase)-independent siderophore synthetases.	[('PMC7005843', 'F30001', 50, 82, 'non-ribosomal peptide synthetase'), ('PMC7005843', 'F30001', 84, 116, 'non-ribosomal peptide synthetase'), ('PMC7005843', 'F30001', 142, 153, 'synthetases')]	['Iron', '##ing', 'out', 'side', '##roph', '##ore', 'biosynthesis', ':', 'a', 'review', 'of', 'non', '-', 'ribosomal', 'peptide', 'synthe', '##tase', '(', 'non', '-', 'ribosomal', 'peptide', 'synthe', '##tase', ')', '-', 'independent', 'side', '##roph', '##ore', 'synthe', '##tase', '##s', '.']	[0, 4, 8, 12, 16, 20, 24, 36, 38, 40, 47, 50, 53, 54, 64, 72, 78, 83, 84, 87, 88, 98, 106, 112, 116, 117, 118, 130, 134, 138, 142, 148, 152, 153]	[4, 7, 11, 16, 20, 23, 36, 37, 39, 46, 49, 53, 54, 63, 71, 78, 82, 84, 87, 88, 97, 105, 112, 116, 117, 118, 129, 134, 138, 141, 148, 152, 153, 154]	['Ironing', 'out', 'siderophore', 'biosynthesis', ':', 'a', 'review', 'of', 'non', '-', 'ribosomal', 'peptide', 'synthetase', '(', 'non', '-', 'ribosomal', 'peptide', 'synthetase', ')', '-', 'independent', 'siderophore', 'synthetases', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Crystal structures of the NO- and CO-bound heme oxygenase from Neisseriae meningitidis.	[('PMC7005843', 'F63001', 43, 57, 'heme oxygenase')]	['Crystal', 'structures', 'of', 'the', 'NO', '-', 'and', 'CO', '-', 'bound', 'heme', 'oxygen', '##ase', 'from', 'Ne', '##isser', '##iae', 'mening', '##iti', '##dis', '.']	[0, 8, 19, 22, 26, 28, 30, 34, 36, 37, 43, 48, 54, 58, 63, 65, 70, 74, 80, 83, 86]	[7, 18, 21, 25, 28, 29, 33, 36, 37, 42, 47, 54, 57, 62, 65, 70, 73, 80, 83, 86, 87]	['Crystal', 'structures', 'of', 'the', 'NO-', 'and', 'CO', '-', 'bound', 'heme', 'oxygenase', 'from', 'Neisseriae', 'meningitidis', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 3, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Nonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens.	[('PMC7005843', 'F78001', 0, 31, 'Nonribosomal peptide synthetase')]	['Non', '##rib', '##osomal', 'peptide', 'synthe', '##tase', 'biosynthetic', 'clusters', 'of', 'ES', '##KA', '##PE', 'pathogens', '.']	[0, 3, 6, 13, 21, 27, 32, 45, 54, 57, 59, 61, 64, 73]	[3, 6, 12, 20, 27, 31, 44, 53, 56, 59, 61, 63, 73, 74]	['Nonribosomal', 'peptide', 'synthetase', 'biosynthetic', 'clusters', 'of', 'ESKAPE', 'pathogens', '.']	[3, 1, 2, 1, 1, 1, 3, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Crystal structure of HugZ, a novel heme oxygenase from Helicobacter pylori.	[('PMC7005843', 'F86001', 35, 49, 'heme oxygenase')]	['Crystal', 'structure', 'of', 'Hug', '##Z', ',', 'a', 'novel', 'heme', 'oxygen', '##ase', 'from', 'Helic', '##obacter', 'pylori', '.']	[0, 8, 18, 21, 24, 25, 27, 29, 35, 40, 46, 50, 55, 60, 68, 74]	[7, 17, 20, 24, 25, 26, 28, 34, 39, 46, 49, 54, 60, 67, 74, 75]	['Crystal', 'structure', 'of', 'HugZ', ',', 'a', 'novel', 'heme', 'oxygenase', 'from', 'Helicobacter', 'pylori', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
For determination of iron oxidation potential, we included the candidate iron oxidase from acidophilic and neutrophilic iron-oxidizing bacteria, Cyc2 (Barco et al., 2015).	[('PMC7005843', 'M05000', 73, 85, 'iron oxidase')]	['For', 'determination', 'of', 'iron', 'oxidation', 'potential', ',', 'we', 'included', 'the', 'candidate', 'iron', 'oxidase', 'from', 'acid', '##ophilic', 'and', 'neutrophil', '##ic', 'iron', '-', 'oxid', '##izing', 'bacteria', ',', 'Cyc', '##2', '(', 'Barc', '##o', 'et', 'al', '.', ',', '2015', ')', '.']	[0, 4, 18, 21, 26, 36, 45, 47, 50, 59, 63, 73, 78, 86, 91, 95, 103, 107, 117, 120, 124, 125, 129, 135, 143, 145, 148, 150, 151, 155, 157, 160, 162, 163, 165, 169, 170]	[3, 17, 20, 25, 35, 45, 46, 49, 58, 62, 72, 77, 85, 90, 95, 102, 106, 117, 119, 124, 125, 129, 134, 143, 144, 148, 149, 151, 155, 156, 159, 162, 163, 164, 169, 170, 171]	['For', 'determination', 'of', 'iron', 'oxidation', 'potential', ',', 'we', 'included', 'the', 'candidate', 'iron', 'oxidase', 'from', 'acidophilic', 'and', 'neutrophilic', 'iron', '-', 'oxidizing', 'bacteria', ',', 'Cyc2', '(', 'Barco', 'et', 'al', '.', ',', '2015', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cluster 1 includes sequences from most known, well-established neutrophilic iron-oxidizers but is yet to be genetically or biochemically verified as an iron oxidase.	[('PMC7005843', 'M05002', 152, 164, 'iron oxidase')]	['Cluster', '1', 'includes', 'sequences', 'from', 'most', 'known', ',', 'well', '-', 'established', 'neutrophil', '##ic', 'iron', '-', 'oxid', '##izers', 'but', 'is', 'yet', 'to', 'be', 'genetically', 'or', 'biochemical', '##ly', 'verified', 'as', 'an', 'iron', 'oxidase', '.']	[0, 8, 10, 19, 29, 34, 39, 44, 46, 50, 51, 63, 73, 76, 80, 81, 85, 91, 95, 98, 102, 105, 108, 120, 123, 134, 137, 146, 149, 152, 157, 164]	[7, 9, 18, 28, 33, 38, 44, 45, 50, 51, 62, 73, 75, 80, 81, 85, 90, 94, 97, 101, 104, 107, 119, 122, 134, 136, 145, 148, 151, 156, 164, 165]	['Cluster', '1', 'includes', 'sequences', 'from', 'most', 'known', ',', 'well', '-', 'established', 'neutrophilic', 'iron', '-', 'oxidizers', 'but', 'is', 'yet', 'to', 'be', 'genetically', 'or', 'biochemically', 'verified', 'as', 'an', 'iron', 'oxidase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
In light of these ambiguities in the function of MtoA, identification of MtoAB by FeGenie is treated with caution as a potential iron oxidase/reductase.	[('PMC7005843', 'M06008', 129, 151, 'iron oxidase/reductase')]	['In', 'light', 'of', 'these', 'ambigu', '##ities', 'in', 'the', 'function', 'of', 'Mt', '##oA', ',', 'identification', 'of', 'Mt', '##oA', '##B', 'by', 'Fe', '##Gen', '##ie', 'is', 'treated', 'with', 'caution', 'as', 'a', 'potential', 'iron', 'oxidase', '/', 'reductase', '.']	[0, 3, 9, 12, 18, 24, 30, 33, 37, 46, 49, 51, 53, 55, 70, 73, 75, 77, 79, 82, 84, 87, 90, 93, 101, 106, 114, 117, 119, 129, 134, 141, 142, 151]	[2, 8, 11, 17, 24, 29, 32, 36, 45, 48, 51, 53, 54, 69, 72, 75, 77, 78, 81, 84, 87, 89, 92, 100, 105, 113, 116, 118, 128, 133, 141, 142, 151, 152]	['In', 'light', 'of', 'these', 'ambiguities', 'in', 'the', 'function', 'of', 'MtoA', ',', 'identification', 'of', 'MtoAB', 'by', 'FeGenie', 'is', 'treated', 'with', 'caution', 'as', 'a', 'potential', 'iron', 'oxidase', '/', 'reductase', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Microorganisms can synthesize siderophores via the non-ribosomal peptide synthetase (non-ribosomal peptide synthetase) or NIS (non-ribosomal peptide synthetase-independent siderophore) pathways (Carroll and Moore, 2018).	[('PMC7005843', 'M09003', 51, 83, 'non-ribosomal peptide synthetase'), ('PMC7005843', 'M09003', 85, 117, 'non-ribosomal peptide synthetase'), ('PMC7005843', 'M09003', 127, 159, 'non-ribosomal peptide synthetase')]	['Micro', '##organ', '##isms', 'can', 'synthesize', 'side', '##roph', '##ores', 'via', 'the', 'non', '-', 'ribosomal', 'peptide', 'synthe', '##tase', '(', 'non', '-', 'ribosomal', 'peptide', 'synthe', '##tase', ')', 'or', 'NI', '##S', '(', 'non', '-', 'ribosomal', 'peptide', 'synthe', '##tase', '-', 'independent', 'side', '##roph', '##ore', ')', 'pathways', '(', 'Carr', '##oll', 'and', 'Moore', ',', '2018', ')', '.']	[0, 5, 10, 15, 19, 30, 34, 38, 43, 47, 51, 54, 55, 65, 73, 79, 84, 85, 88, 89, 99, 107, 113, 117, 119, 122, 124, 126, 127, 130, 131, 141, 149, 155, 159, 160, 172, 176, 180, 183, 185, 194, 195, 199, 203, 207, 212, 214, 218, 219]	[5, 10, 14, 18, 29, 34, 38, 42, 46, 50, 54, 55, 64, 72, 79, 83, 85, 88, 89, 98, 106, 113, 117, 118, 121, 124, 125, 127, 130, 131, 140, 148, 155, 159, 160, 171, 176, 180, 183, 184, 193, 195, 199, 202, 206, 212, 213, 218, 219, 220]	['Microorganisms', 'can', 'synthesize', 'siderophores', 'via', 'the', 'non', '-', 'ribosomal', 'peptide', 'synthetase', '(', 'non', '-', 'ribosomal', 'peptide', 'synthetase', ')', 'or', 'NIS', '(', 'non', '-', 'ribosomal', 'peptide', 'synthetase', '-', 'independent', 'siderophore', ')', 'pathways', '(', 'Carroll', 'and', 'Moore', ',', '2018', ')', '.']	[3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Heme oxygenase and transport genes define another strategy that microorganisms, especially pathogens, use to obtain iron from their environment.	[('PMC7005843', 'M12000', 0, 14, 'Heme oxygenase')]	['Hem', '##e', 'oxygen', '##ase', 'and', 'transport', 'genes', 'define', 'another', 'strategy', 'that', 'microorganisms', ',', 'especially', 'pathogens', ',', 'use', 'to', 'obtain', 'iron', 'from', 'their', 'environment', '.']	[0, 3, 5, 11, 15, 19, 29, 35, 42, 50, 59, 64, 78, 80, 91, 100, 102, 106, 109, 116, 121, 126, 132, 143]	[3, 4, 11, 14, 18, 28, 34, 41, 49, 58, 63, 78, 79, 90, 100, 101, 105, 108, 115, 120, 125, 131, 143, 144]	['Heme', 'oxygenase', 'and', 'transport', 'genes', 'define', 'another', 'strategy', 'that', 'microorganisms', ',', 'especially', 'pathogens', ',', 'use', 'to', 'obtain', 'iron', 'from', 'their', 'environment', '.']	[2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In particular, heme oxygenases enable pathogens to obtain iron from a host through oxidative cleavage of heme, thereby releasing iron (Wilks and Heinzl, 2014).	[('PMC7005843', 'M12001', 15, 30, 'heme oxygenases')]	['In', 'particular', ',', 'heme', 'oxygen', '##ases', 'enable', 'pathogens', 'to', 'obtain', 'iron', 'from', 'a', 'host', 'through', 'oxidative', 'cleavage', 'of', 'heme', ',', 'thereby', 'releasing', 'iron', '(', 'Wil', '##ks', 'and', 'Hein', '##z', '##l', ',', '2014', ')', '.']	[0, 3, 13, 15, 20, 26, 31, 38, 48, 51, 58, 63, 68, 70, 75, 83, 93, 102, 105, 109, 111, 119, 129, 134, 135, 138, 141, 145, 149, 150, 151, 153, 157, 158]	[2, 13, 14, 19, 26, 30, 37, 47, 50, 57, 62, 67, 69, 74, 82, 92, 101, 104, 109, 110, 118, 128, 133, 135, 138, 140, 144, 149, 150, 151, 152, 157, 158, 159]	['In', 'particular', ',', 'heme', 'oxygenases', 'enable', 'pathogens', 'to', 'obtain', 'iron', 'from', 'a', 'host', 'through', 'oxidative', 'cleavage', 'of', 'heme', ',', 'thereby', 'releasing', 'iron', '(', 'Wilks', 'and', 'Heinzl', ',', '2014', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Heme oxygenases are categorized into two groups: (1) “canonical” heme oxygenases (HmuO, PigA, and HemO), which degrade heme to biliverdin and carbon monoxide, and (2) “non-canonical” heme oxygenases (IsdG, IsdI, MhuD, and Isd-LmHde), which degrade heme to products like staphylobilin (IsdG and IsdI) and mycobilin (MhuD) (Wilks and Heinzl, 2014).	[('PMC7005843', 'M12002', 0, 15, 'Heme oxygenases'), ('PMC7005843', 'M12002', 65, 80, 'heme oxygenases'), ('PMC7005843', 'M12002', 183, 198, 'heme oxygenases')]	['Hem', '##e', 'oxygen', '##ases', 'are', 'categorized', 'into', 'two', 'groups', ':', '(', '1', ')', '“', 'canonical', '”', 'heme', 'oxygen', '##ases', '(', 'H', '##mu', '##O', ',', 'Pig', '##A', ',', 'and', 'Hem', '##O', ')', ',', 'which', 'degrade', 'heme', 'to', 'bil', '##iver', '##din', 'and', 'carbon', 'mono', '##xi', '##de', ',', 'and', '(', '2', ')', '“', 'non', '-', 'canonical', '”', 'heme', 'oxygen', '##ases', '(', 'Is', '##d', '##G', ',', 'Is', '##d', '##I', ',', 'M', '##hu', '##D', ',', 'and', 'Is', '##d', '-', 'L', '##m', '##H', '##de', ')', ',', 'which', 'degrade', 'heme', 'to', 'products', 'like', 'st', '##aphyl', '##obil', '##in', '(', 'Is', '##d', '##G', 'and', 'Is', '##d', '##I', ')', 'and', 'myc', '##obil', '##in', '(', 'M', '##hu', '##D', ')', '(', 'Wil', '##ks', 'and', 'Hein', '##z', '##l', ',', '2014', ')', '.']	[0, 3, 5, 11, 16, 20, 32, 37, 41, 47, 49, 50, 51, 53, 54, 63, 65, 70, 76, 81, 82, 83, 85, 86, 88, 91, 92, 94, 98, 101, 102, 103, 105, 111, 119, 124, 127, 130, 134, 138, 142, 149, 153, 155, 157, 159, 163, 164, 165, 167, 168, 171, 172, 181, 183, 188, 194, 199, 200, 202, 203, 204, 206, 208, 209, 210, 212, 213, 215, 216, 218, 222, 224, 225, 226, 227, 228, 229, 231, 232, 234, 240, 248, 253, 256, 265, 270, 272, 277, 281, 284, 285, 287, 288, 290, 294, 296, 297, 298, 300, 304, 307, 311, 314, 315, 316, 318, 319, 321, 322, 325, 328, 332, 336, 337, 338, 340, 344, 345]	[3, 4, 11, 15, 19, 31, 36, 40, 47, 48, 50, 51, 52, 54, 63, 64, 69, 76, 80, 82, 83, 85, 86, 87, 91, 92, 93, 97, 101, 102, 103, 104, 110, 118, 123, 126, 130, 134, 137, 141, 148, 153, 155, 157, 158, 162, 164, 165, 166, 168, 171, 172, 181, 182, 187, 194, 198, 200, 202, 203, 204, 205, 208, 209, 210, 211, 213, 215, 216, 217, 221, 224, 225, 226, 227, 228, 229, 231, 232, 233, 239, 247, 252, 255, 264, 269, 272, 277, 281, 283, 285, 287, 288, 289, 293, 296, 297, 298, 299, 303, 307, 311, 313, 315, 316, 318, 319, 320, 322, 325, 327, 331, 336, 337, 338, 339, 344, 345, 346]	['Heme', 'oxygenases', 'are', 'categorized', 'into', 'two', 'groups', ':', '(', '1', ')', '“', 'canonical', '”', 'heme', 'oxygenases', '(', 'HmuO', ',', 'PigA', ',', 'and', 'HemO', ')', ',', 'which', 'degrade', 'heme', 'to', 'biliverdin', 'and', 'carbon', 'monoxide', ',', 'and', '(', '2', ')', '“', 'non', '-', 'canonical', '”', 'heme', 'oxygenases', '(', 'IsdG', ',', 'IsdI', ',', 'MhuD', ',', 'and', 'Isd-LmHde', ')', ',', 'which', 'degrade', 'heme', 'to', 'products', 'like', 'staphylobilin', '(', 'IsdG', 'and', 'IsdI', ')', 'and', 'mycobilin', '(', 'MhuD', ')', '(', 'Wilks', 'and', 'Heinzl', ',', '2014', ')', '.']	[2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 3, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 3, 1, 1, 3, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All these heme oxygenase genes are included in FeGenie’s HMM library.	[('PMC7005843', 'M12003', 10, 24, 'heme oxygenase')]	['All', 'these', 'heme', 'oxygen', '##ase', 'genes', 'are', 'included', 'in', 'Fe', '##Gen', '##ie', '’', 's', 'HMM', 'library', '.']	[0, 4, 10, 15, 21, 25, 31, 35, 44, 47, 49, 52, 54, 55, 57, 61, 68]	[3, 9, 14, 21, 24, 30, 34, 43, 46, 49, 52, 54, 55, 56, 60, 68, 69]	['All', 'these', 'heme', 'oxygenase', 'genes', 'are', 'included', 'in', 'FeGenie’s', 'HMM', 'library', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This same operon also encodes a catalase (not included in FeGenie), which is a heme-containing protein that deals with oxidative stress and may potentially be expressed together with the iron-reduction genes to deal with the oxidative stress of high intracellular iron concentrations (Touati, 2000), likely resulting from dissimilatory iron reduction.	[('PMC7005843', 'R02003', 32, 40, 'catalase')]	['This', 'same', 'oper', '##on', 'also', 'encodes', 'a', 'catalase', '(', 'not', 'included', 'in', 'Fe', '##Gen', '##ie', ')', ',', 'which', 'is', 'a', 'heme', '-', 'containing', 'protein', 'that', 'deals', 'with', 'oxidative', 'stress', 'and', 'may', 'potentially', 'be', 'expressed', 'together', 'with', 'the', 'iron', '-', 'reduction', 'genes', 'to', 'deal', 'with', 'the', 'oxidative', 'stress', 'of', 'high', 'intracellular', 'iron', 'concentrations', '(', 'To', '##ua', '##ti', ',', '2000', ')', ',', 'likely', 'resulting', 'from', 'diss', '##imi', '##lat', '##ory', 'iron', 'reduction', '.']	[0, 5, 10, 14, 17, 22, 30, 32, 41, 42, 46, 55, 58, 60, 63, 65, 66, 68, 74, 77, 79, 83, 84, 95, 103, 108, 114, 119, 129, 136, 140, 144, 156, 159, 169, 178, 183, 187, 191, 192, 202, 208, 211, 216, 221, 225, 235, 242, 245, 250, 264, 269, 284, 285, 287, 289, 291, 293, 297, 298, 300, 307, 317, 322, 326, 329, 332, 336, 341, 350]	[4, 9, 14, 16, 21, 29, 31, 40, 42, 45, 54, 57, 60, 63, 65, 66, 67, 73, 76, 78, 83, 84, 94, 102, 107, 113, 118, 128, 135, 139, 143, 155, 158, 168, 177, 182, 186, 191, 192, 201, 207, 210, 215, 220, 224, 234, 241, 244, 249, 263, 268, 283, 285, 287, 289, 291, 292, 297, 298, 299, 306, 316, 321, 326, 329, 332, 335, 340, 350, 351]	['This', 'same', 'operon', 'also', 'encodes', 'a', 'catalase', '(', 'not', 'included', 'in', 'FeGenie', ')', ',', 'which', 'is', 'a', 'heme', '-', 'containing', 'protein', 'that', 'deals', 'with', 'oxidative', 'stress', 'and', 'may', 'potentially', 'be', 'expressed', 'together', 'with', 'the', 'iron', '-', 'reduction', 'genes', 'to', 'deal', 'with', 'the', 'oxidative', 'stress', 'of', 'high', 'intracellular', 'iron', 'concentrations', '(', 'Touati', ',', '2000', ')', ',', 'likely', 'resulting', 'from', 'dissimilatory', 'iron', 'reduction', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This gene has been confirmed as an iron-oxidase in Acidithiobacillus ferrooxidans (Castelle et al., 2008) and is also encoded by neutrophilic, obligate iron-oxidizers (Barco et al., 2015).	[('PMC7005843', 'R03001', 35, 47, 'iron-oxidase')]	['This', 'gene', 'has', 'been', 'confirmed', 'as', 'an', 'iron', '-', 'oxidase', 'in', 'Acid', '##ithi', '##obacillus', 'fer', '##ro', '##oxid', '##ans', '(', 'Cast', '##elle', 'et', 'al', '.', ',', '2008', ')', 'and', 'is', 'also', 'encoded', 'by', 'neutrophil', '##ic', ',', 'oblig', '##ate', 'iron', '-', 'oxid', '##izers', '(', 'Barc', '##o', 'et', 'al', '.', ',', '2015', ')', '.']	[0, 5, 10, 14, 19, 29, 32, 35, 39, 40, 48, 51, 55, 59, 69, 72, 74, 78, 82, 83, 87, 92, 95, 97, 98, 100, 104, 106, 110, 113, 118, 126, 129, 139, 141, 143, 148, 152, 156, 157, 161, 167, 168, 172, 174, 177, 179, 180, 182, 186, 187]	[4, 9, 13, 18, 28, 31, 34, 39, 40, 47, 50, 55, 59, 68, 72, 74, 78, 81, 83, 87, 91, 94, 97, 98, 99, 104, 105, 109, 112, 117, 125, 128, 139, 141, 142, 148, 151, 156, 157, 161, 166, 168, 172, 173, 176, 179, 180, 181, 186, 187, 188]	['This', 'gene', 'has', 'been', 'confirmed', 'as', 'an', 'iron', '-', 'oxidase', 'in', 'Acidithiobacillus', 'ferrooxidans', '(', 'Castelle', 'et', 'al', '.', ',', '2008', ')', 'and', 'is', 'also', 'encoded', 'by', 'neutrophilic', ',', 'obligate', 'iron', '-', 'oxidizers', '(', 'Barco', 'et', 'al', '.', ',', '2015', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We note that only one of these cluster 3-affiliated Cyc2 homologs, Cyt572, has been biochemically characterized and determined to have iron oxidase activity (Jeans et al., 2008).	[('PMC7005843', 'R03002', 135, 147, 'iron oxidase')]	['We', 'note', 'that', 'only', 'one', 'of', 'these', 'cluster', '3', '-', 'affili', '##ated', 'Cyc', '##2', 'homolog', '##s', ',', 'Cyt', '##57', '##2', ',', 'has', 'been', 'biochemical', '##ly', 'characterized', 'and', 'determined', 'to', 'have', 'iron', 'oxidase', 'activity', '(', 'Jean', '##s', 'et', 'al', '.', ',', '2008', ')', '.']	[0, 3, 8, 13, 18, 22, 25, 31, 39, 40, 41, 47, 52, 55, 57, 64, 65, 67, 70, 72, 73, 75, 79, 84, 95, 98, 112, 116, 127, 130, 135, 140, 148, 157, 158, 162, 164, 167, 169, 170, 172, 176, 177]	[2, 7, 12, 17, 21, 24, 30, 38, 40, 41, 47, 51, 55, 56, 64, 65, 66, 70, 72, 73, 74, 78, 83, 95, 97, 111, 115, 126, 129, 134, 139, 147, 156, 158, 162, 163, 166, 169, 170, 171, 176, 177, 178]	['We', 'note', 'that', 'only', 'one', 'of', 'these', 'cluster', '3-affiliated', 'Cyc2', 'homologs', ',', 'Cyt572', ',', 'has', 'been', 'biochemically', 'characterized', 'and', 'determined', 'to', 'have', 'iron', 'oxidase', 'activity', '(', 'Jeans', 'et', 'al', '.', ',', '2008', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Without any other candidate iron reductases in AMB-1’s genome, this indicates that MtrAB may be utilized in iron reduction without the outer-membrane component.	[('PMC7005843', 'R04004', 28, 43, 'iron reductases')]	['Without', 'any', 'other', 'candidate', 'iron', 'reductase', '##s', 'in', 'AM', '##B', '-', '1', '’', 's', 'genome', ',', 'this', 'indicates', 'that', 'Mt', '##r', '##AB', 'may', 'be', 'utilized', 'in', 'iron', 'reduction', 'without', 'the', 'outer', '-', 'membrane', 'component', '.']	[0, 8, 12, 18, 28, 33, 42, 44, 47, 49, 50, 51, 52, 53, 55, 61, 63, 68, 78, 83, 85, 86, 89, 93, 96, 105, 108, 113, 123, 131, 135, 140, 141, 150, 159]	[7, 11, 17, 27, 32, 42, 43, 46, 49, 50, 51, 52, 53, 54, 61, 62, 67, 77, 82, 85, 86, 88, 92, 95, 104, 107, 112, 122, 130, 134, 140, 141, 149, 159, 160]	['Without', 'any', 'other', 'candidate', 'iron', 'reductases', 'in', 'AMB-1’s', 'genome', ',', 'this', 'indicates', 'that', 'MtrAB', 'may', 'be', 'utilized', 'in', 'iron', 'reduction', 'without', 'the', 'outer', '-', 'membrane', 'component', '.']	[1, 1, 1, 1, 1, 2, 1, 6, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
FeGenie was also used to identify iron acquisition and transport genes in model microorganisms, including siderophore transport and synthesis genes, heme transport and oxygenases, and Fe(II)/Fe(III) transport.	[('PMC7005843', 'R05000', 168, 178, 'oxygenases')]	['Fe', '##Gen', '##ie', 'was', 'also', 'used', 'to', 'identify', 'iron', 'acquisition', 'and', 'transport', 'genes', 'in', 'model', 'microorganisms', ',', 'including', 'side', '##roph', '##ore', 'transport', 'and', 'synthesis', 'genes', ',', 'heme', 'transport', 'and', 'oxygen', '##ases', ',', 'and', 'Fe', '(', 'II', ')', '/', 'Fe', '(', 'III', ')', 'transport', '.']	[0, 2, 5, 8, 12, 17, 22, 25, 34, 39, 51, 55, 65, 71, 74, 80, 94, 96, 106, 110, 114, 118, 128, 132, 142, 147, 149, 154, 164, 168, 174, 178, 180, 184, 186, 187, 189, 190, 191, 193, 194, 197, 199, 208]	[2, 5, 7, 11, 16, 21, 24, 33, 38, 50, 54, 64, 70, 73, 79, 94, 95, 105, 110, 114, 117, 127, 131, 141, 147, 148, 153, 163, 167, 174, 178, 179, 183, 186, 187, 189, 190, 191, 193, 194, 197, 198, 208, 209]	['FeGenie', 'was', 'also', 'used', 'to', 'identify', 'iron', 'acquisition', 'and', 'transport', 'genes', 'in', 'model', 'microorganisms', ',', 'including', 'siderophore', 'transport', 'and', 'synthesis', 'genes', ',', 'heme', 'transport', 'and', 'oxygenases', ',', 'and', 'Fe', '(II)', '/', 'Fe', '(III)', 'transport', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Indeed, T. pallidum has been reported to bind host lactoferrin and transferrin (Alderete et al., 1988), and may do so using the permease and ATP-binding protein identified by FeGenie (Supplementary Data Sheet S5).	[('PMC7005843', 'R10008', 128, 136, 'permease')]	['Indeed', ',', 'T', '.', 'pall', '##id', '##um', 'has', 'been', 'reported', 'to', 'bind', 'host', 'lact', '##of', '##err', '##in', 'and', 'transfer', '##rin', '(', 'Al', '##der', '##ete', 'et', 'al', '.', ',', '1988', ')', ',', 'and', 'may', 'do', 'so', 'using', 'the', 'perme', '##ase', 'and', 'ATP', '-', 'binding', 'protein', 'identified', 'by', 'Fe', '##Gen', '##ie', '(', 'Supplementary', 'Data', 'She', '##et', 'S', '##5', ')', '.']	[0, 6, 8, 9, 11, 15, 17, 20, 24, 29, 38, 41, 46, 51, 55, 57, 60, 63, 67, 75, 79, 80, 82, 85, 89, 92, 94, 95, 97, 101, 102, 104, 108, 112, 115, 118, 124, 128, 133, 137, 141, 144, 145, 153, 161, 172, 175, 177, 180, 183, 184, 198, 203, 206, 209, 210, 211, 212]	[6, 7, 9, 10, 15, 17, 19, 23, 28, 37, 40, 45, 50, 55, 57, 60, 62, 66, 75, 78, 80, 82, 85, 88, 91, 94, 95, 96, 101, 102, 103, 107, 111, 114, 117, 123, 127, 133, 136, 140, 144, 145, 152, 160, 171, 174, 177, 180, 182, 184, 197, 202, 206, 208, 210, 211, 212, 213]	['Indeed', ',', 'T', '.', 'pallidum', 'has', 'been', 'reported', 'to', 'bind', 'host', 'lactoferrin', 'and', 'transferrin', '(', 'Alderete', 'et', 'al', '.', ',', '1988', ')', ',', 'and', 'may', 'do', 'so', 'using', 'the', 'permease', 'and', 'ATP', '-', 'binding', 'protein', 'identified', 'by', 'FeGenie', '(', 'Supplementary', 'Data', 'Sheet', 'S5', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glutamine resulted from the glutamine synthetase (glutamine synthetase) reaction between glutamate and ammonia in an ATP-dependent manner.	[('PMC7016798', 'D02010', 28, 48, 'glutamine synthetase'), ('PMC7016798', 'D02010', 50, 70, 'glutamine synthetase')]	['Glut', '##amine', 'resulted', 'from', 'the', 'glutamine', 'synthe', '##tase', '(', 'glutamine', 'synthe', '##tase', ')', 'reaction', 'between', 'glutamate', 'and', 'ammonia', 'in', 'an', 'ATP', '-', 'dependent', 'manner', '.']	[0, 4, 10, 19, 24, 28, 38, 44, 49, 50, 60, 66, 70, 72, 81, 89, 99, 103, 111, 114, 117, 120, 121, 131, 137]	[4, 9, 18, 23, 27, 37, 44, 48, 50, 59, 66, 70, 71, 80, 88, 98, 102, 110, 113, 116, 120, 121, 130, 137, 138]	['Glutamine', 'resulted', 'from', 'the', 'glutamine', 'synthetase', '(', 'glutamine', 'synthetase', ')', 'reaction', 'between', 'glutamate', 'and', 'ammonia', 'in', 'an', 'ATP-dependent', 'manner', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Consistently, glutamine synthetase is a marker of HCC, and its high expression may increase the metastatic potential in HCC patients [34].	[('PMC7016798', 'D02011', 14, 34, 'glutamine synthetase')]	['Consistent', '##ly', ',', 'glutamine', 'synthe', '##tase', 'is', 'a', 'marker', 'of', 'HCC', ',', 'and', 'its', 'high', 'expression', 'may', 'increase', 'the', 'metastatic', 'potential', 'in', 'HCC', 'patients', '[', '34', ']', '.']	[0, 10, 12, 14, 24, 30, 35, 38, 40, 47, 50, 53, 55, 59, 63, 68, 79, 83, 92, 96, 107, 117, 120, 124, 133, 134, 136, 137]	[10, 12, 13, 23, 30, 34, 37, 39, 46, 49, 53, 54, 58, 62, 67, 78, 82, 91, 95, 106, 116, 119, 123, 132, 134, 136, 137, 138]	['Consistently', ',', 'glutamine', 'synthetase', 'is', 'a', 'marker', 'of', 'HCC', ',', 'and', 'its', 'high', 'expression', 'may', 'increase', 'the', 'metastatic', 'potential', 'in', 'HCC', 'patients', '[', '34', ']', '.']	[2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recently, it has been reported that a high level of blood serine/glycine might form a protective niche for the maintenance of leukemia cells in xenografted mice [37], and that a downregulation of the glycine decarboxylase, an enzyme involved in glycine catabolism, enhances HCC progression and intrahepatic metastasis [38].	[('PMC7016798', 'D03002', 200, 221, 'glycine decarboxylase')]	['Recently', ',', 'it', 'has', 'been', 'reported', 'that', 'a', 'high', 'level', 'of', 'blood', 'serine', '/', 'glycine', 'might', 'form', 'a', 'protective', 'niche', 'for', 'the', 'maintenance', 'of', 'leukemia', 'cells', 'in', 'xen', '##ograft', '##ed', 'mice', '[', '37', ']', ',', 'and', 'that', 'a', 'downregulation', 'of', 'the', 'glycine', 'dec', '##arboxyl', '##ase', ',', 'an', 'enzyme', 'involved', 'in', 'glycine', 'cat', '##abolism', ',', 'enhances', 'HCC', 'progression', 'and', 'intra', '##hepatic', 'metastasis', '[', '38', ']', '.']	[0, 8, 10, 13, 17, 22, 31, 36, 38, 43, 49, 52, 58, 64, 65, 73, 79, 84, 86, 97, 103, 107, 111, 123, 126, 135, 141, 144, 147, 153, 156, 161, 162, 164, 165, 167, 171, 176, 178, 193, 196, 200, 208, 211, 218, 221, 223, 226, 233, 242, 245, 253, 256, 263, 265, 274, 278, 290, 294, 299, 307, 318, 319, 321, 322]	[8, 9, 12, 16, 21, 30, 35, 37, 42, 48, 51, 57, 64, 65, 72, 78, 83, 85, 96, 102, 106, 110, 122, 125, 134, 140, 143, 147, 153, 155, 160, 162, 164, 165, 166, 170, 175, 177, 192, 195, 199, 207, 211, 218, 221, 222, 225, 232, 241, 244, 252, 256, 263, 264, 273, 277, 289, 293, 299, 306, 317, 319, 321, 322, 323]	['Recently', ',', 'it', 'has', 'been', 'reported', 'that', 'a', 'high', 'level', 'of', 'blood', 'serine', '/', 'glycine', 'might', 'form', 'a', 'protective', 'niche', 'for', 'the', 'maintenance', 'of', 'leukemia', 'cells', 'in', 'xenografted', 'mice', '[', '37', ']', ',', 'and', 'that', 'a', 'downregulation', 'of', 'the', 'glycine', 'decarboxylase', ',', 'an', 'enzyme', 'involved', 'in', 'glycine', 'catabolism', ',', 'enhances', 'HCC', 'progression', 'and', 'intrahepatic', 'metastasis', '[', '38', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glutamate can be converted to glutamine by the action of the glutamine synthetase enzyme.	[('PMC7016798', 'D04002', 61, 81, 'glutamine synthetase')]	['Glut', '##amate', 'can', 'be', 'converted', 'to', 'glutamine', 'by', 'the', 'action', 'of', 'the', 'glutamine', 'synthe', '##tase', 'enzyme', '.']	[0, 4, 10, 14, 17, 27, 30, 40, 43, 47, 54, 57, 61, 71, 77, 82, 88]	[4, 9, 13, 16, 26, 29, 39, 42, 46, 53, 56, 60, 70, 77, 81, 88, 89]	['Glutamate', 'can', 'be', 'converted', 'to', 'glutamine', 'by', 'the', 'action', 'of', 'the', 'glutamine', 'synthetase', 'enzyme', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Tyrosine is an amino acid that can be synthesized mainly in the liver from phenylalanine by the phenylalanine hydroxylase enzyme.	[('PMC7016798', 'D07001', 96, 121, 'phenylalanine hydroxylase')]	['Tyr', '##osine', 'is', 'an', 'amino', 'acid', 'that', 'can', 'be', 'synthesized', 'mainly', 'in', 'the', 'liver', 'from', 'phenyl', '##alanine', 'by', 'the', 'phenyl', '##alanine', 'hydroxyl', '##ase', 'enzyme', '.']	[0, 3, 9, 12, 15, 21, 26, 31, 35, 38, 50, 57, 60, 64, 70, 75, 81, 89, 92, 96, 102, 110, 118, 122, 128]	[3, 8, 11, 14, 20, 25, 30, 34, 37, 49, 56, 59, 63, 69, 74, 81, 88, 91, 95, 102, 109, 118, 121, 128, 129]	['Tyrosine', 'is', 'an', 'amino', 'acid', 'that', 'can', 'be', 'synthesized', 'mainly', 'in', 'the', 'liver', 'from', 'phenylalanine', 'by', 'the', 'phenylalanine', 'hydroxylase', 'enzyme', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
It should be noted that the activity of phenylalanine hydroxylase was reduced in biopsies from liver cirrhosis, alcoholic hepatitis and other liver diseases [52].	[('PMC7016798', 'D07002', 40, 65, 'phenylalanine hydroxylase')]	['It', 'should', 'be', 'noted', 'that', 'the', 'activity', 'of', 'phenyl', '##alanine', 'hydroxyl', '##ase', 'was', 'reduced', 'in', 'biopsies', 'from', 'liver', 'cirrhosis', ',', 'alcoholic', 'hepatitis', 'and', 'other', 'liver', 'diseases', '[', '52', ']', '.']	[0, 3, 10, 13, 19, 24, 28, 37, 40, 46, 54, 62, 66, 70, 78, 81, 90, 95, 101, 110, 112, 122, 132, 136, 142, 148, 157, 158, 160, 161]	[2, 9, 12, 18, 23, 27, 36, 39, 46, 53, 62, 65, 69, 77, 80, 89, 94, 100, 110, 111, 121, 131, 135, 141, 147, 156, 158, 160, 161, 162]	['It', 'should', 'be', 'noted', 'that', 'the', 'activity', 'of', 'phenylalanine', 'hydroxylase', 'was', 'reduced', 'in', 'biopsies', 'from', 'liver', 'cirrhosis', ',', 'alcoholic', 'hepatitis', 'and', 'other', 'liver', 'diseases', '[', '52', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, it has been reported that only in the end-stage of liver disease the reaction catalyzed by phenylalanine hydroxylase may be impaired, and such defects can be corrected by transplantation [53].	[('PMC7016798', 'D08001', 106, 131, 'phenylalanine hydroxylase')]	['Interestingly', ',', 'it', 'has', 'been', 'reported', 'that', 'only', 'in', 'the', 'end', '-', 'stage', 'of', 'liver', 'disease', 'the', 'reaction', 'catalyzed', 'by', 'phenyl', '##alanine', 'hydroxyl', '##ase', 'may', 'be', 'impaired', ',', 'and', 'such', 'defects', 'can', 'be', 'corrected', 'by', 'transplantation', '[', '53', ']', '.']	[0, 13, 15, 18, 22, 27, 36, 41, 46, 49, 53, 56, 57, 63, 66, 72, 80, 84, 93, 103, 106, 112, 120, 128, 132, 136, 139, 147, 149, 153, 158, 166, 170, 173, 183, 186, 202, 203, 205, 206]	[13, 14, 17, 21, 26, 35, 40, 45, 48, 52, 56, 57, 62, 65, 71, 79, 83, 92, 102, 105, 112, 119, 128, 131, 135, 138, 147, 148, 152, 157, 165, 169, 172, 182, 185, 201, 203, 205, 206, 207]	['Interestingly', ',', 'it', 'has', 'been', 'reported', 'that', 'only', 'in', 'the', 'end', '-', 'stage', 'of', 'liver', 'disease', 'the', 'reaction', 'catalyzed', 'by', 'phenylalanine', 'hydroxylase', 'may', 'be', 'impaired', ',', 'and', 'such', 'defects', 'can', 'be', 'corrected', 'by', 'transplantation', '[', '53', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Zhuang H., Li Q., Zhang X., Ma X., Wang Z., Liu Y., Yi X., Chen R., Han F., Zhang N. Downregulation of glycine decarboxylase enhanced cofilin-mediated migration in hepatocellular carcinoma cells.	[('PMC7016798', 'F37001', 103, 124, 'glycine decarboxylase')]	['Zhu', '##ang', 'H', '.', ',', 'Li', 'Q', '.', ',', 'Zhang', 'X', '.', ',', 'Ma', 'X', '.', ',', 'Wang', 'Z', '.', ',', 'Liu', 'Y', '.', ',', 'Yi', 'X', '.', ',', 'Chen', 'R', '.', ',', 'Han', 'F', '.', ',', 'Zhang', 'N', '.', 'Down', '##regulation', 'of', 'glycine', 'dec', '##arboxyl', '##ase', 'enhanced', 'co', '##fil', '##in', '-', 'mediated', 'migration', 'in', 'hepatocellular', 'carcinoma', 'cells', '.']	[0, 3, 7, 8, 9, 11, 14, 15, 16, 18, 24, 25, 26, 28, 31, 32, 33, 35, 40, 41, 42, 44, 48, 49, 50, 52, 55, 56, 57, 59, 64, 65, 66, 68, 72, 73, 74, 76, 82, 83, 85, 89, 100, 103, 111, 114, 121, 125, 134, 136, 139, 141, 142, 151, 161, 164, 179, 189, 194]	[3, 6, 8, 9, 10, 13, 15, 16, 17, 23, 25, 26, 27, 30, 32, 33, 34, 39, 41, 42, 43, 47, 49, 50, 51, 54, 56, 57, 58, 63, 65, 66, 67, 71, 73, 74, 75, 81, 83, 84, 89, 99, 102, 110, 114, 121, 124, 133, 136, 139, 141, 142, 150, 160, 163, 178, 188, 194, 195]	['Zhuang', 'H', '.', ',', 'Li', 'Q', '.', ',', 'Zhang', 'X', '.', ',', 'Ma', 'X', '.', ',', 'Wang', 'Z', '.', ',', 'Liu', 'Y', '.', ',', 'Yi', 'X', '.', ',', 'Chen', 'R', '.', ',', 'Han', 'F', '.', ',', 'Zhang', 'N', '.', 'Downregulation', 'of', 'glycine', 'decarboxylase', 'enhanced', 'cofilin', '-', 'mediated', 'migration', 'in', 'hepatocellular', 'carcinoma', 'cells', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Kim W., Yoon J.-H., Jeong J.-M., Cheon G.-J., Lee T.-S., Yang J.-I., Park S.-C., Lee H.-S. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma.	[('PMC7016798', 'F48001', 132, 145, 'hexokinase II')]	['Kim', 'W', '.', ',', 'Y', '##oon', 'J', '.', '-', 'H', '.', ',', 'Je', '##ong', 'J', '.', '-', 'M', '.', ',', 'Che', '##on', 'G', '.', '-', 'J', '.', ',', 'Lee', 'T', '.', '-', 'S', '.', ',', 'Yang', 'J', '.', '-', 'I', '.', ',', 'Park', 'S', '.', '-', 'C', '.', ',', 'Lee', 'H', '.', '-', 'S', '.', 'Apoptosis', '-', 'inducing', 'antitumor', 'efficacy', 'of', 'hex', '##ok', '##inase', 'II', 'inhibitor', 'in', 'hepatocellular', 'carcinoma', '.']	[0, 4, 5, 6, 8, 9, 13, 14, 15, 16, 17, 18, 20, 22, 26, 27, 28, 29, 30, 31, 33, 36, 39, 40, 41, 42, 43, 44, 46, 50, 51, 52, 53, 54, 55, 57, 62, 63, 64, 65, 66, 67, 69, 74, 75, 76, 77, 78, 79, 81, 85, 86, 87, 88, 89, 91, 100, 101, 110, 120, 129, 132, 135, 137, 143, 146, 156, 159, 174, 183]	[3, 5, 6, 7, 9, 12, 14, 15, 16, 17, 18, 19, 22, 25, 27, 28, 29, 30, 31, 32, 36, 38, 40, 41, 42, 43, 44, 45, 49, 51, 52, 53, 54, 55, 56, 61, 63, 64, 65, 66, 67, 68, 73, 75, 76, 77, 78, 79, 80, 84, 86, 87, 88, 89, 90, 100, 101, 109, 119, 128, 131, 135, 137, 142, 145, 155, 158, 173, 183, 184]	['Kim', 'W', '.', ',', 'Yoon', 'J.-H', '.', ',', 'Jeong', 'J.-M', '.', ',', 'Cheon', 'G.-J', '.', ',', 'Lee', 'T.-S', '.', ',', 'Yang', 'J.-I', '.', ',', 'Park', 'S.-C', '.', ',', 'Lee', 'H.-S', '.', 'Apoptosis', '-', 'inducing', 'antitumor', 'efficacy', 'of', 'hexokinase', 'II', 'inhibitor', 'in', 'hepatocellular', 'carcinoma', '.']	[1, 1, 1, 1, 2, 4, 1, 1, 2, 4, 1, 1, 2, 4, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Palmieri D., Fitzgerald D., Shreeve S.M., Hua E., Bronder J.L., Weil R.J., Davis S., Stark A.M., Merino M.J., Kurek R. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.	[('PMC7016798', 'F49001', 228, 240, 'hexokinase 2')]	['Pal', '##mi', '##eri', 'D', '.', ',', 'Fitz', '##ger', '##ald', 'D', '.', ',', 'Sh', '##ree', '##ve', 'S', '.', 'M', '.', ',', 'Hu', '##a', 'E', '.', ',', 'Bron', '##der', 'J', '.', 'L', '.', ',', 'Wei', '##l', 'R', '.', 'J', '.', ',', 'Davis', 'S', '.', ',', 'Star', '##k', 'A', '.', 'M', '.', ',', 'Mer', '##ino', 'M', '.', 'J', '.', ',', 'Kur', '##ek', 'R', '.', 'Analyses', 'of', 'resected', 'human', 'brain', 'metastases', 'of', 'breast', 'cancer', 'reveal', 'the', 'association', 'between', 'up', '-', 'regulation', 'of', 'hex', '##ok', '##inase', '2', 'and', 'poor', 'prognosis', '.']	[0, 3, 5, 9, 10, 11, 13, 17, 20, 24, 25, 26, 28, 30, 33, 36, 37, 38, 39, 40, 42, 44, 46, 47, 48, 50, 54, 58, 59, 60, 61, 62, 64, 67, 69, 70, 71, 72, 73, 75, 81, 82, 83, 85, 89, 91, 92, 93, 94, 95, 97, 100, 104, 105, 106, 107, 108, 110, 113, 116, 117, 119, 128, 131, 140, 146, 152, 163, 166, 173, 180, 187, 191, 203, 211, 213, 214, 225, 228, 231, 233, 239, 241, 245, 250, 259]	[3, 5, 8, 10, 11, 12, 17, 20, 23, 25, 26, 27, 30, 33, 35, 37, 38, 39, 40, 41, 44, 45, 47, 48, 49, 54, 57, 59, 60, 61, 62, 63, 67, 68, 70, 71, 72, 73, 74, 80, 82, 83, 84, 89, 90, 92, 93, 94, 95, 96, 100, 103, 105, 106, 107, 108, 109, 113, 115, 117, 118, 127, 130, 139, 145, 151, 162, 165, 172, 179, 186, 190, 202, 210, 213, 214, 224, 227, 231, 233, 238, 240, 244, 249, 259, 260]	['Palmieri', 'D', '.', ',', 'Fitzgerald', 'D', '.', ',', 'Shreeve', 'S.M', '.', ',', 'Hua', 'E', '.', ',', 'Bronder', 'J.L', '.', ',', 'Weil', 'R.J', '.', ',', 'Davis', 'S', '.', ',', 'Stark', 'A.M', '.', ',', 'Merino', 'M.J', '.', ',', 'Kurek', 'R', '.', 'Analyses', 'of', 'resected', 'human', 'brain', 'metastases', 'of', 'breast', 'cancer', 'reveal', 'the', 'association', 'between', 'up', '-', 'regulation', 'of', 'hexokinase', '2', 'and', 'poor', 'prognosis', '.']	[3, 1, 1, 1, 3, 1, 1, 1, 3, 3, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 2, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Rayasam GV, Tulasi VK, Sodhi R, Davis JA, Ray A. Glycogen synthase kinase 3:More than a namesake.	[('PMC7029203', 'F25001', 49, 75, 'Glycogen synthase kinase 3')]	['Ray', '##asa', '##m', 'GV', ',', 'Tu', '##las', '##i', 'V', '##K', ',', 'So', '##dh', '##i', 'R', ',', 'Davis', 'JA', ',', 'Ray', 'A', '.', 'Gly', '##co', '##gen', 'synthase', 'kinase', '3', ':', 'More', 'than', 'a', 'names', '##ake', '.']	[0, 3, 6, 8, 10, 12, 14, 17, 19, 20, 21, 23, 25, 27, 29, 30, 32, 38, 40, 42, 46, 47, 49, 52, 54, 58, 67, 74, 75, 76, 81, 86, 88, 93, 96]	[3, 6, 7, 10, 11, 14, 17, 18, 20, 21, 22, 25, 27, 28, 30, 31, 37, 40, 41, 45, 47, 48, 52, 54, 57, 66, 73, 75, 76, 80, 85, 87, 93, 96, 97]	['Rayasam', 'GV', ',', 'Tulasi', 'VK', ',', 'Sodhi', 'R', ',', 'Davis', 'JA', ',', 'Ray', 'A', '.', 'Glycogen', 'synthase', 'kinase', '3', ':', 'More', 'than', 'a', 'namesake', '.']	[3, 1, 1, 3, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Rath G, Jawanjal P, Salhan S, Nalliah M, Dhawan I. Clinical significance of inactivated glycogen synthase kinase 3βin HPV-associated cervical cancer:Relationship with Wnt/β-catenin pathway activation.	[('PMC7029203', 'F37001', 88, 115, 'glycogen synthase kinase 3β')]	['Rat', '##h', 'G', ',', 'Ja', '##wan', '##ja', '##l', 'P', ',', 'Sal', '##han', 'S', ',', 'Na', '##ll', '##ia', '##h', 'M', ',', 'Dh', '##awa', '##n', 'I', '.', 'Clinical', 'significance', 'of', 'inactivated', 'glycogen', 'synthase', 'kinase', '3', '##β', '##in', 'HPV', '-', 'associated', 'cervical', 'cancer', ':', 'Relationship', 'with', 'Wnt', '/', 'β', '-', 'cat', '##eni', '##n', 'pathway', 'activation', '.']	[0, 3, 5, 6, 8, 10, 13, 15, 17, 18, 20, 23, 27, 28, 30, 32, 34, 36, 38, 39, 41, 43, 46, 48, 49, 51, 60, 73, 76, 88, 97, 106, 113, 114, 115, 118, 121, 122, 133, 142, 148, 149, 162, 167, 170, 171, 172, 173, 176, 179, 181, 189, 199]	[3, 4, 6, 7, 10, 13, 15, 16, 18, 19, 23, 26, 28, 29, 32, 34, 36, 37, 39, 40, 43, 46, 47, 49, 50, 59, 72, 75, 87, 96, 105, 112, 114, 115, 117, 121, 122, 132, 141, 148, 149, 161, 166, 170, 171, 172, 173, 176, 179, 180, 188, 199, 200]	['Rath', 'G', ',', 'Jawanjal', 'P', ',', 'Salhan', 'S', ',', 'Nalliah', 'M', ',', 'Dhawan', 'I', '.', 'Clinical', 'significance', 'of', 'inactivated', 'glycogen', 'synthase', 'kinase', '3βin', 'HPV-associated', 'cervical', 'cancer', ':', 'Relationship', 'with', 'Wnt', '/', 'β-catenin', 'pathway', 'activation', '.']	[2, 1, 1, 4, 1, 1, 2, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Chen RH, Ding WV, McCormick F. Wnt signaling to beta-catenin involves two interactive components Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. J Biol Chem.	[('PMC7029203', 'F40001', 97, 127, 'Glycogen synthase kinase-3beta'), ('PMC7029203', 'F40001', 157, 173, 'protein kinase C')]	['Chen', 'RH', ',', 'Ding', 'W', '##V', ',', 'McC', '##orm', '##ick', 'F', '.', 'Wnt', 'signaling', 'to', 'beta', '-', 'cat', '##eni', '##n', 'involves', 'two', 'interactive', 'components', 'Gly', '##co', '##gen', 'synthase', 'kinase', '-', '3', '##beta', 'inhibition', 'and', 'activation', 'of', 'protein', 'kinase', 'C', '.', 'J', 'Biol', 'Chem', '.']	[0, 5, 7, 9, 14, 15, 16, 18, 21, 24, 28, 29, 31, 35, 45, 48, 52, 53, 56, 59, 61, 70, 74, 86, 97, 100, 102, 106, 115, 121, 122, 123, 128, 139, 143, 154, 157, 165, 172, 173, 175, 177, 182, 186]	[4, 7, 8, 13, 15, 16, 17, 21, 24, 27, 29, 30, 34, 44, 47, 52, 53, 56, 59, 60, 69, 73, 85, 96, 100, 102, 105, 114, 121, 122, 123, 127, 138, 142, 153, 156, 164, 171, 173, 174, 176, 181, 186, 187]	['Chen', 'RH', ',', 'Ding', 'WV', ',', 'McCormick', 'F', '.', 'Wnt', 'signaling', 'to', 'beta', '-', 'catenin', 'involves', 'two', 'interactive', 'components', 'Glycogen', 'synthase', 'kinase-3beta', 'inhibition', 'and', 'activation', 'of', 'protein', 'kinase', 'C', '.', 'J', 'Biol', 'Chem', '.']	[1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.	[('PMC7029203', 'F42002', 0, 26, 'Glycogen synthase kinase 3')]	['Gly', '##co', '##gen', 'synthase', 'kinase', '3', 'phosphoryl', '##ates', 'kine', '##sin', 'light', 'chains', 'and', 'negatively', 'regulates', 'kine', '##sin', '-', 'based', 'motility', '.']	[0, 3, 5, 9, 18, 25, 27, 37, 42, 46, 50, 56, 63, 67, 78, 88, 92, 95, 96, 102, 110]	[3, 5, 8, 17, 24, 26, 37, 41, 46, 49, 55, 62, 66, 77, 87, 92, 95, 96, 101, 110, 111]	['Glycogen', 'synthase', 'kinase', '3', 'phosphorylates', 'kinesin', 'light', 'chains', 'and', 'negatively', 'regulates', 'kinesin', '-', 'based', 'motility', '.']	[3, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Noguchi T, Inoue H, Tanaka T. The M1-and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing.	[('PMC7029203', 'F43001', 65, 80, 'pyruvate kinase')]	['No', '##gu', '##chi', 'T', ',', 'In', '##ou', '##e', 'H', ',', 'Tanaka', 'T', '.', 'The', 'M', '##1', '-', 'and', 'M', '##2', '-', 'type', 'iso', '##zymes', 'of', 'rat', 'pyruvate', 'kinase', 'are', 'produced', 'from', 'the', 'same', 'gene', 'by', 'alternative', 'RNA', 'splicing', '.']	[0, 2, 4, 8, 9, 11, 13, 15, 17, 18, 20, 27, 28, 30, 34, 35, 36, 37, 41, 42, 43, 44, 49, 52, 58, 61, 65, 74, 81, 85, 94, 99, 103, 108, 113, 116, 128, 132, 140]	[2, 4, 7, 9, 10, 13, 15, 16, 18, 19, 26, 28, 29, 33, 35, 36, 37, 40, 42, 43, 44, 48, 52, 57, 60, 64, 73, 80, 84, 93, 98, 102, 107, 112, 115, 127, 131, 140, 141]	['Noguchi', 'T', ',', 'Inoue', 'H', ',', 'Tanaka', 'T', '.', 'The', 'M1-and', 'M2', '-', 'type', 'isozymes', 'of', 'rat', 'pyruvate', 'kinase', 'are', 'produced', 'from', 'the', 'same', 'gene', 'by', 'alternative', 'RNA', 'splicing', '.']	[3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mazurek S. Pyruvate kinase type M2:A key regulator of the metabolic budget system in tumor cells.	[('PMC7029203', 'F45001', 11, 34, 'Pyruvate kinase type M2')]	['Maz', '##ure', '##k', 'S', '.', 'Pyr', '##uvate', 'kinase', 'type', 'M', '##2', ':', 'A', 'key', 'regulator', 'of', 'the', 'metabolic', 'budget', 'system', 'in', 'tumor', 'cells', '.']	[0, 3, 6, 8, 9, 11, 14, 20, 27, 32, 33, 34, 35, 37, 41, 51, 54, 58, 68, 75, 82, 85, 91, 96]	[3, 6, 7, 9, 10, 14, 19, 26, 31, 33, 34, 35, 36, 40, 50, 53, 57, 67, 74, 81, 84, 90, 96, 97]	['Mazurek', 'S', '.', 'Pyruvate', 'kinase', 'type', 'M2', ':', 'A', 'key', 'regulator', 'of', 'the', 'metabolic', 'budget', 'system', 'in', 'tumor', 'cells', '.']	[3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.	[('PMC7029203', 'F46002', 0, 18, 'Pyruvate kinase M2')]	['Pyr', '##uvate', 'kinase', 'M', '##2', 'activator', '##s', 'promote', 'tetra', '##mer', 'formation', 'and', 'suppress', 'tumorigenesis', '.']	[0, 3, 9, 16, 17, 19, 28, 30, 38, 43, 47, 57, 61, 70, 83]	[3, 8, 15, 17, 18, 28, 29, 37, 43, 46, 56, 60, 69, 83, 84]	['Pyruvate', 'kinase', 'M2', 'activators', 'promote', 'tetramer', 'formation', 'and', 'suppress', 'tumorigenesis', '.']	[2, 1, 2, 2, 1, 2, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Dürr P, et al. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.	[('PMC7029203', 'F48001', 94, 117, 'type M2 pyruvate kinase')]	['Zw', '##ersch', '##ke', 'W', ',', 'Maz', '##ure', '##k', 'S', ',', 'Mass', '##imi', 'P', ',', 'Bank', '##s', 'L', ',', 'Ei', '##gen', '##bro', '##dt', 'E', ',', 'Jan', '##sen', '-', 'D', '##ür', '##r', 'P', ',', 'et', 'al', '.', 'Mod', '##ulation', 'of', 'type', 'M', '##2', 'pyruvate', 'kinase', 'activity', 'by', 'the', 'human', 'papill', '##oma', '##virus', 'type', '16', 'E', '##7', 'onc', '##oprotein', '.']	[0, 2, 7, 10, 11, 13, 16, 19, 21, 22, 24, 28, 32, 33, 35, 39, 41, 42, 44, 46, 49, 52, 55, 56, 58, 61, 64, 65, 66, 68, 70, 71, 73, 76, 78, 80, 83, 91, 94, 99, 100, 102, 111, 118, 127, 130, 134, 140, 146, 149, 155, 160, 163, 164, 166, 169, 177]	[2, 7, 9, 11, 12, 16, 19, 20, 22, 23, 28, 31, 33, 34, 39, 40, 42, 43, 46, 49, 52, 54, 56, 57, 61, 64, 65, 66, 68, 69, 71, 72, 75, 78, 79, 83, 90, 93, 98, 100, 101, 110, 117, 126, 129, 133, 139, 146, 149, 154, 159, 162, 164, 165, 169, 177, 178]	['Zwerschke', 'W', ',', 'Mazurek', 'S', ',', 'Massimi', 'P', ',', 'Banks', 'L', ',', 'Eigenbrodt', 'E', ',', 'Jansen-Dürr', 'P', ',', 'et', 'al', '.', 'Modulation', 'of', 'type', 'M2', 'pyruvate', 'kinase', 'activity', 'by', 'the', 'human', 'papillomavirus', 'type', '16', 'E7', 'oncoprotein', '.']	[3, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 4, 1, 1, 6, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation.	[('PMC7029203', 'F49002', 0, 18, 'M2 pyruvate kinase')]	['M', '##2', 'pyruvate', 'kinase', 'provides', 'a', 'mechanism', 'for', 'nutrient', 'sensing', 'and', 'regulation', 'of', 'cell', 'proliferation', '.']	[0, 1, 3, 12, 19, 28, 30, 40, 44, 53, 61, 65, 76, 79, 84, 97]	[1, 2, 11, 18, 27, 29, 39, 43, 52, 60, 64, 75, 78, 83, 97, 98]	['M2', 'pyruvate', 'kinase', 'provides', 'a', 'mechanism', 'for', 'nutrient', 'sensing', 'and', 'regulation', 'of', 'cell', 'proliferation', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cheng KY, Hao M. Mammalian target of rapamycin (mTOR) regulates transforming growth factor-β1 (TGF-β1)-induced epithelial-mesenchymal transition via decreased pyruvate kinase M2 (PKM2) expression in cervical cancer cells.	[('PMC7029203', 'F51001', 159, 177, 'pyruvate kinase M2')]	['Cheng', 'KY', ',', 'Ha', '##o', 'M', '.', 'Mamm', '##alian', 'target', 'of', 'rapamycin', '(', 'mTOR', ')', 'regulates', 'transforming', 'growth', 'factor', '-', 'β', '##1', '(', 'TGF', '-', 'β', '##1', ')', '-', 'induced', 'epithelial', '-', 'mesenchymal', 'transition', 'via', 'decreased', 'pyruvate', 'kinase', 'M', '##2', '(', 'PK', '##M', '##2', ')', 'expression', 'in', 'cervical', 'cancer', 'cells', '.']	[0, 6, 8, 10, 12, 14, 15, 17, 21, 27, 34, 37, 47, 48, 52, 54, 64, 77, 84, 90, 91, 92, 94, 95, 98, 99, 100, 101, 102, 103, 111, 121, 122, 134, 145, 149, 159, 168, 175, 176, 178, 179, 181, 182, 183, 185, 196, 199, 208, 215, 220]	[5, 8, 9, 12, 13, 15, 16, 21, 26, 33, 36, 46, 48, 52, 53, 63, 76, 83, 90, 91, 92, 93, 95, 98, 99, 100, 101, 102, 103, 110, 121, 122, 133, 144, 148, 158, 167, 174, 176, 177, 179, 181, 182, 183, 184, 195, 198, 207, 214, 220, 221]	['Cheng', 'KY', ',', 'Hao', 'M', '.', 'Mammalian', 'target', 'of', 'rapamycin', '(', 'mTOR', ')', 'regulates', 'transforming', 'growth', 'factor-β1', '(TGF-β1)-induced', 'epithelial', '-', 'mesenchymal', 'transition', 'via', 'decreased', 'pyruvate', 'kinase', 'M2', '(', 'PKM2', ')', 'expression', 'in', 'cervical', 'cancer', 'cells', '.']	[1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 8, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Shen Y, Chen M, Huang S, Zou X. Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2.	[('PMC7029203', 'F52001', 134, 152, 'pyruvate kinase M2')]	['Shen', 'Y', ',', 'Chen', 'M', ',', 'Huang', 'S', ',', 'Zo', '##u', 'X', '.', 'Pan', '##top', '##razole', 'inhibits', 'human', 'gastric', 'adenocarcinoma', 'SG', '##C', '-', '79', '##01', 'cells', 'by', 'down', '##reg', '##ulating', 'the', 'expression', 'of', 'pyruvate', 'kinase', 'M', '##2', '.']	[0, 5, 6, 8, 13, 14, 16, 22, 23, 25, 27, 29, 30, 32, 35, 38, 45, 54, 60, 68, 83, 85, 86, 87, 89, 92, 98, 101, 105, 108, 116, 120, 131, 134, 143, 150, 151, 152]	[4, 6, 7, 12, 14, 15, 21, 23, 24, 27, 28, 30, 31, 35, 38, 44, 53, 59, 67, 82, 85, 86, 87, 89, 91, 97, 100, 105, 108, 115, 119, 130, 133, 142, 149, 151, 152, 153]	['Shen', 'Y', ',', 'Chen', 'M', ',', 'Huang', 'S', ',', 'Zou', 'X', '.', 'Pantoprazole', 'inhibits', 'human', 'gastric', 'adenocarcinoma', 'SGC-7901', 'cells', 'by', 'downregulating', 'the', 'expression', 'of', 'pyruvate', 'kinase', 'M2', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Definition by functional and structural analysis of two malonyl-coA sites in carnitine palmitoyltransferase 1A. J Biol Chem.	[('PMC7029203', 'F53002', 77, 110, 'carnitine palmitoyltransferase 1A')]	['Definition', 'by', 'functional', 'and', 'structural', 'analysis', 'of', 'two', 'mal', '##onyl', '-', 'co', '##A', 'sites', 'in', 'car', '##nit', '##ine', 'palm', '##ito', '##yl', '##transferase', '1', '##A', '.', 'J', 'Biol', 'Chem', '.']	[0, 11, 14, 25, 29, 40, 49, 52, 56, 59, 63, 64, 66, 68, 74, 77, 80, 83, 87, 91, 94, 96, 108, 109, 110, 112, 114, 119, 123]	[10, 13, 24, 28, 39, 48, 51, 55, 59, 63, 64, 66, 67, 73, 76, 80, 83, 86, 91, 94, 96, 107, 109, 110, 111, 113, 118, 123, 124]	['Definition', 'by', 'functional', 'and', 'structural', 'analysis', 'of', 'two', 'malonyl-coA', 'sites', 'in', 'carnitine', 'palmitoyltransferase', '1A', '.', 'J', 'Biol', 'Chem', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 4, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Rat liver carnitine palmitoyltransferase 1 forms an oligomeric complex within the outer mitochondrial membrane.	[('PMC7029203', 'F54002', 10, 42, 'carnitine palmitoyltransferase 1')]	['Rat', 'liver', 'car', '##nit', '##ine', 'palm', '##ito', '##yl', '##transferase', '1', 'forms', 'an', 'oligomer', '##ic', 'complex', 'within', 'the', 'outer', 'mitochondrial', 'membrane', '.']	[0, 4, 10, 13, 16, 20, 24, 27, 29, 41, 43, 49, 52, 60, 63, 71, 78, 82, 88, 102, 110]	[3, 9, 13, 16, 19, 24, 27, 29, 40, 42, 48, 51, 60, 62, 70, 77, 81, 87, 101, 110, 111]	['Rat', 'liver', 'carnitine', 'palmitoyltransferase', '1', 'forms', 'an', 'oligomeric', 'complex', 'within', 'the', 'outer', 'mitochondrial', 'membrane', '.']	[1, 1, 3, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex.	[('PMC7029203', 'F55002', 14, 47, 'carnitine palmitoyltransferase 1a')]	['Mitochondrial', 'car', '##nit', '##ine', 'palm', '##ito', '##yl', '##transferase', '1', '##a', '(', 'CPT', '##1', '##a', ')', 'is', 'part', 'of', 'an', 'outer', 'membrane', 'fatty', 'acid', 'transfer', 'complex', '.']	[0, 14, 17, 20, 24, 28, 31, 33, 45, 46, 48, 49, 52, 53, 54, 56, 59, 64, 67, 70, 76, 85, 91, 96, 105, 112]	[13, 17, 20, 23, 28, 31, 33, 44, 46, 47, 49, 52, 53, 54, 55, 58, 63, 66, 69, 75, 84, 90, 95, 104, 112, 113]	['Mitochondrial', 'carnitine', 'palmitoyltransferase', '1a', '(', 'CPT1a', ')', 'is', 'part', 'of', 'an', 'outer', 'membrane', 'fatty', 'acid', 'transfer', 'complex', '.']	[1, 3, 4, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.	[('PMC7029203', 'F57002', 0, 33, 'Carnitine palmitoyltransferase 1A')]	['Car', '##nit', '##ine', 'palm', '##ito', '##yl', '##transferase', '1', '##A', 'functions', 'to', 'repres', '##s', 'Fox', '##O', 'transcription', 'factors', 'to', 'allow', 'cell', 'cycle', 'progression', 'in', 'ovarian', 'cancer', '.']	[0, 3, 6, 10, 14, 17, 19, 31, 32, 34, 44, 47, 53, 55, 58, 60, 74, 82, 85, 91, 96, 102, 114, 117, 125, 131]	[3, 6, 9, 14, 17, 19, 30, 32, 33, 43, 46, 53, 54, 58, 59, 73, 81, 84, 90, 95, 101, 113, 116, 124, 131, 132]	['Carnitine', 'palmitoyltransferase', '1A', 'functions', 'to', 'repress', 'FoxO', 'transcription', 'factors', 'to', 'allow', 'cell', 'cycle', 'progression', 'in', 'ovarian', 'cancer', '.']	[3, 4, 2, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation.	[('PMC7029203', 'F58002', 0, 30, 'Glutamate acid decarboxylase 1')]	['Glut', '##amate', 'acid', 'dec', '##arboxyl', '##ase', '1', 'promotes', 'metastasis', 'of', 'human', 'oral', 'cancer', 'by', 'β', '-', 'cat', '##eni', '##n', 'translocation', 'and', 'MMP', '##7', 'activation', '.']	[0, 4, 10, 15, 18, 25, 29, 31, 40, 51, 54, 60, 65, 72, 75, 76, 77, 80, 83, 85, 99, 103, 106, 108, 118]	[4, 9, 14, 18, 25, 28, 30, 39, 50, 53, 59, 64, 71, 74, 76, 77, 80, 83, 84, 98, 102, 106, 107, 118, 119]	['Glutamate', 'acid', 'decarboxylase', '1', 'promotes', 'metastasis', 'of', 'human', 'oral', 'cancer', 'by', 'β-catenin', 'translocation', 'and', 'MMP7', 'activation', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glutamate decarboxylase 1 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.	[('PMC7029203', 'F59002', 0, 25, 'Glutamate decarboxylase 1')]	['Glut', '##amate', 'dec', '##arboxyl', '##ase', '1', 'overexpression', 'as', 'a', 'poor', 'prognostic', 'factor', 'in', 'patients', 'with', 'nas', '##opharyngeal', 'carcinoma', '.']	[0, 4, 10, 13, 20, 24, 26, 41, 44, 46, 51, 62, 69, 72, 81, 86, 89, 101, 110]	[4, 9, 13, 20, 23, 25, 40, 43, 45, 50, 61, 68, 71, 80, 85, 89, 100, 110, 111]	['Glutamate', 'decarboxylase', '1', 'overexpression', 'as', 'a', 'poor', 'prognostic', 'factor', 'in', 'patients', 'with', 'nasopharyngeal', 'carcinoma', '.']	[2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The detection of autoantibodies to glutamic acid decarboxylase (glutamic acid decarboxylase) and/or a fasting C-peptide ≤ 0.03 nmol/l was used to exclude probable cases of type 1 diabetes.	[('PMC7052266', 'M00011', 35, 62, 'glutamic acid decarboxylase'), ('PMC7052266', 'M00011', 64, 91, 'glutamic acid decarboxylase')]	['The', 'detection', 'of', 'autoantibodies', 'to', 'glut', '##amic', 'acid', 'dec', '##arboxyl', '##ase', '(', 'glut', '##amic', 'acid', 'dec', '##arboxyl', '##ase', ')', 'and', '/', 'or', 'a', 'fasting', 'C', '-', 'peptide', '≤', '0', '.', '03', 'nmol', '/', 'l', 'was', 'used', 'to', 'exclude', 'probable', 'cases', 'of', 'type', '1', 'diabetes', '.']	[0, 4, 14, 17, 32, 35, 39, 44, 49, 52, 59, 63, 64, 68, 73, 78, 81, 88, 91, 93, 96, 97, 100, 102, 110, 111, 112, 120, 122, 123, 124, 127, 131, 132, 134, 138, 143, 146, 154, 163, 169, 172, 177, 179, 187]	[3, 13, 16, 31, 34, 39, 43, 48, 52, 59, 62, 64, 68, 72, 77, 81, 88, 91, 92, 96, 97, 99, 101, 109, 111, 112, 119, 121, 123, 124, 126, 131, 132, 133, 137, 142, 145, 153, 162, 168, 171, 176, 178, 187, 188]	['The', 'detection', 'of', 'autoantibodies', 'to', 'glutamic', 'acid', 'decarboxylase', '(', 'glutamic', 'acid', 'decarboxylase', ')', 'and', '/', 'or', 'a', 'fasting', 'C-', 'peptide', '≤', '0.03', 'nmol', '/', 'l', 'was', 'used', 'to', 'exclude', 'probable', 'cases', 'of', 'type', '1', 'diabetes', '.']	[1, 1, 1, 1, 1, 2, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Feature selection analysis on the inferred genes between cases and controls identified 16 genes (log 2 FC ≥1, p < 0.05) that were enriched in cases including Aspartate dehydrogenase (nadX) and cobaltochelatase (cobN) (Table 5 and Figure S8).	[('PMC7052266', 'R07005', 158, 181, 'Aspartate dehydrogenase'), ('PMC7052266', 'R07005', 193, 209, 'cobaltochelatase')]	['Feature', 'selection', 'analysis', 'on', 'the', 'inferred', 'genes', 'between', 'cases', 'and', 'controls', 'identified', '16', 'genes', '(', 'log', '2', 'FC', '≥', '1', ',', 'p', '<', '0', '.', '05', ')', 'that', 'were', 'enriched', 'in', 'cases', 'including', 'Asp', '##art', '##ate', 'dehydrogenase', '(', 'na', '##d', '##X', ')', 'and', 'cobalt', '##oche', '##lat', '##ase', '(', 'co', '##b', '##N', ')', '(', 'Table', '5', 'and', 'Figure', 'S', '##8', ')', '.']	[0, 8, 18, 27, 30, 34, 43, 49, 57, 63, 67, 76, 87, 90, 96, 97, 101, 103, 106, 107, 108, 110, 112, 114, 115, 116, 118, 120, 125, 130, 139, 142, 148, 158, 161, 164, 168, 182, 183, 185, 186, 187, 189, 193, 199, 203, 206, 210, 211, 213, 214, 215, 217, 218, 224, 226, 230, 237, 238, 239, 240]	[7, 17, 26, 29, 33, 42, 48, 56, 62, 66, 75, 86, 89, 95, 97, 100, 102, 105, 107, 108, 109, 111, 113, 115, 116, 118, 119, 124, 129, 138, 141, 147, 157, 161, 164, 167, 181, 183, 185, 186, 187, 188, 192, 199, 203, 206, 209, 211, 213, 214, 215, 216, 218, 223, 225, 229, 236, 238, 239, 240, 241]	['Feature', 'selection', 'analysis', 'on', 'the', 'inferred', 'genes', 'between', 'cases', 'and', 'controls', 'identified', '16', 'genes', '(', 'log', '2', 'FC', '≥', '1', ',', 'p', '<', '0.05', ')', 'that', 'were', 'enriched', 'in', 'cases', 'including', 'Aspartate', 'dehydrogenase', '(', 'nadX', ')', 'and', 'cobaltochelatase', '(', 'cobN', ')', '(', 'Table', '5', 'and', 'Figure', 'S8', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We used this protocol (including a proteinase K pretreatment) to get an estimate of cells able to resist harsh conditions that fecal transplants may face during a freezing period and then, once released in the host intestine by FMT; these include the presence of host antimicrobial proteins and peptides, bacteriocins and antibacterial metabolites of bacterial origin (Ostaff et al., 2013; Kanjan and Hongpattarakere, 2016; Dicks et al., 2018).	[('PMC7058979', 'D01002', 35, 47, 'proteinase K')]	['We', 'used', 'this', 'protocol', '(', 'including', 'a', 'protein', '##ase', 'K', 'pretreatment', ')', 'to', 'get', 'an', 'estimate', 'of', 'cells', 'able', 'to', 'resist', 'har', '##sh', 'conditions', 'that', 'fecal', 'transplant', '##s', 'may', 'face', 'during', 'a', 'freezing', 'period', 'and', 'then', ',', 'once', 'released', 'in', 'the', 'host', 'intestine', 'by', 'FM', '##T', ';', 'these', 'include', 'the', 'presence', 'of', 'host', 'antimicrobial', 'proteins', 'and', 'peptides', ',', 'bacteri', '##ocin', '##s', 'and', 'antibacterial', 'metabolites', 'of', 'bacterial', 'origin', '(', 'Os', '##ta', '##ff', 'et', 'al', '.', ',', '2013', ';', 'Kan', '##jan', 'and', 'Hong', '##pat', '##ta', '##ra', '##ker', '##e', ',', '2016', ';', 'Dick', '##s', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 3, 8, 13, 22, 23, 33, 35, 42, 46, 48, 60, 62, 65, 69, 72, 81, 84, 90, 95, 98, 105, 108, 111, 122, 127, 133, 143, 145, 149, 154, 161, 163, 172, 179, 183, 187, 189, 194, 203, 206, 210, 215, 225, 228, 230, 231, 233, 239, 247, 251, 260, 263, 268, 282, 291, 295, 303, 305, 312, 316, 318, 322, 336, 348, 351, 361, 368, 369, 371, 373, 376, 379, 381, 382, 384, 388, 390, 393, 397, 401, 405, 408, 410, 412, 415, 416, 418, 422, 424, 428, 430, 433, 435, 436, 438, 442, 443]	[2, 7, 12, 21, 23, 32, 34, 42, 45, 47, 60, 61, 64, 68, 71, 80, 83, 89, 94, 97, 104, 108, 110, 121, 126, 132, 143, 144, 148, 153, 160, 162, 171, 178, 182, 187, 188, 193, 202, 205, 209, 214, 224, 227, 230, 231, 232, 238, 246, 250, 259, 262, 267, 281, 290, 294, 303, 304, 312, 316, 317, 321, 335, 347, 350, 360, 367, 369, 371, 373, 375, 378, 381, 382, 383, 388, 389, 393, 396, 400, 405, 408, 410, 412, 415, 416, 417, 422, 423, 428, 429, 432, 435, 436, 437, 442, 443, 444]	['We', 'used', 'this', 'protocol', '(', 'including', 'a', 'proteinase', 'K', 'pretreatment', ')', 'to', 'get', 'an', 'estimate', 'of', 'cells', 'able', 'to', 'resist', 'harsh', 'conditions', 'that', 'fecal', 'transplants', 'may', 'face', 'during', 'a', 'freezing', 'period', 'and', 'then', ',', 'once', 'released', 'in', 'the', 'host', 'intestine', 'by', 'FMT', ';', 'these', 'include', 'the', 'presence', 'of', 'host', 'antimicrobial', 'proteins', 'and', 'peptides', ',', 'bacteriocins', 'and', 'antibacterial', 'metabolites', 'of', 'bacterial', 'origin', '(', 'Ostaff', 'et', 'al', '.', ',', '2013', ';', 'Kanjan', 'and', 'Hongpattarakere', ',', '2016', ';', 'Dicks', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 6, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the MOLZ procedure, according to the manufacturer guidelines, the proteinase K treatment is adapted to solubilize solid human tissues and release bacterial biofilm, whereas the CM buffer, containing a chaotropic agent, selectively disrupts human cells.	[('PMC7058979', 'D02001', 69, 81, 'proteinase K')]	['In', 'the', 'MO', '##L', '##Z', 'procedure', ',', 'according', 'to', 'the', 'manufacturer', 'guidelines', ',', 'the', 'protein', '##ase', 'K', 'treatment', 'is', 'adapted', 'to', 'solub', '##ili', '##ze', 'solid', 'human', 'tissues', 'and', 'release', 'bacterial', 'biofilm', ',', 'whereas', 'the', 'CM', 'buffer', ',', 'containing', 'a', 'cha', '##otropic', 'agent', ',', 'selectively', 'disrupt', '##s', 'human', 'cells', '.']	[0, 3, 7, 9, 10, 12, 21, 23, 33, 36, 40, 53, 63, 65, 69, 76, 80, 82, 92, 95, 103, 106, 111, 114, 117, 123, 129, 137, 141, 149, 159, 166, 168, 176, 180, 183, 189, 191, 202, 204, 207, 215, 220, 222, 234, 241, 243, 249, 254]	[2, 6, 9, 10, 11, 21, 22, 32, 35, 39, 52, 63, 64, 68, 76, 79, 81, 91, 94, 102, 105, 111, 114, 116, 122, 128, 136, 140, 148, 158, 166, 167, 175, 179, 182, 189, 190, 201, 203, 207, 214, 220, 221, 233, 241, 242, 248, 254, 255]	['In', 'the', 'MOLZ', 'procedure', ',', 'according', 'to', 'the', 'manufacturer', 'guidelines', ',', 'the', 'proteinase', 'K', 'treatment', 'is', 'adapted', 'to', 'solubilize', 'solid', 'human', 'tissues', 'and', 'release', 'bacterial', 'biofilm', ',', 'whereas', 'the', 'CM', 'buffer', ',', 'containing', 'a', 'chaotropic', 'agent', ',', 'selectively', 'disrupts', 'human', 'cells', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Indeed, the susceptibility to proteinase K cell lysis depends on the cell wall composition and structure (Moore et al., 2004).	[('PMC7058979', 'D02003', 30, 42, 'proteinase K')]	['Indeed', ',', 'the', 'susceptibility', 'to', 'protein', '##ase', 'K', 'cell', 'lysis', 'depends', 'on', 'the', 'cell', 'wall', 'composition', 'and', 'structure', '(', 'Moore', 'et', 'al', '.', ',', '2004', ')', '.']	[0, 6, 8, 12, 27, 30, 37, 41, 43, 48, 54, 62, 65, 69, 74, 79, 91, 95, 105, 106, 112, 115, 117, 118, 120, 124, 125]	[6, 7, 11, 26, 29, 37, 40, 42, 47, 53, 61, 64, 68, 73, 78, 90, 94, 104, 106, 111, 114, 117, 118, 119, 124, 125, 126]	['Indeed', ',', 'the', 'susceptibility', 'to', 'proteinase', 'K', 'cell', 'lysis', 'depends', 'on', 'the', 'cell', 'wall', 'composition', 'and', 'structure', '(', 'Moore', 'et', 'al', '.', ',', '2004', ')', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One of them relied on a classical mechanical and chemical cell disruption to extract whole (extra- and intracellular) DNA (method NS-MAG); the second (MOLZ), included enzymatic (proteinase K), chemical (patented by Molzym), and DNase pre-treatments to remove DNA from human and damaged bacterial cells, prior to extraction of intracellular DNA from intact bacterial cells.	[('PMC7058979', 'I03002', 178, 190, 'proteinase K')]	['One', 'of', 'them', 'relied', 'on', 'a', 'classical', 'mechanical', 'and', 'chemical', 'cell', 'disruption', 'to', 'extract', 'whole', '(', 'extra', '-', 'and', 'intracellular', ')', 'DNA', '(', 'method', 'NS', '-', 'MAG', ')', ';', 'the', 'second', '(', 'MO', '##L', '##Z', ')', ',', 'included', 'enzymatic', '(', 'protein', '##ase', 'K', ')', ',', 'chemical', '(', 'patent', '##ed', 'by', 'Mol', '##zym', ')', ',', 'and', 'DNase', 'pre', '-', 'treatments', 'to', 'remove', 'DNA', 'from', 'human', 'and', 'damaged', 'bacterial', 'cells', ',', 'prior', 'to', 'extraction', 'of', 'intracellular', 'DNA', 'from', 'intact', 'bacterial', 'cells', '.']	[0, 4, 7, 12, 19, 22, 24, 34, 45, 49, 58, 63, 74, 77, 85, 91, 92, 97, 99, 103, 116, 118, 122, 123, 130, 132, 133, 136, 137, 139, 143, 150, 151, 153, 154, 155, 156, 158, 167, 177, 178, 185, 189, 190, 191, 193, 202, 203, 209, 212, 215, 218, 221, 222, 224, 228, 234, 237, 238, 249, 252, 259, 263, 268, 274, 278, 286, 296, 301, 303, 309, 312, 323, 326, 340, 344, 349, 356, 366, 371]	[3, 6, 11, 18, 21, 23, 33, 44, 48, 57, 62, 73, 76, 84, 90, 92, 97, 98, 102, 116, 117, 121, 123, 129, 132, 133, 136, 137, 138, 142, 149, 151, 153, 154, 155, 156, 157, 166, 176, 178, 185, 188, 190, 191, 192, 201, 203, 209, 211, 214, 218, 221, 222, 223, 227, 233, 237, 238, 248, 251, 258, 262, 267, 273, 277, 285, 295, 301, 302, 308, 311, 322, 325, 339, 343, 348, 355, 365, 371, 372]	['One', 'of', 'them', 'relied', 'on', 'a', 'classical', 'mechanical', 'and', 'chemical', 'cell', 'disruption', 'to', 'extract', 'whole', '(', 'extra-', 'and', 'intracellular', ')', 'DNA', '(', 'method', 'NS-MAG', ')', ';', 'the', 'second', '(', 'MOLZ', ')', ',', 'included', 'enzymatic', '(', 'proteinase', 'K', ')', ',', 'chemical', '(', 'patented', 'by', 'Molzym', ')', ',', 'and', 'DNase', 'pre', '-', 'treatments', 'to', 'remove', 'DNA', 'from', 'human', 'and', 'damaged', 'bacterial', 'cells', ',', 'prior', 'to', 'extraction', 'of', 'intracellular', 'DNA', 'from', 'intact', 'bacterial', 'cells', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The first (MOLZ) was performed using an Ultra-Deep Microbiome Prep kit (Molzym) for selective enrichment of bacterial/fungal DNA according to the manufacturer's instructions for tissue samples (includes a proteinase K pre-treatment).	[('PMC7058979', 'M01002', 205, 217, 'proteinase K')]	"['The', 'first', '(', 'MO', '##L', '##Z', ')', 'was', 'performed', 'using', 'an', 'Ultra', '-', 'Deep', 'Microb', '##io', '##me', 'Pre', '##p', 'kit', '(', 'Mol', '##zym', ')', 'for', 'selective', 'enrichment', 'of', 'bacterial', '/', 'fungal', 'DNA', 'according', 'to', 'the', 'manufacturer', ""'"", 's', 'instructions', 'for', 'tissue', 'samples', '(', 'includes', 'a', 'protein', '##ase', 'K', 'pre', '-', 'treatment', ')', '.']"	[0, 4, 10, 11, 13, 14, 15, 17, 21, 31, 37, 40, 45, 46, 51, 57, 59, 62, 65, 67, 71, 72, 75, 78, 80, 84, 94, 105, 108, 117, 118, 125, 129, 139, 142, 146, 158, 159, 161, 174, 178, 185, 193, 194, 203, 205, 212, 216, 218, 221, 222, 231, 232]	[3, 9, 11, 13, 14, 15, 16, 20, 30, 36, 39, 45, 46, 50, 57, 59, 61, 65, 66, 70, 72, 75, 78, 79, 83, 93, 104, 107, 117, 118, 124, 128, 138, 141, 145, 158, 159, 160, 173, 177, 184, 192, 194, 202, 204, 212, 215, 217, 221, 222, 231, 232, 233]	"['The', 'first', '(', 'MOLZ', ')', 'was', 'performed', 'using', 'an', 'Ultra-Deep', 'Microbiome', 'Prep', 'kit', '(', 'Molzym', ')', 'for', 'selective', 'enrichment', 'of', 'bacterial', '/', 'fungal', 'DNA', 'according', 'to', 'the', ""manufacturer's"", 'instructions', 'for', 'tissue', 'samples', '(', 'includes', 'a', 'proteinase', 'K', 'pre', '-', 'treatment', ')', '.']"	[1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 3, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Bile salt hydrolase activity was not related to the abundances of BSH-active bacteria.	[('PMC7060658', 'A02002', 0, 19, 'Bile salt hydrolase')]	['Bil', '##e', 'salt', 'hydro', '##las', '##e', 'activity', 'was', 'not', 'related', 'to', 'the', 'abundances', 'of', 'BS', '##H', '-', 'active', 'bacteria', '.']	[0, 3, 5, 10, 15, 18, 20, 29, 33, 37, 45, 48, 52, 63, 66, 68, 69, 70, 77, 85]	[3, 4, 9, 15, 18, 19, 28, 32, 36, 44, 47, 51, 62, 65, 68, 69, 70, 76, 85, 86]	['Bile', 'salt', 'hydrolase', 'activity', 'was', 'not', 'related', 'to', 'the', 'abundances', 'of', 'BSH-active', 'bacteria', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After intestinal FXR is activated, intestinal epithelial cells release fibroblast growth factor 19 (FGF19), which inhibits the liver enzyme Cholesterol 7α-hydroxylase (cholesterol 7α-hydroxylase) through the portal vein [25–27].	[('PMC7060658', 'D00014', 140, 166, 'Cholesterol 7α-hydroxylase'), ('PMC7060658', 'D00014', 168, 194, 'cholesterol 7α-hydroxylase')]	['After', 'intestinal', 'FX', '##R', 'is', 'activated', ',', 'intestinal', 'epithelial', 'cells', 'release', 'fibroblast', 'growth', 'factor', '19', '(', 'FGF', '##19', ')', ',', 'which', 'inhibits', 'the', 'liver', 'enzyme', 'Cho', '##les', '##ter', '##ol', '7', '##α', '-', 'hydroxyl', '##ase', '(', 'cholesterol', '7', '##α', '-', 'hydroxyl', '##ase', ')', 'through', 'the', 'portal', 'vein', '[', '25', '–', '27', ']', '.']	[0, 6, 17, 19, 21, 24, 33, 35, 46, 57, 63, 71, 82, 89, 96, 99, 100, 103, 105, 106, 108, 114, 123, 127, 133, 140, 143, 146, 149, 152, 153, 154, 155, 163, 167, 168, 180, 181, 182, 183, 191, 194, 196, 204, 208, 215, 220, 221, 223, 224, 226, 227]	[5, 16, 19, 20, 23, 33, 34, 45, 56, 62, 70, 81, 88, 95, 98, 100, 103, 105, 106, 107, 113, 122, 126, 132, 139, 143, 146, 149, 151, 153, 154, 155, 163, 166, 168, 179, 181, 182, 183, 191, 194, 195, 203, 207, 214, 219, 221, 223, 224, 226, 227, 228]	['After', 'intestinal', 'FXR', 'is', 'activated', ',', 'intestinal', 'epithelial', 'cells', 'release', 'fibroblast', 'growth', 'factor', '19', '(', 'FGF19', ')', ',', 'which', 'inhibits', 'the', 'liver', 'enzyme', 'Cholesterol', '7α-hydroxylase', '(', 'cholesterol', '7α-hydroxylase', ')', 'through', 'the', 'portal', 'vein', '[', '25–', '27', ']', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 5, 1, 1, 5, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Duan et al. showed that the increase in bile acid uptake by intestinal epithelial cells could inhibit Cholesterol 7α-hydroxylase through the FFX-FGF19 pathway.	[('PMC7060658', 'D00015', 102, 128, 'Cholesterol 7α-hydroxylase')]	['Du', '##an', 'et', 'al', '.', 'showed', 'that', 'the', 'increase', 'in', 'bile', 'acid', 'uptake', 'by', 'intestinal', 'epithelial', 'cells', 'could', 'inhibit', 'Cho', '##les', '##ter', '##ol', '7', '##α', '-', 'hydroxyl', '##ase', 'through', 'the', 'FF', '##X', '-', 'FGF', '##19', 'pathway', '.']	[0, 2, 5, 8, 10, 12, 19, 24, 28, 37, 40, 45, 50, 57, 60, 71, 82, 88, 94, 102, 105, 108, 111, 114, 115, 116, 117, 125, 129, 137, 141, 143, 144, 145, 148, 151, 158]	[2, 4, 7, 10, 11, 18, 23, 27, 36, 39, 44, 49, 56, 59, 70, 81, 87, 93, 101, 105, 108, 111, 113, 115, 116, 117, 125, 128, 136, 140, 143, 144, 145, 148, 150, 158, 159]	['Duan', 'et', 'al', '.', 'showed', 'that', 'the', 'increase', 'in', 'bile', 'acid', 'uptake', 'by', 'intestinal', 'epithelial', 'cells', 'could', 'inhibit', 'Cholesterol', '7α-hydroxylase', 'through', 'the', 'FFX-FGF19', 'pathway', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 5, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Since Cholesterol 7α-hydroxylase is a key enzyme in cholesterol elimination, the inhibition of Cholesterol 7α-hydroxylase could cause the accumulation of cholesterol in the liver [28].	[('PMC7060658', 'D00016', 6, 32, 'Cholesterol 7α-hydroxylase'), ('PMC7060658', 'D00016', 95, 121, 'Cholesterol 7α-hydroxylase')]	['Since', 'Cho', '##les', '##ter', '##ol', '7', '##α', '-', 'hydroxyl', '##ase', 'is', 'a', 'key', 'enzyme', 'in', 'cholesterol', 'elimination', ',', 'the', 'inhibition', 'of', 'Cho', '##les', '##ter', '##ol', '7', '##α', '-', 'hydroxyl', '##ase', 'could', 'cause', 'the', 'accumulation', 'of', 'cholesterol', 'in', 'the', 'liver', '[', '28', ']', '.']	[0, 6, 9, 12, 15, 18, 19, 20, 21, 29, 33, 36, 38, 42, 49, 52, 64, 75, 77, 81, 92, 95, 98, 101, 104, 107, 108, 109, 110, 118, 122, 128, 134, 138, 151, 154, 166, 169, 173, 179, 180, 182, 183]	[5, 9, 12, 15, 17, 19, 20, 21, 29, 32, 35, 37, 41, 48, 51, 63, 75, 76, 80, 91, 94, 98, 101, 104, 106, 108, 109, 110, 118, 121, 127, 133, 137, 150, 153, 165, 168, 172, 178, 180, 182, 183, 184]	['Since', 'Cholesterol', '7α-hydroxylase', 'is', 'a', 'key', 'enzyme', 'in', 'cholesterol', 'elimination', ',', 'the', 'inhibition', 'of', 'Cholesterol', '7α-hydroxylase', 'could', 'cause', 'the', 'accumulation', 'of', 'cholesterol', 'in', 'the', 'liver', '[', '28', ']', '.']	[1, 4, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The intestinal bacteria uncouple the bound bile acid into free bile acid through Bile salt hydrolase and then convert the free bile acids into secondary bile acids through 7α-dehydroxylation [29].	[('PMC7060658', 'D01000', 81, 100, 'Bile salt hydrolase')]	['The', 'intestinal', 'bacteria', 'unc', '##oup', '##le', 'the', 'bound', 'bile', 'acid', 'into', 'free', 'bile', 'acid', 'through', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', 'and', 'then', 'convert', 'the', 'free', 'bile', 'acids', 'into', 'secondary', 'bile', 'acids', 'through', '7', '##α', '-', 'dehydr', '##oxyl', '##ation', '[', '29', ']', '.']	[0, 4, 15, 24, 27, 30, 33, 37, 43, 48, 53, 58, 63, 68, 73, 81, 84, 86, 91, 96, 99, 101, 105, 110, 118, 122, 127, 132, 138, 143, 153, 158, 164, 172, 173, 174, 175, 181, 185, 191, 192, 194, 195]	[3, 14, 23, 27, 30, 32, 36, 42, 47, 52, 57, 62, 67, 72, 80, 84, 85, 90, 96, 99, 100, 104, 109, 117, 121, 126, 131, 137, 142, 152, 157, 163, 171, 173, 174, 175, 181, 185, 190, 192, 194, 195, 196]	['The', 'intestinal', 'bacteria', 'uncouple', 'the', 'bound', 'bile', 'acid', 'into', 'free', 'bile', 'acid', 'through', 'Bile', 'salt', 'hydrolase', 'and', 'then', 'convert', 'the', 'free', 'bile', 'acids', 'into', 'secondary', 'bile', 'acids', 'through', '7α-dehydroxylation', '[', '29', ']', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
7α-Dehydroxylating bacteria have bile acid-inducible (bai) genes, which encode 7α-dehydroxylase enzymes.	[('PMC7060658', 'D01002', 79, 95, '7α-dehydroxylase')]	['7', '##α', '-', 'De', '##hydroxy', '##lat', '##ing', 'bacteria', 'have', 'bile', 'acid', '-', 'inducible', '(', 'ba', '##i', ')', 'genes', ',', 'which', 'encode', '7', '##α', '-', 'dehydr', '##oxyl', '##ase', 'enzymes', '.']	[0, 1, 2, 3, 5, 12, 15, 19, 28, 33, 38, 42, 43, 53, 54, 56, 57, 59, 64, 66, 72, 79, 80, 81, 82, 88, 92, 96, 103]	[1, 2, 3, 5, 12, 15, 18, 27, 32, 37, 42, 43, 52, 54, 56, 57, 58, 64, 65, 71, 78, 80, 81, 82, 88, 92, 95, 103, 104]	['7α-Dehydroxylating', 'bacteria', 'have', 'bile', 'acid', '-', 'inducible', '(', 'bai', ')', 'genes', ',', 'which', 'encode', '7α-dehydroxylase', 'enzymes', '.']	[7, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
There are 3 key enzymes in this pathway, which are encoded by baiA2, baiB, and baiE and produce the bile acid 3α-hydroxysteroid dehydrogenase, bile acid coenzyme A-linked enzyme, and bile acid 7-alpha dehydrase, respectively [33].	[('PMC7060658', 'D01003', 110, 141, '3α-hydroxysteroid dehydrogenase'), ('PMC7060658', 'D01003', 153, 177, 'coenzyme A-linked enzyme'), ('PMC7060658', 'D01003', 183, 210, 'bile acid 7-alpha dehydrase')]	['There', 'are', '3', 'key', 'enzymes', 'in', 'this', 'pathway', ',', 'which', 'are', 'encoded', 'by', 'ba', '##i', '##A', '##2', ',', 'ba', '##i', '##B', ',', 'and', 'ba', '##i', '##E', 'and', 'produce', 'the', 'bile', 'acid', '3', '##α', '-', 'hydroxy', '##ster', '##oid', 'dehydrogenase', ',', 'bile', 'acid', 'coe', '##n', '##zyme', 'A', '-', 'linked', 'enzyme', ',', 'and', 'bile', 'acid', '7', '-', 'alpha', 'dehydr', '##ase', ',', 'respectively', '[', '33', ']', '.']	[0, 6, 10, 12, 16, 24, 27, 32, 39, 41, 47, 51, 59, 62, 64, 65, 66, 67, 69, 71, 72, 73, 75, 79, 81, 82, 84, 88, 96, 100, 105, 110, 111, 112, 113, 120, 124, 128, 141, 143, 148, 153, 156, 157, 162, 163, 164, 171, 177, 179, 183, 188, 193, 194, 195, 201, 207, 210, 212, 225, 226, 228, 229]	[5, 9, 11, 15, 23, 26, 31, 39, 40, 46, 50, 58, 61, 64, 65, 66, 67, 68, 71, 72, 73, 74, 78, 81, 82, 83, 87, 95, 99, 104, 109, 111, 112, 113, 120, 124, 127, 141, 142, 147, 152, 156, 157, 161, 163, 164, 170, 177, 178, 182, 187, 192, 194, 195, 200, 207, 210, 211, 224, 226, 228, 229, 230]	['There', 'are', '3', 'key', 'enzymes', 'in', 'this', 'pathway', ',', 'which', 'are', 'encoded', 'by', 'baiA2', ',', 'baiB', ',', 'and', 'baiE', 'and', 'produce', 'the', 'bile', 'acid', '3α-hydroxysteroid', 'dehydrogenase', ',', 'bile', 'acid', 'coenzyme', 'A', '-', 'linked', 'enzyme', ',', 'and', 'bile', 'acid', '7-alpha', 'dehydrase', ',', 'respectively', '[', '33', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Our study showed that the intestinal free bile acids significantly increased in the gallstone group (Fig. ​(Fig.7h),7h), indicating that intestinal Bile salt hydrolase activity was significantly increased.	[('PMC7060658', 'D06001', 148, 167, 'Bile salt hydrolase')]	['Our', 'study', 'showed', 'that', 'the', 'intestinal', 'free', 'bile', 'acids', 'significantly', 'increased', 'in', 'the', 'gall', '##stone', 'group', '(', 'Fig', '.', '(', 'Fig', '.', '7', '##h', ')', ',', '7', '##h', ')', ',', 'indicating', 'that', 'intestinal', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', 'activity', 'was', 'significantly', 'increased', '.']	[0, 4, 10, 17, 22, 26, 37, 42, 47, 53, 67, 77, 80, 84, 88, 94, 100, 101, 104, 107, 108, 111, 112, 113, 114, 115, 116, 117, 118, 119, 121, 132, 137, 148, 151, 153, 158, 163, 166, 168, 177, 181, 195, 204]	[3, 9, 16, 21, 25, 36, 41, 46, 52, 66, 76, 79, 83, 88, 93, 99, 101, 104, 105, 108, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 131, 136, 147, 151, 152, 157, 163, 166, 167, 176, 180, 194, 204, 205]	['Our', 'study', 'showed', 'that', 'the', 'intestinal', 'free', 'bile', 'acids', 'significantly', 'increased', 'in', 'the', 'gallstone', 'group', '(', 'Fig', '.', '\u200b(Fig.7h),7h', ')', ',', 'indicating', 'that', 'intestinal', 'Bile', 'salt', 'hydrolase', 'activity', 'was', 'significantly', 'increased', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 9, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
We analysed the abundances of BSH-active bacteria and found that the abundances of BSH-active bacteria at different levels were not significantly different between the control group and the gallstone group, indicating that Bile salt hydrolase activity was not related to the abundances of BSH-active bacteria [47].	[('PMC7060658', 'D06002', 223, 242, 'Bile salt hydrolase')]	['We', 'analysed', 'the', 'abundances', 'of', 'BS', '##H', '-', 'active', 'bacteria', 'and', 'found', 'that', 'the', 'abundances', 'of', 'BS', '##H', '-', 'active', 'bacteria', 'at', 'different', 'levels', 'were', 'not', 'significantly', 'different', 'between', 'the', 'control', 'group', 'and', 'the', 'gall', '##stone', 'group', ',', 'indicating', 'that', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', 'activity', 'was', 'not', 'related', 'to', 'the', 'abundances', 'of', 'BS', '##H', '-', 'active', 'bacteria', '[', '47', ']', '.']	[0, 3, 12, 16, 27, 30, 32, 33, 34, 41, 50, 54, 60, 65, 69, 80, 83, 85, 86, 87, 94, 103, 106, 116, 123, 128, 132, 146, 156, 164, 168, 176, 182, 186, 190, 194, 200, 205, 207, 218, 223, 226, 228, 233, 238, 241, 243, 252, 256, 260, 268, 271, 275, 286, 289, 291, 292, 293, 300, 309, 310, 312, 313]	[2, 11, 15, 26, 29, 32, 33, 34, 40, 49, 53, 59, 64, 68, 79, 82, 85, 86, 87, 93, 102, 105, 115, 122, 127, 131, 145, 155, 163, 167, 175, 181, 185, 189, 194, 199, 205, 206, 217, 222, 226, 227, 232, 238, 241, 242, 251, 255, 259, 267, 270, 274, 285, 288, 291, 292, 293, 299, 308, 310, 312, 313, 314]	['We', 'analysed', 'the', 'abundances', 'of', 'BSH-active', 'bacteria', 'and', 'found', 'that', 'the', 'abundances', 'of', 'BSH-active', 'bacteria', 'at', 'different', 'levels', 'were', 'not', 'significantly', 'different', 'between', 'the', 'control', 'group', 'and', 'the', 'gallstone', 'group', ',', 'indicating', 'that', 'Bile', 'salt', 'hydrolase', 'activity', 'was', 'not', 'related', 'to', 'the', 'abundances', 'of', 'BSH-active', 'bacteria', '[', '47', ']', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
detected the enzyme activity of different Bile salt hydrolase systems and found that BSH-T3 showed the highest enzyme activity, which was only found in Lactobacillus	[('PMC7060658', 'D06004', 42, 61, 'Bile salt hydrolase')]	['detected', 'the', 'enzyme', 'activity', 'of', 'different', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', 'systems', 'and', 'found', 'that', 'BS', '##H', '-', 'T', '##3', 'showed', 'the', 'highest', 'enzyme', 'activity', ',', 'which', 'was', 'only', 'found', 'in', 'Lact', '##obacillus']	[0, 9, 13, 20, 29, 32, 42, 45, 47, 52, 57, 60, 62, 70, 74, 80, 85, 87, 88, 89, 90, 92, 99, 103, 111, 118, 126, 128, 134, 138, 143, 149, 152, 156]	[8, 12, 19, 28, 31, 41, 45, 46, 51, 57, 60, 61, 69, 73, 79, 84, 87, 88, 89, 90, 91, 98, 102, 110, 117, 126, 127, 133, 137, 142, 148, 151, 156, 165]	['detected', 'the', 'enzyme', 'activity', 'of', 'different', 'Bile', 'salt', 'hydrolase', 'systems', 'and', 'found', 'that', 'BSH-T3', 'showed', 'the', 'highest', 'enzyme', 'activity', ',', 'which', 'was', 'only', 'found', 'in', 'Lactobacillus']	[1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (Bile salt hydrolase) genes based on worldwide human gut microbiome.	[('PMC7060658', 'F20002', 59, 78, 'bile salt hydrolase'), ('PMC7060658', 'F20002', 80, 99, 'Bile salt hydrolase')]	['Tax', '##onomic', 'profiling', 'and', 'population', '##al', 'patterns', 'of', 'bacterial', 'bile', 'salt', 'hydro', '##las', '##e', '(', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', ')', 'genes', 'based', 'on', 'worldwide', 'human', 'gut', 'microbi', '##ome', '.']	[0, 3, 10, 20, 24, 34, 37, 46, 49, 59, 64, 69, 74, 77, 79, 80, 83, 85, 90, 95, 98, 99, 101, 107, 113, 116, 126, 132, 136, 143, 146]	[3, 9, 19, 23, 34, 36, 45, 48, 58, 63, 68, 74, 77, 78, 80, 83, 84, 89, 95, 98, 99, 100, 106, 112, 115, 125, 131, 135, 143, 146, 147]	['Taxonomic', 'profiling', 'and', 'populational', 'patterns', 'of', 'bacterial', 'bile', 'salt', 'hydrolase', '(', 'Bile', 'salt', 'hydrolase', ')', 'genes', 'based', 'on', 'worldwide', 'human', 'gut', 'microbiome', '.']	[2, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacterial bile salt hydrolase in host metabolism: potential for influencing gastrointestinal microbe-host crosstalk.	[('PMC7060658', 'F28002', 10, 29, 'bile salt hydrolase')]	['Bacterial', 'bile', 'salt', 'hydro', '##las', '##e', 'in', 'host', 'metabolism', ':', 'potential', 'for', 'influencing', 'gastro', '##intestinal', 'microb', '##e', '-', 'host', 'crosstalk', '.']	[0, 10, 15, 20, 25, 28, 30, 33, 38, 48, 50, 60, 64, 76, 82, 93, 99, 100, 101, 106, 115]	[9, 14, 19, 25, 28, 29, 32, 37, 48, 49, 59, 63, 75, 82, 92, 99, 100, 101, 105, 115, 116]	['Bacterial', 'bile', 'salt', 'hydrolase', 'in', 'host', 'metabolism', ':', 'potential', 'for', 'influencing', 'gastrointestinal', 'microbe', '-', 'host', 'crosstalk', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Wells JE, Williams KB, Whitehead TR, et al. Development and application of a polymerase chain reaction assay for the detection and enumeration of bile acid 7alpha-dehydroxylating bacteria in human feces.	[('PMC7060658', 'F29001', 77, 87, 'polymerase')]	['Well', '##s', 'JE', ',', 'Williams', 'KB', ',', 'White', '##head', 'TR', ',', 'et', 'al', '.', 'Development', 'and', 'application', 'of', 'a', 'polymerase', 'chain', 'reaction', 'assay', 'for', 'the', 'detection', 'and', 'enumeration', 'of', 'bile', 'acid', '7', '##alpha', '-', 'dehydr', '##oxyl', '##ating', 'bacteria', 'in', 'human', 'fe', '##ces', '.']	[0, 4, 6, 8, 10, 19, 21, 23, 28, 33, 35, 37, 40, 42, 44, 56, 60, 72, 75, 77, 88, 94, 103, 109, 113, 117, 127, 131, 143, 146, 151, 156, 157, 162, 163, 169, 173, 179, 188, 191, 197, 199, 202]	[4, 5, 8, 9, 18, 21, 22, 28, 32, 35, 36, 39, 42, 43, 55, 59, 71, 74, 76, 87, 93, 102, 108, 112, 116, 126, 130, 142, 145, 150, 155, 157, 162, 163, 169, 173, 178, 187, 190, 196, 199, 202, 203]	['Wells', 'JE', ',', 'Williams', 'KB', ',', 'Whitehead', 'TR', ',', 'et', 'al', '.', 'Development', 'and', 'application', 'of', 'a', 'polymerase', 'chain', 'reaction', 'assay', 'for', 'the', 'detection', 'and', 'enumeration', 'of', 'bile', 'acid', '7alpha', '-', 'dehydroxylating', 'bacteria', 'in', 'human', 'feces', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bhowmik S, Chiu HP, Jones DH, et al. Structure and functional characterization of a bile acid 7alpha dehydratase BaiE in secondary bile acid synthesis.	[('PMC7060658', 'F32001', 84, 112, 'bile acid 7alpha dehydratase')]	['Bh', '##ow', '##mi', '##k', 'S', ',', 'Chi', '##u', 'HP', ',', 'Jones', 'DH', ',', 'et', 'al', '.', 'Structure', 'and', 'functional', 'character', '##ization', 'of', 'a', 'bile', 'acid', '7', '##alpha', 'dehydr', '##atase', 'Ba', '##i', '##E', 'in', 'secondary', 'bile', 'acid', 'synthesis', '.']	[0, 2, 4, 6, 8, 9, 11, 14, 16, 18, 20, 26, 28, 30, 33, 35, 37, 47, 51, 62, 71, 79, 82, 84, 89, 94, 95, 101, 107, 113, 115, 116, 118, 121, 131, 136, 141, 150]	[2, 4, 6, 7, 9, 10, 14, 15, 18, 19, 25, 28, 29, 32, 35, 36, 46, 50, 61, 71, 78, 81, 83, 88, 93, 95, 100, 107, 112, 115, 116, 117, 120, 130, 135, 140, 150, 151]	['Bhowmik', 'S', ',', 'Chiu', 'HP', ',', 'Jones', 'DH', ',', 'et', 'al', '.', 'Structure', 'and', 'functional', 'characterization', 'of', 'a', 'bile', 'acid', '7alpha', 'dehydratase', 'BaiE', 'in', 'secondary', 'bile', 'acid', 'synthesis', '.']	[4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 2, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Chemoproteomic Profiling of Gut Microbiota-Associated Bile Salt Hydrolase Activity.	[('PMC7060658', 'F46002', 54, 73, 'Bile Salt Hydrolase')]	['Chem', '##oprot', '##e', '##omic', 'Prof', '##iling', 'of', 'Gut', 'Microb', '##io', '##ta', '-', 'Associated', 'Bil', '##e', 'Sal', '##t', 'Hydro', '##las', '##e', 'Activity', '.']	[0, 4, 9, 10, 15, 19, 25, 28, 32, 38, 40, 42, 43, 54, 57, 59, 62, 64, 69, 72, 74, 82]	[4, 9, 10, 14, 19, 24, 27, 31, 38, 40, 42, 43, 53, 57, 58, 62, 63, 69, 72, 73, 82, 83]	['Chemoproteomic', 'Profiling', 'of', 'Gut', 'Microbiota-Associated', 'Bile', 'Salt', 'Hydrolase', 'Activity', '.']	[4, 2, 1, 1, 5, 2, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
After the extraction of total DNA of the samples, primers were designed according to the conserved region, and sequencing adaptors were attached to the ends of the primers for polymerase chain reaction (PCR) amplification.	[('PMC7060658', 'M01000', 176, 186, 'polymerase')]	['After', 'the', 'extraction', 'of', 'total', 'DNA', 'of', 'the', 'samples', ',', 'primers', 'were', 'designed', 'according', 'to', 'the', 'conserved', 'region', ',', 'and', 'sequencing', 'adapt', '##ors', 'were', 'attached', 'to', 'the', 'ends', 'of', 'the', 'primers', 'for', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', '.']	[0, 6, 10, 21, 24, 30, 34, 37, 41, 48, 50, 58, 63, 72, 82, 85, 89, 99, 105, 107, 111, 122, 127, 131, 136, 145, 148, 152, 157, 160, 164, 172, 176, 187, 193, 202, 203, 206, 208, 221]	[5, 9, 20, 23, 29, 33, 36, 40, 48, 49, 57, 62, 71, 81, 84, 88, 98, 105, 106, 110, 121, 127, 130, 135, 144, 147, 151, 156, 159, 163, 171, 175, 186, 192, 201, 203, 206, 207, 221, 222]	['After', 'the', 'extraction', 'of', 'total', 'DNA', 'of', 'the', 'samples', ',', 'primers', 'were', 'designed', 'according', 'to', 'the', 'conserved', 'region', ',', 'and', 'sequencing', 'adaptors', 'were', 'attached', 'to', 'the', 'ends', 'of', 'the', 'primers', 'for', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The gut microbiota with encoded bile salt hydrolase (Bile salt hydrolase) genes were identified by a literature review [21].	[('PMC7060658', 'M03007', 32, 51, 'bile salt hydrolase'), ('PMC7060658', 'M03007', 53, 72, 'Bile salt hydrolase')]	['The', 'gut', 'microbiota', 'with', 'encoded', 'bile', 'salt', 'hydro', '##las', '##e', '(', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', ')', 'genes', 'were', 'identified', 'by', 'a', 'literature', 'review', '[', '21', ']', '.']	[0, 4, 8, 19, 24, 32, 37, 42, 47, 50, 52, 53, 56, 58, 63, 68, 71, 72, 74, 80, 85, 96, 99, 101, 112, 119, 120, 122, 123]	[3, 7, 18, 23, 31, 36, 41, 47, 50, 51, 53, 56, 57, 62, 68, 71, 72, 73, 79, 84, 95, 98, 100, 111, 118, 120, 122, 123, 124]	['The', 'gut', 'microbiota', 'with', 'encoded', 'bile', 'salt', 'hydrolase', '(', 'Bile', 'salt', 'hydrolase', ')', 'genes', 'were', 'identified', 'by', 'a', 'literature', 'review', '[', '21', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The gut microbiota with Bile salt hydrolase activity in the gallstone group was selected by referring to the literature and the database of the Human Microbiome Project (https://www.hmpdacc.org).	[('PMC7060658', 'M03008', 24, 43, 'Bile salt hydrolase')]	['The', 'gut', 'microbiota', 'with', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', 'activity', 'in', 'the', 'gall', '##stone', 'group', 'was', 'selected', 'by', 'referring', 'to', 'the', 'literature', 'and', 'the', 'database', 'of', 'the', 'Human', 'Microb', '##io', '##me', 'Project', '(', 'https', ':', '/', '/', 'www', '.', 'h', '##mp', '##da', '##cc', '.', 'org', ')', '.']	[0, 4, 8, 19, 24, 27, 29, 34, 39, 42, 44, 53, 56, 60, 64, 70, 76, 80, 89, 92, 102, 105, 109, 120, 124, 128, 137, 140, 144, 150, 156, 158, 161, 169, 170, 175, 176, 177, 178, 181, 182, 183, 185, 187, 189, 190, 193, 194]	[3, 7, 18, 23, 27, 28, 33, 39, 42, 43, 52, 55, 59, 64, 69, 75, 79, 88, 91, 101, 104, 108, 119, 123, 127, 136, 139, 143, 149, 156, 158, 160, 168, 170, 175, 176, 177, 178, 181, 182, 183, 185, 187, 189, 190, 193, 194, 195]	['The', 'gut', 'microbiota', 'with', 'Bile', 'salt', 'hydrolase', 'activity', 'in', 'the', 'gallstone', 'group', 'was', 'selected', 'by', 'referring', 'to', 'the', 'literature', 'and', 'the', 'database', 'of', 'the', 'Human', 'Microbiome', 'Project', '(', 'https', ':', '/', '/', 'www.hmpdacc.org', ')', '.']	[1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 8, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using the literature and databases, the gut microbiota with bile salt hydrolase (Bile salt hydrolase) activity were screened at different levels.	[('PMC7060658', 'R06000', 60, 79, 'bile salt hydrolase'), ('PMC7060658', 'R06000', 81, 100, 'Bile salt hydrolase')]	['Using', 'the', 'literature', 'and', 'databases', ',', 'the', 'gut', 'microbiota', 'with', 'bile', 'salt', 'hydro', '##las', '##e', '(', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', ')', 'activity', 'were', 'screened', 'at', 'different', 'levels', '.']	[0, 6, 10, 21, 25, 34, 36, 40, 44, 55, 60, 65, 70, 75, 78, 80, 81, 84, 86, 91, 96, 99, 100, 102, 111, 116, 125, 128, 138, 144]	[5, 9, 20, 24, 34, 35, 39, 43, 54, 59, 64, 69, 75, 78, 79, 81, 84, 85, 90, 96, 99, 100, 101, 110, 115, 124, 127, 137, 144, 145]	['Using', 'the', 'literature', 'and', 'databases', ',', 'the', 'gut', 'microbiota', 'with', 'bile', 'salt', 'hydrolase', '(', 'Bile', 'salt', 'hydrolase', ')', 'activity', 'were', 'screened', 'at', 'different', 'levels', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The results showed that at the phylum, class, order, family and genus levels, the abundance of bacteria with Bile salt hydrolase activity was reduced in the gallstone group compared with the control group, but this difference was not statistically significant (Fig. 6a).	[('PMC7060658', 'R06001', 109, 128, 'Bile salt hydrolase')]	['The', 'results', 'showed', 'that', 'at', 'the', 'phyl', '##um', ',', 'class', ',', 'order', ',', 'family', 'and', 'genus', 'levels', ',', 'the', 'abundance', 'of', 'bacteria', 'with', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', 'activity', 'was', 'reduced', 'in', 'the', 'gall', '##stone', 'group', 'compared', 'with', 'the', 'control', 'group', ',', 'but', 'this', 'difference', 'was', 'not', 'statistically', 'significant', '(', 'Fig', '.', '6', '##a', ')', '.']	[0, 4, 12, 19, 24, 27, 31, 35, 37, 39, 44, 46, 51, 53, 60, 64, 70, 76, 78, 82, 92, 95, 104, 109, 112, 114, 119, 124, 127, 129, 138, 142, 150, 153, 157, 161, 167, 173, 182, 187, 191, 199, 204, 206, 210, 215, 226, 230, 234, 248, 260, 261, 264, 266, 267, 268, 269]	[3, 11, 18, 23, 26, 30, 35, 37, 38, 44, 45, 51, 52, 59, 63, 69, 76, 77, 81, 91, 94, 103, 108, 112, 113, 118, 124, 127, 128, 137, 141, 149, 152, 156, 161, 166, 172, 181, 186, 190, 198, 204, 205, 209, 214, 225, 229, 233, 247, 259, 261, 264, 265, 267, 268, 269, 270]	['The', 'results', 'showed', 'that', 'at', 'the', 'phylum', ',', 'class', ',', 'order', ',', 'family', 'and', 'genus', 'levels', ',', 'the', 'abundance', 'of', 'bacteria', 'with', 'Bile', 'salt', 'hydrolase', 'activity', 'was', 'reduced', 'in', 'the', 'gallstone', 'group', 'compared', 'with', 'the', 'control', 'group', ',', 'but', 'this', 'difference', 'was', 'not', 'statistically', 'significant', '(', 'Fig', '.', '6a', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
At these different levels, the abundance of bacteria with Bile salt hydrolase activity in the gallstone group was also not correlated with free bile acids (Fig. ​(Fig.6b).6b).	[('PMC7060658', 'R06002', 58, 77, 'Bile salt hydrolase')]	['At', 'these', 'different', 'levels', ',', 'the', 'abundance', 'of', 'bacteria', 'with', 'Bil', '##e', 'salt', 'hydro', '##las', '##e', 'activity', 'in', 'the', 'gall', '##stone', 'group', 'was', 'also', 'not', 'correlated', 'with', 'free', 'bile', 'acids', '(', 'Fig', '.', '(', 'Fig', '.', '6', '##b', ')', '.', '6', '##b', ')', '.']	[0, 3, 9, 19, 25, 27, 31, 41, 44, 53, 58, 61, 63, 68, 73, 76, 78, 87, 90, 94, 98, 104, 110, 114, 119, 123, 134, 139, 144, 149, 155, 156, 159, 162, 163, 166, 167, 168, 169, 170, 171, 172, 173, 174]	[2, 8, 18, 25, 26, 30, 40, 43, 52, 57, 61, 62, 67, 73, 76, 77, 86, 89, 93, 98, 103, 109, 113, 118, 122, 133, 138, 143, 148, 154, 156, 159, 160, 163, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175]	['At', 'these', 'different', 'levels', ',', 'the', 'abundance', 'of', 'bacteria', 'with', 'Bile', 'salt', 'hydrolase', 'activity', 'in', 'the', 'gallstone', 'group', 'was', 'also', 'not', 'correlated', 'with', 'free', 'bile', 'acids', '(', 'Fig', '.', '\u200b(Fig.6b).6b', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 9, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bile salt hydrolase activity was not related to the abundances of BSH-active bacteria.	[('PMC7060658', 'R06004', 0, 19, 'Bile salt hydrolase')]	['Bil', '##e', 'salt', 'hydro', '##las', '##e', 'activity', 'was', 'not', 'related', 'to', 'the', 'abundances', 'of', 'BS', '##H', '-', 'active', 'bacteria', '.']	[0, 3, 5, 10, 15, 18, 20, 29, 33, 37, 45, 48, 52, 63, 66, 68, 69, 70, 77, 85]	[3, 4, 9, 15, 18, 19, 28, 32, 36, 44, 47, 51, 62, 65, 68, 69, 70, 76, 85, 86]	['Bile', 'salt', 'hydrolase', 'activity', 'was', 'not', 'related', 'to', 'the', 'abundances', 'of', 'BSH-active', 'bacteria', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
ADMA is a methylated AA that directly inhibits nitric oxide synthase, thereby increasing systemic vascular resistance and blood pressure.	[('PMC7064164', 'D05002', 47, 68, 'nitric oxide synthase')]	['AD', '##MA', 'is', 'a', 'methylated', 'AA', 'that', 'directly', 'inhibits', 'nitric', 'oxide', 'synthase', ',', 'thereby', 'increasing', 'systemic', 'vascular', 'resistance', 'and', 'blood', 'pressure', '.']	[0, 2, 5, 8, 10, 21, 24, 29, 38, 47, 54, 60, 68, 70, 78, 89, 98, 107, 118, 122, 128, 136]	[2, 4, 7, 9, 20, 23, 28, 37, 46, 53, 59, 68, 69, 77, 88, 97, 106, 117, 121, 127, 136, 137]	['ADMA', 'is', 'a', 'methylated', 'AA', 'that', 'directly', 'inhibits', 'nitric', 'oxide', 'synthase', ',', 'thereby', 'increasing', 'systemic', 'vascular', 'resistance', 'and', 'blood', 'pressure', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SDMA is a stereoisomer of ADMA which does not directly inhibit nitric oxide synthase (51, 52).	[('PMC7064164', 'D05003', 63, 84, 'nitric oxide synthase')]	['SD', '##MA', 'is', 'a', 'stereo', '##iso', '##mer', 'of', 'AD', '##MA', 'which', 'does', 'not', 'directly', 'inhibit', 'nitric', 'oxide', 'synthase', '(', '51', ',', '52', ')', '.']	[0, 2, 5, 8, 10, 16, 19, 23, 26, 28, 31, 37, 42, 46, 55, 63, 70, 76, 85, 86, 88, 90, 92, 93]	[2, 4, 7, 9, 16, 19, 22, 25, 28, 30, 36, 41, 45, 54, 62, 69, 75, 84, 86, 88, 89, 92, 93, 94]	['SDMA', 'is', 'a', 'stereoisomer', 'of', 'ADMA', 'which', 'does', 'not', 'directly', 'inhibit', 'nitric', 'oxide', 'synthase', '(', '51', ',', '52', ')', '.']	[2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
The enriched pathways mainly included focal adhesion, cell adhesion molecules, the Phosphatidylinositide 3-kinase-protein kinase B signalling pathway, ECM-receptor interactions and so on.	[('PMC7066733', 'A02002', 83, 130, 'Phosphatidylinositide 3-kinase-protein kinase B')]	['The', 'enriched', 'pathways', 'mainly', 'included', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'the', 'Phosph', '##atidyl', '##inos', '##iti', '##de', '3', '-', 'kinase', '-', 'protein', 'kinase', 'B', 'signalling', 'pathway', ',', 'ECM', '-', 'receptor', 'interactions', 'and', 'so', 'on', '.']	[0, 4, 13, 22, 29, 38, 44, 52, 54, 59, 68, 77, 79, 83, 89, 95, 99, 102, 105, 106, 107, 113, 114, 122, 129, 131, 142, 149, 151, 154, 155, 164, 177, 181, 184, 186]	[3, 12, 21, 28, 37, 43, 52, 53, 58, 67, 77, 78, 82, 89, 95, 99, 102, 104, 106, 107, 113, 114, 121, 128, 130, 141, 149, 150, 154, 155, 163, 176, 180, 183, 186, 187]	['The', 'enriched', 'pathways', 'mainly', 'included', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'the', 'Phosphatidylinositide', '3-kinase-', 'protein', 'kinase', 'B', 'signalling', 'pathway', ',', 'ECM-receptor', 'interactions', 'and', 'so', 'on', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
According to KEGG function classification analysis, a variety of enriched pathways are involved in HSPN, such as focal adhesion, cell adhesion molecules, the Phosphatidylinositide 3-kinase-protein kinase B signalling pathway, ECM-receptor interactions and regulation of the actin cytoskeleton, which include many common differentially expressed proteins (integrin beta-1, tenascin, collagen alpha-1 (I) and platelet-derived growth factor receptor) that participate in mesangial cell proliferation and fibrosis processes [23–25].	[('PMC7066733', 'D01004', 158, 205, 'Phosphatidylinositide 3-kinase-protein kinase B')]	['According', 'to', 'KE', '##GG', 'function', 'classification', 'analysis', ',', 'a', 'variety', 'of', 'enriched', 'pathways', 'are', 'involved', 'in', 'HSP', '##N', ',', 'such', 'as', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'the', 'Phosph', '##atidyl', '##inos', '##iti', '##de', '3', '-', 'kinase', '-', 'protein', 'kinase', 'B', 'signalling', 'pathway', ',', 'ECM', '-', 'receptor', 'interactions', 'and', 'regulation', 'of', 'the', 'actin', 'cytoskeleton', ',', 'which', 'include', 'many', 'common', 'differentially', 'expressed', 'proteins', '(', 'integrin', 'beta', '-', '1', ',', 'ten', '##asc', '##in', ',', 'collagen', 'alpha', '-', '1', '(', 'I', ')', 'and', 'platelet', '-', 'derived', 'growth', 'factor', 'receptor', ')', 'that', 'participate', 'in', 'mes', '##angi', '##al', 'cell', 'proliferation', 'and', 'fibrosis', 'processes', '[', '23', '–', '25', ']', '.']	[0, 10, 13, 15, 18, 27, 42, 50, 52, 54, 62, 65, 74, 83, 87, 96, 99, 102, 103, 105, 110, 113, 119, 127, 129, 134, 143, 152, 154, 158, 164, 170, 174, 177, 180, 181, 182, 188, 189, 197, 204, 206, 217, 224, 226, 229, 230, 239, 252, 256, 267, 270, 274, 280, 292, 294, 300, 308, 313, 320, 335, 345, 354, 355, 364, 368, 369, 370, 372, 375, 378, 380, 382, 391, 396, 397, 399, 400, 401, 403, 407, 415, 416, 424, 431, 438, 446, 448, 453, 465, 468, 471, 475, 478, 483, 497, 501, 510, 520, 521, 523, 524, 526, 527]	[9, 12, 15, 17, 26, 41, 50, 51, 53, 61, 64, 73, 82, 86, 95, 98, 102, 103, 104, 109, 112, 118, 127, 128, 133, 142, 152, 153, 157, 164, 170, 174, 177, 179, 181, 182, 188, 189, 196, 203, 205, 216, 224, 225, 229, 230, 238, 251, 255, 266, 269, 273, 279, 292, 293, 299, 307, 312, 319, 334, 344, 353, 355, 363, 368, 369, 370, 371, 375, 378, 380, 381, 390, 396, 397, 398, 400, 401, 402, 406, 415, 416, 423, 430, 437, 446, 447, 452, 464, 467, 471, 475, 477, 482, 496, 500, 509, 519, 521, 523, 524, 526, 527, 528]	['According', 'to', 'KEGG', 'function', 'classification', 'analysis', ',', 'a', 'variety', 'of', 'enriched', 'pathways', 'are', 'involved', 'in', 'HSPN', ',', 'such', 'as', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'the', 'Phosphatidylinositide', '3-kinase-', 'protein', 'kinase', 'B', 'signalling', 'pathway', ',', 'ECM-receptor', 'interactions', 'and', 'regulation', 'of', 'the', 'actin', 'cytoskeleton', ',', 'which', 'include', 'many', 'common', 'differentially', 'expressed', 'proteins', '(', 'integrin', 'beta-1', ',', 'tenascin', ',', 'collagen', 'alpha-1', '(I)', 'and', 'platelet', '-', 'derived', 'growth', 'factor', 'receptor', ')', 'that', 'participate', 'in', 'mesangial', 'cell', 'proliferation', 'and', 'fibrosis', 'processes', '[', '23–', '25', ']', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
According to the KEGG function classification analysis, focal adhesion, cell adhesion molecules, the phosphatidylinositide 3-kinase-protein kinase B (Phosphatidylinositide 3-kinase-protein kinase B) signalling pathway, extracellular matrix (ECM)-receptor interactions, platelet activation, complement and coagulation cascades, cholesterol metabolism, and regulation of the actin cytoskeleton were among the top 20 enriched pathways (Fig. 3).	[('PMC7066733', 'R02002', 101, 148, 'phosphatidylinositide 3-kinase-protein kinase B'), ('PMC7066733', 'R02002', 150, 197, 'Phosphatidylinositide 3-kinase-protein kinase B')]	['According', 'to', 'the', 'KE', '##GG', 'function', 'classification', 'analysis', ',', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'the', 'phosphatidyl', '##inos', '##iti', '##de', '3', '-', 'kinase', '-', 'protein', 'kinase', 'B', '(', 'Phosph', '##atidyl', '##inos', '##iti', '##de', '3', '-', 'kinase', '-', 'protein', 'kinase', 'B', ')', 'signalling', 'pathway', ',', 'extracellular', 'matrix', '(', 'ECM', ')', '-', 'receptor', 'interactions', ',', 'platelet', 'activation', ',', 'complement', 'and', 'coagulation', 'cascades', ',', 'cholesterol', 'metabolism', ',', 'and', 'regulation', 'of', 'the', 'actin', 'cytoskeleton', 'were', 'among', 'the', 'top', '20', 'enriched', 'pathways', '(', 'Fig', '.', '3', ')', '.']	[0, 10, 13, 17, 19, 22, 31, 46, 54, 56, 62, 70, 72, 77, 86, 95, 97, 101, 113, 117, 120, 123, 124, 125, 131, 132, 140, 147, 149, 150, 156, 162, 166, 169, 172, 173, 174, 180, 181, 189, 196, 197, 199, 210, 217, 219, 233, 240, 241, 244, 245, 246, 255, 267, 269, 278, 288, 290, 301, 305, 317, 325, 327, 339, 349, 351, 355, 366, 369, 373, 379, 392, 397, 403, 407, 411, 414, 423, 432, 433, 436, 438, 439, 440]	[9, 12, 16, 19, 21, 30, 45, 54, 55, 61, 70, 71, 76, 85, 95, 96, 100, 113, 117, 120, 122, 124, 125, 131, 132, 139, 146, 148, 150, 156, 162, 166, 169, 171, 173, 174, 180, 181, 188, 195, 197, 198, 209, 217, 218, 232, 239, 241, 244, 245, 246, 254, 267, 268, 277, 288, 289, 300, 304, 316, 325, 326, 338, 349, 350, 354, 365, 368, 372, 378, 391, 396, 402, 406, 410, 413, 422, 431, 433, 436, 437, 439, 440, 441]	['According', 'to', 'the', 'KEGG', 'function', 'classification', 'analysis', ',', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'the', 'phosphatidylinositide', '3-kinase-', 'protein', 'kinase', 'B', '(', 'Phosphatidylinositide', '3-kinase-', 'protein', 'kinase', 'B', ')', 'signalling', 'pathway', ',', 'extracellular', 'matrix', '(ECM)-receptor', 'interactions', ',', 'platelet', 'activation', ',', 'complement', 'and', 'coagulation', 'cascades', ',', 'cholesterol', 'metabolism', ',', 'and', 'regulation', 'of', 'the', 'actin', 'cytoskeleton', 'were', 'among', 'the', 'top', '20', 'enriched', 'pathways', '(', 'Fig', '.', '3', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 5, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, the core proteins (integrin beta-1 and tenascin) were involved in multiple pathways, such as focal adhesion, cell adhesion molecules, ECM-receptor interactions and the Phosphatidylinositide 3-kinase-protein kinase B signalling pathway (Fig. 5).	[('PMC7066733', 'R03001', 183, 230, 'Phosphatidylinositide 3-kinase-protein kinase B')]	['Interestingly', ',', 'the', 'core', 'proteins', '(', 'integrin', 'beta', '-', '1', 'and', 'ten', '##asc', '##in', ')', 'were', 'involved', 'in', 'multiple', 'pathways', ',', 'such', 'as', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'ECM', '-', 'receptor', 'interactions', 'and', 'the', 'Phosph', '##atidyl', '##inos', '##iti', '##de', '3', '-', 'kinase', '-', 'protein', 'kinase', 'B', 'signalling', 'pathway', '(', 'Fig', '.', '5', ')', '.']	[0, 13, 15, 19, 24, 33, 34, 43, 47, 48, 50, 54, 57, 60, 62, 64, 69, 78, 81, 90, 98, 100, 105, 108, 114, 122, 124, 129, 138, 147, 149, 152, 153, 162, 175, 179, 183, 189, 195, 199, 202, 205, 206, 207, 213, 214, 222, 229, 231, 242, 250, 251, 254, 256, 257, 258]	[13, 14, 18, 23, 32, 34, 42, 47, 48, 49, 53, 57, 60, 62, 63, 68, 77, 80, 89, 98, 99, 104, 107, 113, 122, 123, 128, 137, 147, 148, 152, 153, 161, 174, 178, 182, 189, 195, 199, 202, 204, 206, 207, 213, 214, 221, 228, 230, 241, 249, 251, 254, 255, 257, 258, 259]	['Interestingly', ',', 'the', 'core', 'proteins', '(', 'integrin', 'beta-1', 'and', 'tenascin', ')', 'were', 'involved', 'in', 'multiple', 'pathways', ',', 'such', 'as', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'ECM-receptor', 'interactions', 'and', 'the', 'Phosphatidylinositide', '3-kinase-', 'protein', 'kinase', 'B', 'signalling', 'pathway', '(', 'Fig', '.', '5', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 5, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, members of the Prevotellaceae possess phosphotransbutyrylase and butyrate kinase, which are key enzymes in the butyrate synthesis pathway [49].	[('PMC7071635', 'D01020', 51, 73, 'phosphotransbutyrylase'), ('PMC7071635', 'D01020', 78, 93, 'butyrate kinase')]	['Furthermore', ',', 'members', 'of', 'the', 'Prev', '##ote', '##lla', '##ce', '##ae', 'possess', 'phospho', '##trans', '##but', '##yr', '##yl', '##ase', 'and', 'but', '##yrate', 'kinase', ',', 'which', 'are', 'key', 'enzymes', 'in', 'the', 'but', '##yrate', 'synthesis', 'pathway', '[', '49', ']', '.']	[0, 11, 13, 21, 24, 28, 32, 35, 38, 40, 43, 51, 58, 63, 66, 68, 70, 74, 78, 81, 87, 93, 95, 101, 105, 109, 117, 120, 124, 127, 133, 143, 151, 152, 154, 155]	[11, 12, 20, 23, 27, 32, 35, 38, 40, 42, 50, 58, 63, 66, 68, 70, 73, 77, 81, 86, 93, 94, 100, 104, 108, 116, 119, 123, 127, 132, 142, 150, 152, 154, 155, 156]	['Furthermore', ',', 'members', 'of', 'the', 'Prevotellaceae', 'possess', 'phosphotransbutyrylase', 'and', 'butyrate', 'kinase', ',', 'which', 'are', 'key', 'enzymes', 'in', 'the', 'butyrate', 'synthesis', 'pathway', '[', '49', ']', '.']	[1, 1, 1, 1, 1, 5, 1, 6, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A link between LPS exposure and defective IgA galactosylation has been confirmed by a study showing that bacterial LPS activates TLR4 in cultured peripheral B lymphocytes to induce Cosmc expression critical for the activity of the enzyme galactosyltransferase [63].	[('PMC7071635', 'D02009', 238, 259, 'galactosyltransferase')]	['A', 'link', 'between', 'LPS', 'exposure', 'and', 'defective', 'IgA', 'galact', '##osyl', '##ation', 'has', 'been', 'confirmed', 'by', 'a', 'study', 'showing', 'that', 'bacterial', 'LPS', 'activates', 'TLR', '##4', 'in', 'cultured', 'peripheral', 'B', 'lymphocytes', 'to', 'induce', 'Cos', '##mc', 'expression', 'critical', 'for', 'the', 'activity', 'of', 'the', 'enzyme', 'galact', '##osyl', '##transferase', '[', '63', ']', '.']	[0, 2, 7, 15, 19, 28, 32, 42, 46, 52, 56, 62, 66, 71, 81, 84, 86, 92, 100, 105, 115, 119, 129, 132, 134, 137, 146, 157, 159, 171, 174, 181, 184, 187, 198, 207, 211, 215, 224, 227, 231, 238, 244, 248, 260, 261, 263, 264]	[1, 6, 14, 18, 27, 31, 41, 45, 52, 56, 61, 65, 70, 80, 83, 85, 91, 99, 104, 114, 118, 128, 132, 133, 136, 145, 156, 158, 170, 173, 180, 184, 186, 197, 206, 210, 214, 223, 226, 230, 237, 244, 248, 259, 261, 263, 264, 265]	['A', 'link', 'between', 'LPS', 'exposure', 'and', 'defective', 'IgA', 'galactosylation', 'has', 'been', 'confirmed', 'by', 'a', 'study', 'showing', 'that', 'bacterial', 'LPS', 'activates', 'TLR4', 'in', 'cultured', 'peripheral', 'B', 'lymphocytes', 'to', 'induce', 'Cosmc', 'expression', 'critical', 'for', 'the', 'activity', 'of', 'the', 'enzyme', 'galactosyltransferase', '[', '63', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
On the first morning, urine samples were collected and centrifuged; then,urinary albumin (uALB) was quantified by a turbidimetric inhibition immune assay, urine creatinine (uCr) was determined with a sarcosine oxidase assay, C-reactive protein (CRP) was quantified by immunoturbidimetric assay and the estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [25].	[('PMC7071635', 'M04002', 200, 217, 'sarcosine oxidase')]	['On', 'the', 'first', 'morning', ',', 'urine', 'samples', 'were', 'collected', 'and', 'centrifuged', ';', 'then', ',', 'urinary', 'albumin', '(', 'u', '##AL', '##B', ')', 'was', 'quantified', 'by', 'a', 'turb', '##idi', '##metric', 'inhibition', 'immune', 'assay', ',', 'urine', 'creatinine', '(', 'u', '##Cr', ')', 'was', 'determined', 'with', 'a', 'sarc', '##osine', 'oxidase', 'assay', ',', 'C', '-', 'reactive', 'protein', '(', 'CRP', ')', 'was', 'quantified', 'by', 'immuno', '##tur', '##bi', '##dim', '##etric', 'assay', 'and', 'the', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'e', '##GFR', ')', 'was', 'calculated', 'using', 'the', 'Chronic', 'Kidney', 'Disease', 'Epidemiology', 'Collaboration', '(', 'CKD', '-', 'EP', '##I', ')', 'equation', '[', '25', ']', '.']	[0, 3, 7, 13, 20, 22, 28, 36, 41, 51, 55, 66, 68, 72, 73, 81, 89, 90, 91, 93, 94, 96, 100, 111, 114, 116, 120, 123, 130, 141, 148, 153, 155, 161, 172, 173, 174, 176, 178, 182, 193, 198, 200, 204, 210, 218, 223, 225, 226, 227, 236, 244, 245, 248, 250, 254, 265, 268, 274, 277, 279, 282, 288, 294, 298, 302, 312, 323, 334, 339, 340, 341, 344, 346, 350, 361, 367, 371, 379, 386, 394, 407, 421, 422, 425, 426, 428, 429, 431, 440, 441, 443, 444]	[2, 6, 12, 20, 21, 27, 35, 40, 50, 54, 66, 67, 72, 73, 80, 88, 90, 91, 93, 94, 95, 99, 110, 113, 115, 120, 123, 129, 140, 147, 153, 154, 160, 171, 173, 174, 176, 177, 181, 192, 197, 199, 204, 209, 217, 223, 224, 226, 227, 235, 243, 245, 248, 249, 253, 264, 267, 274, 277, 279, 282, 287, 293, 297, 301, 311, 322, 333, 338, 340, 341, 344, 345, 349, 360, 366, 370, 378, 385, 393, 406, 420, 422, 425, 426, 428, 429, 430, 439, 441, 443, 444, 445]	['On', 'the', 'first', 'morning', ',', 'urine', 'samples', 'were', 'collected', 'and', 'centrifuged', ';', 'then', ',', 'urinary', 'albumin', '(', 'uALB', ')', 'was', 'quantified', 'by', 'a', 'turbidimetric', 'inhibition', 'immune', 'assay', ',', 'urine', 'creatinine', '(', 'uCr', ')', 'was', 'determined', 'with', 'a', 'sarcosine', 'oxidase', 'assay', ',', 'C-reactive', 'protein', '(', 'CRP', ')', 'was', 'quantified', 'by', 'immunoturbidimetric', 'assay', 'and', 'the', 'estimated', 'glomerular', 'filtration', 'rate', '(', 'eGFR', ')', 'was', 'calculated', 'using', 'the', 'Chronic', 'Kidney', 'Disease', 'Epidemiology', 'Collaboration', '(', 'CKD-EPI', ')', 'equation', '[', '25', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR amplification was carried out in a 50 μL reaction system containing 5 μL of 10× KOD buffer, 5 μL of 2.5 mM dNTPs, 1.5 μL of 5 μM primers, 1 μL of KOD polymerase, and 100 ng of template DNA.	[('PMC7071635', 'M06001', 154, 164, 'polymerase')]	['PCR', 'amplification', 'was', 'carried', 'out', 'in', 'a', '50', 'μ', '##L', 'reaction', 'system', 'containing', '5', 'μ', '##L', 'of', '10', '##×', 'KO', '##D', 'buffer', ',', '5', 'μ', '##L', 'of', '2', '.', '5', 'mM', 'd', '##NT', '##Ps', ',', '1', '.', '5', 'μ', '##L', 'of', '5', 'μ', '##M', 'primers', ',', '1', 'μ', '##L', 'of', 'KO', '##D', 'polymerase', ',', 'and', '100', 'ng', 'of', 'template', 'DNA', '.']	[0, 4, 18, 22, 30, 34, 37, 39, 42, 43, 45, 54, 61, 72, 74, 75, 77, 80, 82, 84, 86, 88, 94, 96, 98, 99, 101, 104, 105, 106, 108, 111, 112, 114, 116, 118, 119, 120, 122, 123, 125, 128, 130, 131, 133, 140, 142, 144, 145, 147, 150, 152, 154, 164, 166, 170, 174, 177, 180, 189, 192]	[3, 17, 21, 29, 33, 36, 38, 41, 43, 44, 53, 60, 71, 73, 75, 76, 79, 82, 83, 86, 87, 94, 95, 97, 99, 100, 103, 105, 106, 107, 110, 112, 114, 116, 117, 119, 120, 121, 123, 124, 127, 129, 131, 132, 140, 141, 143, 145, 146, 149, 152, 153, 164, 165, 169, 173, 176, 179, 188, 192, 193]	['PCR', 'amplification', 'was', 'carried', 'out', 'in', 'a', '50', 'μL', 'reaction', 'system', 'containing', '5', 'μL', 'of', '10×', 'KOD', 'buffer', ',', '5', 'μL', 'of', '2.5', 'mM', 'dNTPs', ',', '1.5', 'μL', 'of', '5', 'μM', 'primers', ',', '1', 'μL', 'of', 'KOD', 'polymerase', ',', 'and', '100', 'ng', 'of', 'template', 'DNA', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 2, 1, 1, 1, 2, 1, 3, 1, 3, 1, 3, 2, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
patients in spite of the use of adjuvant therapy with tamoxifen and/or aromatase inhibitors [35].	[('PMC7072610', 'D05002', 71, 80, 'aromatase')]	['patients', 'in', 'spite', 'of', 'the', 'use', 'of', 'adjuvant', 'therapy', 'with', 'tamoxifen', 'and', '/', 'or', 'arom', '##atase', 'inhibitors', '[', '35', ']', '.']	[0, 9, 12, 18, 21, 25, 29, 32, 41, 49, 54, 64, 67, 68, 71, 75, 81, 92, 93, 95, 96]	[8, 11, 17, 20, 24, 28, 31, 40, 48, 53, 63, 67, 68, 70, 75, 80, 91, 93, 95, 96, 97]	['patients', 'in', 'spite', 'of', 'the', 'use', 'of', 'adjuvant', 'therapy', 'with', 'tamoxifen', 'and', '/', 'or', 'aromatase', 'inhibitors', '[', '35', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
Zhang L., Han J. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.	[('PMC7072610', 'F43001', 17, 57, 'Branched-chain amino acid transaminase 1')]	['Zhang', 'L', '.', ',', 'Han', 'J', '.', 'Branch', '##ed', '-', 'chain', 'amino', 'acid', 'trans', '##aminase', '1', '(', 'BC', '##AT', '##1', ')', 'promotes', 'the', 'growth', 'of', 'breast', 'cancer', 'cells', 'through', 'improving', 'mTOR', '-', 'mediated', 'mitochondrial', 'biogenesis', 'and', 'function', '.']	[0, 6, 7, 8, 10, 14, 15, 17, 23, 25, 26, 32, 38, 43, 48, 56, 58, 59, 61, 63, 64, 66, 75, 79, 86, 89, 96, 103, 109, 117, 127, 131, 132, 141, 155, 166, 170, 178]	[5, 7, 8, 9, 13, 15, 16, 23, 25, 26, 31, 37, 42, 48, 55, 57, 59, 61, 63, 64, 65, 74, 78, 85, 88, 95, 102, 108, 116, 126, 131, 132, 140, 154, 165, 169, 178, 179]	['Zhang', 'L', '.', ',', 'Han', 'J', '.', 'Branched', '-', 'chain', 'amino', 'acid', 'transaminase', '1', '(', 'BCAT1', ')', 'promotes', 'the', 'growth', 'of', 'breast', 'cancer', 'cells', 'through', 'improving', 'mTOR', '-', 'mediated', 'mitochondrial', 'biogenesis', 'and', 'function', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The so prepared tissue samples were deactivated from endogenous peroxidases by incubating with streptavidin-horseradish peroxidase (Dako) 1:100 hydrogen peroxide/diaminobenzidine chromogen.	[('PMC7072610', 'M01001', 64, 75, 'peroxidases'), ('PMC7072610', 'M01001', 108, 130, 'horseradish peroxidase')]	['The', 'so', 'prepared', 'tissue', 'samples', 'were', 'de', '##activated', 'from', 'endogenous', 'peroxidase', '##s', 'by', 'incub', '##ating', 'with', 'strept', '##avidin', '-', 'horse', '##radi', '##sh', 'peroxidase', '(', 'Da', '##ko', ')', '1', ':', '100', 'hydrogen', 'peroxide', '/', 'diam', '##ino', '##benz', '##idine', 'chrom', '##ogen', '.']	[0, 4, 7, 16, 23, 31, 36, 38, 48, 53, 64, 74, 76, 79, 84, 90, 95, 101, 107, 108, 113, 117, 120, 131, 132, 134, 136, 138, 139, 140, 144, 153, 161, 162, 166, 169, 173, 179, 184, 188]	[3, 6, 15, 22, 30, 35, 38, 47, 52, 63, 74, 75, 78, 84, 89, 94, 101, 107, 108, 113, 117, 119, 130, 132, 134, 136, 137, 139, 140, 143, 152, 161, 162, 166, 169, 173, 178, 184, 188, 189]	['The', 'so', 'prepared', 'tissue', 'samples', 'were', 'deactivated', 'from', 'endogenous', 'peroxidases', 'by', 'incubating', 'with', 'streptavidin', '-', 'horseradish', 'peroxidase', '(', 'Dako', ')', '1', ':', '100', 'hydrogen', 'peroxide', '/', 'diaminobenzidine', 'chromogen', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
During the follow-up the ER(+) patients received anti-estrogen adjuvant therapy based on tamoxifen or aromatase inhibitors.	[('PMC7072610', 'R00007', 102, 111, 'aromatase')]	['During', 'the', 'follow', '-', 'up', 'the', 'ER', '(', '+', ')', 'patients', 'received', 'anti', '-', 'estrogen', 'adjuvant', 'therapy', 'based', 'on', 'tamoxifen', 'or', 'arom', '##atase', 'inhibitors', '.']	[0, 7, 11, 17, 18, 21, 25, 27, 28, 29, 31, 40, 49, 53, 54, 63, 72, 80, 86, 89, 99, 102, 106, 112, 122]	[6, 10, 17, 18, 20, 24, 27, 28, 29, 30, 39, 48, 53, 54, 62, 71, 79, 85, 88, 98, 101, 106, 111, 122, 123]	['During', 'the', 'follow', '-', 'up', 'the', 'ER(', '+', ')', 'patients', 'received', 'anti-', 'estrogen', 'adjuvant', 'therapy', 'based', 'on', 'tamoxifen', 'or', 'aromatase', 'inhibitors', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
In children exclusively breastfed for at least 4 months of life, bifidobacteria were increased if the mothers were secretor positive, meaning they express functional fucosyltransferase 2 responsible for the synthesis of 2′-flucosyl-HMOs such as 2′FL in breastmilk.	[('PMC7078481', 'D07007', 166, 186, 'fucosyltransferase 2')]	['In', 'children', 'exclusively', 'breast', '##fed', 'for', 'at', 'least', '4', 'months', 'of', 'life', ',', 'bif', '##ido', '##ba', '##ct', '##eri', '##a', 'were', 'increased', 'if', 'the', 'mothers', 'were', 'secret', '##or', 'positive', ',', 'meaning', 'they', 'express', 'functional', 'fu', '##cos', '##yl', '##transferase', '2', 'responsible', 'for', 'the', 'synthesis', 'of', '2', '′', '-', 'flu', '##cos', '##yl', '-', 'HM', '##Os', 'such', 'as', '2', '′', 'FL', 'in', 'breast', '##mi', '##lk', '.']	[0, 3, 12, 24, 30, 34, 38, 41, 47, 49, 56, 59, 63, 65, 68, 71, 73, 75, 78, 80, 85, 95, 98, 102, 110, 115, 121, 124, 132, 134, 142, 147, 155, 166, 168, 171, 173, 185, 187, 199, 203, 207, 217, 220, 221, 222, 223, 226, 229, 231, 232, 234, 237, 242, 245, 246, 247, 250, 253, 259, 261, 263]	[2, 11, 23, 30, 33, 37, 40, 46, 48, 55, 58, 63, 64, 68, 71, 73, 75, 78, 79, 84, 94, 97, 101, 109, 114, 121, 123, 132, 133, 141, 146, 154, 165, 168, 171, 173, 184, 186, 198, 202, 206, 216, 219, 221, 222, 223, 226, 229, 231, 232, 234, 236, 241, 244, 246, 247, 249, 252, 259, 261, 263, 264]	['In', 'children', 'exclusively', 'breastfed', 'for', 'at', 'least', '4', 'months', 'of', 'life', ',', 'bifidobacteria', 'were', 'increased', 'if', 'the', 'mothers', 'were', 'secretor', 'positive', ',', 'meaning', 'they', 'express', 'functional', 'fucosyltransferase', '2', 'responsible', 'for', 'the', 'synthesis', 'of', '2′-flucosyl-HMOs', 'such', 'as', '2′FL', 'in', 'breastmilk', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 9, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants.	[('PMC7078481', 'F38002', 9, 29, 'fucosyltransferase 2')]	['Maternal', 'fu', '##cos', '##yl', '##transferase', '2', 'status', 'affects', 'the', 'gut', 'bif', '##ido', '##ba', '##ct', '##eri', '##al', 'communities', 'of', 'breast', '##fed', 'infants', '.']	[0, 9, 11, 14, 16, 28, 30, 37, 45, 49, 53, 56, 59, 61, 63, 66, 69, 81, 84, 90, 94, 101]	[8, 11, 14, 16, 27, 29, 36, 44, 48, 52, 56, 59, 61, 63, 66, 68, 80, 83, 90, 93, 101, 102]	['Maternal', 'fucosyltransferase', '2', 'status', 'affects', 'the', 'gut', 'bifidobacterial', 'communities', 'of', 'breastfed', 'infants', '.']	[1, 4, 1, 1, 1, 1, 1, 6, 1, 1, 2, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Muscle histology showed mild variation of fiber diameter, no ragged‐red/cytochrome c oxidase‐negative fibers and a defect of multiple respiratory chain enzymes and coenzyme Q10 (CoQ10) in two cases, suggesting a possible secondary defect of oxidative phosphorylation.	[('PMC7078914', 'A00006', 72, 92, 'cytochrome c oxidase')]	['Muscle', 'histology', 'showed', 'mild', 'variation', 'of', 'fiber', 'diameter', ',', 'no', 'ra', '##gg', '##ed', '‐', 'red', '/', 'cytochrome', 'c', 'oxidase', '‐', 'negative', 'fibers', 'and', 'a', 'defect', 'of', 'multiple', 'respiratory', 'chain', 'enzymes', 'and', 'coe', '##n', '##zyme', 'Q', '##10', '(', 'Co', '##Q', '##10', ')', 'in', 'two', 'cases', ',', 'suggesting', 'a', 'possible', 'secondary', 'defect', 'of', 'oxidative', 'phosphorylation', '.']	[0, 7, 17, 24, 29, 39, 42, 48, 56, 58, 61, 63, 65, 67, 68, 71, 72, 83, 85, 92, 93, 102, 109, 113, 115, 122, 125, 134, 146, 152, 160, 164, 167, 168, 173, 174, 177, 178, 180, 181, 183, 185, 188, 192, 197, 199, 210, 212, 221, 231, 238, 241, 251, 266]	[6, 16, 23, 28, 38, 41, 47, 56, 57, 60, 63, 65, 67, 68, 71, 72, 82, 84, 92, 93, 101, 108, 112, 114, 121, 124, 133, 145, 151, 159, 163, 167, 168, 172, 174, 176, 178, 180, 181, 183, 184, 187, 191, 197, 198, 209, 211, 220, 230, 237, 240, 250, 266, 267]	['Muscle', 'histology', 'showed', 'mild', 'variation', 'of', 'fiber', 'diameter', ',', 'no', 'ragged', '‐', 'red', '/', 'cytochrome', 'c', 'oxidase', '‐', 'negative', 'fibers', 'and', 'a', 'defect', 'of', 'multiple', 'respiratory', 'chain', 'enzymes', 'and', 'coenzyme', 'Q10', '(', 'CoQ10', ')', 'in', 'two', 'cases', ',', 'suggesting', 'a', 'possible', 'secondary', 'defect', 'of', 'oxidative', 'phosphorylation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This CoQ10 reduction might be a secondary effect of the fatty acid oxidation impairment, similar to CoQ10 deficiency in multiple acyl‐CoA dehydrogenase deficiency.14, 15 We initiated a CoQ10 and riboflavin supplementation in subjects 1 and 3.1 which resulted in clinical improvement and stabilization without any further metabolic crisis up until now, however assessing treatment with CoQ10 and measuring CoQ10 in additional patients is needed before our findings can be generalized.	[('PMC7078914', 'D01005', 129, 151, 'acyl‐CoA dehydrogenase')]	['This', 'Co', '##Q', '##10', 'reduction', 'might', 'be', 'a', 'secondary', 'effect', 'of', 'the', 'fatty', 'acid', 'oxidation', 'impairment', ',', 'similar', 'to', 'Co', '##Q', '##10', 'deficiency', 'in', 'multiple', 'acyl', '‐', 'Co', '##A', 'dehydrogenase', 'deficiency', '.', '14', ',', '15', 'We', 'initiated', 'a', 'Co', '##Q', '##10', 'and', 'rib', '##ofl', '##avin', 'supplementation', 'in', 'subjects', '1', 'and', '3', '.', '1', 'which', 'resulted', 'in', 'clinical', 'improvement', 'and', 'stabilization', 'without', 'any', 'further', 'metabolic', 'crisis', 'up', 'until', 'now', ',', 'however', 'assessing', 'treatment', 'with', 'Co', '##Q', '##10', 'and', 'measuring', 'Co', '##Q', '##10', 'in', 'additional', 'patients', 'is', 'needed', 'before', 'our', 'findings', 'can', 'be', 'generalized', '.']	[0, 5, 7, 8, 11, 21, 27, 30, 32, 42, 49, 52, 56, 62, 67, 77, 87, 89, 97, 100, 102, 103, 106, 117, 120, 129, 133, 134, 136, 138, 152, 162, 163, 165, 167, 170, 173, 183, 185, 187, 188, 191, 195, 198, 201, 206, 222, 225, 234, 236, 240, 241, 242, 244, 250, 259, 262, 271, 283, 287, 301, 309, 313, 321, 331, 338, 341, 347, 350, 352, 360, 370, 380, 385, 387, 388, 391, 395, 405, 407, 408, 411, 414, 425, 434, 437, 444, 451, 455, 464, 468, 471, 482]	[4, 7, 8, 10, 20, 26, 29, 31, 41, 48, 51, 55, 61, 66, 76, 87, 88, 96, 99, 102, 103, 105, 116, 119, 128, 133, 134, 136, 137, 151, 162, 163, 165, 166, 169, 172, 182, 184, 187, 188, 190, 194, 198, 201, 205, 221, 224, 233, 235, 239, 241, 242, 243, 249, 258, 261, 270, 282, 286, 300, 308, 312, 320, 330, 337, 340, 346, 350, 351, 359, 369, 379, 384, 387, 388, 390, 394, 404, 407, 408, 410, 413, 424, 433, 436, 443, 450, 454, 463, 467, 470, 482, 483]	['This', 'CoQ10', 'reduction', 'might', 'be', 'a', 'secondary', 'effect', 'of', 'the', 'fatty', 'acid', 'oxidation', 'impairment', ',', 'similar', 'to', 'CoQ10', 'deficiency', 'in', 'multiple', 'acyl‐CoA', 'dehydrogenase', 'deficiency.14', ',', '15', 'We', 'initiated', 'a', 'CoQ10', 'and', 'riboflavin', 'supplementation', 'in', 'subjects', '1', 'and', '3.1', 'which', 'resulted', 'in', 'clinical', 'improvement', 'and', 'stabilization', 'without', 'any', 'further', 'metabolic', 'crisis', 'up', 'until', 'now', ',', 'however', 'assessing', 'treatment', 'with', 'CoQ10', 'and', 'measuring', 'CoQ10', 'in', 'additional', 'patients', 'is', 'needed', 'before', 'our', 'findings', 'can', 'be', 'generalized', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We performed proteomic profiling in fibroblasts, which indicated altered fatty acid oxidation, folic acid and pyrimidine metabolism in mitochondria.16 Impaired fatty acid oxidation was suggested by decrease of fatty aldehyde dehydrogenases (ALDH3A2, ALDH4A1, ALDH6A117;) and SLC25A20, encoding a mitochondrial carnitine/acylcarnitine carrier protein.18, 19 Mutations in these genes lead to severe neurological abnormalities, developmental delay, cardiomyopathy, arrhythmias, skeletal muscle damage, liver dysfunction, and episodes of life‐threatening coma,20, 21 many of these clinical findings are also present in TANGO2‐deficient patients.	[('PMC7078914', 'D02003', 210, 239, 'fatty aldehyde dehydrogenases')]	['We', 'performed', 'proteomic', 'profiling', 'in', 'fibroblasts', ',', 'which', 'indicated', 'altered', 'fatty', 'acid', 'oxidation', ',', 'foli', '##c', 'acid', 'and', 'pyr', '##imid', '##ine', 'metabolism', 'in', 'mitochondria', '.', '16', 'Imp', '##aired', 'fatty', 'acid', 'oxidation', 'was', 'suggested', 'by', 'decrease', 'of', 'fatty', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', '##s', '(', 'AL', '##DH', '##3', '##A', '##2', ',', 'AL', '##DH', '##4', '##A', '##1', ',', 'AL', '##DH', '##6', '##A', '##117', ';', ')', 'and', 'SLC', '##25', '##A', '##20', ',', 'encoding', 'a', 'mitochondrial', 'car', '##nit', '##ine', '/', 'acyl', '##car', '##nit', '##ine', 'carrier', 'protein', '.', '18', ',', '19', 'Mutations', 'in', 'these', 'genes', 'lead', 'to', 'severe', 'neurological', 'abnormalities', ',', 'developmental', 'delay', ',', 'cardiomyopathy', ',', 'arrhythmias', ',', 'skeletal', 'muscle', 'damage', ',', 'liver', 'dysfunction', ',', 'and', 'episodes', 'of', 'life', '‐', 'threat', '##ening', 'com', '##a', ',', '20', ',', '21', 'many', 'of', 'these', 'clinical', 'findings', 'are', 'also', 'present', 'in', 'TA', '##NG', '##O', '##2', '‐', 'deficient', 'patients', '.']	[0, 3, 13, 23, 33, 36, 47, 49, 55, 65, 73, 79, 84, 93, 95, 99, 101, 106, 110, 113, 117, 121, 132, 135, 147, 148, 151, 154, 160, 166, 171, 181, 185, 195, 198, 207, 210, 216, 219, 221, 223, 225, 238, 240, 241, 243, 245, 246, 247, 248, 250, 252, 254, 255, 256, 257, 259, 261, 263, 264, 265, 268, 269, 271, 275, 278, 280, 281, 283, 285, 294, 296, 310, 313, 316, 319, 320, 324, 327, 330, 334, 342, 349, 350, 352, 354, 357, 367, 370, 376, 382, 387, 390, 397, 410, 423, 425, 439, 444, 446, 460, 462, 473, 475, 484, 491, 497, 499, 505, 516, 518, 522, 531, 534, 538, 539, 545, 551, 554, 555, 556, 558, 560, 563, 568, 571, 577, 586, 595, 599, 604, 612, 615, 617, 619, 620, 621, 622, 632, 640]	[2, 12, 22, 32, 35, 47, 48, 54, 64, 72, 78, 83, 93, 94, 99, 100, 105, 109, 113, 117, 120, 131, 134, 147, 148, 150, 154, 159, 165, 170, 180, 184, 194, 197, 206, 209, 215, 219, 221, 223, 224, 238, 239, 241, 243, 245, 246, 247, 248, 249, 252, 254, 255, 256, 257, 258, 261, 263, 264, 265, 268, 269, 270, 274, 278, 280, 281, 283, 284, 293, 295, 309, 313, 316, 319, 320, 324, 327, 330, 333, 341, 349, 350, 352, 353, 356, 366, 369, 375, 381, 386, 389, 396, 409, 423, 424, 438, 444, 445, 460, 461, 473, 474, 483, 490, 497, 498, 504, 516, 517, 521, 530, 533, 538, 539, 545, 550, 554, 555, 556, 558, 559, 562, 567, 570, 576, 585, 594, 598, 603, 611, 614, 617, 619, 620, 621, 622, 631, 640, 641]	['We', 'performed', 'proteomic', 'profiling', 'in', 'fibroblasts', ',', 'which', 'indicated', 'altered', 'fatty', 'acid', 'oxidation', ',', 'folic', 'acid', 'and', 'pyrimidine', 'metabolism', 'in', 'mitochondria.16', 'Impaired', 'fatty', 'acid', 'oxidation', 'was', 'suggested', 'by', 'decrease', 'of', 'fatty', 'aldehyde', 'dehydrogenases', '(', 'ALDH3A2', ',', 'ALDH4A1', ',', 'ALDH6A117', ';', ')', 'and', 'SLC25A20', ',', 'encoding', 'a', 'mitochondrial', 'carnitine', '/', 'acylcarnitine', 'carrier', 'protein.18', ',', '19', 'Mutations', 'in', 'these', 'genes', 'lead', 'to', 'severe', 'neurological', 'abnormalities', ',', 'developmental', 'delay', ',', 'cardiomyopathy', ',', 'arrhythmias', ',', 'skeletal', 'muscle', 'damage', ',', 'liver', 'dysfunction', ',', 'and', 'episodes', 'of', 'life', '‐', 'threatening', 'coma', ',', '20', ',', '21', 'many', 'of', 'these', 'clinical', 'findings', 'are', 'also', 'present', 'in', 'TANGO2‐deficient', 'patients', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 5, 1, 5, 1, 5, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SDC3 organizes cell shape through actin cytoskeleton and regulates adult myogenesis,23 MYLK acts as a calcium/calmodulin‐dependent myosin light chain kinase and CAVN2 plays an important role in caveolar biogenesis and morphology.	[('PMC7078914', 'D03003', 131, 156, 'myosin light chain kinase')]	['SD', '##C', '##3', 'organize', '##s', 'cell', 'shape', 'through', 'actin', 'cytoskeleton', 'and', 'regulates', 'adult', 'my', '##ogenesis', ',', '23', 'MY', '##L', '##K', 'acts', 'as', 'a', 'calcium', '/', 'cal', '##mod', '##ulin', '‐', 'dependent', 'myosin', 'light', 'chain', 'kinase', 'and', 'CA', '##V', '##N', '##2', 'plays', 'an', 'important', 'role', 'in', 'cave', '##olar', 'biogenesis', 'and', 'morphology', '.']	[0, 2, 3, 5, 13, 15, 20, 26, 34, 40, 53, 57, 67, 73, 75, 83, 84, 87, 89, 90, 92, 97, 100, 102, 109, 110, 113, 116, 120, 121, 131, 138, 144, 150, 157, 161, 163, 164, 165, 167, 173, 176, 186, 191, 194, 198, 203, 214, 218, 228]	[2, 3, 4, 13, 14, 19, 25, 33, 39, 52, 56, 66, 72, 75, 83, 84, 86, 89, 90, 91, 96, 99, 101, 109, 110, 113, 116, 120, 121, 130, 137, 143, 149, 156, 160, 163, 164, 165, 166, 172, 175, 185, 190, 193, 198, 202, 213, 217, 228, 229]	['SDC3', 'organizes', 'cell', 'shape', 'through', 'actin', 'cytoskeleton', 'and', 'regulates', 'adult', 'myogenesis', ',', '23', 'MYLK', 'acts', 'as', 'a', 'calcium', '/', 'calmodulin', '‐', 'dependent', 'myosin', 'light', 'chain', 'kinase', 'and', 'CAVN2', 'plays', 'an', 'important', 'role', 'in', 'caveolar', 'biogenesis', 'and', 'morphology', '.']	[3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Jackson TR, Brown FD, Nie Z, et al. ACAPs are arf6 GTPase‐activating proteins that function in the cell periphery.	[('PMC7078914', 'F10001', 51, 57, 'GTPase')]	['Jackson', 'TR', ',', 'Brown', 'FD', ',', 'Ni', '##e', 'Z', ',', 'et', 'al', '.', 'ACA', '##Ps', 'are', 'ar', '##f', '##6', 'GTP', '##ase', '‐', 'activating', 'proteins', 'that', 'function', 'in', 'the', 'cell', 'periphery', '.']	[0, 8, 10, 12, 18, 20, 22, 24, 26, 27, 29, 32, 34, 36, 39, 42, 46, 48, 49, 51, 54, 57, 58, 69, 78, 83, 92, 95, 99, 104, 113]	[7, 10, 11, 17, 20, 21, 24, 25, 27, 28, 31, 34, 35, 39, 41, 45, 48, 49, 50, 54, 57, 58, 68, 77, 82, 91, 94, 98, 103, 113, 114]	['Jackson', 'TR', ',', 'Brown', 'FD', ',', 'Nie', 'Z', ',', 'et', 'al', '.', 'ACAPs', 'are', 'arf6', 'GTPase', '‐', 'activating', 'proteins', 'that', 'function', 'in', 'the', 'cell', 'periphery', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron‐transferring‐flavoprotein dehydrogenase (electron‐transferring‐flavoprotein dehydrogenase) gene.	[('PMC7078914', 'F13002', 76, 124, 'electron‐transferring‐flavoprotein dehydrogenase'), ('PMC7078914', 'F13002', 126, 174, 'electron‐transferring‐flavoprotein dehydrogenase')]	['The', 'my', '##opathic', 'form', 'of', 'coe', '##n', '##zyme', 'Q', '##10', 'deficiency', 'is', 'caused', 'by', 'mutations', 'in', 'the', 'electron', '‐', 'transferring', '‐', 'flav', '##oprotein', 'dehydrogenase', '(', 'electron', '‐', 'transferring', '‐', 'flav', '##oprotein', 'dehydrogenase', ')', 'gene', '.']	[0, 4, 6, 14, 19, 22, 25, 26, 31, 32, 35, 46, 49, 56, 59, 69, 72, 76, 84, 85, 97, 98, 102, 111, 125, 126, 134, 135, 147, 148, 152, 161, 174, 176, 180]	[3, 6, 13, 18, 21, 25, 26, 30, 32, 34, 45, 48, 55, 58, 68, 71, 75, 84, 85, 97, 98, 102, 110, 124, 126, 134, 135, 147, 148, 152, 160, 174, 175, 180, 181]	['The', 'myopathic', 'form', 'of', 'coenzyme', 'Q10', 'deficiency', 'is', 'caused', 'by', 'mutations', 'in', 'the', 'electron', '‐', 'transferring', '‐', 'flavoprotein', 'dehydrogenase', '(', 'electron', '‐', 'transferring', '‐', 'flavoprotein', 'dehydrogenase', ')', 'gene', '.']	[1, 2, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
Baumgartner MR, Rabier D, Nassogne MC, et al. Delta1‐pyrroline‐5‐carboxylate synthase deficiency: neurodegeneration, cataracts and connective tissue manifestations combined with hyperammonaemia and reduced ornithine, citrulline, arginine and proline.	[('PMC7078914', 'F16001', 46, 85, 'Delta1‐pyrroline‐5‐carboxylate synthase')]	['Ba', '##um', '##gart', '##ner', 'MR', ',', 'Rab', '##ier', 'D', ',', 'Nas', '##so', '##gn', '##e', 'MC', ',', 'et', 'al', '.', 'Delta', '##1', '‐', 'pyr', '##rol', '##ine', '‐', '5', '‐', 'carboxyl', '##ate', 'synthase', 'deficiency', ':', 'neurode', '##generation', ',', 'cataract', '##s', 'and', 'connective', 'tissue', 'manifestations', 'combined', 'with', 'hyper', '##amm', '##ona', '##emia', 'and', 'reduced', 'or', '##nit', '##hin', '##e', ',', 'citr', '##ulli', '##ne', ',', 'arginine', 'and', 'proline', '.']	[0, 2, 4, 8, 12, 14, 16, 19, 23, 24, 26, 29, 31, 33, 35, 37, 39, 42, 44, 46, 51, 52, 53, 56, 59, 62, 63, 64, 65, 73, 77, 86, 96, 98, 105, 115, 117, 125, 127, 131, 142, 149, 164, 173, 178, 183, 186, 189, 194, 198, 206, 208, 211, 214, 215, 217, 221, 225, 227, 229, 238, 242, 249]	[2, 4, 8, 11, 14, 15, 19, 22, 24, 25, 29, 31, 33, 34, 37, 38, 41, 44, 45, 51, 52, 53, 56, 59, 62, 63, 64, 65, 73, 76, 85, 96, 97, 105, 115, 116, 125, 126, 130, 141, 148, 163, 172, 177, 183, 186, 189, 193, 197, 205, 208, 211, 214, 215, 216, 221, 225, 227, 228, 237, 241, 249, 250]	['Baumgartner', 'MR', ',', 'Rabier', 'D', ',', 'Nassogne', 'MC', ',', 'et', 'al', '.', 'Delta1‐pyrroline‐5‐carboxylate', 'synthase', 'deficiency', ':', 'neurodegeneration', ',', 'cataracts', 'and', 'connective', 'tissue', 'manifestations', 'combined', 'with', 'hyperammonaemia', 'and', 'reduced', 'ornithine', ',', 'citrulline', ',', 'arginine', 'and', 'proline', '.']	[4, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 11, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Yan HM, Hu H, Ahmed A, et al. Carnitine‐acylcarnitine translocase deficiency with c.199‐10 T>G and novel c.1A>G mutation: two case reports and brief literature review.	[('PMC7078914', 'F18001', 30, 65, 'Carnitine‐acylcarnitine translocase')]	['Yan', 'HM', ',', 'Hu', 'H', ',', 'Ah', '##med', 'A', ',', 'et', 'al', '.', 'Car', '##nit', '##ine', '‐', 'acyl', '##car', '##nit', '##ine', 'transloc', '##ase', 'deficiency', 'with', 'c', '.', '199', '‐', '10', 'T', '>', 'G', 'and', 'novel', 'c', '.', '1', '##A', '>', 'G', 'mutation', ':', 'two', 'case', 'reports', 'and', 'brief', 'literature', 'review', '.']	[0, 4, 6, 8, 11, 12, 14, 16, 20, 21, 23, 26, 28, 30, 33, 36, 39, 40, 44, 47, 50, 54, 62, 66, 77, 82, 83, 84, 87, 88, 91, 92, 93, 95, 99, 105, 106, 107, 108, 109, 110, 112, 120, 122, 126, 131, 139, 143, 149, 160, 166]	[3, 6, 7, 10, 12, 13, 16, 19, 21, 22, 25, 28, 29, 33, 36, 39, 40, 44, 47, 50, 53, 62, 65, 76, 81, 83, 84, 87, 88, 90, 92, 93, 94, 98, 104, 106, 107, 108, 109, 110, 111, 120, 121, 125, 130, 138, 142, 148, 159, 166, 167]	['Yan', 'HM', ',', 'Hu', 'H', ',', 'Ahmed', 'A', ',', 'et', 'al', '.', 'Carnitine', '‐', 'acylcarnitine', 'translocase', 'deficiency', 'with', 'c.199‐10', 'T', '>', 'G', 'and', 'novel', 'c.1A', '>', 'G', 'mutation', ':', 'two', 'case', 'reports', 'and', 'brief', 'literature', 'review', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 4, 2, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency.	[('PMC7078914', 'F19002', 30, 71, 'methylmalonate semialdehyde dehydrogenase')]	['Molecular', 'character', '##ization', 'of', 'methyl', '##mal', '##onate', 'semi', '##aldehyde', 'dehydrogenase', 'deficiency', '.']	[0, 10, 19, 27, 30, 36, 39, 45, 49, 58, 72, 82]	[9, 19, 26, 29, 36, 39, 44, 49, 57, 71, 82, 83]	['Molecular', 'characterization', 'of', 'methylmalonate', 'semialdehyde', 'dehydrogenase', 'deficiency', '.']	[1, 2, 1, 3, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria.	[('PMC7078914', 'F20002', 30, 71, 'methylmalonate semialdehyde dehydrogenase')]	['Mutations', 'in', 'AL', '##DH', '##6', '##A', '##1', 'encoding', 'methyl', '##mal', '##onate', 'semi', '##aldehyde', 'dehydrogenase', 'are', 'associated', 'with', 'dys', '##my', '##elin', '##ation', 'and', 'transient', 'methyl', '##mal', '##onic', 'acid', '##uria', '.']	[0, 10, 13, 15, 17, 18, 19, 21, 30, 36, 39, 45, 49, 58, 72, 76, 87, 92, 95, 97, 101, 107, 111, 121, 127, 130, 135, 139, 143]	[9, 12, 15, 17, 18, 19, 20, 29, 36, 39, 44, 49, 57, 71, 75, 86, 91, 95, 97, 101, 106, 110, 120, 127, 130, 134, 139, 143, 144]	['Mutations', 'in', 'ALDH6A1', 'encoding', 'methylmalonate', 'semialdehyde', 'dehydrogenase', 'are', 'associated', 'with', 'dysmyelination', 'and', 'transient', 'methylmalonic', 'aciduria', '.']	[1, 1, 5, 1, 3, 2, 1, 1, 1, 1, 4, 1, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the presence of rhabdomyolysis with very high creatine kinase (creatine kinase) levels with non‐specific increase of acylcarnitines and dicarboxylic acids were hallmarks of TANGO2 deficiency.1, 5	[('PMC7078914', 'I00010', 55, 70, 'creatine kinase'), ('PMC7078914', 'I00010', 72, 87, 'creatine kinase')]	['However', ',', 'the', 'presence', 'of', 'rh', '##abd', '##omy', '##olysis', 'with', 'very', 'high', 'cre', '##atine', 'kinase', '(', 'cre', '##atine', 'kinase', ')', 'levels', 'with', 'non', '‐', 'specific', 'increase', 'of', 'acyl', '##car', '##nit', '##ines', 'and', 'dic', '##arboxyl', '##ic', 'acids', 'were', 'hallmark', '##s', 'of', 'TA', '##NG', '##O', '##2', 'deficiency', '.', '1', ',', '5']	[0, 7, 9, 13, 22, 25, 27, 30, 33, 40, 45, 50, 55, 58, 64, 71, 72, 75, 81, 87, 89, 96, 101, 104, 105, 114, 123, 126, 130, 133, 136, 141, 145, 148, 155, 158, 164, 169, 177, 179, 182, 184, 186, 187, 189, 199, 200, 201, 203]	[7, 8, 12, 21, 24, 27, 30, 33, 39, 44, 49, 54, 58, 63, 70, 72, 75, 80, 87, 88, 95, 100, 104, 105, 113, 122, 125, 130, 133, 136, 140, 144, 148, 155, 157, 163, 168, 177, 178, 181, 184, 186, 187, 188, 199, 200, 201, 202, 204]	['However', ',', 'the', 'presence', 'of', 'rhabdomyolysis', 'with', 'very', 'high', 'creatine', 'kinase', '(', 'creatine', 'kinase', ')', 'levels', 'with', 'non', '‐', 'specific', 'increase', 'of', 'acylcarnitines', 'and', 'dicarboxylic', 'acids', 'were', 'hallmarks', 'of', 'TANGO2', 'deficiency.1', ',', '5']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 2, 1, 4, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Serum biochemistry testing showed a very similar pattern in all cases with very high (419‐400 000 U/L) creatine kinase levels, lactic acidosis, elevated transaminases and hyperammonemia.	[('PMC7078914', 'I05001', 103, 118, 'creatine kinase'), ('PMC7078914', 'I05001', 153, 166, 'transaminases')]	['Serum', 'bioc', '##hem', '##istry', 'testing', 'showed', 'a', 'very', 'similar', 'pattern', 'in', 'all', 'cases', 'with', 'very', 'high', '(', '41', '##9', '‐', '400', '000', 'U', '/', 'L', ')', 'cre', '##atine', 'kinase', 'levels', ',', 'lactic', 'acid', '##osis', ',', 'elevated', 'trans', '##aminase', '##s', 'and', 'hyper', '##amm', '##one', '##mia', '.']	[0, 6, 10, 13, 19, 27, 34, 36, 41, 49, 57, 60, 64, 70, 75, 80, 85, 86, 88, 89, 90, 94, 98, 99, 100, 101, 103, 106, 112, 119, 125, 127, 134, 138, 142, 144, 153, 158, 165, 167, 171, 176, 179, 182, 185]	[5, 10, 13, 18, 26, 33, 35, 40, 48, 56, 59, 63, 69, 74, 79, 84, 86, 88, 89, 90, 93, 97, 99, 100, 101, 102, 106, 111, 118, 125, 126, 133, 138, 142, 143, 152, 158, 165, 166, 170, 176, 179, 182, 185, 186]	['Serum', 'biochemistry', 'testing', 'showed', 'a', 'very', 'similar', 'pattern', 'in', 'all', 'cases', 'with', 'very', 'high', '(', '419‐400', '000', 'U', '/', 'L', ')', 'creatine', 'kinase', 'levels', ',', 'lactic', 'acidosis', ',', 'elevated', 'transaminases', 'and', 'hyperammonemia', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Subject 2 showed multiple deficiencies in mitochondrial respiratory chain enzyme activities in muscle, relative to an observed increased citrate synthase activity while investigations in fibroblasts were normal.	[('PMC7078914', 'R02003', 137, 153, 'citrate synthase')]	['Subject', '2', 'showed', 'multiple', 'deficiencies', 'in', 'mitochondrial', 'respiratory', 'chain', 'enzyme', 'activities', 'in', 'muscle', ',', 'relative', 'to', 'an', 'observed', 'increased', 'citrate', 'synthase', 'activity', 'while', 'investigations', 'in', 'fibroblasts', 'were', 'normal', '.']	[0, 8, 10, 17, 26, 39, 42, 56, 68, 74, 81, 92, 95, 101, 103, 112, 115, 118, 127, 137, 145, 154, 163, 169, 184, 187, 199, 204, 210]	[7, 9, 16, 25, 38, 41, 55, 67, 73, 80, 91, 94, 101, 102, 111, 114, 117, 126, 136, 144, 153, 162, 168, 183, 186, 198, 203, 210, 211]	['Subject', '2', 'showed', 'multiple', 'deficiencies', 'in', 'mitochondrial', 'respiratory', 'chain', 'enzyme', 'activities', 'in', 'muscle', ',', 'relative', 'to', 'an', 'observed', 'increased', 'citrate', 'synthase', 'activity', 'while', 'investigations', 'in', 'fibroblasts', 'were', 'normal', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The affected proteins are localized in the ER‐Golgi network (eg, cell migration‐inducing and hyaluronan‐binding protein CEMIP, protein transport protein Sec23B), the secretory pathway (eg, peroxidasin homolog PXDN, serine protease HTRA1), the plasma membrane (eg, gap junction protein alpha‐1 CXA1, major prion protein PRIO, sodium dependent phosphate transporter 2 S20A2) and in mitochondria (eg, aldehyde dehydrogenase 4 AL4A1) (Figure ​(Figure2).2).	[('PMC7078914', 'R06002', 215, 230, 'serine protease'), ('PMC7078914', 'R06002', 398, 420, 'aldehyde dehydrogenase')]	['The', 'affected', 'proteins', 'are', 'localized', 'in', 'the', 'ER', '‐', 'Golgi', 'network', '(', 'eg', ',', 'cell', 'migration', '‐', 'inducing', 'and', 'hyal', '##uron', '##an', '‐', 'binding', 'protein', 'CE', '##MI', '##P', ',', 'protein', 'transport', 'protein', 'Sec', '##23', '##B', ')', ',', 'the', 'secretory', 'pathway', '(', 'eg', ',', 'peroxid', '##asi', '##n', 'homolog', 'P', '##X', '##DN', ',', 'serine', 'protease', 'HT', '##RA', '##1', ')', ',', 'the', 'plasma', 'membrane', '(', 'eg', ',', 'gap', 'junction', 'protein', 'alpha', '‐', '1', 'CX', '##A', '##1', ',', 'major', 'pri', '##on', 'protein', 'PRI', '##O', ',', 'sodium', 'dependent', 'phosphate', 'transporter', '2', 'S', '##20', '##A', '##2', ')', 'and', 'in', 'mitochondria', '(', 'eg', ',', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', '4', 'AL', '##4', '##A', '##1', ')', '(', 'Figure', '(', 'Figure', '##2', ')', '.', '2', ')', '.']	[0, 4, 13, 22, 26, 36, 39, 43, 45, 46, 52, 60, 61, 63, 65, 70, 79, 80, 89, 93, 97, 101, 103, 104, 112, 120, 122, 124, 125, 127, 135, 145, 153, 156, 158, 159, 160, 162, 166, 176, 184, 185, 187, 189, 196, 199, 201, 209, 210, 211, 213, 215, 222, 231, 233, 235, 236, 237, 239, 243, 250, 259, 260, 262, 264, 268, 277, 285, 290, 291, 293, 295, 296, 297, 299, 305, 308, 311, 319, 322, 323, 325, 332, 342, 352, 364, 366, 367, 369, 370, 371, 373, 377, 380, 393, 394, 396, 398, 401, 403, 405, 407, 421, 423, 425, 426, 427, 428, 430, 431, 439, 440, 446, 447, 448, 449, 450, 451]	[3, 12, 21, 25, 35, 38, 42, 45, 46, 51, 59, 61, 63, 64, 69, 79, 80, 88, 92, 97, 101, 103, 104, 111, 119, 122, 124, 125, 126, 134, 144, 152, 156, 158, 159, 160, 161, 165, 175, 183, 185, 187, 188, 196, 199, 200, 208, 210, 211, 213, 214, 221, 230, 233, 235, 236, 237, 238, 242, 249, 258, 260, 262, 263, 267, 276, 284, 290, 291, 292, 295, 296, 297, 298, 304, 308, 310, 318, 322, 323, 324, 331, 341, 351, 363, 365, 367, 369, 370, 371, 372, 376, 379, 392, 394, 396, 397, 401, 403, 405, 406, 420, 422, 425, 426, 427, 428, 429, 431, 437, 440, 446, 447, 448, 449, 450, 451, 452]	['The', 'affected', 'proteins', 'are', 'localized', 'in', 'the', 'ER‐Golgi', 'network', '(', 'eg', ',', 'cell', 'migration', '‐', 'inducing', 'and', 'hyaluronan', '‐', 'binding', 'protein', 'CEMIP', ',', 'protein', 'transport', 'protein', 'Sec23B', ')', ',', 'the', 'secretory', 'pathway', '(', 'eg', ',', 'peroxidasin', 'homolog', 'PXDN', ',', 'serine', 'protease', 'HTRA1', ')', ',', 'the', 'plasma', 'membrane', '(', 'eg', ',', 'gap', 'junction', 'protein', 'alpha‐1', 'CXA1', ',', 'major', 'prion', 'protein', 'PRIO', ',', 'sodium', 'dependent', 'phosphate', 'transporter', '2', 'S20A2', ')', 'and', 'in', 'mitochondria', '(', 'eg', ',', 'aldehyde', 'dehydrogenase', '4', 'AL4A1', ')', '(', 'Figure', '\u200b(Figure2).2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, significant changes were detected in proteins involved in fatty acid oxidation (eg, mitochondrial carnitine/acylcarnitine carrier protein MCAT, Fatty aldehyde dehydrogenase AL3A2) and amino acid metabolism (eg, methylmalonate‐semialdehyde dehydrogenase MMSA).	[('PMC7078914', 'R06003', 157, 185, 'Fatty aldehyde dehydrogenase'), ('PMC7078914', 'R06003', 224, 265, 'methylmalonate‐semialdehyde dehydrogenase')]	['In', 'addition', ',', 'significant', 'changes', 'were', 'detected', 'in', 'proteins', 'involved', 'in', 'fatty', 'acid', 'oxidation', '(', 'eg', ',', 'mitochondrial', 'car', '##nit', '##ine', '/', 'acyl', '##car', '##nit', '##ine', 'carrier', 'protein', 'MCA', '##T', ',', 'Fat', '##ty', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', 'AL', '##3', '##A', '##2', ')', 'and', 'amino', 'acid', 'metabolism', '(', 'eg', ',', 'methyl', '##mal', '##onate', '‐', 'semi', '##aldehyde', 'dehydrogenase', 'MM', '##SA', ')', '.']	[0, 3, 11, 13, 25, 33, 38, 47, 50, 59, 68, 71, 77, 82, 92, 93, 95, 97, 111, 114, 117, 120, 121, 125, 128, 131, 135, 143, 151, 154, 155, 157, 160, 163, 166, 168, 170, 172, 186, 188, 189, 190, 191, 193, 197, 203, 208, 219, 220, 222, 224, 230, 233, 238, 239, 243, 252, 266, 268, 270, 271]	[2, 11, 12, 24, 32, 37, 46, 49, 58, 67, 70, 76, 81, 91, 93, 95, 96, 110, 114, 117, 120, 121, 125, 128, 131, 134, 142, 150, 154, 155, 156, 160, 162, 166, 168, 170, 171, 185, 188, 189, 190, 191, 192, 196, 202, 207, 218, 220, 222, 223, 230, 233, 238, 239, 243, 251, 265, 268, 270, 271, 272]	['In', 'addition', ',', 'significant', 'changes', 'were', 'detected', 'in', 'proteins', 'involved', 'in', 'fatty', 'acid', 'oxidation', '(', 'eg', ',', 'mitochondrial', 'carnitine', '/', 'acylcarnitine', 'carrier', 'protein', 'MCAT', ',', 'Fatty', 'aldehyde', 'dehydrogenase', 'AL3A2', ')', 'and', 'amino', 'acid', 'metabolism', '(', 'eg', ',', 'methylmalonate', '‐', 'semialdehyde', 'dehydrogenase', 'MMSA', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 2, 1, 2, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Interestingly, protein levels for OXPHOS complexes I, III, IV, and V were not significantly altered in fibroblasts, whereas complex II and TANGO2 protein were not detected by proteomic analysis in normal and mutant fibroblasts despite being detectable by Western blotting.	[('PMC7078914', 'R06006', 124, 134, 'complex II')]	['Interestingly', ',', 'protein', 'levels', 'for', 'OX', '##PH', '##OS', 'complexes', 'I', ',', 'III', ',', 'IV', ',', 'and', 'V', 'were', 'not', 'significantly', 'altered', 'in', 'fibroblasts', ',', 'whereas', 'complex', 'II', 'and', 'TA', '##NG', '##O', '##2', 'protein', 'were', 'not', 'detected', 'by', 'proteomic', 'analysis', 'in', 'normal', 'and', 'mutant', 'fibroblasts', 'despite', 'being', 'detectable', 'by', 'Western', 'blotting', '.']	[0, 13, 15, 23, 30, 34, 36, 38, 41, 51, 52, 54, 57, 59, 61, 63, 67, 69, 74, 78, 92, 100, 103, 114, 116, 124, 132, 135, 139, 141, 143, 144, 146, 154, 159, 163, 172, 175, 185, 194, 197, 204, 208, 215, 227, 235, 241, 252, 255, 263, 271]	[13, 14, 22, 29, 33, 36, 38, 40, 50, 52, 53, 57, 58, 61, 62, 66, 68, 73, 77, 91, 99, 102, 114, 115, 123, 131, 134, 138, 141, 143, 144, 145, 153, 158, 162, 171, 174, 184, 193, 196, 203, 207, 214, 226, 234, 240, 251, 254, 262, 271, 272]	['Interestingly', ',', 'protein', 'levels', 'for', 'OXPHOS', 'complexes', 'I', ',', 'III', ',', 'IV', ',', 'and', 'V', 'were', 'not', 'significantly', 'altered', 'in', 'fibroblasts', ',', 'whereas', 'complex', 'II', 'and', 'TANGO2', 'protein', 'were', 'not', 'detected', 'by', 'proteomic', 'analysis', 'in', 'normal', 'and', 'mutant', 'fibroblasts', 'despite', 'being', 'detectable', 'by', 'Western', 'blotting', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR setup and cycling conditions for the primary amplification were as follows: 3 µl of template DNA, 15.05 µl of nuclease and DNA free water (VWR International, Darmstadt, Germany), 5 µl of 5 × KAPA High Fidelity Buffer (KAPA Biosystems, Wilmington, USA), 0.6 µl of 10 mM KAPA dNTP Mix, 0.25 µl of 20 mg/ml BSA (Life Technologies GmbH), 0.5 µl of KAPA High Fidelity Hot Start Polymerase, 0.3 µl of forward (10 µM) and 0.3 µl of reverse primer (10 µM).	[('PMC7101307', 'M05001', 114, 122, 'nuclease'), ('PMC7101307', 'M05001', 377, 387, 'Polymerase')]	['PCR', 'setup', 'and', 'cycling', 'conditions', 'for', 'the', 'primary', 'amplification', 'were', 'as', 'follows', ':', '3', '[UNK]', 'of', 'template', 'DNA', ',', '15', '.', '05', '[UNK]', 'of', 'nucle', '##ase', 'and', 'DNA', 'free', 'water', '(', 'V', '##WR', 'International', ',', 'Darm', '##stad', '##t', ',', 'Germany', ')', ',', '5', '[UNK]', 'of', '5', '×', 'KA', '##PA', 'High', 'Fi', '##del', '##ity', 'Bu', '##ffer', '(', 'KA', '##PA', 'Biosystems', ',', 'Wil', '##ming', '##ton', ',', 'USA', ')', ',', '0', '.', '6', '[UNK]', 'of', '10', 'mM', 'KA', '##PA', 'd', '##NT', '##P', 'Mix', ',', '0', '.', '25', '[UNK]', 'of', '20', 'mg', '/', 'ml', 'BSA', '(', 'Life', 'Technologies', 'GmbH', ')', ',', '0', '.', '5', '[UNK]', 'of', 'KA', '##PA', 'High', 'Fi', '##del', '##ity', 'Hot', 'Start', 'Polymer', '##ase', ',', '0', '.', '3', '[UNK]', 'of', 'forward', '(', '10', '[UNK]', ')', 'and', '0', '.', '3', '[UNK]', 'of', 'reverse', 'primer', '(', '10', '[UNK]', ')', '.']	[0, 4, 10, 14, 22, 33, 37, 41, 49, 63, 68, 71, 78, 80, -1, 85, 88, 97, 100, 102, 104, 105, -1, 111, 114, 119, 123, 127, 131, 136, 142, 143, 144, 147, 160, 162, 166, 170, 171, 173, 180, 181, 183, -1, 188, 191, 193, 195, 197, 200, 205, 207, 210, 214, 216, 221, 222, 224, 227, 237, 239, 242, 246, 249, 251, 254, 255, 257, 258, 259, -1, 264, 267, 270, 273, 275, 278, 279, 281, 283, 286, 288, 289, 290, -1, 296, 299, 302, 304, 305, 308, 312, 313, 318, 331, 335, 336, 338, 339, 340, -1, 345, 348, 350, 353, 358, 360, 363, 367, 371, 377, 384, 387, 389, 390, 391, -1, 396, 399, 407, 408, -1, 413, 415, 419, 420, 421, -1, 426, 429, 437, 444, 445, -1, 450, 451]	[3, 9, 13, 21, 32, 36, 40, 48, 62, 67, 70, 78, 79, 81, 4, 87, 96, 100, 101, 104, 105, 107, 4, 113, 119, 122, 126, 130, 135, 141, 143, 144, 146, 160, 161, 166, 170, 171, 172, 180, 181, 182, 184, 4, 190, 192, 194, 197, 199, 204, 207, 210, 213, 216, 220, 222, 224, 226, 237, 238, 242, 246, 249, 250, 254, 255, 256, 258, 259, 260, 4, 266, 269, 272, 275, 277, 279, 281, 282, 286, 287, 289, 290, 292, 4, 298, 301, 304, 305, 307, 311, 313, 317, 330, 335, 336, 337, 339, 340, 341, 4, 347, 350, 352, 357, 360, 363, 366, 370, 376, 384, 387, 388, 390, 391, 392, 4, 398, 406, 408, 410, 4, 414, 418, 420, 421, 422, 4, 428, 436, 443, 445, 447, 4, 451, 452]	['PCR', 'setup', 'and', 'cycling', 'conditions', 'for', 'the', 'primary', 'amplification', 'were', 'as', 'follows', ':', '3', 'µl', 'of', 'template', 'DNA', ',', '15.05', 'µl', 'of', 'nuclease', 'and', 'DNA', 'free', 'water', '(', 'VWR', 'International', ',', 'Darmstadt', ',', 'Germany', ')', ',', '5', 'µl', 'of', '5', '×', 'KAPA', 'High', 'Fidelity', 'Buffer', '(', 'KAPA', 'Biosystems', ',', 'Wilmington', ',', 'USA', ')', ',', '0.6', 'µl', 'of', '10', 'mM', 'KAPA', 'dNTP', 'Mix', ',', '0.25', 'µl', 'of', '20', 'mg', '/', 'ml', 'BSA', '(', 'Life', 'Technologies', 'GmbH', ')', ',', '0.5', 'µl', 'of', 'KAPA', 'High', 'Fidelity', 'Hot', 'Start', 'Polymerase', ',', '0.3', 'µl', 'of', 'forward', '(', '10', 'µM', ')', 'and', '0.3', 'µl', 'of', 'reverse', 'primer', '(', '10', 'µM', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
25.6 µl of nuclease and DNA free water, 10 µl of 5 × KAPA High Fidelity Buffer (KAPA Biosystems), 1.2 µl of dNTP Mix (10 mM) and 0.2 µl of KAPA High Fidelity Hot Start DNA Polymerase were added.	[('PMC7101307', 'M09001', 11, 19, 'nuclease'), ('PMC7101307', 'M09001', 168, 182, 'DNA Polymerase')]	['25', '.', '6', '[UNK]', 'of', 'nucle', '##ase', 'and', 'DNA', 'free', 'water', ',', '10', '[UNK]', 'of', '5', '×', 'KA', '##PA', 'High', 'Fi', '##del', '##ity', 'Bu', '##ffer', '(', 'KA', '##PA', 'Biosystems', ')', ',', '1', '.', '2', '[UNK]', 'of', 'd', '##NT', '##P', 'Mix', '(', '10', 'mM', ')', 'and', '0', '.', '2', '[UNK]', 'of', 'KA', '##PA', 'High', 'Fi', '##del', '##ity', 'Hot', 'Start', 'DNA', 'Polymer', '##ase', 'were', 'added', '.']	[0, 2, 3, -1, 8, 11, 16, 20, 24, 28, 33, 38, 40, -1, 46, 49, 51, 53, 55, 58, 63, 65, 68, 72, 74, 79, 80, 82, 85, 95, 96, 98, 99, 100, -1, 105, 108, 109, 111, 113, 117, 118, 121, 123, 125, 129, 130, 131, -1, 136, 139, 141, 144, 149, 151, 154, 158, 162, 168, 172, 179, 183, 188, 193]	[2, 3, 4, 4, 10, 16, 19, 23, 27, 32, 38, 39, 42, 4, 48, 50, 52, 55, 57, 62, 65, 68, 71, 74, 78, 80, 82, 84, 95, 96, 97, 99, 100, 101, 4, 107, 109, 111, 112, 116, 118, 120, 123, 124, 128, 130, 131, 132, 4, 138, 141, 143, 148, 151, 154, 157, 161, 167, 171, 179, 182, 187, 193, 194]	['25.6', 'µl', 'of', 'nuclease', 'and', 'DNA', 'free', 'water', ',', '10', 'µl', 'of', '5', '×', 'KAPA', 'High', 'Fidelity', 'Buffer', '(', 'KAPA', 'Biosystems', ')', ',', '1.2', 'µl', 'of', 'dNTP', 'Mix', '(', '10', 'mM', ')', 'and', '0.2', 'µl', 'of', 'KAPA', 'High', 'Fidelity', 'Hot', 'Start', 'DNA', 'Polymerase', 'were', 'added', '.']	[3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 2, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O']
Differences were attributed to platelet phospholipase activity during serum clot formation.	[('PMC7122646', 'D04002', 40, 53, 'phospholipase')]	['Differences', 'were', 'attributed', 'to', 'platelet', 'phospholip', '##ase', 'activity', 'during', 'serum', 'clot', 'formation', '.']	[0, 12, 17, 28, 31, 40, 50, 54, 63, 70, 76, 81, 90]	[11, 16, 27, 30, 39, 50, 53, 62, 69, 75, 80, 90, 91]	['Differences', 'were', 'attributed', 'to', 'platelet', 'phospholipase', 'activity', 'during', 'serum', 'clot', 'formation', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Estimation of the phospholipid distribution in the human platelet plasma membrane based on the effect of phospholipase A2 from Naja nigricollis.	[('PMC7122646', 'F32001', 105, 121, 'phospholipase A2')]	['Estimation', 'of', 'the', 'phospholipid', 'distribution', 'in', 'the', 'human', 'platelet', 'plasma', 'membrane', 'based', 'on', 'the', 'effect', 'of', 'phospholip', '##ase', 'A', '##2', 'from', 'Na', '##ja', 'nig', '##ric', '##oll', '##is', '.']	[0, 11, 14, 18, 31, 44, 47, 51, 57, 66, 73, 82, 88, 91, 95, 102, 105, 115, 119, 120, 122, 127, 129, 132, 135, 138, 141, 143]	[10, 13, 17, 30, 43, 46, 50, 56, 65, 72, 81, 87, 90, 94, 101, 104, 115, 118, 120, 121, 126, 129, 131, 135, 138, 141, 143, 144]	['Estimation', 'of', 'the', 'phospholipid', 'distribution', 'in', 'the', 'human', 'platelet', 'plasma', 'membrane', 'based', 'on', 'the', 'effect', 'of', 'phospholipase', 'A2', 'from', 'Naja', 'nigricollis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 2, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As mentioned above, such antimicrobial products include polyketide synthases, cyclic lipopeptidases and extra-ribosomal peptide synthases [11–13].	[('PMC7133001', 'D05005', 56, 76, 'polyketide synthases'), ('PMC7133001', 'D05005', 78, 99, 'cyclic lipopeptidases'), ('PMC7133001', 'D05005', 104, 137, 'extra-ribosomal peptide synthases')]	['As', 'mentioned', 'above', ',', 'such', 'antimicrobial', 'products', 'include', 'poly', '##ket', '##ide', 'synthase', '##s', ',', 'cyclic', 'lip', '##ope', '##pt', '##idase', '##s', 'and', 'extra', '-', 'ribosomal', 'peptide', 'synthase', '##s', '[', '11', '–', '13', ']', '.']	[0, 3, 13, 18, 20, 25, 39, 48, 56, 60, 63, 67, 75, 76, 78, 85, 88, 91, 93, 98, 100, 104, 109, 110, 120, 128, 136, 138, 139, 141, 142, 144, 145]	[2, 12, 18, 19, 24, 38, 47, 55, 60, 63, 66, 75, 76, 77, 84, 88, 91, 93, 98, 99, 103, 109, 110, 119, 127, 136, 137, 139, 141, 142, 144, 145, 146]	['As', 'mentioned', 'above', ',', 'such', 'antimicrobial', 'products', 'include', 'polyketide', 'synthases', ',', 'cyclic', 'lipopeptidases', 'and', 'extra', '-', 'ribosomal', 'peptide', 'synthases', '[', '11–', '13', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 5, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Substrate structure-activity relationships guide rational engineering of modular polyketide synthase ketoreductases.	[('PMC7133001', 'F10002', 81, 115, 'polyketide synthase ketoreductases')]	['Subst', '##rate', 'structure', '-', 'activity', 'relationships', 'guide', 'rational', 'engineering', 'of', 'modular', 'poly', '##ket', '##ide', 'synthase', 'ket', '##ored', '##uct', '##ases', '.']	[0, 5, 10, 19, 20, 29, 43, 49, 58, 70, 73, 81, 85, 88, 92, 101, 104, 108, 111, 115]	[5, 9, 19, 20, 28, 42, 48, 57, 69, 72, 80, 85, 88, 91, 100, 104, 108, 111, 115, 116]	['Substrate', 'structure', '-', 'activity', 'relationships', 'guide', 'rational', 'engineering', 'of', 'modular', 'polyketide', 'synthase', 'ketoreductases', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection.	[('PMC7133001', 'F43002', 0, 11, 'Calcineurin')]	['Calc', '##ine', '##urin', 'inhibitor', 'Ta', '##cr', '##oli', '##mus', 'impairs', 'host', 'immune', 'response', 'against', 'urinary', 'tract', 'infection', '.']	[0, 4, 7, 12, 22, 24, 26, 29, 33, 41, 46, 53, 62, 70, 78, 84, 93]	[4, 7, 11, 21, 24, 26, 29, 32, 40, 45, 52, 61, 69, 77, 83, 93, 94]	['Calcineurin', 'inhibitor', 'Tacrolimus', 'impairs', 'host', 'immune', 'response', 'against', 'urinary', 'tract', 'infection', '.']	[3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among these genomic tools are various fast responding operons, which encode polyketide synthases, cyclic lipopeptide synthases and extra-ribosomal peptide synthases, all generating biologically highly active compounds responsible for competition interference and antagonistic interaction [11–14].	[('PMC7133001', 'I01004', 76, 96, 'polyketide synthases'), ('PMC7133001', 'I01004', 98, 126, 'cyclic lipopeptide synthases'), ('PMC7133001', 'I01004', 131, 164, 'extra-ribosomal peptide synthases')]	['Among', 'these', 'genomic', 'tools', 'are', 'various', 'fast', 'responding', 'oper', '##ons', ',', 'which', 'encode', 'poly', '##ket', '##ide', 'synthase', '##s', ',', 'cyclic', 'lip', '##ope', '##pt', '##ide', 'synthase', '##s', 'and', 'extra', '-', 'ribosomal', 'peptide', 'synthase', '##s', ',', 'all', 'generating', 'biologically', 'highly', 'active', 'compounds', 'responsible', 'for', 'competition', 'interference', 'and', 'antagonist', '##ic', 'interaction', '[', '11', '–', '14', ']', '.']	[0, 6, 12, 20, 26, 30, 38, 43, 54, 58, 61, 63, 69, 76, 80, 83, 87, 95, 96, 98, 105, 108, 111, 113, 117, 125, 127, 131, 136, 137, 147, 155, 163, 164, 166, 170, 181, 194, 201, 208, 218, 230, 234, 246, 259, 263, 273, 276, 288, 289, 291, 292, 294, 295]	[5, 11, 19, 25, 29, 37, 42, 53, 58, 61, 62, 68, 75, 80, 83, 86, 95, 96, 97, 104, 108, 111, 113, 116, 125, 126, 130, 136, 137, 146, 154, 163, 164, 165, 169, 180, 193, 200, 207, 217, 229, 233, 245, 258, 262, 273, 275, 287, 289, 291, 292, 294, 295, 296]	['Among', 'these', 'genomic', 'tools', 'are', 'various', 'fast', 'responding', 'operons', ',', 'which', 'encode', 'polyketide', 'synthases', ',', 'cyclic', 'lipopeptide', 'synthases', 'and', 'extra', '-', 'ribosomal', 'peptide', 'synthases', ',', 'all', 'generating', 'biologically', 'highly', 'active', 'compounds', 'responsible', 'for', 'competition', 'interference', 'and', 'antagonistic', 'interaction', '[', '11–', '14', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 2, 1, 1, 4, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Matsushita M, Endo Y, Fujita T. Cutting edge: complement-activating complex of ficolin and mannose binding lectin-associated serine protease.	[('PMC7248409', 'F22001', 125, 140, 'serine protease')]	['Mats', '##ush', '##ita', 'M', ',', 'End', '##o', 'Y', ',', 'Fuj', '##ita', 'T', '.', 'Cut', '##ting', 'edge', ':', 'complement', '-', 'activating', 'complex', 'of', 'fic', '##olin', 'and', 'mann', '##ose', 'binding', 'lectin', '-', 'associated', 'serine', 'protease', '.']	[0, 4, 7, 11, 12, 14, 17, 19, 20, 22, 25, 29, 30, 32, 35, 40, 44, 46, 56, 57, 68, 76, 79, 82, 87, 91, 95, 99, 107, 113, 114, 125, 132, 140]	[4, 7, 10, 12, 13, 17, 18, 20, 21, 25, 28, 30, 31, 35, 39, 44, 45, 56, 57, 67, 75, 78, 82, 86, 90, 95, 98, 106, 113, 114, 124, 131, 140, 141]	['Matsushita', 'M', ',', 'Endo', 'Y', ',', 'Fujita', 'T', '.', 'Cutting', 'edge', ':', 'complement', '-', 'activating', 'complex', 'of', 'ficolin', 'and', 'mannose', 'binding', 'lectin', '-', 'associated', 'serine', 'protease', '.']	[3, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O']
Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase.	[('PMC7248409', 'F34002', 96, 112, 'sphingomyelinase')]	['Ap', '##olip', '##oprotein', 'C', '-', 'I', 'induces', 'apoptosis', 'in', 'human', 'aortic', 'smooth', 'muscle', 'cells', 'via', 'recruit', '##ing', 'neutral', 'sphing', '##omyel', '##inase', '.']	[0, 2, 6, 15, 16, 17, 19, 27, 37, 40, 46, 53, 60, 67, 73, 77, 84, 88, 96, 102, 107, 112]	[2, 6, 14, 16, 17, 18, 26, 36, 39, 45, 52, 59, 66, 72, 76, 84, 87, 95, 102, 107, 112, 113]	['Apolipoprotein', 'C-I', 'induces', 'apoptosis', 'in', 'human', 'aortic', 'smooth', 'muscle', 'cells', 'via', 'recruiting', 'neutral', 'sphingomyelinase', '.']	[3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Atorvastatin is a member of the statin drug family, which are the main therapeutic agents used to decrease high serum cholesterol levels by inhibiting (HMG-CoA) reductase enzyme.	[('PMC7344724', 'A00001', 151, 170, '(HMG-CoA) reductase')]	['At', '##or', '##vastatin', 'is', 'a', 'member', 'of', 'the', 'statin', 'drug', 'family', ',', 'which', 'are', 'the', 'main', 'therapeutic', 'agents', 'used', 'to', 'decrease', 'high', 'serum', 'cholesterol', 'levels', 'by', 'inhibiting', '(', 'HM', '##G', '-', 'Co', '##A', ')', 'reductase', 'enzyme', '.']	[0, 2, 4, 13, 16, 18, 25, 28, 32, 39, 44, 50, 52, 58, 62, 66, 71, 83, 90, 95, 98, 107, 112, 118, 130, 137, 140, 151, 152, 154, 155, 156, 158, 159, 161, 171, 177]	[2, 4, 12, 15, 17, 24, 27, 31, 38, 43, 50, 51, 57, 61, 65, 70, 82, 89, 94, 97, 106, 111, 117, 129, 136, 139, 150, 152, 154, 155, 156, 158, 159, 160, 170, 177, 178]	['Atorvastatin', 'is', 'a', 'member', 'of', 'the', 'statin', 'drug', 'family', ',', 'which', 'are', 'the', 'main', 'therapeutic', 'agents', 'used', 'to', 'decrease', 'high', 'serum', 'cholesterol', 'levels', 'by', 'inhibiting', '(', 'HMG-CoA', ')', 'reductase', 'enzyme', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Proteomic analysis revealed an increased abundance of proteins associated with an oxidative stress response, such as the glutathione s-transferase family protein (+8.43-fold), heat shock protein Hsp30/Hsp42 (+2.02-fold) and 5-demethoxyubiquinone hydroxylase, mitochondrial (+1.73-fold), as well as secondary metabolites such as isocyanide synthase A icsA (+8.52-fold) and non-ribosomal peptide synthetase fmpE (+3.06-fold).	[('PMC7344724', 'A00005', 121, 146, 'glutathione s-transferase'), ('PMC7344724', 'A00005', 224, 257, '5-demethoxyubiquinone hydroxylase'), ('PMC7344724', 'A00005', 328, 349, 'isocyanide synthase A'), ('PMC7344724', 'A00005', 372, 404, 'non-ribosomal peptide synthetase')]	['Prote', '##omic', 'analysis', 'revealed', 'an', 'increased', 'abundance', 'of', 'proteins', 'associated', 'with', 'an', 'oxidative', 'stress', 'response', ',', 'such', 'as', 'the', 'glutathione', 's', '-', 'transfer', '##ase', 'family', 'protein', '(', '+', '8', '.', '43', '-', 'fold', ')', ',', 'heat', 'shock', 'protein', 'Hsp', '##30', '/', 'Hsp', '##42', '(', '+', '2', '.', '02', '-', 'fold', ')', 'and', '5', '-', 'dem', '##eth', '##oxy', '##ub', '##iqu', '##ino', '##ne', 'hydroxyl', '##ase', ',', 'mitochondrial', '(', '+', '1', '.', '73', '-', 'fold', ')', ',', 'as', 'well', 'as', 'secondary', 'metabolites', 'such', 'as', 'iso', '##cy', '##ani', '##de', 'synthase', 'A', 'ic', '##s', '##A', '(', '+', '8', '.', '52', '-', 'fold', ')', 'and', 'non', '-', 'ribosomal', 'peptide', 'synthe', '##tase', 'fm', '##p', '##E', '(', '+', '3', '.', '06', '-', 'fold', ')', '.']	[0, 5, 10, 19, 28, 31, 41, 51, 54, 63, 74, 79, 82, 92, 99, 107, 109, 114, 117, 121, 133, 134, 135, 143, 147, 154, 162, 163, 164, 165, 166, 168, 169, 173, 174, 176, 181, 187, 195, 198, 200, 201, 204, 207, 208, 209, 210, 211, 213, 214, 218, 220, 224, 225, 226, 229, 232, 235, 237, 240, 243, 246, 254, 257, 259, 273, 274, 275, 276, 277, 279, 280, 284, 285, 287, 290, 295, 298, 308, 320, 325, 328, 331, 333, 336, 339, 348, 350, 352, 353, 355, 356, 357, 358, 359, 361, 362, 366, 368, 372, 375, 376, 386, 394, 400, 405, 407, 408, 410, 411, 412, 413, 414, 416, 417, 421, 422]	[5, 9, 18, 27, 30, 40, 50, 53, 62, 73, 78, 81, 91, 98, 107, 108, 113, 116, 120, 132, 134, 135, 143, 146, 153, 161, 163, 164, 165, 166, 168, 169, 173, 174, 175, 180, 186, 194, 198, 200, 201, 204, 206, 208, 209, 210, 211, 213, 214, 218, 219, 223, 225, 226, 229, 232, 235, 237, 240, 243, 245, 254, 257, 258, 272, 274, 275, 276, 277, 279, 280, 284, 285, 286, 289, 294, 297, 307, 319, 324, 327, 331, 333, 336, 338, 347, 349, 352, 353, 354, 356, 357, 358, 359, 361, 362, 366, 367, 371, 375, 376, 385, 393, 400, 404, 407, 408, 409, 411, 412, 413, 414, 416, 417, 421, 422, 423]	['Proteomic', 'analysis', 'revealed', 'an', 'increased', 'abundance', 'of', 'proteins', 'associated', 'with', 'an', 'oxidative', 'stress', 'response', ',', 'such', 'as', 'the', 'glutathione', 's-transferase', 'family', 'protein', '(', '+8.43-fold', ')', ',', 'heat', 'shock', 'protein', 'Hsp30', '/', 'Hsp42', '(', '+2.02-fold', ')', 'and', '5-demethoxyubiquinone', 'hydroxylase', ',', 'mitochondrial', '(', '+1.73-fold', ')', ',', 'as', 'well', 'as', 'secondary', 'metabolites', 'such', 'as', 'isocyanide', 'synthase', 'A', 'icsA', '(', '+8.52-fold', ')', 'and', 'non', '-', 'ribosomal', 'peptide', 'synthetase', 'fmpE', '(', '+3.06-fold', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 6, 1, 1, 1, 1, 1, 2, 1, 2, 1, 6, 1, 1, 9, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 6, 1, 1, 1, 1, 1, 1, 2, 3, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Statins are widely used for the control of cholesterol and function by inhibiting the action of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase [26,27].	[('PMC7344724', 'D00000', 96, 146, '3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase')]	['Stat', '##ins', 'are', 'widely', 'used', 'for', 'the', 'control', 'of', 'cholesterol', 'and', 'function', 'by', 'inhibiting', 'the', 'action', 'of', '3', '-', 'hydroxy', '-', '3', '-', 'methyl', '##glut', '##aryl', '-', 'Co', '##A', '(', 'HM', '##G', '-', 'Co', '##A', ')', 'reductase', '[', '26', ',', '27', ']', '.']	[0, 4, 8, 12, 19, 24, 28, 32, 40, 43, 55, 59, 68, 71, 82, 86, 93, 96, 97, 98, 105, 106, 107, 108, 114, 118, 122, 123, 125, 127, 128, 130, 131, 132, 134, 135, 137, 147, 148, 150, 151, 153, 154]	[4, 7, 11, 18, 23, 27, 31, 39, 42, 54, 58, 67, 70, 81, 85, 92, 95, 97, 98, 105, 106, 107, 108, 114, 118, 122, 123, 125, 126, 128, 130, 131, 132, 134, 135, 136, 146, 148, 150, 151, 153, 154, 155]	['Statins', 'are', 'widely', 'used', 'for', 'the', 'control', 'of', 'cholesterol', 'and', 'function', 'by', 'inhibiting', 'the', 'action', 'of', '3-hydroxy-3-methylglutaryl-CoA', '(', 'HMG-CoA', ')', 'reductase', '[', '26', ',', '27', ']', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 12, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Proteomic analysis revealed an increased abundance of a range of proteins involved in dealing with oxidative stress, including pyoverdine/dityrosine biosynthesis (+8.52-fold), 5-demethoxyubiquinone hydroxylase, mitochondrial (+1.74-fold) and alcohol dehydrogenase (+1.61-fold).	[('PMC7344724', 'D02000', 176, 209, '5-demethoxyubiquinone hydroxylase'), ('PMC7344724', 'D02000', 242, 263, 'alcohol dehydrogenase')]	['Prote', '##omic', 'analysis', 'revealed', 'an', 'increased', 'abundance', 'of', 'a', 'range', 'of', 'proteins', 'involved', 'in', 'dealing', 'with', 'oxidative', 'stress', ',', 'including', 'py', '##over', '##din', '##e', '/', 'di', '##ty', '##rosine', 'biosynthesis', '(', '+', '8', '.', '52', '-', 'fold', ')', ',', '5', '-', 'dem', '##eth', '##oxy', '##ub', '##iqu', '##ino', '##ne', 'hydroxyl', '##ase', ',', 'mitochondrial', '(', '+', '1', '.', '74', '-', 'fold', ')', 'and', 'alcohol', 'dehydrogenase', '(', '+', '1', '.', '61', '-', 'fold', ')', '.']	[0, 5, 10, 19, 28, 31, 41, 51, 54, 56, 62, 65, 74, 83, 86, 94, 99, 109, 115, 117, 127, 129, 133, 136, 137, 138, 140, 142, 149, 162, 163, 164, 165, 166, 168, 169, 173, 174, 176, 177, 178, 181, 184, 187, 189, 192, 195, 198, 206, 209, 211, 225, 226, 227, 228, 229, 231, 232, 236, 238, 242, 250, 264, 265, 266, 267, 268, 270, 271, 275, 276]	[5, 9, 18, 27, 30, 40, 50, 53, 55, 61, 64, 73, 82, 85, 93, 98, 108, 115, 116, 126, 129, 133, 136, 137, 138, 140, 142, 148, 161, 163, 164, 165, 166, 168, 169, 173, 174, 175, 177, 178, 181, 184, 187, 189, 192, 195, 197, 206, 209, 210, 224, 226, 227, 228, 229, 231, 232, 236, 237, 241, 249, 263, 265, 266, 267, 268, 270, 271, 275, 276, 277]	['Proteomic', 'analysis', 'revealed', 'an', 'increased', 'abundance', 'of', 'a', 'range', 'of', 'proteins', 'involved', 'in', 'dealing', 'with', 'oxidative', 'stress', ',', 'including', 'pyoverdine', '/', 'dityrosine', 'biosynthesis', '(', '+8.52-fold', ')', ',', '5-demethoxyubiquinone', 'hydroxylase', ',', 'mitochondrial', '(', '+1.74-fold', ')', 'and', 'alcohol', 'dehydrogenase', '(', '+1.61-fold', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 6, 1, 1, 9, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, the glutathione S-transferase family protein is increased in abundance (+8.43-fold), and this protein functions to detoxify xenobiotics.	[('PMC7344724', 'D02002', 17, 42, 'glutathione S-transferase')]	['Furthermore', ',', 'the', 'glutathione', 'S', '-', 'transfer', '##ase', 'family', 'protein', 'is', 'increased', 'in', 'abundance', '(', '+', '8', '.', '43', '-', 'fold', ')', ',', 'and', 'this', 'protein', 'functions', 'to', 'detox', '##ify', 'xen', '##obi', '##otics', '.']	[0, 11, 13, 17, 29, 30, 31, 39, 43, 50, 58, 61, 71, 74, 84, 85, 86, 87, 88, 90, 91, 95, 96, 98, 102, 107, 115, 125, 128, 133, 137, 140, 143, 148]	[11, 12, 16, 28, 30, 31, 39, 42, 49, 57, 60, 70, 73, 83, 85, 86, 87, 88, 90, 91, 95, 96, 97, 101, 106, 114, 124, 127, 133, 136, 140, 143, 148, 149]	['Furthermore', ',', 'the', 'glutathione', 'S-transferase', 'family', 'protein', 'is', 'increased', 'in', 'abundance', '(', '+8.43-fold', ')', ',', 'and', 'this', 'protein', 'functions', 'to', 'detoxify', 'xenobiotics', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Maher V.M.G., Thompson G.R. HMG CoA reductase inhibitors as lipid-lowering agents: Five years experience with lovastatin and an appraisal of simvastatin and pravastatin.	[('PMC7344724', 'F12001', 28, 45, 'HMG CoA reductase')]	['Mah', '##er', 'V', '.', 'M', '.', 'G', '.', ',', 'Thompson', 'G', '.', 'R', '.', 'HM', '##G', 'Co', '##A', 'reductase', 'inhibitors', 'as', 'lipid', '-', 'lowering', 'agents', ':', 'Five', 'years', 'experience', 'with', 'lo', '##vastatin', 'and', 'an', 'appraisal', 'of', 'sim', '##vastatin', 'and', 'pr', '##avas', '##ta', '##tin', '.']	[0, 3, 6, 7, 8, 9, 10, 11, 12, 14, 23, 24, 25, 26, 28, 30, 32, 34, 36, 46, 57, 60, 65, 66, 75, 81, 83, 88, 94, 105, 110, 112, 121, 125, 128, 138, 141, 144, 153, 157, 159, 163, 165, 168]	[3, 5, 7, 8, 9, 10, 11, 12, 13, 22, 24, 25, 26, 27, 30, 31, 34, 35, 45, 56, 59, 65, 66, 74, 81, 82, 87, 93, 104, 109, 112, 120, 124, 127, 137, 140, 144, 152, 156, 159, 163, 165, 168, 169]	['Maher', 'V.M.G', '.', ',', 'Thompson', 'G.R', '.', 'HMG', 'CoA', 'reductase', 'inhibitors', 'as', 'lipid', '-', 'lowering', 'agents', ':', 'Five', 'years', 'experience', 'with', 'lovastatin', 'and', 'an', 'appraisal', 'of', 'simvastatin', 'and', 'pravastatin', '.']	[2, 5, 1, 1, 1, 3, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Hernández-Perera O., Pérez-Sala D., Navarro-Antolín J., Sánchez-Pascuala R., Hernández G., Díaz C., Lamas S. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.	[('PMC7344724', 'F25001', 124, 164, '3-hydroxy-3-methylglutaryl-CoA reductase'), ('PMC7344724', 'F25001', 245, 278, 'endothelial nitric oxide synthase')]	['Hern', '##ández', '-', 'Pere', '##ra', 'O', '.', ',', 'P', '##ér', '##ez', '-', 'Sal', '##a', 'D', '.', ',', 'Nav', '##arr', '##o', '-', 'Ant', '##ol', '##ín', 'J', '.', ',', 'S', '##án', '##che', '##z', '-', 'Pasc', '##ual', '##a', 'R', '.', ',', 'Hern', '##ández', 'G', '.', ',', 'D', '##ía', '##z', 'C', '.', ',', 'Lam', '##as', 'S', '.', 'Effects', 'of', 'the', '3', '-', 'hydroxy', '-', '3', '-', 'methyl', '##glut', '##aryl', '-', 'Co', '##A', 'reductase', 'inhibitors', ',', 'at', '##or', '##vastatin', 'and', 'sim', '##vastatin', ',', 'on', 'the', 'expression', 'of', 'endot', '##helin', '-', '1', 'and', 'endothelial', 'nitric', 'oxide', 'synthase', 'in', 'vascular', 'endothelial', 'cells', '.']	[0, 4, 9, 10, 14, 17, 18, 19, 21, 22, 24, 26, 27, 30, 32, 33, 34, 36, 39, 42, 43, 44, 47, 49, 52, 53, 54, 56, 57, 59, 62, 63, 64, 68, 71, 73, 74, 75, 77, 81, 87, 88, 89, 91, 92, 94, 96, 97, 98, 100, 103, 106, 107, 109, 117, 120, 124, 125, 126, 133, 134, 135, 136, 142, 146, 150, 151, 153, 155, 165, 175, 177, 179, 181, 190, 194, 197, 205, 207, 210, 214, 225, 228, 233, 238, 239, 241, 245, 257, 264, 270, 279, 282, 291, 303, 308]	[4, 9, 10, 14, 16, 18, 19, 20, 22, 24, 26, 27, 30, 31, 33, 34, 35, 39, 42, 43, 44, 47, 49, 51, 53, 54, 55, 57, 59, 62, 63, 64, 68, 71, 72, 74, 75, 76, 81, 86, 88, 89, 90, 92, 94, 95, 97, 98, 99, 103, 105, 107, 108, 116, 119, 123, 125, 126, 133, 134, 135, 136, 142, 146, 150, 151, 153, 154, 164, 175, 176, 179, 181, 189, 193, 197, 205, 206, 209, 213, 224, 227, 233, 238, 239, 240, 244, 256, 263, 269, 278, 281, 290, 302, 308, 309]	['Hernández-Perera', 'O', '.', ',', 'Pérez-Sala', 'D', '.', ',', 'Navarro-Antolín', 'J', '.', ',', 'Sánchez-Pascuala', 'R', '.', ',', 'Hernández', 'G', '.', ',', 'Díaz', 'C', '.', ',', 'Lamas', 'S', '.', 'Effects', 'of', 'the', '3-hydroxy-3-methylglutaryl-CoA', 'reductase', 'inhibitors', ',', 'atorvastatin', 'and', 'simvastatin', ',', 'on', 'the', 'expression', 'of', 'endothelin-1', 'and', 'endothelial', 'nitric', 'oxide', 'synthase', 'in', 'vascular', 'endothelial', 'cells', '.']	[5, 1, 1, 1, 6, 1, 1, 1, 7, 1, 1, 1, 8, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 12, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Takemoto M., Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.	[('PMC7344724', 'F26001', 46, 93, '3-hydroxy-3-methylglutaryl coenzyme A reductase')]	['Take', '##mo', '##to', 'M', '.', ',', 'Li', '##ao', 'J', '.', 'K', '.', 'Ple', '##io', '##tro', '##pic', 'effects', 'of', '3', '-', 'hydroxy', '-', '3', '-', 'methyl', '##glut', '##aryl', 'coe', '##n', '##zyme', 'A', 'reductase', 'inhibitors', '.']	[0, 4, 6, 9, 10, 11, 13, 15, 18, 19, 20, 21, 23, 26, 28, 31, 35, 43, 46, 47, 48, 55, 56, 57, 58, 64, 68, 73, 76, 77, 82, 84, 94, 104]	[4, 6, 8, 10, 11, 12, 15, 17, 19, 20, 21, 22, 26, 28, 31, 34, 42, 45, 47, 48, 55, 56, 57, 58, 64, 68, 72, 76, 77, 81, 83, 93, 104, 105]	['Takemoto', 'M', '.', ',', 'Liao', 'J.K', '.', 'Pleiotropic', 'effects', 'of', '3-hydroxy-3-methylglutaryl', 'coenzyme', 'A', 'reductase', 'inhibitors', '.']	[3, 1, 1, 1, 2, 3, 1, 4, 1, 1, 9, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Transcriptome analysis of cyclic AMP-dependent protein kinase A-regulated genes reveals the production of the novel natural compound fumipyrrole by Aspergillus fumigatus.	[('PMC7344724', 'F34002', 26, 63, 'cyclic AMP-dependent protein kinase A')]	['Trans', '##cript', '##ome', 'analysis', 'of', 'cyclic', 'AMP', '-', 'dependent', 'protein', 'kinase', 'A', '-', 'regulated', 'genes', 'reveals', 'the', 'production', 'of', 'the', 'novel', 'natural', 'compound', 'fum', '##ip', '##yr', '##role', 'by', 'Aspergillus', 'fum', '##iga', '##tu', '##s', '.']	[0, 5, 10, 14, 23, 26, 33, 36, 37, 47, 55, 62, 63, 64, 74, 80, 88, 92, 103, 106, 110, 116, 124, 133, 136, 138, 140, 145, 148, 160, 163, 166, 168, 169]	[5, 10, 13, 22, 25, 32, 36, 37, 46, 54, 61, 63, 64, 73, 79, 87, 91, 102, 105, 109, 115, 123, 132, 136, 138, 140, 144, 147, 159, 163, 166, 168, 169, 170]	['Transcriptome', 'analysis', 'of', 'cyclic', 'AMP-dependent', 'protein', 'kinase', 'A-regulated', 'genes', 'reveals', 'the', 'production', 'of', 'the', 'novel', 'natural', 'compound', 'fumipyrrole', 'by', 'Aspergillus', 'fumigatus', '.']	[3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Statins are widely used for the control of cholesterol and act by inhibiting the action of 3-hydroxy-3-methylglutaryl-CoA (HMG-Co A) reductase and thus block cholesterol biosynthesis [13,14].	[('PMC7344724', 'I03000', 91, 142, '3-hydroxy-3-methylglutaryl-CoA (HMG-Co A) reductase')]	['Stat', '##ins', 'are', 'widely', 'used', 'for', 'the', 'control', 'of', 'cholesterol', 'and', 'act', 'by', 'inhibiting', 'the', 'action', 'of', '3', '-', 'hydroxy', '-', '3', '-', 'methyl', '##glut', '##aryl', '-', 'Co', '##A', '(', 'HM', '##G', '-', 'Co', 'A', ')', 'reductase', 'and', 'thus', 'block', 'cholesterol', 'biosynthesis', '[', '13', ',', '14', ']', '.']	[0, 4, 8, 12, 19, 24, 28, 32, 40, 43, 55, 59, 63, 66, 77, 81, 88, 91, 92, 93, 100, 101, 102, 103, 109, 113, 117, 118, 120, 122, 123, 125, 126, 127, 130, 131, 133, 143, 147, 152, 158, 170, 183, 184, 186, 187, 189, 190]	[4, 7, 11, 18, 23, 27, 31, 39, 42, 54, 58, 62, 65, 76, 80, 87, 90, 92, 93, 100, 101, 102, 103, 109, 113, 117, 118, 120, 121, 123, 125, 126, 127, 129, 131, 132, 142, 146, 151, 157, 169, 182, 184, 186, 187, 189, 190, 191]	['Statins', 'are', 'widely', 'used', 'for', 'the', 'control', 'of', 'cholesterol', 'and', 'act', 'by', 'inhibiting', 'the', 'action', 'of', '3-hydroxy-3-methylglutaryl-CoA', '(', 'HMG-Co', 'A', ')', 'reductase', 'and', 'thus', 'block', 'cholesterol', 'biosynthesis', '[', '13', ',', '14', ']', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 12, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The volcano plot shows the relative distribution of these proteins (Figure 5), and of the proteins that increased in abundance following exposure to atorvastatin, the most notable were isocyanide synthase A (+8.52-fold), glutathione S-transferase family protein (+8.43-fold), kynureninase 2 (+4.48-fold), and non-ribosomal peptide synthetase fmpE (+3.06-fold).	[('PMC7344724', 'R04004', 185, 206, 'isocyanide synthase A'), ('PMC7344724', 'R04004', 221, 246, 'glutathione S-transferase'), ('PMC7344724', 'R04004', 276, 290, 'kynureninase 2'), ('PMC7344724', 'R04004', 309, 341, 'non-ribosomal peptide synthetase')]	['The', 'volcan', '##o', 'plot', 'shows', 'the', 'relative', 'distribution', 'of', 'these', 'proteins', '(', 'Figure', '5', ')', ',', 'and', 'of', 'the', 'proteins', 'that', 'increased', 'in', 'abundance', 'following', 'exposure', 'to', 'at', '##or', '##vastatin', ',', 'the', 'most', 'notable', 'were', 'iso', '##cy', '##ani', '##de', 'synthase', 'A', '(', '+', '8', '.', '52', '-', 'fold', ')', ',', 'glutathione', 'S', '-', 'transfer', '##ase', 'family', 'protein', '(', '+', '8', '.', '43', '-', 'fold', ')', ',', 'k', '##yn', '##uren', '##inase', '2', '(', '+', '4', '.', '48', '-', 'fold', ')', ',', 'and', 'non', '-', 'ribosomal', 'peptide', 'synthe', '##tase', 'fm', '##p', '##E', '(', '+', '3', '.', '06', '-', 'fold', ')', '.']	[0, 4, 10, 12, 17, 23, 27, 36, 49, 52, 58, 67, 68, 75, 76, 77, 79, 83, 86, 90, 99, 104, 114, 117, 127, 137, 146, 149, 151, 153, 161, 163, 167, 172, 180, 185, 188, 190, 193, 196, 205, 207, 208, 209, 210, 211, 213, 214, 218, 219, 221, 233, 234, 235, 243, 247, 254, 262, 263, 264, 265, 266, 268, 269, 273, 274, 276, 277, 279, 283, 289, 291, 292, 293, 294, 295, 297, 298, 302, 303, 305, 309, 312, 313, 323, 331, 337, 342, 344, 345, 347, 348, 349, 350, 351, 353, 354, 358, 359]	[3, 10, 11, 16, 22, 26, 35, 48, 51, 57, 66, 68, 74, 76, 77, 78, 82, 85, 89, 98, 103, 113, 116, 126, 136, 145, 148, 151, 153, 161, 162, 166, 171, 179, 184, 188, 190, 193, 195, 204, 206, 208, 209, 210, 211, 213, 214, 218, 219, 220, 232, 234, 235, 243, 246, 253, 261, 263, 264, 265, 266, 268, 269, 273, 274, 275, 277, 279, 283, 288, 290, 292, 293, 294, 295, 297, 298, 302, 303, 304, 308, 312, 313, 322, 330, 337, 341, 344, 345, 346, 348, 349, 350, 351, 353, 354, 358, 359, 360]	['The', 'volcano', 'plot', 'shows', 'the', 'relative', 'distribution', 'of', 'these', 'proteins', '(', 'Figure', '5', ')', ',', 'and', 'of', 'the', 'proteins', 'that', 'increased', 'in', 'abundance', 'following', 'exposure', 'to', 'atorvastatin', ',', 'the', 'most', 'notable', 'were', 'isocyanide', 'synthase', 'A', '(', '+8.52-fold', ')', ',', 'glutathione', 'S-transferase', 'family', 'protein', '(', '+8.43-fold', ')', ',', 'kynureninase', '2', '(', '+4.48-fold', ')', ',', 'and', 'non', '-', 'ribosomal', 'peptide', 'synthetase', 'fmpE', '(', '+3.06-fold', ')', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 6, 1, 1, 1, 4, 1, 1, 1, 6, 1, 1, 4, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The main peptides decreased in abundance were O-methyltransferase (-3.68-fold), allergen Asp f 15 (-2.45-fold) and GNAT family acetyltransferase (-2.25-fold).	[('PMC7344724', 'R04005', 46, 65, 'O-methyltransferase'), ('PMC7344724', 'R04005', 127, 144, 'acetyltransferase')]	['The', 'main', 'peptides', 'decreased', 'in', 'abundance', 'were', 'O', '-', 'methyl', '##transferase', '(', '-', '3', '.', '68', '-', 'fold', ')', ',', 'allergen', 'Asp', 'f', '15', '(', '-', '2', '.', '45', '-', 'fold', ')', 'and', 'GN', '##AT', 'family', 'acetyl', '##transferase', '(', '-', '2', '.', '25', '-', 'fold', ')', '.']	[0, 4, 9, 18, 28, 31, 41, 46, 47, 48, 54, 66, 67, 68, 69, 70, 72, 73, 77, 78, 80, 89, 93, 95, 98, 99, 100, 101, 102, 104, 105, 109, 111, 115, 117, 120, 127, 133, 145, 146, 147, 148, 149, 151, 152, 156, 157]	[3, 8, 17, 27, 30, 40, 45, 47, 48, 54, 65, 67, 68, 69, 70, 72, 73, 77, 78, 79, 88, 92, 94, 97, 99, 100, 101, 102, 104, 105, 109, 110, 114, 117, 119, 126, 133, 144, 146, 147, 148, 149, 151, 152, 156, 157, 158]	['The', 'main', 'peptides', 'decreased', 'in', 'abundance', 'were', 'O-methyltransferase', '(', '-', '3.68-fold', ')', ',', 'allergen', 'Asp', 'f', '15', '(', '-', '2.45-fold', ')', 'and', 'GNAT', 'family', 'acetyltransferase', '(', '-', '2.25-fold', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 2, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The main enzyme classes that were altered in abundance in A. fumigatus treated with atorvastatin were oxidoreductases, transferases and hydrolases (Figure S4).	[('PMC7344724', 'R05000', 102, 117, 'oxidoreductases'), ('PMC7344724', 'R05000', 119, 131, 'transferases'), ('PMC7344724', 'R05000', 136, 146, 'hydrolases')]	['The', 'main', 'enzyme', 'classes', 'that', 'were', 'altered', 'in', 'abundance', 'in', 'A', '.', 'fum', '##iga', '##tu', '##s', 'treated', 'with', 'at', '##or', '##vastatin', 'were', 'oxid', '##ored', '##uct', '##ases', ',', 'transfer', '##ases', 'and', 'hydro', '##las', '##es', '(', 'Figure', 'S', '##4', ')', '.']	[0, 4, 9, 16, 24, 29, 34, 42, 45, 55, 58, 59, 61, 64, 67, 69, 71, 79, 84, 86, 88, 97, 102, 106, 110, 113, 117, 119, 127, 132, 136, 141, 144, 147, 148, 155, 156, 157, 158]	[3, 8, 15, 23, 28, 33, 41, 44, 54, 57, 59, 60, 64, 67, 69, 70, 78, 83, 86, 88, 96, 101, 106, 110, 113, 117, 118, 127, 131, 135, 141, 144, 146, 148, 154, 156, 157, 158, 159]	['The', 'main', 'enzyme', 'classes', 'that', 'were', 'altered', 'in', 'abundance', 'in', 'A', '.', 'fumigatus', 'treated', 'with', 'atorvastatin', 'were', 'oxidoreductases', ',', 'transferases', 'and', 'hydrolases', '(', 'Figure', 'S4', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 4, 1, 2, 1, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Oxidoreductase enzymes that increased in abundance in atorvastatin treatment of A fumigatus were pyoverdine/dityrosine biosynthesis family protein (+8.52-fold), 5-demethoxyubiquinone hydroxylase, mitochondrial (+1.73-fold), alcohol dehydrogenase, putative (+1.6-fold) and Psi-producing oxygenase A (+1.55-fold).	[('PMC7344724', 'R05001', 0, 14, 'Oxidoreductase'), ('PMC7344724', 'R05001', 161, 194, '5-demethoxyubiquinone hydroxylase'), ('PMC7344724', 'R05001', 224, 245, 'alcohol dehydrogenase'), ('PMC7344724', 'R05001', 286, 297, 'oxygenase A')]	['Oxid', '##ored', '##uct', '##ase', 'enzymes', 'that', 'increased', 'in', 'abundance', 'in', 'at', '##or', '##vastatin', 'treatment', 'of', 'A', 'fum', '##iga', '##tu', '##s', 'were', 'py', '##over', '##din', '##e', '/', 'di', '##ty', '##rosine', 'biosynthesis', 'family', 'protein', '(', '+', '8', '.', '52', '-', 'fold', ')', ',', '5', '-', 'dem', '##eth', '##oxy', '##ub', '##iqu', '##ino', '##ne', 'hydroxyl', '##ase', ',', 'mitochondrial', '(', '+', '1', '.', '73', '-', 'fold', ')', ',', 'alcohol', 'dehydrogenase', ',', 'putative', '(', '+', '1', '.', '6', '-', 'fold', ')', 'and', 'Ps', '##i', '-', 'producing', 'oxygen', '##ase', 'A', '(', '+', '1', '.', '55', '-', 'fold', ')', '.']	[0, 4, 8, 11, 15, 23, 28, 38, 41, 51, 54, 56, 58, 67, 77, 80, 82, 85, 88, 90, 92, 97, 99, 103, 106, 107, 108, 110, 112, 119, 132, 139, 147, 148, 149, 150, 151, 153, 154, 158, 159, 161, 162, 163, 166, 169, 172, 174, 177, 180, 183, 191, 194, 196, 210, 211, 212, 213, 214, 216, 217, 221, 222, 224, 232, 245, 247, 256, 257, 258, 259, 260, 261, 262, 266, 268, 272, 274, 275, 276, 286, 292, 296, 298, 299, 300, 301, 302, 304, 305, 309, 310]	[4, 8, 11, 14, 22, 27, 37, 40, 50, 53, 56, 58, 66, 76, 79, 81, 85, 88, 90, 91, 96, 99, 103, 106, 107, 108, 110, 112, 118, 131, 138, 146, 148, 149, 150, 151, 153, 154, 158, 159, 160, 162, 163, 166, 169, 172, 174, 177, 180, 182, 191, 194, 195, 209, 211, 212, 213, 214, 216, 217, 221, 222, 223, 231, 245, 246, 255, 257, 258, 259, 260, 261, 262, 266, 267, 271, 274, 275, 276, 285, 292, 295, 297, 299, 300, 301, 302, 304, 305, 309, 310, 311]	['Oxidoreductase', 'enzymes', 'that', 'increased', 'in', 'abundance', 'in', 'atorvastatin', 'treatment', 'of', 'A', 'fumigatus', 'were', 'pyoverdine', '/', 'dityrosine', 'biosynthesis', 'family', 'protein', '(', '+8.52-fold', ')', ',', '5-demethoxyubiquinone', 'hydroxylase', ',', 'mitochondrial', '(', '+1.73-fold', ')', ',', 'alcohol', 'dehydrogenase', ',', 'putative', '(', '+1.6-fold', ')', 'and', 'Psi', '-', 'producing', 'oxygenase', 'A', '(', '+1.55-fold', ')', '.']	[4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 4, 1, 3, 1, 1, 1, 1, 6, 1, 1, 9, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 2, 1, 1, 2, 1, 1, 6, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thirteen oxidoreductase enzymes showed a decrease in abundance and included aflatoxin B1-aldehyde reductase GliO-like, putative (−2.86-fold), aryl-alcohol dehydrogenase, putative (−1.52-fold) and NADH-dependent flavin oxidoreductase, putative (−1.50-fold).	[('PMC7344724', 'R05002', 9, 23, 'oxidoreductase'), ('PMC7344724', 'R05002', 76, 107, 'aflatoxin B1-aldehyde reductase'), ('PMC7344724', 'R05002', 142, 168, 'aryl-alcohol dehydrogenase'), ('PMC7344724', 'R05002', 196, 232, 'NADH-dependent flavin oxidoreductase')]	['Thi', '##rt', '##een', 'oxid', '##ored', '##uct', '##ase', 'enzymes', 'showed', 'a', 'decrease', 'in', 'abundance', 'and', 'included', 'af', '##lat', '##oxin', 'B', '##1', '-', 'ald', '##eh', '##yd', '##e', 'reductase', 'Gl', '##i', '##O', '-', 'like', ',', 'putative', '(', '−2', '.', '86', '-', 'fold', ')', ',', 'aryl', '-', 'alcohol', 'dehydrogenase', ',', 'putative', '(', '−1', '.', '52', '-', 'fold', ')', 'and', 'NADH', '-', 'dependent', 'flav', '##in', 'oxid', '##ored', '##uct', '##ase', ',', 'putative', '(', '−1', '.', '50', '-', 'fold', ')', '.']	[0, 3, 5, 9, 13, 17, 20, 24, 32, 39, 41, 50, 53, 63, 67, 76, 78, 81, 86, 87, 88, 89, 92, 94, 96, 98, 108, 110, 111, 112, 113, 117, 119, 128, 129, 131, 132, 134, 135, 139, 140, 142, 146, 147, 155, 168, 170, 179, 180, 182, 183, 185, 186, 190, 192, 196, 200, 201, 211, 215, 218, 222, 226, 229, 232, 234, 243, 244, 246, 247, 249, 250, 254, 255]	[3, 5, 8, 13, 17, 20, 23, 31, 38, 40, 49, 52, 62, 66, 75, 78, 81, 85, 87, 88, 89, 92, 94, 96, 97, 107, 110, 111, 112, 113, 117, 118, 127, 129, 131, 132, 134, 135, 139, 140, 141, 146, 147, 154, 168, 169, 178, 180, 182, 183, 185, 186, 190, 191, 195, 200, 201, 210, 215, 217, 222, 226, 229, 232, 233, 242, 244, 246, 247, 249, 250, 254, 255, 256]	['Thirteen', 'oxidoreductase', 'enzymes', 'showed', 'a', 'decrease', 'in', 'abundance', 'and', 'included', 'aflatoxin', 'B1-aldehyde', 'reductase', 'GliO', '-', 'like', ',', 'putative', '(', '−2.86-fold', ')', ',', 'aryl', '-', 'alcohol', 'dehydrogenase', ',', 'putative', '(', '−1.52-fold', ')', 'and', 'NADH-dependent', 'flavin', 'oxidoreductase', ',', 'putative', '(', '−1.50-fold', ')', '.']	[3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 7, 1, 3, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 2, 4, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Enzymes with transferase activity increased in abundance included glutathione S-transferase family protein (+8.43-fold), phosphatidylinositol transporter, putative (+2.00-fold) and allergen Asp f 4 (+1.42-fold), while O-methyltransferase (−3.68-fold), malate synthase (−2.40-fold) and GNAT family acetyltransferase, putative (−2.25-fold) were decreased in abundance.	[('PMC7344724', 'R05003', 13, 24, 'transferase'), ('PMC7344724', 'R05003', 66, 91, 'glutathione S-transferase'), ('PMC7344724', 'R05003', 218, 237, 'O-methyltransferase'), ('PMC7344724', 'R05003', 252, 267, 'malate synthase'), ('PMC7344724', 'R05003', 297, 314, 'acetyltransferase')]	['Enzyme', '##s', 'with', 'transfer', '##ase', 'activity', 'increased', 'in', 'abundance', 'included', 'glutathione', 'S', '-', 'transfer', '##ase', 'family', 'protein', '(', '+', '8', '.', '43', '-', 'fold', ')', ',', 'phosphatidyl', '##inositol', 'transporter', ',', 'putative', '(', '+', '2', '.', '00', '-', 'fold', ')', 'and', 'allergen', 'Asp', 'f', '4', '(', '+', '1', '.', '42', '-', 'fold', ')', ',', 'while', 'O', '-', 'methyl', '##transferase', '(', '−3', '.', '68', '-', 'fold', ')', ',', 'mal', '##ate', 'synthase', '(', '−2', '.', '40', '-', 'fold', ')', 'and', 'GN', '##AT', 'family', 'acetyl', '##transferase', ',', 'putative', '(', '−2', '.', '25', '-', 'fold', ')', 'were', 'decreased', 'in', 'abundance', '.']	[0, 6, 8, 13, 21, 25, 34, 44, 47, 57, 66, 78, 79, 80, 88, 92, 99, 107, 108, 109, 110, 111, 113, 114, 118, 119, 121, 133, 142, 153, 155, 164, 165, 166, 167, 168, 170, 171, 175, 177, 181, 190, 194, 196, 198, 199, 200, 201, 202, 204, 205, 209, 210, 212, 218, 219, 220, 226, 238, 239, 241, 242, 244, 245, 249, 250, 252, 255, 259, 268, 269, 271, 272, 274, 275, 279, 281, 285, 287, 290, 297, 303, 314, 316, 325, 326, 328, 329, 331, 332, 336, 338, 343, 353, 356, 365]	[6, 7, 12, 21, 24, 33, 43, 46, 56, 65, 77, 79, 80, 88, 91, 98, 106, 108, 109, 110, 111, 113, 114, 118, 119, 120, 133, 141, 153, 154, 163, 165, 166, 167, 168, 170, 171, 175, 176, 180, 189, 193, 195, 197, 199, 200, 201, 202, 204, 205, 209, 210, 211, 217, 219, 220, 226, 237, 239, 241, 242, 244, 245, 249, 250, 251, 255, 258, 267, 269, 271, 272, 274, 275, 279, 280, 284, 287, 289, 296, 303, 314, 315, 324, 326, 328, 329, 331, 332, 336, 337, 342, 352, 355, 365, 366]	['Enzymes', 'with', 'transferase', 'activity', 'increased', 'in', 'abundance', 'included', 'glutathione', 'S-transferase', 'family', 'protein', '(', '+8.43-fold', ')', ',', 'phosphatidylinositol', 'transporter', ',', 'putative', '(', '+2.00-fold', ')', 'and', 'allergen', 'Asp', 'f', '4', '(', '+1.42-fold', ')', ',', 'while', 'O-methyltransferase', '(', '−3.68-fold', ')', ',', 'malate', 'synthase', '(', '−2.40-fold', ')', 'and', 'GNAT', 'family', 'acetyltransferase', ',', 'putative', '(', '−2.25-fold', ')', 'were', 'decreased', 'in', 'abundance', '.']	[2, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 4, 1, 5, 1, 1, 2, 1, 1, 5, 1, 1, 2, 1, 2, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Nine hydrolytic enzymes were increased in abundance and these included kynureninase (4.48-fold), amidase putative (+2.77-fold), lipase/esterase putative (+2.12-fold) and methionine aminopeptidase 2-2 (+1.83-fold).	[('PMC7344724', 'R05004', 71, 83, 'kynureninase'), ('PMC7344724', 'R05004', 97, 104, 'amidase'), ('PMC7344724', 'R05004', 128, 143, 'lipase/esterase'), ('PMC7344724', 'R05004', 170, 199, 'methionine aminopeptidase 2-2')]	['Nine', 'hydroly', '##tic', 'enzymes', 'were', 'increased', 'in', 'abundance', 'and', 'these', 'included', 'k', '##yn', '##uren', '##inase', '(', '4', '.', '48', '-', 'fold', ')', ',', 'am', '##idase', 'putative', '(', '+', '2', '.', '77', '-', 'fold', ')', ',', 'lipase', '/', 'ester', '##ase', 'putative', '(', '+', '2', '.', '12', '-', 'fold', ')', 'and', 'methionine', 'amino', '##pe', '##pt', '##idase', '2', '-', '2', '(', '+', '1', '.', '83', '-', 'fold', ')', '.']	[0, 5, 12, 16, 24, 29, 39, 42, 52, 56, 62, 71, 72, 74, 78, 84, 85, 86, 87, 89, 90, 94, 95, 97, 99, 105, 114, 115, 116, 117, 118, 120, 121, 125, 126, 128, 134, 135, 140, 144, 153, 154, 155, 156, 157, 159, 160, 164, 166, 170, 181, 186, 188, 190, 196, 197, 198, 200, 201, 202, 203, 204, 206, 207, 211, 212]	[4, 12, 15, 23, 28, 38, 41, 51, 55, 61, 70, 72, 74, 78, 83, 85, 86, 87, 89, 90, 94, 95, 96, 99, 104, 113, 115, 116, 117, 118, 120, 121, 125, 126, 127, 134, 135, 140, 143, 152, 154, 155, 156, 157, 159, 160, 164, 165, 169, 180, 186, 188, 190, 195, 197, 198, 199, 201, 202, 203, 204, 206, 207, 211, 212, 213]	['Nine', 'hydrolytic', 'enzymes', 'were', 'increased', 'in', 'abundance', 'and', 'these', 'included', 'kynureninase', '(', '4.48-fold', ')', ',', 'amidase', 'putative', '(', '+2.77-fold', ')', ',', 'lipase', '/', 'esterase', 'putative', '(', '+2.12-fold', ')', 'and', 'methionine', 'aminopeptidase', '2-2', '(', '+1.83-fold', ')', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 1, 2, 1, 1, 6, 1, 1, 1, 1, 2, 1, 1, 6, 1, 1, 1, 4, 3, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast two hydrolytic enzymes were reduced in abundance (haloalkanoic acid dehalogenase, putative (−2.99-fold) and phytase, putative (−1.42-fold).	[('PMC7344724', 'R05005', 62, 92, 'haloalkanoic acid dehalogenase'), ('PMC7344724', 'R05005', 120, 127, 'phytase')]	['In', 'contrast', 'two', 'hydroly', '##tic', 'enzymes', 'were', 'reduced', 'in', 'abundance', '(', 'halo', '##alk', '##ano', '##ic', 'acid', 'de', '##hal', '##ogen', '##ase', ',', 'putative', '(', '−2', '.', '99', '-', 'fold', ')', 'and', 'phyt', '##ase', ',', 'putative', '(', '−1', '.', '42', '-', 'fold', ')', '.']	[0, 3, 12, 16, 23, 27, 35, 40, 48, 51, 61, 62, 66, 69, 72, 75, 80, 82, 85, 89, 92, 94, 103, 104, 106, 107, 109, 110, 114, 116, 120, 124, 127, 129, 138, 139, 141, 142, 144, 145, 149, 150]	[2, 11, 15, 23, 26, 34, 39, 47, 50, 60, 62, 66, 69, 72, 74, 79, 82, 85, 89, 92, 93, 102, 104, 106, 107, 109, 110, 114, 115, 119, 124, 127, 128, 137, 139, 141, 142, 144, 145, 149, 150, 151]	['In', 'contrast', 'two', 'hydrolytic', 'enzymes', 'were', 'reduced', 'in', 'abundance', '(', 'haloalkanoic', 'acid', 'dehalogenase', ',', 'putative', '(', '−2.99-fold', ')', 'and', 'phytase', ',', 'putative', '(', '−1.42-fold', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 5, 1, 1, 2, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The amyloid beta A4 protein, apolipoprotein A-IV, gelsolin, contactin-1, gamma-glutamyl hydrolase, and complement factor H-related protein 1 (CFHR1) were selected for further analysis.	[('PMC7346861', 'A02001', 73, 97, 'gamma-glutamyl hydrolase')]	['The', 'amyloid', 'beta', 'A', '##4', 'protein', ',', 'apo', '##lip', '##oprotein', 'A', '-', 'IV', ',', 'gels', '##olin', ',', 'contact', '##in', '-', '1', ',', 'gamma', '-', 'glut', '##amyl', 'hydro', '##las', '##e', ',', 'and', 'complement', 'factor', 'H', '-', 'related', 'protein', '1', '(', 'CF', '##HR', '##1', ')', 'were', 'selected', 'for', 'further', 'analysis', '.']	[0, 4, 12, 17, 18, 20, 27, 29, 32, 35, 44, 45, 46, 48, 50, 54, 58, 60, 67, 69, 70, 71, 73, 78, 79, 83, 88, 93, 96, 97, 99, 103, 114, 121, 122, 123, 131, 139, 141, 142, 144, 146, 147, 149, 154, 163, 167, 175, 183]	[3, 11, 16, 18, 19, 27, 28, 32, 35, 43, 45, 46, 48, 49, 54, 58, 59, 67, 69, 70, 71, 72, 78, 79, 83, 87, 93, 96, 97, 98, 102, 113, 120, 122, 123, 130, 138, 140, 142, 144, 146, 147, 148, 153, 162, 166, 174, 183, 184]	['The', 'amyloid', 'beta', 'A4', 'protein', ',', 'apolipoprotein', 'A-IV', ',', 'gelsolin', ',', 'contactin-1', ',', 'gamma', '-', 'glutamyl', 'hydrolase', ',', 'and', 'complement', 'factor', 'H', '-', 'related', 'protein', '1', '(', 'CFHR1', ')', 'were', 'selected', 'for', 'further', 'analysis', '.']	[1, 1, 1, 2, 1, 1, 3, 3, 1, 2, 1, 4, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CFHR1 blocks C5 convertase activity and interferes with C5b surface association to regulate the complement system (Hannan et al., 2016).	[('PMC7346861', 'D04000', 13, 26, 'C5 convertase')]	['CF', '##HR', '##1', 'blocks', 'C', '##5', 'convert', '##ase', 'activity', 'and', 'interfere', '##s', 'with', 'C', '##5', '##b', 'surface', 'association', 'to', 'regulate', 'the', 'complement', 'system', '(', 'Hann', '##an', 'et', 'al', '.', ',', '2016', ')', '.']	[0, 2, 4, 6, 13, 14, 16, 23, 27, 36, 40, 49, 51, 56, 57, 58, 60, 68, 80, 83, 92, 96, 107, 114, 115, 119, 122, 125, 127, 128, 130, 134, 135]	[2, 4, 5, 12, 14, 15, 23, 26, 35, 39, 49, 50, 55, 57, 58, 59, 67, 79, 82, 91, 95, 106, 113, 115, 119, 121, 124, 127, 128, 129, 134, 135, 136]	['CFHR1', 'blocks', 'C5', 'convertase', 'activity', 'and', 'interferes', 'with', 'C5b', 'surface', 'association', 'to', 'regulate', 'the', 'complement', 'system', '(', 'Hannan', 'et', 'al', '.', ',', '2016', ')', '.']	[3, 1, 2, 2, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Tumor-associated macrophages promote epigenetic silencing of gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells.	[('PMC7346861', 'F28001', 78, 101, 'DNA Methyltransferase 1')]	['Tumor', '-', 'associated', 'macrophages', 'promote', 'epigenetic', 'silencing', 'of', 'gels', '##olin', 'through', 'DNA', 'Methyl', '##transferase', '1', 'in', 'Gas', '##tric', 'Cancer', 'Cells', '.']	[0, 5, 6, 17, 29, 37, 48, 58, 61, 65, 70, 78, 82, 88, 100, 102, 105, 108, 113, 120, 125]	[5, 6, 16, 28, 36, 47, 57, 60, 65, 69, 77, 81, 88, 99, 101, 104, 108, 112, 119, 125, 126]	['Tumor', '-', 'associated', 'macrophages', 'promote', 'epigenetic', 'silencing', 'of', 'gelsolin', 'through', 'DNA', 'Methyltransferase', '1', 'in', 'Gastric', 'Cancer', 'Cells', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
A human complement factor H-related protein 1 (CFHR1) enzyme-linked immunosorbent assay (ELISA) kit (Catalog No: IC-CFHR1-Hu), human contactin 1 (CNTN1) ELISA kit (Catalog No: IC-CNTN1-Hu), human gelsolin ELISA kit (Catalog No: IC-GS-Hu), human amyloid precursor protein ELISA kit (Catalog No: DL-APP-Hu), and human gamma-glutamyl hydrolase ELISA kit (Catalog No: CSB-EL009389HU) were used to validate whether these proteins were differentially expressed in large numbers of samples.	[('PMC7346861', 'M04000', 310, 340, 'human gamma-glutamyl hydrolase')]	['A', 'human', 'complement', 'factor', 'H', '-', 'related', 'protein', '1', '(', 'CF', '##HR', '##1', ')', 'enzyme', '-', 'linked', 'immunosorbent', 'assay', '(', 'ELISA', ')', 'kit', '(', 'Catal', '##og', 'No', ':', 'IC', '-', 'CF', '##HR', '##1', '-', 'Hu', ')', ',', 'human', 'contact', '##in', '1', '(', 'CNT', '##N', '##1', ')', 'ELISA', 'kit', '(', 'Catal', '##og', 'No', ':', 'IC', '-', 'CNT', '##N', '##1', '-', 'Hu', ')', ',', 'human', 'gels', '##olin', 'ELISA', 'kit', '(', 'Catal', '##og', 'No', ':', 'IC', '-', 'GS', '-', 'Hu', ')', ',', 'human', 'amyloid', 'precursor', 'protein', 'ELISA', 'kit', '(', 'Catal', '##og', 'No', ':', 'DL', '-', 'APP', '-', 'Hu', ')', ',', 'and', 'human', 'gamma', '-', 'glut', '##amyl', 'hydro', '##las', '##e', 'ELISA', 'kit', '(', 'Catal', '##og', 'No', ':', 'CS', '##B', '-', 'EL', '##009', '##38', '##9', '##H', '##U', ')', 'were', 'used', 'to', 'validate', 'whether', 'these', 'proteins', 'were', 'differentially', 'expressed', 'in', 'large', 'numbers', 'of', 'samples', '.']	[0, 2, 8, 19, 26, 27, 28, 36, 44, 46, 47, 49, 51, 52, 54, 60, 61, 68, 82, 88, 89, 94, 96, 100, 101, 106, 109, 111, 113, 115, 116, 118, 120, 121, 122, 124, 125, 127, 133, 140, 143, 145, 146, 149, 150, 151, 153, 159, 163, 164, 169, 172, 174, 176, 178, 179, 182, 183, 184, 185, 187, 188, 190, 196, 200, 205, 211, 215, 216, 221, 224, 226, 228, 230, 231, 233, 234, 236, 237, 239, 245, 253, 263, 271, 277, 281, 282, 287, 290, 292, 294, 296, 297, 300, 301, 303, 304, 306, 310, 316, 321, 322, 326, 331, 336, 339, 341, 347, 351, 352, 357, 360, 362, 364, 366, 367, 368, 370, 373, 375, 376, 377, 378, 380, 385, 390, 393, 402, 410, 416, 425, 430, 445, 455, 458, 464, 472, 475, 482]	[1, 7, 18, 25, 27, 28, 35, 43, 45, 47, 49, 51, 52, 53, 60, 61, 67, 81, 87, 89, 94, 95, 99, 101, 106, 108, 111, 112, 115, 116, 118, 120, 121, 122, 124, 125, 126, 132, 140, 142, 144, 146, 149, 150, 151, 152, 158, 162, 164, 169, 171, 174, 175, 178, 179, 182, 183, 184, 185, 187, 188, 189, 195, 200, 204, 210, 214, 216, 221, 223, 226, 227, 230, 231, 233, 234, 236, 237, 238, 244, 252, 262, 270, 276, 280, 282, 287, 289, 292, 293, 296, 297, 300, 301, 303, 304, 305, 309, 315, 321, 322, 326, 330, 336, 339, 340, 346, 350, 352, 357, 359, 362, 363, 366, 367, 368, 370, 373, 375, 376, 377, 378, 379, 384, 389, 392, 401, 409, 415, 424, 429, 444, 454, 457, 463, 471, 474, 482, 483]	['A', 'human', 'complement', 'factor', 'H', '-', 'related', 'protein', '1', '(', 'CFHR1', ')', 'enzyme', '-', 'linked', 'immunosorbent', 'assay', '(', 'ELISA', ')', 'kit', '(', 'Catalog', 'No', ':', 'IC-CFHR1-Hu', ')', ',', 'human', 'contactin', '1', '(', 'CNTN1', ')', 'ELISA', 'kit', '(', 'Catalog', 'No', ':', 'IC-CNTN1-Hu', ')', ',', 'human', 'gelsolin', 'ELISA', 'kit', '(', 'Catalog', 'No', ':', 'IC-GS-Hu', ')', ',', 'human', 'amyloid', 'precursor', 'protein', 'ELISA', 'kit', '(', 'Catalog', 'No', ':', 'DL-APP-Hu', ')', ',', 'and', 'human', 'gamma', '-', 'glutamyl', 'hydrolase', 'ELISA', 'kit', '(', 'Catalog', 'No', ':', 'CSB-EL009389HU', ')', 'were', 'used', 'to', 'validate', 'whether', 'these', 'proteins', 'were', 'differentially', 'expressed', 'in', 'large', 'numbers', 'of', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 7, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 7, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 5, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 2, 1, 1, 9, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gamma-glutamyl hydrolase and CFHR1 were the most strongly upregulated proteins in the TC group, with ratios (cancer/control) of 4.669 and 7.799, respectively.	[('PMC7346861', 'R02001', 0, 24, 'Gamma-glutamyl hydrolase')]	['Gamma', '-', 'glut', '##amyl', 'hydro', '##las', '##e', 'and', 'CF', '##HR', '##1', 'were', 'the', 'most', 'strongly', 'upregulated', 'proteins', 'in', 'the', 'TC', 'group', ',', 'with', 'ratios', '(', 'cancer', '/', 'control', ')', 'of', '4', '.', '66', '##9', 'and', '7', '.', '79', '##9', ',', 'respectively', '.']	[0, 5, 6, 10, 15, 20, 23, 25, 29, 31, 33, 35, 40, 44, 49, 58, 70, 79, 82, 86, 89, 94, 96, 101, 108, 109, 115, 116, 123, 125, 128, 129, 130, 132, 134, 138, 139, 140, 142, 143, 145, 157]	[5, 6, 10, 14, 20, 23, 24, 28, 31, 33, 34, 39, 43, 48, 57, 69, 78, 81, 85, 88, 94, 95, 100, 107, 109, 115, 116, 123, 124, 127, 129, 130, 132, 133, 137, 139, 140, 142, 143, 144, 157, 158]	['Gamma', '-', 'glutamyl', 'hydrolase', 'and', 'CFHR1', 'were', 'the', 'most', 'strongly', 'upregulated', 'proteins', 'in', 'the', 'TC', 'group', ',', 'with', 'ratios', '(', 'cancer', '/', 'control', ')', 'of', '4.669', 'and', '7.799', ',', 'respectively', '.']	[1, 1, 2, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Therefore, we selected six proteins (amyloid beta A4 protein, apolipoprotein A-IV, gelsolin, contactin-1, gamma-glutamyl hydrolase, and CFHR1) for further validation in tests with age- and sex-matched samples.	[('PMC7346861', 'R02003', 106, 130, 'gamma-glutamyl hydrolase')]	['Therefore', ',', 'we', 'selected', 'six', 'proteins', '(', 'amyloid', 'beta', 'A', '##4', 'protein', ',', 'apo', '##lip', '##oprotein', 'A', '-', 'IV', ',', 'gels', '##olin', ',', 'contact', '##in', '-', '1', ',', 'gamma', '-', 'glut', '##amyl', 'hydro', '##las', '##e', ',', 'and', 'CF', '##HR', '##1', ')', 'for', 'further', 'validation', 'in', 'tests', 'with', 'age', '-', 'and', 'sex', '-', 'matched', 'samples', '.']	[0, 9, 11, 14, 23, 27, 36, 37, 45, 50, 51, 53, 60, 62, 65, 68, 77, 78, 79, 81, 83, 87, 91, 93, 100, 102, 103, 104, 106, 111, 112, 116, 121, 126, 129, 130, 132, 136, 138, 140, 141, 143, 147, 155, 166, 169, 175, 180, 183, 185, 189, 192, 193, 201, 208]	[9, 10, 13, 22, 26, 35, 37, 44, 49, 51, 52, 60, 61, 65, 68, 76, 78, 79, 81, 82, 87, 91, 92, 100, 102, 103, 104, 105, 111, 112, 116, 120, 126, 129, 130, 131, 135, 138, 140, 141, 142, 146, 154, 165, 168, 174, 179, 183, 184, 188, 192, 193, 200, 208, 209]	['Therefore', ',', 'we', 'selected', 'six', 'proteins', '(', 'amyloid', 'beta', 'A4', 'protein', ',', 'apolipoprotein', 'A-IV', ',', 'gelsolin', ',', 'contactin-1', ',', 'gamma', '-', 'glutamyl', 'hydrolase', ',', 'and', 'CFHR1', ')', 'for', 'further', 'validation', 'in', 'tests', 'with', 'age-', 'and', 'sex', '-', 'matched', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 3, 1, 2, 1, 4, 1, 1, 1, 2, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although there were significant differences in amyloid beta A4 protein, apolipoprotein A-IV, and gamma-glutamyl hydrolase expression levels among the five groups, the levels of these three biomarkers in patients with TNs were slightly higher than those in patients with PTC, as shown in Figs.	[('PMC7346861', 'R03003', 97, 121, 'gamma-glutamyl hydrolase')]	['Although', 'there', 'were', 'significant', 'differences', 'in', 'amyloid', 'beta', 'A', '##4', 'protein', ',', 'apo', '##lip', '##oprotein', 'A', '-', 'IV', ',', 'and', 'gamma', '-', 'glut', '##amyl', 'hydro', '##las', '##e', 'expression', 'levels', 'among', 'the', 'five', 'groups', ',', 'the', 'levels', 'of', 'these', 'three', 'biomarkers', 'in', 'patients', 'with', 'TN', '##s', 'were', 'slightly', 'higher', 'than', 'those', 'in', 'patients', 'with', 'PT', '##C', ',', 'as', 'shown', 'in', 'Figs', '.']	[0, 9, 15, 20, 32, 44, 47, 55, 60, 61, 63, 70, 72, 75, 78, 87, 88, 89, 91, 93, 97, 102, 103, 107, 112, 117, 120, 122, 133, 140, 146, 150, 155, 161, 163, 167, 174, 177, 183, 189, 200, 203, 212, 217, 219, 221, 226, 235, 242, 247, 253, 256, 265, 270, 272, 273, 275, 278, 284, 287, 291]	[8, 14, 19, 31, 43, 46, 54, 59, 61, 62, 70, 71, 75, 78, 86, 88, 89, 91, 92, 96, 102, 103, 107, 111, 117, 120, 121, 132, 139, 145, 149, 154, 161, 162, 166, 173, 176, 182, 188, 199, 202, 211, 216, 219, 220, 225, 234, 241, 246, 252, 255, 264, 269, 272, 273, 274, 277, 283, 286, 291, 292]	['Although', 'there', 'were', 'significant', 'differences', 'in', 'amyloid', 'beta', 'A4', 'protein', ',', 'apolipoprotein', 'A-IV', ',', 'and', 'gamma', '-', 'glutamyl', 'hydrolase', 'expression', 'levels', 'among', 'the', 'five', 'groups', ',', 'the', 'levels', 'of', 'these', 'three', 'biomarkers', 'in', 'patients', 'with', 'TNs', 'were', 'slightly', 'higher', 'than', 'those', 'in', 'patients', 'with', 'PTC', ',', 'as', 'shown', 'in', 'Figs', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 3, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After hydrolysis by ß-glucuronidase and sulfatase, and solid phase extraction, the sample was silylated and analyzed by gas chromatography-negative ion chemical ionization-tandem mass spectrometry (GC-NICI-MS/MS).	[('PMC7377154', 'A00004', 20, 35, 'ß-glucuronidase'), ('PMC7377154', 'A00004', 40, 49, 'sulfatase')]	['After', 'hydrolysis', 'by', 'ß', '-', 'gluc', '##uron', '##idase', 'and', 'sulf', '##atase', ',', 'and', 'solid', 'phase', 'extraction', ',', 'the', 'sample', 'was', 'sil', '##ylated', 'and', 'analyzed', 'by', 'gas', 'chromatography', '-', 'negative', 'ion', 'chemical', 'ionization', '-', 'tandem', 'mass', 'spectrometry', '(', 'GC', '-', 'NIC', '##I', '-', 'MS', '/', 'MS', ')', '.']	[0, 6, 17, 20, 21, 22, 26, 30, 36, 40, 44, 49, 51, 55, 61, 67, 77, 79, 83, 90, 94, 97, 104, 108, 117, 120, 124, 138, 139, 148, 152, 161, 171, 172, 179, 184, 197, 198, 200, 201, 204, 205, 206, 208, 209, 211, 212]	[5, 16, 19, 21, 22, 26, 30, 35, 39, 44, 49, 50, 54, 60, 66, 77, 78, 82, 89, 93, 97, 103, 107, 116, 119, 123, 138, 139, 147, 151, 160, 171, 172, 178, 183, 196, 198, 200, 201, 204, 205, 206, 208, 209, 211, 212, 213]	['After', 'hydrolysis', 'by', 'ß-glucuronidase', 'and', 'sulfatase', ',', 'and', 'solid', 'phase', 'extraction', ',', 'the', 'sample', 'was', 'silylated', 'and', 'analyzed', 'by', 'gas', 'chromatography', '-', 'negative', 'ion', 'chemical', 'ionization', '-', 'tandem', 'mass', 'spectrometry', '(', 'GC-NICI-MS', '/', 'MS', ')', '.']	[1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[38] Kalow W, Tang BK, Use of caffeine metabolite ratios to explore CYP1A2 and xanthine-oxidase activities, Clin Pharmacol Ther, 50 (1991) 508–519.	[('PMC7377154', 'F37000', 79, 95, 'xanthine-oxidase')]	['[', '38', ']', 'Kal', '##ow', 'W', ',', 'Tang', 'BK', ',', 'Use', 'of', 'caffeine', 'metabolite', 'ratios', 'to', 'explore', 'CYP', '##1', '##A', '##2', 'and', 'x', '##anth', '##ine', '-', 'oxidase', 'activities', ',', 'Clin', 'Pharmacol', 'Ther', ',', '50', '(', '1991', ')', '50', '##8', '–', '51', '##9', '.']	[0, 1, 3, 5, 8, 11, 12, 14, 19, 21, 23, 27, 30, 39, 50, 57, 60, 68, 71, 72, 73, 75, 79, 80, 84, 87, 88, 96, 106, 108, 113, 123, 127, 129, 132, 133, 137, 139, 141, 142, 143, 145, 146]	[1, 3, 4, 8, 10, 12, 13, 18, 21, 22, 26, 29, 38, 49, 56, 59, 67, 71, 72, 73, 74, 78, 80, 84, 87, 88, 95, 106, 107, 112, 122, 127, 128, 131, 133, 137, 138, 141, 142, 143, 145, 146, 147]	['[', '38', ']', 'Kalow', 'W', ',', 'Tang', 'BK', ',', 'Use', 'of', 'caffeine', 'metabolite', 'ratios', 'to', 'explore', 'CYP1A2', 'and', 'xanthine', '-', 'oxidase', 'activities', ',', 'Clin', 'Pharmacol', 'Ther', ',', '50', '(', '1991', ')', '508–', '519', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[47] Hecht SS, Berg JZ, Hochalter JB, Preferential glutathione conjugation of a reverse diol epoxide compared to a bay region diol epoxide of phenanthrene in human hepatocytes: relevance to molecular epidemiology studies of glutathione-S-transferase polymorphisms and cancer, Chem Res Toxicol, 22 (2009) 426–432.	[('PMC7377154', 'F46000', 224, 249, 'glutathione-S-transferase')]	['[', '47', ']', 'He', '##cht', 'SS', ',', 'Berg', 'J', '##Z', ',', 'Hoch', '##alt', '##er', 'JB', ',', 'Pref', '##erential', 'glutathione', 'conjugation', 'of', 'a', 'reverse', 'di', '##ol', 'ep', '##oxide', 'compared', 'to', 'a', 'ba', '##y', 'region', 'di', '##ol', 'ep', '##oxide', 'of', 'phen', '##anth', '##rene', 'in', 'human', 'hepatocytes', ':', 'relevance', 'to', 'molecular', 'epidemiology', 'studies', 'of', 'glutathione', '-', 'S', '-', 'transfer', '##ase', 'polymorphisms', 'and', 'cancer', ',', 'Chem', 'Res', 'Toxicol', ',', '22', '(', '2009', ')', '42', '##6', '–', '43', '##2', '.']	[0, 1, 3, 5, 7, 11, 13, 15, 20, 21, 22, 24, 28, 31, 34, 36, 38, 42, 51, 63, 75, 78, 80, 88, 90, 93, 95, 101, 110, 113, 115, 117, 119, 126, 128, 131, 133, 139, 142, 146, 150, 155, 158, 164, 175, 177, 187, 190, 200, 213, 221, 224, 235, 236, 237, 238, 246, 250, 264, 268, 274, 276, 281, 285, 292, 294, 297, 298, 302, 304, 306, 307, 308, 310, 311]	[1, 3, 4, 7, 10, 13, 14, 19, 21, 22, 23, 28, 31, 33, 36, 37, 42, 50, 62, 74, 77, 79, 87, 90, 92, 95, 100, 109, 112, 114, 117, 118, 125, 128, 130, 133, 138, 141, 146, 150, 154, 157, 163, 175, 176, 186, 189, 199, 212, 220, 223, 235, 236, 237, 238, 246, 249, 263, 267, 274, 275, 280, 284, 292, 293, 296, 298, 302, 303, 306, 307, 308, 310, 311, 312]	['[', '47', ']', 'Hecht', 'SS', ',', 'Berg', 'JZ', ',', 'Hochalter', 'JB', ',', 'Preferential', 'glutathione', 'conjugation', 'of', 'a', 'reverse', 'diol', 'epoxide', 'compared', 'to', 'a', 'bay', 'region', 'diol', 'epoxide', 'of', 'phenanthrene', 'in', 'human', 'hepatocytes', ':', 'relevance', 'to', 'molecular', 'epidemiology', 'studies', 'of', 'glutathione-S-transferase', 'polymorphisms', 'and', 'cancer', ',', 'Chem', 'Res', 'Toxicol', ',', '22', '(', '2009', ')', '426–', '432', '.']	[1, 1, 1, 2, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 2, 1, 2, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
β-Glucuronidase and arylsulfatase (from Helix pomatia) were obtained from Roche Diagnostics Corp. (Indianapolis, IN, USA).	[('PMC7377154', 'M00008', 0, 15, 'β-Glucuronidase'), ('PMC7377154', 'M00008', 20, 33, 'arylsulfatase')]	['β', '-', 'Gluc', '##uron', '##idase', 'and', 'aryl', '##sulf', '##atase', '(', 'from', 'Hel', '##ix', 'po', '##mat', '##ia', ')', 'were', 'obtained', 'from', 'Roche', 'Diagnostics', 'Corp', '.', '(', 'Indian', '##apolis', ',', 'IN', ',', 'USA', ')', '.']	[0, 1, 2, 6, 10, 16, 20, 24, 28, 34, 35, 40, 43, 46, 48, 51, 53, 55, 60, 69, 74, 80, 92, 96, 98, 99, 105, 111, 113, 115, 117, 120, 121]	[1, 2, 6, 10, 15, 19, 24, 28, 33, 35, 39, 43, 45, 48, 51, 53, 54, 59, 68, 73, 79, 91, 96, 97, 99, 105, 111, 112, 115, 116, 120, 121, 122]	['β-Glucuronidase', 'and', 'arylsulfatase', '(', 'from', 'Helix', 'pomatia', ')', 'were', 'obtained', 'from', 'Roche', 'Diagnostics', 'Corp', '.', '(', 'Indianapolis', ',', 'IN', ',', 'USA', ')', '.']	[5, 1, 3, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An aliquot of 1.0 mL urine was added to a 2.0 mL glass vial containing 1.0 mL of 0.5 M NaOAc buffer (pH 5), β-glucuronidase (1000 units) and arylsulfatase (8000 units), and 5 pmol of [13C6]Phe-1,2-D as internal standard.	[('PMC7377154', 'M02001', 108, 123, 'β-glucuronidase'), ('PMC7377154', 'M02001', 141, 154, 'arylsulfatase')]	['An', 'aliquot', 'of', '1', '.', '0', 'mL', 'urine', 'was', 'added', 'to', 'a', '2', '.', '0', 'mL', 'glass', 'via', '##l', 'containing', '1', '.', '0', 'mL', 'of', '0', '.', '5', 'M', 'Na', '##OAc', 'buffer', '(', 'pH', '5', ')', ',', 'β', '-', 'gluc', '##uron', '##idase', '(', '1000', 'units', ')', 'and', 'aryl', '##sulf', '##atase', '(', '800', '##0', 'units', ')', ',', 'and', '5', 'pmol', 'of', '[', '13', '##C', '##6', ']', 'Phe', '-', '1', ',', '2', '-', 'D', 'as', 'internal', 'standard', '.']	[0, 3, 11, 14, 15, 16, 18, 21, 27, 31, 37, 40, 42, 43, 44, 46, 49, 55, 58, 60, 71, 72, 73, 75, 78, 81, 82, 83, 85, 87, 89, 93, 100, 101, 104, 105, 106, 108, 109, 110, 114, 118, 124, 125, 130, 135, 137, 141, 145, 149, 155, 156, 159, 161, 166, 167, 169, 173, 175, 180, 183, 184, 186, 187, 188, 189, 192, 193, 194, 195, 196, 197, 199, 202, 211, 219]	[2, 10, 13, 15, 16, 17, 20, 26, 30, 36, 39, 41, 43, 44, 45, 48, 54, 58, 59, 70, 72, 73, 74, 77, 80, 82, 83, 84, 86, 89, 92, 99, 101, 103, 105, 106, 107, 109, 110, 114, 118, 123, 125, 129, 135, 136, 140, 145, 149, 154, 156, 159, 160, 166, 167, 168, 172, 174, 179, 182, 184, 186, 187, 188, 189, 192, 193, 194, 195, 196, 197, 198, 201, 210, 219, 220]	['An', 'aliquot', 'of', '1.0', 'mL', 'urine', 'was', 'added', 'to', 'a', '2.0', 'mL', 'glass', 'vial', 'containing', '1.0', 'mL', 'of', '0.5', 'M', 'NaOAc', 'buffer', '(', 'pH', '5', ')', ',', 'β-glucuronidase', '(', '1000', 'units', ')', 'and', 'arylsulfatase', '(', '8000', 'units', ')', ',', 'and', '5', 'pmol', 'of', '[13C6]Phe-1,2-D', 'as', 'internal', 'standard', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 12, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The depletion of circulating lysophosphatidylcholines in HCC patients might be attributed to their increased catabolism to lysophosphatidic acids by extracellular lysophospholipase D [18,21].	[('PMC7484529', 'D01003', 149, 182, 'extracellular lysophospholipase D')]	['The', 'depletion', 'of', 'circulating', 'lys', '##ophosph', '##atidyl', '##choline', '##s', 'in', 'HCC', 'patients', 'might', 'be', 'attributed', 'to', 'their', 'increased', 'cat', '##abolism', 'to', 'lys', '##ophosph', '##atid', '##ic', 'acids', 'by', 'extracellular', 'lys', '##ophosph', '##olip', '##ase', 'D', '[', '18', ',', '21', ']', '.']	[0, 4, 14, 17, 29, 32, 39, 45, 52, 54, 57, 61, 70, 76, 79, 90, 93, 99, 109, 112, 120, 123, 126, 133, 137, 140, 146, 149, 163, 166, 173, 177, 181, 183, 184, 186, 187, 189, 190]	[3, 13, 16, 28, 32, 39, 45, 52, 53, 56, 60, 69, 75, 78, 89, 92, 98, 108, 112, 119, 122, 126, 133, 137, 139, 145, 148, 162, 166, 173, 177, 180, 182, 184, 186, 187, 189, 190, 191]	['The', 'depletion', 'of', 'circulating', 'lysophosphatidylcholines', 'in', 'HCC', 'patients', 'might', 'be', 'attributed', 'to', 'their', 'increased', 'catabolism', 'to', 'lysophosphatidic', 'acids', 'by', 'extracellular', 'lysophospholipase', 'D', '[', '18', ',', '21', ']', '.']	[1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Increased serine levels might reflect increased glycolysis, as serine can act as an allosteric activator of pyruvate kinase 2 which is involved in the rate limiting step of converting phosphoenolpyruvate to pyruvate [14,15].	[('PMC7484529', 'D03003', 108, 125, 'pyruvate kinase 2')]	['Increased', 'serine', 'levels', 'might', 'reflect', 'increased', 'glycolysis', ',', 'as', 'serine', 'can', 'act', 'as', 'an', 'allo', '##ster', '##ic', 'activator', 'of', 'pyruvate', 'kinase', '2', 'which', 'is', 'involved', 'in', 'the', 'rate', 'limiting', 'step', 'of', 'converting', 'phospho', '##eno', '##l', '##pyr', '##uvate', 'to', 'pyruvate', '[', '14', ',', '15', ']', '.']	[0, 10, 17, 24, 30, 38, 48, 58, 60, 63, 70, 74, 78, 81, 84, 88, 92, 95, 105, 108, 117, 124, 126, 132, 135, 144, 147, 151, 156, 165, 170, 173, 184, 191, 194, 195, 198, 204, 207, 216, 217, 219, 220, 222, 223]	[9, 16, 23, 29, 37, 47, 58, 59, 62, 69, 73, 77, 80, 83, 88, 92, 94, 104, 107, 116, 123, 125, 131, 134, 143, 146, 150, 155, 164, 169, 172, 183, 191, 194, 195, 198, 203, 206, 215, 217, 219, 220, 222, 223, 224]	['Increased', 'serine', 'levels', 'might', 'reflect', 'increased', 'glycolysis', ',', 'as', 'serine', 'can', 'act', 'as', 'an', 'allosteric', 'activator', 'of', 'pyruvate', 'kinase', '2', 'which', 'is', 'involved', 'in', 'the', 'rate', 'limiting', 'step', 'of', 'converting', 'phosphoenolpyruvate', 'to', 'pyruvate', '[', '14', ',', '15', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We identified several mucin-binding proteins by performing a biomolecular interaction analysis of phosphoketolase, GroEL, elongation factor Tu (EF-Tu), phosphoglycerate kinase, transaldolase (transaldolase), and heat shock protein 20 (Hsp20).	[('PMC7499026', 'A00005', 98, 113, 'phosphoketolase'), ('PMC7499026', 'A00005', 152, 175, 'phosphoglycerate kinase'), ('PMC7499026', 'A00005', 177, 190, 'transaldolase'), ('PMC7499026', 'A00005', 192, 205, 'transaldolase')]	['We', 'identified', 'several', 'muc', '##in', '-', 'binding', 'proteins', 'by', 'performing', 'a', 'biom', '##olecular', 'interaction', 'analysis', 'of', 'phospho', '##ket', '##olas', '##e', ',', 'Gro', '##EL', ',', 'elongation', 'factor', 'Tu', '(', 'EF', '-', 'Tu', ')', ',', 'phospho', '##glycer', '##ate', 'kinase', ',', 'trans', '##ald', '##olas', '##e', '(', 'trans', '##ald', '##olas', '##e', ')', ',', 'and', 'heat', 'shock', 'protein', '20', '(', 'Hsp', '##20', ')', '.']	[0, 3, 14, 22, 25, 27, 28, 36, 45, 48, 59, 61, 65, 74, 86, 95, 98, 105, 108, 112, 113, 115, 118, 120, 122, 133, 140, 143, 144, 146, 147, 149, 150, 152, 159, 165, 169, 175, 177, 182, 185, 189, 191, 192, 197, 200, 204, 205, 206, 208, 212, 217, 223, 231, 234, 235, 238, 240, 241]	[2, 13, 21, 25, 27, 28, 35, 44, 47, 58, 60, 65, 73, 85, 94, 97, 105, 108, 112, 113, 114, 118, 120, 121, 132, 139, 142, 144, 146, 147, 149, 150, 151, 159, 165, 168, 175, 176, 182, 185, 189, 190, 192, 197, 200, 204, 205, 206, 207, 211, 216, 222, 230, 233, 235, 238, 240, 241, 242]	['We', 'identified', 'several', 'mucin', '-', 'binding', 'proteins', 'by', 'performing', 'a', 'biomolecular', 'interaction', 'analysis', 'of', 'phosphoketolase', ',', 'GroEL', ',', 'elongation', 'factor', 'Tu', '(', 'EF-Tu', ')', ',', 'phosphoglycerate', 'kinase', ',', 'transaldolase', '(', 'transaldolase', ')', ',', 'and', 'heat', 'shock', 'protein', '20', '(', 'Hsp20', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The recombinant GroEL and transaldolase proteins showed high binding affinities to mucin.	[('PMC7499026', 'A00006', 26, 39, 'transaldolase')]	['The', 'recombinant', 'Gro', '##EL', 'and', 'trans', '##ald', '##olas', '##e', 'proteins', 'showed', 'high', 'binding', 'affinities', 'to', 'muc', '##in', '.']	[0, 4, 16, 19, 22, 26, 31, 34, 38, 40, 49, 56, 61, 69, 80, 83, 86, 88]	[3, 15, 19, 21, 25, 31, 34, 38, 39, 48, 55, 60, 68, 79, 82, 86, 88, 89]	['The', 'recombinant', 'GroEL', 'and', 'transaldolase', 'proteins', 'showed', 'high', 'binding', 'affinities', 'to', 'mucin', '.']	[1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using the BIA-MS approach, mucin-binding cytoplasmic proteins (phosphoketolase, GroEL, EF-Tu, phosphoglycerate kinase, Tal, and Hsp20) were isolated from B. longum NCC2705 EV fractions.	[('PMC7499026', 'D03000', 63, 78, 'phosphoketolase'), ('PMC7499026', 'D03000', 94, 117, 'phosphoglycerate kinase')]	['Using', 'the', 'BI', '##A', '-', 'MS', 'approach', ',', 'muc', '##in', '-', 'binding', 'cytoplasmic', 'proteins', '(', 'phospho', '##ket', '##olas', '##e', ',', 'Gro', '##EL', ',', 'EF', '-', 'Tu', ',', 'phospho', '##glycer', '##ate', 'kinase', ',', 'Tal', ',', 'and', 'Hsp', '##20', ')', 'were', 'isolated', 'from', 'B', '.', 'long', '##um', 'NC', '##C', '##27', '##05', 'EV', 'fractions', '.']	[0, 6, 10, 12, 13, 14, 17, 25, 27, 30, 32, 33, 41, 53, 62, 63, 70, 73, 77, 78, 80, 83, 85, 87, 89, 90, 92, 94, 101, 107, 111, 117, 119, 122, 124, 128, 131, 133, 135, 140, 149, 154, 155, 157, 161, 164, 166, 167, 169, 172, 175, 184]	[5, 9, 12, 13, 14, 16, 25, 26, 30, 32, 33, 40, 52, 61, 63, 70, 73, 77, 78, 79, 83, 85, 86, 89, 90, 92, 93, 101, 107, 110, 117, 118, 122, 123, 127, 131, 133, 134, 139, 148, 153, 155, 156, 161, 163, 166, 167, 169, 171, 174, 184, 185]	['Using', 'the', 'BIA-MS', 'approach', ',', 'mucin', '-', 'binding', 'cytoplasmic', 'proteins', '(', 'phosphoketolase', ',', 'GroEL', ',', 'EF-Tu', ',', 'phosphoglycerate', 'kinase', ',', 'Tal', ',', 'and', 'Hsp20', ')', 'were', 'isolated', 'from', 'B', '.', 'longum', 'NCC2705', 'EV', 'fractions', '.']	[1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Some of these proteins (particularly, transaldolase and GroEL) exert additional functions, such as adhesion to the host mucosal surface, which might promote the colonization of B. longum in the GI tract as an “adhesive moonlighting protein” (45).	[('PMC7499026', 'D03002', 38, 51, 'transaldolase')]	['Some', 'of', 'these', 'proteins', '(', 'particularly', ',', 'trans', '##ald', '##olas', '##e', 'and', 'Gro', '##EL', ')', 'exert', 'additional', 'functions', ',', 'such', 'as', 'adhesion', 'to', 'the', 'host', 'mucosal', 'surface', ',', 'which', 'might', 'promote', 'the', 'colonization', 'of', 'B', '.', 'long', '##um', 'in', 'the', 'GI', 'tract', 'as', 'an', '“', 'adhesive', 'mo', '##on', '##light', '##ing', 'protein', '”', '(', '45', ')', '.']	[0, 5, 8, 14, 23, 24, 36, 38, 43, 46, 50, 52, 56, 59, 61, 63, 69, 80, 89, 91, 96, 99, 108, 111, 115, 120, 128, 135, 137, 143, 149, 157, 161, 174, 177, 178, 180, 184, 187, 190, 194, 197, 203, 206, 209, 210, 219, 221, 223, 228, 232, 239, 241, 242, 244, 245]	[4, 7, 13, 22, 24, 36, 37, 43, 46, 50, 51, 55, 59, 61, 62, 68, 79, 89, 90, 95, 98, 107, 110, 114, 119, 127, 135, 136, 142, 148, 156, 160, 173, 176, 178, 179, 184, 186, 189, 193, 196, 202, 205, 208, 210, 218, 221, 223, 228, 231, 239, 240, 242, 244, 245, 246]	['Some', 'of', 'these', 'proteins', '(', 'particularly', ',', 'transaldolase', 'and', 'GroEL', ')', 'exert', 'additional', 'functions', ',', 'such', 'as', 'adhesion', 'to', 'the', 'host', 'mucosal', 'surface', ',', 'which', 'might', 'promote', 'the', 'colonization', 'of', 'B', '.', 'longum', 'in', 'the', 'GI', 'tract', 'as', 'an', '“', 'adhesive', 'moonlighting', 'protein', '”', '(', '45', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Specifically, B. bifidum A8 transaldolase promotes adhesion and aggregation to mucin (17), while Bifidobacterium animalis subsp.	[('PMC7499026', 'D03004', 28, 41, 'transaldolase')]	['Specifically', ',', 'B', '.', 'bif', '##id', '##um', 'A', '##8', 'trans', '##ald', '##olas', '##e', 'promotes', 'adhesion', 'and', 'aggregation', 'to', 'muc', '##in', '(', '17', ')', ',', 'while', 'Bi', '##fi', '##do', '##ba', '##ct', '##eri', '##um', 'animal', '##is', 'subsp', '.']	[0, 12, 14, 15, 17, 20, 22, 25, 26, 28, 33, 36, 40, 42, 51, 60, 64, 76, 79, 82, 85, 86, 88, 89, 91, 97, 99, 101, 103, 105, 107, 110, 113, 119, 122, 127]	[12, 13, 15, 16, 20, 22, 24, 26, 27, 33, 36, 40, 41, 50, 59, 63, 75, 78, 82, 84, 86, 88, 89, 90, 96, 99, 101, 103, 105, 107, 110, 112, 119, 121, 127, 128]	['Specifically', ',', 'B', '.', 'bifidum', 'A8', 'transaldolase', 'promotes', 'adhesion', 'and', 'aggregation', 'to', 'mucin', '(', '17', ')', ',', 'while', 'Bifidobacterium', 'animalis', 'subsp', '.']	[1, 1, 1, 1, 3, 2, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 7, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
enolase bind to surface-exposed human plasminogen (18, 19).	[('PMC7499026', 'D03007', 0, 7, 'enolase')]	['en', '##olas', '##e', 'bind', 'to', 'surface', '-', 'exposed', 'human', 'plasmin', '##ogen', '(', '18', ',', '19', ')', '.']	[0, 2, 6, 8, 13, 16, 23, 24, 32, 38, 45, 50, 51, 53, 55, 57, 58]	[2, 6, 7, 12, 15, 23, 24, 31, 37, 45, 49, 51, 53, 54, 57, 58, 59]	['enolase', 'bind', 'to', 'surface', '-', 'exposed', 'human', 'plasminogen', '(', '18', ',', '19', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions.	[('PMC7499026', 'F12002', 8, 15, 'sortase')]	['Role', 'of', 'sort', '##ase', '-', 'dependent', 'pil', '##i', 'of', 'Bi', '##fi', '##do', '##ba', '##ct', '##eri', '##um', 'bif', '##id', '##um', 'PRL', '##201', '##0', 'in', 'modulating', 'bacterium', '-', 'host', 'interactions', '.']	[0, 5, 8, 12, 15, 16, 26, 29, 31, 34, 36, 38, 40, 42, 44, 47, 50, 53, 55, 58, 61, 64, 66, 69, 80, 89, 90, 95, 107]	[4, 7, 12, 15, 16, 25, 29, 30, 33, 36, 38, 40, 42, 44, 47, 49, 53, 55, 57, 61, 64, 65, 68, 79, 89, 90, 94, 107, 108]	['Role', 'of', 'sortase', '-', 'dependent', 'pili', 'of', 'Bifidobacterium', 'bifidum', 'PRL2010', 'in', 'modulating', 'bacterium', '-', 'host', 'interactions', '.']	[1, 1, 2, 1, 1, 2, 1, 7, 3, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The sortase-dependent fimbriome of the genus bifidobacterium: extracellular structures with potential to modulate microbe-host fialogue.	[('PMC7499026', 'F14002', 4, 11, 'sortase')]	['The', 'sort', '##ase', '-', 'dependent', 'fi', '##mb', '##rio', '##me', 'of', 'the', 'genus', 'bif', '##ido', '##ba', '##ct', '##eri', '##um', ':', 'extracellular', 'structures', 'with', 'potential', 'to', 'modulate', 'microb', '##e', '-', 'host', 'fi', '##alo', '##gue', '.']	[0, 4, 8, 11, 12, 22, 24, 26, 29, 32, 35, 39, 45, 48, 51, 53, 55, 58, 60, 62, 76, 87, 92, 102, 105, 114, 120, 121, 122, 127, 129, 132, 135]	[3, 8, 11, 12, 21, 24, 26, 29, 31, 34, 38, 44, 48, 51, 53, 55, 58, 60, 61, 75, 86, 91, 101, 104, 113, 120, 121, 122, 126, 129, 132, 135, 136]	['The', 'sortase', '-', 'dependent', 'fimbriome', 'of', 'the', 'genus', 'bifidobacterium', ':', 'extracellular', 'structures', 'with', 'potential', 'to', 'modulate', 'microbe', '-', 'host', 'fialogue', '.']	[1, 2, 1, 1, 4, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1]	['O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bifidobacterium bifidum extracellular sialidase enhances adhesion to the mucosal surface and supports carbohydrate assimilation.	[('PMC7499026', 'F15002', 38, 47, 'sialidase')]	['Bi', '##fi', '##do', '##ba', '##ct', '##eri', '##um', 'bif', '##id', '##um', 'extracellular', 'sial', '##idase', 'enhances', 'adhesion', 'to', 'the', 'mucosal', 'surface', 'and', 'supports', 'carbohydrate', 'assimilation', '.']	[0, 2, 4, 6, 8, 10, 13, 16, 19, 21, 24, 38, 42, 48, 57, 66, 69, 73, 81, 89, 93, 102, 115, 127]	[2, 4, 6, 8, 10, 13, 15, 19, 21, 23, 37, 42, 47, 56, 65, 68, 72, 80, 88, 92, 101, 114, 127, 128]	['Bifidobacterium', 'bifidum', 'extracellular', 'sialidase', 'enhances', 'adhesion', 'to', 'the', 'mucosal', 'surface', 'and', 'supports', 'carbohydrate', 'assimilation', '.']	[7, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation.	[('PMC7499026', 'F16002', 22, 35, 'transaldolase')]	['Role', 'of', 'extracellular', 'trans', '##ald', '##olas', '##e', 'from', 'Bi', '##fi', '##do', '##ba', '##ct', '##eri', '##um', 'bif', '##id', '##um', 'in', 'muc', '##in', 'adhesion', 'and', 'aggregation', '.']	[0, 5, 8, 22, 27, 30, 34, 36, 41, 43, 45, 47, 49, 51, 54, 57, 60, 62, 65, 68, 71, 74, 83, 87, 98]	[4, 7, 21, 27, 30, 34, 35, 40, 43, 45, 47, 49, 51, 54, 56, 60, 62, 64, 67, 71, 73, 82, 86, 98, 99]	['Role', 'of', 'extracellular', 'transaldolase', 'from', 'Bifidobacterium', 'bifidum', 'in', 'mucin', 'adhesion', 'and', 'aggregation', '.']	[1, 1, 1, 4, 1, 7, 3, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bifidobacterial enolase, a cell surface receptor for human plasminogen involved in the interaction with the host.	[('PMC7499026', 'F17002', 16, 23, 'enolase')]	['Bi', '##fi', '##do', '##ba', '##ct', '##eri', '##al', 'en', '##olas', '##e', ',', 'a', 'cell', 'surface', 'receptor', 'for', 'human', 'plasmin', '##ogen', 'involved', 'in', 'the', 'interaction', 'with', 'the', 'host', '.']	[0, 2, 4, 6, 8, 10, 13, 16, 18, 22, 23, 25, 27, 32, 40, 49, 53, 59, 66, 71, 80, 83, 87, 99, 104, 108, 112]	[2, 4, 6, 8, 10, 13, 15, 18, 22, 23, 24, 26, 31, 39, 48, 52, 58, 66, 70, 79, 82, 86, 98, 103, 107, 112, 113]	['Bifidobacterial', 'enolase', ',', 'a', 'cell', 'surface', 'receptor', 'for', 'human', 'plasminogen', 'involved', 'in', 'the', 'interaction', 'with', 'the', 'host', '.']	[7, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae.	[('PMC7499026', 'F27002', 44, 66, 'pyruvate dehydrogenase')]	['El', '##ong', '##ation', 'factor', 'Tu', 'and', 'E', '##1', 'beta', 'subunit', 'of', 'pyruvate', 'dehydrogenase', 'complex', 'act', 'as', 'fibronectin', 'binding', 'proteins', 'in', 'Myc', '##oplasma', 'pneumoniae', '.']	[0, 2, 5, 11, 18, 21, 25, 26, 28, 33, 41, 44, 53, 67, 75, 79, 82, 94, 102, 111, 114, 117, 125, 135]	[2, 5, 10, 17, 20, 24, 26, 27, 32, 40, 43, 52, 66, 74, 78, 81, 93, 101, 110, 113, 117, 124, 135, 136]	['Elongation', 'factor', 'Tu', 'and', 'E1', 'beta', 'subunit', 'of', 'pyruvate', 'dehydrogenase', 'complex', 'act', 'as', 'fibronectin', 'binding', 'proteins', 'in', 'Mycoplasma', 'pneumoniae', '.']	[3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Identification of the actin and plasminogen binding regions of group B streptococcal phosphoglycerate kinase.	[('PMC7499026', 'F34002', 85, 108, 'phosphoglycerate kinase')]	['Identification', 'of', 'the', 'actin', 'and', 'plasmin', '##ogen', 'binding', 'regions', 'of', 'group', 'B', 'strept', '##ococcal', 'phospho', '##glycer', '##ate', 'kinase', '.']	[0, 15, 18, 22, 28, 32, 39, 44, 52, 60, 63, 69, 71, 77, 85, 92, 98, 102, 108]	[14, 17, 21, 27, 31, 39, 43, 51, 59, 62, 68, 70, 77, 84, 92, 98, 101, 108, 109]	['Identification', 'of', 'the', 'actin', 'and', 'plasminogen', 'binding', 'regions', 'of', 'group', 'B', 'streptococcal', 'phosphoglycerate', 'kinase', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Various types of bifidobacterial extracellular appendages promote adherence to the host mucosal surface, such as fimbriae (12,–15), exo-alpha-sialidase (16), transaldolase (transaldolase) (17), enolase (18), and DnaK (19).	[('PMC7499026', 'I01002', 132, 151, 'exo-alpha-sialidase'), ('PMC7499026', 'I01002', 158, 171, 'transaldolase'), ('PMC7499026', 'I01002', 173, 186, 'transaldolase'), ('PMC7499026', 'I01002', 194, 201, 'enolase')]	['Various', 'types', 'of', 'bif', '##ido', '##ba', '##ct', '##eri', '##al', 'extracellular', 'append', '##ages', 'promote', 'adherence', 'to', 'the', 'host', 'mucosal', 'surface', ',', 'such', 'as', 'fi', '##mb', '##ria', '##e', '(', '12', ',', '–', '15', ')', ',', 'ex', '##o', '-', 'alpha', '-', 'sial', '##idase', '(', '16', ')', ',', 'trans', '##ald', '##olas', '##e', '(', 'trans', '##ald', '##olas', '##e', ')', '(', '17', ')', ',', 'en', '##olas', '##e', '(', '18', ')', ',', 'and', 'Dn', '##a', '##K', '(', '19', ')', '.']	[0, 8, 14, 17, 20, 23, 25, 27, 30, 33, 47, 53, 58, 66, 76, 79, 83, 88, 96, 103, 105, 110, 113, 115, 117, 120, 122, 123, 125, 126, 127, 129, 130, 132, 134, 135, 136, 141, 142, 146, 152, 153, 155, 156, 158, 163, 166, 170, 172, 173, 178, 181, 185, 186, 188, 189, 191, 192, 194, 196, 200, 202, 203, 205, 206, 208, 212, 214, 215, 217, 218, 220, 221]	[7, 13, 16, 20, 23, 25, 27, 30, 32, 46, 53, 57, 65, 75, 78, 82, 87, 95, 103, 104, 109, 112, 115, 117, 120, 121, 123, 125, 126, 127, 129, 130, 131, 134, 135, 136, 141, 142, 146, 151, 153, 155, 156, 157, 163, 166, 170, 171, 173, 178, 181, 185, 186, 187, 189, 191, 192, 193, 196, 200, 201, 203, 205, 206, 207, 211, 214, 215, 216, 218, 220, 221, 222]	['Various', 'types', 'of', 'bifidobacterial', 'extracellular', 'appendages', 'promote', 'adherence', 'to', 'the', 'host', 'mucosal', 'surface', ',', 'such', 'as', 'fimbriae', '(', '12', ',', '–15', ')', ',', 'exo-alpha-', 'sialidase', '(', '16', ')', ',', 'transaldolase', '(', 'transaldolase', ')', '(', '17', ')', ',', 'enolase', '(', '18', ')', ',', 'and', 'DnaK', '(', '19', ')', '.']	[1, 1, 1, 6, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 5, 2, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We then washed and incubated the membrane with alkaline phosphatase-conjugated goat anti-rabbit IgG (Sigma-Aldrich) diluted 1:1,000 in TBS-T for 1 h. After washing, we developed signals with a 5-bromo-4-chloro-3-indolylphosphate (BCIP)-nitroblue tetrazolium (NBT) liquid substrate system (Nacalai Tesque).	[('PMC7499026', 'M07003', 47, 67, 'alkaline phosphatase')]	['We', 'then', 'washed', 'and', 'incubated', 'the', 'membrane', 'with', 'alkaline', 'phosphatase', '-', 'conjugated', 'goat', 'anti', '-', 'rabbit', 'IgG', '(', 'Sigma', '-', 'Aldr', '##ich', ')', 'diluted', '1', ':', '1', ',', '000', 'in', 'TB', '##S', '-', 'T', 'for', '1', 'h', '.', 'After', 'washing', ',', 'we', 'developed', 'signals', 'with', 'a', '5', '-', 'brom', '##o', '-', '4', '-', 'chlor', '##o', '-', '3', '-', 'ind', '##oly', '##l', '##phosphate', '(', 'BC', '##IP', ')', '-', 'nitro', '##blue', 'tetra', '##zol', '##ium', '(', 'NB', '##T', ')', 'liquid', 'substrate', 'system', '(', 'Na', '##cal', '##ai', 'Tes', '##que', ')', '.']	[0, 3, 8, 15, 19, 29, 33, 42, 47, 56, 67, 68, 79, 84, 88, 89, 96, 100, 101, 106, 107, 111, 114, 116, 124, 125, 126, 127, 128, 132, 135, 137, 138, 139, 141, 145, 147, 148, 150, 156, 163, 165, 168, 178, 186, 191, 193, 194, 195, 199, 200, 201, 202, 203, 208, 209, 210, 211, 212, 215, 218, 219, 229, 230, 232, 234, 235, 236, 241, 246, 251, 254, 258, 259, 261, 262, 264, 271, 281, 288, 289, 291, 294, 297, 300, 303, 304]	[2, 7, 14, 18, 28, 32, 41, 46, 55, 67, 68, 78, 83, 88, 89, 95, 99, 101, 106, 107, 111, 114, 115, 123, 125, 126, 127, 128, 131, 134, 137, 138, 139, 140, 144, 146, 148, 149, 155, 163, 164, 167, 177, 185, 190, 192, 194, 195, 199, 200, 201, 202, 203, 208, 209, 210, 211, 212, 215, 218, 219, 228, 230, 232, 234, 235, 236, 241, 245, 251, 254, 257, 259, 261, 262, 263, 270, 280, 287, 289, 291, 294, 296, 300, 303, 304, 305]	['We', 'then', 'washed', 'and', 'incubated', 'the', 'membrane', 'with', 'alkaline', 'phosphatase', '-', 'conjugated', 'goat', 'anti-', 'rabbit', 'IgG', '(', 'Sigma-Aldrich', ')', 'diluted', '1', ':', '1', ',', '000', 'in', 'TBS-T', 'for', '1', 'h', '.', 'After', 'washing', ',', 'we', 'developed', 'signals', 'with', 'a', '5-bromo-4-chloro-3-indolylphosphate', '(BCIP)-nitroblue', 'tetrazolium', '(', 'NBT', ')', 'liquid', 'substrate', 'system', '(', 'Nacalai', 'Tesque', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 16, 7, 3, 1, 2, 1, 1, 1, 1, 1, 3, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genes (bl0959, groEL, tuf, pgk, tal, and bl0576) were amplified by PCR with Ex Taq DNA polymerase (TaKaRa BIO) using B. longum NCC2705 genomic DNA as a template (primer pairs are listed in Table S2).	[('PMC7499026', 'M09001', 79, 97, 'Taq DNA polymerase')]	['Genes', '(', 'bl', '##09', '##59', ',', 'gro', '##EL', ',', 'tu', '##f', ',', 'pg', '##k', ',', 'tal', ',', 'and', 'bl', '##05', '##76', ')', 'were', 'amplified', 'by', 'PCR', 'with', 'Ex', 'Taq', 'DNA', 'polymerase', '(', 'Ta', '##Ka', '##Ra', 'BI', '##O', ')', 'using', 'B', '.', 'long', '##um', 'NC', '##C', '##27', '##05', 'genomic', 'DNA', 'as', 'a', 'template', '(', 'primer', 'pairs', 'are', 'listed', 'in', 'Table', 'S', '##2', ')', '.']	[0, 6, 7, 9, 11, 13, 15, 18, 20, 22, 24, 25, 27, 29, 30, 32, 35, 37, 41, 43, 45, 47, 49, 54, 64, 67, 71, 76, 79, 83, 87, 98, 99, 101, 103, 106, 108, 109, 111, 117, 118, 120, 124, 127, 129, 130, 132, 135, 143, 147, 150, 152, 161, 162, 169, 175, 179, 186, 189, 195, 196, 197, 198]	[5, 7, 9, 11, 13, 14, 18, 20, 21, 24, 25, 26, 29, 30, 31, 35, 36, 40, 43, 45, 47, 48, 53, 63, 66, 70, 75, 78, 82, 86, 97, 99, 101, 103, 105, 108, 109, 110, 116, 118, 119, 124, 126, 129, 130, 132, 134, 142, 146, 149, 151, 160, 162, 168, 174, 178, 185, 188, 194, 196, 197, 198, 199]	['Genes', '(', 'bl0959', ',', 'groEL', ',', 'tuf', ',', 'pgk', ',', 'tal', ',', 'and', 'bl0576', ')', 'were', 'amplified', 'by', 'PCR', 'with', 'Ex', 'Taq', 'DNA', 'polymerase', '(', 'TaKaRa', 'BIO', ')', 'using', 'B', '.', 'longum', 'NCC2705', 'genomic', 'DNA', 'as', 'a', 'template', '(', 'primer', 'pairs', 'are', 'listed', 'in', 'Table', 'S2', ')', '.']	[1, 1, 3, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For the quantification of microbead fecal shedding, 100 μl of recombinant GroEL- or transaldolase-immobilized beads or control beads (approximately 108 particles) was administered per mouse by gavage.	[('PMC7499026', 'M14000', 84, 97, 'transaldolase')]	['For', 'the', 'quantification', 'of', 'microb', '##ead', 'fecal', 'shedding', ',', '100', 'μ', '##l', 'of', 'recombinant', 'Gro', '##EL', '-', 'or', 'trans', '##ald', '##olas', '##e', '-', 'immobilized', 'beads', 'or', 'control', 'beads', '(', 'approximately', '108', 'particles', ')', 'was', 'administered', 'per', 'mouse', 'by', 'ga', '##vage', '.']	[0, 4, 8, 23, 26, 32, 36, 42, 50, 52, 56, 57, 59, 62, 74, 77, 79, 81, 84, 89, 92, 96, 97, 98, 110, 116, 119, 127, 133, 134, 148, 152, 161, 163, 167, 180, 184, 190, 193, 195, 199]	[3, 7, 22, 25, 32, 35, 41, 50, 51, 55, 57, 58, 61, 73, 77, 79, 80, 83, 89, 92, 96, 97, 98, 109, 115, 118, 126, 132, 134, 147, 151, 161, 162, 166, 179, 183, 189, 192, 195, 199, 200]	['For', 'the', 'quantification', 'of', 'microbead', 'fecal', 'shedding', ',', '100', 'μl', 'of', 'recombinant', 'GroEL-', 'or', 'transaldolase', '-', 'immobilized', 'beads', 'or', 'control', 'beads', '(', 'approximately', '108', 'particles', ')', 'was', 'administered', 'per', 'mouse', 'by', 'gavage', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The membrane protein, phosphate ABC transporter permease (PstC, BL0314), was also detected in the KUHIMM broth-cultured B. longum NCC2705 EV fraction, yet was absent from the GAM-cultured EV fraction, indicating that the EV isolation procedure was successful (Fig. 2c).	[('PMC7499026', 'R01005', 22, 56, 'phosphate ABC transporter permease')]	['The', 'membrane', 'protein', ',', 'phosphate', 'ABC', 'transporter', 'perme', '##ase', '(', 'Ps', '##t', '##C', ',', 'BL', '##03', '##14', ')', ',', 'was', 'also', 'detected', 'in', 'the', 'K', '##U', '##HI', '##MM', 'broth', '-', 'cultured', 'B', '.', 'long', '##um', 'NC', '##C', '##27', '##05', 'EV', 'fraction', ',', 'yet', 'was', 'absent', 'from', 'the', 'GA', '##M', '-', 'cultured', 'EV', 'fraction', ',', 'indicating', 'that', 'the', 'EV', 'isolation', 'procedure', 'was', 'successful', '(', 'Fig', '.', '2', '##c', ')', '.']	[0, 4, 13, 20, 22, 32, 36, 48, 53, 57, 58, 60, 61, 62, 64, 66, 68, 70, 71, 73, 77, 82, 91, 94, 98, 99, 100, 102, 105, 110, 111, 120, 121, 123, 127, 130, 132, 133, 135, 138, 141, 149, 151, 155, 159, 166, 171, 175, 177, 178, 179, 188, 191, 199, 201, 212, 217, 221, 224, 234, 244, 248, 259, 260, 263, 265, 266, 267, 268]	[3, 12, 20, 21, 31, 35, 47, 53, 56, 58, 60, 61, 62, 63, 66, 68, 70, 71, 72, 76, 81, 90, 93, 97, 99, 100, 102, 104, 110, 111, 119, 121, 122, 127, 129, 132, 133, 135, 137, 140, 149, 150, 154, 158, 165, 170, 174, 177, 178, 179, 187, 190, 199, 200, 211, 216, 220, 223, 233, 243, 247, 258, 260, 263, 264, 266, 267, 268, 269]	['The', 'membrane', 'protein', ',', 'phosphate', 'ABC', 'transporter', 'permease', '(', 'PstC', ',', 'BL0314', ')', ',', 'was', 'also', 'detected', 'in', 'the', 'KUHIMM', 'broth', '-', 'cultured', 'B', '.', 'longum', 'NCC2705', 'EV', 'fraction', ',', 'yet', 'was', 'absent', 'from', 'the', 'GAM-cultured', 'EV', 'fraction', ',', 'indicating', 'that', 'the', 'EV', 'isolation', 'procedure', 'was', 'successful', '(', 'Fig', '.', '2c', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
include chaperone GroEL, EF-Tu, phosphoglycerate kinase (phosphoglycerate kinase), transaldolase, and heat shock protein 20 (Hsp20), all of which have previously described roles in commensal or pathogenic bacterial colonization (17, 28,–36).	[('PMC7499026', 'R03009', 32, 55, 'phosphoglycerate kinase'), ('PMC7499026', 'R03009', 57, 80, 'phosphoglycerate kinase'), ('PMC7499026', 'R03009', 83, 96, 'transaldolase')]	['include', 'chaperone', 'Gro', '##EL', ',', 'EF', '-', 'Tu', ',', 'phospho', '##glycer', '##ate', 'kinase', '(', 'phospho', '##glycer', '##ate', 'kinase', ')', ',', 'trans', '##ald', '##olas', '##e', ',', 'and', 'heat', 'shock', 'protein', '20', '(', 'Hsp', '##20', ')', ',', 'all', 'of', 'which', 'have', 'previously', 'described', 'roles', 'in', 'commens', '##al', 'or', 'pathogenic', 'bacterial', 'colonization', '(', '17', ',', '28', ',', '–', '36', ')', '.']	[0, 8, 18, 21, 23, 25, 27, 28, 30, 32, 39, 45, 49, 56, 57, 64, 70, 74, 80, 81, 83, 88, 91, 95, 96, 98, 102, 107, 113, 121, 124, 125, 128, 130, 131, 133, 137, 140, 146, 151, 162, 172, 178, 181, 188, 191, 194, 205, 215, 228, 229, 231, 233, 235, 236, 237, 239, 240]	[7, 17, 21, 23, 24, 27, 28, 30, 31, 39, 45, 48, 55, 57, 64, 70, 73, 80, 81, 82, 88, 91, 95, 96, 97, 101, 106, 112, 120, 123, 125, 128, 130, 131, 132, 136, 139, 145, 150, 161, 171, 177, 180, 188, 190, 193, 204, 214, 227, 229, 231, 232, 235, 236, 237, 239, 240, 241]	['include', 'chaperone', 'GroEL', ',', 'EF-Tu', ',', 'phosphoglycerate', 'kinase', '(', 'phosphoglycerate', 'kinase', ')', ',', 'transaldolase', ',', 'and', 'heat', 'shock', 'protein', '20', '(', 'Hsp20', ')', ',', 'all', 'of', 'which', 'have', 'previously', 'described', 'roles', 'in', 'commensal', 'or', 'pathogenic', 'bacterial', 'colonization', '(', '17', ',', '28', ',', '–36', ')', '.']	[1, 1, 2, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Additionally, we selected the most abundant phosphoketolase (phosphoketolase) as a candidate binding protein.	[('PMC7499026', 'R03010', 44, 59, 'phosphoketolase'), ('PMC7499026', 'R03010', 61, 76, 'phosphoketolase')]	['Additionally', ',', 'we', 'selected', 'the', 'most', 'abundant', 'phospho', '##ket', '##olas', '##e', '(', 'phospho', '##ket', '##olas', '##e', ')', 'as', 'a', 'candidate', 'binding', 'protein', '.']	[0, 12, 14, 17, 26, 30, 35, 44, 51, 54, 58, 60, 61, 68, 71, 75, 76, 78, 81, 83, 93, 101, 108]	[12, 13, 16, 25, 29, 34, 43, 51, 54, 58, 59, 61, 68, 71, 75, 76, 77, 80, 82, 92, 100, 108, 109]	['Additionally', ',', 'we', 'selected', 'the', 'most', 'abundant', 'phosphoketolase', '(', 'phosphoketolase', ')', 'as', 'a', 'candidate', 'binding', 'protein', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These proteins have known functions in essential cellular processes—for example, transaldolase and phosphoketolase are enzymes in the pentose phosphate pathway, GroEL and Hsp20 are molecular chaperones, EF-Tu contributes to protein synthesis, and PGK is involved in glycolysis and energy generation.	[('PMC7499026', 'R03011', 81, 94, 'transaldolase'), ('PMC7499026', 'R03011', 99, 114, 'phosphoketolase')]	['These', 'proteins', 'have', 'known', 'functions', 'in', 'essential', 'cellular', 'processes', '—', 'for', 'example', ',', 'trans', '##ald', '##olas', '##e', 'and', 'phospho', '##ket', '##olas', '##e', 'are', 'enzymes', 'in', 'the', 'pent', '##ose', 'phosphate', 'pathway', ',', 'Gro', '##EL', 'and', 'Hsp', '##20', 'are', 'molecular', 'chaperone', '##s', ',', 'EF', '-', 'Tu', 'contributes', 'to', 'protein', 'synthesis', ',', 'and', 'PG', '##K', 'is', 'involved', 'in', 'glycolysis', 'and', 'energy', 'generation', '.']	[0, 6, 15, 20, 26, 36, 39, 49, 58, 67, 68, 72, 79, 81, 86, 89, 93, 95, 99, 106, 109, 113, 115, 119, 127, 130, 134, 138, 142, 152, 159, 161, 164, 167, 171, 174, 177, 181, 191, 200, 201, 203, 205, 206, 209, 221, 224, 232, 241, 243, 247, 249, 251, 254, 263, 266, 277, 281, 288, 298]	[5, 14, 19, 25, 35, 38, 48, 57, 67, 68, 71, 79, 80, 86, 89, 93, 94, 98, 106, 109, 113, 114, 118, 126, 129, 133, 138, 141, 151, 159, 160, 164, 166, 170, 174, 176, 180, 190, 200, 201, 202, 205, 206, 208, 220, 223, 231, 241, 242, 246, 249, 250, 253, 262, 265, 276, 280, 287, 298, 299]	['These', 'proteins', 'have', 'known', 'functions', 'in', 'essential', 'cellular', 'processes', '—', 'for', 'example', ',', 'transaldolase', 'and', 'phosphoketolase', 'are', 'enzymes', 'in', 'the', 'pentose', 'phosphate', 'pathway', ',', 'GroEL', 'and', 'Hsp20', 'are', 'molecular', 'chaperones', ',', 'EF-Tu', 'contributes', 'to', 'protein', 'synthesis', ',', 'and', 'PGK', 'is', 'involved', 'in', 'glycolysis', 'and', 'energy', 'generation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
GroEL and transaldolase showed high binding affinities to PGM.	[('PMC7499026', 'R04004', 10, 23, 'transaldolase')]	['Gro', '##EL', 'and', 'trans', '##ald', '##olas', '##e', 'showed', 'high', 'binding', 'affinities', 'to', 'PG', '##M', '.']	[0, 3, 6, 10, 15, 18, 22, 24, 31, 36, 44, 55, 58, 60, 61]	[3, 5, 9, 15, 18, 22, 23, 30, 35, 43, 54, 57, 60, 61, 62]	['GroEL', 'and', 'transaldolase', 'showed', 'high', 'binding', 'affinities', 'to', 'PGM', '.']	[2, 1, 4, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, phosphoketolase and Hsp20 exhibited more durable binding to the blank cell (nonimmobilized) than to the mucin-immobilized flow cell, with negative RUs (Fig. 4c).	[('PMC7499026', 'R04005', 13, 28, 'phosphoketolase')]	['In', 'contrast', ',', 'phospho', '##ket', '##olas', '##e', 'and', 'Hsp', '##20', 'exhibited', 'more', 'dur', '##able', 'binding', 'to', 'the', 'blank', 'cell', '(', 'non', '##imm', '##obil', '##ized', ')', 'than', 'to', 'the', 'muc', '##in', '-', 'immobilized', 'flow', 'cell', ',', 'with', 'negative', 'RU', '##s', '(', 'Fig', '.', '4', '##c', ')', '.']	[0, 3, 11, 13, 20, 23, 27, 29, 33, 36, 39, 49, 54, 57, 62, 70, 73, 77, 83, 88, 89, 92, 95, 99, 103, 105, 110, 113, 117, 120, 122, 123, 135, 140, 144, 146, 151, 160, 162, 164, 165, 168, 170, 171, 172, 173]	[2, 11, 12, 20, 23, 27, 28, 32, 36, 38, 48, 53, 57, 61, 69, 72, 76, 82, 87, 89, 92, 95, 99, 103, 104, 109, 112, 116, 120, 122, 123, 134, 139, 144, 145, 150, 159, 162, 163, 165, 168, 169, 171, 172, 173, 174]	['In', 'contrast', ',', 'phosphoketolase', 'and', 'Hsp20', 'exhibited', 'more', 'durable', 'binding', 'to', 'the', 'blank', 'cell', '(', 'nonimmobilized', ')', 'than', 'to', 'the', 'mucin', '-', 'immobilized', 'flow', 'cell', ',', 'with', 'negative', 'RUs', '(', 'Fig', '.', '4c', ')', '.']	[1, 1, 1, 4, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Therefore, among the six proteins, GroEL, EF-Tu, phosphoglycerate kinase, and transaldolase were identified as the candidate mucin-binding proteins, while PK and Hsp20 were postulated to likely interact with the CM5 dextran surface rather than PGM.	[('PMC7499026', 'R04006', 49, 72, 'phosphoglycerate kinase'), ('PMC7499026', 'R04006', 78, 91, 'transaldolase')]	['Therefore', ',', 'among', 'the', 'six', 'proteins', ',', 'Gro', '##EL', ',', 'EF', '-', 'Tu', ',', 'phospho', '##glycer', '##ate', 'kinase', ',', 'and', 'trans', '##ald', '##olas', '##e', 'were', 'identified', 'as', 'the', 'candidate', 'muc', '##in', '-', 'binding', 'proteins', ',', 'while', 'PK', 'and', 'Hsp', '##20', 'were', 'postulated', 'to', 'likely', 'interact', 'with', 'the', 'CM', '##5', 'dex', '##tran', 'surface', 'rather', 'than', 'PG', '##M', '.']	[0, 9, 11, 17, 21, 25, 33, 35, 38, 40, 42, 44, 45, 47, 49, 56, 62, 66, 72, 74, 78, 83, 86, 90, 92, 97, 108, 111, 115, 125, 128, 130, 131, 139, 147, 149, 155, 158, 162, 165, 168, 173, 184, 187, 194, 203, 208, 212, 214, 216, 219, 224, 232, 239, 244, 246, 247]	[9, 10, 16, 20, 24, 33, 34, 38, 40, 41, 44, 45, 47, 48, 56, 62, 65, 72, 73, 77, 83, 86, 90, 91, 96, 107, 110, 114, 124, 128, 130, 131, 138, 147, 148, 154, 157, 161, 165, 167, 172, 183, 186, 193, 202, 207, 211, 214, 215, 219, 223, 231, 238, 243, 246, 247, 248]	['Therefore', ',', 'among', 'the', 'six', 'proteins', ',', 'GroEL', ',', 'EF-Tu', ',', 'phosphoglycerate', 'kinase', ',', 'and', 'transaldolase', 'were', 'identified', 'as', 'the', 'candidate', 'mucin', '-', 'binding', 'proteins', ',', 'while', 'PK', 'and', 'Hsp20', 'were', 'postulated', 'to', 'likely', 'interact', 'with', 'the', 'CM5', 'dextran', 'surface', 'rather', 'than', 'PGM', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In particular, GroEL- and transaldolase-immobilized microbeads exhibited diffusion throughout the stomach up to the rectum.	[('PMC7499026', 'R05004', 26, 39, 'transaldolase')]	['In', 'particular', ',', 'Gro', '##EL', '-', 'and', 'trans', '##ald', '##olas', '##e', '-', 'immobilized', 'microb', '##ead', '##s', 'exhibited', 'diffusion', 'throughout', 'the', 'stomach', 'up', 'to', 'the', 'rect', '##um', '.']	[0, 3, 13, 15, 18, 20, 22, 26, 31, 34, 38, 39, 40, 52, 58, 61, 63, 73, 83, 94, 98, 106, 109, 112, 116, 120, 122]	[2, 13, 14, 18, 20, 21, 25, 31, 34, 38, 39, 40, 51, 58, 61, 62, 72, 82, 93, 97, 105, 108, 111, 115, 120, 122, 123]	['In', 'particular', ',', 'GroEL-', 'and', 'transaldolase', '-', 'immobilized', 'microbeads', 'exhibited', 'diffusion', 'throughout', 'the', 'stomach', 'up', 'to', 'the', 'rectum', '.']	[1, 1, 1, 3, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sphingosine (Sph) can be generated under the action of ceramase and further be phosphorylated into S1P by Sphingosine kinase 1 (sphingosine kinase 1) (Figure 1).	[('PMC7506152', 'D03001', 106, 126, 'Sphingosine kinase 1'), ('PMC7506152', 'D03001', 128, 148, 'sphingosine kinase 1')]	['Sp', '##hing', '##osine', '(', 'Sp', '##h', ')', 'can', 'be', 'generated', 'under', 'the', 'action', 'of', 'cer', '##ama', '##se', 'and', 'further', 'be', 'phosphorylated', 'into', 'S', '##1', '##P', 'by', 'Sp', '##hing', '##osine', 'kinase', '1', '(', 'sphing', '##osine', 'kinase', '1', ')', '(', 'Figure', '1', ')', '.']	[0, 2, 6, 12, 13, 15, 16, 18, 22, 25, 35, 41, 45, 52, 55, 58, 61, 64, 68, 76, 79, 94, 99, 100, 101, 103, 106, 108, 112, 118, 125, 127, 128, 134, 140, 147, 148, 150, 151, 158, 159, 160]	[2, 6, 11, 13, 15, 16, 17, 21, 24, 34, 40, 44, 51, 54, 58, 61, 63, 67, 75, 78, 93, 98, 100, 101, 102, 105, 108, 112, 117, 124, 126, 128, 134, 139, 146, 148, 149, 151, 157, 159, 160, 161]	['Sphingosine', '(', 'Sph', ')', 'can', 'be', 'generated', 'under', 'the', 'action', 'of', 'ceramase', 'and', 'further', 'be', 'phosphorylated', 'into', 'S1P', 'by', 'Sphingosine', 'kinase', '1', '(', 'sphingosine', 'kinase', '1', ')', '(', 'Figure', '1', ')', '.']	[3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, inhibiting the activation of sphingosine kinase could promote the apoptosis of HCC cells (40).	[('PMC7506152', 'D03005', 42, 60, 'sphingosine kinase')]	['In', 'addition', ',', 'inhibiting', 'the', 'activation', 'of', 'sphing', '##osine', 'kinase', 'could', 'promote', 'the', 'apoptosis', 'of', 'HCC', 'cells', '(', '40', ')', '.']	[0, 3, 11, 13, 24, 28, 39, 42, 48, 54, 61, 67, 75, 79, 89, 92, 96, 102, 103, 105, 106]	[2, 11, 12, 23, 27, 38, 41, 48, 53, 60, 66, 74, 78, 88, 91, 95, 101, 103, 105, 106, 107]	['In', 'addition', ',', 'inhibiting', 'the', 'activation', 'of', 'sphingosine', 'kinase', 'could', 'promote', 'the', 'apoptosis', 'of', 'HCC', 'cells', '(', '40', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level.	[('PMC7506152', 'F13002', 122, 146, 'alanine aminotransferase')]	['Plasma', 'sphing', '##olipid', '##s', 'as', 'potential', 'indicators', 'of', 'hepatic', 'nec', '##ro', '##infl', '##amma', '##tion', 'in', 'patients', 'with', 'chronic', 'hepatitis', 'C', 'and', 'normal', 'alanine', 'amino', '##transferase', 'level', '.']	[0, 7, 13, 19, 21, 24, 34, 45, 48, 56, 59, 61, 65, 69, 74, 77, 86, 91, 99, 109, 111, 115, 122, 130, 135, 147, 152]	[6, 13, 19, 20, 23, 33, 44, 47, 55, 59, 61, 65, 69, 73, 76, 85, 90, 98, 108, 110, 114, 121, 129, 135, 146, 152, 153]	['Plasma', 'sphingolipids', 'as', 'potential', 'indicators', 'of', 'hepatic', 'necroinflammation', 'in', 'patients', 'with', 'chronic', 'hepatitis', 'C', 'and', 'normal', 'alanine', 'aminotransferase', 'level', '.']	[1, 3, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Increased mrna levels of sphingosine kinases and S1P lyase and reduced levels of S1P were observed in hepatocellular carcinoma in association with poorer differentiation and earlier recurrence.	[('PMC7506152', 'F21002', 25, 44, 'sphingosine kinases'), ('PMC7506152', 'F21002', 49, 58, 'S1P lyase')]	['Increased', 'm', '##rn', '##a', 'levels', 'of', 'sphing', '##osine', 'kinases', 'and', 'S', '##1', '##P', 'ly', '##ase', 'and', 'reduced', 'levels', 'of', 'S', '##1', '##P', 'were', 'observed', 'in', 'hepatocellular', 'carcinoma', 'in', 'association', 'with', 'poorer', 'differentiation', 'and', 'earlier', 'recurrence', '.']	[0, 10, 11, 13, 15, 22, 25, 31, 37, 45, 49, 50, 51, 53, 55, 59, 63, 71, 78, 81, 82, 83, 85, 90, 99, 102, 117, 127, 130, 142, 147, 154, 170, 174, 182, 192]	[9, 11, 13, 14, 21, 24, 31, 36, 44, 48, 50, 51, 52, 55, 58, 62, 70, 77, 80, 82, 83, 84, 89, 98, 101, 116, 126, 129, 141, 146, 153, 169, 173, 181, 192, 193]	['Increased', 'mrna', 'levels', 'of', 'sphingosine', 'kinases', 'and', 'S1P', 'lyase', 'and', 'reduced', 'levels', 'of', 'S1P', 'were', 'observed', 'in', 'hepatocellular', 'carcinoma', 'in', 'association', 'with', 'poorer', 'differentiation', 'and', 'earlier', 'recurrence', '.']	[1, 3, 1, 1, 2, 1, 1, 3, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Identification of sphingosine kinase 1 (sphingosine kinase 1) as a primary target of icaritin in hepatocellular carcinoma cells.	[('PMC7506152', 'F39002', 18, 38, 'sphingosine kinase 1'), ('PMC7506152', 'F39002', 40, 60, 'sphingosine kinase 1')]	['Identification', 'of', 'sphing', '##osine', 'kinase', '1', '(', 'sphing', '##osine', 'kinase', '1', ')', 'as', 'a', 'primary', 'target', 'of', 'ic', '##ari', '##tin', 'in', 'hepatocellular', 'carcinoma', 'cells', '.']	[0, 15, 18, 24, 30, 37, 39, 40, 46, 52, 59, 60, 62, 65, 67, 75, 82, 85, 87, 90, 94, 97, 112, 122, 127]	[14, 17, 24, 29, 36, 38, 40, 46, 51, 58, 60, 61, 64, 66, 74, 81, 84, 87, 90, 93, 96, 111, 121, 127, 128]	['Identification', 'of', 'sphingosine', 'kinase', '1', '(', 'sphingosine', 'kinase', '1', ')', 'as', 'a', 'primary', 'target', 'of', 'icaritin', 'in', 'hepatocellular', 'carcinoma', 'cells', '.']	[1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Stahelin RV, Subramanian P, Vora M, Cho W, Chalfant CE.Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain.	[('PMC7506152', 'F40001', 92, 118, 'cytosolic phospholipase a2')]	['Sta', '##helin', 'RV', ',', 'Sub', '##ram', '##ania', '##n', 'P', ',', 'Vor', '##a', 'M', ',', 'Cho', 'W', ',', 'Cha', '##l', '##fan', '##t', 'CE', '.', 'Cer', '##amide', '-', '1', '-', 'phosphate', 'binds', 'group', 'IV', '##A', 'cytosolic', 'phospholip', '##ase', 'a', '##2', 'via', 'a', 'novel', 'site', 'in', 'the', 'C', '##2', 'domain', '.']	[0, 3, 9, 11, 13, 16, 19, 23, 25, 26, 28, 31, 33, 34, 36, 40, 41, 43, 46, 47, 50, 52, 54, 55, 58, 63, 64, 65, 66, 76, 82, 88, 90, 92, 102, 112, 116, 117, 119, 123, 125, 131, 136, 139, 143, 144, 146, 152]	[3, 8, 11, 12, 16, 19, 23, 24, 26, 27, 31, 32, 34, 35, 39, 41, 42, 46, 47, 50, 51, 54, 55, 58, 63, 64, 65, 66, 75, 81, 87, 90, 91, 101, 112, 115, 117, 118, 122, 124, 130, 135, 138, 142, 144, 145, 152, 153]	['Stahelin', 'RV', ',', 'Subramanian', 'P', ',', 'Vora', 'M', ',', 'Cho', 'W', ',', 'Chalfant', 'CE.Ceramide-1-phosphate', 'binds', 'group', 'IVA', 'cytosolic', 'phospholipase', 'a2', 'via', 'a', 'novel', 'site', 'in', 'the', 'C2', 'domain', '.']	[2, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 4, 8, 1, 1, 2, 1, 2, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured using an Olympus Automatic Biochemical Analyzer AU5400 (Olympus, Tokyo, Japan).	[('PMC7506152', 'M03000', 0, 24, 'Alanine aminotransferase'), ('PMC7506152', 'M03000', 35, 61, 'aspartate aminotransferase')]	['Ala', '##nine', 'amino', '##transferase', '(', 'ALT', ')', 'and', 'aspart', '##ate', 'amino', '##transferase', '(', 'AST', ')', 'were', 'measured', 'using', 'an', 'Ol', '##ymp', '##us', 'Automatic', 'Biochemical', 'Analy', '##zer', 'AU', '##54', '##00', '(', 'Ol', '##ymp', '##us', ',', 'Tokyo', ',', 'Japan', ')', '.']	[0, 3, 8, 13, 25, 26, 29, 31, 35, 41, 45, 50, 62, 63, 66, 68, 73, 82, 88, 91, 93, 96, 99, 109, 121, 126, 130, 132, 134, 137, 138, 140, 143, 145, 147, 152, 154, 159, 160]	[3, 7, 13, 24, 26, 29, 30, 34, 41, 44, 50, 61, 63, 66, 67, 72, 81, 87, 90, 93, 96, 98, 108, 120, 126, 129, 132, 134, 136, 138, 140, 143, 145, 146, 152, 153, 159, 160, 161]	['Alanine', 'aminotransferase', '(', 'ALT', ')', 'and', 'aspartate', 'aminotransferase', '(', 'AST', ')', 'were', 'measured', 'using', 'an', 'Olympus', 'Automatic', 'Biochemical', 'Analyzer', 'AU5400', '(', 'Olympus', ',', 'Tokyo', ',', 'Japan', ')', '.']	[2, 2, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 3, 1, 3, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Various non-invasive markers, such as model for end-stage liver disease (MELD), fibrosis 4 index (FIB-4), and aspartate aminotransferase to platelet ratio index (APRI) (24, 28), were assessed in this study, which were calculated according to clinical and laboratory parameters at the time of inclusion.	[('PMC7506152', 'M04000', 110, 136, 'aspartate aminotransferase')]	['Various', 'non', '-', 'invasive', 'markers', ',', 'such', 'as', 'model', 'for', 'end', '-', 'stage', 'liver', 'disease', '(', 'ME', '##LD', ')', ',', 'fibrosis', '4', 'index', '(', 'FI', '##B', '-', '4', ')', ',', 'and', 'aspart', '##ate', 'amino', '##transferase', 'to', 'platelet', 'ratio', 'index', '(', 'AP', '##RI', ')', '(', '24', ',', '28', ')', ',', 'were', 'assessed', 'in', 'this', 'study', ',', 'which', 'were', 'calculated', 'according', 'to', 'clinical', 'and', 'laboratory', 'parameters', 'at', 'the', 'time', 'of', 'inclusion', '.']	[0, 8, 11, 12, 21, 28, 30, 35, 38, 44, 48, 51, 52, 58, 64, 72, 73, 75, 77, 78, 80, 89, 91, 97, 98, 100, 101, 102, 103, 104, 106, 110, 116, 120, 125, 137, 140, 149, 155, 161, 162, 164, 166, 168, 169, 171, 173, 175, 176, 178, 183, 192, 195, 200, 205, 207, 213, 218, 229, 239, 242, 251, 255, 266, 277, 280, 284, 289, 292, 301]	[7, 11, 12, 20, 28, 29, 34, 37, 43, 47, 51, 52, 57, 63, 71, 73, 75, 77, 78, 79, 88, 90, 96, 98, 100, 101, 102, 103, 104, 105, 109, 116, 119, 125, 136, 139, 148, 154, 160, 162, 164, 166, 167, 169, 171, 172, 175, 176, 177, 182, 191, 194, 199, 205, 206, 212, 217, 228, 238, 241, 250, 254, 265, 276, 279, 283, 288, 291, 301, 302]	['Various', 'non', '-', 'invasive', 'markers', ',', 'such', 'as', 'model', 'for', 'end', '-', 'stage', 'liver', 'disease', '(', 'MELD', ')', ',', 'fibrosis', '4', 'index', '(', 'FIB-4', ')', ',', 'and', 'aspartate', 'aminotransferase', 'to', 'platelet', 'ratio', 'index', '(', 'APRI', ')', '(', '24', ',', '28', ')', ',', 'were', 'assessed', 'in', 'this', 'study', ',', 'which', 'were', 'calculated', 'according', 'to', 'clinical', 'and', 'laboratory', 'parameters', 'at', 'the', 'time', 'of', 'inclusion', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, pathogenic, and commensal bacteria have evolved specific glycoproteases that overcome the steric impediment posed by carbohydrates, cleaving glycoproteins precisely at their glycosylation site(s).	[('PMC7542363', 'A00001', 66, 80, 'glycoproteases')]	['However', ',', 'pathogenic', ',', 'and', 'commens', '##al', 'bacteria', 'have', 'evolved', 'specific', 'glyc', '##oprot', '##ea', '##ses', 'that', 'overcome', 'the', 'steric', 'imped', '##iment', 'posed', 'by', 'carbohydrates', ',', 'cle', '##aving', 'glycoprotein', '##s', 'precisely', 'at', 'their', 'glycosylation', 'site', '(', 's', ')', '.']	[0, 7, 9, 19, 21, 25, 32, 35, 44, 49, 57, 66, 70, 75, 77, 81, 86, 95, 99, 106, 111, 117, 123, 126, 139, 141, 144, 150, 162, 164, 174, 177, 183, 197, 201, 202, 203, 204]	[7, 8, 19, 20, 24, 32, 34, 43, 48, 56, 65, 70, 75, 77, 80, 85, 94, 98, 105, 111, 116, 122, 125, 139, 140, 144, 149, 162, 163, 173, 176, 182, 196, 201, 202, 203, 204, 205]	['However', ',', 'pathogenic', ',', 'and', 'commensal', 'bacteria', 'have', 'evolved', 'specific', 'glycoproteases', 'that', 'overcome', 'the', 'steric', 'impediment', 'posed', 'by', 'carbohydrates', ',', 'cleaving', 'glycoproteins', 'precisely', 'at', 'their', 'glycosylation', 'site(s)', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Medically relevant Acinetobacter strains employ their type II secretion system (T2SS) to secrete the glycoprotease CpaA, which contributes to virulence.	[('PMC7542363', 'A00002', 101, 114, 'glycoprotease')]	['Medical', '##ly', 'relevant', 'Ac', '##inet', '##obacter', 'strains', 'employ', 'their', 'type', 'II', 'secretion', 'system', '(', 'T', '##2', '##SS', ')', 'to', 'secrete', 'the', 'glyc', '##oprot', '##ea', '##se', 'Cp', '##a', '##A', ',', 'which', 'contributes', 'to', 'virulence', '.']	[0, 7, 10, 19, 21, 25, 33, 41, 48, 54, 59, 62, 72, 79, 80, 81, 82, 84, 86, 89, 97, 101, 105, 110, 112, 115, 117, 118, 119, 121, 127, 139, 142, 151]	[7, 9, 18, 21, 25, 32, 40, 47, 53, 58, 61, 71, 78, 80, 81, 82, 84, 85, 88, 96, 100, 105, 110, 112, 114, 117, 118, 119, 120, 126, 138, 141, 151, 152]	['Medically', 'relevant', 'Acinetobacter', 'strains', 'employ', 'their', 'type', 'II', 'secretion', 'system', '(', 'T2SS', ')', 'to', 'secrete', 'the', 'glycoprotease', 'CpaA', ',', 'which', 'contributes', 'to', 'virulence', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Similar bacterial glycoproteases have recently gained attention as tools for proteomic analysis of human glycoproteins, and CpaA appears to be a robust and attractive new component of the glycoproteomics toolbox.	[('PMC7542363', 'A00008', 8, 32, 'bacterial glycoproteases')]	['Similar', 'bacterial', 'glyc', '##oprot', '##ea', '##ses', 'have', 'recently', 'gained', 'attention', 'as', 'tools', 'for', 'proteomic', 'analysis', 'of', 'human', 'glycoprotein', '##s', ',', 'and', 'Cp', '##a', '##A', 'appears', 'to', 'be', 'a', 'robust', 'and', 'attractive', 'new', 'component', 'of', 'the', 'glyc', '##oprot', '##e', '##omics', 'tool', '##box', '.']	[0, 8, 18, 22, 27, 29, 33, 38, 47, 54, 64, 67, 73, 77, 87, 96, 99, 105, 117, 118, 120, 124, 126, 127, 129, 137, 140, 143, 145, 152, 156, 167, 171, 181, 184, 188, 192, 197, 198, 204, 208, 211]	[7, 17, 22, 27, 29, 32, 37, 46, 53, 63, 66, 72, 76, 86, 95, 98, 104, 117, 118, 119, 123, 126, 127, 128, 136, 139, 142, 144, 151, 155, 166, 170, 180, 183, 187, 192, 197, 198, 203, 208, 211, 212]	['Similar', 'bacterial', 'glycoproteases', 'have', 'recently', 'gained', 'attention', 'as', 'tools', 'for', 'proteomic', 'analysis', 'of', 'human', 'glycoproteins', ',', 'and', 'CpaA', 'appears', 'to', 'be', 'a', 'robust', 'and', 'attractive', 'new', 'component', 'of', 'the', 'glycoproteomics', 'toolbox', '.']	[1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Combined, our work provides insight into the function and possible application of CpaA, a member of a widespread class of broad-spectrum bacterial glycoproteases involved in host-pathogen interactions.	[('PMC7542363', 'A00009', 137, 161, 'bacterial glycoproteases')]	['Combined', ',', 'our', 'work', 'provides', 'insight', 'into', 'the', 'function', 'and', 'possible', 'application', 'of', 'Cp', '##a', '##A', ',', 'a', 'member', 'of', 'a', 'widespread', 'class', 'of', 'broad', '-', 'spectrum', 'bacterial', 'glyc', '##oprot', '##ea', '##ses', 'involved', 'in', 'host', '-', 'pathogen', 'interactions', '.']	[0, 8, 10, 14, 19, 28, 36, 41, 45, 54, 58, 67, 79, 82, 84, 85, 86, 88, 90, 97, 100, 102, 113, 119, 122, 127, 128, 137, 147, 151, 156, 158, 162, 171, 174, 178, 179, 188, 200]	[8, 9, 13, 18, 27, 35, 40, 44, 53, 57, 66, 78, 81, 84, 85, 86, 87, 89, 96, 99, 101, 112, 118, 121, 127, 128, 136, 146, 151, 156, 158, 161, 170, 173, 178, 179, 187, 200, 201]	['Combined', ',', 'our', 'work', 'provides', 'insight', 'into', 'the', 'function', 'and', 'possible', 'application', 'of', 'CpaA', ',', 'a', 'member', 'of', 'a', 'widespread', 'class', 'of', 'broad', '-', 'spectrum', 'bacterial', 'glycoproteases', 'involved', 'in', 'host', '-', 'pathogen', 'interactions', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, there is growing evidence that bacterial pathogens and commensals have evolved specific proteases that overcome the steric impediment posed by carbohydrates and indeed use glycans as recognition determinants to cleave glycoproteins right at the glycosylation site.	[('PMC7542363', 'D00002', 97, 106, 'proteases')]	['However', ',', 'there', 'is', 'growing', 'evidence', 'that', 'bacterial', 'pathogens', 'and', 'commens', '##als', 'have', 'evolved', 'specific', 'proteases', 'that', 'overcome', 'the', 'steric', 'imped', '##iment', 'posed', 'by', 'carbohydrates', 'and', 'indeed', 'use', 'glyc', '##ans', 'as', 'recognition', 'determinants', 'to', 'cle', '##ave', 'glycoprotein', '##s', 'right', 'at', 'the', 'glycosylation', 'site', '.']	[0, 7, 9, 15, 18, 26, 35, 40, 50, 60, 64, 71, 75, 80, 88, 97, 107, 112, 121, 125, 132, 137, 143, 149, 152, 166, 170, 177, 181, 185, 189, 192, 204, 217, 220, 223, 227, 239, 241, 247, 250, 254, 268, 272]	[7, 8, 14, 17, 25, 34, 39, 49, 59, 63, 71, 74, 79, 87, 96, 106, 111, 120, 124, 131, 137, 142, 148, 151, 165, 169, 176, 180, 185, 188, 191, 203, 216, 219, 223, 226, 239, 240, 246, 249, 253, 267, 272, 273]	['However', ',', 'there', 'is', 'growing', 'evidence', 'that', 'bacterial', 'pathogens', 'and', 'commensals', 'have', 'evolved', 'specific', 'proteases', 'that', 'overcome', 'the', 'steric', 'impediment', 'posed', 'by', 'carbohydrates', 'and', 'indeed', 'use', 'glycans', 'as', 'recognition', 'determinants', 'to', 'cleave', 'glycoproteins', 'right', 'at', 'the', 'glycosylation', 'site', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In this work, we functionally characterized CpaA, a metzincin glycoprotease and T2SS-secreted virulence factor of several medically relevant Acinetobacter strains (4, 7, 8, 12).	[('PMC7542363', 'D00003', 52, 75, 'metzincin glycoprotease')]	['In', 'this', 'work', ',', 'we', 'functionally', 'characterized', 'Cp', '##a', '##A', ',', 'a', 'met', '##zin', '##cin', 'glyc', '##oprot', '##ea', '##se', 'and', 'T', '##2', '##SS', '-', 'secreted', 'virulence', 'factor', 'of', 'several', 'medical', '##ly', 'relevant', 'Ac', '##inet', '##obacter', 'strains', '(', '4', ',', '7', ',', '8', ',', '12', ')', '.']	[0, 3, 8, 12, 14, 17, 30, 44, 46, 47, 48, 50, 52, 55, 58, 62, 66, 71, 73, 76, 80, 81, 82, 84, 85, 94, 104, 111, 114, 122, 129, 132, 141, 143, 147, 155, 163, 164, 165, 167, 168, 170, 171, 173, 175, 176]	[2, 7, 12, 13, 16, 29, 43, 46, 47, 48, 49, 51, 55, 58, 61, 66, 71, 73, 75, 79, 81, 82, 84, 85, 93, 103, 110, 113, 121, 129, 131, 140, 143, 147, 154, 162, 164, 165, 166, 168, 169, 171, 172, 175, 176, 177]	['In', 'this', 'work', ',', 'we', 'functionally', 'characterized', 'CpaA', ',', 'a', 'metzincin', 'glycoprotease', 'and', 'T2SS-secreted', 'virulence', 'factor', 'of', 'several', 'medically', 'relevant', 'Acinetobacter', 'strains', '(', '4', ',', '7', ',', '8', ',', '12', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 4, 1, 5, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our MS analysis of proteolytic fragments resulting from glycoprotein treatment with CpaA revealed that CpaA has a consensus target sequence consisting of a Pro residue followed by a glycosylated Ser or Thr (P-S/T), which is unprecedented for bacterial glycoproteases.	[('PMC7542363', 'D00006', 242, 266, 'bacterial glycoproteases')]	['Our', 'MS', 'analysis', 'of', 'proteolytic', 'fragments', 'resulting', 'from', 'glycoprotein', 'treatment', 'with', 'Cp', '##a', '##A', 'revealed', 'that', 'Cp', '##a', '##A', 'has', 'a', 'consensus', 'target', 'sequence', 'consisting', 'of', 'a', 'Pro', 'residue', 'followed', 'by', 'a', 'glycos', '##ylated', 'Ser', 'or', 'Thr', '(', 'P', '-', 'S', '/', 'T', ')', ',', 'which', 'is', 'unp', '##rec', '##ede', '##nt', '##ed', 'for', 'bacterial', 'glyc', '##oprot', '##ea', '##ses', '.']	[0, 4, 7, 16, 19, 31, 41, 51, 56, 69, 79, 84, 86, 87, 89, 98, 103, 105, 106, 108, 112, 114, 124, 131, 140, 151, 154, 156, 160, 168, 177, 180, 182, 188, 195, 199, 202, 206, 207, 208, 209, 210, 211, 212, 213, 215, 221, 224, 227, 230, 233, 235, 238, 242, 252, 256, 261, 263, 266]	[3, 6, 15, 18, 30, 40, 50, 55, 68, 78, 83, 86, 87, 88, 97, 102, 105, 106, 107, 111, 113, 123, 130, 139, 150, 153, 155, 159, 167, 176, 179, 181, 188, 194, 198, 201, 205, 207, 208, 209, 210, 211, 212, 213, 214, 220, 223, 227, 230, 233, 235, 237, 241, 251, 256, 261, 263, 266, 267]	['Our', 'MS', 'analysis', 'of', 'proteolytic', 'fragments', 'resulting', 'from', 'glycoprotein', 'treatment', 'with', 'CpaA', 'revealed', 'that', 'CpaA', 'has', 'a', 'consensus', 'target', 'sequence', 'consisting', 'of', 'a', 'Pro', 'residue', 'followed', 'by', 'a', 'glycosylated', 'Ser', 'or', 'Thr', '(', 'P-S', '/', 'T', ')', ',', 'which', 'is', 'unprecedented', 'for', 'bacterial', 'glycoproteases', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
Unlike other secreted glycoproteases, CpaA activity is not affected by sialic acid and is not restricted to highly O-glycosylated proteins (mucins).	[('PMC7542363', 'D00007', 22, 36, 'glycoproteases')]	['Unlike', 'other', 'secreted', 'glyc', '##oprot', '##ea', '##ses', ',', 'Cp', '##a', '##A', 'activity', 'is', 'not', 'affected', 'by', 'sial', '##ic', 'acid', 'and', 'is', 'not', 'restricted', 'to', 'highly', 'O', '-', 'glycos', '##ylated', 'proteins', '(', 'muc', '##ins', ')', '.']	[0, 7, 13, 22, 26, 31, 33, 36, 38, 40, 41, 43, 52, 55, 59, 68, 71, 75, 78, 83, 87, 90, 94, 105, 108, 115, 116, 117, 123, 130, 139, 140, 143, 146, 147]	[6, 12, 21, 26, 31, 33, 36, 37, 40, 41, 42, 51, 54, 58, 67, 70, 75, 77, 82, 86, 89, 93, 104, 107, 114, 116, 117, 123, 129, 138, 140, 143, 146, 147, 148]	['Unlike', 'other', 'secreted', 'glycoproteases', ',', 'CpaA', 'activity', 'is', 'not', 'affected', 'by', 'sialic', 'acid', 'and', 'is', 'not', 'restricted', 'to', 'highly', 'O-glycosylated', 'proteins', '(', 'mucins', ')', '.']	[1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although broad-spectrum secreted or surface-exposed glycoproteases appear to be widespread in bacteria, their identification cannot be assigned based on sequence homology, and biochemical and structural analyses are required to designate them as glycoproteases.	[('PMC7542363', 'D00009', 36, 66, 'surface-exposed glycoproteases'), ('PMC7542363', 'D00009', 246, 260, 'glycoproteases')]	['Although', 'broad', '-', 'spectrum', 'secreted', 'or', 'surface', '-', 'exposed', 'glyc', '##oprot', '##ea', '##ses', 'appear', 'to', 'be', 'widespread', 'in', 'bacteria', ',', 'their', 'identification', 'cannot', 'be', 'assigned', 'based', 'on', 'sequence', 'homology', ',', 'and', 'biochemical', 'and', 'structural', 'analyses', 'are', 'required', 'to', 'design', '##ate', 'them', 'as', 'glyc', '##oprot', '##ea', '##ses', '.']	[0, 9, 14, 15, 24, 33, 36, 43, 44, 52, 56, 61, 63, 67, 74, 77, 80, 91, 94, 102, 104, 110, 125, 132, 135, 144, 150, 153, 162, 170, 172, 176, 188, 192, 203, 212, 216, 225, 228, 234, 238, 243, 246, 250, 255, 257, 260]	[8, 14, 15, 23, 32, 35, 43, 44, 51, 56, 61, 63, 66, 73, 76, 79, 90, 93, 102, 103, 109, 124, 131, 134, 143, 149, 152, 161, 170, 171, 175, 187, 191, 202, 211, 215, 224, 227, 234, 237, 242, 245, 250, 255, 257, 260, 261]	['Although', 'broad', '-', 'spectrum', 'secreted', 'or', 'surface', '-', 'exposed', 'glycoproteases', 'appear', 'to', 'be', 'widespread', 'in', 'bacteria', ',', 'their', 'identification', 'cannot', 'be', 'assigned', 'based', 'on', 'sequence', 'homology', ',', 'and', 'biochemical', 'and', 'structural', 'analyses', 'are', 'required', 'to', 'designate', 'them', 'as', 'glycoproteases', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Considering the different domain organization of the two proteases, it is not surprising that the proteins are classified in different metzincin subfamilies and target different proteins.	[('PMC7542363', 'D01006', 57, 66, 'proteases')]	['Considering', 'the', 'different', 'domain', 'organization', 'of', 'the', 'two', 'proteases', ',', 'it', 'is', 'not', 'surprising', 'that', 'the', 'proteins', 'are', 'classified', 'in', 'different', 'met', '##zin', '##cin', 'sub', '##fa', '##mi', '##lies', 'and', 'target', 'different', 'proteins', '.']	[0, 12, 16, 26, 33, 46, 49, 53, 57, 66, 68, 71, 74, 78, 89, 94, 98, 107, 111, 122, 125, 135, 138, 141, 145, 148, 150, 152, 157, 161, 168, 178, 186]	[11, 15, 25, 32, 45, 48, 52, 56, 66, 67, 70, 73, 77, 88, 93, 97, 106, 110, 121, 124, 134, 138, 141, 144, 148, 150, 152, 156, 160, 167, 177, 186, 187]	['Considering', 'the', 'different', 'domain', 'organization', 'of', 'the', 'two', 'proteases', ',', 'it', 'is', 'not', 'surprising', 'that', 'the', 'proteins', 'are', 'classified', 'in', 'different', 'metzincin', 'subfamilies', 'and', 'target', 'different', 'proteins', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mucin domains are resistant to most commercially available proteases, which makes them difficult to analyze by traditional MS strategies.	[('PMC7542363', 'D05006', 59, 68, 'proteases')]	['Muc', '##in', 'domains', 'are', 'resistant', 'to', 'most', 'commercially', 'available', 'proteases', ',', 'which', 'makes', 'them', 'difficult', 'to', 'analyze', 'by', 'traditional', 'MS', 'strategies', '.']	[0, 3, 6, 14, 18, 28, 31, 36, 49, 59, 68, 70, 76, 82, 87, 97, 100, 108, 111, 123, 126, 136]	[3, 5, 13, 17, 27, 30, 35, 48, 58, 68, 69, 75, 81, 86, 96, 99, 107, 110, 122, 125, 136, 137]	['Mucin', 'domains', 'are', 'resistant', 'to', 'most', 'commercially', 'available', 'proteases', ',', 'which', 'makes', 'them', 'difficult', 'to', 'analyze', 'by', 'traditional', 'MS', 'strategies', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacterial glycoproteases have recently gained attention as tools for proteomic analysis of human glycoproteins (16, 22, 55).	[('PMC7542363', 'D05007', 0, 24, 'Bacterial glycoproteases')]	['Bacterial', 'glyc', '##oprot', '##ea', '##ses', 'have', 'recently', 'gained', 'attention', 'as', 'tools', 'for', 'proteomic', 'analysis', 'of', 'human', 'glycoprotein', '##s', '(', '16', ',', '22', ',', '55', ')', '.']	[0, 10, 14, 19, 21, 25, 30, 39, 46, 56, 59, 65, 69, 79, 88, 91, 97, 109, 111, 112, 114, 116, 118, 120, 122, 123]	[9, 14, 19, 21, 24, 29, 38, 45, 55, 58, 64, 68, 78, 87, 90, 96, 109, 110, 112, 114, 115, 118, 119, 122, 123, 124]	['Bacterial', 'glycoproteases', 'have', 'recently', 'gained', 'attention', 'as', 'tools', 'for', 'proteomic', 'analysis', 'of', 'human', 'glycoproteins', '(', '16', ',', '22', ',', '55', ')', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our study shows that the broad-spectrum O-linked glycoprotease activity of CpaA is not affected by sialic acids.	[('PMC7542363', 'D05008', 40, 62, 'O-linked glycoprotease')]	['Our', 'study', 'shows', 'that', 'the', 'broad', '-', 'spectrum', 'O', '-', 'linked', 'glyc', '##oprot', '##ea', '##se', 'activity', 'of', 'Cp', '##a', '##A', 'is', 'not', 'affected', 'by', 'sial', '##ic', 'acids', '.']	[0, 4, 10, 16, 21, 25, 30, 31, 40, 41, 42, 49, 53, 58, 60, 63, 72, 75, 77, 78, 80, 83, 87, 96, 99, 103, 106, 111]	[3, 9, 15, 20, 24, 30, 31, 39, 41, 42, 48, 53, 58, 60, 62, 71, 74, 77, 78, 79, 82, 86, 95, 98, 103, 105, 111, 112]	['Our', 'study', 'shows', 'that', 'the', 'broad', '-', 'spectrum', 'O-', 'linked', 'glycoprotease', 'activity', 'of', 'CpaA', 'is', 'not', 'affected', 'by', 'sialic', 'acids', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization.	[('PMC7542363', 'F05002', 109, 122, 'phospholipase')]	['The', 'secret', '##ome', 'of', 'Ac', '##inet', '##obacter', 'ba', '##umann', '##ii', 'ATCC', '179', '##78', 'type', 'II', 'secretion', 'system', 'reveals', 'a', 'novel', 'plasmid', 'encoded', 'phospholip', '##ase', 'that', 'could', 'be', 'implicated', 'in', 'lung', 'colonization', '.']	[0, 4, 10, 14, 17, 19, 23, 31, 33, 38, 41, 46, 49, 52, 57, 60, 70, 77, 85, 87, 93, 101, 109, 119, 123, 128, 134, 137, 148, 151, 156, 168]	[3, 10, 13, 16, 19, 23, 30, 33, 38, 40, 45, 49, 51, 56, 59, 69, 76, 84, 86, 92, 100, 108, 119, 122, 127, 133, 136, 147, 150, 155, 168, 169]	['The', 'secretome', 'of', 'Acinetobacter', 'baumannii', 'ATCC', '17978', 'type', 'II', 'secretion', 'system', 'reveals', 'a', 'novel', 'plasmid', 'encoded', 'phospholipase', 'that', 'could', 'be', 'implicated', 'in', 'lung', 'colonization', '.']	[1, 2, 1, 3, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence in Acinetobacter species.	[('PMC7542363', 'F07003', 32, 40, 'protease')]	['Defining', 'the', 'interaction', 'of', 'the', 'protease', 'Cp', '##a', '##A', 'with', 'its', 'type', 'II', 'secretion', 'chaperone', 'Cp', '##a', '##B', 'and', 'its', 'contribution', 'to', 'virulence', 'in', 'Ac', '##inet', '##obacter', 'species', '.']	[0, 9, 13, 25, 28, 32, 41, 43, 44, 46, 51, 55, 60, 63, 73, 83, 85, 86, 88, 92, 96, 109, 112, 122, 125, 127, 131, 139, 146]	[8, 12, 24, 27, 31, 40, 43, 44, 45, 50, 54, 59, 62, 72, 82, 85, 86, 87, 91, 95, 108, 111, 121, 124, 127, 131, 138, 146, 147]	['Defining', 'the', 'interaction', 'of', 'the', 'protease', 'CpaA', 'with', 'its', 'type', 'II', 'secretion', 'chaperone', 'CpaB', 'and', 'its', 'contribution', 'to', 'virulence', 'in', 'Acinetobacter', 'species', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation.	[('PMC7542363', 'F11002', 13, 21, 'protease')]	['Cp', '##a', '##A', 'a', 'novel', 'protease', 'from', 'Ac', '##inet', '##obacter', 'ba', '##umann', '##ii', 'clinical', 'isolates', 'dere', '##gu', '##late', '##s', 'blood', 'coagulation', '.']	[0, 2, 3, 5, 7, 13, 22, 27, 29, 33, 41, 43, 48, 51, 60, 69, 73, 75, 79, 81, 87, 98]	[2, 3, 4, 6, 12, 21, 26, 29, 33, 40, 43, 48, 50, 59, 68, 73, 75, 79, 80, 86, 98, 99]	['CpaA', 'a', 'novel', 'protease', 'from', 'Acinetobacter', 'baumannii', 'clinical', 'isolates', 'deregulates', 'blood', 'coagulation', '.']	[3, 1, 1, 1, 1, 3, 3, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The structure of Acinetobacter-secreted protease CpaA complexed with its chaperone CpaB reveals a novel mode of a T2SS chaperone-substrate interaction.	[('PMC7542363', 'F12002', 40, 48, 'protease')]	['The', 'structure', 'of', 'Ac', '##inet', '##obacter', '-', 'secreted', 'protease', 'Cp', '##a', '##A', 'complex', '##ed', 'with', 'its', 'chaperone', 'Cp', '##a', '##B', 'reveals', 'a', 'novel', 'mode', 'of', 'a', 'T', '##2', '##SS', 'chaperone', '-', 'substrate', 'interaction', '.']	[0, 4, 14, 17, 19, 23, 30, 31, 40, 49, 51, 52, 54, 61, 64, 69, 73, 83, 85, 86, 88, 96, 98, 104, 109, 112, 114, 115, 116, 119, 128, 129, 139, 150]	[3, 13, 16, 19, 23, 30, 31, 39, 48, 51, 52, 53, 61, 63, 68, 72, 82, 85, 86, 87, 95, 97, 103, 108, 111, 113, 115, 116, 118, 128, 129, 138, 150, 151]	['The', 'structure', 'of', 'Acinetobacter', '-', 'secreted', 'protease', 'CpaA', 'complexed', 'with', 'its', 'chaperone', 'CpaB', 'reveals', 'a', 'novel', 'mode', 'of', 'a', 'T2SS', 'chaperone', '-', 'substrate', 'interaction', '.']	[1, 1, 1, 3, 1, 1, 1, 3, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Structural insight into the bacterial mucinase StcE essential to adhesion and immune evasion during enterohemorrhagic E. coli infection.	[('PMC7542363', 'F16002', 28, 46, 'bacterial mucinase')]	['Structural', 'insight', 'into', 'the', 'bacterial', 'muc', '##inase', 'St', '##c', '##E', 'essential', 'to', 'adhesion', 'and', 'immune', 'ev', '##asion', 'during', 'enter', '##oh', '##em', '##orrh', '##agic', 'E', '.', 'coli', 'infection', '.']	[0, 11, 19, 24, 28, 38, 41, 47, 49, 50, 52, 62, 65, 74, 78, 85, 87, 93, 100, 105, 107, 109, 113, 118, 119, 121, 126, 135]	[10, 18, 23, 27, 37, 41, 46, 49, 50, 51, 61, 64, 73, 77, 84, 87, 92, 99, 105, 107, 109, 113, 117, 119, 120, 125, 135, 136]	['Structural', 'insight', 'into', 'the', 'bacterial', 'mucinase', 'StcE', 'essential', 'to', 'adhesion', 'and', 'immune', 'evasion', 'during', 'enterohemorrhagic', 'E', '.', 'coli', 'infection', '.']	[1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Architecture and function of metallopeptidase catalytic domains.	[('PMC7542363', 'F17002', 29, 45, 'metallopeptidase')]	['Architecture', 'and', 'function', 'of', 'metall', '##ope', '##pt', '##idase', 'catalytic', 'domains', '.']	[0, 13, 17, 26, 29, 35, 38, 40, 46, 56, 63]	[12, 16, 25, 28, 35, 38, 40, 45, 55, 63, 64]	['Architecture', 'and', 'function', 'of', 'metallopeptidase', 'catalytic', 'domains', '.']	[1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O']
Catalytic domain architecture of metzincin metalloproteases.	[('PMC7542363', 'F18002', 33, 59, 'metzincin metalloproteases')]	['Catal', '##ytic', 'domain', 'architecture', 'of', 'met', '##zin', '##cin', 'metall', '##oprot', '##ea', '##ses', '.']	[0, 5, 10, 17, 30, 33, 36, 39, 43, 49, 54, 56, 59]	[5, 9, 16, 29, 32, 36, 39, 42, 49, 54, 56, 59, 60]	['Catalytic', 'domain', 'architecture', 'of', 'metzincin', 'metalloproteases', '.']	[2, 1, 1, 1, 3, 4, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor.	[('PMC7542363', 'F19003', 8, 23, 'metalloprotease'), ('PMC7542363', 'F19003', 83, 94, 'C1 esterase')]	['St', '##c', '##E', ',', 'a', 'metall', '##oprot', '##ea', '##se', 'secreted', 'by', 'Escherichia', 'coli', 'O', '##157', ':', 'H', '##7', ',', 'specifically', 'cle', '##aves', 'C', '##1', 'ester', '##ase', 'inhibitor', '.']	[0, 2, 3, 4, 6, 8, 14, 19, 21, 24, 33, 36, 48, 53, 54, 57, 58, 59, 60, 62, 75, 78, 83, 84, 86, 91, 95, 104]	[2, 3, 4, 5, 7, 14, 19, 21, 23, 32, 35, 47, 52, 54, 57, 58, 59, 60, 61, 74, 78, 82, 84, 85, 91, 94, 104, 105]	['StcE', ',', 'a', 'metalloprotease', 'secreted', 'by', 'Escherichia', 'coli', 'O157', ':', 'H7', ',', 'specifically', 'cleaves', 'C1', 'esterase', 'inhibitor', '.']	[3, 1, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
A novel extracellular metallopeptidase domain shared by animal host-associated mutualistic and pathogenic microbes.	[('PMC7542363', 'F20002', 8, 38, 'extracellular metallopeptidase')]	['A', 'novel', 'extracellular', 'metall', '##ope', '##pt', '##idase', 'domain', 'shared', 'by', 'animal', 'host', '-', 'associated', 'mutual', '##istic', 'and', 'pathogenic', 'microbes', '.']	[0, 2, 8, 22, 28, 31, 33, 39, 46, 53, 56, 63, 67, 68, 79, 85, 91, 95, 106, 114]	[1, 7, 21, 28, 31, 33, 38, 45, 52, 55, 62, 67, 68, 78, 85, 90, 94, 105, 114, 115]	['A', 'novel', 'extracellular', 'metallopeptidase', 'domain', 'shared', 'by', 'animal', 'host', '-', 'associated', 'mutualistic', 'and', 'pathogenic', 'microbes', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
TagA is a secreted protease of Vibrio cholerae that specifically cleaves mucin glycoproteins.	[('PMC7542363', 'F25003', 19, 27, 'protease')]	['Tag', '##A', 'is', 'a', 'secreted', 'protease', 'of', 'Vi', '##br', '##io', 'chol', '##era', '##e', 'that', 'specifically', 'cle', '##aves', 'muc', '##in', 'glycoprotein', '##s', '.']	[0, 3, 5, 8, 10, 19, 28, 31, 33, 35, 38, 42, 45, 47, 52, 65, 68, 73, 76, 79, 91, 92]	[3, 4, 7, 9, 18, 27, 30, 33, 35, 37, 42, 45, 46, 51, 64, 68, 72, 76, 78, 91, 92, 93]	['TagA', 'is', 'a', 'secreted', 'protease', 'of', 'Vibrio', 'cholerae', 'that', 'specifically', 'cleaves', 'mucin', 'glycoproteins', '.']	[2, 1, 1, 1, 1, 1, 3, 3, 1, 1, 2, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:	[('PMC7542363', 'F26002', 9, 17, 'protease')]	['The', 'St', '##c', '##E', 'protease', 'contributes', 'to', 'intimate', 'adherence', 'of', 'enter', '##oh', '##em', '##orrh', '##agic', 'Escherichia', 'coli', 'O', '##157', ':']	[0, 4, 6, 7, 9, 18, 30, 33, 42, 52, 55, 60, 62, 64, 68, 73, 85, 90, 91, 94]	[3, 6, 7, 8, 17, 29, 32, 41, 51, 54, 60, 62, 64, 68, 72, 84, 89, 91, 94, 95]	['The', 'StcE', 'protease', 'contributes', 'to', 'intimate', 'adherence', 'of', 'enterohemorrhagic', 'Escherichia', 'coli', 'O157', ':']	[1, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains.	[('PMC7542363', 'F27002', 56, 64, 'mucinase')]	['S', '##sl', '##E', 'elicit', '##s', 'functional', 'antibodies', 'that', 'impair', 'in', 'vitro', 'muc', '##inase', 'activity', 'and', 'in', 'vivo', 'colonization', 'by', 'both', 'intestinal', 'and', 'extra', '##intestinal', 'Escherichia', 'coli', 'strains', '.']	[0, 1, 3, 5, 11, 13, 24, 35, 40, 47, 50, 56, 59, 65, 74, 78, 81, 86, 99, 102, 107, 118, 122, 127, 138, 150, 155, 162]	[1, 3, 4, 11, 12, 23, 34, 39, 46, 49, 55, 59, 64, 73, 77, 80, 85, 98, 101, 106, 117, 121, 127, 137, 149, 154, 162, 163]	['SslE', 'elicits', 'functional', 'antibodies', 'that', 'impair', 'in', 'vitro', 'mucinase', 'activity', 'and', 'in', 'vivo', 'colonization', 'by', 'both', 'intestinal', 'and', 'extraintestinal', 'Escherichia', 'coli', 'strains', '.']	[3, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Identification of an immunomodulating metalloprotease of Pseudomonas aeruginosa (IMPa).	[('PMC7542363', 'F28002', 38, 53, 'metalloprotease')]	['Identification', 'of', 'an', 'immunomod', '##ulating', 'metall', '##oprot', '##ea', '##se', 'of', 'Pseudomonas', 'aeruginosa', '(', 'IMP', '##a', ')', '.']	[0, 15, 18, 21, 30, 38, 44, 49, 51, 54, 57, 69, 80, 81, 84, 85, 86]	[14, 17, 20, 30, 37, 44, 49, 51, 53, 56, 68, 79, 81, 84, 85, 86, 87]	['Identification', 'of', 'an', 'immunomodulating', 'metalloprotease', 'of', 'Pseudomonas', 'aeruginosa', '(', 'IMPa', ')', '.']	[1, 1, 1, 2, 4, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins.	[('PMC7542363', 'F34002', 2, 23, 'neutral glycoprotease')]	['A', 'neutral', 'glyc', '##oprot', '##ea', '##se', 'of', 'Past', '##eur', '##ella', 'haem', '##olytic', '##a', 'A', '##1', 'specifically', 'cle', '##aves', 'O', '-', 'sial', '##ogly', '##coprotein', '##s', '.']	[0, 2, 10, 14, 19, 21, 24, 27, 31, 34, 39, 43, 49, 51, 52, 54, 67, 70, 75, 76, 77, 81, 85, 94, 95]	[1, 9, 14, 19, 21, 23, 26, 31, 34, 38, 43, 49, 50, 52, 53, 66, 70, 74, 76, 77, 81, 85, 94, 95, 96]	['A', 'neutral', 'glycoprotease', 'of', 'Pasteurella', 'haemolytica', 'A1', 'specifically', 'cleaves', 'O-sialoglycoproteins', '.']	[1, 1, 4, 1, 3, 3, 2, 1, 2, 6, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In vitro activity of Neisseria meningitidis PglL O-oligosaccharyltransferase with diverse synthetic lipid donors and a UDP-activated sugar.	[('PMC7542363', 'F36003', 49, 76, 'O-oligosaccharyltransferase')]	['In', 'vitro', 'activity', 'of', 'Ne', '##isser', '##ia', 'mening', '##iti', '##dis', 'P', '##gl', '##L', 'O', '-', 'olig', '##osacchar', '##yl', '##transferase', 'with', 'diverse', 'synthetic', 'lipid', 'donors', 'and', 'a', 'UDP', '-', 'activated', 'sugar', '.']	[0, 3, 9, 18, 21, 23, 28, 31, 37, 40, 44, 45, 47, 49, 50, 51, 55, 63, 65, 77, 82, 90, 100, 106, 113, 117, 119, 122, 123, 133, 138]	[2, 8, 17, 20, 23, 28, 30, 37, 40, 43, 45, 47, 48, 50, 51, 55, 63, 65, 76, 81, 89, 99, 105, 112, 116, 118, 122, 123, 132, 138, 139]	['In', 'vitro', 'activity', 'of', 'Neisseria', 'meningitidis', 'PglL', 'O-oligosaccharyltransferase', 'with', 'diverse', 'synthetic', 'lipid', 'donors', 'and', 'a', 'UDP-activated', 'sugar', '.']	[1, 1, 1, 1, 3, 3, 3, 6, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Plasma membrane profiling during enterohemorrhagic E. coli infection reveals that the metalloprotease StcE cleaves CD55 from host epithelial surfaces.	[('PMC7542363', 'F47002', 86, 101, 'metalloprotease')]	['Plasma', 'membrane', 'profiling', 'during', 'enter', '##oh', '##em', '##orrh', '##agic', 'E', '.', 'coli', 'infection', 'reveals', 'that', 'the', 'metall', '##oprot', '##ea', '##se', 'St', '##c', '##E', 'cle', '##aves', 'CD', '##55', 'from', 'host', 'epithelial', 'surfaces', '.']	[0, 7, 16, 26, 33, 38, 40, 42, 46, 51, 52, 54, 59, 69, 77, 82, 86, 92, 97, 99, 102, 104, 105, 107, 110, 115, 117, 120, 125, 130, 141, 149]	[6, 15, 25, 32, 38, 40, 42, 46, 50, 52, 53, 58, 68, 76, 81, 85, 92, 97, 99, 101, 104, 105, 106, 110, 114, 117, 119, 124, 129, 140, 149, 150]	['Plasma', 'membrane', 'profiling', 'during', 'enterohemorrhagic', 'E', '.', 'coli', 'infection', 'reveals', 'that', 'the', 'metalloprotease', 'StcE', 'cleaves', 'CD55', 'from', 'host', 'epithelial', 'surfaces', '.']	[1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 4, 3, 2, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7.	[('PMC7542363', 'F48002', 48, 56, 'mucinase')]	['Mod', '##ulation', 'of', 'neutrophil', 'function', 'by', 'a', 'secreted', 'muc', '##inase', 'of', 'Escherichia', 'coli', 'O', '##157', ':', 'H', '##7', '.']	[0, 3, 11, 14, 25, 34, 37, 39, 48, 51, 57, 60, 72, 77, 78, 81, 82, 83, 84]	[3, 10, 13, 24, 33, 36, 38, 47, 51, 56, 59, 71, 76, 78, 81, 82, 83, 84, 85]	['Modulation', 'of', 'neutrophil', 'function', 'by', 'a', 'secreted', 'mucinase', 'of', 'Escherichia', 'coli', 'O157', ':', 'H7', '.']	[2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The StcE metalloprotease of enterohaemorrhagic Escherichia coli reduces the inner mucus layer and promotes adherence to human colonic epithelium ex vivo.	[('PMC7542363', 'F49002', 9, 24, 'metalloprotease')]	['The', 'St', '##c', '##E', 'metall', '##oprot', '##ea', '##se', 'of', 'enter', '##oh', '##ae', '##mo', '##rr', '##ha', '##gic', 'Escherichia', 'coli', 'reduces', 'the', 'inner', 'mucus', 'layer', 'and', 'promotes', 'adherence', 'to', 'human', 'colonic', 'epithelium', 'ex', 'vivo', '.']	[0, 4, 6, 7, 9, 15, 20, 22, 25, 28, 33, 35, 37, 39, 41, 43, 47, 59, 64, 72, 76, 82, 88, 94, 98, 107, 117, 120, 126, 134, 145, 148, 152]	[3, 6, 7, 8, 15, 20, 22, 24, 27, 33, 35, 37, 39, 41, 43, 46, 58, 63, 71, 75, 81, 87, 93, 97, 106, 116, 119, 125, 133, 144, 147, 152, 153]	['The', 'StcE', 'metalloprotease', 'of', 'enterohaemorrhagic', 'Escherichia', 'coli', 'reduces', 'the', 'inner', 'mucus', 'layer', 'and', 'promotes', 'adherence', 'to', 'human', 'colonic', 'epithelium', 'ex', 'vivo', '.']	[1, 3, 4, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A novel family of soluble minimal scaffolds provides structural insight into the catalytic domains of integral membrane metallopeptidases.	[('PMC7542363', 'F61002', 111, 137, 'membrane metallopeptidases')]	['A', 'novel', 'family', 'of', 'soluble', 'minimal', 'scaffolds', 'provides', 'structural', 'insight', 'into', 'the', 'catalytic', 'domains', 'of', 'integral', 'membrane', 'metall', '##ope', '##pt', '##idase', '##s', '.']	[0, 2, 8, 15, 18, 26, 34, 44, 53, 64, 72, 77, 81, 91, 99, 102, 111, 120, 126, 129, 131, 136, 137]	[1, 7, 14, 17, 25, 33, 43, 52, 63, 71, 76, 80, 90, 98, 101, 110, 119, 126, 129, 131, 136, 137, 138]	['A', 'novel', 'family', 'of', 'soluble', 'minimal', 'scaffolds', 'provides', 'structural', 'insight', 'into', 'the', 'catalytic', 'domains', 'of', 'integral', 'membrane', 'metallopeptidases', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O']
The serine protease motif of Pic mediates a dose-dependent mucolytic activity after binding to sugar constituents of the mucin substrate.	[('PMC7542363', 'F68002', 4, 19, 'serine protease')]	['The', 'serine', 'protease', 'motif', 'of', 'Pic', 'mediates', 'a', 'dose', '-', 'dependent', 'muc', '##olytic', 'activity', 'after', 'binding', 'to', 'sugar', 'constituents', 'of', 'the', 'muc', '##in', 'substrate', '.']	[0, 4, 11, 20, 26, 29, 33, 42, 44, 48, 49, 59, 62, 69, 78, 84, 92, 95, 101, 114, 117, 121, 124, 127, 136]	[3, 10, 19, 25, 28, 32, 41, 43, 48, 49, 58, 62, 68, 77, 83, 91, 94, 100, 113, 116, 120, 124, 126, 136, 137]	['The', 'serine', 'protease', 'motif', 'of', 'Pic', 'mediates', 'a', 'dose', '-', 'dependent', 'mucolytic', 'activity', 'after', 'binding', 'to', 'sugar', 'constituents', 'of', 'the', 'mucin', 'substrate', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
O-sialoglycoprotein endopeptidase, p 1664–1666.	[('PMC7542363', 'F69002', 0, 33, 'O-sialoglycoprotein endopeptidase')]	['O', '-', 'sial', '##ogly', '##coprotein', 'end', '##ope', '##pt', '##idase', ',', 'p', '166', '##4', '–', '166', '##6', '.']	[0, 1, 2, 6, 10, 20, 23, 26, 28, 33, 35, 37, 40, 41, 42, 45, 46]	[1, 2, 6, 10, 19, 23, 26, 28, 33, 34, 36, 40, 41, 42, 45, 46, 47]	['O-sialoglycoprotein', 'endopeptidase', ',', 'p', '1664–', '1666', '.']	[5, 4, 1, 1, 3, 2, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Role in proinflammatory response of YghJ, a secreted metalloprotease from neonatal septicemic Escherichia coli.	[('PMC7542363', 'F70002', 53, 68, 'metalloprotease')]	['Role', 'in', 'proinflammatory', 'response', 'of', 'Y', '##gh', '##J', ',', 'a', 'secreted', 'metall', '##oprot', '##ea', '##se', 'from', 'neonatal', 'septic', '##emic', 'Escherichia', 'coli', '.']	[0, 5, 8, 24, 33, 36, 37, 39, 40, 42, 44, 53, 59, 64, 66, 69, 74, 83, 89, 94, 106, 110]	[4, 7, 23, 32, 35, 37, 39, 40, 41, 43, 52, 59, 64, 66, 68, 73, 82, 89, 93, 105, 110, 111]	['Role', 'in', 'proinflammatory', 'response', 'of', 'YghJ', ',', 'a', 'secreted', 'metalloprotease', 'from', 'neonatal', 'septicemic', 'Escherichia', 'coli', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The pasteurella haemolytica O-sialoglycoprotein endopeptidase is inhibited by zinc ions and does not cleave fetuin.	[('PMC7542363', 'F71002', 28, 61, 'O-sialoglycoprotein endopeptidase')]	['The', 'paste', '##ure', '##lla', 'haem', '##olytic', '##a', 'O', '-', 'sial', '##ogly', '##coprotein', 'end', '##ope', '##pt', '##idase', 'is', 'inhibited', 'by', 'zinc', 'ions', 'and', 'does', 'not', 'cle', '##ave', 'fet', '##uin', '.']	[0, 4, 9, 12, 16, 20, 26, 28, 29, 30, 34, 38, 48, 51, 54, 56, 62, 65, 75, 78, 83, 88, 92, 97, 101, 104, 108, 111, 114]	[3, 9, 12, 15, 20, 26, 27, 29, 30, 34, 38, 47, 51, 54, 56, 61, 64, 74, 77, 82, 87, 91, 96, 100, 104, 107, 111, 114, 115]	['The', 'pasteurella', 'haemolytica', 'O-sialoglycoprotein', 'endopeptidase', 'is', 'inhibited', 'by', 'zinc', 'ions', 'and', 'does', 'not', 'cleave', 'fetuin', '.']	[1, 3, 3, 5, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among these T2SS effectors, the zinc-metallo-endopeptidase CpaA is the best-characterized and most abundant effector secreted by several medically relevant Acinetobacterstrains (7, 8, 12).	[('PMC7542363', 'I01001', 32, 58, 'zinc-metallo-endopeptidase')]	['Among', 'these', 'T', '##2', '##SS', 'effectors', ',', 'the', 'zinc', '-', 'metall', '##o', '-', 'end', '##ope', '##pt', '##idase', 'Cp', '##a', '##A', 'is', 'the', 'best', '-', 'characterized', 'and', 'most', 'abundant', 'effector', 'secreted', 'by', 'several', 'medical', '##ly', 'relevant', 'Ac', '##inet', '##obacter', '##strain', '##s', '(', '7', ',', '8', ',', '12', ')', '.']	[0, 6, 12, 13, 14, 17, 26, 28, 32, 36, 37, 43, 44, 45, 48, 51, 53, 59, 61, 62, 64, 67, 71, 75, 76, 90, 94, 99, 108, 117, 126, 129, 137, 144, 147, 156, 158, 162, 169, 175, 177, 178, 179, 181, 182, 184, 186, 187]	[5, 11, 13, 14, 16, 26, 27, 31, 36, 37, 43, 44, 45, 48, 51, 53, 58, 61, 62, 63, 66, 70, 75, 76, 89, 93, 98, 107, 116, 125, 128, 136, 144, 146, 155, 158, 162, 169, 175, 176, 178, 179, 180, 182, 183, 186, 187, 188]	['Among', 'these', 'T2SS', 'effectors', ',', 'the', 'zinc', '-', 'metallo', '-', 'endopeptidase', 'CpaA', 'is', 'the', 'best', '-', 'characterized', 'and', 'most', 'abundant', 'effector', 'secreted', 'by', 'several', 'medically', 'relevant', 'Acinetobacterstrains', '(', '7', ',', '8', ',', '12', ')', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Few glycoprotein-targeting zinc metallo-endopeptidases have been structurally characterized.	[('PMC7542363', 'I03000', 27, 54, 'zinc metallo-endopeptidases')]	['Few', 'glycoprotein', '-', 'targeting', 'zinc', 'metall', '##o', '-', 'end', '##ope', '##pt', '##idase', '##s', 'have', 'been', 'structurally', 'characterized', '.']	[0, 4, 16, 17, 27, 32, 38, 39, 40, 43, 46, 48, 53, 55, 60, 65, 78, 91]	[3, 16, 17, 26, 31, 38, 39, 40, 43, 46, 48, 53, 54, 59, 64, 77, 91, 92]	['Few', 'glycoprotein', '-', 'targeting', 'zinc', 'metallo', '-', 'endopeptidases', 'have', 'been', 'structurally', 'characterized', '.']	[1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Metzincin proteases have a characteristic extended zinc-binding motif (HEXXHXXGXXH) and a conserved Met turn, whereas gluzincin proteases have a glutamate residue in the zinc-binding motif (HEXXHE) (18).	[('PMC7542363', 'I03002', 0, 19, 'Metzincin proteases'), ('PMC7542363', 'I03002', 118, 137, 'gluzincin proteases')]	['Met', '##zin', '##cin', 'proteases', 'have', 'a', 'characteristic', 'extended', 'zinc', '-', 'binding', 'motif', '(', 'HE', '##XX', '##H', '##XX', '##G', '##XX', '##H', ')', 'and', 'a', 'conserved', 'Met', 'turn', ',', 'whereas', 'glu', '##zin', '##cin', 'proteases', 'have', 'a', 'glutamate', 'residue', 'in', 'the', 'zinc', '-', 'binding', 'motif', '(', 'HE', '##XX', '##HE', ')', '(', '18', ')', '.']	[0, 3, 6, 10, 20, 25, 27, 42, 51, 55, 56, 64, 70, 71, 73, 75, 76, 78, 79, 81, 82, 84, 88, 90, 100, 104, 108, 110, 118, 121, 124, 128, 138, 143, 145, 155, 163, 166, 170, 174, 175, 183, 189, 190, 192, 194, 196, 198, 199, 201, 202]	[3, 6, 9, 19, 24, 26, 41, 50, 55, 56, 63, 69, 71, 73, 75, 76, 78, 79, 81, 82, 83, 87, 89, 99, 103, 108, 109, 117, 121, 124, 127, 137, 142, 144, 154, 162, 165, 169, 174, 175, 182, 188, 190, 192, 194, 196, 197, 199, 201, 202, 203]	['Metzincin', 'proteases', 'have', 'a', 'characteristic', 'extended', 'zinc', '-', 'binding', 'motif', '(', 'HEXXHXXGXXH', ')', 'and', 'a', 'conserved', 'Met', 'turn', ',', 'whereas', 'gluzincin', 'proteases', 'have', 'a', 'glutamate', 'residue', 'in', 'the', 'zinc', '-', 'binding', 'motif', '(', 'HEXXHE', ')', '(', '18', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, these repeats share fold similarities to a domain present in the metzincin protease StcE, a secreted glycoprotease from enterohemorrhagic Escherichia coli (EHEC), though their detailed sequence and structural similarities are very limited (13, 20).	[('PMC7542363', 'I03006', 116, 129, 'glycoprotease')]	['Interestingly', ',', 'these', 'repeats', 'share', 'fold', 'similarities', 'to', 'a', 'domain', 'present', 'in', 'the', 'met', '##zin', '##cin', 'protease', 'St', '##c', '##E', ',', 'a', 'secreted', 'glyc', '##oprot', '##ea', '##se', 'from', 'enter', '##oh', '##em', '##orrh', '##agic', 'Escherichia', 'coli', '(', 'EH', '##EC', ')', ',', 'though', 'their', 'detailed', 'sequence', 'and', 'structural', 'similarities', 'are', 'very', 'limited', '(', '13', ',', '20', ')', '.']	[0, 13, 15, 21, 29, 35, 40, 53, 56, 58, 65, 73, 76, 80, 83, 86, 90, 99, 101, 102, 103, 105, 107, 116, 120, 125, 127, 130, 135, 140, 142, 144, 148, 153, 165, 170, 171, 173, 175, 176, 178, 185, 191, 200, 209, 213, 224, 237, 241, 246, 254, 255, 257, 259, 261, 262]	[13, 14, 20, 28, 34, 39, 52, 55, 57, 64, 72, 75, 79, 83, 86, 89, 98, 101, 102, 103, 104, 106, 115, 120, 125, 127, 129, 134, 140, 142, 144, 148, 152, 164, 169, 171, 173, 175, 176, 177, 184, 190, 199, 208, 212, 223, 236, 240, 245, 253, 255, 257, 258, 261, 262, 263]	['Interestingly', ',', 'these', 'repeats', 'share', 'fold', 'similarities', 'to', 'a', 'domain', 'present', 'in', 'the', 'metzincin', 'protease', 'StcE', ',', 'a', 'secreted', 'glycoprotease', 'from', 'enterohemorrhagic', 'Escherichia', 'coli', '(', 'EHEC', ')', ',', 'though', 'their', 'detailed', 'sequence', 'and', 'structural', 'similarities', 'are', 'very', 'limited', '(', '13', ',', '20', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 4, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
StcE is also a T2SS-secreted protease known to target highly O-glycosylated epithelial substrates, such as CD55 (16, 17, 21,–23).	[('PMC7542363', 'I03007', 29, 37, 'protease')]	['St', '##c', '##E', 'is', 'also', 'a', 'T', '##2', '##SS', '-', 'secreted', 'protease', 'known', 'to', 'target', 'highly', 'O', '-', 'glycos', '##ylated', 'epithelial', 'substrates', ',', 'such', 'as', 'CD', '##55', '(', '16', ',', '17', ',', '21', ',', '–', '23', ')', '.']	[0, 2, 3, 5, 8, 13, 15, 16, 17, 19, 20, 29, 38, 44, 47, 54, 61, 62, 63, 69, 76, 87, 97, 99, 104, 107, 109, 112, 113, 115, 117, 119, 121, 123, 124, 125, 127, 128]	[2, 3, 4, 7, 12, 14, 16, 17, 19, 20, 28, 37, 43, 46, 53, 60, 62, 63, 69, 75, 86, 97, 98, 103, 106, 109, 111, 113, 115, 116, 119, 120, 123, 124, 125, 127, 128, 129]	['StcE', 'is', 'also', 'a', 'T2SS-secreted', 'protease', 'known', 'to', 'target', 'highly', 'O-glycosylated', 'epithelial', 'substrates', ',', 'such', 'as', 'CD55', '(', '16', ',', '17', ',', '21', ',', '–23', ')', '.']	[3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR was carried out using Phusion DNA polymerase (Thermo Scientific).	[('PMC7542363', 'M02002', 34, 48, 'DNA polymerase')]	['PCR', 'was', 'carried', 'out', 'using', 'Ph', '##usion', 'DNA', 'polymerase', '(', 'Thermo', 'Scientific', ')', '.']	[0, 4, 8, 16, 20, 26, 28, 34, 38, 49, 50, 57, 67, 68]	[3, 7, 15, 19, 25, 28, 33, 37, 48, 50, 56, 67, 68, 69]	['PCR', 'was', 'carried', 'out', 'using', 'Phusion', 'DNA', 'polymerase', '(', 'Thermo', 'Scientific', ')', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
Protein samples were analyzed by SDS-PAGE, transferred to a nitrocellulose membrane, probed with polyclonal anti-CpaA (1:1,000) (8) and/or monoclonal anti-RNA polymerase (1:2,000; BioLegend).	[('PMC7542363', 'M05003', 150, 169, 'anti-RNA polymerase')]	['Protein', 'samples', 'were', 'analyzed', 'by', 'SDS', '-', 'PA', '##GE', ',', 'transferred', 'to', 'a', 'nitro', '##cellulose', 'membrane', ',', 'probed', 'with', 'polyclonal', 'anti', '-', 'Cp', '##a', '##A', '(', '1', ':', '1', ',', '000', ')', '(', '8', ')', 'and', '/', 'or', 'monoclonal', 'anti', '-', 'RNA', 'polymerase', '(', '1', ':', '2', ',', '000', ';', 'Bio', '##Le', '##gend', ')', '.']	[0, 8, 16, 21, 30, 33, 36, 37, 39, 41, 43, 55, 58, 60, 65, 75, 83, 85, 92, 97, 108, 112, 113, 115, 116, 118, 119, 120, 121, 122, 123, 126, 128, 129, 130, 132, 135, 136, 139, 150, 154, 155, 159, 170, 171, 172, 173, 174, 175, 178, 180, 183, 185, 189, 190]	[7, 15, 20, 29, 32, 36, 37, 39, 41, 42, 54, 57, 59, 65, 74, 83, 84, 91, 96, 107, 112, 113, 115, 116, 117, 119, 120, 121, 122, 123, 126, 127, 129, 130, 131, 135, 136, 138, 149, 154, 155, 158, 169, 171, 172, 173, 174, 175, 178, 179, 183, 185, 189, 190, 191]	['Protein', 'samples', 'were', 'analyzed', 'by', 'SDS-PAGE', ',', 'transferred', 'to', 'a', 'nitrocellulose', 'membrane', ',', 'probed', 'with', 'polyclonal', 'anti-CpaA', '(', '1', ':', '1', ',', '000', ')', '(', '8', ')', 'and', '/', 'or', 'monoclonal', 'anti-RNA', 'polymerase', '(', '1', ':', '2', ',', '000', ';', 'BioLegend', ')', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This protein arranges its C-terminal tail into the CpaA catalytic site, similar to zymogens of related metallopeptidases (62), and we assume that this portion of CpaB is displaced by substrate.	[('PMC7542363', 'M14002', 103, 120, 'metallopeptidases')]	['This', 'protein', 'arrang', '##es', 'its', 'C', '-', 'terminal', 'tail', 'into', 'the', 'Cp', '##a', '##A', 'catalytic', 'site', ',', 'similar', 'to', 'z', '##ym', '##ogens', 'of', 'related', 'metall', '##ope', '##pt', '##idase', '##s', '(', '62', ')', ',', 'and', 'we', 'assume', 'that', 'this', 'portion', 'of', 'Cp', '##a', '##B', 'is', 'displaced', 'by', 'substrate', '.']	[0, 5, 13, 19, 22, 26, 27, 28, 37, 42, 47, 51, 53, 54, 56, 66, 70, 72, 80, 83, 84, 86, 92, 95, 103, 109, 112, 114, 119, 121, 122, 124, 125, 127, 131, 134, 141, 146, 151, 159, 162, 164, 165, 167, 170, 180, 183, 192]	[4, 12, 19, 21, 25, 27, 28, 36, 41, 46, 50, 53, 54, 55, 65, 70, 71, 79, 82, 84, 86, 91, 94, 102, 109, 112, 114, 119, 120, 122, 124, 125, 126, 130, 133, 140, 145, 150, 158, 161, 164, 165, 166, 169, 179, 182, 192, 193]	['This', 'protein', 'arranges', 'its', 'C-', 'terminal', 'tail', 'into', 'the', 'CpaA', 'catalytic', 'site', ',', 'similar', 'to', 'zymogens', 'of', 'related', 'metallopeptidases', '(', '62', ')', ',', 'and', 'we', 'assume', 'that', 'this', 'portion', 'of', 'CpaB', 'is', 'displaced', 'by', 'substrate', '.']	[1, 1, 2, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glycoproteases targeting mucins show a wide variability in terms of substrate preferences, even among members of the same family, and therefore, prediction of their targets is not possible (16, 21,–23, 26,–29).	[('PMC7542363', 'R00004', 0, 14, 'Glycoproteases')]	['Gly', '##cop', '##rote', '##ases', 'targeting', 'muc', '##ins', 'show', 'a', 'wide', 'variability', 'in', 'terms', 'of', 'substrate', 'preferences', ',', 'even', 'among', 'members', 'of', 'the', 'same', 'family', ',', 'and', 'therefore', ',', 'prediction', 'of', 'their', 'targets', 'is', 'not', 'possible', '(', '16', ',', '21', ',', '–', '23', ',', '26', ',', '–', '29', ')', '.']	[0, 3, 6, 10, 15, 25, 28, 32, 37, 39, 44, 56, 59, 65, 68, 78, 89, 91, 96, 102, 110, 113, 117, 122, 128, 130, 134, 143, 145, 156, 159, 165, 173, 176, 180, 189, 190, 192, 194, 196, 197, 198, 200, 202, 204, 205, 206, 208, 209]	[3, 6, 10, 14, 24, 28, 31, 36, 38, 43, 55, 58, 64, 67, 77, 89, 90, 95, 101, 109, 112, 116, 121, 128, 129, 133, 143, 144, 155, 158, 164, 172, 175, 179, 188, 190, 192, 193, 196, 197, 198, 200, 201, 204, 205, 206, 208, 209, 210]	['Glycoproteases', 'targeting', 'mucins', 'show', 'a', 'wide', 'variability', 'in', 'terms', 'of', 'substrate', 'preferences', ',', 'even', 'among', 'members', 'of', 'the', 'same', 'family', ',', 'and', 'therefore', ',', 'prediction', 'of', 'their', 'targets', 'is', 'not', 'possible', '(', '16', ',', '21', ',', '–23', ',', '26', ',', '–29', ')', '.']	[4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CpaA and CpaAE520A were incubated overnight with several medically relevant and commercially available glycoproteins (CD55, CD46, TIM1, TIM4, and C1 esterase inhibitor [C1-INH]), for which their glycosylation is at least partially characterized.	[('PMC7542363', 'R00006', 146, 157, 'C1 esterase')]	['Cp', '##a', '##A', 'and', 'Cp', '##a', '##AE', '##52', '##0', '##A', 'were', 'incubated', 'overnight', 'with', 'several', 'medical', '##ly', 'relevant', 'and', 'commercially', 'available', 'glycoprotein', '##s', '(', 'CD', '##55', ',', 'CD', '##46', ',', 'TI', '##M', '##1', ',', 'TI', '##M', '##4', ',', 'and', 'C', '##1', 'ester', '##ase', 'inhibitor', '[', 'C', '##1', '-', 'IN', '##H', ']', ')', ',', 'for', 'which', 'their', 'glycosylation', 'is', 'at', 'least', 'partially', 'characterized', '.']	[0, 2, 3, 5, 9, 11, 12, 14, 16, 17, 19, 24, 34, 44, 49, 57, 64, 67, 76, 80, 93, 103, 115, 117, 118, 120, 122, 124, 126, 128, 130, 132, 133, 134, 136, 138, 139, 140, 142, 146, 147, 149, 154, 158, 168, 169, 170, 171, 172, 174, 175, 176, 177, 179, 183, 189, 195, 209, 212, 215, 221, 231, 244]	[2, 3, 4, 8, 11, 12, 14, 16, 17, 18, 23, 33, 43, 48, 56, 64, 66, 75, 79, 92, 102, 115, 116, 118, 120, 122, 123, 126, 128, 129, 132, 133, 134, 135, 138, 139, 140, 141, 145, 147, 148, 154, 157, 167, 169, 170, 171, 172, 174, 175, 176, 177, 178, 182, 188, 194, 208, 211, 214, 220, 230, 244, 245]	['CpaA', 'and', 'CpaAE520A', 'were', 'incubated', 'overnight', 'with', 'several', 'medically', 'relevant', 'and', 'commercially', 'available', 'glycoproteins', '(', 'CD55', ',', 'CD46', ',', 'TIM1', ',', 'TIM4', ',', 'and', 'C1', 'esterase', 'inhibitor', '[', 'C1-INH', ']', ')', ',', 'for', 'which', 'their', 'glycosylation', 'is', 'at', 'least', 'partially', 'characterized', '.']	[3, 1, 6, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 2, 1, 3, 1, 3, 1, 1, 2, 2, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The activity of glycoproteases is differentially impacted by many factors, such as O-glycosylation density and glycan composition.	[('PMC7542363', 'R01000', 16, 30, 'glycoproteases')]	['The', 'activity', 'of', 'glyc', '##oprot', '##ea', '##ses', 'is', 'differentially', 'impacted', 'by', 'many', 'factors', ',', 'such', 'as', 'O', '-', 'glycosylation', 'density', 'and', 'glyc', '##an', 'composition', '.']	[0, 4, 13, 16, 20, 25, 27, 31, 34, 49, 58, 61, 66, 73, 75, 80, 83, 84, 85, 99, 107, 111, 115, 118, 129]	[3, 12, 15, 20, 25, 27, 30, 33, 48, 57, 60, 65, 73, 74, 79, 82, 84, 85, 98, 106, 110, 115, 117, 129, 130]	['The', 'activity', 'of', 'glycoproteases', 'is', 'differentially', 'impacted', 'by', 'many', 'factors', ',', 'such', 'as', 'O-glycosylation', 'density', 'and', 'glycan', 'composition', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For instance, StcE and TagA, a secreted glycoprotease from Vibrio cholerae, uniquely cleave heavily glycosylated proteins, such as mucins, but they cannot digest less O-glycosylated proteins, such as fetuin (Ft).	[('PMC7542363', 'R01001', 40, 53, 'glycoprotease')]	['For', 'instance', ',', 'St', '##c', '##E', 'and', 'Tag', '##A', ',', 'a', 'secreted', 'glyc', '##oprot', '##ea', '##se', 'from', 'Vi', '##br', '##io', 'chol', '##era', '##e', ',', 'uniquely', 'cle', '##ave', 'heavily', 'glycos', '##ylated', 'proteins', ',', 'such', 'as', 'muc', '##ins', ',', 'but', 'they', 'cannot', 'diges', '##t', 'less', 'O', '-', 'glycos', '##ylated', 'proteins', ',', 'such', 'as', 'fet', '##uin', '(', 'F', '##t', ')', '.']	[0, 4, 12, 14, 16, 17, 19, 23, 26, 27, 29, 31, 40, 44, 49, 51, 54, 59, 61, 63, 66, 70, 73, 74, 76, 85, 88, 92, 100, 106, 113, 121, 123, 128, 131, 134, 137, 139, 143, 148, 155, 160, 162, 167, 168, 169, 175, 182, 190, 192, 197, 200, 203, 207, 208, 209, 210, 211]	[3, 12, 13, 16, 17, 18, 22, 26, 27, 28, 30, 39, 44, 49, 51, 53, 58, 61, 63, 65, 70, 73, 74, 75, 84, 88, 91, 99, 106, 112, 121, 122, 127, 130, 134, 137, 138, 142, 147, 154, 160, 161, 166, 168, 169, 175, 181, 190, 191, 196, 199, 203, 206, 208, 209, 210, 211, 212]	['For', 'instance', ',', 'StcE', 'and', 'TagA', ',', 'a', 'secreted', 'glycoprotease', 'from', 'Vibrio', 'cholerae', ',', 'uniquely', 'cleave', 'heavily', 'glycosylated', 'proteins', ',', 'such', 'as', 'mucins', ',', 'but', 'they', 'cannot', 'digest', 'less', 'O-glycosylated', 'proteins', ',', 'such', 'as', 'fetuin', '(', 'Ft', ')', '.']	[1, 1, 1, 3, 1, 2, 1, 1, 1, 4, 1, 3, 3, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, the activity of other glycoproteases, such as the gluzincin IMPa from Pseudomonas aeruginosa, is unaffected by the degree of O glycosylation (16).	[('PMC7542363', 'R01003', 35, 49, 'glycoproteases')]	['In', 'contrast', ',', 'the', 'activity', 'of', 'other', 'glyc', '##oprot', '##ea', '##ses', ',', 'such', 'as', 'the', 'glu', '##zin', '##cin', 'IMP', '##a', 'from', 'Pseudomonas', 'aeruginosa', ',', 'is', 'unaffected', 'by', 'the', 'degree', 'of', 'O', 'glycosylation', '(', '16', ')', '.']	[0, 3, 11, 13, 17, 26, 29, 35, 39, 44, 46, 49, 51, 56, 59, 63, 66, 69, 73, 76, 78, 83, 95, 105, 107, 110, 121, 124, 128, 135, 138, 140, 154, 155, 157, 158]	[2, 11, 12, 16, 25, 28, 34, 39, 44, 46, 49, 50, 55, 58, 62, 66, 69, 72, 76, 77, 82, 94, 105, 106, 109, 120, 123, 127, 134, 137, 139, 153, 155, 157, 158, 159]	['In', 'contrast', ',', 'the', 'activity', 'of', 'other', 'glycoproteases', ',', 'such', 'as', 'the', 'gluzincin', 'IMPa', 'from', 'Pseudomonas', 'aeruginosa', ',', 'is', 'unaffected', 'by', 'the', 'degree', 'of', 'O', 'glycosylation', '(', '16', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The activity of various glycoproteases can be dependent on, inhibited by, or unaffected by the presence of sialic acid, a negatively charged 9-C sugar with key biological functions (34).	[('PMC7542363', 'R03000', 24, 38, 'glycoproteases')]	['The', 'activity', 'of', 'various', 'glyc', '##oprot', '##ea', '##ses', 'can', 'be', 'dependent', 'on', ',', 'inhibited', 'by', ',', 'or', 'unaffected', 'by', 'the', 'presence', 'of', 'sial', '##ic', 'acid', ',', 'a', 'negatively', 'charged', '9', '-', 'C', 'sugar', 'with', 'key', 'biological', 'functions', '(', '34', ')', '.']	[0, 4, 13, 16, 24, 28, 33, 35, 39, 43, 46, 56, 58, 60, 70, 72, 74, 77, 88, 91, 95, 104, 107, 111, 114, 118, 120, 122, 133, 141, 142, 143, 145, 151, 156, 160, 171, 181, 182, 184, 185]	[3, 12, 15, 23, 28, 33, 35, 38, 42, 45, 55, 58, 59, 69, 72, 73, 76, 87, 90, 94, 103, 106, 111, 113, 118, 119, 121, 132, 140, 142, 143, 144, 150, 155, 159, 170, 180, 182, 184, 185, 186]	['The', 'activity', 'of', 'various', 'glycoproteases', 'can', 'be', 'dependent', 'on', ',', 'inhibited', 'by', ',', 'or', 'unaffected', 'by', 'the', 'presence', 'of', 'sialic', 'acid', ',', 'a', 'negatively', 'charged', '9-C', 'sugar', 'with', 'key', 'biological', 'functions', '(', '34', ')', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For example, glycoproteases from Mannheimia haemolytica and Clostridium perfringens require sialic acid for activity, whereas other glycoproteases are inhibited by this sugar (16, 35, 36).	[('PMC7542363', 'R03001', 13, 27, 'glycoproteases'), ('PMC7542363', 'R03001', 132, 146, 'glycoproteases')]	['For', 'example', ',', 'glyc', '##oprot', '##ea', '##ses', 'from', 'Mann', '##heim', '##ia', 'haem', '##olytic', '##a', 'and', 'Clostr', '##idium', 'perf', '##ring', '##ens', 'require', 'sial', '##ic', 'acid', 'for', 'activity', ',', 'whereas', 'other', 'glyc', '##oprot', '##ea', '##ses', 'are', 'inhibited', 'by', 'this', 'sugar', '(', '16', ',', '35', ',', '36', ')', '.']	[0, 4, 11, 13, 17, 22, 24, 28, 33, 37, 41, 44, 48, 54, 56, 60, 66, 72, 76, 80, 84, 92, 96, 99, 104, 108, 116, 118, 126, 132, 136, 141, 143, 147, 151, 161, 164, 169, 175, 176, 178, 180, 182, 184, 186, 187]	[3, 11, 12, 17, 22, 24, 27, 32, 37, 41, 43, 48, 54, 55, 59, 66, 71, 76, 80, 83, 91, 96, 98, 103, 107, 116, 117, 125, 131, 136, 141, 143, 146, 150, 160, 163, 168, 174, 176, 178, 179, 182, 183, 186, 187, 188]	['For', 'example', ',', 'glycoproteases', 'from', 'Mannheimia', 'haemolytica', 'and', 'Clostridium', 'perfringens', 'require', 'sialic', 'acid', 'for', 'activity', ',', 'whereas', 'other', 'glycoproteases', 'are', 'inhibited', 'by', 'this', 'sugar', '(', '16', ',', '35', ',', '36', ')', '.']	[1, 1, 1, 4, 1, 3, 3, 1, 2, 3, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
StcE is an example of a glycoprotease that is indifferent to sialic acid (22).	[('PMC7542363', 'R03002', 24, 37, 'glycoprotease')]	['St', '##c', '##E', 'is', 'an', 'example', 'of', 'a', 'glyc', '##oprot', '##ea', '##se', 'that', 'is', 'indiff', '##erent', 'to', 'sial', '##ic', 'acid', '(', '22', ')', '.']	[0, 2, 3, 5, 8, 11, 19, 22, 24, 28, 33, 35, 38, 43, 46, 52, 58, 61, 65, 68, 73, 74, 76, 77]	[2, 3, 4, 7, 10, 18, 21, 23, 28, 33, 35, 37, 42, 45, 52, 57, 60, 65, 67, 72, 74, 76, 77, 78]	['StcE', 'is', 'an', 'example', 'of', 'a', 'glycoprotease', 'that', 'is', 'indifferent', 'to', 'sialic', 'acid', '(', '22', ')', '.']	[3, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A similar lack of binding has been reported for other glycoproteases, which may be due to low-affinity or transient interactions with the glycans (41).	[('PMC7542363', 'R07005', 54, 68, 'glycoproteases')]	['A', 'similar', 'lack', 'of', 'binding', 'has', 'been', 'reported', 'for', 'other', 'glyc', '##oprot', '##ea', '##ses', ',', 'which', 'may', 'be', 'due', 'to', 'low', '-', 'affinity', 'or', 'transient', 'interactions', 'with', 'the', 'glyc', '##ans', '(', '41', ')', '.']	[0, 2, 10, 15, 18, 26, 30, 35, 44, 48, 54, 58, 63, 65, 68, 70, 76, 80, 83, 87, 90, 93, 94, 103, 106, 116, 129, 134, 138, 142, 146, 147, 149, 150]	[1, 9, 14, 17, 25, 29, 34, 43, 47, 53, 58, 63, 65, 68, 69, 75, 79, 82, 86, 89, 93, 94, 102, 105, 115, 128, 133, 137, 142, 145, 147, 149, 150, 151]	['A', 'similar', 'lack', 'of', 'binding', 'has', 'been', 'reported', 'for', 'other', 'glycoproteases', ',', 'which', 'may', 'be', 'due', 'to', 'low', '-', 'affinity', 'or', 'transient', 'interactions', 'with', 'the', 'glycans', '(', '41', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CD55 and CD46 levels remained unchanged when cells were infected with A. nosocomialis M2 secreting CpaAE520A, indicating that A. nosocomialis M2 does not secrete any other proteases targeting either glycoprotein (Fig. 5).	[('PMC7542363', 'R10001', 172, 181, 'proteases')]	['CD', '##55', 'and', 'CD', '##46', 'levels', 'remained', 'unchanged', 'when', 'cells', 'were', 'infected', 'with', 'A', '.', 'nos', '##oco', '##mia', '##lis', 'M', '##2', 'secret', '##ing', 'Cp', '##a', '##AE', '##52', '##0', '##A', ',', 'indicating', 'that', 'A', '.', 'nos', '##oco', '##mia', '##lis', 'M', '##2', 'does', 'not', 'secrete', 'any', 'other', 'proteases', 'targeting', 'either', 'glycoprotein', '(', 'Fig', '.', '5', ')', '.']	[0, 2, 5, 9, 11, 14, 21, 30, 40, 45, 51, 56, 65, 70, 71, 73, 76, 79, 82, 86, 87, 89, 95, 99, 101, 102, 104, 106, 107, 108, 110, 121, 126, 127, 129, 132, 135, 138, 142, 143, 145, 150, 154, 162, 166, 172, 182, 192, 199, 212, 213, 216, 218, 219, 220]	[2, 4, 8, 11, 13, 20, 29, 39, 44, 50, 55, 64, 69, 71, 72, 76, 79, 82, 85, 87, 88, 95, 98, 101, 102, 104, 106, 107, 108, 109, 120, 125, 127, 128, 132, 135, 138, 141, 143, 144, 149, 153, 161, 165, 171, 181, 191, 198, 211, 213, 216, 217, 219, 220, 221]	['CD55', 'and', 'CD46', 'levels', 'remained', 'unchanged', 'when', 'cells', 'were', 'infected', 'with', 'A', '.', 'nosocomialis', 'M2', 'secreting', 'CpaAE520A', ',', 'indicating', 'that', 'A', '.', 'nosocomialis', 'M2', 'does', 'not', 'secrete', 'any', 'other', 'proteases', 'targeting', 'either', 'glycoprotein', '(', 'Fig', '.', '5', ')', '.']	[2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 2, 6, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
X-ray structures of the related gluzincin glycopeptidases BT4244	[('PMC7542363', 'R12001', 32, 57, 'gluzincin glycopeptidases')]	['X', '-', 'ray', 'structures', 'of', 'the', 'related', 'glu', '##zin', '##cin', 'glyc', '##ope', '##pt', '##idase', '##s', 'BT', '##42', '##44']	[0, 1, 2, 6, 17, 20, 24, 32, 35, 38, 42, 46, 49, 51, 56, 58, 60, 62]	[1, 2, 5, 16, 19, 23, 31, 35, 38, 41, 46, 49, 51, 56, 57, 60, 62, 64]	['X-ray', 'structures', 'of', 'the', 'related', 'gluzincin', 'glycopeptidases', 'BT4244']	[3, 1, 1, 1, 1, 3, 5, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
RNA polymerase was used as loading and lysis controls for whole cell and supernatant samples, respectively.	[('PMC7542363', 'R18004', 0, 14, 'RNA polymerase')]	['RNA', 'polymerase', 'was', 'used', 'as', 'loading', 'and', 'lysis', 'controls', 'for', 'whole', 'cell', 'and', 'supernatant', 'samples', ',', 'respectively', '.']	[0, 4, 15, 19, 24, 27, 35, 39, 45, 54, 58, 64, 69, 73, 85, 92, 94, 106]	[3, 14, 18, 23, 26, 34, 38, 44, 53, 57, 63, 68, 72, 84, 92, 93, 106, 107]	['RNA', 'polymerase', 'was', 'used', 'as', 'loading', 'and', 'lysis', 'controls', 'for', 'whole', 'cell', 'and', 'supernatant', 'samples', ',', 'respectively', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mounting evidence indicates that both commensal and pathogenic species produce and secrete glycoproteases to modulate adherence, penetrate the inner mucus layer, or evade the host immune response (18, 21, 47).	[('PMC7542363', 'R21000', 91, 105, 'glycoproteases')]	['Moun', '##ting', 'evidence', 'indicates', 'that', 'both', 'commens', '##al', 'and', 'pathogenic', 'species', 'produce', 'and', 'secrete', 'glyc', '##oprot', '##ea', '##ses', 'to', 'modulate', 'adherence', ',', 'penetrate', 'the', 'inner', 'mucus', 'layer', ',', 'or', 'ev', '##ade', 'the', 'host', 'immune', 'response', '(', '18', ',', '21', ',', '47', ')', '.']	[0, 4, 9, 18, 28, 33, 38, 45, 48, 52, 63, 71, 79, 83, 91, 95, 100, 102, 106, 109, 118, 127, 129, 139, 143, 149, 155, 160, 162, 165, 167, 171, 175, 180, 187, 196, 197, 199, 201, 203, 205, 207, 208]	[4, 8, 17, 27, 32, 37, 45, 47, 51, 62, 70, 78, 82, 90, 95, 100, 102, 105, 108, 117, 127, 128, 138, 142, 148, 154, 160, 161, 164, 167, 170, 174, 179, 186, 195, 197, 199, 200, 203, 204, 207, 208, 209]	['Mounting', 'evidence', 'indicates', 'that', 'both', 'commensal', 'and', 'pathogenic', 'species', 'produce', 'and', 'secrete', 'glycoproteases', 'to', 'modulate', 'adherence', ',', 'penetrate', 'the', 'inner', 'mucus', 'layer', ',', 'or', 'evade', 'the', 'host', 'immune', 'response', '(', '18', ',', '21', ',', '47', ')', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These examples are indicative of the pivotal role of glycoproteases in modulating host-pathogen interactions by targeting various host proteins.	[('PMC7542363', 'R21006', 53, 67, 'glycoproteases')]	['These', 'examples', 'are', 'indicative', 'of', 'the', 'pivotal', 'role', 'of', 'glyc', '##oprot', '##ea', '##ses', 'in', 'modulating', 'host', '-', 'pathogen', 'interactions', 'by', 'targeting', 'various', 'host', 'proteins', '.']	[0, 6, 15, 19, 30, 33, 37, 45, 50, 53, 57, 62, 64, 68, 71, 82, 86, 87, 96, 109, 112, 122, 130, 135, 143]	[5, 14, 18, 29, 32, 36, 44, 49, 52, 57, 62, 64, 67, 70, 81, 86, 87, 95, 108, 111, 121, 129, 134, 143, 144]	['These', 'examples', 'are', 'indicative', 'of', 'the', 'pivotal', 'role', 'of', 'glycoproteases', 'in', 'modulating', 'host', '-', 'pathogen', 'interactions', 'by', 'targeting', 'various', 'host', 'proteins', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Despite their relevance, only a relatively small number of bacterial glycoproteases have been biochemically characterized to various extents (Table 1).	[('PMC7542363', 'R21007', 59, 83, 'bacterial glycoproteases')]	['Despite', 'their', 'relevance', ',', 'only', 'a', 'relatively', 'small', 'number', 'of', 'bacterial', 'glyc', '##oprot', '##ea', '##ses', 'have', 'been', 'biochemical', '##ly', 'characterized', 'to', 'various', 'extent', '##s', '(', 'Table', '1', ')', '.']	[0, 8, 14, 23, 25, 30, 32, 43, 49, 56, 59, 69, 73, 78, 80, 84, 89, 94, 105, 108, 122, 125, 133, 139, 141, 142, 148, 149, 150]	[7, 13, 23, 24, 29, 31, 42, 48, 55, 58, 68, 73, 78, 80, 83, 88, 93, 105, 107, 121, 124, 132, 139, 140, 142, 147, 149, 150, 151]	['Despite', 'their', 'relevance', ',', 'only', 'a', 'relatively', 'small', 'number', 'of', 'bacterial', 'glycoproteases', 'have', 'been', 'biochemically', 'characterized', 'to', 'various', 'extents', '(', 'Table', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These glycoproteases differ in their secretion mechanisms, protease class, domain organization, catalytic site, and recognized targets.	[('PMC7542363', 'R21009', 6, 20, 'glycoproteases'), ('PMC7542363', 'R21009', 59, 67, 'protease')]	['These', 'glyc', '##oprot', '##ea', '##ses', 'differ', 'in', 'their', 'secretion', 'mechanisms', ',', 'protease', 'class', ',', 'domain', 'organization', ',', 'catalytic', 'site', ',', 'and', 'recognized', 'targets', '.']	[0, 6, 10, 15, 17, 21, 28, 31, 37, 47, 57, 59, 68, 73, 75, 82, 94, 96, 106, 110, 112, 116, 127, 134]	[5, 10, 15, 17, 20, 27, 30, 36, 46, 57, 58, 67, 73, 74, 81, 94, 95, 105, 110, 111, 115, 126, 134, 135]	['These', 'glycoproteases', 'differ', 'in', 'their', 'secretion', 'mechanisms', ',', 'protease', 'class', ',', 'domain', 'organization', ',', 'catalytic', 'site', ',', 'and', 'recognized', 'targets', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CpaA, IMPa, and ZmpC display broad O-glycoprotease activity targeting mucins, regardless of their glycosylation density, as well as O-glycoproteins with low O-glycan chain density (fetuin).	[('PMC7542363', 'R21011', 35, 50, 'O-glycoprotease')]	['Cp', '##a', '##A', ',', 'IMP', '##a', ',', 'and', 'Z', '##mp', '##C', 'display', 'broad', 'O', '-', 'glyc', '##oprot', '##ea', '##se', 'activity', 'targeting', 'muc', '##ins', ',', 'regardless', 'of', 'their', 'glycosylation', 'density', ',', 'as', 'well', 'as', 'O', '-', 'glycoprotein', '##s', 'with', 'low', 'O', '-', 'glyc', '##an', 'chain', 'density', '(', 'fet', '##uin', ')', '.']	[0, 2, 3, 4, 6, 9, 10, 12, 16, 17, 19, 21, 29, 35, 36, 37, 41, 46, 48, 51, 60, 70, 73, 76, 78, 89, 92, 98, 112, 119, 121, 124, 129, 132, 133, 134, 146, 148, 153, 157, 158, 159, 163, 166, 172, 180, 181, 184, 187, 188]	[2, 3, 4, 5, 9, 10, 11, 15, 17, 19, 20, 28, 34, 36, 37, 41, 46, 48, 50, 59, 69, 73, 76, 77, 88, 91, 97, 111, 119, 120, 123, 128, 131, 133, 134, 146, 147, 152, 156, 158, 159, 163, 165, 171, 179, 181, 184, 187, 188, 189]	['CpaA', ',', 'IMPa', ',', 'and', 'ZmpC', 'display', 'broad', 'O-glycoprotease', 'activity', 'targeting', 'mucins', ',', 'regardless', 'of', 'their', 'glycosylation', 'density', ',', 'as', 'well', 'as', 'O-glycoproteins', 'with', 'low', 'O-glycan', 'chain', 'density', '(', 'fetuin', ')', '.']	[3, 1, 2, 1, 1, 3, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, other glycoproteases can target only a subset of mucins.	[('PMC7542363', 'R21013', 19, 33, 'glycoproteases')]	['In', 'contrast', ',', 'other', 'glyc', '##oprot', '##ea', '##ses', 'can', 'target', 'only', 'a', 'subset', 'of', 'muc', '##ins', '.']	[0, 3, 11, 13, 19, 23, 28, 30, 34, 38, 45, 50, 52, 59, 62, 65, 68]	[2, 11, 12, 18, 23, 28, 30, 33, 37, 44, 49, 51, 58, 61, 65, 68, 69]	['In', 'contrast', ',', 'other', 'glycoproteases', 'can', 'target', 'only', 'a', 'subset', 'of', 'mucins', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Due to low amino acid sequence conservation, it is not possible to differentiate proteases from glycoproteases solely on the basis of primary amino acid sequence.	[('PMC7542363', 'R22000', 81, 90, 'proteases'), ('PMC7542363', 'R22000', 96, 110, 'glycoproteases')]	['Due', 'to', 'low', 'amino', 'acid', 'sequence', 'conservation', ',', 'it', 'is', 'not', 'possible', 'to', 'differentiate', 'proteases', 'from', 'glyc', '##oprot', '##ea', '##ses', 'solely', 'on', 'the', 'basis', 'of', 'primary', 'amino', 'acid', 'sequence', '.']	[0, 4, 7, 11, 17, 22, 31, 43, 45, 48, 51, 55, 64, 67, 81, 91, 96, 100, 105, 107, 111, 118, 121, 125, 131, 134, 142, 148, 153, 161]	[3, 6, 10, 16, 21, 30, 43, 44, 47, 50, 54, 63, 66, 80, 90, 95, 100, 105, 107, 110, 117, 120, 124, 130, 133, 141, 147, 152, 161, 162]	['Due', 'to', 'low', 'amino', 'acid', 'sequence', 'conservation', ',', 'it', 'is', 'not', 'possible', 'to', 'differentiate', 'proteases', 'from', 'glycoproteases', 'solely', 'on', 'the', 'basis', 'of', 'primary', 'amino', 'acid', 'sequence', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, several factors impact substrate targeting by glycoprotease, including glycan chain identity and density, as well as amino acid composition (Table 1).	[('PMC7542363', 'R22002', 56, 69, 'glycoprotease')]	['Moreover', ',', 'several', 'factors', 'impact', 'substrate', 'targeting', 'by', 'glyc', '##oprot', '##ea', '##se', ',', 'including', 'glyc', '##an', 'chain', 'identity', 'and', 'density', ',', 'as', 'well', 'as', 'amino', 'acid', 'composition', '(', 'Table', '1', ')', '.']	[0, 8, 10, 18, 26, 33, 43, 53, 56, 60, 65, 67, 69, 71, 81, 85, 88, 94, 103, 107, 114, 116, 119, 124, 127, 133, 138, 150, 151, 157, 158, 159]	[8, 9, 17, 25, 32, 42, 52, 55, 60, 65, 67, 69, 70, 80, 85, 87, 93, 102, 106, 114, 115, 118, 123, 126, 132, 137, 149, 151, 156, 158, 159, 160]	['Moreover', ',', 'several', 'factors', 'impact', 'substrate', 'targeting', 'by', 'glycoprotease', ',', 'including', 'glycan', 'chain', 'identity', 'and', 'density', ',', 'as', 'well', 'as', 'amino', 'acid', 'composition', '(', 'Table', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thus, even if structural analyses identify putative glycan-binding domains in a protein of interest, it is difficult to predict the specific substrates targeted by the putative glycoprotease.	[('PMC7542363', 'R22004', 177, 190, 'glycoprotease')]	['Thus', ',', 'even', 'if', 'structural', 'analyses', 'identify', 'putative', 'glyc', '##an', '-', 'binding', 'domains', 'in', 'a', 'protein', 'of', 'interest', ',', 'it', 'is', 'difficult', 'to', 'predict', 'the', 'specific', 'substrates', 'targeted', 'by', 'the', 'putative', 'glyc', '##oprot', '##ea', '##se', '.']	[0, 4, 6, 11, 14, 25, 34, 43, 52, 56, 58, 59, 67, 75, 78, 80, 88, 91, 99, 101, 104, 107, 117, 120, 128, 132, 141, 152, 161, 164, 168, 177, 181, 186, 188, 190]	[4, 5, 10, 13, 24, 33, 42, 51, 56, 58, 59, 66, 74, 77, 79, 87, 90, 99, 100, 103, 106, 116, 119, 127, 131, 140, 151, 160, 163, 167, 176, 181, 186, 188, 190, 191]	['Thus', ',', 'even', 'if', 'structural', 'analyses', 'identify', 'putative', 'glycan', '-', 'binding', 'domains', 'in', 'a', 'protein', 'of', 'interest', ',', 'it', 'is', 'difficult', 'to', 'predict', 'the', 'specific', 'substrates', 'targeted', 'by', 'the', 'putative', 'glycoprotease', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Together with the functional analysis, these studies define a functional class of secreted O-glycoproteases that mediate host-pathogen and host-commensal interactions.	[('PMC7542363', 'R22005', 91, 107, 'O-glycoproteases')]	['Together', 'with', 'the', 'functional', 'analysis', ',', 'these', 'studies', 'define', 'a', 'functional', 'class', 'of', 'secreted', 'O', '-', 'glyc', '##oprot', '##ea', '##ses', 'that', 'mediate', 'host', '-', 'pathogen', 'and', 'host', '-', 'commens', '##al', 'interactions', '.']	[0, 9, 14, 18, 29, 37, 39, 45, 53, 60, 62, 73, 79, 82, 91, 92, 93, 97, 102, 104, 108, 113, 121, 125, 126, 135, 139, 143, 144, 151, 154, 166]	[8, 13, 17, 28, 37, 38, 44, 52, 59, 61, 72, 78, 81, 90, 92, 93, 97, 102, 104, 107, 112, 120, 125, 126, 134, 138, 143, 144, 151, 153, 166, 167]	['Together', 'with', 'the', 'functional', 'analysis', ',', 'these', 'studies', 'define', 'a', 'functional', 'class', 'of', 'secreted', 'O-glycoproteases', 'that', 'mediate', 'host', '-', 'pathogen', 'and', 'host', '-', 'commensal', 'interactions', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The results of antioxidant analyses and antibiotic sensitivity, blood survival, lipase, and hemolysis assays validated the proteomic results.	[('PMC7677002', 'A00009', 80, 86, 'lipase')]	['The', 'results', 'of', 'antioxidant', 'analyses', 'and', 'antibiotic', 'sensitivity', ',', 'blood', 'survival', ',', 'lipase', ',', 'and', 'hem', '##olysis', 'assays', 'validated', 'the', 'proteomic', 'results', '.']	[0, 4, 12, 15, 27, 36, 40, 51, 62, 64, 70, 78, 80, 86, 88, 92, 95, 102, 109, 119, 123, 133, 140]	[3, 11, 14, 26, 35, 39, 50, 62, 63, 69, 78, 79, 86, 87, 91, 95, 101, 108, 118, 122, 132, 140, 141]	['The', 'results', 'of', 'antioxidant', 'analyses', 'and', 'antibiotic', 'sensitivity', ',', 'blood', 'survival', ',', 'lipase', ',', 'and', 'hemolysis', 'assays', 'validated', 'the', 'proteomic', 'results', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The results unveiled the downregulation of the gene expression of the response regulator of the biofilm-associated TCS (bfmR), the biofilm-associated protein (bap), the CsuA/BABCDE chaperone-usher complex (csuA-csuB), the outer membrane protein (ompA), the PNAG-encoding locus (pgaA and pgaC), catalase (katE), and superoxide dismutase (sodB), and they were well correlated with the results of the proteomic analysis.	[('PMC7677002', 'D02003', 294, 302, 'catalase'), ('PMC7677002', 'D02003', 315, 335, 'superoxide dismutase')]	['The', 'results', 'un', '##ve', '##iled', 'the', 'downregulation', 'of', 'the', 'gene', 'expression', 'of', 'the', 'response', 'regulator', 'of', 'the', 'biofilm', '-', 'associated', 'TC', '##S', '(', 'b', '##fm', '##R', ')', ',', 'the', 'biofilm', '-', 'associated', 'protein', '(', 'ba', '##p', ')', ',', 'the', 'Cs', '##u', '##A', '/', 'BA', '##BC', '##DE', 'chaperone', '-', 'us', '##her', 'complex', '(', 'cs', '##u', '##A', '-', 'cs', '##u', '##B', ')', ',', 'the', 'outer', 'membrane', 'protein', '(', 'om', '##p', '##A', ')', ',', 'the', 'PN', '##AG', '-', 'encoding', 'locus', '(', 'pg', '##a', '##A', 'and', 'pg', '##a', '##C', ')', ',', 'catalase', '(', 'ka', '##t', '##E', ')', ',', 'and', 'superoxide', 'dismutase', '(', 'so', '##dB', ')', ',', 'and', 'they', 'were', 'well', 'correlated', 'with', 'the', 'results', 'of', 'the', 'proteomic', 'analysis', '.']	[0, 4, 12, 14, 16, 21, 25, 40, 43, 47, 52, 63, 66, 70, 79, 89, 92, 96, 103, 104, 115, 117, 119, 120, 121, 123, 124, 125, 127, 131, 138, 139, 150, 158, 159, 161, 162, 163, 165, 169, 171, 172, 173, 174, 176, 178, 181, 190, 191, 193, 197, 205, 206, 208, 209, 210, 211, 213, 214, 215, 216, 218, 222, 228, 237, 245, 246, 248, 249, 250, 251, 253, 257, 259, 261, 262, 271, 277, 278, 280, 281, 283, 287, 289, 290, 291, 292, 294, 303, 304, 306, 307, 308, 309, 311, 315, 326, 336, 337, 339, 341, 342, 344, 348, 353, 358, 363, 374, 379, 383, 391, 394, 398, 408, 416]	[3, 11, 14, 16, 20, 24, 39, 42, 46, 51, 62, 65, 69, 78, 88, 91, 95, 103, 104, 114, 117, 118, 120, 121, 123, 124, 125, 126, 130, 138, 139, 149, 157, 159, 161, 162, 163, 164, 168, 171, 172, 173, 174, 176, 178, 180, 190, 191, 193, 196, 204, 206, 208, 209, 210, 211, 213, 214, 215, 216, 217, 221, 227, 236, 244, 246, 248, 249, 250, 251, 252, 256, 259, 261, 262, 270, 276, 278, 280, 281, 282, 286, 289, 290, 291, 292, 293, 302, 304, 306, 307, 308, 309, 310, 314, 325, 335, 337, 339, 341, 342, 343, 347, 352, 357, 362, 373, 378, 382, 390, 393, 397, 407, 416, 417]	['The', 'results', 'unveiled', 'the', 'downregulation', 'of', 'the', 'gene', 'expression', 'of', 'the', 'response', 'regulator', 'of', 'the', 'biofilm', '-', 'associated', 'TCS', '(', 'bfmR', ')', ',', 'the', 'biofilm', '-', 'associated', 'protein', '(', 'bap', ')', ',', 'the', 'CsuA', '/', 'BABCDE', 'chaperone', '-', 'usher', 'complex', '(', 'csuA-csuB', ')', ',', 'the', 'outer', 'membrane', 'protein', '(', 'ompA', ')', ',', 'the', 'PNAG-encoding', 'locus', '(', 'pgaA', 'and', 'pgaC', ')', ',', 'catalase', '(', 'katE', ')', ',', 'and', 'superoxide', 'dismutase', '(', 'sodB', ')', ',', 'and', 'they', 'were', 'well', 'correlated', 'with', 'the', 'results', 'of', 'the', 'proteomic', 'analysis', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 3, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
adeH, adeF, adeG, plcD, and plc are associated with the efflux pump, autoinducer, transport, and lipase enzyme production.	[('PMC7677002', 'D05001', 97, 103, 'lipase')]	['ad', '##e', '##H', ',', 'ad', '##e', '##F', ',', 'ad', '##e', '##G', ',', 'pl', '##c', '##D', ',', 'and', 'pl', '##c', 'are', 'associated', 'with', 'the', 'efflux', 'pump', ',', 'auto', '##ind', '##uce', '##r', ',', 'transport', ',', 'and', 'lipase', 'enzyme', 'production', '.']	[0, 2, 3, 4, 6, 8, 9, 10, 12, 14, 15, 16, 18, 20, 21, 22, 24, 28, 30, 32, 36, 47, 52, 56, 63, 67, 69, 73, 76, 79, 80, 82, 91, 93, 97, 104, 111, 121]	[2, 3, 4, 5, 8, 9, 10, 11, 14, 15, 16, 17, 20, 21, 22, 23, 27, 30, 31, 35, 46, 51, 55, 62, 67, 68, 73, 76, 79, 80, 81, 91, 92, 96, 103, 110, 121, 122]	['adeH', ',', 'adeF', ',', 'adeG', ',', 'plcD', ',', 'and', 'plc', 'are', 'associated', 'with', 'the', 'efflux', 'pump', ',', 'autoinducer', ',', 'transport', ',', 'and', 'lipase', 'enzyme', 'production', '.']	[3, 1, 3, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O']
Furthermore, universal stress protein A (UspA) and antioxidant enzymes such as superoxide dismutase and catalase (Kat) of A. baumannii were downregulated in the citral-treated sample.	[('PMC7677002', 'D06006', 13, 39, 'universal stress protein A'), ('PMC7677002', 'D06006', 79, 99, 'superoxide dismutase'), ('PMC7677002', 'D06006', 104, 112, 'catalase')]	['Furthermore', ',', 'universal', 'stress', 'protein', 'A', '(', 'Us', '##p', '##A', ')', 'and', 'antioxidant', 'enzymes', 'such', 'as', 'superoxide', 'dismutase', 'and', 'catalase', '(', 'Kat', ')', 'of', 'A', '.', 'ba', '##umann', '##ii', 'were', 'downregulated', 'in', 'the', 'citr', '##al', '-', 'treated', 'sample', '.']	[0, 11, 13, 23, 30, 38, 40, 41, 43, 44, 45, 47, 51, 63, 71, 76, 79, 90, 100, 104, 113, 114, 117, 119, 122, 123, 125, 127, 132, 135, 140, 154, 157, 161, 165, 167, 168, 176, 182]	[11, 12, 22, 29, 37, 39, 41, 43, 44, 45, 46, 50, 62, 70, 75, 78, 89, 99, 103, 112, 114, 117, 118, 121, 123, 124, 127, 132, 134, 139, 153, 156, 160, 165, 167, 168, 175, 182, 183]	['Furthermore', ',', 'universal', 'stress', 'protein', 'A', '(', 'UspA', ')', 'and', 'antioxidant', 'enzymes', 'such', 'as', 'superoxide', 'dismutase', 'and', 'catalase', '(', 'Kat', ')', 'of', 'A', '.', 'baumannii', 'were', 'downregulated', 'in', 'the', 'citral', '-', 'treated', 'sample', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Antioxidant enzymes (Sod, Kat, and alkyl hydroperoxide reductase	[('PMC7677002', 'D06010', 35, 64, 'alkyl hydroperoxide reductase')]	['Anti', '##oxidant', 'enzymes', '(', 'So', '##d', ',', 'Kat', ',', 'and', 'alkyl', 'hydro', '##per', '##oxide', 'reductase']	[0, 4, 12, 20, 21, 23, 24, 26, 29, 31, 35, 41, 46, 49, 55]	[4, 11, 19, 21, 23, 24, 25, 29, 30, 34, 40, 46, 49, 54, 64]	['Antioxidant', 'enzymes', '(', 'Sod', ',', 'Kat', ',', 'and', 'alkyl', 'hydroperoxide', 'reductase']	[2, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E']
Citral treatment downregulated proteins that play an essential role in the TCA cycle, such as isocitrate lyase, isocitrate dehydrogenase, fumarate hydratase class II, malate synthase G, malate dehydrogenase, fructose-bisphosphate aldolase, and a glyoxalase family protein.	[('PMC7677002', 'D08015', 94, 110, 'isocitrate lyase'), ('PMC7677002', 'D08015', 112, 136, 'isocitrate dehydrogenase'), ('PMC7677002', 'D08015', 138, 165, 'fumarate hydratase class II'), ('PMC7677002', 'D08015', 167, 184, 'malate synthase G'), ('PMC7677002', 'D08015', 186, 206, 'malate dehydrogenase'), ('PMC7677002', 'D08015', 208, 238, 'fructose-bisphosphate aldolase'), ('PMC7677002', 'D08015', 246, 256, 'glyoxalase')]	['Ci', '##tral', 'treatment', 'downregulated', 'proteins', 'that', 'play', 'an', 'essential', 'role', 'in', 'the', 'TCA', 'cycle', ',', 'such', 'as', 'iso', '##cit', '##rate', 'ly', '##ase', ',', 'iso', '##cit', '##rate', 'dehydrogenase', ',', 'fum', '##ara', '##te', 'hydr', '##atase', 'class', 'II', ',', 'mal', '##ate', 'synthase', 'G', ',', 'mal', '##ate', 'dehydrogenase', ',', 'fructose', '-', 'bis', '##phosphate', 'ald', '##olas', '##e', ',', 'and', 'a', 'gly', '##ox', '##ala', '##se', 'family', 'protein', '.']	[0, 2, 7, 17, 31, 40, 45, 50, 53, 63, 68, 71, 75, 79, 84, 86, 91, 94, 97, 100, 105, 107, 110, 112, 115, 118, 123, 136, 138, 141, 144, 147, 151, 157, 163, 165, 167, 170, 174, 183, 184, 186, 189, 193, 206, 208, 216, 217, 220, 230, 233, 237, 238, 240, 244, 246, 249, 251, 254, 257, 264, 271]	[2, 6, 16, 30, 39, 44, 49, 52, 62, 67, 70, 74, 78, 84, 85, 90, 93, 97, 100, 104, 107, 110, 111, 115, 118, 122, 136, 137, 141, 144, 146, 151, 156, 162, 165, 166, 170, 173, 182, 184, 185, 189, 192, 206, 207, 216, 217, 220, 229, 233, 237, 238, 239, 243, 245, 249, 251, 254, 256, 263, 271, 272]	['Citral', 'treatment', 'downregulated', 'proteins', 'that', 'play', 'an', 'essential', 'role', 'in', 'the', 'TCA', 'cycle', ',', 'such', 'as', 'isocitrate', 'lyase', ',', 'isocitrate', 'dehydrogenase', ',', 'fumarate', 'hydratase', 'class', 'II', ',', 'malate', 'synthase', 'G', ',', 'malate', 'dehydrogenase', ',', 'fructose', '-', 'bisphosphate', 'aldolase', ',', 'and', 'a', 'glyoxalase', 'family', 'protein', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 3, 1, 1, 3, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 2, 3, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O']
In addition, a glycosyl hydrolase family protein was found to be upregulated upon treatment with citral, and it is involved in the disassembly of existing biofilms (49).	[('PMC7677002', 'D09004', 15, 33, 'glycosyl hydrolase')]	['In', 'addition', ',', 'a', 'glycos', '##yl', 'hydro', '##las', '##e', 'family', 'protein', 'was', 'found', 'to', 'be', 'upregulated', 'upon', 'treatment', 'with', 'citr', '##al', ',', 'and', 'it', 'is', 'involved', 'in', 'the', 'dis', '##assembly', 'of', 'existing', 'biofilms', '(', '49', ')', '.']	[0, 3, 11, 13, 15, 21, 24, 29, 32, 34, 41, 49, 53, 59, 62, 65, 77, 82, 92, 97, 101, 103, 105, 109, 112, 115, 124, 127, 131, 134, 143, 146, 155, 164, 165, 167, 168]	[2, 11, 12, 14, 21, 23, 29, 32, 33, 40, 48, 52, 58, 61, 64, 76, 81, 91, 96, 101, 103, 104, 108, 111, 114, 123, 126, 130, 134, 142, 145, 154, 163, 165, 167, 168, 169]	['In', 'addition', ',', 'a', 'glycosyl', 'hydrolase', 'family', 'protein', 'was', 'found', 'to', 'be', 'upregulated', 'upon', 'treatment', 'with', 'citral', ',', 'and', 'it', 'is', 'involved', 'in', 'the', 'disassembly', 'of', 'existing', 'biofilms', '(', '49', ')', '.']	[1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Hence, the upregulation of the glycosyl hydrolase family protein could increase biofilm disruption in citral-treated samples.	[('PMC7677002', 'D09005', 31, 49, 'glycosyl hydrolase')]	['Hence', ',', 'the', 'upregulation', 'of', 'the', 'glycos', '##yl', 'hydro', '##las', '##e', 'family', 'protein', 'could', 'increase', 'biofilm', 'disruption', 'in', 'citr', '##al', '-', 'treated', 'samples', '.']	[0, 5, 7, 11, 24, 27, 31, 37, 40, 45, 48, 50, 57, 65, 71, 80, 88, 99, 102, 106, 108, 109, 117, 124]	[5, 6, 10, 23, 26, 30, 37, 39, 45, 48, 49, 56, 64, 70, 79, 87, 98, 101, 106, 108, 109, 116, 124, 125]	['Hence', ',', 'the', 'upregulation', 'of', 'the', 'glycosyl', 'hydrolase', 'family', 'protein', 'could', 'increase', 'biofilm', 'disruption', 'in', 'citral', '-', 'treated', 'samples', '.']	[1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acinetobacter baumannii universal stress protein A plays a pivotal role in stress response and is essential for pneumonia and sepsis pathogenesis.	[('PMC7677002', 'F27002', 24, 50, 'universal stress protein A')]	['Ac', '##inet', '##obacter', 'ba', '##umann', '##ii', 'universal', 'stress', 'protein', 'A', 'plays', 'a', 'pivotal', 'role', 'in', 'stress', 'response', 'and', 'is', 'essential', 'for', 'pneumonia', 'and', 'sepsis', 'pathogenesis', '.']	[0, 2, 6, 14, 16, 21, 24, 34, 41, 49, 51, 57, 59, 67, 72, 75, 82, 91, 95, 98, 108, 112, 122, 126, 133, 145]	[2, 6, 13, 16, 21, 23, 33, 40, 48, 50, 56, 58, 66, 71, 74, 81, 90, 94, 97, 107, 111, 121, 125, 132, 145, 146]	['Acinetobacter', 'baumannii', 'universal', 'stress', 'protein', 'A', 'plays', 'a', 'pivotal', 'role', 'in', 'stress', 'response', 'and', 'is', 'essential', 'for', 'pneumonia', 'and', 'sepsis', 'pathogenesis', '.']	[3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Impact of Acinetobacter baumannii superoxide dismutase on motility, virulence, oxidative stress resistance and susceptibility to antibiotics.	[('PMC7677002', 'F30002', 34, 54, 'superoxide dismutase')]	['Impact', 'of', 'Ac', '##inet', '##obacter', 'ba', '##umann', '##ii', 'superoxide', 'dismutase', 'on', 'motility', ',', 'virulence', ',', 'oxidative', 'stress', 'resistance', 'and', 'susceptibility', 'to', 'antibiotics', '.']	[0, 7, 10, 12, 16, 24, 26, 31, 34, 45, 55, 58, 66, 68, 77, 79, 89, 96, 107, 111, 126, 129, 140]	[6, 9, 12, 16, 23, 26, 31, 33, 44, 54, 57, 66, 67, 77, 78, 88, 95, 106, 110, 125, 128, 140, 141]	['Impact', 'of', 'Acinetobacter', 'baumannii', 'superoxide', 'dismutase', 'on', 'motility', ',', 'virulence', ',', 'oxidative', 'stress', 'resistance', 'and', 'susceptibility', 'to', 'antibiotics', '.']	[1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Iron-regulated phospholipase C activity contributes to the cytolytic activity and virulence of Acinetobacter baumannii.	[('PMC7677002', 'F40002', 0, 30, 'Iron-regulated phospholipase C')]	['Iron', '-', 'regulated', 'phospholip', '##ase', 'C', 'activity', 'contributes', 'to', 'the', 'cyt', '##olytic', 'activity', 'and', 'virulence', 'of', 'Ac', '##inet', '##obacter', 'ba', '##umann', '##ii', '.']	[0, 4, 5, 15, 25, 29, 31, 40, 52, 55, 59, 62, 69, 78, 82, 92, 95, 97, 101, 109, 111, 116, 118]	[4, 5, 14, 25, 28, 30, 39, 51, 54, 58, 62, 68, 77, 81, 91, 94, 97, 101, 108, 111, 116, 118, 119]	['Iron', '-', 'regulated', 'phospholipase', 'C', 'activity', 'contributes', 'to', 'the', 'cytolytic', 'activity', 'and', 'virulence', 'of', 'Acinetobacter', 'baumannii', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 3, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PslG, a self-produced glycosyl hydrolase, triggers biofilm disassembly by disrupting exopolysaccharide matrix.	[('PMC7677002', 'F48002', 22, 40, 'glycosyl hydrolase')]	['Ps', '##l', '##G', ',', 'a', 'self', '-', 'produced', 'glycos', '##yl', 'hydro', '##las', '##e', ',', 'triggers', 'biofilm', 'dis', '##assembly', 'by', 'disrupt', '##ing', 'ex', '##opolysaccharide', 'matrix', '.']	[0, 2, 3, 4, 6, 8, 12, 13, 22, 28, 31, 36, 39, 40, 42, 51, 59, 62, 71, 74, 81, 85, 87, 103, 109]	[2, 3, 4, 5, 7, 12, 13, 21, 28, 30, 36, 39, 40, 41, 50, 58, 62, 70, 73, 81, 84, 87, 102, 109, 110]	['PslG', ',', 'a', 'self', '-', 'produced', 'glycosyl', 'hydrolase', ',', 'triggers', 'biofilm', 'disassembly', 'by', 'disrupting', 'exopolysaccharide', 'matrix', '.']	[3, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 2, 1, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In A. baumannii, outer membrane proteins, the two-component system (TCS) (bfmS and bfmR), the chaperone-usher system, quorum sensing, poly-β-(1,6)-N-acetylglucosamine (PNAG), phospholipase, the secretion of serine proteases, and motility are various virulence systems associated with biofilm formation (6).	[('PMC7677002', 'I01005', 175, 188, 'phospholipase'), ('PMC7677002', 'I01005', 207, 223, 'serine proteases')]	['In', 'A', '.', 'ba', '##umann', '##ii', ',', 'outer', 'membrane', 'proteins', ',', 'the', 'two', '-', 'component', 'system', '(', 'TC', '##S', ')', '(', 'b', '##fm', '##S', 'and', 'b', '##fm', '##R', ')', ',', 'the', 'chaperone', '-', 'us', '##her', 'system', ',', 'qu', '##orum', 'sensing', ',', 'poly', '-', 'β', '-', '(', '1', ',', '6', ')', '-', 'N', '-', 'acetyl', '##gluc', '##osa', '##min', '##e', '(', 'PN', '##AG', ')', ',', 'phospholip', '##ase', ',', 'the', 'secretion', 'of', 'serine', 'proteases', ',', 'and', 'motility', 'are', 'various', 'virulence', 'systems', 'associated', 'with', 'biofilm', 'formation', '(', '6', ')', '.']	[0, 3, 4, 6, 8, 13, 15, 17, 23, 32, 40, 42, 46, 49, 50, 60, 67, 68, 70, 71, 73, 74, 75, 77, 79, 83, 84, 86, 87, 88, 90, 94, 103, 104, 106, 110, 116, 118, 120, 125, 132, 134, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 155, 159, 162, 165, 167, 168, 170, 172, 173, 175, 185, 188, 190, 194, 204, 207, 214, 223, 225, 229, 238, 242, 250, 260, 268, 279, 284, 292, 302, 303, 304, 305]	[2, 4, 5, 8, 13, 15, 16, 22, 31, 40, 41, 45, 49, 50, 59, 66, 68, 70, 71, 72, 74, 75, 77, 78, 82, 84, 86, 87, 88, 89, 93, 103, 104, 106, 109, 116, 117, 120, 124, 132, 133, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 155, 159, 162, 165, 166, 168, 170, 172, 173, 174, 185, 188, 189, 193, 203, 206, 213, 223, 224, 228, 237, 241, 249, 259, 267, 278, 283, 291, 301, 303, 304, 305, 306]	['In', 'A', '.', 'baumannii', ',', 'outer', 'membrane', 'proteins', ',', 'the', 'two', '-', 'component', 'system', '(', 'TCS', ')', '(', 'bfmS', 'and', 'bfmR', ')', ',', 'the', 'chaperone', '-', 'usher', 'system', ',', 'quorum', 'sensing', ',', 'poly-β-(1,6)-N-acetylglucosamine', '(', 'PNAG', ')', ',', 'phospholipase', ',', 'the', 'secretion', 'of', 'serine', 'proteases', ',', 'and', 'motility', 'are', 'various', 'virulence', 'systems', 'associated', 'with', 'biofilm', 'formation', '(', '6', ')', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 17, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Next, the pellet was washed three times with PBS to remove debris and resuspended in 2 ml of 20 mM Tris-HCl containing 1% protease inhibitor cocktail.	[('PMC7677002', 'M13002', 122, 130, 'protease')]	['Next', ',', 'the', 'pellet', 'was', 'washed', 'three', 'times', 'with', 'PBS', 'to', 'remove', 'debris', 'and', 'resuspended', 'in', '2', 'ml', 'of', '20', 'mM', 'Tris', '-', 'HCl', 'containing', '1', '%', 'protease', 'inhibitor', 'cock', '##tail', '.']	[0, 4, 6, 10, 17, 21, 28, 34, 40, 45, 49, 52, 59, 66, 70, 82, 85, 87, 90, 93, 96, 99, 103, 104, 108, 119, 120, 122, 131, 141, 145, 149]	[4, 5, 9, 16, 20, 27, 33, 39, 44, 48, 51, 58, 65, 69, 81, 84, 86, 89, 92, 95, 98, 103, 104, 107, 118, 120, 121, 130, 140, 145, 149, 150]	['Next', ',', 'the', 'pellet', 'was', 'washed', 'three', 'times', 'with', 'PBS', 'to', 'remove', 'debris', 'and', 'resuspended', 'in', '2', 'ml', 'of', '20', 'mM', 'Tris-HCl', 'containing', '1%', 'protease', 'inhibitor', 'cocktail', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O']
A total of 50 μg of protein from control/citral-treated samples was loaded on two different nondenaturing polyacrylamide gels at 8% for catalase activity and 12% for superoxide dismutase (superoxide dismutase) activity, respectively.	[('PMC7677002', 'M21003', 136, 144, 'catalase'), ('PMC7677002', 'M21003', 166, 186, 'superoxide dismutase'), ('PMC7677002', 'M21003', 188, 208, 'superoxide dismutase')]	['A', 'total', 'of', '50', 'μ', '##g', 'of', 'protein', 'from', 'control', '/', 'citr', '##al', '-', 'treated', 'samples', 'was', 'loaded', 'on', 'two', 'different', 'nond', '##ena', '##turing', 'polyacrylamide', 'gels', 'at', '8', '%', 'for', 'catalase', 'activity', 'and', '12', '%', 'for', 'superoxide', 'dismutase', '(', 'superoxide', 'dismutase', ')', 'activity', ',', 'respectively', '.']	[0, 2, 8, 11, 14, 15, 17, 20, 28, 33, 40, 41, 45, 47, 48, 56, 64, 68, 75, 78, 82, 92, 96, 99, 106, 121, 126, 129, 130, 132, 136, 145, 154, 158, 160, 162, 166, 177, 187, 188, 199, 208, 210, 218, 220, 232]	[1, 7, 10, 13, 15, 16, 19, 27, 32, 40, 41, 45, 47, 48, 55, 63, 67, 74, 77, 81, 91, 96, 99, 105, 120, 125, 128, 130, 131, 135, 144, 153, 157, 160, 161, 165, 176, 186, 188, 198, 208, 209, 218, 219, 232, 233]	['A', 'total', 'of', '50', 'μg', 'of', 'protein', 'from', 'control', '/', 'citral', '-', 'treated', 'samples', 'was', 'loaded', 'on', 'two', 'different', 'nondenaturing', 'polyacrylamide', 'gels', 'at', '8%', 'for', 'catalase', 'activity', 'and', '12%', 'for', 'superoxide', 'dismutase', '(', 'superoxide', 'dismutase', ')', 'activity', ',', 'respectively', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
For catalase activity, after electrophoresis, the gel (8%) was washed three times with 50 mM KPi buffer.	[('PMC7677002', 'M22000', 4, 12, 'catalase')]	['For', 'catalase', 'activity', ',', 'after', 'electrophoresis', ',', 'the', 'gel', '(', '8', '%', ')', 'was', 'washed', 'three', 'times', 'with', '50', 'mM', 'KP', '##i', 'buffer', '.']	[0, 4, 13, 21, 23, 29, 44, 46, 50, 54, 55, 56, 57, 59, 63, 70, 76, 82, 87, 90, 93, 95, 97, 103]	[3, 12, 21, 22, 28, 44, 45, 49, 53, 55, 56, 57, 58, 62, 69, 75, 81, 86, 89, 92, 95, 96, 103, 104]	['For', 'catalase', 'activity', ',', 'after', 'electrophoresis', ',', 'the', 'gel', '(', '8%', ')', 'was', 'washed', 'three', 'times', 'with', '50', 'mM', 'KPi', 'buffer', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For superoxide dismutase activity, the 12% gel was incubated in 100 ml of freshly prepared 50 mM KPi buffer with substrates such as 0.1 mM EDTA, 2 mg riboflavin, and 16 mg nitroblue tetrazolium (NBT).	[('PMC7677002', 'M23000', 4, 24, 'superoxide dismutase')]	['For', 'superoxide', 'dismutase', 'activity', ',', 'the', '12', '%', 'gel', 'was', 'incubated', 'in', '100', 'ml', 'of', 'freshly', 'prepared', '50', 'mM', 'KP', '##i', 'buffer', 'with', 'substrates', 'such', 'as', '0', '.', '1', 'mM', 'EDTA', ',', '2', 'mg', 'rib', '##ofl', '##avin', ',', 'and', '16', 'mg', 'nitro', '##blue', 'tetra', '##zol', '##ium', '(', 'NB', '##T', ')', '.']	[0, 4, 15, 25, 33, 35, 39, 41, 43, 47, 51, 61, 64, 68, 71, 74, 82, 91, 94, 97, 99, 101, 108, 113, 124, 129, 132, 133, 134, 136, 139, 143, 145, 147, 150, 153, 156, 160, 162, 166, 169, 172, 177, 182, 187, 190, 194, 195, 197, 198, 199]	[3, 14, 24, 33, 34, 38, 41, 42, 46, 50, 60, 63, 67, 70, 73, 81, 90, 93, 96, 99, 100, 107, 112, 123, 128, 131, 133, 134, 135, 138, 143, 144, 146, 149, 153, 156, 160, 161, 165, 168, 171, 177, 181, 187, 190, 193, 195, 197, 198, 199, 200]	['For', 'superoxide', 'dismutase', 'activity', ',', 'the', '12%', 'gel', 'was', 'incubated', 'in', '100', 'ml', 'of', 'freshly', 'prepared', '50', 'mM', 'KPi', 'buffer', 'with', 'substrates', 'such', 'as', '0.1', 'mM', 'EDTA', ',', '2', 'mg', 'riboflavin', ',', 'and', '16', 'mg', 'nitroblue', 'tetrazolium', '(', 'NBT', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 3, 1, 2, 1, 1]	['O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The superoxide dismutase activity was assessed by the appearance of achromatic bands in the gel with a purple background, and the gel was immediately imaged.	[('PMC7677002', 'M23003', 4, 24, 'superoxide dismutase')]	['The', 'superoxide', 'dismutase', 'activity', 'was', 'assessed', 'by', 'the', 'appearance', 'of', 'ach', '##romatic', 'bands', 'in', 'the', 'gel', 'with', 'a', 'pur', '##ple', 'background', ',', 'and', 'the', 'gel', 'was', 'immediately', 'imaged', '.']	[0, 4, 15, 25, 34, 38, 47, 50, 54, 65, 68, 71, 79, 85, 88, 92, 96, 101, 103, 106, 110, 120, 122, 126, 130, 134, 138, 150, 156]	[3, 14, 24, 33, 37, 46, 49, 53, 64, 67, 71, 78, 84, 87, 91, 95, 100, 102, 106, 109, 120, 121, 125, 129, 133, 137, 149, 156, 157]	['The', 'superoxide', 'dismutase', 'activity', 'was', 'assessed', 'by', 'the', 'appearance', 'of', 'achromatic', 'bands', 'in', 'the', 'gel', 'with', 'a', 'purple', 'background', ',', 'and', 'the', 'gel', 'was', 'immediately', 'imaged', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The extracellular lipase production of control and citral-treated A. baumannii was assessed using p-nitrophenyl palmitate (pNPP) as the substrate.	[('PMC7677002', 'M26000', 4, 24, 'extracellular lipase')]	['The', 'extracellular', 'lipase', 'production', 'of', 'control', 'and', 'citr', '##al', '-', 'treated', 'A', '.', 'ba', '##umann', '##ii', 'was', 'assessed', 'using', 'p', '-', 'nitro', '##phenyl', 'palm', '##itate', '(', 'pN', '##PP', ')', 'as', 'the', 'substrate', '.']	[0, 4, 18, 25, 36, 39, 47, 51, 55, 57, 58, 66, 67, 69, 71, 76, 79, 83, 92, 98, 99, 100, 105, 112, 116, 122, 123, 125, 127, 129, 132, 136, 145]	[3, 17, 24, 35, 38, 46, 50, 55, 57, 58, 65, 67, 68, 71, 76, 78, 82, 91, 97, 99, 100, 105, 111, 116, 121, 123, 125, 127, 128, 131, 135, 145, 146]	['The', 'extracellular', 'lipase', 'production', 'of', 'control', 'and', 'citral', '-', 'treated', 'A', '.', 'baumannii', 'was', 'assessed', 'using', 'p-nitrophenyl', 'palmitate', '(', 'pNPP', ')', 'as', 'the', 'substrate', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 4, 2, 1, 2, 1, 1, 1, 1, 1]	['O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The proteolytic activity of A. baumannii control and citral-treated samples was analyzed by mixing 100 ml of a protease substrate solution (0.2% azocasein dissolved in 0.05 M Tris-hydrochloride) with 100 ml of the CFCS of A. baumannii samples, and the mixture was incubated at 37°C for 30 min.	[('PMC7677002', 'M27000', 111, 119, 'protease')]	['The', 'proteolytic', 'activity', 'of', 'A', '.', 'ba', '##umann', '##ii', 'control', 'and', 'citr', '##al', '-', 'treated', 'samples', 'was', 'analyzed', 'by', 'mixing', '100', 'ml', 'of', 'a', 'protease', 'substrate', 'solution', '(', '0', '.', '2', '%', 'az', '##oca', '##se', '##in', 'dissolved', 'in', '0', '.', '05', 'M', 'Tris', '-', 'hydrochloride', ')', 'with', '100', 'ml', 'of', 'the', 'CF', '##CS', 'of', 'A', '.', 'ba', '##umann', '##ii', 'samples', ',', 'and', 'the', 'mixture', 'was', 'incubated', 'at', '37°', '##C', 'for', '30', 'min', '.']	[0, 4, 16, 25, 28, 29, 31, 33, 38, 41, 49, 53, 57, 59, 60, 68, 76, 80, 89, 92, 99, 103, 106, 109, 111, 120, 130, 139, 140, 141, 142, 143, 145, 147, 150, 152, 155, 165, 168, 169, 170, 173, 175, 179, 180, 193, 195, 200, 204, 207, 210, 214, 216, 219, 222, 223, 225, 227, 232, 235, 242, 244, 248, 252, 260, 264, 274, 277, 280, 282, 286, 289, 292]	[3, 15, 24, 27, 29, 30, 33, 38, 40, 48, 52, 57, 59, 60, 67, 75, 79, 88, 91, 98, 102, 105, 108, 110, 119, 129, 138, 140, 141, 142, 143, 144, 147, 150, 152, 154, 164, 167, 169, 170, 172, 174, 179, 180, 193, 194, 199, 203, 206, 209, 213, 216, 218, 221, 223, 224, 227, 232, 234, 242, 243, 247, 251, 259, 263, 273, 276, 280, 281, 285, 288, 292, 293]	['The', 'proteolytic', 'activity', 'of', 'A', '.', 'baumannii', 'control', 'and', 'citral', '-', 'treated', 'samples', 'was', 'analyzed', 'by', 'mixing', '100', 'ml', 'of', 'a', 'protease', 'substrate', 'solution', '(', '0.2%', 'azocasein', 'dissolved', 'in', '0.05', 'M', 'Tris', '-', 'hydrochloride', ')', 'with', '100', 'ml', 'of', 'the', 'CFCS', 'of', 'A', '.', 'baumannii', 'samples', ',', 'and', 'the', 'mixture', 'was', 'incubated', 'at', '37°C', 'for', '30', 'min', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Native PAGE was performed to assess the effect of citral on catalase and superoxide dismutase (superoxide dismutase) production in A. baumannii.	[('PMC7677002', 'R13000', 60, 68, 'catalase'), ('PMC7677002', 'R13000', 73, 93, 'superoxide dismutase'), ('PMC7677002', 'R13000', 95, 115, 'superoxide dismutase')]	['Native', 'PA', '##GE', 'was', 'performed', 'to', 'assess', 'the', 'effect', 'of', 'citr', '##al', 'on', 'catalase', 'and', 'superoxide', 'dismutase', '(', 'superoxide', 'dismutase', ')', 'production', 'in', 'A', '.', 'ba', '##umann', '##ii', '.']	[0, 7, 9, 12, 16, 26, 29, 36, 40, 47, 50, 54, 57, 60, 69, 73, 84, 94, 95, 106, 115, 117, 128, 131, 132, 134, 136, 141, 143]	[6, 9, 11, 15, 25, 28, 35, 39, 46, 49, 54, 56, 59, 68, 72, 83, 93, 95, 105, 115, 116, 127, 130, 132, 133, 136, 141, 143, 144]	['Native', 'PAGE', 'was', 'performed', 'to', 'assess', 'the', 'effect', 'of', 'citral', 'on', 'catalase', 'and', 'superoxide', 'dismutase', '(', 'superoxide', 'dismutase', ')', 'production', 'in', 'A', '.', 'baumannii', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'B', 'E', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The band intensity was reduced for catalase (Fig. 13A) and superoxide dismutase (Fig. 13B) in citral-treated samples compared to the control samples.	[('PMC7677002', 'R13001', 35, 43, 'catalase'), ('PMC7677002', 'R13001', 59, 79, 'superoxide dismutase')]	['The', 'band', 'intensity', 'was', 'reduced', 'for', 'catalase', '(', 'Fig', '.', '13', '##A', ')', 'and', 'superoxide', 'dismutase', '(', 'Fig', '.', '13', '##B', ')', 'in', 'citr', '##al', '-', 'treated', 'samples', 'compared', 'to', 'the', 'control', 'samples', '.']	[0, 4, 9, 19, 23, 31, 35, 44, 45, 48, 50, 52, 53, 55, 59, 70, 80, 81, 84, 86, 88, 89, 91, 94, 98, 100, 101, 109, 117, 126, 129, 133, 141, 148]	[3, 8, 18, 22, 30, 34, 43, 45, 48, 49, 52, 53, 54, 58, 69, 79, 81, 84, 85, 88, 89, 90, 93, 98, 100, 101, 108, 116, 125, 128, 132, 140, 148, 149]	['The', 'band', 'intensity', 'was', 'reduced', 'for', 'catalase', '(', 'Fig', '.', '13A', ')', 'and', 'superoxide', 'dismutase', '(', 'Fig', '.', '13B', ')', 'in', 'citral', '-', 'treated', 'samples', 'compared', 'to', 'the', 'control', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacteria produce extracellular lipase as a virulence factor.	[('PMC7677002', 'R15000', 17, 37, 'extracellular lipase')]	['Bacter', '##ia', 'produce', 'extracellular', 'lipase', 'as', 'a', 'virulence', 'factor', '.']	[0, 6, 9, 17, 31, 38, 41, 43, 53, 59]	[6, 8, 16, 30, 37, 40, 42, 52, 59, 60]	['Bacteria', 'produce', 'extracellular', 'lipase', 'as', 'a', 'virulence', 'factor', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
In this study, the effect of citral on lipase production by A. baumannii was investigated.	[('PMC7677002', 'R15001', 39, 45, 'lipase')]	['In', 'this', 'study', ',', 'the', 'effect', 'of', 'citr', '##al', 'on', 'lipase', 'production', 'by', 'A', '.', 'ba', '##umann', '##ii', 'was', 'investigated', '.']	[0, 3, 8, 13, 15, 19, 26, 29, 33, 36, 39, 46, 57, 60, 61, 63, 65, 70, 73, 77, 89]	[2, 7, 13, 14, 18, 25, 28, 33, 35, 38, 45, 56, 59, 61, 62, 65, 70, 72, 76, 89, 90]	['In', 'this', 'study', ',', 'the', 'effect', 'of', 'citral', 'on', 'lipase', 'production', 'by', 'A', '.', 'baumannii', 'was', 'investigated', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Citral reduced lipase production by 70% compared to control cells (Fig. 13D).	[('PMC7677002', 'R15002', 15, 21, 'lipase')]	['Ci', '##tral', 'reduced', 'lipase', 'production', 'by', '70', '%', 'compared', 'to', 'control', 'cells', '(', 'Fig', '.', '13', '##D', ')', '.']	[0, 2, 7, 15, 22, 33, 36, 38, 40, 49, 52, 60, 66, 67, 70, 72, 74, 75, 76]	[2, 6, 14, 21, 32, 35, 38, 39, 48, 51, 59, 65, 67, 70, 71, 74, 75, 76, 77]	['Citral', 'reduced', 'lipase', 'production', 'by', '70%', 'compared', 'to', 'control', 'cells', '(', 'Fig', '.', '13D', ')', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
MALDI-TOF MS revealed that 8 peptides in the serum, including myeloid-associated differentiation marker, keratin type I cytoskeletal 18, fibrinogen α-chain, angiotensinogen (AGT), apolipoprotein A-I (APOAI), clusterin and two uncharacterized peptides, and nine peptides in BALF, including argininosuccinate lyase, APOAI, AGT and five uncharacterized peptides, were differentially expressed (molecular-weight range, 1,000-10,000 Da) in the TB group compared with the TIT group.	[('PMC7716632', 'A00006', 289, 312, 'argininosuccinate lyase')]	['MALDI', '-', 'TO', '##F', 'MS', 'revealed', 'that', '8', 'peptides', 'in', 'the', 'serum', ',', 'including', 'myeloid', '-', 'associated', 'differentiation', 'marker', ',', 'keratin', 'type', 'I', 'cytoskeletal', '18', ',', 'fibrinogen', 'α', '-', 'chain', ',', 'angiotensin', '##ogen', '(', 'AG', '##T', ')', ',', 'apo', '##lip', '##oprotein', 'A', '-', 'I', '(', 'AP', '##OA', '##I', ')', ',', 'cluster', '##in', 'and', 'two', 'unc', '##har', '##acter', '##ized', 'peptides', ',', 'and', 'nine', 'peptides', 'in', 'BAL', '##F', ',', 'including', 'arg', '##inin', '##os', '##ucci', '##nat', '##e', 'ly', '##ase', ',', 'AP', '##OA', '##I', ',', 'AG', '##T', 'and', 'five', 'unc', '##har', '##acter', '##ized', 'peptides', ',', 'were', 'differentially', 'expressed', '(', 'molecular', '-', 'weight', 'range', ',', '1', ',', '000', '-', '10', ',', '000', 'Da', ')', 'in', 'the', 'TB', 'group', 'compared', 'with', 'the', 'TI', '##T', 'group', '.']	[0, 5, 6, 8, 10, 13, 22, 27, 29, 38, 41, 45, 50, 52, 62, 69, 70, 81, 97, 103, 105, 113, 118, 120, 133, 135, 137, 148, 149, 150, 155, 157, 168, 173, 174, 176, 177, 178, 180, 183, 186, 195, 196, 197, 199, 200, 202, 204, 205, 206, 208, 215, 218, 222, 226, 229, 232, 237, 242, 250, 252, 256, 261, 270, 273, 276, 277, 279, 289, 292, 296, 298, 302, 305, 307, 309, 312, 314, 316, 318, 319, 321, 323, 325, 329, 334, 337, 340, 345, 350, 358, 360, 365, 380, 390, 391, 400, 401, 408, 413, 415, 416, 417, 420, 421, 423, 424, 428, 430, 432, 435, 439, 442, 448, 457, 462, 466, 468, 470, 475]	[5, 6, 8, 9, 12, 21, 26, 28, 37, 40, 44, 50, 51, 61, 69, 70, 80, 96, 103, 104, 112, 117, 119, 132, 135, 136, 147, 149, 150, 155, 156, 168, 172, 174, 176, 177, 178, 179, 183, 186, 194, 196, 197, 198, 200, 202, 204, 205, 206, 207, 215, 217, 221, 225, 229, 232, 237, 241, 250, 251, 255, 260, 269, 272, 276, 277, 278, 288, 292, 296, 298, 302, 305, 306, 309, 312, 313, 316, 318, 319, 320, 323, 324, 328, 333, 337, 340, 345, 349, 358, 359, 364, 379, 389, 391, 400, 401, 407, 413, 414, 416, 417, 420, 421, 423, 424, 427, 430, 431, 434, 438, 441, 447, 456, 461, 465, 468, 469, 475, 476]	['MALDI-TOF', 'MS', 'revealed', 'that', '8', 'peptides', 'in', 'the', 'serum', ',', 'including', 'myeloid', '-', 'associated', 'differentiation', 'marker', ',', 'keratin', 'type', 'I', 'cytoskeletal', '18', ',', 'fibrinogen', 'α-chain', ',', 'angiotensinogen', '(', 'AGT', ')', ',', 'apolipoprotein', 'A-I', '(', 'APOAI', ')', ',', 'clusterin', 'and', 'two', 'uncharacterized', 'peptides', ',', 'and', 'nine', 'peptides', 'in', 'BALF', ',', 'including', 'argininosuccinate', 'lyase', ',', 'APOAI', ',', 'AGT', 'and', 'five', 'uncharacterized', 'peptides', ',', 'were', 'differentially', 'expressed', '(', 'molecular', '-', 'weight', 'range', ',', '1', ',', '000-10,000', 'Da', ')', 'in', 'the', 'TB', 'group', 'compared', 'with', 'the', 'TIT', 'group', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1, 3, 3, 1, 3, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 6, 2, 1, 3, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Patients with TBS after TB, TBS after TIT and ESLC had been confirmed by chest CT scan and clinical testing, including reverse-transcription PCR assay for TB and tumor markers of CEA, CA15-3, CA19-9, CA125, neuron-specific enolase and cytokeratin fraction 21-1.	[('PMC7716632', 'M00002', 223, 230, 'enolase')]	['Patients', 'with', 'TB', '##S', 'after', 'TB', ',', 'TB', '##S', 'after', 'TI', '##T', 'and', 'ES', '##LC', 'had', 'been', 'confirmed', 'by', 'chest', 'CT', 'scan', 'and', 'clinical', 'testing', ',', 'including', 'reverse', '-', 'transcription', 'PCR', 'assay', 'for', 'TB', 'and', 'tumor', 'markers', 'of', 'CEA', ',', 'CA', '##15', '-', '3', ',', 'CA', '##19', '-', '9', ',', 'CA', '##125', ',', 'neuron', '-', 'specific', 'en', '##olas', '##e', 'and', 'cytok', '##era', '##tin', 'fraction', '21', '-', '1', '.']	[0, 9, 14, 16, 18, 24, 26, 28, 30, 32, 38, 40, 42, 46, 48, 51, 55, 60, 70, 73, 79, 82, 87, 91, 100, 107, 109, 119, 126, 127, 141, 145, 151, 155, 158, 162, 168, 176, 179, 182, 184, 186, 188, 189, 190, 192, 194, 196, 197, 198, 200, 202, 205, 207, 213, 214, 223, 225, 229, 231, 235, 240, 243, 247, 256, 258, 259, 260]	[8, 13, 16, 17, 23, 26, 27, 30, 31, 37, 40, 41, 45, 48, 50, 54, 59, 69, 72, 78, 81, 86, 90, 99, 107, 108, 118, 126, 127, 140, 144, 150, 154, 157, 161, 167, 175, 178, 182, 183, 186, 188, 189, 190, 191, 194, 196, 197, 198, 199, 202, 205, 206, 213, 214, 222, 225, 229, 230, 234, 240, 243, 246, 255, 258, 259, 260, 261]	['Patients', 'with', 'TBS', 'after', 'TB', ',', 'TBS', 'after', 'TIT', 'and', 'ESLC', 'had', 'been', 'confirmed', 'by', 'chest', 'CT', 'scan', 'and', 'clinical', 'testing', ',', 'including', 'reverse', '-', 'transcription', 'PCR', 'assay', 'for', 'TB', 'and', 'tumor', 'markers', 'of', 'CEA', ',', 'CA15-3', ',', 'CA19-9', ',', 'CA125', ',', 'neuron', '-', 'specific', 'enolase', 'and', 'cytokeratin', 'fraction', '21-1', '.']	[1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 2, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In BALF samples, 9 peptides, including argininosuccinate lyase (ASL; 4,200.65), APOAI (two sequences: 4,169.49 and 4,533.75), AGT (4,186.06) and five undefined peptides (6,029.68, 5,763.15, 7,929.01, 6,701.81 and 5,278.1) were sequenced (Table III).	[('PMC7716632', 'R04003', 39, 62, 'argininosuccinate lyase')]	['In', 'BAL', '##F', 'samples', ',', '9', 'peptides', ',', 'including', 'arg', '##inin', '##os', '##ucci', '##nat', '##e', 'ly', '##ase', '(', 'AS', '##L', ';', '4', ',', '200', '.', '65', ')', ',', 'AP', '##OA', '##I', '(', 'two', 'sequences', ':', '4', ',', '169', '.', '49', 'and', '4', ',', '53', '##3', '.', '75', ')', ',', 'AG', '##T', '(', '4', ',', '186', '.', '06', ')', 'and', 'five', 'und', '##efined', 'peptides', '(', '6', ',', '02', '##9', '.', '68', ',', '5', ',', '76', '##3', '.', '15', ',', '7', ',', '92', '##9', '.', '01', ',', '6', ',', '70', '##1', '.', '81', 'and', '5', ',', '278', '.', '1', ')', 'were', 'sequenced', '(', 'Table', 'III', ')', '.']	[0, 3, 6, 8, 15, 17, 19, 27, 29, 39, 42, 46, 48, 52, 55, 57, 59, 63, 64, 66, 67, 69, 70, 71, 74, 75, 77, 78, 80, 82, 84, 86, 87, 91, 100, 102, 103, 104, 107, 108, 111, 115, 116, 117, 119, 120, 121, 123, 124, 126, 128, 130, 131, 132, 133, 136, 137, 139, 141, 145, 150, 153, 160, 169, 170, 171, 172, 174, 175, 176, 178, 180, 181, 182, 184, 185, 186, 188, 190, 191, 192, 194, 195, 196, 198, 200, 201, 202, 204, 205, 206, 209, 213, 214, 215, 218, 219, 220, 222, 227, 237, 238, 244, 247, 248]	[2, 6, 7, 15, 16, 18, 27, 28, 38, 42, 46, 48, 52, 55, 56, 59, 62, 64, 66, 67, 68, 70, 71, 74, 75, 77, 78, 79, 82, 84, 85, 87, 90, 100, 101, 103, 104, 107, 108, 110, 114, 116, 117, 119, 120, 121, 123, 124, 125, 128, 129, 131, 132, 133, 136, 137, 139, 140, 144, 149, 153, 159, 168, 170, 171, 172, 174, 175, 176, 178, 179, 181, 182, 184, 185, 186, 188, 189, 191, 192, 194, 195, 196, 198, 199, 201, 202, 204, 205, 206, 208, 212, 214, 215, 218, 219, 220, 221, 226, 236, 238, 243, 247, 248, 249]	['In', 'BALF', 'samples', ',', '9', 'peptides', ',', 'including', 'argininosuccinate', 'lyase', '(', 'ASL', ';', '4', ',', '200.65', ')', ',', 'APOAI', '(', 'two', 'sequences', ':', '4', ',', '169.49', 'and', '4', ',', '533.75', ')', ',', 'AGT', '(', '4', ',', '186.06', ')', 'and', 'five', 'undefined', 'peptides', '(', '6', ',', '029.68', ',', '5', ',', '763.15', ',', '7', ',', '929.01', ',', '6', ',', '701.81', 'and', '5', ',', '278.1', ')', 'were', 'sequenced', '(', 'Table', 'III', ')', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 6, 2, 1, 2, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Increased VLDL synthesis and secretion is observed as the net effect of overshooting hepatic triglyceride synthesis.17 A decrease in lipoprotein lipase activity leads to delayed clearance and prolonged circulation of triglyceride-rich lipoproteins during inflammatory conditions.	[('PMC7780360', 'D01004', 133, 151, 'lipoprotein lipase')]	['Increased', 'VL', '##DL', 'synthesis', 'and', 'secretion', 'is', 'observed', 'as', 'the', 'net', 'effect', 'of', 'oversh', '##oot', '##ing', 'hepatic', 'triglyceride', 'synthesis', '.', '17', 'A', 'decrease', 'in', 'lipoprotein', 'lipase', 'activity', 'leads', 'to', 'delayed', 'clearance', 'and', 'prolonged', 'circulation', 'of', 'triglyceride', '-', 'rich', 'lipoprotein', '##s', 'during', 'inflammatory', 'conditions', '.']	[0, 10, 12, 15, 25, 29, 39, 42, 51, 54, 58, 62, 69, 72, 78, 81, 85, 93, 106, 115, 116, 119, 121, 130, 133, 145, 152, 161, 167, 170, 178, 188, 192, 202, 214, 217, 229, 230, 235, 246, 248, 255, 268, 278]	[9, 12, 14, 24, 28, 38, 41, 50, 53, 57, 61, 68, 71, 78, 81, 84, 92, 105, 115, 116, 118, 120, 129, 132, 144, 151, 160, 166, 169, 177, 187, 191, 201, 213, 216, 229, 230, 234, 246, 247, 254, 267, 278, 279]	['Increased', 'VLDL', 'synthesis', 'and', 'secretion', 'is', 'observed', 'as', 'the', 'net', 'effect', 'of', 'overshooting', 'hepatic', 'triglyceride', 'synthesis.17', 'A', 'decrease', 'in', 'lipoprotein', 'lipase', 'activity', 'leads', 'to', 'delayed', 'clearance', 'and', 'prolonged', 'circulation', 'of', 'triglyceride', '-', 'rich', 'lipoproteins', 'during', 'inflammatory', 'conditions', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the cerebrospinal fluid (CSF) of patients with probable idiopathic normal‐pressure hydrocephalus (iNPH) by proteome analysis.	[('PMC7821334', 'A00000', 0, 28, 'Protein tyrosine phosphatase')]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTP', '##R', '##Q', ')', 'was', 'extracted', 'from', 'the', 'cerebrospinal', 'fluid', '(', 'CSF', ')', 'of', 'patients', 'with', 'probable', 'idiopathic', 'normal', '‐', 'pressure', 'hydro', '##cephal', '##us', '(', 'i', '##NP', '##H', ')', 'by', 'proteome', 'analysis', '.']	[0, 8, 17, 29, 38, 43, 45, 46, 49, 50, 51, 53, 57, 67, 72, 76, 90, 96, 97, 100, 102, 105, 114, 119, 128, 139, 145, 146, 155, 160, 166, 169, 170, 171, 173, 174, 176, 179, 188, 196]	[7, 16, 28, 37, 42, 44, 46, 49, 50, 51, 52, 56, 66, 71, 75, 89, 95, 97, 100, 101, 104, 113, 118, 127, 138, 145, 146, 154, 160, 166, 168, 170, 171, 173, 174, 175, 178, 187, 196, 197]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTPRQ', ')', 'was', 'extracted', 'from', 'the', 'cerebrospinal', 'fluid', '(', 'CSF', ')', 'of', 'patients', 'with', 'probable', 'idiopathic', 'normal', '‐', 'pressure', 'hydrocephalus', '(', 'iNPH', ')', 'by', 'proteome', 'analysis', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein tyrosine phosphatase receptor type Q (PTPRQ) extracted from CSF of patients with probable idiopathic normal pressure hydrocephalus (iNPH) by proteome analysis was evaluated as potential biomarker for this condition.	[('PMC7821334', 'A04000', 0, 28, 'Protein tyrosine phosphatase')]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTP', '##R', '##Q', ')', 'extracted', 'from', 'CSF', 'of', 'patients', 'with', 'probable', 'idiopathic', 'normal', 'pressure', 'hydro', '##cephal', '##us', '(', 'i', '##NP', '##H', ')', 'by', 'proteome', 'analysis', 'was', 'evaluated', 'as', 'potential', 'biomarker', 'for', 'this', 'condition', '.']	[0, 8, 17, 29, 38, 43, 45, 46, 49, 50, 51, 53, 63, 68, 72, 75, 84, 89, 98, 109, 116, 125, 130, 136, 139, 140, 141, 143, 144, 146, 149, 158, 167, 171, 181, 184, 194, 204, 208, 213, 222]	[7, 16, 28, 37, 42, 44, 46, 49, 50, 51, 52, 62, 67, 71, 74, 83, 88, 97, 108, 115, 124, 130, 136, 138, 140, 141, 143, 144, 145, 148, 157, 166, 170, 180, 183, 193, 203, 207, 212, 222, 223]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTPRQ', ')', 'extracted', 'from', 'CSF', 'of', 'patients', 'with', 'probable', 'idiopathic', 'normal', 'pressure', 'hydrocephalus', '(', 'iNPH', ')', 'by', 'proteome', 'analysis', 'was', 'evaluated', 'as', 'potential', 'biomarker', 'for', 'this', 'condition', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PTPRQ includes an extracellular domain that contains 18 fibronectin III repeats, a membrane‐spanning domain, and a cytoplasmic domain with phosphatidylinositol phosphatase activity [34, 35].	[('PMC7821334', 'D01002', 139, 171, 'phosphatidylinositol phosphatase')]	['PTP', '##R', '##Q', 'includes', 'an', 'extracellular', 'domain', 'that', 'contains', '18', 'fibronectin', 'III', 'repeats', ',', 'a', 'membrane', '‐', 'spanning', 'domain', ',', 'and', 'a', 'cytoplasmic', 'domain', 'with', 'phosphatidyl', '##inositol', 'phosphatase', 'activity', '[', '34', ',', '35', ']', '.']	[0, 3, 4, 6, 15, 18, 32, 39, 44, 53, 56, 68, 72, 79, 81, 83, 91, 92, 101, 107, 109, 113, 115, 127, 134, 139, 151, 160, 172, 181, 182, 184, 186, 188, 189]	[3, 4, 5, 14, 17, 31, 38, 43, 52, 55, 67, 71, 79, 80, 82, 91, 92, 100, 107, 108, 112, 114, 126, 133, 138, 151, 159, 171, 180, 182, 184, 185, 188, 189, 190]	['PTPRQ', 'includes', 'an', 'extracellular', 'domain', 'that', 'contains', '18', 'fibronectin', 'III', 'repeats', ',', 'a', 'membrane', '‐', 'spanning', 'domain', ',', 'and', 'a', 'cytoplasmic', 'domain', 'with', 'phosphatidylinositol', 'phosphatase', 'activity', '[', '34', ',', '35', ']', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Oganesian A, Poot M, Daum G, et alProtein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation.	[('PMC7821334', 'F33001', 34, 62, 'Protein tyrosine phosphatase'), ('PMC7821334', 'F33001', 71, 103, 'phosphatidylinositol phosphatase')]	['Og', '##anes', '##ian', 'A', ',', 'Po', '##ot', 'M', ',', 'Da', '##um', 'G', ',', 'et', 'al', '##Pro', '##tein', 'tyrosine', 'phosphatase', 'RQ', 'is', 'a', 'phosphatidyl', '##inositol', 'phosphatase', 'that', 'can', 'regulate', 'cell', 'survival', 'and', 'proliferation', '.']	[0, 2, 6, 10, 11, 13, 15, 18, 19, 21, 23, 26, 27, 29, 32, 34, 37, 42, 51, 63, 66, 69, 71, 83, 92, 104, 109, 113, 122, 127, 136, 140, 153]	[2, 6, 9, 11, 12, 15, 17, 19, 20, 23, 25, 27, 28, 31, 34, 37, 41, 50, 62, 65, 68, 70, 83, 91, 103, 108, 112, 121, 126, 135, 139, 153, 154]	['Oganesian', 'A', ',', 'Poot', 'M', ',', 'Daum', 'G', ',', 'et', 'alProtein', 'tyrosine', 'phosphatase', 'RQ', 'is', 'a', 'phosphatidylinositol', 'phosphatase', 'that', 'can', 'regulate', 'cell', 'survival', 'and', 'proliferation', '.']	[3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recently, protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the CSF of patients with iNPH by proteome analysis.	[('PMC7821334', 'I02000', 10, 38, 'protein tyrosine phosphatase')]	['Recently', ',', 'protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTP', '##R', '##Q', ')', 'was', 'extracted', 'from', 'the', 'CSF', 'of', 'patients', 'with', 'i', '##NP', '##H', 'by', 'proteome', 'analysis', '.']	[0, 8, 10, 18, 27, 39, 48, 53, 55, 56, 59, 60, 61, 63, 67, 77, 82, 86, 90, 93, 102, 107, 108, 110, 112, 115, 124, 132]	[8, 9, 17, 26, 38, 47, 52, 54, 56, 59, 60, 61, 62, 66, 76, 81, 85, 89, 92, 101, 106, 108, 110, 111, 114, 123, 132, 133]	['Recently', ',', 'protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTPRQ', ')', 'was', 'extracted', 'from', 'the', 'CSF', 'of', 'patients', 'with', 'iNPH', 'by', 'proteome', 'analysis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Endogenous peroxidase was blocked by incubation of the brain sections with 0.3% hydrogen peroxide for 30 min.	[('PMC7821334', 'M12003', 11, 21, 'peroxidase')]	['End', '##ogenous', 'peroxidase', 'was', 'blocked', 'by', 'incubation', 'of', 'the', 'brain', 'sections', 'with', '0', '.', '3', '%', 'hydrogen', 'peroxide', 'for', '30', 'min', '.']	[0, 3, 11, 22, 26, 34, 37, 48, 51, 55, 61, 70, 75, 76, 77, 78, 80, 89, 98, 102, 105, 108]	[3, 10, 21, 25, 33, 36, 47, 50, 54, 60, 69, 74, 76, 77, 78, 79, 88, 97, 101, 104, 108, 109]	['Endogenous', 'peroxidase', 'was', 'blocked', 'by', 'incubation', 'of', 'the', 'brain', 'sections', 'with', '0.3%', 'hydrogen', 'peroxide', 'for', '30', 'min', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein tyrosine phosphatase receptor type Q staining was viewed under an E800 microscope (Nikon, Tokyo, Japan), and images were captured with an AxioCam HRc CCD camera using AxioVison Rel 4.7.2.0 imaging processing software (Carl Zeiss, Microimaging GmbH, Jena, Germany).	[('PMC7821334', 'M14000', 0, 28, 'Protein tyrosine phosphatase')]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', 'staining', 'was', 'viewed', 'under', 'an', 'E', '##800', 'microscope', '(', 'Nik', '##on', ',', 'Tokyo', ',', 'Japan', ')', ',', 'and', 'images', 'were', 'captured', 'with', 'an', 'Ax', '##io', '##Cam', 'HR', '##c', 'CCD', 'camera', 'using', 'Ax', '##io', '##Vis', '##on', 'Rel', '4', '.', '7', '.', '2', '.', '0', 'imaging', 'processing', 'software', '(', 'Carl', 'Zeiss', ',', 'Micro', '##imaging', 'GmbH', ',', 'Jen', '##a', ',', 'Germany', ')', '.']	[0, 8, 17, 29, 38, 43, 45, 54, 58, 65, 71, 74, 75, 79, 90, 91, 94, 96, 98, 103, 105, 110, 111, 113, 117, 124, 129, 138, 143, 146, 148, 150, 154, 156, 158, 162, 169, 175, 177, 179, 182, 185, 189, 190, 191, 192, 193, 194, 195, 197, 205, 216, 225, 226, 231, 236, 238, 243, 251, 255, 257, 260, 261, 263, 270, 271]	[7, 16, 28, 37, 42, 44, 53, 57, 64, 70, 73, 75, 78, 89, 91, 94, 96, 97, 103, 104, 110, 111, 112, 116, 123, 128, 137, 142, 145, 148, 150, 153, 156, 157, 161, 168, 174, 177, 179, 182, 184, 188, 190, 191, 192, 193, 194, 195, 196, 204, 215, 224, 226, 230, 236, 237, 243, 250, 255, 256, 260, 261, 262, 270, 271, 272]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', 'staining', 'was', 'viewed', 'under', 'an', 'E800', 'microscope', '(', 'Nikon', ',', 'Tokyo', ',', 'Japan', ')', ',', 'and', 'images', 'were', 'captured', 'with', 'an', 'AxioCam', 'HRc', 'CCD', 'camera', 'using', 'AxioVison', 'Rel', '4.7.2.0', 'imaging', 'processing', 'software', '(', 'Carl', 'Zeiss', ',', 'Microimaging', 'GmbH', ',', 'Jena', ',', 'Germany', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 4, 1, 7, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After deparaffinization, the sections were boiled in pretreatment solution for 10 min, digested with protease for 20 min, and then hybridized with designed probes against PTPRQ (VA1‐3017466).	[('PMC7821334', 'M16001', 101, 109, 'protease')]	['After', 'depar', '##affin', '##ization', ',', 'the', 'sections', 'were', 'bo', '##iled', 'in', 'pretreatment', 'solution', 'for', '10', 'min', ',', 'digested', 'with', 'protease', 'for', '20', 'min', ',', 'and', 'then', 'hybridized', 'with', 'designed', 'probes', 'against', 'PTP', '##R', '##Q', '(', 'VA', '##1', '‐', '301', '##74', '##66', ')', '.']	[0, 6, 11, 16, 23, 25, 29, 38, 43, 45, 50, 53, 66, 75, 79, 82, 85, 87, 96, 101, 110, 114, 117, 120, 122, 126, 131, 142, 147, 156, 163, 171, 174, 175, 177, 178, 180, 181, 182, 185, 187, 189, 190]	[5, 11, 16, 23, 24, 28, 37, 42, 45, 49, 52, 65, 74, 78, 81, 85, 86, 95, 100, 109, 113, 116, 120, 121, 125, 130, 141, 146, 155, 162, 170, 174, 175, 176, 178, 180, 181, 182, 185, 187, 189, 190, 191]	['After', 'deparaffinization', ',', 'the', 'sections', 'were', 'boiled', 'in', 'pretreatment', 'solution', 'for', '10', 'min', ',', 'digested', 'with', 'protease', 'for', '20', 'min', ',', 'and', 'then', 'hybridized', 'with', 'designed', 'probes', 'against', 'PTPRQ', '(', 'VA1‐3017466', ')', '.']	[1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SARS-CoV-2 entry into the host is mediated by binding of viral spike protein to the Human angiotensin-converting enzyme 2 (Angiotensin-converting enzyme 2) receptor.	[('PMC7928900', 'A00001', 90, 121, 'angiotensin-converting enzyme 2'), ('PMC7928900', 'A00001', 123, 154, 'Angiotensin-converting enzyme 2')]	['SAR', '##S', '-', 'Co', '##V', '-', '2', 'entry', 'into', 'the', 'host', 'is', 'mediated', 'by', 'binding', 'of', 'viral', 'spike', 'protein', 'to', 'the', 'Human', 'angiotensin', '-', 'converting', 'enzyme', '2', '(', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', ')', 'receptor', '.']	[0, 3, 4, 5, 7, 8, 9, 11, 17, 22, 26, 31, 34, 43, 46, 54, 57, 63, 69, 77, 80, 84, 90, 101, 102, 113, 120, 122, 123, 127, 134, 135, 146, 153, 154, 156, 164]	[3, 4, 5, 7, 8, 9, 10, 16, 21, 25, 30, 33, 42, 45, 53, 56, 62, 68, 76, 79, 83, 89, 101, 102, 112, 119, 121, 123, 127, 134, 135, 145, 152, 154, 155, 164, 165]	['SARS-CoV-2', 'entry', 'into', 'the', 'host', 'is', 'mediated', 'by', 'binding', 'of', 'viral', 'spike', 'protein', 'to', 'the', 'Human', 'angiotensin', '-', 'converting', 'enzyme', '2', '(', 'Angiotensin', '-', 'converting', 'enzyme', '2', ')', 'receptor', '.']	[7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
Angiotensin-converting enzyme 2 is an essential member of the Renin–Angiotensin system (RAS) involved in maintaining the blood pressure and vascular remodelling.	[('PMC7928900', 'A00002', 0, 31, 'Angiotensin-converting enzyme 2')]	['Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'is', 'an', 'essential', 'member', 'of', 'the', 'Ren', '##in', '–', 'Angi', '##otensin', 'system', '(', 'RAS', ')', 'involved', 'in', 'maintaining', 'the', 'blood', 'pressure', 'and', 'vascular', 'remod', '##elling', '.']	[0, 4, 11, 12, 23, 30, 32, 35, 38, 48, 55, 58, 62, 65, 67, 68, 72, 80, 87, 88, 91, 93, 102, 105, 117, 121, 127, 136, 140, 149, 154, 160]	[4, 11, 12, 22, 29, 31, 34, 37, 47, 54, 57, 61, 65, 67, 68, 72, 79, 86, 88, 91, 92, 101, 104, 116, 120, 126, 135, 139, 148, 154, 160, 161]	['Angiotensin', '-', 'converting', 'enzyme', '2', 'is', 'an', 'essential', 'member', 'of', 'the', 'Renin', '–', 'Angiotensin', 'system', '(', 'RAS', ')', 'involved', 'in', 'maintaining', 'the', 'blood', 'pressure', 'and', 'vascular', 'remodelling', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although Angiotensin-converting enzyme 2 receptor is the entry point to the host, recent studies show activation of Angiotensin-converting enzyme 2 to modulate the host to develop a suitable environment for its replication.	[('PMC7928900', 'A00003', 9, 40, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'A00003', 116, 147, 'Angiotensin-converting enzyme 2')]	['Although', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'is', 'the', 'entry', 'point', 'to', 'the', 'host', ',', 'recent', 'studies', 'show', 'activation', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'to', 'modulate', 'the', 'host', 'to', 'develop', 'a', 'suitable', 'environment', 'for', 'its', 'replication', '.']	[0, 9, 13, 20, 21, 32, 39, 41, 50, 53, 57, 63, 69, 72, 76, 80, 82, 89, 97, 102, 113, 116, 120, 127, 128, 139, 146, 148, 151, 160, 164, 169, 172, 180, 182, 191, 203, 207, 211, 222]	[8, 13, 20, 21, 31, 38, 40, 49, 52, 56, 62, 68, 71, 75, 80, 81, 88, 96, 101, 112, 115, 120, 127, 128, 138, 145, 147, 150, 159, 163, 168, 171, 179, 181, 190, 202, 206, 210, 222, 223]	['Although', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'is', 'the', 'entry', 'point', 'to', 'the', 'host', ',', 'recent', 'studies', 'show', 'activation', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'to', 'modulate', 'the', 'host', 'to', 'develop', 'a', 'suitable', 'environment', 'for', 'its', 'replication', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the Angiotensin-converting enzyme 2 activating the immune signals on SARS-CoV-2 attachment is still under investigation.	[('PMC7928900', 'A00004', 13, 44, 'Angiotensin-converting enzyme 2')]	['However', ',', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'activating', 'the', 'immune', 'signals', 'on', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'attachment', 'is', 'still', 'under', 'investigation', '.']	[0, 7, 9, 13, 17, 24, 25, 36, 43, 45, 56, 60, 67, 75, 78, 81, 82, 83, 85, 86, 87, 89, 100, 103, 109, 115, 128]	[7, 8, 12, 17, 24, 25, 35, 42, 44, 55, 59, 66, 74, 77, 81, 82, 83, 85, 86, 87, 88, 99, 102, 108, 114, 128, 129]	['However', ',', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'activating', 'the', 'immune', 'signals', 'on', 'SARS-CoV-2', 'attachment', 'is', 'still', 'under', 'investigation', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We have used systems biological approach to construct the host regulatory network upon SARS-CoV-2 attachment to the Angiotensin-converting enzyme 2 receptor.	[('PMC7928900', 'A00005', 116, 147, 'Angiotensin-converting enzyme 2')]	['We', 'have', 'used', 'systems', 'biological', 'approach', 'to', 'construct', 'the', 'host', 'regulatory', 'network', 'upon', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'attachment', 'to', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[0, 3, 8, 13, 21, 32, 41, 44, 54, 58, 63, 74, 82, 87, 90, 91, 92, 94, 95, 96, 98, 109, 112, 116, 120, 127, 128, 139, 146, 148, 156]	[2, 7, 12, 20, 31, 40, 43, 53, 57, 62, 73, 81, 86, 90, 91, 92, 94, 95, 96, 97, 108, 111, 115, 120, 127, 128, 138, 145, 147, 156, 157]	['We', 'have', 'used', 'systems', 'biological', 'approach', 'to', 'construct', 'the', 'host', 'regulatory', 'network', 'upon', 'SARS-CoV-2', 'attachment', 'to', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
The constructed network contains 133 host proteins with 298 interactions that directly or indirectly connect to the Angiotensin-converting enzyme 2 receptor.	[('PMC7928900', 'A00009', 116, 147, 'Angiotensin-converting enzyme 2')]	['The', 'constructed', 'network', 'contains', '133', 'host', 'proteins', 'with', '298', 'interactions', 'that', 'directly', 'or', 'indirectly', 'connect', 'to', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[0, 4, 16, 24, 33, 37, 42, 51, 56, 60, 73, 78, 87, 90, 101, 109, 112, 116, 120, 127, 128, 139, 146, 148, 156]	[3, 15, 23, 32, 36, 41, 50, 55, 59, 72, 77, 86, 89, 100, 108, 111, 115, 120, 127, 128, 138, 145, 147, 156, 157]	['The', 'constructed', 'network', 'contains', '133', 'host', 'proteins', 'with', '298', 'interactions', 'that', 'directly', 'or', 'indirectly', 'connect', 'to', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Altered proteins connect multiple proteins in a network that modulates kinase, carboxypeptidase and cytokine activity, leading to changes in the host immune system, cell cycle and signal transduction mechanisms.	[('PMC7928900', 'A00011', 71, 77, 'kinase'), ('PMC7928900', 'A00011', 79, 95, 'carboxypeptidase')]	['Alter', '##ed', 'proteins', 'connect', 'multiple', 'proteins', 'in', 'a', 'network', 'that', 'modulates', 'kinase', ',', 'carb', '##oxyp', '##epti', '##dase', 'and', 'cytokine', 'activity', ',', 'leading', 'to', 'changes', 'in', 'the', 'host', 'immune', 'system', ',', 'cell', 'cycle', 'and', 'signal', 'transduction', 'mechanisms', '.']	[0, 5, 8, 17, 25, 34, 43, 46, 48, 56, 61, 71, 77, 79, 83, 87, 91, 96, 100, 109, 117, 119, 127, 130, 138, 141, 145, 150, 157, 163, 165, 170, 176, 180, 187, 200, 210]	[5, 7, 16, 24, 33, 42, 45, 47, 55, 60, 70, 77, 78, 83, 87, 91, 95, 99, 108, 117, 118, 126, 129, 137, 140, 144, 149, 156, 163, 164, 169, 175, 179, 186, 199, 210, 211]	['Altered', 'proteins', 'connect', 'multiple', 'proteins', 'in', 'a', 'network', 'that', 'modulates', 'kinase', ',', 'carboxypeptidase', 'and', 'cytokine', 'activity', ',', 'leading', 'to', 'changes', 'in', 'the', 'host', 'immune', 'system', ',', 'cell', 'cycle', 'and', 'signal', 'transduction', 'mechanisms', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Overall, our results will help in understanding the immune molecular regulatory networks influenced by the Angiotensin-converting enzyme 2 mediated interaction in other body tissues, which may aid in identifying the secondary health complications associated with SARS-CoV-2 infection.	[('PMC7928900', 'A00013', 107, 138, 'Angiotensin-converting enzyme 2')]	['Overall', ',', 'our', 'results', 'will', 'help', 'in', 'understanding', 'the', 'immune', 'molecular', 'regulatory', 'networks', 'influenced', 'by', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'mediated', 'interaction', 'in', 'other', 'body', 'tissues', ',', 'which', 'may', 'aid', 'in', 'identifying', 'the', 'secondary', 'health', 'complications', 'associated', 'with', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'infection', '.']	[0, 7, 9, 13, 21, 26, 31, 34, 48, 52, 59, 69, 80, 89, 100, 103, 107, 111, 118, 119, 130, 137, 139, 148, 160, 163, 169, 174, 181, 183, 189, 193, 197, 200, 212, 216, 226, 233, 247, 258, 263, 266, 267, 268, 270, 271, 272, 274, 283]	[7, 8, 12, 20, 25, 30, 33, 47, 51, 58, 68, 79, 88, 99, 102, 106, 111, 118, 119, 129, 136, 138, 147, 159, 162, 168, 173, 181, 182, 188, 192, 196, 199, 211, 215, 225, 232, 246, 257, 262, 266, 267, 268, 270, 271, 272, 273, 283, 284]	['Overall', ',', 'our', 'results', 'will', 'help', 'in', 'understanding', 'the', 'immune', 'molecular', 'regulatory', 'networks', 'influenced', 'by', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'mediated', 'interaction', 'in', 'other', 'body', 'tissues', ',', 'which', 'may', 'aid', 'in', 'identifying', 'the', 'secondary', 'health', 'complications', 'associated', 'with', 'SARS-CoV-2', 'infection', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interactome data from the current study reveals that Angiotensin-converting enzyme 2 is found to interact with AGT directly mediated by AGTR2, NTS and GHRL.	[('PMC7928900', 'D00002', 53, 84, 'Angiotensin-converting enzyme 2')]	['Inter', '##act', '##ome', 'data', 'from', 'the', 'current', 'study', 'reveals', 'that', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'is', 'found', 'to', 'interact', 'with', 'AG', '##T', 'directly', 'mediated', 'by', 'AG', '##TR', '##2', ',', 'NT', '##S', 'and', 'GH', '##RL', '.']	[0, 5, 8, 12, 17, 22, 26, 34, 40, 48, 53, 57, 64, 65, 76, 83, 85, 88, 94, 97, 106, 111, 113, 115, 124, 133, 136, 138, 140, 141, 143, 145, 147, 151, 153, 155]	[5, 8, 11, 16, 21, 25, 33, 39, 47, 52, 57, 64, 65, 75, 82, 84, 87, 93, 96, 105, 110, 113, 114, 123, 132, 135, 138, 140, 141, 142, 145, 146, 150, 153, 155, 156]	['Interactome', 'data', 'from', 'the', 'current', 'study', 'reveals', 'that', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'is', 'found', 'to', 'interact', 'with', 'AGT', 'directly', 'mediated', 'by', 'AGTR2', ',', 'NTS', 'and', 'GHRL', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
From the knowledge which is gathered from the available literature, it can be conceived that the functional hubs involved in Angiotensin-converting enzyme 2/AGT-axis not only modulated host environment for viral entry and replication, but also secondarily can lead to inadvertent signalling leading to exaggerated immune response.	[('PMC7928900', 'D00015', 125, 156, 'Angiotensin-converting enzyme 2')]	['From', 'the', 'knowledge', 'which', 'is', 'gathered', 'from', 'the', 'available', 'literature', ',', 'it', 'can', 'be', 'conceived', 'that', 'the', 'functional', 'hub', '##s', 'involved', 'in', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', '/', 'AG', '##T', '-', 'axis', 'not', 'only', 'modulated', 'host', 'environment', 'for', 'viral', 'entry', 'and', 'replication', ',', 'but', 'also', 'second', '##arily', 'can', 'lead', 'to', 'in', '##ad', '##vert', '##ent', 'signalling', 'leading', 'to', 'exagger', '##ated', 'immune', 'response', '.']	[0, 5, 9, 19, 25, 28, 37, 42, 46, 56, 66, 68, 71, 75, 78, 88, 93, 97, 108, 111, 113, 122, 125, 129, 136, 137, 148, 155, 156, 157, 159, 160, 161, 166, 170, 175, 185, 190, 202, 206, 212, 218, 222, 233, 235, 239, 244, 250, 256, 260, 265, 268, 270, 272, 276, 280, 291, 299, 302, 309, 314, 321, 329]	[4, 8, 18, 24, 27, 36, 41, 45, 55, 66, 67, 70, 74, 77, 87, 92, 96, 107, 111, 112, 121, 124, 129, 136, 137, 147, 154, 156, 157, 159, 160, 161, 165, 169, 174, 184, 189, 201, 205, 211, 217, 221, 233, 234, 238, 243, 250, 255, 259, 264, 267, 270, 272, 276, 279, 290, 298, 301, 309, 313, 320, 329, 330]	['From', 'the', 'knowledge', 'which', 'is', 'gathered', 'from', 'the', 'available', 'literature', ',', 'it', 'can', 'be', 'conceived', 'that', 'the', 'functional', 'hubs', 'involved', 'in', 'Angiotensin', '-', 'converting', 'enzyme', '2', '/', 'AGT-axis', 'not', 'only', 'modulated', 'host', 'environment', 'for', 'viral', 'entry', 'and', 'replication', ',', 'but', 'also', 'secondarily', 'can', 'lead', 'to', 'inadvertent', 'signalling', 'leading', 'to', 'exaggerated', 'immune', 'response', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Further studies have to be undertaken to decipher the role of Angiotensin-converting enzyme 2/Ang-axis involvement with the immune system in detail.	[('PMC7928900', 'D00016', 62, 93, 'Angiotensin-converting enzyme 2')]	['Further', 'studies', 'have', 'to', 'be', 'undertaken', 'to', 'dec', '##ipher', 'the', 'role', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', '/', 'Ang', '-', 'axis', 'involvement', 'with', 'the', 'immune', 'system', 'in', 'detail', '.']	[0, 8, 16, 21, 24, 27, 38, 41, 44, 50, 54, 59, 62, 66, 73, 74, 85, 92, 93, 94, 97, 98, 103, 115, 120, 124, 131, 138, 141, 147]	[7, 15, 20, 23, 26, 37, 40, 44, 49, 53, 58, 61, 66, 73, 74, 84, 91, 93, 94, 97, 98, 102, 114, 119, 123, 130, 137, 140, 147, 148]	['Further', 'studies', 'have', 'to', 'be', 'undertaken', 'to', 'decipher', 'the', 'role', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', '/', 'Ang', '-', 'axis', 'involvement', 'with', 'the', 'immune', 'system', 'in', 'detail', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Based on the annotation of genes interacting with Angiotensin-converting enzyme 2 receptor from our current study, it can be observed that Angiotensin-converting enzyme 2 interacting genes are essential for host-virus interaction and essential for replication, survival and spread of the virus mediated through the deregulated host immune signalling.	[('PMC7928900', 'D00017', 50, 81, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'D00017', 139, 170, 'Angiotensin-converting enzyme 2')]	['Based', 'on', 'the', 'annotation', 'of', 'genes', 'interacting', 'with', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'from', 'our', 'current', 'study', ',', 'it', 'can', 'be', 'observed', 'that', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'interacting', 'genes', 'are', 'essential', 'for', 'host', '-', 'virus', 'interaction', 'and', 'essential', 'for', 'replication', ',', 'survival', 'and', 'spread', 'of', 'the', 'virus', 'mediated', 'through', 'the', 'dere', '##gu', '##lated', 'host', 'immune', 'signalling', '.']	[0, 6, 9, 13, 24, 27, 33, 45, 50, 54, 61, 62, 73, 80, 82, 91, 96, 100, 108, 113, 115, 118, 122, 125, 134, 139, 143, 150, 151, 162, 169, 171, 183, 189, 193, 203, 207, 211, 212, 218, 230, 234, 244, 248, 259, 261, 270, 274, 281, 284, 288, 294, 303, 311, 315, 319, 321, 327, 332, 339, 349]	[5, 8, 12, 23, 26, 32, 44, 49, 54, 61, 62, 72, 79, 81, 90, 95, 99, 107, 113, 114, 117, 121, 124, 133, 138, 143, 150, 151, 161, 168, 170, 182, 188, 192, 202, 206, 211, 212, 217, 229, 233, 243, 247, 259, 260, 269, 273, 280, 283, 287, 293, 302, 310, 314, 319, 321, 326, 331, 338, 349, 350]	['Based', 'on', 'the', 'annotation', 'of', 'genes', 'interacting', 'with', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'from', 'our', 'current', 'study', ',', 'it', 'can', 'be', 'observed', 'that', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'interacting', 'genes', 'are', 'essential', 'for', 'host', '-', 'virus', 'interaction', 'and', 'essential', 'for', 'replication', ',', 'survival', 'and', 'spread', 'of', 'the', 'virus', 'mediated', 'through', 'the', 'deregulated', 'host', 'immune', 'signalling', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
From the over representing pathways associated with regulatory network across different human tissues, highlighted testis to express specific immune molecules, which can interact with Angiotensin-converting enzyme 2 receptor.	[('PMC7928900', 'D01000', 184, 215, 'Angiotensin-converting enzyme 2')]	['From', 'the', 'over', 'representing', 'pathways', 'associated', 'with', 'regulatory', 'network', 'across', 'different', 'human', 'tissues', ',', 'highlighted', 'testis', 'to', 'express', 'specific', 'immune', 'molecules', ',', 'which', 'can', 'interact', 'with', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[0, 5, 9, 14, 27, 36, 47, 52, 63, 71, 78, 88, 94, 101, 103, 115, 122, 125, 133, 142, 149, 158, 160, 166, 170, 179, 184, 188, 195, 196, 207, 214, 216, 224]	[4, 8, 13, 26, 35, 46, 51, 62, 70, 77, 87, 93, 101, 102, 114, 121, 124, 132, 141, 148, 158, 159, 165, 169, 178, 183, 188, 195, 196, 206, 213, 215, 224, 225]	['From', 'the', 'over', 'representing', 'pathways', 'associated', 'with', 'regulatory', 'network', 'across', 'different', 'human', 'tissues', ',', 'highlighted', 'testis', 'to', 'express', 'specific', 'immune', 'molecules', ',', 'which', 'can', 'interact', 'with', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Studies report high Angiotensin-converting enzyme 2 expression levels in testicular cells such as spermatogonia, seminiferous duct, Sertoli and Leydig cells (Wang and Xu 2020).	[('PMC7928900', 'D01001', 20, 51, 'Angiotensin-converting enzyme 2')]	['Studies', 'report', 'high', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'expression', 'levels', 'in', 'testicular', 'cells', 'such', 'as', 'spermato', '##go', '##nia', ',', 'semi', '##ni', '##fer', '##ous', 'duct', ',', 'Ser', '##tol', '##i', 'and', 'Le', '##yd', '##ig', 'cells', '(', 'Wang', 'and', 'Xu', '202', '##0', ')', '.']	[0, 8, 15, 20, 24, 31, 32, 43, 50, 52, 63, 70, 73, 84, 90, 95, 98, 106, 108, 111, 113, 117, 119, 122, 126, 130, 132, 135, 138, 140, 144, 146, 148, 151, 157, 158, 163, 167, 170, 173, 174, 175]	[7, 14, 19, 24, 31, 32, 42, 49, 51, 62, 69, 72, 83, 89, 94, 97, 106, 108, 111, 112, 117, 119, 122, 125, 130, 131, 135, 138, 139, 143, 146, 148, 150, 156, 158, 162, 166, 169, 173, 174, 175, 176]	['Studies', 'report', 'high', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'expression', 'levels', 'in', 'testicular', 'cells', 'such', 'as', 'spermatogonia', ',', 'seminiferous', 'duct', ',', 'Sertoli', 'and', 'Leydig', 'cells', '(', 'Wang', 'and', 'Xu', '2020', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Based on the expression levels of Angiotensin-converting enzyme 2 interacting immune factors in various human tissues, next to testicular cells, stomach, small intestine, colon and duodenum has shown to express Angiotensin-converting enzyme 2 receptor inducible immune molecules in higher amount when compared to the other tissues.	[('PMC7928900', 'D01008', 34, 65, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'D01008', 211, 242, 'Angiotensin-converting enzyme 2')]	['Based', 'on', 'the', 'expression', 'levels', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'interacting', 'immune', 'factors', 'in', 'various', 'human', 'tissues', ',', 'next', 'to', 'testicular', 'cells', ',', 'stomach', ',', 'small', 'intestine', ',', 'colon', 'and', 'duoden', '##um', 'has', 'shown', 'to', 'express', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'inducible', 'immune', 'molecules', 'in', 'higher', 'amount', 'when', 'compared', 'to', 'the', 'other', 'tissues', '.']	[0, 6, 9, 13, 24, 31, 34, 38, 45, 46, 57, 64, 66, 78, 85, 93, 96, 104, 110, 117, 119, 124, 127, 138, 143, 145, 152, 154, 160, 169, 171, 177, 181, 187, 190, 194, 200, 203, 211, 215, 222, 223, 234, 241, 243, 252, 262, 269, 279, 282, 289, 296, 301, 310, 313, 317, 323, 330]	[5, 8, 12, 23, 30, 33, 38, 45, 46, 56, 63, 65, 77, 84, 92, 95, 103, 109, 117, 118, 123, 126, 137, 143, 144, 152, 153, 159, 169, 170, 176, 180, 187, 189, 193, 199, 202, 210, 215, 222, 223, 233, 240, 242, 251, 261, 268, 278, 281, 288, 295, 300, 309, 312, 316, 322, 330, 331]	['Based', 'on', 'the', 'expression', 'levels', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'interacting', 'immune', 'factors', 'in', 'various', 'human', 'tissues', ',', 'next', 'to', 'testicular', 'cells', ',', 'stomach', ',', 'small', 'intestine', ',', 'colon', 'and', 'duodenum', 'has', 'shown', 'to', 'express', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'inducible', 'immune', 'molecules', 'in', 'higher', 'amount', 'when', 'compared', 'to', 'the', 'other', 'tissues', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In this work, we would also like to highlight few genes like insulin-like growth factor (IGF), G protein-coupled receptor kinases 2 (G protein-coupled receptor kinases 2) and Phosphoinositide-3-Kinase Regulatory Subunit 1 (PI3KR1), which are well studied to have roles in insulin signalling mechanism, that were shown have to interact with the regulatory network.	[('PMC7928900', 'D01012', 95, 131, 'G protein-coupled receptor kinases 2'), ('PMC7928900', 'D01012', 133, 169, 'G protein-coupled receptor kinases 2'), ('PMC7928900', 'D01012', 175, 200, 'Phosphoinositide-3-Kinase')]	['In', 'this', 'work', ',', 'we', 'would', 'also', 'like', 'to', 'highlight', 'few', 'genes', 'like', 'insulin', '-', 'like', 'growth', 'factor', '(', 'IGF', ')', ',', 'G', 'protein', '-', 'coupled', 'receptor', 'kinases', '2', '(', 'G', 'protein', '-', 'coupled', 'receptor', 'kinases', '2', ')', 'and', 'Phosph', '##oin', '##osi', '##tide', '-', '3', '-', 'Kin', '##ase', 'Reg', '##ulatory', 'Sub', '##unit', '1', '(', 'PI', '##3', '##K', '##R', '##1', ')', ',', 'which', 'are', 'well', 'studied', 'to', 'have', 'roles', 'in', 'insulin', 'signalling', 'mechanism', ',', 'that', 'were', 'shown', 'have', 'to', 'interact', 'with', 'the', 'regulatory', 'network', '.']	[0, 3, 8, 12, 14, 17, 23, 28, 33, 36, 46, 50, 56, 61, 68, 69, 74, 81, 88, 89, 92, 93, 95, 97, 104, 105, 113, 122, 130, 132, 133, 135, 142, 143, 151, 160, 168, 169, 171, 175, 181, 184, 187, 191, 192, 193, 194, 197, 201, 204, 212, 215, 220, 222, 223, 225, 226, 227, 228, 229, 230, 232, 238, 242, 247, 255, 258, 263, 269, 272, 280, 291, 300, 302, 307, 312, 318, 323, 326, 335, 340, 344, 355, 362]	[2, 7, 12, 13, 16, 22, 27, 32, 35, 45, 49, 55, 60, 68, 69, 73, 80, 87, 89, 92, 93, 94, 96, 104, 105, 112, 121, 129, 131, 133, 134, 142, 143, 150, 159, 167, 169, 170, 174, 181, 184, 187, 191, 192, 193, 194, 197, 200, 204, 211, 215, 219, 221, 223, 225, 226, 227, 228, 229, 230, 231, 237, 241, 246, 254, 257, 262, 268, 271, 279, 290, 300, 301, 306, 311, 317, 322, 325, 334, 339, 343, 354, 362, 363]	['In', 'this', 'work', ',', 'we', 'would', 'also', 'like', 'to', 'highlight', 'few', 'genes', 'like', 'insulin', '-', 'like', 'growth', 'factor', '(', 'IGF', ')', ',', 'G', 'protein', '-', 'coupled', 'receptor', 'kinases', '2', '(', 'G', 'protein', '-', 'coupled', 'receptor', 'kinases', '2', ')', 'and', 'Phosphoinositide-3-Kinase', 'Regulatory', 'Subunit', '1', '(', 'PI3KR1', ')', ',', 'which', 'are', 'well', 'studied', 'to', 'have', 'roles', 'in', 'insulin', 'signalling', 'mechanism', ',', 'that', 'were', 'shown', 'have', 'to', 'interact', 'with', 'the', 'regulatory', 'network', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 9, 2, 2, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Further study has to be undertaken to dissect the functional role of Angiotensin-converting enzyme 2/Ang-axis interaction with the insulin signalling pathway's genes.	[('PMC7928900', 'D01013', 69, 100, 'Angiotensin-converting enzyme 2')]	"['Further', 'study', 'has', 'to', 'be', 'undertaken', 'to', 'diss', '##ect', 'the', 'functional', 'role', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', '/', 'Ang', '-', 'axis', 'interaction', 'with', 'the', 'insulin', 'signalling', 'pathway', ""'"", 's', 'genes', '.']"	[0, 8, 14, 18, 21, 24, 35, 38, 42, 46, 50, 61, 66, 69, 73, 80, 81, 92, 99, 100, 101, 104, 105, 110, 122, 127, 131, 139, 150, 157, 158, 160, 165]	[7, 13, 17, 20, 23, 34, 37, 42, 45, 49, 60, 65, 68, 73, 80, 81, 91, 98, 100, 101, 104, 105, 109, 121, 126, 130, 138, 149, 157, 158, 159, 165, 166]	"['Further', 'study', 'has', 'to', 'be', 'undertaken', 'to', 'dissect', 'the', 'functional', 'role', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', '/', 'Ang', '-', 'axis', 'interaction', 'with', 'the', 'insulin', 'signalling', ""pathway's"", 'genes', '.']"	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alteration in the expression of Angiotensin-converting enzyme 2 receptor transcriptional activity has been reported with chronic heart failure, hypertension and lung injury (Tikellis and Thomas 2012).	[('PMC7928900', 'D02000', 32, 63, 'Angiotensin-converting enzyme 2')]	['Alter', '##ation', 'in', 'the', 'expression', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'transcriptional', 'activity', 'has', 'been', 'reported', 'with', 'chronic', 'heart', 'failure', ',', 'hypertension', 'and', 'lung', 'injury', '(', 'Ti', '##kel', '##lis', 'and', 'Thomas', '2012', ')', '.']	[0, 5, 11, 14, 18, 29, 32, 36, 43, 44, 55, 62, 64, 73, 89, 98, 102, 107, 116, 121, 129, 135, 142, 144, 157, 161, 166, 173, 174, 176, 179, 183, 187, 194, 198, 199]	[5, 10, 13, 17, 28, 31, 36, 43, 44, 54, 61, 63, 72, 88, 97, 101, 106, 115, 120, 128, 134, 142, 143, 156, 160, 165, 172, 174, 176, 179, 182, 186, 193, 198, 199, 200]	['Alteration', 'in', 'the', 'expression', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'transcriptional', 'activity', 'has', 'been', 'reported', 'with', 'chronic', 'heart', 'failure', ',', 'hypertension', 'and', 'lung', 'injury', '(', 'Tikellis', 'and', 'Thomas', '2012', ')', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Modulation of lung Angiotensin-converting enzyme 2 expression is associated with alteration in the Ang II and Ang1–7 levels, which lead to hypoxia and inflammation (Sodhi et al. 2018).	[('PMC7928900', 'D02001', 19, 50, 'Angiotensin-converting enzyme 2')]	['Mod', '##ulation', 'of', 'lung', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'expression', 'is', 'associated', 'with', 'alteration', 'in', 'the', 'Ang', 'II', 'and', 'Ang', '##1', '–', '7', 'levels', ',', 'which', 'lead', 'to', 'hypoxia', 'and', 'inflammation', '(', 'So', '##dh', '##i', 'et', 'al', '.', '2018', ')', '.']	[0, 3, 11, 14, 19, 23, 30, 31, 42, 49, 51, 62, 65, 76, 81, 92, 95, 99, 103, 106, 110, 113, 114, 115, 117, 123, 125, 131, 136, 139, 147, 151, 164, 165, 167, 169, 171, 174, 176, 178, 182, 183]	[3, 10, 13, 18, 23, 30, 31, 41, 48, 50, 61, 64, 75, 80, 91, 94, 98, 102, 105, 109, 113, 114, 115, 116, 123, 124, 130, 135, 138, 146, 150, 163, 165, 167, 169, 170, 173, 176, 177, 182, 183, 184]	['Modulation', 'of', 'lung', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'expression', 'is', 'associated', 'with', 'alteration', 'in', 'the', 'Ang', 'II', 'and', 'Ang1', '–', '7', 'levels', ',', 'which', 'lead', 'to', 'hypoxia', 'and', 'inflammation', '(', 'Sodhi', 'et', 'al', '.', '2018', ')', '.']	[2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thus, Angiotensin-converting enzyme 2 is implicated to play a protective and beneficial role against lung diseases.	[('PMC7928900', 'D02002', 6, 37, 'Angiotensin-converting enzyme 2')]	['Thus', ',', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'is', 'implicated', 'to', 'play', 'a', 'protective', 'and', 'beneficial', 'role', 'against', 'lung', 'diseases', '.']	[0, 4, 6, 10, 17, 18, 29, 36, 38, 41, 52, 55, 60, 62, 73, 77, 88, 93, 101, 106, 114]	[4, 5, 10, 17, 18, 28, 35, 37, 40, 51, 54, 59, 61, 72, 76, 87, 92, 100, 105, 114, 115]	['Thus', ',', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'is', 'implicated', 'to', 'play', 'a', 'protective', 'and', 'beneficial', 'role', 'against', 'lung', 'diseases', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In our study, the computational prediction of genes interacting with the Angiotensin-converting enzyme 2 receptor comprised of signalling molecules from the NF-kappaB and NOS signal transduction pathways, mainly connected through the membrane Angiotensin-converting enzyme 2/AGT/AGTR1/MME hub.	[('PMC7928900', 'D02006', 73, 104, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'D02006', 243, 274, 'Angiotensin-converting enzyme 2')]	['In', 'our', 'study', ',', 'the', 'computational', 'prediction', 'of', 'genes', 'interacting', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'comprised', 'of', 'signalling', 'molecules', 'from', 'the', 'NF', '-', 'kappa', '##B', 'and', 'NOS', 'signal', 'transduction', 'pathways', ',', 'mainly', 'connected', 'through', 'the', 'membrane', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', '/', 'AG', '##T', '/', 'AG', '##TR', '##1', '/', 'MM', '##E', 'hub', '.']	[0, 3, 7, 12, 14, 18, 32, 43, 46, 52, 64, 69, 73, 77, 84, 85, 96, 103, 105, 114, 124, 127, 138, 148, 153, 157, 159, 160, 165, 167, 171, 175, 182, 195, 203, 205, 212, 222, 230, 234, 243, 247, 254, 255, 266, 273, 274, 275, 277, 278, 279, 281, 283, 284, 285, 287, 289, 292]	[2, 6, 12, 13, 17, 31, 42, 45, 51, 63, 68, 72, 77, 84, 85, 95, 102, 104, 113, 123, 126, 137, 147, 152, 156, 159, 160, 165, 166, 170, 174, 181, 194, 203, 204, 211, 221, 229, 233, 242, 247, 254, 255, 265, 272, 274, 275, 277, 278, 279, 281, 283, 284, 285, 287, 288, 292, 293]	['In', 'our', 'study', ',', 'the', 'computational', 'prediction', 'of', 'genes', 'interacting', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'comprised', 'of', 'signalling', 'molecules', 'from', 'the', 'NF-kappaB', 'and', 'NOS', 'signal', 'transduction', 'pathways', ',', 'mainly', 'connected', 'through', 'the', 'membrane', 'Angiotensin', '-', 'converting', 'enzyme', '2', '/', 'AGT', '/', 'AGTR1', '/', 'MME', 'hub', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In a prospective cohort study investigating the biomarkers of host defense and RAS in bronchoalveolar lavage (BAL) fluid from neonates, children, adults and older adults who had acute respiratory distress syndrome (ARDS), highlighted that the activity of ACE and Angiotensin-converting enzyme 2 remind unchanged.	[('PMC7928900', 'D03000', 263, 294, 'Angiotensin-converting enzyme 2')]	['In', 'a', 'prospective', 'cohort', 'study', 'investigating', 'the', 'biomarkers', 'of', 'host', 'defense', 'and', 'RAS', 'in', 'bronch', '##oal', '##veolar', 'la', '##vage', '(', 'BAL', ')', 'fluid', 'from', 'neonates', ',', 'children', ',', 'adults', 'and', 'older', 'adults', 'who', 'had', 'acute', 'respiratory', 'distress', 'syndrome', '(', 'AR', '##DS', ')', ',', 'highlighted', 'that', 'the', 'activity', 'of', 'ACE', 'and', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'remind', 'unchanged', '.']	[0, 3, 5, 17, 24, 30, 44, 48, 59, 62, 67, 75, 79, 83, 86, 92, 95, 102, 104, 109, 110, 113, 115, 121, 126, 134, 136, 144, 146, 153, 157, 163, 170, 174, 178, 184, 196, 205, 214, 215, 217, 219, 220, 222, 234, 239, 243, 252, 255, 259, 263, 267, 274, 275, 286, 293, 295, 302, 311]	[2, 4, 16, 23, 29, 43, 47, 58, 61, 66, 74, 78, 82, 85, 92, 95, 101, 104, 108, 110, 113, 114, 120, 125, 134, 135, 144, 145, 152, 156, 162, 169, 173, 177, 183, 195, 204, 213, 215, 217, 219, 220, 221, 233, 238, 242, 251, 254, 258, 262, 267, 274, 275, 285, 292, 294, 301, 311, 312]	['In', 'a', 'prospective', 'cohort', 'study', 'investigating', 'the', 'biomarkers', 'of', 'host', 'defense', 'and', 'RAS', 'in', 'bronchoalveolar', 'lavage', '(', 'BAL', ')', 'fluid', 'from', 'neonates', ',', 'children', ',', 'adults', 'and', 'older', 'adults', 'who', 'had', 'acute', 'respiratory', 'distress', 'syndrome', '(', 'ARDS', ')', ',', 'highlighted', 'that', 'the', 'activity', 'of', 'ACE', 'and', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'remind', 'unchanged', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
Also, there is a significant alteration in the levels of myeloperoxidase, interleukin (IL)-6, IL-10 and p-selectin, which increased in an age dependent-manner (Schouten et al. 2019).	[('PMC7928900', 'D03002', 57, 72, 'myeloperoxidase')]	['Also', ',', 'there', 'is', 'a', 'significant', 'alteration', 'in', 'the', 'levels', 'of', 'myel', '##oper', '##oxidase', ',', 'interleukin', '(', 'IL', ')', '-', '6', ',', 'IL', '-', '10', 'and', 'p', '-', 'select', '##in', ',', 'which', 'increased', 'in', 'an', 'age', 'dependent', '-', 'manner', '(', 'Sch', '##out', '##en', 'et', 'al', '.', '201', '##9', ')', '.']	[0, 4, 6, 12, 15, 17, 29, 40, 43, 47, 54, 57, 61, 65, 72, 74, 86, 87, 89, 90, 91, 92, 94, 96, 97, 100, 104, 105, 106, 112, 114, 116, 122, 132, 135, 138, 142, 151, 152, 159, 160, 163, 166, 169, 172, 174, 176, 179, 180, 181]	[4, 5, 11, 14, 16, 28, 39, 42, 46, 53, 56, 61, 65, 72, 73, 85, 87, 89, 90, 91, 92, 93, 96, 97, 99, 103, 105, 106, 112, 114, 115, 121, 131, 134, 137, 141, 151, 152, 158, 160, 163, 166, 168, 171, 174, 175, 179, 180, 181, 182]	['Also', ',', 'there', 'is', 'a', 'significant', 'alteration', 'in', 'the', 'levels', 'of', 'myeloperoxidase', ',', 'interleukin', '(IL)-6', ',', 'IL-10', 'and', 'p-selectin', ',', 'which', 'increased', 'in', 'an', 'age', 'dependent', '-', 'manner', '(', 'Schouten', 'et', 'al', '.', '2019', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the present study protein–protein interaction network of Angiotensin-converting enzyme 2 receptor found to influence the chemokine and cytokine activity, cytokine and chemokine receptor binding and bradykinin receptor binding mediated through a major hub involving ATR/G-protein coupled receptors (GPCR).	[('PMC7928900', 'D03005', 60, 91, 'Angiotensin-converting enzyme 2')]	['In', 'the', 'present', 'study', 'protein', '–', 'protein', 'interaction', 'network', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'found', 'to', 'influence', 'the', 'chemokine', 'and', 'cytokine', 'activity', ',', 'cytokine', 'and', 'chemokine', 'receptor', 'binding', 'and', 'bra', '##dy', '##kin', '##in', 'receptor', 'binding', 'mediated', 'through', 'a', 'major', 'hub', 'involving', 'AT', '##R', '/', 'G', '-', 'protein', 'coupled', 'receptors', '(', 'GP', '##CR', ')', '.']	[0, 3, 7, 15, 21, 28, 29, 37, 49, 57, 60, 64, 71, 72, 83, 90, 92, 101, 107, 110, 120, 124, 134, 138, 147, 155, 157, 166, 170, 180, 189, 197, 201, 204, 206, 209, 212, 221, 229, 238, 246, 248, 254, 258, 268, 270, 271, 272, 273, 274, 282, 290, 300, 301, 303, 305, 306]	[2, 6, 14, 20, 28, 29, 36, 48, 56, 59, 64, 71, 72, 82, 89, 91, 100, 106, 109, 119, 123, 133, 137, 146, 155, 156, 165, 169, 179, 188, 196, 200, 204, 206, 209, 211, 220, 228, 237, 245, 247, 253, 257, 267, 270, 271, 272, 273, 274, 281, 289, 299, 301, 303, 305, 306, 307]	['In', 'the', 'present', 'study', 'protein', '–', 'protein', 'interaction', 'network', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'found', 'to', 'influence', 'the', 'chemokine', 'and', 'cytokine', 'activity', ',', 'cytokine', 'and', 'chemokine', 'receptor', 'binding', 'and', 'bradykinin', 'receptor', 'binding', 'mediated', 'through', 'a', 'major', 'hub', 'involving', 'ATR', '/', 'G', '-', 'protein', 'coupled', 'receptors', '(', 'GPCR', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the over representing pathways, compared with other tissues in the human body, lungs contained the highest number of immune molecules, which can functionally interact with the Angiotensin-converting enzyme 2 receptor.	[('PMC7928900', 'D03006', 179, 210, 'Angiotensin-converting enzyme 2')]	['In', 'the', 'over', 'representing', 'pathways', ',', 'compared', 'with', 'other', 'tissues', 'in', 'the', 'human', 'body', ',', 'lungs', 'contained', 'the', 'highest', 'number', 'of', 'immune', 'molecules', ',', 'which', 'can', 'functionally', 'interact', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[0, 3, 7, 12, 25, 33, 35, 44, 49, 55, 63, 66, 70, 76, 80, 82, 88, 98, 102, 110, 117, 120, 127, 136, 138, 144, 148, 161, 170, 175, 179, 183, 190, 191, 202, 209, 211, 219]	[2, 6, 11, 24, 33, 34, 43, 48, 54, 62, 65, 69, 75, 80, 81, 87, 97, 101, 109, 116, 119, 126, 136, 137, 143, 147, 160, 169, 174, 178, 183, 190, 191, 201, 208, 210, 219, 220]	['In', 'the', 'over', 'representing', 'pathways', ',', 'compared', 'with', 'other', 'tissues', 'in', 'the', 'human', 'body', ',', 'lungs', 'contained', 'the', 'highest', 'number', 'of', 'immune', 'molecules', ',', 'which', 'can', 'functionally', 'interact', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Devaux CA, Rolain JM, Raoult D. Angiotensin-converting enzyme 2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.	[('PMC7928900', 'F06000', 32, 63, 'Angiotensin-converting enzyme 2')]	['Dev', '##aux', 'CA', ',', 'Rol', '##ain', 'JM', ',', 'Rao', '##ult', 'D', '.', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'polymorphism', ':', 'susceptibility', 'to', 'SAR', '##S', '-', 'Co', '##V', '-', '2', ',', 'hypertension', ',', 'multi', '-', 'organ', 'failure', ',', 'and', 'CO', '##VI', '##D', '-', '19', 'disease', 'outcome', '.']	[0, 3, 7, 9, 11, 14, 18, 20, 22, 25, 29, 30, 32, 36, 43, 44, 55, 62, 64, 73, 85, 87, 102, 105, 108, 109, 110, 112, 113, 114, 115, 117, 129, 131, 136, 137, 143, 150, 152, 156, 158, 160, 161, 162, 165, 173, 180]	[3, 6, 9, 10, 14, 17, 20, 21, 25, 28, 30, 31, 36, 43, 44, 54, 61, 63, 72, 85, 86, 101, 104, 108, 109, 110, 112, 113, 114, 115, 116, 129, 130, 136, 137, 142, 150, 151, 155, 158, 160, 161, 162, 164, 172, 180, 181]	['Devaux', 'CA', ',', 'Rolain', 'JM', ',', 'Raoult', 'D', '.', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'polymorphism', ':', 'susceptibility', 'to', 'SARS-CoV-2', ',', 'hypertension', ',', 'multi', '-', 'organ', 'failure', ',', 'and', 'COVID-19', 'disease', 'outcome', '.']	[2, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Angiotensin-converting enzyme 2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection, MedRxiv. 2020.	[('PMC7928900', 'F08001', 0, 31, 'Angiotensin-converting enzyme 2')]	['Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'expression', 'in', 'kidney', 'and', 'testis', 'may', 'cause', 'kidney', 'and', 'testis', 'damage', 'after', '201', '##9', '-', 'n', '##Co', '##V', 'infection', ',', 'Med', '##R', '##xi', '##v', '.', '202', '##0', '.']	[0, 4, 11, 12, 23, 30, 32, 43, 46, 53, 57, 64, 68, 74, 81, 85, 92, 99, 105, 108, 109, 110, 111, 113, 115, 124, 126, 129, 130, 132, 133, 135, 138, 139]	[4, 11, 12, 22, 29, 31, 42, 45, 52, 56, 63, 67, 73, 80, 84, 91, 98, 104, 108, 109, 110, 111, 113, 114, 124, 125, 129, 130, 132, 133, 134, 138, 139, 140]	['Angiotensin', '-', 'converting', 'enzyme', '2', 'expression', 'in', 'kidney', 'and', 'testis', 'may', 'cause', 'kidney', 'and', 'testis', 'damage', 'after', '2019-nCoV', 'infection', ',', 'MedRxiv', '.', '2020', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 4, 1, 2, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.	[('PMC7928900', 'F10001', 13, 44, 'angiotensin-converting enzyme 2')]	['Evidence', 'for', 'angiotensin', '-', 'converting', 'enzyme', '2', 'as', 'a', 'therapeutic', 'target', 'for', 'the', 'prevention', 'of', 'pulmonary', 'hypertension', '.']	[0, 9, 13, 24, 25, 36, 43, 45, 48, 50, 62, 69, 73, 77, 88, 91, 101, 113]	[8, 12, 24, 25, 35, 42, 44, 47, 49, 61, 68, 72, 76, 87, 90, 100, 113, 114]	['Evidence', 'for', 'angiotensin', '-', 'converting', 'enzyme', '2', 'as', 'a', 'therapeutic', 'target', 'for', 'the', 'prevention', 'of', 'pulmonary', 'hypertension', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Trilogy of Angiotensin-converting enzyme 2: a peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters.	[('PMC7928900', 'F14001', 11, 42, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'F14001', 46, 55, 'peptidase')]	['Tri', '##log', '##y', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', ':', 'a', 'pepti', '##dase', 'in', 'the', 'renin', '–', 'angiotensin', 'system', ',', 'a', 'SAR', '##S', 'receptor', ',', 'and', 'a', 'partner', 'for', 'amino', 'acid', 'transporters', '.']	[0, 3, 6, 8, 11, 15, 22, 23, 34, 41, 42, 44, 46, 51, 56, 59, 63, 68, 69, 81, 87, 89, 91, 94, 96, 104, 106, 110, 112, 120, 124, 130, 135, 147]	[3, 6, 7, 10, 15, 22, 23, 33, 40, 42, 43, 45, 51, 55, 58, 62, 68, 69, 80, 87, 88, 90, 94, 95, 104, 105, 109, 111, 119, 123, 129, 134, 147, 148]	['Trilogy', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', ':', 'a', 'peptidase', 'in', 'the', 'renin', '–', 'angiotensin', 'system', ',', 'a', 'SARS', 'receptor', ',', 'and', 'a', 'partner', 'for', 'amino', 'acid', 'transporters', '.']	[3, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model–role of tumor stroma cells.	[('PMC7928900', 'F16001', 18, 48, 'membrane metallo-endopeptidase')]	['Hyp', '##oxia', 'increases', 'membrane', 'metall', '##o', '-', 'end', '##ope', '##pt', '##idase', 'expression', 'in', 'a', 'novel', 'lung', 'cancer', 'ex', 'vivo', 'model', '–', 'role', 'of', 'tumor', 'stroma', 'cells', '.']	[0, 3, 8, 18, 27, 33, 34, 35, 38, 41, 43, 49, 60, 63, 65, 71, 76, 83, 86, 91, 96, 97, 102, 105, 111, 118, 123]	[3, 7, 17, 26, 33, 34, 35, 38, 41, 43, 48, 59, 62, 64, 70, 75, 82, 85, 90, 96, 97, 101, 104, 110, 117, 123, 124]	['Hypoxia', 'increases', 'membrane', 'metallo', '-', 'endopeptidase', 'expression', 'in', 'a', 'novel', 'lung', 'cancer', 'ex', 'vivo', 'model', '–', 'role', 'of', 'tumor', 'stroma', 'cells', '.']	[2, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of Angiotensin-converting enzyme 2.	[('PMC7928900', 'F18001', 119, 150, 'Angiotensin-converting enzyme 2')]	['The', 'S', 'proteins', 'of', 'human', 'cor', '##ona', '##virus', 'NL', '##63', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'cor', '##ona', '##virus', 'bind', 'overlapping', 'regions', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', '.']	[0, 4, 6, 15, 18, 24, 27, 30, 36, 38, 41, 45, 52, 58, 70, 79, 82, 85, 91, 96, 108, 116, 119, 123, 130, 131, 142, 149, 150]	[3, 5, 14, 17, 23, 27, 30, 35, 38, 40, 44, 51, 57, 69, 78, 82, 85, 90, 95, 107, 115, 118, 123, 130, 131, 141, 148, 150, 151]	['The', 'S', 'proteins', 'of', 'human', 'coronavirus', 'NL63', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'bind', 'overlapping', 'regions', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', '.']	[1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O']
Membrane metallo-endopeptidase (Neprilysin) regulates inflammatory response and insulin signaling in white preadipocytes.	[('PMC7928900', 'F22001', 0, 30, 'Membrane metallo-endopeptidase')]	['Membrane', 'metall', '##o', '-', 'end', '##ope', '##pt', '##idase', '(', 'Nep', '##ril', '##ysi', '##n', ')', 'regulates', 'inflammatory', 'response', 'and', 'insulin', 'signaling', 'in', 'white', 'pre', '##adi', '##po', '##cyt', '##es', '.']	[0, 9, 15, 16, 17, 20, 23, 25, 31, 32, 35, 38, 41, 42, 44, 54, 67, 76, 80, 88, 98, 101, 107, 110, 113, 115, 118, 120]	[8, 15, 16, 17, 20, 23, 25, 30, 32, 35, 38, 41, 42, 43, 53, 66, 75, 79, 87, 97, 100, 106, 110, 113, 115, 118, 120, 121]	['Membrane', 'metallo', '-', 'endopeptidase', '(', 'Neprilysin', ')', 'regulates', 'inflammatory', 'response', 'and', 'insulin', 'signaling', 'in', 'white', 'preadipocytes', '.']	[1, 2, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Angiotensin-converting enzyme 2, much more than just a receptor for SARS-COV-2.	[('PMC7928900', 'F24001', 0, 31, 'Angiotensin-converting enzyme 2')]	['Angi', '##otensin', '-', 'converting', 'enzyme', '2', ',', 'much', 'more', 'than', 'just', 'a', 'receptor', 'for', 'SAR', '##S', '-', 'CO', '##V', '-', '2', '.']	[0, 4, 11, 12, 23, 30, 31, 33, 38, 43, 48, 53, 55, 64, 68, 71, 72, 73, 75, 76, 77, 78]	[4, 11, 12, 22, 29, 31, 32, 37, 42, 47, 52, 54, 63, 67, 71, 72, 73, 75, 76, 77, 78, 79]	['Angiotensin', '-', 'converting', 'enzyme', '2', ',', 'much', 'more', 'than', 'just', 'a', 'receptor', 'for', 'SARS-COV-2', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The Angiotensin-converting enzyme 2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection.	[('PMC7928900', 'F29001', 4, 35, 'Angiotensin-converting enzyme 2')]	['The', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'expression', 'in', 'Ser', '##tol', '##i', 'cells', 'and', 'germ', 'cells', 'may', 'cause', 'male', 'reproductive', 'disorder', 'after', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'infection', '.']	[0, 4, 8, 15, 16, 27, 34, 36, 47, 50, 53, 56, 58, 64, 68, 73, 79, 83, 89, 94, 107, 116, 122, 125, 126, 127, 129, 130, 131, 133, 142]	[3, 8, 15, 16, 26, 33, 35, 46, 49, 53, 56, 57, 63, 67, 72, 78, 82, 88, 93, 106, 115, 121, 125, 126, 127, 129, 130, 131, 132, 142, 143]	['The', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'expression', 'in', 'Sertoli', 'cells', 'and', 'germ', 'cells', 'may', 'cause', 'male', 'reproductive', 'disorder', 'after', 'SARS-CoV-2', 'infection', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Attenuation of pulmonary Angiotensin-converting enzyme 2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.	[('PMC7928900', 'F30001', 25, 56, 'Angiotensin-converting enzyme 2')]	['Att', '##en', '##uation', 'of', 'pulmonary', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'activity', 'impairs', 'inactivation', 'of', 'des', '-', 'Arg', '##9', 'bra', '##dy', '##kin', '##in', '/', 'BK', '##B', '##1', '##R', 'axis', 'and', 'facilitates', 'LPS', '-', 'induced', 'neutrophil', 'infiltration', '.']	[0, 3, 5, 12, 15, 25, 29, 36, 37, 48, 55, 57, 66, 74, 87, 90, 93, 94, 97, 99, 102, 104, 107, 109, 110, 112, 113, 114, 116, 121, 125, 137, 140, 141, 149, 160, 172]	[3, 5, 11, 14, 24, 29, 36, 37, 47, 54, 56, 65, 73, 86, 89, 93, 94, 97, 98, 102, 104, 107, 109, 110, 112, 113, 114, 115, 120, 124, 136, 140, 141, 148, 159, 172, 173]	['Attenuation', 'of', 'pulmonary', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'activity', 'impairs', 'inactivation', 'of', 'des-Arg9', 'bradykinin', '/', 'BKB1R', 'axis', 'and', 'facilitates', 'LPS-induced', 'neutrophil', 'infiltration', '.']	[3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 4, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Angiotensin-converting enzyme 2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.	[('PMC7928900', 'F31001', 0, 31, 'Angiotensin-converting enzyme 2')]	['Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'overexpression', 'in', 'the', 'para', '##vent', '##ric', '##ular', 'nucleus', 'attenuate', '##s', 'angiotensin', 'II', '-', 'induced', 'hypertension', '.']	[0, 4, 11, 12, 23, 30, 32, 47, 50, 54, 58, 62, 65, 70, 78, 87, 89, 101, 103, 104, 112, 124]	[4, 11, 12, 22, 29, 31, 46, 49, 53, 58, 62, 65, 69, 77, 87, 88, 100, 103, 104, 111, 124, 125]	['Angiotensin', '-', 'converting', 'enzyme', '2', 'overexpression', 'in', 'the', 'paraventricular', 'nucleus', 'attenuates', 'angiotensin', 'II-induced', 'hypertension', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 3, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Angiotensin-converting enzyme 2 (Angiotensin-converting enzyme 2) is a key modulator of the renin angiotensin system in health and disease.	[('PMC7928900', 'F33001', 0, 31, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'F33001', 33, 64, 'Angiotensin-converting enzyme 2')]	['Angi', '##otensin', '-', 'converting', 'enzyme', '2', '(', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', ')', 'is', 'a', 'key', 'modulator', 'of', 'the', 'renin', 'angiotensin', 'system', 'in', 'health', 'and', 'disease', '.']	[0, 4, 11, 12, 23, 30, 32, 33, 37, 44, 45, 56, 63, 64, 66, 69, 71, 75, 85, 88, 92, 98, 110, 117, 120, 127, 131, 138]	[4, 11, 12, 22, 29, 31, 33, 37, 44, 45, 55, 62, 64, 65, 68, 70, 74, 84, 87, 91, 97, 109, 116, 119, 126, 130, 138, 139]	['Angiotensin', '-', 'converting', 'enzyme', '2', '(', 'Angiotensin', '-', 'converting', 'enzyme', '2', ')', 'is', 'a', 'key', 'modulator', 'of', 'the', 'renin', 'angiotensin', 'system', 'in', 'health', 'and', 'disease', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the Angiotensin-converting enzyme 2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells.	[('PMC7928900', 'F38000', 78, 109, 'Angiotensin-converting enzyme 2')]	['Wang', 'Z', ',', 'Xu', 'X', '.', 'sc', '##RNA', '-', 'se', '##q', 'profiling', 'of', 'human', 'testes', 'reveals', 'the', 'presence', 'of', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', ',', 'a', 'target', 'for', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'infection', 'in', 'spermato', '##go', '##nia', ',', 'Le', '##yd', '##ig', 'and', 'Ser', '##tol', '##i', 'cells', '.']	[0, 5, 6, 8, 11, 12, 14, 16, 19, 20, 22, 24, 34, 37, 43, 50, 58, 62, 71, 74, 78, 82, 89, 90, 101, 108, 110, 118, 120, 122, 129, 133, 136, 137, 138, 140, 141, 142, 144, 154, 157, 165, 167, 170, 172, 174, 176, 179, 183, 186, 189, 191, 196]	[4, 6, 7, 10, 12, 13, 16, 19, 20, 22, 23, 33, 36, 42, 49, 57, 61, 70, 73, 77, 82, 89, 90, 100, 107, 109, 118, 119, 121, 128, 132, 136, 137, 138, 140, 141, 142, 143, 153, 156, 165, 167, 170, 171, 174, 176, 178, 182, 186, 189, 190, 196, 197]	['Wang', 'Z', ',', 'Xu', 'X', '.', 'scRNA-seq', 'profiling', 'of', 'human', 'testes', 'reveals', 'the', 'presence', 'of', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', ',', 'a', 'target', 'for', 'SARS-CoV-2', 'infection', 'in', 'spermatogonia', ',', 'Leydig', 'and', 'Sertoli', 'cells', '.']	[1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 3, 1, 3, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For instance, the spike protein of HCoV-NL63 and SARS-CoV binds to Angiotensin-converting enzyme 2 receptor to enter human cells (Li et al. 2007).	[('PMC7928900', 'I01004', 67, 98, 'Angiotensin-converting enzyme 2')]	['For', 'instance', ',', 'the', 'spike', 'protein', 'of', 'HC', '##o', '##V', '-', 'NL', '##63', 'and', 'SAR', '##S', '-', 'Co', '##V', 'binds', 'to', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'to', 'enter', 'human', 'cells', '(', 'Li', 'et', 'al', '.', '2007', ')', '.']	[0, 4, 12, 14, 18, 24, 32, 35, 37, 38, 39, 40, 42, 45, 49, 52, 53, 54, 56, 58, 64, 67, 71, 78, 79, 90, 97, 99, 108, 111, 117, 123, 129, 130, 133, 136, 138, 140, 144, 145]	[3, 12, 13, 17, 23, 31, 34, 37, 38, 39, 40, 42, 44, 48, 52, 53, 54, 56, 57, 63, 66, 71, 78, 79, 89, 96, 98, 107, 110, 116, 122, 128, 130, 132, 135, 138, 139, 144, 145, 146]	['For', 'instance', ',', 'the', 'spike', 'protein', 'of', 'HCoV-NL63', 'and', 'SARS-CoV', 'binds', 'to', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'to', 'enter', 'human', 'cells', '(', 'Li', 'et', 'al', '.', '2007', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 6, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Angiotensin-converting enzyme 2 gene is localized on chromosome X, spanning 39.98 kb in human genomic DNA comprising 18 exons (Samavati and Uhal 2020; Devaux, Rolain and Raoult 2020).	[('PMC7928900', 'I01005', 0, 31, 'Angiotensin-converting enzyme 2')]	['Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'gene', 'is', 'localized', 'on', 'chromosome', 'X', ',', 'spanning', '39', '.', '98', 'kb', 'in', 'human', 'genomic', 'DNA', 'comprising', '18', 'exons', '(', 'Sam', '##ava', '##ti', 'and', 'U', '##hal', '202', '##0', ';', 'Dev', '##aux', ',', 'Rol', '##ain', 'and', 'Rao', '##ult', '202', '##0', ')', '.']	[0, 4, 11, 12, 23, 30, 32, 37, 40, 50, 53, 64, 65, 67, 76, 78, 79, 82, 85, 88, 94, 102, 106, 117, 120, 126, 127, 130, 133, 136, 140, 141, 145, 148, 149, 151, 154, 157, 159, 162, 166, 170, 173, 177, 180, 181, 182]	[4, 11, 12, 22, 29, 31, 36, 39, 49, 52, 63, 65, 66, 75, 78, 79, 81, 84, 87, 93, 101, 105, 116, 119, 125, 127, 130, 133, 135, 139, 141, 144, 148, 149, 150, 154, 157, 158, 162, 165, 169, 173, 176, 180, 181, 182, 183]	['Angiotensin', '-', 'converting', 'enzyme', '2', 'gene', 'is', 'localized', 'on', 'chromosome', 'X', ',', 'spanning', '39.98', 'kb', 'in', 'human', 'genomic', 'DNA', 'comprising', '18', 'exons', '(', 'Samavati', 'and', 'Uhal', '2020', ';', 'Devaux', ',', 'Rolain', 'and', 'Raoult', '2020', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 2, 1, 2, 1, 2, 1, 2, 2, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Angiotensin-converting enzyme 2 encodes a glycoprotein comprised of 805 amino acids, which functionally regulates the RAS (Riordan 2003; Kuba et al., 2010), a control machinery involved in blood pressure homeostasis and electrolyte balance (Zaman et al. 2002).	[('PMC7928900', 'I01006', 0, 31, 'Angiotensin-converting enzyme 2')]	['Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'encodes', 'a', 'glycoprotein', 'comprised', 'of', '80', '##5', 'amino', 'acids', ',', 'which', 'functionally', 'regulates', 'the', 'RAS', '(', 'Rio', '##rd', '##an', '2003', ';', 'Ku', '##ba', 'et', 'al', '.', ',', '2010', ')', ',', 'a', 'control', 'machinery', 'involved', 'in', 'blood', 'pressure', 'homeostasis', 'and', 'electrolyte', 'balance', '(', 'Z', '##aman', 'et', 'al', '.', '2002', ')', '.']	[0, 4, 11, 12, 23, 30, 32, 40, 42, 55, 65, 68, 70, 72, 78, 83, 85, 91, 104, 114, 118, 122, 123, 126, 128, 131, 135, 137, 139, 142, 145, 147, 148, 150, 154, 155, 157, 159, 167, 177, 186, 189, 195, 204, 216, 220, 232, 240, 241, 242, 247, 250, 252, 254, 258, 259]	[4, 11, 12, 22, 29, 31, 39, 41, 54, 64, 67, 70, 71, 77, 83, 84, 90, 103, 113, 117, 121, 123, 126, 128, 130, 135, 136, 139, 141, 144, 147, 148, 149, 154, 155, 156, 158, 166, 176, 185, 188, 194, 203, 215, 219, 231, 239, 241, 242, 246, 249, 252, 253, 258, 259, 260]	['Angiotensin', '-', 'converting', 'enzyme', '2', 'encodes', 'a', 'glycoprotein', 'comprised', 'of', '805', 'amino', 'acids', ',', 'which', 'functionally', 'regulates', 'the', 'RAS', '(', 'Riordan', '2003', ';', 'Kuba', 'et', 'al', '.', ',', '2010', ')', ',', 'a', 'control', 'machinery', 'involved', 'in', 'blood', 'pressure', 'homeostasis', 'and', 'electrolyte', 'balance', '(', 'Zaman', 'et', 'al', '.', '2002', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Modulation of the RAS is expected on binding of the SARS-CoV-2 virus with the Angiotensin-converting enzyme 2 receptor.	[('PMC7928900', 'I01007', 78, 109, 'Angiotensin-converting enzyme 2')]	['Mod', '##ulation', 'of', 'the', 'RAS', 'is', 'expected', 'on', 'binding', 'of', 'the', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'virus', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[0, 3, 11, 14, 18, 22, 25, 34, 37, 45, 48, 52, 55, 56, 57, 59, 60, 61, 63, 69, 74, 78, 82, 89, 90, 101, 108, 110, 118]	[3, 10, 13, 17, 21, 24, 33, 36, 44, 47, 51, 55, 56, 57, 59, 60, 61, 62, 68, 73, 77, 82, 89, 90, 100, 107, 109, 118, 119]	['Modulation', 'of', 'the', 'RAS', 'is', 'expected', 'on', 'binding', 'of', 'the', 'SARS-CoV-2', 'virus', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Also, studies from the past indicate the association of Angiotensin-converting enzyme 2/Ang1–7 and Angiotensin-converting enzyme 2/Ang/1–9/Mas axis control on the regulation of expression of pro-inflammatory cytokines like interleukin (IL)-1b, IL-6, TNF-alpha, chemo-attractant protein-1, monocyte and transforming growth factor-b (TGF-β).	[('PMC7928900', 'I01009', 56, 87, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'I01009', 99, 130, 'Angiotensin-converting enzyme 2')]	['Also', ',', 'studies', 'from', 'the', 'past', 'indicate', 'the', 'association', 'of', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', '/', 'Ang', '##1', '–', '7', 'and', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', '/', 'Ang', '/', '1', '–', '9', '/', 'Mas', 'axis', 'control', 'on', 'the', 'regulation', 'of', 'expression', 'of', 'pro', '-', 'inflammatory', 'cytokines', 'like', 'interleukin', '(', 'IL', ')', '-', '1', '##b', ',', 'IL', '-', '6', ',', 'TNF', '-', 'alpha', ',', 'chemo', '-', 'attract', '##ant', 'protein', '-', '1', ',', 'monocyte', 'and', 'transforming', 'growth', 'factor', '-', 'b', '(', 'TGF', '-', 'β', ')', '.']	[0, 4, 6, 14, 19, 23, 28, 37, 41, 53, 56, 60, 67, 68, 79, 86, 87, 88, 91, 92, 93, 95, 99, 103, 110, 111, 122, 129, 130, 131, 134, 135, 136, 137, 138, 139, 143, 148, 156, 159, 163, 174, 177, 188, 191, 194, 195, 208, 218, 223, 235, 236, 238, 239, 240, 241, 242, 244, 246, 247, 248, 250, 253, 254, 259, 261, 266, 267, 274, 278, 285, 286, 287, 289, 298, 302, 315, 322, 328, 329, 331, 332, 335, 336, 337, 338]	[4, 5, 13, 18, 22, 27, 36, 40, 52, 55, 60, 67, 68, 78, 85, 87, 88, 91, 92, 93, 94, 98, 103, 110, 111, 121, 128, 130, 131, 134, 135, 136, 137, 138, 139, 142, 147, 155, 158, 162, 173, 176, 187, 190, 194, 195, 207, 217, 222, 234, 236, 238, 239, 240, 241, 242, 243, 246, 247, 248, 249, 253, 254, 259, 260, 266, 267, 274, 277, 285, 286, 287, 288, 297, 301, 314, 321, 328, 329, 330, 332, 335, 336, 337, 338, 339]	['Also', ',', 'studies', 'from', 'the', 'past', 'indicate', 'the', 'association', 'of', 'Angiotensin', '-', 'converting', 'enzyme', '2', '/', 'Ang1', '–', '7', 'and', 'Angiotensin', '-', 'converting', 'enzyme', '2', '/', 'Ang', '/', '1–', '9', '/', 'Mas', 'axis', 'control', 'on', 'the', 'regulation', 'of', 'expression', 'of', 'pro', '-', 'inflammatory', 'cytokines', 'like', 'interleukin', '(IL)-1b', ',', 'IL-6', ',', 'TNF-alpha', ',', 'chemo', '-', 'attractant', 'protein-1', ',', 'monocyte', 'and', 'transforming', 'growth', 'factor', '-', 'b', '(', 'TGF-β', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 3, 1, 3, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recent study by our group reported that the binding of SARS-CoV-2 to the Angiotensin-converting enzyme 2 receptor modulates the host to develop a suitable environment for the replicating viral genome (Ahmed et al. 2020).	[('PMC7928900', 'I01013', 73, 104, 'Angiotensin-converting enzyme 2')]	['Recent', 'study', 'by', 'our', 'group', 'reported', 'that', 'the', 'binding', 'of', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'to', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'modulates', 'the', 'host', 'to', 'develop', 'a', 'suitable', 'environment', 'for', 'the', 'replica', '##ting', 'viral', 'genome', '(', 'Ah', '##med', 'et', 'al', '.', '202', '##0', ')', '.']	[0, 7, 13, 16, 20, 26, 35, 40, 44, 52, 55, 58, 59, 60, 62, 63, 64, 66, 69, 73, 77, 84, 85, 96, 103, 105, 114, 124, 128, 133, 136, 144, 146, 155, 167, 171, 175, 182, 187, 193, 200, 201, 203, 207, 210, 212, 214, 217, 218, 219]	[6, 12, 15, 19, 25, 34, 39, 43, 51, 54, 58, 59, 60, 62, 63, 64, 65, 68, 72, 77, 84, 85, 95, 102, 104, 113, 123, 127, 132, 135, 143, 145, 154, 166, 170, 174, 182, 186, 192, 199, 201, 203, 206, 209, 212, 213, 217, 218, 219, 220]	['Recent', 'study', 'by', 'our', 'group', 'reported', 'that', 'the', 'binding', 'of', 'SARS-CoV-2', 'to', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'modulates', 'the', 'host', 'to', 'develop', 'a', 'suitable', 'environment', 'for', 'the', 'replicating', 'viral', 'genome', '(', 'Ahmed', 'et', 'al', '.', '2020', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The altered host regulatory signal and the mechanism mediating the immune process on SARS-CoV-2 attachment with the Angiotensin-converting enzyme 2 receptor is still under investigation.	[('PMC7928900', 'I01014', 116, 147, 'Angiotensin-converting enzyme 2')]	['The', 'altered', 'host', 'regulatory', 'signal', 'and', 'the', 'mechanism', 'mediating', 'the', 'immune', 'process', 'on', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'attachment', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'is', 'still', 'under', 'investigation', '.']	[0, 4, 12, 17, 28, 35, 39, 43, 53, 63, 67, 74, 82, 85, 88, 89, 90, 92, 93, 94, 96, 107, 112, 116, 120, 127, 128, 139, 146, 148, 157, 160, 166, 172, 185]	[3, 11, 16, 27, 34, 38, 42, 52, 62, 66, 73, 81, 84, 88, 89, 90, 92, 93, 94, 95, 106, 111, 115, 120, 127, 128, 138, 145, 147, 156, 159, 165, 171, 185, 186]	['The', 'altered', 'host', 'regulatory', 'signal', 'and', 'the', 'mechanism', 'mediating', 'the', 'immune', 'process', 'on', 'SARS-CoV-2', 'attachment', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'is', 'still', 'under', 'investigation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
In this study, we use systems biological approach to identify the host regulatory network upon SARS-CoV-2 attachment to the human Angiotensin-converting enzyme 2 receptor.	[('PMC7928900', 'I02000', 130, 161, 'Angiotensin-converting enzyme 2')]	['In', 'this', 'study', ',', 'we', 'use', 'systems', 'biological', 'approach', 'to', 'identify', 'the', 'host', 'regulatory', 'network', 'upon', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'attachment', 'to', 'the', 'human', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[0, 3, 8, 13, 15, 18, 22, 30, 41, 50, 53, 62, 66, 71, 82, 90, 95, 98, 99, 100, 102, 103, 104, 106, 117, 120, 124, 130, 134, 141, 142, 153, 160, 162, 170]	[2, 7, 13, 14, 17, 21, 29, 40, 49, 52, 61, 65, 70, 81, 89, 94, 98, 99, 100, 102, 103, 104, 105, 116, 119, 123, 129, 134, 141, 142, 152, 159, 161, 170, 171]	['In', 'this', 'study', ',', 'we', 'use', 'systems', 'biological', 'approach', 'to', 'identify', 'the', 'host', 'regulatory', 'network', 'upon', 'SARS-CoV-2', 'attachment', 'to', 'the', 'human', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Interestingly, we have identified the proteins mediating immune signals on SARS-CoV-2 interaction with the Angiotensin-converting enzyme 2 receptor.	[('PMC7928900', 'I02002', 107, 138, 'Angiotensin-converting enzyme 2')]	['Interestingly', ',', 'we', 'have', 'identified', 'the', 'proteins', 'mediating', 'immune', 'signals', 'on', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'interaction', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[0, 13, 15, 18, 23, 34, 38, 47, 57, 64, 72, 75, 78, 79, 80, 82, 83, 84, 86, 98, 103, 107, 111, 118, 119, 130, 137, 139, 147]	[13, 14, 17, 22, 33, 37, 46, 56, 63, 71, 74, 78, 79, 80, 82, 83, 84, 85, 97, 102, 106, 111, 118, 119, 129, 136, 138, 147, 148]	['Interestingly', ',', 'we', 'have', 'identified', 'the', 'proteins', 'mediating', 'immune', 'signals', 'on', 'SARS-CoV-2', 'interaction', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Additionally, the generated Angiotensin-converting enzyme 2 regulatory network will help in understanding the immune molecular regulatory networks influenced by the Angiotensin-converting enzyme 2 mediated interaction in other body tissues, which may aid in identifying the secondary health complications associated with SARS-CoV-2 infection.	[('PMC7928900', 'I02003', 28, 59, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'I02003', 165, 196, 'Angiotensin-converting enzyme 2')]	['Additionally', ',', 'the', 'generated', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'regulatory', 'network', 'will', 'help', 'in', 'understanding', 'the', 'immune', 'molecular', 'regulatory', 'networks', 'influenced', 'by', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'mediated', 'interaction', 'in', 'other', 'body', 'tissues', ',', 'which', 'may', 'aid', 'in', 'identifying', 'the', 'secondary', 'health', 'complications', 'associated', 'with', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'infection', '.']	[0, 12, 14, 18, 28, 32, 39, 40, 51, 58, 60, 71, 79, 84, 89, 92, 106, 110, 117, 127, 138, 147, 158, 161, 165, 169, 176, 177, 188, 195, 197, 206, 218, 221, 227, 232, 239, 241, 247, 251, 255, 258, 270, 274, 284, 291, 305, 316, 321, 324, 325, 326, 328, 329, 330, 332, 341]	[12, 13, 17, 27, 32, 39, 40, 50, 57, 59, 70, 78, 83, 88, 91, 105, 109, 116, 126, 137, 146, 157, 160, 164, 169, 176, 177, 187, 194, 196, 205, 217, 220, 226, 231, 239, 240, 246, 250, 254, 257, 269, 273, 283, 290, 304, 315, 320, 324, 325, 326, 328, 329, 330, 331, 341, 342]	['Additionally', ',', 'the', 'generated', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'regulatory', 'network', 'will', 'help', 'in', 'understanding', 'the', 'immune', 'molecular', 'regulatory', 'networks', 'influenced', 'by', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'mediated', 'interaction', 'in', 'other', 'body', 'tissues', ',', 'which', 'may', 'aid', 'in', 'identifying', 'the', 'secondary', 'health', 'complications', 'associated', 'with', 'SARS-CoV-2', 'infection', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The proteins interacting with the Angiotensin-converting enzyme 2 receptor were collected from the databases such as BioGRID (https://thebiogrid.org/), Intact (https://www.ebi.ac.uk/intact/), Human Proteinpedia (http://www.humanproteinpedia.org/) and HPRD (https://www.hprd.org/).	[('PMC7928900', 'M00000', 34, 65, 'Angiotensin-converting enzyme 2')]	['The', 'proteins', 'interacting', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'were', 'collected', 'from', 'the', 'databases', 'such', 'as', 'Bio', '##GR', '##ID', '(', 'https', ':', '/', '/', 'the', '##bio', '##grid', '.', 'org', '/', ')', ',', 'Int', '##act', '(', 'https', ':', '/', '/', 'www', '.', 'eb', '##i', '.', 'ac', '.', 'uk', '/', 'intact', '/', ')', ',', 'Human', 'Protein', '##ped', '##ia', '(', 'http', ':', '/', '/', 'www', '.', 'human', '##protein', '##ped', '##ia', '.', 'org', '/', ')', 'and', 'HP', '##RD', '(', 'https', ':', '/', '/', 'www', '.', 'h', '##pr', '##d', '.', 'org', '/', ')', '.']	[0, 4, 13, 25, 30, 34, 38, 45, 46, 57, 64, 66, 75, 80, 90, 95, 99, 109, 114, 117, 120, 122, 125, 126, 131, 132, 133, 134, 137, 140, 144, 145, 148, 149, 150, 152, 155, 159, 160, 165, 166, 167, 168, 171, 172, 174, 175, 176, 178, 179, 181, 182, 188, 189, 190, 192, 198, 205, 208, 211, 212, 216, 217, 218, 219, 222, 223, 228, 235, 238, 240, 241, 244, 245, 247, 251, 253, 256, 257, 262, 263, 264, 265, 268, 269, 270, 272, 273, 274, 277, 278, 279]	[3, 12, 24, 29, 33, 38, 45, 46, 56, 63, 65, 74, 79, 89, 94, 98, 108, 113, 116, 120, 122, 124, 126, 131, 132, 133, 134, 137, 140, 144, 145, 148, 149, 150, 151, 155, 158, 160, 165, 166, 167, 168, 171, 172, 174, 175, 176, 178, 179, 181, 182, 188, 189, 190, 191, 197, 205, 208, 210, 212, 216, 217, 218, 219, 222, 223, 228, 235, 238, 240, 241, 244, 245, 246, 250, 253, 255, 257, 262, 263, 264, 265, 268, 269, 270, 272, 273, 274, 277, 278, 279, 280]	['The', 'proteins', 'interacting', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'were', 'collected', 'from', 'the', 'databases', 'such', 'as', 'BioGRID', '(', 'https', ':', '/', '/', 'thebiogrid.org/', ')', ',', 'Intact', '(', 'https', ':', '/', '/', 'www.ebi.ac.uk', '/', 'intact/', ')', ',', 'Human', 'Proteinpedia', '(', 'http', ':', '/', '/', 'www.humanproteinpedia.org/', ')', 'and', 'HPRD', '(', 'https', ':', '/', '/', 'www.hprd.org/', ')', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1, 8, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 9, 1, 1, 2, 1, 1, 1, 1, 1, 8, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The final lung-specific regulatory network was developed to capture the possible downstream signaling events that can be initiated upon the Angiotensin-converting enzyme 2 mediated modulation that occurs in the human lungs.	[('PMC7928900', 'M00002', 140, 171, 'Angiotensin-converting enzyme 2')]	['The', 'final', 'lung', '-', 'specific', 'regulatory', 'network', 'was', 'developed', 'to', 'capture', 'the', 'possible', 'downstream', 'signaling', 'events', 'that', 'can', 'be', 'initiated', 'upon', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'mediated', 'modulation', 'that', 'occurs', 'in', 'the', 'human', 'lungs', '.']	[0, 4, 10, 14, 15, 24, 35, 43, 47, 57, 60, 68, 72, 81, 92, 102, 109, 114, 118, 121, 131, 136, 140, 144, 151, 152, 163, 170, 172, 181, 192, 197, 204, 207, 211, 217, 222]	[3, 9, 14, 15, 23, 34, 42, 46, 56, 59, 67, 71, 80, 91, 101, 108, 113, 117, 120, 130, 135, 139, 144, 151, 152, 162, 169, 171, 180, 191, 196, 203, 206, 210, 216, 222, 223]	['The', 'final', 'lung', '-', 'specific', 'regulatory', 'network', 'was', 'developed', 'to', 'capture', 'the', 'possible', 'downstream', 'signaling', 'events', 'that', 'can', 'be', 'initiated', 'upon', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'mediated', 'modulation', 'that', 'occurs', 'in', 'the', 'human', 'lungs', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Regulatory network was constructed, highlighting the Angiotensin-converting enzyme 2–protein interaction that represents the modulated host signalling mechanism initiated upon binding of SARS-CoV-2 with the Angiotensin-converting enzyme 2 receptor (Fig. 1).	[('PMC7928900', 'R00000', 53, 84, 'Angiotensin-converting enzyme 2'), ('PMC7928900', 'R00000', 207, 238, 'Angiotensin-converting enzyme 2')]	['Reg', '##ulatory', 'network', 'was', 'constructed', ',', 'highlighting', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', '–', 'protein', 'interaction', 'that', 'represents', 'the', 'modulated', 'host', 'signalling', 'mechanism', 'initiated', 'upon', 'binding', 'of', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '(', 'Fig', '.', '1', ')', '.']	[0, 3, 11, 19, 23, 34, 36, 49, 53, 57, 64, 65, 76, 83, 84, 85, 93, 105, 110, 121, 125, 135, 140, 151, 161, 171, 176, 184, 187, 190, 191, 192, 194, 195, 196, 198, 203, 207, 211, 218, 219, 230, 237, 239, 248, 249, 252, 254, 255, 256]	[3, 10, 18, 22, 34, 35, 48, 52, 57, 64, 65, 75, 82, 84, 85, 92, 104, 109, 120, 124, 134, 139, 150, 160, 170, 175, 183, 186, 190, 191, 192, 194, 195, 196, 197, 202, 206, 211, 218, 219, 229, 236, 238, 247, 249, 252, 253, 255, 256, 257]	['Regulatory', 'network', 'was', 'constructed', ',', 'highlighting', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2–', 'protein', 'interaction', 'that', 'represents', 'the', 'modulated', 'host', 'signalling', 'mechanism', 'initiated', 'upon', 'binding', 'of', 'SARS-CoV-2', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '(', 'Fig', '.', '1', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using a protein interaction database, several host proteins that connect directly or indirectly with the Angiotensin-converting enzyme 2 receptor was obtained.	[('PMC7928900', 'R00001', 105, 136, 'Angiotensin-converting enzyme 2')]	['Using', 'a', 'protein', 'interaction', 'database', ',', 'several', 'host', 'proteins', 'that', 'connect', 'directly', 'or', 'indirectly', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', 'was', 'obtained', '.']	[0, 6, 8, 16, 28, 36, 38, 46, 51, 60, 65, 73, 82, 85, 96, 101, 105, 109, 116, 117, 128, 135, 137, 146, 150, 158]	[5, 7, 15, 27, 36, 37, 45, 50, 59, 64, 72, 81, 84, 95, 100, 104, 109, 116, 117, 127, 134, 136, 145, 149, 158, 159]	['Using', 'a', 'protein', 'interaction', 'database', ',', 'several', 'host', 'proteins', 'that', 'connect', 'directly', 'or', 'indirectly', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', 'was', 'obtained', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Particularly, we have identified proteins such as AGT (Angiotensinogen), NTS (Large neuromedin N) and GHRL (Ghrelin and obestatin prepropeptide) that directly connect other proteins in the network, that are assumed to be activated upon viral binding to the Angiotensin-converting enzyme 2 receptor (Fig. 1).	[('PMC7928900', 'R00004', 257, 288, 'Angiotensin-converting enzyme 2')]	['Particularly', ',', 'we', 'have', 'identified', 'proteins', 'such', 'as', 'AG', '##T', '(', 'Angi', '##otensin', '##ogen', ')', ',', 'NT', '##S', '(', 'Large', 'neurom', '##edi', '##n', 'N', ')', 'and', 'GH', '##RL', '(', 'Gh', '##relin', 'and', 'obes', '##ta', '##tin', 'prep', '##rop', '##eptide', ')', 'that', 'directly', 'connect', 'other', 'proteins', 'in', 'the', 'network', ',', 'that', 'are', 'assumed', 'to', 'be', 'activated', 'upon', 'viral', 'binding', 'to', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '(', 'Fig', '.', '1', ')', '.']	[0, 12, 14, 17, 22, 33, 42, 47, 50, 52, 54, 55, 59, 66, 70, 71, 73, 75, 77, 78, 84, 90, 93, 95, 96, 98, 102, 104, 107, 108, 110, 116, 120, 124, 126, 130, 134, 137, 143, 145, 150, 159, 167, 173, 182, 185, 189, 196, 198, 203, 207, 215, 218, 221, 231, 236, 242, 250, 253, 257, 261, 268, 269, 280, 287, 289, 298, 299, 302, 304, 305, 306]	[12, 13, 16, 21, 32, 41, 46, 49, 52, 53, 55, 59, 66, 70, 71, 72, 75, 76, 78, 83, 90, 93, 94, 96, 97, 101, 104, 106, 108, 110, 115, 119, 124, 126, 129, 134, 137, 143, 144, 149, 158, 166, 172, 181, 184, 188, 196, 197, 202, 206, 214, 217, 220, 230, 235, 241, 249, 252, 256, 261, 268, 269, 279, 286, 288, 297, 299, 302, 303, 305, 306, 307]	['Particularly', ',', 'we', 'have', 'identified', 'proteins', 'such', 'as', 'AGT', '(', 'Angiotensinogen', ')', ',', 'NTS', '(', 'Large', 'neuromedin', 'N', ')', 'and', 'GHRL', '(', 'Ghrelin', 'and', 'obestatin', 'prepropeptide', ')', 'that', 'directly', 'connect', 'other', 'proteins', 'in', 'the', 'network', ',', 'that', 'are', 'assumed', 'to', 'be', 'activated', 'upon', 'viral', 'binding', 'to', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '(', 'Fig', '.', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 1, 2, 1, 2, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The Gene Ontology (GO) based on the molecular function confirmed multiple host processes ( p   < 0.001) related to hydrolase, protein kinase, carboxypeptidase, metallopeptidase and cytokine activity (Fig. 2).	[('PMC7928900', 'R02001', 115, 124, 'hydrolase'), ('PMC7928900', 'R02001', 126, 140, 'protein kinase'), ('PMC7928900', 'R02001', 142, 158, 'carboxypeptidase'), ('PMC7928900', 'R02001', 160, 176, 'metallopeptidase')]	['The', 'Gene', 'Ontology', '(', 'GO', ')', 'based', 'on', 'the', 'molecular', 'function', 'confirmed', 'multiple', 'host', 'processes', '(', 'p', '<', '0', '.', '00', '##1', ')', 'related', 'to', 'hydro', '##las', '##e', ',', 'protein', 'kinase', ',', 'carb', '##oxyp', '##epti', '##dase', ',', 'metall', '##ope', '##pt', '##idase', 'and', 'cytokine', 'activity', '(', 'Fig', '.', '2', ')', '.']	[0, 4, 9, 18, 19, 21, 23, 29, 32, 36, 46, 55, 65, 74, 79, 89, 91, 95, 97, 98, 99, 101, 102, 104, 112, 115, 120, 123, 124, 126, 134, 140, 142, 146, 150, 154, 158, 160, 166, 169, 171, 177, 181, 190, 199, 200, 203, 205, 206, 207]	[3, 8, 17, 19, 21, 22, 28, 31, 35, 45, 54, 64, 73, 78, 88, 90, 92, 96, 98, 99, 101, 102, 103, 111, 114, 120, 123, 124, 125, 133, 140, 141, 146, 150, 154, 158, 159, 166, 169, 171, 176, 180, 189, 198, 200, 203, 204, 206, 207, 208]	['The', 'Gene', 'Ontology', '(', 'GO', ')', 'based', 'on', 'the', 'molecular', 'function', 'confirmed', 'multiple', 'host', 'processes', '(', 'p', '<', '0.001', ')', 'related', 'to', 'hydrolase', ',', 'protein', 'kinase', ',', 'carboxypeptidase', ',', 'metallopeptidase', 'and', 'cytokine', 'activity', '(', 'Fig', '.', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We captured the immune signals in the network influenced by the Angiotensin-converting enzyme 2 receptor.	[('PMC7928900', 'R02004', 64, 95, 'Angiotensin-converting enzyme 2')]	['We', 'captured', 'the', 'immune', 'signals', 'in', 'the', 'network', 'influenced', 'by', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[0, 3, 12, 16, 23, 31, 34, 38, 46, 57, 60, 64, 68, 75, 76, 87, 94, 96, 104]	[2, 11, 15, 22, 30, 33, 37, 45, 56, 59, 63, 68, 75, 76, 86, 93, 95, 104, 105]	['We', 'captured', 'the', 'immune', 'signals', 'in', 'the', 'network', 'influenced', 'by', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
For instance, upon receptor modulation, the Angiotensin-converting enzyme 2 was found to directly influence the AGT, AGTR2 and AGRT1 through which the immune proteins such as THOP1, GRB2, NOS3 and PRCP were signalled (Fig. 4).	[('PMC7928900', 'R02006', 44, 75, 'Angiotensin-converting enzyme 2')]	['For', 'instance', ',', 'upon', 'receptor', 'modulation', ',', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'was', 'found', 'to', 'directly', 'influence', 'the', 'AG', '##T', ',', 'AG', '##TR', '##2', 'and', 'AG', '##RT', '##1', 'through', 'which', 'the', 'immune', 'proteins', 'such', 'as', 'TH', '##OP', '##1', ',', 'GR', '##B', '##2', ',', 'NOS', '##3', 'and', 'PR', '##CP', 'were', 'signal', '##led', '(', 'Fig', '.', '4', ')', '.']	[0, 4, 12, 14, 19, 28, 38, 40, 44, 48, 55, 56, 67, 74, 76, 80, 86, 89, 98, 108, 112, 114, 115, 117, 119, 121, 123, 127, 129, 131, 133, 141, 147, 151, 158, 167, 172, 175, 177, 179, 180, 182, 184, 185, 186, 188, 191, 193, 197, 199, 202, 207, 213, 217, 218, 221, 223, 224, 225]	[3, 12, 13, 18, 27, 38, 39, 43, 48, 55, 56, 66, 73, 75, 79, 85, 88, 97, 107, 111, 114, 115, 116, 119, 121, 122, 126, 129, 131, 132, 140, 146, 150, 157, 166, 171, 174, 177, 179, 180, 181, 184, 185, 186, 187, 191, 192, 196, 199, 201, 206, 213, 216, 218, 221, 222, 224, 225, 226]	['For', 'instance', ',', 'upon', 'receptor', 'modulation', ',', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'was', 'found', 'to', 'directly', 'influence', 'the', 'AGT', ',', 'AGTR2', 'and', 'AGRT1', 'through', 'which', 'the', 'immune', 'proteins', 'such', 'as', 'THOP1', ',', 'GRB2', ',', 'NOS3', 'and', 'PRCP', 'were', 'signalled', '(', 'Fig', '.', '4', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of the analysed tissues, the kindney, placenta, pancreas, testis, small intestine and adrenal gland showed immune signalling proteins that are found to be deregulated on binding of the SARS-CoV-2 with the Angiotensin-converting enzyme 2 receptor; however lung tissue harbored more immune molecules than other tissues (Fig. 5).	[('PMC7928900', 'R02009', 205, 236, 'Angiotensin-converting enzyme 2')]	['Of', 'the', 'analysed', 'tissues', ',', 'the', 'kind', '##ney', ',', 'placenta', ',', 'pancreas', ',', 'testis', ',', 'small', 'intestine', 'and', 'adrenal', 'gland', 'showed', 'immune', 'signalling', 'proteins', 'that', 'are', 'found', 'to', 'be', 'dere', '##gu', '##lated', 'on', 'binding', 'of', 'the', 'SAR', '##S', '-', 'Co', '##V', '-', '2', 'with', 'the', 'Angi', '##otensin', '-', 'converting', 'enzyme', '2', 'receptor', ';', 'however', 'lung', 'tissue', 'harbor', '##ed', 'more', 'immune', 'molecules', 'than', 'other', 'tissues', '(', 'Fig', '.', '5', ')', '.']	[0, 3, 7, 16, 23, 25, 29, 33, 36, 38, 46, 48, 56, 58, 64, 66, 72, 82, 86, 94, 100, 107, 114, 125, 134, 139, 143, 149, 152, 155, 159, 161, 167, 170, 178, 181, 185, 188, 189, 190, 192, 193, 194, 196, 201, 205, 209, 216, 217, 228, 235, 237, 245, 247, 255, 260, 267, 273, 276, 281, 288, 298, 303, 309, 317, 318, 321, 323, 324, 325]	[2, 6, 15, 23, 24, 28, 33, 36, 37, 46, 47, 56, 57, 64, 65, 71, 81, 85, 93, 99, 106, 113, 124, 133, 138, 142, 148, 151, 154, 159, 161, 166, 169, 177, 180, 184, 188, 189, 190, 192, 193, 194, 195, 200, 204, 209, 216, 217, 227, 234, 236, 245, 246, 254, 259, 266, 273, 275, 280, 287, 297, 302, 308, 316, 318, 321, 322, 324, 325, 326]	['Of', 'the', 'analysed', 'tissues', ',', 'the', 'kindney', ',', 'placenta', ',', 'pancreas', ',', 'testis', ',', 'small', 'intestine', 'and', 'adrenal', 'gland', 'showed', 'immune', 'signalling', 'proteins', 'that', 'are', 'found', 'to', 'be', 'deregulated', 'on', 'binding', 'of', 'the', 'SARS-CoV-2', 'with', 'the', 'Angiotensin', '-', 'converting', 'enzyme', '2', 'receptor', ';', 'however', 'lung', 'tissue', 'harbored', 'more', 'immune', 'molecules', 'than', 'other', 'tissues', '(', 'Fig', '.', '5', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 7, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Vitellogenin N and VWD and DUF1943 domain containing protein, poly-cysteine and histidine tailed protein isoform 2, heat shock protein 70, glyceraldehyde-3-phosphate dehydrogenase, actin, and enolase, were among the potential immunoactive proteins.	[('PMC8021180', 'A00011', 139, 179, 'glyceraldehyde-3-phosphate dehydrogenase'), ('PMC8021180', 'A00011', 192, 199, 'enolase')]	['Vit', '##ello', '##gen', '##in', 'N', 'and', 'V', '##WD', 'and', 'DU', '##F', '##19', '##43', 'domain', 'containing', 'protein', ',', 'poly', '-', 'cysteine', 'and', 'histidine', 'tail', '##ed', 'protein', 'isoform', '2', ',', 'heat', 'shock', 'protein', '70', ',', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', ',', 'actin', ',', 'and', 'en', '##olas', '##e', ',', 'were', 'among', 'the', 'potential', 'immuno', '##active', 'proteins', '.']	[0, 3, 7, 10, 13, 15, 19, 20, 23, 27, 29, 30, 32, 35, 42, 53, 60, 62, 66, 67, 76, 80, 90, 94, 97, 105, 113, 114, 116, 121, 127, 135, 137, 139, 145, 153, 154, 155, 156, 166, 179, 181, 186, 188, 192, 194, 198, 199, 201, 206, 212, 216, 226, 232, 239, 247]	[3, 7, 10, 12, 14, 18, 20, 22, 26, 29, 30, 32, 34, 41, 52, 60, 61, 66, 67, 75, 79, 89, 94, 96, 104, 112, 114, 115, 120, 126, 134, 137, 138, 145, 153, 154, 155, 156, 165, 179, 180, 186, 187, 191, 194, 198, 199, 200, 205, 211, 215, 225, 232, 238, 247, 248]	['Vitellogenin', 'N', 'and', 'VWD', 'and', 'DUF1943', 'domain', 'containing', 'protein', ',', 'poly', '-', 'cysteine', 'and', 'histidine', 'tailed', 'protein', 'isoform', '2', ',', 'heat', 'shock', 'protein', '70', ',', 'glyceraldehyde-3-phosphate', 'dehydrogenase', ',', 'actin', ',', 'and', 'enolase', ',', 'were', 'among', 'the', 'potential', 'immunoactive', 'proteins', '.']	[4, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The most abundant transcripts found in this extensive study included proteins we have now definitively identified in the EE proteome, such as two WAP domain containing SLP-like proteins, protease inhibitors such as cystatin-domain containing protein and nematode cuticle collagen N-terminal domain containing proteins and chitin binding domain containing proteins such as CBM14 domain containing proteins (Tables ​(Tables11 and S1).	[('PMC8021180', 'D01004', 187, 195, 'protease')]	['The', 'most', 'abundant', 'transcripts', 'found', 'in', 'this', 'extensive', 'study', 'included', 'proteins', 'we', 'have', 'now', 'definitive', '##ly', 'identified', 'in', 'the', 'EE', 'proteome', ',', 'such', 'as', 'two', 'WA', '##P', 'domain', 'containing', 'SL', '##P', '-', 'like', 'proteins', ',', 'protease', 'inhibitors', 'such', 'as', 'cyst', '##atin', '-', 'domain', 'containing', 'protein', 'and', 'nematode', 'cut', '##icle', 'collagen', 'N', '-', 'terminal', 'domain', 'containing', 'proteins', 'and', 'chi', '##tin', 'binding', 'domain', 'containing', 'proteins', 'such', 'as', 'CB', '##M', '##14', 'domain', 'containing', 'proteins', '(', 'Tables', '(', 'Tables', '##11', 'and', 'S', '##1', ')', '.']	[0, 4, 9, 18, 30, 36, 39, 44, 54, 60, 69, 78, 81, 86, 90, 100, 103, 114, 117, 121, 124, 132, 134, 139, 142, 146, 148, 150, 157, 168, 170, 171, 172, 177, 185, 187, 196, 207, 212, 215, 219, 223, 224, 231, 242, 250, 254, 263, 266, 271, 280, 281, 282, 291, 298, 309, 318, 322, 325, 329, 337, 344, 355, 364, 369, 372, 374, 375, 378, 385, 396, 405, 406, 414, 415, 421, 424, 428, 429, 430, 431]	[3, 8, 17, 29, 35, 38, 43, 53, 59, 68, 77, 80, 85, 89, 100, 102, 113, 116, 120, 123, 132, 133, 138, 141, 145, 148, 149, 156, 167, 170, 171, 172, 176, 185, 186, 195, 206, 211, 214, 219, 223, 224, 230, 241, 249, 253, 262, 266, 270, 279, 281, 282, 290, 297, 308, 317, 321, 325, 328, 336, 343, 354, 363, 368, 371, 374, 375, 377, 384, 395, 404, 406, 412, 415, 421, 423, 427, 429, 430, 431, 432]	['The', 'most', 'abundant', 'transcripts', 'found', 'in', 'this', 'extensive', 'study', 'included', 'proteins', 'we', 'have', 'now', 'definitively', 'identified', 'in', 'the', 'EE', 'proteome', ',', 'such', 'as', 'two', 'WAP', 'domain', 'containing', 'SLP', '-', 'like', 'proteins', ',', 'protease', 'inhibitors', 'such', 'as', 'cystatin', '-', 'domain', 'containing', 'protein', 'and', 'nematode', 'cuticle', 'collagen', 'N-', 'terminal', 'domain', 'containing', 'proteins', 'and', 'chitin', 'binding', 'domain', 'containing', 'proteins', 'such', 'as', 'CBM14', 'domain', 'containing', 'proteins', '(', 'Tables', '\u200b(Tables11', 'and', 'S1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One of the most represented groups of proteins we found in the egg proteome were those related to energy and metabolism and included proteins associated with glycolysis (enolase and glyceraldehyde-3-phosphate dehydrogenase (GADPH), gluconeogenesis (triosephosphate isomerase and phosphoenolpyruvate carboxykinase GTP) and other metabolic enzymes such as alpha-1,4 glucan phosphorylase and malic enzyme (S1 Table).	[('PMC8021180', 'D04001', 170, 177, 'enolase'), ('PMC8021180', 'D04001', 182, 222, 'glyceraldehyde-3-phosphate dehydrogenase'), ('PMC8021180', 'D04001', 249, 274, 'triosephosphate isomerase'), ('PMC8021180', 'D04001', 279, 316, 'phosphoenolpyruvate carboxykinase GTP'), ('PMC8021180', 'D04001', 354, 384, 'alpha-1,4 glucan phosphorylase'), ('PMC8021180', 'D04001', 389, 401, 'malic enzyme')]	['One', 'of', 'the', 'most', 'represented', 'groups', 'of', 'proteins', 'we', 'found', 'in', 'the', 'egg', 'proteome', 'were', 'those', 'related', 'to', 'energy', 'and', 'metabolism', 'and', 'included', 'proteins', 'associated', 'with', 'glycolysis', '(', 'en', '##olas', '##e', 'and', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', '(', 'GAD', '##PH', ')', ',', 'gluc', '##one', '##ogenesis', '(', 'tri', '##ose', '##phosphate', 'isomer', '##ase', 'and', 'phospho', '##eno', '##l', '##pyr', '##uvate', 'carb', '##oxy', '##kinase', 'GTP', ')', 'and', 'other', 'metabolic', 'enzymes', 'such', 'as', 'alpha', '-', '1', ',', '4', 'gluc', '##an', 'phosphoryl', '##ase', 'and', 'mal', '##ic', 'enzyme', '(', 'S', '##1', 'Table', ')', '.']	[0, 4, 7, 11, 16, 28, 35, 38, 47, 50, 56, 59, 63, 67, 76, 81, 87, 95, 98, 105, 109, 120, 124, 133, 142, 153, 158, 169, 170, 172, 176, 178, 182, 188, 196, 197, 198, 199, 209, 223, 224, 227, 229, 230, 232, 236, 239, 248, 249, 252, 255, 265, 271, 275, 279, 286, 289, 290, 293, 299, 303, 306, 313, 316, 318, 322, 328, 338, 346, 351, 354, 359, 360, 361, 362, 364, 368, 371, 381, 385, 389, 392, 395, 402, 403, 404, 406, 411, 412]	[3, 6, 10, 15, 27, 34, 37, 46, 49, 55, 58, 62, 66, 75, 80, 86, 94, 97, 104, 108, 119, 123, 132, 141, 152, 157, 168, 170, 172, 176, 177, 181, 188, 196, 197, 198, 199, 208, 222, 224, 227, 229, 230, 231, 236, 239, 247, 249, 252, 255, 264, 271, 274, 278, 286, 289, 290, 293, 298, 303, 306, 312, 316, 317, 321, 327, 337, 345, 350, 353, 359, 360, 361, 362, 363, 368, 370, 381, 384, 388, 392, 394, 401, 403, 404, 405, 411, 412, 413]	['One', 'of', 'the', 'most', 'represented', 'groups', 'of', 'proteins', 'we', 'found', 'in', 'the', 'egg', 'proteome', 'were', 'those', 'related', 'to', 'energy', 'and', 'metabolism', 'and', 'included', 'proteins', 'associated', 'with', 'glycolysis', '(', 'enolase', 'and', 'glyceraldehyde-3-phosphate', 'dehydrogenase', '(', 'GADPH', ')', ',', 'gluconeogenesis', '(', 'triosephosphate', 'isomerase', 'and', 'phosphoenolpyruvate', 'carboxykinase', 'GTP', ')', 'and', 'other', 'metabolic', 'enzymes', 'such', 'as', 'alpha-1,4', 'glucan', 'phosphorylase', 'and', 'malic', 'enzyme', '(', 'S1', 'Table', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 1, 1, 2, 1, 1, 3, 1, 3, 2, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 1, 5, 2, 2, 1, 2, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
The Cu/Zn superoxide dismutase (Cu/Zn superoxide dismutase) was found in the EE proteome (S1 Table) and has also been identified on the adult surface and larval extracts (secreted and somatic) of Toxocara canis [38], in the somatic extract of adults of Fasciola hepatica, and the S. mansoni egg secretome	[('PMC8021180', 'D06002', 4, 30, 'Cu/Zn superoxide dismutase'), ('PMC8021180', 'D06002', 32, 58, 'Cu/Zn superoxide dismutase')]	['The', 'Cu', '/', 'Zn', 'superoxide', 'dismutase', '(', 'Cu', '/', 'Zn', 'superoxide', 'dismutase', ')', 'was', 'found', 'in', 'the', 'EE', 'proteome', '(', 'S', '##1', 'Table', ')', 'and', 'has', 'also', 'been', 'identified', 'on', 'the', 'adult', 'surface', 'and', 'larval', 'extracts', '(', 'secreted', 'and', 'somatic', ')', 'of', 'To', '##x', '##oca', '##ra', 'can', '##is', '[', '38', ']', ',', 'in', 'the', 'somatic', 'extract', 'of', 'adults', 'of', 'Fas', '##ci', '##ola', 'hepatic', '##a', ',', 'and', 'the', 'S', '.', 'man', '##son', '##i', 'egg', 'secret', '##ome']	[0, 4, 6, 7, 10, 21, 31, 32, 34, 35, 38, 49, 58, 60, 64, 70, 73, 77, 80, 89, 90, 91, 93, 98, 100, 104, 108, 113, 118, 129, 132, 136, 142, 150, 154, 161, 170, 171, 180, 184, 191, 193, 196, 198, 199, 202, 205, 208, 211, 212, 214, 215, 217, 220, 224, 232, 240, 243, 250, 253, 256, 258, 262, 269, 270, 272, 276, 280, 281, 283, 286, 289, 291, 295, 301]	[3, 6, 7, 9, 20, 30, 32, 34, 35, 37, 48, 58, 59, 63, 69, 72, 76, 79, 88, 90, 91, 92, 98, 99, 103, 107, 112, 117, 128, 131, 135, 141, 149, 153, 160, 169, 171, 179, 183, 191, 192, 195, 198, 199, 202, 204, 208, 210, 212, 214, 215, 216, 219, 223, 231, 239, 242, 249, 252, 256, 258, 261, 269, 270, 271, 275, 279, 281, 282, 286, 289, 290, 294, 301, 304]	['The', 'Cu', '/', 'Zn', 'superoxide', 'dismutase', '(', 'Cu', '/', 'Zn', 'superoxide', 'dismutase', ')', 'was', 'found', 'in', 'the', 'EE', 'proteome', '(', 'S1', 'Table', ')', 'and', 'has', 'also', 'been', 'identified', 'on', 'the', 'adult', 'surface', 'and', 'larval', 'extracts', '(', 'secreted', 'and', 'somatic', ')', 'of', 'Toxocara', 'canis', '[', '38', ']', ',', 'in', 'the', 'somatic', 'extract', 'of', 'adults', 'of', 'Fasciola', 'hepatica', ',', 'and', 'the', 'S', '.', 'mansoni', 'egg', 'secretome']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 3, 1, 2]	['O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We identified certain glycolytic enzymes such as enolase and glyceraldehyde-3-phosphate dehydrogenase, as immunoactive components of the T. trichiura EE and FE.	[('PMC8021180', 'D13000', 49, 56, 'enolase'), ('PMC8021180', 'D13000', 61, 101, 'glyceraldehyde-3-phosphate dehydrogenase')]	['We', 'identified', 'certain', 'glycol', '##ytic', 'enzymes', 'such', 'as', 'en', '##olas', '##e', 'and', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', ',', 'as', 'immuno', '##active', 'components', 'of', 'the', 'T', '.', 'trich', '##iu', '##ra', 'EE', 'and', 'FE', '.']	[0, 3, 14, 22, 28, 33, 41, 46, 49, 51, 55, 57, 61, 67, 75, 76, 77, 78, 88, 101, 103, 106, 112, 119, 130, 133, 137, 138, 140, 145, 147, 150, 153, 157, 159]	[2, 13, 21, 28, 32, 40, 45, 48, 51, 55, 56, 60, 67, 75, 76, 77, 78, 87, 101, 102, 105, 112, 118, 129, 132, 136, 138, 139, 145, 147, 149, 152, 156, 159, 160]	['We', 'identified', 'certain', 'glycolytic', 'enzymes', 'such', 'as', 'enolase', 'and', 'glyceraldehyde-3-phosphate', 'dehydrogenase', ',', 'as', 'immunoactive', 'components', 'of', 'the', 'T', '.', 'trichiura', 'EE', 'and', 'FE', '.']	[1, 1, 1, 2, 1, 1, 1, 3, 1, 6, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, enolase plays a vital role in the degradation of the intracellular matrix through the activation of plasminogen facilitating the invasion, migration, and fixation in the host [15,17,33,44] all essential mechanisms to ensure T. trichiura prolonged survival.	[('PMC8021180', 'D13002', 13, 20, 'enolase')]	['Furthermore', ',', 'en', '##olas', '##e', 'plays', 'a', 'vital', 'role', 'in', 'the', 'degradation', 'of', 'the', 'intracellular', 'matrix', 'through', 'the', 'activation', 'of', 'plasmin', '##ogen', 'facilitating', 'the', 'invasion', ',', 'migration', ',', 'and', 'fixation', 'in', 'the', 'host', '[', '15', ',', '17', ',', '33', ',', '44', ']', 'all', 'essential', 'mechanisms', 'to', 'ensure', 'T', '.', 'trich', '##iu', '##ra', 'prolonged', 'survival', '.']	[0, 11, 13, 15, 19, 21, 27, 29, 35, 40, 43, 47, 59, 62, 66, 80, 87, 95, 99, 110, 113, 120, 125, 138, 142, 150, 152, 161, 163, 167, 176, 179, 183, 188, 189, 191, 192, 194, 195, 197, 198, 200, 202, 206, 216, 227, 230, 237, 238, 240, 245, 247, 250, 260, 268]	[11, 12, 15, 19, 20, 26, 28, 34, 39, 42, 46, 58, 61, 65, 79, 86, 94, 98, 109, 112, 120, 124, 137, 141, 150, 151, 161, 162, 166, 175, 178, 182, 187, 189, 191, 192, 194, 195, 197, 198, 200, 201, 205, 215, 226, 229, 236, 238, 239, 245, 247, 249, 259, 268, 269]	['Furthermore', ',', 'enolase', 'plays', 'a', 'vital', 'role', 'in', 'the', 'degradation', 'of', 'the', 'intracellular', 'matrix', 'through', 'the', 'activation', 'of', 'plasminogen', 'facilitating', 'the', 'invasion', ',', 'migration', ',', 'and', 'fixation', 'in', 'the', 'host', '[', '15', ',', '17', ',', '33', ',', '44', ']', 'all', 'essential', 'mechanisms', 'to', 'ensure', 'T', '.', 'trichiura', 'prolonged', 'survival', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Enolase and heat shock proteins have also been classified as exosome markers [26,72] in accordance with our findings of enolase lacking signal peptide.	[('PMC8021180', 'D13004', 0, 7, 'Enolase'), ('PMC8021180', 'D13004', 120, 127, 'enolase')]	['En', '##olas', '##e', 'and', 'heat', 'shock', 'proteins', 'have', 'also', 'been', 'classified', 'as', 'ex', '##osome', 'markers', '[', '26', ',', '72', ']', 'in', 'accordance', 'with', 'our', 'findings', 'of', 'en', '##olas', '##e', 'lacking', 'signal', 'peptide', '.']	[0, 2, 6, 8, 12, 17, 23, 32, 37, 42, 47, 58, 61, 63, 69, 77, 78, 80, 81, 83, 85, 88, 99, 104, 108, 117, 120, 122, 126, 128, 136, 143, 150]	[2, 6, 7, 11, 16, 22, 31, 36, 41, 46, 57, 60, 63, 68, 76, 78, 80, 81, 83, 84, 87, 98, 103, 107, 116, 119, 122, 126, 127, 135, 142, 150, 151]	['Enolase', 'and', 'heat', 'shock', 'proteins', 'have', 'also', 'been', 'classified', 'as', 'exosome', 'markers', '[', '26', ',', '72', ']', 'in', 'accordance', 'with', 'our', 'findings', 'of', 'enolase', 'lacking', 'signal', 'peptide', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
Likewise, glyceraldehyde-3-phosphate dehydrogenase has been previously linked to fibronectin, laminin, entactin, and collagen binding [73] and Cass and collaborators [17] suggested that in the case of S. mansoni this protein could be involved in the attachment of the eggs to host tissues or aid the passage of live eggs across host tissues to the external environment.	[('PMC8021180', 'D13005', 10, 50, 'glyceraldehyde-3-phosphate dehydrogenase')]	['Likewise', ',', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', 'has', 'been', 'previously', 'linked', 'to', 'fibronectin', ',', 'lamin', '##in', ',', 'ent', '##actin', ',', 'and', 'collagen', 'binding', '[', '73', ']', 'and', 'Cass', 'and', 'collabor', '##ators', '[', '17', ']', 'suggested', 'that', 'in', 'the', 'case', 'of', 'S', '.', 'man', '##son', '##i', 'this', 'protein', 'could', 'be', 'involved', 'in', 'the', 'attachment', 'of', 'the', 'eggs', 'to', 'host', 'tissues', 'or', 'aid', 'the', 'passage', 'of', 'live', 'eggs', 'across', 'host', 'tissues', 'to', 'the', 'external', 'environment', '.']	[0, 8, 10, 16, 24, 25, 26, 27, 37, 51, 55, 60, 71, 78, 81, 92, 94, 99, 101, 103, 106, 111, 113, 117, 126, 134, 135, 137, 139, 143, 148, 152, 160, 166, 167, 169, 171, 181, 186, 189, 193, 198, 201, 202, 204, 207, 210, 212, 217, 225, 231, 234, 243, 246, 250, 261, 264, 268, 273, 276, 281, 289, 292, 296, 300, 308, 311, 316, 321, 328, 333, 341, 344, 348, 357, 368]	[8, 9, 16, 24, 25, 26, 27, 36, 50, 54, 59, 70, 77, 80, 92, 93, 99, 101, 102, 106, 111, 112, 116, 125, 133, 135, 137, 138, 142, 147, 151, 160, 165, 167, 169, 170, 180, 185, 188, 192, 197, 200, 202, 203, 207, 210, 211, 216, 224, 230, 233, 242, 245, 249, 260, 263, 267, 272, 275, 280, 288, 291, 295, 299, 307, 310, 315, 320, 327, 332, 340, 343, 347, 356, 368, 369]	['Likewise', ',', 'glyceraldehyde-3-phosphate', 'dehydrogenase', 'has', 'been', 'previously', 'linked', 'to', 'fibronectin', ',', 'laminin', ',', 'entactin', ',', 'and', 'collagen', 'binding', '[', '73', ']', 'and', 'Cass', 'and', 'collaborators', '[', '17', ']', 'suggested', 'that', 'in', 'the', 'case', 'of', 'S', '.', 'mansoni', 'this', 'protein', 'could', 'be', 'involved', 'in', 'the', 'attachment', 'of', 'the', 'eggs', 'to', 'host', 'tissues', 'or', 'aid', 'the', 'passage', 'of', 'live', 'eggs', 'across', 'host', 'tissues', 'to', 'the', 'external', 'environment', '.']	[1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our results suggest glyceraldehyde-3-phosphate dehydrogenase as having a relative abundance in both EE and FE that could align with Cass [17] findings and warrant further study.	[('PMC8021180', 'D13006', 20, 60, 'glyceraldehyde-3-phosphate dehydrogenase')]	['Our', 'results', 'suggest', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', 'as', 'having', 'a', 'relative', 'abundance', 'in', 'both', 'EE', 'and', 'FE', 'that', 'could', 'align', 'with', 'Cass', '[', '17', ']', 'findings', 'and', 'warrant', 'further', 'study', '.']	[0, 4, 12, 20, 26, 34, 35, 36, 37, 47, 61, 64, 71, 73, 82, 92, 95, 100, 103, 107, 110, 115, 121, 127, 132, 137, 138, 140, 142, 151, 155, 163, 171, 176]	[3, 11, 19, 26, 34, 35, 36, 37, 46, 60, 63, 70, 72, 81, 91, 94, 99, 102, 106, 109, 114, 120, 126, 131, 136, 138, 140, 141, 150, 154, 162, 170, 176, 177]	['Our', 'results', 'suggest', 'glyceraldehyde-3-phosphate', 'dehydrogenase', 'as', 'having', 'a', 'relative', 'abundance', 'in', 'both', 'EE', 'and', 'FE', 'that', 'could', 'align', 'with', 'Cass', '[', '17', ']', 'findings', 'and', 'warrant', 'further', 'study', '.']	[1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Luo QL, Qiao ZP, Zhou YD, Li XY, Zhong ZR, Yu YJ, et al.. Application of signaling protein 14-3-3 and 26kDa glutathione-S-transferase to serological diagnosis of Schistosomiasis japonica.	[('PMC8021180', 'F36001', 108, 133, 'glutathione-S-transferase')]	['Luo', 'Q', '##L', ',', 'Qi', '##ao', 'Z', '##P', ',', 'Zhou', 'Y', '##D', ',', 'Li', 'XY', ',', 'Zhong', 'Z', '##R', ',', 'Yu', 'Y', '##J', ',', 'et', 'al', '.', '.', 'Application', 'of', 'signaling', 'protein', '14', '-', '3', '-', '3', 'and', '26', '##kDa', 'glutathione', '-', 'S', '-', 'transfer', '##ase', 'to', 'ser', '##ological', 'diagnosis', 'of', 'Sch', '##ist', '##osom', '##iasis', 'jap', '##onica', '.']	[0, 4, 5, 6, 8, 10, 13, 14, 15, 17, 22, 23, 24, 26, 29, 31, 33, 39, 40, 41, 43, 46, 47, 48, 50, 53, 55, 56, 58, 70, 73, 83, 91, 93, 94, 95, 96, 98, 102, 104, 108, 119, 120, 121, 122, 130, 134, 137, 140, 149, 159, 162, 165, 168, 172, 178, 181, 186]	[3, 5, 6, 7, 10, 12, 14, 15, 16, 21, 23, 24, 25, 28, 31, 32, 38, 40, 41, 42, 45, 47, 48, 49, 52, 55, 56, 57, 69, 72, 82, 90, 93, 94, 95, 96, 97, 101, 104, 107, 119, 120, 121, 122, 130, 133, 136, 140, 148, 158, 161, 165, 168, 172, 177, 181, 186, 187]	['Luo', 'QL', ',', 'Qiao', 'ZP', ',', 'Zhou', 'YD', ',', 'Li', 'XY', ',', 'Zhong', 'ZR', ',', 'Yu', 'YJ', ',', 'et', 'al', '.', '.', 'Application', 'of', 'signaling', 'protein', '14-3-3', 'and', '26kDa', 'glutathione-S-transferase', 'to', 'serological', 'diagnosis', 'of', 'Schistosomiasis', 'japonica', '.']	[1, 2, 1, 2, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 6, 1, 2, 1, 1, 4, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Molecular Cloning and Expression of Cu/Zn-Containing Superoxide Dismutase from Fasciola hepatica.	[('PMC8021180', 'F47002', 36, 73, 'Cu/Zn-Containing Superoxide Dismutase')]	['Molecular', 'Cl', '##oning', 'and', 'Expression', 'of', 'Cu', '/', 'Zn', '-', 'Cont', '##aining', 'Super', '##oxide', 'Dis', '##mut', '##ase', 'from', 'Fas', '##ci', '##ola', 'hepatic', '##a', '.']	[0, 10, 12, 18, 22, 33, 36, 38, 39, 41, 42, 46, 53, 58, 64, 67, 70, 74, 79, 82, 84, 88, 95, 96]	[9, 12, 17, 21, 32, 35, 38, 39, 41, 42, 46, 52, 58, 63, 67, 70, 73, 78, 82, 84, 87, 95, 96, 97]	['Molecular', 'Cloning', 'and', 'Expression', 'of', 'Cu', '/', 'Zn', '-', 'Containing', 'Superoxide', 'Dismutase', 'from', 'Fasciola', 'hepatica', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 3, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cardoso RMF, Silva CHTP, de Araujo APU, Tanaka T, Tanaka M, Garratt RC.Structure of the cytosolic Cu, Zn superoxide dismutase from Schistosoma mansoni.	[('PMC8021180', 'F48001', 98, 125, 'Cu, Zn superoxide dismutase')]	['Card', '##oso', 'RM', '##F', ',', 'Silva', 'CH', '##TP', ',', 'de', 'Ara', '##uj', '##o', 'AP', '##U', ',', 'Tanaka', 'T', ',', 'Tanaka', 'M', ',', 'Gar', '##rat', '##t', 'RC', '.', 'Structure', 'of', 'the', 'cytosolic', 'Cu', ',', 'Zn', 'superoxide', 'dismutase', 'from', 'Sch', '##ist', '##osom', '##a', 'man', '##son', '##i', '.']	[0, 4, 8, 10, 11, 13, 19, 21, 23, 25, 28, 31, 33, 35, 37, 38, 40, 47, 48, 50, 57, 58, 60, 63, 66, 68, 70, 71, 81, 84, 88, 98, 100, 102, 105, 116, 126, 131, 134, 137, 141, 143, 146, 149, 150]	[4, 7, 10, 11, 12, 18, 21, 23, 24, 27, 31, 33, 34, 37, 38, 39, 46, 48, 49, 56, 58, 59, 63, 66, 67, 70, 71, 80, 83, 87, 97, 100, 101, 104, 115, 125, 130, 134, 137, 141, 142, 146, 149, 150, 151]	['Cardoso', 'RMF', ',', 'Silva', 'CHTP', ',', 'de', 'Araujo', 'APU', ',', 'Tanaka', 'T', ',', 'Tanaka', 'M', ',', 'Garratt', 'RC.Structure', 'of', 'the', 'cytosolic', 'Cu', ',', 'Zn', 'superoxide', 'dismutase', 'from', 'Schistosoma', 'mansoni', '.']	[2, 2, 1, 1, 2, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acevedo N, Mohr J, Zakzuk J, Samonig M, Briza P, Erler A, et al.. Proteomic and Immunochemical Characterization of Glutathione Transferase as a New Allergen of the Nematode Ascaris lumbricoides.	[('PMC8021180', 'F54001', 115, 138, 'Glutathione Transferase')]	['Ac', '##ev', '##ed', '##o', 'N', ',', 'Moh', '##r', 'J', ',', 'Z', '##ak', '##zu', '##k', 'J', ',', 'Sam', '##oni', '##g', 'M', ',', 'Bri', '##za', 'P', ',', 'Erl', '##er', 'A', ',', 'et', 'al', '.', '.', 'Prote', '##omic', 'and', 'Immun', '##ochemical', 'Character', '##ization', 'of', 'Glut', '##athione', 'Transfer', '##ase', 'as', 'a', 'New', 'Alle', '##r', '##gen', 'of', 'the', 'Ne', '##mat', '##ode', 'As', '##car', '##is', 'lum', '##br', '##ico', '##ides', '.']	[0, 2, 4, 6, 8, 9, 11, 14, 16, 17, 19, 20, 22, 24, 26, 27, 29, 32, 35, 37, 38, 40, 43, 46, 47, 49, 52, 55, 56, 58, 61, 63, 64, 66, 71, 76, 80, 85, 95, 104, 112, 115, 119, 127, 135, 139, 142, 144, 148, 152, 153, 157, 160, 164, 166, 169, 173, 175, 178, 181, 184, 186, 189, 193]	[2, 4, 6, 7, 9, 10, 14, 15, 17, 18, 20, 22, 24, 25, 27, 28, 32, 35, 36, 38, 39, 43, 45, 47, 48, 52, 54, 56, 57, 60, 63, 64, 65, 71, 75, 79, 85, 94, 104, 111, 114, 119, 126, 135, 138, 141, 143, 147, 152, 153, 156, 159, 163, 166, 169, 172, 175, 178, 180, 184, 186, 189, 193, 194]	['Acevedo', 'N', ',', 'Mohr', 'J', ',', 'Zakzuk', 'J', ',', 'Samonig', 'M', ',', 'Briza', 'P', ',', 'Erler', 'A', ',', 'et', 'al', '.', '.', 'Proteomic', 'and', 'Immunochemical', 'Characterization', 'of', 'Glutathione', 'Transferase', 'as', 'a', 'New', 'Allergen', 'of', 'the', 'Nematode', 'Ascaris', 'lumbricoides', '.']	[4, 1, 1, 2, 1, 1, 4, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 2, 1, 2, 2, 1, 1, 1, 3, 1, 1, 3, 3, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The Cell Wall-Associated Glyceraldehyde-3-Phosphate Dehydrogenase of Candida albicans Is Also a Fibronectin and Laminin Binding Protein.	[('PMC8021180', 'F72002', 25, 65, 'Glyceraldehyde-3-Phosphate Dehydrogenase')]	['The', 'Cell', 'Wall', '-', 'Associated', 'Gly', '##ceral', '##dehyde', '-', '3', '-', 'Phosph', '##ate', 'De', '##hydrogen', '##ase', 'of', 'Candida', 'albicans', 'Is', 'Also', 'a', 'Fib', '##ronectin', 'and', 'Lam', '##inin', 'Binding', 'Protein', '.']	[0, 4, 9, 13, 14, 25, 28, 33, 39, 40, 41, 42, 48, 52, 54, 62, 66, 69, 77, 86, 89, 94, 96, 99, 108, 112, 115, 120, 128, 135]	[3, 8, 13, 14, 24, 28, 33, 39, 40, 41, 42, 48, 51, 54, 62, 65, 68, 76, 85, 88, 93, 95, 99, 107, 111, 115, 119, 127, 135, 136]	['The', 'Cell', 'Wall-Associated', 'Glyceraldehyde-3-Phosphate', 'Dehydrogenase', 'of', 'Candida', 'albicans', 'Is', 'Also', 'a', 'Fibronectin', 'and', 'Laminin', 'Binding', 'Protein', '.']	[1, 1, 3, 8, 3, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
the supernatant was removed and a 1% protease inhibitors cocktail (Complete mini EDTA-free, Roche, Berlin, Germany) with 1% Triton X-100 (Sigma-Aldrich, Steinheim, Germany) in PBS added to the egg pellet which was homogenized as described previously [30].	[('PMC8021180', 'M03003', 37, 45, 'protease')]	['the', 'supernatant', 'was', 'removed', 'and', 'a', '1', '%', 'protease', 'inhibitors', 'cock', '##tail', '(', 'Complete', 'mini', 'EDTA', '-', 'free', ',', 'Roche', ',', 'Berlin', ',', 'Germany', ')', 'with', '1', '%', 'Triton', 'X', '-', '100', '(', 'Sigma', '-', 'Aldr', '##ich', ',', 'Stein', '##heim', ',', 'Germany', ')', 'in', 'PBS', 'added', 'to', 'the', 'egg', 'pellet', 'which', 'was', 'homogenized', 'as', 'described', 'previously', '[', '30', ']', '.']	[0, 4, 16, 20, 28, 32, 34, 35, 37, 46, 57, 61, 66, 67, 76, 81, 85, 86, 90, 92, 97, 99, 105, 107, 114, 116, 121, 122, 124, 131, 132, 133, 137, 138, 143, 144, 148, 151, 153, 158, 162, 164, 171, 173, 176, 180, 186, 189, 193, 197, 204, 210, 214, 226, 229, 239, 250, 251, 253, 254]	[3, 15, 19, 27, 31, 33, 35, 36, 45, 56, 61, 65, 67, 75, 80, 85, 86, 90, 91, 97, 98, 105, 106, 114, 115, 120, 122, 123, 130, 132, 133, 136, 138, 143, 144, 148, 151, 152, 158, 162, 163, 171, 172, 175, 179, 185, 188, 192, 196, 203, 209, 213, 225, 228, 238, 249, 251, 253, 254, 255]	['the', 'supernatant', 'was', 'removed', 'and', 'a', '1%', 'protease', 'inhibitors', 'cocktail', '(', 'Complete', 'mini', 'EDTA-free', ',', 'Roche', ',', 'Berlin', ',', 'Germany', ')', 'with', '1%', 'Triton', 'X-100', '(', 'Sigma-Aldrich', ',', 'Steinheim', ',', 'Germany', ')', 'in', 'PBS', 'added', 'to', 'the', 'egg', 'pellet', 'which', 'was', 'homogenized', 'as', 'described', 'previously', '[', '30', ']', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fifty female adults were obtained from the intestines of naturally infected AGMs, washed five times in PBS and homogenized with a Teflon homogenizer in PBS containing a 1% protease inhibitors cocktail (Complete mini EDTA-free, Roche) with 1% Triton X-100	[('PMC8021180', 'M04001', 172, 180, 'protease')]	['Fifty', 'female', 'adults', 'were', 'obtained', 'from', 'the', 'intestine', '##s', 'of', 'naturally', 'infected', 'AG', '##Ms', ',', 'washed', 'five', 'times', 'in', 'PBS', 'and', 'homogenized', 'with', 'a', 'Te', '##fl', '##on', 'homogen', '##izer', 'in', 'PBS', 'containing', 'a', '1', '%', 'protease', 'inhibitors', 'cock', '##tail', '(', 'Complete', 'mini', 'EDTA', '-', 'free', ',', 'Roche', ')', 'with', '1', '%', 'Triton', 'X', '-', '100']	[0, 6, 13, 20, 25, 34, 39, 43, 52, 54, 57, 67, 76, 78, 80, 82, 89, 94, 100, 103, 107, 111, 123, 128, 130, 132, 134, 137, 144, 149, 152, 156, 167, 169, 170, 172, 181, 192, 196, 201, 202, 211, 216, 220, 221, 225, 227, 232, 234, 239, 240, 242, 249, 250, 251]	[5, 12, 19, 24, 33, 38, 42, 52, 53, 56, 66, 75, 78, 80, 81, 88, 93, 99, 102, 106, 110, 122, 127, 129, 132, 134, 136, 144, 148, 151, 155, 166, 168, 170, 171, 180, 191, 196, 200, 202, 210, 215, 220, 221, 225, 226, 232, 233, 238, 240, 241, 248, 250, 251, 254]	['Fifty', 'female', 'adults', 'were', 'obtained', 'from', 'the', 'intestines', 'of', 'naturally', 'infected', 'AGMs', ',', 'washed', 'five', 'times', 'in', 'PBS', 'and', 'homogenized', 'with', 'a', 'Teflon', 'homogenizer', 'in', 'PBS', 'containing', 'a', '1%', 'protease', 'inhibitors', 'cocktail', '(', 'Complete', 'mini', 'EDTA-free', ',', 'Roche', ')', 'with', '1%', 'Triton', 'X-100']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Their specific molecular functions range from molecules involved in ATP, actin, carbohydrate, chitin, lipid and magnesium ion binding, as well as molecules that take part in oxidoreductase, aminopeptidase, glycogen phosphorylase and metallopeptidase activity (Table 1).	[('PMC8021180', 'R02004', 174, 188, 'oxidoreductase'), ('PMC8021180', 'R02004', 190, 204, 'aminopeptidase'), ('PMC8021180', 'R02004', 206, 228, 'glycogen phosphorylase'), ('PMC8021180', 'R02004', 233, 249, 'metallopeptidase')]	['Their', 'specific', 'molecular', 'functions', 'range', 'from', 'molecules', 'involved', 'in', 'ATP', ',', 'actin', ',', 'carbohydrate', ',', 'chi', '##tin', ',', 'lipid', 'and', 'magnesium', 'ion', 'binding', ',', 'as', 'well', 'as', 'molecules', 'that', 'take', 'part', 'in', 'oxid', '##ored', '##uct', '##ase', ',', 'amino', '##pe', '##pt', '##idase', ',', 'glycogen', 'phosphoryl', '##ase', 'and', 'metall', '##ope', '##pt', '##idase', 'activity', '(', 'Table', '1', ')', '.']	[0, 6, 15, 25, 35, 41, 46, 56, 65, 68, 71, 73, 78, 80, 92, 94, 97, 100, 102, 108, 112, 122, 126, 133, 135, 138, 143, 146, 156, 161, 166, 171, 174, 178, 182, 185, 188, 190, 195, 197, 199, 204, 206, 215, 225, 229, 233, 239, 242, 244, 250, 259, 260, 266, 267, 268]	[5, 14, 24, 34, 40, 45, 55, 64, 67, 71, 72, 78, 79, 92, 93, 97, 100, 101, 107, 111, 121, 125, 133, 134, 137, 142, 145, 155, 160, 165, 170, 173, 178, 182, 185, 188, 189, 195, 197, 199, 204, 205, 214, 225, 228, 232, 239, 242, 244, 249, 258, 260, 265, 267, 268, 269]	['Their', 'specific', 'molecular', 'functions', 'range', 'from', 'molecules', 'involved', 'in', 'ATP', ',', 'actin', ',', 'carbohydrate', ',', 'chitin', ',', 'lipid', 'and', 'magnesium', 'ion', 'binding', ',', 'as', 'well', 'as', 'molecules', 'that', 'take', 'part', 'in', 'oxidoreductase', ',', 'aminopeptidase', ',', 'glycogen', 'phosphorylase', 'and', 'metallopeptidase', 'activity', '(', 'Table', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Others include lipid transporter, motor and protein disulfide isomerase activity, together with structural constituents of the ribosome or proteins associated with the elongation phase of protein synthesis.	[('PMC8021180', 'R02005', 44, 71, 'protein disulfide isomerase')]	['Others', 'include', 'lipid', 'transporter', ',', 'motor', 'and', 'protein', 'disulfide', 'isomer', '##ase', 'activity', ',', 'together', 'with', 'structural', 'constituents', 'of', 'the', 'ribosome', 'or', 'proteins', 'associated', 'with', 'the', 'elongation', 'phase', 'of', 'protein', 'synthesis', '.']	[0, 7, 15, 21, 32, 34, 40, 44, 52, 62, 68, 72, 80, 82, 91, 96, 107, 120, 123, 127, 136, 139, 148, 159, 164, 168, 179, 185, 188, 196, 205]	[6, 14, 20, 32, 33, 39, 43, 51, 61, 68, 71, 80, 81, 90, 95, 106, 119, 122, 126, 135, 138, 147, 158, 163, 167, 178, 184, 187, 195, 205, 206]	['Others', 'include', 'lipid', 'transporter', ',', 'motor', 'and', 'protein', 'disulfide', 'isomerase', 'activity', ',', 'together', 'with', 'structural', 'constituents', 'of', 'the', 'ribosome', 'or', 'proteins', 'associated', 'with', 'the', 'elongation', 'phase', 'of', 'protein', 'synthesis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteins with kinase and intracellular cholesterol transport functions were also identified (Table 1).	[('PMC8021180', 'R02006', 14, 20, 'kinase')]	['Proteins', 'with', 'kinase', 'and', 'intracellular', 'cholesterol', 'transport', 'functions', 'were', 'also', 'identified', '(', 'Table', '1', ')', '.']	[0, 9, 14, 21, 25, 39, 51, 61, 71, 76, 81, 92, 93, 99, 100, 101]	[8, 13, 20, 24, 38, 50, 60, 70, 75, 80, 91, 93, 98, 100, 101, 102]	['Proteins', 'with', 'kinase', 'and', 'intracellular', 'cholesterol', 'transport', 'functions', 'were', 'also', 'identified', '(', 'Table', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Analysis of band 2W identified poly-cysteine and histidine-tailed protein isoform 2 (PCHTP-2), glyceraldehyde-3-phosphate dehydrogenase (glyceraldehyde-3-phosphate dehydrogenase), actin, actin 5C, enolase, and epididymal secretory protein E1 (Table 2) and confirmatory analysis with LC-MS/MS also indicating there were other proteins present such as phosphoglycerate kinase, the dolichyl-diphosphooligosaccharide-protein glycosyltransferase 48 kDa subunit, adenosylhomocysteinase, tubulointerstitial nephritis antigen, calponin domain containing protein, 3 ketoacyl coenzyme A thiolase, elongation factor 1-alpha and serpin domain containing protein (Table 3) while actin 5C and epididymal secretory protein E1 were not confirmed.	[('PMC8021180', 'R08000', 95, 135, 'glyceraldehyde-3-phosphate dehydrogenase'), ('PMC8021180', 'R08000', 137, 177, 'glyceraldehyde-3-phosphate dehydrogenase'), ('PMC8021180', 'R08000', 197, 204, 'enolase'), ('PMC8021180', 'R08000', 350, 373, 'phosphoglycerate kinase'), ('PMC8021180', 'R08000', 379, 440, 'dolichyl-diphosphooligosaccharide-protein glycosyltransferase'), ('PMC8021180', 'R08000', 457, 479, 'adenosylhomocysteinase'), ('PMC8021180', 'R08000', 555, 585, '3 ketoacyl coenzyme A thiolase')]	['Analysis', 'of', 'band', '2', '##W', 'identified', 'poly', '-', 'cysteine', 'and', 'histidine', '-', 'tail', '##ed', 'protein', 'isoform', '2', '(', 'PC', '##HT', '##P', '-', '2', ')', ',', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', '(', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', ')', ',', 'actin', ',', 'actin', '5', '##C', ',', 'en', '##olas', '##e', ',', 'and', 'epid', '##id', '##ymal', 'secretory', 'protein', 'E', '##1', '(', 'Table', '2', ')', 'and', 'confirm', '##atory', 'analysis', 'with', 'LC', '-', 'MS', '/', 'MS', 'also', 'indicating', 'there', 'were', 'other', 'proteins', 'present', 'such', 'as', 'phospho', '##glycer', '##ate', 'kinase', ',', 'the', 'do', '##lich', '##yl', '-', 'diph', '##osph', '##ool', '##ig', '##osacchar', '##ide', '-', 'protein', 'glycos', '##yl', '##transferase', '48', 'kDa', 'subunit', ',', 'aden', '##osyl', '##hom', '##ocyst', '##ei', '##nas', '##e', ',', 'tub', '##ulo', '##inter', '##stit', '##ial', 'neph', '##ritis', 'antigen', ',', 'cal', '##pon', '##in', 'domain', 'containing', 'protein', ',', '3', 'ket', '##oa', '##cy', '##l', 'coe', '##n', '##zyme', 'A', 'thiol', '##ase', ',', 'elongation', 'factor', '1', '-', 'alpha', 'and', 'ser', '##pin', 'domain', 'containing', 'protein', '(', 'Table', '3', ')', 'while', 'actin', '5', '##C', 'and', 'epid', '##id', '##ymal', 'secretory', 'protein', 'E', '##1', 'were', 'not', 'confirmed', '.']	[0, 9, 12, 17, 18, 20, 31, 35, 36, 45, 49, 58, 59, 63, 66, 74, 82, 84, 85, 87, 89, 90, 91, 92, 93, 95, 101, 109, 110, 111, 112, 122, 136, 137, 143, 151, 152, 153, 154, 164, 177, 178, 180, 185, 187, 193, 194, 195, 197, 199, 203, 204, 206, 210, 214, 216, 221, 231, 239, 240, 242, 243, 249, 250, 252, 256, 263, 269, 278, 283, 285, 286, 288, 289, 292, 297, 308, 314, 319, 325, 334, 342, 347, 350, 357, 363, 367, 373, 375, 379, 381, 385, 387, 388, 392, 396, 399, 401, 409, 412, 413, 421, 427, 429, 441, 444, 448, 455, 457, 461, 465, 468, 473, 475, 478, 479, 481, 484, 487, 492, 496, 500, 504, 510, 517, 519, 522, 525, 528, 535, 546, 553, 555, 557, 560, 562, 564, 566, 569, 570, 575, 577, 582, 585, 587, 598, 605, 606, 607, 613, 617, 620, 624, 631, 642, 650, 651, 657, 658, 660, 666, 672, 673, 675, 679, 683, 685, 690, 700, 708, 709, 711, 716, 720, 729]	[8, 11, 16, 18, 19, 30, 35, 36, 44, 48, 58, 59, 63, 65, 73, 81, 83, 85, 87, 89, 90, 91, 92, 93, 94, 101, 109, 110, 111, 112, 121, 135, 137, 143, 151, 152, 153, 154, 163, 177, 178, 179, 185, 186, 192, 194, 195, 196, 199, 203, 204, 205, 209, 214, 216, 220, 230, 238, 240, 241, 243, 248, 250, 251, 255, 263, 268, 277, 282, 285, 286, 288, 289, 291, 296, 307, 313, 318, 324, 333, 341, 346, 349, 357, 363, 366, 373, 374, 378, 381, 385, 387, 388, 392, 396, 399, 401, 409, 412, 413, 420, 427, 429, 440, 443, 447, 455, 456, 461, 465, 468, 473, 475, 478, 479, 480, 484, 487, 492, 496, 499, 504, 509, 517, 518, 522, 525, 527, 534, 545, 553, 554, 556, 560, 562, 564, 565, 569, 570, 574, 576, 582, 585, 586, 597, 604, 606, 607, 612, 616, 620, 623, 630, 641, 649, 651, 656, 658, 659, 665, 671, 673, 674, 678, 683, 685, 689, 699, 707, 709, 710, 715, 719, 729, 730]	['Analysis', 'of', 'band', '2W', 'identified', 'poly', '-', 'cysteine', 'and', 'histidine', '-', 'tailed', 'protein', 'isoform', '2', '(', 'PCHTP-2', ')', ',', 'glyceraldehyde-3-phosphate', 'dehydrogenase', '(', 'glyceraldehyde-3-phosphate', 'dehydrogenase', ')', ',', 'actin', ',', 'actin', '5C', ',', 'enolase', ',', 'and', 'epididymal', 'secretory', 'protein', 'E1', '(', 'Table', '2', ')', 'and', 'confirmatory', 'analysis', 'with', 'LC-MS', '/', 'MS', 'also', 'indicating', 'there', 'were', 'other', 'proteins', 'present', 'such', 'as', 'phosphoglycerate', 'kinase', ',', 'the', 'dolichyl', '-', 'diphosphooligosaccharide', '-', 'protein', 'glycosyltransferase', '48', 'kDa', 'subunit', ',', 'adenosylhomocysteinase', ',', 'tubulointerstitial', 'nephritis', 'antigen', ',', 'calponin', 'domain', 'containing', 'protein', ',', '3', 'ketoacyl', 'coenzyme', 'A', 'thiolase', ',', 'elongation', 'factor', '1-alpha', 'and', 'serpin', 'domain', 'containing', 'protein', '(', 'Table', '3', ')', 'while', 'actin', '5C', 'and', 'epididymal', 'secretory', 'protein', 'E1', 'were', 'not', 'confirmed', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 6, 1, 1, 6, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 6, 1, 1, 3, 1, 1, 1, 1, 7, 1, 5, 2, 1, 1, 3, 1, 1, 1, 1, 1, 4, 3, 1, 2, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The proteomic results of both sections of the band 4W showed some proteins shared between the EE and FE, such as PCHTP-2, Actin and glyceraldehyde-3-phosphate dehydrogenase, suggesting they are likely to be the major ones in both samples.	[('PMC8021180', 'R09002', 132, 172, 'glyceraldehyde-3-phosphate dehydrogenase')]	['The', 'proteomic', 'results', 'of', 'both', 'sections', 'of', 'the', 'band', '4', '##W', 'showed', 'some', 'proteins', 'shared', 'between', 'the', 'EE', 'and', 'FE', ',', 'such', 'as', 'PC', '##HT', '##P', '-', '2', ',', 'Actin', 'and', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', ',', 'suggesting', 'they', 'are', 'likely', 'to', 'be', 'the', 'major', 'ones', 'in', 'both', 'samples', '.']	[0, 4, 14, 22, 25, 30, 39, 42, 46, 51, 52, 54, 61, 66, 75, 82, 90, 94, 97, 101, 103, 105, 110, 113, 115, 117, 118, 119, 120, 122, 128, 132, 138, 146, 147, 148, 149, 159, 172, 174, 185, 190, 194, 201, 204, 207, 211, 217, 222, 225, 230, 237]	[3, 13, 21, 24, 29, 38, 41, 45, 50, 52, 53, 60, 65, 74, 81, 89, 93, 96, 100, 103, 104, 109, 112, 115, 117, 118, 119, 120, 121, 127, 131, 138, 146, 147, 148, 149, 158, 172, 173, 184, 189, 193, 200, 203, 206, 210, 216, 221, 224, 229, 237, 238]	['The', 'proteomic', 'results', 'of', 'both', 'sections', 'of', 'the', 'band', '4W', 'showed', 'some', 'proteins', 'shared', 'between', 'the', 'EE', 'and', 'FE', ',', 'such', 'as', 'PCHTP-2', ',', 'Actin', 'and', 'glyceraldehyde-3-phosphate', 'dehydrogenase', ',', 'suggesting', 'they', 'are', 'likely', 'to', 'be', 'the', 'major', 'ones', 'in', 'both', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although the 2W and 4W major antigenic bands of the EE and FE, respectively, both had a molecular weight of 37 kDa and shared several proteins (PCHTP-2, Actin and glyceraldehyde-3-phosphate dehydrogenase), there were also specific proteins which appeared in only the egg or adult female stage.	[('PMC8021180', 'R10004', 163, 203, 'glyceraldehyde-3-phosphate dehydrogenase')]	['Although', 'the', '2', '##W', 'and', '4', '##W', 'major', 'antigenic', 'bands', 'of', 'the', 'EE', 'and', 'FE', ',', 'respectively', ',', 'both', 'had', 'a', 'molecular', 'weight', 'of', '37', 'kDa', 'and', 'shared', 'several', 'proteins', '(', 'PC', '##HT', '##P', '-', '2', ',', 'Actin', 'and', 'glycer', '##aldehyde', '-', '3', '-', 'phosphate', 'dehydrogenase', ')', ',', 'there', 'were', 'also', 'specific', 'proteins', 'which', 'appeared', 'in', 'only', 'the', 'egg', 'or', 'adult', 'female', 'stage', '.']	[0, 9, 13, 14, 16, 20, 21, 23, 29, 39, 45, 48, 52, 55, 59, 61, 63, 75, 77, 82, 86, 88, 98, 105, 108, 111, 115, 119, 126, 134, 143, 144, 146, 148, 149, 150, 151, 153, 159, 163, 169, 177, 178, 179, 180, 190, 203, 204, 206, 212, 217, 222, 231, 240, 246, 255, 258, 263, 267, 271, 274, 280, 287, 292]	[8, 12, 14, 15, 19, 21, 22, 28, 38, 44, 47, 51, 54, 58, 61, 62, 75, 76, 81, 85, 87, 97, 104, 107, 110, 114, 118, 125, 133, 142, 144, 146, 148, 149, 150, 151, 152, 158, 162, 169, 177, 178, 179, 180, 189, 203, 204, 205, 211, 216, 221, 230, 239, 245, 254, 257, 262, 266, 270, 273, 279, 286, 292, 293]	['Although', 'the', '2W', 'and', '4W', 'major', 'antigenic', 'bands', 'of', 'the', 'EE', 'and', 'FE', ',', 'respectively', ',', 'both', 'had', 'a', 'molecular', 'weight', 'of', '37', 'kDa', 'and', 'shared', 'several', 'proteins', '(', 'PCHTP-2', ',', 'Actin', 'and', 'glyceraldehyde-3-phosphate', 'dehydrogenase', ')', ',', 'there', 'were', 'also', 'specific', 'proteins', 'which', 'appeared', 'in', 'only', 'the', 'egg', 'or', 'adult', 'female', 'stage', '.']	[1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dolichyl-diphosphooligosaccharide-protein glycosyltransferase 48kDa subunit, adenosylhomocysteinase, tubulointerstitial nephritis antigen, calponin domain containing protein, 3 ketoacyl coenzyme A thiolase, elongation factor 1-alpha and serpin domain containing protein appeared as typical of EE (Table 3).	[('PMC8021180', 'R10005', 0, 61, 'Dolichyl-diphosphooligosaccharide-protein glycosyltransferase'), ('PMC8021180', 'R10005', 77, 99, 'adenosylhomocysteinase'), ('PMC8021180', 'R10005', 175, 205, '3 ketoacyl coenzyme A thiolase')]	['Dol', '##ich', '##yl', '-', 'diph', '##osph', '##ool', '##ig', '##osacchar', '##ide', '-', 'protein', 'glycos', '##yl', '##transferase', '48', '##kDa', 'subunit', ',', 'aden', '##osyl', '##hom', '##ocyst', '##ei', '##nas', '##e', ',', 'tub', '##ulo', '##inter', '##stit', '##ial', 'neph', '##ritis', 'antigen', ',', 'cal', '##pon', '##in', 'domain', 'containing', 'protein', ',', '3', 'ket', '##oa', '##cy', '##l', 'coe', '##n', '##zyme', 'A', 'thiol', '##ase', ',', 'elongation', 'factor', '1', '-', 'alpha', 'and', 'ser', '##pin', 'domain', 'containing', 'protein', 'appeared', 'as', 'typical', 'of', 'EE', '(', 'Table', '3', ')', '.']	[0, 3, 6, 8, 9, 13, 17, 20, 22, 30, 33, 34, 42, 48, 50, 62, 64, 68, 75, 77, 81, 85, 88, 93, 95, 98, 99, 101, 104, 107, 112, 116, 120, 124, 130, 137, 139, 142, 145, 148, 155, 166, 173, 175, 177, 180, 182, 184, 186, 189, 190, 195, 197, 202, 205, 207, 218, 225, 226, 227, 233, 237, 240, 244, 251, 262, 270, 279, 282, 290, 293, 296, 297, 303, 304, 305]	[3, 6, 8, 9, 13, 17, 20, 22, 30, 33, 34, 41, 48, 50, 61, 64, 67, 75, 76, 81, 85, 88, 93, 95, 98, 99, 100, 104, 107, 112, 116, 119, 124, 129, 137, 138, 142, 145, 147, 154, 165, 173, 174, 176, 180, 182, 184, 185, 189, 190, 194, 196, 202, 205, 206, 217, 224, 226, 227, 232, 236, 240, 243, 250, 261, 269, 278, 281, 289, 292, 295, 297, 302, 304, 305, 306]	['Dolichyl', '-', 'diphosphooligosaccharide', '-', 'protein', 'glycosyltransferase', '48kDa', 'subunit', ',', 'adenosylhomocysteinase', ',', 'tubulointerstitial', 'nephritis', 'antigen', ',', 'calponin', 'domain', 'containing', 'protein', ',', '3', 'ketoacyl', 'coenzyme', 'A', 'thiolase', ',', 'elongation', 'factor', '1-alpha', 'and', 'serpin', 'domain', 'containing', 'protein', 'appeared', 'as', 'typical', 'of', 'EE', '(', 'Table', '3', ')', '.']	[3, 1, 6, 1, 1, 3, 2, 1, 1, 7, 1, 5, 2, 1, 1, 3, 1, 1, 1, 1, 1, 4, 3, 1, 2, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
MPN patients with high risk scores are treated by hydroxyurea (HU), interferon-α, or ruxolitinib, a tyrosine kinase inhibitor.	[('PMC8036917', 'A00002', 100, 115, 'tyrosine kinase')]	['MP', '##N', 'patients', 'with', 'high', 'risk', 'scores', 'are', 'treated', 'by', 'hydroxy', '##urea', '(', 'HU', ')', ',', 'interferon', '-', 'α', ',', 'or', 'ru', '##x', '##oli', '##tin', '##ib', ',', 'a', 'tyrosine', 'kinase', 'inhibitor', '.']	[0, 2, 4, 13, 18, 23, 28, 35, 39, 47, 50, 57, 62, 63, 65, 66, 68, 78, 79, 80, 82, 85, 87, 88, 91, 94, 96, 98, 100, 109, 116, 125]	[2, 3, 12, 17, 22, 27, 34, 38, 46, 49, 57, 61, 63, 65, 66, 67, 78, 79, 80, 81, 84, 87, 88, 91, 94, 96, 97, 99, 108, 115, 125, 126]	['MPN', 'patients', 'with', 'high', 'risk', 'scores', 'are', 'treated', 'by', 'hydroxyurea', '(', 'HU', ')', ',', 'interferon-α', ',', 'or', 'ruxolitinib', ',', 'a', 'tyrosine', 'kinase', 'inhibitor', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
Indeed, HU increases nitric oxide levels causing soluble guanylyl cyclase activation, subsequently increasing cGMP levels and leading to the activation of the gamma globin gene [25].	[('PMC8036917', 'D00008', 57, 73, 'guanylyl cyclase')]	['Indeed', ',', 'HU', 'increases', 'nitric', 'oxide', 'levels', 'causing', 'soluble', 'guan', '##yl', '##yl', 'cyclase', 'activation', ',', 'subsequently', 'increasing', 'c', '##GMP', 'levels', 'and', 'leading', 'to', 'the', 'activation', 'of', 'the', 'gamma', 'glob', '##in', 'gene', '[', '25', ']', '.']	[0, 6, 8, 11, 21, 28, 34, 41, 49, 57, 61, 63, 66, 74, 84, 86, 99, 110, 111, 115, 122, 126, 134, 137, 141, 152, 155, 159, 165, 169, 172, 177, 178, 180, 181]	[6, 7, 10, 20, 27, 33, 40, 48, 56, 61, 63, 65, 73, 84, 85, 98, 109, 111, 114, 121, 125, 133, 136, 140, 151, 154, 158, 164, 169, 171, 176, 178, 180, 181, 182]	['Indeed', ',', 'HU', 'increases', 'nitric', 'oxide', 'levels', 'causing', 'soluble', 'guanylyl', 'cyclase', 'activation', ',', 'subsequently', 'increasing', 'cGMP', 'levels', 'and', 'leading', 'to', 'the', 'activation', 'of', 'the', 'gamma', 'globin', 'gene', '[', '25', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
HU also increases the expression of the Lu/BCAM adhesion protein on the surface of RBCs in SCD [26,27] and modulates cell signaling pathways by regulating key effectors such as phosphodiesterase 9 in neutrophils [28] and phosphodiesterase 4A in endothelial cells [29].	[('PMC8036917', 'D00009', 177, 196, 'phosphodiesterase 9'), ('PMC8036917', 'D00009', 221, 241, 'phosphodiesterase 4A')]	['HU', 'also', 'increases', 'the', 'expression', 'of', 'the', 'Lu', '/', 'BC', '##AM', 'adhesion', 'protein', 'on', 'the', 'surface', 'of', 'RBC', '##s', 'in', 'SCD', '[', '26', ',', '27', ']', 'and', 'modulates', 'cell', 'signaling', 'pathways', 'by', 'regulating', 'key', 'effectors', 'such', 'as', 'phospho', '##die', '##ster', '##ase', '9', 'in', 'neutrophils', '[', '28', ']', 'and', 'phospho', '##die', '##ster', '##ase', '4', '##A', 'in', 'endothelial', 'cells', '[', '29', ']', '.']	[0, 3, 8, 18, 22, 33, 36, 40, 42, 43, 45, 48, 57, 65, 68, 72, 80, 83, 86, 88, 91, 95, 96, 98, 99, 101, 103, 107, 117, 122, 132, 141, 144, 155, 159, 169, 174, 177, 184, 187, 191, 195, 197, 200, 212, 213, 215, 217, 221, 228, 231, 235, 239, 240, 242, 245, 257, 263, 264, 266, 267]	[2, 7, 17, 21, 32, 35, 39, 42, 43, 45, 47, 56, 64, 67, 71, 79, 82, 86, 87, 90, 94, 96, 98, 99, 101, 102, 106, 116, 121, 131, 140, 143, 154, 158, 168, 173, 176, 184, 187, 191, 194, 196, 199, 211, 213, 215, 216, 220, 228, 231, 235, 238, 240, 241, 244, 256, 262, 264, 266, 267, 268]	['HU', 'also', 'increases', 'the', 'expression', 'of', 'the', 'Lu', '/', 'BCAM', 'adhesion', 'protein', 'on', 'the', 'surface', 'of', 'RBCs', 'in', 'SCD', '[', '26', ',', '27', ']', 'and', 'modulates', 'cell', 'signaling', 'pathways', 'by', 'regulating', 'key', 'effectors', 'such', 'as', 'phosphodiesterase', '9', 'in', 'neutrophils', '[', '28', ']', 'and', 'phosphodiesterase', '4A', 'in', 'endothelial', 'cells', '[', '29', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Ruxolitinib is a widely used drug in PV and myelofibrosis patients where it must be imported in the intracellular compartment in order to block Janus kinase 2 phosphorylation.	[('PMC8036917', 'D01000', 144, 158, 'Janus kinase 2')]	['Ru', '##x', '##oli', '##tin', '##ib', 'is', 'a', 'widely', 'used', 'drug', 'in', 'PV', 'and', 'myel', '##ofib', '##rosis', 'patients', 'where', 'it', 'must', 'be', 'imported', 'in', 'the', 'intracellular', 'compartment', 'in', 'order', 'to', 'block', 'Jan', '##us', 'kinase', '2', 'phosphorylation', '.']	[0, 2, 3, 6, 9, 12, 15, 17, 24, 29, 34, 37, 40, 44, 48, 52, 58, 67, 73, 76, 81, 84, 93, 96, 100, 114, 126, 129, 135, 138, 144, 147, 150, 157, 159, 174]	[2, 3, 6, 9, 11, 14, 16, 23, 28, 33, 36, 39, 43, 48, 52, 57, 66, 72, 75, 80, 83, 92, 95, 99, 113, 125, 128, 134, 137, 143, 147, 149, 156, 158, 174, 175]	['Ruxolitinib', 'is', 'a', 'widely', 'used', 'drug', 'in', 'PV', 'and', 'myelofibrosis', 'patients', 'where', 'it', 'must', 'be', 'imported', 'in', 'the', 'intracellular', 'compartment', 'in', 'order', 'to', 'block', 'Janus', 'kinase', '2', 'phosphorylation', '.']	[5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
ABC proteins act as nutrient importers [30,31,32] but have been linked with resistance to numerous drugs including ABCG2-mediated export of tyrosine kinase inhibitors (TKIs), such as imatinib and nilotinib [7].	[('PMC8036917', 'D01002', 140, 155, 'tyrosine kinase')]	['ABC', 'proteins', 'act', 'as', 'nutrient', 'import', '##ers', '[', '30', ',', '31', ',', '32', ']', 'but', 'have', 'been', 'linked', 'with', 'resistance', 'to', 'numerous', 'drugs', 'including', 'ABC', '##G', '##2', '-', 'mediated', 'export', 'of', 'tyrosine', 'kinase', 'inhibitors', '(', 'TK', '##Is', ')', ',', 'such', 'as', 'im', '##atinib', 'and', 'nil', '##otin', '##ib', '[', '7', ']', '.']	[0, 4, 13, 17, 20, 29, 35, 39, 40, 42, 43, 45, 46, 48, 50, 54, 59, 64, 71, 76, 87, 90, 99, 105, 115, 118, 119, 120, 121, 130, 137, 140, 149, 156, 167, 168, 170, 172, 173, 175, 180, 183, 185, 192, 196, 199, 203, 206, 207, 208, 209]	[3, 12, 16, 19, 28, 35, 38, 40, 42, 43, 45, 46, 48, 49, 53, 58, 63, 70, 75, 86, 89, 98, 104, 114, 118, 119, 120, 121, 129, 136, 139, 148, 155, 166, 168, 170, 172, 173, 174, 179, 182, 185, 191, 195, 199, 203, 205, 207, 208, 209, 210]	['ABC', 'proteins', 'act', 'as', 'nutrient', 'importers', '[', '30', ',', '31', ',', '32', ']', 'but', 'have', 'been', 'linked', 'with', 'resistance', 'to', 'numerous', 'drugs', 'including', 'ABCG2', '-', 'mediated', 'export', 'of', 'tyrosine', 'kinase', 'inhibitors', '(', 'TKIs', ')', ',', 'such', 'as', 'imatinib', 'and', 'nilotinib', '[', '7', ']', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although it is interesting to speculate on a similar phenomenon for ruxolitinib, it is unlikely to take place as ruxolitinib binds with high affinity to the ATP-binding site of Janus kinase 2, and no other binding partners or iron-chelating abilities have been documented for this drug.	[('PMC8036917', 'D01006', 177, 191, 'Janus kinase 2')]	['Although', 'it', 'is', 'interesting', 'to', 'speculate', 'on', 'a', 'similar', 'phenomenon', 'for', 'ru', '##x', '##oli', '##tin', '##ib', ',', 'it', 'is', 'unlikely', 'to', 'take', 'place', 'as', 'ru', '##x', '##oli', '##tin', '##ib', 'binds', 'with', 'high', 'affinity', 'to', 'the', 'ATP', '-', 'binding', 'site', 'of', 'Jan', '##us', 'kinase', '2', ',', 'and', 'no', 'other', 'binding', 'partners', 'or', 'iron', '-', 'chel', '##ating', 'abilities', 'have', 'been', 'documented', 'for', 'this', 'drug', '.']	[0, 9, 12, 15, 27, 30, 40, 43, 45, 53, 64, 68, 70, 71, 74, 77, 79, 81, 84, 87, 96, 99, 104, 110, 113, 115, 116, 119, 122, 125, 131, 136, 141, 150, 153, 157, 160, 161, 169, 174, 177, 180, 183, 190, 191, 193, 197, 200, 206, 214, 223, 226, 230, 231, 235, 241, 251, 256, 261, 272, 276, 281, 285]	[8, 11, 14, 26, 29, 39, 42, 44, 52, 63, 67, 70, 71, 74, 77, 79, 80, 83, 86, 95, 98, 103, 109, 112, 115, 116, 119, 122, 124, 130, 135, 140, 149, 152, 156, 160, 161, 168, 173, 176, 180, 182, 189, 191, 192, 196, 199, 205, 213, 222, 225, 230, 231, 235, 240, 250, 255, 260, 271, 275, 280, 285, 286]	['Although', 'it', 'is', 'interesting', 'to', 'speculate', 'on', 'a', 'similar', 'phenomenon', 'for', 'ruxolitinib', ',', 'it', 'is', 'unlikely', 'to', 'take', 'place', 'as', 'ruxolitinib', 'binds', 'with', 'high', 'affinity', 'to', 'the', 'ATP', '-', 'binding', 'site', 'of', 'Janus', 'kinase', '2', ',', 'and', 'no', 'other', 'binding', 'partners', 'or', 'iron', '-', 'chelating', 'abilities', 'have', 'been', 'documented', 'for', 'this', 'drug', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acquired mutation of the tyrosine kinase Janus kinase 2 in human myeloproliferative disorders.	[('PMC8036917', 'F01002', 25, 40, 'tyrosine kinase'), ('PMC8036917', 'F01002', 41, 55, 'Janus kinase 2')]	['Acqu', '##ired', 'mutation', 'of', 'the', 'tyrosine', 'kinase', 'Jan', '##us', 'kinase', '2', 'in', 'human', 'myel', '##oprol', '##iferative', 'disorders', '.']	[0, 4, 9, 18, 21, 25, 34, 41, 44, 47, 54, 56, 59, 65, 69, 74, 84, 93]	[4, 8, 17, 20, 24, 33, 40, 44, 46, 53, 55, 58, 64, 69, 74, 83, 93, 94]	['Acquired', 'mutation', 'of', 'the', 'tyrosine', 'kinase', 'Janus', 'kinase', '2', 'in', 'human', 'myeloproliferative', 'disorders', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'E', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A unique clonal Janus kinase 2 mutation leading to constitutive signalling causes polycythaemia vera.	[('PMC8036917', 'F02002', 16, 30, 'Janus kinase 2')]	['A', 'unique', 'clonal', 'Jan', '##us', 'kinase', '2', 'mutation', 'leading', 'to', 'constitutive', 'signalling', 'causes', 'polyc', '##yth', '##aemia', 'ver', '##a', '.']	[0, 2, 9, 16, 19, 22, 29, 31, 40, 48, 51, 64, 75, 82, 87, 90, 96, 99, 100]	[1, 8, 15, 19, 21, 28, 30, 39, 47, 50, 63, 74, 81, 87, 90, 95, 99, 100, 101]	['A', 'unique', 'clonal', 'Janus', 'kinase', '2', 'mutation', 'leading', 'to', 'constitutive', 'signalling', 'causes', 'polycythaemia', 'vera', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A gain-of-function mutation of Janus kinase 2 in myeloproliferative disorders.	[('PMC8036917', 'F03002', 31, 45, 'Janus kinase 2')]	['A', 'gain', '-', 'of', '-', 'function', 'mutation', 'of', 'Jan', '##us', 'kinase', '2', 'in', 'myel', '##oprol', '##iferative', 'disorders', '.']	[0, 2, 6, 7, 9, 10, 19, 28, 31, 34, 37, 44, 46, 49, 53, 58, 68, 77]	[1, 6, 7, 9, 10, 18, 27, 30, 34, 36, 43, 45, 48, 53, 58, 67, 77, 78]	['A', 'gain', '-', 'of', '-', 'function', 'mutation', 'of', 'Janus', 'kinase', '2', 'in', 'myeloproliferative', 'disorders', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Activating mutation in the tyrosine kinase Janus kinase 2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.	[('PMC8036917', 'F04002', 27, 42, 'tyrosine kinase'), ('PMC8036917', 'F04002', 43, 57, 'Janus kinase 2')]	['Activ', '##ating', 'mutation', 'in', 'the', 'tyrosine', 'kinase', 'Jan', '##us', 'kinase', '2', 'in', 'polyc', '##ythem', '##ia', 'ver', '##a', ',', 'essential', 'thrombocyt', '##hem', '##ia', ',', 'and', 'myeloid', 'metap', '##las', '##ia', 'with', 'myel', '##ofib', '##rosis', '.']	[0, 5, 11, 20, 23, 27, 36, 43, 46, 49, 56, 58, 61, 66, 71, 74, 77, 78, 80, 90, 100, 103, 105, 107, 111, 119, 124, 127, 130, 135, 139, 143, 148]	[5, 10, 19, 22, 26, 35, 42, 46, 48, 55, 57, 60, 66, 71, 73, 77, 78, 79, 89, 100, 103, 105, 106, 110, 118, 124, 127, 129, 134, 139, 143, 148, 149]	['Activating', 'mutation', 'in', 'the', 'tyrosine', 'kinase', 'Janus', 'kinase', '2', 'in', 'polycythemia', 'vera', ',', 'essential', 'thrombocythemia', ',', 'and', 'myeloid', 'metaplasia', 'with', 'myelofibrosis', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 2, 1, 1, 3, 1, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'E', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cokic V.P., Smith R.D., Beleslin-Cokic B.B., Njoroge J.M., Miller J.L., Gladwin M.T., Schechter A.N. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase.	[('PMC8036917', 'F24001', 190, 206, 'guanylyl cyclase')]	['Co', '##ki', '##c', 'V', '.', 'P', '.', ',', 'Smith', 'R', '.', 'D', '.', ',', 'Bel', '##es', '##lin', '-', 'Co', '##ki', '##c', 'B', '.', 'B', '.', ',', 'N', '##jor', '##oge', 'J', '.', 'M', '.', ',', 'Miller', 'J', '.', 'L', '.', ',', 'Gl', '##ad', '##win', 'M', '.', 'T', '.', ',', 'Sche', '##cht', '##er', 'A', '.', 'N', '.', 'Hydro', '##xy', '##urea', 'induces', 'fetal', 'hemoglobin', 'by', 'the', 'nitric', 'oxide', '-', 'dependent', 'activation', 'of', 'soluble', 'guan', '##yl', '##yl', 'cyclase', '.']	[0, 2, 4, 6, 7, 8, 9, 10, 12, 18, 19, 20, 21, 22, 24, 27, 29, 32, 33, 35, 37, 39, 40, 41, 42, 43, 45, 46, 49, 53, 54, 55, 56, 57, 59, 66, 67, 68, 69, 70, 72, 74, 76, 80, 81, 82, 83, 84, 86, 90, 93, 96, 97, 98, 99, 101, 106, 108, 113, 121, 127, 138, 141, 145, 152, 157, 158, 168, 179, 182, 190, 194, 196, 199, 206]	[2, 4, 5, 7, 8, 9, 10, 11, 17, 19, 20, 21, 22, 23, 27, 29, 32, 33, 35, 37, 38, 40, 41, 42, 43, 44, 46, 49, 52, 54, 55, 56, 57, 58, 65, 67, 68, 69, 70, 71, 74, 76, 79, 81, 82, 83, 84, 85, 90, 93, 95, 97, 98, 99, 100, 106, 108, 112, 120, 126, 137, 140, 144, 151, 157, 158, 167, 178, 181, 189, 194, 196, 198, 206, 207]	['Cokic', 'V.P', '.', ',', 'Smith', 'R.D', '.', ',', 'Beleslin-Cokic', 'B.B', '.', ',', 'Njoroge', 'J.M', '.', ',', 'Miller', 'J.L', '.', ',', 'Gladwin', 'M.T', '.', ',', 'Schechter', 'A.N', '.', 'Hydroxyurea', 'induces', 'fetal', 'hemoglobin', 'by', 'the', 'nitric', 'oxide', '-', 'dependent', 'activation', 'of', 'soluble', 'guanylyl', 'cyclase', '.']	[3, 3, 1, 1, 1, 3, 1, 1, 7, 3, 1, 1, 3, 3, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 3, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Chaar V., Laurance S., Lapoumeroulie C., Cochet S., De Grandis M., Colin Y., Elion J., Le Van Kim C., El Nemer W. Hydroxycarbamide decreases sickle reticulocyte adhesion to resting endothelium by inhibiting endothelial lutheran/basal cell adhesion molecule (Lu/BCAM) through phosphodiesterase 4A activation.	[('PMC8036917', 'F28001', 275, 295, 'phosphodiesterase 4A')]	['Cha', '##ar', 'V', '.', ',', 'Lau', '##ran', '##ce', 'S', '.', ',', 'Lap', '##ou', '##mer', '##oul', '##ie', 'C', '.', ',', 'Coch', '##et', 'S', '.', ',', 'De', 'Grand', '##is', 'M', '.', ',', 'Col', '##in', 'Y', '.', ',', 'El', '##ion', 'J', '.', ',', 'Le', 'Van', 'Kim', 'C', '.', ',', 'El', 'Ne', '##mer', 'W', '.', 'Hydro', '##xy', '##carb', '##amide', 'decreases', 'sick', '##le', 'retic', '##ulo', '##cyt', '##e', 'adhesion', 'to', 'resting', 'endothelium', 'by', 'inhibiting', 'endothelial', 'lu', '##ther', '##an', '/', 'basal', 'cell', 'adhesion', 'molecule', '(', 'Lu', '/', 'BC', '##AM', ')', 'through', 'phospho', '##die', '##ster', '##ase', '4', '##A', 'activation', '.']	[0, 3, 6, 7, 8, 10, 13, 16, 19, 20, 21, 23, 26, 28, 31, 34, 37, 38, 39, 41, 45, 48, 49, 50, 52, 55, 60, 63, 64, 65, 67, 70, 73, 74, 75, 77, 79, 83, 84, 85, 87, 90, 94, 98, 99, 100, 102, 105, 107, 111, 112, 114, 119, 121, 125, 131, 141, 145, 148, 153, 156, 159, 161, 170, 173, 181, 193, 196, 207, 219, 221, 225, 227, 228, 234, 239, 248, 257, 258, 260, 261, 263, 265, 267, 275, 282, 285, 289, 293, 294, 296, 306]	[3, 5, 7, 8, 9, 13, 16, 18, 20, 21, 22, 26, 28, 31, 34, 36, 38, 39, 40, 45, 47, 49, 50, 51, 54, 60, 62, 64, 65, 66, 70, 72, 74, 75, 76, 79, 82, 84, 85, 86, 89, 93, 97, 99, 100, 101, 104, 107, 110, 112, 113, 119, 121, 125, 130, 140, 145, 147, 153, 156, 159, 160, 169, 172, 180, 192, 195, 206, 218, 221, 225, 227, 228, 233, 238, 247, 256, 258, 260, 261, 263, 265, 266, 274, 282, 285, 289, 292, 294, 295, 306, 307]	['Chaar', 'V', '.', ',', 'Laurance', 'S', '.', ',', 'Lapoumeroulie', 'C', '.', ',', 'Cochet', 'S', '.', ',', 'De', 'Grandis', 'M', '.', ',', 'Colin', 'Y', '.', ',', 'Elion', 'J', '.', ',', 'Le', 'Van', 'Kim', 'C', '.', ',', 'El', 'Nemer', 'W', '.', 'Hydroxycarbamide', 'decreases', 'sickle', 'reticulocyte', 'adhesion', 'to', 'resting', 'endothelium', 'by', 'inhibiting', 'endothelial', 'lutheran', '/', 'basal', 'cell', 'adhesion', 'molecule', '(', 'Lu', '/', 'BCAM', ')', 'through', 'phosphodiesterase', '4A', 'activation', '.']	[2, 1, 1, 1, 3, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Vannucchi A.M., Verstovsek S., Guglielmelli P., Griesshammer M., Burn T.C., Naim A., Paranagama D., Marker M., Gadbaw B., Kiladjian J.J. Ruxolitinib reduces Janus kinase 2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study.	[('PMC8036917', 'F34001', 157, 171, 'Janus kinase 2')]	['Van', '##nu', '##cc', '##hi', 'A', '.', 'M', '.', ',', 'Vers', '##to', '##vs', '##ek', 'S', '.', ',', 'Gu', '##gl', '##iel', '##mel', '##li', 'P', '.', ',', 'Gr', '##ies', '##sh', '##ammer', 'M', '.', ',', 'Burn', 'T', '.', 'C', '.', ',', 'Na', '##im', 'A', '.', ',', 'Par', '##ana', '##ga', '##ma', 'D', '.', ',', 'Mark', '##er', 'M', '.', ',', 'Ga', '##db', '##aw', 'B', '.', ',', 'Ki', '##la', '##d', '##ji', '##an', 'J', '.', 'J', '.', 'Ru', '##x', '##oli', '##tin', '##ib', 'reduces', 'Jan', '##us', 'kinase', '2', 'p', '.', 'V', '##61', '##7', '##F', 'allele', 'burden', 'in', 'patients', 'with', 'polyc', '##ythem', '##ia', 'ver', '##a', 'enrolled', 'in', 'the', 'RES', '##PO', '##NS', '##E', 'study', '.']	[0, 3, 5, 7, 10, 11, 12, 13, 14, 16, 20, 22, 24, 27, 28, 29, 31, 33, 35, 38, 41, 44, 45, 46, 48, 50, 53, 55, 61, 62, 63, 65, 70, 71, 72, 73, 74, 76, 78, 81, 82, 83, 85, 88, 91, 93, 96, 97, 98, 100, 104, 107, 108, 109, 111, 113, 115, 118, 119, 120, 122, 124, 126, 127, 129, 132, 133, 134, 135, 137, 139, 140, 143, 146, 149, 157, 160, 163, 170, 172, 173, 174, 175, 177, 178, 180, 187, 194, 197, 206, 211, 216, 221, 224, 227, 229, 238, 241, 245, 248, 250, 252, 254, 259]	[3, 5, 7, 9, 11, 12, 13, 14, 15, 20, 22, 24, 26, 28, 29, 30, 33, 35, 38, 41, 43, 45, 46, 47, 50, 53, 55, 60, 62, 63, 64, 69, 71, 72, 73, 74, 75, 78, 80, 82, 83, 84, 88, 91, 93, 95, 97, 98, 99, 104, 106, 108, 109, 110, 113, 115, 117, 119, 120, 121, 124, 126, 127, 129, 131, 133, 134, 135, 136, 139, 140, 143, 146, 148, 156, 160, 162, 169, 171, 173, 174, 175, 177, 178, 179, 186, 193, 196, 205, 210, 216, 221, 223, 227, 228, 237, 240, 244, 248, 250, 252, 253, 259, 260]	['Vannucchi', 'A.M', '.', ',', 'Verstovsek', 'S', '.', ',', 'Guglielmelli', 'P', '.', ',', 'Griesshammer', 'M', '.', ',', 'Burn', 'T.C', '.', ',', 'Naim', 'A', '.', ',', 'Paranagama', 'D', '.', ',', 'Marker', 'M', '.', ',', 'Gadbaw', 'B', '.', ',', 'Kiladjian', 'J.J', '.', 'Ruxolitinib', 'reduces', 'Janus', 'kinase', '2', 'p.V617F', 'allele', 'burden', 'in', 'patients', 'with', 'polycythemia', 'vera', 'enrolled', 'in', 'the', 'RESPONSE', 'study', '.']	[4, 3, 1, 1, 4, 1, 1, 1, 5, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 5, 3, 1, 5, 1, 2, 1, 1, 6, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Over 95% of PV patients and 60% of ET patients display the V617F mutation in the Janus kinase 2 (Janus kinase 2) tyrosine kinase [1].	[('PMC8036917', 'I00002', 81, 95, 'Janus kinase 2'), ('PMC8036917', 'I00002', 97, 111, 'Janus kinase 2'), ('PMC8036917', 'I00002', 113, 128, 'tyrosine kinase')]	['Over', '95', '%', 'of', 'PV', 'patients', 'and', '60', '%', 'of', 'ET', 'patients', 'display', 'the', 'V', '##61', '##7', '##F', 'mutation', 'in', 'the', 'Jan', '##us', 'kinase', '2', '(', 'Jan', '##us', 'kinase', '2', ')', 'tyrosine', 'kinase', '[', '1', ']', '.']	[0, 5, 7, 9, 12, 15, 24, 28, 30, 32, 35, 38, 47, 55, 59, 60, 62, 63, 65, 74, 77, 81, 84, 87, 94, 96, 97, 100, 103, 110, 111, 113, 122, 129, 130, 131, 132]	[4, 7, 8, 11, 14, 23, 27, 30, 31, 34, 37, 46, 54, 58, 60, 62, 63, 64, 73, 76, 80, 84, 86, 93, 95, 97, 100, 102, 109, 111, 112, 121, 128, 130, 131, 132, 133]	['Over', '95%', 'of', 'PV', 'patients', 'and', '60%', 'of', 'ET', 'patients', 'display', 'the', 'V617F', 'mutation', 'in', 'the', 'Janus', 'kinase', '2', '(', 'Janus', 'kinase', '2', ')', 'tyrosine', 'kinase', '[', '1', ']', '.']	[1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'B', 'E', 'O', 'O', 'O', 'O']
Patients with high prognostic risk scores are treated by cytoreductive therapy, such as hydroxyurea (HU) or interferon-α (IFN-α) or by ruxolitinib, a JAK1/Janus kinase 2 inhibitor.	[('PMC8036917', 'I00006', 155, 169, 'Janus kinase 2')]	['Patients', 'with', 'high', 'prognostic', 'risk', 'scores', 'are', 'treated', 'by', 'cyt', '##ored', '##uct', '##ive', 'therapy', ',', 'such', 'as', 'hydroxy', '##urea', '(', 'HU', ')', 'or', 'interferon', '-', 'α', '(', 'IFN', '-', 'α', ')', 'or', 'by', 'ru', '##x', '##oli', '##tin', '##ib', ',', 'a', 'JAK', '##1', '/', 'Jan', '##us', 'kinase', '2', 'inhibitor', '.']	[0, 9, 14, 19, 30, 35, 42, 46, 54, 57, 60, 64, 67, 71, 78, 80, 85, 88, 95, 100, 101, 103, 105, 108, 118, 119, 121, 122, 125, 126, 127, 129, 132, 135, 137, 138, 141, 144, 146, 148, 150, 153, 154, 155, 158, 161, 168, 170, 179]	[8, 13, 18, 29, 34, 41, 45, 53, 56, 60, 64, 67, 70, 78, 79, 84, 87, 95, 99, 101, 103, 104, 107, 118, 119, 120, 122, 125, 126, 127, 128, 131, 134, 137, 138, 141, 144, 146, 147, 149, 153, 154, 155, 158, 160, 167, 169, 179, 180]	['Patients', 'with', 'high', 'prognostic', 'risk', 'scores', 'are', 'treated', 'by', 'cytoreductive', 'therapy', ',', 'such', 'as', 'hydroxyurea', '(', 'HU', ')', 'or', 'interferon-α', '(', 'IFN-α', ')', 'or', 'by', 'ruxolitinib', ',', 'a', 'JAK1', '/', 'Janus', 'kinase', '2', 'inhibitor', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 5, 1, 1, 2, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O']
Increased protein levels of ABCG2 and ABCB1, another ABC transporter, are linked with increased resistance to numerous drugs including tyrosine kinase inhibitors (TKIs), such as imatinib and nilotinib [7].	[('PMC8036917', 'I01002', 135, 150, 'tyrosine kinase')]	['Increased', 'protein', 'levels', 'of', 'ABC', '##G', '##2', 'and', 'ABC', '##B', '##1', ',', 'another', 'ABC', 'transporter', ',', 'are', 'linked', 'with', 'increased', 'resistance', 'to', 'numerous', 'drugs', 'including', 'tyrosine', 'kinase', 'inhibitors', '(', 'TK', '##Is', ')', ',', 'such', 'as', 'im', '##atinib', 'and', 'nil', '##otin', '##ib', '[', '7', ']', '.']	[0, 10, 18, 25, 28, 31, 32, 34, 38, 41, 42, 43, 45, 53, 57, 68, 70, 74, 81, 86, 96, 107, 110, 119, 125, 135, 144, 151, 162, 163, 165, 167, 168, 170, 175, 178, 180, 187, 191, 194, 198, 201, 202, 203, 204]	[9, 17, 24, 27, 31, 32, 33, 37, 41, 42, 43, 44, 52, 56, 68, 69, 73, 80, 85, 95, 106, 109, 118, 124, 134, 143, 150, 161, 163, 165, 167, 168, 169, 174, 177, 180, 186, 190, 194, 198, 200, 202, 203, 204, 205]	['Increased', 'protein', 'levels', 'of', 'ABCG2', 'and', 'ABCB1', ',', 'another', 'ABC', 'transporter', ',', 'are', 'linked', 'with', 'increased', 'resistance', 'to', 'numerous', 'drugs', 'including', 'tyrosine', 'kinase', 'inhibitors', '(', 'TKIs', ')', ',', 'such', 'as', 'imatinib', 'and', 'nilotinib', '[', '7', ']', '.']	[1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Samples were lysed for 45 min at 4 °C in a lysis buffer containing 20 mM Tris, 150 mM NaCl, 5 mM EDTA, 0.002% NaN3, 1% Triton X-100, 0.2% BSA, and phosphatase (Sigma-Aldrich, St. Louis, MO, USA) and protease inhibitor cocktails (Roche Diagnostics, Basel, Switzerland).	[('PMC8036917', 'M04001', 147, 158, 'phosphatase')]	['Samples', 'were', 'lysed', 'for', '45', 'min', 'at', '4', '°', '##C', 'in', 'a', 'lysis', 'buffer', 'containing', '20', 'mM', 'Tris', ',', '150', 'mM', 'NaCl', ',', '5', 'mM', 'EDTA', ',', '0', '.', '00', '##2', '%', 'Na', '##N', '##3', ',', '1', '%', 'Triton', 'X', '-', '100', ',', '0', '.', '2', '%', 'BSA', ',', 'and', 'phosphatase', '(', 'Sigma', '-', 'Aldr', '##ich', ',', 'St', '.', 'Louis', ',', 'MO', ',', 'USA', ')', 'and', 'protease', 'inhibitor', 'cock', '##tail', '##s', '(', 'Roche', 'Diagnostics', ',', 'Basel', ',', 'Switzerland', ')', '.']	[0, 8, 13, 19, 23, 26, 30, 33, 35, 36, 38, 41, 43, 49, 56, 67, 70, 73, 77, 79, 83, 86, 90, 92, 94, 97, 101, 103, 104, 105, 107, 108, 110, 112, 113, 114, 116, 117, 119, 126, 127, 128, 131, 133, 134, 135, 136, 138, 141, 143, 147, 159, 160, 165, 166, 170, 173, 175, 177, 179, 184, 186, 188, 190, 193, 195, 199, 208, 218, 222, 226, 228, 229, 235, 246, 248, 253, 255, 266, 267]	[7, 12, 18, 22, 25, 29, 32, 34, 36, 37, 40, 42, 48, 55, 66, 69, 72, 77, 78, 82, 85, 90, 91, 93, 96, 101, 102, 104, 105, 107, 108, 109, 112, 113, 114, 115, 117, 118, 125, 127, 128, 131, 132, 134, 135, 136, 137, 141, 142, 146, 158, 160, 165, 166, 170, 173, 174, 177, 178, 184, 185, 188, 189, 193, 194, 198, 207, 217, 222, 226, 227, 229, 234, 246, 247, 253, 254, 266, 267, 268]	['Samples', 'were', 'lysed', 'for', '45', 'min', 'at', '4', '°C', 'in', 'a', 'lysis', 'buffer', 'containing', '20', 'mM', 'Tris', ',', '150', 'mM', 'NaCl', ',', '5', 'mM', 'EDTA', ',', '0.002%', 'NaN3', ',', '1%', 'Triton', 'X-100', ',', '0.2%', 'BSA', ',', 'and', 'phosphatase', '(', 'Sigma-Aldrich', ',', 'St', '.', 'Louis', ',', 'MO', ',', 'USA', ')', 'and', 'protease', 'inhibitor', 'cocktails', '(', 'Roche', 'Diagnostics', ',', 'Basel', ',', 'Switzerland', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 2, 1, 3, 1, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It has been reported that ruxolitinib triggers phosphatidylserine (PS) exposure (an apoptotic marker) on RBCs from healthy individuals via p38 MAP kinase activation downstream of Janus kinase 2 [18].	[('PMC8036917', 'R02001', 139, 153, 'p38 MAP kinase'), ('PMC8036917', 'R02001', 179, 193, 'Janus kinase 2')]	['It', 'has', 'been', 'reported', 'that', 'ru', '##x', '##oli', '##tin', '##ib', 'triggers', 'phosphatidyl', '##ser', '##ine', '(', 'PS', ')', 'exposure', '(', 'an', 'apoptotic', 'marker', ')', 'on', 'RBC', '##s', 'from', 'healthy', 'individuals', 'via', 'p', '##38', 'MAP', 'kinase', 'activation', 'downstream', 'of', 'Jan', '##us', 'kinase', '2', '[', '18', ']', '.']	[0, 3, 7, 12, 21, 26, 28, 29, 32, 35, 38, 47, 59, 62, 66, 67, 69, 71, 80, 81, 84, 94, 100, 102, 105, 108, 110, 115, 123, 135, 139, 140, 143, 147, 154, 165, 176, 179, 182, 185, 192, 194, 195, 197, 198]	[2, 6, 11, 20, 25, 28, 29, 32, 35, 37, 46, 59, 62, 65, 67, 69, 70, 79, 81, 83, 93, 100, 101, 104, 108, 109, 114, 122, 134, 138, 140, 142, 146, 153, 164, 175, 178, 182, 184, 191, 193, 195, 197, 198, 199]	['It', 'has', 'been', 'reported', 'that', 'ruxolitinib', 'triggers', 'phosphatidylserine', '(', 'PS', ')', 'exposure', '(', 'an', 'apoptotic', 'marker', ')', 'on', 'RBCs', 'from', 'healthy', 'individuals', 'via', 'p38', 'MAP', 'kinase', 'activation', 'downstream', 'of', 'Janus', 'kinase', '2', '[', '18', ']', '.']	[1, 1, 1, 1, 1, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Ruxolitinib treatment blocks the Janus kinase 2/STAT5 signaling pathway leading to reduction of the cell count [19].	[('PMC8036917', 'R03001', 33, 47, 'Janus kinase 2')]	['Ru', '##x', '##oli', '##tin', '##ib', 'treatment', 'blocks', 'the', 'Jan', '##us', 'kinase', '2', '/', 'STAT', '##5', 'signaling', 'pathway', 'leading', 'to', 'reduction', 'of', 'the', 'cell', 'count', '[', '19', ']', '.']	[0, 2, 3, 6, 9, 12, 22, 29, 33, 36, 39, 46, 47, 48, 52, 54, 64, 72, 80, 83, 93, 96, 100, 105, 111, 112, 114, 115]	[2, 3, 6, 9, 11, 21, 28, 32, 36, 38, 45, 47, 48, 52, 53, 63, 71, 79, 82, 92, 95, 99, 104, 110, 112, 114, 115, 116]	['Ruxolitinib', 'treatment', 'blocks', 'the', 'Janus', 'kinase', '2', '/', 'STAT5', 'signaling', 'pathway', 'leading', 'to', 'reduction', 'of', 'the', 'cell', 'count', '[', '19', ']', '.']	[5, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Paraoxonase 1 (paraoxonase 1) enzyme has antioxidative properties and is present in mammalian blood and several other body fluids.	[('PMC8045895', 'A00000', 0, 13, 'Paraoxonase 1'), ('PMC8045895', 'A00000', 15, 28, 'paraoxonase 1')]	['Par', '##ao', '##x', '##ona', '##se', '1', '(', 'para', '##oxo', '##nas', '##e', '1', ')', 'enzyme', 'has', 'antioxid', '##ative', 'properties', 'and', 'is', 'present', 'in', 'mammalian', 'blood', 'and', 'several', 'other', 'body', 'fluids', '.']	[0, 3, 5, 6, 9, 12, 14, 15, 19, 22, 25, 27, 28, 30, 37, 41, 49, 55, 66, 70, 73, 81, 84, 94, 100, 104, 112, 118, 123, 129]	[3, 5, 6, 9, 11, 13, 15, 19, 22, 25, 26, 28, 29, 36, 40, 49, 54, 65, 69, 72, 80, 83, 93, 99, 103, 111, 117, 122, 129, 130]	['Paraoxonase', '1', '(', 'paraoxonase', '1', ')', 'enzyme', 'has', 'antioxidative', 'properties', 'and', 'is', 'present', 'in', 'mammalian', 'blood', 'and', 'several', 'other', 'body', 'fluids', '.']	[5, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In blood, paraoxonase 1 is usually integrated into the high-density lipoprotein (HDL) cholesterol.	[('PMC8045895', 'A00001', 10, 23, 'paraoxonase 1')]	['In', 'blood', ',', 'para', '##oxo', '##nas', '##e', '1', 'is', 'usually', 'integrated', 'into', 'the', 'high', '-', 'density', 'lipoprotein', '(', 'HDL', ')', 'cholesterol', '.']	[0, 3, 8, 10, 14, 17, 20, 22, 24, 27, 35, 46, 51, 55, 59, 60, 68, 80, 81, 84, 86, 97]	[2, 8, 9, 14, 17, 20, 21, 23, 26, 34, 45, 50, 54, 59, 60, 67, 79, 81, 84, 85, 97, 98]	['In', 'blood', ',', 'paraoxonase', '1', 'is', 'usually', 'integrated', 'into', 'the', 'high', '-', 'density', 'lipoprotein', '(', 'HDL', ')', 'cholesterol', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
paraoxonase 1 is a highly versatile enzyme displaying diverse functions such as arylesterase, lactonase, and paraoxonase, among others.	[('PMC8045895', 'A00002', 0, 13, 'paraoxonase 1'), ('PMC8045895', 'A00002', 80, 92, 'arylesterase'), ('PMC8045895', 'A00002', 94, 103, 'lactonase'), ('PMC8045895', 'A00002', 109, 120, 'paraoxonase')]	['para', '##oxo', '##nas', '##e', '1', 'is', 'a', 'highly', 'versatile', 'enzyme', 'displaying', 'diverse', 'functions', 'such', 'as', 'aryl', '##ester', '##ase', ',', 'lact', '##ona', '##se', ',', 'and', 'para', '##oxo', '##nas', '##e', ',', 'among', 'others', '.']	[0, 4, 7, 10, 12, 14, 17, 19, 26, 36, 43, 54, 62, 72, 77, 80, 84, 89, 92, 94, 98, 101, 103, 105, 109, 113, 116, 119, 120, 122, 128, 134]	[4, 7, 10, 11, 13, 16, 18, 25, 35, 42, 53, 61, 71, 76, 79, 84, 89, 92, 93, 98, 101, 103, 104, 108, 113, 116, 119, 120, 121, 127, 134, 135]	['paraoxonase', '1', 'is', 'a', 'highly', 'versatile', 'enzyme', 'displaying', 'diverse', 'functions', 'such', 'as', 'arylesterase', ',', 'lactonase', ',', 'and', 'paraoxonase', ',', 'among', 'others', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 4, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
paraoxonase 1 activities are usually investigated with artificial substrates, for example, dihydrocoumarin and thiobutyl butyrolactone for lactonase activity.	[('PMC8045895', 'A00003', 0, 13, 'paraoxonase 1'), ('PMC8045895', 'A00003', 139, 148, 'lactonase')]	['para', '##oxo', '##nas', '##e', '1', 'activities', 'are', 'usually', 'investigated', 'with', 'artificial', 'substrates', ',', 'for', 'example', ',', 'di', '##hydro', '##co', '##umar', '##in', 'and', 'thi', '##obut', '##yl', 'but', '##yr', '##ola', '##ct', '##one', 'for', 'lact', '##ona', '##se', 'activity', '.']	[0, 4, 7, 10, 12, 14, 25, 29, 37, 50, 55, 66, 76, 78, 82, 89, 91, 93, 98, 100, 104, 107, 111, 114, 118, 121, 124, 126, 129, 131, 135, 139, 143, 146, 149, 157]	[4, 7, 10, 11, 13, 24, 28, 36, 49, 54, 65, 76, 77, 81, 89, 90, 93, 98, 100, 104, 106, 110, 114, 118, 120, 124, 126, 129, 131, 134, 138, 143, 146, 148, 157, 158]	['paraoxonase', '1', 'activities', 'are', 'usually', 'investigated', 'with', 'artificial', 'substrates', ',', 'for', 'example', ',', 'dihydrocoumarin', 'and', 'thiobutyl', 'butyrolactone', 'for', 'lactonase', 'activity', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 3, 5, 1, 3, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
The paraoxonase 1 enzyme activities measured with different substrates tend to be falsely assumed as being equivalent in the literature, although there are poor or weak correlations among the paraoxonase 1 enzyme activities with different substrates.	[('PMC8045895', 'A00004', 4, 17, 'paraoxonase 1'), ('PMC8045895', 'A00004', 192, 205, 'paraoxonase 1')]	['The', 'para', '##oxo', '##nas', '##e', '1', 'enzyme', 'activities', 'measured', 'with', 'different', 'substrates', 'tend', 'to', 'be', 'false', '##ly', 'assumed', 'as', 'being', 'equivalent', 'in', 'the', 'literature', ',', 'although', 'there', 'are', 'poor', 'or', 'weak', 'correlations', 'among', 'the', 'para', '##oxo', '##nas', '##e', '1', 'enzyme', 'activities', 'with', 'different', 'substrates', '.']	[0, 4, 8, 11, 14, 16, 18, 25, 36, 45, 50, 60, 71, 76, 79, 82, 87, 90, 98, 101, 107, 118, 121, 125, 135, 137, 146, 152, 156, 161, 164, 169, 182, 188, 192, 196, 199, 202, 204, 206, 213, 224, 229, 239, 249]	[3, 8, 11, 14, 15, 17, 24, 35, 44, 49, 59, 70, 75, 78, 81, 87, 89, 97, 100, 106, 117, 120, 124, 135, 136, 145, 151, 155, 160, 163, 168, 181, 187, 191, 196, 199, 202, 203, 205, 212, 223, 228, 238, 249, 250]	['The', 'paraoxonase', '1', 'enzyme', 'activities', 'measured', 'with', 'different', 'substrates', 'tend', 'to', 'be', 'falsely', 'assumed', 'as', 'being', 'equivalent', 'in', 'the', 'literature', ',', 'although', 'there', 'are', 'poor', 'or', 'weak', 'correlations', 'among', 'the', 'paraoxonase', '1', 'enzyme', 'activities', 'with', 'different', 'substrates', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, and despite our knowledge of the factors influencing paraoxonase 1 paraoxonase and arylesterase activities, there is little knowledge of paraoxonase 1 lactonase activity variations and attendant mechanisms.	[('PMC8045895', 'A00005', 66, 79, 'paraoxonase 1'), ('PMC8045895', 'A00005', 80, 91, 'paraoxonase'), ('PMC8045895', 'A00005', 96, 108, 'arylesterase'), ('PMC8045895', 'A00005', 150, 163, 'paraoxonase 1')]	['In', 'addition', ',', 'and', 'despite', 'our', 'knowledge', 'of', 'the', 'factors', 'influencing', 'para', '##oxo', '##nas', '##e', '1', 'para', '##oxo', '##nas', '##e', 'and', 'aryl', '##ester', '##ase', 'activities', ',', 'there', 'is', 'little', 'knowledge', 'of', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'variations', 'and', 'attend', '##ant', 'mechanisms', '.']	[0, 3, 11, 13, 17, 25, 29, 39, 42, 46, 54, 66, 70, 73, 76, 78, 80, 84, 87, 90, 92, 96, 100, 105, 109, 119, 121, 127, 130, 137, 147, 150, 154, 157, 160, 162, 164, 168, 171, 174, 183, 194, 198, 204, 208, 218]	[2, 11, 12, 16, 24, 28, 38, 41, 45, 53, 65, 70, 73, 76, 77, 79, 84, 87, 90, 91, 95, 100, 105, 108, 119, 120, 126, 129, 136, 146, 149, 154, 157, 160, 161, 163, 168, 171, 173, 182, 193, 197, 204, 207, 218, 219]	['In', 'addition', ',', 'and', 'despite', 'our', 'knowledge', 'of', 'the', 'factors', 'influencing', 'paraoxonase', '1', 'paraoxonase', 'and', 'arylesterase', 'activities', ',', 'there', 'is', 'little', 'knowledge', 'of', 'paraoxonase', '1', 'lactonase', 'activity', 'variations', 'and', 'attendant', 'mechanisms', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This is important considering further that the lactonase activity is the native activity of paraoxonase 1.	[('PMC8045895', 'A00006', 47, 56, 'lactonase'), ('PMC8045895', 'A00006', 92, 105, 'paraoxonase 1')]	['This', 'is', 'important', 'considering', 'further', 'that', 'the', 'lact', '##ona', '##se', 'activity', 'is', 'the', 'native', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', '.']	[0, 5, 8, 18, 30, 38, 43, 47, 51, 54, 57, 66, 69, 73, 80, 89, 92, 96, 99, 102, 104, 105]	[4, 7, 17, 29, 37, 42, 46, 51, 54, 56, 65, 68, 72, 79, 88, 91, 96, 99, 102, 103, 105, 106]	['This', 'is', 'important', 'considering', 'further', 'that', 'the', 'lactonase', 'activity', 'is', 'the', 'native', 'activity', 'of', 'paraoxonase', '1', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
We report here a multi-omics analysis of paraoxonase 1 lactonase activity.	[('PMC8045895', 'A00007', 41, 54, 'paraoxonase 1'), ('PMC8045895', 'A00007', 55, 64, 'lactonase')]	['We', 'report', 'here', 'a', 'multi', '-', 'om', '##ics', 'analysis', 'of', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 3, 10, 15, 17, 22, 23, 25, 29, 38, 41, 45, 48, 51, 53, 55, 59, 62, 65, 73]	[2, 9, 14, 16, 22, 23, 25, 28, 37, 40, 45, 48, 51, 52, 54, 59, 62, 64, 73, 74]	['We', 'report', 'here', 'a', 'multi', '-', 'omics', 'analysis', 'of', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O']
The influence of genetic variations, particularly of single nucleotide polymorphisms and epigenetic, proteomic, and lipidomic variations on paraoxonase 1 lactonase activity are reviewed.	[('PMC8045895', 'A00008', 140, 153, 'paraoxonase 1'), ('PMC8045895', 'A00008', 154, 163, 'lactonase')]	['The', 'influence', 'of', 'genetic', 'variations', ',', 'particularly', 'of', 'single', 'nucleotide', 'polymorphisms', 'and', 'epigenetic', ',', 'proteomic', ',', 'and', 'lipid', '##omic', 'variations', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'are', 'reviewed', '.']	[0, 4, 14, 17, 25, 35, 37, 50, 53, 60, 71, 85, 89, 99, 101, 110, 112, 116, 121, 126, 137, 140, 144, 147, 150, 152, 154, 158, 161, 164, 173, 177, 185]	[3, 13, 16, 24, 35, 36, 49, 52, 59, 70, 84, 88, 99, 100, 110, 111, 115, 121, 125, 136, 139, 144, 147, 150, 151, 153, 158, 161, 163, 172, 176, 185, 186]	['The', 'influence', 'of', 'genetic', 'variations', ',', 'particularly', 'of', 'single', 'nucleotide', 'polymorphisms', 'and', 'epigenetic', ',', 'proteomic', ',', 'and', 'lipidomic', 'variations', 'on', 'paraoxonase', '1', 'lactonase', 'activity', 'are', 'reviewed', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
In addition, the influence of various environmental, clinical, and demographic variables on paraoxonase 1 lactonase activity is discussed.	[('PMC8045895', 'A00009', 92, 105, 'paraoxonase 1'), ('PMC8045895', 'A00009', 106, 115, 'lactonase')]	['In', 'addition', ',', 'the', 'influence', 'of', 'various', 'environmental', ',', 'clinical', ',', 'and', 'demographic', 'variables', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'is', 'discussed', '.']	[0, 3, 11, 13, 17, 27, 30, 38, 51, 53, 61, 63, 67, 79, 89, 92, 96, 99, 102, 104, 106, 110, 113, 116, 125, 128, 137]	[2, 11, 12, 16, 26, 29, 37, 51, 52, 61, 62, 66, 78, 88, 91, 96, 99, 102, 103, 105, 110, 113, 115, 124, 127, 137, 138]	['In', 'addition', ',', 'the', 'influence', 'of', 'various', 'environmental', ',', 'clinical', ',', 'and', 'demographic', 'variables', 'on', 'paraoxonase', '1', 'lactonase', 'activity', 'is', 'discussed', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
Finally, we examine the associations between paraoxonase 1 lactonase activity and health states and common complex diseases such as atherosclerosis, dementias, obesity, and diabetes.	[('PMC8045895', 'A00010', 45, 58, 'paraoxonase 1'), ('PMC8045895', 'A00010', 59, 68, 'lactonase')]	['Finally', ',', 'we', 'examine', 'the', 'associations', 'between', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'and', 'health', 'states', 'and', 'common', 'complex', 'diseases', 'such', 'as', 'atherosclerosis', ',', 'dementia', '##s', ',', 'obesity', ',', 'and', 'diabetes', '.']	[0, 7, 9, 12, 20, 24, 37, 45, 49, 52, 55, 57, 59, 63, 66, 69, 78, 82, 89, 96, 100, 107, 115, 124, 129, 132, 147, 149, 157, 158, 160, 167, 169, 173, 181]	[7, 8, 11, 19, 23, 36, 44, 49, 52, 55, 56, 58, 63, 66, 68, 77, 81, 88, 95, 99, 106, 114, 123, 128, 131, 147, 148, 157, 158, 159, 167, 168, 172, 181, 182]	['Finally', ',', 'we', 'examine', 'the', 'associations', 'between', 'paraoxonase', '1', 'lactonase', 'activity', 'and', 'health', 'states', 'and', 'common', 'complex', 'diseases', 'such', 'as', 'atherosclerosis', ',', 'dementias', ',', 'obesity', ',', 'and', 'diabetes', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To the best of our knowledge, this is the first multi-omics analysis of paraoxonase 1 lactonase activity with an eye to future applications in basic life sciences and translational medicine and the nuances of critically interpreting paraoxonase 1 function with lactones as substrates.	[('PMC8045895', 'A00011', 72, 85, 'paraoxonase 1'), ('PMC8045895', 'A00011', 86, 95, 'lactonase'), ('PMC8045895', 'A00011', 233, 246, 'paraoxonase 1')]	['To', 'the', 'best', 'of', 'our', 'knowledge', ',', 'this', 'is', 'the', 'first', 'multi', '-', 'om', '##ics', 'analysis', 'of', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'with', 'an', 'eye', 'to', 'future', 'applications', 'in', 'basic', 'life', 'sciences', 'and', 'translational', 'medicine', 'and', 'the', 'nu', '##ances', 'of', 'critically', 'interpreting', 'para', '##oxo', '##nas', '##e', '1', 'function', 'with', 'lact', '##ones', 'as', 'substrates', '.']	[0, 3, 7, 12, 15, 19, 28, 30, 35, 38, 42, 48, 53, 54, 56, 60, 69, 72, 76, 79, 82, 84, 86, 90, 93, 96, 105, 110, 113, 117, 120, 127, 140, 143, 149, 154, 163, 167, 181, 190, 194, 198, 200, 206, 209, 220, 233, 237, 240, 243, 245, 247, 256, 261, 265, 270, 273, 283]	[2, 6, 11, 14, 18, 28, 29, 34, 37, 41, 47, 53, 54, 56, 59, 68, 71, 76, 79, 82, 83, 85, 90, 93, 95, 104, 109, 112, 116, 119, 126, 139, 142, 148, 153, 162, 166, 180, 189, 193, 197, 200, 205, 208, 219, 232, 237, 240, 243, 244, 246, 255, 260, 265, 269, 272, 283, 284]	['To', 'the', 'best', 'of', 'our', 'knowledge', ',', 'this', 'is', 'the', 'first', 'multi', '-', 'omics', 'analysis', 'of', 'paraoxonase', '1', 'lactonase', 'activity', 'with', 'an', 'eye', 'to', 'future', 'applications', 'in', 'basic', 'life', 'sciences', 'and', 'translational', 'medicine', 'and', 'the', 'nuances', 'of', 'critically', 'interpreting', 'paraoxonase', '1', 'function', 'with', 'lactones', 'as', 'substrates', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Numerous articles have been published in the last decades about serum paraoxonase 1 (paraoxonase 1), an enzyme found in different mammal species and other animals, including fishes, amphibians, and birds, and its association with various medical conditions in humans.	[('PMC8045895', 'I00000', 70, 83, 'paraoxonase 1'), ('PMC8045895', 'I00000', 85, 98, 'paraoxonase 1')]	['Numerous', 'articles', 'have', 'been', 'published', 'in', 'the', 'last', 'decades', 'about', 'serum', 'para', '##oxo', '##nas', '##e', '1', '(', 'para', '##oxo', '##nas', '##e', '1', ')', ',', 'an', 'enzyme', 'found', 'in', 'different', 'mamm', '##al', 'species', 'and', 'other', 'animals', ',', 'including', 'fishes', ',', 'amphib', '##ians', ',', 'and', 'birds', ',', 'and', 'its', 'association', 'with', 'various', 'medical', 'conditions', 'in', 'humans', '.']	[0, 9, 18, 23, 28, 38, 41, 45, 50, 58, 64, 70, 74, 77, 80, 82, 84, 85, 89, 92, 95, 97, 98, 99, 101, 104, 111, 117, 120, 130, 134, 137, 145, 149, 155, 162, 164, 174, 180, 182, 188, 192, 194, 198, 203, 205, 209, 213, 225, 230, 238, 246, 257, 260, 266]	[8, 17, 22, 27, 37, 40, 44, 49, 57, 63, 69, 74, 77, 80, 81, 83, 85, 89, 92, 95, 96, 98, 99, 100, 103, 110, 116, 119, 129, 134, 136, 144, 148, 154, 162, 163, 173, 180, 181, 188, 192, 193, 197, 203, 204, 208, 212, 224, 229, 237, 245, 256, 259, 266, 267]	['Numerous', 'articles', 'have', 'been', 'published', 'in', 'the', 'last', 'decades', 'about', 'serum', 'paraoxonase', '1', '(', 'paraoxonase', '1', ')', ',', 'an', 'enzyme', 'found', 'in', 'different', 'mammal', 'species', 'and', 'other', 'animals', ',', 'including', 'fishes', ',', 'amphibians', ',', 'and', 'birds', ',', 'and', 'its', 'association', 'with', 'various', 'medical', 'conditions', 'in', 'humans', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Various biological and environmental/social factors can influence paraoxonase 1 expression and activity.	[('PMC8045895', 'I00001', 66, 79, 'paraoxonase 1')]	['Various', 'biological', 'and', 'environmental', '/', 'social', 'factors', 'can', 'influence', 'para', '##oxo', '##nas', '##e', '1', 'expression', 'and', 'activity', '.']	[0, 8, 19, 23, 36, 37, 44, 52, 56, 66, 70, 73, 76, 78, 80, 91, 95, 103]	[7, 18, 22, 36, 37, 43, 51, 55, 65, 70, 73, 76, 77, 79, 90, 94, 103, 104]	['Various', 'biological', 'and', 'environmental', '/', 'social', 'factors', 'can', 'influence', 'paraoxonase', '1', 'expression', 'and', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
The association between paraoxonase 1 and medical conditions is usually investigated with three most common approaches: (1) genotyping of single nucleotide polymorphisms (SNPs), (2) quantification of enzyme in a biological sample, and (3) measurement of enzymatic activity of paraoxonase 1 as determined using different substrates (Ceron et al., 2014).	[('PMC8045895', 'I01000', 24, 37, 'paraoxonase 1'), ('PMC8045895', 'I01000', 276, 289, 'paraoxonase 1')]	['The', 'association', 'between', 'para', '##oxo', '##nas', '##e', '1', 'and', 'medical', 'conditions', 'is', 'usually', 'investigated', 'with', 'three', 'most', 'common', 'approaches', ':', '(', '1', ')', 'genotyping', 'of', 'single', 'nucleotide', 'polymorphisms', '(', 'SNPs', ')', ',', '(', '2', ')', 'quantification', 'of', 'enzyme', 'in', 'a', 'biological', 'sample', ',', 'and', '(', '3', ')', 'measurement', 'of', 'enzymatic', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', 'as', 'determined', 'using', 'different', 'substrates', '(', 'Cer', '##on', 'et', 'al', '.', ',', '2014', ')', '.']	[0, 4, 16, 24, 28, 31, 34, 36, 38, 42, 50, 61, 64, 72, 85, 90, 96, 101, 108, 118, 120, 121, 122, 124, 135, 138, 145, 156, 170, 171, 175, 176, 178, 179, 180, 182, 197, 200, 207, 210, 212, 223, 229, 231, 235, 236, 237, 239, 251, 254, 264, 273, 276, 280, 283, 286, 288, 290, 293, 304, 310, 320, 331, 332, 335, 338, 341, 343, 344, 346, 350, 351]	[3, 15, 23, 28, 31, 34, 35, 37, 41, 49, 60, 63, 71, 84, 89, 95, 100, 107, 118, 119, 121, 122, 123, 134, 137, 144, 155, 169, 171, 175, 176, 177, 179, 180, 181, 196, 199, 206, 209, 211, 222, 229, 230, 234, 236, 237, 238, 250, 253, 263, 272, 275, 280, 283, 286, 287, 289, 292, 303, 309, 319, 330, 332, 335, 337, 340, 343, 344, 345, 350, 351, 352]	['The', 'association', 'between', 'paraoxonase', '1', 'and', 'medical', 'conditions', 'is', 'usually', 'investigated', 'with', 'three', 'most', 'common', 'approaches', ':', '(', '1', ')', 'genotyping', 'of', 'single', 'nucleotide', 'polymorphisms', '(', 'SNPs', ')', ',', '(', '2', ')', 'quantification', 'of', 'enzyme', 'in', 'a', 'biological', 'sample', ',', 'and', '(', '3', ')', 'measurement', 'of', 'enzymatic', 'activity', 'of', 'paraoxonase', '1', 'as', 'determined', 'using', 'different', 'substrates', '(', 'Ceron', 'et', 'al', '.', ',', '2014', ')', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gene polymorphisms, enzyme quantity, and enzyme activity are different parameters that may or may not correlate with each other (Costa et al., 2005); however, it is less well understood that different enzymatic activities of paraoxonase 1 may or may not correlate with each other as well.	[('PMC8045895', 'I01001', 225, 238, 'paraoxonase 1')]	['Gene', 'polymorphisms', ',', 'enzyme', 'quantity', ',', 'and', 'enzyme', 'activity', 'are', 'different', 'parameters', 'that', 'may', 'or', 'may', 'not', 'correlate', 'with', 'each', 'other', '(', 'Costa', 'et', 'al', '.', ',', '2005', ')', ';', 'however', ',', 'it', 'is', 'less', 'well', 'understood', 'that', 'different', 'enzymatic', 'activities', 'of', 'para', '##oxo', '##nas', '##e', '1', 'may', 'or', 'may', 'not', 'correlate', 'with', 'each', 'other', 'as', 'well', '.']	[0, 5, 18, 20, 27, 35, 37, 41, 48, 57, 61, 71, 82, 87, 91, 94, 98, 102, 112, 117, 122, 128, 129, 135, 138, 140, 141, 143, 147, 148, 150, 157, 159, 162, 165, 170, 175, 186, 191, 201, 211, 222, 225, 229, 232, 235, 237, 239, 243, 246, 250, 254, 264, 269, 274, 280, 283, 287]	[4, 18, 19, 26, 35, 36, 40, 47, 56, 60, 70, 81, 86, 90, 93, 97, 101, 111, 116, 121, 127, 129, 134, 137, 140, 141, 142, 147, 148, 149, 157, 158, 161, 164, 169, 174, 185, 190, 200, 210, 221, 224, 229, 232, 235, 236, 238, 242, 245, 249, 253, 263, 268, 273, 279, 282, 287, 288]	['Gene', 'polymorphisms', ',', 'enzyme', 'quantity', ',', 'and', 'enzyme', 'activity', 'are', 'different', 'parameters', 'that', 'may', 'or', 'may', 'not', 'correlate', 'with', 'each', 'other', '(', 'Costa', 'et', 'al', '.', ',', '2005', ')', ';', 'however', ',', 'it', 'is', 'less', 'well', 'understood', 'that', 'different', 'enzymatic', 'activities', 'of', 'paraoxonase', '1', 'may', 'or', 'may', 'not', 'correlate', 'with', 'each', 'other', 'as', 'well', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The three main activities of paraoxonase 1 are aryldialkylphosphatase, more commonly known as paraoxonase activity, arylesterase and lactonase activity (Harel et al., 2004).	[('PMC8045895', 'I02000', 29, 42, 'paraoxonase 1'), ('PMC8045895', 'I02000', 47, 69, 'aryldialkylphosphatase'), ('PMC8045895', 'I02000', 94, 105, 'paraoxonase'), ('PMC8045895', 'I02000', 116, 128, 'arylesterase'), ('PMC8045895', 'I02000', 133, 142, 'lactonase')]	['The', 'three', 'main', 'activities', 'of', 'para', '##oxo', '##nas', '##e', '1', 'are', 'aryl', '##di', '##alk', '##yl', '##phosph', '##atase', ',', 'more', 'commonly', 'known', 'as', 'para', '##oxo', '##nas', '##e', 'activity', ',', 'aryl', '##ester', '##ase', 'and', 'lact', '##ona', '##se', 'activity', '(', 'Har', '##el', 'et', 'al', '.', ',', '2004', ')', '.']	[0, 4, 10, 15, 26, 29, 33, 36, 39, 41, 43, 47, 51, 53, 56, 58, 64, 69, 71, 76, 85, 91, 94, 98, 101, 104, 106, 114, 116, 120, 125, 129, 133, 137, 140, 143, 152, 153, 156, 159, 162, 164, 165, 167, 171, 172]	[3, 9, 14, 25, 28, 33, 36, 39, 40, 42, 46, 51, 53, 56, 58, 64, 69, 70, 75, 84, 90, 93, 98, 101, 104, 105, 114, 115, 120, 125, 128, 132, 137, 140, 142, 151, 153, 156, 158, 161, 164, 165, 166, 171, 172, 173]	['The', 'three', 'main', 'activities', 'of', 'paraoxonase', '1', 'are', 'aryldialkylphosphatase', ',', 'more', 'commonly', 'known', 'as', 'paraoxonase', 'activity', ',', 'arylesterase', 'and', 'lactonase', 'activity', '(', 'Harel', 'et', 'al', '.', ',', '2004', ')', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 6, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Each of these can be investigated with several different artificial substrates (Khersonsky and Tawfik, 2005); however, the exact physiological substrates of paraoxonase 1 are poorly understood.	[('PMC8045895', 'I02001', 157, 170, 'paraoxonase 1')]	['Each', 'of', 'these', 'can', 'be', 'investigated', 'with', 'several', 'different', 'artificial', 'substrates', '(', 'Kh', '##erson', '##sky', 'and', 'Ta', '##w', '##fi', '##k', ',', '2005', ')', ';', 'however', ',', 'the', 'exact', 'physiological', 'substrates', 'of', 'para', '##oxo', '##nas', '##e', '1', 'are', 'poorly', 'understood', '.']	[0, 5, 8, 14, 18, 21, 34, 39, 47, 57, 68, 79, 80, 82, 87, 91, 95, 97, 98, 100, 101, 103, 107, 108, 110, 117, 119, 123, 129, 143, 154, 157, 161, 164, 167, 169, 171, 175, 182, 192]	[4, 7, 13, 17, 20, 33, 38, 46, 56, 67, 78, 80, 82, 87, 90, 94, 97, 98, 100, 101, 102, 107, 108, 109, 117, 118, 122, 128, 142, 153, 156, 161, 164, 167, 168, 170, 174, 181, 192, 193]	['Each', 'of', 'these', 'can', 'be', 'investigated', 'with', 'several', 'different', 'artificial', 'substrates', '(', 'Khersonsky', 'and', 'Tawfik', ',', '2005', ')', ';', 'however', ',', 'the', 'exact', 'physiological', 'substrates', 'of', 'paraoxonase', '1', 'are', 'poorly', 'understood', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
A possible candidate for a physiological substrate is homocysteine thiolactone, which is a known risk factor in atherosclerotic vascular diseases; however, paraoxonase 1 has rather low thiolactonase activity (Aharoni et al., 2004).	[('PMC8045895', 'I02003', 156, 169, 'paraoxonase 1')]	['A', 'possible', 'candidate', 'for', 'a', 'physiological', 'substrate', 'is', 'hom', '##ocysteine', 'thiol', '##act', '##one', ',', 'which', 'is', 'a', 'known', 'risk', 'factor', 'in', 'atherosclerotic', 'vascular', 'diseases', ';', 'however', ',', 'para', '##oxo', '##nas', '##e', '1', 'has', 'rather', 'low', 'thiol', '##act', '##ona', '##se', 'activity', '(', 'Ah', '##aron', '##i', 'et', 'al', '.', ',', '2004', ')', '.']	[0, 2, 11, 21, 25, 27, 41, 51, 54, 57, 67, 72, 75, 78, 80, 86, 89, 91, 97, 102, 109, 112, 128, 137, 145, 147, 154, 156, 160, 163, 166, 168, 170, 174, 181, 185, 190, 193, 196, 199, 208, 209, 211, 215, 217, 220, 222, 223, 225, 229, 230]	[1, 10, 20, 24, 26, 40, 50, 53, 57, 66, 72, 75, 78, 79, 85, 88, 90, 96, 101, 108, 111, 127, 136, 145, 146, 154, 155, 160, 163, 166, 167, 169, 173, 180, 184, 190, 193, 196, 198, 207, 209, 211, 215, 216, 219, 222, 223, 224, 229, 230, 231]	['A', 'possible', 'candidate', 'for', 'a', 'physiological', 'substrate', 'is', 'homocysteine', 'thiolactone', ',', 'which', 'is', 'a', 'known', 'risk', 'factor', 'in', 'atherosclerotic', 'vascular', 'diseases', ';', 'however', ',', 'paraoxonase', '1', 'has', 'rather', 'low', 'thiolactonase', 'activity', '(', 'Aharoni', 'et', 'al', '.', ',', '2004', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Paraoxonase activity is unlikely to be a native activity of paraoxonase 1, as organophosphates are uncommon in nature (Khersonsky and Tawfik, 2005; Metcalf and Bruno, 2016).	[('PMC8045895', 'I03000', 0, 11, 'Paraoxonase'), ('PMC8045895', 'I03000', 60, 73, 'paraoxonase 1')]	['Par', '##ao', '##x', '##ona', '##se', 'activity', 'is', 'unlikely', 'to', 'be', 'a', 'native', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', ',', 'as', 'organ', '##ophosphate', '##s', 'are', 'uncommon', 'in', 'nature', '(', 'Kh', '##erson', '##sky', 'and', 'Ta', '##w', '##fi', '##k', ',', '2005', ';', 'Met', '##cal', '##f', 'and', 'Brun', '##o', ',', '2016', ')', '.']	[0, 3, 5, 6, 9, 12, 21, 24, 33, 36, 39, 41, 48, 57, 60, 64, 67, 70, 72, 73, 75, 78, 83, 93, 95, 99, 108, 111, 118, 119, 121, 126, 130, 134, 136, 137, 139, 140, 142, 146, 148, 151, 154, 156, 160, 164, 165, 167, 171, 172]	[3, 5, 6, 9, 11, 20, 23, 32, 35, 38, 40, 47, 56, 59, 64, 67, 70, 71, 73, 74, 77, 83, 93, 94, 98, 107, 110, 117, 119, 121, 126, 129, 133, 136, 137, 139, 140, 141, 146, 147, 151, 154, 155, 159, 164, 165, 166, 171, 172, 173]	['Paraoxonase', 'activity', 'is', 'unlikely', 'to', 'be', 'a', 'native', 'activity', 'of', 'paraoxonase', '1', ',', 'as', 'organophosphates', 'are', 'uncommon', 'in', 'nature', '(', 'Khersonsky', 'and', 'Tawfik', ',', '2005', ';', 'Metcalf', 'and', 'Bruno', ',', '2016', ')', '.']	[5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Structure-reactivity studies suggest that the primary function of paraoxonase 1 in terms of evolutionary development is lactonase activity (Khersonsky and Tawfik, 2005).	[('PMC8045895', 'I03001', 66, 79, 'paraoxonase 1'), ('PMC8045895', 'I03001', 120, 129, 'lactonase')]	['Structure', '-', 'reactivity', 'studies', 'suggest', 'that', 'the', 'primary', 'function', 'of', 'para', '##oxo', '##nas', '##e', '1', 'in', 'terms', 'of', 'evolutionary', 'development', 'is', 'lact', '##ona', '##se', 'activity', '(', 'Kh', '##erson', '##sky', 'and', 'Ta', '##w', '##fi', '##k', ',', '2005', ')', '.']	[0, 9, 10, 21, 29, 37, 42, 46, 54, 63, 66, 70, 73, 76, 78, 80, 83, 89, 92, 105, 117, 120, 124, 127, 130, 139, 140, 142, 147, 151, 155, 157, 158, 160, 161, 163, 167, 168]	[9, 10, 20, 28, 36, 41, 45, 53, 62, 65, 70, 73, 76, 77, 79, 82, 88, 91, 104, 116, 119, 124, 127, 129, 138, 140, 142, 147, 150, 154, 157, 158, 160, 161, 162, 167, 168, 169]	['Structure', '-', 'reactivity', 'studies', 'suggest', 'that', 'the', 'primary', 'function', 'of', 'paraoxonase', '1', 'in', 'terms', 'of', 'evolutionary', 'development', 'is', 'lactonase', 'activity', '(', 'Khersonsky', 'and', 'Tawfik', ',', '2005', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Especially paraoxonase activity is often poorly correlated with the other two enzymatic activities (Gugliucci et al., 2015; Kowalska et al., 2018; Martinelli et al., 2013; Romani et al., 2009; Rosenblat et al., 2006).	[('PMC8045895', 'I03002', 11, 22, 'paraoxonase')]	['Especially', 'para', '##oxo', '##nas', '##e', 'activity', 'is', 'often', 'poorly', 'correlated', 'with', 'the', 'other', 'two', 'enzymatic', 'activities', '(', 'Gu', '##gl', '##iu', '##cc', '##i', 'et', 'al', '.', ',', '2015', ';', 'Ko', '##wal', '##ska', 'et', 'al', '.', ',', '2018', ';', 'Martin', '##elli', 'et', 'al', '.', ',', '2013', ';', 'Roman', '##i', 'et', 'al', '.', ',', '2009', ';', 'Rosen', '##bl', '##at', 'et', 'al', '.', ',', '2006', ')', '.']	[0, 11, 15, 18, 21, 23, 32, 35, 41, 48, 59, 64, 68, 74, 78, 88, 99, 100, 102, 104, 106, 108, 110, 113, 115, 116, 118, 122, 124, 126, 129, 133, 136, 138, 139, 141, 145, 147, 153, 158, 161, 163, 164, 166, 170, 172, 177, 179, 182, 184, 185, 187, 191, 193, 198, 200, 203, 206, 208, 209, 211, 215, 216]	[10, 15, 18, 21, 22, 31, 34, 40, 47, 58, 63, 67, 73, 77, 87, 98, 100, 102, 104, 106, 108, 109, 112, 115, 116, 117, 122, 123, 126, 129, 132, 135, 138, 139, 140, 145, 146, 153, 157, 160, 163, 164, 165, 170, 171, 177, 178, 181, 184, 185, 186, 191, 192, 198, 200, 202, 205, 208, 209, 210, 215, 216, 217]	['Especially', 'paraoxonase', 'activity', 'is', 'often', 'poorly', 'correlated', 'with', 'the', 'other', 'two', 'enzymatic', 'activities', '(', 'Gugliucci', 'et', 'al', '.', ',', '2015', ';', 'Kowalska', 'et', 'al', '.', ',', '2018', ';', 'Martinelli', 'et', 'al', '.', ',', '2013', ';', 'Romani', 'et', 'al', '.', ',', '2009', ';', 'Rosenblat', 'et', 'al', '.', ',', '2006', ')', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thus, the experimental results of paraoxonase 1 can be grouped by enzymatic activity and those research articles in which the same activity has been investigated, preferably with the same substrate, can be compared.	[('PMC8045895', 'I03003', 34, 47, 'paraoxonase 1')]	['Thus', ',', 'the', 'experimental', 'results', 'of', 'para', '##oxo', '##nas', '##e', '1', 'can', 'be', 'grouped', 'by', 'enzymatic', 'activity', 'and', 'those', 'research', 'articles', 'in', 'which', 'the', 'same', 'activity', 'has', 'been', 'investigated', ',', 'prefer', '##ably', 'with', 'the', 'same', 'substrate', ',', 'can', 'be', 'compared', '.']	[0, 4, 6, 10, 23, 31, 34, 38, 41, 44, 46, 48, 52, 55, 63, 66, 76, 85, 89, 95, 104, 113, 116, 122, 126, 131, 140, 144, 149, 161, 163, 169, 174, 179, 183, 188, 197, 199, 203, 206, 214]	[4, 5, 9, 22, 30, 33, 38, 41, 44, 45, 47, 51, 54, 62, 65, 75, 84, 88, 94, 103, 112, 115, 121, 125, 130, 139, 143, 148, 161, 162, 169, 173, 178, 182, 187, 197, 198, 202, 205, 214, 215]	['Thus', ',', 'the', 'experimental', 'results', 'of', 'paraoxonase', '1', 'can', 'be', 'grouped', 'by', 'enzymatic', 'activity', 'and', 'those', 'research', 'articles', 'in', 'which', 'the', 'same', 'activity', 'has', 'been', 'investigated', ',', 'preferably', 'with', 'the', 'same', 'substrate', ',', 'can', 'be', 'compared', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An extensive review on paraoxonase and arylesterase activities has already been published (Dardiotis et al., 2019).	[('PMC8045895', 'I04000', 23, 34, 'paraoxonase'), ('PMC8045895', 'I04000', 39, 51, 'arylesterase')]	['An', 'extensive', 'review', 'on', 'para', '##oxo', '##nas', '##e', 'and', 'aryl', '##ester', '##ase', 'activities', 'has', 'already', 'been', 'published', '(', 'Dar', '##di', '##oti', '##s', 'et', 'al', '.', ',', '201', '##9', ')', '.']	[0, 3, 13, 20, 23, 27, 30, 33, 35, 39, 43, 48, 52, 63, 67, 75, 80, 90, 91, 94, 96, 99, 101, 104, 106, 107, 109, 112, 113, 114]	[2, 12, 19, 22, 27, 30, 33, 34, 38, 43, 48, 51, 62, 66, 74, 79, 89, 91, 94, 96, 99, 100, 103, 106, 107, 108, 112, 113, 114, 115]	['An', 'extensive', 'review', 'on', 'paraoxonase', 'and', 'arylesterase', 'activities', 'has', 'already', 'been', 'published', '(', 'Dardiotis', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the literature lacks analyses on paraoxonase 1's native (lactonase) activity.	[('PMC8045895', 'I04001', 42, 55, 'paraoxonase 1'), ('PMC8045895', 'I04001', 66, 75, 'lactonase')]	"['However', ',', 'the', 'literature', 'lacks', 'analyses', 'on', 'para', '##oxo', '##nas', '##e', '1', ""'"", 's', 'native', '(', 'lact', '##ona', '##se', ')', 'activity', '.']"	[0, 7, 9, 13, 24, 30, 39, 42, 46, 49, 52, 54, 55, 56, 58, 65, 66, 70, 73, 75, 77, 85]	[7, 8, 12, 23, 29, 38, 41, 46, 49, 52, 53, 55, 56, 57, 64, 66, 70, 73, 75, 76, 85, 86]	"['However', ',', 'the', 'literature', 'lacks', 'analyses', 'on', 'paraoxonase', ""1's"", 'native', '(', 'lactonase', ')', 'activity', '.']"	[1, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O']
Although different research groups have focused on SNP variation in the paraoxonase 1 gene and its association with enzymatic activity (Dardiotis et al., 2019; Darney et al., 2020), factors besides genotype may also influence the enzymatic activity of paraoxonase 1.	[('PMC8045895', 'I04002', 72, 85, 'paraoxonase 1'), ('PMC8045895', 'I04002', 252, 265, 'paraoxonase 1')]	['Although', 'different', 'research', 'groups', 'have', 'focused', 'on', 'SNP', 'variation', 'in', 'the', 'para', '##oxo', '##nas', '##e', '1', 'gene', 'and', 'its', 'association', 'with', 'enzymatic', 'activity', '(', 'Dar', '##di', '##oti', '##s', 'et', 'al', '.', ',', '201', '##9', ';', 'Dar', '##ney', 'et', 'al', '.', ',', '202', '##0', ')', ',', 'factors', 'besides', 'genotype', 'may', 'also', 'influence', 'the', 'enzymatic', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', '.']	[0, 9, 19, 28, 35, 40, 48, 51, 55, 65, 68, 72, 76, 79, 82, 84, 86, 91, 95, 99, 111, 116, 126, 135, 136, 139, 141, 144, 146, 149, 151, 152, 154, 157, 158, 160, 163, 167, 170, 172, 173, 175, 178, 179, 180, 182, 190, 198, 207, 211, 216, 226, 230, 240, 249, 252, 256, 259, 262, 264, 265]	[8, 18, 27, 34, 39, 47, 50, 54, 64, 67, 71, 76, 79, 82, 83, 85, 90, 94, 98, 110, 115, 125, 134, 136, 139, 141, 144, 145, 148, 151, 152, 153, 157, 158, 159, 163, 166, 169, 172, 173, 174, 178, 179, 180, 181, 189, 197, 206, 210, 215, 225, 229, 239, 248, 251, 256, 259, 262, 263, 265, 266]	['Although', 'different', 'research', 'groups', 'have', 'focused', 'on', 'SNP', 'variation', 'in', 'the', 'paraoxonase', '1', 'gene', 'and', 'its', 'association', 'with', 'enzymatic', 'activity', '(', 'Dardiotis', 'et', 'al', '.', ',', '2019', ';', 'Darney', 'et', 'al', '.', ',', '2020', ')', ',', 'factors', 'besides', 'genotype', 'may', 'also', 'influence', 'the', 'enzymatic', 'activity', 'of', 'paraoxonase', '1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
Hence, in this study, we examine different -omics levels that have been associated specifically with the lactonase activity of paraoxonase 1.	[('PMC8045895', 'I04003', 105, 114, 'lactonase'), ('PMC8045895', 'I04003', 127, 140, 'paraoxonase 1')]	['Hence', ',', 'in', 'this', 'study', ',', 'we', 'examine', 'different', '-', 'om', '##ics', 'levels', 'that', 'have', 'been', 'associated', 'specifically', 'with', 'the', 'lact', '##ona', '##se', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', '.']	[0, 5, 7, 10, 15, 20, 22, 25, 33, 43, 44, 46, 50, 57, 62, 67, 72, 83, 96, 101, 105, 109, 112, 115, 124, 127, 131, 134, 137, 139, 140]	[5, 6, 9, 14, 20, 21, 24, 32, 42, 44, 46, 49, 56, 61, 66, 71, 82, 95, 100, 104, 109, 112, 114, 123, 126, 131, 134, 137, 138, 140, 141]	['Hence', ',', 'in', 'this', 'study', ',', 'we', 'examine', 'different', '-', 'omics', 'levels', 'that', 'have', 'been', 'associated', 'specifically', 'with', 'the', 'lactonase', 'activity', 'of', 'paraoxonase', '1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
This article is the first to specifically address and review the lactonase activity of paraoxonase 1.	[('PMC8045895', 'I04004', 65, 74, 'lactonase'), ('PMC8045895', 'I04004', 87, 100, 'paraoxonase 1')]	['This', 'article', 'is', 'the', 'first', 'to', 'specifically', 'address', 'and', 'review', 'the', 'lact', '##ona', '##se', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', '.']	[0, 5, 13, 16, 20, 26, 29, 42, 50, 54, 61, 65, 69, 72, 75, 84, 87, 91, 94, 97, 99, 100]	[4, 12, 15, 19, 25, 28, 41, 49, 53, 60, 64, 69, 72, 74, 83, 86, 91, 94, 97, 98, 100, 101]	['This', 'article', 'is', 'the', 'first', 'to', 'specifically', 'address', 'and', 'review', 'the', 'lactonase', 'activity', 'of', 'paraoxonase', '1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
In this analysis, we also examine and synthesize the associations between various medical conditions and the lactonase activity of paraoxonase 1.	[('PMC8045895', 'I05000', 109, 118, 'lactonase'), ('PMC8045895', 'I05000', 131, 144, 'paraoxonase 1')]	['In', 'this', 'analysis', ',', 'we', 'also', 'examine', 'and', 'synthesize', 'the', 'associations', 'between', 'various', 'medical', 'conditions', 'and', 'the', 'lact', '##ona', '##se', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', '.']	[0, 3, 8, 16, 18, 21, 26, 34, 38, 49, 53, 66, 74, 82, 90, 101, 105, 109, 113, 116, 119, 128, 131, 135, 138, 141, 143, 144]	[2, 7, 16, 17, 20, 25, 33, 37, 48, 52, 65, 73, 81, 89, 100, 104, 108, 113, 116, 118, 127, 130, 135, 138, 141, 142, 144, 145]	['In', 'this', 'analysis', ',', 'we', 'also', 'examine', 'and', 'synthesize', 'the', 'associations', 'between', 'various', 'medical', 'conditions', 'and', 'the', 'lactonase', 'activity', 'of', 'paraoxonase', '1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
As paraoxonase 1 has antioxidative activity, its lactonase activity may be correlated with oxidative stress- and inflammation-related diseases, primarily those associated with aging.	[('PMC8045895', 'I05001', 3, 16, 'paraoxonase 1'), ('PMC8045895', 'I05001', 49, 58, 'lactonase')]	['As', 'para', '##oxo', '##nas', '##e', '1', 'has', 'antioxid', '##ative', 'activity', ',', 'its', 'lact', '##ona', '##se', 'activity', 'may', 'be', 'correlated', 'with', 'oxidative', 'stress', '-', 'and', 'inflammation', '-', 'related', 'diseases', ',', 'primarily', 'those', 'associated', 'with', 'aging', '.']	[0, 3, 7, 10, 13, 15, 17, 21, 29, 35, 43, 45, 49, 53, 56, 59, 68, 72, 75, 86, 91, 101, 107, 109, 113, 125, 126, 134, 142, 144, 154, 160, 171, 176, 181]	[2, 7, 10, 13, 14, 16, 20, 29, 34, 43, 44, 48, 53, 56, 58, 67, 71, 74, 85, 90, 100, 107, 108, 112, 125, 126, 133, 142, 143, 153, 159, 170, 175, 181, 182]	['As', 'paraoxonase', '1', 'has', 'antioxidative', 'activity', ',', 'its', 'lactonase', 'activity', 'may', 'be', 'correlated', 'with', 'oxidative', 'stress-', 'and', 'inflammation', '-', 'related', 'diseases', ',', 'primarily', 'those', 'associated', 'with', 'aging', '.']	[1, 4, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Indeed paraoxonase 1 activity is shown to be associated with neurodegenerative and cardiovascular diseases (CVDs), as well as diabetes, cancer, and other disorders (Shunmoogam et al., 2018).	[('PMC8045895', 'I05002', 7, 20, 'paraoxonase 1')]	['Indeed', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'is', 'shown', 'to', 'be', 'associated', 'with', 'neurode', '##generative', 'and', 'cardiovascular', 'diseases', '(', 'CVD', '##s', ')', ',', 'as', 'well', 'as', 'diabetes', ',', 'cancer', ',', 'and', 'other', 'disorders', '(', 'Sh', '##un', '##mo', '##oga', '##m', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 7, 11, 14, 17, 19, 21, 30, 33, 39, 42, 45, 56, 61, 68, 79, 83, 98, 107, 108, 111, 112, 113, 115, 118, 123, 126, 134, 136, 142, 144, 148, 154, 164, 165, 167, 169, 171, 174, 176, 179, 181, 182, 184, 188, 189]	[6, 11, 14, 17, 18, 20, 29, 32, 38, 41, 44, 55, 60, 68, 78, 82, 97, 106, 108, 111, 112, 113, 114, 117, 122, 125, 134, 135, 142, 143, 147, 153, 163, 165, 167, 169, 171, 174, 175, 178, 181, 182, 183, 188, 189, 190]	['Indeed', 'paraoxonase', '1', 'activity', 'is', 'shown', 'to', 'be', 'associated', 'with', 'neurodegenerative', 'and', 'cardiovascular', 'diseases', '(', 'CVDs', ')', ',', 'as', 'well', 'as', 'diabetes', ',', 'cancer', ',', 'and', 'other', 'disorders', '(', 'Shunmoogam', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Most of the research on paraoxonase 1 lactonase activity has been performed on humans; however, some research groups also investigated lactonase activity in mice, rats, and cows (Farid et al., 2013;	[('PMC8045895', 'I06000', 24, 37, 'paraoxonase 1'), ('PMC8045895', 'I06000', 38, 47, 'lactonase'), ('PMC8045895', 'I06000', 135, 144, 'lactonase')]	['Most', 'of', 'the', 'research', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'has', 'been', 'performed', 'on', 'humans', ';', 'however', ',', 'some', 'research', 'groups', 'also', 'investigated', 'lact', '##ona', '##se', 'activity', 'in', 'mice', ',', 'rats', ',', 'and', 'cows', '(', 'Far', '##id', 'et', 'al', '.', ',', '2013', ';']	[0, 5, 8, 12, 21, 24, 28, 31, 34, 36, 38, 42, 45, 48, 57, 61, 66, 76, 79, 85, 87, 94, 96, 101, 110, 117, 122, 135, 139, 142, 145, 154, 157, 161, 163, 167, 169, 173, 178, 179, 182, 185, 188, 190, 191, 193, 197]	[4, 7, 11, 20, 23, 28, 31, 34, 35, 37, 42, 45, 47, 56, 60, 65, 75, 78, 85, 86, 94, 95, 100, 109, 116, 121, 134, 139, 142, 144, 153, 156, 161, 162, 167, 168, 172, 177, 179, 182, 184, 187, 190, 191, 192, 197, 198]	['Most', 'of', 'the', 'research', 'on', 'paraoxonase', '1', 'lactonase', 'activity', 'has', 'been', 'performed', 'on', 'humans', ';', 'however', ',', 'some', 'research', 'groups', 'also', 'investigated', 'lactonase', 'activity', 'in', 'mice', ',', 'rats', ',', 'and', 'cows', '(', 'Farid', 'et', 'al', '.', ',', '2013', ';']	[1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A number of studies also focused on recombinant variants of paraoxonase 1 (rePON1).	[('PMC8045895', 'I06002', 60, 73, 'paraoxonase 1')]	['A', 'number', 'of', 'studies', 'also', 'focused', 'on', 'recombinant', 'variants', 'of', 'para', '##oxo', '##nas', '##e', '1', '(', 're', '##PO', '##N', '##1', ')', '.']	[0, 2, 9, 12, 20, 25, 33, 36, 48, 57, 60, 64, 67, 70, 72, 74, 75, 77, 79, 80, 81, 82]	[1, 8, 11, 19, 24, 32, 35, 47, 56, 59, 64, 67, 70, 71, 73, 75, 77, 79, 80, 81, 82, 83]	['A', 'number', 'of', 'studies', 'also', 'focused', 'on', 'recombinant', 'variants', 'of', 'paraoxonase', '1', '(', 'rePON1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Because rePON1 variants, unlike native paraoxonase 1, are water soluble, they are preferred instead of native paraoxonase 1 for the investigation of general properties of paraoxonases and for biotechnological applications.	[('PMC8045895', 'I06003', 39, 52, 'paraoxonase 1'), ('PMC8045895', 'I06003', 110, 123, 'paraoxonase 1')]	['Because', 're', '##PO', '##N', '##1', 'variants', ',', 'unlike', 'native', 'para', '##oxo', '##nas', '##e', '1', ',', 'are', 'water', 'soluble', ',', 'they', 'are', 'preferred', 'instead', 'of', 'native', 'para', '##oxo', '##nas', '##e', '1', 'for', 'the', 'investigation', 'of', 'general', 'properties', 'of', 'para', '##oxo', '##nas', '##es', 'and', 'for', 'bio', '##techn', '##ological', 'applications', '.']	[0, 8, 10, 12, 13, 15, 23, 25, 32, 39, 43, 46, 49, 51, 52, 54, 58, 64, 71, 73, 78, 82, 92, 100, 103, 110, 114, 117, 120, 122, 124, 128, 132, 146, 149, 157, 168, 171, 175, 178, 181, 184, 188, 192, 195, 200, 209, 221]	[7, 10, 12, 13, 14, 23, 24, 31, 38, 43, 46, 49, 50, 52, 53, 57, 63, 71, 72, 77, 81, 91, 99, 102, 109, 114, 117, 120, 121, 123, 127, 131, 145, 148, 156, 167, 170, 175, 178, 181, 183, 187, 191, 195, 200, 208, 221, 222]	['Because', 'rePON1', 'variants', ',', 'unlike', 'native', 'paraoxonase', '1', ',', 'are', 'water', 'soluble', ',', 'they', 'are', 'preferred', 'instead', 'of', 'native', 'paraoxonase', '1', 'for', 'the', 'investigation', 'of', 'general', 'properties', 'of', 'paraoxonases', 'and', 'for', 'biotechnological', 'applications', '.']	[1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, these investigations are not included in this study because they are of limited relevance to this article's focus on biological influences of paraoxonase 1 activity, and on paraoxonase 1's influence on the phenome in turn.	[('PMC8045895', 'I06004', 151, 164, 'paraoxonase 1'), ('PMC8045895', 'I06004', 182, 195, 'paraoxonase 1')]	"['However', ',', 'these', 'investigations', 'are', 'not', 'included', 'in', 'this', 'study', 'because', 'they', 'are', 'of', 'limited', 'relevance', 'to', 'this', 'article', ""'"", 's', 'focus', 'on', 'biological', 'influences', 'of', 'para', '##oxo', '##nas', '##e', '1', 'activity', ',', 'and', 'on', 'para', '##oxo', '##nas', '##e', '1', ""'"", 's', 'influence', 'on', 'the', 'phen', '##ome', 'in', 'turn', '.']"	[0, 7, 9, 15, 30, 34, 38, 47, 50, 55, 61, 69, 74, 78, 81, 89, 99, 102, 107, 114, 115, 117, 123, 126, 137, 148, 151, 155, 158, 161, 163, 165, 173, 175, 179, 182, 186, 189, 192, 194, 195, 196, 198, 208, 211, 215, 219, 223, 226, 230]	[7, 8, 14, 29, 33, 37, 46, 49, 54, 60, 68, 73, 77, 80, 88, 98, 101, 106, 114, 115, 116, 122, 125, 136, 147, 150, 155, 158, 161, 162, 164, 173, 174, 178, 181, 186, 189, 192, 193, 195, 196, 197, 207, 210, 214, 219, 222, 225, 230, 231]	"['However', ',', 'these', 'investigations', 'are', 'not', 'included', 'in', 'this', 'study', 'because', 'they', 'are', 'of', 'limited', 'relevance', 'to', 'this', ""article's"", 'focus', 'on', 'biological', 'influences', 'of', 'paraoxonase', '1', 'activity', ',', 'and', 'on', 'paraoxonase', ""1's"", 'influence', 'on', 'the', 'phenome', 'in', 'turn', '.']"	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The two most common lactone substrates used on paraoxonase 1 are dihydrocoumarin (DHC) and thiobutyl butyrolactone (TBBL), which have been cited in at least 100 research articles.	[('PMC8045895', 'I07000', 47, 60, 'paraoxonase 1')]	['The', 'two', 'most', 'common', 'lact', '##one', 'substrates', 'used', 'on', 'para', '##oxo', '##nas', '##e', '1', 'are', 'di', '##hydro', '##co', '##umar', '##in', '(', 'DH', '##C', ')', 'and', 'thi', '##obut', '##yl', 'but', '##yr', '##ola', '##ct', '##one', '(', 'TB', '##BL', ')', ',', 'which', 'have', 'been', 'cited', 'in', 'at', 'least', '100', 'research', 'articles', '.']	[0, 4, 8, 13, 20, 24, 28, 39, 44, 47, 51, 54, 57, 59, 61, 65, 67, 72, 74, 78, 81, 82, 84, 85, 87, 91, 94, 98, 101, 104, 106, 109, 111, 115, 116, 118, 120, 121, 123, 129, 134, 139, 145, 148, 151, 157, 161, 170, 178]	[3, 7, 12, 19, 24, 27, 38, 43, 46, 51, 54, 57, 58, 60, 64, 67, 72, 74, 78, 80, 82, 84, 85, 86, 90, 94, 98, 100, 104, 106, 109, 111, 114, 116, 118, 120, 121, 122, 128, 133, 138, 144, 147, 150, 156, 160, 169, 178, 179]	['The', 'two', 'most', 'common', 'lactone', 'substrates', 'used', 'on', 'paraoxonase', '1', 'are', 'dihydrocoumarin', '(', 'DHC', ')', 'and', 'thiobutyl', 'butyrolactone', '(', 'TBBL', ')', ',', 'which', 'have', 'been', 'cited', 'in', 'at', 'least', '100', 'research', 'articles', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 5, 1, 2, 1, 1, 3, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Some of the factors discussed in this article (e.g., variations in the promoter sequence of the paraoxonase 1 gene) are likely to primarily affect the amount of paraoxonase 1 that is present in an organism, whereas others (e.g., the presence of drugs interacting with PON1 in the bloodstream) are likely to primarily influence PON1's affinity for its substrates.	[('PMC8045895', 'I08001', 96, 109, 'paraoxonase 1'), ('PMC8045895', 'I08001', 161, 174, 'paraoxonase 1')]	"['Some', 'of', 'the', 'factors', 'discussed', 'in', 'this', 'article', '(', 'e', '.', 'g', '.', ',', 'variations', 'in', 'the', 'promoter', 'sequence', 'of', 'the', 'para', '##oxo', '##nas', '##e', '1', 'gene', ')', 'are', 'likely', 'to', 'primarily', 'affect', 'the', 'amount', 'of', 'para', '##oxo', '##nas', '##e', '1', 'that', 'is', 'present', 'in', 'an', 'organism', ',', 'whereas', 'others', '(', 'e', '.', 'g', '.', ',', 'the', 'presence', 'of', 'drugs', 'interacting', 'with', 'PO', '##N', '##1', 'in', 'the', 'blood', '##stream', ')', 'are', 'likely', 'to', 'primarily', 'influence', 'PO', '##N', '##1', ""'"", 's', 'affinity', 'for', 'its', 'substrates', '.']"	[0, 5, 8, 12, 20, 30, 33, 38, 46, 47, 48, 49, 50, 51, 53, 64, 67, 71, 80, 89, 92, 96, 100, 103, 106, 108, 110, 114, 116, 120, 127, 130, 140, 147, 151, 158, 161, 165, 168, 171, 173, 175, 180, 183, 191, 194, 197, 205, 207, 215, 222, 223, 224, 225, 226, 227, 229, 233, 242, 245, 251, 263, 268, 270, 271, 273, 276, 280, 285, 291, 293, 297, 304, 307, 317, 327, 329, 330, 331, 332, 334, 343, 347, 351, 361]	[4, 7, 11, 19, 29, 32, 37, 45, 47, 48, 49, 50, 51, 52, 63, 66, 70, 79, 88, 91, 95, 100, 103, 106, 107, 109, 114, 115, 119, 126, 129, 139, 146, 150, 157, 160, 165, 168, 171, 172, 174, 179, 182, 190, 193, 196, 205, 206, 214, 221, 223, 224, 225, 226, 227, 228, 232, 241, 244, 250, 262, 267, 270, 271, 272, 275, 279, 285, 291, 292, 296, 303, 306, 316, 326, 329, 330, 331, 332, 333, 342, 346, 350, 361, 362]	"['Some', 'of', 'the', 'factors', 'discussed', 'in', 'this', 'article', '(', 'e.g', '.', ',', 'variations', 'in', 'the', 'promoter', 'sequence', 'of', 'the', 'paraoxonase', '1', 'gene', ')', 'are', 'likely', 'to', 'primarily', 'affect', 'the', 'amount', 'of', 'paraoxonase', '1', 'that', 'is', 'present', 'in', 'an', 'organism', ',', 'whereas', 'others', '(', 'e.g', '.', ',', 'the', 'presence', 'of', 'drugs', 'interacting', 'with', 'PON1', 'in', 'the', 'bloodstream', ')', 'are', 'likely', 'to', 'primarily', 'influence', ""PON1's"", 'affinity', 'for', 'its', 'substrates', '.']"	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Because almost all the studies cited in this article used specific activity as the only measure of paraoxonase 1 lactonase activity, it is usually not possible to disentangle these two components.	[('PMC8045895', 'I08002', 99, 112, 'paraoxonase 1'), ('PMC8045895', 'I08002', 113, 122, 'lactonase')]	['Because', 'almost', 'all', 'the', 'studies', 'cited', 'in', 'this', 'article', 'used', 'specific', 'activity', 'as', 'the', 'only', 'measure', 'of', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', ',', 'it', 'is', 'usually', 'not', 'possible', 'to', 'dise', '##nt', '##angle', 'these', 'two', 'components', '.']	[0, 8, 15, 19, 23, 31, 37, 40, 45, 53, 58, 67, 76, 79, 83, 88, 96, 99, 103, 106, 109, 111, 113, 117, 120, 123, 131, 133, 136, 139, 147, 151, 160, 163, 167, 169, 175, 181, 185, 195]	[7, 14, 18, 22, 30, 36, 39, 44, 52, 57, 66, 75, 78, 82, 87, 95, 98, 103, 106, 109, 110, 112, 117, 120, 122, 131, 132, 135, 138, 146, 150, 159, 162, 167, 169, 174, 180, 184, 195, 196]	['Because', 'almost', 'all', 'the', 'studies', 'cited', 'in', 'this', 'article', 'used', 'specific', 'activity', 'as', 'the', 'only', 'measure', 'of', 'paraoxonase', '1', 'lactonase', 'activity', ',', 'it', 'is', 'usually', 'not', 'possible', 'to', 'disentangle', 'these', 'two', 'components', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
paraoxonase 1, paraoxonase 1, TBBL, TBL, DHC, dihydrocoumarin, valerolactone, and the combinations of these.	[('PMC8045895', 'M00002', 0, 13, 'paraoxonase 1'), ('PMC8045895', 'M00002', 15, 28, 'paraoxonase 1')]	['para', '##oxo', '##nas', '##e', '1', ',', 'para', '##oxo', '##nas', '##e', '1', ',', 'TB', '##BL', ',', 'TB', '##L', ',', 'DH', '##C', ',', 'di', '##hydro', '##co', '##umar', '##in', ',', 'val', '##ero', '##lact', '##one', ',', 'and', 'the', 'combinations', 'of', 'these', '.']	[0, 4, 7, 10, 12, 13, 15, 19, 22, 25, 27, 28, 30, 32, 34, 36, 38, 39, 41, 43, 44, 46, 48, 53, 55, 59, 61, 63, 66, 69, 73, 76, 78, 82, 86, 99, 102, 107]	[4, 7, 10, 11, 13, 14, 19, 22, 25, 26, 28, 29, 32, 34, 35, 38, 39, 40, 43, 44, 45, 48, 53, 55, 59, 61, 62, 66, 69, 73, 76, 77, 81, 85, 98, 101, 107, 108]	['paraoxonase', '1', ',', 'paraoxonase', '1', ',', 'TBBL', ',', 'TBL', ',', 'DHC', ',', 'dihydrocoumarin', ',', 'valerolactone', ',', 'and', 'the', 'combinations', 'of', 'these', '.']	[4, 1, 1, 4, 1, 1, 2, 1, 2, 1, 2, 1, 5, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We also searched the references of all the articles thus obtained for additional articles that might discuss paraoxonase 1 lactonase activity.	[('PMC8045895', 'M00003', 109, 122, 'paraoxonase 1'), ('PMC8045895', 'M00003', 123, 132, 'lactonase')]	['We', 'also', 'searched', 'the', 'references', 'of', 'all', 'the', 'articles', 'thus', 'obtained', 'for', 'additional', 'articles', 'that', 'might', 'discuss', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 3, 8, 17, 21, 32, 35, 39, 43, 52, 57, 66, 70, 81, 90, 95, 101, 109, 113, 116, 119, 121, 123, 127, 130, 133, 141]	[2, 7, 16, 20, 31, 34, 38, 42, 51, 56, 65, 69, 80, 89, 94, 100, 108, 113, 116, 119, 120, 122, 127, 130, 132, 141, 142]	['We', 'also', 'searched', 'the', 'references', 'of', 'all', 'the', 'articles', 'thus', 'obtained', 'for', 'additional', 'articles', 'that', 'might', 'discuss', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O']
It has been emphasized that in any study investigating paraoxonase 1 activity, cases and controls should be matched for paraoxonase 1 haplotype, as the amount of PON1 activity is mainly determined by SNP distribution (Mackness and Mackness, 2015).	[('PMC8045895', 'M01000', 55, 68, 'paraoxonase 1'), ('PMC8045895', 'M01000', 120, 133, 'paraoxonase 1')]	['It', 'has', 'been', 'emphasized', 'that', 'in', 'any', 'study', 'investigating', 'para', '##oxo', '##nas', '##e', '1', 'activity', ',', 'cases', 'and', 'controls', 'should', 'be', 'matched', 'for', 'para', '##oxo', '##nas', '##e', '1', 'haplotype', ',', 'as', 'the', 'amount', 'of', 'PO', '##N', '##1', 'activity', 'is', 'mainly', 'determined', 'by', 'SNP', 'distribution', '(', 'Mack', '##ness', 'and', 'Mack', '##ness', ',', '2015', ')', '.']	[0, 3, 7, 12, 23, 28, 31, 35, 41, 55, 59, 62, 65, 67, 69, 77, 79, 85, 89, 98, 105, 108, 116, 120, 124, 127, 130, 132, 134, 143, 145, 148, 152, 159, 162, 164, 165, 167, 176, 179, 186, 197, 200, 204, 217, 218, 222, 227, 231, 235, 239, 241, 245, 246]	[2, 6, 11, 22, 27, 30, 34, 40, 54, 59, 62, 65, 66, 68, 77, 78, 84, 88, 97, 104, 107, 115, 119, 124, 127, 130, 131, 133, 143, 144, 147, 151, 158, 161, 164, 165, 166, 175, 178, 185, 196, 199, 203, 216, 218, 222, 226, 230, 235, 239, 240, 245, 246, 247]	['It', 'has', 'been', 'emphasized', 'that', 'in', 'any', 'study', 'investigating', 'paraoxonase', '1', 'activity', ',', 'cases', 'and', 'controls', 'should', 'be', 'matched', 'for', 'paraoxonase', '1', 'haplotype', ',', 'as', 'the', 'amount', 'of', 'PON1', 'activity', 'is', 'mainly', 'determined', 'by', 'SNP', 'distribution', '(', 'Mackness', 'and', 'Mackness', ',', '2015', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As the overall number of articles dealing with lactonase paraoxonase 1 activity is limited, this criterion could not be fulfilled in this analysis, which is structured according to the omics taxonomy proposed previously (Pirih and Kunej, 2017).	[('PMC8045895', 'M01001', 47, 56, 'lactonase'), ('PMC8045895', 'M01001', 57, 70, 'paraoxonase 1')]	['As', 'the', 'overall', 'number', 'of', 'articles', 'dealing', 'with', 'lact', '##ona', '##se', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'is', 'limited', ',', 'this', 'criterion', 'could', 'not', 'be', 'fulfilled', 'in', 'this', 'analysis', ',', 'which', 'is', 'structured', 'according', 'to', 'the', 'om', '##ics', 'taxonomy', 'proposed', 'previously', '(', 'Pi', '##ri', '##h', 'and', 'Kun', '##ej', ',', '2017', ')', '.']	[0, 3, 7, 15, 22, 25, 34, 42, 47, 51, 54, 57, 61, 64, 67, 69, 71, 80, 83, 90, 92, 97, 107, 113, 117, 120, 130, 133, 138, 146, 148, 154, 157, 168, 178, 181, 185, 187, 191, 200, 209, 220, 221, 223, 225, 227, 231, 234, 236, 238, 242, 243]	[2, 6, 14, 21, 24, 33, 41, 46, 51, 54, 56, 61, 64, 67, 68, 70, 79, 82, 90, 91, 96, 106, 112, 116, 119, 129, 132, 137, 146, 147, 153, 156, 167, 177, 180, 184, 187, 190, 199, 208, 219, 221, 223, 225, 226, 230, 234, 236, 237, 242, 243, 244]	['As', 'the', 'overall', 'number', 'of', 'articles', 'dealing', 'with', 'lactonase', 'paraoxonase', '1', 'activity', 'is', 'limited', ',', 'this', 'criterion', 'could', 'not', 'be', 'fulfilled', 'in', 'this', 'analysis', ',', 'which', 'is', 'structured', 'according', 'to', 'the', 'omics', 'taxonomy', 'proposed', 'previously', '(', 'Pirih', 'and', 'Kunej', ',', '2017', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of the 46 articles in question, 17 discuss the various effects on paraoxonase 1 lactonase activity.	[('PMC8045895', 'R00001', 66, 79, 'paraoxonase 1'), ('PMC8045895', 'R00001', 80, 89, 'lactonase')]	['Of', 'the', '46', 'articles', 'in', 'question', ',', '17', 'discuss', 'the', 'various', 'effects', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 3, 7, 10, 19, 22, 30, 32, 35, 43, 47, 55, 63, 66, 70, 73, 76, 78, 80, 84, 87, 90, 98]	[2, 6, 9, 18, 21, 30, 31, 34, 42, 46, 54, 62, 65, 70, 73, 76, 77, 79, 84, 87, 89, 98, 99]	['Of', 'the', '46', 'articles', 'in', 'question', ',', '17', 'discuss', 'the', 'various', 'effects', 'on', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O']
The influences of genetics, epigenetics, proteomics, and the lipid environment of paraoxonase 1 were grouped together as “biological” effects.	[('PMC8045895', 'R01001', 82, 95, 'paraoxonase 1')]	['The', 'influences', 'of', 'genetics', ',', 'epigenetic', '##s', ',', 'proteomics', ',', 'and', 'the', 'lipid', 'environment', 'of', 'para', '##oxo', '##nas', '##e', '1', 'were', 'grouped', 'together', 'as', '“', 'biological', '”', 'effects', '.']	[0, 4, 15, 18, 26, 28, 38, 39, 41, 51, 53, 57, 61, 67, 79, 82, 86, 89, 92, 94, 96, 101, 109, 118, 121, 122, 132, 134, 141]	[3, 14, 17, 26, 27, 38, 39, 40, 51, 52, 56, 60, 66, 78, 81, 86, 89, 92, 93, 95, 100, 108, 117, 120, 122, 132, 133, 141, 142]	['The', 'influences', 'of', 'genetics', ',', 'epigenetics', ',', 'proteomics', ',', 'and', 'the', 'lipid', 'environment', 'of', 'paraoxonase', '1', 'were', 'grouped', 'together', 'as', '“', 'biological', '”', 'effects', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The most thoroughly studied influence on paraoxonase 1 activity has been that of genetics, followed by molecular environment.	[('PMC8045895', 'R01003', 41, 54, 'paraoxonase 1')]	['The', 'most', 'thoroughly', 'studied', 'influence', 'on', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'has', 'been', 'that', 'of', 'genetics', ',', 'followed', 'by', 'molecular', 'environment', '.']	[0, 4, 9, 20, 28, 38, 41, 45, 48, 51, 53, 55, 64, 68, 73, 78, 81, 89, 91, 100, 103, 113, 124]	[3, 8, 19, 27, 37, 40, 45, 48, 51, 52, 54, 63, 67, 72, 77, 80, 89, 90, 99, 102, 112, 124, 125]	['The', 'most', 'thoroughly', 'studied', 'influence', 'on', 'paraoxonase', '1', 'activity', 'has', 'been', 'that', 'of', 'genetics', ',', 'followed', 'by', 'molecular', 'environment', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The latter is particularly connected to the lipids and proteins that together compose high-density lipoprotein (HDL) particles and associate with paraoxonase 1 protein.	[('PMC8045895', 'R01004', 146, 159, 'paraoxonase 1')]	['The', 'latter', 'is', 'particularly', 'connected', 'to', 'the', 'lipids', 'and', 'proteins', 'that', 'together', 'compos', '##e', 'high', '-', 'density', 'lipoprotein', '(', 'HDL', ')', 'particles', 'and', 'associate', 'with', 'para', '##oxo', '##nas', '##e', '1', 'protein', '.']	[0, 4, 11, 14, 27, 37, 40, 44, 51, 55, 64, 69, 78, 84, 86, 90, 91, 99, 111, 112, 115, 117, 127, 131, 141, 146, 150, 153, 156, 158, 160, 167]	[3, 10, 13, 26, 36, 39, 43, 50, 54, 63, 68, 77, 84, 85, 90, 91, 98, 110, 112, 115, 116, 126, 130, 140, 145, 150, 153, 156, 157, 159, 167, 168]	['The', 'latter', 'is', 'particularly', 'connected', 'to', 'the', 'lipids', 'and', 'proteins', 'that', 'together', 'compose', 'high', '-', 'density', 'lipoprotein', '(', 'HDL', ')', 'particles', 'and', 'associate', 'with', 'paraoxonase', '1', 'protein', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O']
The two most frequently reported polymorphisms on the human paraoxonase 1 gene are SNPs that change the amino acid sequence of paraoxonase 1, rs662 and rs854560, also referred to as Q192R and L55M, respectively (Shunmoogam et al., 2018).	[('PMC8045895', 'R02000', 60, 73, 'paraoxonase 1'), ('PMC8045895', 'R02000', 127, 140, 'paraoxonase 1')]	['The', 'two', 'most', 'frequently', 'reported', 'polymorphisms', 'on', 'the', 'human', 'para', '##oxo', '##nas', '##e', '1', 'gene', 'are', 'SNPs', 'that', 'change', 'the', 'amino', 'acid', 'sequence', 'of', 'para', '##oxo', '##nas', '##e', '1', ',', 'rs', '##66', '##2', 'and', 'rs', '##85', '##456', '##0', ',', 'also', 'referred', 'to', 'as', 'Q', '##19', '##2', '##R', 'and', 'L', '##55', '##M', ',', 'respectively', '(', 'Sh', '##un', '##mo', '##oga', '##m', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 4, 8, 13, 24, 33, 47, 50, 54, 60, 64, 67, 70, 72, 74, 79, 83, 88, 93, 100, 104, 110, 115, 124, 127, 131, 134, 137, 139, 140, 142, 144, 146, 148, 152, 154, 156, 159, 160, 162, 167, 176, 179, 182, 183, 185, 186, 188, 192, 193, 195, 196, 198, 211, 212, 214, 216, 218, 221, 223, 226, 228, 229, 231, 235, 236]	[3, 7, 12, 23, 32, 46, 49, 53, 59, 64, 67, 70, 71, 73, 78, 82, 87, 92, 99, 103, 109, 114, 123, 126, 131, 134, 137, 138, 140, 141, 144, 146, 147, 151, 154, 156, 159, 160, 161, 166, 175, 178, 181, 183, 185, 186, 187, 191, 193, 195, 196, 197, 210, 212, 214, 216, 218, 221, 222, 225, 228, 229, 230, 235, 236, 237]	['The', 'two', 'most', 'frequently', 'reported', 'polymorphisms', 'on', 'the', 'human', 'paraoxonase', '1', 'gene', 'are', 'SNPs', 'that', 'change', 'the', 'amino', 'acid', 'sequence', 'of', 'paraoxonase', '1', ',', 'rs662', 'and', 'rs854560', ',', 'also', 'referred', 'to', 'as', 'Q192R', 'and', 'L55M', ',', 'respectively', '(', 'Shunmoogam', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There is one more SNP in the coding region of paraoxonase 1, rs13306698 or R160G, with a rather low minor allele frequency of 0.02–0.11; there are no studies investigating it in connection with paraoxonase 1 lactonase activity.	[('PMC8045895', 'R02001', 46, 59, 'paraoxonase 1'), ('PMC8045895', 'R02001', 194, 207, 'paraoxonase 1')]	['There', 'is', 'one', 'more', 'SNP', 'in', 'the', 'coding', 'region', 'of', 'para', '##oxo', '##nas', '##e', '1', ',', 'rs', '##133', '##06', '##69', '##8', 'or', 'R', '##160', '##G', ',', 'with', 'a', 'rather', 'low', 'minor', 'allele', 'frequency', 'of', '0', '.', '02', '–', '0', '.', '11', ';', 'there', 'are', 'no', 'studies', 'investigating', 'it', 'in', 'connection', 'with', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 6, 9, 13, 18, 22, 25, 29, 36, 43, 46, 50, 53, 56, 58, 59, 61, 63, 66, 68, 70, 72, 75, 76, 79, 80, 82, 87, 89, 96, 100, 106, 113, 123, 126, 127, 128, 130, 131, 132, 133, 135, 137, 143, 147, 150, 158, 172, 175, 178, 189, 194, 198, 201, 204, 206, 208, 212, 215, 218, 226]	[5, 8, 12, 17, 21, 24, 28, 35, 42, 45, 50, 53, 56, 57, 59, 60, 63, 66, 68, 70, 71, 74, 76, 79, 80, 81, 86, 88, 95, 99, 105, 112, 122, 125, 127, 128, 130, 131, 132, 133, 135, 136, 142, 146, 149, 157, 171, 174, 177, 188, 193, 198, 201, 204, 205, 207, 212, 215, 217, 226, 227]	['There', 'is', 'one', 'more', 'SNP', 'in', 'the', 'coding', 'region', 'of', 'paraoxonase', '1', ',', 'rs13306698', 'or', 'R160G', ',', 'with', 'a', 'rather', 'low', 'minor', 'allele', 'frequency', 'of', '0.02', '–', '0.11', ';', 'there', 'are', 'no', 'studies', 'investigating', 'it', 'in', 'connection', 'with', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
There are also several other SNPs present either in introns or the promoter region of paraoxonase 1, of which the best known is rs705379 (also referred as -107 C/T or -108 C/T) (Shunmoogam et al., 2018).	[('PMC8045895', 'R02002', 86, 99, 'paraoxonase 1')]	['There', 'are', 'also', 'several', 'other', 'SNPs', 'present', 'either', 'in', 'intron', '##s', 'or', 'the', 'promoter', 'region', 'of', 'para', '##oxo', '##nas', '##e', '1', ',', 'of', 'which', 'the', 'best', 'known', 'is', 'rs', '##70', '##53', '##79', '(', 'also', 'referred', 'as', '-', '107', 'C', '/', 'T', 'or', '-', '108', 'C', '/', 'T', ')', '(', 'Sh', '##un', '##mo', '##oga', '##m', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 6, 10, 15, 23, 29, 34, 42, 49, 52, 58, 60, 63, 67, 76, 83, 86, 90, 93, 96, 98, 99, 101, 104, 110, 114, 119, 125, 128, 130, 132, 134, 137, 138, 143, 152, 155, 156, 160, 161, 162, 164, 167, 168, 172, 173, 174, 175, 177, 178, 180, 182, 184, 187, 189, 192, 194, 195, 197, 201, 202]	[5, 9, 14, 22, 28, 33, 41, 48, 51, 58, 59, 62, 66, 75, 82, 85, 90, 93, 96, 97, 99, 100, 103, 109, 113, 118, 124, 127, 130, 132, 134, 136, 138, 142, 151, 154, 156, 159, 161, 162, 163, 166, 168, 171, 173, 174, 175, 176, 178, 180, 182, 184, 187, 188, 191, 194, 195, 196, 201, 202, 203]	['There', 'are', 'also', 'several', 'other', 'SNPs', 'present', 'either', 'in', 'introns', 'or', 'the', 'promoter', 'region', 'of', 'paraoxonase', '1', ',', 'of', 'which', 'the', 'best', 'known', 'is', 'rs705379', '(', 'also', 'referred', 'as', '-', '107', 'C', '/', 'T', 'or', '-', '108', 'C', '/', 'T', ')', '(', 'Shunmoogam', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Two different articles provided numbers for the percentage of variation of activity that is explained by each of the main parameters, such as genetic variations and sex, affecting paraoxonase 1 lactonase activity (Quillen et al., 2012; Rainwater et al., 2009).	[('PMC8045895', 'R03000', 180, 193, 'paraoxonase 1'), ('PMC8045895', 'R03000', 194, 203, 'lactonase')]	['Two', 'different', 'articles', 'provided', 'numbers', 'for', 'the', 'percentage', 'of', 'variation', 'of', 'activity', 'that', 'is', 'explained', 'by', 'each', 'of', 'the', 'main', 'parameters', ',', 'such', 'as', 'genetic', 'variations', 'and', 'sex', ',', 'affecting', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '(', 'Qu', '##illen', 'et', 'al', '.', ',', '2012', ';', 'Rain', '##water', 'et', 'al', '.', ',', '2009', ')', '.']	[0, 4, 14, 23, 32, 40, 44, 48, 59, 62, 72, 75, 84, 89, 92, 102, 105, 110, 113, 117, 122, 132, 134, 139, 142, 150, 161, 165, 168, 170, 180, 184, 187, 190, 192, 194, 198, 201, 204, 213, 214, 216, 222, 225, 227, 228, 230, 234, 236, 240, 246, 249, 251, 252, 254, 258, 259]	[3, 13, 22, 31, 39, 43, 47, 58, 61, 71, 74, 83, 88, 91, 101, 104, 109, 112, 116, 121, 132, 133, 138, 141, 149, 160, 164, 168, 169, 179, 184, 187, 190, 191, 193, 198, 201, 203, 212, 214, 216, 221, 224, 227, 228, 229, 234, 235, 240, 245, 248, 251, 252, 253, 258, 259, 260]	['Two', 'different', 'articles', 'provided', 'numbers', 'for', 'the', 'percentage', 'of', 'variation', 'of', 'activity', 'that', 'is', 'explained', 'by', 'each', 'of', 'the', 'main', 'parameters', ',', 'such', 'as', 'genetic', 'variations', 'and', 'sex', ',', 'affecting', 'paraoxonase', '1', 'lactonase', 'activity', '(', 'Quillen', 'et', 'al', '.', ',', '2012', ';', 'Rainwater', 'et', 'al', '.', ',', '2009', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The genetic factors explained 67% of all the observed interindividual variation, of which 47% of the variation was traced back to chromosome 7, on which the paraoxonase 1 gene is located (Rainwater et al., 2009).	[('PMC8045895', 'R03003', 157, 170, 'paraoxonase 1')]	['The', 'genetic', 'factors', 'explained', '67', '%', 'of', 'all', 'the', 'observed', 'inter', '##individual', 'variation', ',', 'of', 'which', '47', '%', 'of', 'the', 'variation', 'was', 'traced', 'back', 'to', 'chromosome', '7', ',', 'on', 'which', 'the', 'para', '##oxo', '##nas', '##e', '1', 'gene', 'is', 'located', '(', 'Rain', '##water', 'et', 'al', '.', ',', '2009', ')', '.']	[0, 4, 12, 20, 30, 32, 34, 37, 41, 45, 54, 59, 70, 79, 81, 84, 90, 92, 94, 97, 101, 111, 115, 122, 127, 130, 141, 142, 144, 147, 153, 157, 161, 164, 167, 169, 171, 176, 179, 187, 188, 192, 198, 201, 203, 204, 206, 210, 211]	[3, 11, 19, 29, 32, 33, 36, 40, 44, 53, 59, 69, 79, 80, 83, 89, 92, 93, 96, 100, 110, 114, 121, 126, 129, 140, 142, 143, 146, 152, 156, 161, 164, 167, 168, 170, 175, 178, 186, 188, 192, 197, 200, 203, 204, 205, 210, 211, 212]	['The', 'genetic', 'factors', 'explained', '67%', 'of', 'all', 'the', 'observed', 'interindividual', 'variation', ',', 'of', 'which', '47%', 'of', 'the', 'variation', 'was', 'traced', 'back', 'to', 'chromosome', '7', ',', 'on', 'which', 'the', 'paraoxonase', '1', 'gene', 'is', 'located', '(', 'Rainwater', 'et', 'al', '.', ',', '2009', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five loci on chromosomes 3, 4, and 17 explained 7.8% of genetic variation in paraoxonase 1 activity where lactone was used as a substrate.	[('PMC8045895', 'R04001', 77, 90, 'paraoxonase 1')]	['Five', 'loci', 'on', 'chromosomes', '3', ',', '4', ',', 'and', '17', 'explained', '7', '.', '8', '%', 'of', 'genetic', 'variation', 'in', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'where', 'lact', '##one', 'was', 'used', 'as', 'a', 'substrate', '.']	[0, 5, 10, 13, 25, 26, 28, 29, 31, 35, 38, 48, 49, 50, 51, 53, 56, 64, 74, 77, 81, 84, 87, 89, 91, 100, 106, 110, 114, 118, 123, 126, 128, 137]	[4, 9, 12, 24, 26, 27, 29, 30, 34, 37, 47, 49, 50, 51, 52, 55, 63, 73, 76, 81, 84, 87, 88, 90, 99, 105, 110, 113, 117, 122, 125, 127, 137, 138]	['Five', 'loci', 'on', 'chromosomes', '3', ',', '4', ',', 'and', '17', 'explained', '7.8%', 'of', 'genetic', 'variation', 'in', 'paraoxonase', '1', 'activity', 'where', 'lactone', 'was', 'used', 'as', 'a', 'substrate', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genetic polymorphisms Q192R and L55M account for 8.3 and 4.1% of interindividual variation in paraoxonase 1 lactonase activity, respectively, whereas four other SNPs in promoter region, rs854522, rs854534, rs757158, and rs7803148, account for 1.8%, 3.8%, 9.2%, and 1.1% of variability, respectively.	[('PMC8045895', 'R04002', 94, 107, 'paraoxonase 1'), ('PMC8045895', 'R04002', 108, 117, 'lactonase')]	['Genetic', 'polymorphisms', 'Q', '##19', '##2', '##R', 'and', 'L', '##55', '##M', 'account', 'for', '8', '.', '3', 'and', '4', '.', '1', '%', 'of', 'inter', '##individual', 'variation', 'in', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', ',', 'respectively', ',', 'whereas', 'four', 'other', 'SNPs', 'in', 'promoter', 'region', ',', 'rs', '##85', '##45', '##22', ',', 'rs', '##85', '##45', '##34', ',', 'rs', '##75', '##71', '##58', ',', 'and', 'rs', '##78', '##03', '##148', ',', 'account', 'for', '1', '.', '8', '%', ',', '3', '.', '8', '%', ',', '9', '.', '2', '%', ',', 'and', '1', '.', '1', '%', 'of', 'variability', ',', 'respectively', '.']	[0, 8, 22, 23, 25, 26, 28, 32, 33, 35, 37, 45, 49, 50, 51, 53, 57, 58, 59, 60, 62, 65, 70, 81, 91, 94, 98, 101, 104, 106, 108, 112, 115, 118, 126, 128, 140, 142, 150, 155, 161, 166, 169, 178, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 220, 222, 224, 226, 229, 231, 239, 243, 244, 245, 246, 247, 249, 250, 251, 252, 253, 255, 256, 257, 258, 259, 261, 265, 266, 267, 268, 270, 273, 284, 286, 298]	[7, 21, 23, 25, 26, 27, 31, 33, 35, 36, 44, 48, 50, 51, 52, 56, 58, 59, 60, 61, 64, 70, 80, 90, 93, 98, 101, 104, 105, 107, 112, 115, 117, 126, 127, 140, 141, 149, 154, 160, 165, 168, 177, 184, 185, 188, 190, 192, 194, 195, 198, 200, 202, 204, 205, 208, 210, 212, 214, 215, 219, 222, 224, 226, 229, 230, 238, 242, 244, 245, 246, 247, 248, 250, 251, 252, 253, 254, 256, 257, 258, 259, 260, 264, 266, 267, 268, 269, 272, 284, 285, 298, 299]	['Genetic', 'polymorphisms', 'Q192R', 'and', 'L55M', 'account', 'for', '8.3', 'and', '4.1%', 'of', 'interindividual', 'variation', 'in', 'paraoxonase', '1', 'lactonase', 'activity', ',', 'respectively', ',', 'whereas', 'four', 'other', 'SNPs', 'in', 'promoter', 'region', ',', 'rs854522', ',', 'rs854534', ',', 'rs757158', ',', 'and', 'rs7803148', ',', 'account', 'for', '1.8%', ',', '3.8%', ',', '9.2%', ',', 'and', '1.1%', 'of', 'variability', ',', 'respectively', '.']	[1, 1, 4, 1, 3, 1, 1, 3, 1, 4, 1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 4, 1, 1, 4, 1, 1, 1, 4, 1, 4, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Chen et al. (2020) investigated the effect of ncRNA on paraoxonase 1 lactonase activity.	[('PMC8045895', 'R05001', 55, 68, 'paraoxonase 1'), ('PMC8045895', 'R05001', 69, 78, 'lactonase')]	['Chen', 'et', 'al', '.', '(', '202', '##0', ')', 'investigated', 'the', 'effect', 'of', 'nc', '##RNA', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 5, 8, 10, 12, 13, 16, 17, 19, 32, 36, 43, 46, 48, 52, 55, 59, 62, 65, 67, 69, 73, 76, 79, 87]	[4, 7, 10, 11, 13, 16, 17, 18, 31, 35, 42, 45, 48, 51, 54, 59, 62, 65, 66, 68, 73, 76, 78, 87, 88]	['Chen', 'et', 'al', '.', '(', '2020', ')', 'investigated', 'the', 'effect', 'of', 'ncRNA', 'on', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O']
Two ncRNAs were studied in association with paraoxonase 1, namely long ncRNA Linc-OIP5 and short ncRNA micro-RNA miR-616.	[('PMC8045895', 'R05002', 44, 57, 'paraoxonase 1')]	['Two', 'nc', '##RNAs', 'were', 'studied', 'in', 'association', 'with', 'para', '##oxo', '##nas', '##e', '1', ',', 'namely', 'long', 'nc', '##RNA', 'Lin', '##c', '-', 'O', '##IP', '##5', 'and', 'short', 'nc', '##RNA', 'micro', '-', 'RNA', 'miR', '-', '61', '##6', '.']	[0, 4, 6, 11, 16, 24, 27, 39, 44, 48, 51, 54, 56, 57, 59, 66, 71, 73, 77, 80, 81, 82, 83, 85, 87, 91, 97, 99, 103, 108, 109, 113, 116, 117, 119, 120]	[3, 6, 10, 15, 23, 26, 38, 43, 48, 51, 54, 55, 57, 58, 65, 70, 73, 76, 80, 81, 82, 83, 85, 86, 90, 96, 99, 102, 108, 109, 112, 116, 117, 119, 120, 121]	['Two', 'ncRNAs', 'were', 'studied', 'in', 'association', 'with', 'paraoxonase', '1', ',', 'namely', 'long', 'ncRNA', 'Linc-OIP5', 'and', 'short', 'ncRNA', 'micro-RNA', 'miR-616', '.']	[1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 6, 1, 1, 2, 3, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It was shown that low levels of Linc-OIP5 correspond to lower levels of paraoxonase 1 expression and lactonase activity, whereas high levels of miR-616 gene expression had the opposite effect and decreased paraoxonase 1 expression and lactonase activity.	[('PMC8045895', 'R05003', 72, 85, 'paraoxonase 1'), ('PMC8045895', 'R05003', 101, 110, 'lactonase'), ('PMC8045895', 'R05003', 206, 219, 'paraoxonase 1')]	['It', 'was', 'shown', 'that', 'low', 'levels', 'of', 'Lin', '##c', '-', 'O', '##IP', '##5', 'correspond', 'to', 'lower', 'levels', 'of', 'para', '##oxo', '##nas', '##e', '1', 'expression', 'and', 'lact', '##ona', '##se', 'activity', ',', 'whereas', 'high', 'levels', 'of', 'miR', '-', '61', '##6', 'gene', 'expression', 'had', 'the', 'opposite', 'effect', 'and', 'decreased', 'para', '##oxo', '##nas', '##e', '1', 'expression', 'and', 'lact', '##ona', '##se', 'activity', '.']	[0, 3, 7, 13, 18, 22, 29, 32, 35, 36, 37, 38, 40, 42, 53, 56, 62, 69, 72, 76, 79, 82, 84, 86, 97, 101, 105, 108, 111, 119, 121, 129, 134, 141, 144, 147, 148, 150, 152, 157, 168, 172, 176, 185, 192, 196, 206, 210, 213, 216, 218, 220, 231, 235, 239, 242, 245, 253]	[2, 6, 12, 17, 21, 28, 31, 35, 36, 37, 38, 40, 41, 52, 55, 61, 68, 71, 76, 79, 82, 83, 85, 96, 100, 105, 108, 110, 119, 120, 128, 133, 140, 143, 147, 148, 150, 151, 156, 167, 171, 175, 184, 191, 195, 205, 210, 213, 216, 217, 219, 230, 234, 239, 242, 244, 253, 254]	['It', 'was', 'shown', 'that', 'low', 'levels', 'of', 'Linc-OIP5', 'correspond', 'to', 'lower', 'levels', 'of', 'paraoxonase', '1', 'expression', 'and', 'lactonase', 'activity', ',', 'whereas', 'high', 'levels', 'of', 'miR-616', 'gene', 'expression', 'had', 'the', 'opposite', 'effect', 'and', 'decreased', 'paraoxonase', '1', 'expression', 'and', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The activities of paraoxonase 1 toward lactones, phosphotriesters, and arylesters were suggested to all reside in the same active site (Khersonsky and Tawfik, 2005); however, different changes to paraoxonase 1 structure might have an uneven effect on different PON1 activities.	[('PMC8045895', 'R06000', 18, 31, 'paraoxonase 1'), ('PMC8045895', 'R06000', 196, 209, 'paraoxonase 1')]	['The', 'activities', 'of', 'para', '##oxo', '##nas', '##e', '1', 'toward', 'lact', '##ones', ',', 'phospho', '##tries', '##ters', ',', 'and', 'aryl', '##ester', '##s', 'were', 'suggested', 'to', 'all', 'reside', 'in', 'the', 'same', 'active', 'site', '(', 'Kh', '##erson', '##sky', 'and', 'Ta', '##w', '##fi', '##k', ',', '2005', ')', ';', 'however', ',', 'different', 'changes', 'to', 'para', '##oxo', '##nas', '##e', '1', 'structure', 'might', 'have', 'an', 'uneven', 'effect', 'on', 'different', 'PO', '##N', '##1', 'activities', '.']	[0, 4, 15, 18, 22, 25, 28, 30, 32, 39, 43, 47, 49, 56, 61, 65, 67, 71, 75, 80, 82, 87, 97, 100, 104, 111, 114, 118, 123, 130, 135, 136, 138, 143, 147, 151, 153, 154, 156, 157, 159, 163, 164, 166, 173, 175, 185, 193, 196, 200, 203, 206, 208, 210, 220, 226, 231, 234, 241, 248, 251, 261, 263, 264, 266, 276]	[3, 14, 17, 22, 25, 28, 29, 31, 38, 43, 47, 48, 56, 61, 65, 66, 70, 75, 80, 81, 86, 96, 99, 103, 110, 113, 117, 122, 129, 134, 136, 138, 143, 146, 150, 153, 154, 156, 157, 158, 163, 164, 165, 173, 174, 184, 192, 195, 200, 203, 206, 207, 209, 219, 225, 230, 233, 240, 247, 250, 260, 263, 264, 265, 276, 277]	['The', 'activities', 'of', 'paraoxonase', '1', 'toward', 'lactones', ',', 'phosphotriesters', ',', 'and', 'arylesters', 'were', 'suggested', 'to', 'all', 'reside', 'in', 'the', 'same', 'active', 'site', '(', 'Khersonsky', 'and', 'Tawfik', ',', '2005', ')', ';', 'however', ',', 'different', 'changes', 'to', 'paraoxonase', '1', 'structure', 'might', 'have', 'an', 'uneven', 'effect', 'on', 'different', 'PON1', 'activities', '.']	[1, 1, 1, 4, 1, 1, 2, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Hernandez et al. (2009) and Ferretti et al. (2010) investigated the effect of changes in paraoxonase 1 structure on lactonase activity (Ferretti et al., 2010; Hernandez et al., 2009).	[('PMC8045895', 'R06001', 89, 102, 'paraoxonase 1'), ('PMC8045895', 'R06001', 116, 125, 'lactonase')]	['Hern', '##andez', 'et', 'al', '.', '(', '2009', ')', 'and', 'Ferr', '##etti', 'et', 'al', '.', '(', '2010', ')', 'investigated', 'the', 'effect', 'of', 'changes', 'in', 'para', '##oxo', '##nas', '##e', '1', 'structure', 'on', 'lact', '##ona', '##se', 'activity', '(', 'Ferr', '##etti', 'et', 'al', '.', ',', '2010', ';', 'Hern', '##andez', 'et', 'al', '.', ',', '2009', ')', '.']	[0, 4, 10, 13, 15, 17, 18, 22, 24, 28, 32, 37, 40, 42, 44, 45, 49, 51, 64, 68, 75, 78, 86, 89, 93, 96, 99, 101, 103, 113, 116, 120, 123, 126, 135, 136, 140, 145, 148, 150, 151, 153, 157, 159, 163, 169, 172, 174, 175, 177, 181, 182]	[4, 9, 12, 15, 16, 18, 22, 23, 27, 32, 36, 39, 42, 43, 45, 49, 50, 63, 67, 74, 77, 85, 88, 93, 96, 99, 100, 102, 112, 115, 120, 123, 125, 134, 136, 140, 144, 147, 150, 151, 152, 157, 158, 163, 168, 171, 174, 175, 176, 181, 182, 183]	['Hernandez', 'et', 'al', '.', '(', '2009', ')', 'and', 'Ferretti', 'et', 'al', '.', '(', '2010', ')', 'investigated', 'the', 'effect', 'of', 'changes', 'in', 'paraoxonase', '1', 'structure', 'on', 'lactonase', 'activity', '(', 'Ferretti', 'et', 'al', '.', ',', '2010', ';', 'Hernandez', 'et', 'al', '.', ',', '2009', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Hernandez et al. (2009) investigated this hypothesis by adding different metals in vitro in concentrations that could also be encountered in vivo (e.g., after prolonged exposure) and analyzing paraoxonase 1 activity in the sera of healthy volunteers.	[('PMC8045895', 'R07001', 193, 206, 'paraoxonase 1')]	['Hern', '##andez', 'et', 'al', '.', '(', '2009', ')', 'investigated', 'this', 'hypothesis', 'by', 'adding', 'different', 'metals', 'in', 'vitro', 'in', 'concentrations', 'that', 'could', 'also', 'be', 'encountered', 'in', 'vivo', '(', 'e', '.', 'g', '.', ',', 'after', 'prolonged', 'exposure', ')', 'and', 'analyzing', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'in', 'the', 'sera', 'of', 'healthy', 'volunteers', '.']	[0, 4, 10, 13, 15, 17, 18, 22, 24, 37, 42, 53, 56, 63, 73, 80, 83, 89, 92, 107, 112, 118, 123, 126, 138, 141, 146, 147, 148, 149, 150, 151, 153, 159, 169, 177, 179, 183, 193, 197, 200, 203, 205, 207, 216, 219, 223, 228, 231, 239, 249]	[4, 9, 12, 15, 16, 18, 22, 23, 36, 41, 52, 55, 62, 72, 79, 82, 88, 91, 106, 111, 117, 122, 125, 137, 140, 145, 147, 148, 149, 150, 151, 152, 158, 168, 177, 178, 182, 192, 197, 200, 203, 204, 206, 215, 218, 222, 227, 230, 238, 249, 250]	['Hernandez', 'et', 'al', '.', '(', '2009', ')', 'investigated', 'this', 'hypothesis', 'by', 'adding', 'different', 'metals', 'in', 'vitro', 'in', 'concentrations', 'that', 'could', 'also', 'be', 'encountered', 'in', 'vivo', '(', 'e.g', '.', ',', 'after', 'prolonged', 'exposure', ')', 'and', 'analyzing', 'paraoxonase', '1', 'activity', 'in', 'the', 'sera', 'of', 'healthy', 'volunteers', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of the seven metals investigated, only zinc had a statistically significant influence on paraoxonase 1 lactonase activity, and at the same time lactonase was the only activity affected by addition of zinc.	[('PMC8045895', 'R07002', 89, 102, 'paraoxonase 1'), ('PMC8045895', 'R07002', 103, 112, 'lactonase'), ('PMC8045895', 'R07002', 144, 153, 'lactonase')]	['Of', 'the', 'seven', 'metals', 'investigated', ',', 'only', 'zinc', 'had', 'a', 'statistically', 'significant', 'influence', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', ',', 'and', 'at', 'the', 'same', 'time', 'lact', '##ona', '##se', 'was', 'the', 'only', 'activity', 'affected', 'by', 'addition', 'of', 'zinc', '.']	[0, 3, 7, 13, 20, 32, 34, 39, 44, 48, 50, 64, 76, 86, 89, 93, 96, 99, 101, 103, 107, 110, 113, 121, 123, 127, 130, 134, 139, 144, 148, 151, 154, 158, 162, 167, 176, 185, 188, 197, 200, 204]	[2, 6, 12, 19, 32, 33, 38, 43, 47, 49, 63, 75, 85, 88, 93, 96, 99, 100, 102, 107, 110, 112, 121, 122, 126, 129, 133, 138, 143, 148, 151, 153, 157, 161, 166, 175, 184, 187, 196, 199, 204, 205]	['Of', 'the', 'seven', 'metals', 'investigated', ',', 'only', 'zinc', 'had', 'a', 'statistically', 'significant', 'influence', 'on', 'paraoxonase', '1', 'lactonase', 'activity', ',', 'and', 'at', 'the', 'same', 'time', 'lactonase', 'was', 'the', 'only', 'activity', 'affected', 'by', 'addition', 'of', 'zinc', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors suggest that zinc inhibits paraoxonase 1 activity by binding to several histidines (His-115, -134, -155 and -243) that are essential amino acids for the arylesterase and paraoxonase activities of paraoxonase 1 (Josse et al., 2002).	[('PMC8045895', 'R07003', 39, 52, 'paraoxonase 1'), ('PMC8045895', 'R07003', 165, 177, 'arylesterase'), ('PMC8045895', 'R07003', 182, 193, 'paraoxonase'), ('PMC8045895', 'R07003', 208, 221, 'paraoxonase 1')]	['The', 'authors', 'suggest', 'that', 'zinc', 'inhibits', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'by', 'binding', 'to', 'several', 'histidine', '##s', '(', 'His', '-', '115', ',', '-', '134', ',', '-', '155', 'and', '-', '243', ')', 'that', 'are', 'essential', 'amino', 'acids', 'for', 'the', 'aryl', '##ester', '##ase', 'and', 'para', '##oxo', '##nas', '##e', 'activities', 'of', 'para', '##oxo', '##nas', '##e', '1', '(', 'Jos', '##se', 'et', 'al', '.', ',', '2002', ')', '.']	[0, 4, 12, 20, 25, 30, 39, 43, 46, 49, 51, 53, 62, 65, 73, 76, 84, 93, 95, 96, 99, 100, 103, 105, 106, 109, 111, 112, 116, 120, 121, 124, 126, 131, 135, 145, 151, 157, 161, 165, 169, 174, 178, 182, 186, 189, 192, 194, 205, 208, 212, 215, 218, 220, 222, 223, 226, 229, 232, 234, 235, 237, 241, 242]	[3, 11, 19, 24, 29, 38, 43, 46, 49, 50, 52, 61, 64, 72, 75, 83, 93, 94, 96, 99, 100, 103, 104, 106, 109, 110, 112, 115, 119, 121, 124, 125, 130, 134, 144, 150, 156, 160, 164, 169, 174, 177, 181, 186, 189, 192, 193, 204, 207, 212, 215, 218, 219, 221, 223, 226, 228, 231, 234, 235, 236, 241, 242, 243]	['The', 'authors', 'suggest', 'that', 'zinc', 'inhibits', 'paraoxonase', '1', 'activity', 'by', 'binding', 'to', 'several', 'histidines', '(', 'His-115', ',', '-', '134', ',', '-', '155', 'and', '-', '243', ')', 'that', 'are', 'essential', 'amino', 'acids', 'for', 'the', 'arylesterase', 'and', 'paraoxonase', 'activities', 'of', 'paraoxonase', '1', '(', 'Josse', 'et', 'al', '.', ',', '2002', ')', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A similar analysis was carried out investigating the effect of in vitro homocysteinylation of HDL particles, which is known to occur in vivo, on paraoxonase 1 lactonase activity (Ferretti et al., 2010).	[('PMC8045895', 'R08000', 145, 158, 'paraoxonase 1'), ('PMC8045895', 'R08000', 159, 168, 'lactonase')]	['A', 'similar', 'analysis', 'was', 'carried', 'out', 'investigating', 'the', 'effect', 'of', 'in', 'vitro', 'hom', '##ocyst', '##ei', '##ny', '##lation', 'of', 'HDL', 'particles', ',', 'which', 'is', 'known', 'to', 'occur', 'in', 'vivo', ',', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '(', 'Ferr', '##etti', 'et', 'al', '.', ',', '2010', ')', '.']	[0, 2, 10, 19, 23, 31, 35, 49, 53, 60, 63, 66, 72, 75, 80, 82, 84, 91, 94, 98, 107, 109, 115, 118, 124, 127, 133, 136, 140, 142, 145, 149, 152, 155, 157, 159, 163, 166, 169, 178, 179, 183, 188, 191, 193, 194, 196, 200, 201]	[1, 9, 18, 22, 30, 34, 48, 52, 59, 62, 65, 71, 75, 80, 82, 84, 90, 93, 97, 107, 108, 114, 117, 123, 126, 132, 135, 140, 141, 144, 149, 152, 155, 156, 158, 163, 166, 168, 177, 179, 183, 187, 190, 193, 194, 195, 200, 201, 202]	['A', 'similar', 'analysis', 'was', 'carried', 'out', 'investigating', 'the', 'effect', 'of', 'in', 'vitro', 'homocysteinylation', 'of', 'HDL', 'particles', ',', 'which', 'is', 'known', 'to', 'occur', 'in', 'vivo', ',', 'on', 'paraoxonase', '1', 'lactonase', 'activity', '(', 'Ferretti', 'et', 'al', '.', ',', '2010', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors demonstrated a decrease in lactonase activity with increasing addition of homocystein thiolactone.	[('PMC8045895', 'R08001', 39, 48, 'lactonase')]	['The', 'authors', 'demonstrated', 'a', 'decrease', 'in', 'lact', '##ona', '##se', 'activity', 'with', 'increasing', 'addition', 'of', 'hom', '##ocyst', '##ei', '##n', 'thiol', '##act', '##one', '.']	[0, 4, 12, 25, 27, 36, 39, 43, 46, 49, 58, 63, 74, 83, 86, 89, 94, 96, 98, 103, 106, 109]	[3, 11, 24, 26, 35, 38, 43, 46, 48, 57, 62, 73, 82, 85, 89, 94, 96, 97, 103, 106, 109, 110]	['The', 'authors', 'demonstrated', 'a', 'decrease', 'in', 'lactonase', 'activity', 'with', 'increasing', 'addition', 'of', 'homocystein', 'thiolactone', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The concentrations they used were from 10 to 1000 μM, and the last of them led to a two-third decrease in lactonase activity compared with the control HDL, where HcyT was absent.	[('PMC8045895', 'R08002', 106, 115, 'lactonase')]	['The', 'concentrations', 'they', 'used', 'were', 'from', '10', 'to', '1000', 'μ', '##M', ',', 'and', 'the', 'last', 'of', 'them', 'led', 'to', 'a', 'two', '-', 'third', 'decrease', 'in', 'lact', '##ona', '##se', 'activity', 'compared', 'with', 'the', 'control', 'HDL', ',', 'where', 'H', '##cy', '##T', 'was', 'absent', '.']	[0, 4, 19, 24, 29, 34, 39, 42, 45, 50, 51, 52, 54, 58, 62, 67, 70, 75, 79, 82, 84, 87, 88, 94, 103, 106, 110, 113, 116, 125, 134, 139, 143, 151, 154, 156, 162, 163, 165, 167, 171, 177]	[3, 18, 23, 28, 33, 38, 41, 44, 49, 51, 52, 53, 57, 61, 66, 69, 74, 78, 81, 83, 87, 88, 93, 102, 105, 110, 113, 115, 124, 133, 138, 142, 150, 154, 155, 161, 163, 165, 166, 170, 177, 178]	['The', 'concentrations', 'they', 'used', 'were', 'from', '10', 'to', '1000', 'μM', ',', 'and', 'the', 'last', 'of', 'them', 'led', 'to', 'a', 'two', '-', 'third', 'decrease', 'in', 'lactonase', 'activity', 'compared', 'with', 'the', 'control', 'HDL', ',', 'where', 'HcyT', 'was', 'absent', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The lipidomic context of paraoxonase 1 lactonase activity was investigated with DHC as a substrate in two articles (Rosenblat et al., 2006, 2012).	[('PMC8045895', 'R09000', 25, 38, 'paraoxonase 1'), ('PMC8045895', 'R09000', 39, 48, 'lactonase')]	['The', 'lipid', '##omic', 'context', 'of', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'was', 'investigated', 'with', 'DH', '##C', 'as', 'a', 'substrate', 'in', 'two', 'articles', '(', 'Rosen', '##bl', '##at', 'et', 'al', '.', ',', '2006', ',', '2012', ')', '.']	[0, 4, 9, 14, 22, 25, 29, 32, 35, 37, 39, 43, 46, 49, 58, 62, 75, 80, 82, 84, 87, 89, 99, 102, 106, 115, 116, 121, 123, 126, 129, 131, 132, 134, 138, 140, 144, 145]	[3, 9, 13, 21, 24, 29, 32, 35, 36, 38, 43, 46, 48, 57, 61, 74, 79, 82, 83, 86, 88, 98, 101, 105, 114, 116, 121, 123, 125, 128, 131, 132, 133, 138, 139, 144, 145, 146]	['The', 'lipidomic', 'context', 'of', 'paraoxonase', '1', 'lactonase', 'activity', 'was', 'investigated', 'with', 'DHC', 'as', 'a', 'substrate', 'in', 'two', 'articles', '(', 'Rosenblat', 'et', 'al', '.', ',', '2006', ',', '2012', ')', '.']	[1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
They analyzed arylesterase, paraoxonase, and lactonase activities, and as expected, no activity was observed in very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), whereas all three activities were observed in the HDL fraction.	[('PMC8045895', 'R10001', 14, 26, 'arylesterase'), ('PMC8045895', 'R10001', 28, 39, 'paraoxonase'), ('PMC8045895', 'R10001', 45, 54, 'lactonase')]	['They', 'analyzed', 'aryl', '##ester', '##ase', ',', 'para', '##oxo', '##nas', '##e', ',', 'and', 'lact', '##ona', '##se', 'activities', ',', 'and', 'as', 'expected', ',', 'no', 'activity', 'was', 'observed', 'in', 'very', '-', 'low', '-', 'density', 'lipoprotein', '(', 'VL', '##DL', ')', 'and', 'low', '-', 'density', 'lipoprotein', '(', 'LDL', ')', ',', 'whereas', 'all', 'three', 'activities', 'were', 'observed', 'in', 'the', 'HDL', 'fraction', '.']	[0, 5, 14, 18, 23, 26, 28, 32, 35, 38, 39, 41, 45, 49, 52, 55, 65, 67, 71, 74, 82, 84, 87, 96, 100, 109, 112, 116, 117, 120, 121, 129, 141, 142, 144, 146, 148, 152, 155, 156, 164, 176, 177, 180, 181, 183, 191, 195, 201, 212, 217, 226, 229, 233, 237, 245]	[4, 13, 18, 23, 26, 27, 32, 35, 38, 39, 40, 44, 49, 52, 54, 65, 66, 70, 73, 82, 83, 86, 95, 99, 108, 111, 116, 117, 120, 121, 128, 140, 142, 144, 146, 147, 151, 155, 156, 163, 175, 177, 180, 181, 182, 190, 194, 200, 211, 216, 225, 228, 232, 236, 245, 246]	['They', 'analyzed', 'arylesterase', ',', 'paraoxonase', ',', 'and', 'lactonase', 'activities', ',', 'and', 'as', 'expected', ',', 'no', 'activity', 'was', 'observed', 'in', 'very', '-', 'low', '-', 'density', 'lipoprotein', '(', 'VLDL', ')', 'and', 'low', '-', 'density', 'lipoprotein', '(', 'LDL', ')', ',', 'whereas', 'all', 'three', 'activities', 'were', 'observed', 'in', 'the', 'HDL', 'fraction', '.']	[1, 1, 3, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of interest, paraoxonase activity was similar in HDL and LPDS, whereas arylesterase and lactonase activities were significantly higher in HDL compared with LPDS.	[('PMC8045895', 'R11000', 13, 24, 'paraoxonase'), ('PMC8045895', 'R11000', 71, 83, 'arylesterase'), ('PMC8045895', 'R11000', 88, 97, 'lactonase')]	['Of', 'interest', ',', 'para', '##oxo', '##nas', '##e', 'activity', 'was', 'similar', 'in', 'HDL', 'and', 'LP', '##DS', ',', 'whereas', 'aryl', '##ester', '##ase', 'and', 'lact', '##ona', '##se', 'activities', 'were', 'significantly', 'higher', 'in', 'HDL', 'compared', 'with', 'LP', '##DS', '.']	[0, 3, 11, 13, 17, 20, 23, 25, 34, 38, 46, 49, 53, 57, 59, 61, 63, 71, 75, 80, 84, 88, 92, 95, 98, 109, 114, 128, 135, 138, 142, 151, 156, 158, 160]	[2, 11, 12, 17, 20, 23, 24, 33, 37, 45, 48, 52, 56, 59, 61, 62, 70, 75, 80, 83, 87, 92, 95, 97, 108, 113, 127, 134, 137, 141, 150, 155, 158, 160, 161]	['Of', 'interest', ',', 'paraoxonase', 'activity', 'was', 'similar', 'in', 'HDL', 'and', 'LPDS', ',', 'whereas', 'arylesterase', 'and', 'lactonase', 'activities', 'were', 'significantly', 'higher', 'in', 'HDL', 'compared', 'with', 'LPDS', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
With lactonase, the difference in activity between HDL and LPDS was greatest.	[('PMC8045895', 'R11001', 5, 14, 'lactonase')]	['With', 'lact', '##ona', '##se', ',', 'the', 'difference', 'in', 'activity', 'between', 'HDL', 'and', 'LP', '##DS', 'was', 'greatest', '.']	[0, 5, 9, 12, 14, 16, 20, 31, 34, 43, 51, 55, 59, 61, 64, 68, 76]	[4, 9, 12, 14, 15, 19, 30, 33, 42, 50, 54, 58, 61, 63, 67, 76, 77]	['With', 'lactonase', ',', 'the', 'difference', 'in', 'activity', 'between', 'HDL', 'and', 'LPDS', 'was', 'greatest', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Rosenblat et al. (2006) suggested that the environment in HDL stabilizes paraoxonase 1's structure; displacement from HDL causes conformational changes that reduce lactonase and arylesterase activity, whereas paraoxonase activity is less sensitive to such changes.	[('PMC8045895', 'R11002', 73, 86, 'paraoxonase 1'), ('PMC8045895', 'R11002', 164, 173, 'lactonase'), ('PMC8045895', 'R11002', 178, 190, 'arylesterase'), ('PMC8045895', 'R11002', 209, 220, 'paraoxonase')]	"['Rosen', '##bl', '##at', 'et', 'al', '.', '(', '2006', ')', 'suggested', 'that', 'the', 'environment', 'in', 'HDL', 'stabilize', '##s', 'para', '##oxo', '##nas', '##e', '1', ""'"", 's', 'structure', ';', 'displacement', 'from', 'HDL', 'causes', 'conformational', 'changes', 'that', 'reduce', 'lact', '##ona', '##se', 'and', 'aryl', '##ester', '##ase', 'activity', ',', 'whereas', 'para', '##oxo', '##nas', '##e', 'activity', 'is', 'less', 'sensitive', 'to', 'such', 'changes', '.']"	[0, 5, 7, 10, 13, 15, 17, 18, 22, 24, 34, 39, 43, 55, 58, 62, 71, 73, 77, 80, 83, 85, 86, 87, 89, 98, 100, 113, 118, 122, 129, 144, 152, 157, 164, 168, 171, 174, 178, 182, 187, 191, 199, 201, 209, 213, 216, 219, 221, 230, 233, 238, 248, 251, 256, 263]	[5, 7, 9, 12, 15, 16, 18, 22, 23, 33, 38, 42, 54, 57, 61, 71, 72, 77, 80, 83, 84, 86, 87, 88, 98, 99, 112, 117, 121, 128, 143, 151, 156, 163, 168, 171, 173, 177, 182, 187, 190, 199, 200, 208, 213, 216, 219, 220, 229, 232, 237, 247, 250, 255, 263, 264]	"['Rosenblat', 'et', 'al', '.', '(', '2006', ')', 'suggested', 'that', 'the', 'environment', 'in', 'HDL', 'stabilizes', 'paraoxonase', ""1's"", 'structure', ';', 'displacement', 'from', 'HDL', 'causes', 'conformational', 'changes', 'that', 'reduce', 'lactonase', 'and', 'arylesterase', 'activity', ',', 'whereas', 'paraoxonase', 'activity', 'is', 'less', 'sensitive', 'to', 'such', 'changes', '.']"	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the second article, Rosenblat et al. (2012) reported the influence of VLDL and free triglycerides on the activity of serum paraoxonase 1.	[('PMC8045895', 'R12000', 126, 139, 'paraoxonase 1')]	['In', 'the', 'second', 'article', ',', 'Rosen', '##bl', '##at', 'et', 'al', '.', '(', '2012', ')', 'reported', 'the', 'influence', 'of', 'VL', '##DL', 'and', 'free', 'triglycerides', 'on', 'the', 'activity', 'of', 'serum', 'para', '##oxo', '##nas', '##e', '1', '.']	[0, 3, 7, 14, 21, 23, 28, 30, 33, 36, 38, 40, 41, 45, 47, 56, 60, 70, 73, 75, 78, 82, 87, 101, 104, 108, 117, 120, 126, 130, 133, 136, 138, 139]	[2, 6, 13, 21, 22, 28, 30, 32, 35, 38, 39, 41, 45, 46, 55, 59, 69, 72, 75, 77, 81, 86, 100, 103, 107, 116, 119, 125, 130, 133, 136, 137, 139, 140]	['In', 'the', 'second', 'article', ',', 'Rosenblat', 'et', 'al', '.', '(', '2012', ')', 'reported', 'the', 'influence', 'of', 'VLDL', 'and', 'free', 'triglycerides', 'on', 'the', 'activity', 'of', 'serum', 'paraoxonase', '1', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
The authors distinguished paraoxonase 1 lactonase activity in the total serum and in HDL-bound paraoxonase 1.	[('PMC8045895', 'R12001', 26, 39, 'paraoxonase 1'), ('PMC8045895', 'R12001', 40, 49, 'lactonase'), ('PMC8045895', 'R12001', 95, 108, 'paraoxonase 1')]	['The', 'authors', 'distinguished', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'in', 'the', 'total', 'serum', 'and', 'in', 'HDL', '-', 'bound', 'para', '##oxo', '##nas', '##e', '1', '.']	[0, 4, 12, 26, 30, 33, 36, 38, 40, 44, 47, 50, 59, 62, 66, 72, 78, 82, 85, 88, 89, 95, 99, 102, 105, 107, 108]	[3, 11, 25, 30, 33, 36, 37, 39, 44, 47, 49, 58, 61, 65, 71, 77, 81, 84, 88, 89, 94, 99, 102, 105, 106, 108, 109]	['The', 'authors', 'distinguished', 'paraoxonase', '1', 'lactonase', 'activity', 'in', 'the', 'total', 'serum', 'and', 'in', 'HDL', '-', 'bound', 'paraoxonase', '1', '.']	[1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
The addition of VLDL caused a decrease in HDL-bound paraoxonase 1 lactonase activity.	[('PMC8045895', 'R12002', 52, 65, 'paraoxonase 1'), ('PMC8045895', 'R12002', 66, 75, 'lactonase')]	['The', 'addition', 'of', 'VL', '##DL', 'caused', 'a', 'decrease', 'in', 'HDL', '-', 'bound', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 4, 13, 16, 18, 21, 28, 30, 39, 42, 45, 46, 52, 56, 59, 62, 64, 66, 70, 73, 76, 84]	[3, 12, 15, 18, 20, 27, 29, 38, 41, 45, 46, 51, 56, 59, 62, 63, 65, 70, 73, 75, 84, 85]	['The', 'addition', 'of', 'VLDL', 'caused', 'a', 'decrease', 'in', 'HDL', '-', 'bound', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O']
The authors also investigated bezafibrate as a compound, which reverses the effect of VLDL on paraoxonase and arylesterase activity (Rosenblat et al., 2012).	[('PMC8045895', 'R12004', 94, 105, 'paraoxonase'), ('PMC8045895', 'R12004', 110, 122, 'arylesterase')]	['The', 'authors', 'also', 'investigated', 'be', '##za', '##fib', '##rate', 'as', 'a', 'compound', ',', 'which', 'reverse', '##s', 'the', 'effect', 'of', 'VL', '##DL', 'on', 'para', '##oxo', '##nas', '##e', 'and', 'aryl', '##ester', '##ase', 'activity', '(', 'Rosen', '##bl', '##at', 'et', 'al', '.', ',', '2012', ')', '.']	[0, 4, 12, 17, 30, 32, 34, 37, 42, 45, 47, 55, 57, 63, 70, 72, 76, 83, 86, 88, 91, 94, 98, 101, 104, 106, 110, 114, 119, 123, 132, 133, 138, 140, 143, 146, 148, 149, 151, 155, 156]	[3, 11, 16, 29, 32, 34, 37, 41, 44, 46, 55, 56, 62, 70, 71, 75, 82, 85, 88, 90, 93, 98, 101, 104, 105, 109, 114, 119, 122, 131, 133, 138, 140, 142, 145, 148, 149, 150, 155, 156, 157]	['The', 'authors', 'also', 'investigated', 'bezafibrate', 'as', 'a', 'compound', ',', 'which', 'reverses', 'the', 'effect', 'of', 'VLDL', 'on', 'paraoxonase', 'and', 'arylesterase', 'activity', '(', 'Rosenblat', 'et', 'al', '.', ',', '2012', ')', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 4, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All the macroscopic, behavioral, and personal parameters with which researchers have attempted to explain interindividual variation in paraoxonase 1 lactonase activity, such as age, gender, exercise, diet/nutriomics, medications, and exposure to chemicals, were grouped together as “Environmental/Social effects.”	[('PMC8045895', 'R13000', 135, 148, 'paraoxonase 1'), ('PMC8045895', 'R13000', 149, 158, 'lactonase')]	['All', 'the', 'macroscopic', ',', 'behavioral', ',', 'and', 'personal', 'parameters', 'with', 'which', 'researchers', 'have', 'attempted', 'to', 'explain', 'inter', '##individual', 'variation', 'in', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', ',', 'such', 'as', 'age', ',', 'gender', ',', 'exercise', ',', 'diet', '/', 'nutri', '##omics', ',', 'medications', ',', 'and', 'exposure', 'to', 'chemicals', ',', 'were', 'grouped', 'together', 'as', '“', 'Environmental', '/', 'Social', 'effects', '.', '”']	[0, 4, 8, 19, 21, 31, 33, 37, 46, 57, 62, 68, 80, 85, 95, 98, 106, 111, 122, 132, 135, 139, 142, 145, 147, 149, 153, 156, 159, 167, 169, 174, 177, 180, 182, 188, 190, 198, 200, 204, 205, 210, 215, 217, 228, 230, 234, 243, 246, 255, 257, 262, 270, 279, 282, 283, 296, 297, 304, 311, 312]	[3, 7, 19, 20, 31, 32, 36, 45, 56, 61, 67, 79, 84, 94, 97, 105, 111, 121, 131, 134, 139, 142, 145, 146, 148, 153, 156, 158, 167, 168, 173, 176, 180, 181, 188, 189, 198, 199, 204, 205, 210, 215, 216, 228, 229, 233, 242, 245, 255, 256, 261, 269, 278, 281, 283, 296, 297, 303, 311, 312, 313]	['All', 'the', 'macroscopic', ',', 'behavioral', ',', 'and', 'personal', 'parameters', 'with', 'which', 'researchers', 'have', 'attempted', 'to', 'explain', 'interindividual', 'variation', 'in', 'paraoxonase', '1', 'lactonase', 'activity', ',', 'such', 'as', 'age', ',', 'gender', ',', 'exercise', ',', 'diet', '/', 'nutriomics', ',', 'medications', ',', 'and', 'exposure', 'to', 'chemicals', ',', 'were', 'grouped', 'together', 'as', '“', 'Environmental', '/', 'Social', 'effects', '.', '”']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although the influence of age on paraoxonase 1 activity in humans is still not entirely clear for adolescents and adults, it has been shown that neonatal paraoxonase 1 arylesterase activity is much lower than that of toddlers (Cole et al, 2003).	[('PMC8045895', 'R14000', 33, 46, 'paraoxonase 1'), ('PMC8045895', 'R14000', 154, 167, 'paraoxonase 1')]	['Although', 'the', 'influence', 'of', 'age', 'on', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'in', 'humans', 'is', 'still', 'not', 'entirely', 'clear', 'for', 'adolescents', 'and', 'adults', ',', 'it', 'has', 'been', 'shown', 'that', 'neonatal', 'para', '##oxo', '##nas', '##e', '1', 'aryl', '##ester', '##ase', 'activity', 'is', 'much', 'lower', 'than', 'that', 'of', 'to', '##dd', '##lers', '(', 'Cole', 'et', 'al', ',', '2003', ')', '.']	[0, 9, 13, 23, 26, 30, 33, 37, 40, 43, 45, 47, 56, 59, 66, 69, 75, 79, 88, 94, 98, 110, 114, 120, 122, 125, 129, 134, 140, 145, 154, 158, 161, 164, 166, 168, 172, 177, 181, 190, 193, 198, 204, 209, 214, 217, 219, 221, 226, 227, 232, 235, 237, 239, 243, 244]	[8, 12, 22, 25, 29, 32, 37, 40, 43, 44, 46, 55, 58, 65, 68, 74, 78, 87, 93, 97, 109, 113, 120, 121, 124, 128, 133, 139, 144, 153, 158, 161, 164, 165, 167, 172, 177, 180, 189, 192, 197, 203, 208, 213, 216, 219, 221, 225, 227, 231, 234, 237, 238, 243, 244, 245]	['Although', 'the', 'influence', 'of', 'age', 'on', 'paraoxonase', '1', 'activity', 'in', 'humans', 'is', 'still', 'not', 'entirely', 'clear', 'for', 'adolescents', 'and', 'adults', ',', 'it', 'has', 'been', 'shown', 'that', 'neonatal', 'paraoxonase', '1', 'arylesterase', 'activity', 'is', 'much', 'lower', 'than', 'that', 'of', 'toddlers', '(', 'Cole', 'et', 'al', ',', '2003', ')', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For lactonase activity, Gugliucci et al.	[('PMC8045895', 'R14001', 4, 13, 'lactonase')]	['For', 'lact', '##ona', '##se', 'activity', ',', 'Gu', '##gl', '##iu', '##cc', '##i', 'et', 'al', '.']	[0, 4, 8, 11, 14, 22, 24, 26, 28, 30, 32, 34, 37, 39]	[3, 8, 11, 13, 22, 23, 26, 28, 30, 32, 33, 36, 39, 40]	['For', 'lactonase', 'activity', ',', 'Gugliucci', 'et', 'al', '.']	[1, 3, 1, 1, 5, 1, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although the difference between the two categories of women was not significant, newborns had on average 23% and 37% of the paraoxonase 1 lactonase and arylesterase activity of their mothers, respectively (Gugliucci et al., 2014).	[('PMC8045895', 'R14003', 124, 137, 'paraoxonase 1'), ('PMC8045895', 'R14003', 138, 147, 'lactonase'), ('PMC8045895', 'R14003', 152, 164, 'arylesterase')]	['Although', 'the', 'difference', 'between', 'the', 'two', 'categories', 'of', 'women', 'was', 'not', 'significant', ',', 'newborns', 'had', 'on', 'average', '23', '%', 'and', '37', '%', 'of', 'the', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'and', 'aryl', '##ester', '##ase', 'activity', 'of', 'their', 'mothers', ',', 'respectively', '(', 'Gu', '##gl', '##iu', '##cc', '##i', 'et', 'al', '.', ',', '2014', ')', '.']	[0, 9, 13, 24, 32, 36, 40, 51, 54, 60, 64, 68, 79, 81, 90, 94, 97, 105, 107, 109, 113, 115, 117, 120, 124, 128, 131, 134, 136, 138, 142, 145, 148, 152, 156, 161, 165, 174, 177, 183, 190, 192, 205, 206, 208, 210, 212, 214, 216, 219, 221, 222, 224, 228, 229]	[8, 12, 23, 31, 35, 39, 50, 53, 59, 63, 67, 79, 80, 89, 93, 96, 104, 107, 108, 112, 115, 116, 119, 123, 128, 131, 134, 135, 137, 142, 145, 147, 151, 156, 161, 164, 173, 176, 182, 190, 191, 204, 206, 208, 210, 212, 214, 215, 218, 221, 222, 223, 228, 229, 230]	['Although', 'the', 'difference', 'between', 'the', 'two', 'categories', 'of', 'women', 'was', 'not', 'significant', ',', 'newborns', 'had', 'on', 'average', '23%', 'and', '37%', 'of', 'the', 'paraoxonase', '1', 'lactonase', 'and', 'arylesterase', 'activity', 'of', 'their', 'mothers', ',', 'respectively', '(', 'Gugliucci', 'et', 'al', '.', ',', '2014', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 4, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In several articles, the authors grouped their results on lactonase activity into categories, including age.	[('PMC8045895', 'R15000', 58, 67, 'lactonase')]	['In', 'several', 'articles', ',', 'the', 'authors', 'grouped', 'their', 'results', 'on', 'lact', '##ona', '##se', 'activity', 'into', 'categories', ',', 'including', 'age', '.']	[0, 3, 11, 19, 21, 25, 33, 41, 47, 55, 58, 62, 65, 68, 77, 82, 92, 94, 104, 107]	[2, 10, 19, 20, 24, 32, 40, 46, 54, 57, 62, 65, 67, 76, 81, 92, 93, 103, 107, 108]	['In', 'several', 'articles', ',', 'the', 'authors', 'grouped', 'their', 'results', 'on', 'lactonase', 'activity', 'into', 'categories', ',', 'including', 'age', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An example of such a study is the genome-wide association approach by Quillen et al. (2012), where the authors identified that age accounts for 1.4% of interindividual variation in paraoxonase 1 lactonase activity (Quillen et al., 2012).	[('PMC8045895', 'R15001', 181, 194, 'paraoxonase 1'), ('PMC8045895', 'R15001', 195, 204, 'lactonase')]	['An', 'example', 'of', 'such', 'a', 'study', 'is', 'the', 'genome', '-', 'wide', 'association', 'approach', 'by', 'Qu', '##illen', 'et', 'al', '.', '(', '2012', ')', ',', 'where', 'the', 'authors', 'identified', 'that', 'age', 'accounts', 'for', '1', '.', '4', '%', 'of', 'inter', '##individual', 'variation', 'in', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '(', 'Qu', '##illen', 'et', 'al', '.', ',', '2012', ')', '.']	[0, 3, 11, 14, 19, 21, 27, 30, 34, 40, 41, 46, 58, 67, 70, 72, 78, 81, 83, 85, 86, 90, 91, 93, 99, 103, 111, 122, 127, 131, 140, 144, 145, 146, 147, 149, 152, 157, 168, 178, 181, 185, 188, 191, 193, 195, 199, 202, 205, 214, 215, 217, 223, 226, 228, 229, 231, 235, 236]	[2, 10, 13, 18, 20, 26, 29, 33, 40, 41, 45, 57, 66, 69, 72, 77, 80, 83, 84, 86, 90, 91, 92, 98, 102, 110, 121, 126, 130, 139, 143, 145, 146, 147, 148, 151, 157, 167, 177, 180, 185, 188, 191, 192, 194, 199, 202, 204, 213, 215, 217, 222, 225, 228, 229, 230, 235, 236, 237]	['An', 'example', 'of', 'such', 'a', 'study', 'is', 'the', 'genome', '-', 'wide', 'association', 'approach', 'by', 'Quillen', 'et', 'al', '.', '(', '2012', ')', ',', 'where', 'the', 'authors', 'identified', 'that', 'age', 'accounts', 'for', '1.4%', 'of', 'interindividual', 'variation', 'in', 'paraoxonase', '1', 'lactonase', 'activity', '(', 'Quillen', 'et', 'al', '.', ',', '2012', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among other factors that influence paraoxonase 1 activity, Quillen et al. (2012) also focused on the effect of gender on lactonase activity.	[('PMC8045895', 'R16000', 35, 48, 'paraoxonase 1'), ('PMC8045895', 'R16000', 121, 130, 'lactonase')]	['Among', 'other', 'factors', 'that', 'influence', 'para', '##oxo', '##nas', '##e', '1', 'activity', ',', 'Qu', '##illen', 'et', 'al', '.', '(', '2012', ')', 'also', 'focused', 'on', 'the', 'effect', 'of', 'gender', 'on', 'lact', '##ona', '##se', 'activity', '.']	[0, 6, 12, 20, 25, 35, 39, 42, 45, 47, 49, 57, 59, 61, 67, 70, 72, 74, 75, 79, 81, 86, 94, 97, 101, 108, 111, 118, 121, 125, 128, 131, 139]	[5, 11, 19, 24, 34, 39, 42, 45, 46, 48, 57, 58, 61, 66, 69, 72, 73, 75, 79, 80, 85, 93, 96, 100, 107, 110, 117, 120, 125, 128, 130, 139, 140]	['Among', 'other', 'factors', 'that', 'influence', 'paraoxonase', '1', 'activity', ',', 'Quillen', 'et', 'al', '.', '(', '2012', ')', 'also', 'focused', 'on', 'the', 'effect', 'of', 'gender', 'on', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Although the authors' model indicates that 0.4% of the interindividual difference in both paraoxonase and arylesterase activities can be explained by gender, we suggest that gender does not appreciably explain interindividual variation in DHC lactonase activity.	[('PMC8045895', 'R16001', 90, 101, 'paraoxonase'), ('PMC8045895', 'R16001', 106, 118, 'arylesterase'), ('PMC8045895', 'R16001', 243, 252, 'lactonase')]	"['Although', 'the', 'authors', ""'"", 'model', 'indicates', 'that', '0', '.', '4', '%', 'of', 'the', 'inter', '##individual', 'difference', 'in', 'both', 'para', '##oxo', '##nas', '##e', 'and', 'aryl', '##ester', '##ase', 'activities', 'can', 'be', 'explained', 'by', 'gender', ',', 'we', 'suggest', 'that', 'gender', 'does', 'not', 'appreci', '##ably', 'explain', 'inter', '##individual', 'variation', 'in', 'DH', '##C', 'lact', '##ona', '##se', 'activity', '.']"	[0, 9, 13, 20, 22, 28, 38, 43, 44, 45, 46, 48, 51, 55, 60, 71, 82, 85, 90, 94, 97, 100, 102, 106, 110, 115, 119, 130, 134, 137, 147, 150, 156, 158, 161, 169, 174, 181, 186, 190, 197, 202, 210, 215, 226, 236, 239, 241, 243, 247, 250, 253, 261]	[8, 12, 20, 21, 27, 37, 42, 44, 45, 46, 47, 50, 54, 60, 70, 81, 84, 89, 94, 97, 100, 101, 105, 110, 115, 118, 129, 133, 136, 146, 149, 156, 157, 160, 168, 173, 180, 185, 189, 197, 201, 209, 215, 225, 235, 238, 241, 242, 247, 250, 252, 261, 262]	"['Although', 'the', 'authors', ""'"", 'model', 'indicates', 'that', '0.4%', 'of', 'the', 'interindividual', 'difference', 'in', 'both', 'paraoxonase', 'and', 'arylesterase', 'activities', 'can', 'be', 'explained', 'by', 'gender', ',', 'we', 'suggest', 'that', 'gender', 'does', 'not', 'appreciably', 'explain', 'interindividual', 'variation', 'in', 'DHC', 'lactonase', 'activity', '.']"	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
A more recent article also focused on the influence of gender on paraoxonase 1, with TBL as a substrate, and concludes that gender does influence lactonase activity (Trentini et al., 2019).	[('PMC8045895', 'R17000', 65, 78, 'paraoxonase 1'), ('PMC8045895', 'R17000', 146, 155, 'lactonase')]	['A', 'more', 'recent', 'article', 'also', 'focused', 'on', 'the', 'influence', 'of', 'gender', 'on', 'para', '##oxo', '##nas', '##e', '1', ',', 'with', 'TB', '##L', 'as', 'a', 'substrate', ',', 'and', 'concludes', 'that', 'gender', 'does', 'influence', 'lact', '##ona', '##se', 'activity', '(', 'Tre', '##nt', '##ini', 'et', 'al', '.', ',', '201', '##9', ')', '.']	[0, 2, 7, 14, 22, 27, 35, 38, 42, 52, 55, 62, 65, 69, 72, 75, 77, 78, 80, 85, 87, 89, 92, 94, 103, 105, 109, 119, 124, 131, 136, 146, 150, 153, 156, 165, 166, 169, 171, 175, 178, 180, 181, 183, 186, 187, 188]	[1, 6, 13, 21, 26, 34, 37, 41, 51, 54, 61, 64, 69, 72, 75, 76, 78, 79, 84, 87, 88, 91, 93, 103, 104, 108, 118, 123, 130, 135, 145, 150, 153, 155, 164, 166, 169, 171, 174, 177, 180, 181, 182, 186, 187, 188, 189]	['A', 'more', 'recent', 'article', 'also', 'focused', 'on', 'the', 'influence', 'of', 'gender', 'on', 'paraoxonase', '1', ',', 'with', 'TBL', 'as', 'a', 'substrate', ',', 'and', 'concludes', 'that', 'gender', 'does', 'influence', 'lactonase', 'activity', '(', 'Trentini', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Trentini et al. detected higher paraoxonase 1 lactonase activity among women than among men, even after accounting for confounders such as concentrations of HDL and cholesterol, age, smoking, body mass index, and waist circumference.	[('PMC8045895', 'R17001', 32, 45, 'paraoxonase 1'), ('PMC8045895', 'R17001', 46, 55, 'lactonase')]	['Tre', '##nt', '##ini', 'et', 'al', '.', 'detected', 'higher', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'among', 'women', 'than', 'among', 'men', ',', 'even', 'after', 'accounting', 'for', 'confounders', 'such', 'as', 'concentrations', 'of', 'HDL', 'and', 'cholesterol', ',', 'age', ',', 'smoking', ',', 'body', 'mass', 'index', ',', 'and', 'waist', 'circumference', '.']	[0, 3, 5, 9, 12, 14, 16, 25, 32, 36, 39, 42, 44, 46, 50, 53, 56, 65, 71, 77, 82, 88, 91, 93, 98, 104, 115, 119, 131, 136, 139, 154, 157, 161, 165, 176, 178, 181, 183, 190, 192, 197, 202, 207, 209, 213, 219, 232]	[3, 5, 8, 11, 14, 15, 24, 31, 36, 39, 42, 43, 45, 50, 53, 55, 64, 70, 76, 81, 87, 91, 92, 97, 103, 114, 118, 130, 135, 138, 153, 156, 160, 164, 176, 177, 181, 182, 190, 191, 196, 201, 207, 208, 212, 218, 232, 233]	['Trentini', 'et', 'al', '.', 'detected', 'higher', 'paraoxonase', '1', 'lactonase', 'activity', 'among', 'women', 'than', 'among', 'men', ',', 'even', 'after', 'accounting', 'for', 'confounders', 'such', 'as', 'concentrations', 'of', 'HDL', 'and', 'cholesterol', ',', 'age', ',', 'smoking', ',', 'body', 'mass', 'index', ',', 'and', 'waist', 'circumference', '.']	[3, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors reported a significant difference between genders for both lactonase and arylesterase activities (Trentini et al., 2019).	[('PMC8045895', 'R17002', 71, 80, 'lactonase'), ('PMC8045895', 'R17002', 85, 97, 'arylesterase')]	['The', 'authors', 'reported', 'a', 'significant', 'difference', 'between', 'gender', '##s', 'for', 'both', 'lact', '##ona', '##se', 'and', 'aryl', '##ester', '##ase', 'activities', '(', 'Tre', '##nt', '##ini', 'et', 'al', '.', ',', '201', '##9', ')', '.']	[0, 4, 12, 21, 23, 35, 46, 54, 60, 62, 66, 71, 75, 78, 81, 85, 89, 94, 98, 109, 110, 113, 115, 119, 122, 124, 125, 127, 130, 131, 132]	[3, 11, 20, 22, 34, 45, 53, 60, 61, 65, 70, 75, 78, 80, 84, 89, 94, 97, 108, 110, 113, 115, 118, 121, 124, 125, 126, 130, 131, 132, 133]	['The', 'authors', 'reported', 'a', 'significant', 'difference', 'between', 'genders', 'for', 'both', 'lactonase', 'and', 'arylesterase', 'activities', '(', 'Trentini', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
When investigating the association between paraoxonase 1 activity and medical conditions, the influence of diet on enzymatic activity is thus a major potential confounder.	[('PMC8045895', 'R18001', 43, 56, 'paraoxonase 1')]	['When', 'investigating', 'the', 'association', 'between', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'and', 'medical', 'conditions', ',', 'the', 'influence', 'of', 'diet', 'on', 'enzymatic', 'activity', 'is', 'thus', 'a', 'major', 'potential', 'confound', '##er', '.']	[0, 5, 19, 23, 35, 43, 47, 50, 53, 55, 57, 66, 70, 78, 88, 90, 94, 104, 107, 112, 115, 125, 134, 137, 142, 144, 150, 160, 168, 170]	[4, 18, 22, 34, 42, 47, 50, 53, 54, 56, 65, 69, 77, 88, 89, 93, 103, 106, 111, 114, 124, 133, 136, 141, 143, 149, 159, 168, 170, 171]	['When', 'investigating', 'the', 'association', 'between', 'paraoxonase', '1', 'activity', 'and', 'medical', 'conditions', ',', 'the', 'influence', 'of', 'diet', 'on', 'enzymatic', 'activity', 'is', 'thus', 'a', 'major', 'potential', 'confounder', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One foodstuff, which has been associated with paraoxonase 1 activity in several articles, is pomegranate.	[('PMC8045895', 'R18002', 46, 59, 'paraoxonase 1')]	['One', 'foods', '##tu', '##ff', ',', 'which', 'has', 'been', 'associated', 'with', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'in', 'several', 'articles', ',', 'is', 'po', '##me', '##gran', '##ate', '.']	[0, 4, 9, 11, 13, 15, 21, 25, 30, 41, 46, 50, 53, 56, 58, 60, 69, 72, 80, 88, 90, 93, 95, 97, 101, 104]	[3, 9, 11, 13, 14, 20, 24, 29, 40, 45, 50, 53, 56, 57, 59, 68, 71, 79, 88, 89, 92, 95, 97, 101, 104, 105]	['One', 'foodstuff', ',', 'which', 'has', 'been', 'associated', 'with', 'paraoxonase', '1', 'activity', 'in', 'several', 'articles', ',', 'is', 'pomegranate', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Rock et al. (2008) measured the effect of pomegranate juice on lactonase activity.	[('PMC8045895', 'R18003', 63, 72, 'lactonase')]	['Rock', 'et', 'al', '.', '(', '2008', ')', 'measured', 'the', 'effect', 'of', 'po', '##me', '##gran', '##ate', 'juice', 'on', 'lact', '##ona', '##se', 'activity', '.']	[0, 5, 8, 10, 12, 13, 17, 19, 28, 32, 39, 42, 44, 46, 50, 54, 60, 63, 67, 70, 73, 81]	[4, 7, 10, 11, 13, 17, 18, 27, 31, 38, 41, 44, 46, 50, 53, 59, 62, 67, 70, 72, 81, 82]	['Rock', 'et', 'al', '.', '(', '2008', ')', 'measured', 'the', 'effect', 'of', 'pomegranate', 'juice', 'on', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
The authors concluded that pomegranate juice consumption temporarily and significantly increases serum paraoxonase 1 lactonase activity, both in HDL and LPDS, when both DHC and TBBL were used as substrates.	[('PMC8045895', 'R18004', 103, 116, 'paraoxonase 1'), ('PMC8045895', 'R18004', 117, 126, 'lactonase')]	['The', 'authors', 'concluded', 'that', 'po', '##me', '##gran', '##ate', 'juice', 'consumption', 'temporarily', 'and', 'significantly', 'increases', 'serum', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', ',', 'both', 'in', 'HDL', 'and', 'LP', '##DS', ',', 'when', 'both', 'DH', '##C', 'and', 'TB', '##BL', 'were', 'used', 'as', 'substrates', '.']	[0, 4, 12, 22, 27, 29, 31, 35, 39, 45, 57, 69, 73, 87, 97, 103, 107, 110, 113, 115, 117, 121, 124, 127, 135, 137, 142, 145, 149, 153, 155, 157, 159, 164, 169, 171, 173, 177, 179, 182, 187, 192, 195, 205]	[3, 11, 21, 26, 29, 31, 35, 38, 44, 56, 68, 72, 86, 96, 102, 107, 110, 113, 114, 116, 121, 124, 126, 135, 136, 141, 144, 148, 152, 155, 157, 158, 163, 168, 171, 172, 176, 179, 181, 186, 191, 194, 205, 206]	['The', 'authors', 'concluded', 'that', 'pomegranate', 'juice', 'consumption', 'temporarily', 'and', 'significantly', 'increases', 'serum', 'paraoxonase', '1', 'lactonase', 'activity', ',', 'both', 'in', 'HDL', 'and', 'LPDS', ',', 'when', 'both', 'DHC', 'and', 'TBBL', 'were', 'used', 'as', 'substrates', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aviram and Rosenblat (2012) also investigated how the consumption of several different juices impacts paraoxonase 1 lactonase activity for DHC.	[('PMC8045895', 'R19000', 102, 115, 'paraoxonase 1'), ('PMC8045895', 'R19000', 116, 125, 'lactonase')]	['Av', '##ira', '##m', 'and', 'Rosen', '##bl', '##at', '(', '2012', ')', 'also', 'investigated', 'how', 'the', 'consumption', 'of', 'several', 'different', 'juice', '##s', 'impacts', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'for', 'DH', '##C', '.']	[0, 2, 5, 7, 11, 16, 18, 21, 22, 26, 28, 33, 46, 50, 54, 66, 69, 77, 87, 92, 94, 102, 106, 109, 112, 114, 116, 120, 123, 126, 135, 139, 141, 142]	[2, 5, 6, 10, 16, 18, 20, 22, 26, 27, 32, 45, 49, 53, 65, 68, 76, 86, 92, 93, 101, 106, 109, 112, 113, 115, 120, 123, 125, 134, 138, 141, 142, 143]	['Aviram', 'and', 'Rosenblat', '(', '2012', ')', 'also', 'investigated', 'how', 'the', 'consumption', 'of', 'several', 'different', 'juices', 'impacts', 'paraoxonase', '1', 'lactonase', 'activity', 'for', 'DHC', '.']	[3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
They found that in healthy subjects, consumption of currant juice and pomegranate juice both led to an increase in paraoxonase 1 lactonase activity after 1 week.	[('PMC8045895', 'R19001', 115, 128, 'paraoxonase 1'), ('PMC8045895', 'R19001', 129, 138, 'lactonase')]	['They', 'found', 'that', 'in', 'healthy', 'subjects', ',', 'consumption', 'of', 'cur', '##ran', '##t', 'juice', 'and', 'po', '##me', '##gran', '##ate', 'juice', 'both', 'led', 'to', 'an', 'increase', 'in', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'after', '1', 'week', '.']	[0, 5, 11, 16, 19, 27, 35, 37, 49, 52, 55, 58, 60, 66, 70, 72, 74, 78, 82, 88, 93, 97, 100, 103, 112, 115, 119, 122, 125, 127, 129, 133, 136, 139, 148, 154, 156, 160]	[4, 10, 15, 18, 26, 35, 36, 48, 51, 55, 58, 59, 65, 69, 72, 74, 78, 81, 87, 92, 96, 99, 102, 111, 114, 119, 122, 125, 126, 128, 133, 136, 138, 147, 153, 155, 160, 161]	['They', 'found', 'that', 'in', 'healthy', 'subjects', ',', 'consumption', 'of', 'currant', 'juice', 'and', 'pomegranate', 'juice', 'both', 'led', 'to', 'an', 'increase', 'in', 'paraoxonase', '1', 'lactonase', 'activity', 'after', '1', 'week', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Acai, grape juice, and wine however did not significantly impact paraoxonase 1 activity (Aviram and Rosenblat, 2012).	[('PMC8045895', 'R19002', 65, 78, 'paraoxonase 1')]	['Ac', '##ai', ',', 'grap', '##e', 'juice', ',', 'and', 'wine', 'however', 'did', 'not', 'significantly', 'impact', 'para', '##oxo', '##nas', '##e', '1', 'activity', '(', 'Av', '##ira', '##m', 'and', 'Rosen', '##bl', '##at', ',', '2012', ')', '.']	[0, 2, 4, 6, 10, 12, 17, 19, 23, 28, 36, 40, 44, 58, 65, 69, 72, 75, 77, 79, 88, 89, 91, 94, 96, 100, 105, 107, 109, 111, 115, 116]	[2, 4, 5, 10, 11, 17, 18, 22, 27, 35, 39, 43, 57, 64, 69, 72, 75, 76, 78, 87, 89, 91, 94, 95, 99, 105, 107, 109, 110, 115, 116, 117]	['Acai', ',', 'grape', 'juice', ',', 'and', 'wine', 'however', 'did', 'not', 'significantly', 'impact', 'paraoxonase', '1', 'activity', '(', 'Aviram', 'and', 'Rosenblat', ',', '2012', ')', '.']	[2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Kameyama et al. (2016) studied the impact of diet on paraoxonase 1 lactonase activity.	[('PMC8045895', 'R20000', 53, 66, 'paraoxonase 1'), ('PMC8045895', 'R20000', 67, 76, 'lactonase')]	['Kam', '##ey', '##ama', 'et', 'al', '.', '(', '2016', ')', 'studied', 'the', 'impact', 'of', 'diet', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 3, 5, 9, 12, 14, 16, 17, 21, 23, 31, 35, 42, 45, 50, 53, 57, 60, 63, 65, 67, 71, 74, 77, 85]	[3, 5, 8, 11, 14, 15, 17, 21, 22, 30, 34, 41, 44, 49, 52, 57, 60, 63, 64, 66, 71, 74, 76, 85, 86]	['Kameyama', 'et', 'al', '.', '(', '2016', ')', 'studied', 'the', 'impact', 'of', 'diet', 'on', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O']
In their study, male volunteers who consumed three different meals and lactonase activity, with TBBL as a substrate, was determined after consumption of these meals.	[('PMC8045895', 'R20001', 71, 80, 'lactonase')]	['In', 'their', 'study', ',', 'male', 'volunteers', 'who', 'consumed', 'three', 'different', 'meals', 'and', 'lact', '##ona', '##se', 'activity', ',', 'with', 'TB', '##BL', 'as', 'a', 'substrate', ',', 'was', 'determined', 'after', 'consumption', 'of', 'these', 'meals', '.']	[0, 3, 9, 14, 16, 21, 32, 36, 45, 51, 61, 67, 71, 75, 78, 81, 89, 91, 96, 98, 101, 104, 106, 115, 117, 121, 132, 138, 150, 153, 159, 164]	[2, 8, 14, 15, 20, 31, 35, 44, 50, 60, 66, 70, 75, 78, 80, 89, 90, 95, 98, 100, 103, 105, 115, 116, 120, 131, 137, 149, 152, 158, 164, 165]	['In', 'their', 'study', ',', 'male', 'volunteers', 'who', 'consumed', 'three', 'different', 'meals', 'and', 'lactonase', 'activity', ',', 'with', 'TBBL', 'as', 'a', 'substrate', ',', 'was', 'determined', 'after', 'consumption', 'of', 'these', 'meals', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
paraoxonase 1 lactonase activity was significantly decreased by 5% in the postprandial period after all test meals.	[('PMC8045895', 'R20003', 0, 13, 'paraoxonase 1'), ('PMC8045895', 'R20003', 14, 23, 'lactonase')]	['para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'was', 'significantly', 'decreased', 'by', '5', '%', 'in', 'the', 'post', '##pr', '##andial', 'period', 'after', 'all', 'test', 'meals', '.']	[0, 4, 7, 10, 12, 14, 18, 21, 24, 33, 37, 51, 61, 64, 65, 67, 70, 74, 78, 80, 87, 94, 100, 104, 109, 114]	[4, 7, 10, 11, 13, 18, 21, 23, 32, 36, 50, 60, 63, 65, 66, 69, 73, 78, 80, 86, 93, 99, 103, 108, 114, 115]	['paraoxonase', '1', 'lactonase', 'activity', 'was', 'significantly', 'decreased', 'by', '5%', 'in', 'the', 'postprandial', 'period', 'after', 'all', 'test', 'meals', '.']	[4, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Conversely, arylesterase activity was increased by 10% in all three groups.	[('PMC8045895', 'R20004', 12, 24, 'arylesterase')]	['Conversely', ',', 'aryl', '##ester', '##ase', 'activity', 'was', 'increased', 'by', '10', '%', 'in', 'all', 'three', 'groups', '.']	[0, 10, 12, 16, 21, 25, 34, 38, 48, 51, 53, 55, 58, 62, 68, 74]	[10, 11, 16, 21, 24, 33, 37, 47, 50, 53, 54, 57, 61, 67, 74, 75]	['Conversely', ',', 'arylesterase', 'activity', 'was', 'increased', 'by', '10%', 'in', 'all', 'three', 'groups', '.']	[1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the type of meal did not influence subsequent lactonase and arylesterase activities.	[('PMC8045895', 'R20005', 55, 64, 'lactonase'), ('PMC8045895', 'R20005', 69, 81, 'arylesterase')]	['However', ',', 'the', 'type', 'of', 'meal', 'did', 'not', 'influence', 'subsequent', 'lact', '##ona', '##se', 'and', 'aryl', '##ester', '##ase', 'activities', '.']	[0, 7, 9, 13, 18, 21, 26, 30, 34, 44, 55, 59, 62, 65, 69, 73, 78, 82, 92]	[7, 8, 12, 17, 20, 25, 29, 33, 43, 54, 59, 62, 64, 68, 73, 78, 81, 92, 93]	['However', ',', 'the', 'type', 'of', 'meal', 'did', 'not', 'influence', 'subsequent', 'lactonase', 'and', 'arylesterase', 'activities', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O']
Model organisms have also been used to perform experiments about the impact of diet high in polyunsaturated fatty acids (PUFA) on paraoxonase 1 lactonase activity.	[('PMC8045895', 'R21000', 130, 143, 'paraoxonase 1'), ('PMC8045895', 'R21000', 144, 153, 'lactonase')]	['Model', 'organisms', 'have', 'also', 'been', 'used', 'to', 'perform', 'experiments', 'about', 'the', 'impact', 'of', 'diet', 'high', 'in', 'poly', '##uns', '##aturated', 'fatty', 'acids', '(', 'PU', '##FA', ')', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 6, 16, 21, 26, 31, 36, 39, 47, 59, 65, 69, 76, 79, 84, 89, 92, 96, 99, 108, 114, 120, 121, 123, 125, 127, 130, 134, 137, 140, 142, 144, 148, 151, 154, 162]	[5, 15, 20, 25, 30, 35, 38, 46, 58, 64, 68, 75, 78, 83, 88, 91, 96, 99, 107, 113, 119, 121, 123, 125, 126, 129, 134, 137, 140, 141, 143, 148, 151, 153, 162, 163]	['Model', 'organisms', 'have', 'also', 'been', 'used', 'to', 'perform', 'experiments', 'about', 'the', 'impact', 'of', 'diet', 'high', 'in', 'polyunsaturated', 'fatty', 'acids', '(', 'PUFA', ')', 'on', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O']
No significant difference in lactonase activity of rat serum before and after a PUFA-rich meal has been demonstrated.	[('PMC8045895', 'R21001', 29, 38, 'lactonase')]	['No', 'significant', 'difference', 'in', 'lact', '##ona', '##se', 'activity', 'of', 'rat', 'serum', 'before', 'and', 'after', 'a', 'PU', '##FA', '-', 'rich', 'meal', 'has', 'been', 'demonstrated', '.']	[0, 3, 15, 26, 29, 33, 36, 39, 48, 51, 55, 61, 68, 72, 78, 80, 82, 84, 85, 90, 95, 99, 104, 116]	[2, 14, 25, 28, 33, 36, 38, 47, 50, 54, 60, 67, 71, 77, 79, 82, 84, 85, 89, 94, 98, 103, 116, 117]	['No', 'significant', 'difference', 'in', 'lactonase', 'activity', 'of', 'rat', 'serum', 'before', 'and', 'after', 'a', 'PUFA-rich', 'meal', 'has', 'been', 'demonstrated', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, authors also found no difference in lactonase activity between the nondiabetic control without oil administration and the diabetic group (Kopál et al., 2014).	[('PMC8045895', 'R21002', 46, 55, 'lactonase')]	['Moreover', ',', 'authors', 'also', 'found', 'no', 'difference', 'in', 'lact', '##ona', '##se', 'activity', 'between', 'the', 'nond', '##ia', '##bet', '##ic', 'control', 'without', 'oil', 'administration', 'and', 'the', 'diabetic', 'group', '(', 'Kop', '##á', '##l', 'et', 'al', '.', ',', '2014', ')', '.']	[0, 8, 10, 18, 23, 29, 32, 43, 46, 50, 53, 56, 65, 73, 77, 81, 83, 86, 89, 97, 105, 109, 124, 128, 132, 141, 147, 148, 151, 152, 154, 157, 159, 160, 162, 166, 167]	[8, 9, 17, 22, 28, 31, 42, 45, 50, 53, 55, 64, 72, 76, 81, 83, 86, 88, 96, 104, 108, 123, 127, 131, 140, 146, 148, 151, 152, 153, 156, 159, 160, 161, 166, 167, 168]	['Moreover', ',', 'authors', 'also', 'found', 'no', 'difference', 'in', 'lactonase', 'activity', 'between', 'the', 'nondiabetic', 'control', 'without', 'oil', 'administration', 'and', 'the', 'diabetic', 'group', '(', 'Kopál', 'et', 'al', '.', ',', '2014', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although the interactions of paraoxonase 1 with various mediations have been established and are displayed in databases such as DrugBank (Wishart et al., 2017), only few of these studies investigated lactonase activity.	[('PMC8045895', 'R22000', 29, 42, 'paraoxonase 1'), ('PMC8045895', 'R22000', 200, 209, 'lactonase')]	['Although', 'the', 'interactions', 'of', 'para', '##oxo', '##nas', '##e', '1', 'with', 'various', 'mediation', '##s', 'have', 'been', 'established', 'and', 'are', 'displayed', 'in', 'databases', 'such', 'as', 'Drug', '##Bank', '(', 'Wi', '##sh', '##art', 'et', 'al', '.', ',', '2017', ')', ',', 'only', 'few', 'of', 'these', 'studies', 'investigated', 'lact', '##ona', '##se', 'activity', '.']	[0, 9, 13, 26, 29, 33, 36, 39, 41, 43, 48, 56, 65, 67, 72, 77, 89, 93, 97, 107, 110, 120, 125, 128, 132, 137, 138, 140, 142, 146, 149, 151, 152, 154, 158, 159, 161, 166, 170, 173, 179, 187, 200, 204, 207, 210, 218]	[8, 12, 25, 28, 33, 36, 39, 40, 42, 47, 55, 65, 66, 71, 76, 88, 92, 96, 106, 109, 119, 124, 127, 132, 136, 138, 140, 142, 145, 148, 151, 152, 153, 158, 159, 160, 165, 169, 172, 178, 186, 199, 204, 207, 209, 218, 219]	['Although', 'the', 'interactions', 'of', 'paraoxonase', '1', 'with', 'various', 'mediations', 'have', 'been', 'established', 'and', 'are', 'displayed', 'in', 'databases', 'such', 'as', 'DrugBank', '(', 'Wishart', 'et', 'al', '.', ',', '2017', ')', ',', 'only', 'few', 'of', 'these', 'studies', 'investigated', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
For example, of the 12 articles focusing on association of paraoxonase 1 activity and medications for schizophrenia, which were analyzed in a recent review (Moreira et al., 2018), only Gilca et al. (2014) investigated lactonase activity using DHC as a substrate.	[('PMC8045895', 'R22001', 59, 72, 'paraoxonase 1'), ('PMC8045895', 'R22001', 218, 227, 'lactonase')]	['For', 'example', ',', 'of', 'the', '12', 'articles', 'focusing', 'on', 'association', 'of', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'and', 'medications', 'for', 'schizophrenia', ',', 'which', 'were', 'analyzed', 'in', 'a', 'recent', 'review', '(', 'More', '##ira', 'et', 'al', '.', ',', '2018', ')', ',', 'only', 'Gil', '##ca', 'et', 'al', '.', '(', '2014', ')', 'investigated', 'lact', '##ona', '##se', 'activity', 'using', 'DH', '##C', 'as', 'a', 'substrate', '.']	[0, 4, 11, 13, 16, 20, 23, 32, 41, 44, 56, 59, 63, 66, 69, 71, 73, 82, 86, 98, 102, 115, 117, 123, 128, 137, 140, 142, 149, 156, 157, 161, 165, 168, 170, 171, 173, 177, 178, 180, 185, 188, 191, 194, 196, 198, 199, 203, 205, 218, 222, 225, 228, 237, 243, 245, 247, 250, 252, 261]	[3, 11, 12, 15, 19, 22, 31, 40, 43, 55, 58, 63, 66, 69, 70, 72, 81, 85, 97, 101, 115, 116, 122, 127, 136, 139, 141, 148, 155, 157, 161, 164, 167, 170, 171, 172, 177, 178, 179, 184, 188, 190, 193, 196, 197, 199, 203, 204, 217, 222, 225, 227, 236, 242, 245, 246, 249, 251, 261, 262]	['For', 'example', ',', 'of', 'the', '12', 'articles', 'focusing', 'on', 'association', 'of', 'paraoxonase', '1', 'activity', 'and', 'medications', 'for', 'schizophrenia', ',', 'which', 'were', 'analyzed', 'in', 'a', 'recent', 'review', '(', 'Moreira', 'et', 'al', '.', ',', '2018', ')', ',', 'only', 'Gilca', 'et', 'al', '.', '(', '2014', ')', 'investigated', 'lactonase', 'activity', 'using', 'DHC', 'as', 'a', 'substrate', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
compared lactonase activity in patients taking clozapine, patients taking risperidone, and with healthy individuals.	[('PMC8045895', 'R23001', 9, 18, 'lactonase')]	['compared', 'lact', '##ona', '##se', 'activity', 'in', 'patients', 'taking', 'cl', '##oz', '##apine', ',', 'patients', 'taking', 'ris', '##per', '##idone', ',', 'and', 'with', 'healthy', 'individuals', '.']	[0, 9, 13, 16, 19, 28, 31, 40, 47, 49, 51, 56, 58, 67, 74, 77, 80, 85, 87, 91, 96, 104, 115]	[8, 13, 16, 18, 27, 30, 39, 46, 49, 51, 56, 57, 66, 73, 77, 80, 85, 86, 90, 95, 103, 115, 116]	['compared', 'lactonase', 'activity', 'in', 'patients', 'taking', 'clozapine', ',', 'patients', 'taking', 'risperidone', ',', 'and', 'with', 'healthy', 'individuals', '.']	[1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors demonstrated that taking risperidone resulted in significantly lower lactonase activity than the healthy control group.	[('PMC8045895', 'R23002', 81, 90, 'lactonase')]	['The', 'authors', 'demonstrated', 'that', 'taking', 'ris', '##per', '##idone', 'resulted', 'in', 'significantly', 'lower', 'lact', '##ona', '##se', 'activity', 'than', 'the', 'healthy', 'control', 'group', '.']	[0, 4, 12, 25, 30, 37, 40, 43, 49, 58, 61, 75, 81, 85, 88, 91, 100, 105, 109, 117, 125, 130]	[3, 11, 24, 29, 36, 40, 43, 48, 57, 60, 74, 80, 85, 88, 90, 99, 104, 108, 116, 124, 130, 131]	['The', 'authors', 'demonstrated', 'that', 'taking', 'risperidone', 'resulted', 'in', 'significantly', 'lower', 'lactonase', 'activity', 'than', 'the', 'healthy', 'control', 'group', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors also showed that the patients taking clozapine in turn had a significantly lower lactonase activity than the patients taking risperidone.	[('PMC8045895', 'R23003', 93, 102, 'lactonase')]	['The', 'authors', 'also', 'showed', 'that', 'the', 'patients', 'taking', 'cl', '##oz', '##apine', 'in', 'turn', 'had', 'a', 'significantly', 'lower', 'lact', '##ona', '##se', 'activity', 'than', 'the', 'patients', 'taking', 'ris', '##per', '##idone', '.']	[0, 4, 12, 17, 24, 29, 33, 42, 49, 51, 53, 59, 62, 67, 71, 73, 87, 93, 97, 100, 103, 112, 117, 121, 130, 137, 140, 143, 148]	[3, 11, 16, 23, 28, 32, 41, 48, 51, 53, 58, 61, 66, 70, 72, 86, 92, 97, 100, 102, 111, 116, 120, 129, 136, 140, 143, 148, 149]	['The', 'authors', 'also', 'showed', 'that', 'the', 'patients', 'taking', 'clozapine', 'in', 'turn', 'had', 'a', 'significantly', 'lower', 'lactonase', 'activity', 'than', 'the', 'patients', 'taking', 'risperidone', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Another group of medications, which has been associated with paraoxonase 1 lactonase activity in one study, are oral contraceptives (Kowalska et al., 2018).	[('PMC8045895', 'R24000', 61, 74, 'paraoxonase 1'), ('PMC8045895', 'R24000', 75, 84, 'lactonase')]	['Another', 'group', 'of', 'medications', ',', 'which', 'has', 'been', 'associated', 'with', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'in', 'one', 'study', ',', 'are', 'oral', 'contraceptive', '##s', '(', 'Ko', '##wal', '##ska', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 8, 14, 17, 28, 30, 36, 40, 45, 56, 61, 65, 68, 71, 73, 75, 79, 82, 85, 94, 97, 101, 106, 108, 112, 117, 130, 132, 133, 135, 138, 142, 145, 147, 148, 150, 154, 155]	[7, 13, 16, 28, 29, 35, 39, 44, 55, 60, 65, 68, 71, 72, 74, 79, 82, 84, 93, 96, 100, 106, 107, 111, 116, 130, 131, 133, 135, 138, 141, 144, 147, 148, 149, 154, 155, 156]	['Another', 'group', 'of', 'medications', ',', 'which', 'has', 'been', 'associated', 'with', 'paraoxonase', '1', 'lactonase', 'activity', 'in', 'one', 'study', ',', 'are', 'oral', 'contraceptives', '(', 'Kowalska', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that taking contraceptives correlated with a significant increase in lactonase and arylesterase activity, but with a significant decrease in paraoxonase activity.	[('PMC8045895', 'R24001', 91, 100, 'lactonase'), ('PMC8045895', 'R24001', 105, 117, 'arylesterase'), ('PMC8045895', 'R24001', 163, 174, 'paraoxonase')]	['The', 'authors', 'concluded', 'that', 'taking', 'contraceptive', '##s', 'correlated', 'with', 'a', 'significant', 'increase', 'in', 'lact', '##ona', '##se', 'and', 'aryl', '##ester', '##ase', 'activity', ',', 'but', 'with', 'a', 'significant', 'decrease', 'in', 'para', '##oxo', '##nas', '##e', 'activity', '.']	[0, 4, 12, 22, 27, 34, 47, 49, 60, 65, 67, 79, 88, 91, 95, 98, 101, 105, 109, 114, 118, 126, 128, 132, 137, 139, 151, 160, 163, 167, 170, 173, 175, 183]	[3, 11, 21, 26, 33, 47, 48, 59, 64, 66, 78, 87, 90, 95, 98, 100, 104, 109, 114, 117, 126, 127, 131, 136, 138, 150, 159, 162, 167, 170, 173, 174, 183, 184]	['The', 'authors', 'concluded', 'that', 'taking', 'contraceptives', 'correlated', 'with', 'a', 'significant', 'increase', 'in', 'lactonase', 'and', 'arylesterase', 'activity', ',', 'but', 'with', 'a', 'significant', 'decrease', 'in', 'paraoxonase', 'activity', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
paraoxonase 1 is among the few enzymes that offer protection against organophosphate pesticides.	[('PMC8045895', 'R25000', 0, 13, 'paraoxonase 1')]	['para', '##oxo', '##nas', '##e', '1', 'is', 'among', 'the', 'few', 'enzymes', 'that', 'offer', 'protection', 'against', 'organ', '##ophosphate', 'pesticides', '.']	[0, 4, 7, 10, 12, 14, 17, 23, 27, 31, 39, 44, 50, 61, 69, 74, 85, 95]	[4, 7, 10, 11, 13, 16, 22, 26, 30, 38, 43, 49, 60, 68, 74, 84, 95, 96]	['paraoxonase', '1', 'is', 'among', 'the', 'few', 'enzymes', 'that', 'offer', 'protection', 'against', 'organophosphate', 'pesticides', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lozano-Paniagua et al. (2016) conducted a study in which they addressed the effect of pesticide exposure on paraoxonase 1 lactonase activity for DHC.	[('PMC8045895', 'R25001', 108, 121, 'paraoxonase 1'), ('PMC8045895', 'R25001', 122, 131, 'lactonase')]	['Lo', '##za', '##no', '-', 'Pan', '##ia', '##gu', '##a', 'et', 'al', '.', '(', '2016', ')', 'conducted', 'a', 'study', 'in', 'which', 'they', 'addressed', 'the', 'effect', 'of', 'pesticide', 'exposure', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'for', 'DH', '##C', '.']	[0, 2, 4, 6, 7, 10, 12, 14, 16, 19, 21, 23, 24, 28, 30, 40, 42, 48, 51, 57, 62, 72, 76, 83, 86, 96, 105, 108, 112, 115, 118, 120, 122, 126, 129, 132, 141, 145, 147, 148]	[2, 4, 6, 7, 10, 12, 14, 15, 18, 21, 22, 24, 28, 29, 39, 41, 47, 50, 56, 61, 71, 75, 82, 85, 95, 104, 107, 112, 115, 118, 119, 121, 126, 129, 131, 140, 144, 147, 148, 149]	['Lozano-Paniagua', 'et', 'al', '.', '(', '2016', ')', 'conducted', 'a', 'study', 'in', 'which', 'they', 'addressed', 'the', 'effect', 'of', 'pesticide', 'exposure', 'on', 'paraoxonase', '1', 'lactonase', 'activity', 'for', 'DHC', '.']	[8, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
The authors concluded that while lactonase activity is not significantly affected by the amount of exposure to pesticides, there is a significant decrease in lactonase activity in greenhouse workers in comparison with the healthy controls with no occupational exposure to pesticides.	[('PMC8045895', 'R25002', 33, 42, 'lactonase'), ('PMC8045895', 'R25002', 158, 167, 'lactonase')]	['The', 'authors', 'concluded', 'that', 'while', 'lact', '##ona', '##se', 'activity', 'is', 'not', 'significantly', 'affected', 'by', 'the', 'amount', 'of', 'exposure', 'to', 'pesticides', ',', 'there', 'is', 'a', 'significant', 'decrease', 'in', 'lact', '##ona', '##se', 'activity', 'in', 'greenhouse', 'workers', 'in', 'comparison', 'with', 'the', 'healthy', 'controls', 'with', 'no', 'occupational', 'exposure', 'to', 'pesticides', '.']	[0, 4, 12, 22, 27, 33, 37, 40, 43, 52, 55, 59, 73, 82, 85, 89, 96, 99, 108, 111, 121, 123, 129, 132, 134, 146, 155, 158, 162, 165, 168, 177, 180, 191, 199, 202, 213, 218, 222, 230, 239, 244, 247, 260, 269, 272, 282]	[3, 11, 21, 26, 32, 37, 40, 42, 51, 54, 58, 72, 81, 84, 88, 95, 98, 107, 110, 121, 122, 128, 131, 133, 145, 154, 157, 162, 165, 167, 176, 179, 190, 198, 201, 212, 217, 221, 229, 238, 243, 246, 259, 268, 271, 282, 283]	['The', 'authors', 'concluded', 'that', 'while', 'lactonase', 'activity', 'is', 'not', 'significantly', 'affected', 'by', 'the', 'amount', 'of', 'exposure', 'to', 'pesticides', ',', 'there', 'is', 'a', 'significant', 'decrease', 'in', 'lactonase', 'activity', 'in', 'greenhouse', 'workers', 'in', 'comparison', 'with', 'the', 'healthy', 'controls', 'with', 'no', 'occupational', 'exposure', 'to', 'pesticides', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors tested several different organophosphate substrates and reported that higher exposure to pesticides did however lead to a significant decrease in arylesterase activity and, interestingly, to a nonsignificant increase in paraoxonase activity (Lozano-Paniagua et al., 2016).	[('PMC8045895', 'R25003', 158, 170, 'arylesterase'), ('PMC8045895', 'R25003', 232, 243, 'paraoxonase')]	['The', 'authors', 'tested', 'several', 'different', 'organ', '##ophosphate', 'substrates', 'and', 'reported', 'that', 'higher', 'exposure', 'to', 'pesticides', 'did', 'however', 'lead', 'to', 'a', 'significant', 'decrease', 'in', 'aryl', '##ester', '##ase', 'activity', 'and', ',', 'interesting', '##ly', ',', 'to', 'a', 'nons', '##ignificant', 'increase', 'in', 'para', '##oxo', '##nas', '##e', 'activity', '(', 'Lo', '##za', '##no', '-', 'Pan', '##ia', '##gu', '##a', 'et', 'al', '.', ',', '2016', ')', '.']	[0, 4, 12, 19, 27, 37, 42, 53, 64, 68, 77, 82, 89, 98, 101, 112, 116, 124, 129, 132, 134, 146, 155, 158, 162, 167, 171, 180, 183, 185, 196, 198, 200, 203, 205, 209, 220, 229, 232, 236, 239, 242, 244, 253, 254, 256, 258, 260, 261, 264, 266, 268, 270, 273, 275, 276, 278, 282, 283]	[3, 11, 18, 26, 36, 42, 52, 63, 67, 76, 81, 88, 97, 100, 111, 115, 123, 128, 131, 133, 145, 154, 157, 162, 167, 170, 179, 183, 184, 196, 198, 199, 202, 204, 209, 219, 228, 231, 236, 239, 242, 243, 252, 254, 256, 258, 260, 261, 264, 266, 268, 269, 272, 275, 276, 277, 282, 283, 284]	['The', 'authors', 'tested', 'several', 'different', 'organophosphate', 'substrates', 'and', 'reported', 'that', 'higher', 'exposure', 'to', 'pesticides', 'did', 'however', 'lead', 'to', 'a', 'significant', 'decrease', 'in', 'arylesterase', 'activity', 'and', ',', 'interestingly', ',', 'to', 'a', 'nonsignificant', 'increase', 'in', 'paraoxonase', 'activity', '(', 'Lozano-Paniagua', 'et', 'al', '.', ',', '2016', ')', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 4, 1, 1, 8, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A study followed the effects of an exercise regimen in a group of obese human subjects on the DHC lactonase and paraoxonase activities of their serum paraoxonase 1 (Russo et al., 2018).	[('PMC8045895', 'R26000', 98, 107, 'lactonase'), ('PMC8045895', 'R26000', 112, 123, 'paraoxonase'), ('PMC8045895', 'R26000', 150, 163, 'paraoxonase 1')]	['A', 'study', 'followed', 'the', 'effects', 'of', 'an', 'exercise', 'regimen', 'in', 'a', 'group', 'of', 'obese', 'human', 'subjects', 'on', 'the', 'DH', '##C', 'lact', '##ona', '##se', 'and', 'para', '##oxo', '##nas', '##e', 'activities', 'of', 'their', 'serum', 'para', '##oxo', '##nas', '##e', '1', '(', 'Russ', '##o', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 2, 8, 17, 21, 29, 32, 35, 44, 52, 55, 57, 63, 66, 72, 78, 87, 90, 94, 96, 98, 102, 105, 108, 112, 116, 119, 122, 124, 135, 138, 144, 150, 154, 157, 160, 162, 164, 165, 169, 171, 174, 176, 177, 179, 183, 184]	[1, 7, 16, 20, 28, 31, 34, 43, 51, 54, 56, 62, 65, 71, 77, 86, 89, 93, 96, 97, 102, 105, 107, 111, 116, 119, 122, 123, 134, 137, 143, 149, 154, 157, 160, 161, 163, 165, 169, 170, 173, 176, 177, 178, 183, 184, 185]	['A', 'study', 'followed', 'the', 'effects', 'of', 'an', 'exercise', 'regimen', 'in', 'a', 'group', 'of', 'obese', 'human', 'subjects', 'on', 'the', 'DHC', 'lactonase', 'and', 'paraoxonase', 'activities', 'of', 'their', 'serum', 'paraoxonase', '1', '(', 'Russo', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 4, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A significant increase in paraoxonase 1 lactonase activity was found in physically active and physically active stressed rats with respect to the sedentary and sedentary-stressed rats.	[('PMC8045895', 'R27003', 26, 39, 'paraoxonase 1'), ('PMC8045895', 'R27003', 40, 49, 'lactonase')]	['A', 'significant', 'increase', 'in', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'was', 'found', 'in', 'physically', 'active', 'and', 'physically', 'active', 'stressed', 'rats', 'with', 'respect', 'to', 'the', 'sedentary', 'and', 'sedentary', '-', 'stressed', 'rats', '.']	[0, 2, 14, 23, 26, 30, 33, 36, 38, 40, 44, 47, 50, 59, 63, 69, 72, 83, 90, 94, 105, 112, 121, 126, 131, 139, 142, 146, 156, 160, 169, 170, 179, 183]	[1, 13, 22, 25, 30, 33, 36, 37, 39, 44, 47, 49, 58, 62, 68, 71, 82, 89, 93, 104, 111, 120, 125, 130, 138, 141, 145, 155, 159, 169, 170, 178, 183, 184]	['A', 'significant', 'increase', 'in', 'paraoxonase', '1', 'lactonase', 'activity', 'was', 'found', 'in', 'physically', 'active', 'and', 'physically', 'active', 'stressed', 'rats', 'with', 'respect', 'to', 'the', 'sedentary', 'and', 'sedentary', '-', 'stressed', 'rats', '.']	[1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Significant increase in arylesterase activity was found in physically active rats in comparison with the sedentary, sedentary-stressed, and physically active stressed rats.	[('PMC8045895', 'R27004', 24, 36, 'arylesterase')]	['Significant', 'increase', 'in', 'aryl', '##ester', '##ase', 'activity', 'was', 'found', 'in', 'physically', 'active', 'rats', 'in', 'comparison', 'with', 'the', 'sedentary', ',', 'sedentary', '-', 'stressed', ',', 'and', 'physically', 'active', 'stressed', 'rats', '.']	[0, 12, 21, 24, 28, 33, 37, 46, 50, 56, 59, 70, 77, 82, 85, 96, 101, 105, 114, 116, 125, 126, 134, 136, 140, 151, 158, 167, 171]	[11, 20, 23, 28, 33, 36, 45, 49, 55, 58, 69, 76, 81, 84, 95, 100, 104, 114, 115, 125, 126, 134, 135, 139, 150, 157, 166, 171, 172]	['Significant', 'increase', 'in', 'arylesterase', 'activity', 'was', 'found', 'in', 'physically', 'active', 'rats', 'in', 'comparison', 'with', 'the', 'sedentary', ',', 'sedentary', '-', 'stressed', ',', 'and', 'physically', 'active', 'stressed', 'rats', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
paraoxonase 1 lactonase activity has been studied regarding several diseases and other medical conditions.	[('PMC8045895', 'R28000', 0, 13, 'paraoxonase 1'), ('PMC8045895', 'R28000', 14, 23, 'lactonase')]	['para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'has', 'been', 'studied', 'regarding', 'several', 'diseases', 'and', 'other', 'medical', 'conditions', '.']	[0, 4, 7, 10, 12, 14, 18, 21, 24, 33, 37, 42, 50, 60, 68, 77, 81, 87, 95, 105]	[4, 7, 10, 11, 13, 18, 21, 23, 32, 36, 41, 49, 59, 67, 76, 80, 86, 94, 105, 106]	['paraoxonase', '1', 'lactonase', 'activity', 'has', 'been', 'studied', 'regarding', 'several', 'diseases', 'and', 'other', 'medical', 'conditions', '.']	[4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of the 46 articles listed in Table 1 and discussed in this study, 28 concern themselves with various medical condition that have been associated with paraoxonase 1 lactonase activity.	[('PMC8045895', 'R28003', 150, 163, 'paraoxonase 1'), ('PMC8045895', 'R28003', 164, 173, 'lactonase')]	['Of', 'the', '46', 'articles', 'listed', 'in', 'Table', '1', 'and', 'discussed', 'in', 'this', 'study', ',', '28', 'concern', 'themselves', 'with', 'various', 'medical', 'condition', 'that', 'have', 'been', 'associated', 'with', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', '.']	[0, 3, 7, 10, 19, 26, 29, 35, 37, 41, 51, 54, 59, 64, 66, 69, 77, 88, 93, 101, 109, 119, 124, 129, 134, 145, 150, 154, 157, 160, 162, 164, 168, 171, 174, 182]	[2, 6, 9, 18, 25, 28, 34, 36, 40, 50, 53, 58, 64, 65, 68, 76, 87, 92, 100, 108, 118, 123, 128, 133, 144, 149, 154, 157, 160, 161, 163, 168, 171, 173, 182, 183]	['Of', 'the', '46', 'articles', 'listed', 'in', 'Table', '1', 'and', 'discussed', 'in', 'this', 'study', ',', '28', 'concern', 'themselves', 'with', 'various', 'medical', 'condition', 'that', 'have', 'been', 'associated', 'with', 'paraoxonase', '1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O']
Of all the medical conditions studied in association with paraoxonase 1 activity, one of the most frequently investigated one is CVD: coronary artery disease and atherosclerosis.	[('PMC8045895', 'R29000', 58, 71, 'paraoxonase 1')]	['Of', 'all', 'the', 'medical', 'conditions', 'studied', 'in', 'association', 'with', 'para', '##oxo', '##nas', '##e', '1', 'activity', ',', 'one', 'of', 'the', 'most', 'frequently', 'investigated', 'one', 'is', 'CVD', ':', 'coronary', 'artery', 'disease', 'and', 'atherosclerosis', '.']	[0, 3, 7, 11, 19, 30, 38, 41, 53, 58, 62, 65, 68, 70, 72, 80, 82, 86, 89, 93, 98, 109, 122, 126, 129, 132, 134, 143, 150, 158, 162, 177]	[2, 6, 10, 18, 29, 37, 40, 52, 57, 62, 65, 68, 69, 71, 80, 81, 85, 88, 92, 97, 108, 121, 125, 128, 132, 133, 142, 149, 157, 161, 177, 178]	['Of', 'all', 'the', 'medical', 'conditions', 'studied', 'in', 'association', 'with', 'paraoxonase', '1', 'activity', ',', 'one', 'of', 'the', 'most', 'frequently', 'investigated', 'one', 'is', 'CVD', ':', 'coronary', 'artery', 'disease', 'and', 'atherosclerosis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Many articles have been published investigating the association of these with paraoxonase 1, including six articles that included lactonase activity, four of which have been carried out on humans (Gugliucci et al., 2015; Martinelli et al., 2009; Murillo-González et al., 2020; Ponce-Ruiz et al., 2020) and two on animals (De Keyzer et al., 2009; Zhang et al., 2010).	[('PMC8045895', 'R29001', 78, 91, 'paraoxonase 1'), ('PMC8045895', 'R29001', 130, 139, 'lactonase')]	['Many', 'articles', 'have', 'been', 'published', 'investigating', 'the', 'association', 'of', 'these', 'with', 'para', '##oxo', '##nas', '##e', '1', ',', 'including', 'six', 'articles', 'that', 'included', 'lact', '##ona', '##se', 'activity', ',', 'four', 'of', 'which', 'have', 'been', 'carried', 'out', 'on', 'humans', '(', 'Gu', '##gl', '##iu', '##cc', '##i', 'et', 'al', '.', ',', '2015', ';', 'Martin', '##elli', 'et', 'al', '.', ',', '2009', ';', 'Mur', '##illo', '-', 'Gonz', '##á', '##lez', 'et', 'al', '.', ',', '202', '##0', ';', 'Pon', '##ce', '-', 'Ru', '##iz', 'et', 'al', '.', ',', '202', '##0', ')', 'and', 'two', 'on', 'animals', '(', 'De', 'Key', '##zer', 'et', 'al', '.', ',', '2009', ';', 'Zhang', 'et', 'al', '.', ',', '2010', ')', '.']	[0, 5, 14, 19, 24, 34, 48, 52, 64, 67, 73, 78, 82, 85, 88, 90, 91, 93, 103, 107, 116, 121, 130, 134, 137, 140, 148, 150, 155, 158, 164, 169, 174, 182, 186, 189, 196, 197, 199, 201, 203, 205, 207, 210, 212, 213, 215, 219, 221, 227, 232, 235, 237, 238, 240, 244, 246, 249, 253, 254, 258, 259, 263, 266, 268, 269, 271, 274, 275, 277, 280, 282, 283, 285, 288, 291, 293, 294, 296, 299, 300, 302, 306, 310, 313, 321, 322, 325, 328, 332, 335, 337, 338, 340, 344, 346, 352, 355, 357, 358, 360, 364, 365]	[4, 13, 18, 23, 33, 47, 51, 63, 66, 72, 77, 82, 85, 88, 89, 91, 92, 102, 106, 115, 120, 129, 134, 137, 139, 148, 149, 154, 157, 163, 168, 173, 181, 185, 188, 195, 197, 199, 201, 203, 205, 206, 209, 212, 213, 214, 219, 220, 227, 231, 234, 237, 238, 239, 244, 245, 249, 253, 254, 258, 259, 262, 265, 268, 269, 270, 274, 275, 276, 280, 282, 283, 285, 287, 290, 293, 294, 295, 299, 300, 301, 305, 309, 312, 320, 322, 324, 328, 331, 334, 337, 338, 339, 344, 345, 351, 354, 357, 358, 359, 364, 365, 366]	['Many', 'articles', 'have', 'been', 'published', 'investigating', 'the', 'association', 'of', 'these', 'with', 'paraoxonase', '1', ',', 'including', 'six', 'articles', 'that', 'included', 'lactonase', 'activity', ',', 'four', 'of', 'which', 'have', 'been', 'carried', 'out', 'on', 'humans', '(', 'Gugliucci', 'et', 'al', '.', ',', '2015', ';', 'Martinelli', 'et', 'al', '.', ',', '2009', ';', 'Murillo-González', 'et', 'al', '.', ',', '2020', ';', 'Ponce-Ruiz', 'et', 'al', '.', ',', '2020', ')', 'and', 'two', 'on', 'animals', '(', 'De', 'Keyzer', 'et', 'al', '.', ',', '2009', ';', 'Zhang', 'et', 'al', '.', ',', '2010', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that DHC lactonase activity was similar between the CRF and CVD groups, and both of which were significantly lower than the lactonase activity of the control group.	[('PMC8045895', 'R30001', 31, 40, 'lactonase'), ('PMC8045895', 'R30001', 146, 155, 'lactonase')]	['The', 'authors', 'concluded', 'that', 'DH', '##C', 'lact', '##ona', '##se', 'activity', 'was', 'similar', 'between', 'the', 'CRF', 'and', 'CVD', 'groups', ',', 'and', 'both', 'of', 'which', 'were', 'significantly', 'lower', 'than', 'the', 'lact', '##ona', '##se', 'activity', 'of', 'the', 'control', 'group', '.']	[0, 4, 12, 22, 27, 29, 31, 35, 38, 41, 50, 54, 62, 70, 74, 78, 82, 86, 92, 94, 98, 103, 106, 112, 117, 131, 137, 142, 146, 150, 153, 156, 165, 168, 172, 180, 185]	[3, 11, 21, 26, 29, 30, 35, 38, 40, 49, 53, 61, 69, 73, 77, 81, 85, 92, 93, 97, 102, 105, 111, 116, 130, 136, 141, 145, 150, 153, 155, 164, 167, 171, 179, 185, 186]	['The', 'authors', 'concluded', 'that', 'DHC', 'lactonase', 'activity', 'was', 'similar', 'between', 'the', 'CRF', 'and', 'CVD', 'groups', ',', 'and', 'both', 'of', 'which', 'were', 'significantly', 'lower', 'than', 'the', 'lactonase', 'activity', 'of', 'the', 'control', 'group', '.']	[1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
At first, the difference in TBBL lactonase activity between both groups was nonsignificant.	[('PMC8045895', 'R31001', 33, 42, 'lactonase')]	['At', 'first', ',', 'the', 'difference', 'in', 'TB', '##BL', 'lact', '##ona', '##se', 'activity', 'between', 'both', 'groups', 'was', 'nons', '##ignificant', '.']	[0, 3, 8, 10, 14, 25, 28, 30, 33, 37, 40, 43, 52, 60, 65, 72, 76, 80, 90]	[2, 8, 9, 13, 24, 27, 30, 32, 37, 40, 42, 51, 59, 64, 71, 75, 80, 90, 91]	['At', 'first', ',', 'the', 'difference', 'in', 'TBBL', 'lactonase', 'activity', 'between', 'both', 'groups', 'was', 'nonsignificant', '.']	[1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors then normalized TBBL activity by dividing it with 7-O-diethyl phosphoryl,3-cyano,4-methyl,7-hydroxycoumarin (DEPCyMC) activity, which has been indicated as a surrogate marker for determining paraoxonase 1 concentration (Gaidukov and Tawfik, 2007).	[('PMC8045895', 'R31002', 203, 216, 'paraoxonase 1')]	['The', 'authors', 'then', 'normalized', 'TB', '##BL', 'activity', 'by', 'dividing', 'it', 'with', '7', '-', 'O', '-', 'diet', '##hyl', 'phosphoryl', ',', '3', '-', 'cyan', '##o', ',', '4', '-', 'methyl', ',', '7', '-', 'hydroxy', '##co', '##umar', '##in', '(', 'DEP', '##Cy', '##MC', ')', 'activity', ',', 'which', 'has', 'been', 'indicated', 'as', 'a', 'surrogate', 'marker', 'for', 'determining', 'para', '##oxo', '##nas', '##e', '1', 'concentration', '(', 'Ga', '##id', '##uk', '##ov', 'and', 'Ta', '##w', '##fi', '##k', ',', '2007', ')', '.']	[0, 4, 12, 17, 28, 30, 33, 42, 45, 54, 57, 62, 63, 64, 65, 66, 70, 74, 84, 85, 86, 87, 91, 92, 93, 94, 95, 101, 102, 103, 104, 111, 113, 117, 120, 121, 124, 126, 128, 130, 138, 140, 146, 150, 155, 165, 168, 170, 180, 187, 191, 203, 207, 210, 213, 215, 217, 231, 232, 234, 236, 238, 241, 245, 247, 248, 250, 251, 253, 257, 258]	[3, 11, 16, 27, 30, 32, 41, 44, 53, 56, 61, 63, 64, 65, 66, 70, 73, 84, 85, 86, 87, 91, 92, 93, 94, 95, 101, 102, 103, 104, 111, 113, 117, 119, 121, 124, 126, 128, 129, 138, 139, 145, 149, 154, 164, 167, 169, 179, 186, 190, 202, 207, 210, 213, 214, 216, 230, 232, 234, 236, 238, 240, 244, 247, 248, 250, 251, 252, 257, 258, 259]	['The', 'authors', 'then', 'normalized', 'TBBL', 'activity', 'by', 'dividing', 'it', 'with', '7-O-diethyl', 'phosphoryl', ',', '3-cyano,4-methyl,7-hydroxycoumarin', '(', 'DEPCyMC', ')', 'activity', ',', 'which', 'has', 'been', 'indicated', 'as', 'a', 'surrogate', 'marker', 'for', 'determining', 'paraoxonase', '1', 'concentration', '(', 'Gaidukov', 'and', 'Tawfik', ',', '2007', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 6, 1, 1, 15, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The resulting normalized lactonase activity was significantly higher in the group with CAD, especially noticeable in individuals with the paraoxonase 1 192QQ genotype.	[('PMC8045895', 'R32000', 25, 34, 'lactonase'), ('PMC8045895', 'R32000', 138, 151, 'paraoxonase 1')]	['The', 'resulting', 'normalized', 'lact', '##ona', '##se', 'activity', 'was', 'significantly', 'higher', 'in', 'the', 'group', 'with', 'CAD', ',', 'especially', 'noticeable', 'in', 'individuals', 'with', 'the', 'para', '##oxo', '##nas', '##e', '1', '192', '##Q', '##Q', 'genotype', '.']	[0, 4, 14, 25, 29, 32, 35, 44, 48, 62, 69, 72, 76, 82, 87, 90, 92, 103, 114, 117, 129, 134, 138, 142, 145, 148, 150, 152, 155, 156, 158, 166]	[3, 13, 24, 29, 32, 34, 43, 47, 61, 68, 71, 75, 81, 86, 90, 91, 102, 113, 116, 128, 133, 137, 142, 145, 148, 149, 151, 155, 156, 157, 166, 167]	['The', 'resulting', 'normalized', 'lactonase', 'activity', 'was', 'significantly', 'higher', 'in', 'the', 'group', 'with', 'CAD', ',', 'especially', 'noticeable', 'in', 'individuals', 'with', 'the', 'paraoxonase', '1', '192QQ', 'genotype', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
When they grouped the CAD patients into those with and without myocardial infarction, however, they found no significant difference for any measure of lactonase activity.	[('PMC8045895', 'R32001', 151, 160, 'lactonase')]	['When', 'they', 'grouped', 'the', 'CAD', 'patients', 'into', 'those', 'with', 'and', 'without', 'myocardial', 'infarction', ',', 'however', ',', 'they', 'found', 'no', 'significant', 'difference', 'for', 'any', 'measure', 'of', 'lact', '##ona', '##se', 'activity', '.']	[0, 5, 10, 18, 22, 26, 35, 40, 46, 51, 55, 63, 74, 84, 86, 93, 95, 100, 106, 109, 121, 132, 136, 140, 148, 151, 155, 158, 161, 169]	[4, 9, 17, 21, 25, 34, 39, 45, 50, 54, 62, 73, 84, 85, 93, 94, 99, 105, 108, 120, 131, 135, 139, 147, 150, 155, 158, 160, 169, 170]	['When', 'they', 'grouped', 'the', 'CAD', 'patients', 'into', 'those', 'with', 'and', 'without', 'myocardial', 'infarction', ',', 'however', ',', 'they', 'found', 'no', 'significant', 'difference', 'for', 'any', 'measure', 'of', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Other paraoxonase 1 enzyme activities were not significantly different between any two categories of patients that they compared.	[('PMC8045895', 'R32002', 6, 19, 'paraoxonase 1')]	['Other', 'para', '##oxo', '##nas', '##e', '1', 'enzyme', 'activities', 'were', 'not', 'significantly', 'different', 'between', 'any', 'two', 'categories', 'of', 'patients', 'that', 'they', 'compared', '.']	[0, 6, 10, 13, 16, 18, 20, 27, 38, 43, 47, 61, 71, 79, 83, 87, 98, 101, 110, 115, 120, 128]	[5, 10, 13, 16, 17, 19, 26, 37, 42, 46, 60, 70, 78, 82, 86, 97, 100, 109, 114, 119, 128, 129]	['Other', 'paraoxonase', '1', 'enzyme', 'activities', 'were', 'not', 'significantly', 'different', 'between', 'any', 'two', 'categories', 'of', 'patients', 'that', 'they', 'compared', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gugliucci et al. (2015) compared two different ethnic populations, Palestinians and Israelis, and their paraoxonase 1 enzymatic activities.	[('PMC8045895', 'R33000', 104, 117, 'paraoxonase 1')]	['Gu', '##gl', '##iu', '##cc', '##i', 'et', 'al', '.', '(', '2015', ')', 'compared', 'two', 'different', 'ethnic', 'populations', ',', 'Pal', '##est', '##inia', '##ns', 'and', 'Israel', '##is', ',', 'and', 'their', 'para', '##oxo', '##nas', '##e', '1', 'enzymatic', 'activities', '.']	[0, 2, 4, 6, 8, 10, 13, 15, 17, 18, 22, 24, 33, 37, 47, 54, 65, 67, 70, 73, 77, 80, 84, 90, 92, 94, 98, 104, 108, 111, 114, 116, 118, 128, 138]	[2, 4, 6, 8, 9, 12, 15, 16, 18, 22, 23, 32, 36, 46, 53, 65, 66, 70, 73, 77, 79, 83, 90, 92, 93, 97, 103, 108, 111, 114, 115, 117, 127, 138, 139]	['Gugliucci', 'et', 'al', '.', '(', '2015', ')', 'compared', 'two', 'different', 'ethnic', 'populations', ',', 'Palestinians', 'and', 'Israelis', ',', 'and', 'their', 'paraoxonase', '1', 'enzymatic', 'activities', '.']	[5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
They found that Palestinians had significantly lower DHC lactonase and arylesterase activities, whereas paraoxonase activity was similar in both populations.	[('PMC8045895', 'R33001', 57, 66, 'lactonase'), ('PMC8045895', 'R33001', 71, 83, 'arylesterase'), ('PMC8045895', 'R33001', 104, 115, 'paraoxonase')]	['They', 'found', 'that', 'Pal', '##est', '##inia', '##ns', 'had', 'significantly', 'lower', 'DH', '##C', 'lact', '##ona', '##se', 'and', 'aryl', '##ester', '##ase', 'activities', ',', 'whereas', 'para', '##oxo', '##nas', '##e', 'activity', 'was', 'similar', 'in', 'both', 'populations', '.']	[0, 5, 11, 16, 19, 22, 26, 29, 33, 47, 53, 55, 57, 61, 64, 67, 71, 75, 80, 84, 94, 96, 104, 108, 111, 114, 116, 125, 129, 137, 140, 145, 156]	[4, 10, 15, 19, 22, 26, 28, 32, 46, 52, 55, 56, 61, 64, 66, 70, 75, 80, 83, 94, 95, 103, 108, 111, 114, 115, 124, 128, 136, 139, 144, 156, 157]	['They', 'found', 'that', 'Palestinians', 'had', 'significantly', 'lower', 'DHC', 'lactonase', 'and', 'arylesterase', 'activities', ',', 'whereas', 'paraoxonase', 'activity', 'was', 'similar', 'in', 'both', 'populations', '.']	[1, 1, 1, 4, 1, 1, 1, 2, 3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
From this finding, the authors concluded that the lower lactonase paraoxonase 1 activity in a Palestinian population is a risk factor for CAD and diabetes.	[('PMC8045895', 'R33002', 56, 65, 'lactonase'), ('PMC8045895', 'R33002', 66, 79, 'paraoxonase 1')]	['From', 'this', 'finding', ',', 'the', 'authors', 'concluded', 'that', 'the', 'lower', 'lact', '##ona', '##se', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'in', 'a', 'Pal', '##est', '##inia', '##n', 'population', 'is', 'a', 'risk', 'factor', 'for', 'CAD', 'and', 'diabetes', '.']	[0, 5, 10, 17, 19, 23, 31, 41, 46, 50, 56, 60, 63, 66, 70, 73, 76, 78, 80, 89, 92, 94, 97, 100, 104, 106, 117, 120, 122, 127, 134, 138, 142, 146, 154]	[4, 9, 17, 18, 22, 30, 40, 45, 49, 55, 60, 63, 65, 70, 73, 76, 77, 79, 88, 91, 93, 97, 100, 104, 105, 116, 119, 121, 126, 133, 137, 141, 145, 154, 155]	['From', 'this', 'finding', ',', 'the', 'authors', 'concluded', 'that', 'the', 'lower', 'lactonase', 'paraoxonase', '1', 'activity', 'in', 'a', 'Palestinian', 'population', 'is', 'a', 'risk', 'factor', 'for', 'CAD', 'and', 'diabetes', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Another study investigated paraoxonase 1 activity in apolipoprotein-deficient mice expressing human paraoxonase 1 by adenovirus-mediated insertion of human paraoxonase 1 (hPON1) into mice cells (Zhang et al., 2010).	[('PMC8045895', 'R34000', 27, 40, 'paraoxonase 1'), ('PMC8045895', 'R34000', 100, 113, 'paraoxonase 1')]	['Another', 'study', 'investigated', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'in', 'apo', '##lip', '##oprotein', '-', 'deficient', 'mice', 'expressing', 'human', 'para', '##oxo', '##nas', '##e', '1', 'by', 'adenovirus', '-', 'mediated', 'insertion', 'of', 'human', 'para', '##oxo', '##nas', '##e', '1', '(', 'h', '##PO', '##N', '##1', ')', 'into', 'mice', 'cells', '(', 'Zhang', 'et', 'al', '.', ',', '2010', ')', '.']	[0, 8, 14, 27, 31, 34, 37, 39, 41, 50, 53, 56, 59, 67, 68, 78, 83, 94, 100, 104, 107, 110, 112, 114, 117, 127, 128, 137, 147, 150, 156, 160, 163, 166, 168, 170, 171, 172, 174, 175, 176, 178, 183, 188, 194, 195, 201, 204, 206, 207, 209, 213, 214]	[7, 13, 26, 31, 34, 37, 38, 40, 49, 52, 56, 59, 67, 68, 77, 82, 93, 99, 104, 107, 110, 111, 113, 116, 127, 128, 136, 146, 149, 155, 160, 163, 166, 167, 169, 171, 172, 174, 175, 176, 177, 182, 187, 193, 195, 200, 203, 206, 207, 208, 213, 214, 215]	['Another', 'study', 'investigated', 'paraoxonase', '1', 'activity', 'in', 'apolipoprotein', '-', 'deficient', 'mice', 'expressing', 'human', 'paraoxonase', '1', 'by', 'adenovirus', '-', 'mediated', 'insertion', 'of', 'human', 'paraoxonase', '1', '(', 'hPON1', ')', 'into', 'mice', 'cells', '(', 'Zhang', 'et', 'al', '.', ',', '2010', ')', '.']	[1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors investigated the size of atherosclerotic lesions, which are a risk factor for CVD, and found that transgenic mice with overexpressed hPON1 had significantly higher DHC lactonase activity in their serum, and reduced atherosclerotic lesion size.	[('PMC8045895', 'R34001', 180, 189, 'lactonase')]	['The', 'authors', 'investigated', 'the', 'size', 'of', 'atherosclerotic', 'lesions', ',', 'which', 'are', 'a', 'risk', 'factor', 'for', 'CVD', ',', 'and', 'found', 'that', 'transgenic', 'mice', 'with', 'overexpressed', 'h', '##PO', '##N', '##1', 'had', 'significantly', 'higher', 'DH', '##C', 'lact', '##ona', '##se', 'activity', 'in', 'their', 'serum', ',', 'and', 'reduced', 'atherosclerotic', 'lesion', 'size', '.']	[0, 4, 12, 25, 29, 34, 37, 53, 60, 62, 68, 72, 74, 79, 86, 90, 93, 95, 99, 105, 110, 121, 126, 131, 145, 146, 148, 149, 151, 155, 169, 176, 178, 180, 184, 187, 190, 199, 202, 208, 213, 215, 219, 227, 243, 250, 254]	[3, 11, 24, 28, 33, 36, 52, 60, 61, 67, 71, 73, 78, 85, 89, 93, 94, 98, 104, 109, 120, 125, 130, 144, 146, 148, 149, 150, 154, 168, 175, 178, 179, 184, 187, 189, 198, 201, 207, 213, 214, 218, 226, 242, 249, 254, 255]	['The', 'authors', 'investigated', 'the', 'size', 'of', 'atherosclerotic', 'lesions', ',', 'which', 'are', 'a', 'risk', 'factor', 'for', 'CVD', ',', 'and', 'found', 'that', 'transgenic', 'mice', 'with', 'overexpressed', 'hPON1', 'had', 'significantly', 'higher', 'DHC', 'lactonase', 'activity', 'in', 'their', 'serum', ',', 'and', 'reduced', 'atherosclerotic', 'lesion', 'size', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The paraoxonase 1–atherosclerosis association has also been investigated in pigs (De Keyzer et al., 2009).	[('PMC8045895', 'R35000', 4, 17, 'paraoxonase 1')]	['The', 'para', '##oxo', '##nas', '##e', '1', '–', 'atherosclerosis', 'association', 'has', 'also', 'been', 'investigated', 'in', 'pigs', '(', 'De', 'Key', '##zer', 'et', 'al', '.', ',', '2009', ')', '.']	[0, 4, 8, 11, 14, 16, 17, 18, 34, 46, 50, 55, 60, 73, 76, 81, 82, 85, 88, 92, 95, 97, 98, 100, 104, 105]	[3, 8, 11, 14, 15, 17, 18, 33, 45, 49, 54, 59, 72, 75, 80, 82, 84, 88, 91, 94, 97, 98, 99, 104, 105, 106]	['The', 'paraoxonase', '1–', 'atherosclerosis', 'association', 'has', 'also', 'been', 'investigated', 'in', 'pigs', '(', 'De', 'Keyzer', 'et', 'al', '.', ',', '2009', ')', '.']	[1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As the group fed with a cholesterol-rich diet had both significantly higher paraoxonase 1 lactonase activity for TBBL and larger atherosclerotic plaques, the authors concluded that paraoxonase 1 lactonase activity correlates with atherosclerosis.	[('PMC8045895', 'R35002', 76, 89, 'paraoxonase 1'), ('PMC8045895', 'R35002', 90, 99, 'lactonase'), ('PMC8045895', 'R35002', 181, 194, 'paraoxonase 1')]	['As', 'the', 'group', 'fed', 'with', 'a', 'cholesterol', '-', 'rich', 'diet', 'had', 'both', 'significantly', 'higher', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'for', 'TB', '##BL', 'and', 'larger', 'atherosclerotic', 'plaques', ',', 'the', 'authors', 'concluded', 'that', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'correlates', 'with', 'atherosclerosis', '.']	[0, 3, 7, 13, 17, 22, 24, 35, 36, 41, 46, 50, 55, 69, 76, 80, 83, 86, 88, 90, 94, 97, 100, 109, 113, 115, 118, 122, 129, 145, 152, 154, 158, 166, 176, 181, 185, 188, 191, 193, 195, 199, 202, 205, 214, 225, 230, 245]	[2, 6, 12, 16, 21, 23, 35, 36, 40, 45, 49, 54, 68, 75, 80, 83, 86, 87, 89, 94, 97, 99, 108, 112, 115, 117, 121, 128, 144, 152, 153, 157, 165, 175, 180, 185, 188, 191, 192, 194, 199, 202, 204, 213, 224, 229, 245, 246]	['As', 'the', 'group', 'fed', 'with', 'a', 'cholesterol', '-', 'rich', 'diet', 'had', 'both', 'significantly', 'higher', 'paraoxonase', '1', 'lactonase', 'activity', 'for', 'TBBL', 'and', 'larger', 'atherosclerotic', 'plaques', ',', 'the', 'authors', 'concluded', 'that', 'paraoxonase', '1', 'lactonase', 'activity', 'correlates', 'with', 'atherosclerosis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
paraoxonase 1 lactonase activity has also been investigated in association with liver illnesses.	[('PMC8045895', 'R36000', 0, 13, 'paraoxonase 1'), ('PMC8045895', 'R36000', 14, 23, 'lactonase')]	['para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'has', 'also', 'been', 'investigated', 'in', 'association', 'with', 'liver', 'illnesses', '.']	[0, 4, 7, 10, 12, 14, 18, 21, 24, 33, 37, 42, 47, 60, 63, 75, 80, 86, 95]	[4, 7, 10, 11, 13, 18, 21, 23, 32, 36, 41, 46, 59, 62, 74, 79, 85, 95, 96]	['paraoxonase', '1', 'lactonase', 'activity', 'has', 'also', 'been', 'investigated', 'in', 'association', 'with', 'liver', 'illnesses', '.']	[4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It was found that paraoxonase 1 lactonase activity for DHC was significantly lower in alcoholic hepatitis compared with controls, and being significantly lower in viral hepatitis compared with alcoholic hepatitis.	[('PMC8045895', 'R36002', 18, 31, 'paraoxonase 1'), ('PMC8045895', 'R36002', 32, 41, 'lactonase')]	['It', 'was', 'found', 'that', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'for', 'DH', '##C', 'was', 'significantly', 'lower', 'in', 'alcoholic', 'hepatitis', 'compared', 'with', 'controls', ',', 'and', 'being', 'significantly', 'lower', 'in', 'viral', 'hepatitis', 'compared', 'with', 'alcoholic', 'hepatitis', '.']	[0, 3, 7, 13, 18, 22, 25, 28, 30, 32, 36, 39, 42, 51, 55, 57, 59, 63, 77, 83, 86, 96, 106, 115, 120, 128, 130, 134, 140, 154, 160, 163, 169, 179, 188, 193, 203, 212]	[2, 6, 12, 17, 22, 25, 28, 29, 31, 36, 39, 41, 50, 54, 57, 58, 62, 76, 82, 85, 95, 105, 114, 119, 128, 129, 133, 139, 153, 159, 162, 168, 178, 187, 192, 202, 212, 213]	['It', 'was', 'found', 'that', 'paraoxonase', '1', 'lactonase', 'activity', 'for', 'DHC', 'was', 'significantly', 'lower', 'in', 'alcoholic', 'hepatitis', 'compared', 'with', 'controls', ',', 'and', 'being', 'significantly', 'lower', 'in', 'viral', 'hepatitis', 'compared', 'with', 'alcoholic', 'hepatitis', '.']	[1, 1, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Both significant differences were the same for arylesterase activity.	[('PMC8045895', 'R36003', 47, 59, 'arylesterase')]	['Both', 'significant', 'differences', 'were', 'the', 'same', 'for', 'aryl', '##ester', '##ase', 'activity', '.']	[0, 5, 17, 29, 34, 38, 43, 47, 51, 56, 60, 68]	[4, 16, 28, 33, 37, 42, 46, 51, 56, 59, 68, 69]	['Both', 'significant', 'differences', 'were', 'the', 'same', 'for', 'arylesterase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
In another article, the authors investigated TBBL lactonase activity of paraoxonase 1 in individuals with liver cirrhosis and patients with mild-to-moderate changes in liver function (Marsillach et al., 2009).	[('PMC8045895', 'R37000', 50, 59, 'lactonase'), ('PMC8045895', 'R37000', 72, 85, 'paraoxonase 1')]	['In', 'another', 'article', ',', 'the', 'authors', 'investigated', 'TB', '##BL', 'lact', '##ona', '##se', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', 'in', 'individuals', 'with', 'liver', 'cirrhosis', 'and', 'patients', 'with', 'mild', '-', 'to', '-', 'moderate', 'changes', 'in', 'liver', 'function', '(', 'Mars', '##illa', '##ch', 'et', 'al', '.', ',', '2009', ')', '.']	[0, 3, 11, 18, 20, 24, 32, 45, 47, 50, 54, 57, 60, 69, 72, 76, 79, 82, 84, 86, 89, 101, 106, 112, 122, 126, 135, 140, 144, 145, 147, 148, 157, 165, 168, 174, 183, 184, 188, 192, 195, 198, 200, 201, 203, 207, 208]	[2, 10, 18, 19, 23, 31, 44, 47, 49, 54, 57, 59, 68, 71, 76, 79, 82, 83, 85, 88, 100, 105, 111, 121, 125, 134, 139, 144, 145, 147, 148, 156, 164, 167, 173, 182, 184, 188, 192, 194, 197, 200, 201, 202, 207, 208, 209]	['In', 'another', 'article', ',', 'the', 'authors', 'investigated', 'TBBL', 'lactonase', 'activity', 'of', 'paraoxonase', '1', 'in', 'individuals', 'with', 'liver', 'cirrhosis', 'and', 'patients', 'with', 'mild', '-', 'to', '-', 'moderate', 'changes', 'in', 'liver', 'function', '(', 'Marsillach', 'et', 'al', '.', ',', '2009', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors did not find a statistically significant correlation between enzymatic activities of paraoxonase 1 and the presence and/or severity of disease.	[('PMC8045895', 'R37001', 97, 110, 'paraoxonase 1')]	['The', 'authors', 'did', 'not', 'find', 'a', 'statistically', 'significant', 'correlation', 'between', 'enzymatic', 'activities', 'of', 'para', '##oxo', '##nas', '##e', '1', 'and', 'the', 'presence', 'and', '/', 'or', 'severity', 'of', 'disease', '.']	[0, 4, 12, 16, 20, 25, 27, 41, 53, 65, 73, 83, 94, 97, 101, 104, 107, 109, 111, 115, 119, 128, 131, 132, 135, 144, 147, 154]	[3, 11, 15, 19, 24, 26, 40, 52, 64, 72, 82, 93, 96, 101, 104, 107, 108, 110, 114, 118, 127, 131, 132, 134, 143, 146, 154, 155]	['The', 'authors', 'did', 'not', 'find', 'a', 'statistically', 'significant', 'correlation', 'between', 'enzymatic', 'activities', 'of', 'paraoxonase', '1', 'and', 'the', 'presence', 'and', '/', 'or', 'severity', 'of', 'disease', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Serum lactonase activity for DHC was also investigated in dairy cows (Samir Farid et al., 2013).	[('PMC8045895', 'R38000', 6, 15, 'lactonase')]	['Serum', 'lact', '##ona', '##se', 'activity', 'for', 'DH', '##C', 'was', 'also', 'investigated', 'in', 'dairy', 'cows', '(', 'Sam', '##ir', 'Far', '##id', 'et', 'al', '.', ',', '2013', ')', '.']	[0, 6, 10, 13, 16, 25, 29, 31, 33, 37, 42, 55, 58, 64, 69, 70, 73, 76, 79, 82, 85, 87, 88, 90, 94, 95]	[5, 10, 13, 15, 24, 28, 31, 32, 36, 41, 54, 57, 63, 68, 70, 73, 75, 79, 81, 84, 87, 88, 89, 94, 95, 96]	['Serum', 'lactonase', 'activity', 'for', 'DHC', 'was', 'also', 'investigated', 'in', 'dairy', 'cows', '(', 'Samir', 'Farid', 'et', 'al', '.', ',', '2013', ')', '.']	[1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that paraoxonase, DHC lactonase, and arylesterase activity were all significantly lower in animals with fatty liver compared with the control group.	[('PMC8045895', 'R38002', 27, 38, 'paraoxonase'), ('PMC8045895', 'R38002', 44, 53, 'lactonase'), ('PMC8045895', 'R38002', 59, 71, 'arylesterase')]	['The', 'authors', 'concluded', 'that', 'para', '##oxo', '##nas', '##e', ',', 'DH', '##C', 'lact', '##ona', '##se', ',', 'and', 'aryl', '##ester', '##ase', 'activity', 'were', 'all', 'significantly', 'lower', 'in', 'animals', 'with', 'fatty', 'liver', 'compared', 'with', 'the', 'control', 'group', '.']	[0, 4, 12, 22, 27, 31, 34, 37, 38, 40, 42, 44, 48, 51, 53, 55, 59, 63, 68, 72, 81, 86, 90, 104, 110, 113, 121, 126, 132, 138, 147, 152, 156, 164, 169]	[3, 11, 21, 26, 31, 34, 37, 38, 39, 42, 43, 48, 51, 53, 54, 58, 63, 68, 71, 80, 85, 89, 103, 109, 112, 120, 125, 131, 137, 146, 151, 155, 163, 169, 170]	['The', 'authors', 'concluded', 'that', 'paraoxonase', ',', 'DHC', 'lactonase', ',', 'and', 'arylesterase', 'activity', 'were', 'all', 'significantly', 'lower', 'in', 'animals', 'with', 'fatty', 'liver', 'compared', 'with', 'the', 'control', 'group', '.']	[1, 1, 1, 1, 4, 1, 2, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Another factor that has been thoroughly studied in association with paraoxonase 1 lactonase activity is body weight.	[('PMC8045895', 'R39000', 68, 81, 'paraoxonase 1'), ('PMC8045895', 'R39000', 82, 91, 'lactonase')]	['Another', 'factor', 'that', 'has', 'been', 'thoroughly', 'studied', 'in', 'association', 'with', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'is', 'body', 'weight', '.']	[0, 8, 15, 20, 24, 29, 40, 48, 51, 63, 68, 72, 75, 78, 80, 82, 86, 89, 92, 101, 104, 109, 115]	[7, 14, 19, 23, 28, 39, 47, 50, 62, 67, 72, 75, 78, 79, 81, 86, 89, 91, 100, 103, 108, 115, 116]	['Another', 'factor', 'that', 'has', 'been', 'thoroughly', 'studied', 'in', 'association', 'with', 'paraoxonase', '1', 'lactonase', 'activity', 'is', 'body', 'weight', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Three articles reported on the association between body weight and DHC lactonase activity (Alaminos-Castillo et al., 2019; Bacchetti et al., 2019; Rupérez et al., 2013), Ferré et al. (2013) investigated TBBL and Cervellati et al.	[('PMC8045895', 'R39001', 71, 80, 'lactonase')]	['Three', 'articles', 'reported', 'on', 'the', 'association', 'between', 'body', 'weight', 'and', 'DH', '##C', 'lact', '##ona', '##se', 'activity', '(', 'Ala', '##min', '##os', '-', 'Cast', '##illo', 'et', 'al', '.', ',', '201', '##9', ';', 'Bac', '##che', '##tt', '##i', 'et', 'al', '.', ',', '201', '##9', ';', 'Ru', '##p', '##ér', '##ez', 'et', 'al', '.', ',', '2013', ')', ',', 'Ferr', '##é', 'et', 'al', '.', '(', '2013', ')', 'investigated', 'TB', '##BL', 'and', 'Cer', '##vel', '##lat', '##i', 'et', 'al', '.']	[0, 6, 15, 24, 27, 31, 43, 51, 56, 63, 67, 69, 71, 75, 78, 81, 90, 91, 94, 97, 99, 100, 104, 109, 112, 114, 115, 117, 120, 121, 123, 126, 129, 131, 133, 136, 138, 139, 141, 144, 145, 147, 149, 150, 152, 155, 158, 160, 161, 163, 167, 168, 170, 174, 176, 179, 181, 183, 184, 188, 190, 203, 205, 208, 212, 215, 218, 221, 223, 226, 228]	[5, 14, 23, 26, 30, 42, 50, 55, 62, 66, 69, 70, 75, 78, 80, 89, 91, 94, 97, 99, 100, 104, 108, 111, 114, 115, 116, 120, 121, 122, 126, 129, 131, 132, 135, 138, 139, 140, 144, 145, 146, 149, 150, 152, 154, 157, 160, 161, 162, 167, 168, 169, 174, 175, 178, 181, 182, 184, 188, 189, 202, 205, 207, 211, 215, 218, 221, 222, 225, 228, 229]	['Three', 'articles', 'reported', 'on', 'the', 'association', 'between', 'body', 'weight', 'and', 'DHC', 'lactonase', 'activity', '(', 'Alaminos-Castillo', 'et', 'al', '.', ',', '2019', ';', 'Bacchetti', 'et', 'al', '.', ',', '2019', ';', 'Rupérez', 'et', 'al', '.', ',', '2013', ')', ',', 'Ferré', 'et', 'al', '.', '(', '2013', ')', 'investigated', 'TBBL', 'and', 'Cervellati', 'et', 'al', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 6, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of these five articles, three of them found a significant correlation between paraoxonase 1 lactonase activity and obesity (Alaminos-Castillo et al., 2019; Bacchetti et al., 2019; Ferré et al., 2013).	[('PMC8045895', 'R39004', 78, 91, 'paraoxonase 1'), ('PMC8045895', 'R39004', 92, 101, 'lactonase')]	['Of', 'these', 'five', 'articles', ',', 'three', 'of', 'them', 'found', 'a', 'significant', 'correlation', 'between', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'and', 'obesity', '(', 'Ala', '##min', '##os', '-', 'Cast', '##illo', 'et', 'al', '.', ',', '201', '##9', ';', 'Bac', '##che', '##tt', '##i', 'et', 'al', '.', ',', '201', '##9', ';', 'Ferr', '##é', 'et', 'al', '.', ',', '2013', ')', '.']	[0, 3, 9, 14, 22, 24, 30, 33, 38, 44, 46, 58, 70, 78, 82, 85, 88, 90, 92, 96, 99, 102, 111, 115, 123, 124, 127, 130, 132, 133, 137, 142, 145, 147, 148, 150, 153, 154, 156, 159, 162, 164, 166, 169, 171, 172, 174, 177, 178, 180, 184, 186, 189, 191, 192, 194, 198, 199]	[2, 8, 13, 22, 23, 29, 32, 37, 43, 45, 57, 69, 77, 82, 85, 88, 89, 91, 96, 99, 101, 110, 114, 122, 124, 127, 130, 132, 133, 137, 141, 144, 147, 148, 149, 153, 154, 155, 159, 162, 164, 165, 168, 171, 172, 173, 177, 178, 179, 184, 185, 188, 191, 192, 193, 198, 199, 200]	['Of', 'these', 'five', 'articles', ',', 'three', 'of', 'them', 'found', 'a', 'significant', 'correlation', 'between', 'paraoxonase', '1', 'lactonase', 'activity', 'and', 'obesity', '(', 'Alaminos-Castillo', 'et', 'al', '.', ',', '2019', ';', 'Bacchetti', 'et', 'al', '.', ',', '2019', ';', 'Ferré', 'et', 'al', '.', ',', '2013', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 6, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alaminos-Castillo et al. (2019) reported that DHC lactonase activity is significantly decreased in obese subjects compared with nonobese controls, and increases after surgery.	[('PMC8045895', 'R40000', 50, 59, 'lactonase')]	['Ala', '##min', '##os', '-', 'Cast', '##illo', 'et', 'al', '.', '(', '201', '##9', ')', 'reported', 'that', 'DH', '##C', 'lact', '##ona', '##se', 'activity', 'is', 'significantly', 'decreased', 'in', 'obese', 'subjects', 'compared', 'with', 'non', '##obe', '##se', 'controls', ',', 'and', 'increases', 'after', 'surgery', '.']	[0, 3, 6, 8, 9, 13, 18, 21, 23, 25, 26, 29, 30, 32, 41, 46, 48, 50, 54, 57, 60, 69, 72, 86, 96, 99, 105, 114, 123, 128, 131, 134, 137, 145, 147, 151, 161, 167, 174]	[3, 6, 8, 9, 13, 17, 20, 23, 24, 26, 29, 30, 31, 40, 45, 48, 49, 54, 57, 59, 68, 71, 85, 95, 98, 104, 113, 122, 127, 131, 134, 136, 145, 146, 150, 160, 166, 174, 175]	['Alaminos-Castillo', 'et', 'al', '.', '(', '2019', ')', 'reported', 'that', 'DHC', 'lactonase', 'activity', 'is', 'significantly', 'decreased', 'in', 'obese', 'subjects', 'compared', 'with', 'nonobese', 'controls', ',', 'and', 'increases', 'after', 'surgery', '.']	[6, 1, 1, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacchetti et al. (2019) grouped cases into two categories, overweight women and obese women, and detected that DHC lactonase activity is significantly decreased in each subsequent category compared with healthy individuals (Bacchetti et al., 2019).	[('PMC8045895', 'R40001', 115, 124, 'lactonase')]	['Bac', '##che', '##tt', '##i', 'et', 'al', '.', '(', '201', '##9', ')', 'grouped', 'cases', 'into', 'two', 'categories', ',', 'overweight', 'women', 'and', 'obese', 'women', ',', 'and', 'detected', 'that', 'DH', '##C', 'lact', '##ona', '##se', 'activity', 'is', 'significantly', 'decreased', 'in', 'each', 'subsequent', 'category', 'compared', 'with', 'healthy', 'individuals', '(', 'Bac', '##che', '##tt', '##i', 'et', 'al', '.', ',', '201', '##9', ')', '.']	[0, 3, 6, 8, 10, 13, 15, 17, 18, 21, 22, 24, 32, 38, 43, 47, 57, 59, 70, 76, 80, 86, 91, 93, 97, 106, 111, 113, 115, 119, 122, 125, 134, 137, 151, 161, 164, 169, 180, 189, 198, 203, 211, 223, 224, 227, 230, 232, 234, 237, 239, 240, 242, 245, 246, 247]	[3, 6, 8, 9, 12, 15, 16, 18, 21, 22, 23, 31, 37, 42, 46, 57, 58, 69, 75, 79, 85, 91, 92, 96, 105, 110, 113, 114, 119, 122, 124, 133, 136, 150, 160, 163, 168, 179, 188, 197, 202, 210, 222, 224, 227, 230, 232, 233, 236, 239, 240, 241, 245, 246, 247, 248]	['Bacchetti', 'et', 'al', '.', '(', '2019', ')', 'grouped', 'cases', 'into', 'two', 'categories', ',', 'overweight', 'women', 'and', 'obese', 'women', ',', 'and', 'detected', 'that', 'DHC', 'lactonase', 'activity', 'is', 'significantly', 'decreased', 'in', 'each', 'subsequent', 'category', 'compared', 'with', 'healthy', 'individuals', '(', 'Bacchetti', 'et', 'al', '.', ',', '2019', ')', '.']	[4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Ferré et al. (2013) showed a significant decrease in TBBL lactonase activity in obese children compared with nonobese controls.	[('PMC8045895', 'R40002', 58, 67, 'lactonase')]	['Ferr', '##é', 'et', 'al', '.', '(', '2013', ')', 'showed', 'a', 'significant', 'decrease', 'in', 'TB', '##BL', 'lact', '##ona', '##se', 'activity', 'in', 'obese', 'children', 'compared', 'with', 'non', '##obe', '##se', 'controls', '.']	[0, 4, 6, 9, 11, 13, 14, 18, 20, 27, 29, 41, 50, 53, 55, 58, 62, 65, 68, 77, 80, 86, 95, 104, 109, 112, 115, 118, 126]	[4, 5, 8, 11, 12, 14, 18, 19, 26, 28, 40, 49, 52, 55, 57, 62, 65, 67, 76, 79, 85, 94, 103, 108, 112, 115, 117, 126, 127]	['Ferré', 'et', 'al', '.', '(', '2013', ')', 'showed', 'a', 'significant', 'decrease', 'in', 'TBBL', 'lactonase', 'activity', 'in', 'obese', 'children', 'compared', 'with', 'nonobese', 'controls', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
paraoxonase 1 concentration was the same in both groups, based on which the authors suggested that in obese children, there is higher oxidative stress, which leads to partial inhibition of paraoxonase 1 by lipid peroxides.	[('PMC8045895', 'R40003', 0, 13, 'paraoxonase 1'), ('PMC8045895', 'R40003', 189, 202, 'paraoxonase 1')]	['para', '##oxo', '##nas', '##e', '1', 'concentration', 'was', 'the', 'same', 'in', 'both', 'groups', ',', 'based', 'on', 'which', 'the', 'authors', 'suggested', 'that', 'in', 'obese', 'children', ',', 'there', 'is', 'higher', 'oxidative', 'stress', ',', 'which', 'leads', 'to', 'partial', 'inhibition', 'of', 'para', '##oxo', '##nas', '##e', '1', 'by', 'lipid', 'peroxide', '##s', '.']	[0, 4, 7, 10, 12, 14, 28, 32, 36, 41, 44, 49, 55, 57, 63, 66, 72, 76, 84, 94, 99, 102, 108, 116, 118, 124, 127, 134, 144, 150, 152, 158, 164, 167, 175, 186, 189, 193, 196, 199, 201, 203, 206, 212, 220, 221]	[4, 7, 10, 11, 13, 27, 31, 35, 40, 43, 48, 55, 56, 62, 65, 71, 75, 83, 93, 98, 101, 107, 116, 117, 123, 126, 133, 143, 150, 151, 157, 163, 166, 174, 185, 188, 193, 196, 199, 200, 202, 205, 211, 220, 221, 222]	['paraoxonase', '1', 'concentration', 'was', 'the', 'same', 'in', 'both', 'groups', ',', 'based', 'on', 'which', 'the', 'authors', 'suggested', 'that', 'in', 'obese', 'children', ',', 'there', 'is', 'higher', 'oxidative', 'stress', ',', 'which', 'leads', 'to', 'partial', 'inhibition', 'of', 'paraoxonase', '1', 'by', 'lipid', 'peroxides', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Rupérez et al (2013) did not find an association between paraoxonase 1 lactonase activity and obesity.	[('PMC8045895', 'R41000', 57, 70, 'paraoxonase 1'), ('PMC8045895', 'R41000', 71, 80, 'lactonase')]	['Ru', '##p', '##ér', '##ez', 'et', 'al', '(', '2013', ')', 'did', 'not', 'find', 'an', 'association', 'between', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'and', 'obesity', '.']	[0, 2, 3, 5, 8, 11, 14, 15, 19, 21, 25, 29, 34, 37, 49, 57, 61, 64, 67, 69, 71, 75, 78, 81, 90, 94, 101]	[2, 3, 5, 7, 10, 13, 15, 19, 20, 24, 28, 33, 36, 48, 56, 61, 64, 67, 68, 70, 75, 78, 80, 89, 93, 101, 102]	['Rupérez', 'et', 'al', '(', '2013', ')', 'did', 'not', 'find', 'an', 'association', 'between', 'paraoxonase', '1', 'lactonase', 'activity', 'and', 'obesity', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
Although the authors did not find an association between childhood obesity and any of paraoxonase 1's enzymatic activities, they did find a positive correlation of DHC lactonase activity with HDL, as well as with concentration of antioxidants.	[('PMC8045895', 'R41001', 86, 99, 'paraoxonase 1'), ('PMC8045895', 'R41001', 168, 177, 'lactonase')]	"['Although', 'the', 'authors', 'did', 'not', 'find', 'an', 'association', 'between', 'childhood', 'obesity', 'and', 'any', 'of', 'para', '##oxo', '##nas', '##e', '1', ""'"", 's', 'enzymatic', 'activities', ',', 'they', 'did', 'find', 'a', 'positive', 'correlation', 'of', 'DH', '##C', 'lact', '##ona', '##se', 'activity', 'with', 'HDL', ',', 'as', 'well', 'as', 'with', 'concentration', 'of', 'antioxidants', '.']"	[0, 9, 13, 21, 25, 29, 34, 37, 49, 57, 67, 75, 79, 83, 86, 90, 93, 96, 98, 99, 100, 102, 112, 122, 124, 129, 133, 138, 140, 149, 161, 164, 166, 168, 172, 175, 178, 187, 192, 195, 197, 200, 205, 208, 213, 227, 230, 242]	[8, 12, 20, 24, 28, 33, 36, 48, 56, 66, 74, 78, 82, 85, 90, 93, 96, 97, 99, 100, 101, 111, 122, 123, 128, 132, 137, 139, 148, 160, 163, 166, 167, 172, 175, 177, 186, 191, 195, 196, 199, 204, 207, 212, 226, 229, 242, 243]	"['Although', 'the', 'authors', 'did', 'not', 'find', 'an', 'association', 'between', 'childhood', 'obesity', 'and', 'any', 'of', 'paraoxonase', ""1's"", 'enzymatic', 'activities', ',', 'they', 'did', 'find', 'a', 'positive', 'correlation', 'of', 'DHC', 'lactonase', 'activity', 'with', 'HDL', ',', 'as', 'well', 'as', 'with', 'concentration', 'of', 'antioxidants', '.']"	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
demonstrated a significant decrease in arylesterase activity in very obese subjects; however, they did not show any difference in paraoxonase activity and TBBL lactonase activity between the groups.	[('PMC8045895', 'R41004', 39, 51, 'arylesterase'), ('PMC8045895', 'R41004', 130, 141, 'paraoxonase'), ('PMC8045895', 'R41004', 160, 169, 'lactonase')]	['demonstrated', 'a', 'significant', 'decrease', 'in', 'aryl', '##ester', '##ase', 'activity', 'in', 'very', 'obese', 'subjects', ';', 'however', ',', 'they', 'did', 'not', 'show', 'any', 'difference', 'in', 'para', '##oxo', '##nas', '##e', 'activity', 'and', 'TB', '##BL', 'lact', '##ona', '##se', 'activity', 'between', 'the', 'groups', '.']	[0, 13, 15, 27, 36, 39, 43, 48, 52, 61, 64, 69, 75, 83, 85, 92, 94, 99, 103, 107, 112, 116, 127, 130, 134, 137, 140, 142, 151, 155, 157, 160, 164, 167, 170, 179, 187, 191, 197]	[12, 14, 26, 35, 38, 43, 48, 51, 60, 63, 68, 74, 83, 84, 92, 93, 98, 102, 106, 111, 115, 126, 129, 134, 137, 140, 141, 150, 154, 157, 159, 164, 167, 169, 178, 186, 190, 197, 198]	['demonstrated', 'a', 'significant', 'decrease', 'in', 'arylesterase', 'activity', 'in', 'very', 'obese', 'subjects', ';', 'however', ',', 'they', 'did', 'not', 'show', 'any', 'difference', 'in', 'paraoxonase', 'activity', 'and', 'TBBL', 'lactonase', 'activity', 'between', 'the', 'groups', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Hence, the authors concluded that the apparent obesity-associated decrease of paraoxonase 1 activity might simply reflect the decrease in concentration of HDL.	[('PMC8045895', 'R41005', 78, 91, 'paraoxonase 1')]	['Hence', ',', 'the', 'authors', 'concluded', 'that', 'the', 'apparent', 'obesity', '-', 'associated', 'decrease', 'of', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'might', 'simply', 'reflect', 'the', 'decrease', 'in', 'concentration', 'of', 'HDL', '.']	[0, 5, 7, 11, 19, 29, 34, 38, 47, 54, 55, 66, 75, 78, 82, 85, 88, 90, 92, 101, 107, 114, 122, 126, 135, 138, 152, 155, 158]	[5, 6, 10, 18, 28, 33, 37, 46, 54, 55, 65, 74, 77, 82, 85, 88, 89, 91, 100, 106, 113, 121, 125, 134, 137, 151, 154, 158, 159]	['Hence', ',', 'the', 'authors', 'concluded', 'that', 'the', 'apparent', 'obesity', '-', 'associated', 'decrease', 'of', 'paraoxonase', '1', 'activity', 'might', 'simply', 'reflect', 'the', 'decrease', 'in', 'concentration', 'of', 'HDL', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five articles reported on paraoxonase 1 lactonase activity in the context of diabetes (Craciun et al., 2016, Rosenblat et al., 2006, Passaro et al., 2018, Zhou et al., 2020a, 2020b).	[('PMC8045895', 'R42000', 26, 39, 'paraoxonase 1'), ('PMC8045895', 'R42000', 40, 49, 'lactonase')]	['Five', 'articles', 'reported', 'on', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'in', 'the', 'context', 'of', 'diabetes', '(', 'Cra', '##ci', '##un', 'et', 'al', '.', ',', '2016', ',', 'Rosen', '##bl', '##at', 'et', 'al', '.', ',', '2006', ',', 'Pass', '##aro', 'et', 'al', '.', ',', '2018', ',', 'Zhou', 'et', 'al', '.', ',', '202', '##0', '##a', ',', '202', '##0', '##b', ')', '.']	[0, 5, 14, 23, 26, 30, 33, 36, 38, 40, 44, 47, 50, 59, 62, 66, 74, 77, 86, 87, 90, 92, 95, 98, 100, 101, 103, 107, 109, 114, 116, 119, 122, 124, 125, 127, 131, 133, 137, 141, 144, 146, 147, 149, 153, 155, 160, 163, 165, 166, 168, 171, 172, 173, 175, 178, 179, 180, 181]	[4, 13, 22, 25, 30, 33, 36, 37, 39, 44, 47, 49, 58, 61, 65, 73, 76, 85, 87, 90, 92, 94, 97, 100, 101, 102, 107, 108, 114, 116, 118, 121, 124, 125, 126, 131, 132, 137, 140, 143, 146, 147, 148, 153, 154, 159, 162, 165, 166, 167, 171, 172, 173, 174, 178, 179, 180, 181, 182]	['Five', 'articles', 'reported', 'on', 'paraoxonase', '1', 'lactonase', 'activity', 'in', 'the', 'context', 'of', 'diabetes', '(', 'Craciun', 'et', 'al', '.', ',', '2016', ',', 'Rosenblat', 'et', 'al', '.', ',', '2006', ',', 'Passaro', 'et', 'al', '.', ',', '2018', ',', 'Zhou', 'et', 'al', '.', ',', '2020a', ',', '2020b', ')', '.']	[1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In women with gestational diabetes mellitus, no significant difference was found in either TBBL lactonase activity or paraoxonase 1 concentration between women with diabetes and healthy controls (Zhou et al., 2020a).	[('PMC8045895', 'R43000', 96, 105, 'lactonase'), ('PMC8045895', 'R43000', 118, 131, 'paraoxonase 1')]	['In', 'women', 'with', 'gestational', 'diabetes', 'mellitus', ',', 'no', 'significant', 'difference', 'was', 'found', 'in', 'either', 'TB', '##BL', 'lact', '##ona', '##se', 'activity', 'or', 'para', '##oxo', '##nas', '##e', '1', 'concentration', 'between', 'women', 'with', 'diabetes', 'and', 'healthy', 'controls', '(', 'Zhou', 'et', 'al', '.', ',', '202', '##0', '##a', ')', '.']	[0, 3, 9, 14, 26, 35, 43, 45, 48, 60, 71, 75, 81, 84, 91, 93, 96, 100, 103, 106, 115, 118, 122, 125, 128, 130, 132, 146, 154, 160, 165, 174, 178, 186, 195, 196, 201, 204, 206, 207, 209, 212, 213, 214, 215]	[2, 8, 13, 25, 34, 43, 44, 47, 59, 70, 74, 80, 83, 90, 93, 95, 100, 103, 105, 114, 117, 122, 125, 128, 129, 131, 145, 153, 159, 164, 173, 177, 185, 194, 196, 200, 203, 206, 207, 208, 212, 213, 214, 215, 216]	['In', 'women', 'with', 'gestational', 'diabetes', 'mellitus', ',', 'no', 'significant', 'difference', 'was', 'found', 'in', 'either', 'TBBL', 'lactonase', 'activity', 'or', 'paraoxonase', '1', 'concentration', 'between', 'women', 'with', 'diabetes', 'and', 'healthy', 'controls', '(', 'Zhou', 'et', 'al', '.', ',', '2020a', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A significant decrease in δ-valerolactone lactonase activity was noted between controls and patients who had both type 1 diabetes and a high amount of hemoglobin glycation.	[('PMC8045895', 'R44001', 26, 51, 'δ-valerolactone lactonase')]	['A', 'significant', 'decrease', 'in', 'δ', '-', 'val', '##ero', '##lact', '##one', 'lact', '##ona', '##se', 'activity', 'was', 'noted', 'between', 'controls', 'and', 'patients', 'who', 'had', 'both', 'type', '1', 'diabetes', 'and', 'a', 'high', 'amount', 'of', 'hemoglobin', 'glyc', '##ation', '.']	[0, 2, 14, 23, 26, 27, 28, 31, 34, 38, 42, 46, 49, 52, 61, 65, 71, 79, 88, 92, 101, 105, 109, 114, 119, 121, 130, 134, 136, 141, 148, 151, 162, 166, 171]	[1, 13, 22, 25, 27, 28, 31, 34, 38, 41, 46, 49, 51, 60, 64, 70, 78, 87, 91, 100, 104, 108, 113, 118, 120, 129, 133, 135, 140, 147, 150, 161, 166, 171, 172]	['A', 'significant', 'decrease', 'in', 'δ-valerolactone', 'lactonase', 'activity', 'was', 'noted', 'between', 'controls', 'and', 'patients', 'who', 'had', 'both', 'type', '1', 'diabetes', 'and', 'a', 'high', 'amount', 'of', 'hemoglobin', 'glycation', '.']	[1, 1, 1, 1, 6, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
No difference was found between cases and controls for any other type of paraoxonase 1 activity (paraoxonase or arylesterase).	[('PMC8045895', 'R44002', 73, 86, 'paraoxonase 1'), ('PMC8045895', 'R44002', 97, 108, 'paraoxonase'), ('PMC8045895', 'R44002', 112, 124, 'arylesterase')]	['No', 'difference', 'was', 'found', 'between', 'cases', 'and', 'controls', 'for', 'any', 'other', 'type', 'of', 'para', '##oxo', '##nas', '##e', '1', 'activity', '(', 'para', '##oxo', '##nas', '##e', 'or', 'aryl', '##ester', '##ase', ')', '.']	[0, 3, 14, 18, 24, 32, 38, 42, 51, 55, 59, 65, 70, 73, 77, 80, 83, 85, 87, 96, 97, 101, 104, 107, 109, 112, 116, 121, 124, 125]	[2, 13, 17, 23, 31, 37, 41, 50, 54, 58, 64, 69, 72, 77, 80, 83, 84, 86, 95, 97, 101, 104, 107, 108, 111, 116, 121, 124, 125, 126]	['No', 'difference', 'was', 'found', 'between', 'cases', 'and', 'controls', 'for', 'any', 'other', 'type', 'of', 'paraoxonase', '1', 'activity', '(', 'paraoxonase', 'or', 'arylesterase', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O']
DHC lactonase activity was also investigated in a study that compared patients with diabetes, patients with hypercholesterolemia, and healthy controls.	[('PMC8045895', 'R45000', 4, 13, 'lactonase')]	['DH', '##C', 'lact', '##ona', '##se', 'activity', 'was', 'also', 'investigated', 'in', 'a', 'study', 'that', 'compared', 'patients', 'with', 'diabetes', ',', 'patients', 'with', 'hyper', '##cholesterol', '##emia', ',', 'and', 'healthy', 'controls', '.']	[0, 2, 4, 8, 11, 14, 23, 27, 32, 45, 48, 50, 56, 61, 70, 79, 84, 92, 94, 103, 108, 113, 124, 128, 130, 134, 142, 150]	[2, 3, 8, 11, 13, 22, 26, 31, 44, 47, 49, 55, 60, 69, 78, 83, 92, 93, 102, 107, 113, 124, 128, 129, 133, 141, 150, 151]	['DHC', 'lactonase', 'activity', 'was', 'also', 'investigated', 'in', 'a', 'study', 'that', 'compared', 'patients', 'with', 'diabetes', ',', 'patients', 'with', 'hypercholesterolemia', ',', 'and', 'healthy', 'controls', '.']	[2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The conclusion was that lactonase activity was significantly reduced in both groups of patients, where diabetic patients had the lowest activity.	[('PMC8045895', 'R45001', 24, 33, 'lactonase')]	['The', 'conclusion', 'was', 'that', 'lact', '##ona', '##se', 'activity', 'was', 'significantly', 'reduced', 'in', 'both', 'groups', 'of', 'patients', ',', 'where', 'diabetic', 'patients', 'had', 'the', 'lowest', 'activity', '.']	[0, 4, 15, 19, 24, 28, 31, 34, 43, 47, 61, 69, 72, 77, 84, 87, 95, 97, 103, 112, 121, 125, 129, 136, 144]	[3, 14, 18, 23, 28, 31, 33, 42, 46, 60, 68, 71, 76, 83, 86, 95, 96, 102, 111, 120, 124, 128, 135, 144, 145]	['The', 'conclusion', 'was', 'that', 'lactonase', 'activity', 'was', 'significantly', 'reduced', 'in', 'both', 'groups', 'of', 'patients', ',', 'where', 'diabetic', 'patients', 'had', 'the', 'lowest', 'activity', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The same results were acquired for both paraoxonase activity and arylesterase activity (Rosenblat et al., 2006).	[('PMC8045895', 'R45002', 40, 51, 'paraoxonase'), ('PMC8045895', 'R45002', 65, 77, 'arylesterase')]	['The', 'same', 'results', 'were', 'acquired', 'for', 'both', 'para', '##oxo', '##nas', '##e', 'activity', 'and', 'aryl', '##ester', '##ase', 'activity', '(', 'Rosen', '##bl', '##at', 'et', 'al', '.', ',', '2006', ')', '.']	[0, 4, 9, 17, 22, 31, 35, 40, 44, 47, 50, 52, 61, 65, 69, 74, 78, 87, 88, 93, 95, 98, 101, 103, 104, 106, 110, 111]	[3, 8, 16, 21, 30, 34, 39, 44, 47, 50, 51, 60, 64, 69, 74, 77, 86, 88, 93, 95, 97, 100, 103, 104, 105, 110, 111, 112]	['The', 'same', 'results', 'were', 'acquired', 'for', 'both', 'paraoxonase', 'activity', 'and', 'arylesterase', 'activity', '(', 'Rosenblat', 'et', 'al', '.', ',', '2006', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
compared paraoxonase 1 activity for TBL in patients with type 2 diabetes and in healthy controls.	[('PMC8045895', 'R46001', 9, 22, 'paraoxonase 1')]	['compared', 'para', '##oxo', '##nas', '##e', '1', 'activity', 'for', 'TB', '##L', 'in', 'patients', 'with', 'type', '2', 'diabetes', 'and', 'in', 'healthy', 'controls', '.']	[0, 9, 13, 16, 19, 21, 23, 32, 36, 38, 40, 43, 52, 57, 62, 64, 73, 77, 80, 88, 96]	[8, 13, 16, 19, 20, 22, 31, 35, 38, 39, 42, 51, 56, 61, 63, 72, 76, 79, 87, 96, 97]	['compared', 'paraoxonase', '1', 'activity', 'for', 'TBL', 'in', 'patients', 'with', 'type', '2', 'diabetes', 'and', 'in', 'healthy', 'controls', '.']	[1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that there is no correlation between lactonase activity and presence of diabetes, whereas diabetic patients on average had significantly lower arylesterase activity than healthy controls (Passaro et al., 2018).	[('PMC8045895', 'R46002', 59, 68, 'lactonase'), ('PMC8045895', 'R46002', 165, 177, 'arylesterase')]	['The', 'authors', 'concluded', 'that', 'there', 'is', 'no', 'correlation', 'between', 'lact', '##ona', '##se', 'activity', 'and', 'presence', 'of', 'diabetes', ',', 'whereas', 'diabetic', 'patients', 'on', 'average', 'had', 'significantly', 'lower', 'aryl', '##ester', '##ase', 'activity', 'than', 'healthy', 'controls', '(', 'Pass', '##aro', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 4, 12, 22, 27, 33, 36, 39, 51, 59, 63, 66, 69, 78, 82, 91, 94, 102, 104, 112, 121, 130, 133, 141, 145, 159, 165, 169, 174, 178, 187, 192, 200, 209, 210, 214, 218, 221, 223, 224, 226, 230, 231]	[3, 11, 21, 26, 32, 35, 38, 50, 58, 63, 66, 68, 77, 81, 90, 93, 102, 103, 111, 120, 129, 132, 140, 144, 158, 164, 169, 174, 177, 186, 191, 199, 208, 210, 214, 217, 220, 223, 224, 225, 230, 231, 232]	['The', 'authors', 'concluded', 'that', 'there', 'is', 'no', 'correlation', 'between', 'lactonase', 'activity', 'and', 'presence', 'of', 'diabetes', ',', 'whereas', 'diabetic', 'patients', 'on', 'average', 'had', 'significantly', 'lower', 'arylesterase', 'activity', 'than', 'healthy', 'controls', '(', 'Passaro', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
compared paraoxonase 1 lactonase activity for TBBL in neonates with diabetic mothers and in neonates with mothers without diabetes (Zhou et al., 2020b).	[('PMC8045895', 'R47001', 9, 22, 'paraoxonase 1'), ('PMC8045895', 'R47001', 23, 32, 'lactonase')]	['compared', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'for', 'TB', '##BL', 'in', 'neonates', 'with', 'diabetic', 'mothers', 'and', 'in', 'neonates', 'with', 'mothers', 'without', 'diabetes', '(', 'Zhou', 'et', 'al', '.', ',', '202', '##0', '##b', ')', '.']	[0, 9, 13, 16, 19, 21, 23, 27, 30, 33, 42, 46, 48, 51, 54, 63, 68, 77, 85, 89, 92, 101, 106, 114, 122, 131, 132, 137, 140, 142, 143, 145, 148, 149, 150, 151]	[8, 13, 16, 19, 20, 22, 27, 30, 32, 41, 45, 48, 50, 53, 62, 67, 76, 84, 88, 91, 100, 105, 113, 121, 130, 132, 136, 139, 142, 143, 144, 148, 149, 150, 151, 152]	['compared', 'paraoxonase', '1', 'lactonase', 'activity', 'for', 'TBBL', 'in', 'neonates', 'with', 'diabetic', 'mothers', 'and', 'in', 'neonates', 'with', 'mothers', 'without', 'diabetes', '(', 'Zhou', 'et', 'al', '.', ',', '2020b', ')', '.']	[1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
They found a significant increase in both lactonase activity and DEPCyMC-normalized lactonase activity in children of diabetic patients compared with healthy controls.	[('PMC8045895', 'R47002', 42, 51, 'lactonase'), ('PMC8045895', 'R47002', 84, 93, 'lactonase')]	['They', 'found', 'a', 'significant', 'increase', 'in', 'both', 'lact', '##ona', '##se', 'activity', 'and', 'DEP', '##Cy', '##MC', '-', 'normalized', 'lact', '##ona', '##se', 'activity', 'in', 'children', 'of', 'diabetic', 'patients', 'compared', 'with', 'healthy', 'controls', '.']	[0, 5, 11, 13, 25, 34, 37, 42, 46, 49, 52, 61, 65, 68, 70, 72, 73, 84, 88, 91, 94, 103, 106, 115, 118, 127, 136, 145, 150, 158, 166]	[4, 10, 12, 24, 33, 36, 41, 46, 49, 51, 60, 64, 68, 70, 72, 73, 83, 88, 91, 93, 102, 105, 114, 117, 126, 135, 144, 149, 157, 166, 167]	['They', 'found', 'a', 'significant', 'increase', 'in', 'both', 'lactonase', 'activity', 'and', 'DEPCyMC-normalized', 'lactonase', 'activity', 'in', 'children', 'of', 'diabetic', 'patients', 'compared', 'with', 'healthy', 'controls', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
paraoxonase 1 lactonase activity for DHC was also compared for Alzheimer's disease (AD) patients and healthy controls.	[('PMC8045895', 'R48000', 0, 13, 'paraoxonase 1'), ('PMC8045895', 'R48000', 14, 23, 'lactonase')]	"['para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'for', 'DH', '##C', 'was', 'also', 'compared', 'for', 'Alzheimer', ""'"", 's', 'disease', '(', 'AD', ')', 'patients', 'and', 'healthy', 'controls', '.']"	[0, 4, 7, 10, 12, 14, 18, 21, 24, 33, 37, 39, 41, 45, 50, 59, 63, 72, 73, 75, 83, 84, 86, 88, 97, 101, 109, 117]	[4, 7, 10, 11, 13, 18, 21, 23, 32, 36, 39, 40, 44, 49, 58, 62, 72, 73, 74, 82, 84, 86, 87, 96, 100, 108, 117, 118]	"['paraoxonase', '1', 'lactonase', 'activity', 'for', 'DHC', 'was', 'also', 'compared', 'for', ""Alzheimer's"", 'disease', '(', 'AD', ')', 'patients', 'and', 'healthy', 'controls', '.']"	[4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The researchers measured lactonase activity and calculated the quotients lactonase activity/HDL concentration and lactonase activity/LDL concentration.	[('PMC8045895', 'R48001', 25, 34, 'lactonase'), ('PMC8045895', 'R48001', 73, 82, 'lactonase'), ('PMC8045895', 'R48001', 114, 123, 'lactonase')]	['The', 'researchers', 'measured', 'lact', '##ona', '##se', 'activity', 'and', 'calculated', 'the', 'quotient', '##s', 'lact', '##ona', '##se', 'activity', '/', 'HDL', 'concentration', 'and', 'lact', '##ona', '##se', 'activity', '/', 'LDL', 'concentration', '.']	[0, 4, 16, 25, 29, 32, 35, 44, 48, 59, 63, 71, 73, 77, 80, 83, 91, 92, 96, 110, 114, 118, 121, 124, 132, 133, 137, 150]	[3, 15, 24, 29, 32, 34, 43, 47, 58, 62, 71, 72, 77, 80, 82, 91, 92, 95, 109, 113, 118, 121, 123, 132, 133, 136, 150, 151]	['The', 'researchers', 'measured', 'lactonase', 'activity', 'and', 'calculated', 'the', 'quotients', 'lactonase', 'activity', '/', 'HDL', 'concentration', 'and', 'lactonase', 'activity', '/', 'LDL', 'concentration', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Several other medical conditions were studied in association with paraoxonase 1 lactonase activity: among them are intestinal cancer, psoriasis, celiac disease, hereditary hemochromatosis, chronic kidney disease (CKD), renal disease, chronic obstructive pulmonary disease (COPB), bronchial asthma, and acute pancreatitis.	[('PMC8045895', 'R49000', 66, 79, 'paraoxonase 1'), ('PMC8045895', 'R49000', 80, 89, 'lactonase')]	['Several', 'other', 'medical', 'conditions', 'were', 'studied', 'in', 'association', 'with', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', ':', 'among', 'them', 'are', 'intestinal', 'cancer', ',', 'psoriasis', ',', 'ce', '##li', '##ac', 'disease', ',', 'hereditary', 'hem', '##ochrom', '##atosis', ',', 'chronic', 'kidney', 'disease', '(', 'CKD', ')', ',', 'renal', 'disease', ',', 'chronic', 'obstructive', 'pulmonary', 'disease', '(', 'COP', '##B', ')', ',', 'bronchial', 'asthma', ',', 'and', 'acute', 'pancreatitis', '.']	[0, 8, 14, 22, 33, 38, 46, 49, 61, 66, 70, 73, 76, 78, 80, 84, 87, 90, 98, 100, 106, 111, 115, 126, 132, 134, 143, 145, 147, 149, 152, 159, 161, 172, 175, 181, 187, 189, 197, 204, 212, 213, 216, 217, 219, 225, 232, 234, 242, 254, 264, 272, 273, 276, 277, 278, 280, 290, 296, 298, 302, 308, 320]	[7, 13, 21, 32, 37, 45, 48, 60, 65, 70, 73, 76, 77, 79, 84, 87, 89, 98, 99, 105, 110, 114, 125, 132, 133, 143, 144, 147, 149, 151, 159, 160, 171, 175, 181, 187, 188, 196, 203, 211, 213, 216, 217, 218, 224, 232, 233, 241, 253, 263, 271, 273, 276, 277, 278, 279, 289, 296, 297, 301, 307, 320, 321]	['Several', 'other', 'medical', 'conditions', 'were', 'studied', 'in', 'association', 'with', 'paraoxonase', '1', 'lactonase', 'activity', ':', 'among', 'them', 'are', 'intestinal', 'cancer', ',', 'psoriasis', ',', 'celiac', 'disease', ',', 'hereditary', 'hemochromatosis', ',', 'chronic', 'kidney', 'disease', '(', 'CKD', ')', ',', 'renal', 'disease', ',', 'chronic', 'obstructive', 'pulmonary', 'disease', '(', 'COPB', ')', ',', 'bronchial', 'asthma', ',', 'and', 'acute', 'pancreatitis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bains et al. (2019) compared paraoxonase 1 lactonase activity in patients with intestinal cancer before and after treatment.	[('PMC8045895', 'R50000', 29, 42, 'paraoxonase 1'), ('PMC8045895', 'R50000', 43, 52, 'lactonase')]	['Ba', '##ins', 'et', 'al', '.', '(', '201', '##9', ')', 'compared', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'in', 'patients', 'with', 'intestinal', 'cancer', 'before', 'and', 'after', 'treatment', '.']	[0, 2, 6, 9, 11, 13, 14, 17, 18, 20, 29, 33, 36, 39, 41, 43, 47, 50, 53, 62, 65, 74, 79, 90, 97, 104, 108, 114, 123]	[2, 5, 8, 11, 12, 14, 17, 18, 19, 28, 33, 36, 39, 40, 42, 47, 50, 52, 61, 64, 73, 78, 89, 96, 103, 107, 113, 123, 124]	['Bains', 'et', 'al', '.', '(', '2019', ')', 'compared', 'paraoxonase', '1', 'lactonase', 'activity', 'in', 'patients', 'with', 'intestinal', 'cancer', 'before', 'and', 'after', 'treatment', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that both arylesterase and DHC lactonase activity significantly decreased after the surgery (compared with before treatment), and then increased again with time (Bains et al., 2019).	[('PMC8045895', 'R50001', 32, 44, 'arylesterase'), ('PMC8045895', 'R50001', 53, 62, 'lactonase')]	['The', 'authors', 'concluded', 'that', 'both', 'aryl', '##ester', '##ase', 'and', 'DH', '##C', 'lact', '##ona', '##se', 'activity', 'significantly', 'decreased', 'after', 'the', 'surgery', '(', 'compared', 'with', 'before', 'treatment', ')', ',', 'and', 'then', 'increased', 'again', 'with', 'time', '(', 'Ba', '##ins', 'et', 'al', '.', ',', '201', '##9', ')', '.']	[0, 4, 12, 22, 27, 32, 36, 41, 45, 49, 51, 53, 57, 60, 63, 72, 86, 96, 102, 106, 114, 115, 124, 129, 136, 145, 146, 148, 152, 157, 167, 173, 178, 183, 184, 186, 190, 193, 195, 196, 198, 201, 202, 203]	[3, 11, 21, 26, 31, 36, 41, 44, 48, 51, 52, 57, 60, 62, 71, 85, 95, 101, 105, 113, 115, 123, 128, 135, 145, 146, 147, 151, 156, 166, 172, 177, 182, 184, 186, 189, 192, 195, 196, 197, 201, 202, 203, 204]	['The', 'authors', 'concluded', 'that', 'both', 'arylesterase', 'and', 'DHC', 'lactonase', 'activity', 'significantly', 'decreased', 'after', 'the', 'surgery', '(', 'compared', 'with', 'before', 'treatment', ')', ',', 'and', 'then', 'increased', 'again', 'with', 'time', '(', 'Bains', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 1, 3, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In psoriatic children, DHC lactonase activity of paraoxonase 1, as well as arylesterase and paraoxonase activities were found to all be significantly reduced compared with healthy controls (Bacchetti et al., 2020).	[('PMC8045895', 'R51000', 27, 36, 'lactonase'), ('PMC8045895', 'R51000', 49, 62, 'paraoxonase 1'), ('PMC8045895', 'R51000', 75, 87, 'arylesterase'), ('PMC8045895', 'R51000', 92, 103, 'paraoxonase')]	['In', 'ps', '##oria', '##tic', 'children', ',', 'DH', '##C', 'lact', '##ona', '##se', 'activity', 'of', 'para', '##oxo', '##nas', '##e', '1', ',', 'as', 'well', 'as', 'aryl', '##ester', '##ase', 'and', 'para', '##oxo', '##nas', '##e', 'activities', 'were', 'found', 'to', 'all', 'be', 'significantly', 'reduced', 'compared', 'with', 'healthy', 'controls', '(', 'Bac', '##che', '##tt', '##i', 'et', 'al', '.', ',', '202', '##0', ')', '.']	[0, 3, 5, 9, 13, 21, 23, 25, 27, 31, 34, 37, 46, 49, 53, 56, 59, 61, 62, 64, 67, 72, 75, 79, 84, 88, 92, 96, 99, 102, 104, 115, 120, 126, 129, 133, 136, 150, 158, 167, 172, 180, 189, 190, 193, 196, 198, 200, 203, 205, 206, 208, 211, 212, 213]	[2, 5, 9, 12, 21, 22, 25, 26, 31, 34, 36, 45, 48, 53, 56, 59, 60, 62, 63, 66, 71, 74, 79, 84, 87, 91, 96, 99, 102, 103, 114, 119, 125, 128, 132, 135, 149, 157, 166, 171, 179, 188, 190, 193, 196, 198, 199, 202, 205, 206, 207, 211, 212, 213, 214]	['In', 'psoriatic', 'children', ',', 'DHC', 'lactonase', 'activity', 'of', 'paraoxonase', '1', ',', 'as', 'well', 'as', 'arylesterase', 'and', 'paraoxonase', 'activities', 'were', 'found', 'to', 'all', 'be', 'significantly', 'reduced', 'compared', 'with', 'healthy', 'controls', '(', 'Bacchetti', 'et', 'al', '.', ',', '2020', ')', '.']	[1, 3, 1, 1, 2, 3, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors also measured the concentration of myeloperoxidase (myeloperoxidase), another enzyme in HDL, which can interact with paraoxonase 1 and influence its activity.	[('PMC8045895', 'R51001', 47, 62, 'myeloperoxidase'), ('PMC8045895', 'R51001', 64, 79, 'myeloperoxidase'), ('PMC8045895', 'R51001', 129, 142, 'paraoxonase 1')]	['The', 'authors', 'also', 'measured', 'the', 'concentration', 'of', 'myel', '##oper', '##oxidase', '(', 'myel', '##oper', '##oxidase', ')', ',', 'another', 'enzyme', 'in', 'HDL', ',', 'which', 'can', 'interact', 'with', 'para', '##oxo', '##nas', '##e', '1', 'and', 'influence', 'its', 'activity', '.']	[0, 4, 12, 17, 26, 30, 44, 47, 51, 55, 63, 64, 68, 72, 79, 80, 82, 90, 97, 100, 103, 105, 111, 115, 124, 129, 133, 136, 139, 141, 143, 147, 157, 161, 169]	[3, 11, 16, 25, 29, 43, 46, 51, 55, 62, 64, 68, 72, 79, 80, 81, 89, 96, 99, 103, 104, 110, 114, 123, 128, 133, 136, 139, 140, 142, 146, 156, 160, 169, 170]	['The', 'authors', 'also', 'measured', 'the', 'concentration', 'of', 'myeloperoxidase', '(', 'myeloperoxidase', ')', ',', 'another', 'enzyme', 'in', 'HDL', ',', 'which', 'can', 'interact', 'with', 'paraoxonase', '1', 'and', 'influence', 'its', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
myeloperoxidase concentration and activity were both significantly decreased and negatively correlated with a decrease in all paraoxonase 1 enzymatic activities in psoriatic patients.	[('PMC8045895', 'R51002', 0, 15, 'myeloperoxidase'), ('PMC8045895', 'R51002', 126, 139, 'paraoxonase 1')]	['myel', '##oper', '##oxidase', 'concentration', 'and', 'activity', 'were', 'both', 'significantly', 'decreased', 'and', 'negatively', 'correlated', 'with', 'a', 'decrease', 'in', 'all', 'para', '##oxo', '##nas', '##e', '1', 'enzymatic', 'activities', 'in', 'ps', '##oria', '##tic', 'patients', '.']	[0, 4, 8, 16, 30, 34, 43, 48, 53, 67, 77, 81, 92, 103, 108, 110, 119, 122, 126, 130, 133, 136, 138, 140, 150, 161, 164, 166, 170, 174, 182]	[4, 8, 15, 29, 33, 42, 47, 52, 66, 76, 80, 91, 102, 107, 109, 118, 121, 125, 130, 133, 136, 137, 139, 149, 160, 163, 166, 170, 173, 182, 183]	['myeloperoxidase', 'concentration', 'and', 'activity', 'were', 'both', 'significantly', 'decreased', 'and', 'negatively', 'correlated', 'with', 'a', 'decrease', 'in', 'all', 'paraoxonase', '1', 'enzymatic', 'activities', 'in', 'psoriatic', 'patients', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A significant decrease in paraoxonase 1 DHC lactonase activity was shown in celiac disease (Ferretti et al., 2012).	[('PMC8045895', 'R52000', 26, 39, 'paraoxonase 1'), ('PMC8045895', 'R52000', 44, 53, 'lactonase')]	['A', 'significant', 'decrease', 'in', 'para', '##oxo', '##nas', '##e', '1', 'DH', '##C', 'lact', '##ona', '##se', 'activity', 'was', 'shown', 'in', 'ce', '##li', '##ac', 'disease', '(', 'Ferr', '##etti', 'et', 'al', '.', ',', '2012', ')', '.']	[0, 2, 14, 23, 26, 30, 33, 36, 38, 40, 42, 44, 48, 51, 54, 63, 67, 73, 76, 78, 80, 83, 91, 92, 96, 101, 104, 106, 107, 109, 113, 114]	[1, 13, 22, 25, 30, 33, 36, 37, 39, 42, 43, 48, 51, 53, 62, 66, 72, 75, 78, 80, 82, 90, 92, 96, 100, 103, 106, 107, 108, 113, 114, 115]	['A', 'significant', 'decrease', 'in', 'paraoxonase', '1', 'DHC', 'lactonase', 'activity', 'was', 'shown', 'in', 'celiac', 'disease', '(', 'Ferretti', 'et', 'al', '.', ',', '2012', ')', '.']	[1, 1, 1, 1, 4, 1, 2, 3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lactonase activity was lower in diet-treated patients compared with healthy controls, and even lower in patients at diagnosis, when they had not yet begun their diet.	[('PMC8045895', 'R52001', 0, 9, 'Lactonase')]	['Lact', '##ona', '##se', 'activity', 'was', 'lower', 'in', 'diet', '-', 'treated', 'patients', 'compared', 'with', 'healthy', 'controls', ',', 'and', 'even', 'lower', 'in', 'patients', 'at', 'diagnosis', ',', 'when', 'they', 'had', 'not', 'yet', 'begun', 'their', 'diet', '.']	[0, 4, 7, 10, 19, 23, 29, 32, 36, 37, 45, 54, 63, 68, 76, 84, 86, 90, 95, 101, 104, 113, 116, 125, 127, 132, 137, 141, 145, 149, 155, 161, 165]	[4, 7, 9, 18, 22, 28, 31, 36, 37, 44, 53, 62, 67, 75, 84, 85, 89, 94, 100, 103, 112, 115, 125, 126, 131, 136, 140, 144, 148, 154, 160, 165, 166]	['Lactonase', 'activity', 'was', 'lower', 'in', 'diet', '-', 'treated', 'patients', 'compared', 'with', 'healthy', 'controls', ',', 'and', 'even', 'lower', 'in', 'patients', 'at', 'diagnosis', ',', 'when', 'they', 'had', 'not', 'yet', 'begun', 'their', 'diet', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Similar results were obtained for paraoxonase 1 arylesterase and paraoxonase activities.	[('PMC8045895', 'R52002', 34, 47, 'paraoxonase 1'), ('PMC8045895', 'R52002', 48, 60, 'arylesterase'), ('PMC8045895', 'R52002', 65, 76, 'paraoxonase')]	['Similar', 'results', 'were', 'obtained', 'for', 'para', '##oxo', '##nas', '##e', '1', 'aryl', '##ester', '##ase', 'and', 'para', '##oxo', '##nas', '##e', 'activities', '.']	[0, 8, 16, 21, 30, 34, 38, 41, 44, 46, 48, 52, 57, 61, 65, 69, 72, 75, 77, 87]	[7, 15, 20, 29, 33, 38, 41, 44, 45, 47, 52, 57, 60, 64, 69, 72, 75, 76, 87, 88]	['Similar', 'results', 'were', 'obtained', 'for', 'paraoxonase', '1', 'arylesterase', 'and', 'paraoxonase', 'activities', '.']	[1, 1, 1, 1, 1, 4, 1, 3, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
In hereditary hemochromatosis, paraoxonase 1 paraoxonase activity was significantly decreased in patients with the condition compared with healthy controls, but DHC lactonase and arylesterase activities were not decreased significantly (Martinelli et al., 2013).	[('PMC8045895', 'R53000', 31, 44, 'paraoxonase 1'), ('PMC8045895', 'R53000', 45, 56, 'paraoxonase'), ('PMC8045895', 'R53000', 165, 174, 'lactonase'), ('PMC8045895', 'R53000', 179, 191, 'arylesterase')]	['In', 'hereditary', 'hem', '##ochrom', '##atosis', ',', 'para', '##oxo', '##nas', '##e', '1', 'para', '##oxo', '##nas', '##e', 'activity', 'was', 'significantly', 'decreased', 'in', 'patients', 'with', 'the', 'condition', 'compared', 'with', 'healthy', 'controls', ',', 'but', 'DH', '##C', 'lact', '##ona', '##se', 'and', 'aryl', '##ester', '##ase', 'activities', 'were', 'not', 'decreased', 'significantly', '(', 'Martin', '##elli', 'et', 'al', '.', ',', '2013', ')', '.']	[0, 3, 14, 17, 23, 29, 31, 35, 38, 41, 43, 45, 49, 52, 55, 57, 66, 70, 84, 94, 97, 106, 111, 115, 125, 134, 139, 147, 155, 157, 161, 163, 165, 169, 172, 175, 179, 183, 188, 192, 203, 208, 212, 222, 236, 237, 243, 248, 251, 253, 254, 256, 260, 261]	[2, 13, 17, 23, 29, 30, 35, 38, 41, 42, 44, 49, 52, 55, 56, 65, 69, 83, 93, 96, 105, 110, 114, 124, 133, 138, 146, 155, 156, 160, 163, 164, 169, 172, 174, 178, 183, 188, 191, 202, 207, 211, 221, 235, 237, 243, 247, 250, 253, 254, 255, 260, 261, 262]	['In', 'hereditary', 'hemochromatosis', ',', 'paraoxonase', '1', 'paraoxonase', 'activity', 'was', 'significantly', 'decreased', 'in', 'patients', 'with', 'the', 'condition', 'compared', 'with', 'healthy', 'controls', ',', 'but', 'DHC', 'lactonase', 'and', 'arylesterase', 'activities', 'were', 'not', 'decreased', 'significantly', '(', 'Martinelli', 'et', 'al', '.', ',', '2013', ')', '.']	[1, 1, 3, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors also subdivided patients into those undergoing treatment through phlebotomy and those not undergoing it, and found that none of the paraoxonase 1 activities correlated with presence of treatment, except for DEPCyMCase activity.	[('PMC8045895', 'R53001', 144, 157, 'paraoxonase 1')]	['The', 'authors', 'also', 'subdivided', 'patients', 'into', 'those', 'undergoing', 'treatment', 'through', 'ph', '##leb', '##otomy', 'and', 'those', 'not', 'undergoing', 'it', ',', 'and', 'found', 'that', 'none', 'of', 'the', 'para', '##oxo', '##nas', '##e', '1', 'activities', 'correlated', 'with', 'presence', 'of', 'treatment', ',', 'except', 'for', 'DEP', '##Cy', '##MC', '##ase', 'activity', '.']	[0, 4, 12, 17, 28, 37, 42, 48, 59, 69, 77, 79, 82, 88, 92, 98, 102, 113, 115, 117, 121, 127, 132, 137, 140, 144, 148, 151, 154, 156, 158, 169, 180, 185, 194, 197, 206, 208, 215, 219, 222, 224, 226, 230, 238]	[3, 11, 16, 27, 36, 41, 47, 58, 68, 76, 79, 82, 87, 91, 97, 101, 112, 115, 116, 120, 126, 131, 136, 139, 143, 148, 151, 154, 155, 157, 168, 179, 184, 193, 196, 206, 207, 214, 218, 222, 224, 226, 229, 238, 239]	['The', 'authors', 'also', 'subdivided', 'patients', 'into', 'those', 'undergoing', 'treatment', 'through', 'phlebotomy', 'and', 'those', 'not', 'undergoing', 'it', ',', 'and', 'found', 'that', 'none', 'of', 'the', 'paraoxonase', '1', 'activities', 'correlated', 'with', 'presence', 'of', 'treatment', ',', 'except', 'for', 'DEPCyMCase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In CKD, a significant decrease in paraoxonase 1 benzopiran-2-one lactonase activity was reported in cases compared with healthy controls (Mohammed et al., 2019).	[('PMC8045895', 'R54000', 34, 47, 'paraoxonase 1'), ('PMC8045895', 'R54000', 48, 74, 'benzopiran-2-one lactonase')]	['In', 'CKD', ',', 'a', 'significant', 'decrease', 'in', 'para', '##oxo', '##nas', '##e', '1', 'benz', '##op', '##ira', '##n', '-', '2', '-', 'one', 'lact', '##ona', '##se', 'activity', 'was', 'reported', 'in', 'cases', 'compared', 'with', 'healthy', 'controls', '(', 'Moh', '##amm', '##ed', 'et', 'al', '.', ',', '201', '##9', ')', '.']	[0, 3, 6, 8, 10, 22, 31, 34, 38, 41, 44, 46, 48, 52, 54, 57, 58, 59, 60, 61, 65, 69, 72, 75, 84, 88, 97, 100, 106, 115, 120, 128, 137, 138, 141, 144, 147, 150, 152, 153, 155, 158, 159, 160]	[2, 6, 7, 9, 21, 30, 33, 38, 41, 44, 45, 47, 52, 54, 57, 58, 59, 60, 61, 64, 69, 72, 74, 83, 87, 96, 99, 105, 114, 119, 127, 136, 138, 141, 144, 146, 149, 152, 153, 154, 158, 159, 160, 161]	['In', 'CKD', ',', 'a', 'significant', 'decrease', 'in', 'paraoxonase', '1', 'benzopiran-2-one', 'lactonase', 'activity', 'was', 'reported', 'in', 'cases', 'compared', 'with', 'healthy', 'controls', '(', 'Mohammed', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 8, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After adjusting for concentration, the authors showed that lactonase activity was significantly higher in patients compared with non-CKD controls.	[('PMC8045895', 'R54001', 59, 68, 'lactonase')]	['After', 'adjusting', 'for', 'concentration', ',', 'the', 'authors', 'showed', 'that', 'lact', '##ona', '##se', 'activity', 'was', 'significantly', 'higher', 'in', 'patients', 'compared', 'with', 'non', '-', 'CKD', 'controls', '.']	[0, 6, 16, 20, 33, 35, 39, 47, 54, 59, 63, 66, 69, 78, 82, 96, 103, 106, 115, 124, 129, 132, 133, 137, 145]	[5, 15, 19, 33, 34, 38, 46, 53, 58, 63, 66, 68, 77, 81, 95, 102, 105, 114, 123, 128, 132, 133, 136, 145, 146]	['After', 'adjusting', 'for', 'concentration', ',', 'the', 'authors', 'showed', 'that', 'lactonase', 'activity', 'was', 'significantly', 'higher', 'in', 'patients', 'compared', 'with', 'non-CKD', 'controls', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors also compared the groups of CKD patients with high and low lactonase activity in terms of survival rate and reported that patients with higher lactonase activity also had a higher survival rate.	[('PMC8045895', 'R54002', 71, 80, 'lactonase'), ('PMC8045895', 'R54002', 155, 164, 'lactonase')]	['The', 'authors', 'also', 'compared', 'the', 'groups', 'of', 'CKD', 'patients', 'with', 'high', 'and', 'low', 'lact', '##ona', '##se', 'activity', 'in', 'terms', 'of', 'survival', 'rate', 'and', 'reported', 'that', 'patients', 'with', 'higher', 'lact', '##ona', '##se', 'activity', 'also', 'had', 'a', 'higher', 'survival', 'rate', '.']	[0, 4, 12, 17, 26, 30, 37, 40, 44, 53, 58, 63, 67, 71, 75, 78, 81, 90, 93, 99, 102, 111, 116, 120, 129, 134, 143, 148, 155, 159, 162, 165, 174, 179, 183, 185, 192, 201, 205]	[3, 11, 16, 25, 29, 36, 39, 43, 52, 57, 62, 66, 70, 75, 78, 80, 89, 92, 98, 101, 110, 115, 119, 128, 133, 142, 147, 154, 159, 162, 164, 173, 178, 182, 184, 191, 200, 205, 206]	['The', 'authors', 'also', 'compared', 'the', 'groups', 'of', 'CKD', 'patients', 'with', 'high', 'and', 'low', 'lactonase', 'activity', 'in', 'terms', 'of', 'survival', 'rate', 'and', 'reported', 'that', 'patients', 'with', 'higher', 'lactonase', 'activity', 'also', 'had', 'a', 'higher', 'survival', 'rate', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
No such difference in survival rate was shown when comparing the group with a high paraoxonase 1 enzyme concentration against the group with a low paraoxonase 1 concentration.	[('PMC8045895', 'R54003', 83, 96, 'paraoxonase 1'), ('PMC8045895', 'R54003', 147, 160, 'paraoxonase 1')]	['No', 'such', 'difference', 'in', 'survival', 'rate', 'was', 'shown', 'when', 'comparing', 'the', 'group', 'with', 'a', 'high', 'para', '##oxo', '##nas', '##e', '1', 'enzyme', 'concentration', 'against', 'the', 'group', 'with', 'a', 'low', 'para', '##oxo', '##nas', '##e', '1', 'concentration', '.']	[0, 3, 8, 19, 22, 31, 36, 40, 46, 51, 61, 65, 71, 76, 78, 83, 87, 90, 93, 95, 97, 104, 118, 126, 130, 136, 141, 143, 147, 151, 154, 157, 159, 161, 174]	[2, 7, 18, 21, 30, 35, 39, 45, 50, 60, 64, 70, 75, 77, 82, 87, 90, 93, 94, 96, 103, 117, 125, 129, 135, 140, 142, 146, 151, 154, 157, 158, 160, 174, 175]	['No', 'such', 'difference', 'in', 'survival', 'rate', 'was', 'shown', 'when', 'comparing', 'the', 'group', 'with', 'a', 'high', 'paraoxonase', '1', 'enzyme', 'concentration', 'against', 'the', 'group', 'with', 'a', 'low', 'paraoxonase', '1', 'concentration', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O']
For end-stage renal patients, a study compared DHC lactonase before and after dialysis and found that activity increases significantly after dialysis, as do arylesterase and paraoxonase activities (Gugliucci et al., 2011).	[('PMC8045895', 'R55000', 51, 60, 'lactonase'), ('PMC8045895', 'R55000', 157, 169, 'arylesterase'), ('PMC8045895', 'R55000', 174, 185, 'paraoxonase')]	['For', 'end', '-', 'stage', 'renal', 'patients', ',', 'a', 'study', 'compared', 'DH', '##C', 'lact', '##ona', '##se', 'before', 'and', 'after', 'dialysis', 'and', 'found', 'that', 'activity', 'increases', 'significantly', 'after', 'dialysis', ',', 'as', 'do', 'aryl', '##ester', '##ase', 'and', 'para', '##oxo', '##nas', '##e', 'activities', '(', 'Gu', '##gl', '##iu', '##cc', '##i', 'et', 'al', '.', ',', '2011', ')', '.']	[0, 4, 7, 8, 14, 20, 28, 30, 32, 38, 47, 49, 51, 55, 58, 61, 68, 72, 78, 87, 91, 97, 102, 111, 121, 135, 141, 149, 151, 154, 157, 161, 166, 170, 174, 178, 181, 184, 186, 197, 198, 200, 202, 204, 206, 208, 211, 213, 214, 216, 220, 221]	[3, 7, 8, 13, 19, 28, 29, 31, 37, 46, 49, 50, 55, 58, 60, 67, 71, 77, 86, 90, 96, 101, 110, 120, 134, 140, 149, 150, 153, 156, 161, 166, 169, 173, 178, 181, 184, 185, 196, 198, 200, 202, 204, 206, 207, 210, 213, 214, 215, 220, 221, 222]	['For', 'end', '-', 'stage', 'renal', 'patients', ',', 'a', 'study', 'compared', 'DHC', 'lactonase', 'before', 'and', 'after', 'dialysis', 'and', 'found', 'that', 'activity', 'increases', 'significantly', 'after', 'dialysis', ',', 'as', 'do', 'arylesterase', 'and', 'paraoxonase', 'activities', '(', 'Gugliucci', 'et', 'al', '.', ',', '2011', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Both groups of patients had significantly lower TBBL lactonase activities than controls.	[('PMC8045895', 'R56001', 53, 62, 'lactonase')]	['Both', 'groups', 'of', 'patients', 'had', 'significantly', 'lower', 'TB', '##BL', 'lact', '##ona', '##se', 'activities', 'than', 'controls', '.']	[0, 5, 12, 15, 24, 28, 42, 48, 50, 53, 57, 60, 63, 74, 79, 87]	[4, 11, 14, 23, 27, 41, 47, 50, 52, 57, 60, 62, 73, 78, 87, 88]	['Both', 'groups', 'of', 'patients', 'had', 'significantly', 'lower', 'TBBL', 'lactonase', 'activities', 'than', 'controls', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
The same trend was present with paraoxonase activity (Soler et al., 2013).	[('PMC8045895', 'R56002', 32, 43, 'paraoxonase')]	['The', 'same', 'trend', 'was', 'present', 'with', 'para', '##oxo', '##nas', '##e', 'activity', '(', 'Sol', '##er', 'et', 'al', '.', ',', '2013', ')', '.']	[0, 4, 9, 15, 19, 27, 32, 36, 39, 42, 44, 53, 54, 57, 60, 63, 65, 66, 68, 72, 73]	[3, 8, 14, 18, 26, 31, 36, 39, 42, 43, 52, 54, 57, 59, 62, 65, 66, 67, 72, 73, 74]	['The', 'same', 'trend', 'was', 'present', 'with', 'paraoxonase', 'activity', '(', 'Soler', 'et', 'al', '.', ',', '2013', ')', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the case of bronchial asthma, both arylesterase and DHC lactonase paraoxonase 1 activities were shown to be lower in asthmatics compared with healthy controls (Chen et al., 2018).	[('PMC8045895', 'R57000', 38, 50, 'arylesterase'), ('PMC8045895', 'R57000', 59, 68, 'lactonase'), ('PMC8045895', 'R57000', 69, 82, 'paraoxonase 1')]	['In', 'the', 'case', 'of', 'bronchial', 'asthma', ',', 'both', 'aryl', '##ester', '##ase', 'and', 'DH', '##C', 'lact', '##ona', '##se', 'para', '##oxo', '##nas', '##e', '1', 'activities', 'were', 'shown', 'to', 'be', 'lower', 'in', 'asthma', '##tics', 'compared', 'with', 'healthy', 'controls', '(', 'Chen', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 3, 7, 12, 15, 25, 31, 33, 38, 42, 47, 51, 55, 57, 59, 63, 66, 69, 73, 76, 79, 81, 83, 94, 99, 105, 108, 111, 117, 120, 126, 131, 140, 145, 153, 162, 163, 168, 171, 173, 174, 176, 180, 181]	[2, 6, 11, 14, 24, 31, 32, 37, 42, 47, 50, 54, 57, 58, 63, 66, 68, 73, 76, 79, 80, 82, 93, 98, 104, 107, 110, 116, 119, 126, 130, 139, 144, 152, 161, 163, 167, 170, 173, 174, 175, 180, 181, 182]	['In', 'the', 'case', 'of', 'bronchial', 'asthma', ',', 'both', 'arylesterase', 'and', 'DHC', 'lactonase', 'paraoxonase', '1', 'activities', 'were', 'shown', 'to', 'be', 'lower', 'in', 'asthmatics', 'compared', 'with', 'healthy', 'controls', '(', 'Chen', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors verified this by addition of paraoxonase 1 to the serum sample, which resulted in a very significant rise in lactonase activity.	[('PMC8045895', 'R57001', 41, 54, 'paraoxonase 1'), ('PMC8045895', 'R57001', 121, 130, 'lactonase')]	['The', 'authors', 'verified', 'this', 'by', 'addition', 'of', 'para', '##oxo', '##nas', '##e', '1', 'to', 'the', 'serum', 'sample', ',', 'which', 'resulted', 'in', 'a', 'very', 'significant', 'rise', 'in', 'lact', '##ona', '##se', 'activity', '.']	[0, 4, 12, 21, 26, 29, 38, 41, 45, 48, 51, 53, 55, 58, 62, 68, 74, 76, 82, 91, 94, 96, 101, 113, 118, 121, 125, 128, 131, 139]	[3, 11, 20, 25, 28, 37, 40, 45, 48, 51, 52, 54, 57, 61, 67, 74, 75, 81, 90, 93, 95, 100, 112, 117, 120, 125, 128, 130, 139, 140]	['The', 'authors', 'verified', 'this', 'by', 'addition', 'of', 'paraoxonase', '1', 'to', 'the', 'serum', 'sample', ',', 'which', 'resulted', 'in', 'a', 'very', 'significant', 'rise', 'in', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
In both the smoking- and the nonsmoking group, pancreatitis patients had significantly lower paraoxonase 1 lactonase activity upon admission to hospital than healthy controls.	[('PMC8045895', 'R58001', 93, 106, 'paraoxonase 1'), ('PMC8045895', 'R58001', 107, 116, 'lactonase')]	['In', 'both', 'the', 'smoking', '-', 'and', 'the', 'nons', '##mo', '##king', 'group', ',', 'pancreatitis', 'patients', 'had', 'significantly', 'lower', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'upon', 'admission', 'to', 'hospital', 'than', 'healthy', 'controls', '.']	[0, 3, 8, 12, 19, 21, 25, 29, 33, 35, 40, 45, 47, 60, 69, 73, 87, 93, 97, 100, 103, 105, 107, 111, 114, 117, 126, 131, 141, 144, 153, 158, 166, 174]	[2, 7, 11, 19, 20, 24, 28, 33, 35, 39, 45, 46, 59, 68, 72, 86, 92, 97, 100, 103, 104, 106, 111, 114, 116, 125, 130, 140, 143, 152, 157, 165, 174, 175]	['In', 'both', 'the', 'smoking-', 'and', 'the', 'nonsmoking', 'group', ',', 'pancreatitis', 'patients', 'had', 'significantly', 'lower', 'paraoxonase', '1', 'lactonase', 'activity', 'upon', 'admission', 'to', 'hospital', 'than', 'healthy', 'controls', '.']	[1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Both the smoking and nonsmoking patients' paraoxonase 1 lactonase activity significantly declined on both day 3 and day 7 of hospitalization compared with day 1.	[('PMC8045895', 'R58002', 42, 55, 'paraoxonase 1'), ('PMC8045895', 'R58002', 56, 65, 'lactonase')]	"['Both', 'the', 'smoking', 'and', 'nons', '##mo', '##king', 'patients', ""'"", 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'significantly', 'declined', 'on', 'both', 'day', '3', 'and', 'day', '7', 'of', 'hospitalization', 'compared', 'with', 'day', '1', '.']"	[0, 5, 9, 17, 21, 25, 27, 32, 40, 42, 46, 49, 52, 54, 56, 60, 63, 66, 75, 89, 98, 101, 106, 110, 112, 116, 120, 122, 125, 141, 150, 155, 159, 160]	[4, 8, 16, 20, 25, 27, 31, 40, 41, 46, 49, 52, 53, 55, 60, 63, 65, 74, 88, 97, 100, 105, 109, 111, 115, 119, 121, 124, 140, 149, 154, 158, 160, 161]	"['Both', 'the', 'smoking', 'and', 'nonsmoking', 'patients', ""'"", 'paraoxonase', '1', 'lactonase', 'activity', 'significantly', 'declined', 'on', 'both', 'day', '3', 'and', 'day', '7', 'of', 'hospitalization', 'compared', 'with', 'day', '1', '.']"	[1, 1, 1, 1, 3, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
When the authors measured paraoxonase 1 arylesterase activity, they found significantly lower activity in pancreatitis patients compared with healthy controls for both subgroups.	[('PMC8045895', 'R58003', 26, 39, 'paraoxonase 1'), ('PMC8045895', 'R58003', 40, 52, 'arylesterase')]	['When', 'the', 'authors', 'measured', 'para', '##oxo', '##nas', '##e', '1', 'aryl', '##ester', '##ase', 'activity', ',', 'they', 'found', 'significantly', 'lower', 'activity', 'in', 'pancreatitis', 'patients', 'compared', 'with', 'healthy', 'controls', 'for', 'both', 'subgroups', '.']	[0, 5, 9, 17, 26, 30, 33, 36, 38, 40, 44, 49, 53, 61, 63, 68, 74, 88, 94, 103, 106, 119, 128, 137, 142, 150, 159, 163, 168, 177]	[4, 8, 16, 25, 30, 33, 36, 37, 39, 44, 49, 52, 61, 62, 67, 73, 87, 93, 102, 105, 118, 127, 136, 141, 149, 158, 162, 167, 177, 178]	['When', 'the', 'authors', 'measured', 'paraoxonase', '1', 'arylesterase', 'activity', ',', 'they', 'found', 'significantly', 'lower', 'activity', 'in', 'pancreatitis', 'patients', 'compared', 'with', 'healthy', 'controls', 'for', 'both', 'subgroups', '.']	[1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For paraoxonase 1 paraoxonase activity, there was significantly lower activity in pancreatitis patients in comparison with healthy controls, for the nonsmoking subgroups (Marek et al., 2018).	[('PMC8045895', 'R58004', 4, 17, 'paraoxonase 1'), ('PMC8045895', 'R58004', 18, 29, 'paraoxonase')]	['For', 'para', '##oxo', '##nas', '##e', '1', 'para', '##oxo', '##nas', '##e', 'activity', ',', 'there', 'was', 'significantly', 'lower', 'activity', 'in', 'pancreatitis', 'patients', 'in', 'comparison', 'with', 'healthy', 'controls', ',', 'for', 'the', 'nons', '##mo', '##king', 'subgroups', '(', 'Mar', '##ek', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 4, 8, 11, 14, 16, 18, 22, 25, 28, 30, 38, 40, 46, 50, 64, 70, 79, 82, 95, 104, 107, 118, 123, 131, 139, 141, 145, 149, 153, 155, 160, 170, 171, 174, 177, 180, 182, 183, 185, 189, 190]	[3, 8, 11, 14, 15, 17, 22, 25, 28, 29, 38, 39, 45, 49, 63, 69, 78, 81, 94, 103, 106, 117, 122, 130, 139, 140, 144, 148, 153, 155, 159, 169, 171, 174, 176, 179, 182, 183, 184, 189, 190, 191]	['For', 'paraoxonase', '1', 'paraoxonase', 'activity', ',', 'there', 'was', 'significantly', 'lower', 'activity', 'in', 'pancreatitis', 'patients', 'in', 'comparison', 'with', 'healthy', 'controls', ',', 'for', 'the', 'nonsmoking', 'subgroups', '(', 'Marek', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Different approaches for measuring paraoxonase 1 lactonase activity do not produce the same results.	[('PMC8045895', 'R59000', 35, 48, 'paraoxonase 1'), ('PMC8045895', 'R59000', 49, 58, 'lactonase')]	['Different', 'approaches', 'for', 'measuring', 'para', '##oxo', '##nas', '##e', '1', 'lact', '##ona', '##se', 'activity', 'do', 'not', 'produce', 'the', 'same', 'results', '.']	[0, 10, 21, 25, 35, 39, 42, 45, 47, 49, 53, 56, 59, 68, 71, 75, 83, 87, 92, 99]	[9, 20, 24, 34, 39, 42, 45, 46, 48, 53, 56, 58, 67, 70, 74, 82, 86, 91, 99, 100]	['Different', 'approaches', 'for', 'measuring', 'paraoxonase', '1', 'lactonase', 'activity', 'do', 'not', 'produce', 'the', 'same', 'results', '.']	[1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Ceron et al. (2014) published an extensive and systematic review on measurement of serum paraoxonase 1 activity, presenting the main reference for paraoxonase 1 experimental conditions.	[('PMC8045895', 'R59002', 89, 102, 'paraoxonase 1'), ('PMC8045895', 'R59002', 147, 160, 'paraoxonase 1')]	['Cer', '##on', 'et', 'al', '.', '(', '2014', ')', 'published', 'an', 'extensive', 'and', 'systematic', 'review', 'on', 'measurement', 'of', 'serum', 'para', '##oxo', '##nas', '##e', '1', 'activity', ',', 'presenting', 'the', 'main', 'reference', 'for', 'para', '##oxo', '##nas', '##e', '1', 'experimental', 'conditions', '.']	[0, 3, 6, 9, 11, 13, 14, 18, 20, 30, 33, 43, 47, 58, 65, 68, 80, 83, 89, 93, 96, 99, 101, 103, 111, 113, 124, 128, 133, 143, 147, 151, 154, 157, 159, 161, 174, 184]	[3, 5, 8, 11, 12, 14, 18, 19, 29, 32, 42, 46, 57, 64, 67, 79, 82, 88, 93, 96, 99, 100, 102, 111, 112, 123, 127, 132, 142, 146, 151, 154, 157, 158, 160, 173, 184, 185]	['Ceron', 'et', 'al', '.', '(', '2014', ')', 'published', 'an', 'extensive', 'and', 'systematic', 'review', 'on', 'measurement', 'of', 'serum', 'paraoxonase', '1', 'activity', ',', 'presenting', 'the', 'main', 'reference', 'for', 'paraoxonase', '1', 'experimental', 'conditions', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
In their articles, the authors focused on two lactone substrates, TBBL and DHC, two arylesterase substrates, phenyl acetate and 4-nitrophenyl acetate, and paraoxon.	[('PMC8045895', 'R59003', 84, 96, 'arylesterase')]	['In', 'their', 'articles', ',', 'the', 'authors', 'focused', 'on', 'two', 'lact', '##one', 'substrates', ',', 'TB', '##BL', 'and', 'DH', '##C', ',', 'two', 'aryl', '##ester', '##ase', 'substrates', ',', 'phenyl', 'acetate', 'and', '4', '-', 'nitro', '##phenyl', 'acetate', ',', 'and', 'para', '##oxo', '##n', '.']	[0, 3, 9, 17, 19, 23, 31, 39, 42, 46, 50, 54, 64, 66, 68, 71, 75, 77, 78, 80, 84, 88, 93, 97, 107, 109, 116, 124, 128, 129, 130, 135, 142, 149, 151, 155, 159, 162, 163]	[2, 8, 17, 18, 22, 30, 38, 41, 45, 50, 53, 64, 65, 68, 70, 74, 77, 78, 79, 83, 88, 93, 96, 107, 108, 115, 123, 127, 129, 130, 135, 141, 149, 150, 154, 159, 162, 163, 164]	['In', 'their', 'articles', ',', 'the', 'authors', 'focused', 'on', 'two', 'lactone', 'substrates', ',', 'TBBL', 'and', 'DHC', ',', 'two', 'arylesterase', 'substrates', ',', 'phenyl', 'acetate', 'and', '4-nitrophenyl', 'acetate', ',', 'and', 'paraoxon', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
paraoxonase 1 activity that was reported in the studies cited by the present review was always presented as specific enzyme activity.	[('PMC8045895', 'R60000', 0, 13, 'paraoxonase 1')]	['para', '##oxo', '##nas', '##e', '1', 'activity', 'that', 'was', 'reported', 'in', 'the', 'studies', 'cited', 'by', 'the', 'present', 'review', 'was', 'always', 'presented', 'as', 'specific', 'enzyme', 'activity', '.']	[0, 4, 7, 10, 12, 14, 23, 28, 32, 41, 44, 48, 56, 62, 65, 69, 77, 84, 88, 95, 105, 108, 117, 124, 132]	[4, 7, 10, 11, 13, 22, 27, 31, 40, 43, 47, 55, 61, 64, 68, 76, 83, 87, 94, 104, 107, 116, 123, 132, 133]	['paraoxonase', '1', 'activity', 'that', 'was', 'reported', 'in', 'the', 'studies', 'cited', 'by', 'the', 'present', 'review', 'was', 'always', 'presented', 'as', 'specific', 'enzyme', 'activity', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Billecke et al. (2000) compared the specific activities of human paraoxonase 1 isoforms Q and R for DHC and found a difference of <20% between these two isoforms, whereas the difference between the highest and the lowest observed specific activity in Table 2 of this article is more than an order of magnitude.	[('PMC8045895', 'R65001', 65, 78, 'paraoxonase 1')]	['Bill', '##eck', '##e', 'et', 'al', '.', '(', '2000', ')', 'compared', 'the', 'specific', 'activities', 'of', 'human', 'para', '##oxo', '##nas', '##e', '1', 'isoforms', 'Q', 'and', 'R', 'for', 'DH', '##C', 'and', 'found', 'a', 'difference', 'of', '<', '20', '%', 'between', 'these', 'two', 'isoforms', ',', 'whereas', 'the', 'difference', 'between', 'the', 'highest', 'and', 'the', 'lowest', 'observed', 'specific', 'activity', 'in', 'Table', '2', 'of', 'this', 'article', 'is', 'more', 'than', 'an', 'order', 'of', 'magnitude', '.']	[0, 4, 7, 9, 12, 14, 16, 17, 21, 23, 32, 36, 45, 56, 59, 65, 69, 72, 75, 77, 79, 88, 90, 94, 96, 100, 102, 104, 108, 114, 116, 127, 130, 131, 133, 135, 143, 149, 153, 161, 163, 171, 175, 186, 194, 198, 206, 210, 214, 221, 230, 239, 248, 251, 257, 259, 262, 267, 275, 278, 283, 288, 291, 297, 300, 309]	[4, 7, 8, 11, 14, 15, 17, 21, 22, 31, 35, 44, 55, 58, 64, 69, 72, 75, 76, 78, 87, 89, 93, 95, 99, 102, 103, 107, 113, 115, 126, 129, 131, 133, 134, 142, 148, 152, 161, 162, 170, 174, 185, 193, 197, 205, 209, 213, 220, 229, 238, 247, 250, 256, 258, 261, 266, 274, 277, 282, 287, 290, 296, 299, 309, 310]	['Billecke', 'et', 'al', '.', '(', '2000', ')', 'compared', 'the', 'specific', 'activities', 'of', 'human', 'paraoxonase', '1', 'isoforms', 'Q', 'and', 'R', 'for', 'DHC', 'and', 'found', 'a', 'difference', 'of', '<', '20%', 'between', 'these', 'two', 'isoforms', ',', 'whereas', 'the', 'difference', 'between', 'the', 'highest', 'and', 'the', 'lowest', 'observed', 'specific', 'activity', 'in', 'Table', '2', 'of', 'this', 'article', 'is', 'more', 'than', 'an', 'order', 'of', 'magnitude', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
EDTA binds calcium, which is a cofactor of paraoxonase 1, and thus irreversibly inhibits the enzyme.	[('PMC8045895', 'R66001', 43, 56, 'paraoxonase 1')]	['EDTA', 'binds', 'calcium', ',', 'which', 'is', 'a', 'co', '##factor', 'of', 'para', '##oxo', '##nas', '##e', '1', ',', 'and', 'thus', 'irrever', '##sibly', 'inhibits', 'the', 'enzyme', '.']	[0, 5, 11, 18, 20, 26, 29, 31, 33, 40, 43, 47, 50, 53, 55, 56, 58, 62, 67, 74, 80, 89, 93, 99]	[4, 10, 18, 19, 25, 28, 30, 33, 39, 42, 47, 50, 53, 54, 56, 57, 61, 66, 74, 79, 88, 92, 99, 100]	['EDTA', 'binds', 'calcium', ',', 'which', 'is', 'a', 'cofactor', 'of', 'paraoxonase', '1', ',', 'and', 'thus', 'irreversibly', 'inhibits', 'the', 'enzyme', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These effects were mainly caused by increased cyclin dependent kinase 1 and 2 (cyclin dependent kinase 1 and 2), LIM domain kinase 1 and 2 (LIM domain kinase 1 and 2), mitogen-activated protein kinase 7 (MAPK7) and protein kinase C delta (PRKCD) activity in responder cells.	[('PMC8125016', 'A01005', 46, 77, 'cyclin dependent kinase 1 and 2'), ('PMC8125016', 'A01005', 79, 110, 'cyclin dependent kinase 1 and 2'), ('PMC8125016', 'A01005', 113, 138, 'LIM domain kinase 1 and 2'), ('PMC8125016', 'A01005', 140, 165, 'LIM domain kinase 1 and 2')]	['These', 'effects', 'were', 'mainly', 'caused', 'by', 'increased', 'cyclin', 'dependent', 'kinase', '1', 'and', '2', '(', 'cyclin', 'dependent', 'kinase', '1', 'and', '2', ')', ',', 'LI', '##M', 'domain', 'kinase', '1', 'and', '2', '(', 'LI', '##M', 'domain', 'kinase', '1', 'and', '2', ')', ',', 'mitogen', '-', 'activated', 'protein', 'kinase', '7', '(', 'MAPK', '##7', ')', 'and', 'protein', 'kinase', 'C', 'delta', '(', 'PR', '##K', '##CD', ')', 'activity', 'in', 'respond', '##er', 'cells', '.']	[0, 6, 14, 19, 26, 33, 36, 46, 53, 63, 70, 72, 76, 78, 79, 86, 96, 103, 105, 109, 110, 111, 113, 115, 117, 124, 131, 133, 137, 139, 140, 142, 144, 151, 158, 160, 164, 165, 166, 168, 175, 176, 186, 194, 201, 203, 204, 208, 209, 211, 215, 223, 230, 232, 238, 239, 241, 242, 244, 246, 255, 258, 265, 268, 273]	[5, 13, 18, 25, 32, 35, 45, 52, 62, 69, 71, 75, 77, 79, 85, 95, 102, 104, 108, 110, 111, 112, 115, 116, 123, 130, 132, 136, 138, 140, 142, 143, 150, 157, 159, 163, 165, 166, 167, 175, 176, 185, 193, 200, 202, 204, 208, 209, 210, 214, 222, 229, 231, 237, 239, 241, 242, 244, 245, 254, 257, 265, 267, 273, 274]	['These', 'effects', 'were', 'mainly', 'caused', 'by', 'increased', 'cyclin', 'dependent', 'kinase', '1', 'and', '2', '(', 'cyclin', 'dependent', 'kinase', '1', 'and', '2', ')', ',', 'LIM', 'domain', 'kinase', '1', 'and', '2', '(', 'LIM', 'domain', 'kinase', '1', 'and', '2', ')', ',', 'mitogen', '-', 'activated', 'protein', 'kinase', '7', '(', 'MAPK7', ')', 'and', 'protein', 'kinase', 'C', 'delta', '(', 'PRKCD', ')', 'activity', 'in', 'responder', 'cells', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, immune-mediated mechanisms may also be important for chemosensitivity because ATRA/VP reduces the levels of circulating T cells [5] and members of the neutrophil degranulation network are regarded as a possible leukemia-associated antigen (proteinase 3, PRTN3) and as a regulator of antileukemic immune reactivity (major histocompatibility complex, class I, B; HLA-B).	[('PMC8125016', 'D04010', 249, 261, 'proteinase 3')]	['Finally', ',', 'immune', '-', 'mediated', 'mechanisms', 'may', 'also', 'be', 'important', 'for', 'chemo', '##sen', '##si', '##tivity', 'because', 'AT', '##RA', '/', 'VP', 'reduces', 'the', 'levels', 'of', 'circulating', 'T', 'cells', '[', '5', ']', 'and', 'members', 'of', 'the', 'neutrophil', 'deg', '##ran', '##ulation', 'network', 'are', 'regarded', 'as', 'a', 'possible', 'leukemia', '-', 'associated', 'antigen', '(', 'protein', '##ase', '3', ',', 'PR', '##TN', '##3', ')', 'and', 'as', 'a', 'regulator', 'of', 'anti', '##le', '##uk', '##emic', 'immune', 'reactivity', '(', 'major', 'hist', '##ocomp', '##ati', '##bility', 'complex', ',', 'class', 'I', ',', 'B', ';', 'HLA', '-', 'B', ')', '.']	[0, 7, 9, 15, 16, 25, 36, 40, 45, 48, 58, 62, 67, 70, 72, 79, 87, 89, 91, 92, 95, 103, 107, 114, 117, 129, 131, 137, 138, 139, 141, 145, 153, 156, 160, 171, 174, 177, 185, 193, 197, 206, 209, 211, 220, 228, 229, 240, 248, 249, 256, 260, 261, 263, 265, 267, 268, 270, 274, 277, 279, 289, 292, 296, 298, 300, 305, 312, 323, 324, 330, 334, 339, 342, 349, 356, 358, 364, 365, 367, 368, 370, 373, 374, 375, 376]	[7, 8, 15, 16, 24, 35, 39, 44, 47, 57, 61, 67, 70, 72, 78, 86, 89, 91, 92, 94, 102, 106, 113, 116, 128, 130, 136, 138, 139, 140, 144, 152, 155, 159, 170, 174, 177, 184, 192, 196, 205, 208, 210, 219, 228, 229, 239, 247, 249, 256, 259, 261, 262, 265, 267, 268, 269, 273, 276, 278, 288, 291, 296, 298, 300, 304, 311, 322, 324, 329, 334, 339, 342, 348, 356, 357, 363, 365, 366, 368, 369, 373, 374, 375, 376, 377]	['Finally', ',', 'immune', '-', 'mediated', 'mechanisms', 'may', 'also', 'be', 'important', 'for', 'chemosensitivity', 'because', 'ATRA', '/', 'VP', 'reduces', 'the', 'levels', 'of', 'circulating', 'T', 'cells', '[', '5', ']', 'and', 'members', 'of', 'the', 'neutrophil', 'degranulation', 'network', 'are', 'regarded', 'as', 'a', 'possible', 'leukemia', '-', 'associated', 'antigen', '(', 'proteinase', '3', ',', 'PRTN3', ')', 'and', 'as', 'a', 'regulator', 'of', 'antileukemic', 'immune', 'reactivity', '(', 'major', 'histocompatibility', 'complex', ',', 'class', 'I', ',', 'B', ';', 'HLA-B', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the regulation of ELANE, NME/NM23 nucleoside diphosphate kinase 3, NME3, and hydroxyesteroid 17-beta dehydrogenase 11, HSD17B11, by both -omics approaches, well represent the biological mechanisms that are affected in the two patient groups (Table A1).	[('PMC8125016', 'D06003', 43, 74, 'nucleoside diphosphate kinase 3'), ('PMC8125016', 'D06003', 86, 126, 'hydroxyesteroid 17-beta dehydrogenase 11')]	['However', ',', 'the', 'regulation', 'of', 'EL', '##AN', '##E', ',', 'NM', '##E', '/', 'NM', '##23', 'nucle', '##oside', 'diph', '##osphate', 'kinase', '3', ',', 'NM', '##E', '##3', ',', 'and', 'hydroxy', '##ester', '##oid', '17', '-', 'beta', 'dehydrogenase', '11', ',', 'HS', '##D', '##17', '##B', '##11', ',', 'by', 'both', '-', 'om', '##ics', 'approaches', ',', 'well', 'represent', 'the', 'biological', 'mechanisms', 'that', 'are', 'affected', 'in', 'the', 'two', 'patient', 'groups', '(', 'Table', 'A', '##1', ')', '.']	[0, 7, 9, 13, 24, 27, 29, 31, 32, 34, 36, 37, 38, 40, 43, 48, 54, 58, 66, 73, 74, 76, 78, 79, 80, 82, 86, 93, 98, 102, 104, 105, 110, 124, 126, 128, 130, 131, 133, 134, 136, 138, 141, 146, 147, 149, 153, 163, 165, 170, 180, 184, 195, 206, 211, 215, 224, 227, 231, 235, 243, 250, 251, 257, 258, 259, 260]	[7, 8, 12, 23, 26, 29, 31, 32, 33, 36, 37, 38, 40, 42, 48, 53, 58, 65, 72, 74, 75, 78, 79, 80, 81, 85, 93, 98, 101, 104, 105, 109, 123, 126, 127, 130, 131, 133, 134, 136, 137, 140, 145, 147, 149, 152, 163, 164, 169, 179, 183, 194, 205, 210, 214, 223, 226, 230, 234, 242, 249, 251, 256, 258, 259, 260, 261]	['However', ',', 'the', 'regulation', 'of', 'ELANE', ',', 'NME', '/', 'NM23', 'nucleoside', 'diphosphate', 'kinase', '3', ',', 'NME3', ',', 'and', 'hydroxyesteroid', '17-beta', 'dehydrogenase', '11', ',', 'HSD17B11', ',', 'by', 'both', '-', 'omics', 'approaches', ',', 'well', 'represent', 'the', 'biological', 'mechanisms', 'that', 'are', 'affected', 'in', 'the', 'two', 'patient', 'groups', '(', 'Table', 'A1', ')', '.']	[1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 2, 2, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Third, experimental studies suggest that the expression of lysine acetyltransferase 2B (GCN5) and lysine demethylase 1A (LSD1) may be important for the antileukemic effect of ATRA	[('PMC8125016', 'D07005', 59, 86, 'lysine acetyltransferase 2B'), ('PMC8125016', 'D07005', 98, 119, 'lysine demethylase 1A')]	['Third', ',', 'experimental', 'studies', 'suggest', 'that', 'the', 'expression', 'of', 'lysine', 'acetyl', '##transferase', '2', '##B', '(', 'GC', '##N', '##5', ')', 'and', 'lysine', 'dem', '##ethyl', '##ase', '1', '##A', '(', 'LS', '##D', '##1', ')', 'may', 'be', 'important', 'for', 'the', 'anti', '##le', '##uk', '##emic', 'effect', 'of', 'AT', '##RA']	[0, 5, 7, 20, 28, 36, 41, 45, 56, 59, 66, 72, 84, 85, 87, 88, 90, 91, 92, 94, 98, 105, 108, 113, 117, 118, 120, 121, 123, 124, 125, 127, 131, 134, 144, 148, 152, 156, 158, 160, 165, 172, 175, 177]	[5, 6, 19, 27, 35, 40, 44, 55, 58, 65, 72, 83, 85, 86, 88, 90, 91, 92, 93, 97, 104, 108, 113, 116, 118, 119, 121, 123, 124, 125, 126, 130, 133, 143, 147, 151, 156, 158, 160, 164, 171, 174, 177, 179]	['Third', ',', 'experimental', 'studies', 'suggest', 'that', 'the', 'expression', 'of', 'lysine', 'acetyltransferase', '2B', '(', 'GCN5', ')', 'and', 'lysine', 'demethylase', '1A', '(', 'LSD1', ')', 'may', 'be', 'important', 'for', 'the', 'antileukemic', 'effect', 'of', 'ATRA']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 3, 1, 1, 1, 3, 2, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, aldehyde dehydrogenases are important for both the synthesis of retinoids and the metabolism of reactive aldehydes.	[('PMC8125016', 'D07007', 9, 32, 'aldehyde dehydrogenases')]	['Finally', ',', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', '##s', 'are', 'important', 'for', 'both', 'the', 'synthesis', 'of', 'retin', '##oids', 'and', 'the', 'metabolism', 'of', 'reactive', 'ald', '##eh', '##yd', '##es', '.']	[0, 7, 9, 12, 14, 16, 18, 31, 33, 37, 47, 51, 56, 60, 70, 73, 78, 83, 87, 91, 102, 105, 114, 117, 119, 121, 123]	[7, 8, 12, 14, 16, 17, 31, 32, 36, 46, 50, 55, 59, 69, 72, 78, 82, 86, 90, 101, 104, 113, 117, 119, 121, 123, 124]	['Finally', ',', 'aldehyde', 'dehydrogenases', 'are', 'important', 'for', 'both', 'the', 'synthesis', 'of', 'retinoids', 'and', 'the', 'metabolism', 'of', 'reactive', 'aldehydes', '.']	[1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, aldehyde dehydrogenase activity may be generally high among our patients because both high-risk chemoresistance and AML in the elderly are associated with high protein levels of aldehyde dehydrogenase 2 family member (ALDH2)	[('PMC8125016', 'D07008', 9, 31, 'aldehyde dehydrogenase'), ('PMC8125016', 'D07008', 187, 211, 'aldehyde dehydrogenase 2')]	['However', ',', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', 'activity', 'may', 'be', 'generally', 'high', 'among', 'our', 'patients', 'because', 'both', 'high', '-', 'risk', 'chemo', '##resistance', 'and', 'AML', 'in', 'the', 'elderly', 'are', 'associated', 'with', 'high', 'protein', 'levels', 'of', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', '2', 'family', 'member', '(', 'AL', '##DH', '##2', ')']	[0, 7, 9, 12, 14, 16, 18, 32, 41, 45, 48, 58, 63, 69, 73, 82, 90, 95, 99, 100, 105, 110, 121, 125, 129, 132, 136, 144, 148, 159, 164, 169, 177, 184, 187, 190, 192, 194, 196, 210, 212, 219, 226, 227, 229, 231, 232]	[7, 8, 12, 14, 16, 17, 31, 40, 44, 47, 57, 62, 68, 72, 81, 89, 94, 99, 100, 104, 110, 120, 124, 128, 131, 135, 143, 147, 158, 163, 168, 176, 183, 186, 190, 192, 194, 195, 209, 211, 218, 225, 227, 229, 231, 232, 233]	['However', ',', 'aldehyde', 'dehydrogenase', 'activity', 'may', 'be', 'generally', 'high', 'among', 'our', 'patients', 'because', 'both', 'high', '-', 'risk', 'chemoresistance', 'and', 'AML', 'in', 'the', 'elderly', 'are', 'associated', 'with', 'high', 'protein', 'levels', 'of', 'aldehyde', 'dehydrogenase', '2', 'family', 'member', '(', 'ALDH2', ')']	[1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our present study suggests that the AML cell biology for a subset of NPM1-insertion (INS)/fms-related receptor tyrosine kinase 3-internal tandem duplications (FLT3-ITD) negative non-responders differs from other non-responders, including NPM1-INS positive non-responders.	[('PMC8125016', 'D08007', 111, 128, 'tyrosine kinase 3')]	['Our', 'present', 'study', 'suggests', 'that', 'the', 'AML', 'cell', 'biology', 'for', 'a', 'subset', 'of', 'NP', '##M', '##1', '-', 'insertion', '(', 'INS', ')', '/', 'fm', '##s', '-', 'related', 'receptor', 'tyrosine', 'kinase', '3', '-', 'internal', 'tandem', 'duplication', '##s', '(', 'FL', '##T', '##3', '-', 'IT', '##D', ')', 'negative', 'non', '-', 'responders', 'differs', 'from', 'other', 'non', '-', 'responders', ',', 'including', 'NP', '##M', '##1', '-', 'INS', 'positive', 'non', '-', 'responders', '.']	[0, 4, 12, 18, 27, 32, 36, 40, 45, 53, 57, 59, 66, 69, 71, 72, 73, 74, 84, 85, 88, 89, 90, 92, 93, 94, 102, 111, 120, 127, 128, 129, 138, 145, 156, 158, 159, 161, 162, 163, 164, 166, 167, 169, 178, 181, 182, 193, 201, 206, 212, 215, 216, 226, 228, 238, 240, 241, 242, 243, 247, 256, 259, 260, 270]	[3, 11, 17, 26, 31, 35, 39, 44, 52, 56, 58, 65, 68, 71, 72, 73, 74, 83, 85, 88, 89, 90, 92, 93, 94, 101, 110, 119, 126, 128, 129, 137, 144, 156, 157, 159, 161, 162, 163, 164, 166, 167, 168, 177, 181, 182, 192, 200, 205, 211, 215, 216, 226, 227, 237, 240, 241, 242, 243, 246, 255, 259, 260, 270, 271]	['Our', 'present', 'study', 'suggests', 'that', 'the', 'AML', 'cell', 'biology', 'for', 'a', 'subset', 'of', 'NPM1-insertion', '(', 'INS', ')', '/', 'fms', '-', 'related', 'receptor', 'tyrosine', 'kinase', '3-internal', 'tandem', 'duplications', '(', 'FLT3-ITD', ')', 'negative', 'non', '-', 'responders', 'differs', 'from', 'other', 'non', '-', 'responders', ',', 'including', 'NPM1-INS', 'positive', 'non', '-', 'responders', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 2, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Histone deacetylase inhibitors and DNA methylation inhibitors also seem to have overlapping effects on gene expression [98].	[('PMC8125016', 'D10001', 0, 19, 'Histone deacetylase')]	['Hist', '##one', 'de', '##acetyl', '##ase', 'inhibitors', 'and', 'DNA', 'methylation', 'inhibitors', 'also', 'seem', 'to', 'have', 'overlapping', 'effects', 'on', 'gene', 'expression', '[', '98', ']', '.']	[0, 4, 8, 10, 16, 20, 31, 35, 39, 51, 62, 67, 72, 75, 80, 92, 100, 103, 108, 119, 120, 122, 123]	[4, 7, 10, 16, 19, 30, 34, 38, 50, 61, 66, 71, 74, 79, 91, 99, 102, 107, 118, 120, 122, 123, 124]	['Histone', 'deacetylase', 'inhibitors', 'and', 'DNA', 'methylation', 'inhibitors', 'also', 'seem', 'to', 'have', 'overlapping', 'effects', 'on', 'gene', 'expression', '[', '98', ']', '.']	[2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our kinase prediction analyses identified an enrichment of LIMK1/K2 and cyclin dependent kinase substrates in the responder group.	[('PMC8125016', 'D11002', 4, 10, 'kinase'), ('PMC8125016', 'D11002', 72, 95, 'cyclin dependent kinase')]	['Our', 'kinase', 'prediction', 'analyses', 'identified', 'an', 'enrichment', 'of', 'LI', '##MK', '##1', '/', 'K', '##2', 'and', 'cyclin', 'dependent', 'kinase', 'substrates', 'in', 'the', 'respond', '##er', 'group', '.']	[0, 4, 11, 22, 31, 42, 45, 56, 59, 61, 63, 64, 65, 66, 68, 72, 79, 89, 96, 107, 110, 114, 121, 124, 129]	[3, 10, 21, 30, 41, 44, 55, 58, 61, 63, 64, 65, 66, 67, 71, 78, 88, 95, 106, 109, 113, 121, 123, 129, 130]	['Our', 'kinase', 'prediction', 'analyses', 'identified', 'an', 'enrichment', 'of', 'LIMK1', '/', 'K2', 'and', 'cyclin', 'dependent', 'kinase', 'substrates', 'in', 'the', 'responder', 'group', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
LIMK1 expression was significantly correlated with shorter survival of AML patients along with FLT3 mutations, lysine methyltransferase 2A (KMT2A) rearrangements and elevated homeobox D10 (HOXD10) gene expression [101].	[('PMC8125016', 'D11004', 111, 138, 'lysine methyltransferase 2A')]	['LI', '##MK', '##1', 'expression', 'was', 'significantly', 'correlated', 'with', 'shorter', 'survival', 'of', 'AML', 'patients', 'along', 'with', 'FL', '##T', '##3', 'mutations', ',', 'lysine', 'methyl', '##transferase', '2', '##A', '(', 'KM', '##T', '##2', '##A', ')', 'rearrangements', 'and', 'elevated', 'home', '##ob', '##ox', 'D', '##10', '(', 'HO', '##X', '##D', '##10', ')', 'gene', 'expression', '[', '101', ']', '.']	[0, 2, 4, 6, 17, 21, 35, 46, 51, 59, 68, 71, 75, 84, 90, 95, 97, 98, 100, 109, 111, 118, 124, 136, 137, 139, 140, 142, 143, 144, 145, 147, 162, 166, 175, 179, 181, 184, 185, 188, 189, 191, 192, 193, 195, 197, 202, 213, 214, 217, 218]	[2, 4, 5, 16, 20, 34, 45, 50, 58, 67, 70, 74, 83, 89, 94, 97, 98, 99, 109, 110, 117, 124, 135, 137, 138, 140, 142, 143, 144, 145, 146, 161, 165, 174, 179, 181, 183, 185, 187, 189, 191, 192, 193, 195, 196, 201, 212, 214, 217, 218, 219]	['LIMK1', 'expression', 'was', 'significantly', 'correlated', 'with', 'shorter', 'survival', 'of', 'AML', 'patients', 'along', 'with', 'FLT3', 'mutations', ',', 'lysine', 'methyltransferase', '2A', '(', 'KMT2A', ')', 'rearrangements', 'and', 'elevated', 'homeobox', 'D10', '(', 'HOXD10', ')', 'gene', 'expression', '[', '101', ']', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 2, 1, 4, 1, 1, 1, 1, 3, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, it was observed a reciprocal regulation between LIM kinases and CDK6.	[('PMC8125016', 'D11005', 61, 72, 'LIM kinases')]	['Furthermore', ',', 'it', 'was', 'observed', 'a', 'reciprocal', 'regulation', 'between', 'LI', '##M', 'kinases', 'and', 'CDK', '##6', '.']	[0, 11, 13, 16, 20, 29, 31, 42, 53, 61, 63, 65, 73, 77, 80, 81]	[11, 12, 15, 19, 28, 30, 41, 52, 60, 63, 64, 72, 76, 80, 81, 82]	['Furthermore', ',', 'it', 'was', 'observed', 'a', 'reciprocal', 'regulation', 'between', 'LIM', 'kinases', 'and', 'CDK6', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
Our present work observed a high activity of both kinase types (not reciprocity) although LIM domain kinase 1 and 2 activity was enhanced in treatment-responders.	[('PMC8125016', 'D11006', 50, 56, 'kinase'), ('PMC8125016', 'D11006', 90, 115, 'LIM domain kinase 1 and 2')]	['Our', 'present', 'work', 'observed', 'a', 'high', 'activity', 'of', 'both', 'kinase', 'types', '(', 'not', 'reciproc', '##ity', ')', 'although', 'LI', '##M', 'domain', 'kinase', '1', 'and', '2', 'activity', 'was', 'enhanced', 'in', 'treatment', '-', 'responders', '.']	[0, 4, 12, 17, 26, 28, 33, 42, 45, 50, 57, 63, 64, 68, 76, 79, 81, 90, 92, 94, 101, 108, 110, 114, 116, 125, 129, 138, 141, 150, 151, 161]	[3, 11, 16, 25, 27, 32, 41, 44, 49, 56, 62, 64, 67, 76, 79, 80, 89, 92, 93, 100, 107, 109, 113, 115, 124, 128, 137, 140, 150, 151, 161, 162]	['Our', 'present', 'work', 'observed', 'a', 'high', 'activity', 'of', 'both', 'kinase', 'types', '(', 'not', 'reciprocity', ')', 'although', 'LIM', 'domain', 'kinase', '1', 'and', '2', 'activity', 'was', 'enhanced', 'in', 'treatment', '-', 'responders', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As the LIMK1-mediated cofilin pathway appeared to modulate retinoid receptor functionality, the role of LIM kinases in the survival of patients treated with AML-stabilizing therapy requires further investigations [102].	[('PMC8125016', 'D11007', 104, 115, 'LIM kinases')]	['As', 'the', 'LI', '##MK', '##1', '-', 'mediated', 'co', '##fil', '##in', 'pathway', 'appeared', 'to', 'modulate', 'retin', '##oid', 'receptor', 'functionality', ',', 'the', 'role', 'of', 'LI', '##M', 'kinases', 'in', 'the', 'survival', 'of', 'patients', 'treated', 'with', 'AML', '-', 'stabilizing', 'therapy', 'requires', 'further', 'investigations', '[', '102', ']', '.']	[0, 3, 7, 9, 11, 12, 13, 22, 24, 27, 30, 38, 47, 50, 59, 64, 68, 77, 90, 92, 96, 101, 104, 106, 108, 116, 119, 123, 132, 135, 144, 152, 157, 160, 161, 173, 181, 190, 198, 213, 214, 217, 218]	[2, 6, 9, 11, 12, 13, 21, 24, 27, 29, 37, 46, 49, 58, 64, 67, 76, 90, 91, 95, 100, 103, 106, 107, 115, 118, 122, 131, 134, 143, 151, 156, 160, 161, 172, 180, 189, 197, 212, 214, 217, 218, 219]	['As', 'the', 'LIMK1', '-', 'mediated', 'cofilin', 'pathway', 'appeared', 'to', 'modulate', 'retinoid', 'receptor', 'functionality', ',', 'the', 'role', 'of', 'LIM', 'kinases', 'in', 'the', 'survival', 'of', 'patients', 'treated', 'with', 'AML-stabilizing', 'therapy', 'requires', 'further', 'investigations', '[', '102', ']', '.']	[1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A dependency of the prognostic impact of a certain biomarker on the received treatment has also been described in other diseases, e.g., the impact of the BCR-ABL translocation in acute lymphoblastic leukemia (ALL) treated with kinase inhibitors [103] and especially the Burkit B cell variant of ALL that was originally regarded as a high-risk variant but was later classified as a favorable variant when new therapeutic strategies were introduced [104].	[('PMC8125016', 'D12006', 227, 233, 'kinase')]	['A', 'dependency', 'of', 'the', 'prognostic', 'impact', 'of', 'a', 'certain', 'biomarker', 'on', 'the', 'received', 'treatment', 'has', 'also', 'been', 'described', 'in', 'other', 'diseases', ',', 'e', '.', 'g', '.', ',', 'the', 'impact', 'of', 'the', 'BCR', '-', 'AB', '##L', 'translocation', 'in', 'acute', 'lymph', '##oblastic', 'leukemia', '(', 'ALL', ')', 'treated', 'with', 'kinase', 'inhibitors', '[', '103', ']', 'and', 'especially', 'the', 'Burk', '##it', 'B', 'cell', 'variant', 'of', 'ALL', 'that', 'was', 'originally', 'regarded', 'as', 'a', 'high', '-', 'risk', 'variant', 'but', 'was', 'later', 'classified', 'as', 'a', 'favorable', 'variant', 'when', 'new', 'therapeutic', 'strategies', 'were', 'introduced', '[', '104', ']', '.']	[0, 2, 13, 16, 20, 31, 38, 41, 43, 51, 61, 64, 68, 77, 87, 91, 96, 101, 111, 114, 120, 128, 130, 131, 132, 133, 134, 136, 140, 147, 150, 154, 157, 158, 160, 162, 176, 179, 185, 190, 199, 208, 209, 212, 214, 222, 227, 234, 245, 246, 249, 251, 255, 266, 270, 274, 277, 279, 284, 292, 295, 299, 304, 308, 319, 328, 331, 333, 337, 338, 343, 351, 355, 359, 365, 376, 379, 381, 391, 399, 404, 408, 420, 431, 436, 447, 448, 451, 452]	[1, 12, 15, 19, 30, 37, 40, 42, 50, 60, 63, 67, 76, 86, 90, 95, 100, 110, 113, 119, 128, 129, 131, 132, 133, 134, 135, 139, 146, 149, 153, 157, 158, 160, 161, 175, 178, 184, 190, 198, 207, 209, 212, 213, 221, 226, 233, 244, 246, 249, 250, 254, 265, 269, 274, 276, 278, 283, 291, 294, 298, 303, 307, 318, 327, 330, 332, 337, 338, 342, 350, 354, 358, 364, 375, 378, 380, 390, 398, 403, 407, 419, 430, 435, 446, 448, 451, 452, 453]	['A', 'dependency', 'of', 'the', 'prognostic', 'impact', 'of', 'a', 'certain', 'biomarker', 'on', 'the', 'received', 'treatment', 'has', 'also', 'been', 'described', 'in', 'other', 'diseases', ',', 'e.g', '.', ',', 'the', 'impact', 'of', 'the', 'BCR-ABL', 'translocation', 'in', 'acute', 'lymphoblastic', 'leukemia', '(', 'ALL', ')', 'treated', 'with', 'kinase', 'inhibitors', '[', '103', ']', 'and', 'especially', 'the', 'Burkit', 'B', 'cell', 'variant', 'of', 'ALL', 'that', 'was', 'originally', 'regarded', 'as', 'a', 'high', '-', 'risk', 'variant', 'but', 'was', 'later', 'classified', 'as', 'a', 'favorable', 'variant', 'when', 'new', 'therapeutic', 'strategies', 'were', 'introduced', '[', '104', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, several proteins (ANO6, PLD1, ARSA, myeloperoxidase and CPNE3) of the neutrophil degranulation cluster upregulated in PRE-R patients, with the exception of ARSA, were also found to be regulated in the paired sample study with AML cells derived at both first diagnosis and first relapse time points and in the high-risk vs. low-risk comparison (Figure S5b and S5c)	[('PMC8125016', 'D13003', 46, 61, 'myeloperoxidase')]	['Moreover', ',', 'several', 'proteins', '(', 'ANO', '##6', ',', 'PL', '##D', '##1', ',', 'AR', '##SA', ',', 'myel', '##oper', '##oxidase', 'and', 'CP', '##NE', '##3', ')', 'of', 'the', 'neutrophil', 'deg', '##ran', '##ulation', 'cluster', 'upregulated', 'in', 'PRE', '-', 'R', 'patients', ',', 'with', 'the', 'exception', 'of', 'AR', '##SA', ',', 'were', 'also', 'found', 'to', 'be', 'regulated', 'in', 'the', 'paired', 'sample', 'study', 'with', 'AML', 'cells', 'derived', 'at', 'both', 'first', 'diagnosis', 'and', 'first', 'relapse', 'time', 'points', 'and', 'in', 'the', 'high', '-', 'risk', 'vs', '.', 'low', '-', 'risk', 'comparison', '(', 'Figure', 'S', '##5', '##b', 'and', 'S', '##5', '##c', ')']	[0, 8, 10, 18, 27, 28, 31, 32, 34, 36, 37, 38, 40, 42, 44, 46, 50, 54, 62, 66, 68, 70, 71, 73, 76, 80, 91, 94, 97, 105, 113, 125, 128, 131, 132, 134, 142, 144, 149, 153, 163, 166, 168, 170, 172, 177, 182, 188, 191, 194, 204, 207, 211, 218, 225, 231, 236, 240, 246, 254, 257, 262, 268, 278, 282, 288, 296, 301, 308, 312, 315, 319, 323, 324, 329, 331, 333, 336, 337, 342, 353, 354, 361, 362, 363, 365, 369, 370, 371, 372]	[8, 9, 17, 26, 28, 31, 32, 33, 36, 37, 38, 39, 42, 44, 45, 50, 54, 61, 65, 68, 70, 71, 72, 75, 79, 90, 94, 97, 104, 112, 124, 127, 131, 132, 133, 142, 143, 148, 152, 162, 165, 168, 170, 171, 176, 181, 187, 190, 193, 203, 206, 210, 217, 224, 230, 235, 239, 245, 253, 256, 261, 267, 277, 281, 287, 295, 300, 307, 311, 314, 318, 323, 324, 328, 331, 332, 336, 337, 341, 352, 354, 360, 362, 363, 364, 368, 370, 371, 372, 373]	['Moreover', ',', 'several', 'proteins', '(', 'ANO6', ',', 'PLD1', ',', 'ARSA', ',', 'myeloperoxidase', 'and', 'CPNE3', ')', 'of', 'the', 'neutrophil', 'degranulation', 'cluster', 'upregulated', 'in', 'PRE-R', 'patients', ',', 'with', 'the', 'exception', 'of', 'ARSA', ',', 'were', 'also', 'found', 'to', 'be', 'regulated', 'in', 'the', 'paired', 'sample', 'study', 'with', 'AML', 'cells', 'derived', 'at', 'both', 'first', 'diagnosis', 'and', 'first', 'relapse', 'time', 'points', 'and', 'in', 'the', 'high', '-', 'risk', 'vs', '.', 'low', '-', 'risk', 'comparison', '(', 'Figure', 'S5b', 'and', 'S5c', ')']	[1, 1, 1, 1, 1, 2, 1, 3, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, the most important additional effects on phosphoproteomic profiles also involved GTPase activity and G-protein signaling for responders and non-responders, respectively.	[('PMC8125016', 'D15011', 90, 96, 'GTPase')]	['Finally', ',', 'the', 'most', 'important', 'additional', 'effects', 'on', 'phospho', '##prot', '##e', '##omic', 'profiles', 'also', 'involved', 'GTP', '##ase', 'activity', 'and', 'G', '-', 'protein', 'signaling', 'for', 'responders', 'and', 'non', '-', 'responders', ',', 'respectively', '.']	[0, 7, 9, 13, 18, 28, 39, 47, 50, 57, 61, 62, 67, 76, 81, 90, 93, 97, 106, 110, 111, 112, 120, 130, 134, 145, 149, 152, 153, 163, 165, 177]	[7, 8, 12, 17, 27, 38, 46, 49, 57, 61, 62, 66, 75, 80, 89, 93, 96, 105, 109, 111, 112, 119, 129, 133, 144, 148, 152, 153, 163, 164, 177, 178]	['Finally', ',', 'the', 'most', 'important', 'additional', 'effects', 'on', 'phosphoproteomic', 'profiles', 'also', 'involved', 'GTPase', 'activity', 'and', 'G', '-', 'protein', 'signaling', 'for', 'responders', 'and', 'non', '-', 'responders', ',', 'respectively', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In our previous phosphoproteomics study on relapse-free and relapse patients CSNK2A1, CDKs and PRKCA/protein kinase C delta were found to influence AML prognosis [26].	[('PMC8125016', 'D15013', 101, 123, 'protein kinase C delta')]	['In', 'our', 'previous', 'phospho', '##prot', '##e', '##omics', 'study', 'on', 'relapse', '-', 'free', 'and', 'relapse', 'patients', 'CS', '##NK', '##2', '##A', '##1', ',', 'CDK', '##s', 'and', 'PR', '##K', '##CA', '/', 'protein', 'kinase', 'C', 'delta', 'were', 'found', 'to', 'influence', 'AML', 'prognosis', '[', '26', ']', '.']	[0, 3, 7, 16, 23, 27, 28, 34, 40, 43, 50, 51, 56, 60, 68, 77, 79, 81, 82, 83, 84, 86, 89, 91, 95, 97, 98, 100, 101, 109, 116, 118, 124, 129, 135, 138, 148, 152, 162, 163, 165, 166]	[2, 6, 15, 23, 27, 28, 33, 39, 42, 50, 51, 55, 59, 67, 76, 79, 81, 82, 83, 84, 85, 89, 90, 94, 97, 98, 100, 101, 108, 115, 117, 123, 128, 134, 137, 147, 151, 161, 163, 165, 166, 167]	['In', 'our', 'previous', 'phosphoproteomics', 'study', 'on', 'relapse', '-', 'free', 'and', 'relapse', 'patients', 'CSNK2A1', ',', 'CDKs', 'and', 'PRKCA', '/', 'protein', 'kinase', 'C', 'delta', 'were', 'found', 'to', 'influence', 'AML', 'prognosis', '[', '26', ']', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Herein, while PRKCA/protein kinase C delta were predicted to be activated in responders and non-responders in earlier stages of the triple combination, CSNK2A1 seemed to be activated in non-responders at day 8 of the treatment (Figure 7c) suggesting a CSNK2A1-VP crosstalk that might influence cell cycle progression.	[('PMC8125016', 'D15014', 20, 42, 'protein kinase C delta')]	['Herein', ',', 'while', 'PR', '##K', '##CA', '/', 'protein', 'kinase', 'C', 'delta', 'were', 'predicted', 'to', 'be', 'activated', 'in', 'responders', 'and', 'non', '-', 'responders', 'in', 'earlier', 'stages', 'of', 'the', 'triple', 'combination', ',', 'CS', '##NK', '##2', '##A', '##1', 'seemed', 'to', 'be', 'activated', 'in', 'non', '-', 'responders', 'at', 'day', '8', 'of', 'the', 'treatment', '(', 'Figure', '7', '##c', ')', 'suggesting', 'a', 'CS', '##NK', '##2', '##A', '##1', '-', 'VP', 'crosstalk', 'that', 'might', 'influence', 'cell', 'cycle', 'progression', '.']	[0, 6, 8, 14, 16, 17, 19, 20, 28, 35, 37, 43, 48, 58, 61, 64, 74, 77, 88, 92, 95, 96, 107, 110, 118, 125, 128, 132, 139, 150, 152, 154, 156, 157, 158, 160, 167, 170, 173, 183, 186, 189, 190, 201, 204, 208, 210, 213, 217, 227, 228, 235, 236, 237, 239, 250, 252, 254, 256, 257, 258, 259, 260, 263, 273, 278, 284, 294, 299, 305, 316]	[6, 7, 13, 16, 17, 19, 20, 27, 34, 36, 42, 47, 57, 60, 63, 73, 76, 87, 91, 95, 96, 106, 109, 117, 124, 127, 131, 138, 150, 151, 154, 156, 157, 158, 159, 166, 169, 172, 182, 185, 189, 190, 200, 203, 207, 209, 212, 216, 226, 228, 234, 236, 237, 238, 249, 251, 254, 256, 257, 258, 259, 260, 262, 272, 277, 283, 293, 298, 304, 316, 317]	['Herein', ',', 'while', 'PRKCA', '/', 'protein', 'kinase', 'C', 'delta', 'were', 'predicted', 'to', 'be', 'activated', 'in', 'responders', 'and', 'non', '-', 'responders', 'in', 'earlier', 'stages', 'of', 'the', 'triple', 'combination', ',', 'CSNK2A1', 'seemed', 'to', 'be', 'activated', 'in', 'non', '-', 'responders', 'at', 'day', '8', 'of', 'the', 'treatment', '(', 'Figure', '7c', ')', 'suggesting', 'a', 'CSNK2A1-VP', 'crosstalk', 'that', 'might', 'influence', 'cell', 'cycle', 'progression', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fredly H., Gjertsen B.T., Bruserud O. Histone deacetylase inhibition in the treatment of acute myeloid leukemia: The effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents.	[('PMC8125016', 'F04001', 38, 57, 'Histone deacetylase')]	['Fred', '##ly', 'H', '.', ',', 'G', '##je', '##rt', '##sen', 'B', '.', 'T', '.', ',', 'Br', '##user', '##ud', 'O', '.', 'Hist', '##one', 'de', '##acetyl', '##ase', 'inhibition', 'in', 'the', 'treatment', 'of', 'acute', 'myeloid', 'leukemia', ':', 'The', 'effects', 'of', 'val', '##pro', '##ic', 'acid', 'on', 'leuk', '##emic', 'cells', ',', 'and', 'the', 'clinical', 'and', 'experimental', 'evidence', 'for', 'combining', 'val', '##pro', '##ic', 'acid', 'with', 'other', 'anti', '##le', '##uk', '##emic', 'agents', '.']	[0, 4, 7, 8, 9, 11, 12, 14, 16, 20, 21, 22, 23, 24, 26, 28, 32, 35, 36, 38, 42, 46, 48, 54, 58, 69, 72, 76, 86, 89, 95, 103, 111, 113, 117, 125, 128, 131, 134, 137, 142, 145, 149, 154, 159, 161, 165, 169, 178, 182, 195, 204, 208, 218, 221, 224, 227, 232, 237, 243, 247, 249, 251, 256, 262]	[4, 6, 8, 9, 10, 12, 14, 16, 19, 21, 22, 23, 24, 25, 28, 32, 34, 36, 37, 42, 45, 48, 54, 57, 68, 71, 75, 85, 88, 94, 102, 111, 112, 116, 124, 127, 131, 134, 136, 141, 144, 149, 153, 159, 160, 164, 168, 177, 181, 194, 203, 207, 217, 221, 224, 226, 231, 236, 242, 247, 249, 251, 255, 262, 263]	['Fredly', 'H', '.', ',', 'Gjertsen', 'B.T', '.', ',', 'Bruserud', 'O', '.', 'Histone', 'deacetylase', 'inhibition', 'in', 'the', 'treatment', 'of', 'acute', 'myeloid', 'leukemia', ':', 'The', 'effects', 'of', 'valproic', 'acid', 'on', 'leukemic', 'cells', ',', 'and', 'the', 'clinical', 'and', 'experimental', 'evidence', 'for', 'combining', 'valproic', 'acid', 'with', 'other', 'antileukemic', 'agents', '.']	[2, 1, 1, 1, 4, 3, 1, 1, 3, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Jensen P., Carlet M., Schlenk R.F., Weber A., Kress J., Brunner I., Slabicki M., Grill G., Weisemann S., Cheng Y.Y., et al. Requirement for LIM kinases in acute myeloid leukemia.	[('PMC8125016', 'F100001', 140, 151, 'LIM kinases')]	['Jensen', 'P', '.', ',', 'Carl', '##et', 'M', '.', ',', 'Schl', '##enk', 'R', '.', 'F', '.', ',', 'Weber', 'A', '.', ',', 'Kre', '##ss', 'J', '.', ',', 'Brun', '##ner', 'I', '.', ',', 'Sl', '##abi', '##ck', '##i', 'M', '.', ',', 'Gr', '##ill', 'G', '.', ',', 'Wei', '##sem', '##ann', 'S', '.', ',', 'Cheng', 'Y', '.', 'Y', '.', ',', 'et', 'al', '.', 'Require', '##ment', 'for', 'LI', '##M', 'kinases', 'in', 'acute', 'myeloid', 'leukemia', '.']	[0, 7, 8, 9, 11, 15, 18, 19, 20, 22, 26, 30, 31, 32, 33, 34, 36, 42, 43, 44, 46, 49, 52, 53, 54, 56, 60, 64, 65, 66, 68, 70, 73, 75, 77, 78, 79, 81, 83, 87, 88, 89, 91, 94, 97, 101, 102, 103, 105, 111, 112, 113, 114, 115, 117, 120, 122, 124, 131, 136, 140, 142, 144, 152, 155, 161, 169, 177]	[6, 8, 9, 10, 15, 17, 19, 20, 21, 26, 29, 31, 32, 33, 34, 35, 41, 43, 44, 45, 49, 51, 53, 54, 55, 60, 63, 65, 66, 67, 70, 73, 75, 76, 78, 79, 80, 83, 86, 88, 89, 90, 94, 97, 100, 102, 103, 104, 110, 112, 113, 114, 115, 116, 119, 122, 123, 131, 135, 139, 142, 143, 151, 154, 160, 168, 177, 178]	['Jensen', 'P', '.', ',', 'Carlet', 'M', '.', ',', 'Schlenk', 'R.F', '.', ',', 'Weber', 'A', '.', ',', 'Kress', 'J', '.', ',', 'Brunner', 'I', '.', ',', 'Slabicki', 'M', '.', ',', 'Grill', 'G', '.', ',', 'Weisemann', 'S', '.', ',', 'Cheng', 'Y.Y', '.', ',', 'et', 'al', '.', 'Requirement', 'for', 'LIM', 'kinases', 'in', 'acute', 'myeloid', 'leukemia', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Ishaq M., Lin B.R., Bosche M., Zheng X., Yang J., Huang D., Lempicki R.A., Aguilera-Gutierrez A., Natarajan V. LIM kinase 1—dependent cofilin 1 pathway and actin dynamics mediate nuclear retinoid receptor function in T lymphocytes.	[('PMC8125016', 'F101001', 111, 123, 'LIM kinase 1')]	['Ish', '##a', '##q', 'M', '.', ',', 'Lin', 'B', '.', 'R', '.', ',', 'Bos', '##che', 'M', '.', ',', 'Zheng', 'X', '.', ',', 'Yang', 'J', '.', ',', 'Huang', 'D', '.', ',', 'Lem', '##pic', '##ki', 'R', '.', 'A', '.', ',', 'Ag', '##ui', '##ler', '##a', '-', 'Gut', '##ier', '##rez', 'A', '.', ',', 'Nat', '##araj', '##an', 'V', '.', 'LI', '##M', 'kinase', '1', '—', 'dependent', 'co', '##fil', '##in', '1', 'pathway', 'and', 'actin', 'dynamics', 'mediate', 'nuclear', 'retin', '##oid', 'receptor', 'function', 'in', 'T', 'lymphocytes', '.']	[0, 3, 4, 6, 7, 8, 10, 14, 15, 16, 17, 18, 20, 23, 27, 28, 29, 31, 37, 38, 39, 41, 46, 47, 48, 50, 56, 57, 58, 60, 63, 66, 69, 70, 71, 72, 73, 75, 77, 79, 82, 83, 84, 87, 90, 94, 95, 96, 98, 101, 105, 108, 109, 111, 113, 115, 122, 123, 124, 134, 136, 139, 142, 144, 152, 156, 162, 171, 179, 187, 192, 196, 205, 214, 217, 219, 230]	[3, 4, 5, 7, 8, 9, 13, 15, 16, 17, 18, 19, 23, 26, 28, 29, 30, 36, 38, 39, 40, 45, 47, 48, 49, 55, 57, 58, 59, 63, 66, 68, 70, 71, 72, 73, 74, 77, 79, 82, 83, 84, 87, 90, 93, 95, 96, 97, 101, 105, 107, 109, 110, 113, 114, 121, 123, 124, 133, 136, 139, 141, 143, 151, 155, 161, 170, 178, 186, 192, 195, 204, 213, 216, 218, 230, 231]	['Ishaq', 'M', '.', ',', 'Lin', 'B.R', '.', ',', 'Bosche', 'M', '.', ',', 'Zheng', 'X', '.', ',', 'Yang', 'J', '.', ',', 'Huang', 'D', '.', ',', 'Lempicki', 'R.A', '.', ',', 'Aguilera-Gutierrez', 'A', '.', ',', 'Natarajan', 'V', '.', 'LIM', 'kinase', '1—', 'dependent', 'cofilin', '1', 'pathway', 'and', 'actin', 'dynamics', 'mediate', 'nuclear', 'retinoid', 'receptor', 'function', 'in', 'T', 'lymphocytes', '.']	[3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 8, 1, 1, 1, 3, 1, 1, 2, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bleibaum F., Sommer A., Veit M., Rabe B., Andra J., Kunzelmann K., Nehls C., Correa W., Gutsmann T., Grotzinger J., et al. ADAM10 sheddase activation is controlled by cell membrane asymmetry.	[('PMC8125016', 'F112001', 130, 138, 'sheddase')]	['Ble', '##iba', '##um', 'F', '.', ',', 'So', '##mm', '##er', 'A', '.', ',', 'Ve', '##it', 'M', '.', ',', 'Rab', '##e', 'B', '.', ',', 'Andr', '##a', 'J', '.', ',', 'Kun', '##zel', '##mann', 'K', '.', ',', 'Ne', '##hl', '##s', 'C', '.', ',', 'Cor', '##rea', 'W', '.', ',', 'Gut', '##sm', '##ann', 'T', '.', ',', 'Gro', '##tz', '##inger', 'J', '.', ',', 'et', 'al', '.', 'ADAM', '##10', 'shed', '##dase', 'activation', 'is', 'controlled', 'by', 'cell', 'membrane', 'asymmetry', '.']	[0, 3, 6, 9, 10, 11, 13, 15, 17, 20, 21, 22, 24, 26, 29, 30, 31, 33, 36, 38, 39, 40, 42, 46, 48, 49, 50, 52, 55, 58, 63, 64, 65, 67, 69, 71, 73, 74, 75, 77, 80, 84, 85, 86, 88, 91, 93, 97, 98, 99, 101, 104, 106, 112, 113, 114, 116, 119, 121, 123, 127, 130, 134, 139, 150, 153, 164, 167, 172, 181, 190]	[3, 6, 8, 10, 11, 12, 15, 17, 19, 21, 22, 23, 26, 28, 30, 31, 32, 36, 37, 39, 40, 41, 46, 47, 49, 50, 51, 55, 58, 62, 64, 65, 66, 69, 71, 72, 74, 75, 76, 80, 83, 85, 86, 87, 91, 93, 96, 98, 99, 100, 104, 106, 111, 113, 114, 115, 118, 121, 122, 127, 129, 134, 138, 149, 152, 163, 166, 171, 180, 190, 191]	['Bleibaum', 'F', '.', ',', 'Sommer', 'A', '.', ',', 'Veit', 'M', '.', ',', 'Rabe', 'B', '.', ',', 'Andra', 'J', '.', ',', 'Kunzelmann', 'K', '.', ',', 'Nehls', 'C', '.', ',', 'Correa', 'W', '.', ',', 'Gutsmann', 'T', '.', ',', 'Grotzinger', 'J', '.', ',', 'et', 'al', '.', 'ADAM10', 'sheddase', 'activation', 'is', 'controlled', 'by', 'cell', 'membrane', 'asymmetry', '.']	[3, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Molecular functions of anoctamin 6 (TMEM16F): A chloride channel, cation channel, or phospholipid scramblase?	[('PMC8125016', 'F114002', 98, 108, 'scramblase')]	['Molecular', 'functions', 'of', 'an', '##oct', '##amin', '6', '(', 'TM', '##EM', '##16', '##F', ')', ':', 'A', 'chloride', 'channel', ',', 'cation', 'channel', ',', 'or', 'phospholipid', 'scr', '##amb', '##las', '##e', '?']	[0, 10, 20, 23, 25, 28, 33, 35, 36, 38, 40, 42, 43, 44, 46, 48, 57, 64, 66, 73, 80, 82, 85, 98, 101, 104, 107, 108]	[9, 19, 22, 25, 28, 32, 34, 36, 38, 40, 42, 43, 44, 45, 47, 56, 64, 65, 72, 80, 81, 84, 97, 101, 104, 107, 108, 109]	['Molecular', 'functions', 'of', 'anoctamin', '6', '(', 'TMEM16F', ')', ':', 'A', 'chloride', 'channel', ',', 'cation', 'channel', ',', 'or', 'phospholipid', 'scramblase', '?']	[1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Anoctamin-6 regulates ADAM sheddase function.	[('PMC8125016', 'F117002', 27, 35, 'sheddase')]	['An', '##oct', '##amin', '-', '6', 'regulates', 'ADAM', 'shed', '##dase', 'function', '.']	[0, 2, 5, 9, 10, 12, 22, 27, 31, 36, 44]	[2, 5, 9, 10, 11, 21, 26, 31, 35, 44, 45]	['Anoctamin-6', 'regulates', 'ADAM', 'sheddase', 'function', '.']	[5, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
Kovacs Z., Jung I., Gurzu S. Arylsulfatases A and B: From normal tissues to malignant tumors.	[('PMC8125016', 'F118001', 29, 43, 'Arylsulfatases')]	['Ko', '##vac', '##s', 'Z', '.', ',', 'Jung', 'I', '.', ',', 'Gu', '##r', '##zu', 'S', '.', 'Ar', '##yl', '##sulf', '##atase', '##s', 'A', 'and', 'B', ':', 'From', 'normal', 'tissues', 'to', 'malignant', 'tumors', '.']	[0, 2, 5, 7, 8, 9, 11, 16, 17, 18, 20, 22, 23, 26, 27, 29, 31, 33, 37, 42, 44, 46, 50, 51, 53, 58, 65, 73, 76, 86, 92]	[2, 5, 6, 8, 9, 10, 15, 17, 18, 19, 22, 23, 25, 27, 28, 31, 33, 37, 42, 43, 45, 49, 51, 52, 57, 64, 72, 75, 85, 92, 93]	['Kovacs', 'Z', '.', ',', 'Jung', 'I', '.', ',', 'Gurzu', 'S', '.', 'Arylsulfatases', 'A', 'and', 'B', ':', 'From', 'normal', 'tissues', 'to', 'malignant', 'tumors', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Kzhyshkowska J., Yin S., Liu T., Riabov V., Mitrofanova I. Role of chitinase-like proteins in cancer.	[('PMC8125016', 'F119001', 67, 76, 'chitinase')]	['K', '##zh', '##ys', '##hk', '##ows', '##ka', 'J', '.', ',', 'Yin', 'S', '.', ',', 'Liu', 'T', '.', ',', 'Ri', '##ab', '##ov', 'V', '.', ',', 'Mit', '##rof', '##ano', '##va', 'I', '.', 'Role', 'of', 'chi', '##tin', '##ase', '-', 'like', 'proteins', 'in', 'cancer', '.']	[0, 1, 3, 5, 7, 10, 13, 14, 15, 17, 21, 22, 23, 25, 29, 30, 31, 33, 35, 37, 40, 41, 42, 44, 47, 50, 53, 56, 57, 59, 64, 67, 70, 73, 76, 77, 82, 91, 94, 100]	[1, 3, 5, 7, 10, 12, 14, 15, 16, 20, 22, 23, 24, 28, 30, 31, 32, 35, 37, 39, 41, 42, 43, 47, 50, 53, 55, 57, 58, 63, 66, 70, 73, 76, 77, 81, 90, 93, 100, 101]	['Kzhyshkowska', 'J', '.', ',', 'Yin', 'S', '.', ',', 'Liu', 'T', '.', ',', 'Riabov', 'V', '.', ',', 'Mitrofanova', 'I', '.', 'Role', 'of', 'chitinase', '-', 'like', 'proteins', 'in', 'cancer', '.']	[6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Patel R.K., Weir M.C., Shen K., Snyder D., Cooper V.S., Smithgall T.E. Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance.	[('PMC8125016', 'F124001', 104, 111, 'kinases'), ('PMC8125016', 'F124001', 177, 183, 'kinase')]	['Patel', 'R', '.', 'K', '.', ',', 'Wei', '##r', 'M', '.', 'C', '.', ',', 'Shen', 'K', '.', ',', 'Sn', '##yd', '##er', 'D', '.', ',', 'Cooper', 'V', '.', 'S', '.', ',', 'Smith', '##gal', '##l', 'T', '.', 'E', '.', 'Expression', 'of', 'myeloid', 'Src', '-', 'family', 'kinases', 'is', 'associated', 'with', 'poor', 'prognosis', 'in', 'AML', 'and', 'influences', 'Fl', '##t', '##3', '-', 'IT', '##D', 'kinase', 'inhibitor', 'acquired', 'resistance', '.']	[0, 6, 7, 8, 9, 10, 12, 15, 17, 18, 19, 20, 21, 23, 28, 29, 30, 32, 34, 36, 39, 40, 41, 43, 50, 51, 52, 53, 54, 56, 61, 64, 66, 67, 68, 69, 71, 82, 85, 93, 96, 97, 104, 112, 115, 126, 131, 136, 146, 149, 153, 157, 168, 170, 171, 172, 173, 175, 177, 184, 194, 203, 213]	[5, 7, 8, 9, 10, 11, 15, 16, 18, 19, 20, 21, 22, 27, 29, 30, 31, 34, 36, 38, 40, 41, 42, 49, 51, 52, 53, 54, 55, 61, 64, 65, 67, 68, 69, 70, 81, 84, 92, 96, 97, 103, 111, 114, 125, 130, 135, 145, 148, 152, 156, 167, 170, 171, 172, 173, 175, 176, 183, 193, 202, 213, 214]	['Patel', 'R.K', '.', ',', 'Weir', 'M.C', '.', ',', 'Shen', 'K', '.', ',', 'Snyder', 'D', '.', ',', 'Cooper', 'V.S', '.', ',', 'Smithgall', 'T.E', '.', 'Expression', 'of', 'myeloid', 'Src', '-', 'family', 'kinases', 'is', 'associated', 'with', 'poor', 'prognosis', 'in', 'AML', 'and', 'influences', 'Flt3-ITD', 'kinase', 'inhibitor', 'acquired', 'resistance', '.']	[1, 3, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O']
The Src family kinase Fgr is a transforming oncoprotein that functions independently of SH3-SH2 domain regulation.	[('PMC8125016', 'F125002', 15, 21, 'kinase')]	['The', 'Src', 'family', 'kinase', 'F', '##gr', 'is', 'a', 'transforming', 'onc', '##oprotein', 'that', 'functions', 'independently', 'of', 'SH', '##3', '-', 'SH', '##2', 'domain', 'regulation', '.']	[0, 4, 8, 15, 22, 23, 26, 29, 31, 44, 47, 56, 61, 71, 85, 88, 90, 91, 92, 94, 96, 103, 113]	[3, 7, 14, 21, 23, 25, 28, 30, 43, 47, 55, 60, 70, 84, 87, 90, 91, 92, 94, 95, 102, 113, 114]	['The', 'Src', 'family', 'kinase', 'Fgr', 'is', 'a', 'transforming', 'oncoprotein', 'that', 'functions', 'independently', 'of', 'SH3-SH2', 'domain', 'regulation', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Weir M.C., Shu S.T., Patel R.K., Hellwig S., Chen L., Tan L., Gray N.S., Smithgall T.E. Selective Inhibition of the Myeloid Src-Family Kinase Fgr Potently Suppresses AML Cell Growth in Vitro and in Vivo.	[('PMC8125016', 'F126001', 135, 141, 'Kinase')]	['Wei', '##r', 'M', '.', 'C', '.', ',', 'Sh', '##u', 'S', '.', 'T', '.', ',', 'Patel', 'R', '.', 'K', '.', ',', 'Hel', '##l', '##wig', 'S', '.', ',', 'Chen', 'L', '.', ',', 'Tan', 'L', '.', ',', 'Gray', 'N', '.', 'S', '.', ',', 'Smith', '##gal', '##l', 'T', '.', 'E', '.', 'Selective', 'Inhibition', 'of', 'the', 'My', '##elo', '##id', 'Src', '-', 'Family', 'Kin', '##ase', 'F', '##gr', 'Pot', '##ently', 'Supp', '##ress', '##es', 'AML', 'Cell', 'Growth', 'in', 'Vit', '##ro', 'and', 'in', 'Vi', '##vo', '.']	[0, 3, 5, 6, 7, 8, 9, 11, 13, 15, 16, 17, 18, 19, 21, 27, 28, 29, 30, 31, 33, 36, 37, 41, 42, 43, 45, 50, 51, 52, 54, 58, 59, 60, 62, 67, 68, 69, 70, 71, 73, 78, 81, 83, 84, 85, 86, 88, 98, 109, 112, 116, 118, 121, 124, 127, 128, 135, 138, 142, 143, 146, 149, 155, 159, 163, 166, 170, 175, 182, 185, 188, 191, 195, 198, 200, 202]	[3, 4, 6, 7, 8, 9, 10, 13, 14, 16, 17, 18, 19, 20, 26, 28, 29, 30, 31, 32, 36, 37, 40, 42, 43, 44, 49, 51, 52, 53, 57, 59, 60, 61, 66, 68, 69, 70, 71, 72, 78, 81, 82, 84, 85, 86, 87, 97, 108, 111, 115, 118, 121, 123, 127, 128, 134, 138, 141, 143, 145, 149, 154, 159, 163, 165, 169, 174, 181, 184, 188, 190, 194, 197, 200, 202, 203]	['Weir', 'M.C', '.', ',', 'Shu', 'S.T', '.', ',', 'Patel', 'R.K', '.', ',', 'Hellwig', 'S', '.', ',', 'Chen', 'L', '.', ',', 'Tan', 'L', '.', ',', 'Gray', 'N.S', '.', ',', 'Smithgall', 'T.E', '.', 'Selective', 'Inhibition', 'of', 'the', 'Myeloid', 'Src-Family', 'Kinase', 'Fgr', 'Potently', 'Suppresses', 'AML', 'Cell', 'Growth', 'in', 'Vitro', 'and', 'in', 'Vivo', '.']	[2, 3, 1, 1, 2, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 3, 3, 2, 2, 2, 3, 1, 1, 1, 1, 2, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Kumar M., Birdi A., Gupta Y.N., Gupta S. Serum lactic dehydrogenase isoenzymes alteration in carcinoma cervix uteri.	[('PMC8125016', 'F133001', 47, 67, 'lactic dehydrogenase')]	['Kumar', 'M', '.', ',', 'Bir', '##di', 'A', '.', ',', 'Gupta', 'Y', '.', 'N', '.', ',', 'Gupta', 'S', '.', 'Serum', 'lactic', 'dehydrogenase', 'iso', '##enzyme', '##s', 'alteration', 'in', 'carcinoma', 'cerv', '##ix', 'uter', '##i', '.']	[0, 6, 7, 8, 10, 13, 16, 17, 18, 20, 26, 27, 28, 29, 30, 32, 38, 39, 41, 47, 54, 68, 71, 77, 79, 90, 93, 103, 107, 110, 114, 115]	[5, 7, 8, 9, 13, 15, 17, 18, 19, 25, 27, 28, 29, 30, 31, 37, 39, 40, 46, 53, 67, 71, 77, 78, 89, 92, 102, 107, 109, 114, 115, 116]	['Kumar', 'M', '.', ',', 'Birdi', 'A', '.', ',', 'Gupta', 'Y.N', '.', ',', 'Gupta', 'S', '.', 'Serum', 'lactic', 'dehydrogenase', 'isoenzymes', 'alteration', 'in', 'carcinoma', 'cervix', 'uteri', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia.	[('PMC8125016', 'F137002', 52, 67, 'myeloperoxidase')]	['Dist', '##inct', 'gene', 'alterations', 'with', 'a', 'high', 'percentage', 'of', 'myel', '##oper', '##oxidase', '-', 'positive', 'leuk', '##emic', 'blast', '##s', 'in', 'de', 'novo', 'acute', 'myeloid', 'leukemia', '.']	[0, 4, 9, 14, 26, 31, 33, 38, 49, 52, 56, 60, 67, 68, 77, 81, 86, 91, 93, 96, 99, 104, 110, 118, 126]	[4, 8, 13, 25, 30, 32, 37, 48, 51, 56, 60, 67, 68, 76, 81, 85, 91, 92, 95, 98, 103, 109, 117, 126, 127]	['Distinct', 'gene', 'alterations', 'with', 'a', 'high', 'percentage', 'of', 'myeloperoxidase', '-', 'positive', 'leukemic', 'blasts', 'in', 'de', 'novo', 'acute', 'myeloid', 'leukemia', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Roberson J.R., Onciu M., Pounds S., Rubnitz J.E., Pui C.H., Razzouk B.I. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.	[('PMC8125016', 'F138001', 100, 115, 'myeloperoxidase')]	['Rob', '##erson', 'J', '.', 'R', '.', ',', 'Onc', '##iu', 'M', '.', ',', 'Po', '##und', '##s', 'S', '.', ',', 'Rub', '##nit', '##z', 'J', '.', 'E', '.', ',', 'Pu', '##i', 'C', '.', 'H', '.', ',', 'Ra', '##zz', '##ou', '##k', 'B', '.', 'I', '.', 'Progn', '##ostic', 'significance', 'of', 'myel', '##oper', '##oxidase', 'expression', 'in', 'childhood', 'acute', 'myeloid', 'leukemia', '.']	[0, 3, 9, 10, 11, 12, 13, 15, 18, 21, 22, 23, 25, 27, 30, 32, 33, 34, 36, 39, 42, 44, 45, 46, 47, 48, 50, 52, 54, 55, 56, 57, 58, 60, 62, 64, 66, 68, 69, 70, 71, 73, 78, 84, 97, 100, 104, 108, 116, 127, 130, 140, 146, 154, 162]	[3, 8, 10, 11, 12, 13, 14, 18, 20, 22, 23, 24, 27, 30, 31, 33, 34, 35, 39, 42, 43, 45, 46, 47, 48, 49, 52, 53, 55, 56, 57, 58, 59, 62, 64, 66, 67, 69, 70, 71, 72, 78, 83, 96, 99, 104, 108, 115, 126, 129, 139, 145, 153, 162, 163]	['Roberson', 'J.R', '.', ',', 'Onciu', 'M', '.', ',', 'Pounds', 'S', '.', ',', 'Rubnitz', 'J.E', '.', ',', 'Pui', 'C.H', '.', ',', 'Razzouk', 'B.I', '.', 'Prognostic', 'significance', 'of', 'myeloperoxidase', 'expression', 'in', 'childhood', 'acute', 'myeloid', 'leukemia', '.']	[2, 3, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 3, 1, 1, 2, 3, 1, 1, 4, 3, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Brown F.D., Thompson N., Saqib K.M., Clark J.M., Powner D., Thompson N.T., Solari R., Wakelam M.J. Phospholipase D1 localises to secretory granules and lysosomes and is plasma-membrane translocated on cellular stimulation.	[('PMC8125016', 'F139001', 99, 115, 'Phospholipase D1')]	['Brown', 'F', '.', 'D', '.', ',', 'Thompson', 'N', '.', ',', 'Sa', '##qi', '##b', 'K', '.', 'M', '.', ',', 'Clark', 'J', '.', 'M', '.', ',', 'Pow', '##ner', 'D', '.', ',', 'Thompson', 'N', '.', 'T', '.', ',', 'Solar', '##i', 'R', '.', ',', 'Wa', '##kel', '##am', 'M', '.', 'J', '.', 'Phosph', '##olip', '##ase', 'D', '##1', 'local', '##ises', 'to', 'secretory', 'granules', 'and', 'lys', '##osomes', 'and', 'is', 'plasma', '-', 'membrane', 'transloc', '##ated', 'on', 'cellular', 'stimulation', '.']	[0, 6, 7, 8, 9, 10, 12, 21, 22, 23, 25, 27, 29, 31, 32, 33, 34, 35, 37, 43, 44, 45, 46, 47, 49, 52, 56, 57, 58, 60, 69, 70, 71, 72, 73, 75, 80, 82, 83, 84, 86, 88, 91, 94, 95, 96, 97, 99, 105, 109, 113, 114, 116, 121, 126, 129, 139, 148, 152, 155, 162, 166, 169, 175, 176, 185, 193, 198, 201, 210, 221]	[5, 7, 8, 9, 10, 11, 20, 22, 23, 24, 27, 29, 30, 32, 33, 34, 35, 36, 42, 44, 45, 46, 47, 48, 52, 55, 57, 58, 59, 68, 70, 71, 72, 73, 74, 80, 81, 83, 84, 85, 88, 91, 93, 95, 96, 97, 98, 105, 109, 112, 114, 115, 121, 125, 128, 138, 147, 151, 155, 161, 165, 168, 175, 176, 184, 193, 197, 200, 209, 221, 222]	['Brown', 'F.D', '.', ',', 'Thompson', 'N', '.', ',', 'Saqib', 'K.M', '.', ',', 'Clark', 'J.M', '.', ',', 'Powner', 'D', '.', ',', 'Thompson', 'N.T', '.', ',', 'Solari', 'R', '.', ',', 'Wakelam', 'M.J', '.', 'Phospholipase', 'D1', 'localises', 'to', 'secretory', 'granules', 'and', 'lysosomes', 'and', 'is', 'plasma', '-', 'membrane', 'translocated', 'on', 'cellular', 'stimulation', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 3, 1, 3, 2, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lu Y., Zhou J., Pei R., Li F., Jin J., Jiang L. Expression and clinical significance of phospholipase D1 in de novo acute myeloid leukemia.	[('PMC8125016', 'F140001', 88, 104, 'phospholipase D1')]	['Lu', 'Y', '.', ',', 'Zhou', 'J', '.', ',', 'Pe', '##i', 'R', '.', ',', 'Li', 'F', '.', ',', 'Jin', 'J', '.', ',', 'Jiang', 'L', '.', 'Expression', 'and', 'clinical', 'significance', 'of', 'phospholip', '##ase', 'D', '##1', 'in', 'de', 'novo', 'acute', 'myeloid', 'leukemia', '.']	[0, 3, 4, 5, 7, 12, 13, 14, 16, 18, 20, 21, 22, 24, 27, 28, 29, 31, 35, 36, 37, 39, 45, 46, 48, 59, 63, 72, 85, 88, 98, 102, 103, 105, 108, 111, 116, 122, 130, 138]	[2, 4, 5, 6, 11, 13, 14, 15, 18, 19, 21, 22, 23, 26, 28, 29, 30, 34, 36, 37, 38, 44, 46, 47, 58, 62, 71, 84, 87, 98, 101, 103, 104, 107, 110, 115, 121, 129, 138, 139]	['Lu', 'Y', '.', ',', 'Zhou', 'J', '.', ',', 'Pei', 'R', '.', ',', 'Li', 'F', '.', ',', 'Jin', 'J', '.', ',', 'Jiang', 'L', '.', 'Expression', 'and', 'clinical', 'significance', 'of', 'phospholipase', 'D1', 'in', 'de', 'novo', 'acute', 'myeloid', 'leukemia', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteinase 3 Limits the Number of Hematopoietic Stem and Progenitor Cells in Murine Bone Marrow.	[('PMC8125016', 'F145002', 0, 12, 'Proteinase 3')]	['Protein', '##ase', '3', 'Lim', '##its', 'the', 'Number', 'of', 'Hemat', '##opoietic', 'Stem', 'and', 'Prog', '##eni', '##tor', 'Cells', 'in', 'Mur', '##ine', 'Bone', 'Mar', '##row', '.']	[0, 7, 11, 13, 16, 20, 24, 31, 34, 39, 48, 53, 57, 61, 64, 68, 74, 77, 80, 84, 89, 92, 95]	[7, 10, 12, 16, 19, 23, 30, 33, 39, 47, 52, 56, 61, 64, 67, 73, 76, 80, 83, 88, 92, 95, 96]	['Proteinase', '3', 'Limits', 'the', 'Number', 'of', 'Hematopoietic', 'Stem', 'and', 'Progenitor', 'Cells', 'in', 'Murine', 'Bone', 'Marrow', '.']	[2, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 2, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lakshmaiah K.C., Jacob L.A., Aparna S., Lokanatha D., Saldanha S.C. Epigenetic therapy of cancer with histone deacetylase inhibitors.	[('PMC8125016', 'F17001', 102, 121, 'histone deacetylase')]	['La', '##ks', '##hma', '##ia', '##h', 'K', '.', 'C', '.', ',', 'Jacob', 'L', '.', 'A', '.', ',', 'Ap', '##arn', '##a', 'S', '.', ',', 'Lo', '##kan', '##ath', '##a', 'D', '.', ',', 'Sal', '##dan', '##ha', 'S', '.', 'C', '.', 'Ep', '##igenetic', 'therapy', 'of', 'cancer', 'with', 'histone', 'de', '##acetyl', '##ase', 'inhibitors', '.']	[0, 2, 4, 7, 9, 11, 12, 13, 14, 15, 17, 23, 24, 25, 26, 27, 29, 31, 34, 36, 37, 38, 40, 42, 45, 48, 50, 51, 52, 54, 57, 60, 63, 64, 65, 66, 68, 70, 79, 87, 90, 97, 102, 110, 112, 118, 122, 132]	[2, 4, 7, 9, 10, 12, 13, 14, 15, 16, 22, 24, 25, 26, 27, 28, 31, 34, 35, 37, 38, 39, 42, 45, 48, 49, 51, 52, 53, 57, 60, 62, 64, 65, 66, 67, 70, 78, 86, 89, 96, 101, 109, 112, 118, 121, 132, 133]	['Lakshmaiah', 'K.C', '.', ',', 'Jacob', 'L.A', '.', ',', 'Aparna', 'S', '.', ',', 'Lokanatha', 'D', '.', ',', 'Saldanha', 'S.C', '.', 'Epigenetic', 'therapy', 'of', 'cancer', 'with', 'histone', 'deacetylase', 'inhibitors', '.']	[5, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 3, 3, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
Ceccacci E., Minucci S. Inhibition of histone deacetylases in cancer therapy:	[('PMC8125016', 'F18001', 38, 58, 'histone deacetylases')]	['Ce', '##cc', '##acc', '##i', 'E', '.', ',', 'Min', '##ucci', 'S', '.', 'Inhibition', 'of', 'histone', 'de', '##acetyl', '##ases', 'in', 'cancer', 'therapy', ':']	[0, 2, 4, 7, 9, 10, 11, 13, 16, 21, 22, 24, 35, 38, 46, 48, 54, 59, 62, 69, 76]	[2, 4, 7, 8, 10, 11, 12, 16, 20, 22, 23, 34, 37, 45, 48, 54, 58, 61, 68, 76, 77]	['Ceccacci', 'E', '.', ',', 'Minucci', 'S', '.', 'Inhibition', 'of', 'histone', 'deacetylases', 'in', 'cancer', 'therapy', ':']	[4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Bradbury C.A., Khanim F.L., Hayden R., Bunce C.M., White D.A., Drayson M.T., Craddock C., Turner B.M. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.	[('PMC8125016', 'F21001', 102, 122, 'Histone deacetylases'), ('PMC8125016', 'F21001', 231, 242, 'deacetylase')]	['Brad', '##bury', 'C', '.', 'A', '.', ',', 'Khan', '##im', 'F', '.', 'L', '.', ',', 'Hay', '##den', 'R', '.', ',', 'Bu', '##nce', 'C', '.', 'M', '.', ',', 'White', 'D', '.', 'A', '.', ',', 'Dr', '##ays', '##on', 'M', '.', 'T', '.', ',', 'Cra', '##dd', '##ock', 'C', '.', ',', 'Turner', 'B', '.', 'M', '.', 'Hist', '##one', 'de', '##acetyl', '##ases', 'in', 'acute', 'myeloid', 'leuk', '##aemia', 'show', 'a', 'distinctive', 'pattern', 'of', 'expression', 'that', 'changes', 'selectively', 'in', 'response', 'to', 'de', '##acetyl', '##ase', 'inhibitors', '.']	[0, 4, 9, 10, 11, 12, 13, 15, 19, 22, 23, 24, 25, 26, 28, 31, 35, 36, 37, 39, 41, 45, 46, 47, 48, 49, 51, 57, 58, 59, 60, 61, 63, 65, 68, 71, 72, 73, 74, 75, 77, 80, 82, 86, 87, 88, 90, 97, 98, 99, 100, 102, 106, 110, 112, 118, 123, 126, 132, 140, 144, 150, 155, 157, 169, 177, 180, 191, 196, 204, 216, 219, 228, 231, 233, 239, 243, 253]	[4, 8, 10, 11, 12, 13, 14, 19, 21, 23, 24, 25, 26, 27, 31, 34, 36, 37, 38, 41, 44, 46, 47, 48, 49, 50, 56, 58, 59, 60, 61, 62, 65, 68, 70, 72, 73, 74, 75, 76, 80, 82, 85, 87, 88, 89, 96, 98, 99, 100, 101, 106, 109, 112, 118, 122, 125, 131, 139, 144, 149, 154, 156, 168, 176, 179, 190, 195, 203, 215, 218, 227, 230, 233, 239, 242, 253, 254]	['Bradbury', 'C.A', '.', ',', 'Khanim', 'F.L', '.', ',', 'Hayden', 'R', '.', ',', 'Bunce', 'C.M', '.', ',', 'White', 'D.A', '.', ',', 'Drayson', 'M.T', '.', ',', 'Craddock', 'C', '.', ',', 'Turner', 'B.M', '.', 'Histone', 'deacetylases', 'in', 'acute', 'myeloid', 'leukaemia', 'show', 'a', 'distinctive', 'pattern', 'of', 'expression', 'that', 'changes', 'selectively', 'in', 'response', 'to', 'deacetylase', 'inhibitors', '.']	[2, 3, 1, 1, 2, 3, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 2, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Stapnes C., Ryningen A., Hatfield K., Oyan A.M., Eide G.E., Corbascio M., Kalland K.H., Gjertsen B.T., Bruserud O. Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors.	[('PMC8125016', 'F22001', 272, 291, 'histone deacetylase')]	['Sta', '##pn', '##es', 'C', '.', ',', 'Ry', '##ning', '##en', 'A', '.', ',', 'Hat', '##field', 'K', '.', ',', 'O', '##yan', 'A', '.', 'M', '.', ',', 'Ei', '##de', 'G', '.', 'E', '.', ',', 'Cor', '##bas', '##ci', '##o', 'M', '.', ',', 'Kal', '##land', 'K', '.', 'H', '.', ',', 'G', '##je', '##rt', '##sen', 'B', '.', 'T', '.', ',', 'Br', '##user', '##ud', 'O', '.', 'Functional', 'characteristics', 'and', 'gene', 'expression', 'profiles', 'of', 'primary', 'acute', 'myeloid', 'leuk', '##aemia', 'cells', 'identify', 'patient', 'subgroups', 'that', 'differ', 'in', 'susceptibility', 'to', 'histone', 'de', '##acetyl', '##ase', 'inhibitors', '.']	[0, 3, 5, 8, 9, 10, 12, 14, 18, 21, 22, 23, 25, 28, 34, 35, 36, 38, 39, 43, 44, 45, 46, 47, 49, 51, 54, 55, 56, 57, 58, 60, 63, 66, 68, 70, 71, 72, 74, 77, 82, 83, 84, 85, 86, 88, 89, 91, 93, 97, 98, 99, 100, 101, 103, 105, 109, 112, 113, 115, 126, 142, 146, 151, 162, 171, 174, 182, 188, 196, 200, 206, 212, 221, 229, 239, 244, 251, 254, 269, 272, 280, 282, 288, 292, 302]	[3, 5, 7, 9, 10, 11, 14, 18, 20, 22, 23, 24, 28, 33, 35, 36, 37, 39, 42, 44, 45, 46, 47, 48, 51, 53, 55, 56, 57, 58, 59, 63, 66, 68, 69, 71, 72, 73, 77, 81, 83, 84, 85, 86, 87, 89, 91, 93, 96, 98, 99, 100, 101, 102, 105, 109, 111, 113, 114, 125, 141, 145, 150, 161, 170, 173, 181, 187, 195, 200, 205, 211, 220, 228, 238, 243, 250, 253, 268, 271, 279, 282, 288, 291, 302, 303]	['Stapnes', 'C', '.', ',', 'Ryningen', 'A', '.', ',', 'Hatfield', 'K', '.', ',', 'Oyan', 'A.M', '.', ',', 'Eide', 'G.E', '.', ',', 'Corbascio', 'M', '.', ',', 'Kalland', 'K.H', '.', ',', 'Gjertsen', 'B.T', '.', ',', 'Bruserud', 'O', '.', 'Functional', 'characteristics', 'and', 'gene', 'expression', 'profiles', 'of', 'primary', 'acute', 'myeloid', 'leukaemia', 'cells', 'identify', 'patient', 'subgroups', 'that', 'differ', 'in', 'susceptibility', 'to', 'histone', 'deacetylase', 'inhibitors', '.']	[3, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 2, 3, 1, 1, 4, 1, 1, 1, 2, 3, 1, 1, 4, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
Wiredja D.D., Koyuturk M., Chance M.R. The KSEA App: A web-based tool for kinase activity inference from quantitative phosphoproteomics.	[('PMC8125016', 'F43001', 74, 80, 'kinase')]	['Wir', '##ed', '##ja', 'D', '.', 'D', '.', ',', 'Ko', '##y', '##ut', '##urk', 'M', '.', ',', 'Chan', '##ce', 'M', '.', 'R', '.', 'The', 'KS', '##EA', 'App', ':', 'A', 'web', '-', 'based', 'tool', 'for', 'kinase', 'activity', 'inference', 'from', 'quantitative', 'phospho', '##prot', '##e', '##omics', '.']	[0, 3, 5, 8, 9, 10, 11, 12, 14, 16, 17, 19, 23, 24, 25, 27, 31, 34, 35, 36, 37, 39, 43, 45, 48, 51, 53, 55, 58, 59, 65, 70, 74, 81, 90, 100, 105, 118, 125, 129, 130, 135]	[3, 5, 7, 9, 10, 11, 12, 13, 16, 17, 19, 22, 24, 25, 26, 31, 33, 35, 36, 37, 38, 42, 45, 47, 51, 52, 54, 58, 59, 64, 69, 73, 80, 89, 99, 104, 117, 125, 129, 130, 135, 136]	['Wiredja', 'D.D', '.', ',', 'Koyuturk', 'M', '.', ',', 'Chance', 'M.R', '.', 'The', 'KSEA', 'App', ':', 'A', 'web', '-', 'based', 'tool', 'for', 'kinase', 'activity', 'inference', 'from', 'quantitative', 'phosphoproteomics', '.']	[3, 3, 1, 1, 4, 1, 1, 1, 2, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Casado P., Rodriguez-Prados J.C., Cosulich S.C., Guichard S., Vanhaesebroeck B., Joel S., Cutillas P.R. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells.	[('PMC8125016', 'F44001', 104, 110, 'Kinase')]	['Cas', '##ado', 'P', '.', ',', 'Rodriguez', '-', 'Pr', '##ados', 'J', '.', 'C', '.', ',', 'Cos', '##ulic', '##h', 'S', '.', 'C', '.', ',', 'Gu', '##ich', '##ard', 'S', '.', ',', 'Van', '##ha', '##ese', '##bro', '##eck', 'B', '.', ',', 'Jo', '##el', 'S', '.', ',', 'Cut', '##illa', '##s', 'P', '.', 'R', '.', 'Kin', '##ase', '-', 'substrate', 'enrichment', 'analysis', 'provides', 'insights', 'into', 'the', 'heterogeneity', 'of', 'signaling', 'pathway', 'activation', 'in', 'leukemia', 'cells', '.']	[0, 3, 7, 8, 9, 11, 20, 21, 23, 28, 29, 30, 31, 32, 34, 37, 41, 43, 44, 45, 46, 47, 49, 51, 54, 58, 59, 60, 62, 65, 67, 70, 73, 77, 78, 79, 81, 83, 86, 87, 88, 90, 93, 97, 99, 100, 101, 102, 104, 107, 110, 111, 121, 132, 141, 150, 159, 164, 168, 182, 185, 195, 203, 214, 217, 226, 231]	[3, 6, 8, 9, 10, 20, 21, 23, 27, 29, 30, 31, 32, 33, 37, 41, 42, 44, 45, 46, 47, 48, 51, 54, 57, 59, 60, 61, 65, 67, 70, 73, 76, 78, 79, 80, 83, 85, 87, 88, 89, 93, 97, 98, 100, 101, 102, 103, 107, 110, 111, 120, 131, 140, 149, 158, 163, 167, 181, 184, 194, 202, 213, 216, 225, 231, 232]	['Casado', 'P', '.', ',', 'Rodriguez-Prados', 'J.C', '.', ',', 'Cosulich', 'S.C', '.', ',', 'Guichard', 'S', '.', ',', 'Vanhaesebroeck', 'B', '.', ',', 'Joel', 'S', '.', ',', 'Cutillas', 'P.R', '.', 'Kinase', '-', 'substrate', 'enrichment', 'analysis', 'provides', 'insights', 'into', 'the', 'heterogeneity', 'of', 'signaling', 'pathway', 'activation', 'in', 'leukemia', 'cells', '.']	[2, 1, 1, 1, 4, 3, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 3, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Liu T., Deng M., Li J., Tong X., Wei Q., Ye X. Phosphorylation of right open reading frame 2 (Rio2) protein kinase by polo-like kinase 1 regulates mitotic progression.	[('PMC8125016', 'F57001', 100, 114, 'protein kinase'), ('PMC8125016', 'F57001', 118, 136, 'polo-like kinase 1')]	['Liu', 'T', '.', ',', 'Den', '##g', 'M', '.', ',', 'Li', 'J', '.', ',', 'Tong', 'X', '.', ',', 'Wei', 'Q', '.', ',', 'Ye', 'X', '.', 'Phosph', '##orylation', 'of', 'right', 'open', 'reading', 'frame', '2', '(', 'Rio', '##2', ')', 'protein', 'kinase', 'by', 'pol', '##o', '-', 'like', 'kinase', '1', 'regulates', 'mitotic', 'progression', '.']	[0, 4, 5, 6, 8, 11, 13, 14, 15, 17, 20, 21, 22, 24, 29, 30, 31, 33, 37, 38, 39, 41, 44, 45, 47, 53, 63, 66, 72, 77, 85, 91, 93, 94, 97, 98, 100, 108, 115, 118, 121, 122, 123, 128, 135, 137, 147, 155, 166]	[3, 5, 6, 7, 11, 12, 14, 15, 16, 19, 21, 22, 23, 28, 30, 31, 32, 36, 38, 39, 40, 43, 45, 46, 53, 62, 65, 71, 76, 84, 90, 92, 94, 97, 98, 99, 107, 114, 117, 121, 122, 123, 127, 134, 136, 146, 154, 166, 167]	['Liu', 'T', '.', ',', 'Deng', 'M', '.', ',', 'Li', 'J', '.', ',', 'Tong', 'X', '.', ',', 'Wei', 'Q', '.', ',', 'Ye', 'X', '.', 'Phosphorylation', 'of', 'right', 'open', 'reading', 'frame', '2', '(', 'Rio2', ')', 'protein', 'kinase', 'by', 'polo', '-', 'like', 'kinase', '1', 'regulates', 'mitotic', 'progression', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Nakano K., Kanai-Azuma M., Kanai Y., Moriyama K., Yazaki K., Hayashi Y., Kitamura N. Cofilin phosphorylation and actin polymerization by NRK/NESK, a member of the germinal center kinase family.	[('PMC8125016', 'F59001', 179, 185, 'kinase')]	['Nak', '##ano', 'K', '.', ',', 'Kan', '##ai', '-', 'Az', '##uma', 'M', '.', ',', 'Kan', '##ai', 'Y', '.', ',', 'Mor', '##i', '##yama', 'K', '.', ',', 'Y', '##aza', '##ki', 'K', '.', ',', 'Hay', '##ashi', 'Y', '.', ',', 'Kit', '##amura', 'N', '.', 'Co', '##fil', '##in', 'phosphorylation', 'and', 'actin', 'polymerization', 'by', 'NR', '##K', '/', 'NE', '##SK', ',', 'a', 'member', 'of', 'the', 'germ', '##inal', 'center', 'kinase', 'family', '.']	[0, 3, 7, 8, 9, 11, 14, 16, 17, 19, 23, 24, 25, 27, 30, 33, 34, 35, 37, 40, 41, 46, 47, 48, 50, 51, 54, 57, 58, 59, 61, 64, 69, 70, 71, 73, 76, 82, 83, 85, 87, 90, 93, 109, 113, 119, 134, 137, 139, 140, 141, 143, 145, 147, 149, 156, 159, 163, 167, 172, 179, 186, 192]	[3, 6, 8, 9, 10, 14, 16, 17, 19, 22, 24, 25, 26, 30, 32, 34, 35, 36, 40, 41, 45, 47, 48, 49, 51, 54, 56, 58, 59, 60, 64, 68, 70, 71, 72, 76, 81, 83, 84, 87, 90, 92, 108, 112, 118, 133, 136, 139, 140, 141, 143, 145, 146, 148, 155, 158, 162, 167, 171, 178, 185, 192, 193]	['Nakano', 'K', '.', ',', 'Kanai-Azuma', 'M', '.', ',', 'Kanai', 'Y', '.', ',', 'Moriyama', 'K', '.', ',', 'Yazaki', 'K', '.', ',', 'Hayashi', 'Y', '.', ',', 'Kitamura', 'N', '.', 'Cofilin', 'phosphorylation', 'and', 'actin', 'polymerization', 'by', 'NRK', '/', 'NESK', ',', 'a', 'member', 'of', 'the', 'germinal', 'center', 'kinase', 'family', '.']	[2, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O']
Rabilloud T. A quantitative proteomic analysis of cofilin phosphorylation in myeloid cells and its modulation using the LIM kinase inhibitor Pyr1.	[('PMC8125016', 'F60002', 120, 130, 'LIM kinase')]	['Rab', '##illo', '##ud', 'T', '.', 'A', 'quantitative', 'proteomic', 'analysis', 'of', 'co', '##fil', '##in', 'phosphorylation', 'in', 'myeloid', 'cells', 'and', 'its', 'modulation', 'using', 'the', 'LI', '##M', 'kinase', 'inhibitor', 'Pyr', '##1', '.']	[0, 3, 7, 10, 11, 13, 15, 28, 38, 47, 50, 52, 55, 58, 74, 77, 85, 91, 95, 99, 110, 116, 120, 122, 124, 131, 141, 144, 145]	[3, 7, 9, 11, 12, 14, 27, 37, 46, 49, 52, 55, 57, 73, 76, 84, 90, 94, 98, 109, 115, 119, 122, 123, 130, 140, 144, 145, 146]	['Rabilloud', 'T', '.', 'A', 'quantitative', 'proteomic', 'analysis', 'of', 'cofilin', 'phosphorylation', 'in', 'myeloid', 'cells', 'and', 'its', 'modulation', 'using', 'the', 'LIM', 'kinase', 'inhibitor', 'Pyr1', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
McDonald J.A. Canonical and noncanonical roles of Par-1/MARK kinases in cell migration.	[('PMC8125016', 'F63001', 61, 68, 'kinases')]	['McD', '##onald', 'J', '.', 'A', '.', 'Can', '##onical', 'and', 'nonc', '##ano', '##nic', '##al', 'roles', 'of', 'Par', '-', '1', '/', 'MAR', '##K', 'kinases', 'in', 'cell', 'migration', '.']	[0, 3, 9, 10, 11, 12, 14, 17, 24, 28, 32, 35, 38, 41, 47, 50, 53, 54, 55, 56, 59, 61, 69, 72, 77, 86]	[3, 8, 10, 11, 12, 13, 17, 23, 27, 32, 35, 38, 40, 46, 49, 53, 54, 55, 56, 59, 60, 68, 71, 76, 86, 87]	['McDonald', 'J.A', '.', 'Canonical', 'and', 'noncanonical', 'roles', 'of', 'Par-1', '/', 'MARK', 'kinases', 'in', 'cell', 'migration', '.']	[2, 3, 1, 2, 1, 4, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O']
Pilz R.B. Protein kinase G and focal adhesion kinase converge on Src/Akt/beta-catenin signaling module in osteoblast mechanotransduction.	[('PMC8125016', 'F64002', 10, 26, 'Protein kinase G'), ('PMC8125016', 'F64002', 31, 52, 'focal adhesion kinase')]	['Pil', '##z', 'R', '.', 'B', '.', 'Protein', 'kinase', 'G', 'and', 'focal', 'adhesion', 'kinase', 'converge', 'on', 'Src', '/', 'Akt', '/', 'beta', '-', 'cat', '##eni', '##n', 'signaling', 'module', 'in', 'oste', '##oblast', 'mechan', '##otrans', '##duction', '.']	[0, 3, 5, 6, 7, 8, 10, 18, 25, 27, 31, 37, 46, 53, 62, 65, 68, 69, 72, 73, 77, 78, 81, 84, 86, 96, 103, 106, 110, 117, 123, 129, 136]	[3, 4, 6, 7, 8, 9, 17, 24, 26, 30, 36, 45, 52, 61, 64, 68, 69, 72, 73, 77, 78, 81, 84, 85, 95, 102, 105, 110, 116, 123, 129, 136, 137]	['Pilz', 'R.B', '.', 'Protein', 'kinase', 'G', 'and', 'focal', 'adhesion', 'kinase', 'converge', 'on', 'Src', '/', 'Akt', '/', 'beta', '-', 'catenin', 'signaling', 'module', 'in', 'osteoblast', 'mechanotransduction', '.']	[2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dobrikov M., Dobrikova E., Shveygert M., Gromeier M. Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1.	[('PMC8125016', 'F66001', 129, 152, 'protein kinase C{alpha}')]	['Do', '##br', '##iko', '##v', 'M', '.', ',', 'Do', '##br', '##iko', '##va', 'E', '.', ',', 'Sh', '##vey', '##ger', '##t', 'M', '.', ',', 'Gro', '##me', '##ier', 'M', '.', 'Phosph', '##orylation', 'of', 'eukaryotic', 'translation', 'initiation', 'factor', '4', '##G', '##1', '(', 'eIF', '##4', '##G', '##1', ')', 'by', 'protein', 'kinase', 'C', '{', 'alpha', '}', 'regulates', 'eIF', '##4', '##G', '##1', 'binding', 'to', 'Mn', '##k', '##1', '.']	[0, 2, 4, 7, 9, 10, 11, 13, 15, 17, 20, 23, 24, 25, 27, 29, 32, 35, 37, 38, 39, 41, 44, 46, 50, 51, 53, 59, 69, 72, 83, 95, 106, 113, 114, 115, 117, 118, 121, 122, 123, 124, 126, 129, 137, 144, 145, 146, 151, 153, 163, 166, 167, 168, 170, 178, 181, 183, 184, 185]	[2, 4, 7, 8, 10, 11, 12, 15, 17, 20, 22, 24, 25, 26, 29, 32, 35, 36, 38, 39, 40, 44, 46, 49, 51, 52, 59, 68, 71, 82, 94, 105, 112, 114, 115, 116, 118, 121, 122, 123, 124, 125, 128, 136, 143, 145, 146, 151, 152, 162, 166, 167, 168, 169, 177, 180, 183, 184, 185, 186]	['Dobrikov', 'M', '.', ',', 'Dobrikova', 'E', '.', ',', 'Shveygert', 'M', '.', ',', 'Gromeier', 'M', '.', 'Phosphorylation', 'of', 'eukaryotic', 'translation', 'initiation', 'factor', '4G1', '(', 'eIF4G1', ')', 'by', 'protein', 'kinase', 'C{alpha}', 'regulates', 'eIF4G1', 'binding', 'to', 'Mnk1', '.']	[4, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 4, 1, 4, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Deluche E., Bessette B., Durand S., Caire F., Rigau V., Robert S., Chaunavel A., Forestier L., Labrousse F., Jauberteau M.O., et al. CHI3L1, NTRK2, 1p/19q and isocitrate dehydrogenase Status Predicts Prognosis in Glioma.	[('PMC8125016', 'F79001', 159, 183, 'isocitrate dehydrogenase')]	['Del', '##uche', 'E', '.', ',', 'Bes', '##set', '##te', 'B', '.', ',', 'Dur', '##and', 'S', '.', ',', 'Cai', '##re', 'F', '.', ',', 'Rig', '##au', 'V', '.', ',', 'Robert', 'S', '.', ',', 'Cha', '##una', '##vel', 'A', '.', ',', 'Forest', '##ier', 'L', '.', ',', 'Lab', '##rous', '##se', 'F', '.', ',', 'Ja', '##uber', '##te', '##au', 'M', '.', 'O', '.', ',', 'et', 'al', '.', 'CH', '##I', '##3', '##L', '##1', ',', 'NT', '##RK', '##2', ',', '1', '##p', '/', '19', '##q', 'and', 'iso', '##cit', '##rate', 'dehydrogenase', 'Status', 'Predic', '##ts', 'Progn', '##osis', 'in', 'Gl', '##io', '##ma', '.']	[0, 3, 8, 9, 10, 12, 15, 18, 21, 22, 23, 25, 28, 32, 33, 34, 36, 39, 42, 43, 44, 46, 49, 52, 53, 54, 56, 63, 64, 65, 67, 70, 73, 77, 78, 79, 81, 87, 91, 92, 93, 95, 98, 102, 105, 106, 107, 109, 111, 115, 117, 120, 121, 122, 123, 124, 126, 129, 131, 133, 135, 136, 137, 138, 139, 141, 143, 145, 146, 148, 149, 150, 151, 153, 155, 159, 162, 165, 170, 184, 191, 197, 200, 205, 210, 213, 215, 217, 219]	[3, 7, 9, 10, 11, 15, 18, 20, 22, 23, 24, 28, 31, 33, 34, 35, 39, 41, 43, 44, 45, 49, 51, 53, 54, 55, 62, 64, 65, 66, 70, 73, 76, 78, 79, 80, 87, 90, 92, 93, 94, 98, 102, 104, 106, 107, 108, 111, 115, 117, 119, 121, 122, 123, 124, 125, 128, 131, 132, 135, 136, 137, 138, 139, 140, 143, 145, 146, 147, 149, 150, 151, 153, 154, 158, 162, 165, 169, 183, 190, 197, 199, 205, 209, 212, 215, 217, 219, 220]	['Deluche', 'E', '.', ',', 'Bessette', 'B', '.', ',', 'Durand', 'S', '.', ',', 'Caire', 'F', '.', ',', 'Rigau', 'V', '.', ',', 'Robert', 'S', '.', ',', 'Chaunavel', 'A', '.', ',', 'Forestier', 'L', '.', ',', 'Labrousse', 'F', '.', ',', 'Jauberteau', 'M.O', '.', ',', 'et', 'al', '.', 'CHI3L1', ',', 'NTRK2', ',', '1p', '/', '19q', 'and', 'isocitrate', 'dehydrogenase', 'Status', 'Predicts', 'Prognosis', 'in', 'Glioma', '.']	[2, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 5, 1, 3, 1, 2, 1, 2, 1, 3, 1, 1, 2, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.	[('PMC8125016', 'F88002', 4, 21, 'acetyltransferase')]	['The', 'acetyl', '##transferase', 'GC', '##N', '##5', 'maintains', 'AT', '##RA', '-', 'resistance', 'in', 'non', '-', 'AP', '##L', 'AML', '.']	[0, 4, 10, 22, 24, 25, 27, 37, 39, 41, 42, 53, 56, 59, 60, 62, 64, 67]	[3, 10, 21, 24, 25, 26, 36, 39, 41, 42, 52, 55, 59, 60, 62, 63, 67, 68]	['The', 'acetyltransferase', 'GCN5', 'maintains', 'ATRA-resistance', 'in', 'non-APL', 'AML', '.']	[1, 2, 3, 1, 4, 1, 4, 1, 1]	['O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Hernandez-Valladares M., Aasebo E., Berven F., Selheim F., Bruserud O. Biological characteristics of aging in human acute myeloid leukemia cells: The possible importance of aldehyde dehydrogenase, the cytoskeleton and altered transcriptional regulation.	[('PMC8125016', 'F89001', 173, 195, 'aldehyde dehydrogenase')]	['Hern', '##andez', '-', 'Val', '##la', '##da', '##res', 'M', '.', ',', 'A', '##ase', '##bo', 'E', '.', ',', 'Ber', '##ven', 'F', '.', ',', 'Sel', '##heim', 'F', '.', ',', 'Br', '##user', '##ud', 'O', '.', 'Biological', 'characteristics', 'of', 'aging', 'in', 'human', 'acute', 'myeloid', 'leukemia', 'cells', ':', 'The', 'possible', 'importance', 'of', 'ald', '##eh', '##yd', '##e', 'dehydrogenase', ',', 'the', 'cytoskeleton', 'and', 'altered', 'transcriptional', 'regulation', '.']	[0, 4, 9, 10, 13, 15, 17, 21, 22, 23, 25, 26, 29, 32, 33, 34, 36, 39, 43, 44, 45, 47, 50, 55, 56, 57, 59, 61, 65, 68, 69, 71, 82, 98, 101, 107, 110, 116, 122, 130, 139, 144, 146, 150, 159, 170, 173, 176, 178, 180, 182, 195, 197, 201, 214, 218, 226, 242, 252]	[4, 9, 10, 13, 15, 17, 20, 22, 23, 24, 26, 29, 31, 33, 34, 35, 39, 42, 44, 45, 46, 50, 54, 56, 57, 58, 61, 65, 67, 69, 70, 81, 97, 100, 106, 109, 115, 121, 129, 138, 144, 145, 149, 158, 169, 172, 176, 178, 180, 181, 195, 196, 200, 213, 217, 225, 241, 252, 253]	['Hernandez-Valladares', 'M', '.', ',', 'Aasebo', 'E', '.', ',', 'Berven', 'F', '.', ',', 'Selheim', 'F', '.', ',', 'Bruserud', 'O', '.', 'Biological', 'characteristics', 'of', 'aging', 'in', 'human', 'acute', 'myeloid', 'leukemia', 'cells', ':', 'The', 'possible', 'importance', 'of', 'aldehyde', 'dehydrogenase', ',', 'the', 'cytoskeleton', 'and', 'altered', 'transcriptional', 'regulation', '.']	[7, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.	[('PMC8125016', 'F97002', 19, 38, 'histone deacetylase'), ('PMC8125016', 'F97002', 54, 75, 'DNA methyltransferase')]	['The', 'interaction', 'of', 'histone', 'de', '##acetyl', '##ase', 'inhibitors', 'and', 'DNA', 'methyl', '##transferase', 'inhibitors', 'in', 'the', 'treatment', 'of', 'human', 'cancer', 'cells', '.']	[0, 4, 16, 19, 27, 29, 35, 39, 50, 54, 58, 64, 76, 87, 90, 94, 104, 107, 113, 120, 125]	[3, 15, 18, 26, 29, 35, 38, 49, 53, 57, 64, 75, 86, 89, 93, 103, 106, 112, 119, 125, 126]	['The', 'interaction', 'of', 'histone', 'deacetylase', 'inhibitors', 'and', 'DNA', 'methyltransferase', 'inhibitors', 'in', 'the', 'treatment', 'of', 'human', 'cancer', 'cells', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, clinical studies also suggest that the antileukemic effects of ATRA could be detected, especially for patients with an altered expression of chromatin-modifying genes, MDS1 and EVI1 complex locus (MECOM) overexpression, nucleophosmin 1 (NPM1) mutations or isocitrate dehydrogenase (isocitrate dehydrogenase) mutations with lysine demethylase 1A (KDM1A) deregulation [13,17].	[('PMC8125016', 'I01004', 265, 289, 'isocitrate dehydrogenase'), ('PMC8125016', 'I01004', 291, 315, 'isocitrate dehydrogenase'), ('PMC8125016', 'I01004', 332, 353, 'lysine demethylase 1A')]	['Finally', ',', 'clinical', 'studies', 'also', 'suggest', 'that', 'the', 'anti', '##le', '##uk', '##emic', 'effects', 'of', 'AT', '##RA', 'could', 'be', 'detected', ',', 'especially', 'for', 'patients', 'with', 'an', 'altered', 'expression', 'of', 'chromatin', '-', 'modifying', 'genes', ',', 'MDS', '##1', 'and', 'EV', '##I', '##1', 'complex', 'locus', '(', 'ME', '##COM', ')', 'overexpression', ',', 'nucle', '##oph', '##osm', '##in', '1', '(', 'NP', '##M', '##1', ')', 'mutations', 'or', 'iso', '##cit', '##rate', 'dehydrogenase', '(', 'iso', '##cit', '##rate', 'dehydrogenase', ')', 'mutations', 'with', 'lysine', 'dem', '##ethyl', '##ase', '1', '##A', '(', 'KD', '##M', '##1', '##A', ')', 'dere', '##gulation', '[', '13', ',', '17', ']', '.']	[0, 7, 9, 18, 26, 31, 39, 44, 48, 52, 54, 56, 61, 69, 72, 74, 77, 83, 86, 94, 96, 107, 111, 120, 125, 128, 136, 147, 150, 159, 160, 170, 175, 177, 180, 182, 186, 188, 189, 191, 199, 205, 206, 208, 211, 213, 227, 229, 234, 237, 240, 243, 245, 246, 248, 249, 250, 252, 262, 265, 268, 271, 276, 290, 291, 294, 297, 302, 315, 317, 327, 332, 339, 342, 347, 351, 352, 354, 355, 357, 358, 359, 360, 362, 366, 375, 376, 378, 379, 381, 382]	[7, 8, 17, 25, 30, 38, 43, 47, 52, 54, 56, 60, 68, 71, 74, 76, 82, 85, 94, 95, 106, 110, 119, 124, 127, 135, 146, 149, 159, 160, 169, 175, 176, 180, 181, 185, 188, 189, 190, 198, 204, 206, 208, 211, 212, 227, 228, 234, 237, 240, 242, 244, 246, 248, 249, 250, 251, 261, 264, 268, 271, 275, 289, 291, 294, 297, 301, 315, 316, 326, 331, 338, 342, 347, 350, 352, 353, 355, 357, 358, 359, 360, 361, 366, 374, 376, 378, 379, 381, 382, 383]	['Finally', ',', 'clinical', 'studies', 'also', 'suggest', 'that', 'the', 'antileukemic', 'effects', 'of', 'ATRA', 'could', 'be', 'detected', ',', 'especially', 'for', 'patients', 'with', 'an', 'altered', 'expression', 'of', 'chromatin', '-', 'modifying', 'genes', ',', 'MDS1', 'and', 'EVI1', 'complex', 'locus', '(', 'MECOM', ')', 'overexpression', ',', 'nucleophosmin', '1', '(', 'NPM1', ')', 'mutations', 'or', 'isocitrate', 'dehydrogenase', '(', 'isocitrate', 'dehydrogenase', ')', 'mutations', 'with', 'lysine', 'demethylase', '1A', '(', 'KDM1A', ')', 'deregulation', '[', '13', ',', '17', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 3, 2, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein acetylation is regulated by the balance between histone acetyltransferases (HATs) and histone deacetylases (histone deacetylases)	[('PMC8125016', 'I02000', 56, 82, 'histone acetyltransferases'), ('PMC8125016', 'I02000', 94, 114, 'histone deacetylases'), ('PMC8125016', 'I02000', 116, 136, 'histone deacetylases')]	['Protein', 'acetylation', 'is', 'regulated', 'by', 'the', 'balance', 'between', 'histone', 'acetyl', '##transferase', '##s', '(', 'HA', '##Ts', ')', 'and', 'histone', 'de', '##acetyl', '##ases', '(', 'histone', 'de', '##acetyl', '##ases', ')']	[0, 8, 20, 23, 33, 36, 40, 48, 56, 64, 70, 81, 83, 84, 86, 88, 90, 94, 102, 104, 110, 115, 116, 124, 126, 132, 136]	[7, 19, 22, 32, 35, 39, 47, 55, 63, 70, 81, 82, 84, 86, 88, 89, 93, 101, 104, 110, 114, 116, 123, 126, 132, 136, 137]	['Protein', 'acetylation', 'is', 'regulated', 'by', 'the', 'balance', 'between', 'histone', 'acetyltransferases', '(', 'HATs', ')', 'and', 'histone', 'deacetylases', '(', 'histone', 'deacetylases', ')']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 3, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'E', 'O']
Kinase activity estimates were predicted with the online KSEA App.	[('PMC8125016', 'M13006', 0, 6, 'Kinase')]	['Kin', '##ase', 'activity', 'estimates', 'were', 'predicted', 'with', 'the', 'online', 'KS', '##EA', 'App', '.']	[0, 3, 7, 16, 26, 31, 41, 46, 50, 57, 59, 62, 65]	[3, 6, 15, 25, 30, 40, 45, 49, 56, 59, 61, 65, 66]	['Kinase', 'activity', 'estimates', 'were', 'predicted', 'with', 'the', 'online', 'KSEA', 'App', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Significantly regulated kinases with false discovery rate (FDR) <0.05 were shown in bar plots created with Prism8.	[('PMC8125016', 'M13009', 24, 31, 'kinases')]	['Significantly', 'regulated', 'kinases', 'with', 'false', 'discovery', 'rate', '(', 'FD', '##R', ')', '<', '0', '.', '05', 'were', 'shown', 'in', 'bar', 'plots', 'created', 'with', 'Prism', '##8', '.']	[0, 14, 24, 32, 37, 43, 53, 58, 59, 61, 62, 64, 65, 66, 67, 70, 75, 81, 84, 88, 94, 102, 107, 112, 113]	[13, 23, 31, 36, 42, 52, 57, 59, 61, 62, 63, 65, 66, 67, 69, 74, 80, 83, 87, 93, 101, 106, 112, 113, 114]	['Significantly', 'regulated', 'kinases', 'with', 'false', 'discovery', 'rate', '(', 'FDR', ')', '<', '0.05', 'were', 'shown', 'in', 'bar', 'plots', 'created', 'with', 'Prism8', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Kinase prediction analysis by deep learning with the DeepPhos architecture was performed in the piNET web platform [48,49].	[('PMC8125016', 'M13010', 0, 6, 'Kinase')]	['Kin', '##ase', 'prediction', 'analysis', 'by', 'deep', 'learning', 'with', 'the', 'Deep', '##Ph', '##os', 'architecture', 'was', 'performed', 'in', 'the', 'pi', '##NET', 'web', 'platform', '[', '48', ',', '49', ']', '.']	[0, 3, 7, 18, 27, 30, 35, 44, 49, 53, 57, 59, 62, 75, 79, 89, 92, 96, 98, 102, 106, 115, 116, 118, 119, 121, 122]	[3, 6, 17, 26, 29, 34, 43, 48, 52, 57, 59, 61, 74, 78, 88, 91, 95, 98, 101, 105, 114, 116, 118, 119, 121, 122, 123]	['Kinase', 'prediction', 'analysis', 'by', 'deep', 'learning', 'with', 'the', 'DeepPhos', 'architecture', 'was', 'performed', 'in', 'the', 'piNET', 'web', 'platform', '[', '48', ',', '49', ']', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The kinase activation loop analysis was carried out with the online tool at http://phomics.jensenlab.org (accessed on October 2020).	[('PMC8125016', 'M13011', 4, 10, 'kinase')]	['The', 'kinase', 'activation', 'loop', 'analysis', 'was', 'carried', 'out', 'with', 'the', 'online', 'tool', 'at', 'http', ':', '/', '/', 'ph', '##omics', '.', 'je', '##ns', '##en', '##lab', '.', 'org', '(', 'accessed', 'on', 'October', '202', '##0', ')', '.']	[0, 4, 11, 22, 27, 36, 40, 48, 52, 57, 61, 68, 73, 76, 80, 81, 82, 83, 85, 90, 91, 93, 95, 97, 100, 101, 105, 106, 115, 118, 126, 129, 130, 131]	[3, 10, 21, 26, 35, 39, 47, 51, 56, 60, 67, 72, 75, 80, 81, 82, 83, 85, 90, 91, 93, 95, 97, 100, 101, 104, 106, 114, 117, 125, 129, 130, 131, 132]	['The', 'kinase', 'activation', 'loop', 'analysis', 'was', 'carried', 'out', 'with', 'the', 'online', 'tool', 'at', 'http', ':', '/', '/', 'phomics.jensenlab.org', '(', 'accessed', 'on', 'October', '2020', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 9, 1, 1, 1, 1, 2, 1, 1]	['O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These terms include proteins such as myeloperoxidase (myeloperoxidase), elastase, neutrophil expressed (ELANE), FGR proto-oncogene, Src family tyrosine kinase (FGR), serpin family B member 1 (SERPINB1), chitinase 3 like 1 (CHI3L1)	[('PMC8125016', 'R05001', 37, 52, 'myeloperoxidase'), ('PMC8125016', 'R05001', 54, 69, 'myeloperoxidase'), ('PMC8125016', 'R05001', 72, 80, 'elastase'), ('PMC8125016', 'R05001', 143, 158, 'tyrosine kinase'), ('PMC8125016', 'R05001', 203, 221, 'chitinase 3 like 1')]	['These', 'terms', 'include', 'proteins', 'such', 'as', 'myel', '##oper', '##oxidase', '(', 'myel', '##oper', '##oxidase', ')', ',', 'elast', '##ase', ',', 'neutrophil', 'expressed', '(', 'EL', '##AN', '##E', ')', ',', 'FG', '##R', 'proto', '-', 'onc', '##ogene', ',', 'Src', 'family', 'tyrosine', 'kinase', '(', 'FG', '##R', ')', ',', 'ser', '##pin', 'family', 'B', 'member', '1', '(', 'SER', '##PI', '##NB', '##1', ')', ',', 'chi', '##tin', '##ase', '3', 'like', '1', '(', 'CH', '##I', '##3', '##L', '##1', ')']	[0, 6, 12, 20, 29, 34, 37, 41, 45, 53, 54, 58, 62, 69, 70, 72, 77, 80, 82, 93, 103, 104, 106, 108, 109, 110, 112, 114, 116, 121, 122, 125, 130, 132, 136, 143, 152, 159, 160, 162, 163, 164, 166, 169, 173, 180, 182, 189, 191, 192, 195, 197, 199, 200, 201, 203, 206, 209, 213, 215, 220, 222, 223, 225, 226, 227, 228, 229]	[5, 11, 19, 28, 33, 36, 41, 45, 52, 54, 58, 62, 69, 70, 71, 77, 80, 81, 92, 102, 104, 106, 108, 109, 110, 111, 114, 115, 121, 122, 125, 130, 131, 135, 142, 151, 158, 160, 162, 163, 164, 165, 169, 172, 179, 181, 188, 190, 192, 195, 197, 199, 200, 201, 202, 206, 209, 212, 214, 219, 221, 223, 225, 226, 227, 228, 229, 230]	['These', 'terms', 'include', 'proteins', 'such', 'as', 'myeloperoxidase', '(', 'myeloperoxidase', ')', ',', 'elastase', ',', 'neutrophil', 'expressed', '(', 'ELANE', ')', ',', 'FGR', 'proto', '-', 'oncogene', ',', 'Src', 'family', 'tyrosine', 'kinase', '(', 'FGR', ')', ',', 'serpin', 'family', 'B', 'member', '1', '(', 'SERPINB1', ')', ',', 'chitinase', '3', 'like', '1', '(', 'CHI3L1', ')']	[1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, levels of proteins involved in processes such as hematopoietic or lymphoid organ development (e.g., sphingosine-1-phosphate lyase 1, SGPL1; SBDS ribosome maturation factor, SBDS), transcription by RNA polymerase II and cell death were higher in PRE-NR patients (Figure 2b, bottom plot; Table 2).	[('PMC8125016', 'R06000', 113, 144, 'sphingosine-1-phosphate lyase 1'), ('PMC8125016', 'R06000', 210, 227, 'RNA polymerase II')]	['In', 'contrast', ',', 'levels', 'of', 'proteins', 'involved', 'in', 'processes', 'such', 'as', 'hematopoietic', 'or', 'lymphoid', 'organ', 'development', '(', 'e', '.', 'g', '.', ',', 'sphing', '##osine', '-', '1', '-', 'phosphate', 'ly', '##ase', '1', ',', 'SG', '##PL', '##1', ';', 'SB', '##DS', 'ribosome', 'maturation', 'factor', ',', 'SB', '##DS', ')', ',', 'transcription', 'by', 'RNA', 'polymerase', 'II', 'and', 'cell', 'death', 'were', 'higher', 'in', 'PRE', '-', 'NR', 'patients', '(', 'Figure', '2', '##b', ',', 'bottom', 'plot', ';', 'Table', '2', ')', '.']	[0, 3, 11, 13, 20, 23, 32, 41, 44, 54, 59, 62, 76, 79, 88, 94, 106, 107, 108, 109, 110, 111, 113, 119, 124, 125, 126, 127, 137, 139, 143, 144, 146, 148, 150, 151, 153, 155, 158, 167, 178, 184, 186, 188, 190, 191, 193, 207, 210, 214, 225, 228, 232, 237, 243, 248, 255, 258, 261, 262, 265, 274, 275, 282, 283, 284, 286, 293, 297, 299, 305, 306, 307]	[2, 11, 12, 19, 22, 31, 40, 43, 53, 58, 61, 75, 78, 87, 93, 105, 107, 108, 109, 110, 111, 112, 119, 124, 125, 126, 127, 136, 139, 142, 144, 145, 148, 150, 151, 152, 155, 157, 166, 177, 184, 185, 188, 190, 191, 192, 206, 209, 213, 224, 227, 231, 236, 242, 247, 254, 257, 261, 262, 264, 273, 275, 281, 283, 284, 285, 292, 297, 298, 304, 306, 307, 308]	['In', 'contrast', ',', 'levels', 'of', 'proteins', 'involved', 'in', 'processes', 'such', 'as', 'hematopoietic', 'or', 'lymphoid', 'organ', 'development', '(', 'e.g', '.', ',', 'sphingosine-1-phosphate', 'lyase', '1', ',', 'SGPL1', ';', 'SBDS', 'ribosome', 'maturation', 'factor', ',', 'SBDS', ')', ',', 'transcription', 'by', 'RNA', 'polymerase', 'II', 'and', 'cell', 'death', 'were', 'higher', 'in', 'PRE-NR', 'patients', '(', 'Figure', '2b', ',', 'bottom', 'plot', ';', 'Table', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 6, 2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The sphingolipid metabolism was the most significant KEGG pathway in this group with higher levels of SGPL1 and arylsulfatase A (ARSA).	[('PMC8125016', 'R06002', 112, 127, 'arylsulfatase A')]	['The', 'sphing', '##olipid', 'metabolism', 'was', 'the', 'most', 'significant', 'KE', '##GG', 'pathway', 'in', 'this', 'group', 'with', 'higher', 'levels', 'of', 'SG', '##PL', '##1', 'and', 'aryl', '##sulf', '##atase', 'A', '(', 'AR', '##SA', ')', '.']	[0, 4, 10, 17, 28, 32, 36, 41, 53, 55, 58, 66, 69, 74, 80, 85, 92, 99, 102, 104, 106, 108, 112, 116, 120, 126, 128, 129, 131, 133, 134]	[3, 10, 16, 27, 31, 35, 40, 52, 55, 57, 65, 68, 73, 79, 84, 91, 98, 101, 104, 106, 107, 111, 116, 120, 125, 127, 129, 131, 133, 134, 135]	['The', 'sphingolipid', 'metabolism', 'was', 'the', 'most', 'significant', 'KEGG', 'pathway', 'in', 'this', 'group', 'with', 'higher', 'levels', 'of', 'SGPL1', 'and', 'arylsulfatase', 'A', '(', 'ARSA', ')', '.']	[1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
One of them was composed of 10 proteins mostly involved in catalytic antimicrobial activity and described in the GO and KEGG pathway enrichment analysis (Figure 2b, top plot) while the other was composed of four proteins connected to specific granule membrane (i.e., ANO6, phospholipase D1, PLD1; mast cell expressed membrane protein 1, MCEMP1; motile sperm domain containing 2, MOSPD2).	[('PMC8125016', 'R07002', 273, 289, 'phospholipase D1')]	['One', 'of', 'them', 'was', 'composed', 'of', '10', 'proteins', 'mostly', 'involved', 'in', 'catalytic', 'antimicrobial', 'activity', 'and', 'described', 'in', 'the', 'GO', 'and', 'KE', '##GG', 'pathway', 'enrichment', 'analysis', '(', 'Figure', '2', '##b', ',', 'top', 'plot', ')', 'while', 'the', 'other', 'was', 'composed', 'of', 'four', 'proteins', 'connected', 'to', 'specific', 'granule', 'membrane', '(', 'i', '.', 'e', '.', ',', 'ANO', '##6', ',', 'phospholip', '##ase', 'D', '##1', ',', 'PL', '##D', '##1', ';', 'mast', 'cell', 'expressed', 'membrane', 'protein', '1', ',', 'MC', '##EM', '##P', '##1', ';', 'mot', '##ile', 'sperm', 'domain', 'containing', '2', ',', 'MOS', '##PD', '##2', ')', '.']	[0, 4, 7, 12, 16, 25, 28, 31, 40, 47, 56, 59, 69, 83, 92, 96, 106, 109, 113, 116, 120, 122, 125, 133, 144, 153, 154, 161, 162, 163, 165, 169, 173, 175, 181, 185, 191, 195, 204, 207, 212, 221, 231, 234, 243, 251, 260, 261, 262, 263, 264, 265, 267, 270, 271, 273, 283, 287, 288, 289, 291, 293, 294, 295, 297, 302, 307, 317, 326, 334, 335, 337, 339, 341, 342, 343, 345, 348, 352, 358, 365, 376, 377, 379, 382, 384, 385, 386]	[3, 6, 11, 15, 24, 27, 30, 39, 46, 55, 58, 68, 82, 91, 95, 105, 108, 112, 115, 119, 122, 124, 132, 143, 152, 154, 160, 162, 163, 164, 168, 173, 174, 180, 184, 190, 194, 203, 206, 211, 220, 230, 233, 242, 250, 259, 261, 262, 263, 264, 265, 266, 270, 271, 272, 283, 286, 288, 289, 290, 293, 294, 295, 296, 301, 306, 316, 325, 333, 335, 336, 339, 341, 342, 343, 344, 348, 351, 357, 364, 375, 377, 378, 382, 384, 385, 386, 387]	['One', 'of', 'them', 'was', 'composed', 'of', '10', 'proteins', 'mostly', 'involved', 'in', 'catalytic', 'antimicrobial', 'activity', 'and', 'described', 'in', 'the', 'GO', 'and', 'KEGG', 'pathway', 'enrichment', 'analysis', '(', 'Figure', '2b', ',', 'top', 'plot', ')', 'while', 'the', 'other', 'was', 'composed', 'of', 'four', 'proteins', 'connected', 'to', 'specific', 'granule', 'membrane', '(', 'i.e', '.', ',', 'ANO6', ',', 'phospholipase', 'D1', ',', 'PLD1', ';', 'mast', 'cell', 'expressed', 'membrane', 'protein', '1', ',', 'MCEMP1', ';', 'motile', 'sperm', 'domain', 'containing', '2', ',', 'MOSPD2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 2, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In regard to the PRE-NR group, several phosphoproteins involved in mRNA splicing/binding (e.g., heterogeneous nuclear ribonucleoprotein M, HNRNPM; NPM1; microtubule associated protein 4, MAP4; matrin 3, MATR3) and in protein tyrosine kinase binding (interleukin-1 receptor accessory protein, IL1RAP; phosphoprotein membrane anchor with glycosphingolipid microdomains 1, PAG1) were significantly overrepresented.	[('PMC8125016', 'R10002', 217, 240, 'protein tyrosine kinase')]	['In', 'regard', 'to', 'the', 'PRE', '-', 'NR', 'group', ',', 'several', 'phospho', '##protein', '##s', 'involved', 'in', 'mRNA', 'splicing', '/', 'binding', '(', 'e', '.', 'g', '.', ',', 'heterogeneous', 'nuclear', 'rib', '##onucle', '##oprotein', 'M', ',', 'HN', '##RN', '##PM', ';', 'NP', '##M', '##1', ';', 'microtubule', 'associated', 'protein', '4', ',', 'MAP', '##4', ';', 'mat', '##rin', '3', ',', 'MAT', '##R', '##3', ')', 'and', 'in', 'protein', 'tyrosine', 'kinase', 'binding', '(', 'interleukin', '-', '1', 'receptor', 'accessory', 'protein', ',', 'IL', '##1', '##RAP', ';', 'phospho', '##protein', 'membrane', 'anchor', 'with', 'glycos', '##ph', '##ing', '##olipid', 'micro', '##domains', '1', ',', 'PA', '##G', '##1', ')', 'were', 'significantly', 'overr', '##ep', '##res', '##ented', '.']	[0, 3, 10, 13, 17, 20, 21, 24, 29, 31, 39, 46, 53, 55, 64, 67, 72, 80, 81, 89, 90, 91, 92, 93, 94, 96, 110, 118, 121, 127, 136, 137, 139, 141, 143, 145, 147, 149, 150, 151, 153, 165, 176, 184, 185, 187, 190, 191, 193, 196, 200, 201, 203, 206, 207, 208, 210, 214, 217, 225, 234, 241, 249, 250, 261, 262, 264, 273, 283, 290, 292, 294, 295, 298, 300, 307, 315, 324, 331, 336, 342, 344, 347, 354, 359, 367, 368, 370, 372, 373, 374, 376, 381, 395, 400, 402, 405, 410]	[2, 9, 12, 16, 20, 21, 23, 29, 30, 38, 46, 53, 54, 63, 66, 71, 80, 81, 88, 90, 91, 92, 93, 94, 95, 109, 117, 121, 127, 135, 137, 138, 141, 143, 145, 146, 149, 150, 151, 152, 164, 175, 183, 185, 186, 190, 191, 192, 196, 199, 201, 202, 206, 207, 208, 209, 213, 216, 224, 233, 240, 248, 250, 261, 262, 263, 272, 282, 290, 291, 294, 295, 298, 299, 307, 314, 323, 330, 335, 342, 344, 347, 353, 359, 366, 368, 369, 372, 373, 374, 375, 380, 394, 400, 402, 405, 410, 411]	['In', 'regard', 'to', 'the', 'PRE-NR', 'group', ',', 'several', 'phosphoproteins', 'involved', 'in', 'mRNA', 'splicing', '/', 'binding', '(', 'e.g', '.', ',', 'heterogeneous', 'nuclear', 'ribonucleoprotein', 'M', ',', 'HNRNPM', ';', 'NPM1', ';', 'microtubule', 'associated', 'protein', '4', ',', 'MAP4', ';', 'matrin', '3', ',', 'MATR3', ')', 'and', 'in', 'protein', 'tyrosine', 'kinase', 'binding', '(', 'interleukin-1', 'receptor', 'accessory', 'protein', ',', 'IL1RAP', ';', 'phosphoprotein', 'membrane', 'anchor', 'with', 'glycosphingolipid', 'microdomains', '1', ',', 'PAG1', ')', 'were', 'significantly', 'overrepresented', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 4, 2, 1, 1, 3, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One of them involved RNA splicing factors such as serine/arginine repetitive matrix protein 2, SRRM2; splicing factor 3b subunit 1, SF3B1; splicing factor 1, SF1; and serine and arginine rich splicing factor 11, SRSF11; while the other one was composed of ribosomal protein S10, RPS10; ribosomal protein S6, RPS6; and RIO kinase 2, RIOK2.	[('PMC8125016', 'R11001', 318, 330, 'RIO kinase 2')]	['One', 'of', 'them', 'involved', 'RNA', 'splicing', 'factors', 'such', 'as', 'serine', '/', 'arginine', 'repetitive', 'matrix', 'protein', '2', ',', 'SR', '##RM', '##2', ';', 'splicing', 'factor', '3', '##b', 'subunit', '1', ',', 'SF', '##3', '##B', '##1', ';', 'splicing', 'factor', '1', ',', 'SF', '##1', ';', 'and', 'serine', 'and', 'arginine', 'rich', 'splicing', 'factor', '11', ',', 'SR', '##SF', '##11', ';', 'while', 'the', 'other', 'one', 'was', 'composed', 'of', 'ribosomal', 'protein', 'S', '##10', ',', 'RP', '##S', '##10', ';', 'ribosomal', 'protein', 'S', '##6', ',', 'RP', '##S', '##6', ';', 'and', 'RI', '##O', 'kinase', '2', ',', 'RI', '##O', '##K', '##2', '.']	[0, 4, 7, 12, 21, 25, 34, 42, 47, 50, 56, 57, 66, 77, 84, 92, 93, 95, 97, 99, 100, 102, 111, 118, 119, 121, 129, 130, 132, 134, 135, 136, 137, 139, 148, 155, 156, 158, 160, 161, 163, 167, 174, 178, 187, 192, 201, 208, 210, 212, 214, 216, 218, 220, 226, 230, 236, 240, 244, 253, 256, 266, 274, 275, 277, 279, 281, 282, 284, 286, 296, 304, 305, 306, 308, 310, 311, 312, 314, 318, 320, 322, 329, 330, 332, 334, 335, 336, 337]	[3, 6, 11, 20, 24, 33, 41, 46, 49, 56, 57, 65, 76, 83, 91, 93, 94, 97, 99, 100, 101, 110, 117, 119, 120, 128, 130, 131, 134, 135, 136, 137, 138, 147, 154, 156, 157, 160, 161, 162, 166, 173, 177, 186, 191, 200, 207, 210, 211, 214, 216, 218, 219, 225, 229, 235, 239, 243, 252, 255, 265, 273, 275, 277, 278, 281, 282, 284, 285, 295, 303, 305, 306, 307, 310, 311, 312, 313, 317, 320, 321, 328, 330, 331, 334, 335, 336, 337, 338]	['One', 'of', 'them', 'involved', 'RNA', 'splicing', 'factors', 'such', 'as', 'serine', '/', 'arginine', 'repetitive', 'matrix', 'protein', '2', ',', 'SRRM2', ';', 'splicing', 'factor', '3b', 'subunit', '1', ',', 'SF3B1', ';', 'splicing', 'factor', '1', ',', 'SF1', ';', 'and', 'serine', 'and', 'arginine', 'rich', 'splicing', 'factor', '11', ',', 'SRSF11', ';', 'while', 'the', 'other', 'one', 'was', 'composed', 'of', 'ribosomal', 'protein', 'S10', ',', 'RPS10', ';', 'ribosomal', 'protein', 'S6', ',', 'RPS6', ';', 'and', 'RIO', 'kinase', '2', ',', 'RIOK2', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
A sequence logo of the amino acid sequence windows surrounding the phosphorylation sites of the splicing factor network (Figure S1) identified the SP and the SXR/K motifs for mitogen-activated protein kinases (MAPKs) and protein kinase C delta/protein kinase cAMP-activated catalytic subunit alpha protein kinase C delta/PRKACA, respectively, although RNA polymerase II subunit A (POLR2A) S1920 and SRSF11 S207 are phosphorylated by cyclin dependent kinase (cyclin dependent kinase)1 and CDK2, respectively [46].	[('PMC8125016', 'R11002', 175, 208, 'mitogen-activated protein kinases'), ('PMC8125016', 'R11002', 221, 243, 'protein kinase C delta'), ('PMC8125016', 'R11002', 244, 297, 'protein kinase cAMP-activated catalytic subunit alpha'), ('PMC8125016', 'R11002', 298, 320, 'protein kinase C delta'), ('PMC8125016', 'R11002', 352, 379, 'RNA polymerase II subunit A'), ('PMC8125016', 'R11002', 433, 456, 'cyclin dependent kinase'), ('PMC8125016', 'R11002', 458, 481, 'cyclin dependent kinase')]	['A', 'sequence', 'log', '##o', 'of', 'the', 'amino', 'acid', 'sequence', 'windows', 'surrounding', 'the', 'phosphorylation', 'sites', 'of', 'the', 'splicing', 'factor', 'network', '(', 'Figure', 'S', '##1', ')', 'identified', 'the', 'SP', 'and', 'the', 'S', '##XR', '/', 'K', 'motifs', 'for', 'mitogen', '-', 'activated', 'protein', 'kinases', '(', 'MAPK', '##s', ')', 'and', 'protein', 'kinase', 'C', 'delta', '/', 'protein', 'kinase', 'cAMP', '-', 'activated', 'catalytic', 'subunit', 'alpha', 'protein', 'kinase', 'C', 'delta', '/', 'PR', '##KA', '##CA', ',', 'respectively', ',', 'although', 'RNA', 'polymerase', 'II', 'subunit', 'A', '(', 'POL', '##R', '##2', '##A', ')', 'S', '##19', '##20', 'and', 'SR', '##SF', '##11', 'S', '##207', 'are', 'phosphorylated', 'by', 'cyclin', 'dependent', 'kinase', '(', 'cyclin', 'dependent', 'kinase', ')', '1', 'and', 'CDK', '##2', ',', 'respectively', '[', '46', ']', '.']	[0, 2, 11, 14, 16, 19, 23, 29, 34, 43, 51, 63, 67, 83, 89, 92, 96, 105, 112, 120, 121, 128, 129, 130, 132, 143, 147, 150, 154, 158, 159, 161, 162, 164, 171, 175, 182, 183, 193, 201, 209, 210, 214, 215, 217, 221, 229, 236, 238, 243, 244, 252, 259, 263, 264, 274, 284, 292, 298, 306, 313, 315, 320, 321, 323, 325, 327, 329, 341, 343, 352, 356, 367, 370, 378, 380, 381, 384, 385, 386, 387, 389, 390, 392, 395, 399, 401, 403, 406, 407, 411, 415, 430, 433, 440, 450, 457, 458, 465, 475, 481, 482, 484, 488, 491, 492, 494, 507, 508, 510, 511]	[1, 10, 14, 15, 18, 22, 28, 33, 42, 50, 62, 66, 82, 88, 91, 95, 104, 111, 119, 121, 127, 129, 130, 131, 142, 146, 149, 153, 157, 159, 161, 162, 163, 170, 174, 182, 183, 192, 200, 208, 210, 214, 215, 216, 220, 228, 235, 237, 243, 244, 251, 258, 263, 264, 273, 283, 291, 297, 305, 312, 314, 320, 321, 323, 325, 327, 328, 341, 342, 351, 355, 366, 369, 377, 379, 381, 384, 385, 386, 387, 388, 390, 392, 394, 398, 401, 403, 405, 407, 410, 414, 429, 432, 439, 449, 456, 458, 464, 474, 481, 482, 483, 487, 491, 492, 493, 506, 508, 510, 511, 512]	['A', 'sequence', 'logo', 'of', 'the', 'amino', 'acid', 'sequence', 'windows', 'surrounding', 'the', 'phosphorylation', 'sites', 'of', 'the', 'splicing', 'factor', 'network', '(', 'Figure', 'S1', ')', 'identified', 'the', 'SP', 'and', 'the', 'SXR', '/', 'K', 'motifs', 'for', 'mitogen', '-', 'activated', 'protein', 'kinases', '(', 'MAPKs', ')', 'and', 'protein', 'kinase', 'C', 'delta', '/', 'protein', 'kinase', 'cAMP-activated', 'catalytic', 'subunit', 'alpha', 'protein', 'kinase', 'C', 'delta', '/', 'PRKACA', ',', 'respectively', ',', 'although', 'RNA', 'polymerase', 'II', 'subunit', 'A', '(', 'POLR2A', ')', 'S1920', 'and', 'SRSF11', 'S207', 'are', 'phosphorylated', 'by', 'cyclin', 'dependent', 'kinase', '(', 'cyclin', 'dependent', 'kinase)1', 'and', 'CDK2', ',', 'respectively', '[', '46', ']', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The phosphorylation of RPS6 at S236 by several members of the ribosomal protein S6 kinase family (i.e., RPS6KA1, RPS6KA3 or RPS6KB1) facilitates the assembly of the translation preinitiation complex [57] whereas polo like kinase 1 (PLK1) phosphorylation at RIOK2 S380 regulates mitotic progression [58].	[('PMC8125016', 'R11003', 62, 89, 'ribosomal protein S6 kinase'), ('PMC8125016', 'R11003', 212, 230, 'polo like kinase 1')]	['The', 'phosphorylation', 'of', 'RP', '##S', '##6', 'at', 'S', '##23', '##6', 'by', 'several', 'members', 'of', 'the', 'ribosomal', 'protein', 'S', '##6', 'kinase', 'family', '(', 'i', '.', 'e', '.', ',', 'RP', '##S', '##6', '##KA', '##1', ',', 'RP', '##S', '##6', '##KA', '##3', 'or', 'RP', '##S', '##6', '##KB', '##1', ')', 'facilitates', 'the', 'assembly', 'of', 'the', 'translation', 'pre', '##initi', '##ation', 'complex', '[', '57', ']', 'whereas', 'pol', '##o', 'like', 'kinase', '1', '(', 'PL', '##K', '##1', ')', 'phosphorylation', 'at', 'RI', '##O', '##K', '##2', 'S', '##38', '##0', 'regulates', 'mitotic', 'progression', '[', '58', ']', '.']	[0, 4, 20, 23, 25, 26, 28, 31, 32, 34, 36, 39, 47, 55, 58, 62, 72, 80, 81, 83, 90, 97, 98, 99, 100, 101, 102, 104, 106, 107, 108, 110, 111, 113, 115, 116, 117, 119, 121, 124, 126, 127, 128, 130, 131, 133, 145, 149, 158, 161, 165, 177, 180, 185, 191, 199, 200, 202, 204, 212, 215, 217, 222, 229, 231, 232, 234, 235, 236, 238, 254, 257, 259, 260, 261, 263, 264, 266, 268, 278, 286, 298, 299, 301, 302]	[3, 19, 22, 25, 26, 27, 30, 32, 34, 35, 38, 46, 54, 57, 61, 71, 79, 81, 82, 89, 96, 98, 99, 100, 101, 102, 103, 106, 107, 108, 110, 111, 112, 115, 116, 117, 119, 120, 123, 126, 127, 128, 130, 131, 132, 144, 148, 157, 160, 164, 176, 180, 185, 190, 198, 200, 202, 203, 211, 215, 216, 221, 228, 230, 232, 234, 235, 236, 237, 253, 256, 259, 260, 261, 262, 264, 266, 267, 277, 285, 297, 299, 301, 302, 303]	['The', 'phosphorylation', 'of', 'RPS6', 'at', 'S236', 'by', 'several', 'members', 'of', 'the', 'ribosomal', 'protein', 'S6', 'kinase', 'family', '(', 'i.e', '.', ',', 'RPS6KA1', ',', 'RPS6KA3', 'or', 'RPS6KB1', ')', 'facilitates', 'the', 'assembly', 'of', 'the', 'translation', 'preinitiation', 'complex', '[', '57', ']', 'whereas', 'polo', 'like', 'kinase', '1', '(', 'PLK1', ')', 'phosphorylation', 'at', 'RIOK2', 'S380', 'regulates', 'mitotic', 'progression', '[', '58', ']', '.']	[1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 5, 1, 5, 1, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among them, four phosphoproteins showed a higher phosphorylation in PRE-R patients (i.e., cofilin 1, CFL1; RPS6, protein tyrosine phosphatase non-receptor type 2, PTPN2; and MYC associated factor X, MAX).	[('PMC8125016', 'R12001', 113, 141, 'protein tyrosine phosphatase')]	['Among', 'them', ',', 'four', 'phospho', '##protein', '##s', 'showed', 'a', 'higher', 'phosphorylation', 'in', 'PRE', '-', 'R', 'patients', '(', 'i', '.', 'e', '.', ',', 'co', '##fil', '##in', '1', ',', 'CF', '##L', '##1', ';', 'RP', '##S', '##6', ',', 'protein', 'tyrosine', 'phosphatase', 'non', '-', 'receptor', 'type', '2', ',', 'PTP', '##N', '##2', ';', 'and', 'MY', '##C', 'associated', 'factor', 'X', ',', 'MAX', ')', '.']	[0, 6, 10, 12, 17, 24, 31, 33, 40, 42, 49, 65, 68, 71, 72, 74, 83, 84, 85, 86, 87, 88, 90, 92, 95, 98, 99, 101, 103, 104, 105, 107, 109, 110, 111, 113, 121, 130, 142, 145, 146, 155, 160, 161, 163, 166, 167, 168, 170, 174, 176, 178, 189, 196, 197, 199, 202, 203]	[5, 10, 11, 16, 24, 31, 32, 39, 41, 48, 64, 67, 71, 72, 73, 82, 84, 85, 86, 87, 88, 89, 92, 95, 97, 99, 100, 103, 104, 105, 106, 109, 110, 111, 112, 120, 129, 141, 145, 146, 154, 159, 161, 162, 166, 167, 168, 169, 173, 176, 177, 188, 195, 197, 198, 202, 203, 204]	['Among', 'them', ',', 'four', 'phosphoproteins', 'showed', 'a', 'higher', 'phosphorylation', 'in', 'PRE-R', 'patients', '(', 'i.e', '.', ',', 'cofilin', '1', ',', 'CFL1', ';', 'RPS6', ',', 'protein', 'tyrosine', 'phosphatase', 'non', '-', 'receptor', 'type', '2', ',', 'PTPN2', ';', 'and', 'MYC', 'associated', 'factor', 'X', ',', 'MAX', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The F-actin depolymerizing activity of CFL1 is inactivated by phosphorylation on S3 by NIK related kinase (NRK)/NIK-like embryo-specific kinase (NIK-like embryo-specific kinase), testis associated actin remodeling kinase 1 (TESK1), protein kinase D1 (PRKD1) and LIM domain kinase 1/2 (LIMK1/LIMK2)	[('PMC8125016', 'R13000', 87, 105, 'NIK related kinase'), ('PMC8125016', 'R13000', 112, 143, 'NIK-like embryo-specific kinase'), ('PMC8125016', 'R13000', 145, 176, 'NIK-like embryo-specific kinase'), ('PMC8125016', 'R13000', 179, 222, 'testis associated actin remodeling kinase 1'), ('PMC8125016', 'R13000', 232, 249, 'protein kinase D1'), ('PMC8125016', 'R13000', 262, 283, 'LIM domain kinase 1/2')]	['The', 'F', '-', 'actin', 'dep', '##olymer', '##izing', 'activity', 'of', 'CF', '##L', '##1', 'is', 'inactivated', 'by', 'phosphorylation', 'on', 'S', '##3', 'by', 'NI', '##K', 'related', 'kinase', '(', 'NR', '##K', ')', '/', 'NI', '##K', '-', 'like', 'embryo', '-', 'specific', 'kinase', '(', 'NI', '##K', '-', 'like', 'embryo', '-', 'specific', 'kinase', ')', ',', 'testis', 'associated', 'actin', 'remodeling', 'kinase', '1', '(', 'TE', '##SK', '##1', ')', ',', 'protein', 'kinase', 'D', '##1', '(', 'PR', '##KD', '##1', ')', 'and', 'LI', '##M', 'domain', 'kinase', '1', '/', '2', '(', 'LI', '##MK', '##1', '/', 'LI', '##MK', '##2', ')']	[0, 4, 5, 6, 12, 15, 21, 27, 36, 39, 41, 42, 44, 47, 59, 62, 78, 81, 82, 84, 87, 89, 91, 99, 106, 107, 109, 110, 111, 112, 114, 115, 116, 121, 127, 128, 137, 144, 145, 147, 148, 149, 154, 160, 161, 170, 176, 177, 179, 186, 197, 203, 214, 221, 223, 224, 226, 228, 229, 230, 232, 240, 247, 248, 250, 251, 253, 255, 256, 258, 262, 264, 266, 273, 280, 281, 282, 284, 285, 287, 289, 290, 291, 293, 295, 296]	[3, 5, 6, 11, 15, 21, 26, 35, 38, 41, 42, 43, 46, 58, 61, 77, 80, 82, 83, 86, 89, 90, 98, 105, 107, 109, 110, 111, 112, 114, 115, 116, 120, 127, 128, 136, 143, 145, 147, 148, 149, 153, 160, 161, 169, 176, 177, 178, 185, 196, 202, 213, 220, 222, 224, 226, 228, 229, 230, 231, 239, 246, 248, 249, 251, 253, 255, 256, 257, 261, 264, 265, 272, 279, 281, 282, 283, 285, 287, 289, 290, 291, 293, 295, 296, 297]	['The', 'F-actin', 'depolymerizing', 'activity', 'of', 'CFL1', 'is', 'inactivated', 'by', 'phosphorylation', 'on', 'S3', 'by', 'NIK', 'related', 'kinase', '(', 'NRK', ')', '/', 'NIK', '-', 'like', 'embryo', '-', 'specific', 'kinase', '(', 'NIK', '-', 'like', 'embryo', '-', 'specific', 'kinase', ')', ',', 'testis', 'associated', 'actin', 'remodeling', 'kinase', '1', '(', 'TESK1', ')', ',', 'protein', 'kinase', 'D1', '(', 'PRKD1', ')', 'and', 'LIM', 'domain', 'kinase', '1', '/', '2', '(', 'LIMK1', '/', 'LIMK2', ')']	[1, 3, 3, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, some of these kinases were predicted to be activated in the PRE-R group by kinase–substrate enrichment analysis (KSEA) (Figure 3e, see results below).	[('PMC8125016', 'R13002', 29, 36, 'kinases'), ('PMC8125016', 'R13002', 90, 96, 'kinase')]	['Interestingly', ',', 'some', 'of', 'these', 'kinases', 'were', 'predicted', 'to', 'be', 'activated', 'in', 'the', 'PRE', '-', 'R', 'group', 'by', 'kinase', '–', 'substrate', 'enrichment', 'analysis', '(', 'KS', '##EA', ')', '(', 'Figure', '3', '##e', ',', 'see', 'results', 'below', ')', '.']	[0, 13, 15, 20, 23, 29, 37, 42, 52, 55, 58, 68, 71, 75, 78, 79, 81, 87, 90, 96, 97, 107, 118, 127, 128, 130, 132, 134, 135, 142, 143, 144, 146, 150, 158, 163, 164]	[13, 14, 19, 22, 28, 36, 41, 51, 54, 57, 67, 70, 74, 78, 79, 80, 86, 89, 96, 97, 106, 117, 126, 128, 130, 132, 133, 135, 141, 143, 144, 145, 149, 157, 163, 164, 165]	['Interestingly', ',', 'some', 'of', 'these', 'kinases', 'were', 'predicted', 'to', 'be', 'activated', 'in', 'the', 'PRE-R', 'group', 'by', 'kinase', '–', 'substrate', 'enrichment', 'analysis', '(', 'KSEA', ')', '(', 'Figure', '3e', ',', 'see', 'results', 'below', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the role of that phosphorylated residue in its interaction with ATR serine/threonine kinase (ATR) is unknown.	[('PMC8125016', 'R13005', 77, 100, 'serine/threonine kinase')]	['However', ',', 'the', 'role', 'of', 'that', 'phosphorylated', 'residue', 'in', 'its', 'interaction', 'with', 'AT', '##R', 'serine', '/', 'thre', '##onine', 'kinase', '(', 'AT', '##R', ')', 'is', 'unknown', '.']	[0, 7, 9, 13, 18, 21, 26, 41, 49, 52, 56, 68, 73, 75, 77, 83, 84, 88, 94, 101, 102, 104, 105, 107, 110, 117]	[7, 8, 12, 17, 20, 25, 40, 48, 51, 55, 67, 72, 75, 76, 83, 84, 88, 93, 100, 102, 104, 105, 106, 109, 117, 118]	['However', ',', 'the', 'role', 'of', 'that', 'phosphorylated', 'residue', 'in', 'its', 'interaction', 'with', 'ATR', 'serine', '/', 'threonine', 'kinase', '(', 'ATR', ')', 'is', 'unknown', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, we also detected differences in kinase activity/intracellular signaling as well as in the regulation of cell cycle progression and apoptosis.	[('PMC8125016', 'R15002', 41, 47, 'kinase')]	['However', ',', 'we', 'also', 'detected', 'differences', 'in', 'kinase', 'activity', '/', 'intracellular', 'signaling', 'as', 'well', 'as', 'in', 'the', 'regulation', 'of', 'cell', 'cycle', 'progression', 'and', 'apoptosis', '.']	[0, 7, 9, 12, 17, 26, 38, 41, 48, 56, 57, 71, 81, 84, 89, 92, 95, 99, 110, 113, 118, 124, 136, 140, 149]	[7, 8, 11, 16, 25, 37, 40, 47, 56, 57, 70, 80, 83, 88, 91, 94, 98, 109, 112, 117, 123, 135, 139, 149, 150]	['However', ',', 'we', 'also', 'detected', 'differences', 'in', 'kinase', 'activity', '/', 'intracellular', 'signaling', 'as', 'well', 'as', 'in', 'the', 'regulation', 'of', 'cell', 'cycle', 'progression', 'and', 'apoptosis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to determine whether the protein phosphorylation levels were due to changes in protein abundance or to kinase activation, we investigated the expression of 85 phosphoproteins to the 107 differentially regulated phosphosites.	[('PMC8125016', 'R16000', 112, 118, 'kinase')]	['In', 'order', 'to', 'determine', 'whether', 'the', 'protein', 'phosphorylation', 'levels', 'were', 'due', 'to', 'changes', 'in', 'protein', 'abundance', 'or', 'to', 'kinase', 'activation', ',', 'we', 'investigated', 'the', 'expression', 'of', '85', 'phospho', '##protein', '##s', 'to', 'the', '107', 'differentially', 'regulated', 'phospho', '##site', '##s', '.']	[0, 3, 9, 12, 22, 30, 34, 42, 58, 65, 70, 74, 77, 85, 88, 96, 106, 109, 112, 119, 129, 131, 134, 147, 151, 162, 165, 168, 175, 182, 184, 187, 191, 195, 210, 220, 227, 231, 232]	[2, 8, 11, 21, 29, 33, 41, 57, 64, 69, 73, 76, 84, 87, 95, 105, 108, 111, 118, 129, 130, 133, 146, 150, 161, 164, 167, 175, 182, 183, 186, 190, 194, 209, 219, 227, 231, 232, 233]	['In', 'order', 'to', 'determine', 'whether', 'the', 'protein', 'phosphorylation', 'levels', 'were', 'due', 'to', 'changes', 'in', 'protein', 'abundance', 'or', 'to', 'kinase', 'activation', ',', 'we', 'investigated', 'the', 'expression', 'of', '85', 'phosphoproteins', 'to', 'the', '107', 'differentially', 'regulated', 'phosphosites', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This demonstrated that most of the differentially regulated phosphorylation sites in the PRE-R vs. PRE-NR study could not be explained by protein expression changes, which suggested an increased kinase-specific phosphorylation in the AML proteome.	[('PMC8125016', 'R16004', 195, 201, 'kinase')]	['This', 'demonstrated', 'that', 'most', 'of', 'the', 'differentially', 'regulated', 'phosphorylation', 'sites', 'in', 'the', 'PRE', '-', 'R', 'vs', '.', 'PRE', '-', 'NR', 'study', 'could', 'not', 'be', 'explained', 'by', 'protein', 'expression', 'changes', ',', 'which', 'suggested', 'an', 'increased', 'kinase', '-', 'specific', 'phosphorylation', 'in', 'the', 'AML', 'proteome', '.']	[0, 5, 18, 23, 28, 31, 35, 50, 60, 76, 82, 85, 89, 92, 93, 95, 97, 99, 102, 103, 106, 112, 118, 122, 125, 135, 138, 146, 157, 164, 166, 172, 182, 185, 195, 201, 202, 211, 227, 230, 234, 238, 246]	[4, 17, 22, 27, 30, 34, 49, 59, 75, 81, 84, 88, 92, 93, 94, 97, 98, 102, 103, 105, 111, 117, 121, 124, 134, 137, 145, 156, 164, 165, 171, 181, 184, 194, 201, 202, 210, 226, 229, 233, 237, 246, 247]	['This', 'demonstrated', 'that', 'most', 'of', 'the', 'differentially', 'regulated', 'phosphorylation', 'sites', 'in', 'the', 'PRE-R', 'vs', '.', 'PRE-NR', 'study', 'could', 'not', 'be', 'explained', 'by', 'protein', 'expression', 'changes', ',', 'which', 'suggested', 'an', 'increased', 'kinase', '-', 'specific', 'phosphorylation', 'in', 'the', 'AML', 'proteome', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To identify protein kinases differentially activated in the PRE-R and PRE-NR groups, we performed phosphorylation site motif analysis (IceLogo)	[('PMC8125016', 'R17000', 12, 27, 'protein kinases')]	['To', 'identify', 'protein', 'kinases', 'differentially', 'activated', 'in', 'the', 'PRE', '-', 'R', 'and', 'PRE', '-', 'NR', 'groups', ',', 'we', 'performed', 'phosphorylation', 'site', 'motif', 'analysis', '(', 'I', '##ce', '##Log', '##o', ')']	[0, 3, 12, 20, 28, 43, 53, 56, 60, 63, 64, 66, 70, 73, 74, 77, 83, 85, 88, 98, 114, 119, 125, 134, 135, 136, 138, 141, 142]	[2, 11, 19, 27, 42, 52, 55, 59, 63, 64, 65, 69, 73, 74, 76, 83, 84, 87, 97, 113, 118, 124, 133, 135, 136, 138, 141, 142, 143]	['To', 'identify', 'protein', 'kinases', 'differentially', 'activated', 'in', 'the', 'PRE-R', 'and', 'PRE-NR', 'groups', ',', 'we', 'performed', 'phosphorylation', 'site', 'motif', 'analysis', '(', 'IceLogo', ')']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We found basophilic RXXpS/pT and RPPS motifs characteristics of PRKCA/protein kinase C delta and dual specificity tyrosine phosphorylation regulated kinase 2 (DYRK2), respectively, in PRE-R patient samples when compared to the PRE-NR group (Figure 3d).	[('PMC8125016', 'R17002', 70, 92, 'protein kinase C delta'), ('PMC8125016', 'R17002', 97, 157, 'dual specificity tyrosine phosphorylation regulated kinase 2')]	['We', 'found', 'bas', '##ophilic', 'RX', '##X', '##p', '##S', '/', 'pT', 'and', 'RP', '##PS', 'motifs', 'characteristics', 'of', 'PR', '##K', '##CA', '/', 'protein', 'kinase', 'C', 'delta', 'and', 'dual', 'specificity', 'tyrosine', 'phosphorylation', 'regulated', 'kinase', '2', '(', 'DY', '##RK', '##2', ')', ',', 'respectively', ',', 'in', 'PRE', '-', 'R', 'patient', 'samples', 'when', 'compared', 'to', 'the', 'PRE', '-', 'NR', 'group', '(', 'Figure', '3', '##d', ')', '.']	[0, 3, 9, 12, 20, 22, 23, 24, 25, 26, 29, 33, 35, 38, 45, 61, 64, 66, 67, 69, 70, 78, 85, 87, 93, 97, 102, 114, 123, 139, 149, 156, 158, 159, 161, 163, 164, 165, 167, 179, 181, 184, 187, 188, 190, 198, 206, 211, 220, 223, 227, 230, 231, 234, 240, 241, 248, 249, 250, 251]	[2, 8, 12, 19, 22, 23, 24, 25, 26, 28, 32, 35, 37, 44, 60, 63, 66, 67, 69, 70, 77, 84, 86, 92, 96, 101, 113, 122, 138, 148, 155, 157, 159, 161, 163, 164, 165, 166, 179, 180, 183, 187, 188, 189, 197, 205, 210, 219, 222, 226, 230, 231, 233, 239, 241, 247, 249, 250, 251, 252]	['We', 'found', 'basophilic', 'RXXpS', '/', 'pT', 'and', 'RPPS', 'motifs', 'characteristics', 'of', 'PRKCA', '/', 'protein', 'kinase', 'C', 'delta', 'and', 'dual', 'specificity', 'tyrosine', 'phosphorylation', 'regulated', 'kinase', '2', '(', 'DYRK2', ')', ',', 'respectively', ',', 'in', 'PRE-R', 'patient', 'samples', 'when', 'compared', 'to', 'the', 'PRE-NR', 'group', '(', 'Figure', '3d', ')', '.']	[1, 1, 2, 4, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, the KSEA [44,45], which is based on phosphorylation FCs to estimate kinase’s activity, confirmed the higher activity of these kinases together with LIM domain kinase 1 and 2 and CDK2 in the PRE-R group (Figure 3e).	[('PMC8125016', 'R17003', 81, 89, 'kinase’s'), ('PMC8125016', 'R17003', 139, 146, 'kinases'), ('PMC8125016', 'R17003', 161, 186, 'LIM domain kinase 1 and 2')]	['Furthermore', ',', 'the', 'KS', '##EA', '[', '44', ',', '45', ']', ',', 'which', 'is', 'based', 'on', 'phosphorylation', 'FC', '##s', 'to', 'estimate', 'kinase', '’', 's', 'activity', ',', 'confirmed', 'the', 'higher', 'activity', 'of', 'these', 'kinases', 'together', 'with', 'LI', '##M', 'domain', 'kinase', '1', 'and', '2', 'and', 'CDK', '##2', 'in', 'the', 'PRE', '-', 'R', 'group', '(', 'Figure', '3', '##e', ')', '.']	[0, 11, 13, 17, 19, 22, 23, 25, 26, 28, 29, 31, 37, 40, 46, 49, 65, 67, 69, 72, 81, 87, 88, 90, 98, 100, 110, 114, 121, 130, 133, 139, 147, 156, 161, 163, 165, 172, 179, 181, 185, 187, 191, 194, 196, 199, 203, 206, 207, 209, 215, 216, 223, 224, 225, 226]	[11, 12, 16, 19, 21, 23, 25, 26, 28, 29, 30, 36, 39, 45, 48, 64, 67, 68, 71, 80, 87, 88, 89, 98, 99, 109, 113, 120, 129, 132, 138, 146, 155, 160, 163, 164, 171, 178, 180, 184, 186, 190, 194, 195, 198, 202, 206, 207, 208, 214, 216, 222, 224, 225, 226, 227]	['Furthermore', ',', 'the', 'KSEA', '[', '44', ',', '45', ']', ',', 'which', 'is', 'based', 'on', 'phosphorylation', 'FCs', 'to', 'estimate', 'kinase’s', 'activity', ',', 'confirmed', 'the', 'higher', 'activity', 'of', 'these', 'kinases', 'together', 'with', 'LIM', 'domain', 'kinase', '1', 'and', '2', 'and', 'CDK2', 'in', 'the', 'PRE-R', 'group', '(', 'Figure', '3e', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Only two kinases, protein kinase cGMP-dependent 2 (PRKG2) and microtubule affinity regulating kinase 1 (MARK1) involved in the activation of the extracellular signal-regulated kinases in osteoblasts and cell polarity, respectively [64,65], were predicted to be more active in the PRE-NR group.	[('PMC8125016', 'R18001', 9, 16, 'kinases'), ('PMC8125016', 'R18001', 18, 49, 'protein kinase cGMP-dependent 2'), ('PMC8125016', 'R18001', 62, 102, 'microtubule affinity regulating kinase 1'), ('PMC8125016', 'R18001', 145, 183, 'extracellular signal-regulated kinases')]	['Only', 'two', 'kinases', ',', 'protein', 'kinase', 'c', '##GMP', '-', 'dependent', '2', '(', 'PR', '##K', '##G', '##2', ')', 'and', 'microtubule', 'affinity', 'regulating', 'kinase', '1', '(', 'MAR', '##K', '##1', ')', 'involved', 'in', 'the', 'activation', 'of', 'the', 'extracellular', 'signal', '-', 'regulated', 'kinases', 'in', 'osteoblasts', 'and', 'cell', 'polarity', ',', 'respectively', '[', '64', ',', '65', ']', ',', 'were', 'predicted', 'to', 'be', 'more', 'active', 'in', 'the', 'PRE', '-', 'NR', 'group', '.']	[0, 5, 9, 16, 18, 26, 33, 34, 37, 38, 48, 50, 51, 53, 54, 55, 56, 58, 62, 74, 83, 94, 101, 103, 104, 107, 108, 109, 111, 120, 123, 127, 138, 141, 145, 159, 165, 166, 176, 184, 187, 199, 203, 208, 216, 218, 231, 232, 234, 235, 237, 238, 240, 245, 255, 258, 261, 266, 273, 276, 280, 283, 284, 287, 292]	[4, 8, 16, 17, 25, 32, 34, 37, 38, 47, 49, 51, 53, 54, 55, 56, 57, 61, 73, 82, 93, 100, 102, 104, 107, 108, 109, 110, 119, 122, 126, 137, 140, 144, 158, 165, 166, 175, 183, 186, 198, 202, 207, 216, 217, 230, 232, 234, 235, 237, 238, 239, 244, 254, 257, 260, 265, 272, 275, 279, 283, 284, 286, 292, 293]	['Only', 'two', 'kinases', ',', 'protein', 'kinase', 'cGMP-dependent', '2', '(', 'PRKG2', ')', 'and', 'microtubule', 'affinity', 'regulating', 'kinase', '1', '(', 'MARK1', ')', 'involved', 'in', 'the', 'activation', 'of', 'the', 'extracellular', 'signal', '-', 'regulated', 'kinases', 'in', 'osteoblasts', 'and', 'cell', 'polarity', ',', 'respectively', '[', '64', ',', '65', ']', ',', 'were', 'predicted', 'to', 'be', 'more', 'active', 'in', 'the', 'PRE-NR', 'group', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'S', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The prediction of phosphorylation sites by a novel deep learning architecture based on multi-layer convolution neural networks (i.e., DeepPhos) installed in the piNET web platform [48,49] confirmed the higher number of activated kinases on substrates more phosphorylated in PRE-R patients when compared with the PRE-NR group (Figure S3) as previously observed in the KSEA analysis.	[('PMC8125016', 'R18002', 219, 236, 'activated kinases')]	['The', 'prediction', 'of', 'phosphorylation', 'sites', 'by', 'a', 'novel', 'deep', 'learning', 'architecture', 'based', 'on', 'multi', '-', 'layer', 'convolution', 'neural', 'networks', '(', 'i', '.', 'e', '.', ',', 'Deep', '##Ph', '##os', ')', 'installed', 'in', 'the', 'pi', '##NET', 'web', 'platform', '[', '48', ',', '49', ']', 'confirmed', 'the', 'higher', 'number', 'of', 'activated', 'kinases', 'on', 'substrates', 'more', 'phosphorylated', 'in', 'PRE', '-', 'R', 'patients', 'when', 'compared', 'with', 'the', 'PRE', '-', 'NR', 'group', '(', 'Figure', 'S', '##3', ')', 'as', 'previously', 'observed', 'in', 'the', 'KS', '##EA', 'analysis', '.']	[0, 4, 15, 18, 34, 40, 43, 45, 51, 56, 65, 78, 84, 87, 92, 93, 99, 111, 118, 127, 128, 129, 130, 131, 132, 134, 138, 140, 142, 144, 154, 157, 161, 163, 167, 171, 180, 181, 183, 184, 186, 188, 198, 202, 209, 216, 219, 229, 237, 240, 251, 256, 271, 274, 277, 278, 280, 289, 294, 303, 308, 312, 315, 316, 319, 325, 326, 333, 334, 335, 337, 340, 351, 360, 363, 367, 369, 372, 380]	[3, 14, 17, 33, 39, 42, 44, 50, 55, 64, 77, 83, 86, 92, 93, 98, 110, 117, 126, 128, 129, 130, 131, 132, 133, 138, 140, 142, 143, 153, 156, 160, 163, 166, 170, 179, 181, 183, 184, 186, 187, 197, 201, 208, 215, 218, 228, 236, 239, 250, 255, 270, 273, 277, 278, 279, 288, 293, 302, 307, 311, 315, 316, 318, 324, 326, 332, 334, 335, 336, 339, 350, 359, 362, 366, 369, 371, 380, 381]	['The', 'prediction', 'of', 'phosphorylation', 'sites', 'by', 'a', 'novel', 'deep', 'learning', 'architecture', 'based', 'on', 'multi', '-', 'layer', 'convolution', 'neural', 'networks', '(', 'i.e', '.', ',', 'DeepPhos', ')', 'installed', 'in', 'the', 'piNET', 'web', 'platform', '[', '48', ',', '49', ']', 'confirmed', 'the', 'higher', 'number', 'of', 'activated', 'kinases', 'on', 'substrates', 'more', 'phosphorylated', 'in', 'PRE-R', 'patients', 'when', 'compared', 'with', 'the', 'PRE-NR', 'group', '(', 'Figure', 'S3', ')', 'as', 'previously', 'observed', 'in', 'the', 'KSEA', 'analysis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among them, cyclin dependent kinase 1 and 2, MAPK4 (displayed as ERK1 in the figure) and protein kinase C delta were again predicted to be more activated in the PRE-R group.	[('PMC8125016', 'R18003', 12, 43, 'cyclin dependent kinase 1 and 2'), ('PMC8125016', 'R18003', 89, 111, 'protein kinase C delta')]	['Among', 'them', ',', 'cyclin', 'dependent', 'kinase', '1', 'and', '2', ',', 'MAPK', '##4', '(', 'displayed', 'as', 'ERK', '##1', 'in', 'the', 'figure', ')', 'and', 'protein', 'kinase', 'C', 'delta', 'were', 'again', 'predicted', 'to', 'be', 'more', 'activated', 'in', 'the', 'PRE', '-', 'R', 'group', '.']	[0, 6, 10, 12, 19, 29, 36, 38, 42, 43, 45, 49, 51, 52, 62, 65, 68, 70, 73, 77, 83, 85, 89, 97, 104, 106, 112, 117, 123, 133, 136, 139, 144, 154, 157, 161, 164, 165, 167, 172]	[5, 10, 11, 18, 28, 35, 37, 41, 43, 44, 49, 50, 52, 61, 64, 68, 69, 72, 76, 83, 84, 88, 96, 103, 105, 111, 116, 122, 132, 135, 138, 143, 153, 156, 160, 164, 165, 166, 172, 173]	['Among', 'them', ',', 'cyclin', 'dependent', 'kinase', '1', 'and', '2', ',', 'MAPK4', '(', 'displayed', 'as', 'ERK1', 'in', 'the', 'figure', ')', 'and', 'protein', 'kinase', 'C', 'delta', 'were', 'again', 'predicted', 'to', 'be', 'more', 'activated', 'in', 'the', 'PRE-R', 'group', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The search of our phosphosite dataset by the kinase activation loop tool (see Materials and Methods) did not find any phosphorylated residue in the domain activation loops.	[('PMC8125016', 'R19000', 45, 51, 'kinase')]	['The', 'search', 'of', 'our', 'phospho', '##site', 'dataset', 'by', 'the', 'kinase', 'activation', 'loop', 'tool', '(', 'see', 'Materials', 'and', 'Methods', ')', 'did', 'not', 'find', 'any', 'phosphorylated', 'residue', 'in', 'the', 'domain', 'activation', 'loops', '.']	[0, 4, 11, 14, 18, 25, 30, 38, 41, 45, 52, 63, 68, 73, 74, 78, 88, 92, 99, 101, 105, 109, 114, 118, 133, 141, 144, 148, 155, 166, 171]	[3, 10, 13, 17, 25, 29, 37, 40, 44, 51, 62, 67, 72, 74, 77, 87, 91, 99, 100, 104, 108, 113, 117, 132, 140, 143, 147, 154, 165, 171, 172]	['The', 'search', 'of', 'our', 'phosphosite', 'dataset', 'by', 'the', 'kinase', 'activation', 'loop', 'tool', '(', 'see', 'Materials', 'and', 'Methods', ')', 'did', 'not', 'find', 'any', 'phosphorylated', 'residue', 'in', 'the', 'domain', 'activation', 'loops', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, we identified two kinases (in addition to the RIOK2 identified previously), CDK13 and pre-mRNA processing factor 4B (PRPF4B) more phosphorylated at S395 and S397 in PRE-NR and at S578 and S580 in PRE-R patients, respectively.	[('PMC8125016', 'R19001', 27, 34, 'kinases')]	['However', ',', 'we', 'identified', 'two', 'kinases', '(', 'in', 'addition', 'to', 'the', 'RI', '##O', '##K', '##2', 'identified', 'previously', ')', ',', 'CDK', '##13', 'and', 'pre', '-', 'mRNA', 'processing', 'factor', '4', '##B', '(', 'PR', '##PF', '##4', '##B', ')', 'more', 'phosphorylated', 'at', 'S', '##39', '##5', 'and', 'S', '##39', '##7', 'in', 'PRE', '-', 'NR', 'and', 'at', 'S', '##57', '##8', 'and', 'S', '##58', '##0', 'in', 'PRE', '-', 'R', 'patients', ',', 'respectively', '.']	[0, 7, 9, 12, 23, 27, 35, 36, 39, 48, 51, 55, 57, 58, 59, 61, 72, 82, 83, 85, 88, 91, 95, 98, 99, 104, 115, 122, 123, 125, 126, 128, 130, 131, 132, 134, 139, 154, 157, 158, 160, 162, 166, 167, 169, 171, 174, 177, 178, 181, 185, 188, 189, 191, 193, 197, 198, 200, 202, 205, 208, 209, 211, 219, 221, 233]	[7, 8, 11, 22, 26, 34, 36, 38, 47, 50, 54, 57, 58, 59, 60, 71, 82, 83, 84, 88, 90, 94, 98, 99, 103, 114, 121, 123, 124, 126, 128, 130, 131, 132, 133, 138, 153, 156, 158, 160, 161, 165, 167, 169, 170, 173, 177, 178, 180, 184, 187, 189, 191, 192, 196, 198, 200, 201, 204, 208, 209, 210, 219, 220, 233, 234]	['However', ',', 'we', 'identified', 'two', 'kinases', '(', 'in', 'addition', 'to', 'the', 'RIOK2', 'identified', 'previously', ')', ',', 'CDK13', 'and', 'pre-mRNA', 'processing', 'factor', '4B', '(', 'PRPF4B', ')', 'more', 'phosphorylated', 'at', 'S395', 'and', 'S397', 'in', 'PRE-NR', 'and', 'at', 'S578', 'and', 'S580', 'in', 'PRE-R', 'patients', ',', 'respectively', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 4, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Descending (cluster 5) and ascending (cluster 7) temporal proteomic profiles where enriched with chromatin binding/histone modification (e.g., HDAC2; CREB binding protein, CREBBP) and T cell receptor signaling pathway/proteasome complex (e.g., proteasome 26S subunit, non-ATPase 11, PSMD11; proteasome 20S subunit alpha 2, PSMA2) GO terms, respectively (Figure 4a, right plot).	[('PMC8125016', 'R24001', 268, 281, 'non-ATPase 11')]	['Des', '##ce', '##nd', '##ing', '(', 'cluster', '5', ')', 'and', 'ascending', '(', 'cluster', '7', ')', 'temporal', 'proteomic', 'profiles', 'where', 'enriched', 'with', 'chromatin', 'binding', '/', 'histone', 'modification', '(', 'e', '.', 'g', '.', ',', 'HDAC', '##2', ';', 'CREB', 'binding', 'protein', ',', 'CREB', '##BP', ')', 'and', 'T', 'cell', 'receptor', 'signaling', 'pathway', '/', 'proteasome', 'complex', '(', 'e', '.', 'g', '.', ',', 'proteasome', '26', '##S', 'subunit', ',', 'non', '-', 'ATPase', '11', ',', 'PS', '##MD', '##11', ';', 'proteasome', '20', '##S', 'subunit', 'alpha', '2', ',', 'PS', '##MA', '##2', ')', 'GO', 'terms', ',', 'respectively', '(', 'Figure', '4', '##a', ',', 'right', 'plot', ')', '.']	[0, 3, 5, 7, 11, 12, 20, 21, 23, 27, 37, 38, 46, 47, 49, 58, 68, 77, 83, 92, 97, 107, 114, 115, 123, 136, 137, 138, 139, 140, 141, 143, 147, 148, 150, 155, 163, 170, 172, 176, 178, 180, 184, 186, 191, 200, 210, 217, 218, 229, 237, 238, 239, 240, 241, 242, 244, 255, 257, 259, 266, 268, 271, 272, 279, 281, 283, 285, 287, 289, 291, 302, 304, 306, 314, 320, 321, 323, 325, 327, 328, 330, 333, 338, 340, 353, 354, 361, 362, 363, 365, 371, 375, 376]	[3, 5, 7, 10, 12, 19, 21, 22, 26, 36, 38, 45, 47, 48, 57, 67, 76, 82, 91, 96, 106, 114, 115, 122, 135, 137, 138, 139, 140, 141, 142, 147, 148, 149, 154, 162, 170, 171, 176, 178, 179, 183, 185, 190, 199, 209, 217, 218, 228, 236, 238, 239, 240, 241, 242, 243, 254, 257, 258, 266, 267, 271, 272, 278, 281, 282, 285, 287, 289, 290, 301, 304, 305, 313, 319, 321, 322, 325, 327, 328, 329, 332, 338, 339, 352, 354, 360, 362, 363, 364, 370, 375, 376, 377]	['Descending', '(', 'cluster', '5', ')', 'and', 'ascending', '(', 'cluster', '7', ')', 'temporal', 'proteomic', 'profiles', 'where', 'enriched', 'with', 'chromatin', 'binding', '/', 'histone', 'modification', '(', 'e.g', '.', ',', 'HDAC2', ';', 'CREB', 'binding', 'protein', ',', 'CREBBP', ')', 'and', 'T', 'cell', 'receptor', 'signaling', 'pathway', '/', 'proteasome', 'complex', '(', 'e.g', '.', ',', 'proteasome', '26S', 'subunit', ',', 'non-ATPase', '11', ',', 'PSMD11', ';', 'proteasome', '20S', 'subunit', 'alpha', '2', ',', 'PSMA2', ')', 'GO', 'terms', ',', 'respectively', '(', 'Figure', '4a', ',', 'right', 'plot', ')', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters with low protein expression in the non-responder proteome at 8D (cluster 1 and 2) were enriched with extracellular organelle (e.g., ras homolog family member A, RHOA; cell division cycle 42h, CDC42) and the regulation of actin cytoskeleton organization GO terms, whereas clusters with high protein expression at 8D (cluster 3 and 4) were enriched with nucleic acid binding (e.g., high mobility group nucleosomal binding domain 2, HMGN2; DNA methyltransferase 1, DNMT1; lysine demethylase 2A, KDM2A) (Figure 5a, right plot).	[('PMC8125016', 'R26001', 446, 469, 'DNA methyltransferase 1'), ('PMC8125016', 'R26001', 478, 499, 'lysine demethylase 2A')]	['Cluster', '##s', 'with', 'low', 'protein', 'expression', 'in', 'the', 'non', '-', 'respond', '##er', 'proteome', 'at', '8', '##D', '(', 'cluster', '1', 'and', '2', ')', 'were', 'enriched', 'with', 'extracellular', 'organ', '##elle', '(', 'e', '.', 'g', '.', ',', 'ra', '##s', 'homolog', 'family', 'member', 'A', ',', 'RH', '##OA', ';', 'cell', 'division', 'cycle', '42', '##h', ',', 'CDC', '##42', ')', 'and', 'the', 'regulation', 'of', 'actin', 'cytoskeleton', 'organization', 'GO', 'terms', ',', 'whereas', 'clusters', 'with', 'high', 'protein', 'expression', 'at', '8', '##D', '(', 'cluster', '3', 'and', '4', ')', 'were', 'enriched', 'with', 'nucleic', 'acid', 'binding', '(', 'e', '.', 'g', '.', ',', 'high', 'mobility', 'group', 'nucle', '##osomal', 'binding', 'domain', '2', ',', 'HM', '##GN', '##2', ';', 'DNA', 'methyl', '##transferase', '1', ',', 'DN', '##MT', '##1', ';', 'lysine', 'dem', '##ethyl', '##ase', '2', '##A', ',', 'KD', '##M', '##2', '##A', ')', '(', 'Figure', '5', '##a', ',', 'right', 'plot', ')', '.']	[0, 7, 9, 14, 18, 26, 37, 40, 44, 47, 48, 55, 58, 67, 70, 71, 73, 74, 82, 84, 88, 89, 91, 96, 105, 110, 124, 129, 134, 135, 136, 137, 138, 139, 141, 143, 145, 153, 160, 167, 168, 170, 172, 174, 176, 181, 190, 196, 198, 199, 201, 204, 206, 208, 212, 216, 227, 230, 236, 249, 262, 265, 270, 272, 280, 289, 294, 299, 307, 318, 321, 322, 324, 325, 333, 335, 339, 340, 342, 347, 356, 361, 369, 374, 382, 383, 384, 385, 386, 387, 389, 394, 403, 409, 414, 421, 429, 436, 437, 439, 441, 443, 444, 446, 450, 456, 468, 469, 471, 473, 475, 476, 478, 485, 488, 493, 497, 498, 499, 501, 503, 504, 505, 506, 508, 509, 516, 517, 518, 520, 526, 530, 531]	[7, 8, 13, 17, 25, 36, 39, 43, 47, 48, 55, 57, 66, 69, 71, 72, 74, 81, 83, 87, 89, 90, 95, 104, 109, 123, 129, 133, 135, 136, 137, 138, 139, 140, 143, 144, 152, 159, 166, 168, 169, 172, 174, 175, 180, 189, 195, 198, 199, 200, 204, 206, 207, 211, 215, 226, 229, 235, 248, 261, 264, 270, 271, 279, 288, 293, 298, 306, 317, 320, 322, 323, 325, 332, 334, 338, 340, 341, 346, 355, 360, 368, 373, 381, 383, 384, 385, 386, 387, 388, 393, 402, 408, 414, 420, 428, 435, 437, 438, 441, 443, 444, 445, 449, 456, 467, 469, 470, 473, 475, 476, 477, 484, 488, 493, 496, 498, 499, 500, 503, 504, 505, 506, 507, 509, 515, 517, 518, 519, 525, 530, 531, 532]	['Clusters', 'with', 'low', 'protein', 'expression', 'in', 'the', 'non', '-', 'responder', 'proteome', 'at', '8D', '(', 'cluster', '1', 'and', '2', ')', 'were', 'enriched', 'with', 'extracellular', 'organelle', '(', 'e.g', '.', ',', 'ras', 'homolog', 'family', 'member', 'A', ',', 'RHOA', ';', 'cell', 'division', 'cycle', '42h', ',', 'CDC42', ')', 'and', 'the', 'regulation', 'of', 'actin', 'cytoskeleton', 'organization', 'GO', 'terms', ',', 'whereas', 'clusters', 'with', 'high', 'protein', 'expression', 'at', '8D', '(', 'cluster', '3', 'and', '4', ')', 'were', 'enriched', 'with', 'nucleic', 'acid', 'binding', '(', 'e.g', '.', ',', 'high', 'mobility', 'group', 'nucleosomal', 'binding', 'domain', '2', ',', 'HMGN2', ';', 'DNA', 'methyltransferase', '1', ',', 'DNMT1', ';', 'lysine', 'demethylase', '2A', ',', 'KDM2A', ')', '(', 'Figure', '5a', ',', 'right', 'plot', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 3, 2, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters with the highest protein expression at 3D (cluster 5 and 6) were enriched with a nuclear part and RNA splicing (e.g., HNRNPC, HNRNPL and HNRNPK; SF1, SF3A2 and SF3A3) GO terms, whereas clusters with the lowest protein expression at 3D, cluster 7 and 8, were enriched with hydrolase activity/hydrolyzing O-glycosyl compounds and clathrin complex, respectively, when compared to pre-treatment and 8D conditions.	[('PMC8125016', 'R26002', 281, 290, 'hydrolase')]	['Cluster', '##s', 'with', 'the', 'highest', 'protein', 'expression', 'at', '3', '##D', '(', 'cluster', '5', 'and', '6', ')', 'were', 'enriched', 'with', 'a', 'nuclear', 'part', 'and', 'RNA', 'splicing', '(', 'e', '.', 'g', '.', ',', 'HN', '##RN', '##PC', ',', 'HN', '##RN', '##PL', 'and', 'HN', '##RN', '##PK', ';', 'SF', '##1', ',', 'SF', '##3', '##A', '##2', 'and', 'SF', '##3', '##A', '##3', ')', 'GO', 'terms', ',', 'whereas', 'clusters', 'with', 'the', 'lowest', 'protein', 'expression', 'at', '3', '##D', ',', 'cluster', '7', 'and', '8', ',', 'were', 'enriched', 'with', 'hydro', '##las', '##e', 'activity', '/', 'hydroly', '##zing', 'O', '-', 'glycos', '##yl', 'compounds', 'and', 'cl', '##ath', '##rin', 'complex', ',', 'respectively', ',', 'when', 'compared', 'to', 'pre', '-', 'treatment', 'and', '8', '##D', 'conditions', '.']	[0, 7, 9, 14, 18, 26, 34, 45, 48, 49, 51, 52, 60, 62, 66, 67, 69, 74, 83, 88, 90, 98, 103, 107, 111, 120, 121, 122, 123, 124, 125, 127, 129, 131, 133, 135, 137, 139, 142, 146, 148, 150, 152, 154, 156, 157, 159, 161, 162, 163, 165, 169, 171, 172, 173, 174, 176, 179, 184, 186, 194, 203, 208, 212, 219, 227, 238, 241, 242, 243, 245, 253, 255, 259, 260, 262, 267, 276, 281, 286, 289, 291, 299, 300, 307, 312, 313, 314, 320, 323, 333, 337, 339, 342, 346, 353, 355, 367, 369, 374, 383, 386, 389, 390, 400, 404, 405, 407, 417]	[7, 8, 13, 17, 25, 33, 44, 47, 49, 50, 52, 59, 61, 65, 67, 68, 73, 82, 87, 89, 97, 102, 106, 110, 119, 121, 122, 123, 124, 125, 126, 129, 131, 133, 134, 137, 139, 141, 145, 148, 150, 152, 153, 156, 157, 158, 161, 162, 163, 164, 168, 171, 172, 173, 174, 175, 178, 184, 185, 193, 202, 207, 211, 218, 226, 237, 240, 242, 243, 244, 252, 254, 258, 260, 261, 266, 275, 280, 286, 289, 290, 299, 300, 307, 311, 313, 314, 320, 322, 332, 336, 339, 342, 345, 353, 354, 367, 368, 373, 382, 385, 389, 390, 399, 403, 405, 406, 417, 418]	['Clusters', 'with', 'the', 'highest', 'protein', 'expression', 'at', '3D', '(', 'cluster', '5', 'and', '6', ')', 'were', 'enriched', 'with', 'a', 'nuclear', 'part', 'and', 'RNA', 'splicing', '(', 'e.g', '.', ',', 'HNRNPC', ',', 'HNRNPL', 'and', 'HNRNPK', ';', 'SF1', ',', 'SF3A2', 'and', 'SF3A3', ')', 'GO', 'terms', ',', 'whereas', 'clusters', 'with', 'the', 'lowest', 'protein', 'expression', 'at', '3D', ',', 'cluster', '7', 'and', '8', ',', 'were', 'enriched', 'with', 'hydrolase', 'activity', '/', 'hydrolyzing', 'O-glycosyl', 'compounds', 'and', 'clathrin', 'complex', ',', 'respectively', ',', 'when', 'compared', 'to', 'pre', '-', 'treatment', 'and', '8D', 'conditions', '.']	[2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 3, 1, 3, 1, 2, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters corresponding to ten different response patterns were identified in the responder group; two of them with low site-specific phosphorylation at 8D (cluster 1–4) were enriched with RNA processing, mRNA splicing, via spliceosome (e.g., SRRM1/2; RNA binding motif protein 15, RBM15; serine and arginine rich splicing factor 2, SRSF2) and nuclear speck (e.g., SRSF1; RB binding protein 6, ubiquitin ligase, RBBP6) GO terms whereas clusters with high site-specific phosphorylation at 8D (cluster 5–7) were enriched with Rho GTPase binding, cytoplasmic mRNA processing body assembly and actin filament binding (Figure 6a, right plot).	[('PMC8125016', 'R29001', 393, 409, 'ubiquitin ligase'), ('PMC8125016', 'R29001', 527, 533, 'GTPase')]	['Cluster', '##s', 'corresponding', 'to', 'ten', 'different', 'response', 'patterns', 'were', 'identified', 'in', 'the', 'respond', '##er', 'group', ';', 'two', 'of', 'them', 'with', 'low', 'site', '-', 'specific', 'phosphorylation', 'at', '8', '##D', '(', 'cluster', '1', '–', '4', ')', 'were', 'enriched', 'with', 'RNA', 'processing', ',', 'mRNA', 'splicing', ',', 'via', 'splice', '##osome', '(', 'e', '.', 'g', '.', ',', 'SR', '##RM', '##1', '/', '2', ';', 'RNA', 'binding', 'motif', 'protein', '15', ',', 'RB', '##M', '##15', ';', 'serine', 'and', 'arginine', 'rich', 'splicing', 'factor', '2', ',', 'SR', '##SF', '##2', ')', 'and', 'nuclear', 'spec', '##k', '(', 'e', '.', 'g', '.', ',', 'SR', '##SF', '##1', ';', 'RB', 'binding', 'protein', '6', ',', 'ubiquitin', 'ligase', ',', 'RB', '##BP', '##6', ')', 'GO', 'terms', 'whereas', 'clusters', 'with', 'high', 'site', '-', 'specific', 'phosphorylation', 'at', '8', '##D', '(', 'cluster', '5', '–', '7', ')', 'were', 'enriched', 'with', 'Rho', 'GTP', '##ase', 'binding', ',', 'cytoplasmic', 'mRNA', 'processing', 'body', 'assembly', 'and', 'actin', 'filament', 'binding', '(', 'Figure', '6', '##a', ',', 'right', 'plot', ')', '.']	[0, 7, 9, 23, 26, 30, 40, 49, 58, 63, 74, 77, 81, 88, 91, 96, 98, 102, 105, 110, 115, 119, 123, 124, 133, 149, 152, 153, 155, 156, 164, 165, 166, 167, 169, 174, 183, 188, 192, 202, 204, 209, 217, 219, 223, 229, 235, 236, 237, 238, 239, 240, 242, 244, 246, 247, 248, 249, 251, 255, 263, 269, 277, 279, 281, 283, 284, 286, 288, 295, 299, 308, 313, 322, 329, 330, 332, 334, 336, 337, 339, 343, 351, 355, 357, 358, 359, 360, 361, 362, 364, 366, 368, 369, 371, 374, 382, 390, 391, 393, 403, 409, 411, 413, 415, 416, 418, 421, 427, 435, 444, 449, 454, 458, 459, 468, 484, 487, 488, 490, 491, 499, 500, 501, 502, 504, 509, 518, 523, 527, 530, 534, 541, 543, 555, 560, 571, 576, 585, 589, 595, 604, 612, 613, 620, 621, 622, 624, 630, 634, 635]	[7, 8, 22, 25, 29, 39, 48, 57, 62, 73, 76, 80, 88, 90, 96, 97, 101, 104, 109, 114, 118, 123, 124, 132, 148, 151, 153, 154, 156, 163, 165, 166, 167, 168, 173, 182, 187, 191, 202, 203, 208, 217, 218, 222, 229, 234, 236, 237, 238, 239, 240, 241, 244, 246, 247, 248, 249, 250, 254, 262, 268, 276, 279, 280, 283, 284, 286, 287, 294, 298, 307, 312, 321, 328, 330, 331, 334, 336, 337, 338, 342, 350, 355, 356, 358, 359, 360, 361, 362, 363, 366, 368, 369, 370, 373, 381, 389, 391, 392, 402, 409, 410, 413, 415, 416, 417, 420, 426, 434, 443, 448, 453, 458, 459, 467, 483, 486, 488, 489, 491, 498, 500, 501, 502, 503, 508, 517, 522, 526, 530, 533, 541, 542, 554, 559, 570, 575, 584, 588, 594, 603, 611, 613, 619, 621, 622, 623, 629, 634, 635, 636]	['Clusters', 'corresponding', 'to', 'ten', 'different', 'response', 'patterns', 'were', 'identified', 'in', 'the', 'responder', 'group', ';', 'two', 'of', 'them', 'with', 'low', 'site', '-', 'specific', 'phosphorylation', 'at', '8D', '(', 'cluster', '1–', '4', ')', 'were', 'enriched', 'with', 'RNA', 'processing', ',', 'mRNA', 'splicing', ',', 'via', 'spliceosome', '(', 'e.g', '.', ',', 'SRRM1', '/', '2', ';', 'RNA', 'binding', 'motif', 'protein', '15', ',', 'RBM15', ';', 'serine', 'and', 'arginine', 'rich', 'splicing', 'factor', '2', ',', 'SRSF2', ')', 'and', 'nuclear', 'speck', '(', 'e.g', '.', ',', 'SRSF1', ';', 'RB', 'binding', 'protein', '6', ',', 'ubiquitin', 'ligase', ',', 'RBBP6', ')', 'GO', 'terms', 'whereas', 'clusters', 'with', 'high', 'site', '-', 'specific', 'phosphorylation', 'at', '8D', '(', 'cluster', '5–', '7', ')', 'were', 'enriched', 'with', 'Rho', 'GTPase', 'binding', ',', 'cytoplasmic', 'mRNA', 'processing', 'body', 'assembly', 'and', 'actin', 'filament', 'binding', '(', 'Figure', '6a', ',', 'right', 'plot', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters with high and low site-specific phosphorylation at 3D were enriched with the negative regulation of vasculature development/RNA polymerase I core binding (e.g., PML nuclear body scaffold, PML; programmed cell death 4, PDCD4; nucleolar and coiled-body phosphoprotein 1, NOLC1) and cyclin/CDK positive transcription elongation (i.e., RB transcriptional corepressor 1, RB1; CDK12) GO terms, respectively.	[('PMC8125016', 'R29002', 133, 149, 'RNA polymerase I')]	['Cluster', '##s', 'with', 'high', 'and', 'low', 'site', '-', 'specific', 'phosphorylation', 'at', '3', '##D', 'were', 'enriched', 'with', 'the', 'negative', 'regulation', 'of', 'vasculature', 'development', '/', 'RNA', 'polymerase', 'I', 'core', 'binding', '(', 'e', '.', 'g', '.', ',', 'PM', '##L', 'nuclear', 'body', 'scaffold', ',', 'PM', '##L', ';', 'programmed', 'cell', 'death', '4', ',', 'PD', '##CD', '##4', ';', 'nucle', '##olar', 'and', 'coil', '##ed', '-', 'body', 'phospho', '##protein', '1', ',', 'NO', '##LC', '##1', ')', 'and', 'cyclin', '/', 'CDK', 'positive', 'transcription', 'elongation', '(', 'i', '.', 'e', '.', ',', 'RB', 'transcriptional', 'core', '##press', '##or', '1', ',', 'RB', '##1', ';', 'CDK', '##12', ')', 'GO', 'terms', ',', 'respectively', '.']	[0, 7, 9, 14, 19, 23, 27, 31, 32, 41, 57, 60, 61, 63, 68, 77, 82, 86, 95, 106, 109, 121, 132, 133, 137, 148, 150, 155, 163, 164, 165, 166, 167, 168, 170, 172, 174, 182, 187, 195, 197, 199, 200, 202, 213, 218, 224, 225, 227, 229, 231, 232, 234, 239, 244, 248, 252, 254, 255, 260, 267, 275, 276, 278, 280, 282, 283, 285, 289, 295, 296, 300, 309, 323, 334, 335, 336, 337, 338, 339, 341, 344, 360, 364, 369, 372, 373, 375, 377, 378, 380, 383, 385, 387, 390, 395, 397, 409]	[7, 8, 13, 18, 22, 26, 31, 32, 40, 56, 59, 61, 62, 67, 76, 81, 85, 94, 105, 108, 120, 132, 133, 136, 147, 149, 154, 162, 164, 165, 166, 167, 168, 169, 172, 173, 181, 186, 195, 196, 199, 200, 201, 212, 217, 223, 225, 226, 229, 231, 232, 233, 239, 243, 247, 252, 254, 255, 259, 267, 274, 276, 277, 280, 282, 283, 284, 288, 295, 296, 299, 308, 322, 333, 335, 336, 337, 338, 339, 340, 343, 359, 364, 369, 371, 373, 374, 377, 378, 379, 383, 385, 386, 389, 395, 396, 409, 410]	['Clusters', 'with', 'high', 'and', 'low', 'site', '-', 'specific', 'phosphorylation', 'at', '3D', 'were', 'enriched', 'with', 'the', 'negative', 'regulation', 'of', 'vasculature', 'development', '/', 'RNA', 'polymerase', 'I', 'core', 'binding', '(', 'e.g', '.', ',', 'PML', 'nuclear', 'body', 'scaffold', ',', 'PML', ';', 'programmed', 'cell', 'death', '4', ',', 'PDCD4', ';', 'nucleolar', 'and', 'coiled', '-', 'body', 'phosphoprotein', '1', ',', 'NOLC1', ')', 'and', 'cyclin', '/', 'CDK', 'positive', 'transcription', 'elongation', '(', 'i.e', '.', ',', 'RB', 'transcriptional', 'corepressor', '1', ',', 'RB1', ';', 'CDK12', ')', 'GO', 'terms', ',', 'respectively', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To identify protein kinases differentially activated in the temporal pair-wise comparisons we performed phosphorylation site motif analysis with WebLogo [43].	[('PMC8125016', 'R31000', 12, 27, 'protein kinases')]	['To', 'identify', 'protein', 'kinases', 'differentially', 'activated', 'in', 'the', 'temporal', 'pair', '-', 'wi', '##se', 'comparisons', 'we', 'performed', 'phosphorylation', 'site', 'motif', 'analysis', 'with', 'Web', '##Log', '##o', '[', '43', ']', '.']	[0, 3, 12, 20, 28, 43, 53, 56, 60, 69, 73, 74, 76, 79, 91, 94, 104, 120, 125, 131, 140, 145, 148, 151, 153, 154, 156, 157]	[2, 11, 19, 27, 42, 52, 55, 59, 68, 73, 74, 76, 78, 90, 93, 103, 119, 124, 130, 139, 144, 148, 151, 152, 154, 156, 157, 158]	['To', 'identify', 'protein', 'kinases', 'differentially', 'activated', 'in', 'the', 'temporal', 'pair', '-', 'wise', 'comparisons', 'we', 'performed', 'phosphorylation', 'site', 'motif', 'analysis', 'with', 'WebLogo', '[', '43', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We found the basophilic R/KXpS/pT and the SP motif characteristics of PRKCA/protein kinase C delta and MAPK3/1, respectively, in pre-treatment patient samples when compared to the 3D group (Figure 6c, left plot).	[('PMC8125016', 'R31001', 76, 98, 'protein kinase C delta')]	['We', 'found', 'the', 'bas', '##ophilic', 'R', '/', 'K', '##X', '##p', '##S', '/', 'pT', 'and', 'the', 'SP', 'motif', 'characteristics', 'of', 'PR', '##K', '##CA', '/', 'protein', 'kinase', 'C', 'delta', 'and', 'MAPK', '##3', '/', '1', ',', 'respectively', ',', 'in', 'pre', '-', 'treatment', 'patient', 'samples', 'when', 'compared', 'to', 'the', '3', '##D', 'group', '(', 'Figure', '6', '##c', ',', 'left', 'plot', ')', '.']	[0, 3, 9, 13, 16, 24, 25, 26, 27, 28, 29, 30, 31, 34, 38, 42, 45, 51, 67, 70, 72, 73, 75, 76, 84, 91, 93, 99, 103, 107, 108, 109, 110, 112, 124, 126, 129, 132, 133, 143, 151, 159, 164, 173, 176, 180, 181, 183, 189, 190, 197, 198, 199, 201, 206, 210, 211]	[2, 8, 12, 16, 23, 25, 26, 27, 28, 29, 30, 31, 33, 37, 41, 44, 50, 66, 69, 72, 73, 75, 76, 83, 90, 92, 98, 102, 107, 108, 109, 110, 111, 124, 125, 128, 132, 133, 142, 150, 158, 163, 172, 175, 179, 181, 182, 188, 190, 196, 198, 199, 200, 205, 210, 211, 212]	['We', 'found', 'the', 'basophilic', 'R', '/', 'KXpS', '/', 'pT', 'and', 'the', 'SP', 'motif', 'characteristics', 'of', 'PRKCA', '/', 'protein', 'kinase', 'C', 'delta', 'and', 'MAPK3', '/', '1', ',', 'respectively', ',', 'in', 'pre', '-', 'treatment', 'patient', 'samples', 'when', 'compared', 'to', 'the', '3D', 'group', '(', 'Figure', '6c', ',', 'left', 'plot', ')', '.']	[1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, the basophilic RRRSXpS/pT, the SP and the acidic SXD/ED/E motif characteristics of AKT serine/threonine kinase 1 (AKT1), MAPK3/1 and casein kinase 2 alpha 1 (casein kinase 2 alpha 1), respectively, were observed in the 8D when compared to the pre-treatment group (Figure 6c, middle plot).	[('PMC8125016', 'R31002', 96, 125, 'AKT serine/threonine kinase 1'), ('PMC8125016', 'R31002', 146, 169, 'casein kinase 2 alpha 1'), ('PMC8125016', 'R31002', 171, 194, 'casein kinase 2 alpha 1')]	['Furthermore', ',', 'the', 'bas', '##ophilic', 'RR', '##RS', '##X', '##p', '##S', '/', 'pT', ',', 'the', 'SP', 'and', 'the', 'acidic', 'S', '##X', '##D', '/', 'ED', '/', 'E', 'motif', 'characteristics', 'of', 'AKT', 'serine', '/', 'thre', '##onine', 'kinase', '1', '(', 'AKT', '##1', ')', ',', 'MAPK', '##3', '/', '1', 'and', 'case', '##in', 'kinase', '2', 'alpha', '1', '(', 'case', '##in', 'kinase', '2', 'alpha', '1', ')', ',', 'respectively', ',', 'were', 'observed', 'in', 'the', '8', '##D', 'when', 'compared', 'to', 'the', 'pre', '-', 'treatment', 'group', '(', 'Figure', '6', '##c', ',', 'middle', 'plot', ')', '.']	[0, 11, 13, 17, 20, 28, 30, 32, 33, 34, 35, 36, 38, 40, 44, 47, 51, 55, 62, 63, 64, 65, 66, 68, 69, 71, 77, 93, 96, 100, 106, 107, 111, 117, 124, 126, 127, 130, 131, 132, 134, 138, 139, 140, 142, 146, 150, 153, 160, 162, 168, 170, 171, 175, 178, 185, 187, 193, 194, 195, 197, 209, 211, 216, 225, 228, 232, 233, 235, 240, 249, 252, 256, 259, 260, 270, 276, 277, 284, 285, 286, 288, 295, 299, 300]	[11, 12, 16, 20, 27, 30, 32, 33, 34, 35, 36, 38, 39, 43, 46, 50, 54, 61, 63, 64, 65, 66, 68, 69, 70, 76, 92, 95, 99, 106, 107, 111, 116, 123, 125, 127, 130, 131, 132, 133, 138, 139, 140, 141, 145, 150, 152, 159, 161, 167, 169, 171, 175, 177, 184, 186, 192, 194, 195, 196, 209, 210, 215, 224, 227, 231, 233, 234, 239, 248, 251, 255, 259, 260, 269, 275, 277, 283, 285, 286, 287, 294, 299, 300, 301]	['Furthermore', ',', 'the', 'basophilic', 'RRRSXpS', '/', 'pT', ',', 'the', 'SP', 'and', 'the', 'acidic', 'SXD', '/', 'ED', '/', 'E', 'motif', 'characteristics', 'of', 'AKT', 'serine', '/', 'threonine', 'kinase', '1', '(', 'AKT1', ')', ',', 'MAPK3', '/', '1', 'and', 'casein', 'kinase', '2', 'alpha', '1', '(', 'casein', 'kinase', '2', 'alpha', '1', ')', ',', 'respectively', ',', 'were', 'observed', 'in', 'the', '8D', 'when', 'compared', 'to', 'the', 'pre', '-', 'treatment', 'group', '(', 'Figure', '6c', ',', 'middle', 'plot', ')', '.']	[1, 1, 1, 2, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To briefly summarize the important observations from this part of our study, we observed again that the triple combination altered the phosphorylation of proteins, especially those involved in the regulation of translation/transcription/RNA metabolism, but additional effects were also observed for cytoskeletal/actin proteins and Rho GTPase binding.	[('PMC8125016', 'R32000', 335, 341, 'GTPase')]	['To', 'briefly', 'summarize', 'the', 'important', 'observations', 'from', 'this', 'part', 'of', 'our', 'study', ',', 'we', 'observed', 'again', 'that', 'the', 'triple', 'combination', 'altered', 'the', 'phosphorylation', 'of', 'proteins', ',', 'especially', 'those', 'involved', 'in', 'the', 'regulation', 'of', 'translation', '/', 'transcription', '/', 'RNA', 'metabolism', ',', 'but', 'additional', 'effects', 'were', 'also', 'observed', 'for', 'cytoskeletal', '/', 'actin', 'proteins', 'and', 'Rho', 'GTP', '##ase', 'binding', '.']	[0, 3, 11, 21, 25, 35, 48, 53, 58, 63, 66, 70, 75, 77, 80, 89, 95, 100, 104, 111, 123, 131, 135, 151, 154, 162, 164, 175, 181, 190, 193, 197, 208, 211, 222, 223, 236, 237, 241, 251, 253, 257, 268, 276, 281, 286, 295, 299, 311, 312, 318, 327, 331, 335, 338, 342, 349]	[2, 10, 20, 24, 34, 47, 52, 57, 62, 65, 69, 75, 76, 79, 88, 94, 99, 103, 110, 122, 130, 134, 150, 153, 162, 163, 174, 180, 189, 192, 196, 207, 210, 222, 223, 236, 237, 240, 251, 252, 256, 267, 275, 280, 285, 294, 298, 311, 312, 317, 326, 330, 334, 338, 341, 349, 350]	['To', 'briefly', 'summarize', 'the', 'important', 'observations', 'from', 'this', 'part', 'of', 'our', 'study', ',', 'we', 'observed', 'again', 'that', 'the', 'triple', 'combination', 'altered', 'the', 'phosphorylation', 'of', 'proteins', ',', 'especially', 'those', 'involved', 'in', 'the', 'regulation', 'of', 'translation', '/', 'transcription', '/', 'RNA', 'metabolism', ',', 'but', 'additional', 'effects', 'were', 'also', 'observed', 'for', 'cytoskeletal', '/', 'actin', 'proteins', 'and', 'Rho', 'GTPase', 'binding', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O']
Clusters with an increasing temporal phosphorylation profiling (clusters 1 and 8), i.e., from PRE to 8D, in the non-responder phosphoproteome were enriched with cyclin dependent kinase activity (e.g., CDK1, CDK2, CDK11B, CDK12) and RNA splicing (e.g., DEAH-box helicase 16, DHX16) whereas clusters with a decreasing temporal phosphorylation profiling (clusters 2 and 5) were enriched with G-protein coupled receptor signaling pathway (e.g., IQ motif containing GTPase activating protein 2, IGGAP2; Rho guanine nucleotide exchange factor 7, ARHGEF7) and RNA polymerase II transcription factor activity (e.g., high mobility group protein HMG-I/HMG-Y and HMGA1) GO terms (Figure 7a, right plot).	[('PMC8125016', 'R33001', 161, 184, 'cyclin dependent kinase'), ('PMC8125016', 'R33001', 252, 272, 'DEAH-box helicase 16'), ('PMC8125016', 'R33001', 461, 467, 'GTPase'), ('PMC8125016', 'R33001', 553, 570, 'RNA polymerase II')]	['Cluster', '##s', 'with', 'an', 'increasing', 'temporal', 'phosphorylation', 'profiling', '(', 'clusters', '1', 'and', '8', ')', ',', 'i', '.', 'e', '.', ',', 'from', 'PRE', 'to', '8', '##D', ',', 'in', 'the', 'non', '-', 'respond', '##er', 'phospho', '##prot', '##e', '##ome', 'were', 'enriched', 'with', 'cyclin', 'dependent', 'kinase', 'activity', '(', 'e', '.', 'g', '.', ',', 'CDK', '##1', ',', 'CDK', '##2', ',', 'CDK', '##11', '##B', ',', 'CDK', '##12', ')', 'and', 'RNA', 'splicing', '(', 'e', '.', 'g', '.', ',', 'DE', '##AH', '-', 'box', 'helic', '##ase', '16', ',', 'DH', '##X', '##16', ')', 'whereas', 'clusters', 'with', 'a', 'decreasing', 'temporal', 'phosphorylation', 'profiling', '(', 'clusters', '2', 'and', '5', ')', 'were', 'enriched', 'with', 'G', '-', 'protein', 'coupled', 'receptor', 'signaling', 'pathway', '(', 'e', '.', 'g', '.', ',', 'IQ', 'motif', 'containing', 'GTP', '##ase', 'activating', 'protein', '2', ',', 'IG', '##GAP', '##2', ';', 'Rho', 'guan', '##ine', 'nucleotide', 'exchange', 'factor', '7', ',', 'AR', '##HG', '##EF', '##7', ')', 'and', 'RNA', 'polymerase', 'II', 'transcription', 'factor', 'activity', '(', 'e', '.', 'g', '.', ',', 'high', 'mobility', 'group', 'protein', 'HM', '##G', '-', 'I', '/', 'HM', '##G', '-', 'Y', 'and', 'HM', '##GA', '##1', ')', 'GO', 'terms', '(', 'Figure', '7', '##a', ',', 'right', 'plot', ')', '.']	[0, 7, 9, 14, 17, 28, 37, 53, 63, 64, 73, 75, 79, 80, 81, 83, 84, 85, 86, 87, 89, 94, 98, 101, 102, 103, 105, 108, 112, 115, 116, 123, 126, 133, 137, 138, 142, 147, 156, 161, 168, 178, 185, 194, 195, 196, 197, 198, 199, 201, 204, 205, 207, 210, 211, 213, 216, 218, 219, 221, 224, 226, 228, 232, 236, 245, 246, 247, 248, 249, 250, 252, 254, 256, 257, 261, 266, 270, 272, 274, 276, 277, 279, 281, 289, 298, 303, 305, 316, 325, 341, 351, 352, 361, 363, 367, 368, 370, 375, 384, 389, 390, 391, 399, 407, 416, 426, 434, 435, 436, 437, 438, 439, 441, 444, 450, 461, 464, 468, 479, 487, 488, 490, 492, 495, 496, 498, 502, 506, 510, 521, 530, 537, 538, 540, 542, 544, 546, 547, 549, 553, 557, 568, 571, 585, 592, 601, 602, 603, 604, 605, 606, 608, 613, 622, 628, 636, 638, 639, 640, 641, 642, 644, 645, 646, 648, 652, 654, 656, 657, 659, 662, 668, 669, 676, 677, 678, 680, 686, 690, 691]	[7, 8, 13, 16, 27, 36, 52, 62, 64, 72, 74, 78, 80, 81, 82, 84, 85, 86, 87, 88, 93, 97, 100, 102, 103, 104, 107, 111, 115, 116, 123, 125, 133, 137, 138, 141, 146, 155, 160, 167, 177, 184, 193, 195, 196, 197, 198, 199, 200, 204, 205, 206, 210, 211, 212, 216, 218, 219, 220, 224, 226, 227, 231, 235, 244, 246, 247, 248, 249, 250, 251, 254, 256, 257, 260, 266, 269, 272, 273, 276, 277, 279, 280, 288, 297, 302, 304, 315, 324, 340, 350, 352, 360, 362, 366, 368, 369, 374, 383, 388, 390, 391, 398, 406, 415, 425, 433, 435, 436, 437, 438, 439, 440, 443, 449, 460, 464, 467, 478, 486, 488, 489, 492, 495, 496, 497, 501, 506, 509, 520, 529, 536, 538, 539, 542, 544, 546, 547, 548, 552, 556, 567, 570, 584, 591, 600, 602, 603, 604, 605, 606, 607, 612, 621, 627, 635, 638, 639, 640, 641, 642, 644, 645, 646, 647, 651, 654, 656, 657, 658, 661, 667, 669, 675, 677, 678, 679, 685, 690, 691, 692]	['Clusters', 'with', 'an', 'increasing', 'temporal', 'phosphorylation', 'profiling', '(', 'clusters', '1', 'and', '8', ')', ',', 'i.e', '.', ',', 'from', 'PRE', 'to', '8D', ',', 'in', 'the', 'non', '-', 'responder', 'phosphoproteome', 'were', 'enriched', 'with', 'cyclin', 'dependent', 'kinase', 'activity', '(', 'e.g', '.', ',', 'CDK1', ',', 'CDK2', ',', 'CDK11B', ',', 'CDK12', ')', 'and', 'RNA', 'splicing', '(', 'e.g', '.', ',', 'DEAH-box', 'helicase', '16', ',', 'DHX16', ')', 'whereas', 'clusters', 'with', 'a', 'decreasing', 'temporal', 'phosphorylation', 'profiling', '(', 'clusters', '2', 'and', '5', ')', 'were', 'enriched', 'with', 'G', '-', 'protein', 'coupled', 'receptor', 'signaling', 'pathway', '(', 'e.g', '.', ',', 'IQ', 'motif', 'containing', 'GTPase', 'activating', 'protein', '2', ',', 'IGGAP2', ';', 'Rho', 'guanine', 'nucleotide', 'exchange', 'factor', '7', ',', 'ARHGEF7', ')', 'and', 'RNA', 'polymerase', 'II', 'transcription', 'factor', 'activity', '(', 'e.g', '.', ',', 'high', 'mobility', 'group', 'protein', 'HMG-I', '/', 'HMG-Y', 'and', 'HMGA1', ')', 'GO', 'terms', '(', 'Figure', '7a', ',', 'right', 'plot', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 4, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters with the highest protein phosphorylation at 3D (cluster 3, 4 and 6) were enriched with RNA splicing, protein–DNA complex assembly (e.g., H1.4 linker histone, cluster member, H1-4; heterochromatin protein 1 binding protein 3, HP1BP3; remodeling and spacing factor 1, Rsf-1, RSF1) and the sites of the DNA damage (e.g., replication timing regulatory factor 1, RIF1) GO terms, whereas clusters with the lowest protein phosphorylation at 3D (clusters 7, 9 and 10) were enriched with a negative regulation of the cellular catabolic process (e.g., PML, dyskerin pseudouridine synthase 1, DKC1), nuclear chromosome, telomeric region and the negative regulation of T cell activation (e.g., CD74 molecule, CD74; sialophorin, SPN) when compared to pre-treatment and 8D conditions.	[('PMC8125016', 'R34000', 556, 589, 'dyskerin pseudouridine synthase 1')]	['Cluster', '##s', 'with', 'the', 'highest', 'protein', 'phosphorylation', 'at', '3', '##D', '(', 'cluster', '3', ',', '4', 'and', '6', ')', 'were', 'enriched', 'with', 'RNA', 'splicing', ',', 'protein', '–', 'DNA', 'complex', 'assembly', '(', 'e', '.', 'g', '.', ',', 'H', '##1', '.', '4', 'linker', 'histone', ',', 'cluster', 'member', ',', 'H', '##1', '-', '4', ';', 'heter', '##ochrom', '##atin', 'protein', '1', 'binding', 'protein', '3', ',', 'HP', '##1', '##BP', '##3', ';', 'remodeling', 'and', 'spacing', 'factor', '1', ',', 'Rs', '##f', '-', '1', ',', 'RS', '##F', '##1', ')', 'and', 'the', 'sites', 'of', 'the', 'DNA', 'damage', '(', 'e', '.', 'g', '.', ',', 'replication', 'timing', 'regulatory', 'factor', '1', ',', 'RI', '##F', '##1', ')', 'GO', 'terms', ',', 'whereas', 'clusters', 'with', 'the', 'lowest', 'protein', 'phosphorylation', 'at', '3', '##D', '(', 'clusters', '7', ',', '9', 'and', '10', ')', 'were', 'enriched', 'with', 'a', 'negative', 'regulation', 'of', 'the', 'cellular', 'cat', '##abolic', 'process', '(', 'e', '.', 'g', '.', ',', 'PM', '##L', ',', 'dys', '##ker', '##in', 'pseudo', '##uri', '##din', '##e', 'synthase', '1', ',', 'DK', '##C', '##1', ')', ',', 'nuclear', 'chromosome', ',', 'telom', '##eric', 'region', 'and', 'the', 'negative', 'regulation', 'of', 'T', 'cell', 'activation', '(', 'e', '.', 'g', '.', ',', 'CD', '##74', 'molecule', ',', 'CD', '##74', ';', 'sial', '##oph', '##ori', '##n', ',', 'SP', '##N', ')', 'when', 'compared', 'to', 'pre', '-', 'treatment', 'and', '8', '##D', 'conditions', '.']	[0, 7, 9, 14, 18, 26, 34, 50, 53, 54, 56, 57, 65, 66, 68, 70, 74, 75, 77, 82, 91, 96, 100, 108, 110, 117, 118, 122, 130, 139, 140, 141, 142, 143, 144, 146, 147, 148, 149, 151, 158, 165, 167, 175, 181, 183, 184, 185, 186, 187, 189, 194, 200, 205, 213, 215, 223, 231, 232, 234, 236, 237, 239, 240, 242, 253, 257, 265, 272, 273, 275, 277, 278, 279, 280, 282, 284, 285, 286, 288, 292, 296, 302, 305, 309, 313, 320, 321, 322, 323, 324, 325, 327, 339, 346, 357, 364, 365, 367, 369, 370, 371, 373, 376, 381, 383, 391, 400, 405, 409, 416, 424, 440, 443, 444, 446, 447, 456, 457, 459, 461, 465, 467, 469, 474, 483, 488, 490, 499, 510, 513, 517, 526, 529, 536, 544, 545, 546, 547, 548, 549, 551, 553, 554, 556, 559, 562, 565, 571, 574, 577, 579, 588, 589, 591, 593, 594, 595, 596, 598, 606, 616, 618, 623, 628, 635, 639, 643, 652, 663, 666, 668, 673, 684, 685, 686, 687, 688, 689, 691, 693, 696, 704, 706, 708, 710, 712, 716, 719, 722, 723, 725, 727, 728, 730, 735, 744, 747, 750, 751, 761, 765, 766, 768, 778]	[7, 8, 13, 17, 25, 33, 49, 52, 54, 55, 57, 64, 66, 67, 69, 73, 75, 76, 81, 90, 95, 99, 108, 109, 117, 118, 121, 129, 138, 140, 141, 142, 143, 144, 145, 147, 148, 149, 150, 157, 165, 166, 174, 181, 182, 184, 185, 186, 187, 188, 194, 200, 204, 212, 214, 222, 230, 232, 233, 236, 237, 239, 240, 241, 252, 256, 264, 271, 273, 274, 277, 278, 279, 280, 281, 284, 285, 286, 287, 291, 295, 301, 304, 308, 312, 319, 321, 322, 323, 324, 325, 326, 338, 345, 356, 363, 365, 366, 369, 370, 371, 372, 375, 381, 382, 390, 399, 404, 408, 415, 423, 439, 442, 444, 445, 447, 455, 457, 458, 460, 464, 467, 468, 473, 482, 487, 489, 498, 509, 512, 516, 525, 529, 535, 543, 545, 546, 547, 548, 549, 550, 553, 554, 555, 559, 562, 564, 571, 574, 577, 578, 587, 589, 590, 593, 594, 595, 596, 597, 605, 616, 617, 623, 627, 634, 638, 642, 651, 662, 665, 667, 672, 683, 685, 686, 687, 688, 689, 690, 693, 695, 704, 705, 708, 710, 711, 716, 719, 722, 723, 724, 727, 728, 729, 734, 743, 746, 750, 751, 760, 764, 766, 767, 778, 779]	['Clusters', 'with', 'the', 'highest', 'protein', 'phosphorylation', 'at', '3D', '(', 'cluster', '3', ',', '4', 'and', '6', ')', 'were', 'enriched', 'with', 'RNA', 'splicing', ',', 'protein', '–', 'DNA', 'complex', 'assembly', '(', 'e.g', '.', ',', 'H1.4', 'linker', 'histone', ',', 'cluster', 'member', ',', 'H1-4', ';', 'heterochromatin', 'protein', '1', 'binding', 'protein', '3', ',', 'HP1BP3', ';', 'remodeling', 'and', 'spacing', 'factor', '1', ',', 'Rsf-1', ',', 'RSF1', ')', 'and', 'the', 'sites', 'of', 'the', 'DNA', 'damage', '(', 'e.g', '.', ',', 'replication', 'timing', 'regulatory', 'factor', '1', ',', 'RIF1', ')', 'GO', 'terms', ',', 'whereas', 'clusters', 'with', 'the', 'lowest', 'protein', 'phosphorylation', 'at', '3D', '(', 'clusters', '7', ',', '9', 'and', '10', ')', 'were', 'enriched', 'with', 'a', 'negative', 'regulation', 'of', 'the', 'cellular', 'catabolic', 'process', '(', 'e.g', '.', ',', 'PML', ',', 'dyskerin', 'pseudouridine', 'synthase', '1', ',', 'DKC1', ')', ',', 'nuclear', 'chromosome', ',', 'telomeric', 'region', 'and', 'the', 'negative', 'regulation', 'of', 'T', 'cell', 'activation', '(', 'e.g', '.', ',', 'CD74', 'molecule', ',', 'CD74', ';', 'sialophorin', ',', 'SPN', ')', 'when', 'compared', 'to', 'pre', '-', 'treatment', 'and', '8D', 'conditions', '.']	[2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 3, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several phosphosites on proteins belonging to the metabolism of RNA Reactome pathway (e.g., EIF4G1 S1188; tankyrase 1 binding protein 1, TNKS1BP1, S1666) showed higher phosphorylation at 8D of the ATRA–VP–TP treatment when compared to the pre-treatment condition.	[('PMC8125016', 'R35003', 106, 135, 'tankyrase 1 binding protein 1')]	['Several', 'phospho', '##site', '##s', 'on', 'proteins', 'belonging', 'to', 'the', 'metabolism', 'of', 'RNA', 'Re', '##act', '##ome', 'pathway', '(', 'e', '.', 'g', '.', ',', 'EI', '##F', '##4', '##G', '##1', 'S', '##118', '##8', ';', 'tank', '##yr', '##ase', '1', 'binding', 'protein', '1', ',', 'TN', '##KS', '##1', '##BP', '##1', ',', 'S', '##166', '##6', ')', 'showed', 'higher', 'phosphorylation', 'at', '8', '##D', 'of', 'the', 'AT', '##RA', '–', 'VP', '–', 'TP', 'treatment', 'when', 'compared', 'to', 'the', 'pre', '-', 'treatment', 'condition', '.']	[0, 8, 15, 19, 21, 24, 33, 43, 46, 50, 61, 64, 68, 70, 73, 77, 85, 86, 87, 88, 89, 90, 92, 94, 95, 96, 97, 99, 100, 103, 104, 106, 110, 112, 116, 118, 126, 134, 135, 137, 139, 141, 142, 144, 145, 147, 148, 151, 152, 154, 161, 168, 184, 187, 188, 190, 193, 197, 199, 201, 202, 204, 205, 208, 218, 223, 232, 235, 239, 242, 243, 253, 262]	[7, 15, 19, 20, 23, 32, 42, 45, 49, 60, 63, 67, 70, 73, 76, 84, 86, 87, 88, 89, 90, 91, 94, 95, 96, 97, 98, 100, 103, 104, 105, 110, 112, 115, 117, 125, 133, 135, 136, 139, 141, 142, 144, 145, 146, 148, 151, 152, 153, 160, 167, 183, 186, 188, 189, 192, 196, 199, 201, 202, 204, 205, 207, 217, 222, 231, 234, 238, 242, 243, 252, 262, 263]	['Several', 'phosphosites', 'on', 'proteins', 'belonging', 'to', 'the', 'metabolism', 'of', 'RNA', 'Reactome', 'pathway', '(', 'e.g', '.', ',', 'EIF4G1', 'S1188', ';', 'tankyrase', '1', 'binding', 'protein', '1', ',', 'TNKS1BP1', ',', 'S1666', ')', 'showed', 'higher', 'phosphorylation', 'at', '8D', 'of', 'the', 'ATRA', '–', 'VP', '–', 'TP', 'treatment', 'when', 'compared', 'to', 'the', 'pre', '-', 'treatment', 'condition', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 5, 3, 1, 3, 1, 1, 1, 1, 1, 5, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Phosphorylation at EIF4G1 S1188 by PRKCA induces binding to MAPK interacting serine/threonine kinase 1 (MKNK1), an interaction that has been linked to malignant transformation [67].	[('PMC8125016', 'R35005', 60, 102, 'MAPK interacting serine/threonine kinase 1')]	['Phosph', '##orylation', 'at', 'EI', '##F', '##4', '##G', '##1', 'S', '##118', '##8', 'by', 'PR', '##K', '##CA', 'induces', 'binding', 'to', 'MAPK', 'interacting', 'serine', '/', 'thre', '##onine', 'kinase', '1', '(', 'MK', '##NK', '##1', ')', ',', 'an', 'interaction', 'that', 'has', 'been', 'linked', 'to', 'malignant', 'transformation', '[', '67', ']', '.']	[0, 6, 16, 19, 21, 22, 23, 24, 26, 27, 30, 32, 35, 37, 38, 41, 49, 57, 60, 65, 77, 83, 84, 88, 94, 101, 103, 104, 106, 108, 109, 110, 112, 115, 127, 132, 136, 141, 148, 151, 161, 176, 177, 179, 180]	[6, 15, 18, 21, 22, 23, 24, 25, 27, 30, 31, 34, 37, 38, 40, 48, 56, 59, 64, 76, 83, 84, 88, 93, 100, 102, 104, 106, 108, 109, 110, 111, 114, 126, 131, 135, 140, 147, 150, 160, 175, 177, 179, 180, 181]	['Phosphorylation', 'at', 'EIF4G1', 'S1188', 'by', 'PRKCA', 'induces', 'binding', 'to', 'MAPK', 'interacting', 'serine', '/', 'threonine', 'kinase', '1', '(', 'MKNK1', ')', ',', 'an', 'interaction', 'that', 'has', 'been', 'linked', 'to', 'malignant', 'transformation', '[', '67', ']', '.']	[2, 1, 5, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The analysis of kinase substrates using the WebLogo tool found an enrichment of basophilic R/KXpS/pT and the SP motif characteristics of PRKCA/protein kinase C delta and MAPK3/1, respectively, in the 3D-NR and 8D-NR patient samples when compared to the pre-treatment group (Figure 7c, left and middle plot).	[('PMC8125016', 'R36000', 16, 22, 'kinase'), ('PMC8125016', 'R36000', 143, 165, 'protein kinase C delta')]	['The', 'analysis', 'of', 'kinase', 'substrates', 'using', 'the', 'Web', '##Log', '##o', 'tool', 'found', 'an', 'enrichment', 'of', 'bas', '##ophilic', 'R', '/', 'K', '##X', '##p', '##S', '/', 'pT', 'and', 'the', 'SP', 'motif', 'characteristics', 'of', 'PR', '##K', '##CA', '/', 'protein', 'kinase', 'C', 'delta', 'and', 'MAPK', '##3', '/', '1', ',', 'respectively', ',', 'in', 'the', '3', '##D', '-', 'NR', 'and', '8', '##D', '-', 'NR', 'patient', 'samples', 'when', 'compared', 'to', 'the', 'pre', '-', 'treatment', 'group', '(', 'Figure', '7', '##c', ',', 'left', 'and', 'middle', 'plot', ')', '.']	[0, 4, 13, 16, 23, 34, 40, 44, 47, 50, 52, 57, 63, 66, 77, 80, 83, 91, 92, 93, 94, 95, 96, 97, 98, 101, 105, 109, 112, 118, 134, 137, 139, 140, 142, 143, 151, 158, 160, 166, 170, 174, 175, 176, 177, 179, 191, 193, 196, 200, 201, 202, 203, 206, 210, 211, 212, 213, 216, 224, 232, 237, 246, 249, 253, 256, 257, 267, 273, 274, 281, 282, 283, 285, 290, 294, 301, 305, 306]	[3, 12, 15, 22, 33, 39, 43, 47, 50, 51, 56, 62, 65, 76, 79, 83, 90, 92, 93, 94, 95, 96, 97, 98, 100, 104, 108, 111, 117, 133, 136, 139, 140, 142, 143, 150, 157, 159, 165, 169, 174, 175, 176, 177, 178, 191, 192, 195, 199, 201, 202, 203, 205, 209, 211, 212, 213, 215, 223, 231, 236, 245, 248, 252, 256, 257, 266, 272, 274, 280, 282, 283, 284, 289, 293, 300, 305, 306, 307]	['The', 'analysis', 'of', 'kinase', 'substrates', 'using', 'the', 'WebLogo', 'tool', 'found', 'an', 'enrichment', 'of', 'basophilic', 'R', '/', 'KXpS', '/', 'pT', 'and', 'the', 'SP', 'motif', 'characteristics', 'of', 'PRKCA', '/', 'protein', 'kinase', 'C', 'delta', 'and', 'MAPK3', '/', '1', ',', 'respectively', ',', 'in', 'the', '3D-NR', 'and', '8D-NR', 'patient', 'samples', 'when', 'compared', 'to', 'the', 'pre', '-', 'treatment', 'group', '(', 'Figure', '7c', ',', 'left', 'and', 'middle', 'plot', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The acidic SXD/ED/E kinase motif of CSNK2A1 was clearly observed in the 8D-NR when compared to the 3D-NR group (Figure 7c, right plot).	[('PMC8125016', 'R36001', 20, 26, 'kinase')]	['The', 'acidic', 'S', '##X', '##D', '/', 'ED', '/', 'E', 'kinase', 'motif', 'of', 'CS', '##NK', '##2', '##A', '##1', 'was', 'clearly', 'observed', 'in', 'the', '8', '##D', '-', 'NR', 'when', 'compared', 'to', 'the', '3', '##D', '-', 'NR', 'group', '(', 'Figure', '7', '##c', ',', 'right', 'plot', ')', '.']	[0, 4, 11, 12, 13, 14, 15, 17, 18, 20, 27, 33, 36, 38, 40, 41, 42, 44, 48, 56, 65, 68, 72, 73, 74, 75, 78, 83, 92, 95, 99, 100, 101, 102, 105, 111, 112, 119, 120, 121, 123, 129, 133, 134]	[3, 10, 12, 13, 14, 15, 17, 18, 19, 26, 32, 35, 38, 40, 41, 42, 43, 47, 55, 64, 67, 71, 73, 74, 75, 77, 82, 91, 94, 98, 100, 101, 102, 104, 110, 112, 118, 120, 121, 122, 128, 133, 134, 135]	['The', 'acidic', 'SXD', '/', 'ED', '/', 'E', 'kinase', 'motif', 'of', 'CSNK2A1', 'was', 'clearly', 'observed', 'in', 'the', '8D-NR', 'when', 'compared', 'to', 'the', '3D-NR', 'group', '(', 'Figure', '7c', ',', 'right', 'plot', ')', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Taken together, the non-responder group differed from the responders both with regard to the phosphorylation events on the actin/cytoskeleton but also with regard to transcriptional regulation and GTPase/G-protein coupled signaling.	[('PMC8125016', 'R37000', 197, 203, 'GTPase')]	['Taken', 'together', ',', 'the', 'non', '-', 'respond', '##er', 'group', 'differed', 'from', 'the', 'responders', 'both', 'with', 'regard', 'to', 'the', 'phosphorylation', 'events', 'on', 'the', 'actin', '/', 'cytoskeleton', 'but', 'also', 'with', 'regard', 'to', 'transcriptional', 'regulation', 'and', 'GTP', '##ase', '/', 'G', '-', 'protein', 'coupled', 'signaling', '.']	[0, 6, 14, 16, 20, 23, 24, 31, 34, 40, 49, 54, 58, 69, 74, 79, 86, 89, 93, 109, 116, 119, 123, 128, 129, 142, 146, 151, 156, 163, 166, 182, 193, 197, 200, 203, 204, 205, 206, 214, 222, 231]	[5, 14, 15, 19, 23, 24, 31, 33, 39, 48, 53, 57, 68, 73, 78, 85, 88, 92, 108, 115, 118, 122, 128, 129, 141, 145, 150, 155, 162, 165, 181, 192, 196, 200, 203, 204, 205, 206, 213, 221, 231, 232]	['Taken', 'together', ',', 'the', 'non', '-', 'responder', 'group', 'differed', 'from', 'the', 'responders', 'both', 'with', 'regard', 'to', 'the', 'phosphorylation', 'events', 'on', 'the', 'actin', '/', 'cytoskeleton', 'but', 'also', 'with', 'regard', 'to', 'transcriptional', 'regulation', 'and', 'GTPase', '/', 'G', '-', 'protein', 'coupled', 'signaling', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fifty percent of the butyrate-producing isolates were net acetate consumers during growth, suggesting that they employ the butyryl coenzyme A-acetyl coenzyme A transferase pathway for butyrate production.	[('PMC92037', 'A00014', 123, 171, 'butyryl coenzyme A-acetyl coenzyme A transferase')]	['Fifty', 'percent', 'of', 'the', 'but', '##yrate', '-', 'producing', 'isolates', 'were', 'net', 'acetate', 'consumers', 'during', 'growth', ',', 'suggesting', 'that', 'they', 'employ', 'the', 'but', '##yr', '##yl', 'coe', '##n', '##zyme', 'A', '-', 'acetyl', 'coe', '##n', '##zyme', 'A', 'transfer', '##ase', 'pathway', 'for', 'but', '##yrate', 'production', '.']	[0, 6, 14, 17, 21, 24, 29, 30, 40, 49, 54, 58, 66, 76, 83, 89, 91, 102, 107, 112, 119, 123, 126, 128, 131, 134, 135, 140, 141, 142, 149, 152, 153, 158, 160, 168, 172, 180, 184, 187, 193, 203]	[5, 13, 16, 20, 24, 29, 30, 39, 48, 53, 57, 65, 75, 82, 89, 90, 101, 106, 111, 118, 122, 126, 128, 130, 134, 135, 139, 141, 142, 148, 152, 153, 157, 159, 168, 171, 179, 183, 187, 192, 203, 204]	['Fifty', 'percent', 'of', 'the', 'butyrate', '-', 'producing', 'isolates', 'were', 'net', 'acetate', 'consumers', 'during', 'growth', ',', 'suggesting', 'that', 'they', 'employ', 'the', 'butyryl', 'coenzyme', 'A-acetyl', 'coenzyme', 'A', 'transferase', 'pathway', 'for', 'butyrate', 'production', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 3, 3, 1, 2, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Such utilization is consistent with the operation of the butyryl coenzyme A-acetyl coenzyme A transferase route for butyrate synthesis (20).	[('PMC92037', 'D03001', 57, 105, 'butyryl coenzyme A-acetyl coenzyme A transferase')]	['Such', 'utilization', 'is', 'consistent', 'with', 'the', 'operation', 'of', 'the', 'but', '##yr', '##yl', 'coe', '##n', '##zyme', 'A', '-', 'acetyl', 'coe', '##n', '##zyme', 'A', 'transfer', '##ase', 'route', 'for', 'but', '##yrate', 'synthesis', '(', '20', ')', '.']	[0, 5, 17, 20, 31, 36, 40, 50, 53, 57, 60, 62, 65, 68, 69, 74, 75, 76, 83, 86, 87, 92, 94, 102, 106, 112, 116, 119, 125, 135, 136, 138, 139]	[4, 16, 19, 30, 35, 39, 49, 52, 56, 60, 62, 64, 68, 69, 73, 75, 76, 82, 86, 87, 91, 93, 102, 105, 111, 115, 119, 124, 134, 136, 138, 139, 140]	['Such', 'utilization', 'is', 'consistent', 'with', 'the', 'operation', 'of', 'the', 'butyryl', 'coenzyme', 'A-acetyl', 'coenzyme', 'A', 'transferase', 'route', 'for', 'butyrate', 'synthesis', '(', '20', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 3, 3, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The alternative butyrate kinase pathway is known to operate in many Clostridium spp.	[('PMC92037', 'D03008', 16, 31, 'butyrate kinase')]	['The', 'alternative', 'but', '##yrate', 'kinase', 'pathway', 'is', 'known', 'to', 'operate', 'in', 'many', 'Clostr', '##idium', 'spp', '.']	[0, 4, 16, 19, 25, 32, 40, 43, 49, 52, 60, 63, 68, 74, 80, 83]	[3, 15, 19, 24, 31, 39, 42, 48, 51, 59, 62, 67, 74, 79, 83, 84]	['The', 'alternative', 'butyrate', 'kinase', 'pathway', 'is', 'known', 'to', 'operate', 'in', 'many', 'Clostridium', 'spp', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lawson P A, Gharbia S E, Shah H N, Clark D R. Intrageneric relationships of members of the genus Fusobacterium as determined by reverse transcriptase sequencing of small-subunit rRNA.	[('PMC92037', 'F27001', 128, 149, 'reverse transcriptase')]	['Law', '##son', 'P', 'A', ',', 'Gh', '##arb', '##ia', 'S', 'E', ',', 'Shah', 'H', 'N', ',', 'Clark', 'D', 'R', '.', 'Intra', '##gener', '##ic', 'relationships', 'of', 'members', 'of', 'the', 'genus', 'Fus', '##obacterium', 'as', 'determined', 'by', 'reverse', 'transcriptase', 'sequencing', 'of', 'small', '-', 'subunit', 'rRNA', '.']	[0, 3, 7, 9, 10, 12, 14, 17, 20, 22, 23, 25, 30, 32, 33, 35, 41, 43, 44, 46, 51, 56, 59, 73, 76, 84, 87, 91, 97, 100, 111, 114, 125, 128, 136, 150, 161, 164, 169, 170, 178, 182]	[3, 6, 8, 10, 11, 14, 17, 19, 21, 23, 24, 29, 31, 33, 34, 40, 42, 44, 45, 51, 56, 58, 72, 75, 83, 86, 90, 96, 100, 110, 113, 124, 127, 135, 149, 160, 163, 169, 170, 177, 182, 183]	['Lawson', 'P', 'A', ',', 'Gharbia', 'S', 'E', ',', 'Shah', 'H', 'N', ',', 'Clark', 'D', 'R', '.', 'Intrageneric', 'relationships', 'of', 'members', 'of', 'the', 'genus', 'Fusobacterium', 'as', 'determined', 'by', 'reverse', 'transcriptase', 'sequencing', 'of', 'small', '-', 'subunit', 'rRNA', '.']	[2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Three microliters of 20-mg/ml proteinase K and 30 μl of 10% (wt/vol) sodium dodecyl sulfate were added, and the solution was mixed and incubated for 1 h at 37°C.	[('PMC92037', 'M04003', 30, 42, 'proteinase K')]	['Three', 'microl', '##iter', '##s', 'of', '20', '-', 'mg', '/', 'ml', 'protein', '##ase', 'K', 'and', '30', 'μ', '##l', 'of', '10', '%', '(', 'wt', '/', 'vol', ')', 'sodium', 'dodecyl', 'sulfate', 'were', 'added', ',', 'and', 'the', 'solution', 'was', 'mixed', 'and', 'incubated', 'for', '1', 'h', 'at', '37°', '##C', '.']	[0, 6, 12, 16, 18, 21, 23, 24, 26, 27, 30, 37, 41, 43, 47, 50, 51, 53, 56, 58, 60, 61, 63, 64, 67, 69, 76, 84, 92, 97, 102, 104, 108, 112, 121, 125, 131, 135, 145, 149, 151, 153, 156, 159, 160]	[5, 12, 16, 17, 20, 23, 24, 26, 27, 29, 37, 40, 42, 46, 49, 51, 52, 55, 58, 59, 61, 63, 64, 67, 68, 75, 83, 91, 96, 102, 103, 107, 111, 120, 124, 130, 134, 144, 148, 150, 152, 155, 159, 160, 161]	['Three', 'microliters', 'of', '20-mg', '/', 'ml', 'proteinase', 'K', 'and', '30', 'μl', 'of', '10%', '(', 'wt', '/', 'vol', ')', 'sodium', 'dodecyl', 'sulfate', 'were', 'added', ',', 'and', 'the', 'solution', 'was', 'mixed', 'and', 'incubated', 'for', '1', 'h', 'at', '37°C', '.']	[1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Muyzer G, de Waal E C, Uitterlinden A G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA.	[('PMC92614', 'F26001', 139, 149, 'polymerase')]	['Mu', '##yz', '##er', 'G', ',', 'de', 'Wa', '##al', 'E', 'C', ',', 'Ui', '##tte', '##r', '##lin', '##den', 'A', 'G', '.', 'Prof', '##iling', 'of', 'complex', 'microbial', 'populations', 'by', 'den', '##aturing', 'gradient', 'gel', 'electrophoresis', 'analysis', 'of', 'polymerase', 'chain', 'reaction', '-', 'amplified', 'genes', 'coding', 'for', '16', '##S', 'rRNA', '.']	[0, 2, 4, 7, 8, 10, 13, 15, 18, 20, 21, 23, 25, 28, 29, 32, 36, 38, 39, 41, 45, 51, 54, 62, 72, 84, 87, 90, 98, 107, 111, 127, 136, 139, 150, 156, 164, 165, 175, 181, 188, 192, 194, 196, 200]	[2, 4, 6, 8, 9, 12, 15, 17, 19, 21, 22, 25, 28, 29, 32, 35, 37, 39, 40, 45, 50, 53, 61, 71, 83, 86, 90, 97, 106, 110, 126, 135, 138, 149, 155, 164, 165, 174, 180, 187, 191, 194, 195, 200, 201]	['Muyzer', 'G', ',', 'de', 'Waal', 'E', 'C', ',', 'Uitterlinden', 'A', 'G', '.', 'Profiling', 'of', 'complex', 'microbial', 'populations', 'by', 'denaturing', 'gradient', 'gel', 'electrophoresis', 'analysis', 'of', 'polymerase', 'chain', 'reaction', '-', 'amplified', 'genes', 'coding', 'for', '16S', 'rRNA', '.']	[3, 1, 1, 1, 2, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Roy D, Ward P, Champagne G. Differentiation of bifidobacteria by use of pulsed-field gel electrophoresis and polymerase chain reaction.	[('PMC92614', 'F32001', 109, 119, 'polymerase')]	['Roy', 'D', ',', 'Ward', 'P', ',', 'Cham', '##pa', '##gn', '##e', 'G', '.', 'Different', '##iation', 'of', 'bif', '##ido', '##ba', '##ct', '##eri', '##a', 'by', 'use', 'of', 'pulsed', '-', 'field', 'gel', 'electrophoresis', 'and', 'polymerase', 'chain', 'reaction', '.']	[0, 4, 5, 7, 12, 13, 15, 19, 21, 23, 25, 26, 28, 37, 44, 47, 50, 53, 55, 57, 60, 62, 65, 69, 72, 78, 79, 85, 89, 105, 109, 120, 126, 134]	[3, 5, 6, 11, 13, 14, 19, 21, 23, 24, 26, 27, 37, 43, 46, 50, 53, 55, 57, 60, 61, 64, 68, 71, 78, 79, 84, 88, 104, 108, 119, 125, 134, 135]	['Roy', 'D', ',', 'Ward', 'P', ',', 'Champagne', 'G', '.', 'Differentiation', 'of', 'bifidobacteria', 'by', 'use', 'of', 'pulsed', '-', 'field', 'gel', 'electrophoresis', 'and', 'polymerase', 'chain', 'reaction', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O']
PCRs were performed using a Taq DNA polymerase kit from Life Technologies (Gaithersburg, Md.).	[('PMC92614', 'M04000', 28, 46, 'Taq DNA polymerase')]	['PCR', '##s', 'were', 'performed', 'using', 'a', 'Taq', 'DNA', 'polymerase', 'kit', 'from', 'Life', 'Technologies', '(', 'Ga', '##ither', '##s', '##burg', ',', 'M', '##d', '.', ')', '.']	[0, 3, 5, 10, 20, 26, 28, 32, 36, 47, 51, 56, 61, 74, 75, 77, 82, 83, 87, 89, 90, 91, 92, 93]	[3, 4, 9, 19, 25, 27, 31, 35, 46, 50, 55, 60, 73, 75, 77, 82, 83, 87, 88, 90, 91, 92, 93, 94]	['PCRs', 'were', 'performed', 'using', 'a', 'Taq', 'DNA', 'polymerase', 'kit', 'from', 'Life', 'Technologies', '(', 'Gaithersburg', ',', 'Md', '.', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The reaction mixture consisted of 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 3 mM MgCl2, 0.2 mM deoxynucleoside triphosphate (dNTP), a 0.2 μM concentration of each primer, 1.25 U of Taq polymerase, and 1 μl of appropriately diluted template DNA in a final volume of 50 μl.	[('PMC92614', 'M04001', 175, 189, 'Taq polymerase')]	['The', 'reaction', 'mixture', 'consisted', 'of', '20', 'mM', 'Tris', '-', 'HCl', '(', 'pH', '8', '.', '4', ')', ',', '50', 'mM', 'KCl', ',', '3', 'mM', 'MgCl', '##2', ',', '0', '.', '2', 'mM', 'deoxy', '##nucle', '##oside', 'trip', '##ho', '##sp', '##hat', '##e', '(', 'd', '##NT', '##P', ')', ',', 'a', '0', '.', '2', 'μ', '##M', 'concentration', 'of', 'each', 'primer', ',', '1', '.', '25', 'U', 'of', 'Taq', 'polymerase', ',', 'and', '1', 'μ', '##l', 'of', 'appropriately', 'diluted', 'template', 'DNA', 'in', 'a', 'final', 'volume', 'of', '50', 'μ', '##l', '.']	[0, 4, 13, 21, 31, 34, 37, 40, 44, 45, 49, 50, 53, 54, 55, 56, 57, 59, 62, 65, 68, 70, 72, 75, 79, 80, 82, 83, 84, 86, 89, 94, 99, 105, 109, 111, 113, 116, 118, 119, 120, 122, 123, 124, 126, 128, 129, 130, 132, 133, 135, 149, 152, 157, 163, 165, 166, 167, 170, 172, 175, 179, 189, 191, 195, 197, 198, 200, 203, 217, 225, 234, 238, 241, 243, 249, 256, 259, 262, 263, 264]	[3, 12, 20, 30, 33, 36, 39, 44, 45, 48, 50, 52, 54, 55, 56, 57, 58, 61, 64, 68, 69, 71, 74, 79, 80, 81, 83, 84, 85, 88, 94, 99, 104, 109, 111, 113, 116, 117, 119, 120, 122, 123, 124, 125, 127, 129, 130, 131, 133, 134, 148, 151, 156, 163, 164, 166, 167, 169, 171, 174, 178, 189, 190, 194, 196, 198, 199, 202, 216, 224, 233, 237, 240, 242, 248, 255, 258, 261, 263, 264, 265]	['The', 'reaction', 'mixture', 'consisted', 'of', '20', 'mM', 'Tris-HCl', '(', 'pH', '8.4', ')', ',', '50', 'mM', 'KCl', ',', '3', 'mM', 'MgCl2', ',', '0.2', 'mM', 'deoxynucleoside', 'triphosphate', '(', 'dNTP', ')', ',', 'a', '0.2', 'μM', 'concentration', 'of', 'each', 'primer', ',', '1.25', 'U', 'of', 'Taq', 'polymerase', ',', 'and', '1', 'μl', 'of', 'appropriately', 'diluted', 'template', 'DNA', 'in', 'a', 'final', 'volume', 'of', '50', 'μl', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 5, 1, 3, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In PCR with primers 7-f and 1510-r, the dNTP concentration was increased to 0.3 mM and the amount of Taq polymerase was increased to 1.5 U.	[('PMC92614', 'M04002', 101, 115, 'Taq polymerase')]	['In', 'PCR', 'with', 'primers', '7', '-', 'f', 'and', '151', '##0', '-', 'r', ',', 'the', 'd', '##NT', '##P', 'concentration', 'was', 'increased', 'to', '0', '.', '3', 'mM', 'and', 'the', 'amount', 'of', 'Taq', 'polymerase', 'was', 'increased', 'to', '1', '.', '5', 'U', '.']	[0, 3, 7, 12, 20, 21, 22, 24, 28, 31, 32, 33, 34, 36, 40, 41, 43, 45, 59, 63, 73, 76, 77, 78, 80, 83, 87, 91, 98, 101, 105, 116, 120, 130, 133, 134, 135, 137, 138]	[2, 6, 11, 19, 21, 22, 23, 27, 31, 32, 33, 34, 35, 39, 41, 43, 44, 58, 62, 72, 75, 77, 78, 79, 82, 86, 90, 97, 100, 104, 115, 119, 129, 132, 134, 135, 136, 138, 139]	['In', 'PCR', 'with', 'primers', '7-f', 'and', '1510-r', ',', 'the', 'dNTP', 'concentration', 'was', 'increased', 'to', '0.3', 'mM', 'and', 'the', 'amount', 'of', 'Taq', 'polymerase', 'was', 'increased', 'to', '1.5', 'U', '.']	[1, 1, 1, 1, 3, 1, 4, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
RT-PCR was performed with the Geneamp Thermostable rTth Reverse Transcriptase RNA PCR kit (Perkin-Elmer, Norwalk, Conn.).	[('PMC92614', 'M05000', 56, 77, 'Reverse Transcriptase')]	['RT', '-', 'PCR', 'was', 'performed', 'with', 'the', 'Gene', '##amp', 'Thermo', '##stable', 'r', '##T', '##th', 'Reverse', 'Trans', '##cript', '##ase', 'RNA', 'PCR', 'kit', '(', 'Per', '##kin', '-', 'El', '##mer', ',', 'Nor', '##wal', '##k', ',', 'Conn', '.', ')', '.']	[0, 2, 3, 7, 11, 21, 26, 30, 34, 38, 44, 51, 52, 53, 56, 64, 69, 74, 78, 82, 86, 90, 91, 94, 97, 98, 100, 103, 105, 108, 111, 112, 114, 118, 119, 120]	[2, 3, 6, 10, 20, 25, 29, 34, 37, 44, 50, 52, 53, 55, 63, 69, 74, 77, 81, 85, 89, 91, 94, 97, 98, 100, 103, 104, 108, 111, 112, 113, 118, 119, 120, 121]	['RT-PCR', 'was', 'performed', 'with', 'the', 'Geneamp', 'Thermostable', 'rTth', 'Reverse', 'Transcriptase', 'RNA', 'PCR', 'kit', '(', 'Perkin-Elmer', ',', 'Norwalk', ',', 'Conn', '.', ')', '.']	[3, 1, 1, 1, 1, 2, 2, 3, 1, 3, 1, 1, 1, 1, 5, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Reverse transcription reaction mixtures (10 μl) consisted of 10 mM Tris-HCl (pH 8.3), 90 mM KCl, 1 mM MnCl2, 0.25 mM dNTP, 0.75 μM primer 1401-r, 1.25 U of recombinant Tth DNA polymerase, and 1 μl of appropriately diluted RNA.	[('PMC92614', 'M05001', 172, 186, 'DNA polymerase')]	['Reverse', 'transcription', 'reaction', 'mixtures', '(', '10', 'μ', '##l', ')', 'consisted', 'of', '10', 'mM', 'Tris', '-', 'HCl', '(', 'pH', '8', '.', '3', ')', ',', '90', 'mM', 'KCl', ',', '1', 'mM', 'Mn', '##Cl', '##2', ',', '0', '.', '25', 'mM', 'd', '##NT', '##P', ',', '0', '.', '75', 'μ', '##M', 'primer', '140', '##1', '-', 'r', ',', '1', '.', '25', 'U', 'of', 'recombinant', 'T', '##th', 'DNA', 'polymerase', ',', 'and', '1', 'μ', '##l', 'of', 'appropriately', 'diluted', 'RNA', '.']	[0, 8, 22, 31, 40, 41, 44, 45, 46, 48, 58, 61, 64, 67, 71, 72, 76, 77, 80, 81, 82, 83, 84, 86, 89, 92, 95, 97, 99, 102, 104, 106, 107, 109, 110, 111, 114, 117, 118, 120, 121, 123, 124, 125, 128, 129, 131, 138, 141, 142, 143, 144, 146, 147, 148, 151, 153, 156, 168, 169, 172, 176, 186, 188, 192, 194, 195, 197, 200, 214, 222, 225]	[7, 21, 30, 39, 41, 43, 45, 46, 47, 57, 60, 63, 66, 71, 72, 75, 77, 79, 81, 82, 83, 84, 85, 88, 91, 95, 96, 98, 101, 104, 106, 107, 108, 110, 111, 113, 116, 118, 120, 121, 122, 124, 125, 127, 129, 130, 137, 141, 142, 143, 144, 145, 147, 148, 150, 152, 155, 167, 169, 171, 175, 186, 187, 191, 193, 195, 196, 199, 213, 221, 225, 226]	['Reverse', 'transcription', 'reaction', 'mixtures', '(', '10', 'μl', ')', 'consisted', 'of', '10', 'mM', 'Tris-HCl', '(', 'pH', '8.3', ')', ',', '90', 'mM', 'KCl', ',', '1', 'mM', 'MnCl2', ',', '0.25', 'mM', 'dNTP', ',', '0.75', 'μM', 'primer', '1401-r', ',', '1.25', 'U', 'of', 'recombinant', 'Tth', 'DNA', 'polymerase', ',', 'and', '1', 'μl', 'of', 'appropriately', 'diluted', 'RNA', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 3, 2, 1, 4, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sequencing was performed with the Sequenase sequencing kit (Amersham, Slough, United Kingdom) according to manufacturer's instructions.	[('PMC92614', 'M09001', 34, 43, 'Sequenase')]	"['Sequencing', 'was', 'performed', 'with', 'the', 'Sequ', '##ena', '##se', 'sequencing', 'kit', '(', 'Amer', '##sh', '##am', ',', 'Slo', '##ugh', ',', 'United', 'Kingdom', ')', 'according', 'to', 'manufacturer', ""'"", 's', 'instructions', '.']"	[0, 11, 15, 25, 30, 34, 38, 41, 44, 55, 59, 60, 64, 66, 68, 70, 73, 76, 78, 85, 92, 94, 104, 107, 119, 120, 122, 134]	[10, 14, 24, 29, 33, 38, 41, 43, 54, 58, 60, 64, 66, 68, 69, 73, 76, 77, 84, 92, 93, 103, 106, 119, 120, 121, 134, 135]	"['Sequencing', 'was', 'performed', 'with', 'the', 'Sequenase', 'sequencing', 'kit', '(', 'Amersham', ',', 'Slough', ',', 'United', 'Kingdom', ')', 'according', 'to', ""manufacturer's"", 'instructions', '.']"	[1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
